<SEC-DOCUMENT>0001140361-23-012418.txt : 20230320
<SEC-HEADER>0001140361-23-012418.hdr.sgml : 20230320
<ACCEPTANCE-DATETIME>20230320063136
ACCESSION NUMBER:		0001140361-23-012418
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		114
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230320
DATE AS OF CHANGE:		20230320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eterna Therapeutics Inc.
		CENTRAL INDEX KEY:			0000748592
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				311103425
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		23744892

	BUSINESS ADDRESS:	
		STREET 1:		1035 CAMBRIDGE STREET
		STREET 2:		SUITE 18A
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
		BUSINESS PHONE:		(212) 582-1199

	MAIL ADDRESS:	
		STREET 1:		10531 4S COMMONS DRIVE
		STREET 2:		SUITE 166-550
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92127

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Brooklyn ImmunoTherapeutics, Inc.
		DATE OF NAME CHANGE:	20210325

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN BUZZTIME INC
		DATE OF NAME CHANGE:	20051230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>brhc10049677_10k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:erna="http://eternatx.com/20221231" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="background-color: #ffffff; color: #000000;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_e05c6b7ffe0743eb9882dd8f0e4569f5" contextRef="c20220101to20221231" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" id="Fact_2412ca9c247947aa9179e55ffcb0d40b" contextRef="c20220101to20221231" format="ixt:date-month-day">12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" id="Fact_33138cc39c2d49a0abf5aafdaeda9a21" contextRef="c20220101to20221231">2022</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" id="Fact_ce9465e70644499caac3b66eeab6d267" contextRef="c20220101to20221231">FY</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_835746ea76014b48a6c77b86f596f30f" contextRef="c20220101to20221231">0000748592</ix:nonNumeric><ix:nonNumeric name="dei:AuditorName" id="Fact_c4417aff140a4c9c8ba87a360a3b0175" contextRef="c20210101to20211231">Marcum LLP</ix:nonNumeric><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_cd1a85f5a00d40e2a9ec630f5346c135" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember">P5Y6M</ix:nonNumeric><ix:nonFraction name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" id="Fact_abe396817a904d8ea2336e844b48953a" contextRef="c20210325to20210325" unitRef="U005" decimals="INF">0.5</ix:nonFraction><ix:nonFraction name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" id="Fact_9ec8b708b2c6467a940f0725195187c5" contextRef="c20220921to20220921" unitRef="U005" decimals="2">0.05</ix:nonFraction><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_1f3e03cde5674ee69b274ec5dc980a3c" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">P5Y6M</ix:nonNumeric><ix:nonNumeric name="erna:LicenseAgreementExtensionTerm" id="Fact_5dfb948eb44f4984b296bd33047f7cfb" contextRef="c20220101to20221231_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember">P2Y6M</ix:nonNumeric><ix:nonNumeric name="erna:LicenseAgreementExtensionTerm" id="Fact_7c1d5587e87d44e08e7579d3d8b39dd7" contextRef="c20220101to20221231_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember">P2Y6M</ix:nonNumeric><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_d45bfc25257042c4abeb3af3c960c760" contextRef="c20220306to20220306_InvestmentTypeAxis_PIPEInvestorMember">P5Y6M</ix:nonNumeric><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_ead7f34b09d749a6b4ac3742e9967755" contextRef="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorOneMember">P5Y6M</ix:nonNumeric><ix:nonNumeric name="us-gaap:OpenTaxYear" id="Fact_f5787a4f89d441eb816e0f3918c8cfa1" contextRef="c20220101to20221231">2019 2020 2021 2022</ix:nonNumeric><ix:nonNumeric name="dei:AuditorFirmId" id="Fact_171a355144ac40c4a867492ecadd0a91" contextRef="c20220101to20221231">248</ix:nonNumeric><ix:nonNumeric name="dei:AuditorFirmId" id="Fact_d4a22f6ee0d543c686e66a7f41ccef3c" contextRef="c20210101to20211231">688</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="erna-20221231.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220101to20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">erna:CommonUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">erna:CommonUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">erna:CommonUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">erna:CommonUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">erna:CommonUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">erna:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221123_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-23</xbrli:startDate><xbrli:endDate>2022-11-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221202to20221202_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-02</xbrli:startDate><xbrli:endDate>2022-12-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221018"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220921to20220921"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-21</xbrli:startDate><xbrli:endDate>2022-09-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_PropertyPlantAndEquipmentByTypeAxis_LaboratoryAndManufacturingEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">erna:LaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_UnusualOrInfrequentItemAxis_CoronavirusAidReliefAndEconomicSecurityActMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">erna:CoronavirusAidReliefAndEconomicSecurityActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_UnusualOrInfrequentItemAxis_CoronavirusAidReliefAndEconomicSecurityActMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">erna:CoronavirusAidReliefAndEconomicSecurityActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">erna:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">erna:PurchasePriceAllocationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">erna:PurchasePriceAllocationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">erna:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">erna:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">erna:PurchasePriceAllocationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">erna:NTNBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-26</xbrli:startDate><xbrli:endDate>2021-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">erna:NTNBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">erna:NTNBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">erna:NTNBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210701to20210930_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716_OwnershipAxis_CitiusPharmaceuticalsIncMember_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">erna:CitiusPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">erna:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">erna:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">erna:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">erna:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220712_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220309_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-12</xbrli:startDate><xbrli:endDate>2022-07-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230109to20230109_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-09</xbrli:startDate><xbrli:endDate>2023-01-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221229to20221229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-29</xbrli:startDate><xbrli:endDate>2022-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221018_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221018_PledgingPurposeAxis_LetterOfCreditMember_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PledgingPurposeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221018to20221018_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-18</xbrli:startDate><xbrli:endDate>2022-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221231_BalanceSheetLocationAxis_OtherNoncurrentAssetsMember_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190418to20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-18</xbrli:startDate><xbrli:endDate>2019-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221001to20221031_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221008to20221008_RelatedPartyTransactionsByRelatedPartyAxis_ExacisBiotherapeuticsIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ExacisBiotherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-08</xbrli:startDate><xbrli:endDate>2022-10-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20181231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200504_DebtInstrumentAxis_PaycheckProtectionProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:PaycheckProtectionProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_DebtInstrumentAxis_PaycheckProtectionProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:PaycheckProtectionProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221231_DebtInstrumentAxis_PaycheckProtectionProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:PaycheckProtectionProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExclusiveFactorLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221101to20221130_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExclusiveFactorLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221130_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExclusiveFactorLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_LegalEntityAxis_UniversityOfSouthFloridaMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:UniversityOfSouthFloridaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20181101to20181130_TypeOfArrangementAxis_CollaboratorRoyaltyAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:CollaboratorRoyaltyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:InvestorRoyaltyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-22</xbrli:startDate><xbrli:endDate>2021-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20181101to20181130_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:InvestorRoyaltyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">erna:RetirementPlan401KMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20230101_RangeAxis_MaximumMember_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">erna:RetirementPlan401KMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_PlanNameAxis_EquityIncentivePlan2020Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_PlanNameAxis_InducementPlan2021Member_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:InducementPlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_PlanNameAxis_EquityIncentivePlan2020Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AwardTypeAxis_IncentiveStockOptionsMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:IncentiveStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AwardTypeAxis_NonQualifiedStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:NonQualifiedStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221231_PlanNameAxis_InducementPlan2021Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:InducementPlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_PlanNameAxis_InducementPlan2021Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:InducementPlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_PlanNameAxis_EquityIncentivePlan2020Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220501to20220531_AwardTypeAxis_TimeBasedStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:TimeBasedStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220501to20220531_AwardTypeAxis_PerformanceBasedStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:PerformanceBasedStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_InvestmentTypeAxis_PIPEInvestorMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221202to20221202_InvestmentTypeAxis_PIPEInvestorOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-02</xbrli:startDate><xbrli:endDate>2022-12-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220306to20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-06</xbrli:startDate><xbrli:endDate>2022-03-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember_InvestmentTypeAxis_PIPEInvestorOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-23</xbrli:startDate><xbrli:endDate>2022-11-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306to20220306_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-06</xbrli:startDate><xbrli:endDate>2022-03-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220714to20220714_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-14</xbrli:startDate><xbrli:endDate>2022-07-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221231_InvestmentTypeAxis_PIPEInvestorMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220601to20220630_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_ClassOfWarrantOrRightAxis_November2022WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:November2022WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_ClassOfWarrantOrRightAxis_March2022WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:March2022WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_ClassOfWarrantOrRightAxis_November2022WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:November2022WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_ClassOfWarrantOrRightAxis_March2022WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:March2022WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_March2022WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:March2022WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_November2022WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:November2022WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210426to20210426_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember_TypeOfArrangementAxis_FirstPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:FirstPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-26</xbrli:startDate><xbrli:endDate>2021-04-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210526to20210526_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:SecondPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-26</xbrli:startDate><xbrli:endDate>2021-05-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210426to20210426_LegalEntityAxis_LincolnParkCapitalFundLLCMember_TypeOfArrangementAxis_FirstPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:FirstPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-26</xbrli:startDate><xbrli:endDate>2021-04-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221231_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:SecondPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210426_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:SecondPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210426_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210526to20210526_TypeOfArrangementAxis_SecondPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:SecondPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-26</xbrli:startDate><xbrli:endDate>2021-05-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210426to20210426_TypeOfArrangementAxis_FirstPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:FirstPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-26</xbrli:startDate><xbrli:endDate>2021-04-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_TypeOfArrangementAxis_SecondPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:SecondPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_StatementClassOfStockAxis_CommonClassCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_IncomeTaxAuthorityAxis_ForeignCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_IncomeTaxAuthorityAxis_DomesticCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_IncomeTaxAuthorityAxis_ForeignCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230221to20230221_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-21</xbrli:startDate><xbrli:endDate>2023-02-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U001"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U002"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U003"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U004"><xbrli:measure>erna:Patents</xbrli:measure></xbrli:unit><xbrli:unit id="U005"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U006"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U007"><xbrli:measure>erna:Segments</xbrli:measure></xbrli:unit><xbrli:unit id="U008"><xbrli:measure>erna:BoardMember</xbrli:measure></xbrli:unit><xbrli:unit id="U009"><xbrli:measure>erna:Installment</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold; font-family: 'Times New Roman';">UNITED STATES<br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold; font-family: 'Times New Roman';">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 12pt; font-weight: bold; font-family: 'Times New Roman';">Washington, D.C. 20549</div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

        <div>
          <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto; height: 2px; width: 15%; color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto;" /></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 18pt; font-weight: bold; font-family: 'Times New Roman';">Form <ix:nonNumeric name="dei:DocumentType" id="Fact_8ff40d95797942bd9fa79b086471aafa" contextRef="c20220101to20221231">10-K</ix:nonNumeric> <br />
      </div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

        <div>
          <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto; height: 2px; width: 15%; color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto;" /></div>

        <div><span style="font-weight: bold;"> </span></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;">(Mark One)</span><br />
        </div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 27pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: normal;"><ix:nonNumeric name="dei:DocumentAnnualReport" id="Fact_2821c35e756943febc9f4ca49b163084" contextRef="c20220101to20221231" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></span></div>
              </td>

    <td style="vertical-align: top; width: auto;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">
<div>For the Fiscal Year Ended <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_e1123512dd274d8c8b57628d05dd1b78" contextRef="c20220101to20221231" format="ixt:date-monthname-day-year-en">December 31, 2022</ix:nonNumeric></div>

        <div><br />
        </div>

        <div>OR<br />
        </div>

        <div> <br />
        </div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 27pt;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-weight: normal;"><ix:nonNumeric name="dei:DocumentTransitionReport" id="Fact_b8abc9c77cb44053b6d406784b0442c4" contextRef="c20220101to20221231" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></span></div>
              </td>

    <td style="vertical-align: top; width: auto;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
        </div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For the transition period from ________ to ________</div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
        </div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Commission File Number <ix:nonNumeric name="dei:EntityFileNumber" id="Fact_4acf8ec6436b44ed809edf62b3611022" contextRef="c20220101to20221231">1-11460</ix:nonNumeric></div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><img src="image00007.jpg" alt="graphic" /> </div>

        <div>
          <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto; height: 2px; width: 15%; color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto;" /></div>

        <div style="text-align: center; margin-right: 216pt; margin-left: 216pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 24pt; font-weight: bold; font-family: 'Times New Roman';"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_11a87ffe74f54c1e90a2172bf6cdb093" contextRef="c20220101to20221231">Eterna Therapeutics Inc.</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of registrant as specified in its charter)</div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

        <div>
          <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto; height: 2px; width: 15%; color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto;" /></div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_a143b70c877e42c4a7e080b9f5357134" contextRef="c20220101to20221231" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_daad45e37b084094a01ee9ab3e2d151a" contextRef="c20220101to20221231">31-1103425</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(State or Other Jurisdiction of </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Incorporation or Organization)</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(I.R.S. Employer </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_7d15c6b6e097435e889371b8ed2f8741" contextRef="c20220101to20221231">10355 Cambridge Street, Suite 18A,</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_cfd84825eabc4308b77b5b14a4a4aa3e" contextRef="c20220101to20221231">Cambridge</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_ff873037c90b4160aeaccdcc2ade5358" contextRef="c20220101to20221231">MA</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_41f389f4a17947eea2ec2f3e40d9f611" contextRef="c20220101to20221231">02141</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(Address of Principal Executive Offices)</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_cda1b37005af46d49cf4355cca5b3ba0" contextRef="c20220101to20221231">212</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_50fe65c25d2640eabb4031a837059f74" contextRef="c20220101to20221231">582-1199</ix:nonNumeric></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(Registrant&#8217;s telephone number, including Area Code)</div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

        <div>
          <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto; height: 2px; width: 15%; color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto;" /></div>

        <div style="text-align: center; margin-right: 216pt; margin-left: 216pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Title of Each Class</div>
              </div>
            </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Trading Symbol(s)</div>
              </div>
            </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Name of Each Exchange on Which Registered</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_62d2660290e647f2b9fec2ad13fa5469" contextRef="c20220101to20221231">Common Stock, $0.005 par value</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 32%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_a926f36d377a46e49d5518cf21baca43" contextRef="c20220101to20221231">ERNA</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-weight: normal;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_c60506f182794472a675d0397563cebf" contextRef="c20220101to20221231" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span><br />
              </div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes&#160; &#9744; <ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" id="Fact_c32a3335746448a18a869c4f75e56d16" contextRef="c20220101to20221231">No</ix:nonNumeric>&#160; &#9746;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.&#160; Yes&#160; &#9744;&#160; <ix:nonNumeric name="dei:EntityVoluntaryFilers" id="Fact_e60644f741794cabb684d6c583031e9c" contextRef="c20220101to20221231">No</ix:nonNumeric>&#160; &#9746;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act
        of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days.&#160; &#160; <ix:nonNumeric name="dei:EntityCurrentReportingStatus" id="Fact_4b4ca7b09f754c8c9332ca186d838ffe" contextRef="c20220101to20221231">Yes</ix:nonNumeric>&#160; &#9746;&#160; &#160; No&#160; &#9744;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
        405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160; &#160; <ix:nonNumeric name="dei:EntityInteractiveDataCurrent" id="Fact_855ad3b2f36b4b858d43c22c16cbb119" contextRef="c20220101to20221231">Yes</ix:nonNumeric>&#160; &#9746;&#160; &#160; No&#160; &#9744;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
        company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>

      <div style="margin-left: 27pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">


  <tr>

    <td style="width: 50%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">Large accelerated filer&#160; &#9744;</div>
              </td>

    <td style="width: 50%; vertical-align: bottom;">
                <div style="text-align: center; color: rgb(0, 0, 0);">Accelerated filer&#160; &#9744;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:EntityFilerCategory" id="Fact_d9a134672de9430abb440b0c53e3a2b7" contextRef="c20220101to20221231" format="ixt-sec:entityfilercategoryen">Non-accelerated filer</ix:nonNumeric>&#160; &#9746;</div>
              </td>

    <td style="width: 50%; vertical-align: bottom;">
                <div style="text-align: center; color: rgb(0, 0, 0);">Smaller reporting company&#160; <ix:nonNumeric name="dei:EntitySmallBusiness" id="Fact_f856c3f91280438393cc5f4e476dcb10" contextRef="c20220101to20221231" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></div>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 50%; vertical-align: bottom; text-align: center;" rowspan="1">Emerging growth company&#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_9285f17a1cf54d2982dfb47d228734d9" contextRef="c20220101to20221231" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
        any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
<div>Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its
        internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;&#9744;
        </div>
<div><br />
        </div>

        <div>If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. &#9744;</div>

        <div><br />
        </div>

        <div>Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive- based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period
          pursuant to &#167;240.10D- 1(b). <ix:nonNumeric name="dei:IcfrAuditorAttestationFlag" id="Fact_c4821b01d94347b38d990bee31b96bac" contextRef="c20220101to20221231" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

        <div><br />
        </div>

      </div>

      <div style="margin-left: 27pt;">Indicate by check mark whether the registrant is a shell compan<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">y (as defined in Rule 12b-2 of the Act).&#160; </span>&#160; Yes&#160; <ix:nonNumeric name="dei:EntityShellCompany" id="Fact_4d173ca4ef9948cab95514005e26ce4e" contextRef="c20220101to20221231" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric>&#160; &#160; No&#160; &#9746; </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The aggregate market value of the common stock held by non-affiliates of the registrant as of the last business day of the registrant&#8217;s most
        recently completed second fiscal quarter (June 30, 2022), computed by reference to the closing sale price of the common stock on the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) on such date, was approximately $<ix:nonFraction name="dei:EntityPublicFloat" id="Fact_efd98dd7c1d24cadbeac24ad37ced73d" contextRef="c20220630" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">23.8</ix:nonFraction> million. <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">For purposes of this determination shares beneficially owned by executive officers, directors and ten percent stockholders have been excluded, which does not represent an admission by the registrant as
          to the affiliate status of such person</span>.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of March 20, 2023, the registrant had <ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" id="Fact_d79b1192c5f84302896ab803ab3d5f26" contextRef="c20230320" unitRef="U002" decimals="INF" scale="0" format="ixt:num-dot-decimal">5,127,070</ix:nonFraction>
        shares of common stock outstanding.</div>
<div>
      &#160; <br /></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="border-width: 1px medium 4px; border-style: solid none; border-color: black -moz-use-text-color; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; border-image: none; height: 10px; color: rgb(255, 255, 255); background-color: rgb(255, 255, 255); text-align: center; margin-left: auto; margin-right: auto;" /></div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" /></div>

      </div>

      <!--PROfilePageNumberReset%LCR%2%%%--> </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="text-align: center; color: #000000; font-weight: bold;"><a id="TABLEOFCONTENTS"><!--Anchor--></a>TABLE OF CONTENTS</div>

    <div>
      <div style="color: #000000;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Item</div>
            </td>

    <td style="width: 88%; vertical-align: bottom; padding-bottom: 2px;"><br />
            </td>

    <td style="width: 6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: right;" colspan="1">&#160;Page </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Part I</div>
            </td>

    <td style="width: 6%; vertical-align: bottom; text-align: right;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle;">&#160;</td>

    <td style="width: 88%; vertical-align: middle;">&#160;</td>

    <td style="width: 6%; vertical-align: middle; text-align: right;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">1.</div>
            </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#Business">Business</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">&#160;1</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">1A.</div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><a href="#RiskFactors">Risk Factors</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; text-align: right;" colspan="1">24</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">1B.</div>
            </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#UnresolvedStaffComments">Unresolved Staff Comments</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">39</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">2.</div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><a href="#Properties">Properties</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; text-align: right;" colspan="1">39</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">3.</div>
            </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#LegalProceedings">Legal Proceedings<br />
                </a> </div>
            </td>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">39</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">4.</div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><a href="#MineSafetyDisclosures">Mine Safety Disclosures</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; text-align: right;" colspan="1">&#160;40</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 88%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 6%; vertical-align: middle; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Part II</div>
            </td>

    <td style="width: 6%; vertical-align: bottom; text-align: right;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 88%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 6%; vertical-align: middle; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">5.</div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><a href="#MarketforRegistrantsCommo">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></div>
            </td>

    <td style="width: 6%; vertical-align: top; text-align: right;" colspan="1">&#160;41</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">6.</div>
            </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#Reserved">[Reserved]<br />
                </a> </div>
            </td>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">&#160;41</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">7.</div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><a href="#ManagementsDiscussionandA">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></div>
            </td>

    <td style="width: 6%; vertical-align: top; text-align: right;" colspan="1">&#160;41</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">7A.</div>
            </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#QuantitativeandQualitativ">Quantitative and Qualitative Disclosures About Market Risk</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">49</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">8.</div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><a href="#FinancialStatementsandSup">Financial Statements and Supplementary Data</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; text-align: right;" colspan="1">49</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">9.</div>
            </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#ChangesinandDisagreements">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></div>
            </td>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">49</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">9A.</div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><a href="#ControlsandProcedures">Controls and Procedures<br />
                </a> </div>
            </td>

    <td style="width: 6%; vertical-align: top; text-align: right;" colspan="1">&#160;49</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">9B.</div>
            </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#OtherInformation">Other Information</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">&#160;51</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">9C.</div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><a href="#DisclosureRegardingForeig">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; text-align: right;" colspan="1">51</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 88%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 6%; vertical-align: middle; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Part III</div>
            </td>

    <td style="width: 6%; vertical-align: bottom; text-align: right;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 88%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 6%; vertical-align: middle; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">10.</div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><a href="#DirectorsExecutiveOfficer">Directors, Executive Officers and Corporate Governance</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; text-align: right;" colspan="1">52</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">11.</div>
            </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#ExecutiveCompensation">Executive Compensation</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">58</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">12.</div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><a href="#SecurityOwnershipofCertai">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></div>
            </td>

    <td style="width: 6%; vertical-align: top; text-align: right;" colspan="1">&#160;<span style="color: rgb(0, 0, 0);">72</span></td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">13.</div>
            </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#CertainRelationshipsandRe">Certain Relationships and Related Transactions, and Director Independence</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">&#160;<span style="color: rgb(0, 0, 0);">74</span></td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">14.</div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><a href="#PrincipalAccountingFeesan">Principal Accountant Fees and Services</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; text-align: right;" colspan="1">&#160;<span style="color: rgb(0, 0, 0);">77</span></td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 88%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 6%; vertical-align: middle; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Part IV</div>
            </td>

    <td style="width: 6%; vertical-align: bottom; text-align: right;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 88%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 6%; vertical-align: middle; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">15.</div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><a href="#ExhibitsFinancialStatemen">Exhibits and Financial Statement Schedules</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; text-align: right;" colspan="1">&#160;<span style="color: rgb(0, 0, 0);">79</span></td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">16.</div>
            </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#Form10-KSummary">Form 10-K Summary</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">&#160;<span style="color: rgb(0, 0, 0);">81</span></td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 88%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><a href="#SIGNATURES">Signatures<br />
                </a> </div>
            </td>

    <td style="width: 6%; vertical-align: top; text-align: right;" colspan="1">82</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#INDEX">Index to Financial Statements and Schedule</a><br />
              </div>
            </td>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" colspan="1">&#160;<span style="color: rgb(0, 0, 0);">F-1</span></td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">ii</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: center; color: #000000; font-weight: bold;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

      <div style="text-align: center; color: #000000;">&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">This Annual Report on Form 10-K contains &#8220;forward-looking statements&#8221; as that term is defined under the Private Securities Litigation Reform Act of 1995 (&#8220;PSLRA&#8221;), Section 27A of
        the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Forward-looking statements include statements related to future events, results, performance,
        prospects and opportunities, including statements related to our strategic plans and targets, revenue generation, product availability and offerings, capital needs, capital expenditures, industry trends and our financial position. Forward-looking
        statements are based on information currently available to us, on our current expectations, estimates, forecasts, and projections about the industries in which we operate and on the beliefs and assumptions of management. Forward looking statements
        often contain words such as &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;could,&#8221; &#8220;targets,&#8221; &#8220;projects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and similar expressions. In addition, any statements that refer to projections of
        our future financial performance, our anticipated growth and trends in our business, and other characterizations of future events or circumstances, are forward-looking statements. Forward-looking statements by their nature address matters that are,
        to different degrees, subject to risks and uncertainties that could cause actual results to differ materially and adversely from those expressed in any forward-looking statements. For us, particular factors that might cause or contribute to such
        differences include those identified in the &#8220;Summary of Principal Risk Factors&#8221; below and the other risks and uncertainties described in Part I, Item 1A &#8220;Risk Factors&#8221; of this Annual Report on Form 10-K and described in other documents we file from
        time to time with the Securities and Exchange Commission, or SEC, including our Quarterly Reports on Form 10-Q.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Readers are urged not to place undue reliance on the forward-looking statements in this Annual Report on Form 10-K, which speak only as of the date of this Annual Report on Form
        10-K. We are including this cautionary note to make applicable, and take advantage of, the safe harbor provisions of the PSLRA. Except as required by law, we do not undertake, and expressly disclaim any obligation, to disseminate, after the date
        hereof, any updates or revisions to any such forward-looking statements to reflect any change in expectations or events, conditions or circumstances on which any such statements are based.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We believe that the expectations reflected in forward-looking statements in this Annual Report on Form 10-K are based upon reasonable assumptions at the time made. However, given
        the risks and uncertainties, you should not rely on any forward- looking statements as a prediction of actual results, developments or other outcomes. You should read these forward-looking statements with the understanding that we may be unable to
        achieve projected results, developments or other outcomes and that actual results, developments or other outcomes may be materially different from what we expect.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On October 11, 2022 we changed our name from Brooklyn ImmunoTherapeutics, Inc. to Eterna Therapeutics Inc. upon our filing with the Secretary of State of the State of Delaware a
        Certificate of Amendment to our Restated Certificate of Incorporation, as amended. On December 20, 2022, we changed the name of one of our subsidiaries from Brooklyn ImmunoTherapeutics, LLC to Eterna Therapeutics LLC. Unless stated otherwise or the
        context otherwise requires, all references in this Annual Report on Form 10-K to &#8220;Eterna&#8221; refer to Eterna Therapeutics Inc., references to &#8220;Eterna LLC&#8221; refer to Eterna Therapeutics LLC, and references to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; refer to
        Eterna and its consolidated subsidiaries, including Eterna LLC, Novellus, Inc. and Novellus Therapeutics Limited.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">iii</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: center; margin-left: 0.05pt; color: #000000; font-weight: bold;">SUMMARY OF PRINCIPAL RISK FACTORS</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">You should carefully consider the summary of principal risk factors below, together with the more detailed risk factors related to our business and industry described under &#8220;Risk
        Factors&#8221; contained in Item 1A of this Annual Report on Form 10-K. The occurrence of any of the events discussed below could significantly and adversely affect our business, prospects, results of operations, financial condition, and cash flows,
        which could result in a decline in the market price of our common stock.</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">We are substantially dependent on intellectual property we in-licensed from Factor Limited, and expect in the future to continue to depend on in-licensed technology, and if we lose the license to such
                intellectual property or the Exclusive Factor License Agreement is terminated for any reason, our ability to enter into strategic partnerships or develop therapeutics products would be harmed.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">We may not realize the benefits of strategic partnerships that we may form in the future or of potential future product acquisitions of licenses.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">We or our licensors may be subject to claims challenging the inventorship or ownership of the patents and other intellectual property that we own or license now or in the future.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">The failure of our licensees to fulfill their financial obligations with respect to royalty payments under their license agreements or to otherwise perform under their license agreement could have a material
                adverse effect on our business, financial condition and results of operations.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">If conflicts arise between us and our future strategic partners or collaborators, these parties may act in a manner adverse to us and could limit our ability to implement our strategies</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">We expect to incur significant losses for the foreseeable future and may never achieve or maintain profitability.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">We will require substantial additional capital to fund our operations, and if we fail to obtain the necessary financing, we may not be able to pursue our business strategy.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">We may face business disruption and related risks resulting from a resurgence of the novel coronavirus (COVID-19) pandemic, or other similar event,
                which could have a material adverse effect on our business plan.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Our business and operations would suffer in the event of system failures, cyber-attacks or a deficiency in our cyber-security.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">If we fail to comply with applicable laws and regulations, we could become subject to fines or penalties or incur costs that could harm our business.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">If we are not successful in attracting and retaining highly qualified personnel, we may not be able to successfully implement our business strategy.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">If we are unable to obtain and maintain patent and other intellectual property protection, or if the scope of the patent and other intellectual property protection obtained is not sufficiently broad, our
                competitors could develop and commercialize products similar or identical to those derived from our intellectual property, and our ability to achieve profitability may be adversely affected.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">iv</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <!--PROfilePageNumberReset%Num%1%%%-->
      <div style="text-align: center; color: #000000; font-weight: bold;">PART I</div>

      <div>&#160;</div>

      <a id="Business"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54.05pt; vertical-align: top; color: #000000; font-weight: bold;">ITEM 1.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Business</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;"><span style="text-decoration: underline;">About Eterna</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We are a preclinical-stage biopharmaceutical company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines.&#160; We have
        in-licensed a portfolio of over 100 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> and UltraSlice<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> gene-editing proteins, and the ToRNAdo<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> mRNA
        delivery system, which we collectively refer to as our &#8220;mRNA technology platform.&#8221; We plan to develop and advance a pipeline of therapeutic products, both internally and through strategic partnerships, with the near-term focus on deploying our mRNA
        technology platform through strategic partnerships.&#160; We license our mRNA technology platform from Factor Bioscience Limited (&#8220;Factor Limited&#8221;) under an exclusive license agreement.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;"><span style="text-decoration: underline;">Background</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000;"><span style="text-decoration: underline;">Merger with NTN Buzztime, Inc.</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On August 12, 2020, Eterna (then known as NTN Buzztime, Inc.), Eterna LLC (then known as Brooklyn Immunotherapeutics LLC) and BIT Merger Sub, Inc., a wholly owned subsidiary of
        Eterna (&#8220;Merger Sub&#8221;), entered into an agreement and plan of merger and reorganization (the &#8220;Merger Agreement&#8221;), pursuant to which, among other matters, Merger Sub merged with and into Eterna LLC, with Eterna LLC surviving the merger as a wholly
        owned subsidiary of Eterna (the &#8220;Merger&#8221;). The Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which Eterna LLC was deemed the acquiring company for accounting purposes. In March 2021, we sold the NTN
        Buzztime legacy assets to a third party (the &#8220;Disposition&#8221;).</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000;"><span style="text-decoration: underline;">Acquisition of Novellus</span></div>

      <div style="text-align: justify; text-indent: 36pt;"><span style="color: #000000;"> </span><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On July 16, 2021, we completed the acquisition (the &#8220;Novellus Acquisition&#8221;) of Novellus, Inc. (&#8220;Novellus&#8221;) and its subsidiary, Novellus Therapeutics Limited (&#8220;Novellus Limited&#8221;). At
        the time of the acquisition, Novellus was focused on the development of next-generation engineered mesenchymal stem cell therapies using mRNA-based cell reprogramming and gene editing technologies licensed from Factor Bioscience.&#160; As part of the
        Novellus Acquisition, we also acquired 25.0% of the total outstanding equity interests of NoveCite, Inc. (&#8220;NoveCite&#8221;), a corporation focused on developing an allogeneic mesenchymal stem cell product for patients with acute respiratory distress
        syndrome (&#8220;ARDS&#8221;), including from COVID-19.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000;"><span style="text-decoration: underline;">Principal Executive Offices</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our principal executive offices are located at 1035 Cambridge Street, Suite 18A, Cambridge, Massachusetts 02141, and our phone number is (212) 582-1199. We maintain a website at
        www.eternatx.com. Information contained on, or accessible through, our website is not a part of and is not incorporated by reference into this Annual Report on Form 10-K.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;"><span style="text-decoration: underline;">Recent Developments</span></div>

      <div style="text-align: justify;"><span style="color: #000000;"> </span><br />
      </div>

      <div style="text-align: justify; color: #000000;"><span style="text-decoration: underline;">Cell Line Customization and License Agreement</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On February 21, 2023, we entered into a cell line customization and license agreement (the &#8220;Lineage Agreement&#8221;) with Lineage Cell
        Therapeutics, Inc. (&#8220;Lineage&#8221;), pursuant to which, Lineage may request prior to August 22, 2023 that we develop for, and deliver to, Lineage certain induced pluripotent stem cell lines, which Lineage would use to evaluate the possible development
        of cell transplant therapies for treatment of diseases of the central nervous system in humans, (a) excluding ophthalmologic indications, (b) diseases and conditions of the peripheral nervous system, (c) psychiatric, respiratory, musculoskeletal,
        and hematological diseases, disorders, and conditions, and (d) cancer.&#160; The Lineage Agreement also provides Lineage with the option to obtain an exclusive sublicense to certain related technology for preclinical, clinical and commercial purposes,
        which would permit Lineage to sublicense such intellectual property, subject to payment of certain sublicense royalty fees.&#160; Lineage has six months from our delivery to Lineage of such induced pluripotent stem cell lines to exercise such option,
        and upon any such exercise, Lineage would agree to use its commercially reasonable efforts to exploit and make commercially available one or more licensed products derived from such induced pluripotent stem cell lines in accordance with the Lineage
        Agreement. Upon entry into the Lineage Agreement, Lineage paid us a $250,000 non-refundable up-front payment.&#160; We are also entitled to certain cell line customization fees with respect to cell lines that Lineage may request that we develop for
        Lineage, as well as royalty payments with respect to any such licensed products, certain sublicense fees and certain milestone payments under the Lineage Agreement.</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000;"><span style="text-decoration: underline;">Name and Ticker Symbol Changes and Nasdaq Listing Change</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On October 17, 2022, we changed our name from Brooklyn ImmunoTherapeutics, Inc. to Eterna Therapeutics Inc., and the trading symbol of our common stock on The Nasdaq Global Market
        changed from &#8220;BTX&#8221; to &#8220;ERNA.&#8221;&#160; On January 11, 2023, we transferred the listing of our common stock from The Nasdaq Global Market to the Nasdaq Capital Market, on which our common stock continues to trade under the trading symbol &#8220;ERNA&#8221;.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000;"><span style="text-decoration: underline;">Reverse Stock Split</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Effective at 11:59 p.m. Eastern time on October 16, 2022, we effected a reverse stock split of our common stock at a ratio of 1-for-20 (the &#8220;Reverse Stock Split&#8221;). Upon the
        effectiveness of the Reverse Stock Split, every twenty shares of the issued and outstanding common stock were automatically combined and reclassified into one issued and outstanding share of common stock. The Reverse Stock Split did not affect any
        stockholder&#8217;s ownership percentage of the common stock, alter the par value of the common stock or modify any voting rights or other terms of the common stock. The number of authorized shares of common stock under our Charter remains unchanged. No
        fractional shares were issued in connection with the Reverse Stock Split. In lieu of any fractional shares to which a stockholder would otherwise be entitled, we paid an amount of cash equal to the product of (i) the fractional share to which the
        holder would otherwise be entitled and (ii) the then fair value of a share as determined in good faith by our Board of Directors.&#160; We paid an aggregate of $719 for a total of 175 fractional shares.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">All share and per share data in this Annual Report on Form 10-K have been adjusted for all periods presented to reflect the Reverse Stock Split.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;"><span style="text-decoration: underline;">Overview</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000;"><span style="text-decoration: underline;">mRNA, Gene-Editing, and Cellular Medicines</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We are a preclinical-stage biopharmaceutical company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines.&#160; We have
        in-licensed a portfolio of over 100 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> and UltraSlice<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> gene-editing proteins, and the ToRNAdo<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> mRNA
        delivery system, which we collectively refer to as our &#8220;mRNA technology platform.&#8221; We plan to develop and advance a pipeline of therapeutic products both internally and through strategic partnerships, with the near-term focus on deploying our mRNA
        technology platform through strategic partnerships.&#160; We license our mRNA technology platform from Factor Limited under an exclusive license agreement.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Through strategic partnerships, we expect that our mRNA technology platform will be used for preclinical and eventual clinical development of product candidates for a variety of
        clinical indications. We expect that the initial product candidates developed by our strategic partners utilizing our mRNA technology platform will include hypoimmune induced pluripotent stem cell (&#8220;iPSC&#8221;)-derived product candidates for the
        treatment of neurological indications and iPSC-derived immune-modulating cells (&#8220;iIMCs&#8221;) for indications such as acute myeloid leukemia (&#8220;AML&#8221;) and solid tumors.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We refer to aspects of our mRNA technology platform as &#8220;mRNA delivery,&#8221; &#8220;mRNA gene editing&#8221; and &#8220;mRNA cell reprogramming.&#8221;</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">mRNA Delivery</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Nucleic acids, such as mRNA, can be used to induce cells to express desired proteins, including proteins that are capable of re-writing genetic and epigenetic cellular programs.
        However, the plasma membrane surrounding cells normally protects cells from exogenous nucleic acids, preventing efficient uptake and protein translation. Delivery systems can be used to enhance the uptake of nucleic acids by cells.&#160; Conventional
        delivery systems, such as lipid nanoparticle (&#8220;LNP&#8221;)-based delivery, often suffer from endosomal entrapment and toxicity, which can limit their therapeutic use.&#160; Our mRNA delivery technology is designed to use a novel chemical substance that is
        designed to deliver nucleic acids, including mRNA, to cells both <span style="font-style: italic;">ex vivo</span> and <span style="font-style: italic;">in vivo</span>. Our nucleic-acid delivery technology is also designed for <span style="font-style: italic;">ex vivo</span> delivery of mRNA encoding gene-editing proteins and reprogramming factors, including to primary cells, insertion of exogenous sequences into genomic safe-harbor loci, and <span style="font-style: italic;">in vivo</span> delivery of mRNA to the brain, eye, skin, and lung, which may be useful for the development of mRNA-based therapeutic.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">mRNA Gene Editing</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our mRNA gene-editing technology is designed to delete, insert, and repair DNA sequences in living cells, which may be useful for correcting disease-causing mutations, making cells
        resistant to infection and degenerative disease, modulating the expression of immunoregulatory proteins to enable the generation of durable allogeneic cell therapies, and engineering immune cells to more effectively fight cancer.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Conventional gene-editing technologies typically employ plasmids or viruses to express gene-editing proteins, which can result in low-efficiency editing and unwanted mutagenesis
        when an exogenous nucleic acid fragment is inserted at random locations in the genome. Our mRNA gene-editing technology instead is designed to employ mRNA to express gene-editing proteins, which can potentially enable gene editing without unwanted
        insertional mutagenesis, because, unlike conventional gene-editing technologies that employ viruses or DNA-based vectors, mRNA does not typically cause unwanted insertional mutagenesis. We believe the efficiency of our mRNA gene-editing technology
        has the potential to support development of product candidates that could create new therapeutic approaches. For example, we anticipate that our mRNA gene-editing technology can be used to generate allogeneic chimeric antigen receptor T-cell
        (&#8220;CAR-T&#8221;) therapies for the treatment of cancer. In such allogeneic CAR-T therapies, mRNA encoding gene-editing proteins would be used to inactivate the endogenous T-cell receptor to prevent therapeutic T-cells from causing graft-versus-host
        disease (&#8220;GvHD&#8221;). GvHD occurs when transplanted cells view the patient&#8217;s (i.e. the host&#8217;s) cells as a threat and attack the host&#8217;s cells. We expect that this same mechanism of action can generate allogeneic stem cell-derived therapies in which mRNA
        encoding gene-editing proteins could be used to inactivate one or more components of the human leukocyte antigen (&#8220;HLA&#8221;) complex to render the cells immuno-nonreactive or &#8220;stealth,&#8221; which may be useful for the development of allogeneic cell-based
        therapies.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">mRNA Cell Reprogramming</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our mRNA cell-reprogramming technology is capable of generating clonal lines of pluripotent stem cells that can be expanded and differentiated into many desired cell types that may
        be useful for the development of regenerative cell therapies.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Conventional cell-reprogramming technologies (e.g., using Sendai virus or episomal vectors) can result in low efficiency reprogramming, can select for cells with abnormal growth
        characteristics, and can leave traces of the vector in reprogrammed cells.<span style="font-weight: bold;">&#160;</span>Our mRNA cell-reprogramming technology instead is designed to employ mRNA to express reprogramming factors, which can enable cell
        reprogramming without leaving traces of the vector in reprogrammed cells, because, unlike conventional cell-reprogramming technologies that employ viruses or DNA-based vectors, mRNA does not typically leave traces of the vector in reprogrammed
        cells.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000;"><span style="text-decoration: underline;">IRX-2</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">IRX-2, our former clinical product candidate, is a mixed, human-derived cytokine product with multiple active constituents, including Interleukin-2, or IL2, and other key cytokines.
        Together, these cytokines are believed to signal, enhance and restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells, unlike many existing cancer therapies, which rely on targeting the cancer
        directly. IRX-2 is prepared from the supernatant of pooled allogeneic peripheral blood mononuclear cells, known as PBMCs, that have been stimulated using a proprietary process employing a specific population of cells and a specific mitogen.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We currently do not have plans to further develop the IRX-2 product candidate. Results of the 150-patient Phase 2b INSPIRE trial (the &#8220;INSPIRE trial&#8221;), released in June 2022, showed
        outcomes favored IRX-2 in certain predefined subgroups but the INSPIRE trial did not meet the primary endpoint of event-free survival at two years of follow up. There were no new safety signals observed with IRX-2.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The INSPIRE trial was the only Company-sponsored study of IRX-2.&#160; IRX-2 has been studied externally in other clinical settings outside of head and neck cancer in the form of
        investigator sponsored trials, all of which have either ended or are not currently active. We had previously provided IRX-2 as a study drug and financial support to conduct those investigator sponsored trials, but are no longer providing either.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;"><span style="text-decoration: underline;">License and Royalty Agreements</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;">Cell and Gene Therapy License Agreements</div>

      <div>
        <div><br />
        </div>

      </div>

      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;">Exclusive Factor License Agreement</div>

      </div>

      <div>
        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">In November 2020, Novellus Limited and Factor Limited entered into a license agreement (the &#8220;Novellus-Factor License Agreement&#8221;), pursuant to which Factor Limited granted to
          Novellus Limited an exclusive license to certain patents owned by Factor Limited for the development of certain stem cell-based cellular therapies for treating diseases and conditions in humans and animals.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">In April 2021, Eterna LLC, Novellus Limited and Factor Limited entered into an exclusive license agreement (the &#8220;Original Factor License Agreement&#8221;), pursuant to which Eterna LLC
          acquired an exclusive worldwide license to intellectual property and mRNA cell reprogramming and gene editing technology for use in the development of certain mRNA, gene-editing, and cellular therapies to be evaluated and developed for treating
          human diseases, including certain types of cancer, sickle cell disease, and beta thalassemia.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">As a result of the Novellus Acquisition, the rights and obligations of Novellus Limited under the Novellus-Factor License Agreement pertaining to any and all licensed products
          from Factor Limited inured to Eterna, and the Original Factor License Agreement remained unchanged.</div>

        <div><br />
        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">In November 2022, following the expiration of one of the delineated milestone deadlines for certain regulatory filings required under the Novellus-Factor License Agreement, which
          permitted Factor Limited to terminate the license granted to Novellus Limited thereunder, we entered into the first amendment to the Original Factor License Agreement (the &#8220;Amended Factor License Agreement&#8221;), pursuant to which, among other
          things, Factor Limited granted to Eterna LLC an exclusive, sublicensable license under certain patents owned by Factor Limited (the &#8220;Factor Patents&#8221;) for the purpose of identifying and pursuing certain opportunities to grant to third parties
          sublicenses to the Factor Patents. The Amended Factor License Agreement also (i) terminated the Novellus-Factor License Agreement, (ii) confirmed Factor Limited&#8217;s grant to Eterna LLC of the rights and licenses Novellus Limited previously granted
          to Eterna LLC under the Novellus-Factor License Agreement on the same terms and conditions as granted by Novellus Limited to Eterna LLC under such agreement, (iii) confirmed that the sublicense granted by Novellus Limited in accordance with the
          Novellus-Factor License Agreement to NoveCite (as discussed below), survived termination of the Novellus-Factor License Agreement and (iv) removed Novellus Limited from the Amended Factor License Agreement and the NoveCite Agreement and replaced
          Novellus Limited with Factor Limited as the direct licensor to Eterna LLC and NoveCite under such agreements, respectively.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">On February 20, 2023, we and Factor Limited entered into an exclusive license agreement (the &#8220;Exclusive Factor License Agreement&#8221;), which terminated and replaced in its entirety
          the Amended Factor License Agreement.&#160; Subject to certain exclusive licenses or other rights granted by Factor Limited to certain third parties as of the effective date of the Exclusive Factor License Agreement, Factor granted us the exclusive,
          sublicensable license under the Factor Patents.</div>

        <div><br />
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">The term of the Exclusive Factor License Agreement expires on November 22, 2027, but will be automatically extended for an additional two and a half years (such period, the
          &#8220;Renewal Term&#8221;) if we receive at least $100 million in fees from sublicenses to the Factor Patents (&#8220;Sublicense Fees&#8221;) granted by us pursuant to the Exclusive Factor License Agreement.&#160; Pursuant to the Exclusive Factor License Agreement, we will
          pay to Factor 20% of any Sublicense Fee received by us before the initial expiration date of such license and 30% of any Sublicense Fees received by us during the Renewal Term.&#160; We may terminate the Exclusive Factor License Agreement upon 120
          days&#8217; written notice to Factor, and both parties otherwise have additional customary termination rights, including in connection with certain uncured material breaches of the Exclusive Factor License Agreement and specified bankruptcy events.&#160;
          Under the Exclusive Factor License Agreement, we are obligated to pay the expenses incurred by Factor Limited in preparing, filing, prosecuting and maintaining the Factor Patents and agreed to bear all costs and expenses associated with enforcing
          and defending the Factor Patents in any action or proceeding arising from pursuit of sublicensing opportunities under the license granted under the Exclusive Factor License Agreement.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">There can be no assurance that we can successfully develop and commercialize the technology licensed under the Exclusive Factor License Agreement. See Item 1A &#8220;Risk Factors&#8212;Risks
          Related to our Business and Industry<span style="font-weight: bold;">&#8212;</span>We depend substantially, and expect in the future to continue to depend, on in-licensed intellectual property. Such licenses impose obligations on our business, and if
          we fail to comply with those obligations, we could lose license rights, which would substantially harm our business&#8221; contained in this Annual Report on Form 10-K.</div>

      </div>

      <div>
        <div><br />
        </div>

      </div>

      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;">NoveCite</div>

      </div>

      <div>
        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">In October 2020, Novellus Limited (as sublicensor) and NoveCite (as sublicensee) entered into an exclusive license agreement (the &#8220;NoveCite Agreement&#8221;) to license a novel cellular
          therapy for acute respiratory indications, which Novellus Limited was licensing from Factor Limited under the Novellus-Factor License Agreement.&#160; As discussed above, as a result of the Amended Factor License Agreement and the termination of the
          Novellus-Factor License Agreement, the NoveCite Agreement was amended to remove Novellus Limited as sublicensor and create a direct license between Factor Limited and NoveCite effective November 1, 2022.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;">IRX-2 License Agreements</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-style: italic;">Unless otherwise stated below, each royalty to be paid under these license and royalty agreements is payable until the last patent for IRX-2 expires and
          runs in perpetuity unless earlier terminated pursuant to the terms described below. There are no milestone payments due under any of these agreements. While the licenses described below remain in force, we currently do not have plans to further
          develop the IRX-2 product candidate.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">License Agreement with the University of South Florida Research Association</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">On June 28, 2000, IRX Therapeutics, a predecessor of Eterna LLC, entered into a series of License Agreements (collectively, as amended, the &#8220;USF License Agreement&#8221;) with the
          University of South Florida Research Association, Inc. (&#8220;Research Association&#8221;). Pursuant to the USF License Agreement, the Research Association licensed to IRX Therapeutics the exclusive worldwide rights to certain patents on IRX-2 in exchange
          for royalties equal to 7% of the gross product sales of IRX-2. The USF License Agreement was assigned to Eterna LLC in connection with the sale of the assets of IRX Therapeutics to Eterna LLC in November 2018.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Royalty Agreement with certain former IRX Therapeutics investors</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">On May 1, 2012, IRX Therapeutics entered into a royalty agreement (the &#8220;IRX Investor Royalty Agreement&#8221;) with certain investors who participated in a financing transaction. The
          IRX Investor Royalty Agreement was assigned to Eterna LLC in November 2018 when Eterna LLC acquired the assets of IRX Therapeutics. Pursuant to the IRX Investor Royalty Agreement, if and when Eterna LLC becomes obligated to pay royalties to the
          Research Association under the USF License Agreement, it will pay an additional royalty of 1% of gross sales to an entity organized by the investors who participated in such financing transaction.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Collaborator License Agreement</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Effective June 28, 2018, IRX Therapeutics terminated its Research, Development and Option Facilitation Agreement and certain related agreements with a collaborative partner
          (the &#8220;Collaborator&#8221;), pursuant to a termination agreement (the &#8220;Termination Agreement&#8221;). The Termination Agreement was assigned to Eterna LLC in connection with the sale of the assets of IRX Therapeutics to Eterna LLC in November 2018.&#160; As
          consideration for entering into the Termination Agreement, the Collaborator is entitled to receive a royalty equal to 6% of revenues from the sale of IRX-2, for the period of time beginning with the first sale of IRX-2 through the later of (i)
          the twelfth anniversary of the first sale of IRX-2, or (ii) the expiration of the last IRX patent or other exclusivity of IRX-2.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Investor Royalty Agreement</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">On November 6, 2018, Eterna LLC entered into a royalty agreement, as amended (the &#8220;Royalty Agreement&#8221;) with Brooklyn Immunotherapeutics Investors LP (&#8220;Investors LP&#8221;) and
          Brooklyn Immunotherapeutics Investors GP (&#8220;Investors GP&#8221;), and certain beneficial holders of Investors LP and Investors GP, which entities provided the financing required by Eterna LLC in connection with Eterna LLC&#8217;s acquisition of the assets of
          IRX Therapeutics. Under the Royalty Agreement, Eterna LLC is required to pay royalties to Investors LP, Investors GP and such beneficial holders based on gross sales of IRX-2. This royalty continues in perpetuity.&#160; The Royalty Agreement specifies
          royalty payments to certain beneficial holders, including Charles Cherington and Nicholas J. Singer, who are both current directors and stockholders of Eterna; however, we have not paid and, because we are no longer pursuing the development of
          IRX-2, we do not expect to pay, any such royalties.</div>

      </div>

      <div><br />
      </div>

      <div style="color: #000000; font-weight: bold;"><span style="text-decoration: underline;">Patent Portfolio</span></div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000; font-weight: bold;">Cell and Gene Therapy</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">
          <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Our strategy is to develop and advance a pipeline of therapeutic products both internally and through strategic partnerships,
            leveraging our in-licensed mRNA technology platform, with the near-term focus on deploying our mRNA technology platform through strategic partnerships. As of March 20, 2023, we had in-licensed approximately 12 patent families filed in the
            United States and other major markets worldwide, including 125 granted patents, 9 allowed patent applications, 64 published patent applications, 25 pending, unpublished non-provisional patent applications, and 2 published, pre-nationalization
            PCT applications. Patent protection for the mRNA technology platform includes:</div>

        </div>

      </div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 48%; vertical-align: middle;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><span style="text-decoration: underline;">Family Number and Title</span></div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><span style="text-decoration: underline;">United States or Foreign</span></div>
              <div style="text-align: center; color: rgb(0, 0, 0);"><span style="text-decoration: underline;">Jurisdiction</span></div>
            </td>

    <td style="width: 2%; vertical-align: bottom;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><span style="text-decoration: underline;">Earliest Effective Date</span></div>
              <div style="text-align: center; color: rgb(0, 0, 0);"><span style="text-decoration: underline;">of Patent Application</span></div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 48%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 28%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">FAB-001: &#8220;Methods and Products for Transfecting Cells&#8221;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 9,422,577, 9,605,277, 9,605,278, 10,472,611, 10,662,410, 10,829,738, 10,982,229, and 11,466,293), EP (CH, DE, FR, GB, IE), EP (BE, CH, DE, DK, FR, GB, IE,
                NL), AU (6X), CA (Allowed), CN (4X), HK (5X), JP (2X), KR (2X), MX, MX (Allowed), RU (2X)</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Published</span>: US (3X), EP, BR (2X), CA, CN, HK (2X), KR, RU</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: US (4X), AU, CA, MX (3X)</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);">12/05/2011</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 48%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 28%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">FAB-003: &#8220;Methods and Products for Transfection&#8221;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 8,497,124, 9,127,248, 9,399,761, 9,562,218, 9,695,401, 9,879,228, 9,969,983, 10,131,882, 10,301,599, 10,443,045, 11,492,600)</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: US</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);">12/05/2011</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">FAB-005: &#8220;Methods and Products for Expressing Proteins in Cells&#8221;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 9,376,669, 9,447,395, 9,464,285, 9,487,768, 9,657,282, 9,758,797, 10,415,060, 10,590,437, 10,724,053, 10,752,917, 10,752,918, 10,752,919, 10,767,195,
                11,332,758, 11,332,759, 11,339,409, and</div>
              <div style="color: #000000;">11,339,410), EP (CH, DE, FR, GB, IE), AU (2X), BR (3X Allowed), CA (Allowed), HK, JP (3X), KR (2X), MX, RU</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Published</span>: US (2X), EP, BR, CA, CN, HK, JP, KR, MX</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: AU</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);">11/01/2012</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 48%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 28%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">FAB-008: &#8220;Methods and Products for Nucleic Acid Production and Delivery&#8221;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 9,770,489 and 10,124,042), EP (CH, DE, ES, FR, IE), EP (BE, CH, DE, DK, ES, FI, FR, GB, IE, NL, NO, SE), AU, CA (Allowed), HK, JP (Allowed), KR, MX</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Published</span>: US (2X), AU, BR (2X), CA, CN, JP, KR, MX</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: AU, EP</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);">08/18/2014</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 48%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 28%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">FAB-009: &#8220;Nucleic Acid Products and Methods of Administration Thereof&#8221;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (No. 11,241,505), AU, JP</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Published</span>: US, EP, CA, CN, HK (2X), JP, NZ</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: AU</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);">02/13/2015</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 48%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 28%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">FAB-010: &#8220;Nucleic Acid Products and Methods of Administration Thereof&#8221;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 10,137,206, 10,350,304, 10,363,321, 10,369,233, 10,576,167, 10,888,627, and 10,894,092), CN (Allowed)</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Published</span>: US (3X), EP, AU, CA, CN, HK, JP, IL, IN, NZ</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: CN, JP (2X), NZ</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);">08/17/2016</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">FAB-011: &#8220;Nucleic Acid-Based Therapeutics&#8221;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Published</span>: US, EP, AU, CA, HK</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);">03/27/2018</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 48%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 28%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">FAB-012: &#8220;Cationic Lipids and Transfection Methods&#8221;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 10,501,404, 10,556,855, 10,611,722, 10,752,576, and 11,242,311)</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Published</span>: US (2X), AU, CA, CN, EP, HK, JP, KR, MX</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: AU, NZ</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: top;">
              <div style="text-align: center; color: #000000;">US: 07/30/2019</div>
              <div>&#160;</div>
              <div style="text-align: center; color: #000000;">Foreign: 07/03/2019</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 48%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 28%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">FAB-013: &#8220;Engineered Gene-Editing Proteins&#8221;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: US, EP</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);">05/12/2020</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 48%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 28%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">FAB-016: &#8220;Mesenchymal Stem Cell Therapies&#8221;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Published</span>: CN, EP</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: US, AU, JP</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: top;">
              <div style="text-align: center; color: #000000;">04/28/2020</div>
              <div>&#160;</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 48%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 28%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">FAB-017: &#8220;Engineered Immune Cell Therapies&#8221;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Published</span>: PCT</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);">03/05/2021</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 48%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 28%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">FAB-018: &#8220;Circular RNA&#8221;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Published</span>: PCT</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);">04/27/2021</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 2%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 28%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 2%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: top;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: #000000;">US &#8211; United States of America</div>
              <div style="color: #000000;">EP &#8211; European Patent Convention</div>
              <div style="color: #000000;">PCT &#8211; Patent Cooperation Treaty</div>
              <div style="color: #000000;">AU &#8211; Australia</div>
              <div style="color: #000000;">BE &#8211; Belgium</div>
              <div style="color: #000000;">BR &#8211; Brazil</div>
              <div style="color: #000000;">CA &#8211; Canada</div>
              <div style="color: #000000;">CH &#8211; Switzerland</div>
              <div style="color: #000000;">CN &#8211; Peoples&#8217; Republic of China</div>
              <div style="color: #000000;">DE &#8211; Germany</div>
              <div style="color: #000000;">DK &#8211; Denmark</div>
              <div style="color: #000000;">ES &#8211; Spain</div>
              <div style="color: #000000;">FI &#8211; Finland</div>
              <div style="color: #000000;">GB &#8211; Great Britain</div>
              <div style="color: #000000;">HK &#8211; Hong Kong</div>
              <div style="color: #000000;">IE &#8211; Ireland</div>
              <div style="color: #000000;">IL &#8211; Israel</div>
              <div style="color: #000000;">IN &#8211; India</div>
              <div style="color: #000000;">JP &#8211; Japan</div>
              <div style="color: #000000;">KR &#8211; Republic of Korea (South Korea)</div>
              <div style="color: #000000;">MX &#8211; Mexico</div>
              <div style="color: #000000;">NL &#8211; Netherlands</div>
              <div style="color: #000000;">NO &#8211; Norway</div>
              <div style="color: #000000;">NZ &#8211; New Zealand</div>
              <div style="color: #000000;">SE &#8211; Sweden</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 20%; vertical-align: middle;">&#160;</td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Patent Families</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000;">Descriptions of our patent families are as follows:</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">FAB-001: &#8220;Methods and Products for Transfecting Cells&#8221; - The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising
                nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits,
                and devices. Methods for inducing cells to express proteins and for reprogramming and gene-editing cells using RNA are disclosed. Methods for producing cells from patient samples, cells produced using these methods, and therapeutics
                comprising cells produced using these methods are also disclosed.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">FAB-003: &#8220;Methods and Products for Transfection&#8221; - The present invention relates in part to methods for producing tissue-specific cells from patient samples, and to tissue-specific cells produced using these
                methods. Methods for reprogramming cells using RNA are disclosed. Therapeutics comprising cells produced using these methods are also disclosed.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">FAB-005: &#8220;Methods and Products for Expressing Proteins in Cells&#8221; - The present invention relates in part to nucleic acids encoding proteins, therapeutics comprising nucleic acids encoding proteins, methods
                for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods
                and products for altering the DNA sequence of a cell are described, as are methods and products for inducing cells to express proteins using synthetic RNA molecules. Therapeutics comprising nucleic acids encoding gene-editing proteins are
                also described.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">FAB-008: &#8220;Methods and Products for Nucleic Acid Production and Delivery&#8221; - The present invention relates in part to nucleic acids, including nucleic acids encoding proteins, therapeutics and cosmetics
                comprising nucleic acids, methods for delivering nucleic acids to cells, tissues, organs, and patients, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and
                reprogramming cells, and cells, organisms, therapeutics, and cosmetics produced using these methods, kits, and devices. Methods and products for altering the DNA sequence of a cell are described, as are methods and products for inducing
                cells to express proteins using synthetic RNA molecules, including cells present in vivo. Therapeutics comprising nucleic acids encoding gene-editing proteins are also described.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">FAB-009: &#8220;Nucleic Acid Products and Methods of Administration Thereof&#8221; - The present invention relates in part to nucleic acids, including nucleic acids encoding proteins, therapeutics and cosmetics
                comprising nucleic acids, methods for delivering nucleic acids to cells, tissues, organs, and patients, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and
                reprogramming cells, and cells, organisms, therapeutics, and cosmetics produced using these methods, kits, and devices.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">FAB-010: &#8220;Nucleic Acid Products and Methods of Administration Thereof&#8221; - The present invention relates in part to nucleic acids, including nucleic acids encoding proteins, therapeutics and cosmetics
                comprising nucleic acids, methods for delivering nucleic acids to cells, tissues, organs, and patients, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and
                reprogramming cells, and cells, organisms, therapeutics, and cosmetics produced using these methods, kits, and devices.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">FAB-011: &#8220;Nucleic Acid-Based Therapeutics&#8221; - The present invention relates in part to nucleic acids, including nucleic acids encoding proteins, therapeutics and cosmetics comprising nucleic acids, methods for
                delivering nucleic acids to cells, tissues, organs, and patients, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms,
                therapeutics, and cosmetics produced using these methods, kits, and devices.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">FAB-012: &#8220;Cationic Lipids and Transfection Methods&#8221; - The present invention relates in part to novel cationic lipids and their use, e.g., in delivering nucleic acids to cells.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">FAB-013: &#8220;Engineered Gene-Editing Proteins&#8221; - The present invention relates in part to nucleic acids encoding gene editing proteins, including novel engineered variants.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">FAB-016: &#8220;Mesenchymal Stem Cell Therapies&#8221; - Cell-based therapies based on mesenchymal stem cells (MSCs) are described.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">FAB-017: &#8220;Engineered Immune Cell Therapies&#8221; - The present disclosure relates in part to engineered immune cells that are, inter alia, silenced from a host immune response.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">FAB-018: &#8220;Circular RNA&#8221; - Nucleic acid structures that promote formation of circular RNAs (circRNAs), which may comprise hybridization of substantially complimentary regions within the nucleic acid and
                contact with an RNA ligase. The nucleic acid structures may be used in gene editing and/or therapeutic applications. In some embodiments, the nucleic acid comprises the structure: 5&#8217;-X-Y-A-IRES-B-CDS-C-Y&#8217;-Z-3&#8217;, wherein X, Y, Y&#8217; and Z each
                independently comprise one or more nucleotides; Y and Y&#8217; are substantially complementary; X and Z are not substantially complementary; IRES comprises an internal ribosome entry site; CDS comprises a coding sequence; and A, B, and C are each
                independently a spacer comprising one or more nucleotides or null.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; margin-left: 18pt; color: #000000; font-weight: bold;">IRX-2</div>

      <div>
        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">As of March 20, 2023, we owned or controlled approximately 10 patent families filed in the United States and other major markets worldwide related to IRX-2, including 94 granted,
          12 pending and 6 published patent applications, directed to novel compounds, formulations, methods of treatments and platform technologies. Patent protection for IRX-2 includes:</div>

      </div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 48%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
              <div style="text-align: center; color: #000000;">Summary Description of Patent or Patent Application</div>
            </td>

    <td style="width: 2%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">United States or Foreign</div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Jurisdiction</div>
            </td>

    <td style="width: 2%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 20%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0);">Anticipated Expiration Date</div>
              <div style="text-align: center; color: rgb(0, 0, 0);">of Patent Application</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 20%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">IRX-2 Modified Manufacturing Process</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted: </span>US (No. 8,470,562), EP (BE, CH, DE, DK, ES, FI, FR, GB, IT, LI, NL, SW), AU, CA, JP, MX, TR</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 20%; vertical-align: top;">
              <div style="color: #000000;">US: 04/14/2029</div>
              <div>&#160;</div>
              <div style="color: #000000;">All Others: 04/14/2029</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Method of Reversing Immune Suppression of Langerhans Cells</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 9,333,238 and 9,931,378), EP (BE, CH, DE, DK, ES, FI, FR, GB, LI, NL), AU, CA</div>
              <div>&#160;</div>
              <div style="color: #000000;">JP,<span style="font-weight: bold;">&#160;</span>CN, HK</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 20%; vertical-align: top;">
              <div style="color: #000000;">US: 12/30/2030 (No. 9,333,238), 12/08/2030 (No. 9,931,378)</div>
              <div>&#160;</div>
              <div style="color: #000000;">All Others: 12/8/2030</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Method of Increasing Immunological Effect</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 7,993,660 and 8,591,956), EP (BE, CH, DE, DK, ES, FI, FR, GB, IT, LI, NL), AU, CA, JP, HK</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 20%; vertical-align: top;">
              <div style="color: #000000;">US: 12/11/2028 (No. 7,993,660), 11/26/2028 (No. 8,591,956)</div>
              <div>&#160;</div>
              <div style="color: #000000;">All Others: 11/26/2028</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Vaccine Immunotherapy</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted: </span>US (Nos. 9,539,320 and 9,566,331), EP (BE, CH, DE, DK, ES, FI, FR, GB, IT, LI, NL), AU, CA, HK, JP</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 20%; vertical-align: top;">
              <div style="color: #000000;">US: 05/17/2030 (No. 9,539,230), 09/04/2030 (No. 9,566,331).</div>
              <div>&#160;</div>
              <div style="color: #000000;">All Others: 5/17/2030</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Vaccine Immunotherapy</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted: </span>US (Nos. 9,492,517, 9,492,519), JP, CA, AU</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending: </span>EP, HK</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 20%; vertical-align: top;">
              <div style="color: #000000;">US: 02/25/2024 (No. 9,492,517), 06/30/2023 (No. 9,492,519)</div>
              <div>&#160;</div>
              <div style="color: #000000;">All Others: 7/24/2027</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Immunotherapy for Reversing Immune Suppression</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (No. 7,731,945)</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 20%; vertical-align: top;">
              <div style="color: #000000; font-size: 12pt;"><span style="font-size: 10pt;">US: 02/06/2025</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Vaccine Immunotherapy for Immune Suppressed Patients</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Patent Nos. 6,977,072, 9,789,172 and 9,789,173)</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 20%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">US: 04/14/2023 (No. 6,977,072), 08/17/2023 (Nos. 9,789,172 and 9,789,173)</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Immunotherapy for Immune Suppressed Patients</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: EP (BE, CH, DE, ES, FR, GB, IT, NL, LI)</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 20%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">All Others:&#160; 3/9/2027</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Composition for the Treatment of Advanced Prostate Cancer</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: CA</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 20%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;7/24/2027</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 28%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Uses of PD-1/PD-L1 Inhibitors and/or CTLA-4 Inhibitors with a Biologic Containing Multiple Cytokine Components to Treat Cancer</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted:</span> ZA</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: AU, CA, EP, IL, JP, KR, NZ, PH, SG, US (16/326,611)</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Published</span>: BR, CN, EA, IN, MX, ZA</div>
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 20%; vertical-align: top;">
              <div>&#160;</div>
              <div>&#160;</div>
              <div style="color: #000000;">US:8/18/2037*</div>
              <div style="color: #000000;">Subject to potential PTA</div>
              <div>&#160;</div>
              <div>&#160;</div>
              <div style="color: #000000;">All Other: 8/18/2037</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;</div>
            </td>

    <td style="width: 28%; vertical-align: top; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;</div>
            </td>

    <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;</div>
            </td>

    <td style="width: 20%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48%; vertical-align: top;">
              <div style="color: #000000;">US &#8211; United States of America</div>
              <div style="color: #000000;">EP &#8211; European Patent Convention</div>
              <div style="color: #000000;">BE &#8211; Belgium</div>
              <div style="color: #000000;">CH &#8211; Switzerland</div>
              <div style="color: #000000;">DE &#8211; Germany</div>
              <div style="color: #000000;">DK &#8211; Denmark</div>
              <div style="color: #000000;">ES &#8211; Spain</div>
              <div style="color: #000000;">FI &#8211; Finland</div>
              <div style="color: #000000;">GB &#8211; Great Britain</div>
              <div style="color: #000000;">IT &#8211; Italy</div>
              <div style="color: #000000;">LI &#8211; Lichtenstein</div>
              <div style="color: #000000;">NL &#8211; Netherlands</div>
              <div style="color: #000000;">SW &#8211; Sweden</div>
              <div style="color: #000000;">AU &#8211; Australia</div>
              <div style="color: #000000;">BR - Brazil</div>
              <div style="color: #000000;">CA &#8211; Canada</div>
              <div style="color: #000000;">CN &#8211; Peoples&#8217; Republic of China</div>
              <div style="color: #000000;">EA &#8211; Eurasian Patent Organization</div>
              <div style="color: #000000;">HK &#8211; Hong Kong</div>
              <div style="color: #000000;">IL &#8211; Israel</div>
              <div style="color: #000000;">IN - India</div>
              <div style="color: #000000;">JP &#8211; Japan</div>
              <div style="color: #000000;">KR &#8211; Republic of Korea (South Korea)</div>
              <div style="color: #000000;">MX &#8211; Mexico</div>
              <div style="color: #000000;">PH &#8211; Philippines</div>
              <div style="color: #000000;">SG - Singapore</div>
              <div style="color: #000000;">TR &#8211; Turkey</div>
              <div style="color: #000000;">ZA &#8211; South Africa</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 28%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 20%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="color: #000000; font-style: italic;">IRX-2 Patent Families</div>

      <div><br />
      </div>

      <div style="color: #000000;">Descriptions of our patent families with issued patents in the United States or European Union are as follows:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">IRX-2 Modified Manufacturing Process - A method of making a primary cell derived biologic, including the steps of: (a) removing contaminating cells from mononuclear cells (&#8220;MNCs&#8221;) by loading leukocytes onto
                lymphocyte separation medium (&#8220;LSM&#8221;), and washing and centrifuging the medium with an automated cell processing and washing system; (b) storing the MNCs overnight in a closed sterile bag system; (c) stimulating the MNCs with a mitogen and
                ciprofloxacin in a disposable cell culture system to produce cytokines; (d) removing the mitogen from the mononuclear cells by filtering; (e) incubating the filtered MNCs in a culture medium; (f) producing a clarified supernatant by
                filtering the MNCs from the culture medium; (g) producing a chromatographed supernatant by removing DNA from the clarified supernatant by anion exchange chromatography; and (h) removing viruses from the chromatographed supernatant by
                filtering with dual 15 nanometer filters in series, thereby producing a primary cell derived biologic, wherein the primary cell derived biologic comprises IL-1.beta., IL-2, and IFN-.gamma.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Method of Reversing Immune Suppression of Langerhans Cells - A method of treating human papillomavirus (&#8220;HPV&#8221;), by administering a therapeutically effective amount of a primary cell-derived biologic to a
                patient infected with HPV and inducing an immune response to HPV. A method of overcoming HPV-induced immune suppression of Langerhans cells (&#8220;LC&#8221;), by administering a therapeutically effective amount of a primary cell-derived biologic to a
                patient infected with HPV and activating LC. A method of increasing LC migration towards lymph nodes, by administering a therapeutically effective amount of a primary cell-derived biologic to a patient infected with HPV, activating LC, and
                inducing LC migration towards lymph nodes. A method of generating immunity against HPV, by administering an effective amount of a primary cell derived biologic to a patient infected with HPV, generating immunity against HPV, and preventing
                new lesions from developing.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Method of Increasing Immunological Effect - A method of increasing immunological effect in a patient by administering an effective amount of a primary cell derived biologic to the patient, inducing immune
                production, blocking immune destruction, and increasing immunological effect in the patient. Methods of treating an immune target, treating a tumor, immune prophylaxis, and preventing tumor escape.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Vaccine Immunotherapy/Composition for the Treatment of Advanced Prostate Cancer &#8211; A method providing compositions and methods of immunotherapy to treat cancer or other antigen-producing diseases or lesions.
                According to one embodiment of the invention, a composition is provided for eliciting an immune response to at least one antigen in a patient having an antigen-producing disease or lesion, the composition comprising an effective amount of a
                cytokine mixture, preferably comprising IL-1, IL-2, IL-6, IL-8, IFN-gamma. (gamma) and TNF- alpha (alpha). The cytokine mixture acts as an adjuvant with the antigen associated with the antigen-producing disease or lesion to enhance the
                immune response of the patient to the antigen. Methods are therefore also provided for eliciting an immune response to at least one antigen in a patient having an antigen-producing disease or lesion utilizing the cytokine mixture of the
                invention. The compositions and methods are useful in the treatment of antigen-producing diseases such as cancer, infectious diseases or persistent lesions.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">12</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Immunotherapy for Reversing Immune Suppression - A method for overcoming immune suppression including the steps of inducing production of na&#239;ve T-cells and restoring T cell immunity.&#160; A method of vaccine
                immunotherapy includes the steps of inducing production of na&#239;ve T cells and exposing the na&#239;ve T cells to endogenous or exogenous antigens at an appropriate site.&#160; Additionally, a method for unblocking immunization at a regional lymph node
                includes the steps of promoting differentiation and maturation of immature dendritic cells, thus, for example, exposing tumor peptides to T cells to gain immunization of the T cells.&#160; Further, a method of treating cancer and other
                persistent lesions includes the steps of administering an effective amount of a natural cytokine mixtures an adjuvant to endogenous or exogenous administered antigen to the cancer or other persistent lesions; preferably the natural cytokine
                mixture is administered with thymosin.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Vaccine Immunotherapy for Immune Suppressed Patients - A method for overcoming mild to moderate immune suppression includes the steps of inducing production of naive T-cells and restoring T-cell immunity. A
                method of vaccine immunotherapy includes the steps of inducing production of naive T-cells and exposing the naive T-cells to endogenous or exogenous antigens at an appropriate site. Additionally, a method for unblocking immunization at a
                regional lymph node includes the steps of promoting differentiation and maturation of immature dendritic cells at a regional lymph node and allowing presentation of processed peptides by resulting mature dendritic cells, thus, for example,
                exposing tumor peptides to T-cells to gain immunization of the T-cells. Further, a method of treating cancer and other persistent lesions includes the steps of administering an effective amount of a natural cytokine mixture as an adjuvant
                to endogenous or exogenous administered antigen to the cancer or other persistent lesions.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Immunotherapy for Immune Suppressed Patients &#8211; A method providing compositions of a natural cytokine mixture (&#8220;NCM&#8221;) for treating a cellular immunodeficiency characterized by T lymphocytopenia, one or more
                dendritic cell functional defects such as those associated with lymph node sinus histiocytosis, and/or one or more monocyte functional defects such as those associated with a negative skin test to NCM. The invention includes methods of
                treating these cellular immunodeficiencies using the NCM of the invention. The compositions and methods are useful in the treatment of diseases associated with cellular immunodeficiencies such as cancer. Also provided are compositions and
                methods for reversing tumor-induced immune suppression comprising a chemical inhibitor and a non-steroidal anti-inflammatory drug (&#8220;NSAID&#8221;). The invention also provides a diagnostic skin test comprising NCM for predicting treatment outcome
                in cancer patients.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;"><span style="text-decoration: underline;">Patent Term and Term Extensions</span></div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Individual patents have terms for varying periods depending on the date of filing of the patent application or the date of patent issuance and the legal term of patents in
          the countries in which they are obtained. Generally, utility patents issued for applications filed in the United States and the European Union are granted a term of 20 years from the earliest effective filing date of a non-provisional patent
          application. In addition, in certain instances, a patent term can be extended to recapture a portion of the U.S. Patent and Trademark Office, or the USPTO, delay in issuing the patent as well as a portion of the term effectively lost as a result
          of the United States Food and Drug Administration (&#8220;FDA&#8221;) regulatory review period. However, as to the FDA component, the restoration period cannot be longer than five years and the restoration period cannot extend the patent term beyond 14 years
          from FDA approval. The duration of foreign patents varies in accordance with provisions of applicable local law, but typically are also 20 years from the earliest effective filing date. All taxes or annuities for a patent, as required by the
          USPTO and various foreign jurisdictions, must be timely paid in order for the patent to remain in force during this period of time.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">The actual protection afforded by a patent may vary on a product-by-product basis, from country to country, and can depend upon many factors, including the type of patent,
          the scope of its coverage, the availability of regulatory-related extensions, the availability of legal remedies in a particular country and the validity and enforceability of the patent.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Our patents and patent applications may be subject to procedural or legal challenges by others. As of March 17, 2022, three of our in-licensed patents were subject to
          re-examination by the USPTO: US 90/019,127, re-examination of US10,662,410, US 90/019,128, re-examination of US10,829,738, and US 90/019,129, re-examination of US10,982,229. We may be unable to obtain, maintain and protect the intellectual
          property rights necessary to conduct our business, and we may be subject to claims that we infringe or otherwise violate the intellectual property rights of others, which could materially harm our business. For more information, see Item 1A &#8220;Risk
          Factors-Risks Related to Our Intellectual Property&#8221; contained in this Annual Report on Form 10-K.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">13</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;"><span style="text-decoration: underline;">Supply and Manufacturing</span></div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">We currently do not have any agreements for the supply or manufacturing of cell lines. However, together with our license partner, Factor Limited, we believe that we have
          considerable experience in developing engineered cell lines. Pursuant to a Master Services Agreement, dated as of September 9, 2022 (the &#8220;MSA&#8221;), by and between us and Factor Bioscience Inc. (&#8220;Factor Bioscience&#8221;), the parent company of Factor
          Limited, Factor Bioscience has agreed to provide us with certain mRNA cell engineering research support services, including (i) access to Factor Bioscience&#8217;s research laboratory facilities located in Cambridge, Massachusetts, (ii) access to
          Factor Bioscience&#8217;s scientific equipment, (iii) training of our research staff in certain mRNA, iPSC, and gene editing technologies, (iv) copies of protocols, formulations, and sequences that may be useful for the development of mRNA cell
          engineering products and (v) in vitro transcription templates, mRNA constructs, and iPS cells that may be useful for the development of mRNA cell engineering products. To the extent that we need to obtain a supply of cell lines or manufacture
          them, we expect to contract with a contract manufacturing organization or to enter into a new work order under the MSA.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;"><span style="text-decoration: underline;">Regulatory Matters</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Government regulation and product approval</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Government authorities in the United States, at the federal, state and local level, and in other countries extensively regulate, among other things, the research,
          development, testing, manufacture, labeling, record-keeping, promotion, storage, advertising, distribution, marketing and export and import of products such as those we are developing. Drugs and biologics must be approved by the FDA through the
          New Drug Application, (&#8220;NDA&#8221;) process or the Biologic License Application (&#8220;BLA&#8221;) process before they may be legally marketed in the United States. Henceforth, we will use the term &#8220;marketing application,&#8221; or MA, to apply to both.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">There are two centers within the FDA that are responsible for the review and approval of drug and biologic marketing applications and general regulatory oversight: the Center
          for Drug Evaluation and Research, or CDER, and the Center for Biologics Evaluation and Research (&#8220;CBER&#8221;). While all conventional drug products are regulated by CDER, biologic products can be regulated by either CDER or CBER, depending on the
          product&#8217;s classification.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">The majority of BLA submissions are assigned to CBER; however, BLAs for certain biologic product categories are reviewed by CDER. These product categories include monoclonal
          antibodies for in vivo use, most proteins for therapeutic use, and categories such as cytokines, enzymes, and other novel proteins. Regardless of the category, NDAs for all drug products fall under the jurisdiction of CDER.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In the United States, drugs are subject to rigorous regulation by the FDA under the federal Food, Drug, and Cosmetic Act(&#8220;FDCA&#8221;) and implementing regulations, and biologics
          under the FDCA, the Public Health Services Act (&#8220;PHSA&#8221;), and their implementing regulations. Additionally, drugs and biologics are subject to other federal and state statutes. The process of obtaining regulatory approvals and the subsequent
          compliance with appropriate federal, state, local, and foreign statutes and regulations require the expenditure of substantial time and financial resources. Failure to comply with the applicable United States requirements at any time during the
          product development process, approval process, or after approval, may subject an applicant to administrative or judicial sanctions. These sanctions could include the FDA&#8217;s refusal to approve pending applications, license suspension or revocation,
          withdrawal of an approval, a clinical hold, warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, civil penalties or criminal prosecution. Any agency or judicial
          enforcement action could have a material adverse effect on us. The process required by the FDA before a drug or biologic may be marketed in the United States generally involves the following:</div>

      </div>

      <div style="text-align: justify;"><span style="color: #000000;"> </span><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">completion of pre-clinical laboratory tests, animal studies and formulation studies according to the FDA&#8217;s good laboratory practice, or GLP, regulations;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">submission of an investigational new drug application, or IND, which must become effective before human clinical trials may begin and which must include approval by an institutional
                review board, or IRB, at each clinical site before the trials are initiated;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">performance of adequate and well-controlled human clinical trials to establish the safety and efficacy of the proposed drug for its intended use conducted in compliance with federal
                regulations and good clinical practice, or GCP, an international standard meant to protect the rights and health of human clinical trial subjects and to define the roles of clinical trial sponsors, administrators, and monitors;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">14</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">submission to, and acceptance by, the FDA of a MA;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">satisfactory completion of an FDA inspection of our manufacturing facility or other facilities at which the drug or biologic is produced to assess compliance with current good
                  manufacturing practice, or cGMP, regulations to assure that the facilities, methods and controls are adequate to preserve the drug&#8217;s identity, strength, quality and purity;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">potential FDA audit of the non-clinical and clinical trial sites that generated the data in support of the MA: and</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">FDA review and approval of the MA.</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">The testing and approval process require substantial time, effort and financial resources, and the receipt and timing of any approval is uncertain.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">United States drug development process</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Once a pharmaceutical candidate is identified for development it enters the pre-clinical testing stage. Pre-clinical tests include laboratory evaluations of product
          chemistry, toxicity and formulation, as well as animal studies. Prior to beginning human clinical trials, a sponsor must submit an IND to the FDA, which includes the results of the pre-clinical tests, together with manufacturing information and
          analytical data. Some pre-clinical or non-clinical testing may continue even after the IND is submitted. In addition to including the results of the pre-clinical studies, the IND will also include a protocol detailing, among other things, the
          objectives of the clinical trial, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated, if the trial lends itself to an efficacy evaluation. The IND automatically becomes effective 30 days after receipt by
          the FDA, unless the FDA, within the 30-day time period, raises concerns or questions about the conduct of the trial. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. The FDA
          may, at any time, impose a clinical hold on ongoing clinical trials. If the FDA imposes a clinical hold, clinical trials cannot commence or recommence without FDA authorization and then only under terms authorized by the FDA.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Clinical trials involve the administration of the investigational new drug to healthy volunteers or patients under the supervision of one or more qualified investigators in
          accordance with federal regulations and GCP.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Clinical trials must be conducted under protocols detailing the objectives of the trial and the safety and effectiveness criteria to be evaluated. Each protocol must be
          submitted to the FDA as part of the IND. Further, an IRB affiliated with each institution participating in the clinical trial must review and approve each protocol before any clinical trial commences at that institution. All research subjects
          must provide informed consent, and informed consent information must be submitted to the IRB for approval prior to initiation of the trial and prior to providing it to potential subjects. Progress reports detailing the results of the clinical
          trials must be submitted at least annually to the FDA and more frequently if adverse events or other certain types of other changes occur.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Human clinical trials are typically conducted in three phases. A fourth, or post-approval, phase may include additional clinical studies. These phases generally include the
          following, and may be sequential, or may overlap or be combined:</div>

      </div>

      <div style="text-align: justify;"><span style="color: #000000;"> </span><br />
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">Phase 1 clinical trials involve the initial introduction of the drug or biologic into human subjects. These studies are designed to determine the safety of usually single doses of the
                  compound and determine any dose limiting intolerance, as well as evidence of the metabolism and pharmacokinetics of the drug in humans. For some products for severe or life-threatening diseases, especially if the product may be too toxic
                  to administer to healthy humans, the initial clinical trials may be conducted in individuals having a specific disease for which use the tested product is indicated.</div>
              </td>

  </tr>


</table>
        <div>
          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="width: 18pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                  <div style="text-align: left;"><span style="color: #000000;">&#9679;</span></div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="text-align: justify;"><span style="color: rgb(0, 0, 0);">Phase 2 clinical trials usually involve studies in a limited patient population to evaluate the safety and efficacy of the drug or biologic for specific, targeted
                      indications, to determine dosage tolerance and optimal dosage, and to identify possible adverse effects and safety risks</span></div>
                </td>

  </tr>


</table>
          <div> <br />
          </div>

        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">15</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">In Phase 3, if a compound is found to be potentially effective and to have an acceptable safety profile in Phase 2 (or occasionally Phase 1) studies, the Phase 3 studies will be
                  conducted to further confirm clinical efficacy, optimal dosage and safety within an expanded population which may involve geographically diverse clinical trial sites. Generally, but not always, two adequate and well-controlled Phase 3
                  clinical trials are required by the FDA for approval of a marketing application.</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">Phase 4 clinical trials are studies required of or agreed to by a sponsor that are conducted after the FDA has approved a product for marketing. These studies are used to gain
                  additional experience from the treatment of patients in the intended therapeutic indication and to document a clinical benefit in the case of drugs approved under accelerated approval regulations. If the FDA approves a product while a
                  company has ongoing clinical trials that were not necessary for approval, a company may be able to use the data from these clinical trials to meet all or part of any Phase 4 clinical trial requirement. Failure to promptly conduct Phase 4
                  clinical trials where necessary could result in withdrawal of approval for products approved under accelerated approval regulations.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">While Phase 1, Phase 2, and Phase 3 studies are generally required for approval of a marketing application, certain drugs and biologics may not require one or more steps in
          the process depending on other testing and the situation involved. Additionally, the FDA, an IRB, or the sponsor may stop testing at any time if results show patients being exposed to unnecessary health risks or overly dangerous side effects.&#160;
          Prior to the initiation of a clinical trial or at any time during the conduct of studies with human subjects, the FDA may place a study on clinical hold where patients may not be enrolled and ongoing trial activities are suspended until questions
          around potential safety issues with investigational products are addressed.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In addition, the manufacturer of an investigational drug in a Phase 2 or Phase 3 clinical trial for a serious or life-threatening disease is required to make available, such
          as by posting on its website, its policy on evaluating and responding to requests for expanded access to such investigational drug.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Concurrent with clinical trials, companies usually complete additional animal studies and must also develop additional information about the mechanism of action and physical
          characteristics of the drug and finalize a process for manufacturing the product in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product and, among other
          requirements, the manufacturer must develop methods for testing the identity, strength, quality, potency, and purity of the final product. Additionally, appropriate packaging must be selected and validated, and stability studies must be conducted
          to demonstrate that the product does not undergo unacceptable deterioration over its shelf life.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">United States drug review and approval process</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Following completion of clinical studies, the results are evaluated and, depending on the outcome, submitted to the FDA in the form of an NDA or BLA in order to obtain FDA
          approval of the product and authorization to commence commercial marketing. In responding to an NDA or BLA, the FDA may require additional testing or information, may require that the product labeling be modified, may impose a post-approval study
          and other commitments or reporting requirements or other restrictions on product distribution, or may deny the application.&#160; The timing of final FDA review and action varies greatly but can take years in some cases and may involve the input of an
          FDA advisory committee of outside experts. Product sales in the United States may commence only upon FDA approval of an NDA or BLA.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">FDA approval of a marketing application is required before marketing of the product may begin in the United States. The MA must include the results of product development,
          pre-clinical studies and clinical studies, together with other detailed information, including information on the chemistry, manufacture and controls utilized in manufacture of the product. In addition, a MA must also demonstrate purity,
          specifically in terms of showing that the final product does not contain extraneous material. The FDA has 60 days from its receipt of the MA to review the application to ensure that it is sufficiently complete for substantive review before
          accepting it for filing. The FDA may request additional information rather than accept an MA for filing. In this event, the MA must be resubmitted with the additional information. The resubmitted application also is subject to review before the
          FDA accepts it for filing. Once the submission is accepted for filing, the FDA begins an in-depth substantive review. The submission of an MA is also subject to the payment of a substantial application fee (for FDA fiscal year 2023 this fee may
          exceed 3 million dollars, although a waiver of such fee may be obtained under certain limited circumstances, including when the drug that is subject of the application has received Orphan Drug Designation for the indication sought). Further, the
          sponsor of an approved MA is subject to an annual program fee, which for FDA fiscal year 2023 is $393,933 per prescription drug product. User fees typically increase annually. The approval process is lengthy and complex, and the FDA may refuse to
          approve an MA if the applicable regulatory criteria are not satisfied or may require additional clinical or other data and information. Even if such data and information is submitted, the FDA may ultimately decide that the NDA or BLA does not
          satisfy the criteria for approval. The FDA may also refer applications for novel drug products or drug products which present difficult questions of safety or efficacy to an advisory committee, typically a panel that includes clinicians and other
          experts, for review, evaluation and a recommendation as to whether the application should be approved. The FDA is not bound by the recommendation of an advisory committee. The FDA reviews an application to determine, among other things, whether a
          product is safe and effective for its intended use. Before approving an MA, the FDA will inspect the facility or facilities where the product is manufactured to determine whether its manufacturing is cGMP&#8211;compliant to assure and preserve the
          product&#8217;s identity, potency, quality, purity and stability.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">16</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">If the FDA&#8217;s evaluation of the marketing submission or manufacturing facilities is not favorable, the FDA will issue a complete response letter. The complete response letter
          outlines the deficiencies in the submission and often requires additional testing or information in order for the FDA to reconsider the application. Even after submitting this additional information, the FDA ultimately may decide that the
          application does not satisfy the regulatory criteria for approval. With limited exceptions, the FDA may withhold approval of a MA regardless of prior advice it may have provided or commitments it may have made to the sponsor.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Once an MA is approved, changes to the conditions of approval, including additional indications, are made by the submission of a supplement to the MA The supplemental NDA, or
          sNDA, or the supplemental BLA, or sBLA must contain all of the information necessary to support the change. In the case of a new indication, that information usually consists of at least one clinical trial, and often more. Like an MA, FDA
          determines whether the supplemental application is sufficiently complete to permit review before it is filed. FDA then reviews the supplemental application. The FDA can either approve or issue a complete response letter outlining the
          deficiencies.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Manufacturing readiness</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">As part of the approval process, the FDA must inspect and approve each manufacturing facility. Among the conditions of approval is the requirement that a manufacturer&#8217;s
          quality control and manufacturing procedures conform to cGMP. Manufacturers must expend significant time, money and effort to ensure continued compliance, and the FDA conducts periodic inspections to verify compliance.&#160; If we, or our contract
          manufacturers, fail to comply or cannot remedy regulator identified deficiencies, then we may be prohibited from marketing product.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">If the FDA grants approval, the approval will be limited to those conditions and patient populations for which the product is safe and effective, as demonstrated through
          clinical studies. Further, a product may be marketed only in those dosage forms and for those indications approved in the MA. Certain changes to an approved MA, including, with certain exceptions, any significant changes to labeling, require
          approval of a supplemental application before the drug may be marketed as changed. Any products that we manufacture or distribute pursuant to FDA approvals are subject to continuing monitoring and regulation by the FDA, including compliance with
          cGMP and the reporting of adverse experiences with the drugs. The nature of marketing claims that the FDA will permit us to make in the labeling and advertising of our products will generally be limited to those specified in FDA approved
          labeling, and the advertising of our products will be subject to comprehensive monitoring and regulation by the FDA. Products whose review was accelerated may carry additional restrictions on marketing activities, including the requirement that
          all promotional materials are pre-submitted to the FDA. Claims exceeding those contained in approved labeling will constitute a violation of the FDCA. Violations of the FDCA or regulatory requirements at any time during the product development
          process, approval process, or marketing and sale following approval may result in agency enforcement actions, including corrective advertising, cessation of violative promotion, withdrawal of approval, recall, seizure of products, warning
          letters, injunctions, fines and/or civil or criminal penalties. Any agency enforcement action could have a material adverse effect on our business.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Failure to comply with applicable federal, state and foreign laws and regulations would likely have a material adverse effect on our business. In addition, federal, state and
          foreign laws and regulations regarding the manufacture and sale of new drugs are subject to future changes.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">17</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Post-approval requirements and consideration</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Once an MA is approved, a product will be subject to certain post-approval requirements. For instance, the FDA and Federal Trade Commission closely regulate the post-approval
          marketing and promotion of drugs and biologics, including standards and regulations for direct-to-consumer advertising, off-label promotion, industry-sponsored scientific and educational activities and promotional activities involving the
          internet. As a condition of MA approval, the FDA may also require a risk evaluation and mitigation strategy, or REMS, to help ensure that the benefits of the drug or biologic outweigh the potential risks. REMS can include medication guides,
          communication plans for the healthcare professionals, and other Elements to Assure Safe Use, or ETASU. ETASU can include, but are not limited to, special training or certification for prescribing or dispensing, dispensing only under certain
          circumstances, special monitoring, and the use of patient registries. The requirement for a REMS can materially affect the potential market and profitability of the drug or biologic.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Drugs and biologics may be marketed only for the approved indications and in accordance with the provisions of the approved labeling. Changes to some of the conditions
          established in an approved application, including changes in indications, labeling, or manufacturing processes or facilities, require submission and FDA approval of a new MA supplement before the change can be implemented. An MA supplement for a
          new indication typically requires clinical data similar to that in the original application, and the FDA uses the same procedures and actions in reviewing MA supplements as it does in reviewing MAs.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Adverse event reporting and submission of periodic reports are required following FDA approval of an MA. The FDA also may require post-marketing testing, known as Phase 4
          testing, and surveillance to monitor the effects of an approved product or place conditions on an approval that could restrict the distribution or use of the product. In addition, quality control as well as drug manufacture, packaging, and
          labeling procedures must continue to conform to cGMPs after approval. Drug and biologic manufacturers and certain of their subcontractors are required to register their establishments with the FDA and certain state agencies and are subject to
          periodic unannounced inspections by the FDA during which the agency inspects manufacturing facilities to assess compliance with cGMPs. Accordingly, manufacturers must continue to expend time, money and effort in the areas of production and
          quality control to maintain compliance with cGMPs. Regulatory authorities may withdraw product approvals or request product recalls if a company fails to comply with regulatory standards, if it encounters problems following initial marketing, or
          if previously unrecognized problems are subsequently discovered.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Foreign regulatory requirements</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In addition to regulation by the FDA and certain state regulatory agencies, we are also subject to a variety of foreign regulations governing clinical trials and the
          marketing of other products. Outside of the United States, our ability to market a product depends upon receiving a marketing authorization from the appropriate regulatory agencies. The requirements governing the conduct of clinical trials,
          marketing authorization, pricing and reimbursement vary widely from country to country. In any country, however, we will only be permitted to commercialize our products if the appropriate regulatory agency is satisfied that we have presented
          adequate evidence of safety, quality and efficacy. Whether or not FDA approval has been obtained, approval of a product by the comparable regulatory authorities of foreign countries must be obtained prior to the commencement of marketing of the
          product in those countries. The regulatory approval and oversight process in other countries includes all of the risks associated with regulation by the FDA and certain state regulatory agencies as described above.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">
          <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Under the European Union regulatory system, applications for drug approval may be submitted either in a
            centralized or decentralized manner. Under the centralized procedure, a single application to the European Medicines Agency (&#8220;EMA&#8221;) may lead to an approval granted by the European Commission which permits marketing of the product throughout the
            European Union. The decentralized procedure provides for mutual recognition of nationally approved decisions and is used for products that do not comply with requirements for the centralized procedure. Under the decentralized procedure, the
            holders of national marketing authorization in one of the countries within the European Union may submit further applications to other countries within the European Union, who will be requested to recognize the original authorization based on
            an assessment report provided by the country in which marketing authorization is held.</div>

        </div>

      </div>

      <div><br />
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">18</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Pharmaceutical pricing and reimbursement</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In both United States and foreign markets, our ability to commercialize our products successfully, and to attract commercialization partners for our products, depends in
          significant part on the availability of adequate financial coverage and reimbursement from third-party payors, including, in the United States, governmental payors such as Medicare and Medicaid, managed care organizations, private commercial
          health insurers and pharmacy benefit managers, or PBMs. Third party payors are increasingly challenging the prices charged for medicines and examining their cost effectiveness, in addition to their safety and efficacy. We may need to conduct
          expensive pharmacoeconomic or other studies in order to further demonstrate the value of our products. Even with the availability of such studies, any future products of ours may be considered less safe, less effective or less cost-effective than
          alternative products, and third-party payors may not provide coverage and reimbursement for any future product candidates, in whole or in part.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Political, economic and regulatory influences are subjecting the health care industry in the United States to fundamental changes. There have been, and we expect there will
          continue to be, legislative and regulatory proposals to change the healthcare system in ways that could significantly affect our business, including the Patient Protection and Affordable Care Act of 2010 (the &#8220;Affordable Care Act&#8221;).</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">We anticipate that in the United States, Congress, state legislatures, and private sector entities will continue to consider and may adopt healthcare policies intended to
          curb rising healthcare costs. These cost containment measures could include:</div>

      </div>

      <div style="text-align: justify;">
<div><span style="color: #000000;"> </span><br /></div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">controls on government-funded reimbursement for drugs;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">mandatory rebates or additional charges to manufacturers for their products to be covered on Medicare Part D formularies;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">controls on healthcare providers;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">controls on pricing of pharmaceutical products, including the possible reference of the pricing of United States drugs to non-United States drug pricing for the same product;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">challenges to the pricing of drugs or limits or prohibitions on reimbursement for specific products through other means;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">reform of drug importation laws;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">entering into contractual agreements with payors; and</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">expansion of use of managed-care systems in which healthcare providers contract to provide comprehensive healthcare for a fixed cost per person</div>
              </td>

  </tr>


</table>
        <div><br /></div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">The Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;) contained several provisions designed to curb the prices of drugs and biologics to Medicare beneficiaries.&#160; For instance, the IRA
          will require the federal government to directly negotiate the prices of certain drugs and biologics beginning in 2026.&#160; Additionally, beginning in 2023, the IRA requires manufacturers of drugs and biologics to offer rebates if the price of the
          drug or biologic raises faster than inflation.&#160; These and other provisions in the IRA could have a material adverse effect on our business prospects.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">We are unable to predict what additional legislation, regulations or policies, if any, relating to the healthcare industry or third-party coverage and reimbursement may be enacted
          in the future or what effect such legislation, regulations or policies would have on our business. Any cost containment measures, including those listed above, or other healthcare system reforms that are adopted may have a material adverse effect
          on our business prospects.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Further, the pricing of pharmaceutical products generally, and particularly the pricing of orphan drugs, has recently received scrutiny from the press and from members of
          Congress in both parties. Some members of the medical community have also made statements in the press on the pricing of orphan drugs. The impact of this scrutiny on the pricing of orphan drugs and other pharmaceutical products generally cannot
          be determined with any certainty at this time.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">The Biologics Price Competition and Innovation Act of 2009, which was included in the Affordable Care Act, authorized the FDA to approve similar versions of innovative
          biologics, commonly known as biosimilars. Under the Affordable Care Act, a manufacturer may submit an application for licensure of a biologic product that is &#8220;biosimilar to&#8221; or &#8220;interchangeable with&#8221; a previously approved biologic product or
          &#8220;reference product.&#8221; Manufacturers may not submit an application for a biosimilar to the FDA until four years following approval of the reference product, and the FDA may not approve a biosimilar product until 12 years from the date on which the
          reference product was approved. Even if IRX-2 or any other biologic product we may acquire or in-license, if approved, are deemed to be reference products eligible for exclusivity, another company could market a competing version of that product
          if the FDA approves a full BLA for such product containing the sponsor&#8217;s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and potency of its product.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">19</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Orphan drug exclusivity</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Some jurisdictions, including the United States and Europe, may designate drugs or biologic products for relatively small patient populations as orphan drugs. Under the
          Orphan Drug Act of 1983 (&#8220;ODA&#8221;), the FDA may grant orphan drug designation to drugs or biologic products intended to treat a rare disease or condition that affects fewer than 200,000 individuals in the United States, or more than 200,000
          individuals in the United States and for which there is no reasonable expectation that the cost of developing and making available in the United States a drug for this type of disease or condition will be recovered from sales in the United States
          for that drug. In the United States, orphan drug designation must be requested before submitting an application for marketing approval. An orphan drug designation does not shorten the duration of the regulatory review and approval process. The
          grant of an orphan drug designation request does not alter the standard regulatory requirements and process for obtaining marketing approval. Safety and efficacy of a product candidate must be established through adequate and well-controlled
          studies. If a product which has been granted orphan drug designation subsequently receives the first FDA approval for the indication for which it has such designation, the product is entitled to an orphan drug exclusivity period, which means the
          FDA may not approve any other application to market the same drug for the same disease or condition for a period of seven years, except in limited circumstances, such as where an alternative product demonstrates clinical superiority to the
          product with orphan exclusivity. In addition, holders of exclusivity for orphan drugs are expected to assure the availability of sufficient quantities of their orphan drugs to meet the needs of patients. Failure to do so could result in the
          withdrawal of marketing exclusivity for the drug.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">The orphan drug exclusivity contained in the ODA has been the subject of recent scrutiny from the press, from some members of Congress and from some in the medical community.
          There can be no assurance that the exclusivity granted in ODA to orphan drugs approved by the FDA will not be modified in the future, and as to how any such change might affect our products.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">
          <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The European Orphan Drug Regulation is considered for drugs intended to diagnose, prevent or treat a
            life-threatening or very serious condition afflicting five or fewer per 10,000 people in the EU, including compounds that for serious and chronic conditions would likely not be marketed without incentives due to low market return on the
            sponsor&#8217;s development investment. The medicinal product considered should be of significant benefit to those affected by the condition. Benefits of being granted Orphan Medicinal Product Designation are significant, including ten years of
            marketing exclusivity with a potential two-year extension. The EU Community and Member States may not accept or grant for ten years a new marketing authorization or application for another drug for the same therapeutic indication as the orphan
            drug, although the ten-year period can be reduced to six years if, after the end of the fifth year, available evidence establishes that the product is sufficiently profitable not to justify maintenance of the marketing exclusivity. A
            supplementary protection certificate may extend the protection six months beyond patent expiration if that is later than the orphan drug exclusivity period. To apply for the supplementary protection, a pediatric investigation plan, or PIP, must
            be included in the market application. In Europe all drugs now seeking marketing authorization need to have a PIP agreed with the EMA before it can be approved, even if it is a drug being developed specifically for a pediatric indication. If a
            product is developed solely for use in the pediatric population, then a Pediatric Use Marketing Authorization, or PUMA, may provide eight years of data exclusivity and ten years of marketing exclusivity.</div>

        </div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Fast track designation and accelerated approval</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">The FDA is required to facilitate the development, and expedite the review, of drugs or biologics that are intended for the treatment of a serious or life-threatening disease
          or condition for which there is no effective treatment and which demonstrate the potential to address unmet medical needs for the condition. Under the fast-track program, the sponsor of a new product candidate may request that FDA designate the
          product candidate for a specific indication as a fast-track drug concurrent with, or after, the filing of the IND for the product candidate. FDA must determine if the product qualifies for fast-track designation within 60 days of receipt of the
          sponsor&#8217;s request.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">20</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Under the fast track program and FDA&#8217;s accelerated approval regulations, FDA may approve a product for a serious or life-threatening illness that provides meaningful
          therapeutic benefit to patients over existing treatments based upon a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that
          is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In clinical trials, a surrogate endpoint is a measurement of laboratory or clinical signs of a disease or condition that substitutes for a direct measurement of how a patient
          feels, functions, or survives. Surrogate endpoints can often be measured more easily or more rapidly than clinical endpoints. A product approved on this basis is subject to rigorous post-marketing compliance requirements, including the completion
          of Phase 4 or post-approval clinical trials to confirm the effect on the clinical endpoint. Failure to conduct required post-approval studies, or confirm a clinical benefit during post-marketing studies, will allow FDA to withdraw the product
          from the market on an expedited basis. All promotional materials for products approved under accelerated regulations are subject to prior review by FDA.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In addition to other benefits such as the ability to use surrogate endpoints and engage in more frequent interactions with FDA, FDA may initiate review of sections of a
          fast-track drug&#8217;s MA before the application is complete. This rolling review is available if the applicant provides, and FDA approves, a schedule for the submission of the remaining information and the applicant pays applicable user fees.
          However, FDA&#8217;s time period goal for reviewing an application does not begin until the last section of the MA is submitted. Additionally, the fast-track designation may be withdrawn by the FDA if they believe that the designation is no longer
          supported by data emerging in the clinical trial process.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Priority review</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Under FDA policies, a product candidate is eligible for priority review, or review within a six to eight-month time frame from the time a complete MA is submitted, if the
          product candidate is intended for the treatment, diagnosis, or prevention of a serious or life-threatening condition, demonstrates the potential to address an unmet medical need, or provides a significant improvement compared to marketed drugs.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Disclosure of clinical trial information</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Sponsors of clinical trials of FDA-regulated products, including drugs and biologics, are required to register and disclose certain clinical trial information. Information
          related to the product, patient population, phase of investigation, study sites and investigators, and other aspects of the clinical trial is then made public as part of the registration. Sponsors are also obligated to disclose the results of
          their clinical trials after completion. Disclosure of results of these trials can be delayed in certain circumstances for up to two years after the date of completion of the clinical trial. Competitors may use this publicly available information
          to gain knowledge regarding the progress of development programs. Finally, there can be no assurance that fast track designation will result in a faster review process.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Anti-Kickback, False Claims Laws, Stark Law &amp; the Prescription Drug Marketing Act</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In addition to FDA restrictions on marketing of pharmaceutical products, other state and federal laws have been applied to restrict certain marketing practices in the
          pharmaceutical industry in recent years. These laws include anti-kickback prohibition, statutes and false claims statutes. The federal healthcare program Anti-Kickback Statute, or Anti-Kickback Statute, prohibits, among other things, knowingly
          and willfully offering, paying, soliciting or receiving remuneration to induce or in return for purchasing, leasing, ordering or arranging for the purchase, lease or order of any healthcare item or service reimbursable under Medicare, Medicaid or
          other federally financed healthcare programs. This statute has been interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand and patients, prescribers, purchasers and formulary managers on the other. Violations of
          the Anti-Kickback Statute are punishable by imprisonment, criminal fines, civil monetary penalties, and exclusion from participation in federal healthcare programs. Although there are a number of statutory exceptions and regulatory safe harbors
          protecting certain common activities from prosecution or other regulatory sanctions, the exceptions and safe harbors are drawn narrowly, and practices that involve remuneration intended to induce prescribing, purchases or recommendations may be
          subject to scrutiny if they do not qualify for an exemption or safe harbor.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">21</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Federal false claims laws prohibit, among other things, any person from knowingly presenting, or causing to be presented, a false claim for payment to the federal government,
          or knowingly making, or causing to be made, a false statement to have a false claim paid. Recently, several pharmaceutical and other healthcare companies have been prosecuted under these laws for allegedly inflating drug prices they report to
          pricing services, which in turn were used by the government to set Medicare and Medicaid reimbursement rates, and for allegedly providing free product to customers with the expectation that the customers would bill federal programs for the
          product. In addition, certain marketing practices, including off-label promotion, may also violate false claims laws. The majority of states also have statutes or regulations similar to the Anti-Kickback Statute and false claims laws, which apply
          to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payer.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Federal law includes a provision commonly known as the &#8220;Stark Law.&#8221; This law prohibits a physician (defined to include a doctor of medicine or osteopathy, a doctor of dental
          surgery or dental medicine, a doctor of podiatric medicine, a doctor of optometry, or a chiropractor) from referring Medicare and Medicaid patients to certain types of entities with which the physician or any of the physician&#8217;s immediate family
          members have a financial relationship, unless an exception to the law&#8217;s prohibition is met. Subject to adherence to their respective criteria requirements, the self-referral prohibition contains a number of exceptions, including exceptions
          covering employment or independent contractor arrangements, space and equipment leases, and recruitment agreements.&#160; Sanctions within the Stark Law include significant civil penalties including over $25,000 for each violation, over $169,000 for
          schemes to circumvent the Stark Law restrictions, and up to $10,000 for each day an entity fails to report required information and exclusion from the federal healthcare programs.&#160; Violations of the Stark Law may also result in payment denials,
          false claim recoveries, civil monetary penalties, and/or federal program exclusion.&#160; Further, several states have enacted statutes similar in scope and purpose to the Stark Law. These state laws may mirror the federal Stark Law or may be
          different in scope. The available guidance and enforcement activity associated with such state laws varies considerably.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">The Physician Payments Sunshine Act, created under the ACA, and its implementing regulations require manufacturers of approved prescription drugs, devices, biologics, and
          medical supplies, for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program, with specific exceptions, to annually collect and report information on payments or transfers of value to physicians and
          teaching hospitals, as well as investment interests held by physicians and their immediate family members. The information reported each year is made publicly available on a searchable website. Failure to submit required information may result in
          civil monetary penalties.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In addition, several states now require prescription drug companies to report expenses relating to the marketing and promotion of drug products and to report gifts and
          payments to individual physicians in these states. Other states prohibit various other marketing-related activities. Still other states require the posting of information relating to clinical studies and their outcomes. In addition, California,
          Connecticut, Nevada, and Massachusetts require pharmaceutical companies to implement compliance programs and/or marketing codes. Several additional states are considering similar proposals. Compliance with these laws is difficult and time
          consuming, and companies that do not comply with these state laws face civil penalties.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Prescription drug advertising is subject to federal, state and foreign regulations. In the United States, the FDA, along with the Federal Trade Commission, regulates
          prescription drug promotion, including direct-to-consumer advertising. Prescription drug promotional materials must be submitted to the FDA in conjunction with their first use. Any distribution of prescription drug products and pharmaceutical
          samples must comply with the United States Prescription Drug Marketing Act, or PDMA, a part of the FDCA. In addition, Title II of the Federal Drug Quality and Security Act of 2013, known as the Drug Supply Chain Security Act, or DSCSA, has
          imposed new &#8220;track and trace&#8221; requirements on the distribution of prescription drug products by manufacturers, distributors, and other entities in the drug supply chain. The DSCSA requires product identifiers (i.e., serialization) on prescription
          drug products in order to eventually establish an electronic interoperable prescription product system to identify and trace certain prescription drugs distributed in the United States and preempts existing state drug pedigree laws and
          regulations on this topic. The DSCSA also establishes new requirements for the licensing of wholesale distributors and third-party logistic providers. The FDA is the process of finalizing regulations addressing wholesale distributors and
          third-party logistics providers. We serialize our product at both the package and homogeneous case level, pass serialization and required transaction information to our customers, and believe that we comply with all such requirements.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">22</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">The Health Insurance Portability and Accountability Act of 1996, or HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, sets
          standards governing the conduct of certain electronic healthcare transactions and protects the security and privacy of protected health information that is stored or transmitted electronically.&#160; These include standards for common healthcare
          transactions, such as: claims information, plan eligibility, payment information and the use of electronic signatures; unique identifiers for providers, employers, health plans and individuals; and security, privacy, breach notification and
          enforcement.&#160; HIPAA transaction regulations establish form, format and data content requirements for most electronic healthcare transactions, such as healthcare claims that are submitted electronically. The HIPAA privacy regulations establish
          comprehensive requirements relating to the use and disclosure of protected health information. The HIPAA security regulations establish minimum standards for the protection of protected health information that is stored or transmitted
          electronically. The HIPAA breach notification regulations establish the applicable requirements for notifying individuals, the HHS, and the media in the event of a data breach affecting protected health information. Violations of the privacy,
          security and breach notification regulations are punishable by civil and criminal penalties.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In addition to the federal HIPAA regulations, most states also have laws that regulate the collection, storage, use, retention, security, disclosure, transfer and other
          processing of health information and other confidential, sensitive and personal data. Certain of these laws grant individuals rights with respect to their information, and we may be required to expend significant resources to comply with these
          laws. For example, various states, such as California and Massachusetts, have implemented privacy laws and regulations, such as the California Confidentiality of Medical Information Act, that impose restrictive requirements regulating the use and
          disclosure of personally identifiable information, including protected health information. These laws in many cases are more restrictive than, and may not be preempted by, the HIPAA rules and may be subject to varying interpretations by courts
          and government agencies.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;">Competition</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">We have competitors both in the United States and internationally, including major multinational pharmaceutical companies, established biotechnology companies, specialty
          pharmaceutical companies, universities and other research institutions. Many of our competitors have significantly greater financial, manufacturing, marketing, product development, technical and human resources than we do. Large pharmaceutical
          companies, in particular, have extensive experience in clinical testing, obtaining marketing approvals, recruiting patients and manufacturing pharmaceutical products. Some of these companies also have significantly greater research and marketing
          capabilities than we do and may also have products or strategic partnerships with entities with products that have been approved or are in late stages of development, and collaborative arrangements in our target markets with leading companies and
          research institutions. Established pharmaceutical companies may also invest heavily to accelerate discovery and development of novel compounds or to in-license novel compounds that could make our mRNA technology platform or any therapeutic
          products that we develop obsolete. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. As a result of all of these factors,
          our competitors may succeed in obtaining patent protection and/or marketing approval or discovering, developing and commercializing products in our field before we do.</div>

      </div>

      <div style="text-align: justify;"><span style="color: #000000;"> </span><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">
          <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">There are a large number of companies developing or marketing treatments for cancer, including many major
            pharmaceutical and biotechnology companies. These treatments include both small molecule drug products, such as traditional chemotherapy, as well as novel immunotherapies. Our commercial opportunities could be reduced or eliminated if our
            competitors develop intellectual property and commercialize products that are safer, more effective, have fewer or less severe effects, are more convenient, have a broader label, are marketed more effectively, are reimbursed or are less
            expensive than any products developed using our intellectual property or that we may develop. Our competitors also may obtain FDA, EMA or other marketing approval for their products more rapidly than we may obtain approval for ours, which could
            result in our competitors establishing a strong market position before we are able to enter the market.</div>

        </div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">23</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;">Human Capital Resources</div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic;">Employees</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">We perform in a highly competitive industry and recognize that our success relies upon our ability to attract, develop and retain a diverse team of talented individuals. We
          place high value on the satisfaction and well-being of our employees and operate with fair labor standards and industry-competitive compensation and benefits. As of March 20, 2023, we had nine full-time employees, which includes four research and
          development positions and five administrative positions. None of our employees are covered by collective bargaining agreements.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Compensation, Benefits and Development</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Our approach to employee compensation and benefits is designed to deliver cash, equity and benefit programs that are competitive with those offered by leading companies in
          the biotechnology and pharmaceutical industries to attract, motivate and retain talent with a focus on encouraging performance, promoting accountability and adherence to our values and alignment with the interests of our stockholders.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Our base pay program aims to compensate staff members relative to the value of the contributions of their role, which takes into account the skills, knowledge and abilities
          required to perform each position, as well as the experience brought to the job. We may also provide our employees with opportunities to earn cash and equity incentive compensation to reward the achievement of company-wide goals that are
          established annually and designed to drive aspects of our strategic priorities that support and advance our strategy across our company. Our employees are also eligible for the grant of equity awards under our long-term incentive program that are
          designed to align interests of our employees with that of our stockholders.&#160; All employees also participate in a regular performance measurement process through which staff receive performance and development feedback, which is taken into account
          in determining annual compensation.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Our benefit programs are generally broad-based, promote health and overall well-being and emphasize saving for retirement. All employees are eligible to participate in the
          same health and retirement savings plans.</div>

      </div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic;">Code of Business Conduct and Ethics</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">We are committed to conducting business in accordance with the highest ethical standards. Our Code of Conduct and Ethics emphasizes the importance of integrity, honesty,
          forthrightness, respect and fairness.&#160; Our Code of Conduct and Ethics applies to all our employees, including those who are integrated into the Company through acquisitions.</div>

      </div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic;">Health, Safety and Well-Being</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">We actively promote the safety, health and well-being of our employees. For example, we focused on employee safety throughout the COVID-19 pandemic by implementing extensive
          safety measures, which have included, on-site COVID-19 testing protocols and flexible remote working options for most of our employees.</div>

      </div>

      <div>
        <div><br />
        </div>

        <div>
          <a id="RiskFactors"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 63pt;">
                  <div><span style="font-weight: bold; color: #000000;">ITEM 1A</span><span style="font-weight: bold; font-style: italic; color: #000000;">.</span></div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div><span style="font-weight: bold; color: rgb(0, 0, 0); font-style: italic;">Risk Factors</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div>
        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our business, financial condition and operating results can be affected by many factors, whether currently known or unknown, many of which are not exclusively within our control,
          including but not limited to those described below, any one or more of which could, directly or indirectly, cause our financial condition and operating results to differ materially from historical or anticipated future financial condition and
          operating results. Any of these factors, in whole or in part, could materially and adversely affect our business, financial condition, operating results and stock price. We urge investors to carefully consider the risk factors described below in
          evaluating our stock and the information in this Annual Report on Form 10-K, including the consolidated financial statements and the notes thereto and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221;</div>

      </div>

      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">24</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;">Risks Related to our Business and Industry</div>

      <div>&#160;</div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">We depend substantially, and expect in the future to continue to depend, on in-licensed intellectual property. Such licenses impose obligations on our business,
        and if we fail to comply with those obligations, we could lose license rights, which would substantially harm our business.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We are dependent on patents, know-how and proprietary technology licensed from Factor Limited under the Exclusive Factor License Agreement. We may in the future become party to
        additional license agreements pursuant to which we in-license key intellectual property for the development of therapeutics products both through strategic partnerships and internally. We are party to the Exclusive Factor License Agreement with
        Factor Limited, pursuant to which we acquired our mRNA technology platform. The Exclusive Factor License Agreement imposes various sublicense fees and other obligations on us. For example, we are obligated to pay the expenses incurred by Factor
        Limited in preparing, filing, prosecuting and maintaining the Factor Patents and agreed to bear all costs and expenses associated with enforcing and defending the Factor Patents in any action or proceeding arising from pursuit of sublicensing
        opportunities under the license granted under the Exclusive Factor License Agreement. Factor Limited has customary termination rights under the Exclusive Factor License Agreement, including in connection with certain uncured material breaches of
        the Exclusive Factor License Agreement and specified bankruptcy events. Any termination of our existing or future licenses could result in the loss of significant rights and would harm our business significantly.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Disputes may also arise between us and our licensors regarding intellectual property subject to a license agreement, including:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">the scope of rights granted under the license agreement and other interpretation-related issues;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">whether and the extent to which our technology and processes infringe intellectual property of the licensor that is not subject to the licensing agreement;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">our right to sublicense patents and other intellectual property to third parties under the license agreement; and</div>
              </div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">the ownership of inventions and know-how resulting from any joint creation or use of intellectual property by our licensors and us or our partners.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">If disputes over intellectual property that we have licensed, or license in the future, prevent or impair our ability to maintain our current licensing arrangements on acceptable
        terms, we may be unable to successfully enter into strategic partnerships or develop therapeutic products. In addition, the resolution of any such disputes could narrow what we believe to be the scope of our rights to the relevant intellectual
        property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations, and
        prospects.</div>

      <div>
        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">Additionally, we may have limited control over the maintenance, prosecution or enforcement of rights we in-license, and we may also have limited control over activities previously
          or separately conducted by our licensors. For example, we cannot be certain that activities conducted by Factor Limited or any other present or future licensors have been or will be conducted in compliance with applicable laws and regulations or
          will result in valid and enforceable patents and other intellectual property rights. We may also have limited control over other intellectual property that is not licensed to us but that may be related to our in-licensed intellectual property. We
          may have limited control over the manner in which our licensors initiate an infringement proceeding against a third-party infringer or the intellectual property or defend certain of the intellectual property that is licensed to us. It is possible
          that the licensors&#8217; infringement proceedings or defense activities may be less vigorous than had we conducted them ourselves.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">We are generally also subject to all of the same risks with respect to protection of intellectual property that we own, as we are for intellectual property that we license. If we
          or our licensors fail to adequately protect the intellectual property underlying our mRNA technology platform and any other in-licensed intellectual property, our ability to enter into strategic partnerships or develop and commercialize
          therapeutic products could materially suffer.</div>

        <div>&#160;</div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">25</span></div>

          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
            </div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">We may not realize the benefits of strategic partnerships that we may form in the future or of potential future product acquisitions of licenses.</div>

        <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold;"> <br />
        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;"><span style="color: #231F20;">We intend to form strategic partnerships leveraging our mRNA technology platform, and we may desire to create joint ventures of collaborations, enter into licensing
            agreements with third parties or acquire products or businesses, in each case that we believe will complement or augment this business strategy. T</span><span style="color: #000000;">hese relationships or transactions, or those like them, may
            require us to incur nonrecurring and other charges, increase our near- and long-term expenditures, issue securities that dilute our existing stockholders, reduce the potential profitability of any products that are the subject of the
            relationship or disrupt our management and business. In addition, we face significant competition in seeking appropriate strategic partnerships and transactions and the negotiation process is time-consuming and complex and there can be no
            assurance that we can enter into any of these transactions even if we desire to do so.</span></div>

        <div>&#160;</div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">Moreover, we may not be able to realize the anticipated benefit of these transactions if our strategic partners&#8217; development of therapeutic products using our in-licensed
          intellectual property does not meet our expectations. We cannot be certain that, following license, we will achieve the financial or strategic results that would justify the transaction.</div>

        <div><br />
        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">We are substantially dependent on intellectual property we in-licensed from Factor Limited, and if we lose the license to such intellectual property or the
        Exclusive Factor License Agreement is terminated for any reason, our ability to enter into strategic partnerships or develop therapeutics products would be harmed, and our business, financial condition and results of operations would be materially
        and adversely affected.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our business is dependent upon the mRNA technology platform licensed from Factor Limited. Pursuant to the Exclusive Factor License Agreement, Factor Limited has customary
        termination rights, including in connection with certain uncured material breaches of the Exclusive Factor License Agreement, failure to make payments and specified bankruptcy events. Our ability to enter into strategic partnerships or develop
        therapeutics products using the Factor Patents depends entirely on the effectiveness and continuation of the Exclusive Factor License Agreement. If we lose the right to license any of the mRNA technology platform, our ability to enter into
        strategic partnerships or develop therapeutic products in the foreseeable future would be harmed.&#160; Further, if the Exclusive Factor License Agreement is terminated, there is no guarantee that we will be able to enter into a new license agreement
        that aligns with our business strategy on the same or similar terms, if at all, and our competitors could in-license the technology, which would result in a significant market disadvantage to us.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">We or our licensors may be subject to claims challenging the inventorship or ownership of the patents and other intellectual property that we own or license now
        or in the future.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We or our licensors may be subject to claims that former employees, collaborators or other third parties have an ownership interest in the patents and intellectual property that we
        in-license or that we may own or in-license in the future. While it is our policy to require our employees or contractors who may be involved in the development of intellectual property to execute agreements assigning such intellectual property to
        us, we may be unsuccessful in executing such an agreement with each party who in fact develops intellectual property that we regard as our own or such assignment may not be self-executing, for example, as part of employment or consulting
        agreements, or may be breached. Our licensors may face similar obstacles. Litigation may be necessary to defend against any claims challenging inventorship or ownership, including in derivation proceedings in the USPTO. If we or our licensors fail
        in defending any such claims, we may have to pay monetary damages and may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property, which could adversely impact our business, results of
        operations and financial condition.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">The failure of our licensees to fulfill their financial obligations with respect to royalty payments under their license agreements or to otherwise perform under
        their license agreement could have a material adverse effect on our business, financial condition and results of operations.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our revenues may be dependent on royalty payments made to us pursuant to strategic partnership arrangements or license agreements we may enter into with respect to the mRNA
        technology platform. We anticipate that such arrangements will often require that licensees advance payment to us for royalties or other milestone payments. The failure of our licensees to satisfy their financial obligations under these
        arrangements, or their inability to operate successfully or at all, could result in a breach of an agreement, early termination of an agreement or non-renewal of an agreement, each of which could eliminate some or all of that revenue stream. A
        decrease or elimination of revenue could have a material adverse effect on our financial condition, results of operations and cash flows. During the term of a license agreement, our revenues will substantially depend on our licensees&#8217; ability to
        develop a successful product candidate with the mRNA technology platform and their failure to do so could harm our future growth and prospects. If our strategic partnerships do not meet expectations and licensees are not successful, our business,
        financial condition and results of operation could be materially adversely affected.</div>

      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">26</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">If conflicts arise between us and our future strategic partners or collaborators, these parties may act in a manner adverse to us and could limit our ability to
        implement our strategies.</div>

      <div style="text-align: justify;"><span style="color: #000000;"> </span><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">If conflicts arise between our future strategic partners or corporate or academic collaborators and us, the other party may act in a manner adverse to us and could limit our ability
        to implement our strategies. Future strategic partners or collaborators may develop, either alone or with others, products in related fields that are competitive with the products or potential products that are the subject of our collaborations
        with such partners or collaborators. Competing products, either developed by the collaborators or strategic partners or to which the collaborators or strategic partners have rights, may result in the withdrawal of partner support for any future
        product candidates based on our mRNA technology platform or other intellectual property. Our current or future strategic partners or collaborators may preclude us from entering into arrangements with their competitors, terminate their agreements
        with us prematurely, or fail to devote sufficient resources to the development and commercialization of products. Any of these developments could harm any future product development efforts, which could materially and adversely affect our business
        and operating results.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">We have identified material weaknesses in our internal control over financial reporting. If we are unable to develop and maintain an effective system of internal
        control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us, and materially and adversely affect our business and operating results.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: rgb(0, 0, 0);">
        <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In prior periods, we identified two material weaknesses as discussed below.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">We identified a material weakness that pertained to us having insufficient accounting staff available to enable and
          ensure adequate segregation of duties and our lacking appropriate and complete documentation of policies and procedures critical to the accomplishment of financial reporting objectives. In connection with this prior material weakness we
          implemented remediation measures including the following:</div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable">


  <tr>

    <td style="width: 24.5pt;"><br />
              </td>

    <td style="width: 18.35pt; vertical-align: top; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Increased the number of accounting personnel and reallocated and/or reassigned roles and responsibilities of users to accommodate increased personnel;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable">


  <tr>

    <td style="width: 24.5pt;"><br />
              </td>

    <td style="width: 18.35pt; vertical-align: top; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Completed a comprehensive risk assessment to identify, design, and implement our internal controls;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable">


  <tr>

    <td style="width: 24.5pt;"><br />
              </td>

    <td style="width: 18.35pt; vertical-align: top; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Implemented improvement and refinement of our internal controls related to our review of users with access to its key financial systems, specifically to validate
                  and evidence that all users were subject to review and access was appropriate;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable">


  <tr>

    <td style="width: 24.5pt;"><br />
              </td>

    <td style="width: 18.35pt; vertical-align: top; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Refined our review of user access controls which restrict system users from having access to create and post journal entries; and</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable">


  <tr>

    <td style="width: 24.5pt;"><br />
              </td>

    <td style="width: 18.35pt; vertical-align: top; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Completed the documentation, review, and enhancement of business policies, procedures, and related internal controls to standardize business processes.</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As a result of the above remediation measures, this prior material weakness was remediated as of December 31, 2022.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">We were unable to timely file our Q1
            2022 10Q with the SEC due to identifying errors in our financial statements reported in the Annual Report on Form 10-K for the years ended December 31, 2021 and 2020 during our preparation of the financial statements for the quarter ended March
            31, 2022. Management concluded that the errors were the result of accounting personnel&#8217;s lack of technical proficiency in complex matters. </span>This material weakness remained unremediated as of December 31, 2022. <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">We filed an amendment to our Annual Report on Form 10-K/A for the years ended December 31, 2021 and 2020 on June 30, 2022 to correct the errors in our financial statements for
            the years ended December 31, 2021 and 2020 and for the quarters ended June 30, 2020, September 30, 2020, March 31, 2021, June 30, 2021 and September 30, 2021.</span></div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">
        <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As disclosed in Part II, Item 9A to this Annual Report on Form 10-K, our Chief Executive Officer and Chief Financial Officer concluded
            that, as of December 31, 2022, our disclosure controls and procedures were not effective and did not provide reasonable assurance of achieving the desired control objectives.</div>

        </div>

      </div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">
        <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For a discussion of management&#8217;s consideration of its material weaknesses and plans for remediation, see Part II, Item 9A:
          Controls and Procedures included in this Annual Report on Form 10-K.</div>

      </div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material
        misstatement of our annual or interim financial statements will not be prevented or detected and corrected on a timely basis.</div>

      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">27</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">
        <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud. Management
          plans to implement measures designed to ensure that the deficiencies contributing to the ineffectiveness of our internal control over financial reporting are promptly remediated, such that the internal controls are designed, implemented and
          operating effectively. The remediation actions planned include: enhancing the business process controls related to reviews over technical, complex, and non-recurring transactions; and providing additional training to accounting personnel and
          consulting with an accounting advisor for technical, complex and non-recurring matters, with whom we have engaged and begun consulting. We will continue to evaluate steps to remediate the material weaknesses in addition to those currently planned
          by management. These remediation measures may be costly and there is no assurance that these initiatives will ultimately have the intended effects.</div>

      </div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">If we identify any additional material weaknesses in the future, any such newly identified material weakness could limit our ability to prevent or detect a misstatement of our
        accounts or disclosures and could result in a material misstatement of our annual or interim financial statements. In such case, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports,
        investors may lose confidence in our financial reporting and our stock price may decline as a result. We cannot assure you that the measures we have taken to date, or any measures we may take in the future, will be sufficient to avoid potential
        future material weaknesses.</div>

      <div>&#160;</div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">We may face litigation and other risks as a result of the material weaknesses in our internal control over financial reporting.</div>

      <div>&#160;</div>

      <div style="text-align: justify; color: #000000;">
        <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">We identified two material weaknesses in our internal controls over financial reporting, one of which was remediated as of December 31, 2022. As a
          result of the material weaknesses, restating our previously issued financial statements, and other matters that may in the future be raised by the SEC, we may face the potential for litigation or other disputes which may include, among others,
          claims invoking the federal and state securities laws, contractual claims or other claims arising from the material weakness in our internal control over financial reporting and the preparation of our financial statements. As of the date of this
          Annual Report on Form 10-K, we have no knowledge of any such litigation or dispute. However, we can provide no assurance that such litigation or dispute will not arise in the future. Any such litigation or dispute, whether successful or not,
          could have a material adverse effect on our business, results of operations and financial condition or our ability to complete a business combination.</div>

      </div>

      <div>&#160;</div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">Our business and operations would suffer in the event of system failures, cyber-attacks or a deficiency in our cyber-security.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000;">Our computer systems, as well as those of various third parties on which it relies, may sustain damage from computer viruses, unauthorized access, data breaches, phishing attacks, cybercriminals,
        natural disasters (including hurricanes and earthquakes), terrorism, war and telecommunication and electrical failures. We rely on our third-party providers to implement effective security measures and identify and correct for any such failures,
        deficiencies or breaches. The risk of a security breach or disruption, particularly through cyber-attacks or cyber intrusion, including by computer hackers, foreign governments and cyber terrorists, has generally increased as the number, intensity
        and sophistication of attempted attacks and intrusions from around the world have increased. If such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our drug development and other
        programs. To the extent that any disruption or security breach were to result in a loss of or damage to our data or applications, or inappropriate disclosure of personal, confidential or proprietary information, we could incur liability and the
        further development of any product candidate could be delayed.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">28</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">
        <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">We face business
            disruption and related risks resulting from a resurgence of the novel coronavirus (COVID-19) pandemic </span>or a similar pandemic health event in the future<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">.</span></div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">
          <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">In December 2019, Chinese officials
              reported a novel coronavirus (&#8220;COVID-19&#8221;) outbreak. COVID-19 has since spread throughout the world, leading the World Health Organization to declare on March 11, 2020, that COVID-19 reached the magnitude of a global pandemic. The rapid spread
              of COVID-19 throughout the U.S. led federal, state and local governments to take significant steps in an attempt to reduce exposure to COVID-19 and variants of the virus and control their negative effects on public health and the U.S.
              economy, which steps changed over time and varied by locality. The COVID-19 pandemic has subsided with the normalization of living with COVID-19 following the increase in accessibility to COVID-19 vaccines and antiviral treatments. The
              development of our product candidates was disrupted by the COVID-19 pandemic, and a resurgence of COVID-19 could disrupt production and cause delays in the supply and delivery of products used in our operations, may affect our operations,
              including the conduct of clinical studies or other collaborative activities by our strategic partners, may further divert the attention and efforts of the medical community to coping with the COVID-19 and disrupt the marketplace in which we
              operate and may have a material adverse effects on our operations. COVID-19 may also affect our employees and employees and operations at suppliers that may result in delays or disruptions in supply. In addition, a recession or market
              correction resulting from the spread of COVID-19 could materially affect our business and the value of our common stock.</span><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> A future pandemic unrelated to
              COVID-19 may lead to similar disruptions to our operations and materially affect our business and the value of our common stock.</span></div>

        </div>

      </div>

      <div>
        <div><br />
        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;">Risks Related to New, Cutting Edge Technologies</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">Because gene-editing and cell therapy product candidates that may be developed using our mRNA technology platform are based on novel technologies, we cannot
        assure that such products will be successful.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Cellular immunotherapies, stem cell therapies, gene-edited, and iPSC-derived product candidates represent relatively new therapeutic areas, and the FDA has cautioned
          consumers about potential safety risks associated with them. To date, there are relatively few approved cell therapies. As a result, the regulatory approval process for a gene-editing or cellular therapy product candidates are uncertain and may
          be more expensive and take longer than the approval process for product candidates based on other, better known or more extensively studied technologies and therapeutic approaches. For example, there are no new FDA approved products with a label
          designation that supports the use of a product to treat and reduce the severity of ARDS in patients with COVID-19, which makes it difficult to determine the clinical endpoints and data required to support an application or regulatory approval,
          and the time and cost required to obtain regulatory approval in the United States for the product candidates we or our strategic partners may develop.</div>

      </div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;"><span style="color: #000000;">Cell reprogramming technology and related cell therapy products using iPSC lines represent novel therapeutic approaches, and to our knowledge no iPSC-derived cell
            products are currently approved for commercial sale anywhere in the world. As such, it is difficult to accurately predict the type and scope of challenges that we will incur </span>effecting our plan to develop and advance a pipeline of
          therapeutic products both internally and through strategic partnerships<span style="color: #000000;">. We and our strategic partners thus face uncertainties associated with the preclinical and clinical development, manufacture, and regulatory
            compliance for the initiation and conduct of clinical trials, regulatory approval, and reimbursement required for successful commercialization of product candidates.</span></div>

      </div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">Regulatory processes in the United States governing cell therapy products have changed frequently and the FDA or other regulatory bodies may change the requirements, or identify
          different regulatory pathways, for approval of these product candidates. For example, within the FDA, the Center for Biologics Evaluation and Research, CBER, restructured and created a new Office of Tissues and Advanced Therapies, OTAT, to better
          align its oversight activities with FDA Centers for Drugs and Medical Devices. It is possible that over time new or different divisions may be established or be granted the authority for regulating cell and/or gene therapy products, including
          iPSC-derived cell products. As a result, we or our strategic partners may be required to change regulatory strategies or to modify applications for regulatory approval, which could delay and impair our ability to complete the pre-clinical and
          clinical development and manufacture of, and obtain regulatory approval for, our product candidates. Changes in regulatory authorities and advisory groups, or any new requirements or guidelines they promulgate, may lengthen the regulatory review
          process, require us to perform additional studies, increase development and manufacturing costs, lead to changes in regulatory pathways, positions and interpretations, delay or prevent approval and commercialization of product candidates
          developed through our strategic partners or lead to significant post-approval limitations or restrictions that may reduce the anticipated benefits of our strategic partnerships.</div>

        <div><br />
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">29</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Likewise, gene editing technology is relatively new, and no products based on such technology have been approved in the U.S. or the E.U. to date, and only a limited number of
          clinical trials of product candidates based on gene-editing technologies have been commenced. As such, it is difficult to accurately predict the developmental challenges we may incur pursuing our business strategy. There may be long-term effects
          from treatment with any such product candidates that we or our strategic partners may develop that we cannot predict at this time. Any such product candidates may interact with genetic material (RNA/DNA) and because animal genetic materials
          differ from human genetic material, past testing of any such product candidates in animal models may not be predictive of results in human clinical trials for safety or efficacy. As a result of these factors, it is more difficult to predict the
          time and cost of such product candidate development, and we cannot predict whether the application of gene editing technology, or other similar or competitive gene editing technologies, will result in the identification, development and
          regulatory approval of any products.</div>

      </div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">The clinical trial requirements of the FDA, the EMA and other regulatory authorities and the criteria these regulators use to determine the safety and efficacy of a product
          candidate vary substantially according to the type, complexity, novelty and intended use and market of the product candidate. No products based on gene-editing technologies have been approved by regulators to date. As a result, the regulatory
          approval process for product candidates using such technology is uncertain and may be more expensive and take longer than the approval process for product candidates based on other, better known or more extensively studied technologies. It is
          difficult to determine how long it will take or how much it will cost to obtain regulatory approvals for product candidates using this technology in either the United States or the E.U. or how long it will take to commercialize any product
          candidates. Delay or failure to obtain, or unexpected costs in obtaining, the regulatory approval necessary to bring a potential product candidate to market could decrease our ability to generate sufficient product revenue, and our business,
          financial condition, results of operations and prospects may be harmed.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Regulatory requirements in the United States and in other jurisdictions governing gene therapy products have changed frequently and may continue to change in the future. In January
        2020, the FDA issued several new guidance documents on gene therapy products. The FDA established the Office of Tissues and Advanced Therapies within its Center for Biologics Evaluation and Research to consolidate the review of gene therapy and
        related products, and established the Cellular, Tissue and Gene Therapies Advisory Committee to advise this review. Adverse developments in clinical trials of gene therapy products conducted by others may cause the FDA or other oversight bodies to
        change the requirements for approval of any of our or our strategic partners&#8217; product candidates. Similarly, the EMA governs the development of gene therapies in the EU and may issue new guidelines concerning the development and marketing
        authorization for gene therapy products and require that we comply with these new guidelines. These regulatory review agencies and committees and the new requirements or guidelines they promulgate may lengthen the regulatory review process, which
        may reduce the anticipated benefits of our strategic partnerships or adversely affect the commercialization of any future therapeutic products that we may develop.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;">Risks Related to Ownership of our Common Stock</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">We have a limited operating history and have never generated any product revenue.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">&#160;We were formed in September 2018, for the purpose of consummating a business combination with IRX Therapeutics, Inc., which business combination was consummated in November
          2018. Since inception, we have incurred significant net losses. As of December 31, 2022, we had an accumulated deficit of approximately $165.3 million. Since inception, we have financed our operations with capital contributions from the former
          beneficial holders of Eterna LLC&#8217;s Class A membership interests, as well as through the sale of our securities under the Purchase Agreements with the Investment Group and in connection with certain private placement transactions.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">We have never been profitable, have no products approved for commercial sale, and have not generated any product revenue.</div>

        <div><br />
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">30</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">While we plan to develop and advance a pipeline of therapeutic products both internally and through strategic partnerships, it is possible that none of such products will
          obtain necessary regulatory approvals or be commercialized.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Our expenses could increase beyond expectations. Even if our strategic partners successfully develop and advance therapeutic products using our mRNA technology platform or
          our other intellectual property and such products are commercialized, we may incur significant costs associated with the related strategic partnership. If we cannot successfully execute any one of the foregoing, our business may not succeed, and
          your investment will be negatively impacted.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Furthermore, we sometimes estimate for planning purposes the timing of the accomplishment of various scientific, clinical, regulatory and other product development objectives
          by our strategic partners or collaborators, as well as milestones under our strategic arrangements or sublicense agreements with third parties. These milestones may include our expectations regarding the commencement or completion of scientific
          studies, clinical trials, the submission of regulatory filings or commercialization objectives. From time to time, we may publicly announce the expected timing of some of these milestones. The achievement of these milestones by our strategic
          partners or collaborators will generally be outside of our control. All of these milestones are based on a variety of assumptions, which may cause the timing of achievement of the milestones to vary considerably from our estimates. If our
          strategic partners or collaborators fail to achieve milestones in the timeframes we expect, we may not be entitled to receive certain contractual payments, which could have a material adverse effect on our business, financial position, results of
          operations and future growth prospects.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">If we are not successful in attracting and retaining highly qualified personnel, we may not be able to successfully implement our business strategy.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Our ability to compete in the highly competitive pharmaceuticals industry depends in large part upon the ability to attract highly qualified managerial, scientific and
          medical personnel. In order to induce valuable employees to remain with us, we intend to provide employees with stock options that vest over time. The value to employees of stock options that vest over time will be significantly affected by
          movements in the price of the common stock that it will not be able to control and may at any time be insufficient to counteract more lucrative offers from other companies.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Competition for skilled personnel in our industry is intense and competition for experienced scientists may limit our ability to hire and retain highly qualified personnel on
          acceptable terms. Despite our efforts to retain valuable employees, members of our management, scientific and medical teams may terminate their employment with us on short notice. Our success also depends on our ability to continue to attract,
          retain and motivate highly skilled junior, mid-level, and senior managers as well as junior, mid-level, and senior scientific and medical personnel.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Other companies with which we compete for qualified personnel have greater financial and other resources, different risk profiles, and a longer history in the industry than
          we do, and such companies also may provide more diverse opportunities and better chances for career advancement. Some of these characteristics may be more appealing to high-quality candidates than what Eterna has to offer. If we are unable to
          continue to attract and retain high-quality personnel, the rate and success at which we can pursue our business strategy would be limited.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;">Risks Related to our Financial Position and Capital Requirements</div>

      <div>&#160;</div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">We may acquire businesses, assets or products, or form strategic alliances, in the future, and we may not realize the benefits of such acquisitions.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">We may acquire additional businesses, assets or products, form strategic alliances or create joint ventures with third parties that we believe will complement or augment our
          existing business. If we acquire businesses with promising intellectual property, markets or technologies, we may not be able to realize the benefit of acquiring such businesses if we are unable to successfully integrate them with our existing
          operations and company culture. We may encounter numerous difficulties in developing, manufacturing and marketing any new acquisition. Difficulties may prevent us from realizing its expected benefits or enhancing our business. We cannot assure
          you that, following any such acquisition, we will achieve the expected synergies to justify the transaction.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">31</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">We will require substantial additional capital to fund our operations, and if we fail to obtain the necessary financing, we may not be able to pursue our
        business strategy.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;"><span style="color: #000000;">We will require additional capital to develop and advance our pipeline of therapeutic products </span>both internally and through strategic partnerships<span style="color: #000000;">. Because the length of time and activities associated with successful development of such products by us or our strategic partners are highly uncertain, we are unable to estimate with certainty the actual funds we will
            require for development and commercialization activities. Our future funding requirements, both near- and long-term, will depend on many factors, including, but not limited to:</span></div>

      </div>

      <div style="text-align: justify;"><span style="color: #000000;"> </span><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">the cost of filing, prosecuting, defending and enforcing its patent claims and other intellectual property rights;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">the cost of defending potential intellectual property disputes, including patent infringement actions brought by third parties against us or any of our strategic partners or collaborators; and</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">the effect of competing market developments.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Based on currently available information and our ongoing operations, we believe that our existing cash will not be sufficient for us to fund our operating expenses and
          capital expenditure requirements through the twelve-month period subsequent to the issuance date of this report.&#160; We intend to raise additional sources of capital, which could be in the form of debt, grants or equity.&#160; We cannot be certain that
          additional capital will be available on acceptable terms, or at all. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back or discontinue our business
          activities, or potentially discontinue operations altogether. In addition, attempting to secure additional capital may divert the time and attention of our management from day-to-day activities and harm its ability to execute on our overall
          strategy. We are unable to estimate the amounts of increased capital outlays, operating expenditures and capital requirements associated with our current commercialization strategy.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">Raising additional funds by issuing equity securities may cause dilution to existing holders, raising additional funds through debt financings may involve
        restrictive covenants, and raising funds through lending and licensing arrangements may restrict our operations or require us to relinquish proprietary rights.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">We expect that significant additional capital will be needed in the future to continue our planned operations. Until such time, if ever, that we can generate substantial
          product revenue, directly or through our strategic partnerships, we expect to finance our cash needs through a combination of equity offerings, debt financings, strategic alliances and license and development agreements or other collaborations.
          To the extent that we raise additional capital by issuing equity securities, existing stockholder ownership may experience substantial dilution, and the securities may include preferred shares with liquidation or other preferences that could harm
          the rights of a common stockholder.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">We plan to raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, and as a result we may
          have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates, or grant licenses on terms that may not be favorable to us.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;">Risks Related to Regulatory Requirements</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">We are subject to extensive and costly government regulation.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Product candidates employing medical technology are subject to extensive and rigorous domestic government regulation including regulation by the FDA, the Centers for Medicare
          and Medicaid Services, or CMS, other divisions of the United States Department of Health and Human Services, the United States Department of Justice, state and local governments, and their respective foreign equivalents. If products employing our
          technologies are marketed abroad, they will also be subject to extensive regulation by foreign governments, whether or not they have obtained FDA approval for a given product and its uses. Such foreign regulation may be equally or more demanding
          than corresponding United States regulation.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">32</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Government regulation substantially increases the cost and risk of researching, developing, manufacturing, and selling medical products. Even if we or our strategic partners
          are able to obtain regulatory approval for a particular product, the approval may limit the indicated medical uses for the product, may otherwise limit our ability to promote, sell, and distribute the product, may require costly post-marketing
          surveillance, and/or may require ongoing post-marketing studies. Material changes to an approved product, such as, for example, manufacturing changes or revised labeling, may require further regulatory review and approval. Once obtained, any
          approvals may be withdrawn, including, for example, if there is a later discovery of previously unknown problems with the product, such as a previously unknown safety issue.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In addition, regulatory agencies may not approve the labeling claims that are necessary or desirable for the successful commercialization of a product candidate. For example,
          regulatory agencies may approve a product candidate for fewer or more limited indications than requested or may grant approval subject to the performance of post-marketing studies. Regulators may approve a product candidate for a smaller patient
          population, a different drug formulation or a different manufacturing process, than we or our strategic partners are seeking.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">Healthcare legislative reform measures and constraints on national budget social security systems may have a material adverse effect on our business and results
        of operations.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Payors, whether domestic or foreign, or governmental or private, are developing increasingly sophisticated or complex methods of controlling healthcare costs and those
          methods are not always specifically adapted for new technologies such as those we are developing. In both the United States and certain foreign jurisdictions, there have been a number of legislative and regulatory changes to the health care
          system that could impact our ability to sell our products profitably. In particular, in the United States, the Affordable Care Act, among other things, subjects biologic products to potential competition by lower-cost biosimilars; addresses a new
          methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected; increases the minimum Medicaid rebates owed by most manufacturers
          under the Medicaid Drug Rebate Program; extends the Medicaid Drug Rebate program to utilization of prescriptions of individuals enrolled in Medicaid managed care organizations; subjects manufacturers to new annual fees and taxes for certain
          branded prescription drugs; and provides incentives to programs that increase the federal government&#8217;s comparative effectiveness research.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In addition, other legislative changes have been proposed and adopted in the United States since the Affordable Care Act was enacted. In August 2011, the Budget Control Act
          of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.5 trillion for the years 2013 through 2021, was
          unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of 2% per fiscal year, which went into effect in April
          2013, and due to subsequent legislative amendments, including the BBA, will remain in effect through 2027 unless additional Congressional action is taken. The CARES Act, the Consolidated Appropriations Act of 2021, and the Act to Prevent
          Across-the-Board Direct Spending Cuts suspended the 2% sequestration mandated by the Budget Control Act of 2011 and the American Relief Act of 2011 through December 31, 2021. In December 2021, Congress extended the suspension of the automatic 2%
          reduction through March 2022 and reduced the sequestration adjustment to 1% beginning on April 1, 2022 through June 30, 2022, with the full 2% reduction for sequestration resuming thereafter. In January 2013, the American Taxpayer Relief Act of
          2012, was signed into law, which, among other things, further reduced Medicare payments to several providers, including hospitals and cancer treatment centers, and increased the statute of limitations period for the government to recover
          overpayments to providers from three to five years. We cannot anticipate whether Congress will further extend the sequestration and when the sequestration reimbursement will return.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Also, there has been heightened governmental scrutiny recently over the manner in which drug manufacturers set prices for their marketed products, which has resulted in
          several Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and
          reform government program reimbursement methodologies for drug products. For example, in November 2018, CMS issued a proposed rule for comment that would, among other things, provide Medicare prescription drug plans under Part D more transparency
          in pricing and greater flexibility to negotiate discounts for, and in certain circumstances exclude, drugs in the six &#8220;protected&#8221; formulary classes and allow Medicare Advantage plans to use certain drug management tools such as step therapy for
          physician-administered drugs. The IRA, among other things, requires drug manufacturers to offer rebates if the prices rise faster than inflation. Although a number of these, and other proposed measures will require authorization through
          additional legislation to become effective, Congress and the Biden administration has each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">33</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">There have been, and likely will continue to be, legislative and regulatory proposals at the foreign, federal and state levels directed at broadening the availability of
          healthcare and containing or lowering the cost of healthcare. We cannot predict the initiatives that may be adopted in the future. The continuing efforts of these governments and other payors to contain or reduce costs of healthcare and/or impose
          price controls may adversely affect:</div>

      </div>

      <div style="text-align: justify;"><span style="color: #000000;"> </span><br />
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">the demand for our or our strategic partners&#8217; product candidates, if we or they obtain regulatory approval;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">the ability to set a price that we believe is fair for such products;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">our ability to generate revenue and achieve or maintain profitability;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">the level of taxes that we are required to pay; and</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">the availability of capital.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Any denial in coverage or reduction in reimbursement from Medicare or any other government programs may result in a similar denial or reduction in payments from private
          payors, which may adversely affect our future profitability.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;">Risks Relating to Eterna&#8217;s Intellectual Property</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">If we are unable to obtain and maintain patent and other intellectual property protection, or if the scope of the patent and other intellectual property
        protection obtained is not sufficiently broad, our competitors could develop and commercialize products similar or identical to those derived from our intellectual property, and our ability to achieve profitability may be adversely affected.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">
          <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Our ability to compete effectively will depend, in part, on our ability to maintain the proprietary nature of our technology and
            manufacturing processes. We rely on research, manufacturing and other know-how, patents, trade secrets, license agreements and contractual provisions to establish our intellectual property rights. These legal means, however, afford only limited
            protection and may not adequately protect our rights. <br />
          </div>

        </div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In certain situations, and as considered appropriate, we have sought, and we intend to continue to seek to protect our proprietary position by filing patent applications in
          the United States and, in at least some cases, one or more countries outside the United States relating to future products and product candidates that we or our strategic partners or collaborators may develop that are important to our business.
          However, we cannot predict whether the patent applications currently being pursued will issue as patents, or whether the claims of any resulting patents will provide us with a competitive advantage or whether we will be able to successfully
          pursue patent applications in the future relating to such products and product candidates. Moreover, the patent application and approval processes are expensive and time-consuming. We may not be able to file and prosecute all necessary or
          desirable patent applications at a reasonable cost or in a timely manner. Furthermore, we, or any future partners, collaborators, or licensees, may fail to identify patentable aspects of inventions made in the course of development and
          commercialization activities before it is too late to obtain patent protection on them. Therefore, we may miss potential opportunities to seek additional patent protection. It is possible that defects of form in the preparation or filing of
          patent applications may exist, or may arise in the future, for example with respect to proper priority claims, inventorship, claim scope, or requests for patent term adjustments. If we fail to establish, maintain or protect such patents and other
          intellectual property rights, such rights may be reduced or eliminated. If there are material defects in the form, preparation, prosecution or enforcement of our patents or patent applications, such patents may be invalid and/or unenforceable,
          and such applications may never result in valid, enforceable patents.</div>

      </div>

      <div><br /></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">34</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Even if they are unchallenged, our patents and patent applications, if issued, may not provide us with any meaningful protection or prevent competitors from designing around
          our patent claims by developing similar or alternative technologies or therapeutics in a non-infringing manner. For example, a third party may develop a competitive therapy that provides benefits similar to one or more of the future products and
          product candidates that we or our strategic partners or collaborators may develop but that falls outside the scope of our patent protection. If the patent protection provided by the patents and patent applications we hold or pursue with respect
          to such product candidates is not sufficiently broad to impede such competition, the successful commercialization of such product candidates could be negatively affected.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Other parties, many of whom have substantially greater resources and have made significant investments in competing technologies, have developed or may develop technologies
          that may be related or competitive with our approach, and may have filed or may file patent applications and may have been issued or may be issued patents with claims that overlap or conflict with our patent applications, either by claiming the
          same compositions, formulations or methods or by claiming subject matter that could dominate our patent position. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States. As a
          result, any patents we may obtain in the future may not provide us with adequate and continuing patent protection sufficient to exclude others from commercializing products similar to future products and product candidates that we or our
          strategic partners or collaborators may develop.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain. No consistent policy regarding the breadth of claims allowed in biotechnology
          and pharmaceutical patents has emerged to date in the United States or in many foreign jurisdictions. In addition, the determination of patent rights with respect to pharmaceutical compounds commonly involves complex legal and factual questions,
          which has in recent years been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our competitors may also seek approval to market their own
          products similar to or otherwise competitive with our products. Alternatively, our competitors may seek to market generic versions of any approved products by submitting ANDAs or ABLAs to the FDA in which they claim that our patents are invalid,
          unenforceable or not infringed. In these circumstances, we may need to defend or assert our patents, or both, including by filing lawsuits alleging patent infringement. In any of these types of proceedings, a court or other agency with
          jurisdiction may find our patents invalid or unenforceable, or that our competitors are competing in a non-infringing manner. Thus, even if we have valid and enforceable patents, these patents still may not provide protection against competing
          products or processes sufficient to achieve our business objectives.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In addition to patent protection, we expect to rely heavily on trade secrets, know-how and other unpatented technology, which are difficult to protect. Although we seek such
          protection in part by entering into confidentiality agreements with our vendors, employees, consultants and others who may have access to proprietary information, we cannot be certain that these agreements will not be breached, adequate remedies
          for any breach would be available, or our trade secrets, know-how and other unpatented proprietary technology will not otherwise become known to or be independently developed by our competitors. If we are unsuccessful in protecting our
          intellectual property rights, sales of our products may suffer and our ability to generate revenue could be severely impacted.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000;"><span style="font-weight: bold; font-style: italic;">Issued patents covering future products and product candidates that we or our strategic partners or collaborators may develop</span>&#160;<span style="font-weight: bold; font-style: italic;">could be found invalid or unenforceable if challenged in court or in administrative proceedings. We may not be able to protect our trade secrets in court.</span></div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">If we initiate legal proceedings against a third-party to enforce a patent covering future products and product candidates that we or our strategic partners or collaborators
          may develop, the defendant could counterclaim that the patent covering such products or product candidates is invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are
          commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, written description or non-enablement. Grounds for an unenforceability assertion
          could be an allegation that someone connected with prosecution of the patent withheld information material to patentability from the USPTO, or made a misleading statement, during prosecution. Third parties also may raise similar claims before
          administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include re- examination, post grant review, inter partes review and equivalent proceedings in foreign jurisdictions. An adverse
          determination in any of the foregoing proceedings could result in the revocation or cancellation of, or amendment to, our patents in such a way that they no longer cover future products and product candidates that we or our strategic partners or
          collaborators may develop. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which the
          patent examiner and we were unaware during prosecution. If a defendant or third party were to prevail on a legal assertion of invalidity or unenforceability, we could lose at least part, and perhaps all, of the patent protection on one or more of
          the future products and product candidates that we or our strategic partners or collaborators may develop. Such a loss of patent protection could have a material adverse impact on our business.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">35</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In addition, our trade secrets may otherwise become known or be independently discovered by competitors. Competitors and other third parties could purchase future products
          and product candidates that we or our strategic partners or collaborators may develop and attempt to replicate some or all of the competitive advantages we derive from our development efforts, willfully infringe, misappropriate or otherwise
          violate our intellectual property rights, design around our protected technology or develop their own competitive technologies that fall outside of our intellectual property rights. If any of our trade secrets were to be lawfully obtained or
          independently developed by a competitor or other third party, we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us. If our trade secrets are not adequately
          protected or sufficient to provide an advantage over our competitors, our competitive position could be adversely affected, as could our business. Additionally, if the steps taken to maintain our trade secrets are deemed inadequate, we may have
          insufficient recourse against third parties for misappropriating our trade secrets.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by
        governmental patent agencies, and our patent protection could be reduced or eliminated for non- compliance with these requirements.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on patents and applications are required to be paid to the USPTO and various
          governmental patent agencies outside of the United States in several stages over the lifetime of the patents and applications. The USPTO and various non-U.S. governmental patent agencies require compliance with a number of procedurals,
          documentary, fee payment and other similar provisions during the patent application process and after a patent has issued. There are situations in which non- compliance can result in abandonment or lapse of the patent or patent application,
          resulting in partial or complete loss of patent rights in the relevant jurisdiction. The terms of one or more licenses that we enter into the future may not provide us with the ability to maintain or prosecute patents in the portfolio and must
          therefore rely on third parties to do so. If we fail to obtain and maintain the patents and patent applications covering our products or procedures, we may not be able to stop a competitor from marketing products that are the same as our product
          candidates, which could have a material adverse effect on our business.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">If we do not obtain patent term extension and data exclusivity for future products and product candidates that we or our strategic partners or collaborators may
        develop, our business may be materially harmed.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest
          U.S. non-provisional filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering future products and product candidates that we or our strategic partners or
          collaborators may develop are obtained, once the patent life has expired for a product candidate, we or our strategic partners or collaborators may be open to competition from competitive products. Given the amount of time required for the
          development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our patent portfolio may not provide us with sufficient
          rights to exclude others from commercializing products similar or identical to ours.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In the future, if we obtain an issued patent covering one of future products and product candidates that we or our strategic partners or collaborators may develop, depending
          upon the timing, duration and specifics of any FDA marketing approval of such product candidates, such patent may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, or
          Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit a patent extension term of up to five years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a
          patent beyond a total of 14 years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for using it or a method for manufacturing it may be extended. A patent may only be
          extended once and only based on a single approved product. However, we may not be granted an extension because of, for example, failure to obtain a granted patent before approval of a product candidate, failure to exercise due diligence during
          the testing phase or regulatory review process, failure to apply within applicable deadlines, failure to apply prior to expiration of relevant patents or otherwise our failure to satisfy applicable requirements. A patent licensed to us by a third
          party may not be available for patent term extension. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or the term of any such
          extension is less than we request, our competitors may obtain approval of competing products following our patent expiration, and our revenue could be reduced, possibly materially.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">36</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">Changes in patent law in the United States and other jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect
        future products and product candidates that we or our strategic partners or collaborators may develop.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Changes in either the patent laws or the interpretation of the patent laws in the United States or other jurisdictions could increase the uncertainties and costs surrounding
          the prosecution of patent applications and the enforcement or defense of issued patents. On September 16, 2011, the Leahy-Smith America Invents Act, or the Leahy-Smith Act, was signed into law. When implemented, the Leahy-Smith Act included
          several significant changes to U.S. patent law that impacted how patent rights could be prosecuted, enforced and defended. In particular, the Leahy-Smith Act also included provisions that switched the United States from a &#8220;first-to-invent&#8221; system
          to a &#8220;first-to-file&#8221; system, allowed third- party submission of prior art to the USPTO during patent prosecution and set forth additional procedures to attack the validity of a patent by the USPTO administered post grant proceedings. Under a
          first-to-file system, assuming the other requirements for patentability are met, the first inventor to file a patent application generally will be entitled to the patent on an invention regardless of whether another inventor had made the
          invention earlier. The USPTO developed new regulations and procedures governing the administration of the Leahy-Smith Act, and many of the substantive changes to patent law associated with the Leahy-Smith Act, and in particular, the first to file
          provisions, only became effective on March 16, 2013. Some of the Company&#8217;s patents and patent applications have effective dates later than March 16, 2013 and thus will be subject to the provisions of the Leahy-Smith Act.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In addition, the patent positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. Recent rulings from the
          U.S. Court of Appeals for the Federal Circuit and the U.S. Supreme Court have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. This combination of events
          has created uncertainty with respect to the validity and enforceability of patents, once obtained. Depending on future actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in
          unpredictable ways that could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce our intellectual property in the future.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">We may not be able to protect our intellectual property rights throughout the world.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Filing, prosecuting, maintaining, defending and enforcing patents on products and product candidates in all countries throughout the world would be prohibitively expensive,
          and our intellectual property rights in some countries outside the United States could be less extensive than those in the United States. The requirements for patentability may differ in certain countries, particularly in developing countries;
          thus, even in countries where we do pursue patent protection, there can be no assurance that any patents will issue with claims that cover our products. There can be no assurance that we will obtain or maintain patent rights in or outside the
          United States under any future license agreements. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to
          prevent third parties from utilizing our inventions in all countries outside the United States, even in jurisdictions where we pursue patent protection, or from selling or importing products made using our inventions in and into the United States
          or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not pursued and obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we
          have patent protection, but enforcement is not as strong as that in the United States. These products may compete with future products and product candidates that we or our strategic partners or collaborators may develop and our patents or other
          intellectual property rights may not be effective or sufficient to prevent them from competing.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">37</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain
          countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to biotechnology and pharmaceutical products, which could make it
          difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. For example, many foreign countries have compulsory licensing laws under which a patent owner must grant
          licenses to third parties. Proceedings to enforce our patent rights, even if obtained, in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at
          risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other
          remedies awarded, if any, may not be commercially meaningful. While we intend to protect our intellectual property rights in major markets for our products, we cannot ensure that we will be able to initiate or maintain similar efforts in all
          jurisdictions in which we may wish to market our products. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we
          develop.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">We may be subject to claims by third parties asserting that our employees or we have misappropriated their intellectual property or claiming ownership of what we
        regard as our own intellectual property.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Many of our current and former employees, including our senior management, were previously employed at universities or at other biotechnology or pharmaceutical companies,
          including some which may be competitors or potential competitors. Some of these employees may be subject to proprietary rights, non-disclosure and non- competition agreements, or similar agreements, in connection with such previous employment.
          Although we try to ensure that our employees do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these employees have used or disclosed intellectual property, including trade
          secrets or other proprietary information, of any such third party. Litigation may be necessary to defend against such claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual
          property rights or personnel or sustain damages. Such intellectual property rights could be awarded to a third party, and we could be required to obtain a license from such third party to commercialize our technology or products. Such a license
          may not be available on commercially reasonable terms or at all. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In addition, while we typically require our employees, consultants and contractors who may be involved in the development of intellectual property to execute agreements
          assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who in fact develops intellectual property that we regard as our own, which may result in claims by or against us related to the
          ownership of such intellectual property. If we fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights. Even if we are successful in prosecuting or defending
          against such claims, litigation could result in substantial costs and be a distraction to our senior management and scientific personnel.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">We may become involved in lawsuits to protect or enforce our patents and other intellectual property rights, which could be expensive, time-consuming and
        unsuccessful.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Competitors may infringe our patents, trademarks, copyrights or other intellectual property. To counter infringement or unauthorized use, we may be required to file
          infringement claims, which can be expensive and time consuming and divert the time and attention of our management and scientific personnel. In addition, our patents may become, involved in inventorship, priority, or validity disputes. To counter
          or defend against such claims can be expensive and time-consuming, and our adversaries may have the ability to dedicate substantially greater resources to prosecuting these legal actions than we can. Any claims we assert against perceived
          infringers could provoke these parties to assert counterclaims against us alleging that we infringe their patents, in addition to counterclaims asserting that our patents are invalid or unenforceable, or both.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In an infringement proceeding, a court may decide that a patent is invalid or unenforceable or may refuse to stop the other party from using the technology at issue on the
          grounds that our patents do not cover the technology in question. Accordingly, despite our efforts, we may not be able to prevent third parties from infringing upon or misappropriating intellectual property rights we own or control. An adverse
          result in any litigation proceeding could put one or more of our owned or in-licensed patents at risk of being invalidated or interpreted narrowly. Further, because of the substantial amount of discovery required in connection with intellectual
          property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">38</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Even if resolved in our favor, the court may decide not to grant an injunction against further infringing activity and instead award only monetary damages, which may or may
          not be an adequate remedy. Litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our personnel from their normal responsibilities. In addition, there could be
          public announcements of the results of hearings, motions, or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our
          common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing, or distribution activities.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such
          litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation
          or other proceedings could have a material adverse effect on our ability to compete in the marketplace.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic; font-weight: bold;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our marks of interest and our business may
        be adversely affected.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Our trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We rely on both registration and
          common law protection for our trademarks. We may not be able to protect our rights to these trademarks and trade names or may be forced to stop using these names, which we need for name recognition by potential partners or customers in our
          markets of interest. During trademark registration proceedings, we may receive rejections. Although we would be given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, with the USPTO and
          with comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against our
          trademarks, and our trademarks may not survive such proceedings. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected.</div>

      </div>

      <div><br /></div>

      <a id="UnresolvedStaffComments"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 1B.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-style: italic; font-weight: bold;">Unresolved Staff Comments</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-indent: 36pt; color: #000000;">We do not have any unresolved comments issued by the SEC Staff.</div>

      <div>&#160;</div>

      <a id="Properties"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 2.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-style: italic; font-weight: bold;">Properties</div>
            </td>

  </tr>


</table>
      <div>
        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">We currently lease approximately 49,000 square feet of office and laboratory space in New York and Massachusetts, of which, approximately 45,000 square feet is attributable to a
          new sublease of office and laboratory space in Somerville, Massachusetts that we entered into in October 2022. We intend to begin building out the Somerville leased space in the second quarter of 2023, which we expect to be substantially complete
          during the fourth quarter of 2023. The terms of our leases expire from December 2026 through approximately December 2032. We believe that our leased property meets our current needs.</div>

      </div>

      <div>&#160;</div>

      <a id="LegalProceedings"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 3.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-style: italic; font-weight: bold;">Legal Proceedings</div>
            </td>

  </tr>


</table>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">From time to time, we become involved in litigation and arbitrations in the ordinary course of business. Legal fees and other costs associated with such actions are expensed
          as incurred. In addition, we assess the need to record a liability for litigation and contingencies. We reserve for costs relating to these matters when a loss is probable, and the amount can be reasonably estimated.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="text-decoration: underline;">Dhesh Govender v. Eterna Therapeutics LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021)</span></div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">On or about February 5, 2021, Dhesh Govender, a former short-term consultant of Eterna LLC, filed a complaint against Eterna LLC and certain individuals that plaintiff
          alleged were directors of Eterna LLC. Plaintiff alleged that Eterna LLC and certain of its officers and directors (&#8220;Govender defendants&#8221;) engaged in unlawful and discriminatory conduct based on race, national origin and hostile work environment.
          Plaintiff also asserted various breach of contract, fraud and quantum meruit claims based on an alleged oral agreement pursuant to which he alleged Eterna LLC agreed to hire him as an executive once the Merger was completed. On December 15, 2022,
          the parties executed a Confidential Settlement Agreement and Release of All Claims. On January 11, 2023, the parties filed a Stipulation to Discontinue in the Court action. Also on January 11, 2023, Govender voluntarily dismissed the arbitration.</div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">39</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-indent: 36pt; color: rgb(0, 0, 0);"><span style="text-decoration: underline;">John Westman v. Novellus, Inc., Christopher Rohde, and Matthew Angel, Civil Action No. 2181CV01949 (Middlesex County (Massachusetts) Superior Court)</span></div>

      </div>

      <div>
        <div><br />
        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On or about September 7, 2021, John Westman, a former employee of Novellus, Inc. filed a Complaint in Middlesex County (Massachusetts) Superior Court against Novellus, Inc. and
        Novellus, Inc.&#8217;s founders and former executives, Dr. Christopher Rohde and Dr. Matthew Angel.&#160; The case includes allegations that Novellus, Inc. violated the Massachusetts Wage Act (&#8220;Wage Act&#8221;).&#160; Eterna acquired Novellus, Inc. on July 16, 2021.&#160;
        Mr. Westman&#8217;s claims relate to alleged conduct that took place before Eterna acquired Novellus, Inc.&#160;&#160; Westman agreed to dismiss the lawsuit and proceed with his claims in arbitration.&#160; Following mediation, the parties settled this dispute in
        December 2022.</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The aggregate settlement amount payable by the Company for the two matters discussed above is approximately $0.5 million.</div>

      <div>&#160;</div>

      <div style="text-indent: 36pt; color: #000000;"><span style="text-decoration: underline;">Novellus, Inc. v. Sowyrda et al., C.A. No. 2184CV02436-BLS2</span></div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">On October 25, 2021 Novellus, Inc. filed a complaint in the Superior Court of Massachusetts, Suffolk County, against former Novellus, Inc. employees Paul Sowyrda and John Westman
          and certain other former investors in Novellus LLC (Novellus, Inc.&#8217;s former parent company prior to our acquisition of Novellus, Inc.), alleging breach of fiduciary duty, breach of contract and civil conspiracy. Eterna acquired Novellus, Inc. on
          July 16, 2021.&#160; On May 27, 2022 Novellus, Inc. amended the complaint to withdraw all claims against all defendants except Paul Sowyrda and John Westman.&#160; On July 1, 2022, Westman filed a motion to compel arbitration or in the alternative, to stay
          the litigation pending the disposition of certain litigation in the Court of Chancery for the State of Delaware filed by Mr. Sowyrda against Novellus LLC, Dr. Christopher Rohde, Dr. Matthew Angel, Leonard Mazur and Factor Bioscience, Inc.
          captioned <span style="font-style: italic;">Zelickson et al., v. Angel et al.,</span> C.A. 2021-1014-JRS and by Westman against Novellus LLC captioned <span style="font-style: italic;">Westman v. Novellus LLC</span>, C.A. No. 2021-0882-NAC (the
          &#8220;Delaware Actions&#8221;).&#160; On July 1, 2022, Sowyrda answered the complaint and asserted counterclaims against Novellus, Inc, and third-party defendants Dr. Matthew Angel and Dr. Christopher Rohde alleging violations of the Massachusetts Wage Act,
          Massachusetts Minimum Fair Wage Law, the Fair Labor Standards Act, breach of contract, unjust enrichment and quantum meruit.&#160; Sowyrda also joined in Westman&#8217;s motion to stay the case pending the Delaware Actions.&#160; Novellus, Inc.&#8217;s claims and Mr.
          Sowyrda&#8217;s counterclaims relate to alleged conduct that took place before Eterna acquired Novellus, Inc.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On November 15, 2022, prior to a decision on Westman&#8217;s and Sowyrda&#8217;s motion to compel or stay, the Parties agreed to voluntarily dismiss and
            consolidate the Delaware Actions with this action.&#160; On December 15, 2022, Sowyrda filed an Amended Answer to the Amended Complaint, asserted affirmative defenses and filed Amended Counterclaims against Dr. Angel, Dr. Rohde, Novellus LLC,
            Novellus Inc., Factor Bioscience Inc., and Eterna Therapeutics Inc. (&#8220;Counterclaim Defendants&#8221;) alleging against various Counterclaim Defendants breach of contract, breaches of the implied duty of good faith and fair dealing, breaches of
            fiduciary duty, breaches of the operating agreement, aiding and abetting breaches of fiduciary duty, tortious interference with contract, equitable accounting, violations of the Massachusetts Wage Act, Massachusetts Minimum Fair Wage Law, the
            Fair Labor Standards Act, unjust enrichment, and quantum meruit.&#160; Also on December 15, 2022, Westman filed an answer to the Amended Complaint and asserted similar counterclaims against the same Counterclaim Defendants.&#160; Westman and Sowyrda each
            asserted claims for indemnification and/or advancement against Novellus, Inc.&#160; On January 11, 2023, Westman and Sowyrda served a joint motion to enforce their advancement and/or indemnification rights against Novellus Inc.&#160; Novellus Inc.
            vigorously opposes this motion and served its opposition on January 27, 2023.&#160; On February 8, 2023, Westman and Sowyrda served a reply in support of their motion to enforce indemnification/advancement rights, and submitted the motion to the
            Court.&#160; Novellus Inc. answered Westman and Sowyrda&#8217;s counterclaims on January 27, 2023, denying liability.&#160; The remaining Counterclaim Defendants served a motion to dismiss most of the remaining counterclaims on January 27, 2023.&#160; Sowyrda&#8217;s and
            Westman&#8217;s oppositions to the motion to dismiss were served on March 3, 2023, and Counterclaim Defendants&#8217; reply is due March 24, 2023, at which point the motion to dismiss will be fully briefed.&#160; The Court announced that it would hold oral
            argument on April 5, 2023 on (a) the Counterclaim Defendants&#8217; motion to dismiss, and (b) Sowyrda&#8217;s and Westman&#8217;s motion to enforce.&#160;&#160; The parties attended an initial status and scheduling conference with the Court on February 7, 2023.&#160; The
            Court deferred entering a case scheduling until after the April 5 hearing.</div>

        </div>

      </div>

      <div>&#160;</div>

      <div>
        <a id="MineSafetyDisclosures"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54.05pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 4.</td>

    <td style="vertical-align: top;">
                <div style="color: #000000; font-style: italic; font-weight: bold;">Mine Safety Disclosures</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-indent: 36pt; color: #000000;"> <br />
      </div>

      <div style="text-indent: 36pt; color: #000000;">Not Applicable.</div>

      <div style="text-indent: 36pt; color: #000000;"> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">40</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: center; color: #000000; font-weight: bold;">PART II</div>

      <div>&#160;</div>

      <a id="MarketforRegistrantsCommo"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 55.1pt; vertical-align: top; color: #000000; font-weight: bold;">ITEM 5.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</div>
            </td>

  </tr>


</table>
      <div>
        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our common stock is listed on The Nasdaq Capital Market under the symbol &#8220;ERNA.&#8221;</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">
          <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As of March 20, 2023, there were approximately 145 stockholders of record based on the actual number of holders registered on
            our books at such date.</div>

        </div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">We have 156,112 shares of Series A Preferred Stock issued and outstanding. The Series A Preferred Stock provides for a cumulative annual dividend of 10 cents per share, payable in
          semi-annual installments in June and December. Dividends may be paid in cash or in shares of our common stock. In 2022, we paid approximately $16,000 in cash dividends to the holders of our Series A Preferred Stock.&#160; We expect to pay the
          dividends on our Series A Preferred Stock in accordance with its terms, though we may elect to pay the dividend in shares of our common stock in the future.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">We have not declared or paid any cash dividends on our common stock. No cash dividends have been previously paid on our common stock and none are anticipated in 2023.</div>

        <div><br />
        </div>

      </div>

      <div style="text-indent: 36pt; color: #000000;">For information regarding securities authorized for issuance under our equity compensation plans, see Part III, Item 12, &#8220;Security Ownership of Certain Beneficial Owners and Management and Related
        Stockholder Matters.&#8221;</div>

      <div>&#160;</div>

      <div>
        <a id="Reserved"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 54pt;">
                <div style="text-align: justify;"><span style="font-weight: bold; color: #000000;">ITEM 6.</span></div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify;"><span style="font-weight: bold; color: rgb(0, 0, 0); font-style: italic;">[Reserved]</span></div>
              </td>

  </tr>


</table>
      </div>

      <div>&#160;</div>

      <a id="ManagementsDiscussionandA"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 55.1pt; vertical-align: top; color: #000000; font-weight: bold;">ITEM 7.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">This Annual Report on Form 10-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (&#8220;PSLRA&#8221;), Section 27A of the
          Securities Act of 1933, as amended, (the &#8220;Securities Act&#8221;), and Section 21E of the Exchange Act, about our expectations, beliefs, or intentions regarding our product development efforts, business, financial condition, results of operations,
          strategies and prospects. You can identify forward-looking statements by the fact that these statements do not relate to historical or current matters. Rather, forward-looking statements relate to anticipated or expected events, activities,
          trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ
          materially from any future results expressed or implied by the forward-looking statements. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements.
          These factors include those contained in &#8220;Item 1A &#8212; Risk Factors&#8221; of this Annual Report on Form 10-K. We do not undertake any obligation to update forward-looking statements except as required by applicable law. We intend that all forward-looking
          statements be subject to the safe harbor provisions of PSLRA. These forward-looking statements reflect our views only as of the date they are made.</div>

      </div>

      <div>&#160;</div>

      <div style="text-align: justify; color: #000000; font-weight: bold;">Overview</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We are a preclinical-stage biopharmaceutical company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines.&#160; We have
        in-licensed a portfolio of over 100 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> and UltraSlice<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> gene-editing proteins, and the ToRNAdo<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> mRNA
        delivery system, which we collectively refer to as our &#8220;mRNA technology platform.&#8221; We plan to develop and advance a pipeline of therapeutic products, both internally and through strategic partnerships, with the near-term focus on deploying our mRNA
        technology platform through strategic partnerships.&#160; We license our mRNA technology platform from Factor Limited under an exclusive license agreement.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">41</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="color: #000000; font-weight: bold;">Basis of Presentation</div>

      <div style="color: #000000;">&#160;</div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Revenues</div>

      <div style="color: #000000;">&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We are a pre-clinical stage company and have had no revenues from product sales to date. We will not have revenues from product sales until such time as we receive regulatory
        approval of our product candidates, successfully commercialize our products or enter into a licensing agreement with respect to our intellectual property, which may include up-front licensing fees, of which there can be no assurance.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Research and Development Expenses</div>

      <div style="color: #000000;">&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We expense our research and development costs as incurred. Our research and development expenses consist of costs incurred for company-sponsored research and development activities,
        as well as support for selected investigator-sponsored research. Upfront payments and milestone payments for the licensing of technology are expensed as research and development in the period in which they are incurred if the technology is not
        expected to have any alternative future uses other than the specific research and development project for which it was intended. In-process research and development (&#8220;IPR&amp;D&#8221;) that we acquire and which has no alternative future uses and,
        therefore, no separate economic values, is expensed to research and development costs at the time the costs are incurred.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The major components of research and development costs have included preclinical study costs, clinical manufacturing costs, clinical study and trial expenses, insurance coverage for
        clinical trials, expensed licensed technology, consulting, scientific advisors and other third-party costs, salaries and employee benefits, stock-based compensation expense, supplies and materials and allocations of various overhead costs related
        to our product development efforts.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; color: #000000;">We have contracted with third parties to perform various clinical study and trial activities in the development and testing of potential
        products. The financial terms of these agreements vary from contract to contract and may result in uneven payment flows. We accrue for third party expenses based on estimates of the services received and efforts expended during the reporting
        period.&#160; If the actual timing of the performance of the services or the level of effort varies from the estimate, the accrual is adjusted accordingly.&#160; The expenses for some third-party services may be recognized on a straight-line basis if the
        expected costs are expected to be incurred ratably during the period. Payments under the contracts depend on factors such as the achievement of certain events or milestones, the successful enrollment of patients, the allocation of responsibilities
        among the parties to the agreement, and the completion of portions of the clinical study or trial or similar conditions. Preclinical and clinical study and trial associated activities such as production and testing of clinical material require
        significant up-front expenditures.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">General and Administrative Expenses</div>

      <div style="color: #000000;">&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our general and administrative expenses consist primarily of salaries, benefits and other costs, including equity-based compensation, for our executive and administrative personnel,
        legal and other professional fees, travel, insurance, and other corporate costs.</div>

      <div style="text-align: justify;"><span style="color: #000000;"> </span><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">42</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; color: #000000; font-weight: bold;">Comparison of the Years Ended December 31, 2022 and 2021</div>

        <div style="text-align: justify; color: #000000; font-weight: bold;"> <br />
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" rowspan="1" colspan="6">
              <div style="text-align: center; font-weight: bold;">Years ended December 31,</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2"><br />
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;"> 2022</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">2021</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">Change</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="font-style: italic; font-weight: bold;">(in thousands)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div>Operating expenses:</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div>Research and development</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>10,392</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>12,705</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(2,313</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div>Impairment of in-process research and development</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>5,990</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>5,990</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div>In-process research and development</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>80,538</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(80,538</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div>General and administrative</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>16,835</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>14,724</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>2,111</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>Transaction costs</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>5,765</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(5,765</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Total operating expenses</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>33,217</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>113,732</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(80,515</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
              <div>Loss from operations</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div>(33,217</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div>(113,732</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div>80,515</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div>Other income (expense), net:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div>Loss on sale of NTN assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(9,648</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>9,648</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div>Change in fair value of warrant liabilities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>10,795</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>10,795</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div>Loss on non-controlling investment</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(941</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(941</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
              <div>Other (expense) income, net</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div>(1,171</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div>899</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div>(2,070</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Total other income (expense), net</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>8,683</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(8,749</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>17,432</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div>Loss before income taxes</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(24,534</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(122,481</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>97,947</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div>Provision for income taxes</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(45</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(64</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>19</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;">
              <div>Net loss</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>(24,579</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>(122,545</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>97,966</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Research and Development Expenses</div>

      <div style="color: #000000;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="10">
              <div style="text-align: center; font-weight: bold;">Years ended December 31,</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;"> 2022</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">2021</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">Change</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="font-style: italic; font-weight: bold;">(in thousands)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div>License and MSA expense</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>4,761</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>6,500</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(1,739</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div>Payroll-related</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>2,426</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>2,342</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>84</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div>Stock-based compensation</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>1,249</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>1,597</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(348</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div>Clinical</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>1,047</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>1,292</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(245</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>Other expenses, net</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>909</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>974</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(65</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;">
              <div style="margin-left: 9pt;">Total research and development expenses</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>10,392</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>12,705</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>(2,313</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">For the year ended December 31, 2022, our research and development expenses decreased primarily due to a reduction in license expenses under the Original Factor License Agreement,
        less stock-based compensation expense due to forfeitures of stock options and restricted stock units, and lower clinical trial expense.&#160; These reductions were offset by expenses incurred related to the MSA, which was not in place in the prior year,
        and other miscellaneous expense during 2022 when compared to the year ended December 31, 2021.</div>

      <div style="text-align: justify;"><span style="color: #000000;"> </span><br />
      </div>

      <div style="color: #000000;"><span style="font-style: italic;">Impairment of In-Process Research and Development</span>&#160;</div>

      <div style="color: #000000;">&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">As discussed in Part I, Item 1 of this Annual Report on Form 10-K, in June 2022, we received the results from the INSPIRE phase 2 trial of IRX-2. The IRX-2 multi-cytokine biologic
        immunotherapy represents substantially all the fair value assigned to the technologies of IRX that we acquired in 2018. Despite outcomes that favored IRX-2 in certain predefined subgroups, the INSPIRE trial did not meet the primary endpoint of
        Event-Free Survival (EFS) at two years of follow up. Significant additional clinical development work would be required to advance IRX-2 in the form of additional Phase 2 and 3 studies to further evaluate the treatment effect of IRX-2 in patient
        subgroups and in combination with checkpoint inhibitor therapies.&#160; The INSPIRE trial is the only Company-sponsored study of IRX-2.&#160; IRX-2 has been studied externally in other clinical settings outside of head and neck cancer in the form of
        investigator sponsored trials, which have either ended or are not currently active. Based on the totality of available information, we currently do not have plans to further develop the IRX-2 product candidate. As such, we determined that the
        carrying value of the IPR&amp;D asset was impaired and recognized a non-cash impairment charge of approximately $6.0 million for the year ended December 31, 2022.&#160; There was no similar impairment charge for the year ended December 31, 2021.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">43</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="color: #000000;"><span style="font-style: italic;">In-Process Research and Development</span>&#160;</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">During the year ended December 31, 2021, we expensed the $80.5 million fair value of IPR&amp;D acquired in the Novellus Acquisition because there was no future alternative use for
        the IPR&amp;D other than for its intended purpose.&#160; There was no similar transaction for the year ended December 31, 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">General and Administrative Expenses</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">Years ended December 31,</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;"> 2022</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2021</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">Change</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-style: italic; font-weight: bold;">(in thousands)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Professional fees</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>8,499</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>7,351</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>1,148</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Payroll-related</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>2,942</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>1,299</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>1,643</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Insurance</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>1,951</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>1,134</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>817</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Stock-based compensation</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>1,686</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>3,638</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>(1,952</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Loss on disposal or sale of fixed assets</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>280</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>-</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>280</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Other expenses, net</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>1,477</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>1,302</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>175</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Total general and administrative expenses</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>16,835</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>14,724</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>2,111</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The increase in general and administrative expense for the year ended December 31, 2022 primarily related to increased legal fees, settlements related to certain legal matters and
        increased headcount, as well as severance expense for certain employees, including our former Chief Executive Officer, who resigned effective May 26, 2022.&#160; Other increases included premiums for public company insurance policies and losses on the
        disposal or sale of fixed assets, as compared to the same period in 2021.&#160; These increases were offset by decreased stock-based compensation expense due primarily to forfeitures of stock options and restricted stock units as compared to the year
        ended December 31, 2021.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Transaction Costs</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">For the year ended December 31, 2021, we incurred approximately $5.8 million in transaction costs related to the issuance of common stock to Eterna LLC&#8217;s financial advisor upon
        consummation of the Merger, and there were no comparable transaction costs for the year ended December 31, 2022.</div>

      <div style="text-align: justify;"><span style="color: #000000;"> </span><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Loss on Sales of NTN Assets</div>

      <div style="text-align: justify;"><span style="color: #000000;"> </span><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We incurred a $9.6 million loss on the sale of NTN assets for year ended December 31, 2021 in connection with the Disposition, and there were no comparable transaction costs for the
        year ended December 31, 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Change in Fair Value of Warrant Liabilities</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">For the year ended December 31, 2022, we recognized a credit of $11.4 million for the change in the fair value of warrant liabilities, which was offset by $0.6 million in expense
        related to the excess fair value of the Q1-22 Common Warrants and Q1-22 Pre-Funded Warrant (as defined below) issued in connection with the Q1-22 PIPE Transaction (as defined below) over the $12.0 million gross proceeds received. There were no
        comparable credits or expenses for the year ended December 31, 2021.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Loss on Non-Controlling Investment</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We account for our investment in NoveCite under the equity method.&#160; During the year ended December 31, 2022, we recognized approximately $0.9 million of loss on our 25%
        non-controlling investment in NoveCite.&#160; Of the $0.9 million loss for the year ended December 31, 2022, $0.5 million related to NoveCite&#8217;s results of operations for the year ended December 31, 2021.&#160; We have not guaranteed obligation of NoveCite
        nor are we otherwise committed to provide any financial support for NoveCite.&#160; Therefore, we will record losses only up to our investment carrying amount.&#160; There was no comparable loss for the year ended December 31, 2021.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">44</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Other (Expense) Income, Net</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="10">
              <div style="text-align: center; font-weight: bold;">Years ended December 31,</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">&#160;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;"> 2022</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">2021</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">Change</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-style: italic; font-weight: bold;">(in thousands)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Q1-22 PIPE transaction fees</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(1,007</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(1,007</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Liquidated damages</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(240</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(240</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Interest expense, net</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(30</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(74</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>44</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">PPP Loan forgiveness and ERC refunds</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>974</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(974</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Other income, net</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>106</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(1</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>107</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Total other (expense), income net</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>(1,171</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>899</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>(2,070</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">For the year ended December 31, 2022, the increase in other expense, net was primarily due to fees related to the Q1-22 PIPE Transaction (as defined below), which were allocated to
        the warrants issued in connection with the transaction. Additionally, we recorded a loss related to the liquidated damages we incurred under our registration rights agreement with the Q1-22 PIPE Investor (as defined below) as a result of not timely
        filing with the SEC our Quarterly Report on Form 10-Q for the quarter ended March 31, 2022.&#160; These increases in expense to the year ended December 31, 2022 were offset by income from the sale of certain fixed assets and a decrease in interest
        expense when compared to the year ended December 31, 2021.&#160; During the year ended December 31, 2021, we recognized income from the forgiveness of our Paycheck Protection Program loan and for payroll tax refunds under the Employee Retention Credit
        program, both of which were under the Coronavirus Aid, Relief, and Economic Security Act administered by the U.S. Small Business Administration (the &#8220;CARES Act&#8221;).&#160; We did not receive any such income for the year ended December 31, 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Provision for Income Taxes</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We recognized a provision for income taxes of approximately $45,000 and $64,000 for the years ended December 31, 2022 and 2021, respectively. Our income tax provision is primarily
        for U.S. state income tax.&#160; At December 31, 2022 and 2021, we had available net operating loss (&#8220;NOL&#8221;) carryforwards of approximately $35.6 million and $20.7 million for federal income tax purposes, respectively, of which $35.6 million can be
        carried forward indefinitely. We have available $28.8 million and $20.7 million of state NOLs for the years ended December 31, 2022 and 2021, respectively, which begin to expire in 2041. We also have foreign NOL carryforwards of $6.3 million and
        $4.8 million for the years ended December 31, 2022 and 2021, respectively, which carry forward indefinitely. Section 382 of the Internal Revenue Code (&#8220;IRC&#8221;) imposes limits on the ability to use NOL carryforwards that existed prior to a change in
        control to offset future taxable income. Such limitations would reduce, potentially significantly, the gross deferred tax assets disclosed in the table above related to the NOL carryforwards.&#160; We continue to disclose the NOL carryforwards at their
        original amount in the table above as no potential limitation has been quantified. We have also established a full valuation allowance for all deferred tax assets, including the NOL carryforwards, since we could not conclude that we were more
        likely than not able to generate future taxable income to realize these assets.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;">Liquidity and Capital Resources</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">At December 31, 2022, we had cash and cash equivalents of approximately $15.5 million, of which approximately $4.1 million was restricted cash, as discussed below.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On March 6, 2022, we entered into a securities purchase agreement (the &#8220;Q1-2022 Purchase Agreement&#8221;) with an investor (the &#8220;Q1-22 PIPE Investor&#8221;), providing for the private
        placement (the &#8220;Q1-22 PIPE Transaction&#8221;) to the Q1-22 PIPE Investor of approximately 343,000 units, each unit consisting of (i) one share of our common stock (or, in lieu thereof, one pre-funded warrant (each, a &#8220;Q1-22 Pre-Funded Warrant&#8221;) to
        purchase one share of common stock) and (ii) one warrant (each, a &#8220;Q1-22 Common Warrant&#8221;) to purchase one share of common stock, for an aggregate gross purchase price of approximately $12.0 million. The Q1-22 PIPE Transaction closed on March 9,
        2022 for net proceeds of approximately $11.0 million.&#160; The Q1-22 PIPE Investor exercised all of the Q1-22 Pre-Funded Warrants on July 12, 2022 at an exercise price of $0.10 per share for total proceeds of approximately $7,000.&#160; Pursuant to Q1-22
        Purchase Agreement, we are prohibited from issuing equity in variable rate transactions for a period of one-year following consummation of the Q1-22 PIPE Transaction, including issuing equity under the Second Purchase Agreement (as defined below).</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">45</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On October 18, 2022, we entered into a facility sublease agreement (the &#8220;Sublease&#8221;) for approximately 45,500 square feet of office and laboratory space in Somerville,
        Massachusetts.&#160; The term of the Sublease is approximately 10 years, and we will pay approximately $63.0 million in base rental payments over the 10-year term, plus our share of the Sublessor&#8217;s parking spaces and operating expenses. As part of the
        Sublease, we delivered a security deposit in the form of a letter of credit in the amount of $4.1 million, which will be reduced on an incremental basis throughout the term of the lease.&#160; The letter of credit was issued by our commercial bank,
        which required that we cash collateralize the letter of credit with $4.1 million of cash deposited in a restricted account maintained by such bank.&#160; The amount of required restricted cash collateral will decline in parallel with the reduction in
        the amount of the letter of credit over the term of the sublease.&#160; The amount of restricted cash reduces by an equal amount our available working capital.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On November 23, 2022, we entered into a securities purchase agreement (the &#8220;Q4-22 Purchase Agreement&#8221;) with certain investors (the &#8220;Q4-22 PIPE Investors&#8221;), providing for the private
        placement (the &#8220;Q4-22 PIPE Transaction&#8221;) to the Q4-22 Investors of approximately 2,185,000 units, each unit consisting of (i) one share of common stock and (ii) two warrants, each exercisable to purchase one share of common stock at an exercise
        price of $3.28 per share (the &#8220;Q4-22 Warrants&#8221;), at a purchase price of $3.53 per unit (inclusive of $0.125 per Q4-22 Warrant), for net proceeds of approximately $7.4 million.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; margin-right: 0.5pt; color: #000000;">In April 2021, we and an investment group (the &#8220;Investment Group&#8221;) executed a purchase&#160;agreement (the &#8220;First Purchase Agreement&#8221;), pursuant to which we had the
        right, but not the obligation, to sell to the Investment Group, and the Investment Group was obligated to purchase, up to $20.0 million of shares of our common stock. Sales of common stock by us were subject to certain limitations, and could occur
        from time to time, at our sole discretion. In consideration for the Investment Group&#8217;s entry into the First Purchase Agreement, we issued the Investment Group approximately 3,000 shares of common stock. As of December 31, 2022, we had issued and
        sold to the Investment Group approximately 56,000 shares of common stock under the First Purchase Agreement for gross proceeds of $20.0 million, and no further shares may be sold to the Investment Group under the First Purchase Agreement.</div>

      <div style="color: #000000;">&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; margin-right: 0.5pt; color: #000000;">In May 2021, we and the Investment Group executed a second purchase agreement (the &#8220;Second Purchase Agreement&#8221;), pursuant to which we have the right, but not
        the obligation, to sell to the Investment Group, and the Investment Group would be obligated to purchase, up to $40.0 million of shares of our common stock. Sales of common stock by us are subject to certain limitations, and may occur from time to
        time, at our sole discretion. In consideration of the Investment Group&#8217;s entry into the Second Purchase Agreement, we issued to the Investment Group 50,000 shares of common stock.</div>

      <div style="color: #000000;">&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; margin-right: 0.5pt; color: #000000;">Actual sales of shares of common stock to the Investment Group under the Second Purchase Agreement depend on a variety of factors to be determined by us from
        time to time, including, among others, market conditions, the trading price of the common stock and determinations by us as to the appropriate sources of funding for us and our operations.</div>

      <div style="text-align: justify;"><span style="color: #000000;"> </span><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; margin-right: 0.5pt; color: #000000;">As of December 31, 2022, we had issued and sold approximately 121,000 shares of common stock under the Second Purchase Agreement for total gross proceeds of
        $34.1 million.&#160; Pursuant to the securities purchase agreement in respect of the Q1-22 PIPE Transaction, we were prohibited from issuing additional shares under the Second Purchase Agreement for a period of one-year immediately following the closing
        of the Q1-22 PIPE Transaction.</div>

      <div style="text-align: justify;"><span style="color: #000000;"> </span><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We have to date incurred operating losses, and we expect these losses to continue in the future as we further develop our product development programs and operate as a publicly
        traded company.&#160; In the near-term, we intend to focus on licensing opportunities for our in-licensed technology, but there can be no assurance that we will enter into agreements with respect to such opportunities on such terms and within a
        timeframe necessary to satisfy our need for working capital.&#160; While we are not presently pursuing product development, we may do so in the future, and current and potential licensing partners may seek to do so.&#160; Developing product candidates,
        conducting clinical trials and commercializing products are expensive, and we would need to raise substantial additional funds if we were to pursue the development of one or more product candidates Based on our current financial condition and
        forecasts of available cash, we believe we do not have sufficient funds to fund our operations for the next twelve months from the filing of the financial statements contained in this Annual Report on Form 10-K for the year ended December 31, 2022.
        We can provide no assurance that we will be able to satisfy our near- or long-term cash needs through licensing transactions, or that we will obtain any additional financing that we require in the future or, even if such financing is available,
        that it will be obtainable on terms acceptable to us.</div>

      <div style="text-indent: 36pt; color: #000000;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">46</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">In that regard, our future funding requirements will depend on many factors, including:</div>

      <div style="color: #000000;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">the terms and timing of any collaborative, licensing and other agreements that we may establish;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">the cost of filing and potentially prosecuting, defending and enforcing any patent claims and other intellectual property rights;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">the cost and timing of regulatory approvals;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">the cost and delays in product development as a result of any changes in regulatory oversight applicable to our products;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">the cost and timing of establishing sales, marketing and distribution capabilities;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">the effect of competition and market developments;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">the scope, rate of progress and cost of clinical trials and other product development activities; and</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">future clinical trial results.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We plan to raise additional funds to support our product development activities and working capital requirements through public or private equity offerings, debt financings,
        strategic partnerships, out-license collaborations or other means. Any sale by us of additional equity or convertible debt securities could result in dilution to our stockholders. There can be no assurance that any such required additional funding
        will be available to us at all or available on terms acceptable to us.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Further, to the extent that we raise additional funds through collaborative arrangements, it may be necessary to relinquish some rights to our technologies or grant sublicenses on
        terms that are not favorable to us. If we are not able to secure additional funding when needed, we may have to delay the commercialize of our products, reduce the scope of or eliminate one or more research and development programs, which could
        have an adverse effect on our business.</div>

      <div><br />
      </div>

      <div style="text-indent: 36pt; color: #000000; font-style: italic;">Cash Flows</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Cash flows from operating, investing and financing activities, as reflected in the accompanying consolidated statements of cash flows, are summarized as follows:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">For the years ended<br />
                December 31,</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(in thousands)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Change</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Cash (used in) provided by:</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Operating activities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(20,976</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(23,488</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">2,512</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Investing activities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(47</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(22,742</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">22,695</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Financing activities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">19,579</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">61,585</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(42,006</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">Net (decrease) increase in cash and cash equivalents</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(1,444</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">15,355</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(16,799</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">47</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="text-decoration: underline;">Net Cash Used in Operating Activities</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The decrease in cash used in operating activities was due to a decrease in net loss of $3.5 million, after giving effect to adjustments made for non-cash transactions, offset by an
        increase in cash provided by operating assets and liabilities of $6.0 million during the year ended December 31, 2022 compared to the year ended December 31, 2021.&#160; The decrease in cash used in operations was primarily driven by increased accrued
        compensation due to severance accruals, accrued costs for litigation matters, amounts due to related party for the License Fee Obligation and increased insurance liabilities.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="text-decoration: underline;">Net Cash Used in Investing Activities</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The decrease in net cash used in investing activities was primarily due to $22.9 million of cash used to purchase Novellus during the year ended December 31, 2021, which was offset
        by proceeds of approximately $0.3 million from the Merger and the Disposition.&#160; There were no similar transactions during the year ended December 31, 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="text-decoration: underline;">Net Cash Provided by Financing Activities</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The decrease in net cash provided by financing activities was primarily the result of a decrease in net proceeds from capital raising transactions of approximately $42.9 million,
        net, offset by a decrease in principal payments made for long-term debt arrangements of $0.9 million during the year ended December 31, 2022 compared to the year ended December 31, 2021.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-weight: bold;">Critical Accounting Estimates</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with U.S.
        GAAP. The preparation of these consolidated financial statements requires us to make judgments, estimates, and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the
        date of the consolidated financial statements, as well as the reported expenses during the reporting periods. We continually evaluate our judgments, estimates and assumptions. We base our estimates on the terms of underlying agreements, our
        expected course of development, historical experience and other factors we believe are reasonable based on the circumstances, the results of which form our management&#8217;s basis for making judgments about the carrying value of assets and liabilities
        that are not readily apparent from other sources. Actual results may differ from these estimates. We believe the following critical accounting estimates affect our more significant judgments and estimates used in the preparation of our consolidated
        financial statements.</div>

      <div>&#160;</div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Goodwill Impairment<br />
      </div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in the acquisition of IRX Therapeutics, Inc. in November 2018 (the &#8220;IRX
        Acquisition&#8221;), which was accounted for as a business combination. Goodwill is not amortized but is tested for impairment annually, or if events occur or circumstances change that would reduce the fair value of a reporting unit below its carrying
        value. Since management evaluates Eterna as a single reporting unit, goodwill is tested for impairment at the entity level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the
        entity is less than its carrying value. Such qualitative factors include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and other relevant events.&#160; If the entity does not pass the
        qualitative assessment, then the entity&#8217;s carrying value is compared to its fair value. Goodwill is considered impaired if the carrying value of the entity exceeds its fair value.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-weight: bold;">Recent Accounting Pronouncements</div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic;">Newly Adopted Accounting Standards</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">In July 2021, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2021-05, <span style="font-style: italic;">Leases (Topic 842) &#8211; Lessors - Certain Leases with Variable Lease
          Payments,</span> which amends the lessor classification guidance to introduce additional criteria when classifying leases with variable lease payments that do not depend on a reference index or a rate. We adopted this ASU effective January 1,
        2022, which did not have a material impact on our financial statements.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">48</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">In May 2021, the FASB issued ASU 2021-04<span style="font-style: italic;">, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50),
          Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options</span>.
        ASU 2021-04 addresses the accounting for certain modifications or exchanges of freestanding equity-classified written call options. We adopted this ASU effective January 1, 2022, which did not have a material impact on our financial statements.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">In November 2021, the FASB issued ASU 2021-10, <span style="font-style: italic;">Disclosures by Business Entities about Government Assistance, </span> which requires a business
        entity to disclose information about certain government assistance that it has received, including (i) the type of assistance, (ii) an entity&#8217;s accounting for the assistance and (iii) the effect of the assistance on the entities accounting
        statements.&#160; We adopted this standard effective January 1, 2022, which did not have a material impact on the Company&#8217;s financial statements.&#160; We have approximately $0.6 million in payroll tax refunds recorded in other receivable on the accompanying
        consolidated balance sheets as of December 31, 2022 and 2021 pursuant to the Employee Retention Credit program under the CARES Act.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Accounting Standard to be Adopted</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">In June 2022, the FASB issued ASU No. 2022-03, <span style="font-style: italic;">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to
          Contractual Sale Restrictions </span>(&#8220;ASU 2022-03&#8221;). The FASB issued ASU 2022-03 to (1) clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that
        prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new disclosure requirements for equity related securities subject to contractual sale restrictions that are measured at fair value in
        accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The
        guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years with early adoption permitted. We are evaluating when to adopt the amendments in ASU 2022-02. We do not expect a material impact
        as a result of adopting this amendment.</div>

      <div>&#160;</div>

      <a id="QuantitativeandQualitativ"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54.05pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 7A.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Quantitative and Qualitative Disclosures about Market Risk</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Under SEC rules and regulations, as a smaller reporting company we are not required to provide the information otherwise required by this item.</div>

      <div><br />
      </div>

      <a id="FinancialStatementsandSup"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 55.1pt; vertical-align: top; color: #000000; font-weight: bold;">ITEM 8.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Financial Statements and Supplementary Data</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">See &#8220;Index to Consolidated Financial Statements&#8221; on page F-1 for a listing of the Consolidated Financial Statements filed with this Annual Report on Form 10-K.</div>

      <div>&#160;</div>

      <div>
        <a id="ChangesinandDisagreements"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 54pt;">
                <div style="text-align: left;"><span style="font-weight: bold; color: #000000;">ITEM 9.</span></div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><span style="font-weight: bold; color: rgb(0, 0, 0); font-style: italic;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div>
              </td>

  </tr>


</table>
      </div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">None.</div>

      <div><br />
      </div>

      <div>
        <div>
          <a id="ControlsandProcedures"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 54pt;">
                  <div style="text-align: justify;"><span style="font-weight: bold; color: #000000;">ITEM 9A.</span></div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="text-align: justify;"><span style="font-weight: bold; color: rgb(0, 0, 0); font-style: italic;">Controls and Procedures</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div>&#160;</div>

      <div style="text-indent: 36pt; color: #000000; font-style: italic;">Disclosure Controls and Procedures</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We maintain &#8220;disclosure controls and procedures,&#8221; as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act, designed to ensure that information required to be
        disclosed in our reports filed pursuant to the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management,
        including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosures.</div>

      <div>
        <div><br />
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">49</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">In designing and evaluating the disclosure controls and procedures, we recognized that any controls and procedures, no matter how well designed and operated, can provide only
        reasonable assurance of achieving the desired control objectives, and we were required to apply our judgment in evaluating the cost-benefit relationship of possible controls and procedures. We have carried out an evaluation as of the end of the
        period covered by this Annual Report on Form 10-K under the supervision, and with the participation, of our management, including our Chief Executive Officer and President (who serves as our principal executive officer) and our Chief Financial
        Officer (who serves as our principal financial officer), of the effectiveness of the design and operation of our disclosure controls and procedures.</div>

      <div>
        <div><br />
        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of the end of the
        period covered by this Annual Report on Form 10-K in providing reasonable assurance of achieving the desired control objectives due primarily to the material weakness discussed below.</div>

      <div>
        <div><br />
        </div>

        <div style="text-align: justify; color: #000000; font-style: italic;">Management&#8217;s Report on Internal Control over Financial Reporting</div>

        <div><br />
        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is a process
        designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Management, under the supervision of and with the participation of our Chief Executive Officer and our Chief Financial Officer, conducted an evaluation of the effectiveness of our
        internal control over financial reporting as of December 31, 2022 based on the framework and criteria established in Internal Control &#8212; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
        Based on such evaluation, management concluded that the Company&#8217;s internal control over financial reporting was not effective as of December 31, 2022 due to the material weakness described below.</div>

      <div>
        <div><br />
        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">
        <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
          <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">We were unable to timely file our Q1 2022 10Q with the SEC due to identifying errors in our financial statements
            reported in the Annual Report on Form 10-K for the years ended December 31, 2021 and 2020 during our preparation of the financial statements for the quarter ended March 31, 2022. Management concluded that the errors were the result of
            accounting personnel&#8217;s lack of technical proficiency in complex matters. We filed an amendment to our Annual Report on Form 10-K/A for the years ended December 31, 2021 and 2020 on June 30, 2022 to correct the errors in our financial statements
            for the years ended December 31, 2021 and 2020 and for the quarters ended June 30, 2020, September 30, 2020, March 31, 2021, June 30, 2021 and September 30, 2021.</div>

        </div>

      </div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">50</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;">Management&#8217;s Plan for Remediation of the Material Weakness in Internal Control over Financial Reporting</div>

      </div>

      <div>
        <div><br />
        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Management is implementing measures designed to ensure that the deficiencies contributing to the ineffectiveness of our internal control over financial reporting are promptly
        remediated, such that the internal controls are designed, implemented and operating effectively. The remediation actions include:</div>

      <div>
        <div><br />
        </div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="color: rgb(0, 0, 0);">enhancing the business process controls related to reviews over technical, complex, and non-recurring transactions; and</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="color: rgb(0, 0, 0);">providing additional training to accounting personnel; and</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="color: rgb(0, 0, 0);">consulting with an accounting advisor for technical, complex and non-recurring matters, with whom we have engaged and begun consulting.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <div><br />
        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The material weakness cannot be considered remediated until the applicable remedial controls operate for a sufficient period of time and management has concluded, through testing,
        that these controls are operating effectively.</div>

      <div>
        <div><br />
        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We are committed to developing a strong internal control environment, and we believe the remediation efforts that we have implemented and will implement will result in significant
        improvements in our control environment. Our management will continue to monitor and evaluate the relevance of our risk-based approach and the effectiveness of our internal controls and procedures over financial reporting on an ongoing basis and is
        committed to taking further action and implementing additional enhancements or improvements, as necessary.</div>

      <div>
        <div><br />
        </div>

        <div>
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Remediation of Previously Identified Material Weakness</div>

          <div><br />
          </div>

          <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">We have previously identified and disclosed the following material weakness in our internal control over financial reporting for
            the year ended December 31, 2021:</div>

          <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
          </div>

          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; text-align: right;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top; width: auto;">
                    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Upon completion of the Merger in March 2021 and the resulting change in our business model and strategy, we experienced a complete
                      turnover of our employees, including all of the members of our executive management team, which resulted in, among other things, our having insufficient accounting staff available to enable and ensure adequate segregation of duties
                      and our lacking appropriate and complete documentation of policies and procedures critical to the accomplishment of financial reporting objectives. The accounting personnel and documentation deficiencies each increase the risk that a
                      material misstatement of our financial statements will not be prevented or detected on a timely basis.</div>
                  </td>

  </tr>


</table>
          </div>

          <div>&#160;</div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As of December 31, 2022, management sufficiently completed its remediation of this material weakness by taking the following
              measures:</div>

          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
          </div>

          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; text-align: right;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="width: auto; vertical-align: top;">
                    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Increased the number of accounting personnel and reallocated and/or reassigned roles and responsibilities of users to accommodate
                      increased personnel;</div>
                  </td>

  </tr>


</table>
            <div> <br />
            </div>

          </div>

          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; text-align: right;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="width: auto; vertical-align: top;">
                    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Completed a comprehensive risk assessment to identify, design, and implement our internal controls;</div>
                  </td>

  </tr>


</table>
            <div> <br />
            </div>

          </div>

          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; text-align: right;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="width: auto; vertical-align: top;">
                    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Implemented improvement and refinement of our internal controls related to our review of users with access to its key financial systems,
                      specifically to validate and evidence that all users were subject to review and access was appropriate;</div>
                  </td>

  </tr>


</table>
            <div> <br />
            </div>

          </div>

          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; text-align: right;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="width: auto; vertical-align: top;">
                    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Refined our review of user access controls which restrict system users from having access to create and post journal entries; and</div>
                  </td>

  </tr>


</table>
            <div> <br />
            </div>

          </div>

          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; text-align: right;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="width: auto; vertical-align: top;">
                    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Completed the documentation, review, and enhancement of business policies, procedures, and related internal controls to standardize
                      business processes.</div>
                  </td>

  </tr>


</table>
          </div>

          <div>&#160;</div>

          <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">We have completed the documentation and review of the corrective actions described above, and our management has concluded that
            the design and operation of our financial reporting processes as it relates to segregation of duties and documentation of policies and procedures is effective and therefore that the related previously identified material weakness has been fully
            remediated as of December 31, 2022.</div>

        </div>

        <div><br />
        </div>

        <div style="text-align: justify; color: #000000; font-style: italic;">Changes in Internal Control over Financial Reporting</div>

      </div>

      <div>
        <div><br />
        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">
        <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As described above, there was a change in our internal control over financial reporting during the most recent fiscal quarter that
          has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</div>

      </div>

      <div>&#160;</div>

      <a id="OtherInformation"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 9B.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Other Information</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Not Applicable.</div>

      <div><br />
      </div>

      <a id="DisclosureRegardingForeig"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 9C.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Not Applicable.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">51</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: center; color: #000000; font-weight: bold;">PART III</div>

      <div><br />
      </div>

      <a id="DirectorsExecutiveOfficer"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54.05pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 10.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Directors, Executive Officers and Corporate Governance</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: center; color: #000000; font-weight: bold;">DIRECTORS &amp; EXECUTIVE OFFICERS</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The names of our directors and executive officers and their respective ages, positions, biographies and, in the case of directors, their qualifications to serve as directors, are
        set forth below as of March 20, 2023.</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 35.9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Name</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5.12%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Age</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 55%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Position<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>

  </tr>

  <tr>

    <td style="width: 35.9%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Matthew Angel</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5.12%; vertical-align: bottom; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">42</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 55%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">President and Chief Executive Officer and Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 35.9%; vertical-align: bottom; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0);">Andrew Jackson</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5.12%; vertical-align: bottom; background-color: rgb(204, 236, 255); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">54</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 55%; vertical-align: bottom; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 35.9%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Sandra Gurrola</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5.12%; vertical-align: bottom; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">56</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 55%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Vice President, Finance</div>
            </td>

  </tr>

  <tr>

    <td style="width: 35.9%; vertical-align: bottom; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0);">Charles Cherington</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5.12%; vertical-align: bottom; background-color: rgb(204, 236, 255); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">60</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 55%; vertical-align: bottom; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0);">Chairman of the Board</div>
            </td>

  </tr>

  <tr>

    <td style="width: 35.9%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Gregory Fiore</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5.12%; vertical-align: bottom; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">53</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 55%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 35.9%; vertical-align: bottom; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0);">William Wexler</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5.12%; vertical-align: bottom; background-color: rgb(204, 236, 255); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">63</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 55%; vertical-align: bottom; background-color: rgb(204, 236, 255);">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>

  <tr>

    <td style="width: 35.9%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Nicholas J. Singer</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5.12%; vertical-align: bottom; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">43</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 0.64%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 55%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Director</div>
            </td>

  </tr>


</table>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;"> <br />
        </span></div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Matthew Angel,</span> Ph.D., has served as Chief Executive Officer since January 1, 2023 and as Interim President, Chief
        Executive Officer and one of our directors since May 2022. Prior to that, Dr. Angel co-founded Factor Bioscience, and has served as its President, Chief Executive Officer and Chairman of its Board of Directors from since 2011. In 2020, Dr. Angel
        co-founded Exacis, for which he serves as the Scientific Advisory Board Chair. Dr. Angel previously served as the Chief Science Officer, Secretary, Treasurer and as a director of Exacis and as the Chief Science Officer, Secretary and as a director
        of Novellus from 2014 until the sale of Novellus to us in July 2021. Dr. Angel received a Ph.D. from the Massachusetts Institute of Technology in 2012 and a B.S. in Engineering from Princeton University in 2003.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Dr. Angel&#8217;s qualifications to serve on our Board include his expertise in the healthcare industry, his business training and education, and his extensive experience managing
        biotechnology companies.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Andrew Jackson</span> has served as our Chief Financial Officer since May 2022. Prior to that, Mr. Jackson served as the Chief
        Financial Officer of Ra Medical Systems, Inc. from April 2018 until May 2022, and as its Secretary from August 2021 to May 2022. From October 2016 to April 2018, he was Chief Financial Officer for AltheaDx, Inc, a molecular diagnostics company
        specializing in precision medicine. From March 2014 to March 2016, Mr. Jackson held senior financial positions, including Chief Financial Officer, at Celladon Corporation, a publicly traded, clinical stage biotechnology company. From April 2013 to
        March 2014, he held senior financial positions at Sapphire Energy, an industrial biotechnology company. Mr. Jackson received a MSBA in Finance in December 2006 from San Diego State University and a BSB in Accounting in June 1992 from the University
        of Minnesota. Mr. Jackson is also a certified public accountant (inactive).</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Sandra Gurrola</span> has served as our Vice President of Finance since June 2021. Prior to that, she served as the Senior Vice
        President of eGames.com Holdings, LLC from March 2021 to June 2021 and as a consultant to us. Ms. Gurrola served as Senior Vice President of Finance to NTN Buzztime, Inc. from September 2019 to March 2021 and its Vice President of Finance from 2014
        until 2019. From 2009 to 2014, Ms. Gurrola served NTN Buzztime, Inc. in various leadership accounting roles, including Controller, Director of Accounting, and Director of Financial Reporting and Compliance. Previously, she was a senior manager of
        financial reporting for Metabasis Therapeutics, Inc., a biotechnology company. Ms. Gurrola received a B.A. in English from San Diego State University.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">52</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Charles Cherington,</span> Chairman, has served on our Board of Directors since March 2021. Prior to that, Mr. Cherington served
        on our board of managers from 2018 through 2021. Mr. Cherington is a Co-Founder and Managing Partner of Ara Partners, a global private equity firm focused on industrial decarbonization investments founded in 2017. Previously, Mr. Cherington
        co-founded and served as Managing Partner of Intervale Capital, a middle-market private equity firm focused on investments in energy and infrastructure sectors, from 2006 to 2017. Mr. Cherington was Founder and Sole Partner of Cherington Capital, a
        private equity firm, from 2002 to 2006. In 1999, Mr. Cherington co-founded Paratus Capital Management, LLC, a venture capital firm, where he served as Partner until 2004. Prior to 1999, Mr. Cherington served in various positions with Lochridge
        &amp; Company, Inc., a business management consulting firm, and as an investment banker for Credit Suisse First Boston. Mr. Cherington received a B.A. in History from Wesleyan University and an M.B.A. from the University of Chicago.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Mr. Cherington&#8217;s qualifications to serve on our Board of Directors include his extensive experience and senior management roles in companies in the life sciences and private equity
        industries, and his business training and education.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Gregory Fiore,</span> M.D., has served on our Board of Directors since June 2022. Dr. Fiore has served as a director and as the
        President and Chief Executive Officer of Exacis since June 2020. Dr. Fiore co-founded Sollis Therapeutics (&#8220;<span style="text-decoration: underline;">Sollis</span>&#8221;), a clinical-stage pharmaceutical company, where he served as President, Chief Executive Officer and Director from 2017 to
        2019 and as Vice President and Chief Medical Officer from 2019 to 2020. Prior to Sollis, Dr. Fiore provided senior medical support as a consultant and acting Chief Medical Officer for various early-stage biotechnology companies through the
        following private healthcare consulting firms he founded, Fiore Healthcare Advisors, SSI Strategy and GJFMD Consulting. Dr. Fiore was also the Chief Medical Officer of The Medicines Company (NASDAQ: MDCO), held leadership roles at Merck &amp; Co.,
        Inc. (NYSE: MRK) and Abbott Laboratories (NYSE: ABT) and was a management consultant at McKinsey and Company. Dr. Fiore has served as a member of the Business Advisory Board for The Advanced Group of Companies since 2017. Dr. Fiore completed his
        Internal Medicine internship and residency at Harvard Medical School and received his MD degree from New York Medical College.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Dr. Fiore&#8217;s qualifications to serve on our Board include his extensive background in the healthcare and pharmaceutical industries, and his medical education and training.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">William Wexler</span> has served on our Board of Directors since June 2022. Prior to joining our Board of Directors, Mr. Wexler
        worked on over 150 individual projects, serving in various capacities including as Chairman, Chief Executive Officer, Chief Restructuring Officer and other designated roles of senior responsibility. Mr. Wexler has served as the Managing Member of
        WEXLER Consulting LLC, a management consulting firm, since 2012. From 2012 to 2019, he served in various roles, including as Chairman of the Board, interim Chief Executive Officer, Chief Executive Officer and sole director and stockholder
        representative of Upstate New York Power Products, Inc., a holding company that owned and operated power plants throughout upstate New York. From 2012 to 2013, Mr. Wexler served as Chief Restructuring Officer of VMR Electronics, LLC, a manufacturer
        of cable assembly products for the electronics interconnect industry. Prior to that, he served as a Managing Director and national finance practice lead at BBK, Ltd., a turn-around advisory firm, from 2006 to 2011. Mr. Wexler served as group
        Managing Director of corporate restructuring at Huron Consulting Group, LLC from 2002 to 2005. Previously, he was a Managing Director at Berenson Minella &amp; Co., a boutique investment-banking firm, from 2000 to 2002. Between 1986 and 2000 he
        served as a Senior Director at BNP Paribas, where he established and led Paribas Properties, Inc., a real estate investment arm of the bank, and also where he was a lead officer of the then newly created U.S. asset workout group. Mr. Wexler started
        his professional career in 1981 in commercial lease brokerage, asset management and investment sales at Jones Lang Wootton (now Jones Lang LaSalle) where he worked until 1986. He earned a B.A. in Political Science from Johns Hopkins University.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Mr. Wexler&#8217;s qualifications to serve on our Board include his experience in investment and senior management roles, as well as his business training and education.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Nicholas J. Singer</span> has served on our Board of Directors since June 2022. Mr. Singer has over 20 years of experience in
        finance and investments and is the Founder and Managing Partner of Purchase Capital. He is also the Founder &amp; Executive Chairman of United Parks, Chairman of IntegriCo Composites, the Chairman of OWYN (Only What You Need), a Board Member of
        Eterna Therapeutics Inc., a Board Member of the National Medal of Honor Museum Foundation, a Trustee of the Perez Art Museum Miami, and a member of the James Madison Council at the Library of Congress.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">53</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">From 2007 to 2013, Mr. Singer was the Co-Founder &amp; Co-Managing Member of Standard General, an SEC registered investment advisor which managed over $1 billion of assets during
        his tenure. Prior to that, he was a Founding Partner of Cyrus Capital Partners, a Principal at Och-Ziff Capital Management, and an Analyst in High Yield Trading and in the Principal Investment Area at Goldman Sachs &amp; Co. He graduated summa cum
        laude with a B.S. in Economics from the Wharton School and a B.A.S. in Electrical Engineering from the School of Engineering and Applied Science at the University of Pennsylvania.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Mr. Singer&#8217;s qualifications to serve on our Board include his extensive management, investment and financial experience, his business training and education, and his background
        serving on boards.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-weight: bold;">Family Relationships</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">There are no family relationships between any of our officers or directors.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-weight: bold;">Involvement in Certain Legal Proceedings</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our directors and executive officers are not parties to any material legal proceedings other than as set forth in Part II, Item 3 above.</div>

      <div><br />
      </div>

      <div style="text-align: center; color: #000000; font-weight: bold;">CORPORATE GOVERNANCE</div>

      <div style="color: #000000; font-weight: bold;">Overall Role of the Board</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our common stock is listed on the Nasdaq Capital Market under the symbol &#8220;ERNA.&#8221; Pursuant to our Bylaws and the Delaware General Corporation Law, our business and affairs are
        managed under the direction of our Board. Directors are kept informed of the Company&#8217;s business through discussions with management, by reviewing materials provided to them and by participating in meetings of the Board and its committees.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The Board has adopted Corporate Governance Guidelines that contain general principles regarding the responsibilities and function of our Board and Board Committees, a copy of which
        is available at: www.eternatx.com under Investor Relations&#8212;Governance. Information contained on, or accessible through, our website does not form a part of this Annual Report on Form 10-K and is not incorporated by reference.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-weight: bold;">Board Leadership Structure</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The Board believes it is appropriate to separate the roles of the Chairman of the Board and the Chief Executive Officer. The Chairman of the Board is charged with acting as a
        liaison between the Board and our management team, including oversight of management&#8217;s implementation of the Board&#8217;s strategies and directives. The Chief Executive Officer is responsible for providing general supervision of the affairs of the
        Company and general control of all of our business subject to the ultimate authority of the Board.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Mr. Cherington has served as the Chairman of the Board of Directors since March 2021, and Dr. Angel has served as the Chief Executive Officer since January 2023 and as Interim Chief
        Executive Officer since May 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The Board believes it is appropriate at this time in our growth for Mr. Cherington to serve as Chairman because his strong management experience, knowledge of our industry, and
        innovative leadership skills support management&#8217;s execution of our strategy and focus our directors&#8217; attention on the most critical matters affecting our business.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Risk Oversight.</span> One of the key functions of our Board is informed oversight of our risk management process. Our Board
        administers this oversight function directly through our Board as a whole, as well as through various standing committees of our Board that address risks inherent in their respective areas of oversight. In particular, our Board is responsible for
        monitoring and assessing strategic risk exposure, and our Audit Committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures. The Audit
        Committee also has the responsibility to review with management the process by which risk assessment and management is undertaken, monitor compliance with legal and regulatory requirements, and review the adequacy and effectiveness of our internal
        controls over financial reporting. Our Nominating and Corporate Governance Committee is responsible for periodically evaluating our company&#8217;s corporate governance policies and systems.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">54</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Diversity and Inclusion.</span> Although we do not have a formal diversity policy, the Nominating and Corporate Governance
        Committee, in accordance with its policies and procedures for director candidates, seeks to identify candidates who will enhance the Board&#8217;s overall diversity.</div>

      <div><br />
      </div>

      <div style="text-align: center; color: #000000; font-weight: bold;">Board Diversity Matrix as of March 20, 2023</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 52%;" rowspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Total number of directors</div>
              </div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="14" rowspan="1">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">5</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 52%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><br />
                </div>
              </div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Female</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Male</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Non-</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Binary</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Did Not</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Disclose</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Gender</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Part I: Gender Identity</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 52%;">
              <div style="color: rgb(0, 0, 0);">Directors</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">5</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Part II: Demographic Background</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">African-American or Black</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="color: rgb(0, 0, 0);">Alaskan Native or Native American</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Asian</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="color: rgb(0, 0, 0);">Hispanic</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Native Hawaiian or Pacific Islander</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="color: rgb(0, 0, 0);">White</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">4</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Two or more races or ethnicities</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="color: rgb(0, 0, 0);">LGBTQ+</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Did not disclose demographic background</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">1</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Corporate Governance Guidelines.</span> Our Board strongly supports effective corporate governance and has developed and
        followed a program of strong corporate governance. Our Nominating and Corporate Governance Committee is responsible for overseeing our governance guidelines and reporting and making recommendations to the Board concerning corporate governance
        matters. Our guidelines are published on our website at www.eternatx.com and are available in print to any stockholder who requests them from our Secretary.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Code of Ethics.</span> Our Board has adopted a Code of Conduct and Ethics that applies to all of our employees, officers and
        directors, including our Chief Executive Officer, Chief Financial Officer and other executive and senior financial officers. The full text of our Code of Conduct and Ethics is available on our website at www.eternatx.com under Investor
        Relations&#8212;Governance and is available in print to any stockholder who requests a copy from our Secretary. We intend to disclose future amendments to certain provisions of our Code of Business Conduct and Ethics, or waivers of certain provisions as
        they relate to our directors and executive officers, at the same location on our website or in our public filings. The information on our website is not intended to form a part of or be incorporated by reference into this Annual Report on Form
        10-K.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">55</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Board and Committee Meetings; Meeting Attendance. </span>The Board and its Committees meet regularly during the year, and they
        hold special meetings and act by unanimous written consent as circumstances require. Independent directors meet at regularly scheduled executive sessions without management present.&#160; Our Board held 28 meetings in calendar year 2022. Each director
        attended at least 75 percent of the aggregate of the total number of Board meetings and the total number of meetings held by all committees of the Board on which he or she served.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Although we do not have a formal policy with respect to the attendance of directors at our annual stockholder meetings, we encourage all of our directors to attend our annual
        stockholder meetings.&#160;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"></sup></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Board Committees. </span>Our Board has three standing committees: an Audit Committee; a Compensation Committee; and a
        Nominating and Corporate Governance Committee. Each of the committees reports to the Board as it deems appropriate and as the Board may request. The composition, duties and responsibilities of these committees are set forth below. In the future,
        our Board may establish other committees, as it deems appropriate, to assist it with its responsibilities.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The table below provides current committee membership information:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 61%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Name</div>
            </td>

    <td style="width: 1.31%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.31%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 11%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Audit</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Committee</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 10.54%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Compensation</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Committee</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 11%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nominating and</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Corporate</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Governance</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Committee</div>
            </td>

  </tr>

  <tr>

    <td style="width: 61%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">William Wexler</div>
            </td>

    <td style="width: 1.31%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.31%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 11%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Chair</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 10.54%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; color: rgb(0, 0, 0);">X</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 11%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; color: rgb(0, 0, 0);">X</div>
            </td>

  </tr>

  <tr>

    <td style="width: 61%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Nicholas J. Singer</div>
            </td>

    <td style="width: 1.31%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.31%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 11%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0);">X</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 10.54%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0);">Chair</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 11%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0);">X</div>
            </td>

  </tr>

  <tr>

    <td style="width: 61%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Charles Cherington</div>
            </td>

    <td style="width: 1.31%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.31%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 11%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; color: rgb(0, 0, 0);">X</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 10.54%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; color: rgb(0, 0, 0);">X</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.32%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 11%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Chair</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Committee Meetings.</span> During 2022, our Audit Committee held 11 meetings and took action by written consent two times; our
        Compensation Committee held six meetings and took action by written consent eight times; and our Nominating and Corporate Governance Committee held one.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Audit Committee.</span> We have a standing audit committee established in accordance with Section 3(a)(58)(A) of the Exchange
        Act. Our Audit Committee is responsible for, among other things:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">discussing with our independent registered public accounting firm their independence from management;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">reviewing, with our independent registered public accounting firm, the scope and results of their audit;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">approving all audit and permissible non-audit services to be performed by our independent registered public accounting firm;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the quarterly and annual financial statements that we file
                with the SEC;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">overseeing our financial and accounting controls and compliance with legal and regulatory requirements;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">reviewing our policies on risk assessment and risk management;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">reviewing related person transactions; and</div>
            </td>

  </tr>


</table>
      <div>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls or auditing matters.</div>
              </td>

  </tr>


</table>
      </div>

      <div><br /></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">56</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our Audit Committee consists of William Wexler (Chair), Charles Cherington and Nicholas J. Singer, all of whom meet the requirements for independence of Audit Committee members
        under applicable Nasdaq and SEC rules, including Rule 10A-3 promulgated under the Exchange Act. All of the members of our Audit Committee meet the requirements for financial literacy under the applicable rules and regulations of the SEC and Nasdaq.
        In addition, Mr. Singer qualifies as our &#8220;Audit Committee financial expert,&#8221; as such term is defined in Item 407 of Regulation S-K.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our Board has adopted a written charter for the Audit Committee, which is available on our website at: www.eternatx.com under Investor Relations&#8212;Governance. The information on our
        website is not intended to form a part of or be incorporated by reference into this Annual Report on Form 10-K.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Compensation Committee.</span> Our Compensation Committee is responsible for, among other things:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">reviewing and approving the corporate goals and objectives, evaluating the performance and reviewing and approving the compensation of our executive officers;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">reviewing and approving or making recommendations to our Board of Directors regarding our incentive compensation and equity-based plans, policies and programs;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">reviewing and approving all employment agreement and severance arrangements for our executive officers;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">making recommendations to our Board of Directors regarding the compensation of our directors; and</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">retaining and overseeing any compensation consultants.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our Compensation Committee consists of Nicholas J. Singer, Charles Cherington and William Wexler, with Mr. Singer serving as the chair. Each member of our Compensation Committee is
        independent, as defined under the Nasdaq listing rules, including Nasdaq&#8217;s additional independence standards for Compensation Committee members. Each member of our Compensation Committee is a non-employee director (within the meaning of Rule 16b-3
        under the Exchange Act).</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The Compensation Committee may establish and delegate authority to one or more subcommittees consisting of one or more of its members, when the Compensation Committee deems it
        appropriate to do so in order to carry out its responsibilities. In carrying out its responsibilities, the Compensation Committee shall be entitled to rely upon the advice and information that it receives in its discussions and communications with
        management and such experts, advisors and professionals with whom the Compensation Committee may consult.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our Board has adopted a written charter for the Compensation Committee, which is available on our website at: www.eternatx.com under Investor Relations&#8212;Governance. The information
        on our website is not intended to form a part of or be incorporated by reference into this Annual Report on Form 10-K.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Nominating and Corporate Governance Committee. </span>Our Nominating and Corporate Governance Committee is responsible for,
        among other things:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">identifying individuals qualified to become members of our Board of Directors, consistent with criteria approved by our Board of Directors;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">overseeing succession planning for our executive officers;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">periodically reviewing our Board of Directors&#8217; leadership structure and recommending any proposed changes to our Board of Directors;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">overseeing periodic evaluations of the effectiveness of our Board of Directors and its committees; and</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">developing and recommending to our Board of Directors a set of corporate governance guidelines.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">57</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our Nominating and Corporate Governance Committee consists of Charles Cherington, Nicholas J. Singer and William Wexler, with Mr. Cherington serving as the chair. Each member of our
        Nominating and Corporate Governance Committee is independent as defined under the Nasdaq listing rules.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our Board has adopted a written charter for the Nominating and Corporate Governance Committee, which is available on our website at: www.eternatx.com under Investor
        Relations&#8212;Governance. The information on our website is not intended to form a part of or be incorporated by reference into this Annual Report on Form 10-K.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-weight: bold;">Section 16(a) Beneficial Ownership Reporting Compliance</div>

      <div><br />
      </div>

      <div style="text-indent: 36pt; color: #000000;">Section 16(a) of the Exchange Act requires our directors, executive officers and persons who beneficially own more than 10% of a registered class of our equity securities to file with the SEC reports of
        ownership of, and transactions in, our equity securities. To our knowledge, based solely on a review of copies of such reports that we received, our records and written representations received from our directors, executive officers and certain of
        those persons who own greater than 10% of any class of our equity securities, for the year ended December 31, 2022, all applicable Section 16(a) filing requirements were complied with on a timely basis.</div>

      <div><br />
      </div>

      <a id="ExecutiveCompensation"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54.05pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 11.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Executive Compensation</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="color: #000000; font-weight: bold;">Introduction</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">When determining executive officer compensation, and the various components that comprise it, our Compensation Committee evaluates and considers publicly available executive officer
        compensation survey data to present a competitive compensation package to attract and retain top talent, including an appropriate level of salary, performance-based bonus and equity incentives. Typically, the Compensation Committee evaluates
        between three and five different sources of compensation data to provide relevant market benchmark data for a given executive role. Additionally, the Compensation Committee is authorized to engage outside advisors and experts to assist and advise
        the Compensation Committee on matters relating to executive compensation. The Compensation Committee currently retains the services of Aon&#8217;s Human Capital Solutions practice, a division of Aon plc (&#8220;Aon&#8221;), an independent compensation consultant.
        Our Chief Executive Officer presents compensation recommendations to the Compensation Committee with respect to the executive officers other than himself. The Compensation Committee considers such recommendations, in conjunction with input from the
        Compensation Committee&#8217;s independent compensation consultant, in making compensation decisions or recommendations to the full Board. The full board of directors participates in evaluating the performance of our executive officers, except that
        neither our former CEO, Howard J. Federoff, or our current CEO, Dr. Matthew Angel, participated when the Board evaluated their respective performance, and neither was present during voting or deliberations regarding their respective performance or
        compensation matters.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-weight: bold;">Named Executive Officers</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Under applicable SEC rules and regulations, all individuals who served as our principal executive officer during 2022, our two most highly compensated executive officers (other than
        our principal executive officer) who were serving as executive officers at December 31, 2022, and up to two additional individuals who would have been one of our top two most highly compensated executive officer had they been serving as an
        executive officer at the end of 2022 are referred to as our &#8220;named executive officers&#8221; and identified in the table below:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 34%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Name</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 64.12%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Title</div>
            </td>

  </tr>

  <tr>

    <td style="width: 34%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Matthew Angel</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 64.12%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Chief Executive Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 34%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Howard J. Federoff</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 64.12%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Former Chief Executive Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 34%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Andrew Jackson</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 64.12%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 34%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Roger Sidhu<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 64.12%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Chief Medical Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 34%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Kevin D&#8217;Amour</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 64.12%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Former Chief Scientific Officer</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">(1)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">Dr. Sidhu resigned as our Chief Medical Officer effective January 31, 2023.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">58</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="color: #000000; font-weight: bold;">Summary Compensation Table</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The following table sets out the compensation for our Named Executive Officers for the years ended December 31, 2022 and December 31, 2021:</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"> <br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 20%;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Name and</div>
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Principal Position</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 6%;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fiscal</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Year</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.71%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Salary (US$)</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.71%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Bonus (US$)</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Stock-Based</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Awards</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(US$)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.71%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Option-Based</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Awards</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(US$)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Non-Equity</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Incentive Plan</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Compensation</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(US$)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
            </td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.71%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nonqualified</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">deferred</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">compensation</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">earnings</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(US$)</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.71%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">All Other</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Compensation</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(US$)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Compensation</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(US$)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.59%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 20%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Matthew Angel, Chief Executive Officer and President<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="vertical-align: bottom; width: 6%; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2022</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">210,959</div>
            </td>

    <td style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);"> <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup>&#160; </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">910,453</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">29,842</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup>&#160;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">1,151,254</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.59%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 20%;" rowspan="2">
              <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Howard J. Federoff, Former Chief Executive Officer and President<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></div>
            </td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
              &#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 6%; text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2022</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">182,811</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">798,557</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">599,422</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">225,000</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">424,231</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">2,230,021</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.59%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td colspan="1" style="vertical-align: bottom; width: 6%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0); text-align: center;">2021</div>
              </div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">318,750</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">23,612,647</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">159,375</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">24,090,772</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.59%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 20%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Andrew Jackson, Chief Financial Officer<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup></div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="vertical-align: bottom; width: 6%; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2022</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">243,679</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">305,466</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">549,145</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.59%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 20%;" rowspan="2">
              <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Roger Sidhu, Former Chief Medical Officer<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup></div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 6%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: center;">2022</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">447,200</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">274,369</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">205,903</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">927,472</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.59%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 6%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: center;">2021</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">127,045</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">803,274</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">1,486,131</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">48,277</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">2,464,727</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.59%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 20%; background-color: rgb(204, 238, 255);" rowspan="2">
              <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Kevin D&#8217;Amour, Former Chief Scientific Officer<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(10)</sup></div>
            </td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
              &#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 6%; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2022</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">259,375</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">267,112</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">200,542</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">175,289</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(11)</sup>&#160;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">902,318</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.59%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td colspan="1" style="vertical-align: bottom; width: 6%; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">2021</div>
              </div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">212,216</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">1,500,592</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">2,773,903</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">84,886</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.71%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 6%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">4,571,697</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.59%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      <div><br />
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: left; text-indent: -13.5pt; margin-left: 13.5pt; color: rgb(0, 0, 0);">1.</div>
              </td>

    <td style="vertical-align: top; width: auto;">
                <div style="text-align: justify; color: rgb(0, 0, 0);">The amounts reported in this column represents the aggregate grant date fair value of stock options granted during the applicable year. These amounts were calculated in accordance with
                  FASB ASC Topic 718, Compensation &#8211; Stock Compensation, except that any estimate of forfeitures was disregarded. For a description of the assumptions used in computing the dollar amount recognized for financial statement reporting
                  purposes, see Note 14, Stock-Based Compensation, in the Notes to the Consolidated Financial Statements contained in this Annual Report on Form 10-K.2.Represents discretionary bonuses earned by the applicable named executive officer for
                  2021, as determined by the Compensation Committee.</div>
              </td>

  </tr>


</table>
      </div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 13.5pt; vertical-align: top; color: rgb(0, 0, 0);">3.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">Dr. Angel was appointed our Interim Chief Executive Officer and President on May 26, 2022 and a member of the Board effective June 6, 2022.&#160; Dr. Angel was appointed our Chief Executive
                Officer and President on January 1, 2023.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 13.5pt; vertical-align: top; color: rgb(0, 0, 0);">4.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">A cash signing bonus, which represents the salary Dr. Angel would have earned for the period during which he served as interim Chief Executive Officer and President, had Dr. Angel&#8217;s
                appointment as Chief Executive Officer and President been in effect beginning May 26, 2022.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 13.5pt; vertical-align: top; color: rgb(0, 0, 0);">5.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">Represents a reimbursement of legal fees Dr. Angel incurred in connection with entering into his employment offer letter.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 13.5pt; vertical-align: top; color: rgb(0, 0, 0);">6.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">Dr. Federoff resigned as the Company&#8217;s Chief Executive Officer and as a member of the Board effective on May&#160;26, 2022.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 13.5pt; vertical-align: top; color: rgb(0, 0, 0);">7.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">Includes $384,237 of severance payments, payment of $36,780 for final accrued paid time off, $2,965 for reimbursed legal fees Dr. Federoff incurred in connection with entering into his
                separation agreement and $250 for cell phone reimbursement.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 13.5pt; vertical-align: top; color: rgb(0, 0, 0);">8.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">Mr. Jackson was appointed Chief Financial Officer effective May 31, 2022.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 13.5pt; vertical-align: top; color: rgb(0, 0, 0);">9.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">Dr. Sidhu resigned as Chief Medical Officer effective January 31, 2023.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 20pt; vertical-align: top; color: rgb(0, 0, 0);">10.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Dr. D&#8217;Amour resigned as Chief Scientific Officer on August 26, 2022.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 20pt; vertical-align: top; color: rgb(0, 0, 0);">11.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">Includes $145,609 of severance payments, payment of $24,305 for final accrued paid time off, $5,000 for reimbursed legal fees Dr. D&#8217;Amour incurred in connection with entering into his
                separation agreement and $375 for cell phone reimbursement.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">59</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="color: #000000; font-weight: bold;">Narrative to Summary Compensation Table</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The following is a discussion of each component of our executive compensation program for 2022.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic; font-weight: bold;">Base Salary</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Each of our named executive officers receives a base salary. The base salary is the fixed cash compensation component of our executive compensation program and it recognizes
        individual performance, time in role, scope of responsibility, leadership skills and experience. The base salary compensates an executive for performing his or her job responsibilities on a day-to-day basis. Generally, base salaries are reviewed
        annually company-wide and adjusted (upward or downward) when appropriate based upon individual performance, expanded duties, changes in the competitive marketplace and, with respect to upward adjustments, if we are, financially and otherwise, able
        to pay it. We try to offer competitive base salaries to help attract and retain executive talent.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic; font-weight: bold;">Annual Bonus and Incentive Compensation and Benefits</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">In addition to base salaries, our Compensation Committee has the authority to award discretionary annual bonuses to our named executive officers based on corporate and individual
        performance. Incentives, as a percent of salary, increase with executive rank so that, as rank increases, a greater portion of total annual cash compensation is based on annual corporate and individual performance.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Annual incentives are awarded based on quantitative performance standards and reward performance of each named executive officer individually. The determination of a named executive
        officer&#8217;s performance may vary from year to year depending on economic conditions and conditions in the industry in which we operate and may be based on measures such as revenue, achievement of certain research and development milestones,
        completion of a strategic transaction, and other metrics the directors and management believe to provide proper incentives for achieving long-term shareholder value for Eterna. The Board retains full discretion over performance evaluation and the
        amount of any bonuses to be paid to a named executive officer.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic; font-weight: bold;">Equity-Based Compensation Programs</div>

      <div><br />
      </div>

      <div style="color: #000000;"><span style="text-decoration: underline;">Restated Plan</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">At our 2021 annual meeting of stockholders, our stockholders approved a restatement of the Eterna Therapeutics Inc. Restated 2020 Stock Incentive Plan (the &#8220;Restated Plan&#8221;). The
        general purpose of the Restated Plan is to provide a means whereby eligible employees, officers, employee and non-employee directors, consultants and prospective employees may develop a sense of proprietorship and personal involvement in our
        development and financial success, and to encourage them to devote their best efforts to us, thereby advancing our interests and the interests of stockholders. The Board believes that the granting of stock options, restricted stock, restricted
        stock units, performance awards, unrestricted stock awards and similar kinds of equity-based compensation promotes continuity of management and increases incentive and personal interest in our welfare by those who are primarily responsible for
        shaping and carrying out our long-range plans and securing growth and financial success. In general, the Restated Plan is administered by the Compensation Committee. The Compensation Committee determines the persons to whom awards issuable under
        the Restated Plan may be granted. The Compensation Committee may also establish rules and regulations for the administration of the Restated Plan and amendments or modifications of outstanding awards. The Compensation Committee also delegates
        authority to certain executive officers grant awards and execute award agreements, subject to applicable law and the Restated Plan. Each award is set forth in a separate agreement with the person receiving the award and will indicate the type,
        terms and conditions of the award. A brief description of the material terms of the Restated Plan and the equity awards thereunder follows.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">60</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-style: italic;">Eligibility</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Persons eligible to receive awards under the Restated Plan consist of our employees, officers, directors, consultants, independent contractors who, in the opinion of the
        Compensation Committee, are in a position to contribute to our success, or any other person who is determined by the Compensation Committee to be a prospective employee, officer, director, consultant, advisor or other individual service provider,
        any entity whose financials statements are required to be consolidated with our company, and any other entity that the Compensation Committee determines to be an affiliate of our company. As of March 20, 2022, we had nine full-time employees,
        including three executive officers.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic;">Shares Subject to the Restated Plan</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The aggregate number of shares of common stock initially available for issuance in connection with awards granted under the Restated Plan is equal to the sum of (a) approximately
        424,000 shares and (b) an annual increase on January 1 of each year from 2022 through 2031 equal to the lesser of (i) 5% of the number of shares of common stock outstanding on the immediately preceding December 31 and (ii) such smaller number of
        shares of common stock as may be determined by the Board.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Incentive stock options, or ISOs, that are intended to meet the requirements of Section 422 of the Code may be granted under the Restated Plan with respect to all of the shares of
        common stock authorized for issuance under the Restated Plan.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">If any option or stock appreciation right, or SAR, granted under the Restated Plan is terminated without having been exercised in full or if any award is forfeited, the number of
        shares of common stock as to which such option, SAR or award was terminated or forfeited will be available for future grants under the Restated Plan. Awards settled in cash will not count against the number of shares available for issuance under
        the Restated Plan; however, if any award is cancelled forfeited or terminated in order to pay the exercise price of a stock option, purchase price or any taxes or tax withholdings on an award, such shares will not be available for future awards
        under the Restated Plan.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The number of shares authorized for issuance under the Restated Plan and the foregoing share limitations are subject to customary adjustments for stock splits, stock dividends or
        similar transactions effected after the effective time of the Restated Plan.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic;">Terms and Conditions of Options</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Options granted under the Restated Plan may be either ISOs or &#8220;nonstatutory stock options,&#8221; or NSOs, that do not meet the requirements of Section 422 of the Code. The Compensation
        Committee will determine the exercise price of options granted under the Restated Plan. The exercise price of options may not be less than the fair market value per share of common stock on the date of grant (or 110% of fair market value in the
        case of ISOs granted to a ten-percent stockholder).</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">If on the date of grant the common stock is listed on a stock exchange or is quoted on an automated quotation system, the fair market value will generally be the closing sale price
        on the last trading day before the date of grant. If no such prices are available, the fair market value will be determined in good faith by the Compensation Committee based on the reasonable application of a reasonable valuation method.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">No option may be exercisable for more than ten years (five years in the case of an ISO granted to a ten-percent stockholder) from the date of grant. Options granted under the
        Restated Plan will be exercisable at such time or times as the Compensation Committee prescribes at the time of grant. No employee may receive ISOs that first become exercisable in any calendar year in an amount exceeding $100,000.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Generally, the option price may be paid (a) in cash or by certified check, bank draft or money order, (b) through delivery of shares of common stock having a fair market value equal
        to the purchase price, or (c) any other methods of payment that the Compensation Committee permits in its sole and absolute discretion, including a cashless exercise program.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">61</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="color: #000000; font-style: italic;">Stock Appreciation Rights</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The Compensation Committee may grant SARs under the Restated Plan. The Compensation Committee will determine the other terms applicable to SARs. The exercise price per share of a
        SAR will not be less than 100% of the fair market value of a share of common stock on the date of grant, as determined by the Compensation Committee. The maximum term of any SAR granted under the Restated Plan is ten years from the date of grant.
        Generally, each SAR will entitle a participant upon exercise to an amount equal to:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">the excess of the fair market value on the exercise date of one share of common stock over the exercise price, multiplied by</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">the number of shares of common stock covered by the SAR.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Payment may be made in shares of common stock, in cash, or partly in common stock and partly in cash, all as determined by the Compensation Committee.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic;">Restricted Stock and Restricted Stock Units</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The Compensation Committee may award restricted common stock and/or restricted stock units under the Restated Plan. Restricted stock awards consist of shares of stock that are
        transferred to a participant subject to restrictions that may result in forfeiture if specified conditions are not satisfied. Restricted stock units confer the right to receive shares of common stock, cash, or a combination of shares and cash, at a
        future date upon or following the attainment of certain conditions specified by the Compensation Committee. The restrictions and conditions applicable to each award of restricted stock or restricted stock units may include performance-based
        conditions. Dividends with respect to restricted stock may be paid to the holder of the shares as and when dividends are paid to stockholders or at the time that the restricted stock vests, as determined by the Compensation Committee. Dividend
        equivalent amounts may be paid with respect to restricted stock units either when cash dividends are paid to stockholders or when the units vest. Unless the Compensation Committee determines otherwise, holders of restricted stock will have the
        right to vote the shares.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic;">Performance Shares and Performance Units</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The Compensation Committee may award performance shares and/or performance units under the Restated Plan. Performance shares and performance units are awards, denominated in either
        shares or U.S. dollars, which are earned during a specified performance period subject to the attainment of performance criteria, as established by the Compensation Committee. The Compensation Committee will determine the restrictions and
        conditions applicable to each award of performance shares and performance units.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic;">Other Stock-Based and Cash-Based Awards</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The Compensation Committee may award other types of equity-based or cash-based awards under the Restated Plan, including the grant or offer for sale of shares of common stock that
        do not have vesting requirements and the right to receive one or more cash payments subject to satisfaction of such conditions as the Compensation Committee may impose.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic;">Transferability of an Award</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">No award option may be transferred other than by will or by the laws of descent and distribution, and during a recipient&#8217;s lifetime an option may be exercised only by the recipient.
        However, the Compensation Committee may permit the holder of an option, restricted stock or other award to transfer the option, restricted stock or other award to immediate family members.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">62</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="color: #000000;"><span style="text-decoration: underline;">2021 Inducement Plan</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On May 20, 2021, the Board also approved our 2021 Inducement Stock Incentive Plan (the &#8220;<span style="text-decoration: underline;">2021 Inducement Plan</span>&#8221;). The 2021 Inducement Plan was adopted without stockholder
        approval pursuant to Section 711 of the Company Guide of the NYSE American LLC, the stock exchange on which our common stock was previously listed . The 2021 Inducement Plan provides for the grant of equity-based awards, including non-qualified
        stock options, performance shares, performance unis, restricted stock, restricted stock units, and stock appreciation rights, and its terms are substantially similar to the Restated Plan, including with respect to treatment of equity awards in the
        event of a &#8220;Change in Control&#8221; as defined under both Restated Plan and the 2021 Inducement Plan. The awards available for grant under the 2021 Inducement Plan are available only to new employees and cannot be issued pursuant to ISOs under Section
        422 of the Code.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic; font-weight: bold;">Benefits and Perquisites</div>

      <div><br />
      </div>

      <div style="color: #000000;"><span style="text-decoration: underline;">Employee Benefit Plans</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Named executive officers are eligible to participate in our employee benefit plans, including our medical, disability and life insurance plans, in each case, on the same basis as
        all of our other employees. The employee benefit plans are designed to assist in attracting and retaining skilled employees critical to our long-term success. We also maintain a 401(k) plan for the benefit of our eligible employees, including the
        named executive officers, as discussed below.</div>

      <div><br />
      </div>

      <div style="color: #000000;"><span style="text-decoration: underline;">401(k) Plan</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We maintain a retirement savings plan, or 401(k) plan, that provides eligible U.S. employees with an opportunity to save for retirement on a tax advantaged basis. Under the 401(k)
        Plan, eligible employees may defer up to 90% of their compensation subject to applicable annual contribution limits imposed by the Internal Revenue Code of 1986, as amended, or the Code and limits imposed by non-discrimination testing. Our
        employees&#8217; pre-tax contributions are allocated to each participant&#8217;s individual account and participants are immediately and fully vested in their contributions. The 401(k) plan is intended to be qualified under Section 401(a) of the Code with the
        401(k) plan&#8217;s related trust intended to be tax exempt under Section 501(a) of the Code. As a tax-qualified retirement plan, contributions to the 401(k) plan and earnings on those contributions are not taxable to the employees until distributed from
        the 401(k) plan. As of December 31, 2022, we had not contributed a match to the employees&#8217; contribution.&#160; Beginning on January 1, 2023, we began matching employees&#8217; contributions at a rate of 100% of the first 3% of the employee&#8217;s contribution and
        50% of the next 2% of the employee&#8217;s contribution, for a maximum match of 4%.</div>

      <div><br />
      </div>

      <div style="color: #000000;"><span style="text-decoration: underline;">Pension Benefits</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We do not maintain any pension benefit or retirement plans other than the 401(k) Plan.</div>

      <div><br />
      </div>

      <div style="color: #000000;"><span style="text-decoration: underline;">Nonqualified Deferred Compensation</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We do not maintain any nonqualified deferred compensation plans.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-style: italic; font-weight: bold;">Executive Employment Agreements and Change in Control Arrangements</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The following descriptions summarize the principal terms of our employment agreements with our named executive officers as of December 31, 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000;"><span style="text-decoration: underline;">Matthew Angel</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On May 24, 2022, the Board appointed Dr. Angel as our interim Chief Executive Officer and President, which appointment became effective on May 26, 2022.&#160; On June 6, 2023, Dr. Angel
        was appointed as a member of our Board.&#160; Dr. Angel did not receive a salary or other cash compensation during his tenure as interim Chief Executive Officer and President, and he does not receive compensation for services as a member of the Board.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On August 1, 2022, we granted Dr. Angel a time-based non-qualified stock option covering 124,350 shares of common stock, of which 5,181 shares vested immediately on the grant date
        and the remaining 119,169 shares vest in 46 substantially equal monthly installments thereafter (the &#8220;2022 Grant&#8221;).</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">63</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On December 30, 2022, we entered into an offer letter with Dr. Angel (the &#8220;Offer Letter&#8221;) effective on January 1, 2023 with respect to terms of his employment as our Chief Executive
        Officer and President.&#160; The compensatory terms of the Offer Letter, including equity awards, were approved by the Compensation Committee. Dr. Angel&#8217;s hiring, and his Offer Letter, were approved by the Board.&#160; We have been working together with Dr.
        Angel to negotiate in good faith and execute and deliver a formal, written employment agreement by March 31, 2023 containing such other terms and conditions as are mutually acceptable to Dr. Angel and us (the &#8220;Employment Agreement&#8221;) as contemplated
        by the Offer Letter.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Under the terms of the Offer Letter, we will pay Dr. Angel an annual base salary of $350,000, which amount is subject to annual review by the Board or the Compensation Committee and
        subject to adjustment to reflect market practices among our peers in the sole discretion of the Board or the Compensation Committee.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We also paid Dr. Angel a cash signing bonus of $210,959, which represents the salary Dr. Angel would have earned for the period during which he served as interim Chief Executive
        Officer had the Offer Letter been in effect as of May 26, 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Dr. Angel will be eligible to receive a performance bonus (the &#8220;Performance Bonus&#8221;) equal to two percent of the gross proceeds that we actually receive pursuant to all licensing,
        option, collaboration, partnership, joint venture, settlement, other similar agreements that we entered into, or other actions, judgments, or orders that generate cash proceeds to us, that are originated, negotiated and/or entered into by us during
        Dr. Angel&#8217;s employment (commencing on May 26, 2022), subject to certain conditions to be set forth in the Employment Agreement, including that Dr. Angel has not voluntarily resigned other than for good reason or has been terminated for cause.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">In accordance with the terms of the Offer Letter, on January 12, 2023, we granted to Dr. Angel a time-based incentive stock option covering 132,003 shares of common stock, of which
        110,043 shares vested immediately on the grant date and the remaining 21,960 shares vest in 35 substantially equal monthly installments on the first day of each month thereafter (the &#8220;2023 Grant&#8221;).</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">For both the 2022 Grant and the 2023 Grant, vesting generally requires Dr. Angel&#8217;s continued employment through the relevant vesting date.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">If Dr. Angel&#8217;s employment is terminated by us without Cause or by Dr. Angel for Good Reason (which shall have the meaning as mutually agreed in the Employment Agreement), the
        portion of the 2022 Grant, the 2023 Grant and any other grant subsequently issued that would have vested during the twelve months following the date of termination would immediately vest, and Dr. Angel will have twelve months following the date of
        termination to exercise any vested options.&#160; In addition, the Performance Bonus will remain a continuing obligation of ours to pay Dr. Angel so long as Dr. Angel has remained employed by us for two years following the applicable
        agreement/arrangement underlying the applicable Performance Bonus and so long as Dr. Angel does not voluntarily resign other than for Good Reason or for Cause.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">Pursuant to the Offer Letter, Dr. Angel is eligible for (a) reimbursement of reasonable business expenses, (b) participation in our benefit plans and (c) paid vacation days
          in accordance with our policies, as in effect from time to time.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">For information on related party transactions with Dr. Angel, see Item 13, <span style="font-style: italic;">Certain Relationships and Related Transactions, and Director
            Independence.</span></div>

      </div>

      <div><br />
      </div>

      <div style="color: #000000;"><span style="text-decoration: underline;">Howard J. Federoff</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We entered into an executive employment agreement, dated April 1, 2021 and effective as of April 16, 2021, with Howard J. Federoff with respect to terms of his employment as our
        Chief Executive Officer and President. The compensatory terms of the executive employment agreement, including equity awards, were approved by the Compensation Committee, which consists of two disinterested members of the Board. Dr. Federoff&#8217;s
        hiring, and his executive employment agreement, were approved by the Board.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">64</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The executive employment agreement provided for our at-will employment of Dr. Federoff as our Chief Executive Officer and President for a term commencing on April 16, 2021 and
        continuing until terminated by us or Dr. Federoff. Dr. Federoff resigned as the Company&#8217;s Chief Executive, which became effective on May 26, 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Under the terms of the executive employment agreement, we paid Dr. Federoff an annual base salary of $450,000, which amount was subject to annual review by the Board or the
        Compensation Committee and subject to adjustment to reflect market practices among our peers in the sole discretion of the Board or the Compensation Committee.&#160; Dr. Federoff was also eligible to receive an annual cash bonus award in an amount up to
        50% of his base salary upon achievement of reasonable performance targets set by the Board or the Compensation Committee, each in its sole discretion. The bonus would be determined by the Board or the Compensation Committee and paid annually in
        March in the year following the performance year on which such bonus was based. For the year ended December 31, 2021 we paid Dr. Federoff a $159,375 cash bonus.&#160; The agreement also provided for the grant of certain equity awards and severance
        benefits.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Effective May 26, 2022 (the &#8220;Separation Date&#8221;), Dr. Federoff resigned as an employee. Upon the effective date of his resignation, we entered into a Separation Agreement and General
        Release with Dr. Federoff (the &#8220;Separation Agreement&#8221;), pursuant to which Dr. Federoff resigned from his positions as Chief Executive Officer and as an officer, director and employee of the Company and all subsidiaries. In consideration for Dr.
        Federoff&#8217;s execution of the Separation Agreement and non-revocation of a waiver and release of claims relating thereto, Dr. Federoff was entitled to the following benefits under the Separation Agreement:</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">a lump sum cash severance benefit in the amount of $225,000, representing Dr. Federoff&#8217;s target bonus for 2022;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">payment of Dr. Federoff&#8217;s annual base salary for a period of twelve (12) months after the expiration of the applicable revocation period (the &#8220;Separation Period&#8221;), for a total gross amount equal to $450,000;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">payment of Dr. Federoff&#8217;s premiums for continued health benefits provided under COBRA for the Separation Period;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">full acceleration of the vesting of all outstanding options (with the exception of the Milestone Options) that would have vested during the Separation Period, and such options, together with outstanding
                options that vested prior to the Separation Date, representing collectively 71,004 shares of common stock, may be exercised for a period of thirty-six (36) months after the Separation Date;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">acceleration and vesting of 25/36<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the Milestone Options, and such accelerated options, representing collectively 20,737
                shares of common stock, may be exercised for a period of thirty-six (36) months after the Separation Date; and</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">a lump sum cash severance benefit in the amount of $130,347, representing the value Dr. Federoff would have received if he was entitled to receive a settlement of a pro rata portion of the Federoff PSU Grant
                through the expiration of the Separation Period, assuming the performance metrics were waived and assuming a per share value of $16.20.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Under the Separation Agreement, Dr. Federoff agreed to cooperate with and assist us regarding certain matters and transitioning his employment duties and responsibilities. Subject
        to certain exceptions and limitations, the Separation Agreement included a general release of claims by Dr. Federoff in favor of us and certain related persons and parties, and customary confidentiality and mutual non-disparagement provisions. The
        Separation Agreement also included certain other customary representations, warranties and covenants of Dr. Federoff, and provided for reimbursement of certain expenses incurred by Dr Federoff. The Separation Agreement superseded all other
        agreements or arrangements between Dr. Federoff and us regarding the subject matter of the agreement, including those with respect to severance payments and benefits.</div>

      <div><br />
      </div>

      <div style="color: #000000;"><span style="text-decoration: underline;">Andrew Jackson</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We entered into an amended and restated employment agreement, dated as of May 10, 2022, with Andrew Jackson with respect to his employment as our Chief Financial Officer. The
        employment agreement provides for our at-will employment of Mr. Jackson as our Chief Financial Officer for a term commencing on May 31, 2022 and continuing until terminated by us or Mr. Jackson.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">65</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Under the terms of the employment agreement, we will pay Mr. Jackson an annual base salary of $415,000, which amount is subject to periodic review by the Board or the Compensation
        Committee.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Mr. Jackson is eligible to receive an annual cash bonus award in an amount up to 40% of his base salary upon achievement of agreed upon performance targets. The bonus will be
        determined by the Board or the Compensation Committee and paid annually by March 15 in the year following the performance year on which such bonus is based. For the year ended December 31, 2022, there was no bonus earned.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">In accordance with the terms of the employment agreement, Mr. Jackson is entitled to receive equity awards, consisting of a time-based nonqualified stock option, which we refer to
        as the Jackson Option Grant, covering 33,239 shares of common stock, 25% of which will vest on the first anniversary of the employment agreement&#8217;s effective date, and the remainder will vest ratably on a monthly basis over the three-year period
        thereafter. Vesting generally requires Mr. Jackson&#8217;s continued employment through the relevant vesting date.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">If Mr. Jackson&#8217;s employment is terminated by us without Cause or by Mr. Jackson for Good Reason (each such capitalized term as defined in the employment agreement), we will pay Mr.
        Jackson all amounts accrued but unpaid as of the effective date of such termination, as well as continuation of his salary and benefits for the following nine month period (such period, the &#8220;Severance Period&#8221;). Notwithstanding the foregoing, if a
        termination without Cause or for Good Reason occurs within three months before or twelve months after a Change in Control (as defined in the employment agreement), Mr. Jackson will receive the benefits described in the preceding sentence, but the
        Severance Period shall run for a period of twelve months, and, in addition, Mr. Jackson will receive a lump-sum payment of his target bonus and the Jackson Option Grant shall become fully vested. Any such severance benefits under the employment
        agreement are contingent on Mr. Jackson entering into and not revoking a general release of claims in favor of our company.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The employment agreement provides for (a) reimbursement of reasonable business expenses, (b) participation in our benefit plans and (c) paid vacation days in accordance with our
        policies, as in effect from time to time, and up to an additional seven floating paid vacation days a year.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The employment agreement contains customary covenants related to non-solicitation for one year following termination of employment, as well as customary covenants related to
        non-competition, confidentiality, inventions and intellectual property rights.</div>

      <div><br />
      </div>

      <div style="color: #000000;"><span style="text-decoration: underline;">Roger Sidhu</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We had entered into an employment agreement, effective as of September 20, 2021, with Roger Sidhu with respect to terms of his employment as our Chief Medical Officer.&#160; The
        employment agreement provided for at-will employment of Dr. Sidhu as our Chief Medical Officer for a term commencing on September 20, 2021 and continuing until terminated by us or Dr. Sidhu. Dr. Sidhu resigned as our Chief Medical Officer effective
        January 31, 2023.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Under the terms of the employment agreement, we paid Dr. Sidhu an annual base salary of $447,200, which amount was subject to annual review by the Board or the Compensation
        Committee and subject to adjustment to reflect market practices among our peers in the sole discretion of the Board or the Compensation Committee.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Dr. Sidhu was eligible to receive an annual cash bonus award in an amount up to 40% of his base salary upon achievement of reasonable performance targets set by the board or the
        Compensation Committee, each in its sole discretion. The bonus would be determined by the Board or the Compensation Committee and paid annually in March in the year following the performance year on which such bonus was based. For the year ended
        December 31, 2021 we paid Dr. Sidhu a $48,277 cash bonus.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">In accordance with the terms of the employment agreement, we granted to Dr. Sidhu, effective as of September 20, 2021, a time-based nonqualified stock option, which we refer to as
        the Sidhu Option Grant, and a time-based restricted stock unit grant, which we refer to as the RSU Grant. The Sidhu Option Grant covered 8,065 shares of common stock, and the RSU Grant covered 4,032 shares of common stock. The Sidhu Option Grant
        and the RSU Grant each vested over four years, with vesting generally subject to Dr. Sidhu&#8217;s continued employment through the relevant vesting date. Consistent with the employment inducement grant rules set forth in Section 711(a) of the NYSE
        American LLC Company Guide, the equity award to Dr. Sidhu was made as an inducement material to his entering into employment with us and was approved by the Compensation Committee without need for stockholder approval.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">66</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">If Dr. Sidhu&#8217;s employment was terminated by us without Cause or by Dr. Sidhu for Good Reason (each such capitalized term as defined in the employment agreement), he would be
        entitled to, among other things, continued base salary for nine months following the termination date and the total monthly cost of health care continuation coverage pursuant to COBRA for such period. Notwithstanding the foregoing, if a termination
        without Cause or for Good Reason occurs within ninety days before or twelve months after a Change in Control (as defined in the employment agreement), Dr. Sidhu would become entitled to (a) receive the continued-based salary and total monthly cost
        of health care continuation coverage described in the preceding sentence for a period of twelve months rather than nine months, (b) receive a lump sum payment of his target annual bonus and (c) accelerated vesting in full of the Sidhu Option Grant
        and the RSU Grant. Any of such severance benefits under the employment agreement are contingent on Dr. Sidhu entering into and not revoking a general release of claims in favor of our company.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The employment agreement provided for (a) reimbursement of reasonable business expenses, (b) participation in our benefit plans and (c) twenty paid vacation days per year.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The employment agreement also contained customary covenants related to non-competition and non-solicitation for one year following termination of employment, as well as customary
        covenants related to confidentiality, inventions and intellectual property rights.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On March 11, 2022, we issued Dr. Sidhu a performance-based restricted stock unit grant (the &#8220;Sidhu PSU Grant&#8221;). The Sidhu PSU Grant covered 7,108 shares of common stock and were
        subject to the achievement of four performance goals, which were weighted equally.&#160; Once a performance goal was achieved, the tranche of shares allocated to that performance goal would be earned and would begin to vest annually over a three-year
        period beginning on the date the performance goal was achieved subject to Dr. Sidhu&#8217;s continued employment through the relevant vesting date.&#160; If a performance goal was not achieved, then tranche of shares allocated to that performance goal would
        be unearned and forfeited. As of December 31, 2022, none of the performance goals were achieved, and as a result, the shares covered under the Sidhu PSU Grant were cancelled.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">There was no separation agreement entered into upon Dr. Sidhu&#8217;s voluntary resignation effective January 31, 2023.</div>

      <div><br />
      </div>

      <div style="color: #000000;"><span style="text-decoration: underline;">Kevin D&#8217;Amour</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We entered into an employment agreement, dated June 5, 2021 and effective as of June 28, 2021, with Kevin A. D&#8217;Amour with respect to terms of his employment as our Chief Scientific
        Officer. The employment agreement provided for our at-will employment of Dr. D&#8217;Amour as our Chief Scientific Officer for a term commencing on June 28, 2021 and continuing until terminated by us or Dr. D&#8217;Amour. Dr. D&#8217;Amour resigned as our Chief
        Scientific Officer effective August 26, 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Under the terms of the employment agreement, we paid Dr. D&#8217;Amour an annual base salary of $415,000, which amount was subject to annual review by the Board or the Compensation
        Committee and subject to adjustment to reflect market practices among our peers in the sole discretion of the Board or the Compensation Committee.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Dr. D&#8217;Amour was eligible to receive an annual cash bonus award in an amount up to 40% of his base salary upon achievement of reasonable performance targets set by the Board or the
        Compensation Committee, each in its sole discretion. The bonus would be determined by the Board or the Compensation Committee and paid annually in March in the year following the performance year on which such bonus was based. For the year ended
        December 31, 2021 we paid Dr. D&#8217;Amour a $84,886 cash bonus.&#160; We additionally granted certain equity awards to Dr. D&#8217;Amour under his employment agreement.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">67</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Effective August 26, 2022, Dr. D&#8217;Amour resigned as an employee. Upon the effective date of his resignation, we entered into a Separation Agreement and General Release with Dr.
        D&#8217;Amour (the &#8220;D&#8217;Amour Separation Agreement&#8221;), pursuant to which Dr. D&#8217;Amour resigned from his position as Chief Scientific Officer. In consideration for Dr. D&#8217;Amour&#8217;s execution of the D&#8217;Amour Separation Agreement and non-revocation of a waiver and
        release of claims relating thereto, Dr. D&#8217;Amour was entitled to the following benefits under the D&#8217;Amour Separation Agreement:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">payment of Dr. D&#8217;Amour&#8217;s annual base salary for a period of nine (9) months after the expiration of the applicable revocation period (the &#8220;D&#8217;Amour Separation Period&#8221;), for a total gross amount equal to
                $311,250;</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">payment of Dr. D&#8217;Amour&#8217;s premiums for continued health benefits provided under COBRA for the D&#8217;Amour Separation Period; and</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">the vested portions of all Dr. D&#8217;Amour&#8217;s outstanding options, representing 57,296 shares of the Company&#8217;s common stock, were eligible to be exercised for a period of ninety (90) days following the separation
                date, and all unvested options, restricted stock units and performance stock units were immediately forfeited as of the separation date.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Under the D&#8217;Amour Separation Agreement, Dr. D&#8217;Amour agreed to cooperate with and assist us regarding certain matters and transitioning his employment duties and responsibilities.
        Subject to certain exceptions and limitations, the D&#8217;Amour Separation Agreement included a general release of claims by Dr. D&#8217;Amour in favor of us and certain related persons and parties, and customary confidentiality and mutual non-disparagement
        provisions. The D&#8217;Amour Separation Agreement also included certain other customary representations, warranties and covenants of Dr. D&#8217;Amour, and provided for reimbursement of certain expenses incurred by Dr D&#8217;Amour. The D&#8217;Amour Separation Agreement
        superseded all other agreements or arrangements between Dr. D&#8217;Amour and us regarding the subject matter of the agreement, including those with respect to severance payments and benefits.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-weight: bold;">Outstanding Equity Awards at 2022 Fiscal Year-End</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The following table summarizes the number of shares of our common stock underlying outstanding equity incentive plan awards for each named executive officer as of December 31, 2022.</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 21%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 1.04%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="21">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Option Awards</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="15">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Stock Awards</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 21%;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Name</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 1.04%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 5%;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Grant Date</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 0.84%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">securities</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">underlying</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">unexercised</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">options (#)</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">exercisable</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">securities</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">underlying</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">unexercised</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">options (#)</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">unexercisable</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Equity</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">incentive</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">plan</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">awards:</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">securities</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">underlying</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">unexercised</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">unearned</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">options (#)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Option</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">exercise</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">price</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">($)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2" rowspan="1">
              <div>&#160; </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Option</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">expiration</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">date</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">shares or</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">units of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">stock that</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">have not</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">vested (#)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Market</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">value of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">shares of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">units of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">stock that</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">have not</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">vested ($)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.84%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Equity</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">incentive</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">plan</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">awards:</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">unearned</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">shares,</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">units or</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">other</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">rights</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">that have</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">not</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">vested</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(#)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.65%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 0.65%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Equity</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">incentive</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">plan</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">awards:</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Market or</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">payout</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">value of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">unearned</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">shares,</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">units or</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">other</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">rights that</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">have not</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">vested</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">shares ($)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 21%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Matthew Angel,</div>
              <div style="color: rgb(0, 0, 0);">Chief Executive Officer and President<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1.04%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="vertical-align: bottom; width: 5%; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: left;">8/1/2022<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 0.84%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">15,542</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">108,808</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1"><br />
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">9.80</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; width: 5.25%; background-color: rgb(204, 238, 255); text-align: right; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">8/1/2032</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 4.93%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 21%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Howard J. Federoff,</div>
              <div style="color: rgb(0, 0, 0);">Former Chief Executive Officer and President</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1.04%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="vertical-align: bottom; width: 5%; text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: left;">4/16/2021<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 0.84%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">68,434</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1"><br />
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">158.80</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; width: 5.25%; text-align: right; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">5/26/2025</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 4.93%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 1.04%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 21%;">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1.04%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: top; width: 5%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">4/16/2021<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
              <div style="color: rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">3/11/2022<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
                <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"> </sup></div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 0.84%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">20,737</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1"><br />
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">158.80</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; width: 5.25%; text-align: right; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">5/26/2025</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 4.93%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 1.04%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 21%;">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1.04%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 0.84%;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">8,043</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">38.60</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; width: 5.25%; text-align: right; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"> 5/26/2025</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 4.93%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 1.04%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 21%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Andrew Jackson,</div>
              <div style="color: rgb(0, 0, 0);">Chief Financial Officer<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1.04%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="vertical-align: bottom; width: 5%; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: left;">6/3/2022<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 0.84%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">33,239</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1"><br />
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">12.17</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; width: 5.25%; background-color: rgb(204, 238, 255); text-align: right; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">6/3/2032</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 4.93%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 21%;">
              <div style="color: rgb(0, 0, 0);">Roger Sidhu,</div>
              <div style="color: rgb(0, 0, 0);">Chief Medical Officer</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1.04%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="vertical-align: bottom; width: 5%; text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: left;">9/20/2021<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 0.84%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">2,520</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">5,545</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">199.20</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; width: 5.25%; text-align: right; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">9/20/2031</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 4.93%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 1.04%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 21%;">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1.04%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td colspan="1" rowspan="2" style="vertical-align: bottom; width: 5%; text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: left;">
                <div>9/20/2021<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup> </div>
                <div style="color: rgb(0, 0, 0);">3/11/2022<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup></div>
              </div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 0.84%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1"><br />
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; width: 5.25%; text-align: right; white-space: nowrap;" rowspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">3,024</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 4.93%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">9,737</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 1.04%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 21%;">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1.04%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 0.84%;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">1,776</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">5,329</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">38.60</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; width: 5.25%; text-align: right; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">3/11/2032</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 4.93%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 1.04%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 21%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Kevin D&#8217;Amour,</div>
              <div style="color: rgb(0, 0, 0);">Chief Scientific Officer</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 1.04%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="vertical-align: bottom; width: 5%; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: left;">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 0.84%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1"><br />
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; width: 5.25%; background-color: rgb(204, 238, 255); text-align: right; white-space: nowrap;" rowspan="1">
              <div>&#160; </div>
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 4.93%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 21%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" style="vertical-align: top; width: 1.04%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="vertical-align: bottom; width: 5%; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-align: left;">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: top; width: 0.84%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1"><br />
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.25%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; width: 5.25%; background-color: rgb(204, 238, 255); text-align: right; white-space: nowrap;" rowspan="1">
              <div>&#160; </div>
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.19%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 4.93%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.84%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 0.65%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5.06%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">1.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">The option vests at a rate of 2/48<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the shares subject to the award on the grant date, with the remaining shares subject to
                the award vesting in 46 substantially equal monthly installments thereafter.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">2.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">The options vested pursuant to Dr. Federoff&#8217;s Separation Agreement.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">3.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">The option vests at a rate of 25% of the shares subject to the award on the one-year anniversary of the grant date, with the remaining shares subject to the award vesting in 36 substantially equal monthly
                installments thereafter.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">4.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">The restricted stock units vest at a rate of 25% of the shares subject to the award in four substantially equal annual installments on the anniversary of the grant date.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">5.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">The option vests over 36 substantially equal monthly installments.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">68</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="color: #000000; font-weight: bold;">Hedging and Pledging Company Securities</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our Insider Trading Policy prohibits our directors, officers, employees, family members of such persons and entities controlled by such persons from engaging in hedging, short
        sales, or trading in publicly traded put or call options with respect to our securities. Additionally, such policy prohibits the same persons from purchasing our securities on margin, borrowing against any account in which our securities are held,
        or pledging our securities as collateral for a loan.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-weight: bold;">Compensation-Related Risk Assessment</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our Compensation Committee assesses and monitors whether any of our compensation policies and programs is reasonably likely to have a material adverse effect on our Company. The
        Compensation Committee and management do not believe that the Company presently maintains compensation policies or practices that are reasonably likely to have a material adverse effect on the Company&#8217;s risk management or create incentives that
        could lead to excessive or inappropriate risk taking by employees. In reaching this conclusion, the Compensation Committee considered all components of our compensation program and assessed any associated risks. The Compensation Committee also
        considered the various strategies and measures employed by the company that mitigate such risk, including: (i) the overall balance achieved through our use of a mix of cash and equity, annual and long-term incentives and time-and performance-based
        compensation; (ii) our use of multi-year vesting periods for equity grants; and (ii) the oversight exercised by the Compensation Committee over the performance metrics and results under the Restated Plan and the 2021 Inducement Plan.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">69</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="color: #000000; font-weight: bold;">Director Compensation.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We compensate our non-employee directors for their service in such capacity with annual retainers and equity compensation as described below. Directors who are also our employees do
        not receive any additional compensation for their services as directors. We do not pay fees to any of our directors for meeting attendance.</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Compensation Element</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td colspan="4" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Amount</div>
            </td>

  </tr>

  <tr>

    <td rowspan="5" style="width: 45%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Annual Board Member Compensation</div>
            </td>

    <td rowspan="5" style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td colspan="4" style="vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Paid in cash or stock options, at the Board&#8217;s discretion. Cash paid in quarterly installments or upon the effective date of an earlier resignation of the non-employee director.&#160; Stock Options to vest
                quarterly over one year from grant date:</div>
            </td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td colspan="4" style="vertical-align: bottom;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;">a.</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 46.16%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Board Member: $40,000</div>
            </td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 46.16%; vertical-align: bottom;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;">b.</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 46.16%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Board Chair: $70,000</div>
            </td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 46.16%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

  </tr>

  <tr>

    <td rowspan="7" style="width: 45%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Committee Member Retainers</div>
            </td>

    <td rowspan="7" style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td colspan="4" style="vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Paid in cash or stock options, at the Board&#8217;s discretion. Cash paid in quarterly installments or upon the effective date of an earlier resignation of the non-employee director.&#160; Stock Options to vest
                quarterly over one year from grant date:</div>
            </td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td colspan="4" style="vertical-align: bottom;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;">c.</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 46.16%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Audit Committee: $7,500</div>
            </td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 46.16%; vertical-align: bottom;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;">d.</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 46.16%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Compensation Committee: $5,000</div>
            </td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 46.16%; vertical-align: bottom;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;">e.</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 46.16%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Nominating/Governance Committee: $4,000</div>
            </td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5%; vertical-align: bottom;">
              <div style="text-align: right; color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 46.16%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

  </tr>

  <tr>

    <td rowspan="7" style="width: 45%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Leadership Supplemental Retainer</div>
            </td>

    <td rowspan="7" style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td colspan="4" style="vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Paid in cash or stock options, at the Board&#8217;s discretion. Cash paid in quarterly installments or upon the effective date of an earlier resignation of the non-employee director.&#160; Stock Options to vest
                quarterly over one year from grant date:</div>
            </td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td colspan="4" style="vertical-align: bottom;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;">f.</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 46.16%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Audit Committee Chair: $15,000</div>
            </td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 46.16%; vertical-align: bottom;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;">g.</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 46.16%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Compensation Committee Chair: $10,000</div>
            </td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 1.28%; vertical-align: middle;" rowspan="1">&#160;</td>

    <td style="width: 46.16%; vertical-align: bottom;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;">h.</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 46.16%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Nominating/Governance Committee Chair: $8,000</div>
            </td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 5%; vertical-align: bottom;">
              <div style="text-align: right; color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 46.16%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">New Director Equity Award (outside directors)</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td style="width: 1.28%; vertical-align: middle;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td colspan="4" style="vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Option for 8,260 shares of Common Stock, which option shall have an exercise price equal to the fair market value per share of common stock, as determined under the 2020&#160;Plan, and, subject to continued
                service on the Board, vest in an initial installment of 1/3 of the shares on the first anniversary of the grant date, with the remaining shares to vest in 24 substantially equal installments thereafter.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The Board and the Compensation Committee designed our non-employee director compensation program to reward directors for their contributions to our success, align the director
        compensation program with stockholder interests, and provide competitive compensation necessary to attract and retain high quality non-employee directors. The Compensation Committee expects to review director compensation periodically to ensure
        that director compensation remains competitive such that we can recruit and retain qualified directors.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">70</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="color: #000000; font-style: italic; font-weight: bold;">2022 Director Compensation</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The following table provides summary information concerning compensation paid or accrued by us to or on behalf of our non-employee directors for services rendered to us during the
        last fiscal year.</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 15%;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Name</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fees Earned</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">or</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Paid in</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Cash</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">($)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Stock</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">awards</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">($)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Option</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">awards</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">($)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Non-equity</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">incentive</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">plan</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">compensation</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">($)</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nonqualified</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">deferred</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">compensation</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">earnings</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">($)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">All other</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">compensation</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">($)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total ($)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Charles Cherington</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">21,661</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9.65%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">134,516</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">156,177</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 15%;">
              <div style="color: rgb(0, 0, 0);">Gregory Fiore<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9.65%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">92,178</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">92,178</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Nicholas Singer<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9.65%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">110,171</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">110,171</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 15%;">
              <div style="color: rgb(0, 0, 0);">William Wexler<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9.65%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">112,288</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">112,288</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Dennis Langer<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">10,382</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9.65%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">10,382</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 15%;">
              <div style="color: rgb(0, 0, 0);">Erich Mohr<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">9,569</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9.65%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">9,569</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Erin Enright<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">10,822</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9.65%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">162,073</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">172,895</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 15%;">
              <div style="color: rgb(0, 0, 0);">Heather Redman<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">9,299</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9.65%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">162,073</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: middle; width: 1%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">171,372</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      <div>&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 27pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0);">1.</div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; color: rgb(0, 0, 0);">As of December 31, 2022, our non-employee directors had the following options outstanding:</div>
              </td>

  </tr>


</table>
      </div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 88%;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Name</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Options</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Outstanding</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Charles Cherington</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">22,395</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Gregory Fiore</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">13,045</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Nicholas Singer</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">15,595</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
              <div style="color: rgb(0, 0, 0);">William Wexler</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">15,895</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Dennis Langer</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Erich Mohr</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Erin Enright</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Heather Redman</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-align: justify; color: rgb(0, 0, 0); margin-left: 27pt;">The amounts reported in this column represents the aggregate grant date fair value of stock options granted during the applicable year. These amounts were calculated in
        accordance with FASB ASC Topic 718, Compensation &#8211; Stock Compensation, except that any estimate of forfeitures was disregarded. For a description of the assumptions used in computing the dollar amount recognized for financial statement reporting
        purposes, see Note 14, Stock-Based Compensation, in the Notes to the Consolidated Financial Statements contained in this Annual Report on Form 10-K.</div>

      <div>
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-size: 10pt;">(2)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-size: 10pt;">Appointed to the Board on June 6, 2022.</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
                  <div style="text-align: left; font-size: 10pt;"><span style="color: rgb(0, 0, 0);">(3)</span></div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; font-size: 10pt;"><span style="color: rgb(0, 0, 0);">Resigned from the Board effective June&#160;5, 2022</span></div>
                </td>

  </tr>


</table>
          <div> <br />
          </div>

        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">71</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <a id="SecurityOwnershipofCertai"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54.05pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 12.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: center; color: #000000; font-weight: bold;">STOCK OWNERSHIP</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The following table sets forth information known to us regarding beneficial ownership of common stock as of March 20, 2023 by:</div>

      <div>
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">each person known by us to be the beneficial owner of more than 5% of outstanding common stock;</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">each of our named executive officers and directors; and</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">all of our executive officers and directors as a group.</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"> <br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or
        shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. In computing the number of shares beneficially owned by a person or entity and the percentage
        ownership of that person or entity in the table below, all shares subject to options, warrants and restricted stock units held by such person or entity were deemed outstanding if such securities are currently exercisable, or exercisable or would
        vest based on service-based vesting conditions within 60 days of March 20, 2023, assuming that the liquidity event vesting conditions had been satisfied as of such date. These shares were not deemed outstanding, however, for the purpose of
        computing the percentage ownership of any other person or entity.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The beneficial ownership of our common stock is based on 5,127,070 shares of our common stock outstanding as of March 20, 2023.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Unless otherwise indicated, we believe that each person named in the table below has sole voting and investment power with respect to all shares of common stock beneficially owned
        by him.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Unless otherwise noted, the business address of each of these shareholders is c/o Eterna Therapeutics, Inc., 1035 Cambridge Street, Suite 18A, Cambridge, MA 02141.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">72</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Name and Address of Beneficial Owner</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Common</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Shares</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Beneficially</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Owned</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Percentage</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">of Common</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Shares</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Beneficially</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Owned</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Series A</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Convertible</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Preferred</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Stock</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Beneficially</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Owned</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Percentage</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">of Series A</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Convertible</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Preferred</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Stock</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Beneficially</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Owned</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Percentage</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">of Total</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Voting</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Power</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;"><span style="font-weight: bold; font-style: italic;">Greater than 5% Stockholders</span>:</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Charles Cherington<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">574,104</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">11.2</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">71,306</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">45.7</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">11.2</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">George Denny<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">460,209</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">9.0</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">71,306</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">45.7</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">9.0</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">John Halpern<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">452,283</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">8.8</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">8.8</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Nicholas J. Singer<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">398,349</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">7.8</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">7.8</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Factor Bioscience Inc.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">129,033</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">2.5</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">2.5</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;"><span style="font-weight: bold; font-style: italic;">Named Executive Officers and Directors</span>:</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Charles Cherington<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">574,104</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">11.2</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">71,306</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">45.7</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">11.2</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Nicholas J. Singer<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">398,349</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">7.8</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">7.8</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Matthew Angel<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">315,460</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">6.0</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">6.0</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">William Wexler<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">10,538</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">*</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">*</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Gregory Fiore<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">8,401</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">*</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">*</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Andrew Jackson</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Howard Federoff<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">97,214</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">1.9</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">1.9</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Roger Sidhu</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">1,008</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">*</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8213;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8213;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">*</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Kevin D&#8217;Amour</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">574</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">*</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">*</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%;">
                <div style="color: rgb(0, 0, 0); font-weight: bold; text-indent: -9pt; margin-left: 9pt;">AlAll current directors and executive officers as a group (7 persons)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">1,309,747</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">24.6</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">71,306</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">45.7</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">24.6</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">%</div>
              </td>

  </tr>


</table>
      </div>

      <div><br />
      </div>

      <div style="text-align: center;">
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">*</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">Less than 1%</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(1)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">Includes 14,668 shares of common stock subject to issuance upon exercise of options and 2,971 shares of common stock issuable upon conversion of Series A convertible preferred stock.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(2)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">Includes 2,971 shares of common stock issuable upon conversion of Series A convertible preferred stock. Denny Family Partners II, LLC owns 50,453 shares of common stock and the George
                  Denny III Trust dated 6/11/1981 owns 406,785 shares of common stock. Mr. Denny disclaims beneficial ownership of the shares held by Denny Family Partners II, LLC except to the extent of his pecuniary interest therein.&#160; Mr. Denny&#8217;s address
                  is. Mr. Denny has sole voting and dispositive power over 204 shares and has shared voting and dispositive power over 460,209 shares.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(3)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">Shares held by the John D. Halpern Revocable Trust, of which, Mr. Halpern and Katherine H. Halpern are trustees.&#160; Mr. Halpern and Ms. Halpern share voting and dispositive powers.&#160; Mr.
                  Halpern&#8217;s address is PO Box 540 Portsmouth, New Hampshire 03802..</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(4)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">Includes (i) 121,882 shares of common stock held by Purchase Capital LLC and (ii) 266,214 shares of common stock held by Pacific Premier Trust as Custodian for the benefit of
                  Mr.&#160;Singer. Mr.&#160;Singer has sole voting and investment power over all 398,349 shares. Also includes 64,478 shares of common stock subject to issuance upon exercise of options.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(5)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">Factor Bioscience Inc. owns 129,033 shares of common stock, over which Messrs. Angel and Rohde have shared voting and investment power. Mr.&#160;Angel also has sole voting and investment
                  power over 45,449 shares, and Mr.&#160;Rohde has sole voting and investment power over 67,885 shares. Factor Biosciences, Inc. and Messers. Angel and Rohde have entered into lock-up agreements with respect to 168,884 shares of common stock
                  listed above. Each lock-up agreement extends for a period of three years, provided that up to 75% of the shares of common stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common
                  stock on The Nasdaq Capital Market stock exchange exceeds specified thresholds. The lock-up agreements include customary exceptions for transfers during the applicable lock-up period. Factor Bioscience, Inc.&#8217;s address is 1035 Cambridge
                  Street, Suite 17B, Cambridge,&#160;MA&#160;02141.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(6)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">Includes 129,033 shares of common stock owned by Factor Biosciences Inc., of which Dr. Angel owns approximately 64% of the outstanding equity, and 140,978 shares of common stock subject
                  to issuance upon exercise of options.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(7)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">Represents shares of common stock subject to issuance upon exercise of options.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(8)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); text-align: justify;">Includes 187,124 shares of common stock issuable upon exercise of options and 2,971 shares of common stock issuable upon conversion of Series A convertible preferred stock.</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">73</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: center; color: #000000; font-weight: bold;">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The following table contains information as of December 31, 2022 with respect to compensation plans under which any of our equity securities are authorized for issuance.</div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"> <br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-left: 24%; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="10">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Equity Compensation Plan Information</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Plan Category</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">securities to be</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">issued upon</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">exercise of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">outstanding</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">options,</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">warrants and</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">rights</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted-</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">average</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">exercise price of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">outstanding</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">options,</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">warrants and</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">rights</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">securities</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">remaining</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">available for future</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">issuance under</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">equity</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">compensation</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">plans (excluding</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">securities reflected</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">in column (a))</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-left: 24%;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(a)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(b)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(c)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-left: 24%;" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Equity compensation plans approved by securityholders</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">258,092</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">16.72</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">165,694</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0);">Equity compensation plans not approved by securityholders<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">105,072</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">160.83</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">56,774</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Total</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">363,164</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">57.18</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">222,468</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000;">(1)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">Our 2021 Inducement Plan was not approved by our stockholders. For additional information on the 2021 Inducement Plan, see &#8220;Item 11. Executive Compensation&#8212;Narrative to Summary
                Compensation Table&#8212;Equity-Based Compensation Programs&#8212;2021 Inducement Plan&#8221; contained in this Annual Report on Form 10-K.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <a id="CertainRelationshipsandRe"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54.05pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 13.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Certain Relationships and Related Transactions, and Director Independence</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Except as set forth below, since January 1, 2021, there has not been nor are there currently proposed any transactions or series of similar transactions to which we were or are to
        be a party in which the amount involved exceeds the lesser of $120,000 or one percent (1%) of the average of our total assets at year-end for the last two completed fiscal years and in which any director, executive officer, holder of more than 5%
        of the common stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As previously reported, we paid consideration totaling approximately $124.0 million in respect of our acquisition of Novellus,
          Inc., which we refer to as the Novellus Acquisition, consisting of (a) $22.8 million in cash and (b) approximately 351,000 shares of our common stock, which under the terms of the agreement and plan of acquisition, dated as of July 16, 2021, by
          and between us, Novellus and the other parties thereto (the &#8220;Novellus Acquisition Agreement&#8221;), were valued at a total of $102.0 million, based on a price of 290.51 per share of our common stock. In connection with the Novellus Acquisition, (i)
          Factor, of which Dr. Angel beneficially owns approximately 64% of its outstanding equity, received approximately $1.7 million in cash consideration from us and approximately 129,000 shares of common stock, and (ii) Dr. Angel received
          approximately $2.0 million in cash consideration from us and approximately 31,000 shares of common stock. In addition, Dr. Angel also received approximately 14,000 shares of common stock, which we had placed in escrow for a period that ended on
          July 16, 2022 to secure indemnification obligations to us under the Novellus Acquisition Agreement.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">In November 2020, Novellus Limited, our wholly owned subsidiary following the Novellus Acquisition, and Factor Limited entered into the Third Amended and Restated Exclusive
          License Agreement (the &#8220;<span style="text-decoration: underline;">Novellus-Factor License Agreement</span>&#8221;), pursuant to which Factor Limited granted to Novellus Limited an exclusive license under certain patents owned by Factor Limited for the development of certain stem cell-based
          cellular therapies for treating diseases and conditions in humans and animals (the &#8220;<span style="text-decoration: underline;">Factor Licensed Technology</span>&#8221;).</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">In December 2020, Eterna LLC, our wholly owned subsidiary, entered into option agreements (the &#8220;Novellus-Factor Option Agreements&#8221;) with Novellus Limited. and Factor Limited
          (together, the &#8220;Licensors&#8221;) to obtain the right to exclusively license the Licensors&#8217; intellectual property and mRNA cell reprogramming and gene editing technology for use in the development of certain cell-based therapies to be evaluated and
          developed for treating human diseases, including certain types of cancer, sickle cell disease, and beta thalassemia (the &#8220;Licensed Technology&#8221;).</div>

        <div><br />
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">74</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In April 2021, Eterna LLC and the Licensors entered into an exclusive license agreement (the &#8220;Original Factor License Agreement&#8221;) pursuant to which Eterna LLC acquired an
          exclusive worldwide license to the Licensed Technology for use in the development of certain mRNA, gene-editing, and cellular therapies to be evaluated and developed for treating human diseases, including certain types of cancer, sickle cell
          disease, and beta thalassemia.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">As a result of our July 2021 Novellus Acquisition, the rights and obligations of Novellus Limited under the Novellus-Factor License Agreement pertaining to any and all licensed
          products from Factor Limited inured to Eterna. Our agreement with Factor Limited under the Original Factor License Agreement remained unchanged after the completion of the Novellus Acquisition.</div>

        <div><br />
        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 24.5pt; color: #000000;">In November 2022, following the expiration of one of the delineated milestone deadlines for certain regulatory filings required under the Novellus-Factor License Agreement
          expired, which permitted Factor Limited to terminate the license granted to Novellus Limited thereunder, we entered into the first amendment to the Original Factor License Agreement (the &#8220;Amended Factor License Agreement&#8221;), pursuant to which,
          among other things, Factor Limited granted to Eterna LLC an exclusive, sublicensable license under certain patents owned by Factor Limited (the &#8220;<span style="text-decoration: underline;">Factor Patents</span>&#8221;) for the purpose of identifying and pursuing certain opportunities to grant to
          third parties sublicenses to the Factor Patents. The Amended Factor License Agreement also (i) terminated the Novellus-Factor License Agreement, (ii) confirmed Factor Limited&#8217;s grant to Eterna LLC of the rights and licenses Novellus Limited
          previously granted to Eterna LLC under the Novellus-Factor License Agreement on the same terms and conditions as granted by Novellus Limited to Eterna LLC under such agreement, (iii) confirmed that the sublicense granted by Novellus Limited in
          accordance with the Novellus-Factor License Agreement to NoveCite (as discussed below), survived termination of the Novellus-Factor License Agreement; and (iv) removed Novellus Limited from the Amended Factor License Agreement and the NoveCite
          Agreement and replaced Novellus Limited with Factor Limited as the direct licensor to Eterna LLC and NoveCite under such agreements, respectively.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 24.5pt; color: #000000;">On February 20, 2023, we and Factor Limited entered into an exclusive license agreement (the &#8220;Exclusive Factor License Agreement&#8221;), which terminated and replaced in its entirety
          the Amended Factor License Agreement.&#160; Subject to certain exclusive licenses or other rights granted by Factor Limited to certain third parties as of the effective date of the Amended Factor License Agreement, Factor granted us the exclusive,
          sublicensable license under the Factor Patents.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 24.5pt; color: #000000;">The term of the Exclusive Factor License Agreement expires on November 22, 2027 (the &#8220;Expiration date&#8221;) but will be automatically extended for an additional two and a half years
          (such period, the &#8220;Renewal Term&#8221;) if we receive at least $100 million in fees from sublicenses to the Factor Patents (&#8220;Sublicense Fees&#8221;) granted by it pursuant to the Exclusive Factor License Agreement.&#160; Pursuant to the Exclusive Factor License
          Agreement, we will pay to Factor 20% of any Sublicense Fee received by us before the Expiration Date and 30% of any Sublicense Fees received by us during the Renewal Term.&#160; We may terminate the Exclusive Factor License Agreement upon 120 days&#8217;
          written notice to Factor, and both parties otherwise have additional customary termination rights, including in connection with certain uncured material breaches of the Exclusive Factor License Agreement and specified bankruptcy events.&#160; Under
          the Exclusive Factor License Agreement, we are obligated to pay the expenses incurred by Factor Limited in preparing, filing, prosecuting and maintaining the Factor Patents and agreed to bear all costs and expenses associated with enforcing and
          defending the Factor Patents in any action or proceeding arising from pursuit of sublicensing opportunities under the license granted under the Exclusive Factor License Agreement.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 24.5pt; color: #000000;">There can be no assurance that we can successfully develop and commercialize the technology licensed under the Exclusive Factor License Agreement. See &#8220;Risk Factors&#8212;Risks
          Related to our Business and Industry<span style="font-weight: bold;">&#8212;</span>We depend substantially, and expect in the future to continue to depend, on in-licensed intellectual property. Such licenses impose obligations on our business, and if
          we fail to comply with those obligations, we could lose license rights, which would substantially harm our business.&#8221;</div>

      </div>

      <div>
        <div><br />
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">75</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">
          <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the MSA we entered into with Factor Bioscience and the related Work Order No. 1 (the &#8220;WO1&#8221;), Factor
            Bioscience is providing us with certain mRNA cell engineering research support services, including (i) access to Factor Bioscience&#8217;s research laboratory facilities located in Cambridge, Massachusetts, (ii) access to Factor Bioscience&#8217;s
            scientific equipment, (iii) training of our research staff in mRNA, iPSC, and gene editing technology, (iv) copies of protocols, formulations, and sequences useful for the development of mRNA cell engineering products and (v) in vitro
            transcription templates, mRNA constructs, and iPS cells useful for the development of mRNA cell engineering products.&#160; In consideration for entry into the MSA, we agreed to pay Factor Bioscience an initial fee of $5.0 million, payable in twelve
            equal monthly installments of approximately $0.4 million, and, following the initial 12-month period, a monthly fee of $0.4 million until such time as the WO1 is terminated.&#160; We may terminate the work under the WO1 on or after the second
            anniversary of the date of the MSA, subject to providing Factor Bioscience with 120 days&#8217; prior notice.&#160; Factor Bioscience may terminate such work order only on and after the fourth anniversary of the date of the MSA, subject to providing us
            with 120 days&#8217; prior notice.<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br />
            </span></div>

        </div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">On October 8, 2022, we entered into the Exacis Option Agreement with Exacis, pursuant to which Exacis granted us the option to negotiate and enter into an exclusive worldwide
          license to certain of the technology licensed by Exacis for the treatment of cancer in humans. The Exacis Option Agreement provided for us paying Exacis a fee of $250,000 for the option, which would be creditable against the fees or purchase
          price payable under any such license if entered into by us in accordance with Exacis Option Agreement. We did not exercise the option, and the Exacis Option Agreement terminated on December 31, 2022.</div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;"> <br />
        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; color: #000000;">On November 23, 2022, the Company entered into the Q4-22 Purchase Agreement with the Q4-22 PIPE Investors in respect of the Q4-22 PIPE
        Transaction, pursuant to which the Company issued and sold to the Q4-22 PIPE Investors approximately 2,185,000 units, each unit consisting of (i) one share of common stock and (ii) two Q4-22 Warrants, each exercisable to purchase one share of
        common stock at an exercise price of $3.28 per share, at a purchase price of $3.53 per unit (inclusive of $0.125 per Q4-22 Warrant). The Company received aggregate gross proceeds of approximately $7.7 million, and the Q4-22 PIPE Transaction closed
        on December 2, 2022.&#160; Each Q4-22 Warrant becomes exercisable six months following the date of closing, expires five-and-one-half years following such date, and is subject to customary adjustments.</div>

      <div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; color: #000000;"> <br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 24.5pt; color: #000000;">Mr. Charles Cherington, Chairman of the Company&#8217;s Board of Directors, and Mr. Nicholas Singer, a director of the Company, participated in the Q4-22 PIPE Transaction on the same
          terms and subject to the same conditions as all other Q4-22 PIPE Investors.</div>

        <div><br />
        </div>

      </div>

      <div style="color: #000000; font-weight: bold;">Related Party Transaction Policy</div>

      <div>
        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our Audit Committee is responsible for the review, approval, or ratification of any potential conflict of interest transaction involving any of our directors or executive
          officers, director nominees, any person known by us to be the beneficial owner of more than 5% of our outstanding capital stock, or any family member of or related party to such persons, including any transaction required to be reported under
          Item 404(a) of Regulation S-K promulgated by the SEC.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">In reviewing any such proposed transaction, our Audit Committee is tasked with considering all relevant facts and circumstances, including the commercial reasonableness of
          the terms, the benefit or perceived benefit, or lack thereof, to us, opportunity costs of alternate transactions, the materiality and character of the related person&#8217;s direct or indirect interest and the actual or apparent conflict of interest of
          the related person.</div>

      </div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">Under our policy, employees are required to report any material transaction or relationship that could result in a conflict of interest to our compliance officer.</div>

        <div>&#160;</div>

      </div>

      <div style="color: #000000; font-weight: bold;">Director Independence</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our Board undertook a review of the independence of each director. Based on information provided by each director concerning his or her background, employment, and affiliations, our
        Board has determined that the Board meets independence standards under the applicable rules and regulations of the SEC and the listing standards of Nasdaq. The Board of Directors has affirmatively determined that the following Directors are
        &#8220;independent&#8221; as defined in the listing standards of Nasdaq: Charles Cherington; Nicholas J. Singer; and William Wexler. In making these determinations, our Board considered the current and prior relationships that each non-employee director has
        with our Company and all other facts and circumstances our Board deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each non-employee director, and the transactions involving them described
        in the section titled &#8220;Certain Relationships and Related Party Transactions.&#8221;</div>

      <div><br /></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">76</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <a id="PrincipalAccountingFeesan"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54.05pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 14.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Principal Accounting Fees and Services</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="color: #000000; font-weight: bold;">Change in Certifying Accountant</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On January 18, 2022, we notified Marcum LLP (&#8220;Marcum&#8221;) that it would be dismissed as our independent registered public accounting firm effective after the completion of Marcum&#8217;s
        audit of our financial statements for the year ended December 31, 2021. The Audit Committee approved Marcum&#8217;s dismissal on January 18, 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Marcum performed audits of our consolidated financial statements for the years ended December 31, 2021 and 2020. Marcum&#8217;s reports for such years did not contain an adverse opinion
        or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles. During the two years ended December 31, 2021, and from December 31, 2020 through January 24, 2022, there were no (i)
        disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions to Item 304 of Regulation S-K promulgated by the SEC pursuant to the Exchange Act) between us and Marcum on any matter of accounting principles or
        practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to satisfaction of Marcum, would have caused Marcum to make reference to the subject matter of such disagreements in connection with its
        report, or (ii) &#8220;reportable events,&#8221; as described in Item 304(a)(1)(v) of Regulation S-K, that would require disclosure under Item 304(a)(1)(v) of Regulation S-K, except for the material weaknesses previously reported in our Quarterly Report on
        Form 10-Q for the period ended September 30, 2021 related to (a) segregation of duties and (b) documentation of policies and procedures critical to the accomplishment of financial reporting objectives. We previously furnished Marcum with a copy of
        the disclosure under this heading &#8220;Change in Certifying Accountant&#8221; prior to filing a Current Report on Form 8-K containing such disclosure with the SEC on January 24, 2022 and requested that Marcum furnish it with a letter addressed to the SEC
        stating whether or not it agreed with the statements made by us in such Current Report on Form 8-K insofar as they related to Marcum&#8217;s audit services and engagement as our independent registered public accounting firm. A copy of Marcum&#8217;s letter
        concurring with the foregoing disclosures was attached as Exhibit 16.1 to the Current Report on Form 8-K filed by us on January 24, 2022. Marcum&#8217;s dismissal became effective on April 15, 2022, and no events had occurred since the filing of such
        Form 8-K that would have required the filing of an amendment to such Form 8-K.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On January 18, 2022, we notified Grant Thornton LLP (&#8220;Grant Thornton&#8221;) that the Audit Committee had selected Grant Thornton to serve as our independent registered public accounting
        firm for the fiscal year ending December 31, 2022 and related interim periods, and Grant Thornton&#8217;s engagement became effective on April 18, 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">During the two years ended December 31, 2021 and from December 31, 2019 through April 19, 2022 (the date on which we filed a Current Report on Form 8-K, reporting the respective
        effective dates of Marcum&#8217;s dismissal and Grant Thornton&#8217;s engagement), neither we nor anyone acting on its behalf has consulted Grant Thornton regarding either: (i) the application of accounting principles to a specified transaction, either
        completed or proposed; or the type of audit opinion that might be rendered on our financial statements, and no written report or oral advice was provided to us by Grant Thornton that Grant Thornton concluded was an important factor considered by us
        in reaching a decision as to an accounting, auditing or financial reporting issue; or (ii) any matter that was either subject of a disagreement, as that term is defined in Item 304 (a)(1)(iv) of Regulation S-K and the related instructions to Item
        304 of Regulation S-K, or a &#8220;reportable event,&#8221; as that term is described in Item 304(a)(1)(v) of Regulation S-K.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-weight: bold;">Fees and Services of Independent Registered Public Accounting Firm</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The table below summarizes the fees and expenses billed to us by Grant Thornton and Marcum for the years ended December 31, 2022 and 2021.</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 40%;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Year</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Audit Fees</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Audit-Related Fees</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Tax Fees</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">All Other Fees</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; color: rgb(0, 0, 0);">2022</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">435,750</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">435,750</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%;">
              <div style="text-align: center; color: rgb(0, 0, 0);">2021</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">357,925</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">18,540</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">&#8212;</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">376,465</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">77</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Audit Fees.</span> Audit fees consist of services rendered by an independent registered public accounting firm for the audit of
        our consolidated financial statements (including tax services performed to fulfill the auditor&#8217;s responsibility under generally accepted auditing standards) and our internal control over financial reporting, reviews of the interim financial
        statements included in Forms 10-Q and includes services that generally only an external auditor can reasonably provide, such as comfort letters, statutory audits, attest services, consents and assistance with and review of documents filed with the
        SEC.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Audit-Related Fees.</span> Audit-related fees consist of assurance and related services (e.g., due diligence) by an external
        auditor that are reasonably related to the audit or review of financial statements, including employee benefit plan audits, due diligence related to mergers and acquisitions, accounting consultations and audits in connection with proposed or
        consummated acquisitions, internal control reviews, attest services related to financial reporting that are not required by statute or regulation, and consultation concerning financial accounting and reporting standards.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Tax Fees.</span> Tax fees consist of services rendered by an external auditor for tax compliance, tax consulting and tax
        planning.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">All Other Fees.</span> All other fees are for any other permissible work that is not an Audit, Audit-Related or Tax Fee.</div>

      <div><br />
      </div>

      <div style="color: #000000; font-weight: bold;">Policy for Approval of Audit and Permitted Non-Audit Services</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">All audit and permissible non-audit services provided by the independent auditors are pre-approved by the Audit Committee (or the Chair of the Audit Committee, pursuant to a
        delegation of authority). These services may include audit services, audit-related services, tax services and other services. Pre-approval is generally provided for up to one year and any pre-approval is detailed as to the particular service or
        category of services and is generally subject to a specific budget. The independent auditors and management are required to periodically report to the Audit Committee regarding the extent of services provided by the independent auditors in
        accordance with this pre-approval, and the fees for the services performed to date. The Audit Committee may also pre-approve particular services on a case-by-case basis.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">78</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: center; color: #000000; font-weight: bold;">PART IV</div>

      <div>&#160;</div>

      <a id="ExhibitsFinancialStatemen"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54.05pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 15.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Exhibits, Financial Statement Schedules</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-indent: 27pt; color: #000000;">(a) The following documents are filed as a part of this Annual Report on Form 10-K:</div>

      <div>&#160;</div>

      <div style="text-indent: 27pt;"><span style="font-style: italic; color: #000000;">(1)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color: rgb(0, 0, 0);"><span style="font-style: italic;">Consolidated Financial Statements.</span> The consolidated financial statements
          of the Company and its consolidated subsidiaries are set forth in the &#8220;Index to Consolidated Financial Statements&#8221; on page F-1.</span></div>

      <div>&#160;</div>

      <div style="text-indent: 27pt;"><span style="font-style: italic; color: #000000;">(2)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color: rgb(0, 0, 0);"><span style="font-style: italic;">Financial Statement Schedules. </span>None</span></div>

      <div>&#160;</div>

      <div style="text-indent: 27pt;"><span style="font-style: italic; color: #000000;">(3)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="color: rgb(0, 0, 0);"><span style="font-style: italic;">Exhibits. </span>The following exhibits are submitted with this Annual Report
          on Form 10-K or, where indicated, incorporated by reference to other filings. TBD</span></div>

      <div>&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 12%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
                <div style="font-weight: bold;">Exhibit</div>
              </td>

    <td style="width: 1%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 62.42%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div>&#160;</div>
                <div style="color: #000000; font-weight: bold;">Description</div>
              </td>

    <td style="width: 1.36%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="color: #000000; font-weight: bold;">Incorporated By Reference</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000149315221001359/forms-4a.htm#aa_001">2.1(b)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Agreement and Plan of Merger and Reorganization, dated August 12, 2020, among NTN Buzztime, Inc., BIT Merger Sub, Inc. and Eterna Therapeutics LLC</div>
              </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Exhibit 2.1 to the proxy statement/prospectus on Form S-4/A filed on January 20, 2021</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121024732/brhc10026994_ex10-1.htm">2.2(b)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 62.42%; vertical-align: top;">
                <div style="color: #000000;">Agreement and Plan of Acquisition, dated as of July 16, 2021, by and among Eterna Therapeutics&#160; Inc., Brooklyn Acquisition Sub, Inc., Novellus LLC, Novellus, Inc., and the Sellers&#8217; Representative</div>
              </td>

    <td style="width: 1.36%; vertical-align: top;">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top;">
                <div style="color: #000000;">Exhibit 10.1 to Form 8-K filed on July 19, 2021</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="brhc10049677_ex3-1.htm">3.1</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Composite Restated Certificate of Incorporation of the Company</div>
              </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122036744/brhc10042808_ex3-2.htm">3.2</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 62.42%; vertical-align: top;">
                <div style="color: #000000;">Second Amended and Restated Bylaws of the Company</div>
              </td>

    <td style="width: 1.36%; vertical-align: top;">
                <div>&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top;">
                <div>Exhibit 3.2 to Form 8-K filed on October 11, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121030987/brhc10028852_ex3-1.htm">3.3</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Certificate of Validation of <span style="color: #000000;">Eterna Therapeutics </span>Inc., as filed with the Secretary of State of the State of Delaware on September 3, 2021</div>
              </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 3.1 to Form 8-K filed on September 13, 2021</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122014764/brhc10036185_ex4-1.htm">4.1</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 62.42%; vertical-align: top;">
                <div style="color: #000000;">Description of Registrant&#8217;s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934</div>
              </td>

    <td style="width: 1.36%; vertical-align: top;">&#160;</td>

    <td style="width: 23.78%; vertical-align: top;">
                <div>Exhibit 4.1 to Form 10-K filed on April 15, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122008622/brhc10034972_ex10-1.htm">10.1</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Securities Purchase Agreement, dated as of March 6, 2022, between Eterna Therapeutics Inc. and the purchaser party thereto</div>
              </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Exhibit 10.1 to Form 8-K filed on March 9, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122008622/brhc10034972_ex10-4.htm">10.2</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 62.42%; vertical-align: top;">
                <div style="color: #000000;">Registration Rights Agreement, dated as of March 6, 2022, between Eterna Therapeutics Inc. and the purchaser party thereto</div>
              </td>

    <td style="width: 1.36%; vertical-align: top;">
                <div>&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top;">
                <div style="color: #000000;">Exhibit 10.4 to Form 8-K filed on March 9, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122008622/brhc10034972_ex10-2.htm">10.3</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Form of Pre-Funded Warrant</div>
              </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Exhibit 10.2 to Form 8-K filed on March 9, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122008622/brhc10034972_ex10-3.htm">10.4</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 62.42%; vertical-align: top;">
                <div style="color: #000000;">Form of Common Stock Warrant</div>
              </td>

    <td style="width: 1.36%; vertical-align: top;">
                <div>&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top;">
                <div style="color: #000000;">Exhibit 10.3 to Form 8-K filed on March 9, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122024669/brhc10039260_ex10-5.htm">10.5</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Agreement to Assign Space Lease dated March 5, 2022 between Eterna Therapeutics LLC and Regen Lab USA LLC.</div>
              </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Exhibit 10.5 to Form 10-Q filed on July 1, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122024669/brhc10039260_ex10-6.htm">10.6</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 62.42%; vertical-align: top;">
                <div style="color: #000000;">Assignment and Assumption of Lease dated March 25, 2022 between Eterna Therapeutics LLC and Regen Lab USA LLC</div>
              </td>

    <td style="width: 1.36%; vertical-align: top;">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top;">
                <div style="color: #000000;">Exhibit 10.6 to Form 10-Q filed on July 1, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122021148/brhc10038309_ex10-1.htm">10.7(a)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Amended and Restated Executive Employment Agreement, dated as of May 10, 2022, by and between Eterna Therapeutics Inc. and Andrew Jackson</div>
              </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Exhibit 10.1 to Form 8-K filed on May 31, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122021148/brhc10038309_ex10-2.htm">10.8(a)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 62.42%; vertical-align: top;">
                <div style="color: #000000;">Separation Agreement and General Release, dated May 25, 2022, by and between Eterna Therapeutics Inc. and Howard J. Federoff</div>
              </td>

    <td style="width: 1.36%; vertical-align: top;">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top;">
                <div style="color: #000000;">Exhibit 10.2 to Form 8-K filed on May 31, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122029251/brhc10040603_ex10-3.htm">10.9</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Torrey Pines Science Center Lease, dated March 31, 2022, between Eterna Therapeutics Inc. and Torrey Pines Science Center Limited Partnership</div>
              </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Exhibit 10.3 to Form 10-Q filed on August 11, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121015275/nt10023650x2_ex10-3.htm">10.10</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#160;</div>
              </td>

    <td style="width: 62.42%; vertical-align: top;">
                <div>Exclusive License Agreement, dated as of April 26, 2021, between Factor Bioscience Limited, Novellus Therapeutics Limited and <span style="color: #000000;">Eterna Therapeutics</span></div>
              </td>

    <td style="width: 1.36%; vertical-align: top;">
                <div>&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top;">
                <div>Exhibit 10.3 to Form 8-K filed on April 30, 2021</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122042770/brhc10044587_ex10-1.htm">10.11</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">First Amendment to Exclusive License Agreement, dated November 22, 2022, by and among Eterna Therapeutics Inc., Eterna Therapeutics LLC, Novellus Therapeutics Limited and Factor Bioscience Limited</div>
              </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">&#160;</div>
              </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: #000000;">Exhibit 10.1 to Form 8-K filed on November 22, 2022</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">79</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123008076/brhc10048628_ex10-1.htm">10.12</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Exclusive License Agreement, dated February 20, 2023, by and between Factor Bioscience Limited and Eterna Therapeutics Inc.</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Exhibit 10.1 to Form 8-K filed on February 22, 2023</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122041399/brhc10043851_ex10-3.htm">10.13</a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top;">
              <div style="color: #000000;">Third Amended and Restated Exclusive License Agreement, dated November 1, 2020, by and between Factor Bioscience Limited and Novellus Therapeutics Limited</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top;">
              <div style="color: #000000;">Exhibit 10.3 to Form 10-Q filed<span style="background-color: #CCEEFF;">&#160;</span>on November 14, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122033478/brhc10041894_ex10-1.htm">10.14</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Master Services Agreement, dated September 9, 2022, by and between Factor Bioscience Inc. and Eterna Therapeutics Inc.</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Exhibit 10.1 to Form 8-K filed on September 15, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122031997/brhc10041542_ex10-1.htm">10.15(a)</a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top;">
              <div style="color: #000000;">Separation Agreement and General Release, dated August 24, 2022, by and between Eterna Therapeutics Inc and Kevin D&#8217;Amour</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top;">
              <div style="color: #000000;">Exhibit 10.1 to Form 8-K/A filed on September 1, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="brhc10049677_ex10-16.htm">10.16</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Sublease Agreement, dated October 18, 2022, by and between E.R. Squibb &amp; Sons, LLC and Eterna Therapeutics Inc.</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122037240/brhc10042946_10-1.htm">10.17</a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top;">
              <div style="color: #000000;">Option Agreement, dated October 8, 2022, by and between Exacis Biotherapeutics, Inc. and Eterna Therapeutics Inc.</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top;">
              <div style="color: #000000;">Exhibit 10.1 to Form 8-K filed on October 14, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122043061/brhc10044682_ex10-1.htm">10.18</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Securities Purchase Agreement, dated as of November 23, 2022, by and among Eterna Therapeutics Inc. and the purchasers party thereto</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Exhibit 10.1 to Form 8-K filed on November 25, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122044329/brhc10045002_ex10-1.htm">10.19</a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top;">
              <div style="color: #000000;">Form of Warrant</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top;">
              <div style="color: #000000;">Exhibit 10.1 to Form 8-K filed on December 5, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122044329/brhc10045002_ex10-2.htm">10.20</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Registration Rights Agreement, dated as of December 2, 2022, by and among Eterna Therapeutics Inc. and the purchasers party thereto</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Exhibit 10.2 to Form 8-K filed on December 5, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div><a href="brhc10049677_ex10-21.htm">10.21</a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top;">
              <div style="color: #000000;">Lease Termination Agreement, dated November 30, 2022, by and between Torrey Pines Science Center Limited Partnership and Eterna Therapeutics Inc.</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top;">
              <div style="color: #000000;">Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="brhc10049677_ex10-22.htm">10.22</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">First Amendment to Lease Termination Agreement, dated December 29, 2022, by and between Torrey Pines Science Center Limited Partnership and Eterna Therapeutics Inc.</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123000340/brhc10046238_ex10-1.htm">10.23</a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top;">
              <div style="color: #000000;">Angel Offer Letter, dated December 30, 2022, by and among Eterna Therapeutics Inc. and Dr. Matthew Angel</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top;">
              <div style="color: #000000;">Exhibit 10.1 to Form 8-K filed on January 4, 2023</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="font-size: 12pt;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121015275/nt10023650x2_ex10-2.htm"><span style="font-size: 10pt;">10.24</span></a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Registration Rights Agreement, dated as of April 26, 2021, between&#160;<span style="color: #000000;">Eterna Therapeutics</span> Inc. and Lincoln Park Capital Fund, LLC</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Exhibit 10.2 to Form 8-K filed on April 30, 2021</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121018871/brhc10025183_ex10-2.htm">10.25</a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 62.42%; vertical-align: top;">
              <div>Registration Rights Agreement, dated as of May 26, 2021, between <span style="color: #000000;">Eterna Therapeutics</span> Inc. and Lincoln Park Capital Fund, LLC</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">&#160;</td>

    <td style="width: 23.78%; vertical-align: top;">
              <div>Exhibit 10.2 to Form 8-K filed on May 26, 2021</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121024732/brhc10026994_ex10-2.htm">10.26</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Registration Rights Agreement, dated as of July 16, 2021, by and among <span style="color: #000000;">Eterna Therapeutics</span> Inc. and the individuals and entities named therein.</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Exhibit 10.2 to Form 8-K filed on July 19, 2021</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121015275/nt10023650x2_ex10-1.htm">10.27</a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top;">
              <div>Purchase Agreement, dated as of April 26, 2021, between <span style="color: #000000;">Eterna Therapeutics</span> Inc. and Lincoln Park Capital Fund, LLC</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top;">
              <div>Exhibit 10.1 to Form 8-K filed on April 30, 2021</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121018871/brhc10025183_ex10-1.htm">10.28</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Purchase Agreement, dated as of May 26, 2021, between <span style="color: #000000;">Eterna Therapeutics</span> Inc. and Lincoln Park Capital Fund, LLC</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Exhibit 10.1 to Form 8-K filed on May 26, 2021</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 12pt;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121018871/brhc10025183_ex10-3.htm"><span style="font-size: 10pt;">10.29(a)</span></a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top;">
              <div><span style="color: #000000;">Eterna Therapeutics</span> Inc. 2021 Inducement Stock<span style="background-color: #CCEEFF;">&#160;</span>Incentive Plan</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top;">
              <div>Exhibit 10.3 to Form 8-K filed&#160;on May 26, 2021</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="font-size: 12pt;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121030987/brhc10028852_ex99-1.htm"><span style="font-size: 10pt;">10.29(a)</span></a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><span style="color: #000000;">Eterna Therapeutics</span> Inc. Restated 2020 Stock Incentive Plan</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Exhibit 99.1 to Form 8-K filed on September 13, 2021</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122002499/brhc10033022_16-1.htm">16.1</a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 62.42%; vertical-align: top;">
              <div style="color: #000000;">Marcum, LLP letter dated January 24, 2022</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">&#160;</td>

    <td style="width: 23.78%; vertical-align: top;">
              <div>Exhibit 16.1 to Form 8-K filed on January 24, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122015034/brhc10036518_ex16-1.htm">16.2</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Marcum, LLP letter dated April 19, 2022</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Exhibit 16.1 to Form 8-K filed on April 19, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div style="color: #000000;"><a href="brhc10049677_ex21-1.htm">21.1</a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 62.42%; vertical-align: top;">
              <div>Subsidiaries of the Company</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">&#160;</td>

    <td style="width: 23.78%; vertical-align: top;">
              <div>Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;"><a href="brhc10049677_ex23-1.htm">23.1</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Consent of the Independent Registered Accounting Firm, Grant Thornton LLP</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div style="color: #000000;"><a href="brhc10049677_ex23-2.htm">23.2</a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 62.42%; vertical-align: top;">
              <div>Consent of the Independent Registered Accounting Firm, Marcum LLP.</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">&#160;</td>

    <td style="width: 23.78%; vertical-align: top;">
              <div>Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="brhc10049677_ex31-1.htm">31.1</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div><a href="brhc10049677_ex31-2.htm">31.2</a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top;">
              <div>Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top;">
              <div>Filed herewith</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">80</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="brhc10049677_ex32-1.htm">32.1</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Furnished herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div><a href="brhc10049677_ex32-2.htm">32.2</a></div>
            </td>

    <td style="width: 1%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top;">
              <div>Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top;">
              <div>Furnished herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>101.INS</div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div>101.SCH</div>
            </td>

    <td style="width: 1%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top;">
              <div>Inline XBRL Taxonomy Extension Schema Document</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top;">
              <div>Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>101.CAL</div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Inline XBRL Taxonomy Extension Calculation Linkbase Document</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div>101.DEF</div>
            </td>

    <td style="width: 1%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top;">
              <div>Inline XBRL Taxonomy Extension Definition Linkbase Document</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top;">
              <div>Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>101.LAB</div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Inline XBRL Taxonomy Extension Label Linkbase Document</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
              <div>101.PRE</div>
            </td>

    <td style="width: 1%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top;">
              <div>Inline XBRL Taxonomy Extension Presentation Linkbase Document</div>
            </td>

    <td style="width: 1.36%; vertical-align: top;">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top;">
              <div>Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>104</div>
            </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
            </td>

    <td style="width: 62.42%; vertical-align: top; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</div>
            </td>

    <td style="width: 1.36%; vertical-align: top; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
              <div>&#160;</div>
            </td>

    <td style="width: 23.78%; vertical-align: top; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
              <div>&#160;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: #000000;">(a)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Indicates management contract or compensatory plan.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <a id="Form10-KSummary"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 72.05pt; vertical-align: top; color: #000000; font-weight: bold;">ITEM 16.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Form 10-K Summary</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-indent: 27pt; color: #000000;">None.</div>

      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">81</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <div style="text-align: center; color: #000000; font-weight: bold;"><a id="SIGNATURES"><!--Anchor--></a>SIGNATURES</div>

      <div>&#160;</div>

      <div style="text-indent: 24.5pt; color: #000000;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned,
        thereunto duly authorized<span style="font-weight: bold;">.</span></div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">ETERNA THERAPEUTICS INC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: middle;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Date: March 20, 2023</div>
            </td>

    <td style="width: 5%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">By:</div>
            </td>

    <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-style: italic; font-variant: small-caps;">/s/ Andrew Jackson</span><br />
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom;">&#160;</td>

    <td style="width: 5%; vertical-align: middle;">&#160;</td>

    <td style="width: 45%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Andrew Jackson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45%; vertical-align: bottom;">
              <div style="text-align: center; color: #000000; font-weight: bold;">Chief Financial Officer</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 50%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 45%; vertical-align: bottom; font-weight: bold; text-align: center;">(Principal Financial Officer)</td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-indent: 24.5pt; color: #000000;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant in the capacities and on the
        dates indicated.</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32.74%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Name</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Title</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Date</div>
            </td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-style: italic; font-variant: small-caps;">/s/ Matthew Angel</span><br />
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Chief Executive Officer, President and Director (Principal Executive Officer)</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;March 20, 2023</div>
            </td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Matthew Angel</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom; text-align: center;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-style: italic; font-variant: small-caps;">/s/ Andrew Jackson</span><br />
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Chief Financial Officer (Principal Financial Officer)</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;March 20, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Andrew Jackson</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom; text-align: center;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-style: italic; font-variant: small-caps;">/s/ Sandra Gurrola</span><br />
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Vice President of Finance (Principal Accounting Officer)</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;March 20, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Sandra Gurrola</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom; text-align: center;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-style: italic; font-variant: small-caps;">/s/ Charles Cherington</span><br />
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;Chairman of the Board</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">March 20, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Charles Cherington</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom; text-align: center;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-style: italic; font-variant: small-caps;">/s/ Gregory Fiore</span><br />
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;Director</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;March 20, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Gregory Fiore</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom; text-align: center;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-style: italic; font-variant: small-caps;">/s/ Nicholas Singer</span><br />
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;Director</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;March 20, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nicholas Singer</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom; text-align: center;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-style: italic; font-variant: small-caps;">/s/ William Wexler</span><br />
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;Director</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">&#160;March 20, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 32.74%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">William Wexler</div>
            </td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 43.88%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.01%; vertical-align: bottom;">&#160;</td>

    <td style="width: 21.36%; vertical-align: bottom;">&#160;</td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">82</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <!--PROfilePageNumberReset%Num%1%F-%%--> </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ETERNA THERAPEUTICS INC. AND SUBSIDIARIES</div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><a id="INDEX"><!--Anchor--></a><a id="INDEXTOCONSOLIDATEDFINANC"><!--Anchor--></a>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 92%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td style="width: 8%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Page</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);"><a href="#REPORT1">Report of Independent Registered Public Accounting Firm</a> (PCAOB ID: <span style="-sec-ix-hidden:Fact_171a355144ac40c4a867492ecadd0a91">248</span>) </td>

    <td rowspan="1" style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right; white-space: nowrap;">&#160;F-2</td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 92%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 8%; vertical-align: top; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#REPORT2">Report of Independent Registered Public Accounting Firm</a> (PCAOB ID: <span style="-sec-ix-hidden:Fact_d4a22f6ee0d543c686e66a7f41ccef3c">688</span>)<br />
              </div>
            </td>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0);">F-3</div>
            </td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: middle;">&#160;</td>

    <td style="width: 8%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Consolidated Financial Statements:</div>
            </td>

    <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: middle;">
              <div style="margin-left: 18pt;">&#160;</div>
            </td>

    <td style="width: 8%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;"><a href="#BALANCESHEETS">Consolidated Balance Sheets as of December 31, 2022 and 2021</a></div>
            </td>

    <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0);">F-4</div>
            </td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: middle;">
              <div style="margin-left: 18pt;">&#160;</div>
            </td>

    <td style="width: 8%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;"><a href="#OPERATIONS">Consolidated Statements of Operations for the years ended December 31, 2022 and 2021</a></div>
            </td>

    <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0);">F-5</div>
            </td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: middle;">
              <div style="margin-left: 18pt;">&#160;</div>
            </td>

    <td style="width: 8%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;"><a href="#EQUITY">Consolidated Statements of Members&#8217;/Stockholders&#8217; Equity for the years ended December 31, 2022 and 2021</a></div>
            </td>

    <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0);">F-6</div>
            </td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: middle;">&#160;</td>

    <td style="width: 8%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;"><a href="#CASHFLOW">Consolidated Statements of Cash Flows for the years ended December 31, 2022 and 2021</a></div>
            </td>

    <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0);">F-7</div>
            </td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: middle;">&#160;</td>

    <td style="width: 8%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#NOTES">Notes to the Consolidated Financial Statements</a></div>
            </td>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0);">F-8</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">F-1</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <!--PROfilePageNumberReset%Num%3%F-%%--> </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a id="REPORT"><!--Anchor--></a>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a id="REPORTOFINDEPENDENTREGIST"><!--Anchor--></a><a id="REPORT1"><!--Anchor--></a>REPORT OF INDEPENDENT REGISTERED PUBLIC
          ACCOUNTING FIRM</div>

        <div>
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
          </div>

          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Board of Directors and Stockholders</div>

          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Eterna Therapeutics, Inc.</div>

          <div><br />
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Opinion on the financial statements</div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">We have audited the accompanying consolidated<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #0000FF;">&#160;</span>balance sheet of Eterna
            Therapeutics, Inc. (a Delaware corporation)<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #0000FF;">&#160;</span>and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2022, the related consolidated statements of operations,
            changes in members&#8217;/stockholders&#8217; equity, and cash flows for the year then ended, and the related notes<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #0000FF;">&#160;</span>(collectively referred to as the &#8220;financial
            statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #0000FF;">&#160;</span>as of December 31,
            2022, and the results of its<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #0000FF;">&#160;</span>operations and its<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #0000FF;">&#160;</span>cash flows for the year
            then ended, in conformity with accounting principles generally accepted in the United States of America.</div>

          <div>&#160;</div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Going concern</div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial
            statements, the Company incurred a net loss of $24,579,000 during the year ended December 31, 2022. This condition, along with other matters as set forth in Note 2, raise substantial doubt about the Company&#8217;s ability to continue as a going
            concern. Management&#8217;s plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</div>

          <div>&#160;</div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Basis for opinion</div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements
            based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal
            securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</div>

          <div>&#160;</div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance
            about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of
            our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we
            express no such opinion.</div>

          <div>&#160;</div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud,
            and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles
            used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</div>

          <div><br />
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Critical Audit Matters</div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the
            audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.</div>

          <div><br />
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ <ix:nonNumeric name="dei:AuditorName" id="Fact_547e3b0034ca4c45a6d713aa4233c65d" contextRef="c20220101to20221231">GRANT THORNTON LLP</ix:nonNumeric></div>

          <div>&#160;</div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">We have served as the Company&#8217;s auditor since 2022.</div>

          <div>&#160;</div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:AuditorLocation" id="Fact_175ad20a0be54254bcca05d0065905af" contextRef="c20220101to20221231">New York, New York</ix:nonNumeric><br />
          </div>

          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">March 20, 2023</div>

        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">F-2</span></div>

            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

            <div style="width: 100%;" class="BRPFPageHeader">
              <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
              </div>

            </div>

          </div>

          <!--PROfilePageNumberReset%Num%3%F-%%-->
<div><br /></div>

          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a id="REPORT2"><!--Anchor--></a>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

          <div>
            <div> <br />
            </div>

            <div>
              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">To the Stockholders, Members and Board of Directors of</div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Eterna Therapeutics Inc. (formerly known as Brooklyn ImmunoTherapeutics, Inc.)</div>

              <div><br />
              </div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Opinion on the Financial Statements</div>

              <div><br />
              </div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">We have audited the accompanying consolidated balance sheet of Eterna Therapeutics Inc. (formerly known as Brooklyn ImmunoTherapeutics, Inc.)
                (the &#8220;Company&#8221;) as of December 31, 2021, the related consolidated<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;</span>statements of operations, stockholders&#8217; and members&#8217; equity&#160; and cash flows for the&#160;
                year&#160; ended December 31, 2021, and the related notes (collectively referred to as the &#8220;financial statements&#8221;).&#160; In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of
                December 31, 2021, and the results of its operations and its cash flows for&#160; the&#160; year&#160; ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</div>

              <div><br />
              </div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Explanatory Paragraph &#8211; Going Concern</div>

              <div>&#160;</div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more fully
                described in Note 2, the Company has has incurred significant losses and needs to raise additional funds to meet its obligations and sustain its operations. These conditions raise substantial doubt about the Company's ability to continue as
                a going concern. Management's plans in regard to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</div>

              <div>&#160;</div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restatement of Previously Issued Financial Statements</div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As disclosed in Note 3 to the 2021 consolidated financial statements, the Company has restated its financial statements for the year ended
                December 31, 2021 to correct an error.</div>

              <div><br />
              </div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Basis for Opinion</div>

              <div><br />
              </div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's
                financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance
                with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</div>

              <div><br />
              </div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
                reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
                financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over
                financial reporting. Accordingly, we express no such opinion.</div>

              <div><br />
              </div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
                fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting
                principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</div>

              <div><br />
              </div>

              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Critical Audit Matters</div>

              <div><br />
              </div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be
                communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex judgments. We determined that there are no
                critical audit matters.</div>

              <div><br />
              </div>

              <div><br />
              </div>

              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ <span style="-sec-ix-hidden:Fact_c4417aff140a4c9c8ba87a360a3b0175">Marcum</span> <span style="font-size: 10pt; font-family: 'Times New Roman'; font-variant: small-caps;">llp</span></div>

              <div><br />
              </div>

              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Marcum <span style="font-size: 10pt; font-family: 'Times New Roman'; font-variant: small-caps;">llp</span></div>

              <div><br />
              </div>

              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">We are uncertain as to the year we began serving consecutively as the auditor of the Company&#8217;s financial statements; however, we are aware that
                we were the Company&#8217;s auditor consecutively since at least 2013 through 2022.</div>

              <div><br />
              </div>

              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:AuditorLocation" id="Fact_da25c66401d14d4f8d79bb2762041132" contextRef="c20210101to20211231">New York, NY</ix:nonNumeric><br />
              </div>

              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">April 15, 2022, except for Note 3, Restatement of Previously Reported Information and Note 15, Income Taxes, as to which the date is June 30, 2022</div>

            </div>

          </div>

          <div>&#160;</div>

        </div>

      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-3</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">ETERNA THERAPEUTICS INC.<br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">CONSOLIDATED <a id="BALANCESHEETS"><!--Anchor--></a>BALANCE SHEETS</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(In thousands, except par value amounts)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">December 31,</div>
              <div style="text-align: center; font-weight: bold;">2022<br />
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">December 31,</div>
              <div style="text-align: center; font-weight: bold;">2021<br />
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="font-weight: bold;">ASSETS</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center;"><br />
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center;"><br />
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="margin-left: 9pt;">Current assets:</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Cash</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Cash" id="Fact_4d6c08d38c45460aab422d206980b6c5" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,446</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Cash" id="Fact_fa4216fe2b2545c18eefd83f63559cdf" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,985</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Other receivable</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" id="Fact_a25c429eac74421cb7f11979dda690ff" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">951</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" id="Fact_d129541be24b45569d87311250fca146" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">684</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Prepaid expenses and other current assets</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" id="Fact_096caa837e3e47b9a586941facf1705a" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,284</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" id="Fact_e0518ad7e2d54eeb985bb5394968b0c7" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,097</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 18pt;">Total current assets</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_2a4e0cdd20ae47febb93a9d36cd2dddb" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">13,681</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_0199ec07a3364086886bbbb1afe041ff" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">18,766</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 18pt;">Restricted cash<br />
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:RestrictedCashNoncurrent" id="Fact_dca6b6e7e7064a239705de6adcf6a8dd" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,095</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:RestrictedCashNoncurrent" id="Fact_bddc55d04fc442c1a5f7b4ea0399372b" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Property and equipment, net</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_559b8bffd03f4eb1a2b2b85006f96050" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">236</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_3441247eb41549809a8dc9e1c5376d7c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">670</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Right-of-use assets - operating leases</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_4780d8a0e2ec4d32965bddd68e4e64ae" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,030</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_c92593d9d4fd45fcac546968ae47d2fc" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,567</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Goodwill</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Goodwill" id="Fact_8c6a8be77f4a43ab95cc31b6b00b6f04" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,044</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Goodwill" id="Fact_e12ac8776c5f44f38d3565680fd35230" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,044</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">In-process research and development</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" id="Fact_c0ade8ad05c64952be84febaa6642e6f" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" id="Fact_273f811095694e37942fbe3e349da56a" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,990</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Investment in non-controlling interest</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:EquityMethodInvestments" id="Fact_b4df2b38209c469b8048584daf03b517" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">59</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:EquityMethodInvestments" id="Fact_4b806e181fe34a728a1fa10e374ff550" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Other assets</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_56ea93ebfa0f404bbfdda81aab753ac8" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,134</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_5deba22fb82547adbecd9cd94a3e9769" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">488</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div style="margin-left: 18pt;">Total assets</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Assets" id="Fact_d55ddb17f75940899552f5dbcbe5ca6f" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,279</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Assets" id="Fact_cc07c99f4d094a4e99e49cc445468ac2" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">31,525</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="font-weight: bold;">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Current liabilities:</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Accounts payable</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AccountsPayableCurrent" id="Fact_6a87d02e2e2d404aa79d6d048e45787d" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,620</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AccountsPayableCurrent" id="Fact_9428a2a24e3b446fad63385cb95718f4" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,755</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Accrued expenses</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_72c80b0d4bb941f0b4836b6667b5ee24" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,626</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_e40d068275154c51a5e9d01fe8faa47e" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,249</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">
                <div style="margin-left: 9pt;">Due to related party, current <br />
                </div>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" id="Fact_333b50c41dfc49faa328d65d9bbd0ccf" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,750</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" id="Fact_59bca42bfb394f129d7d5879c6fd6fa0" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Operating lease liabilities, current</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_abf8c00b38494e8582097cec9b98af12" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">295</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_b7f1a296f84447cdbe71a84254218c50" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">426</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 9pt;">Other current liabilities</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" id="Fact_c56446bf1ace474295302e5f8a648d60" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">363</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" id="Fact_d3968758f9ba457da226f88119bcb149" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">247</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 18pt;">Total current liabilities</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_d0db517431d2467cb7580a76e24a20c3" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,654</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_8d75bf20760843a187d08b822efe95e0" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,677</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; white-space: nowrap;">
              <div style="margin-left: 18pt;">Due to related party, non-current <br />
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:DueToRelatedPartiesNoncurrent" id="Fact_7ccc6572e0914262aebcd847b9189014" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,206</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:DueToRelatedPartiesNoncurrent" id="Fact_875e13870db9403395e604552a8a52fd" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 18pt;">Warrant liabilities <br />
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" id="Fact_f15c1d79cdb642f5bc96ea7740575be2" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">331</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" id="Fact_74f42e7b69664793ba9d6ff733e7d8c6" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Operating lease liabilities, non-current</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_be38b114bd654c7ea4f5d4039d3e6c66" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">887</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_d97446b97d524f5b9261d9c5c1a178d4" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,297</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Other liabilities</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_337cf3c0c30d4e8b913900f2cb147051" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">94</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_ab4d1647afa147459fae6e9c70bac40e" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">48</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div style="margin-left: 18pt;">Total liabilities</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Liabilities" id="Fact_ef521011624d46799d0cf8b010d7197c" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,172</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Liabilities" id="Fact_8d467db2bc084f999dc7508255130ebd" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,022</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; white-space: nowrap;">
              <div style="margin-left: 18pt;">Commitments and contingencies (Note 12) <br />
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;<ix:nonFraction name="us-gaap:CommitmentsAndContingencies" id="Fact_46594c8591b04d57badf7d01cd474de1" contextRef="c20221231" unitRef="U001" xsi:nil="true" format="ixt:fixed-empty"></ix:nonFraction><br />
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;<ix:nonFraction name="us-gaap:CommitmentsAndContingencies" id="Fact_385d4939437a4df7b11000566800a0e6" contextRef="c20211231" unitRef="U001" xsi:nil="true" format="ixt:fixed-empty"></ix:nonFraction><br />
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div>Stockholders&#8217; equity:</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
              <div style="margin-left: 9pt;">Preferred stock, $<ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_6017e08797084dbfb77816978f71608b" contextRef="c20221231" unitRef="U003" decimals="3" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_01b245be86134eddb7d3627cdf857083" contextRef="c20211231" unitRef="U003" decimals="3" scale="0" format="ixt:num-dot-decimal">0.005</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_b13bb3bbe0074a339df9a7874070a235" contextRef="c20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_26ac4c14d9ee40a4baafd8848ce3d3af" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_9f8016c60a574428b4a2d6230f579b82" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_0a12f4ff50a547f98b1bf23e79ee5680" contextRef="c20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_1aef977bd5eb4c0cbea66703048adbf2" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_95ae1f1607154928ba9eea571e7003c3" contextRef="c20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">156</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> designated and outstanding of Series
                A convertible preferred stock at December 31, 2022 and 2021, $<ix:nonFraction name="us-gaap:PreferredStockLiquidationPreferenceValue" id="Fact_3358e6fbe7f34ff093a12aa3764fa44b" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockLiquidationPreferenceValue" id="Fact_2a2feaef5eb24c0caa2217eca6afb3d8" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">156</ix:nonFraction></ix:nonFraction> liquidation preference <br />
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_f176c9300f714c2f943a1bb6848ef5b8" contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_dffbc502186f44c9b9deb741760727e7" contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="margin-left: 18pt; text-indent: -9pt;">Common stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_b7792e63291c4405998a0ea8bfc06a71" contextRef="c20221231" unitRef="U003" decimals="3" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_1c2ec87765df47cfa1d8ce04b5530d75" contextRef="c20211231" unitRef="U003" decimals="3" scale="0" format="ixt:num-dot-decimal">0.005</ix:nonFraction></ix:nonFraction></span> par value, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_547e1fc06cd24abbb539c716a0b0fc06" contextRef="c20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_3478ab00207149648f759d42c5b616e5" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">100,000</ix:nonFraction></ix:nonFraction></span> shares authorized at <span style="text-indent: 0pt;">December 31, 2022</span> and
                <span style="text-indent: 0pt;">2021</span>; <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_4fba1a51450b4c8183fe0e0196c35f84" contextRef="c20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_0e42136741c54654b4eecfd28f57782b" contextRef="c20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,127</ix:nonFraction></ix:nonFraction></span>
                and <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_7ed27b6fb585414a9210c78b3ef181e5" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_196458a81c2b4582914a2cff08cac4bc" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,601</ix:nonFraction></ix:nonFraction></span> issued and outstanding at <span style="text-indent: 0pt;">December 31, 2022</span> and <span style="text-indent: 0pt;">2021</span>, respectively</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_c58b9481d58b468881661ee656eefb3f" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">26</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_c332b82d7dae4a078de9fd062293dbe1" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">13</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Additional paid-in capital</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_5090af07b5034b148d8ffa132e2a9ecc" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">177,377</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_95681a219a9a47979c03c08b575d789c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">166,191</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 9pt;">Accumulated deficit</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_c28db29db75b40a880d6198d633d7fd0" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">165,297</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_52e29e084d914b47b6303c262fae77ae" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">140,702</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 18pt;">Total stockholders&#8217; equity<br />
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_c285b2393179401f96e4ce6c810451a2" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,107</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_1a665a92419c435797a1de8c6d1b94df" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">25,503</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div style="margin-left: 18pt;">Total liabilities and stockholders&#8217; equity<br />
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_9df133542e254975a181acb894863bfe" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,279</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_bc8d9fd8f24249baac8b53a73f617996" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">31,525</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The accompanying notes are an integral part of these consolidated financial statements.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-4</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">CONSOLIDATED STATEMENTS OF <a id="OPERATIONS"><!--Anchor--></a>OPERATIONS</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(In thousands, except per share amounts)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="6">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Year ended December 31,</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">2022<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">2021<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center; white-space: nowrap;" rowspan="1" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center; white-space: nowrap;" rowspan="1" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; white-space: nowrap;">
              <div>Operating expenses:</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div>Research and development</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" id="Fact_e08c059fff1b43a49e57b359cc17b951" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,392</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" id="Fact_aab2b0e229d743aba3cdcc2faf44c529" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,705</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div>Impairment of in-process research and development</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_d72e700eead646edb3ba84b062c81424" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,990</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_65aeb867b41e49168cf63a3fec09c789" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div>In-process research and development</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ResearchAndDevelopmentInProcess" id="Fact_ffda5340ad8f4f91a6207889a73c7b77" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ResearchAndDevelopmentInProcess" id="Fact_ebc71e3531124b96903f24f9470295c1" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">80,538</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div>General and administrative</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" id="Fact_2a45a6a9d773439e87e292dee93cbefd" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,835</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" id="Fact_78610be6d0674883880ee22dff2bff21" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">14,724</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>Transaction costs</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_c6ffcb643d00414cb575c8e1bc28c9c2" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_5f5b891ed393461eb76f8a72bd7fac7b" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,765</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 9pt;">Total operating expenses</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_4cda2738666e4360959c8b057cff78e6" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">33,217</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_c15733253f69402ca202fe690eeee00d" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">113,732</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div>Loss from operations</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_48275537a4a34b6db026e3e25b12b70b" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">33,217</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_b38d7d3e579d48169c4183f281689e51" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">113,732</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; width: 76%; white-space: nowrap;">
              <div>Other income (expenses):</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div>Loss on sale of NTN assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" id="Fact_3d47b701ef6f4560bbd606e7181a6e9e" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" id="Fact_21fc45f14bed4a5ca127fbefaacc2971" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">9,648</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="margin-left: 9pt;">Change in fair value of warrant liabilities <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:WarrantLiabilitiesExpense" id="Fact_fc6da15ada4348e8a309b3ad6a9c7275" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,795</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:WarrantLiabilitiesExpense" id="Fact_06229dfc8e8d486bb2137bd5f13e3727" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="margin-left: 9pt;">Loss on non-controlling investment <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:LossOnNonControllingInvestment" id="Fact_97e7c5792e974d9c9225dbff32550d1e" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">941</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:LossOnNonControllingInvestment" id="Fact_dc4b07ac9918405ca4f440a30cb96348" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div>Other (expense) income, net</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_8c0ce0f37a73416cb33c96937b38d7de" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,171</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_29162345e1cd4b6a93506063bc7a1bd0" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">899</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Total other income (expenses), net</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_bf2a073d681a42abbb145f8abede3091" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,683</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_073cba25519842ebb94d23d4746ba362" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">8,749</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div>Loss before income taxes <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_3aff42effc934babab2dbbc0f79e5c12" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,534</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_fd97bac0eeb645569a5a5cdfa2afcd65" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">122,481</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div>Provision for income taxes <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_576b5a3f691e45ed8072acdb21caff56" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">45</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_90ac2edb68364de58268c75cd6d613ad" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">64</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; width: 76%; white-space: nowrap;">
              <div>Net loss</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_30f4f222aef1474ba5f920642b307c8b" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,579</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_a947ba21d25742d696a8801454066227" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">122,545</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>Series A preferred stock dividend</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:PreferredStockDividendsAndOtherAdjustments" id="Fact_e8a3181d92e542c1a94e2e32ab82284b" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:PreferredStockDividendsAndOtherAdjustments" id="Fact_de336daaa0cf428b830dd8464c2fb306" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div>Net loss attributable to common stockholders</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" id="Fact_9c8af24a963c43e38d9b1e1c77db81c2" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,595</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" id="Fact_bc8a68ba0f68485badd4349e983cddbd" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">122,561</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div>Net loss per common share - basic and diluted</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_d0cb27a84d6849a38ec7b70a107483dc" contextRef="c20220101to20221231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_cb074f5d46c240a6ae4f00ddbdfd2ffd" contextRef="c20220101to20221231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:num-dot-decimal">8.06</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_4b52e655a03b4ddbbdb856ea1053491d" contextRef="c20210101to20211231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_cf4e3640668d451f94234ac5951e5d1d" contextRef="c20210101to20211231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:num-dot-decimal">56.61</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div>Weighted average shares outstanding - basic and diluted</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_c24a68b1ab2c4f4ea6c344f353e0ae8a" contextRef="c20220101to20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_aa3530300c8046619c4360e8eb819a8d" contextRef="c20220101to20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,051</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_662dd55fb5df4136a1dbd807f4a5f671" contextRef="c20210101to20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_37a45672ef3f4b438e836d7a976bd2ec" contextRef="c20210101to20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,165</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The accompanying notes are an integral part of these consolidated financial statements.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-5</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">CONSOLIDATED STATEMENTS OF MEMBERS&#8217;/STOCKHOLDERS&#8217; <a id="EQUITY"><!--Anchor--></a>EQUITY<br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">For the years ended December 31, 2022 and 2021</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(In thousands)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1" colspan="14">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1" colspan="6">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: bold; text-align: center; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; text-align: center; white-space: nowrap;" rowspan="1" colspan="6"> Series A Preferred<br />
            </td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1" colspan="1">&#160;</td>

    <td style="vertical-align: top; text-align: center;" rowspan="1" colspan="2"><span style="font-weight: bold;">Additional</span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" rowspan="1" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="14">
              <div style="text-align: center; font-weight: bold;"> Membership Equity</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
              <div style="text-align: center; font-weight: bold;"> Common Stock</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="6">
              <div style="text-align: center; font-weight: bold;">Stock</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="2">
              <div style="text-align: center; font-weight: bold;"> Paid-in</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="2">
              <div style="text-align: center; font-weight: bold;"> Accumulated</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;"> Class A</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;"> Class B</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;"> Class C</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">Common</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;"> Shares</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">Amount</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">Shares</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">Amount</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">Capital</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;"> Deficit</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">Total</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Balances at January 1, 2021<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_555636185c664423aaddea628da53a0f" contextRef="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">23,202</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_07f41317349c4f04b90041c8b6902f6c" contextRef="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,400</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_072f22ca85b04b0ba9ae65cea79c5564" contextRef="c20201231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_eeb037057c204eccaa16e98cf6617ac7" contextRef="c20201231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">198</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_5d6f1206d0ba47bbb1623d1f0238ca4d" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_6b4088828d9c47e1880e127e8c982112" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_0c87ebdbbb42469e95009a3058134795" contextRef="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_e794ec30c0914ac38958fbc9384ffd4b" contextRef="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_d399a794e05e44dc94cc376ee3485a7a" contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_5a9d947d39f74aacb9e7c75fcf577e36" contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">18,141</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_35dd798edfc94e9db92a4df13f56f78f" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,659</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Brooklyn rights offerings membership units</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_c2bba67bd80b45cb8c4868dfa06520b8" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,500</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_7ab57bcdf6e943468a9e6e2cf473a8ce" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_3b54a96857c942f69a8cf062bb40348b" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_7bc651fdf5f24d459a66995939470d04" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_4ec45699aa664ab3a91c0ecb6bd8f92e" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_c021601bd583463a94af959e17914db0" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_dda33a8cb8df41e99d732b813e4a4796" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_886001ba0e9f4b47b2fa7038e028f329" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_35918b7b2a8242c68ada1a99e24b1e5f" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,500</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9pt; margin-left: 9pt;">Elimination of Eterna LLC&#8217;s historical members&#8217; equity</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_aa6c2a573dd242e7b67dff1cf07429d3" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">33,702</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_e068f4df28af47dda3fb9b2b31f23c75" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,400</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_42d6c1f1400047a39dcce7a2414faee0" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_ff4550453e0140b7b2ad2e8ca6cf5762" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">198</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_ad47be85e3c8479092fff17ac9b767bc" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_5521887e98df4a27a1bfaffa237ea338" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_788cc9df1e50477e92d474140a02b48b" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">36,300</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_fd44a75e7aa149699eae03fa1f9ac984" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_35bbe7a1280044b7950fd206b831b920" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Common stock to be retained by NTN stockholders</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_312c842d26fe40909874cdbdd08df6b0" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_7c772195964a47308b283975f3309bef" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_4fd080ef23a545c3ab4d0aaa6f6dc37c" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_cb0f48730bb945488f9ebb08345e0e34" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesAcquisitions1" id="Fact_dcf84115009b4bc18e8927a28d7f7850" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">76</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_4a71c3276adb445f98deb78e3a0e6cbe" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesAcquisitions1" id="Fact_58ce76a0f5f44a27be26fc7942f5913f" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_31affa14796a41b08149a31c0dd454f6" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_fb764e119bad405b9d6defa53a6286b4" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,178</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_d7176b06bede4f7ab31c9cb844cf3cb7" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_4d11cff5e91a4605b5682ca04727b436" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,178</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; background-color: rgb(204, 238, 255);">
              <div>
                <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of Series A preferred stock retained by NTN stockholders</div>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_59b61b68d9214aa182ff545537931eb8" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_f5dbca3a144a40d087adc7ad22f405fc" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_c4a3cb7cee5f438ea52bad37410c4b22" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_a9cb5a0e4031415cafff92c0512741ff" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_84cecac2f2f64b1b9503e5b82b257e45" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_4f121dc32684441fb6351f73e5487406" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_a48eeffa419b4f2fb0066154e0217b0f" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">156</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_0dcee2e5e8c84cd5addd06298bbcfa4f" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_11f1a61c699d4414a3d7cdd911ce4255" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_7b6c250642694df3b98be93ed4d11c34" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_bf177afe56124c5e92bb3760965b2050" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock to Eterna LLC members</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_9281f7ae521641839c817943595e8bdb" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_c84b275096094ef798847b6bb174fc2e" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_af6aaeb54fc04cab9cdd887b4c4763a6" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_9febf576f0234b1a86c5bf05ef772ece" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:PartnersCapitalAccountUnitsAcquisitions" id="Fact_b71eab6cc29440f08850a1c7586f9161" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,946</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_2c61c2bc82704d2d9cfcce7f7c8c0735" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:PartnersCapitalAccountUnitsAcquisitions" id="Fact_294098517b2a48abb299feedef50cacd" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_f5beceb37cc94b28bdc5dc585e80029b" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_3978adbd8ddb48ab96d327ea6b8c785c" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_c206ba7da5774fdcb6b745a614df83d2" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_9c0579b3a5e14b00a92398b788f4d8a4" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; background-color: rgb(204, 238, 255);">
              <div>
                <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock to Financial Advisor upon consummation of merger</div>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_3cc55cabfdbc46a184ab149511eb13c4" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_ee7d728d851b45378940fd136d1b4d3f" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_041436f7063b4c5faaf7b4a7a6248438" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_38c181256cba4935a7e6b9ad31ddce81" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" id="Fact_b57fcb34f05d4c3eba2c50b462a2cf7e" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">53</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_f47d0e898bd243d5b0167a5e51b97d04" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" id="Fact_2902e5dc08234ca0a9f7077476f65146" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_121c2840789d4608ae5a084927fe9d43" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_ac6640a591554a6da8a5252caf6323b0" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,765</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_a35166d30aa14d98bfda531a4a099bd8" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_1bea15cff057454ba3d464d0c1118542" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,765</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%;">
              <div>
                <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock from the exercise of stock options</div>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_fcbd0295354b42559d97039578666ac9" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_bb85ede553e944d9a94c64381057e0d6" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_c5f912e848fe4424a1bf64f8f50c6044" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_4398291f6fea4eae878d796205a37158" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_fa536e41762e4fe7a6f0f2464cde0b56" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_8441c540220448478fc7b29a8f7e62cd" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_3065bc41630346c1b5a51c430a9cfde3" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_225beb7dc9754eeabfb32fb4ac586952" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_020f16cba680491c83ef0c2c7c4c3f1a" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_b077e68e8c8b42fbb6d87d20d178a9af" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_ed915aad8fca495e98a06187ba32ad04" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; background-color: rgb(204, 238, 255);">
              <div>
                <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net</div>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_ca2291eaa74b43e6b6e5017d21679e85" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_fd2b37e72d574c0ba621a361fa08471a" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_5ffc769bf9684b13b83f81379c1edd71" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_a194580142404f7289d49a9865b34bff" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesStockPurchaseAgreement" id="Fact_1ca7301293604e2d82e76f09021731b4" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">178</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_d8e8d013d1da46c4914c3ce855d7fe33" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesStockPurchaseAgreement" id="Fact_788953baf1ec433f94a33e1ddea93e90" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_388cef2d731e4774b486ba5a857a4465" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_9a32ac16ae5e438198e769ae30562f01" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">52,024</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_a83548f92bac437b9a10b3afb7d925c9" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_aacd82877e214839bac2b83db6ba0a43" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">52,025</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%;">
              <div>
                <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock in connection with the acquisition of Novellus, Inc.</div>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_91710d2316624ed5a6764ca8d5204029" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_ee5143e8466c4f2ea5a1cc920ad18d80" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_81b4fd595db54694b80b3e36f14e576e" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_bfe34a4a54b6488aad0e288eb766f021" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesAcquisitions2" id="Fact_6ea2f4525c2841fd8664a58b92a589e3" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">351</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_e310329bcb7641098ef268c4f7b9889f" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesAcquisitions2" id="Fact_766210d8003e465e81f42103333b3382" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_968220067b0f4b19909242f34882e7e5" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_8aafd6a34c754969b01c7243d4970a0b" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">58,682</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_605db32e513c4a5f8f8bc1313b8be09e" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_faf0c535de6f41e58111dbfa99320789" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">58,684</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9pt; margin-left: 9pt;">Cash dividends to Series A preferred stockholders</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_8580f9b6a149478ba4d590f689e2c284" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_e19f7fdbcaf94fbcbebff50e0b3c8fa3" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_a73f6d0bd76f4802a567f82ac4b99a1f" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_6d93da918a85490fa3081641bc8899f4" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:PreferredStockDividendsShares" id="Fact_146100a72ccc44cca46edfd4d6ba5853" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_864d0215573549ae88bc25e71d0a7982" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:PreferredStockDividendsShares" id="Fact_23dc6fd82f7b483999c79e189b1d0554" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_4f2a11e4b1d84335b26c0c5fa77f9181" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_24edb106ddcf4ce6be68b769b5179862" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_ab0023acd1334ca09defc7b3fd7c72be" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_3b3052c634344ff7b9e430039e02cd8e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%;">
              <div>
                <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock in lieu of cash</div>
                <div style="text-indent: -9pt; margin-left: 9pt;">dividend to Series A preferred stockholders</div>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_b4724dbc34134ef8822b6eb2489c3c93" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_28bf35715bf64e5c97ad9cb8a7171373" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_83937ac681ec4c8e9ed9eebb758961cd" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_50990322af8d4a2a91f465e0a7d2c1d4" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesInLieuOfDividends" id="Fact_a8649309bec048c8b2617470a64f263d" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_e8922ef9ccf345aab1930a755e3a52d9" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesInLieuOfDividends" id="Fact_642b4f4502e9472d82eadee808b27d11" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_7bd0bc183856491392af734b66b22ff5" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_051f51c9d0d044f4967e84c4c0b70c4e" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="erna:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_20fd4b4753d4455094d94796d8a91ca9" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">8</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_3e7e3ae653634029a904d6d1766294e3" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -9pt; margin-left: 9pt;">Forfeiture of unvested restricted stock</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_fa0b3297694648399272b23494f8343f" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_1ce24c5cb52743b3b8e2274ff8d39cfb" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_d1e41edb91584e4095ae24d015ccee5a" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_e667dd0d0eb6440c8158e1b8d52fe1e9" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_325998a1c6f946e19de7f41cf4164a3d" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_a5ba23d55608406bb06238863eedea65" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_837cec91f07f4d90902c3bd270cc2aa3" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_899cdcb719174d77b56723295157a92d" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_22c6c21ff39a4e60a6f9c823cd92c263" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_b1218af8029a44d383316302bc5cccc1" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_76b5343a70a54fa4afb103c264b9f524" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Stock based compensation</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_7472d3fd9ae4470592cbf11b57440732" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_d49e19a01c3a4699a27458b61aa2a041" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_c96f310e9a9d4ffe9cf318ca8025ac8d" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_4cdb7d1b51774a039a1bffba31b0589a" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_714168b550c14852832a275d1f4448d5" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_18cbeb1d310449f98b96aacefbf44a72" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_74247fc49dfe4c9782211af3f8fb845d" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,235</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_912ca88dc03f4ce8b0fc0787a85c86bd" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_ba92007b645e4238aa41365e83171c66" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,235</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Net loss</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_9299476f1d1a4c699ce908751b22ee96" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_da368bb2cd0d4d2aaea198bf8ad00e9b" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_b6f2f1a571b04ddd80fcf0163c7a8f29" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_0fdb9f2030ef47bb858e05658cfae40e" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_b8cd9fe596f947f78f515e96be217e6a" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_b3bd3e1316864a89a578c474bf0248d0" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_a2d17fac40854fb7bddf0b15f91232a6" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_1e87ee6967de4855aa76bdb50b76356e" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">122,545</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_5bfff9707c464aedb8e393bb7f618261" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">122,545</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; white-space: nowrap;">
              <div style="font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Balances at December 31, 2021 <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_09bece4e9d74429494a350c1775d009e" contextRef="c20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_c7935a544ad143bf924dea7ada142d74" contextRef="c20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_619c64d8e2594e199bfe05fa4d77aaf7" contextRef="c20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_be8594789cdf48c98000e5361f910b82" contextRef="c20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_4c42a71ab60e4e1b9274a42b2a16905f" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,601</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_8d838f73a04943528bd4fa524976b47f" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">13</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_3faa44e25efc4145b66aa79a976c38a6" contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">156</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_45cb4cd0dd4e4048b94770f7e021294f" contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_e14ce654f9d64d9c8c96409814829b8f" contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">166,191</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_82451e4e77c245fb820e061f9ab8cd1b" contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">140,702</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_900e7846a8a1479a8319a8f4be0d9cfe" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">25,503</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1"><br />
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock and pre-funded warrants in connection with March 2022 private offering, net.</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_fbe125244c6c4e3eaab99f0dbe677225" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_75967a1b4b8f42de90fd3b964da802fc" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_7a457b0ffb694bde82da04750744e2a8" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_581ffac312c440babb9b8f77895668f2" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" id="Fact_b0774ce2e948467f8055541e777621ba" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">275</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_c8b1c63fe00f4e049565961ff9306055" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" id="Fact_399bb7a1995f43ffa74f056b00959057" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_1e3a1c682e764078b6d6fa643f723d5d" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_0a1f8786e7664eaeb26b4c7e4589b58f" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_16f0cc9a9ee3421e88383c6e04111e7f" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_da3e9543dbc5453f963ae03f3c6cea25" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; background-color: rgb(204, 238, 255);" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock from exercise of pre-funded warrants</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" id="Fact_10fc6411d30548a198bdd09bb57cbcfd" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" id="Fact_dadec8b3cd4d47daa279d1aba7e2655c" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" id="Fact_7b66ae6ff2b4443fb81bbf87887b5e17" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" id="Fact_646a6cff615646e6a40147ae14ea3db2" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" id="Fact_1028bfcab3324e15ade459f1bc0e4c8c" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">68</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" id="Fact_139a5ae7db3e4e86ae5337d1f7dc2a1c" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" id="Fact_78d469f0823e4ed3ad3a41acfcaf809a" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" id="Fact_3cea3034c445455aae8eaa788b09efa6" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" id="Fact_46e29913af4b481baa56df60c7a7851c" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">874</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" id="Fact_ce4683563bfb478097ba9f03e9b7f9d3" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" id="Fact_5bb92111aafb4e7084a72ea3879f8091" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">874</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock and warrants in connection with November 2022 private offering, net.</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_1de2fe3106c7454bb9e6ba256e6b1a45" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_a7fc816ce2dc4be69bbdc3574b68617b" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_2c76568cb05645caa0203943cf0c2e46" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_2e392d46021949de922e51a7b0d5b8eb" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_4bda2ea9703b4cb3889deadcac9c21f9" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,185</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_26d0e01ba2f640e6b2590ea49149a435" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">12</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_ca07be54407d4c5ba35cf88d6c2dc209" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_cc383c3f6fc046f29189304ef874d440" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_b0db921ac38b48458c2e0fc1549c5af0" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,383</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_2c197ea5af5e46a1b258aed059252d95" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_56393247732345858b5dbd11b4bca243" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,395</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; background-color: rgb(204, 238, 255);" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 9pt;">Forfeiture of unvested restricted stock&#160; <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_fb0026ced3f5413d942435f3bb6a9e2c" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_40adb9743846491ab951f2970ea91be1" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_07ead9eac73c44bab73a1b9abceb4663" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_93e7156d5a674a5a97c38a7454766d0e" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_e976f47ec8e34c67b211cc21ef36f689" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_ffcb67af4a764e04b48d2c3217fa8a23" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_881f00e9f85346789f0db0ca88a8d38d" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_7d7aee6300734049b01add308349cdbd" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_b0a19c42f19c47d98a49e49eba061241" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_c6d87be84c52454a90338ec2fe460dcd" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_8b960748c7834ebe8e602a37f1dfb290" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock from vested restricted stock units <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_6ca66e0558f4411c8fe19eba3829d566" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_5972c92e19ae4b17bb562210abbe624a" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_87c9ab5982b2445688d5baab4effc6fc" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_a07b806ea7a04b68b7ede830a53bce11" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_0b681a7132144348ae51adfa97ff5087" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">2</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_adeb02b0a6c14445adc3c4baf2354f76" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_ce7752c926434abeb4ba99a3e73f5dbd" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_6e572f5078c54ce7a0cf25128124384b" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_d307a195ce1e46a2bcc74d6be0137006" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_45c7ad202e7e408b965537b082242d3d" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_0b7463cfa66d413a936e26679c59d2a2" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; background-color: rgb(204, 238, 255);" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 9pt;">Cash dividends to Series A preferred stockholders <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_6177b58a61a04193be85320ba19cc0c0" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_45f175ab105b469fa99bfec9c05b3ecc" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_a34a9f52f1344ae1b5115a6c773ebe3a" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_cc81cc446b904200980685b838f6258f" contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:PreferredStockDividendsShares" id="Fact_9cbb445688c74ad2b03b643b1899e81a" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_d60e99ac1f3d4566be66d92703f6d62b" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:PreferredStockDividendsShares" id="Fact_bbd83b30a3464b97a169e90fef819be2" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_cce100584776444e979c8a8828c0fb15" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_bbd746125ec6481a9dd2fd380a3a2955" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_fca65238688142e8a5bb735db404f594" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_89496344140d4745a11864e639115867" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 9pt;">Stock based compensation <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_04cec13c687444c895d1857a9194cce3" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_9cbc275b621848d19c370eeccc3dea51" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_dd274007dd7a4888a61e21af8667119a" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_5593e5e99c494e629ec7a7f2b6fedbcb" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1">-</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_8c792d43a451425ba8d4bcbe401957ef" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1">-</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_87e39e1c24704f62b5f9c0ee33f15008" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_1c130d83f3ea4a49bb7518c28e8926b8" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,935</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_1506472e817145259e5b0d19d927eb52" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_f2ec80647a95454da8080fcabf1dc232" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,935</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 9pt;">Net loss <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_26c03f5e8fa744c2bccb91b5afdc6e81" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_f2d29b34f5544ab7a28b5e3a8f79c254" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_bbe73b3ea48d4e41b133f4af1e7bafd4" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_a8be1c2f408c4e29b90809184a58e31a" contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">-</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_6f89e3daa9f24876be385be67483305d" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">-</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_a62c7f6425e7455b927766632b827430" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_b222b790a21d4827a96e2401f3f438f0" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_d0db408060b24a6c9f7c7fef632b7320" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,579</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_ba6ace3d0225423dae8483bf7ce8a6fe" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,579</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 12%; padding-bottom: 4px; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 9pt;">Balances at December 31, 2022 <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_8ae924c88c4b46789788111191b5bb97" contextRef="c20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_0ad3e5931350424fbd2efb061d8e4b74" contextRef="c20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_816a331da5b64626b466dc1fc6940e41" contextRef="c20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_25bf3a7c7520427a8be32efbbcb70ed1" contextRef="c20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_9b88f6198b6746efb962d7ba097cb30f" contextRef="c20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,127</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_a20785824bec4807a69656df781b83b5" contextRef="c20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">26</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_5da8c0714c2f41c7b22b11d96889c53f" contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">156</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_6a02c87ca8524f5c95e0f47404ee9c5d" contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_f9467d34ef854f35a02a57d193afeb03" contextRef="c20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">177,377</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_16e0ec89d21242328e70870e658c79a6" contextRef="c20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">165,297</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_4b51b834c0c947dfa6a9d19cc21de665" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,107</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The accompanying notes are an integral part of these consolidated financial statements.</div>

      <div><br /></div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-6</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">ETERNA THERAPEUTICS INC.</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">CONSOLIDATED STATEMENTS OF <a id="CASHFLOW"><!--Anchor--></a>CASH FLOWS</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(In thousands)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center; font-weight: bold;" rowspan="1" colspan="6"> For years ended</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
              <div style="text-align: center; font-weight: bold;">December 31,</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">2022<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">2021<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div>Cash flows from operating activities:</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Net loss</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_97ae97b0f746486ab74dd483d3309d3f" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,579</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_521cc7943d01464ca6e251e21eff2472" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">122,545</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Adjustments to reconcile net loss to net cash used in operating activities:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 18pt;">Depreciation and amortization</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_995212e6d7184a7cbbae0e9179dd308c" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">161</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_2c406f47175c4a5484cc73223f49329b" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">117</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 18pt;">Stock-based compensation</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_8f2be070befa432c884fbc3e24a49e0a" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,935</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_6b2077a4216a428e82fd850c11a0e4a5" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,235</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 18pt;">Amortization of right-to-use asset</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" id="Fact_229dec39c4e4464fad5ca19ecd0e4621" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">336</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" id="Fact_d4da1ffadf11438db601c99e73c91571" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">342</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -18pt; margin-left: 36pt;">Impairment of right-of-use asset</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" id="Fact_7f6bdbe4830f42d69639e2febca59529" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">772</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" id="Fact_6b180a0afa2e433a8674f35779cea118" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="margin-left: 9pt;">
                <div style="margin-left: 9pt;">
                  <div style="margin-left: 9pt;">Gain on remeasurement of operating lease liability and right-of-use-asset<br />
                  </div>
                </div>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" id="Fact_2fe99dcba24c4aa5ab24f7ae577af80f" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">642</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" id="Fact_f3f2e3219e8649bd9f2860f26f21cf41" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="margin-left: 9pt;">
                <div style="margin-left: 9pt;">
                  <div style="margin-left: 9pt;">Impairment of in-process research and development</div>
                </div>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_d993c1127ba14c158d937fc6f1a48e3d" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,990</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_5f3bc78ff44d45fc9fb3dcf7afe18214" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="margin-left: 9pt;">
                <div style="margin-left: 9pt;">
                  <div style="margin-left: 9pt;">In-process research and development<br />
                  </div>
                </div>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:ResearchAndDevelopmentInProcessAssetAcquisition" id="Fact_91ef35c17ddb48b091e146bfd99890da" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:ResearchAndDevelopmentInProcessAssetAcquisition" id="Fact_a2f986a242fc4b70a58d77c41a150375" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">80,538</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 18pt;">Loss on disposal of fixed assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:GainLossOnDisposalOfFixedAssets" id="Fact_b0854ac69a594f3e86a8baf811ae16aa" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">280</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:GainLossOnDisposalOfFixedAssets" id="Fact_8caa3400228d4360962cd19c51b3a98f" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">13</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 27pt;">Gain on lease termination</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:GainOnTerminationOfLease" id="Fact_322e5d7f53e34b69b33f8d566347b33e" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">85</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:GainOnTerminationOfLease" id="Fact_8c1b1221683f42d6a528b240ca8970f0" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 27pt;">Gain on warrant liabilities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:WarrantLiabilitiesExpense" id="Fact_5f906708b2954ed2aafcd7f1dbffbbd7" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,795</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:WarrantLiabilitiesExpense" id="Fact_d900b71a9de74a88a48cbf187fa216e6" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 27pt;">Loss on non-controlling investment</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:LossOnNonControllingInvestment" id="Fact_91b436d942aa41f39f7bc2971c76346d" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">941</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:LossOnNonControllingInvestment" id="Fact_593d0fba8f1649159ddae3202cfd14cb" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="margin-left: 27pt;">Transaction costs - shares to Financial Advisor <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_99e1dbbf019b4613a0ddf40ab6e566fd" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_4fa60cf56543488b9c2c97dc821abc46" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,765</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="margin-left: 27pt;">Loss on sale of NTN assets <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" id="Fact_fafdcf4d10144edd9d5530ca2fc1cfe1" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" id="Fact_07db12df9a254ec2885d1b8ec0b4c17e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">9,648</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 18pt;">Gain on forgiveness of PPP loan</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:GainLossOnForgivenessOfPaycheckProtectionProgramLoan" id="Fact_fabbc27badc84bea9fb890a07f29b575" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="erna:GainLossOnForgivenessOfPaycheckProtectionProgramLoan" id="Fact_c70e48c6225d40f5b3273431539b61f4" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">310</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 18pt;">Changes in operating assets and liabilities:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 27pt;">Other receivables</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherReceivables" id="Fact_76a60c2b18354f0cb755833b2c05e689" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">262</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherReceivables" id="Fact_9cc65d45214d45218d8cdf13cdabaea9" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">659</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 27pt;">Prepaid expenses and other current assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" id="Fact_a04557f2838f4eb7a8bfc2f2a0d84f04" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">187</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" id="Fact_6a2c7e939cba4cb281f91a8ff6e524b8" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">850</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 27pt;">Other non-current assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" id="Fact_dcbcd166c4494d61b3e6a9e0b857c3f6" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">646</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" id="Fact_a1001d16b9194180b215a3d4496f0f5e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 27pt;">Accounts payable and accrued expenses</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_4926bf6ac3ce4d5fb8df01210c228472" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,034</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_64b9a54055c149ed8bde7b198f49c0d7" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">485</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 36pt;">Due to related party</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" id="Fact_1859b01d9a744104a3d3073aa4d6cf94" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,956</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" id="Fact_15f95142188c4d879b83c9b00bc98dd0" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 27pt;">Operating lease liability</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="erna:IncreaseDecreaseInOperatingLeaseLiabilities" id="Fact_6bb2bd76db7245288e1f4d882e122027" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">340</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="erna:IncreaseDecreaseInOperatingLeaseLiabilities" id="Fact_c076d51c96214f50a9ca001259b8f5a5" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">322</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 27pt;">Other liabilities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" id="Fact_a0e003339978464d98080c31e4ebd301" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">155</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" id="Fact_7580c48d09f5451bac3101db0d8e187d" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 36pt;">Net cash used in operating activities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_9438c6d8a00446beb4803abe7545c1a0" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">20,976</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_c218a9208bd54844b95c96b7b03c7b6c" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">23,488</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div>Cash flows from investing activities:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Purchase of property and equipment</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" id="Fact_90c2b0f080d442ddaa45704c187d7964" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">297</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" id="Fact_9967ecc016e945adb3b34ec01ac26e53" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">154</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Proceeds from the sale of fixed assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" id="Fact_4ef1ec54c5004d99ae288f0465d1be67" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">250</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" id="Fact_1fdf53e94a394869bd943ac9046e6256" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Purchase of NTN, net of cash acquired</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ProceedsFromSalesOfAssetsInvestingActivities" id="Fact_a88d2b95513848ab936cb1df79885596" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ProceedsFromSalesOfAssetsInvestingActivities" id="Fact_14d3972df77847f18a5b13eb9f100081" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">147</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Purchase of Novellus, net of common stock issued and cash acquired</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:PaymentsToAcquireProductiveAssetsNet" id="Fact_165896434f174639a135a1cb62f54f97" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="erna:PaymentsToAcquireProductiveAssetsNet" id="Fact_7445bfdefe694523a4a01d6f510195fc" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,854</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Proceeds from the sale of NTN assets, net of cash disposed</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_8b72cfdc061b447e97dd15aea0d84490" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_8ebc215bf857469d991990792449453c" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">119</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 18pt;">Net cash used in investing activities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_91a9d98a2e8a4770a5e4b6bfc676b5eb" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">47</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_2518c08135a642b3864b8d85c80c0620" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">22,742</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div>Cash flows from financing activities:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Proceeds from issuance of common stock and warrants in connection with private offerings</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_8a33d494f58d43208c34c609ac7be65c" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">19,706</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_0f6c1d2e96094d949ec039dd1d4b0d63" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Expenses paid in connection with private offering</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:ExpensesPaidInConnectionWithPrivateOffering" id="Fact_68c2ff06f92e4ca7a0ca676d92ce0f7f" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">110</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:ExpensesPaidInConnectionWithPrivateOffering" id="Fact_fd8289819c8c4464947d59b8bb2fe795" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="margin-left: 18pt;">Issuance of common stock from exercise of pre-funded warrants <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" id="Fact_2acea41995d247f384e727bea044204c" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">7</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" id="Fact_eedd1a24d03d46e1a9cdc589b7de8408" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="margin-left: 18pt;">Payroll tax remitted on net share settlement of equity awards <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" id="Fact_19dd11c31af54ac780a62a9e50798fe0" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" id="Fact_7bbeefe3a4b541db9419da5adb62c51f" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="margin-left: 18pt;">Principal payments on finance leases <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:FinanceLeasePrincipalPayments" id="Fact_d2377164fbf247ecb75db0a3a8028bbd" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:FinanceLeasePrincipalPayments" id="Fact_223d9ac43f1e45758cec394ff882eadb" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Dividends paid to Series A preferred shareholders</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" id="Fact_2cd5d320c4b3447bbdf10524202f3909" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" id="Fact_3a8f9dd656d34990a21318d03cae1789" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Cash paid for fractional shares in connection with reverse stock split</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit" id="Fact_d80f39083e844ef88135cba101b4e409" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit" id="Fact_5286e282163b489ea6b1eebec9060420" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Net proceeds of common stock issued to Lincoln Park</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><ix:nonFraction name="erna:ProceedsFromIssuanceOfCommonStockToLincolnPark" id="Fact_8db377942e9d43b7b940480f97dc3162" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><ix:nonFraction name="erna:ProceedsFromIssuanceOfCommonStockToLincolnPark" id="Fact_d3f0b20d70bb4ad3a1e0c5b317b935f4" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">52,025</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Proceeds from sale of members&#8217; equity</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" id="Fact_81059b5d6e2d417e9e46de0382e36b29" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" id="Fact_ec3b02e7f9cc433bb379f31c02ce0777" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,500</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Proceeds from the exercise of stock options</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" id="Fact_20bd34df1d674c18853e9cebd227974f" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" id="Fact_69fb32a37e784ed2b6013e68688c0989" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Repayment of <span style="font-style: normal;">NTN&#8217;s</span> PPP loan</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:PaymentsOfPaycheckProtectionProgramLoan" id="Fact_c82ddc23f84b4376883f54ff3d123a51" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="erna:PaymentsOfPaycheckProtectionProgramLoan" id="Fact_bc50e7369ee04aa1932e95398276c8a3" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">532</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 9pt;">Principal payments on notes payable</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" id="Fact_46256f2dbc4643e59164b07c033e807c" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" id="Fact_4523452ea396420fb4aa5df88ffc392d" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">410</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 18pt;">Net cash provided by financing activities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_7e0935250a9d425586ca9850bc3d79fe" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">19,579</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_ebb648f21fe448009b43ff11e100ee12" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">61,585</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Net (decrease) increase in cash, cash equivalents and restricted cash</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" id="Fact_a392c83c1f964fe4a1ebef3bf636d557" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,444</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" id="Fact_e6da942c86bc4f1fa36e6c1e89b89acb" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">15,355</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div>Cash, cash equivalents and restricted cash at beginning of period</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_cd16d33f438845489c4a507bbec427d4" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,985</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_a3a7542fb7124aba941849042f4847da" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,630</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div>Cash, cash equivalents and restricted cash at end of period</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_0e1a65aa80df482d84072238ea16f061" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">15,541</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_55d5dbdf0bda431cb015e1b474c98ff6" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,985</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div>Supplemental disclosures of cash flow information:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Cash paid during the period for:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 18pt;">Interest</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_16158331690542da9563876126fe224c" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">30</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_6036a4ad6cb147e1bf0cb91113e13497" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">225</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div style="margin-left: 18pt;">Income taxes</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_ce5e6271ff3b45c5956e0cd02e8fc7d1" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">15</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_107a4b9de5944a26a6c1dd7619ff65b2" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div>Supplemental disclosure of non-cash investing and financing activities:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Conversion of warrant liability to equity</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:ConversionOfWarrantLiabilityToEquity" id="Fact_2473d24f0ff9488187b48c9daf800fc7" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">867</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:ConversionOfWarrantLiabilityToEquity" id="Fact_3cf67b71fe254724a391a95b712f368e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Initial measurement of ROU assets and operating lease liabilities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" id="Fact_a71e3ce637f2400c8ef97f8c9f0c9727" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,706</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" id="Fact_65df2dff199b4f43a0bbe85799f6d40d" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">866</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Unpaid fees incurred in connction with private offering</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:UnpaidFeesIncurredInConnectionWithPrivateOffering" id="Fact_b1be55513a314f7c8ed96e2dd373ad75" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">208</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:UnpaidFeesIncurredInConnectionWithPrivateOffering" id="Fact_7162d1ed923a4894a103eed6053c9584" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Initial measurement of finance lease liability</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:InitialMeasurementOfFinanceLeaseLiabilities" id="Fact_7a310ed939304861aa170fcd5f120549" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:InitialMeasurementOfFinanceLeaseLiabilities" id="Fact_e924fbeaf7e047b1bbbb85471febc32b" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Issuance of common stock for Series A preferred stock dividend</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:IssuanceOfCommonStockForSeriesAPreferredStockDividend" id="Fact_43b002cf4d7c45e3b7d386fa64c6c5c3" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:IssuanceOfCommonStockForSeriesAPreferredStockDividend" id="Fact_26fd7c695cc44e3ab319f0809a3d4009" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div style="margin-left: 9pt;">Issuance of common stock for business combination</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssued1" id="Fact_07593f35c2314c66958dc6fdf7a4d1d2" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:StockIssued1" id="Fact_6bcac8f62de14dd4993167f85eb9e18b" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,178</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Issuance of common Stock for Novellus acquisition</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:IssuanceOfCommonStockForAssetAcquisition" id="Fact_625555836d4b4915be65656c95b8bc73" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:IssuanceOfCommonStockForAssetAcquisition" id="Fact_63ae8daa21f9468bb05dd349831ec7ea" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">58,684</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div style="margin-left: 9pt;">Preferred shares issued in connection with reverse merger</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" id="Fact_8e28e357347e4428a5f12d3a748dd905" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" id="Fact_d83c72c9f91a4cf987e8fdb78fa65220" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;"><br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Reconciliation of cash, cash equivalents and restricted cash at end of period:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Cash and cash equivalents</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_432e2e37f14842ea8e2140377e01f649" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,446</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_a43f6f5bbd084f9886b9485ec94b06a7" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,985</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Restricted Cash</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:RestrictedCashCurrent" id="Fact_616e4d25d2cd41eda1b0215c19a53d2b" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,095</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:RestrictedCashCurrent" id="Fact_78d4ee5de04b465d9fb6b4a4c4ee93e0" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total Cash, cash equivalents and restriced cash at end of period</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_cc2d14d3c67f4c95907aee6c0af64665" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">15,541</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_fbbcf0ee649d46dfaa8409b08cf1c01d" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,985</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The accompanying notes are an integral part of these consolidated financial statements.</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-7</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <!--PROfilePageNumberReset%Num%7%F-%%--> </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ETERNA THERAPEUTICS INC. AND SUBSIDIARIES</div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><a id="NOTES"><!--Anchor--></a>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">For the Years Ended December 31, 2022 and 2021</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>


      <ix:nonNumeric name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="Text_e8e4b46423fc459bb75555fc7279ec7b" contextRef="c20220101to20221231" escape="true" continuedAt="Text_161cab132b5a401db5afb00f59b2a8c31">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">1)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Organization and Description of Business Operations</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <div>
        <ix:continuation id="Text_161cab132b5a401db5afb00f59b2a8c31" continuedAt="Text_161cab132b5a401db5afb00f59b2a8c32">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);"> </span><br />
        </div>
</ix:continuation>
      </div>

      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_161cab132b5a401db5afb00f59b2a8c32" continuedAt="Text_161cab132b5a401db5afb00f59b2a8c33">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On October 11, 2022, Eterna Therapeutics Inc., a Delaware corporation, (&#8220;Eterna&#8221; or the &#8220;Company&#8221;), changed its name from
            Brooklyn ImmunoTherapeutics, Inc. to Eterna Therapeutics Inc. upon its filing with the Secretary of State of the State of Delaware a Certificate of Amendment to its Restated Certificate of Incorporation, as amended (the &#8220;Charter&#8221;).</div>
</ix:continuation>
          <ix:continuation id="Text_161cab132b5a401db5afb00f59b2a8c33" continuedAt="Text_161cab132b5a401db5afb00f59b2a8c34">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_161cab132b5a401db5afb00f59b2a8c34" continuedAt="Text_161cab132b5a401db5afb00f59b2a8c35">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Eterna, together with its subsidiaries including Eterna Therapeutics LLC (formerly Brooklyn Immunotherapeutics LLC)
            (&#8220;Eterna LLC&#8221;), Novellus, Inc. (&#8220;Novellus&#8221;) and Novellus Therapeutics Limited (&#8220;Novellus Limited&#8221;), is a preclinical-stage biopharmaceutical company committed to realizing the potential of mRNA cell engineering to provide patients with
            transformational new medicines. Eterna has in -licensed a portfolio of over <ix:nonFraction name="erna:NumberOfInLicensedPortfolioPatents" id="Fact_dcba2fae1a6f4654a860fbf3ef6845f2" contextRef="c20220101to20221231_RangeAxis_MinimumMember" unitRef="U004" decimals="0" scale="0" format="ixt:num-dot-decimal">100</ix:nonFraction> patents covering key mRNA cell engineering
            technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice<sup style="line-height: 1; font-size: smaller; vertical-align: text-top;">TM</sup> and UltraSlice<sup style="line-height: 1; font-size: smaller; vertical-align: text-top;">TM</sup> gene-editing proteins, and the ToRNAdo<sup style="line-height: 1; font-size: smaller; vertical-align: text-top;">TM</sup> mRNA delivery system. Eterna plans to develop and advance a pipeline of therapeutic
            products both internally and through strategic partnerships, with the near-term focus on strategic partnerships. Eterna licenses its mRNA technology platform from Factor Bioscience Limited (&#8220;Factor Limited&#8221;) under an exclusive license
            agreement. As used herein, the &#8220;Company&#8221; refers collectively to Eterna and its subsidiaries.</div>
</ix:continuation>
          <ix:continuation id="Text_161cab132b5a401db5afb00f59b2a8c35" continuedAt="Text_161cab132b5a401db5afb00f59b2a8c36">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_161cab132b5a401db5afb00f59b2a8c36" continuedAt="Text_161cab132b5a401db5afb00f59b2a8c37">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On August 12, 2020, Eterna (then known as &#8220;NTN Buzztime, Inc.&#8221;), Eterna LLC (then known as &#8220;Brooklyn Immunotherapeutics
            LLC&#8221;) and BIT Merger Sub, Inc., a wholly owned subsidiary of Eterna (the &#8220;Merger Sub&#8221;), entered into an agreement and plan of merger and reorganization (the &#8220;Merger Agreement&#8221;) pursuant to which, among other matters, Merger Sub merged with and
            into Eterna LLC, with Eterna LLC surviving the merger as a wholly owned subsidiary of Eterna (the &#8220;Merger&#8221;). The Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which Eterna LLC was deemed the
            acquiring company for accounting purposes.</div>
</ix:continuation>
          <ix:continuation id="Text_161cab132b5a401db5afb00f59b2a8c37" continuedAt="Text_161cab132b5a401db5afb00f59b2a8c38">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_161cab132b5a401db5afb00f59b2a8c38" continuedAt="Text_161cab132b5a401db5afb00f59b2a8c39">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On March 26, 2021, Eterna sold its rights, title and interest in and to the assets relating to the pre-Merger business
            operated under the name &#8220;NTN Buzztime, Inc.&#8221; (the &#8220;Disposition&#8221;) to eGames.com Holdings LLC (&#8220;eGames.com&#8221;) in accordance with the terms of an asset purchase agreement dated September 18, 2020, as amended, between Eterna and eGames.com (the
            &#8220;Asset Purchase Agreement&#8221;).</div>
</ix:continuation>
          <ix:continuation id="Text_161cab132b5a401db5afb00f59b2a8c39" continuedAt="Text_161cab132b5a401db5afb00f59b2a8c310">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_161cab132b5a401db5afb00f59b2a8c310">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On July 16, 2021, Eterna and its newly formed, wholly owned subsidiary Brooklyn Acquisition Sub, Inc. entered into an
            agreement and plan of acquisition (the &#8220;Novellus Acquisition Agreement&#8221;) with Novellus LLC, Novellus (the sole equity holder of Novellus Limited and, prior to the closing under the Novellus Acquisition Agreement, a subsidiary of Novellus LLC),
            and (c) a seller representative, pursuant to which Eterna acquired Novellus and its subsidiary, Novellus Limited (the &#8220;Novellus Acquisition&#8221;). As part of the Novellus Acquisition, Eterna also acquired <ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" id="Fact_da6389e1d75345679e8be3f09903ccf4" contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U005" decimals="3" scale="-2" format="ixt:num-dot-decimal">25.0</ix:nonFraction>% of the total outstanding equity interests of NoveCite, Inc. (&#8220;NoveCite&#8221;), a corporation focused on developing an allogeneic mesenchymal stem cell product for patients
            with acute respiratory distress syndrome, including from COVID-19.</div>
</ix:continuation>
        </div>


      </div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="erna:LiquidityAndCapitalResourcesTextBlock" id="Text_fc15066e43c442738a9103a62a510e6f" contextRef="c20220101to20221231" escape="true" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b1">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">2)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Liquidity and Capital Resources</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <div>
        <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b1" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b2" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b3">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has incurred significant operating losses and has an accumulated deficit as a result of its efforts to develop
        product candidates, including conducting clinical trials and providing general and administrative support for operations. As of December 31, 2022, the Company had an unrestricted cash balance of approximately $<ix:nonFraction name="us-gaap:Cash" id="Fact_3be2952f3e3f4dc987debb8d207e6a9d" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">11.4</ix:nonFraction> million and an accumulated deficit of approximately $<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_be6cebbb4ed14fd6879b7baa56c04bb4" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal">165.3</ix:nonFraction>
        million. For the year ended December 31, 2022, the Company incurred a net loss of $<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_16e04402cae34c39bc6f799ff00ef9d5" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal">24.6</ix:nonFraction> million, and the Company used cash in operating
        activities of $<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_131616b6a92e4ae583d9e3de79acf38d" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal">21.0</ix:nonFraction> million.</div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b3" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b4">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
          </span></div>
</ix:continuation>
        <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b4" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b5">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></div>

      <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b5" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b6">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b6" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b7">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On March 6, 2022, the Company entered into a securities purchase agreement (the &#8220;Q1-22 Purchase Agreement&#8221;) with an investor (the &#8220;Q1-22 PIPE Investor&#8221;), providing for the private placement (the
              &#8220;Q1-22 PIPE Transaction&#8221;) to the Q1-22 PIPE Investor of approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_b8422f73819d423d91e7a1dd5566123f" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">343,000</ix:nonFraction> units, each unit consisting of (i) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_6754e9a435094e6dbb04304ef5e49411" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of our common stock, par value $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_3e0725435892487abaac5494c55c1a24" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U003" decimals="3" scale="0" format="ixt:num-dot-decimal">0.005</ix:nonFraction>
              per share (or, in lieu thereof, one pre-funded warrant (each, a <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#8220;</span></span>Q1-22



















              Pre-Funded Warrant<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#8221;)</span></span> to purchase <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_4efa0081f13d4034b4a661cce9aaadd3" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of common stock) and (ii) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_75d8b3941e6148d783374f924cd5c2d0" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction>
              warrant (each, a &#8220;Q1-22 Common Warrant&#8221;) to purchase one share of common stock, for an aggregate gross purchase price of approximately $<ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" id="Fact_f1ff74e1588f460588a69fa22bccdbb8" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">12.0</ix:nonFraction>
              million. The Q1-22 PIPE Transaction closed on March 9, 2022.</span><br />
          </span></div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b7" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b8">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b8" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b9">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-8</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b9" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b10">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On October 18, 2022, the Company entered into a facility sublease agreement (the &#8220;Sublease&#8221;) for approximately <ix:nonFraction name="us-gaap:AreaOfRealEstateProperty" id="Fact_2d71ecbb551e4afa96782aa967f8a059" contextRef="c20221018" unitRef="U006" decimals="0" scale="0" format="ixt:num-dot-decimal">45,500</ix:nonFraction> square feet of office and laboratory space in Somerville, Massachusetts.&#160; Pursuant to the Sublease, the Company delivered to the sublessor a security deposit in the
          form of a letter of credit in the amount of $<ix:nonFraction name="us-gaap:LineOfCredit" id="Fact_6c281fa60236482684fca3ae5e8a2fb8" contextRef="c20221018" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.1</ix:nonFraction> million, which will be reduced on an incremental basis throughout the term of the
          lease.&#160; The letter of credit was issued by the Company&#8217;s commercial bank, which required that the Company cash collateralize the letter of credit by depositing $<ix:nonFraction name="us-gaap:RestrictedCash" id="Fact_6dd9591faa5e4a908c2621d58b3da3cb" contextRef="c20221018" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.1</ix:nonFraction> million in a restricted cash account with such bank.&#160; The amount of required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of
          credit over the term of the Sublease; and the amount of restricted cash reduces by an equal amount the Company&#8217;s available working capital.<br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b10" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b11">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b11" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b12">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br />
        <!--PROfilePageNumberReset%Num%8%F-%%--> </div>
</ix:continuation>
      <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b12" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b13">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On November 23, 2022, the Company entered into a securities purchase agreement (the &#8220;Q4-22 Purchase Agreement&#8221;) with certain investors (the &#8220;Q4-22 PIPE Investors&#8221;),
          providing for the private placement (the &#8220;Q4-22 PIPE Transaction&#8221;) to the Q4-22 PIPE Investors of approximately of <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_90b68aac26574835b71aa5fe8982958b" contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">2,185,000</ix:nonFraction> units,
          each unit consisting of (i) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_a76abbeb1b9a46978e8b16cf0c4a3b89" contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of common stock and (ii) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_4d35e2b46c9047d28fcc45d5ef215940" contextRef="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> warrants, each exercisable to purchase one share of common stock at an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_dee178fabbac40489a340f667d4b8d94" contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">3.28</ix:nonFraction>
          per share (the &#8220;Q4-22 Warrants&#8221;), at a purchase price of $<ix:nonFraction name="erna:UnitPriceOfWarrants" id="Fact_7662d2e7c59c471fb0bff7e6193b196b" contextRef="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">3.53</ix:nonFraction> per unit (inclusive of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_3e6104e3640446c1b2b94632f956b01f" contextRef="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U003" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.125</ix:nonFraction> per Q4-22 Warrant). <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company received aggregate gross proceeds of approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" id="Fact_266c5121a65c49f49dda367ee7c54a20" contextRef="c20221202to20221202_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">7.7</ix:nonFraction>
            million, </span>and the Q4-22 PIPE Transaction closed on December 2, 2022. Each Q4-22 Warrant becomes exercisable <ix:nonNumeric name="erna:ClassOfWarrantOrRightsExercisableTerm" id="Fact_bb556dac4b224e6582b90dc09b796b05" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember" format="ixt-sec:durwordsen">six months</ix:nonNumeric>
          following the date of closing, expires <span style="-sec-ix-hidden:Fact_cd1a85f5a00d40e2a9ec630f5346c135">five-and-one-half</span> years following such date, and is subject to customary adjustments.</span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b13" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b14">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
        </span></div>
</ix:continuation><ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b14" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b15">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
       <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <div><ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b15" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b16">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b16" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b17">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b17" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b18">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">In
















            connection with preparing the accompanying consolidated financial statements as of and for the year ended December 31, 2022, the Company&#8217;s management concluded that there is substantial doubt regarding the Company&#8217;s ability to continue as a
            going concern because it does not expect to have sufficient cash or working capital resources to fund operations for the twelve-month period subsequent to the issuance date of these financial statements. The Company will need to raise
            additional capital, which could be through public or private equity offerings, debt financings, strategic partnerships or other means. The Company currently has no arrangements for such capital, and no assurances can be given that it will be
            able to raise such capital when needed, on acceptable terms, or at all.</div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b18" continuedAt="Text_2af6df0f78f24dbeae53e196e9f5818b19">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_2af6df0f78f24dbeae53e196e9f5818b19">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The
        accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The accompanying consolidated financial
        statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to the Company&#8217;s ability
        to continue as a going concern.</div>
</ix:continuation>
       </div>

    <div> <br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="Text_58dd98addd9c452ab1c0163aa9b955ed" contextRef="c20220101to20221231" escape="true" continuedAt="Text_e8ed8a260bec4f9495765b57570851b91">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">3)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Basis of Accounting Presentation and Summary of Significant Accounting Policies</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b91" continuedAt="Text_e8ed8a260bec4f9495765b57570851b92">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b92" continuedAt="Text_e8ed8a260bec4f9495765b57570851b93"><ix:nonNumeric name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="Text_00959b52567a41a3b8e8cec794fec4cb" contextRef="c20220101to20221231" escape="true" continuedAt="Text_8a81ccbd73b347f3a6fdcac005cbabee1">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Basis of Accounting Presentation</div>
</ix:nonNumeric></ix:continuation>
      <div>
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b93" continuedAt="Text_e8ed8a260bec4f9495765b57570851b94"><ix:continuation id="Text_8a81ccbd73b347f3a6fdcac005cbabee1" continuedAt="Text_8a81ccbd73b347f3a6fdcac005cbabee2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b94" continuedAt="Text_e8ed8a260bec4f9495765b57570851b95"><ix:continuation id="Text_8a81ccbd73b347f3a6fdcac005cbabee2" continuedAt="Text_8a81ccbd73b347f3a6fdcac005cbabee3">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles
        (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;). All
        significant intercompany balances and transactions have been eliminated in consolidation.</div>
</ix:continuation></ix:continuation>
      <div>
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b95" continuedAt="Text_e8ed8a260bec4f9495765b57570851b96"><ix:continuation id="Text_8a81ccbd73b347f3a6fdcac005cbabee3" continuedAt="Text_8a81ccbd73b347f3a6fdcac005cbabee4">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation></ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b96" continuedAt="Text_e8ed8a260bec4f9495765b57570851b97"><ix:continuation id="Text_8a81ccbd73b347f3a6fdcac005cbabee4" continuedAt="Text_8a81ccbd73b347f3a6fdcac005cbabee5">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">As described above, the Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which
          Eterna LLC was deemed the acquiring company for accounting purposes. Eterna LLC&#8217;s historical financial statements replaced Eterna&#8217;s historical financial statements with respect to periods prior to the completion of the Merger (when Eterna
          operated under the name &#8220;NTN Buzztime, Inc.&#8221;). The Company retrospectively adjusted the weighted average shares used in determining loss per common share to reflect the conversion of the outstanding Class A units, Class B units, Class C units,
          and common units of Eterna LLC that converted into shares of Eterna&#8217;s common stock upon consummation of&#160; the Merger and to reflect the effect of a <span style="-sec-ix-hidden:Fact_abe396817a904d8ea2336e844b48953a">2-to-1</span>
          reverse stock split of Eterna&#8217;s common stock that occurred immediately prior to the Merger.</div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b97" continuedAt="Text_e8ed8a260bec4f9495765b57570851b98"><ix:continuation id="Text_8a81ccbd73b347f3a6fdcac005cbabee5" continuedAt="Text_8a81ccbd73b347f3a6fdcac005cbabee6">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b98" continuedAt="Text_e8ed8a260bec4f9495765b57570851b99"><ix:continuation id="Text_8a81ccbd73b347f3a6fdcac005cbabee6">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Also as described above, the Novellus Acquisition closed on July 16, 2021. The Novellus Acquisition was accounted for as an
          asset acquisition, and substantially all of the value was attributed to in-process research and development (&#8220;IPR&amp;D&#8221;), with the exception of the cash paid for the investment in NoveCite, which has been accounted for as an investment in equity
          securities. The IPR&amp;D had no alternative future uses and no separate economic value from its originally intended purpose and was therefore expensed at the acquisition date.</div>
</ix:continuation></ix:continuation>
         </div>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b99" continuedAt="Text_e8ed8a260bec4f9495765b57570851b910">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b910" continuedAt="Text_e8ed8a260bec4f9495765b57570851b911"><ix:nonNumeric name="erna:ReverseStockSplitPolicyTextBlock" id="Text_46d89bbe0daa4b598267f4b6e0b73746" contextRef="c20220101to20221231" escape="true" continuedAt="Text_6679465df1734ad8babae351741faf661">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none;">October 2022 Reverse Stock Split</div>
</ix:nonNumeric></ix:continuation>
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b911" continuedAt="Text_e8ed8a260bec4f9495765b57570851b912"><ix:continuation id="Text_6679465df1734ad8babae351741faf661" continuedAt="Text_6679465df1734ad8babae351741faf662">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none;"> <br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b912" continuedAt="Text_e8ed8a260bec4f9495765b57570851b913"><ix:continuation id="Text_6679465df1734ad8babae351741faf662" continuedAt="Text_6679465df1734ad8babae351741faf663">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As approved by the Company&#8217;s stockholders at the Company&#8217;s Annual Meeting of Stockholders held on September 21,
            2022, the Company effected a reverse stock split of its common stock at a ratio of <span style="-sec-ix-hidden:Fact_9ec8b708b2c6467a940f0725195187c5">1-for-20</span>, as determined by the Company&#8217;s Board of
            Directors within the parameters approved by the Company&#8217;s stockholders (the &#8220;October 2022 Reverse Stock Split&#8221;).&#160; The October 2022 Reverse Stock Split became effective under Delaware law at 11:59 p.m. Eastern time on October 16, 2022.</span> </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b913" continuedAt="Text_e8ed8a260bec4f9495765b57570851b914"><ix:continuation id="Text_6679465df1734ad8babae351741faf663" continuedAt="Text_6679465df1734ad8babae351741faf664">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 27pt;"><br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b914" continuedAt="Text_e8ed8a260bec4f9495765b57570851b915"><ix:continuation id="Text_6679465df1734ad8babae351741faf664" continuedAt="Text_6679465df1734ad8babae351741faf665">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-variant: normal; text-transform: none;"> <span style="font-size: 10pt;"> </span> </span></div>
</ix:continuation></ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-9</span></div>

          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="BRPFPageHeader">
            <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
            </div>

          </div>

        </div>

        <!--PROfilePageNumberReset%Num%9%F-%%-->
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b915" continuedAt="Text_e8ed8a260bec4f9495765b57570851b916"><ix:continuation id="Text_6679465df1734ad8babae351741faf665">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"> Upon the effectiveness of the October
          2022 Reverse Stock Split, every twenty shares of the issued and outstanding common stock were automatically combined and reclassified into one issued and outstanding share of common stock. The October 2022 Reverse Stock Split did not affect any
          stockholder&#8217;s ownership percentage of the common stock, alter the par value of the common stock or modify any voting rights or other terms of the common stock. The number of authorized shares of common stock under the Charter remains unchanged.
          No fractional shares were issued in connection with the October Reverse Stock Split. In lieu of any fractional shares to which a stockholder would otherwise be entitled, the Company paid an amount of cash equal to the product of (i) the
          fractional share to which the holder would otherwise be entitled and (ii) the then fair value of a share as determined in good faith by the Board.&#160; The Company paid an aggregate of $<ix:nonFraction name="erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit" id="Fact_f94d1a856ada47b48a889b068aa5dbdc" contextRef="c20220921to20220921" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">719</ix:nonFraction> for a total of <ix:nonFraction name="erna:NumberOfSharesConsideredAsFractionalInReverseStock" id="Fact_6457ce84a743435894692b11115e4c88" contextRef="c20220921to20220921" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">175</ix:nonFraction> fractional shares.<br />
        </div>
</ix:continuation></ix:continuation>

        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b916" continuedAt="Text_e8ed8a260bec4f9495765b57570851b917">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b917" continuedAt="Text_e8ed8a260bec4f9495765b57570851b918">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">All share and per share data in this
          Annual Report on Form 10-K have been adjusted for all periods presented to reflect the October 2022 Reverse Stock Split.<br />
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b918" continuedAt="Text_e8ed8a260bec4f9495765b57570851b919">
<div><br /></div>
</ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b919" continuedAt="Text_e8ed8a260bec4f9495765b57570851b920">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Summary of Significant Accounting Policies</div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b920" continuedAt="Text_e8ed8a260bec4f9495765b57570851b921">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
      </div>


      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b921" continuedAt="Text_e8ed8a260bec4f9495765b57570851b922"><ix:nonNumeric name="us-gaap:UseOfEstimates" id="Text_c45d270b2b8544d091aa6a102988a144" contextRef="c20220101to20221231" escape="true" continuedAt="Text_0b8b933cf7fd4db08e6b28ddbd19495a1">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Use of Estimates</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b922" continuedAt="Text_e8ed8a260bec4f9495765b57570851b923"><ix:continuation id="Text_0b8b933cf7fd4db08e6b28ddbd19495a1" continuedAt="Text_0b8b933cf7fd4db08e6b28ddbd19495a2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b923" continuedAt="Text_e8ed8a260bec4f9495765b57570851b924"><ix:continuation id="Text_0b8b933cf7fd4db08e6b28ddbd19495a2">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and
        assumptions that affect: (a) the reported amounts of assets and liabilities; (b) disclosure of contingent assets and liabilities at the date of the consolidated financial statements; (c) the reported amounts of expenses during the reporting period;
        and (d) the reported amount of the fair value of assets acquired in connection with business combinations. On an ongoing basis, the Company evaluates its estimates, including those related to the recoverability and useful lives of long-lived
        assets; stock-based compensation assumptions; valuation assumptions of warrants; contingencies; and the provision for income taxes, including the valuation allowance. The Company bases its estimates on a combination of historical experience and
        various other assumptions that it believes are reasonable under the circumstances. Actual results may differ materially from these estimates.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b924" continuedAt="Text_e8ed8a260bec4f9495765b57570851b925">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b925" continuedAt="Text_e8ed8a260bec4f9495765b57570851b926"><ix:nonNumeric name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="Text_48422aca8e0b4de1b6a610801a9b8cb8" contextRef="c20220101to20221231" escape="true" continuedAt="Text_2039778b3b154301af18d4895751d12d1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Cash, Cash Equivalents and Restricted Cash</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b926" continuedAt="Text_e8ed8a260bec4f9495765b57570851b927"><ix:continuation id="Text_2039778b3b154301af18d4895751d12d1" continuedAt="Text_2039778b3b154301af18d4895751d12d2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b927" continuedAt="Text_e8ed8a260bec4f9495765b57570851b928"><ix:continuation id="Text_2039778b3b154301af18d4895751d12d2" continuedAt="Text_2039778b3b154301af18d4895751d12d3">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company classifies highly liquid investments with a remaining contractual maturity at date of purchase of three months or
        less as cash equivalents. The Company had <ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" id="Fact_5d422f5f847e455cbfa8e72cc4b038ec" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" id="Fact_5035f7e500784769a9fc45b1573b9651" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> cash equivalents as of December 31, 2022 or 2021.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b928" continuedAt="Text_e8ed8a260bec4f9495765b57570851b929"><ix:continuation id="Text_2039778b3b154301af18d4895751d12d3" continuedAt="Text_2039778b3b154301af18d4895751d12d4">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b929" continuedAt="Text_e8ed8a260bec4f9495765b57570851b930"><ix:continuation id="Text_2039778b3b154301af18d4895751d12d4">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> Restricted cash consists of a cash collateralization of $<ix:nonFraction name="us-gaap:RestrictedCash" id="Fact_4f8f0674f714422db851006fbdde984b" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.1</ix:nonFraction> million for a security deposit in the form of a letter of credit issued by the Company&#8217;s commercial bank and delivered to the sublessor of the Sublease. The amount of
        required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of credit over the term of the Sublease.<br />
      </div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b930" continuedAt="Text_e8ed8a260bec4f9495765b57570851b931">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b931" continuedAt="Text_e8ed8a260bec4f9495765b57570851b932"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="Text_2da43536e14c489382ce5eef9701b4b4" contextRef="c20220101to20221231" escape="true" continuedAt="Text_647c2ab3baeb452d84b06b1a0d21490d1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Property and Equipment</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b932" continuedAt="Text_e8ed8a260bec4f9495765b57570851b933"><ix:continuation id="Text_647c2ab3baeb452d84b06b1a0d21490d1" continuedAt="Text_647c2ab3baeb452d84b06b1a0d21490d2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b933" continuedAt="Text_e8ed8a260bec4f9495765b57570851b934"><ix:continuation id="Text_647c2ab3baeb452d84b06b1a0d21490d2">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Property and equipment are recorded at cost and are depreciated over their estimated useful lives using the straight-line
        method. Laboratory and manufacturing equipment are depreciated over an estimated useful life of <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_b2fff27d8bff45d1b89e1cac87d2521e" contextRef="c20220101to20221231_PropertyPlantAndEquipmentByTypeAxis_LaboratoryAndManufacturingEquipmentMember" format="ixt-sec:durwordsen">seven years</ix:nonNumeric>. Leasehold improvements are
        depreciated over the shorter of their estimated useful life, or the lease term. Computer equipment are depreciated over an estimated useful life of <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_18482e3cc28e4ec4813b6299346bf6cc" contextRef="c20220101to20221231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric>. Upon retirement or other disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the resulting gain or losses are reflected in the results of
        operations. Expenditures for maintenance and repairs are charged to operations. Renewals and betterments are capitalized.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b934" continuedAt="Text_e8ed8a260bec4f9495765b57570851b935">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b935" continuedAt="Text_e8ed8a260bec4f9495765b57570851b936"><ix:nonNumeric name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="Text_c6a6f33ca0aa4d9d911c3133c23c4c45" contextRef="c20220101to20221231" escape="true" continuedAt="Text_0e6fb17daa56415b80510c469fc0e9791">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Goodwill</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b936" continuedAt="Text_e8ed8a260bec4f9495765b57570851b937"><ix:continuation id="Text_0e6fb17daa56415b80510c469fc0e9791" continuedAt="Text_0e6fb17daa56415b80510c469fc0e9792">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b937" continuedAt="Text_e8ed8a260bec4f9495765b57570851b938"><ix:continuation id="Text_0e6fb17daa56415b80510c469fc0e9792">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in the acquisition
        of IRX Therapeutics, Inc. (&#8220;IRX&#8221;) in November 2018 (the &#8220;IRX Acquisition&#8221;), which was accounted for as a business combination. Goodwill is not amortized but is tested for impairment annually or if events occur or circumstances change that would
        reduce the fair value of a reporting unit below its carrying value. Because management evaluates the Company as a single reporting unit, goodwill is tested for impairment at the entity level by first performing a qualitative assessment to determine
        whether it is more likely than not that the fair value of the entity is less than its carrying value. Such qualitative factors include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and
        other relevant events.&#160; If the entity does not pass the qualitative assessment, then the entity&#8217;s carrying value is compared to its fair value. Goodwill is considered impaired if the carrying value of the entity exceeds its fair value.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b938" continuedAt="Text_e8ed8a260bec4f9495765b57570851b939">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-10</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>


      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b939" continuedAt="Text_e8ed8a260bec4f9495765b57570851b940"><ix:nonNumeric name="us-gaap:InProcessResearchAndDevelopmentPolicy" id="Text_c2367262f15e42dd88fba84a270f0b9e" contextRef="c20220101to20221231" escape="true" continuedAt="Text_3f76dfe16a1f4b2d803532e523874d921">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">IPR&amp;D</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b940" continuedAt="Text_e8ed8a260bec4f9495765b57570851b941"><ix:continuation id="Text_3f76dfe16a1f4b2d803532e523874d921" continuedAt="Text_3f76dfe16a1f4b2d803532e523874d922">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b941" continuedAt="Text_e8ed8a260bec4f9495765b57570851b942"><ix:continuation id="Text_3f76dfe16a1f4b2d803532e523874d922">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">IPR&amp;D assets represent the fair value assigned to technologies that were acquired in connection with the IRX Acquisition,
        which have not reached technological feasibility and have no alternative future use. IPR&amp;D assets are considered to be indefinite lived until the completion or abandonment of the associated research and development projects. During the period
        that the IPR&amp;D assets are considered indefinite-lived, they are tested for impairment on an annual basis or more frequently if the Company becomes aware of any events occurring or changes in circumstances that indicate that the fair value of
        the IPR&amp;D assets are less than their carrying amounts. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize products associated with the IPR&amp;D assets, these assets
        are then deemed definite-lived and are amortized based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a full or partial impairment charge related to the IPR&amp;D
        assets, calculated as the excess of carrying value of the IPR&amp;D assets over fair value.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b942" continuedAt="Text_e8ed8a260bec4f9495765b57570851b943">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b943" continuedAt="Text_e8ed8a260bec4f9495765b57570851b944"><ix:nonNumeric name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="Text_3a7f085e167c4fe3adab4b68b5c77eb4" contextRef="c20220101to20221231" escape="true" continuedAt="Text_37ee33f65f3441d098966a3754c1fe771">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Research and Development</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b944" continuedAt="Text_e8ed8a260bec4f9495765b57570851b945"><ix:continuation id="Text_37ee33f65f3441d098966a3754c1fe771" continuedAt="Text_37ee33f65f3441d098966a3754c1fe772">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b945" continuedAt="Text_e8ed8a260bec4f9495765b57570851b946"><ix:continuation id="Text_37ee33f65f3441d098966a3754c1fe772" continuedAt="Text_37ee33f65f3441d098966a3754c1fe773">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company expenses its research and development costs as incurred. Research and development expenses consist of costs
        incurred for company-sponsored research and development activities, as well as support for selected investigator-sponsored research. Upfront payments and milestone payments made for the licensing of technology are expensed as research and
        development in the period in which they are incurred if the technology is not expected to have any alternative future uses other than the specific research and development project for which it was intended. IPR&amp;D that is acquired through an
        asset acquisition (as opposed to a business combination) and has no alternative future uses and, therefore, no separate economic values, is expensed to research and development costs at the time the costs are incurred.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b946" continuedAt="Text_e8ed8a260bec4f9495765b57570851b947"><ix:continuation id="Text_37ee33f65f3441d098966a3754c1fe773" continuedAt="Text_37ee33f65f3441d098966a3754c1fe774">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b947" continuedAt="Text_e8ed8a260bec4f9495765b57570851b948"><ix:continuation id="Text_37ee33f65f3441d098966a3754c1fe774" continuedAt="Text_37ee33f65f3441d098966a3754c1fe775">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The major components of research and development costs include preclinical study costs, clinical manufacturing costs, clinical
        study and trial expenses, insurance coverage for clinical trials, expensed licensed technology, expensed IPR&amp;D, consulting, scientific advisors and other third-party costs, salaries and employee benefits, stock-based compensation expense,
        supplies and materials and allocations of various overhead costs related to our product development efforts.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b948" continuedAt="Text_e8ed8a260bec4f9495765b57570851b949"><ix:continuation id="Text_37ee33f65f3441d098966a3754c1fe775" continuedAt="Text_37ee33f65f3441d098966a3754c1fe776">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b949" continuedAt="Text_e8ed8a260bec4f9495765b57570851b950"><ix:continuation id="Text_37ee33f65f3441d098966a3754c1fe776">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has contracted with third parties to perform various clinical study and trial activities in the development and
        testing of potential products. The financial terms of these agreements vary from contract to contract and may result in uneven payment flows. The Company accrues for third party expenses based on estimates of the services received and efforts
        expended during the reporting period. If the actual timing of the performance of the services or the level of effort varies from the estimate, the accrual is adjusted accordingly. The expenses for some third-party services may be recognized on a
        straight-line basis if the expected costs are expected to be incurred ratably during the period. Payments under the contracts depend on factors such as the achievement of certain events or milestones, the successful enrollment of patients, the
        allocation of responsibilities among the parties to the agreement, and the completion of portions of the clinical study or trial or similar conditions. Preclinical and clinical study and trial associated activities such as production and testing of
        clinical material require significant up-front expenditures.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b950" continuedAt="Text_e8ed8a260bec4f9495765b57570851b951">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b951" continuedAt="Text_e8ed8a260bec4f9495765b57570851b952"><ix:nonNumeric name="us-gaap:IncomeTaxPolicyTextBlock" id="Text_498e5018dea24bdf8cc2b8a498488b16" contextRef="c20220101to20221231" escape="true" continuedAt="Text_6b6ee748530740dcace649e7c27f3f171">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Income Taxes</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b952" continuedAt="Text_e8ed8a260bec4f9495765b57570851b953"><ix:continuation id="Text_6b6ee748530740dcace649e7c27f3f171" continuedAt="Text_6b6ee748530740dcace649e7c27f3f172">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b953" continuedAt="Text_e8ed8a260bec4f9495765b57570851b954"><ix:continuation id="Text_6b6ee748530740dcace649e7c27f3f172" continuedAt="Text_6b6ee748530740dcace649e7c27f3f173">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company records deferred tax liabilities and assets based on the differences between the consolidated financial statements
        carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and establishing a valuation allowance when it was more likely than not that some portion or all of
        the deferred tax assets would not be realized. Income tax expense consists of the tax payable for the period and the change during the period in deferred tax assets and liabilities.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b954" continuedAt="Text_e8ed8a260bec4f9495765b57570851b955"><ix:continuation id="Text_6b6ee748530740dcace649e7c27f3f173" continuedAt="Text_6b6ee748530740dcace649e7c27f3f174">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b955" continuedAt="Text_e8ed8a260bec4f9495765b57570851b956"><ix:continuation id="Text_6b6ee748530740dcace649e7c27f3f174">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Tax benefits from uncertain tax positions are recognized only if it is more likely than not that the tax position will be
        sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a
        greater than 50% likelihood of being realized upon ultimate resolution. The Company has no material uncertain tax positions for any of the reporting periods presented.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b956" continuedAt="Text_e8ed8a260bec4f9495765b57570851b957">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b957" continuedAt="Text_e8ed8a260bec4f9495765b57570851b958"><ix:nonNumeric name="us-gaap:EarningsPerSharePolicyTextBlock" id="Text_7951f8cc83434eda9aa97204d7a1dd30" contextRef="c20220101to20221231" escape="true" continuedAt="Text_fdc60a44c7454d7093eb29bb2690cb941">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Loss Per Share</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b958" continuedAt="Text_e8ed8a260bec4f9495765b57570851b959"><ix:continuation id="Text_fdc60a44c7454d7093eb29bb2690cb941" continuedAt="Text_fdc60a44c7454d7093eb29bb2690cb942">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b959" continuedAt="Text_e8ed8a260bec4f9495765b57570851b960"><ix:continuation id="Text_fdc60a44c7454d7093eb29bb2690cb942">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Basic and diluted loss per common share have been computed by dividing the losses attributable to common stockholders by the
        weighted average number of common shares outstanding. The Company&#8217;s basic and fully diluted loss per share calculations are the same because the increased number of shares that would be included in the diluted calculation from assumed exercise of
        common stock equivalents would be anti-dilutive to the net loss in each of the years shown in the consolidated financial statements.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b960" continuedAt="Text_e8ed8a260bec4f9495765b57570851b961">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-11</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>


      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b961" continuedAt="Text_e8ed8a260bec4f9495765b57570851b962"><ix:nonNumeric name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="Text_eed8acfbc096446e81415cdb77dd5376" contextRef="c20220101to20221231" escape="true" continuedAt="Text_8bfb88c41d4e474a8a469bca9f9dd2181">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Segment Reporting</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b962" continuedAt="Text_e8ed8a260bec4f9495765b57570851b963"><ix:continuation id="Text_8bfb88c41d4e474a8a469bca9f9dd2181" continuedAt="Text_8bfb88c41d4e474a8a469bca9f9dd2182">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b963" continuedAt="Text_e8ed8a260bec4f9495765b57570851b964"><ix:continuation id="Text_8bfb88c41d4e474a8a469bca9f9dd2182">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company&#8217;s chief operating decision maker, who is the chief executive officer, reviews operating results on a consolidated
        basis to make decisions about allocating resources and assessing performance of the Company.&#160; As a result, in accordance with ASC No. 280, <span style="font-style: italic;">Segment Reporting,</span> the Company has determined that it operates as <ix:nonFraction name="us-gaap:NumberOfOperatingSegments" id="Fact_46d5a933f8b0422fa6833aa11c3ed48b" contextRef="c20220101to20221231" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> operating segment.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b964" continuedAt="Text_e8ed8a260bec4f9495765b57570851b965">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b965" continuedAt="Text_e8ed8a260bec4f9495765b57570851b966"><ix:nonNumeric name="us-gaap:ConcentrationRiskCreditRisk" id="Text_8b2098fc4dcc48598043cbdf4eb2f4e7" contextRef="c20220101to20221231" escape="true" continuedAt="Text_2f7e6cce03e84c718333c82f8fa6d0b41">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Concentration of Credit Risk</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b966" continuedAt="Text_e8ed8a260bec4f9495765b57570851b967"><ix:continuation id="Text_2f7e6cce03e84c718333c82f8fa6d0b41" continuedAt="Text_2f7e6cce03e84c718333c82f8fa6d0b42">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b967" continuedAt="Text_e8ed8a260bec4f9495765b57570851b968"><ix:continuation id="Text_2f7e6cce03e84c718333c82f8fa6d0b42" continuedAt="Text_2f7e6cce03e84c718333c82f8fa6d0b43">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company maintains its cash balances in financial institutions located in the United States. Accounts at each institution
        are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $250,000. The Company&#8217;s cash balances are uninsured for deposit accounts that exceed the FDIC insurance limit.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b968" continuedAt="Text_e8ed8a260bec4f9495765b57570851b969"><ix:continuation id="Text_2f7e6cce03e84c718333c82f8fa6d0b43" continuedAt="Text_2f7e6cce03e84c718333c82f8fa6d0b44">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b969" continuedAt="Text_e8ed8a260bec4f9495765b57570851b970"><ix:continuation id="Text_2f7e6cce03e84c718333c82f8fa6d0b44">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In the Company&#8217;s business, vendor concentrations could be indicative of vulnerabilities in the Company&#8217;s supply chain, which
        could ultimately impact the Company&#8217;s ability to continue its research and development activities. For the years ended December 31, 2022 and 2021, there was no vendor concentration related to the Company&#8217;s research and development activities.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b970" continuedAt="Text_e8ed8a260bec4f9495765b57570851b971">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b971" continuedAt="Text_e8ed8a260bec4f9495765b57570851b972"><ix:nonNumeric name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="Text_2791aa3d01e245a0bf8c2ac430d9635d" contextRef="c20220101to20221231" escape="true" continuedAt="Text_950c09e51ba843458663889d864184c01">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Fair Value of Financial Instruments</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b972" continuedAt="Text_e8ed8a260bec4f9495765b57570851b973"><ix:continuation id="Text_950c09e51ba843458663889d864184c01" continuedAt="Text_950c09e51ba843458663889d864184c02">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b973" continuedAt="Text_e8ed8a260bec4f9495765b57570851b974"><ix:continuation id="Text_950c09e51ba843458663889d864184c02" continuedAt="Text_950c09e51ba843458663889d864184c03">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly
        transaction between willing market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to
        unobservable inputs. The fair value hierarchy is as follows:</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b974" continuedAt="Text_e8ed8a260bec4f9495765b57570851b975"><ix:continuation id="Text_950c09e51ba843458663889d864184c03" continuedAt="Text_950c09e51ba843458663889d864184c04">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b975" continuedAt="Text_e8ed8a260bec4f9495765b57570851b976"><ix:continuation id="Text_950c09e51ba843458663889d864184c04" continuedAt="Text_950c09e51ba843458663889d864184c05">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 1 Inputs &#8211; Valued based on quoted prices in active markets
          for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b976" continuedAt="Text_e8ed8a260bec4f9495765b57570851b977"><ix:continuation id="Text_950c09e51ba843458663889d864184c05" continuedAt="Text_950c09e51ba843458663889d864184c06">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">&#160;</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b977" continuedAt="Text_e8ed8a260bec4f9495765b57570851b978"><ix:continuation id="Text_950c09e51ba843458663889d864184c06" continuedAt="Text_950c09e51ba843458663889d864184c07">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 2 Inputs &#8211; Valued based on inputs other than quoted prices
          included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities
          in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or
          corroborated by market data by correlation or other means.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b978" continuedAt="Text_e8ed8a260bec4f9495765b57570851b979"><ix:continuation id="Text_950c09e51ba843458663889d864184c07" continuedAt="Text_950c09e51ba843458663889d864184c08">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b979" continuedAt="Text_e8ed8a260bec4f9495765b57570851b980"><ix:continuation id="Text_950c09e51ba843458663889d864184c08" continuedAt="Text_950c09e51ba843458663889d864184c09">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 3 Inputs &#8211; Valued based on inputs for which there is
          little or no market value, which require the reporting entity to develop its own assumptions.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b980" continuedAt="Text_e8ed8a260bec4f9495765b57570851b981"><ix:continuation id="Text_950c09e51ba843458663889d864184c09" continuedAt="Text_950c09e51ba843458663889d864184c010">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b981" continuedAt="Text_e8ed8a260bec4f9495765b57570851b982"><ix:continuation id="Text_950c09e51ba843458663889d864184c010">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The carrying amounts reported on the balance sheet for cash and cash equivalents, accounts receivable, prepaid assets and other
        current assets, accounts payable and accrued expenses, other current liabilities and other liabilities approximate fair value based due to their short maturities.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b982" continuedAt="Text_e8ed8a260bec4f9495765b57570851b983">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br /></div>
</ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b983" continuedAt="Text_e8ed8a260bec4f9495765b57570851b984"><ix:nonNumeric name="us-gaap:LesseeLeasesPolicyTextBlock" id="Text_50f18a33557b4d308295462934021741" contextRef="c20220101to20221231" escape="true" continuedAt="Text_13bbffbf178f4f9cb7980ca76aaf65761">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Leases</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b984" continuedAt="Text_e8ed8a260bec4f9495765b57570851b985"><ix:continuation id="Text_13bbffbf178f4f9cb7980ca76aaf65761" continuedAt="Text_13bbffbf178f4f9cb7980ca76aaf65762">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b985" continuedAt="Text_e8ed8a260bec4f9495765b57570851b986"><ix:continuation id="Text_13bbffbf178f4f9cb7980ca76aaf65762" continuedAt="Text_13bbffbf178f4f9cb7980ca76aaf65763">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The Company accounts for its leases under
        ASC Topic 842, <span style="font-style: italic;">Leases.</span> Operating lease liabilities represent the present value of lease payments not yet paid. Right-of-use (&#8220;ROU&#8221;) assets represent the Company&#8217;s right to use an underlying asset and are
        based upon the operating lease liabilities adjusted for prepaid or accrued lease payments, initial direct costs, lease incentives and impairment of operating lease assets. If the interest rate implicit in the lease is not readily determinable, the
        Company uses the incremental borrowing rates for collateralized borrowings in an amount equal to the lease payments under similar terms.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b986" continuedAt="Text_e8ed8a260bec4f9495765b57570851b987"><ix:continuation id="Text_13bbffbf178f4f9cb7980ca76aaf65763" continuedAt="Text_13bbffbf178f4f9cb7980ca76aaf65764">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b987" continuedAt="Text_e8ed8a260bec4f9495765b57570851b988"><ix:continuation id="Text_13bbffbf178f4f9cb7980ca76aaf65764" continuedAt="Text_13bbffbf178f4f9cb7980ca76aaf65765">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b988" continuedAt="Text_e8ed8a260bec4f9495765b57570851b989"><ix:continuation id="Text_13bbffbf178f4f9cb7980ca76aaf65765" continuedAt="Text_13bbffbf178f4f9cb7980ca76aaf65766">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b989" continuedAt="Text_e8ed8a260bec4f9495765b57570851b990"><ix:continuation id="Text_13bbffbf178f4f9cb7980ca76aaf65766" continuedAt="Text_13bbffbf178f4f9cb7980ca76aaf65767">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The Company has elected the practical
        expedient to not separate non-lease components from the lease components to which they relate and instead account for each as a single lease component for all underlying asset classes. Some leasing arrangements require variable payments that are
        dependent on usage or may vary for other reasons, such as payments for insurance, tax payments and other miscellaneous costs. The variable portion of payments contemplated in the lease that do not depend on an index or rate are not included in the
        ROU assets or lease liabilities. Rather, variable payments that do not depend on an index or rate are expensed when the obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease
        contract are accounted for as lease expenses.</div>
</ix:continuation></ix:continuation>
      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b990" continuedAt="Text_e8ed8a260bec4f9495765b57570851b991"><ix:continuation id="Text_13bbffbf178f4f9cb7980ca76aaf65767" continuedAt="Text_13bbffbf178f4f9cb7980ca76aaf65768">
<div><br /></div>
</ix:continuation></ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-12</span></div>

          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="BRPFPageHeader">
            <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
            </div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b991" continuedAt="Text_e8ed8a260bec4f9495765b57570851b992"><ix:continuation id="Text_13bbffbf178f4f9cb7980ca76aaf65768">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has also elected not to recognize ROU and lease liabilities for short-term leases that have a term of 12 months
          or less.</div>
</ix:continuation></ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b992" continuedAt="Text_e8ed8a260bec4f9495765b57570851b993">
<div><br />
        </div>
</ix:continuation>
      </div>


      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b993" continuedAt="Text_e8ed8a260bec4f9495765b57570851b994"><ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="Text_4f18285a39af4e629713ec9c7a2a2f1d" contextRef="c20220101to20221231" escape="true" continuedAt="Text_67b96831bb6543d892741383123389211">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Commitment and Contingencies</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b994" continuedAt="Text_e8ed8a260bec4f9495765b57570851b995"><ix:continuation id="Text_67b96831bb6543d892741383123389211" continuedAt="Text_67b96831bb6543d892741383123389212">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b995" continuedAt="Text_e8ed8a260bec4f9495765b57570851b996"><ix:continuation id="Text_67b96831bb6543d892741383123389212">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company follows ASC No.450-20, <span style="font-style: italic;">Loss Contingencies,</span> to report accounting for
        contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be
        reasonably estimated.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b996" continuedAt="Text_e8ed8a260bec4f9495765b57570851b997">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b997" continuedAt="Text_e8ed8a260bec4f9495765b57570851b998"><ix:nonNumeric name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="Text_326ab3d8fd264d64a32f3ad506798d11" contextRef="c20220101to20221231" escape="true" continuedAt="Text_5cf6fdd3e2c346138b3b95f7f87eda091">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Stock-Based Compensation</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b998" continuedAt="Text_e8ed8a260bec4f9495765b57570851b999"><ix:continuation id="Text_5cf6fdd3e2c346138b3b95f7f87eda091" continuedAt="Text_5cf6fdd3e2c346138b3b95f7f87eda092">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b999" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9100"><ix:continuation id="Text_5cf6fdd3e2c346138b3b95f7f87eda092">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company recognizes stock-based compensation expense for equity awards granted to employees, directors and certain
        consultants. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-lined basis.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9100" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9101">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9101" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9102"><ix:nonNumeric name="us-gaap:DerivativesMethodsOfAccountingNonhedgingDerivatives" id="Text_80aad676cc3543da99880f689a019949" contextRef="c20220101to20221231" escape="true" continuedAt="Text_34a821e4702b4641944f704f08b331581">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Warrants</span><br />
      </div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9102" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9103"><ix:continuation id="Text_34a821e4702b4641944f704f08b331581" continuedAt="Text_34a821e4702b4641944f704f08b331582">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;"> <br />
        </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9103" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9104"><ix:continuation id="Text_34a821e4702b4641944f704f08b331582">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an
        assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480, <span style="font-style: italic;">Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging.</span> The assessment considers
        whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or meet all of the requirements for equity classification under ASC 815, including whether the warrants are
        indexed to the Company&#8217;s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification. This assessment, which
        requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.<span style="text-decoration: underline;"><br />
        </span></div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9104" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9105">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9105" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9106"><ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Text_ebab9e05a0a34b64914cfb784e536bc2" contextRef="c20220101to20221231" escape="true" continuedAt="Text_69537803e07e407188749a321fca34781">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Recent Accounting Standards</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9106" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9107"><ix:continuation id="Text_69537803e07e407188749a321fca34781" continuedAt="Text_69537803e07e407188749a321fca34782">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="text-decoration: underline;"> </span><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9107" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9108"><ix:continuation id="Text_69537803e07e407188749a321fca34782" continuedAt="Text_69537803e07e407188749a321fca34783">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9108" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9109"><ix:continuation id="Text_69537803e07e407188749a321fca34783" continuedAt="Text_69537803e07e407188749a321fca34784">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;">Newly Adopted Accounting
        Standards:</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9109" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9110"><ix:continuation id="Text_69537803e07e407188749a321fca34784" continuedAt="Text_69537803e07e407188749a321fca34785">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9110" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9111"><ix:continuation id="Text_69537803e07e407188749a321fca34785" continuedAt="Text_69537803e07e407188749a321fca34786">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9111" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9112"><ix:continuation id="Text_69537803e07e407188749a321fca34786" continuedAt="Text_69537803e07e407188749a321fca34787">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9112" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9113"><ix:continuation id="Text_69537803e07e407188749a321fca34787" continuedAt="Text_69537803e07e407188749a321fca34788">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In July 2021, the FASB issued Accounting
        Standards Update (&#8220;ASU&#8221;) 2021-05, <span style="font-style: italic;">Leases (Topic 842) &#8211; Lessors - Certain Leases with Variable Lease Payments,</span> which amends the lessor classification guidance to introduce additional criteria when
        classifying leases with variable lease payments that do not depend on a reference index or a rate. The Company adopted this ASU effective January 1, 2022, which did not have a material impact on its financial statements.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9113" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9114"><ix:continuation id="Text_69537803e07e407188749a321fca34788" continuedAt="Text_69537803e07e407188749a321fca34789">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9114" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9115"><ix:continuation id="Text_69537803e07e407188749a321fca34789" continuedAt="Text_69537803e07e407188749a321fca347810">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9115" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9116"><ix:continuation id="Text_69537803e07e407188749a321fca347810" continuedAt="Text_69537803e07e407188749a321fca347811">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9116" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9117"><ix:continuation id="Text_69537803e07e407188749a321fca347811" continuedAt="Text_69537803e07e407188749a321fca347812">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In May 2021, the FASB issued ASU 2021-04<span style="font-style: italic;">, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40):
          Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options</span>. ASU 2021-04 addresses the accounting for certain modifications or exchanges of freestanding equity-classified written call
        options. The Company adopted this ASU effective January 1, 2022, which did not have a material impact on the Company&#8217;s financial statements.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9117" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9118"><ix:continuation id="Text_69537803e07e407188749a321fca347812" continuedAt="Text_69537803e07e407188749a321fca347813">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9118" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9119"><ix:continuation id="Text_69537803e07e407188749a321fca347813" continuedAt="Text_69537803e07e407188749a321fca347814">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9119" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9120"><ix:continuation id="Text_69537803e07e407188749a321fca347814" continuedAt="Text_69537803e07e407188749a321fca347815">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9120" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9121"><ix:continuation id="Text_69537803e07e407188749a321fca347815" continuedAt="Text_69537803e07e407188749a321fca347816">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In November 2021, the FASB issued ASU
        2021-10, <span style="font-style: italic;">Disclosures by Business Entities about Government Assistance, </span> which requires a business entity to disclose information about certain government assistance that it has received, including (i) the
        type of assistance, (ii) an entity&#8217;s accounting for the assistance and (iii) the effect of the assistance on the entities accounting statements.&#160; The Company adopted this standard effective January 1, 2022, which did not have a material impact on
        the Company&#8217;s financial statements. The Company has approximately $<ix:nonFraction name="us-gaap:IncomeTaxesReceivable" id="Fact_3fa8f00f7f9043b5bc48dfc77028817d" contextRef="c20211231_UnusualOrInfrequentItemAxis_CoronavirusAidReliefAndEconomicSecurityActMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:IncomeTaxesReceivable" id="Fact_6cb1962e20f04d99822d67367c4d82a3" contextRef="c20221231_UnusualOrInfrequentItemAxis_CoronavirusAidReliefAndEconomicSecurityActMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction></ix:nonFraction> million in payroll tax refunds recorded in other receivable on
        the accompanying consolidated balance sheets as of December 31, 2022 and 2021 pursuant to the Employee Retention Credit program under the CARES Act.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9121" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9122"><ix:continuation id="Text_69537803e07e407188749a321fca347816" continuedAt="Text_69537803e07e407188749a321fca347817">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9122" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9123"><ix:continuation id="Text_69537803e07e407188749a321fca347817" continuedAt="Text_69537803e07e407188749a321fca347818">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9123" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9124"><ix:continuation id="Text_69537803e07e407188749a321fca347818" continuedAt="Text_69537803e07e407188749a321fca347819">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9124" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9125"><ix:continuation id="Text_69537803e07e407188749a321fca347819" continuedAt="Text_69537803e07e407188749a321fca347820">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;">Accounting Standards to
        be Adopted:</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9125" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9126"><ix:continuation id="Text_69537803e07e407188749a321fca347820" continuedAt="Text_69537803e07e407188749a321fca347821">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9126" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9127"><ix:continuation id="Text_69537803e07e407188749a321fca347821" continuedAt="Text_69537803e07e407188749a321fca347822">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9127" continuedAt="Text_e8ed8a260bec4f9495765b57570851b9128"><ix:continuation id="Text_69537803e07e407188749a321fca347822" continuedAt="Text_69537803e07e407188749a321fca347823">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e8ed8a260bec4f9495765b57570851b9128"><ix:continuation id="Text_69537803e07e407188749a321fca347823">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">In June 2022, the FASB issued ASU No.
        2022-03, <span style="font-style: italic;">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions </span>(&#8220;ASU 2022-03&#8221;). The FASB issued ASU 2022-03 to (1) clarify the guidance in
        Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new
        disclosure requirements for equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is
        not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years
        with early adoption permitted. The Company is evaluating when to adopt the amendments in ASU 2022-02. The Company does not expect a material impact as a result of adopting this ASU.</div>
</ix:continuation></ix:continuation>

      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-13</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="Text_affbe44113d8430c92fe1e05d1450975" contextRef="c20220101to20221231" escape="true" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e081">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">4)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Merger, Disposition and Acquisition Transactions</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e081" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e082">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e082" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e083">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Merger</div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e083" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e084">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e084" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e085">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e085" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e086">
<div style="display:none;"><br /></div>
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">On
        August 12, 2020, Eterna, Eterna LLC and the Merger Sub entered into the Merger Agreement and consummated the Merger on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which Eterna LLC was deemed the acquiring company for
        accounting purposes. Eterna LLC, as the accounting acquirer, recorded the assets acquired and liabilities assumed of Eterna in the Merger at their fair values as of the acquisition date.</div>
</ix:continuation><ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e086" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e087">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
       <br /></div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e087" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e088">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Eterna LLC was determined to be the accounting acquirer based upon the terms of the Merger and other factors including that (i) Eterna LLC members received common stock in the Merger that represented</span><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_c17727cbd89d4811ba8b4da8476f81a8" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">96.35</ix:nonFraction>% <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">of Eterna&#8217;s outstanding common stock on a fully diluted basis, (ii) all of the directors of Eterna immediately after the Merger were
              designated by Eterna LLC under the terms of the Merger Agreement and (iii) existing members of Eterna LLC&#8217;s management became the management of Eterna immediately after the Merger.</span></span></div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e088" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e089">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e089" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0810">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">At the closing of the Merger, all the outstanding membership interests of Eterna LLC converted into the right to receive an
        aggregate of approximately <ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" id="Fact_2417794a2d164f84956927b50843373e" contextRef="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">1,999,000</ix:nonFraction> shares of common stock, of which <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="Fact_dd6c22be1ee74994a9cf7a33621a9d2e" contextRef="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">53,000</ix:nonFraction> shares were issued as compensation to Eterna LLC&#8217;s financial advisor for its services to Eterna LLC in connection with the Merger.</div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0810" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0811">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0811" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0812">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The purchase price of $<ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" id="Fact_1caa9d0fb50d43f4b629ff9a89132ac8" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">8.2</ix:nonFraction>
        million, which represents the consideration transferred in the Merger to stockholders of Eterna immediately before the Merger, was calculated based on the closing price of $<ix:nonFraction name="us-gaap:BusinessAcquisitionSharePrice" id="Fact_b3729adea0274fe8b79aaa853e748b4b" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">108</ix:nonFraction> per share of common stock for approximately <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_1493f3af1f804d17bf2405ce6f59f4dd" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">76,000</ix:nonFraction> shares
        that those stockholders owned on March 25, 2021 immediately prior to the Merger because that represented a more reliable measure of the fair value of consideration transferred in the Merger.<br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0812" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0813">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0813" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0814">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Under the acquisition method of accounting, the total purchase price has been allocated to the acquired tangible and intangible
        assets and assumed liabilities of Eterna based on their estimated fair values as of March 25, 2021, the Merger closing date. Because the consideration paid by Eterna LLC in the Merger is more than the estimated fair values of Eterna&#8217;s net assets
        deemed to be acquired, goodwill is equal to the difference of approximately $<ix:nonFraction name="us-gaap:Goodwill" id="Fact_37a5ca9bbc6d47d1a714068309ddfefc" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">8.6</ix:nonFraction> million, which has been calculated using the fair values
        of the net assets of Eterna as of March 25, 2021.</div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0814" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0815">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0815" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0816"><ix:nonNumeric name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="Text_9d066e9db16c44f0b50877d1ebe9e227" contextRef="c20220101to20221231" escape="true" continuedAt="Text_899eef172ce140ffb0ec35b2a21266cf1">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The allocation of the purchase price to
        the tangible and intangible assets acquired and liabilities deemed to be assumed from Eterna, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>

      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0816" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0817">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0817" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0818"><ix:continuation id="Text_899eef172ce140ffb0ec35b2a21266cf1">
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Historical Balance<br />
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Sheet of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Eterna at</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 25, 2021</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair Value</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Adjustment to<br />
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Eterna</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Pre-Merger</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Assets</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" colspan="2">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Purchase</div>
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Price</div>
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Allocation<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Cash and cash equivalents</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" id="Fact_df2e60fee30343198174af8f409e2d64" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">148</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" id="Fact_0e906023d6fb4638a2ea287ecdd91f4b" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" id="Fact_1efc876cb8f34d74871dbb90e69d3898" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">148</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Accounts receivable</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_c12b5bf0fbbd439fab40c1121d69de4e" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">103</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_0d092678f1884e32aee877fb383d650b" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_df9ba9c3170241e3ab7dea4a33f3622c" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">103</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Prepaid expense and other current assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" id="Fact_f4d13cb9513c4eabaec8766690a1d2f2" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">329</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" id="Fact_03ccdc2c418d435caf7756c45fa6fa85" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" id="Fact_0778e548ac3c40789fbe258d7e0d2115" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">329</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Property and equipment, net</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" id="Fact_de463661e840477c827d34e55642d50e" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,015</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" id="Fact_dc377a0421e84ddb90cafcf654fe8805" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" id="Fact_3fc7edf645f8430a952da38fe62c45e4" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,015</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Software development costs</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" id="Fact_85f4b80aeedb4fb09b472abb793b8fc6" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,296</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" id="Fact_677de49fc4274c72b3cdf5ba565cb1ca" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">368</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" id="Fact_76cbd7496da14499b53d781feea00b87" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">928</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Customers</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_fa88143e1b3747a980ba655928dc27e3" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_926683e6b88141c69484f4782414aa30" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">548</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_53e30b8c84784e9a9cabb0bab0abec48" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">548</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Trade name</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_21d715b1ae004087ad46d5895c3336c6" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_07dbdf362c7149ed9999a01e441930d3" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">299</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_4837654c2adf447c85af7e05c6678e69" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">299</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Accounts payable, accrued liabilities and other current liabilities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_4903545390344c2bad13962d51621e9b" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,781</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_e114a9dfb0ab4285abc622997dfe0fd9" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_80b6bc7edfb24216a560f163e650983c" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,781</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Net assets acquired, excluding goodwill</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_bfb20e48c2b44cccbb68d8738146f393" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">890</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_91384ea001654080a66d0d607d57fdb4" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">479</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_895926fcba8a4f7287e4164d275f89f8" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">411</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Total consideration</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" id="Fact_fbbb508bae76493299366d5a0c1f2fe8" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,178</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Net assets acquired, excluding goodwill</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_423da4ea4af8481aa45acef8b3524fc1" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">411</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Goodwill</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_b1d54f4a88d9477f86c52e4a5e7bade9" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,589</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0818" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0819">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-14</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0819" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0820">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Eterna LLC was obligated under the Merger Agreement to have $<ix:nonFraction name="erna:ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" id="Fact_f6ab42e138d04f86b1a2c3d69be281ac" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction> million in cash and cash equivalents on its balance sheet at the effective time of the Merger. To ensure Eterna LLC had the required funds, certain beneficial holders of Eterna LLC&#8217;s
        Class A membership interests entered into contractual commitments to invest $<ix:nonFraction name="erna:BeneficialHoldersContractualCommitmentsToInvest" id="Fact_255a3dc219134854821170fb24411524" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction> million into Eterna LLC immediately prior to the
        closing of the Merger. During March 2021, Eterna offered its Class A unit holders an additional <ix:nonFraction name="erna:PercentageOfAdditionalRightsOffering" id="Fact_653a2d2e80d64dfcb909e1b7e52c746b" contextRef="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% rights offering for an additional $<ix:nonFraction name="erna:ProceedsFromSaleOfRights" id="Fact_f5edfb243c4f4525aac7d8e90e37fcc2" contextRef="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction> million to be raised by a rights offering. Eterna received funds from the rights offering between February 17, 2021 and April 5, 2021.</div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0820" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0821">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0821" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0822">
<div style="color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Disposition</div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0822" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0823">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0823" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0824"><ix:nonNumeric name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="Text_ce7246fb9a084f1d95d792a5effb4108" contextRef="c20220101to20221231" escape="true" continuedAt="Text_396cbec589e54e9dae0a656cddbdf30e1">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On March 26, 2021, Eterna sold its rights, title and interest in and to the assets relating to the business it operated (under
        the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $<ix:nonFraction name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" id="Fact_4855ec7934374c378a32371c297c63b0" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction> million and assumption of
        specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of the Disposition are as follows <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">(in thousands)</span>:</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0824" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0825"><ix:continuation id="Text_396cbec589e54e9dae0a656cddbdf30e1" continuedAt="Text_396cbec589e54e9dae0a656cddbdf30e2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0825" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0826"><ix:continuation id="Text_396cbec589e54e9dae0a656cddbdf30e2">
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Proceeds from sale:</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Cash</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" id="Fact_5b92b13117ad4a5d9f610a3bd298c90e" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">132</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Escrow</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" id="Fact_fda03b9ccbad45fe80859698eee269b8" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">50</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Assume advance/loans</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" id="Fact_29008d3ee45841a6ab6d3bcb7d3f7436" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,700</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Interest on advance/loans</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" id="Fact_0db56ecde4aa4dcfb926e61441785c11" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">68</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Carrying value of assets sold:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Cash and cash equivalents</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" id="Fact_3931cf3f6f6141debb687f27230ce3f0" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">14</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Accounts receivable</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" id="Fact_fb617004c8f14998a28b6ecfc1825b88" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">75</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Prepaids and other current assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" id="Fact_70eb23598ef142288d8500d6bab28e53" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">124</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Property and equipment, net</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" id="Fact_43121df3ce124d1eb38943648ee6958c" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,014</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Software development costs</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" id="Fact_6153aeb995564d30ba1addd551420008" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">927</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Customers</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" id="Fact_2c49bd829b874b68a56c0a4ed6dc0d93" contextRef="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">548</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Trade name</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" id="Fact_89a05edbd7e94ace9c3d5c16c24c5904" contextRef="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">299</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Goodwill</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" id="Fact_0a597d115cbc4168b23da3dd09baf83d" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,589</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Other assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" id="Fact_0e4a99ef1d874087b9f7645a55f2db3c" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">103</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Liabilities transferred upon sale:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Accounts payable and accrued expenses</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" id="Fact_9a482438dafe485b8d26db27321d28be" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">113</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Obligations under finance leases</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" id="Fact_6f8813d38d7442d9a00cfbad720cd39c" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">17</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Lease liability</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:DisposalGroupIncludingDiscontinuedOperationLeaseLiability" id="Fact_108c81db092d4cfdb686ddb51ef3bf4f" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">26</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Deferred revenue</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" id="Fact_5256d84bbd5345df9ecd2986dc9dccf5" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">55</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Other current liabilities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" id="Fact_f3c8743c27ad4c5d9316ae303db340bc" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">149</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Transaction costs</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:DisposalGroupIncludingDiscontinuedOperationTransactionCosts" id="Fact_d20260ff9f1548f8890926d741c7358c" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">265</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; padding-bottom: 4px;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Total loss on sale of assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">(<ix:nonFraction name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" id="Fact_52b4f4c50be14347ac0b54fd1674ba73" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">9,648</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">)</div>
            </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0826" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0827">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0827" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0828">
<div style="color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Acquisition</div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0828" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0829">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0829" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0830">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On July 16, 2021, Eterna and Brooklyn Acquisition Sub, Inc. entered into the Novellus Acquisition Agreement. The Novellus
          Acquisition closed contemporaneously with the execution and delivery of the Novellus Acquisition Agreement. At the closing:</div>
</ix:continuation>
        <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0830" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0831">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0831" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0832">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -18pt; margin-left: 36pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; Eterna acquired all of the outstanding equity interests of Novellus as the
          result of the merger of Brooklyn Acquisition Sub, Inc. with and into Novellus, following which, Novellus, as the surviving corporation, became Eterna&#8217;s wholly owned subsidiary and Novellus Limited became Eterna&#8217;s indirectly owned subsidiary; and<span style="color: rgb(0, 0, 0);"><br />
          </span></div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0832" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0833">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0833" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0834">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Eterna acquired <ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" id="Fact_37705f8d38ec4b3781f01cd45f57d85c" contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U005" decimals="3" scale="-2" format="ixt:num-dot-decimal">25.0</ix:nonFraction>% of the total outstanding equity interests of NoveCite.</span></div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0834" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0835">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0835" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0836">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As consideration for the Novellus Acquisition, Eterna paid $<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" id="Fact_bbb22e72c4c449c99a775b218b4ddbef" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">22.9</ix:nonFraction> million in cash and delivered approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" id="Fact_3b75d178a95d4a2b812cac67f19186f9" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">351,000</ix:nonFraction> shares of common stock, which under the terms of the Novellus Acquisition Agreement, were valued at a total of $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_372d16e35426419e8ce7346dbbca4497" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">102.0</ix:nonFraction> million based on an agreed upon price of $<ix:nonFraction name="erna:AssetAcquisitionSharePrice" id="Fact_b35aab21b444471f99c354870a69a705" contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">290.51</ix:nonFraction>
          per share.&#160; At the date of issuance, the fair value of the shares was approximately $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_22bba9598d434dd6846aff37e48c7b52" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">58.7</ix:nonFraction> million.<br />
        </span> </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0836" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0837">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0837" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0838">
<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-15</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0838" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0839">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0839" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0840">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Novellus Acquisition Agreement contained customary representations, warranties and certain indemnification provisions. Approximately <ix:nonFraction name="erna:EscrowShares" id="Fact_20451241abb94c7dbae83c481c76c7b6" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">37,000</ix:nonFraction> of the shares issued as consideration were placed in escrow to secure indemnification obligations to Eterna under the Novellus Acquisition Agreement, and all such shares were released to the sellers in
          July 2022.&#160; The Novellus Acquisition Agreement also contains certain non-competition and non-solicitation provisions pursuant to which Novellus LLC agreed not to engage in certain competitive activities for a period of <ix:nonNumeric name="erna:AcquisitionAgreementNonCompetitivePeriod" id="Fact_98f3ef9a3eab4660acde4ea44ae12b76" contextRef="c20220101to20221231_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric> following the closing, including customary restrictions relating to employees. No employees of Novellus Limited or Novellus prior to the
          Novellus Acquisition continued their employment, or were otherwise engaged by Eterna, immediately following the Novellus Acquisition.<br />
        </span> </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0840" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0841">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0841" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0842">
<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0842" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0843">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0843" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0844">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> In connection with the Novellus Acquisition, the co-founders of Novellus entered into lock-up agreements with respect to approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="Fact_2e18011f02894dbbaeaee754b98458b7" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">169,000</ix:nonFraction> of the shares of common stock received in the Novellus Acquisition, and Eterna&#8217;s Chairman of the Board and its former Chief Executive Officer and President entered into identical lock-up agreements with
          respect to their current holdings of Eterna stock. Each lock-up agreement extends for a period of <ix:nonNumeric name="erna:EachLockUpAgreementExtendsTerm" id="Fact_e194377eb5a94fad88ad9e3c9bdb6836" contextRef="c20220101to20221231_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric>, provided that up to <ix:nonFraction name="erna:PercentageOfCommonStockSubjectToLockUpAgreement" id="Fact_f4b1b6b1559443fc9bebcf2d6ece341a" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">75</ix:nonFraction>% of the shares of common stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock
          on the Nasdaq exceeds specified thresholds. The lock-up agreements include customary exceptions for transfers during the applicable lock-up period.<br />
        </span> </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0844" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0845">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0845" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0846">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0846" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0847">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0847" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0848">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company executed the Novellus Acquisition to advance its evolution into a platform company with a pipeline of next generation mRNA cellular and gene editing programs.<br />
        </span> </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0848" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0849">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0849" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0850">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0850" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0851">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0851" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0852">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Although Eterna acquired all of the outstanding equity interests of Novellus, the Company accounted for the Novellus Acquisition as an asset acquisition (as the assets acquired did not constitute a business as defined in
          ASC Topic 805, <span style="font-style: italic;">Business Combinations</span>), and was measured by the amount of cash paid and by the fair value of the shares of common stock issued. As a result, substantially all of the value acquired was
          attributed to IPR&amp;D, with the exception of the cash paid for the investment in NoveCite, which is being accounted for as an investment in equity securities, as discussed further below.<br />
        </span> </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0852" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0853">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0853" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0854">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0854" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0855">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0855" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0856">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;<span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Eterna paid $<ix:nonFraction name="erna:PaymentsToAcquireProductiveAssetsNet" id="Fact_a233acbe5f514502bbd75f968e1d863a" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">22.9</ix:nonFraction> million
            in cash, net of cash acquired, as part of the consideration for the Novellus Acquisition, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" id="Fact_f625cb69e1934bbc83902cfe0bb572d1" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.0</ix:nonFraction> million was paid in cash for
            the investment in NoveCite. Eterna also issued approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" id="Fact_5672bfe38f6646e391a33cc2f1829a93" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">351,000</ix:nonFraction> shares of the Company&#8217;s common stock, of which approximately <ix:nonFraction name="erna:StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" id="Fact_a461f4ae97f14b159714641b5572ee7a" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">182,000</ix:nonFraction> shares are unrestricted and <ix:nonFraction name="erna:StockIssuedDuringPeriodRestrictedSharesAcquisitions" id="Fact_d29ee4d102994573b6e8b1df06e944bf" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">169,000</ix:nonFraction>
            shares are subject to the <ix:nonNumeric name="erna:LockUpPeriodForRestrictedShares" id="Fact_b99cc2ae9caa4d488170fbb685d9b5d1" contextRef="c20220101to20221231_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" format="ixt-sec:durwordsen">three-year</ix:nonNumeric> lockup. The unrestricted shares were valued at $<ix:nonFraction name="erna:AssetAcquisitionUnrestrictedSharesSharePrice" id="Fact_73aab93f296c436f8da7969996603a74" contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">201</ix:nonFraction> per share, which was the closing price of Eterna&#8217;s common stock on July 16, 2021. The fair value of the restricted shares was discounted by approximately <ix:nonFraction name="erna:PercentageOfDiscountOnFairValueOfRestrictedShares" id="Fact_2203b0ab918d4853b9795e7e3635d4f8" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">35</ix:nonFraction>% to $<ix:nonFraction name="erna:AssetAcquisitionRestrictedSharesSharePrice" id="Fact_5143e0a71b0d4c6b9e6444bb934360b2" contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">130.60</ix:nonFraction> per restricted share,
            which was derived from the average discount rate between the Black Scholes and Finnerty valuation models.</span></span><ix:nonNumeric name="us-gaap:AssetAcquisitionTableTextBlock" id="Text_82e0e11bff704f09a63602ac532be334" contextRef="c20220101to20221231" escape="true" continuedAt="Text_e68f7e153f004fd392dca9ead30c93d81"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The resulting fair value of the asset acquired is as follows (in thousands):</span></span></ix:nonNumeric></div>
</ix:continuation>
      <ix:continuation id="Text_e68f7e153f004fd392dca9ead30c93d81" continuedAt="Text_e68f7e153f004fd392dca9ead30c93d82"><ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0856" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0857">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e68f7e153f004fd392dca9ead30c93d82"><ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0857" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0858">
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair Value of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Consideration</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Cash paid</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" id="Fact_53607202de0448379de6303fa5fea874" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,882</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Cash acquired</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" id="Fact_fb99541e6bf247bc8022dc108661d68b" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">28</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 83.46%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Unrestricted shares</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1.44%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 12.34%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" id="Fact_3022c2720cde401d85966300a4d31358" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">36,628</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 83.46%; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Restricted shares</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" id="Fact_14aec4b4acc44b8cbd976a50df925a9e" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,056</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 83.46%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Total fair value of consideration paid</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1.44%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 12.34%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AssetAcquisitionFairValueOfConsiderationPaid" id="Fact_d6300fcb446e49bf86f39c9566397561" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">81,538</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 83.46%; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Less amount of cash paid for NoveCite investment</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" id="Fact_c4a618efe3454b278535a354dde5c820" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 83.46%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Fair value of IPR&amp;D acquired</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ResearchAndDevelopmentInProcessAssetAcquisition" id="Fact_9bd0c11dc926402ba0c880cbb5a139f4" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">80,538</ix:nonFraction><br />
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0858" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0859">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0859" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0860">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">IPR&amp;D that is acquired through an asset purchase that has no alternative future uses and no separate economic values from
          its original intended purpose is expensed in the period the cost is incurred. Accordingly, the Company expensed the fair value of the IPR&amp;D during the third quarter of 2021 in the amount of $<ix:nonFraction name="erna:ResearchAndDevelopmentInProcessAssetAcquisition" id="Fact_d384157929fd4d0abbdb022c36c5ffc9" contextRef="c20210701to20210930_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">80.5</ix:nonFraction> million.<br />
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0860" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0861">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0861" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0862">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Investment in NoveCite</span></div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0862" continuedAt="Text_0530fbd6acfe43e1ab42cf0fff5a2e0863">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0530fbd6acfe43e1ab42cf0fff5a2e0863">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">As a result of the Novellus Acquisition, Eterna acquired and currently owns <ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" id="Fact_f1f61ae62a124fa7955884c159edb799" contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">25</ix:nonFraction>% of NoveCite, and Citius Pharmaceuticals, Inc. (&#8220;Citius&#8221;) owns the remaining <ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" id="Fact_7a0cb0f857624ee7974e6ac454b7fd23" contextRef="c20210716_OwnershipAxis_CitiusPharmaceuticalsIncMember_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">75</ix:nonFraction>%.
        A member of the Company&#8217;s management is entitled to hold one of <ix:nonFraction name="erna:NumberOfBoardSeats" id="Fact_c8ff41475563408db23121c8d65c3cb1" contextRef="c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U008" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction> board seats on NoveCite&#8217;s board of directors. Citius&#8217; s officers
        and directors hold the other two board seats. The Company is accounting for its interest in NoveCite under ASC Topic 323, <span style="font-style: italic;">Investments &#8211; Equity Method and Joint Ventures.</span> The investment was recorded at cost,
        which was $<ix:nonFraction name="us-gaap:EquityMethodInvestments" id="Fact_d26d29deec634db1bc2e74f749d21531" contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.0</ix:nonFraction> million, and is adjusted for the Company&#8217;s share of NoveCite&#8217;s earnings or losses, which are reflected in the accompanying
        consolidated statements of operations. The investment may also reflect an equity loss in the event that circumstances indicate an other-than-temporary impairment.&#160; For the year ended December 31, 2022, the Company recorded approximately $<ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" id="Fact_0463e72fdae34eb393c12fb13ed77eb3" contextRef="c20220101to20221231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.9</ix:nonFraction> million in losses from its investment in NoveCite, and, of the $<ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" id="Fact_1ca20dbf79d24889b910e2a89ca28756" contextRef="c20220101to20221231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.9</ix:nonFraction> million loss for year ended December 31, 2022, $<ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" id="Fact_33f95b64bbf4415bbcc320dcb5360054" contextRef="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction> million related to NoveCite&#8217;s year ended
        December 31, 2021.&#160; The Company does not guarantee obligations of NoveCite nor is it otherwise committed to provide&#160; financial support for NoveCite.&#160; Therefore, the Company will record losses only up to its investment carrying amount.<br />
      </div>
</ix:continuation>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-16</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:FairValueDisclosuresTextBlock" id="Text_37da32b66e184899b6d646f65abc294e" contextRef="c20220101to20221231" escape="true" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b1">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">5)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Fair Value of Financial Instruments</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b1" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b2" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b3"><ix:nonNumeric name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="Text_d1d410b472cb473a8933d35f428a2c09" contextRef="c20220101to20221231" escape="true" continuedAt="Text_822b7a06bd664039bc70d6c3c40c69be1">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">There were <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_0ffc98c2fb154979b9b42e9f05221925" contextRef="c20211231" unitRef="U001" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> liabilities measured
        at fair value as of December 31, 2021. The following tables summarize the liabilities that are measured at fair value as of December 31, 2022 (in thousands):</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b3" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b4"><ix:continuation id="Text_822b7a06bd664039bc70d6c3c40c69be1" continuedAt="Text_822b7a06bd664039bc70d6c3c40c69be2">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br />
      </div>
</ix:continuation></ix:continuation>
      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b4" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b5"><ix:continuation id="Text_822b7a06bd664039bc70d6c3c40c69be2">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31, 2022</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 1</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 2</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 3</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Liabilities:</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Q1-22 Common Warrants</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_7307f2cc6d634f328406c54b63035838" contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_72412634565f49129d611b5cd50e3787" contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_06f75986463441ebb4289c3f880b04cb" contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">331</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_d1b1594efe634bb59bcb2faa55b2211d" contextRef="c20221231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_c55ca66ed6f7418393665f0c749e44c4" contextRef="c20221231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_ebdcb4007f294bcabd970a22f4c7c3ca" contextRef="c20221231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">331</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b5" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b6">
<div><br />
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b6" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b7">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">On March 9, 2022, upon closing the Q1-22 PIPE Transaction, the Company issued to the Q1-22 PIPE Investor the Q1-22 Pre-Funded Warrants, exercisable
        for approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_86049ca8ac1f4efeba715640a658fbba" contextRef="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">68,000</ix:nonFraction> shares of common stock, and the Q1-22 Common Warrants, exercisable for approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_965bc6302ede4b27881a1305194443a1" contextRef="c20220309_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">343,000</ix:nonFraction> shares of common stock.&#160; On July 12, 2022, the Q1-22 PIPE Investor exercised all of the Q1-22 Pre-Funded Warrants at an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_862ce396c4634a17917ad07b1cbb2853" contextRef="c20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">0.10</ix:nonFraction> per share for an aggregate exercise price of approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" id="Fact_851dcf45c1794682aad239d8c9499fe0" contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction>,000 in cash,&#160; and the Company issued <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_58cf6f0a8ec743a8900d095fe1d9cdda" contextRef="c20220712_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">68,000</ix:nonFraction> shares of common stock to the Q1-22 PIPE Investor upon
        receipt of the cash proceeds.&#160; Following the exercise, <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_f4d8f741bf4749d98ccddacaa6938a4e" contextRef="c20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> Q1-22 Pre-Funded Warrants remained outstanding.&#160; See Note 15 for more
        information related to the Q1-22 PIPE Transaction.<br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b7" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b8">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b8" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b9">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Q1-22 Common Warrants and Q1-22 Pre-Funded Warrants were accounted for as liabilities under ASC 815-40,&#160;</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-style: italic;">Derivatives














          and Hedging, Contracts in Entity&#8217;s Own Equity</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">&#160;(&#8220;ASC 815-40&#8221;), as these warrants
          provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40.&#160; These warrant liabilities were measured at fair value at inception and are then subsequently measured on a recurring
          basis, with changes in fair value presented within the Company&#8217;s statements of operations.</span> </div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b9" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b10">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b10" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b11">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b11" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b12">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b12" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b13">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> The Company uses a Black-Scholes option pricing model to estimate the fair value of the Q1-22 Common Warrants, which is considered a Level 3 fair value measurement.&#160; Certain inputs used in this Black-Scholes pricing model may
          fluctuate in future periods based upon factors that are outside of the Company&#8217;s control.&#160; A significant change in one or more of these inputs used in the calculation of the fair value may cause a significant change to the fair value of the
          Company&#8217;s warrant liabilities, which could also result in material non-cash gains or losses being reported in the Company&#8217;s consolidated statement of operations.<br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b13" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b14">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b14" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b15">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b15" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b16">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b16" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b17">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> The estimated fair value of the Q1-22 Pre-Funded Warrants was deemed a Level 2 measurement as all significant inputs to the valuation model used to estimate the fair value of the Q1-22 Pre-Funded Warrants were directly observable
          from the Company&#8217;s publicly-traded common stock.&#160; Upon exercise of the Q1-22 Pre-Funded Warrants on July 12, 2022, the Company reclassified the approximately $<ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" id="Fact_b5bbb12080d34b528988244fcc14509f" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.9</ix:nonFraction> million fair value of the Pre-Funded Warrants to equity.<br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b17" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b18">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b18" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b19">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b19" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b20">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b20" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b21">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> The fair values of the Q1-22 Common Warrants and the Q1-22 Pre-Funded Warrants at the issuance date totaled $<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_cb74c340f89c44b8a6be3c849980ddc8" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">12.6</ix:nonFraction>
          million in the aggregate, which was $<ix:nonFraction name="erna:OverSubscriptionAmountReceived" id="Fact_b1ec0706ef4840a6a78b337e1f7ddc71" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million more than the $<ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" id="Fact_f6e2188c8d1743df8ca53a6dfcb14f7b" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">12.0</ix:nonFraction> million proceeds received in the Q1-22 PIPE Transaction.&#160; The excess $<ix:nonFraction name="erna:OverSubscriptionAmountReceived" id="Fact_f116a653bf274fef9da6e485468f05d8" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction>
          million represents an inducement to the purchaser to enter into the Q1-22 PIPE Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of operations.<br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b21" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b22">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br />
        </span></div>
</ix:continuation><ix:nonNumeric name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="Text_4cd9c85c76984f399a48923ac3aac313" contextRef="c20220101to20221231" escape="true" continuedAt="Text_fe10be4a620d41ab8e550ea17bf013ef1"><ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b22" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b23">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
      </div>
</ix:continuation></ix:nonNumeric>
      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <ix:continuation id="Text_fe10be4a620d41ab8e550ea17bf013ef1" continuedAt="Text_fe10be4a620d41ab8e550ea17bf013ef2"><ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b23" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b24">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;"> <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);">The Company remeasured the fair value of the Q1-22 Common Warrants as of
                December 31, 2022. The following table presents the changes in the warrant liabilities from the issuance date (in thousands):</span></span></span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_fe10be4a620d41ab8e550ea17bf013ef2" continuedAt="Text_fe10be4a620d41ab8e550ea17bf013ef3"><ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b24" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b25">
<div><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);"> <br />
              </span></span></span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_fe10be4a620d41ab8e550ea17bf013ef3" continuedAt="Text_fe10be4a620d41ab8e550ea17bf013ef4"><ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b25" continuedAt="Text_4fa2981cb6e24162a95a9fcf3461b61b26">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;"><br />
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Q1-22</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pre-Funded </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Warrants</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Level 2)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Q1-22 </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Warrants</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Level 3)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Warrant<br />
                </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Liabilities</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at January 1, 2022</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_e5bdef7f05164665b8b73ba2f7c41a6b" contextRef="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_46a9a7e1d3384fd6a13800de9750db17" contextRef="c20211231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_49a6d84b66cf451888709573ed10a17e" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at March 9, 2022 (issuance date)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_a8766fcc6171451aaafa816f2edef0d1" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,646</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_333bb6bcb0df4a48973af904fe87ed23" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,943</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_d49ca972a9be45a096747c6d43b7845d" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,589</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in fair value of warrant liabilities</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" id="Fact_713654cd4d014070976ab5817050ef97" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,779</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" id="Fact_0a698463008941b8bd3ec8815093ed68" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">9,612</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" id="Fact_5b1f03d928d14dce9e2bcf13e2e46838" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">11,391</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Exercise of Q1-22 Pre-Funded Warrants</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" id="Fact_892906dba43041ea966dd0f55c6dec35" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">867</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" id="Fact_fb35795132b74d11b1e2fdaee52c41cc" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" id="Fact_18cc741a58124f59b24dc4cc453dd355" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">867</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at December 31, 2022</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_07acac25f6364630adde4603d4e54a73" contextRef="c20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_48de475c55ff4e79ba91846c090d22a1" contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">331</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_5b115fab52934bc4817f181334f828ea" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">331</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_fe10be4a620d41ab8e550ea17bf013ef4"><ix:continuation id="Text_4fa2981cb6e24162a95a9fcf3461b61b26">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> </span></div>
</ix:continuation></ix:continuation></div>

      <div>
        <div> </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-17</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="Text_04f70f6d71f24cdaa97b8877306a3d65" contextRef="c20220101to20221231" escape="true" continuedAt="Text_ec8a44072905460fb85ff103bfe1e4611">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">6)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Property and Equipment</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <div>
        <ix:continuation id="Text_ec8a44072905460fb85ff103bfe1e4611" continuedAt="Text_ec8a44072905460fb85ff103bfe1e4612">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
      </div>


      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_ec8a44072905460fb85ff103bfe1e4612" continuedAt="Text_ec8a44072905460fb85ff103bfe1e4613"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="Text_d6baae7027f6405f93a110b8d03de481" contextRef="c20220101to20221231" escape="true" continuedAt="Text_b1e6a7e9c3284c828061744ecfe4f8c81">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Property and equipment consist of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation>
      </div>

      <ix:continuation id="Text_ec8a44072905460fb85ff103bfe1e4613" continuedAt="Text_ec8a44072905460fb85ff103bfe1e4614"><ix:continuation id="Text_b1e6a7e9c3284c828061744ecfe4f8c81" continuedAt="Text_b1e6a7e9c3284c828061744ecfe4f8c82">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_ec8a44072905460fb85ff103bfe1e4614" continuedAt="Text_ec8a44072905460fb85ff103bfe1e4615"><ix:continuation id="Text_b1e6a7e9c3284c828061744ecfe4f8c82">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,<br />
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Laboratory and manufacturing equipment</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_330a19d003e64ffeaf752973f08fbcf9" contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">28</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_cc68246183c249a9ad1850f3f09b4d26" contextRef="c20211231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">258</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="color: rgb(0, 0, 0);">Leasehold improvements<br />
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_717211d7e35d48f1969608c5f3616e2c" contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_f3240e5512f04c7aa379362617a312ea" contextRef="c20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">464</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">Computer equipment and programs</div>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_39eca011b32b47b2b309303c39d94e37" contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">240</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_e343c90c44524bc18626bbaf3f276e3e" contextRef="c20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">155</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_7b3501df5c4f4290b55e92d82a7a0854" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">268</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_806a995bb99944aa9a036df1d2fc3b66" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">877</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Less accumulated depreciation and amortization</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" id="Fact_df75fb3bcd8d486b973092faedb0146c" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">32</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" id="Fact_40e86deab4b546d4a61f584e8ad41637" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">207</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
              <div style="color: rgb(0, 0, 0);">Property and equipment, net</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_3070d91807b9488f8cbf301e34fcce3b" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">236</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_bdb214ad875341bd80f7a9ce9d22c262" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">670</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_ec8a44072905460fb85ff103bfe1e4615" continuedAt="Text_ec8a44072905460fb85ff103bfe1e4616">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_ec8a44072905460fb85ff103bfe1e4616" continuedAt="Text_ec8a44072905460fb85ff103bfe1e4617">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">During the year ended December 31, 2022, the Company consolidated its research and development activities in Cambridge,
        Massachusetts and entered into lease termination agreements for its Brooklyn, New York and San Diego, California facilities. (See Note 7 for more information on lease terminations.)&#160; As a result, the Company disposed of certain assets it would no
        longer use and recognized a loss on disposal of fixed assets of approximately $<ix:nonFraction name="erna:GainLossOnDisposalOfFixedAssets" id="Fact_3c914b6914e04441a8cedb54750b4f57" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million, which was composed of $<ix:nonFraction name="erna:RemainingNetBookValueOfFixedAssets" id="Fact_b0761f1b1ba146edabb1d5f75206aba5" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million in remaining net book value of such assets, offset by proceeds received from selling certain fixed assets for approximately $<ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" id="Fact_5f0e3bf2b28345cbbd62f77517a259e8" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million. </div>
</ix:continuation>
      <ix:continuation id="Text_ec8a44072905460fb85ff103bfe1e4617" continuedAt="Text_ec8a44072905460fb85ff103bfe1e4618">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_ec8a44072905460fb85ff103bfe1e4618">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Depreciation expense totaled $<ix:nonFraction name="us-gaap:Depreciation" id="Fact_2344b4c1e61844e389a4b2660e041f09" contextRef="c20220101to20221231" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">161,000</ix:nonFraction>
        and $<ix:nonFraction name="us-gaap:Depreciation" id="Fact_6054f0f9dd204838971c4fbad1d27691" contextRef="c20210101to20211231" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">117,000</ix:nonFraction> for the years ended December 31, 2022 and 2021, respectively. No depreciation expense is recorded on fixed assets in process
        until such time as the assets are completed and are placed into service.</div>
</ix:continuation>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:LesseeOperatingLeasesTextBlock" id="Text_78e995807758407d9d97f05dc600df1c" contextRef="c20220101to20221231" escape="true" continuedAt="Text_f489aa8011644cea99cd9829553f63001">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">7)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Leases</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <div>
        <ix:continuation id="Text_f489aa8011644cea99cd9829553f63001" continuedAt="Text_f489aa8011644cea99cd9829553f63002">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_f489aa8011644cea99cd9829553f63002" continuedAt="Text_f489aa8011644cea99cd9829553f63003">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he </span>Company has operating leases for office and
        laboratory space in the borough of Manhattan in New York, New York, in Cambridge, Massachusetts and in Somerville, Massachusetts, which expire in 2026, 2028, and 2032 respectively<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f63003" continuedAt="Text_f489aa8011644cea99cd9829553f63004">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f63004" continuedAt="Text_f489aa8011644cea99cd9829553f63005">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company also leased a facility in Brooklyn, New York (the &#8220;Brooklyn Lease&#8221;). On March 5, 2022, the Company entered into an
        agreement to assign the Brooklyn Lease to Regen Lab USA LLC (&#8220;Regen&#8221;).&#160; Regen agreed to purchase certain equipment from the Company for $<ix:nonFraction name="erna:LesseeCommitmentToPurchaseProperty" id="Fact_e91821115ce54409917749435483b760" contextRef="c20220305" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">50,000</ix:nonFraction>,
        which partially reimbursed the Company for certain existing unamortized leasehold improvements, and to reimburse the Company for the existing security deposit the Company had under the Brooklyn Lease of approximately $<ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" id="Fact_28400bc1fbc049d584ee25ff6e98a031" contextRef="c20220305" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">63,000</ix:nonFraction>.</div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f63005" continuedAt="Text_f489aa8011644cea99cd9829553f63006">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f63006" continuedAt="Text_f489aa8011644cea99cd9829553f63007">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On March 25, 2022, the Company entered into an Assignment and Assumption of Lease Agreement (the &#8220;Assignment Agreement&#8221;) with
        Regen. The effective date of the assignment was March 28, 2022.&#160; Under the Assignment Agreement, Regen assumed all of the obligations, liabilities, covenants and conditions of the Company as tenant under the Brooklyn Lease.&#160; As a result of the
        lease assignment, the Company wrote off the remaining ROU asset balance of approximately $<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_c4706f1f967d48ad98495effec51b69d" contextRef="c20220325" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.4</ix:nonFraction> million and the corresponding lease
        liability of approximately $<ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_cb6858fdd0984d1ba6d67317aad140fa" contextRef="c20220325" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.5</ix:nonFraction> million.</div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f63007" continuedAt="Text_f489aa8011644cea99cd9829553f63008">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f63008" continuedAt="Text_f489aa8011644cea99cd9829553f63009">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On March 31, 2022, the Company entered into a facility lease in San Diego, California (the &#8220;San Diego Lease&#8221;) with Torrey Pines
        Science Center Limited Partnership for approximately <ix:nonFraction name="erna:OperatingLeaseArea" id="Fact_dde15d4673de4167b065962b46b2f092" contextRef="c20220331" unitRef="U006" decimals="0" scale="0" format="ixt:num-dot-decimal">5,200</ix:nonFraction> square feet of laboratory and office space.&#160; The term of the San Diego Lease
        was <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseTermOfContract" id="Fact_ac0621d1740b4392a1db4e13f43d80d7" contextRef="c20221231" format="ixt-sec:durmonth">62</ix:nonNumeric> months and the lease commencement date was April 19, 2022. The Company recorded a $<ix:nonFraction name="erna:InitialMeasurementOfOperatingLeaseROUAssets" id="Fact_010f920ee1d54527addb15cb440ef04c" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.7</ix:nonFraction> million ROU asset and $<ix:nonFraction name="erna:InitialMeasurementOfOperatingLeaseLiabilities" id="Fact_719df252a6d542a0b889d33f877b893e" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.7</ix:nonFraction> million lease liabilities for the
        San Diego Lease.</div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f63009" continuedAt="Text_f489aa8011644cea99cd9829553f630010">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630010" continuedAt="Text_f489aa8011644cea99cd9829553f630011">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">During 2022, the Company decided to consolidate its research and
          development efforts in Cambridge, Massachusetts, and the Company determined to sublease the San Diego </span>laboratory<span style="font-size: 10pt; font-family: 'Times New Roman';"> and office space.&#160; As a result, the Company recognized an
          impairment charge of approximately $<ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" id="Fact_4fd82ef30bda4679b6e92357dc875572" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.8</ix:nonFraction> million on the San Diego Lease ROU asset during 2022, which is recorded in general and
          administrative expense on the consolidated statements of operations.</span></div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630011" continuedAt="Text_f489aa8011644cea99cd9829553f630012">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630012" continuedAt="Text_f489aa8011644cea99cd9829553f630013">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On November 30, 2022, the Company and the lessor of the San Diego Lease entered into a lease termination agreement, as amended
        on December 29, 2022 (the &#8220;Lease Termination Agreement&#8221;), pursuant to which the lessor agreed to terminate the San Diego lease effective January 31, 2023 provided that (i) the Company pay a $<ix:nonFraction name="erna:LeaseTerminationFeePayable" id="Fact_9ed37d47cbd840ec8b35989281332f81" contextRef="c20221229" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million lease termination fee and (ii) the lessor was able to enter into a new lease for the space with a new tenant by January 15, 2023.&#160; On January 9, 2023, the lessor
        provided notice to the Company that it had entered into a new lease with a new tenant, and the Company paid the $<ix:nonFraction name="erna:LeaseTerminationFee" id="Fact_8b0c61eba14b4af9895aa58902d7356b" contextRef="c20230109to20230109_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million termination
        fee.&#160; As a result, the San Diego Lease terminated on January 31, 2023.</div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630013" continuedAt="Text_f489aa8011644cea99cd9829553f630014">
<div><br />
      </div>
</ix:continuation>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-18</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630014" continuedAt="Text_f489aa8011644cea99cd9829553f630015">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Lease Termination Agreement was accounted for as a modification to the San Diego Lease rather than as a lease termination
        because the Company did not contemporaneously terminate the San Diego Lease upon the November 30, 2022 modification date and had a continued right-of-use of the facility through January 31, 2023.&#160; As a result, the Company remeasured the remaining
        lease payments, including the $<ix:nonFraction name="erna:LeaseTerminationFeePayable" id="Fact_b64ccdb89b6f47078db9633266d5c2e5" contextRef="c20221229" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million termination fee, and reduced the lease liability the Company had on its balance sheet at the
        time of the modification by approximately $<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" id="Fact_1b889a0d3c3543bd93875e0cdfe1e2d8" contextRef="c20221229to20221229" unitRef="U001" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal">1.4</ix:nonFraction> million to the present value of the remeasured lease liability of approximately $<ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_24fb0e0a422a4d0b845f02261d076136" contextRef="c20221229" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million.&#160; For a lease modification that is not accounted for as a separate contract, a lessee recognizes the amount of the remeasured lease
        liability as an adjustment to the corresponding ROU asset without affecting profit or loss.&#160; However, because the ROU asset balance as of the modification date was only $<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_fe18cd9fd1324065bc6a93131593ace0" contextRef="c20221229" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.8</ix:nonFraction> million due to the impairment charge of $<ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" id="Fact_c7eb8c79e244468e946c9803f81d88e0" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.8</ix:nonFraction> million the Company recognized during the second
        quarter of 2022 (as discussed above), the Company reduced the ROU asset to <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_b6a5d1818cee43d897455a2cc2ca9e8e" contextRef="c20220630" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen">zero</ix:nonFraction>, and the remaining $<ix:nonFraction name="erna:LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" id="Fact_145b210d76f5436f80fe3485661f4ab9" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million of the $<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_dae2e78d87cc4d9898b88b36c7bd7834" contextRef="c20220325" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.4</ix:nonFraction> million
        adjustment was recognized as a credit to general and administrative expense on the consolidated statement of operations for the year ended December 31, 2022.</div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630015" continuedAt="Text_f489aa8011644cea99cd9829553f630016">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630016" continuedAt="Text_f489aa8011644cea99cd9829553f630017">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On October 18, 2022, the Company entered into the Sublease with E.R. Squibb &amp; Sons, L.L.C., a Delaware limited liability
        company and subsidiary of Bristol-Myers Squibb Company (&#8220;Sublessor&#8221;), for office, laboratory and research and development space (the &#8220;Premises&#8221;). The Premises consist of approximately <ix:nonFraction name="us-gaap:AreaOfRealEstateProperty" id="Fact_24fa6449ff594f16ae10d25bae25605b" contextRef="c20221018_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U006" decimals="0" scale="0" format="ixt:num-dot-decimal">45,500</ix:nonFraction> square feet on the ninth floor of the building currently under construction located at 250 Water Street, Somerville, Massachusetts 02141.</div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630017" continuedAt="Text_f489aa8011644cea99cd9829553f630018">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630018" continuedAt="Text_f489aa8011644cea99cd9829553f630019">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Payments of the Sublease rent commence on the date that is the earlier of (i) the date that the Company commences business
        operations from the Premises and (ii) the one-year anniversary of the date that Sublessor obtained the primary landlord&#8217;s consent for the Sublease, which was November 29, 2022 (such applicable date, the &#8220;Rent Commencement Date&#8221;). The Sublease has a
        term of <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseTermOfContract" id="Fact_21efca9824da4ee99a1b41123c3442ea" contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" format="ixt-sec:duryear">10</ix:nonNumeric> years from the Rent Commencement Date (the &#8220;Term&#8221;), subject to a <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="Fact_2f86dfa8e5a240da8609cc76cac63b32" contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" format="ixt-sec:durwordsen">five-year</ix:nonNumeric> extension in accordance with the terms of the Sublease.</div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630019" continuedAt="Text_f489aa8011644cea99cd9829553f630020">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630020" continuedAt="Text_f489aa8011644cea99cd9829553f630021">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the Sublease, the Company paid the Sublessor a security deposit in the form of a letter of credit in the amount of
        approximately $<ix:nonFraction name="us-gaap:LineOfCredit" id="Fact_52b1b0deb7c14801a8f3b9a2abfc8d18" contextRef="c20221018_PledgingPurposeAxis_LetterOfCreditMember_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.1</ix:nonFraction> million. Provided there are no events of default by the Company under the Sublease, the letter of credit will be
        reduced on an incremental basis throughout the Term. Pursuant to the Sublease, the Company has agreed to pay base rent of approximately $<ix:nonFraction name="erna:OperatingLeasesMonthlyBaseRent" id="Fact_5a7e226cebdc4b8db69f7cc7592b78f0" contextRef="c20221018to20221018_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction>
        million per month during the first year of the Term, increasing on an incremental basis each subsequent year of the Term for a total of approximately $<ix:nonFraction name="erna:OperatingLeasesIncrementalBaseRentalPayment" id="Fact_1108b0c293284e99ae653fb206695184" contextRef="c20221018_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">63.0</ix:nonFraction>
        million in base rental payments, as well as parking and traditional lease expenses, including certain taxes, operating expenses and utilities.</div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630021" continuedAt="Text_f489aa8011644cea99cd9829553f630022">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630022" continuedAt="Text_f489aa8011644cea99cd9829553f630023">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the Sublease, the Sublessor will provide the Company with a tenant improvement allowance of $<ix:nonFraction name="erna:TenantImprovementAllowancePerRentableSquareFoot" id="Fact_e61a172178014745b159fe7721dd5013" contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">190</ix:nonFraction> per rentable square foot, or $<ix:nonFraction name="erna:TenantImprovementAllowance" id="Fact_2f15e8abb85547b3b77fe7c2cd0a7b2b" contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">8.6</ix:nonFraction>
        million.&#160; Tenant improvements to the Premises in excess of this amount, if any, will be at the Company&#8217;s own cost. As of December 31, 2022, the Premises had not been made available for the Company to begin the construction of the tenant
        improvements.&#160; It is expected that the Premises will be made available to begin the construction in March or April 2023, and it is anticipated that the construction will be complete and ready for operational use in November or December 2023.&#160; As a
        result, the commencement date of the Sublease did not occur as of December 31, 2022, and accordingly, the Company did <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_6b7e59e88d16443ab0be4e1fede1a87d" contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_0d2657ff7d8d45b694bb8b68569be611" contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>t recognize
        a lease liability and corresponding ROU asset for the Sublease as of December 31, 2022.</div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630023" continuedAt="Text_f489aa8011644cea99cd9829553f630024">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630024" continuedAt="Text_f489aa8011644cea99cd9829553f630025">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of December 31, 2022, the Company had incurred approximately $<ix:nonFraction name="erna:SubleaseCost" id="Fact_1e5c366fcc054918bc7511e0b3afefd9" contextRef="c20221231_BalanceSheetLocationAxis_OtherNoncurrentAssetsMember_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million in costs in connection with the Sublease, which consisted of approximately $<ix:nonFraction name="erna:SubleaseCostForTenantImprovements" id="Fact_ed111a1202bf47eaae5381bda7017d61" contextRef="c20221231_BalanceSheetLocationAxis_OtherNoncurrentAssetsMember_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction> million for the architect to design the tenant improvements to the Premises and for a project manager to manage the construction of the tenant improvements as well as approximately $<ix:nonFraction name="erna:CostRelatedToIssuanceOfLetterOfCredit" id="Fact_44cab13e85644cc5a65525e0e8c00765" contextRef="c20221231_BalanceSheetLocationAxis_OtherNoncurrentAssetsMember_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million in bank fees related to the issuance of the letter of credit discussed above.&#160; These costs are recorded in other assets in the accompanying
        consolidated balance sheet as of December 31, 2022.</div>
</ix:continuation>
      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630025" continuedAt="Text_f489aa8011644cea99cd9829553f630026">
<div> <br />
      </div>
</ix:continuation>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <div>
            <ix:continuation id="Text_f489aa8011644cea99cd9829553f630026" continuedAt="Text_f489aa8011644cea99cd9829553f630027"><ix:nonNumeric name="us-gaap:LeaseCostTableTextBlock" id="Text_48e17f2ddd0d43088c17bf4695ba7c4a" contextRef="c20220101to20221231" escape="true" continuedAt="Text_ce6db1ddd08d43b5abdad66c415baee01">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For the years ended December 31, 2022 and 2021, the net operating lease expenses were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          </div>

        </div>

        <ix:continuation id="Text_f489aa8011644cea99cd9829553f630027" continuedAt="Text_f489aa8011644cea99cd9829553f630028"><ix:continuation id="Text_ce6db1ddd08d43b5abdad66c415baee01" continuedAt="Text_ce6db1ddd08d43b5abdad66c415baee02">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630028" continuedAt="Text_f489aa8011644cea99cd9829553f630029"><ix:continuation id="Text_ce6db1ddd08d43b5abdad66c415baee02">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Years ended December 31,</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2021</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Operating lease expense</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_c9e363e463724369a3065ad9d1c471a4" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">595</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_5e20e410669444118170b1825b58e270" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">688</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Sublease income</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:SubleaseIncome" id="Fact_0f3798459d434cfda5b2fd8b5e77392d" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">84</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:SubleaseIncome" id="Fact_99ad558b94a749138e02191b597e0a86" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">84</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Variable lease expense</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_f3c0e28d2a3048129cf42abe0b7e658d" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">150</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_010c36b639d240669a4a4ffb854a3b9d" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">19</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Total lease expense</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_4b053b65301140cb8d1640b9a358bee2" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">661</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_529c7b0f65fb47859e41815c64394055" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">623</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <div>
        <ix:continuation id="Text_f489aa8011644cea99cd9829553f630029" continuedAt="Text_f489aa8011644cea99cd9829553f630030">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-19</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="BRPFPageHeader">
            <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
            </div>

          </div>

        </div>

      </div>


      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_f489aa8011644cea99cd9829553f630030" continuedAt="Text_f489aa8011644cea99cd9829553f630031"><ix:nonNumeric name="erna:OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" id="Text_a21c6faafd8b41f3b40b59e2c3ab2115" contextRef="c20220101to20221231" escape="true" continuedAt="Text_f90666652041431d810b1106d5e8a2941">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2022 and
            the ending balances as of December 31, 2022, including the changes during the period (in thousands).</div>
</ix:nonNumeric></ix:continuation>
        </div>

        <ix:continuation id="Text_f489aa8011644cea99cd9829553f630031" continuedAt="Text_f489aa8011644cea99cd9829553f630032"><ix:continuation id="Text_f90666652041431d810b1106d5e8a2941" continuedAt="Text_f90666652041431d810b1106d5e8a2942">
<div><br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_f489aa8011644cea99cd9829553f630032" continuedAt="Text_f489aa8011644cea99cd9829553f630033"><ix:continuation id="Text_f90666652041431d810b1106d5e8a2942" continuedAt="Text_f90666652041431d810b1106d5e8a2943">
<table cellspacing="0" cellpadding="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operating </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Lease</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">ROU Assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">Operating lease ROU assets at January 1, 2022</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_6aab0bd0b5c541868dec52b8076c6050" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,567</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Initial measurement of ROU asset</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:InitialMeasurementOfOperatingLeaseROUAssets" id="Fact_074853c096274371b493c1b541571492" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,706</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Amortization of operating lease ROU assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" id="Fact_02b73af7552c4cdd9a963ec91e256300" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">336</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Impairment of ROU asset</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" id="Fact_c217a6a2ddde44cda806b4898670a876" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">772</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Remeasurment of ROU asset</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:RemeasurementOfOperatingLeaseRightOfUseAsset" id="Fact_68919775903a4717b9350fcd0dc0a7f0" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">813</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Reclassification from fixed assets to ROU assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ReclassificationFromFixedAssetsToRightOfUseAsset" id="Fact_cce457ac6cd145349b4078ad017d23ba" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">50</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Write off of ROU asset due to lease termination</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:WriteOffOfOperatingLeaseRightOfUseAsset" id="Fact_373f06d41e0c400f86a43e94a98c60ae" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,372</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">Operating lease ROU assets at December 31, 2022</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_865ca52e61d34b54ad3fd4ce466e04b8" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,030</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_f489aa8011644cea99cd9829553f630033" continuedAt="Text_f489aa8011644cea99cd9829553f630034"><ix:continuation id="Text_f90666652041431d810b1106d5e8a2943" continuedAt="Text_f90666652041431d810b1106d5e8a2944">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_f489aa8011644cea99cd9829553f630034" continuedAt="Text_f489aa8011644cea99cd9829553f630035"><ix:continuation id="Text_f90666652041431d810b1106d5e8a2944">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellspacing="0" cellpadding="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operating</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Lease</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Liabilities</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Operating lease liabilities at January 1, 2022</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_058b3b868ff9402494d8d859d0395027" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,723</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Initial measurement of operating lease liabilities</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:InitialMeasurementOfOperatingLeaseLiabilities" id="Fact_d0620834aa5647c5bcddeb520a5ad540" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,706</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Principal payments on operating lease liabilties</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:PrincipalPaymentsOnOperatingLeaseLiabilities" id="Fact_69986d0e447e471399a3cc7f0f335955" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">340</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Remeasurment of lease liability</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:RemeasurementOfOperatingLeaseLiability" id="Fact_711e28c2dcfd491c9a2ef1b1389d4249" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,454</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Write off of lease liability due to lease termination</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:WriteOffOfOperatingLeaseLiability" id="Fact_af966742a2864121adf289d83aaf1e95" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,453</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Operating lease liabilities at December 31, 2022</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_152a7aae43224e6689c342999fefd44b" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,182</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Less non-current portion</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_fa584694b50f423ba53bbfbc425108b9" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">887</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Current portion at December 31, 2022</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_29b0d2c384944bcebe2a222b337640ac" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">295</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
        </div>
</ix:continuation></ix:continuation>
      </div>


      <div>
        <ix:continuation id="Text_f489aa8011644cea99cd9829553f630035" continuedAt="Text_f489aa8011644cea99cd9829553f630036">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_f489aa8011644cea99cd9829553f630036" continuedAt="Text_f489aa8011644cea99cd9829553f630037">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of December 31, 2022, the Company&#8217;s operating leases had a weighted-average remaining life of <ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Fact_ac644f82de1645088f405552b1fb92e7" contextRef="c20221231" format="ixt-sec:duryear">4.5</ix:nonNumeric> years with a weighted-average discount rate of <ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" id="Fact_ddac135ce567429a871f47e3f5a763a5" contextRef="c20221231" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">9.98</ix:nonFraction>%.
          <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="Text_e03d0948964e4f94bf38b0d419663594" contextRef="c20220101to20221231" escape="true" continuedAt="Text_5370a8721dbb4da39dbee6b96a42124b1"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The maturities of the
          operating lease liabilities are as follows (in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_5370a8721dbb4da39dbee6b96a42124b1" continuedAt="Text_5370a8721dbb4da39dbee6b96a42124b2"><ix:continuation id="Text_f489aa8011644cea99cd9829553f630037" continuedAt="Text_f489aa8011644cea99cd9829553f630038">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_5370a8721dbb4da39dbee6b96a42124b2"><ix:continuation id="Text_f489aa8011644cea99cd9829553f630038" continuedAt="Text_f489aa8011644cea99cd9829553f630039">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br />
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2023</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" id="Fact_02a4a5a179144f25badc714cacdc40f7" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">403</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2024</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" id="Fact_1ce5e45016be430a91b10fde9c5e4ab4" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">272</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2025</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" id="Fact_60f32a333d89420090c160cd98130dd0" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">274</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2026</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" id="Fact_7e9e19f1f0dc4540ba9b7ecaedbde6b4" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">267</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2027</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" id="Fact_70cf059c96864313800356418acfb2c3" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">163</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Thereafter</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" id="Fact_61ca46739f7f44608c5736e21f0378d3" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">82</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Total payments</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" id="Fact_599484458f3d4f89a2c1770dcbde39b8" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,461</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Less imputed interest</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" id="Fact_2f50445dadd0457ea5a2e137dc596ded" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">279</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Total operating lease liabilities</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_c6a71605e9f04b8c88a9df250a5131ab" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,182</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_f489aa8011644cea99cd9829553f630039" continuedAt="Text_f489aa8011644cea99cd9829553f630040">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_f489aa8011644cea99cd9829553f630040" continuedAt="Text_f489aa8011644cea99cd9829553f630041">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The maturities of the operating lease liabilities show in the table above does not include future payments due under the
            Sublease that the Company entered into in October 2022, as the commencement date of the Sublease had not begun as of December 31, 2022, and therefore, the Company did <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_fc5926badd0e45409fc03e2e39bf593f" contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_69fe541da62445a2a24c3b83f6178141" contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>t record a corresponding lease liability and ROU asset.</div>
</ix:continuation>
          <ix:continuation id="Text_f489aa8011644cea99cd9829553f630041" continuedAt="Text_f489aa8011644cea99cd9829553f630042">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
          </div>
</ix:continuation>
          <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div>
              <ix:continuation id="Text_f489aa8011644cea99cd9829553f630042" continuedAt="Text_f489aa8011644cea99cd9829553f630043">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Sublease Agreement</div>
</ix:continuation>
              <ix:continuation id="Text_f489aa8011644cea99cd9829553f630043" continuedAt="Text_f489aa8011644cea99cd9829553f630044">
<div><br />
              </div>
</ix:continuation>
            </div>

            <ix:continuation id="Text_f489aa8011644cea99cd9829553f630044" continuedAt="Text_f489aa8011644cea99cd9829553f630045">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">In April 2019, the Company entered into a sublease agreement with Nezu Asia Capital Management, LLC
              (the &#8220;Tenant&#8221;), whereby the Tenant agreed to sublease approximately <ix:nonFraction name="erna:AreaOfSubleaseSpaceCurrentlyRented" id="Fact_223b9f91406d4ea9b3c6d90f099ca8b9" contextRef="c20190418" unitRef="U006" decimals="0" scale="0" format="ixt:num-dot-decimal">999</ix:nonFraction> square feet of space currently rented by the Company in
              the borough of Manhattan in New York, New York commencing on May 15, 2019. The term of this sublease expires on October 31, 2026 with no option to extend the sublease term. Rent payments provided by the Tenant under the sublease agreement
              began on September 1, 2019. The sublease agreement stipulates an annual rent increase of <ix:nonFraction name="erna:PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" id="Fact_bdc0edf3750b40e19d20998981d97344" contextRef="c20190418to20190418" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">2.25</ix:nonFraction>%. The Tenant is also responsible for
              paying to the Company all tenant energy costs, annual operating costs, and annual tax costs attributable to the subleased space during the term of the sublease.</div>
</ix:continuation>
            <div>
              <ix:continuation id="Text_f489aa8011644cea99cd9829553f630045" continuedAt="Text_f489aa8011644cea99cd9829553f630046">
<div><br />
              </div>
</ix:continuation>
            </div>

            <ix:continuation id="Text_f489aa8011644cea99cd9829553f630046" continuedAt="Text_f489aa8011644cea99cd9829553f630047">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company received sublease payments of approximately $<ix:nonFraction name="us-gaap:ProceedsFromLeasePayments" id="Fact_665ddcf16c5f4c7f89549d9dfe276f23" contextRef="c20210101to20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:ProceedsFromLeasePayments" id="Fact_fc9713abc05c48f180775fe9df2f0cbc" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction></ix:nonFraction> million for each of the years ended December 31, 2022 and 2021, respectively. In accordance with ASC Topic 842, the Company treats the sublease as a separate
              lease, as the Company was not relieved of the primary obligation under the original lease. The Company continues to account for the Manhattan lease as a lessee and in the same manner as prior to the commencement date of the sublease. The
              Company accounts for the sublease as a lessor of the lease. The sublease is classified as an operating lease, as it does not meet the criteria of a sale-type or direct financing lease.</div>
</ix:continuation>
            <ix:continuation id="Text_f489aa8011644cea99cd9829553f630047" continuedAt="Text_f489aa8011644cea99cd9829553f630048">
<div><br />
            </div>
</ix:continuation>

            <ix:continuation id="Text_f489aa8011644cea99cd9829553f630048" continuedAt="Text_f489aa8011644cea99cd9829553f630049"><ix:nonNumeric name="erna:FutureLeasePaymentsSubleaseAgreementTableTextBlock" id="Text_75b8b2d545f54483bf68ce80fe030d20" contextRef="c20220101to20221231" escape="true" continuedAt="Text_37b017fa54234d2c9b072e6eea17665b1">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">The following tables shows the future payments the Company expects to receive from the Tenant over
              the remaining term of the sublease (in thousands):</div>
</ix:nonNumeric></ix:continuation>
            <div>
              <ix:continuation id="Text_f489aa8011644cea99cd9829553f630049" continuedAt="Text_f489aa8011644cea99cd9829553f630050"><ix:continuation id="Text_37b017fa54234d2c9b072e6eea17665b1" continuedAt="Text_37b017fa54234d2c9b072e6eea17665b2">
<div><br />
              </div>
</ix:continuation></ix:continuation>
            </div>

            <ix:continuation id="Text_f489aa8011644cea99cd9829553f630050"><ix:continuation id="Text_37b017fa54234d2c9b072e6eea17665b2">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of</div>
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">$ <br />
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" id="Fact_50541847215c480c995d4113e4a367d7" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">84</ix:nonFraction><br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; white-space: nowrap;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" id="Fact_b7a42098612f43b58c981aa9124b83ed" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">86</ix:nonFraction><br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" id="Fact_4ac4ac5c5af243769bdedd479b7d7403" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">88</ix:nonFraction><br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" id="Fact_c5eee822abdb481ea4f26c18ba7d0477" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">75</ix:nonFraction><br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentals" id="Fact_0473a9500d3f47f3ba0a844616916c3f" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">333</ix:nonFraction><br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
             </div>

          <div><br /></div>

        </div>

      </div>

      <div><br />
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);"> <div><span style="font-family: 'Times New Roman';"> </span></div>

    <div>
      <div style="font-family: 'Times New Roman';">
        <ix:nonNumeric name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="Text_0606de2f709c4b09b62da3884ecc3a1f" contextRef="c20220101to20221231" escape="true" continuedAt="Text_26a6f8db777745a28da767e67972d3d31">
<div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">8)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;">In-Process Research &amp; Development and Goodwill</div>
                </td>

  </tr>


</table>
        </div>
</ix:nonNumeric>
      </div>

      <div style="font-family: 'Times New Roman';">
        <ix:continuation id="Text_26a6f8db777745a28da767e67972d3d31" continuedAt="Text_26a6f8db777745a28da767e67972d3d32">
<div><br />
        </div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">
        <ix:continuation id="Text_26a6f8db777745a28da767e67972d3d32" continuedAt="Text_26a6f8db777745a28da767e67972d3d33">
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">In-Process Research
          &amp; Development</div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman';">
        <ix:continuation id="Text_26a6f8db777745a28da767e67972d3d33" continuedAt="Text_26a6f8db777745a28da767e67972d3d34">
<div><br />
        </div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
        <ix:continuation id="Text_26a6f8db777745a28da767e67972d3d34" continuedAt="Text_26a6f8db777745a28da767e67972d3d35">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          2018, the Company acquired IRX, which was accounted for as a business combination.&#160; The Company recorded IPR&amp;D in the amount of $<ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" id="Fact_f16e4560ecec4d37947eb95c8603a157" contextRef="c20181231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.0</ix:nonFraction>
          million, which represented the fair value assigned to technologies that were acquired in connection with the IRX acquisition and which have not reached technological feasibility and have no alternative future use.</div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
        <ix:continuation id="Text_26a6f8db777745a28da767e67972d3d35" continuedAt="Text_26a6f8db777745a28da767e67972d3d36">
<div><br />
        </div>
</ix:continuation>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-20</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
            </div>

          </div>

        </div>

      </div>

      <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
        <ix:continuation id="Text_26a6f8db777745a28da767e67972d3d36" continuedAt="Text_26a6f8db777745a28da767e67972d3d37">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          June 2022, the Company received results from the INSPIRE phase 2 trial of IRX-2, a multi-cytokine biologic immunotherapy, in patients with newly diagnosed stage II, III or IVA squamous cell carcinoma of the oral cavity. The IRX-2 multi-cytokine
          biologic immunotherapy represents substantially all the fair value assigned to the technologies of IRX that the Company acquired. Despite outcomes that favored IRX-2 in certain predefined subgroups, the INSPIRE trial did not meet the primary
          endpoint of Event-Free Survival. Significant additional clinical development work would be required to advance IRX-2 in the form of additional Phase 2 and 3 studies to further evaluate the treatment effect of IRX-2 in patient subgroups and in
          combination with checkpoint inhibitor therapies.&#160; The INSPIRE trial was the only Company-sponsored study of IRX-2.&#160; Based on the totality of available information, the Company currently does not have plans to further develop the IRX-2 product
          candidate. As such, the Company determined that the carrying value of the IPR&amp;D asset was impaired and recognized a non-cash impairment charge of approximately $<ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_73fa8e6d8b5d497c987e74392bc18b9e" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.0</ix:nonFraction> million on the consolidated statement of operations during 2022, which reduced the value of the asset to <ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" id="Fact_46f669bd5c744128962bc862cc648659" contextRef="c20221231" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen">zero</ix:nonFraction>.</div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman';">
        <ix:continuation id="Text_26a6f8db777745a28da767e67972d3d37" continuedAt="Text_26a6f8db777745a28da767e67972d3d38">
<div><br />
        </div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">
        <ix:continuation id="Text_26a6f8db777745a28da767e67972d3d38" continuedAt="Text_26a6f8db777745a28da767e67972d3d39">
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Goodwill</div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
        <ix:continuation id="Text_26a6f8db777745a28da767e67972d3d39" continuedAt="Text_26a6f8db777745a28da767e67972d3d310">
<div><br />
        </div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_26a6f8db777745a28da767e67972d3d310">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The
















          Company recorded goodwill in the amount of $<ix:nonFraction name="us-gaap:Goodwill" id="Fact_481790f766df45848bc4934fd7e709d8" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction> million related to the IRX Acquisition. As of December 31, 2022, the Company performed
          a qualitative assessment to determine whether it was more likely than not that the fair value of the entity is less than its carrying value of goodwill. Such qualitative factors include macroeconomic conditions, industry and market
          considerations, cost factors, overall financial performance and other relevant events.&#160; Due to the decline in the Company&#8217;s stock price during 2022, the Company determined there were indications of impairment of the goodwill. Accordingly, the
          Company proceeded to a quantitative assessment of impairment and determined that the fair value of the reporting unit exceeded the carrying amount of goodwill, and therefore, the goodwill was not impaired as of December 31, 2022.
        </div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
        <div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
        </div>

      </div>

    </div>

    <div><span style="font-family: 'Times New Roman';"> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div>
      <ix:nonNumeric name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="Text_348a8a747cad464eb8f0428093b9c2c0" contextRef="c20220101to20221231" escape="true" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca81">
<div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="align: right; vertical-align: top; width: 9pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: -36pt; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-left: 36pt;"><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9)</span></div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">Related Party Transactions</span></span></div>
              </td>

  </tr>


</table>
      </div>
</ix:nonNumeric>
      <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca81" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca82">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca82" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca83">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;">Agreements Related to Factor Bioscience and Dr. Matthew Angel</div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca83" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca84">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca84" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca85">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          September 2022, the Company entered into a Master Services Agreement (the &#8220;MSA&#8221;) with Factor Bioscience Inc. (&#8220;Factor Bioscience&#8221;), pursuant to which Factor Bioscience has agreed to provide services to the Company as agreed between the Company
          and Factor Bioscience and as set forth in one or more work orders under the MSA, including the first work order included in the MSA (&#8220;WO1&#8221;). Under WO1, Factor Bioscience has agreed to provide the Company with mRNA cell engineering research
          support services, including access to certain facilities, equipment, materials and training, and the Company has agreed to pay Factor Bioscience an initial fee of $<ix:nonFraction name="erna:MasterServiceAgreementInitialFeesPayable" id="Fact_b08af770d44d403d81e96daa3f53d7d1" contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.0</ix:nonFraction> million, payable in <ix:nonFraction name="erna:NumberOfMonthlyInstallmentsForFeesPayable" id="Fact_3c03a9e15bc04c109ac272963890310e" contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U009" decimals="INF" scale="0" format="ixt-sec:numwordsen">twelve</ix:nonFraction> equal monthly installments of approximately $<ix:nonFraction name="erna:RelatedPartyTransactionPeriodicFeesPaymentAmount" id="Fact_25c3e0c940cf41b195062ed8e32f0924" contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million. Of the $<ix:nonFraction name="erna:MasterServiceAgreementInitialFeesPayable" id="Fact_3b2db18238e84ee598e8f9ad7cb1150c" contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.0</ix:nonFraction> million, the
          Company allocated $<ix:nonFraction name="erna:InitialLicenseFeeObligation" id="Fact_aac6735f460e4ffd90abd02aee3fd20a" contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.5</ix:nonFraction> million to the License Fee Obligation (as defined below). Following the initial 12-month period, the Company has
          agreed to pay Factor Bioscience a monthly fee of $<ix:nonFraction name="erna:MonthlyMasterServicesAgreementFeesPayable" id="Fact_027a1923189e4f36bdab7c9a2aec4b73" contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million until such time as WO1 is terminated. The Company paid a deposit of $<ix:nonFraction name="erna:DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" id="Fact_e3d58ba262b04d7ba3303bb765bdfbd2" contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million, which will be applied to the last month of the first work order.</div>
</ix:continuation>
      </div>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca85" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca86">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;"><br />
        </div>
</ix:continuation>
      </div>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca86" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca87">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company may terminate WO1 under the MSA on or after the second anniversary of the date of the MSA, subject to providing
          Factor Bioscience with 120 days&#8217; prior notice.&#160; Factor Bioscience may terminate such work order only on and after the fourth anniversary of the date of the MSA, subject to providing the Company with <ix:nonNumeric name="erna:NoticePeriodForFirstTerminationOfContract" id="Fact_8a0e7fbb7ad64b37bdecf9aa7b98c0a9" contextRef="c20220101to20221231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" format="ixt-sec:durwordsen">120 days</ix:nonNumeric>&#8217; prior notice.&#160; The MSA contains customary confidentiality provisions and representations and warranties of the parties, and the MSA may be terminated by ether party
          upon <ix:nonNumeric name="erna:NoticePeriodForSupersedingTerminationProvisions" id="Fact_752ad4a10420487884b4fa91eaec6847" contextRef="c20220101to20221231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" format="ixt-sec:durwordsen">30 days</ix:nonNumeric>&#8217; prior notice, subject to any superseding termination provisions contained in a particular work order.</div>
</ix:continuation>
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca87" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca88">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca88" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca89">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In connection with entering into the MSA, Factor Bioscience&#8217;s subsidiary, Factor Limited, entered into a waiver agreement
          (the &#8220;Waiver Agreement&#8221;) with Eterna LLC, pursuant to which Factor Limited agreed to waive payment of $<ix:nonFraction name="erna:AgreedWaivePayment" id="Fact_ac30bc56904b413187fa910b16552616" contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.5</ix:nonFraction> million otherwise payable to
          it (the &#8220;License Fee Obligation&#8221;) in October 2022 by Eterna LLC under the Original Factor License Agreement, as defined in Note 13,&#160;<span style="font-style: italic;">License Agreements</span>.&#160; Under the terms of the Waiver Agreement, the License
          Fee Obligation is waived conditionally on the Company paying Factor Bioscience amounts due under the MSA.</div>
</ix:continuation>
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca89" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca810">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca810" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca811">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As a result of entering into the Waiver Agreement and the MSA, the Company recognized $<ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" id="Fact_a6e05fb286fe47cdaf44b04f9b04aded" contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.5</ix:nonFraction> million in research and development expense, as the license does not have an alternative future use, and a corresponding liability for the License
          Fee Obligation.&#160; As of December 31, 2022, there was approximately $<ix:nonFraction name="erna:RemainingLicenseFeeObligation" id="Fact_456114ca93ff4e0ea3d2a5d45a6a189d" contextRef="c20220101to20221231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.0</ix:nonFraction> million of the License Fee Obligation remaining, which is
          recorded on the accompanying consolidated balance sheet in the &#8220;due to related party&#8221; line items.</div>
</ix:continuation>
      </div>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca811" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca812">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;"><br />
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-21</span></div>

          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
            </div>

          </div>

        </div>

      </div>

      <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca812" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca813">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">In September 2022, Novellus and Eterna entered into a Second Amendment to the Limited
        Waiver and Assignment Agreement (the &#8220;Waiver and Assignment Agreement&#8221;) with Drs. Matthew Angel and Christopher Rohde (the &#8220;Founders&#8221;) whereby the Company has agreed to be responsible for all future, reasonable and substantiated legal fees, costs,
        settlements and judgments incurred by the Founders, the Company or Novellus for certain claims and actions and any pending or future litigation brought against the Founders, Novellus and/or the Company by or on behalf of the Westman and Sowyrda
        legal matters described in Note 12 (the &#8220;Covered Claims&#8221;).&#160; The Founders will continue to be solely responsible for any payments made to satisfy a judgement or settlement of any pending or future wage act claims.&#160; Under the Waiver and Assignment
        Agreement, the Founders agreed that they are not entitled to, and waived any right to, indemnification or advancement of past, present or future legal fees, costs, judgments, settlement or other liabilities they may have been entitled to receive
        from the Company or Novellus in respect of the Covered Claims. The Company and the Founders will share in any recoveries up to the point at which the parties have been fully compensated for legal fees, costs and expenses incurred, with the Company
        retaining any excess recoveries. The Company has the sole authority to direct and control the prosecution, defense and settlement of the Covered Claims.</div>
</ix:continuation>
      <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca813" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca814">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca814" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca815">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">In September 2022, the Company entered into an assignment and assumption of contracts
        agreement (the &#8220;Assignment and Assumption Agreement&#8221;) with Factor Bioscience, pursuant to which the Company assumed certain contracts with third parties that Factor Bioscience had previously entered into in anticipation of entering into a sublease
        for premises in Somerville, Massachusetts.&#160; In October 2022, the Company entered into a sublease for the premises (see Note 7).&#160; Under the Assignment and Assumption Agreement, the Company agreed to reimburse Factor Bioscience for costs already
        incurred or paid by it under the assumed contracts in the amount of approximately $<ix:nonFraction name="erna:ReimburseCostsIncurredOrPaid" id="Fact_234179d7b0da40f4948f42fca0e47f2a" contextRef="c20221001to20221031_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million, and the Company assumed the future
        obligations under these contracts, which relate to the design and build-out of the subleased space.</div>
</ix:continuation>
      <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca815" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca816">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca816" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca817">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          November 2022, following the expiration of one of the delineated milestone deadlines for certain regulatory filings required under the Novellus-Factor License Agreement (as defined in Note 12), which permitted Factor Limited to terminate the
          license granted to Novellus Limited thereunder, the Company entered into the first amendment to the Original Factor License Agreement (the &#8220;Amended Factor License Agreement&#8221;), pursuant to which, among other things, Factor Limited granted to
          Eterna LLC an exclusive, sublicensable license under certain patents owned by Factor Limited (the &#8220;Factor Patents&#8221;) for the purpose of identifying and pursuing certain opportunities to grant to third parties sublicenses to the Factor Patents. The
          Amended Factor License Agreement also (i) terminated the Novellus-Factor License Agreement, (ii) confirmed Factor Limited&#8217;s grant to Eterna LLC of the rights and licenses Novellus Limited previously granted to Eterna LLC under the Novellus-Factor
          License Agreement on the same terms and conditions as granted by Novellus Limited to Eterna LLC under such agreement, (iii) confirmed that sublicense granted by Novellus Limited in accordance with the Novellus-Factor License Agreement to NoveCite
          (as discussed in Note 12), survived termination of the Novellus-Factor License Agreement; and (iv) removed Novellus Limited from the Amended Factor License Agreement and the NoveCite Agreement (as defined in Note 12) and replaced Novellus Limited
          with Factor Limited as the direct licensor to Eterna LLC and NoveCite under such agreements, respectively.</div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca817" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca818">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca818" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca819">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The















          agreements discussed above have been deemed related party transactions, as the Company&#8217;s Chief Executive Officer, Dr. Matthew Angel, is also the Chairman and Chief Executive Officer of Factor Bioscience and a Director of Factor Limited.</div>
</ix:continuation>
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca819" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca820">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);"> <br />
        </div>
</ix:continuation>
      </div>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca820" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca821">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Exacis Option Agreement</span><br />
          <br />
        </div>
</ix:continuation>
      </div>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca821" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca822">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On October 8, 2022, the Company entered into an option agreement (the &#8220;Exacis Option Agreement&#8221;) with Exacis Biotherapeutics,
          Inc., a Delaware corporation (&#8220;Exacis&#8221;), pursuant to which Exacis granted the Company the option to negotiate and enter into an exclusive worldwide sublicense by December 31, 2022 to certain technology licensed by Exacis for the treatment of
          cancer in humans (the &#8220;Exacis Option&#8221;). Under the Exacis Option Agreement, the Company paid Exacis a fee of $<ix:nonFraction name="erna:PaymentOfOptionFee" id="Fact_b2246484b5dd47b7bcede4def8b91596" contextRef="c20221008to20221008_RelatedPartyTransactionsByRelatedPartyAxis_ExacisBiotherapeuticsIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million for the Exacis
          Option, which would be creditable against the fees or purchase price payable under any such license if entered into by the Company in accordance with the Exacis Option Agreement. The Exacis Option Agreement provided for certain payments upon the
          execution of a definitive license agreement, which would become payable only upon execution and in accordance with the terms of the applicable license agreement, if any.&#160; The Company decided not to exercise the Exacis Option, and the Exacis
          Option Agreement expired in accordance with its terms on December 31, 2022.</div>
</ix:continuation>
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca822" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca823">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca823" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca824">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Exacis Option Agreement has been deemed a related party transaction, as one of the Company&#8217;s Board members, Dr. Gregory
          Fiore, is the Chief Executive Officer of Exacis.&#160; Additionally, the Company&#8217;s Chief Executive Office, Dr. Matthew Angel, is Chairman of Exacis&#8217; scientific advisory board. Dr. Angel is also the Chairman and Chief Executive Officer of Factor
          Bioscience LLC, which is the majority shareholder of Exacis.</div>
</ix:continuation>
        <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca824" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca825">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br />
        </div>
</ix:continuation>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca825" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca826">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;">Q4-22 PIPE Transaction </div>
</ix:continuation>
            <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca826" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca827">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;"> <br />
            </div>
</ix:continuation>
          </div>

          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca827" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca828">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On November 23, 2022, the Company entered into the Q4-22 Purchase Agreement with the Q4-22 PIPE Investors in respect of
              the Q4-22 PIPE Transaction, pursuant to which the Company issued and sold to the Q4-22 PIPE Investors approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_bb361b9d5211413aa1b3cf9b3759cc0e" contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">2,185,000</ix:nonFraction>
              units, each unit consisting of (i) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_c52529b759cc4ab5929bc1fc8a42683e" contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of common stock and (ii) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_84b98019e2ae4e508759d9af2f49c7b9" contextRef="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> Q4-22 Warrants, at a purchase price of $<ix:nonFraction name="erna:UnitPriceOfWarrants" id="Fact_5c025c553d7747eda10f79154f50b5f5" contextRef="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">3.53</ix:nonFraction> per unit
              (inclusive of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_a57bed73a5ae4abab71d433fffd49f12" contextRef="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U003" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.125</ix:nonFraction> per Q4-22 Warrant). The Company received aggregate gross proceeds of approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" id="Fact_bd4fc959d8714e7aa3d6a6e370e1f5cf" contextRef="c20221202to20221202_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">7.7</ix:nonFraction> million, The Q4-22 PIPE Transaction closed on December 2, 2022.</div>
</ix:continuation>
            <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca828" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca829">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
            </div>
</ix:continuation>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-22</span></div>

              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

              <div class="BRPFPageHeader" style="width: 100%;">
                <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
                </div>

              </div>

            </div>

            <div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca829" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca830">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Each Q4-22 Warrant becomes exercisable <ix:nonNumeric name="erna:ClassOfWarrantOrRightsExercisableTerm" id="Fact_0b8a030d69864c969b7286bfb3a2389c" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" format="ixt-sec:durwordsen">six months</ix:nonNumeric> following the date of closing, expires <span style="-sec-ix-hidden:Fact_1f3e03cde5674ee69b274ec5dc980a3c">five-and-one-half</span> years following such date,
                and is subject to customary adjustments.</div>
</ix:continuation>
            </div>

            <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca830" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca831">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
            </div>
</ix:continuation>
            <div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca831" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca832">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Mr. Charles Cherington, Chairman of the Company&#8217;s Board of Directors, and Mr. Nicholas Singer, a director of the
                Company, participated in the Q4-22 PIPE Transaction on the same terms and subject to the same conditions as all other Q4-22 PIPE Investors.</div>
</ix:continuation>
            </div>

            <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca832" continuedAt="Text_0ccd722600ab4dc79b1a566a3a7abca833">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_0ccd722600ab4dc79b1a566a3a7abca833">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On the closing date of the Q4-22 PIPE Transaction, the Company and the Q4-22 PIPE Investors, including Messrs. Cherington
              and Singer, entered into a registration rights agreement, pursuant to which the Company has agreed to prepare and file a registration statement on Form S-3 with the Securities and Exchange Commission no later than 30 days following the date
              on which the Company becomes eligible to use Form S-3 to register the resale of the shares of common stock included in the units described above and the shares of common stock issuable upon exercise of the Q4-22 Warrants.</div>
</ix:continuation>
          </div>

        </div>

        </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div><br />
      </div>


      <ix:nonNumeric name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="Text_09ff2d1d1d51425899784ee7a9d40e93" contextRef="c20220101to20221231" escape="true" continuedAt="Text_b434e0c08c074a27a1e828b3242149e91">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">10)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Accrued Expenses</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_b434e0c08c074a27a1e828b3242149e91" continuedAt="Text_b434e0c08c074a27a1e828b3242149e92">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_b434e0c08c074a27a1e828b3242149e92" continuedAt="Text_b434e0c08c074a27a1e828b3242149e93"><ix:nonNumeric name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="Text_7d93a6d21dd346b99df188153b132581" contextRef="c20220101to20221231" escape="true" continuedAt="Text_a92ba5d20ff44ad8962c1181887b97211">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Accrued expenses consisted of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_b434e0c08c074a27a1e828b3242149e93" continuedAt="Text_b434e0c08c074a27a1e828b3242149e94"><ix:continuation id="Text_a92ba5d20ff44ad8962c1181887b97211" continuedAt="Text_a92ba5d20ff44ad8962c1181887b97212">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_b434e0c08c074a27a1e828b3242149e94"><ix:continuation id="Text_a92ba5d20ff44ad8962c1181887b97212">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="6">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Accrued compensation</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_20cf85cd84c04ee8a9a3cf9785d883b3" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,065</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_165e1ff05dab47babc45843935676f5c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">656</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Legal fees and related</span></div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" id="Fact_e8ea9961d6c34861bc3854cab7f9991f" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,138</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" id="Fact_69247117975741e58bb1b14e66138270" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">241</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Clinical</span></div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AccruedClinicalCurrent" id="Fact_ac64df674a5947278f7ff70fd7927751" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">570</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AccruedClinicalCurrent" id="Fact_bbeb0f1c7d07424c9a163e4a37806c60" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">200</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Q4-22 PIPE</span></td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AccruedPrivatePlacementInPublicEquityCurrent" id="Fact_a342194857a04af989389ec97bcf416a" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">208</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AccruedPrivatePlacementInPublicEquityCurrent" id="Fact_529db28790604a149681e7fd9c45bd36" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" rowspan="1">Other<br />
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_2ca7139fea334124beab324422acdb82" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">645</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_1663c775cade4651af51a39608c5f5bb" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">152</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
              <div style="color: rgb(0, 0, 0);">Total accrued expenses</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_db3678ff7e6a4d6a902d4bbe229a7388" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,626</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_ebd989d8fe924530a9103a3135fbe950" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,249</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>&#160;</div>
            </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
        </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div> <br />
      </div>


      <ix:nonNumeric name="us-gaap:DebtDisclosureTextBlock" id="Text_e0a9604a8f0746a2a82ba18894737c70" contextRef="c20220101to20221231" escape="true" continuedAt="Text_5d30bed3c822415393d62bde156226451">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">11)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Debt</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <div>
        <ix:continuation id="Text_5d30bed3c822415393d62bde156226451" continuedAt="Text_5d30bed3c822415393d62bde156226452">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_5d30bed3c822415393d62bde156226452" continuedAt="Text_5d30bed3c822415393d62bde156226453">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Loans Payable</div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_5d30bed3c822415393d62bde156226453" continuedAt="Text_5d30bed3c822415393d62bde156226454">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_5d30bed3c822415393d62bde156226454" continuedAt="Text_5d30bed3c822415393d62bde156226455">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In connection with the IRX Acquisition in 2018, Eterna LLC assumed certain notes payable (the &#8220;IRX Notes&#8221;) in the amount of $<ix:nonFraction name="us-gaap:LoansPayableCurrent" id="Fact_77513174f9d04964b205cc8116bf42da" contextRef="c20181231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million. On January 27, 2020, the IRX Notes were amended to extend the maturity date to the earlier of (i) a change of control, as defined in the
          IRX Notes, and (ii) December 31, 2021. On December 31, 2021, the Company paid the outstanding $<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" id="Fact_b1ff87ceec1545ef9e5cc5467a29a723" contextRef="c20210101to20211231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million in principal plus accrued
          and unpaid interest of approximately $<ix:nonFraction name="erna:PaymentOfAccruedAndUnpaidInterest" id="Fact_54e5a754b95240639d5e5d92699cf406" contextRef="c20210101to20211231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million under the IRX Notes, and the Company has <ix:nonFraction name="us-gaap:LoansPayableCurrent" id="Fact_5a80d82c953d49369838120671354897" contextRef="c20221231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction> further obligations thereunder.</div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_5d30bed3c822415393d62bde156226455" continuedAt="Text_5d30bed3c822415393d62bde156226456">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_5d30bed3c822415393d62bde156226456" continuedAt="Text_5d30bed3c822415393d62bde156226457">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Payment Protection Program Loan</div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_5d30bed3c822415393d62bde156226457" continuedAt="Text_5d30bed3c822415393d62bde156226458">
<div><br /></div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_5d30bed3c822415393d62bde156226458" continuedAt="Text_5d30bed3c822415393d62bde156226459">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On May 4, 2020, Eterna LLC issued a note in the principal amount of approximately $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" id="Fact_51ccc2dc8fc84af18e67f284a46bc535" contextRef="c20200504_DebtInstrumentAxis_PaycheckProtectionProgramMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million to Silicon Valley Bank evidencing a loan (the &#8220;Eterna LLC PPP Loan&#8221;) that Eterna LLC received under the Paycheck Protection Program (the &#8220;PPP&#8221;) of the Coronavirus
          Aid, Relief, and Economic Security Act administered by the U.S. Small Business Administration (the &#8220;CARES Act&#8221;). Eterna LLC PPP Loan incurred interest at a rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_0004ad9747784720a6510c15e1911bbb" contextRef="c20200504_DebtInstrumentAxis_PaycheckProtectionProgramMember" unitRef="U005" decimals="3" scale="-2" format="ixt:num-dot-decimal">1.0</ix:nonFraction>% per annum.</div>
</ix:continuation>
        <ix:continuation id="Text_5d30bed3c822415393d62bde156226459" continuedAt="Text_5d30bed3c822415393d62bde1562264510">
<div><br /></div>
</ix:continuation>
        <ix:continuation id="Text_5d30bed3c822415393d62bde1562264510">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Under the terms of the CARES Act, certain amounts of the Eterna LLC PPP Loan could be forgiven if they were used for
          qualifying expenses, as described in the CARES Act. In September 2021, the lender informed Eterna LLC that the U.S Small Business Administration approved the forgiveness of 100% of the outstanding principal and interest of the Eterna LLC PPP
          Loan. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">As a result, the Company recognized a gain during 2021 of $<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" id="Fact_88d0143092824fae82fa8f52d9976301" contextRef="c20210101to20211231_DebtInstrumentAxis_PaycheckProtectionProgramMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million during recorded in other (expense) income, net, on the accompanying consolidated statements of operations. The Company has <ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_3739e72ec6154d90a54d23203addbabc" contextRef="c20221231_DebtInstrumentAxis_PaycheckProtectionProgramMember" unitRef="U001" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> further obligations under this loan</span>.</div>
</ix:continuation>
      </div>

      <div>  </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Text_2fde8b23a8364cbd9fe75501088788fb" contextRef="c20220101to20221231" escape="true" continuedAt="Text_b8c70cdcab96448db4161e3df20050e41">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">12)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Commitments and Contingencies</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e41" continuedAt="Text_b8c70cdcab96448db4161e3df20050e42">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e42" continuedAt="Text_b8c70cdcab96448db4161e3df20050e43">
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Litigation Matters</div>
</ix:continuation>
      <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e43" continuedAt="Text_b8c70cdcab96448db4161e3df20050e44">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e44" continuedAt="Text_b8c70cdcab96448db4161e3df20050e45">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The









          Company is involved in litigation and arbitrations from time to time in the ordinary course of business. Legal fees and other costs associated with such actions are expensed as incurred. In addition, the Company assesses the need to record a
          liability for litigation and contingencies. The Company reserves for costs relating to these matters when a loss is probable, and the amount can be reasonably estimated.</div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e45" continuedAt="Text_b8c70cdcab96448db4161e3df20050e46">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;"> <span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
            </span></span></div>
</ix:continuation>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-23</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="BRPFPageHeader">
            <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
            </div>

          </div>

        </div>

        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e46" continuedAt="Text_b8c70cdcab96448db4161e3df20050e47">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;">Dhesh Govender v. Eterna Therapeutics LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021)</span></div>
</ix:continuation>
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e47" continuedAt="Text_b8c70cdcab96448db4161e3df20050e48">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
        </div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e48" continuedAt="Text_b8c70cdcab96448db4161e3df20050e49">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On









            or about February 5, 2021, Dhesh Govender, a former short-term consultant of Eterna LLC, filed a complaint against Eterna LLC and certain individuals that plaintiff alleged were directors of Eterna LLC. Plaintiff alleged that Eterna LLC and
            certain of its officers and directors (&#8220;defendants&#8221;) engaged in unlawful and discriminatory conduct based on race, national origin and hostile work environment. Plaintiff also asserted various breach of contract, fraud and quantum meruit claims
            based on an alleged oral agreement pursuant to which he alleged Eterna LLC agreed to hire him as an executive once the Merger was completed. On December 15, 2022, the parties executed a Confidential Settlement Agreement and Release of All
            Claims. On January 11, 2023, the parties filed a Stipulation to Discontinue in the Court action. Also on January 11, 2023, Govender voluntarily dismissed the arbitration.</div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e49" continuedAt="Text_b8c70cdcab96448db4161e3df20050e410">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
        </div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e410" continuedAt="Text_b8c70cdcab96448db4161e3df20050e411">
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">John Westman v.
              Novellus, Inc., Christopher Rohde, and Matthew Angel, Civil Action No. 2181CV01949 (Middlesex County (Massachusetts) Superior Court)</span></div>
</ix:continuation>
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e411" continuedAt="Text_b8c70cdcab96448db4161e3df20050e412">
<div><br />
          </div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e412" continuedAt="Text_b8c70cdcab96448db4161e3df20050e413">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On or about September 7, 2021, John Westman, a former employee of Novellus, Inc.
          filed a Complaint in Middlesex County (Massachusetts) Superior Court against Novellus, Inc. and Novellus, Inc.&#8217;s founders and former executives, Dr. Christopher Rohde and Dr. Matthew Angel (collectively, &#8220;Defendants&#8221;).&#160; The case includes
          allegations that Novellus, Inc. violated the Massachusetts Wage Act (&#8220;Wage Act&#8221;).&#160; Eterna acquired Novellus, Inc. on July 16, 2021.&#160; Mr. Westman&#8217;s claims relate to alleged conduct that took place before Eterna acquired Novellus, Inc.&#160; Westman
          agreed to dismiss the lawsuit and proceed with his claims in arbitration.&#160; Following mediation, the parties settled this dispute in December 2022.</div>
</ix:continuation>
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e413" continuedAt="Text_b8c70cdcab96448db4161e3df20050e414">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e414" continuedAt="Text_b8c70cdcab96448db4161e3df20050e415">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> The aggregate settlement amount payable by the Company for the two matters
          discussed above is approximately $<ix:nonFraction name="erna:LitigationSettlementAmountPayable" id="Fact_eba85e270580486baafb07c9bf31501e" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction> million.<br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e415" continuedAt="Text_b8c70cdcab96448db4161e3df20050e416">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </span></div>
</ix:continuation>
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e416" continuedAt="Text_b8c70cdcab96448db4161e3df20050e417">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="text-decoration: underline;">Novellus, Inc. v. Sowyrda et al., C.A. No. 2184CV02436-BLS2</span></div>
</ix:continuation>
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e417" continuedAt="Text_b8c70cdcab96448db4161e3df20050e418">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
        </div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e418" continuedAt="Text_b8c70cdcab96448db4161e3df20050e419">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On October 25, 2021 Novellus, Inc. filed a complaint in the Superior Court of Massachusetts, Suffolk County, against former
            Novellus, Inc. employees Paul Sowyrda and John Westman and certain other former investors in Novellus LLC (Novellus, Inc.&#8217;s former parent company prior to our acquisition of Novellus, Inc.), alleging breach of fiduciary duty, breach of contract
            and civil conspiracy. Eterna acquired Novellus, Inc. on July 16, 2021.&#160; On May 27, 2022 Novellus, Inc. amended the complaint to withdraw all claims against all defendants except Paul Sowyrda and John Westman.&#160; On July 1, 2022, Westman filed a
            motion to compel arbitration or in the alternative, to stay the litigation pending the disposition of certain litigation in the Court of Chancery for the State of Delaware filed by Mr. Sowyrda against Novellus LLC, Dr. Christopher Rohde, Dr.
            Matthew Angel, Leonard Mazur and Factor Bioscience, Inc. captioned&#160;<span style="font-style: italic;">Zelickson et al., v. Angel et al.,</span>&#160;C.A. 2021-1014-JRS and by Westman against Novellus LLC captioned&#160;<span style="font-style: italic;">Westman

























              v. Novellus LLC</span>, C.A. No. 2021-0882-NAC (the &#8220;Delaware Actions&#8221;).&#160; On July 1, 2022, Sowyrda answered the complaint and asserted counterclaims against Novellus, Inc, and third-party defendants Dr. Matthew Angel and Dr. Christopher Rohde
            alleging violations of the Massachusetts Wage Act, Massachusetts Minimum Fair Wage Law, the Fair Labor Standards Act, breach of contract, unjust enrichment and quantum meruit.&#160; Sowyrda also joined in Westman&#8217;s motion to stay the case pending
            the Delaware Actions.&#160; Novellus, Inc.&#8217;s claims and Mr. Sowyrda&#8217;s counterclaims relate to alleged conduct that took place before Eterna acquired Novellus, Inc.</div>
</ix:continuation>
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e419" continuedAt="Text_b8c70cdcab96448db4161e3df20050e420">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e420" continuedAt="Text_b8c70cdcab96448db4161e3df20050e421">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On November 15, 2022, prior to a decision on Westman&#8217;s and Sowyrda&#8217;s motion to compel or stay, the Parties agreed to
            voluntarily dismiss and consolidate the Delaware Actions with this action.&#160; On December 15, 2022, Sowyrda filed an Amended Answer to the Amended Complaint, asserted affirmative defenses and filed Amended Counterclaims against Dr. Angel, Dr.
            Rohde, Novellus LLC, Novellus Inc., Factor Bioscience Inc., and Eterna Therapeutics Inc. (&#8220;Counterclaim Defendants&#8221;) alleging against various Counterclaim Defendants breach of contract, breaches of the implied duty of good faith and fair
            dealing, breaches of fiduciary duty, breaches of the operating agreement, aiding and abetting breaches of fiduciary duty, tortious interference with contract, equitable accounting, violations of the Massachusetts Wage Act, Massachusetts Minimum
            Fair Wage Law, the Fair Labor Standards Act, unjust enrichment, and quantum meruit.&#160; Also on December 15, 2022, Westman filed an answer to the Amended Complaint and asserted similar counterclaims against the same Counterclaim Defendants.&#160;
            Westman and Sowyrda each asserted claims for indemnification and/or advancement against Novellus, Inc.&#160; On January 11, 2023, Westman and Sowyrda served a joint motion to enforce their advancement and/or indemnification rights against Novellus
            Inc.&#160; Novellus Inc. vigorously opposes this motion and served its opposition on January 27, 2023.&#160; On February 8, 2023, Westman and Sowyrda served a reply in support of their motion to enforce indemnification/advancement rights, and submitted
            the motion to the Court.&#160; Novellus Inc. answered Westman and Sowyrda&#8217;s counterclaims on January 27, 2023, denying liability.&#160; The remaining Counterclaim Defendants served a motion to dismiss most of the remaining counterclaims on January 27,
            2023.&#160; Sowyrda&#8217;s and Westman&#8217;s oppositions to the motion to dismiss were served on March 3, 2023, and Counterclaim Defendants&#8217; reply is due March 24, 2023, at which point the motion to dismiss will be fully briefed.&#160; The Court announced that it
            would hold oral argument on April 5, 2023 on (a) the Counterclaim Defendants&#8217; motion to dismiss, and (b) Sowyrda&#8217;s and Westman&#8217;s motion to enforce.&#160;&#160; The parties attended an initial status and scheduling conference with the Court on February 7,
            2023.&#160; The Court deferred entering a case scheduling until after the April 5 hearing.</div>
</ix:continuation>
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e421" continuedAt="Text_b8c70cdcab96448db4161e3df20050e422">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </div>
</ix:continuation>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-24</span></div>

            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

            <div style="width: 100%;" class="BRPFPageHeader">
              <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
              </div>

            </div>

          </div>

          <a id="z_Hlk110956120"></a><ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e422" continuedAt="Text_b8c70cdcab96448db4161e3df20050e423">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Under applicable Delaware law and Novellus Inc.&#8217;s organizational documents, the Company may be
            required to advance or reimburse certain legal expenses incurred by former officers and directors of Novellus, Inc. in connection with the foregoing Westman and Sowyrda matters. However, a future advance or reimbursement is not currently
            probable nor can it be reasonably estimated.</div>
</ix:continuation>
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e423" continuedAt="Text_b8c70cdcab96448db4161e3df20050e424">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e424" continuedAt="Text_b8c70cdcab96448db4161e3df20050e425">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"> <span style="text-decoration: underline;">Emerald Private Equity Fund, LLC Matter</span></div>
</ix:continuation>
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e425" continuedAt="Text_b8c70cdcab96448db4161e3df20050e426">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"><span style="text-decoration: underline;"> <br />
            </span></div>
</ix:continuation>
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e426" continuedAt="Text_b8c70cdcab96448db4161e3df20050e427">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> By a letter dated July 7, 2021, Emerald Private Equity Fund, LLC (&#8220;Emerald&#8221;), a stockholder of Eterna, made a demand
            pursuant to 8 Del. C. 220 to inspect certain books and records of Eterna. The stated purpose of the demand was to investigate possible wrongdoing by persons responsible for the implementation of the Merger and the issuance of paper stock
            certificates, including investigating&#160; whether: (i) Eterna&#8217;s stock certificates were issued in accordance with the Merger Agreement; (ii) certain restrictions on the sale of Eterna common stock following the Merger were proper and applied
            without favor; (iii) anyone received priority in post-Merger issuances of Eterna&#8217;s stock certificates that allowed them to benefit from an increase in the trading price of Eterna&#8217;s common stock; and (iv) it should pursue remedial measures
            and/or report alleged misconduct to the SEC. Eterna responded to the demand letter and produced certain information to Emerald in connection with the demand, which is subject to the terms of a confidentiality agreement entered into among the
            parties, including certain additional stockholders who subsequently joined as parties to such agreement.&#160; Following discussions, with no admission of wrongdoing, the Company and the Emerald Plaintiffs entered into a confidential settlement
            agreement, pursuant to which the Company paid $<ix:nonFraction name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" id="Fact_aa9e7c0a7b3e48b8bab9dbd7cfa8664f" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.2</ix:nonFraction> million in 2022 in full settlement of all of the Emerald Plaintiffs&#8217; purported
            claims, including a release by the Emerald Plaintiffs in favor of the Company in respect of any and all such claims.</div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e427" continuedAt="Text_b8c70cdcab96448db4161e3df20050e428">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
        </div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e428" continuedAt="Text_b8c70cdcab96448db4161e3df20050e429">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Licensing
              Agreements</span></div>
</ix:continuation>
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e429" continuedAt="Text_b8c70cdcab96448db4161e3df20050e430">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e430" continuedAt="Text_b8c70cdcab96448db4161e3df20050e431">
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Exclusive Factor
              License Agreement.</span></div>
</ix:continuation>
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e431" continuedAt="Text_b8c70cdcab96448db4161e3df20050e432">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e432" continuedAt="Text_b8c70cdcab96448db4161e3df20050e433">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In April 2021, Eterna LLC and the Licensors entered into an exclusive license agreement (the &#8220;Original Factor License
            Agreement&#8221;) pursuant to which Eterna LLC acquired an exclusive worldwide license to the Licensed Technology for use in the development of certain mRNA, gene-editing, and cellular therapies to be evaluated and developed for treating human
            diseases, including certain types of cancer, sickle cell disease, and beta thalassemia.</div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e433" continuedAt="Text_b8c70cdcab96448db4161e3df20050e434">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
        </div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e434" continuedAt="Text_b8c70cdcab96448db4161e3df20050e435">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As a result of the Novellus Acquisition, the rights and obligations of Novellus Limited under the Novellus-Factor License
            Agreement pertaining to any and all licensed products from Factor Limited inured to Eterna. The Company&#8217;s agreement with Factor Limited under the Original Factor License Agreement remained unchanged after the completion of the Novellus
            Acquisition.</div>
</ix:continuation>
          <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e435" continuedAt="Text_b8c70cdcab96448db4161e3df20050e436">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </div>
</ix:continuation>
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
            <div>
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
                <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e436" continuedAt="Text_b8c70cdcab96448db4161e3df20050e437">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">In November 2022, the Company
                    entered into the first amendment to the Original Factor License Agreement (the &#8220;Amended Factor License Agreement&#8221;), pursuant to which, among other things, Factor Limited granted to Eterna LLC an exclusive, sublicensable license under
                    the Factor Patents for the purpose of identifying and pursuing certain opportunities to grant to third parties sublicenses to the Factor Patents. The term of the Amended Factor License Agreement is <ix:nonNumeric name="erna:LicenseAgreementTerm" id="Fact_dec72587a832402b960a9d7660274160" contextRef="c20220101to20221231_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric> from the effective date of this amendment and is extendable for an additional <span style="-sec-ix-hidden:Fact_7c1d5587e87d44e08e7579d3d8b39dd7">two and a half years</span> if the Company receives at least $<ix:nonFraction name="erna:ThresholdIncomeForAutomaticExtensionOfLicensePeriod" id="Fact_8aea9ab6be8b420595cb95a2a7ea9719" contextRef="c20221101to20221130_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember" unitRef="U001" decimals="-6" scale="6" format="ixt:num-dot-decimal">100</ix:nonFraction>
                    million from sublicenses granted by it with respect to the sublicensing opportunities contemplated by the&#160; Amended Factor License Agreement. Pursuant to the Amended Factor License Agreement, the Company will pay to Factor Limited <ix:nonFraction name="erna:PercentageOfSublicenseFeePayableBeforeExpirationPeriod" id="Fact_af73d6ccd51e456da8c61823cd35cfbe" contextRef="c20221130_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">20</ix:nonFraction>% of any sublicense fees it receives under a sublicense during the first <span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><ix:nonNumeric name="erna:LicenseAgreementTerm" id="Fact_c6177993d28348cfa61fe84e760c19f5" contextRef="c20220101to20221231_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric></span> and <ix:nonFraction name="erna:PercentageOfSublicenseFeePayableDuringRenewalTerm" id="Fact_3a4cda8733de41fa967b189533a79ede" contextRef="c20221130_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">30</ix:nonFraction>% of any sublicense fees it receives during the potential additional <span style="-sec-ix-hidden:Fact_5dfb948eb44f4984b296bd33047f7cfb">two and a half years</span></span><span style="font-family: 'Times New Roman';">.</span></div>
</ix:continuation>
                <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e437" continuedAt="Text_b8c70cdcab96448db4161e3df20050e438">
<div><br /></div>
</ix:continuation>
                <div>
                  <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e438" continuedAt="Text_b8c70cdcab96448db4161e3df20050e439">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"><span style="text-decoration: underline;">USF</span></div>
</ix:continuation>
                  <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e439" continuedAt="Text_b8c70cdcab96448db4161e3df20050e440">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
                  <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e440" continuedAt="Text_b8c70cdcab96448db4161e3df20050e441">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Eterna LLC has license
                        agreements with University of South Florida Research Association, Inc. (&#8220;USF&#8221;), granting Eterna LLC the right to sell, market, and distribute IRX-</span><span style="font-family: 'Times New Roman';">2,<span style="font-size: 10pt; color: rgb(0, 0, 0);"> subject to a <ix:nonFraction name="erna:LossContingencyPercentageOfRoyaltyPayable" id="Fact_97e6a69e50e6441e820dce56fae2e2cb" contextRef="c20220101to20221231_LegalEntityAxis_UniversityOfSouthFloridaMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">7</ix:nonFraction>% royalty payable to USF based on a</span> percentage<span style="font-size: 10pt; color: rgb(0, 0, 0);"> of gross product sales. Under the license agreement with USF, Eterna LLC is obligated to repay patent prosecution expenses incurred by USF. To date, Eterna LLC has not recorded any product sales, or
                          obligations related to USF patent prosecution expenses. The license agreement terminates upon the expiration of the IRX-</span>2<span style="font-size: 10pt; color: rgb(0, 0, 0);"> patents.</span></span></div>
</ix:continuation>
                  </div>

                  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                    <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-25</span></div>

                    <div class="BRPFPageBreak" style="page-break-after: always;">
                      <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

                    <div style="width: 100%;" class="BRPFPageHeader">
                      <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
                      </div>

                    </div>

                  </div>

                  <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e441" continuedAt="Text_b8c70cdcab96448db4161e3df20050e442">
<div><span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Royalty Agreements</span></div>
</ix:continuation>
                  <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e442" continuedAt="Text_b8c70cdcab96448db4161e3df20050e443">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
                    <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e443" continuedAt="Text_b8c70cdcab96448db4161e3df20050e444">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">While the agreements described below remain in force, the Company currently does not have plans to further
                      develop the IRX-2 product candidate<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.</span><br />
                    </div>
</ix:continuation>
                  </div>

                </div>

              </div>

            </div>

          </div>

        </div>

      </div>

      <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e444" continuedAt="Text_b8c70cdcab96448db4161e3df20050e445">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e445" continuedAt="Text_b8c70cdcab96448db4161e3df20050e446">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Collaborator Royalty Agreement</span></div>
</ix:continuation>
      <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e446" continuedAt="Text_b8c70cdcab96448db4161e3df20050e447">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e447" continuedAt="Text_b8c70cdcab96448db4161e3df20050e448">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Pursuant to a royalty agreement the
            Company assumed when it acquired the assets of IRX in November 2018, the Company will pay a former collaborator a royalty equal to <ix:nonFraction name="erna:LossContingencyPercentageOfRoyaltyPayable" id="Fact_2b101bc1b0354b159d2a768f65596459" contextRef="c20181101to20181130_TypeOfArrangementAxis_CollaboratorRoyaltyAgreementMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">6</ix:nonFraction>%
            of any sales of IRX-2, for the period of time beginning with the first sale of IRX-2 through the later of (i) the twelfth anniversary of the first sale of IRX-2 or (ii) the expiration of the last IRX patent, or other exclusivity of IRX-</span><span style="font-family: 'Times New Roman';">2.</span></div>
</ix:continuation>
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e448" continuedAt="Text_b8c70cdcab96448db4161e3df20050e449">
<div><br /></div>
</ix:continuation>
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e449" continuedAt="Text_b8c70cdcab96448db4161e3df20050e450">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"><span style="text-decoration: underline;">Royalty Agreement with certain former IRX Therapeutics Investors</span></div>
</ix:continuation>
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e450" continuedAt="Text_b8c70cdcab96448db4161e3df20050e451">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e451" continuedAt="Text_b8c70cdcab96448db4161e3df20050e452">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to a royalty agreement (the &#8220;IRX Investor Royalty Agreement&#8221;) with certain former IRX investors the Company assumed
          when it acquired the assets of IRX in November 2018, when Eterna LLC becomes obligated to pay royalties to USF under the agreement described above under &#8220;Licensing Agreements-USF,&#8221; it will pay an additional royalty of <ix:nonFraction name="erna:PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" id="Fact_6d7a303a95f042cb93f627e2613834ef" contextRef="c20181101to20181130_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">1</ix:nonFraction>% of gross sales to an entity organized by such former investors.</div>
</ix:continuation>
        <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e452" continuedAt="Text_b8c70cdcab96448db4161e3df20050e453">
<div><br /></div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e453" continuedAt="Text_b8c70cdcab96448db4161e3df20050e454">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Investor Royalty Agreement</span></div>
</ix:continuation>
      <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e454" continuedAt="Text_b8c70cdcab96448db4161e3df20050e455">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e455" continuedAt="Text_b8c70cdcab96448db4161e3df20050e456">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On March 22, 2021, Eterna LLC restated its royalty agreement with certain beneficial holders of Brooklyn ImmunoTherapeutics
        Investors GP LLC and Brooklyn ImmunoTherapeutics Investors LP, whereby such beneficial holders will continue to receive, on an annual basis, royalties in an aggregate amount equal to <ix:nonFraction name="erna:PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" id="Fact_3d74852687b142e7bede2c6092596278" contextRef="c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">4</ix:nonFraction>% of the net revenues of IRX-2, a cytokine-based therapy that was previously being developed by Eterna LLC to treat patients with cancer.</div>
</ix:continuation>
      <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e456" continuedAt="Text_b8c70cdcab96448db4161e3df20050e457">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e457" continuedAt="Text_b8c70cdcab96448db4161e3df20050e458">
<div style="text-align: justify; margin-right: 0.3pt; margin-top: 0.1pt; margin-bottom: 0.1pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Retirement Savings Plan</div>
</ix:continuation>
      <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e458" continuedAt="Text_b8c70cdcab96448db4161e3df20050e459">
<div style="margin-top: 0.1pt; margin-bottom: 0.1pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_b8c70cdcab96448db4161e3df20050e459">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company established a defined contribution plan, organized under Section 401(k) of the Internal Revenue Code, which allows
        employees to defer up to <ix:nonFraction name="erna:DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" id="Fact_86717dc9793e49b78819866638dd0dfd" contextRef="c20220101to20221231_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">90</ix:nonFraction>% of their pay on a pre-tax basis. As of December 31, 2022, the Company had not contributed a match to the
        employees&#8217; contribution. Beginning on January 1, 2023, the Company began matching employees&#8217; contributions at a rate of <ix:nonFraction name="erna:DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" id="Fact_0ceed1df412848ac98179ad034244419" contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% of the
        first <ix:nonFraction name="erna:DefinedContributionPlanEmployeeContributionAtThresholdOne" id="Fact_557e180571754c61951c6c5be061195e" contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">3</ix:nonFraction>% of the employee&#8217;s contribution and <ix:nonFraction name="erna:DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" id="Fact_e91ddbd9886b4e6f9de040241d095ce0" contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">50</ix:nonFraction>% of the next <ix:nonFraction name="erna:DefinedContributionPlanEmployeeContributionAtThresholdTwo" id="Fact_4d3f007617364965ba17cd0b8fbf40e0" contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">2</ix:nonFraction>% of the employee&#8217;s contribution, for a maximum Company match
        of <ix:nonFraction name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" id="Fact_4c61b01d00c24d71b25f1e07524089b2" contextRef="c20230101to20230101_RangeAxis_MaximumMember_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">4</ix:nonFraction>%.</div>
</ix:continuation>

      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:EarningsPerShareTextBlock" id="Text_73a0f143ec0e4578abb3a368832ca6c7" contextRef="c20220101to20221231" escape="true" continuedAt="Text_68724d67df894c48b9aa71caab2719741">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">13)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">
                <div><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Basic and Diluted Loss per Common Share</span></div>
              </div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_68724d67df894c48b9aa71caab2719741" continuedAt="Text_68724d67df894c48b9aa71caab2719742">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_68724d67df894c48b9aa71caab2719742" continuedAt="Text_68724d67df894c48b9aa71caab2719743">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted
        net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding plus dilutive securities.&#160; Shares of common stock issuable upon exercise, conversion or vesting of stock options, RSUs, warrants and
        other convertible securities, including our outstanding Series A Convertible Preferred Stock, are considered potential common shares and are included in the calculation of diluted net loss per share using the treasury method when their effect is
        dilutive. Diluted net loss per share is the same as basic net loss per share for periods in which the effect of potentially dilutive shares of common stock is antidilutive. <ix:nonNumeric name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="Text_a07923affcd647b7ba6eb50b89054ae0" contextRef="c20220101to20221231" escape="true" continuedAt="Text_6da69f9634ff4430bd4ae7b76c95c2301"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;">The following table presents the amount of warrants,
        stock options, convertible preferred stock and RSUs that were excluded from the computation of diluted net loss per common share for the years ended December 31, 2022 and 2021, as their effect was anti-dilutive (in thousands):<br />
      </span></ix:nonNumeric></div>
</ix:continuation>
      <ix:continuation id="Text_6da69f9634ff4430bd4ae7b76c95c2301" continuedAt="Text_6da69f9634ff4430bd4ae7b76c95c2302"><ix:continuation id="Text_68724d67df894c48b9aa71caab2719743" continuedAt="Text_68724d67df894c48b9aa71caab2719744">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_6da69f9634ff4430bd4ae7b76c95c2302"><ix:continuation id="Text_68724d67df894c48b9aa71caab2719744">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center; white-space: nowrap;" rowspan="1" colspan="6">
                <div style="text-align: center;"> <span style="font-weight: bold;">Years ended December 31,<br />
                  </span></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;"><br />
              </td>

    <td valign="bottom" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br />
                </div>
              </td>

    <td valign="bottom" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center;">&#160;<span style="font-size: 10pt; font-weight: bold;">2021</span></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; text-indent: -9pt; margin-left: 9pt; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
                <div style="margin-left: 9pt;"><span style="font-size: 10pt;">Warrants</span></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right; font-size: 10pt; white-space: nowrap;" rowspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_bbb735eb7b3d4a588bf542634d47a25c" contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,713</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" rowspan="1"></td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" rowspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_3d679e7c701a4f4cbc3b1b8727f1b984" contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 76%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Stock options</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_23c18ec29f334944b245522b9dfec95b" contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">359</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_c8b879610e524a5386bdb43d569e3c86" contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">199</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Preferred stock converted into common stock</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_c3b61d901c354c51b382c62b2889f7d9" contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_61008ca317854be0b7c51853cd3cd7a8" contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">2</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 76%; padding-bottom: 2px; white-space: nowrap;" rowspan="1"><span style="font-size: 10pt;">RSUs</span></td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_695fb40fc164486ab7f69d50cae94c22" contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_0b25872cd95d4ad08451bf57d0706f0c" contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">12</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Total potential common shares excluded from computation</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_2e718d7222e64dafa979243029b74bae" contextRef="c20220101to20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,083</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_41f64da39bde4a69b5a1afc073a41b33" contextRef="c20210101to20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">213</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>

      </div>
</ix:continuation></ix:continuation>

      <div><br />
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-26</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="Text_cbefb7b6443c4b948ef2e409c69e0a9e" contextRef="c20220101to20221231" escape="true" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d1">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">14)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Stock-Based Compensation</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d1" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d2" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d3">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Equity Incentive Plans</div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d3" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d4">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d4" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d5">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company&#8217;s stock-based compensation plans consist of the Restated 2020 Equity Incentive Plan (the &#8220;Restated 2020 Plan&#8221;) and
        the 2021 Inducement Equity Incentive Plan (the &#8220;2021 Inducement Plan&#8221;). The Company&#8217;s board of directors has designated its Compensation Committee as the administrator of the foregoing plans (the &#8220;Plan Administrator&#8221;). Among other things, the Plan
        Administrator selects persons to receive awards and determines the number of shares subject to each award and the terms, conditions, performance measures, if any, and other provisions of the award.</div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d5" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d6">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d6" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d7">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The
        Restated 2020 Plan provides for (a) approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_8d78243d7381405b8e9ecc900d00f49f" contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">424,000</ix:nonFraction> shares of common stock that can be issued under the Restated 2020 Plan and (b)
        an annual increase in the number of shares reserved for issuance on January 1 of each year from 2022 through 2031 equal to the lesser of (i) <ix:nonFraction name="erna:PercentageOfSharesOfCommonStockOutstanding" id="Fact_414fa7367af041bfb6485ee8c4ecf446" contextRef="c20221231_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>%
        of the number of shares of common stock outstanding on the immediately preceding December 31 and (ii) such smaller number of shares of common stock as may be determine by the board of directors (the &#8220;Annual Evergreen Shares&#8221;). Based on the number
        of shares of common stock outstanding on December 31, 2022, the maximum increase to the number of Annual Evergreen Shares of common stock that can be issued under the Restated 2020 Plan in 2023 is approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_08c8882607e94cfb95c2394b012c5c61" contextRef="c20221231_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">256,000</ix:nonFraction> shares. As of December 31, 2022, there have been <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" id="Fact_49952b977ebd4ea1bdd9587fb407c98c" contextRef="c20220101to20221231_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction>
        Annual Evergreen Shares added to the Restated 2020 Plan.<br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d7" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d8">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d8" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d9">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d9" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d10">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Awards under the Restated 2020 Plan may be granted to officers, directors, employees and consultants of the Company.&#160; Stock
        options granted under the Restated 2020 Plan may either be incentive stock options or nonqualified stock options, may have a term of up to <ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_bfaa85c5a56e4c23b8b5f82bb20fb30d" contextRef="c20220101to20221231_AwardTypeAxis_NonQualifiedStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember" format="ixt-sec:durwordsen"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_2607e669317543b7ac211ccc4132f82f" contextRef="c20220101to20221231_AwardTypeAxis_IncentiveStockOptionsMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">ten years</ix:nonNumeric></ix:nonNumeric>,
        and are exercisable at a price per share not less than the fair market value on the date of grant.&#160; As of December 31, 2022, there was approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_9d022489615c44739fe764706813131d" contextRef="c20221231_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">166,000</ix:nonFraction>
        shares of common stock remaining to be issued under the Restated 2020 Plan. As of December 31, 2021, there were approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_058c6ab36b624a84a6a6b577df6b5a10" contextRef="c20211231_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">258,000</ix:nonFraction>
        stock options outstanding under the Restated 2020 Plan. There were <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_24cc8a7b44b040aaa3632dd70c2c942b" contextRef="c20221231_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> RSUs outstanding under the Restated 2020 Plan as of December 31,
        2022.</div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d10" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d11">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d11" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d12">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The 2021 Inducement Plan provides for the grant of up to <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_dccbc67254b44d87b97e204d1e0e128a" contextRef="c20221231_PlanNameAxis_InducementPlan2021Member_RangeAxis_MaximumMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">75,000</ix:nonFraction> share-based awards as material inducement awards to new employees in accordance with the employment inducement grant rules set forth in Section 711(a) of the NYSE American LLC Company
        Guide. The 2021 Inducement Plan expires in May 2031. As of December 31, 2022, there was approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_27ecb145d740486e91ba3b8263d0f1c8" contextRef="c20221231_PlanNameAxis_InducementPlan2021Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">57,000</ix:nonFraction> shares of common stock
        remaining to be issued under the Restated 2020 Plan. As of December 31, 2021, there were approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_38c8e58ca2314d81951fd67e0625f7c8" contextRef="c20211231_PlanNameAxis_InducementPlan2021Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">12,000</ix:nonFraction> stock options outstanding
        and approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_c18ed5f7a8a54f3bb3d59ad10b11c463" contextRef="c20211231_PlanNameAxis_InducementPlan2021Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">4,000</ix:nonFraction> RSUs outstanding under the Restated 2020 Plan.</div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d12" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d13">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d13" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d14">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Equity Awards</div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d14" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d15">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d15" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d16">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Stock Options</span></div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d16" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d17">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d17" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d18">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company records stock-based compensation in accordance with ASC Topic 718, Compensation &#8211; Stock Compensation.&#160; The Company
        estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-lined basis.</div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d18" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d19">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d19" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d20">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The risk-free rate is based on the observed interest rates appropriate for the expected life. The expected life (estimated
        period of time outstanding) of the stock options granted is estimated using the &#8220;<span style="font-style: normal;">simplified</span>&#8221; method as permitted by the SEC&#8217;s Staff Accounting Bulletin No. 110, <span style="font-style: italic;">Share-Based
          Payment</span>. Expected volatility is based on the volatility of the Company&#8217;s peer group over the expected life of the stock option granted, and the Company assumes no dividends. Forfeitures are recognized as incurred.</div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d20" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d21">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d21" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d22">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;">&#160;<ix:nonNumeric name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="Text_79d90495a65a437688a20cd2e3b15161" contextRef="c20220101to20221231" escape="true" continuedAt="Text_310b70ede3d24fb48d0a4bac2c3a1e671"><span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following weighted-average assumptions were used for stock options granted during the years ended December 31, 2022 and 2021: </span></ix:nonNumeric></div>
</ix:continuation>
      <ix:continuation id="Text_310b70ede3d24fb48d0a4bac2c3a1e671" continuedAt="Text_310b70ede3d24fb48d0a4bac2c3a1e672"><ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d22" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d23">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_310b70ede3d24fb48d0a4bac2c3a1e672"><ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d23" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d24">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center; white-space: nowrap;" rowspan="1" colspan="6"><span style="font-weight: bold;">Year ended</span> <span style="font-weight: bold;">December 31,</span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" colspan="2">2021</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Weighted average risk-free rate</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact_71914c47188441b0b5dc7f6e122fe22d" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">2.52</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact_67a5656d736c4eea902bad0b44e67d10" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">1.09</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Weighted average volatility</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact_29f5aad58ddc49c3a950f67dc64918e3" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">90.49</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact_f6817ef8d4134a50ac7db6731c92484a" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">134.64</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Dividend yield</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" id="Fact_5dbace4d26eb47829bd34457f3425399" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" id="Fact_217ec9717b6f47ffa1b1d94c8b633d14" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Expected term</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; white-space: nowrap;" colspan="2"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Fact_fd4b4f94bde24a5681e5b4fcbed68721" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">5.79</ix:nonNumeric> years </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; white-space: nowrap;" colspan="2"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Fact_9a91271dbe164871984aea52d5caa451" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">6.10</ix:nonNumeric> years <br />
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d24" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d25">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-27</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>


      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d25" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d26"><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="Text_e14ca8bd850640aaa46f800cb8a5947e" contextRef="c20220101to20221231" escape="true" continuedAt="Text_126f7238903b4b73af0ffb5fdead5a9c1">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following table summarizes stock option activity for the years ended December 31, 2022 and 2021 (in thousands except for
        per-share and remaining contractual life data):</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d26" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d27"><ix:continuation id="Text_126f7238903b4b73af0ffb5fdead5a9c1" continuedAt="Text_126f7238903b4b73af0ffb5fdead5a9c2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d27" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d28"><ix:continuation id="Text_126f7238903b4b73af0ffb5fdead5a9c2">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-weight: bold;">Outstanding</span></div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Options</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">
                <div>Weighted </div>
                <div>Average </div>
                <div>Exercise</div>
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Price per</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Share</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Average</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Remaining </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Contractual </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Life (in</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">years)</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Aggregate</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Intrinsic</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Outstanding January 1, 2021</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_d50827d95e3a42b49f4443476435cb43" contextRef="c20201231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction><br />
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="Fact_494aa0e6f02f41b98abb57a155605f60" contextRef="c20201231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">-</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" id="Fact_9a9b935584844d06a32556aa84db92da" contextRef="c20201231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Granted</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_0f5b96da021d4eacb28c6db7ea27da1a" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">199</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" id="Fact_9debdf03284440f1b70d106445fa8506" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">168.04</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="margin-left: 9pt;">Cancelled<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" id="Fact_2e3ea5427dd24ceba0dc3ed29c840499" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" id="Fact_1287189444a6429d935985e8c72c801d" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Outstanding December 31, 2021</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_150365a7cd9a4e0fbbfa75edd035384d" contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">199</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="Fact_5a9716246add402ca32d40b91e355869" contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">168.04</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Fact_fdd187b26ef1469bb6854ce39be5b72d" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">9.38</ix:nonNumeric></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" id="Fact_f368ddaa6074420aa09d74102eeb5adf" contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Granted</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_b29bcde23b824f05a13e2566d6312b1b" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">287</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" id="Fact_fea40b62edb54d759bec3129f8856fce" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">17.29</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;" rowspan="1">
              <div style="margin-left: 9pt;">Cancelled</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" id="Fact_2ecdbb09f4b0484a81b1264c00c0a64f" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">127</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" id="Fact_7993359c01d646eabd1ef2dabeed1b8e" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">140.56</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">Outstanding December 31, 2022</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_cb25c2092f1944a4acbc3f003791ae27" contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">359</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="Fact_8add438f47ef400490816fd9f56f9a90" contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">57.18</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Fact_9ffb5a82fc894077b94f2161cc79bb27" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">7.57</ix:nonNumeric></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">$ <br />
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" id="Fact_f91b2f3c0fdd466ebb4f1a6dd9c9f971" contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; width: 52%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Options vested and exercisable at December 31, 2022</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" id="Fact_b3161b8ec1bf487c86609b40b374b771" contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">146</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" id="Fact_a19fe94541004e479e0d765a10dc2158" contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">109.60</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="Fact_af62c6f9589a43c3ae4ddb5c1caf991c" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">4.79</ix:nonNumeric><br />
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" id="Fact_43921ff8e5c942649a6387f565a7e780" contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d28" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d29">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d29" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d30">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The per-share weighted average grant-date fair value of stock options granted during the year ended December 31, 2022 and 2021 was $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_6b0917ed604e48c6949cdb7256c3b092" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">12.91</ix:nonFraction> and $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_785cfed293cd4884b23b1657366bf147" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">151.40</ix:nonFraction>, respectively.</div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d30" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d31">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d31" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d32">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">Pursuant



















          to a separation agreement entered into in May 2022 with the Company&#8217;s former chief executive officer, Dr. Howard Federoff, the Company accelerated the vesting of approximately <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" id="Fact_3e1733b2fab74df9804f8be46ef6e722" contextRef="c20220501to20220531_AwardTypeAxis_TimeBasedStockOptionMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">40,000</ix:nonFraction> stock options under certain time-based vesting stock option grants previously awarded to Dr. Federoff.&#160; The Company also waived a performance condition under a performance-based
          stock option grant and accelerated the vesting of approximately <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" id="Fact_4d93a705e8784865839776e18e4c2a56" contextRef="c20220501to20220531_AwardTypeAxis_PerformanceBasedStockOptionMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">21,000</ix:nonFraction> stock options under such grant.&#160; Lastly, the Company extended
          the post-termination exercise period from <ix:nonNumeric name="erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" id="Fact_b2dffa83e0fb4be0a8b7f2d66943a333" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember" format="ixt-sec:durwordsen">90 days</ix:nonNumeric> to <ix:nonNumeric name="erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" id="Fact_4721a98264f242c695e54b0de1b97600" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">36 months</ix:nonNumeric> immediately following his separation date for any options that were vested, including the options that accelerating in vesting, as described above.</div>
</ix:continuation>
        <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d32" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d33">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
          </span></div>
</ix:continuation>
        <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d33" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d34">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The above modifications to Dr. Federoff&#8217;s stock options grants resulted in modification accounting under ASC 718, <span style="font-style: italic;">Compensation



















              &#8211; Stock Compensation</span>. As a result, the Company immediately recognized approximately $<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" id="Fact_e5548919a34648229b576f049fe87c1d" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million during 2022 for the
            incremental fair value of stock options that were vested prior to the modification by calculating the difference between the fair value of the modified award and the fair value of the original award immediately before it was modified.&#160; For
            stock options that were not vested prior to the modification but then vested as a result of the acceleration, the Company reversed any stock compensation expense previously recognized, remeasured the fair value of the modified award and
            immediately recognized approximately $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_4bd019647f6a49aca3c2396efc3404a4" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million during 2022 of stock compensation expense in full since there was no future service
            period required to be provided.</span></div>
</ix:continuation>
        <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d34" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d35">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d35" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d36">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">As of December 31, 2022, the unamortized stock-based compensation expense related to outstanding unvested options was
        approximately $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" id="Fact_6e4414df41e14a4cbe4d56d6918586fa" contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="1" scale="0" format="ixt:num-dot-decimal">3.2</ix:nonFraction> million with a weighted average remaining requisite service period of <ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Fact_0d0b926b28764d2fb85855edf08387af" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">2.70</ix:nonNumeric> years. The Company expects to amortize this expense over the remaining requisite service period of these stock options.<br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d36" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d37">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d37" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d38">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Vesting of all stock options grants is subject to continuous service with the Company through such vesting dates.</div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d38" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d39">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br />
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-28</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d39" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d40">
<div><span style="text-decoration: underline;">Restricted Stock Units</span></div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d40" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d41">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <ix:nonNumeric name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="Text_9cd4792e81544e4da3dcf0dcca53502c" contextRef="c20220101to20221231" escape="true" continuedAt="Text_b5bc269efbc5494aaa901c2df4db64ae1"><ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d41" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d42">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following table summarizes RSU activity for the years ended December 31, 2022 and 2021 (in thousands except for per-share data):</div>
</ix:continuation></ix:nonNumeric>
      <ix:continuation id="Text_b5bc269efbc5494aaa901c2df4db64ae1" continuedAt="Text_b5bc269efbc5494aaa901c2df4db64ae2"><ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d42" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d43">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_b5bc269efbc5494aaa901c2df4db64ae2"><ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d43" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d44">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Outstanding</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Restricted</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Stock Units</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Average</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value per</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Share</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">January 1, 2021</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_c1bc34fc93664f769ce418a2c668ef63" contextRef="c20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" id="Fact_bd6d53e8ea2643f8a8c57a3060fbd0f8" contextRef="c20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Granted</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_d7dcbf180368456ba595369aa40a992b" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">12</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_4614d86ce41e4622a886c337afc0c001" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">276.00</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">December 31, 2021</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_9024ecb003154440b6dd275a4814048b" contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">12</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><br />
              </div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" id="Fact_0c806c041cf94892a7dc958d53c4522d" contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">276.00</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="margin-left: 9pt;">Granted</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_b28c134b355040d88d672c548ea3ede8" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">55</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_ecf08e94126b429292ad68485c2cd0ac" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">38.60</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" rowspan="1">
              <div style="margin-left: 9pt;">Released<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" id="Fact_a4202984efb047b981f950a74e5b5185" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" id="Fact_06865a1436154d839acd96566c7421c3" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">271.42</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" rowspan="1">
              <div style="margin-left: 9pt;">Cancelled<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_7246f86e56b6406aa9a3d2a000332b3f" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">60</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" id="Fact_4c810561639b48ba80f12d4cb3ebe139" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">61.03</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1">December 31, 2022</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_187f9dece5af41efbe8f2c6e22fac34b" contextRef="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" id="Fact_cb6df8e7358b42008adc82c2abae9f2b" contextRef="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">236.36</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; width: 76%;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">Balance expected to vest at December 31, 2022</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" id="Fact_75cfa96e358c4ec989b2af5f22894ade" contextRef="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d44" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d45">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;">
        <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d45" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d46">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The














          Company recognizes the fair value of RSUs granted as expense on a straight-line basis over the requisite service period. For performance based RSUs, the Company begins recognizing the expense once the achievement of the related performance goal
          is determined to be probable.</div>
</ix:continuation>
        <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d46" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d47">
<div><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d47" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d48">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Outstanding



















          RSUs are settled in an equal number of shares of common stock on the vesting date of the award. An RSU award is settled only to the extent vested. Vesting generally requires the continued employment or service by the award recipient through the
          respective vesting date. Because RSUs are settled in an equal number of shares of common stock without any offsetting payment by the recipient, the measurement of cost is based on the quoted market price of the stock at the measurement date,
          which is the grant date.</div>
</ix:continuation>
        <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d48" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d49">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
          </span> </div>
</ix:continuation>
        <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d49" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d50">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d50" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d51">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In lieu of paying cash to satisfy withholding taxes due upon the settlement of vested RSUs, at the Company&#8217;s discretion, an employee may elect to have shares of
            common stock withheld that would otherwise be issued at settlement, the value of which is equal to the amount of withholding taxes payable.&#160; There were <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" id="Fact_03024b08767343ac98fa851d73c16a95" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction> RSUs that vested during the year ended December 31, 2021.&#160; <ix:nonNumeric name="erna:ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" id="Text_38d30aca54634f919f03733502d22337" contextRef="c20220101to20221231" escape="true" continuedAt="Text_ca4a26959b5b47e7b4234a32d67d57f21"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal;">The following table shows the number of RSUs that vested and were settled during the year ended December 31, 2022, as well as the number of shares of common
            stock withheld to cover the withholding taxes and the net shares issued upon settlement (in thousands):</span></ix:nonNumeric></span></div>
</ix:continuation>
        <ix:continuation id="Text_ca4a26959b5b47e7b4234a32d67d57f21" continuedAt="Text_ca4a26959b5b47e7b4234a32d67d57f22"><ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d51" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d52">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 54pt; margin-right: 0.7pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_ca4a26959b5b47e7b4234a32d67d57f22"><ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d52" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d53">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 54pt; margin-right: 0.7pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: top; width: 86%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year ended</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 86%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 86%; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs vested</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 11%; background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" id="Fact_bcfdc372e7584c55a9e5db28a800e1c7" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 86%; padding-bottom: 2px;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Common stock withheld to cover taxes</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 11%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="erna:CommonStockWithheldToCoverTaxes" id="Fact_a497138f117246a79184d05cf4efc929" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 86%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Common stock issued</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 11%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_8ef95b9ef2f84af5841a8b85f69b94a2" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">2</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
           </div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d53" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d54">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d54" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d55">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Restricted Stock</span></div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d55" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d56">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d56" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d57">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Pursuant to the Merger, Eterna LLC&#8217;s approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_17074b36654a4ba1b37a61acd0d14e5a" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">3,000</ix:nonFraction> outstanding restricted common units were exchanged for approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_6352884327534da0b53b8391721b85d5" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">32,000</ix:nonFraction>
        shares of Eterna&#8217;s restricted common stock. There were no changes to any conditions and requirements of the restricted common stock. The shares vested quarterly beginning on March 31, 2021 and were to continue through December 31, 2022, contingent
        on continued service. Due to the modification of the restricted common units, the fair value of the restricted common stock immediately after the Merger was compared to the fair value of the restricted common units immediately prior to the Merger,
        and the change in fair value of $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_5d3f7cbba2cf4a50a3a77fbae9c2353f" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million was recognized in the statement of operations during the year ended December 31, 2021. The
        Company recognizes the fair value of restricted common stock as an expense on a straight-line basis over the requisite service period. During the year ended December 31, 2022, approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_c3e6ac4459e6465e8949bab0d20f9f7e" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">4,000</ix:nonFraction> shares of unvested restricted common stock were forfeited due to the holders of such shares no longer providing services to the Company. As of December 31, 2022 there
        were <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_0ce797c9211a47ad9d99c9edf3fd0c0a" contextRef="c20221231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> shares of unvested restricted stock outstanding.<br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d57" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d58">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d58" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d59">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Stock-Based Compensation Expense</div>
</ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d59" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d60">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d60" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d61"><ix:nonNumeric name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="Text_ba87933c6b6740c9be4aa9fc77f92191" contextRef="c20220101to20221231" escape="true" continuedAt="Text_73178a25461943a692f2e425593662241">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">For the years ended December 31, 2022 and 2021, the Company recognized stock-based compensation expense as follows (in
        thousands): <br />
      </div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d61" continuedAt="Text_368f0c7aa5a04df1b4421b6c1556dd2d62"><ix:continuation id="Text_73178a25461943a692f2e425593662241" continuedAt="Text_73178a25461943a692f2e425593662242">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;"> <br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_368f0c7aa5a04df1b4421b6c1556dd2d62"><ix:continuation id="Text_73178a25461943a692f2e425593662242">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: top; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; white-space: nowrap;" colspan="6">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ended December 31,</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2022<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2021<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Research and development</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">$<br />
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_e5f9146dbfbe43b69f1587607183e6af" contextRef="c20220101to20221231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,249</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">$<br />
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_9f93b8d6b4bb49b2aafa662afa2d31af" contextRef="c20210101to20211231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,597</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">General and administrative</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_395fcc523da0406dbdc0cdaff54a1903" contextRef="c20220101to20221231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,686</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_7a0be236d91f4acb82f9de304ca47c95" contextRef="c20210101to20211231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,638</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">$<br />
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_24b83cddeb2845e48045d6b2f34e788c" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,935</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">$<br />
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_fc22bac1df644747aa74d3f658ea7c92" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,235</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
         </div>
</ix:continuation></ix:continuation>
      <div><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-29</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="Text_521b4bd2711b4967be514bf5dae19c4c" contextRef="c20220101to20221231" escape="true" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc1">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">15)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Equity and Warrants</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <div>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc1" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc2" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc3">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-style: italic;">Private Placements of Equity</div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc3" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc4">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc4" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc5">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;">Q4-22 PIPE Transaction<br />
            </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc5" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc6">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc6" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc7">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On November 23, 2022, the Company entered into the Q4-22 Purchase Agreement with
            the Q4-22 PIPE Investors for the Q4-22 PIPE Transaction, pursuant to which the Company issued to the Q4-22 PIPE Investors an aggregate of&#160; approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_4503b28eb31d4c468fec151cca0a1b19" contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember" unitRef="U002" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,185,000</ix:nonFraction> units, with each unit consisting of (i) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_15cfe76ee51549368e760bd792b6991c" contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of common
            stock and (ii) <ix:nonFraction name="erna:NumberOfWarrantsInEachUnit" id="Fact_e2d761f5244a4e7ea4a6a591b0e9ef12" contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember_InvestmentTypeAxis_PIPEInvestorOneMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> Q4-22 Warrants, each exercisable to purchase <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_f32124102f924926bd748ea6ba27f1af" contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of common stock at an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_65838fb5dcab43ebad34e9b73a8712e3" contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">3.28</ix:nonFraction> per, at a purchase
            price of $<ix:nonFraction name="erna:UnitPriceOfWarrants" id="Fact_b46beca1dc6f4f7da591ad392e3c451e" contextRef="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorOneMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">3.53</ix:nonFraction> per unit (inclusive of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_eda40665fbff463e946c033769e0fa7a" contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember_InvestmentTypeAxis_PIPEInvestorOneMember" unitRef="U003" decimals="3" scale="0" format="ixt:num-dot-decimal">0.125</ix:nonFraction>
            per Q4-22 Warrant). The Company received aggregate gross proceeds of approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" id="Fact_2e9a78fd8d514ecaa3acb9e92f119730" contextRef="c20221202to20221202_InvestmentTypeAxis_PIPEInvestorOneMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">7.7</ix:nonFraction> million, and the Q4-22 PIPE Transaction
            closed on December 2, 2022. The Company incurred fees of approximately $<ix:nonFraction name="erna:TransactionFeesPayable" id="Fact_3ea099b16c394ebbaa3baa4e60c8c1f8" contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million through December 31, 2022 related to the Q4-22
            PIPE Transaction.</div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc7" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc8">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
          </div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc8" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc9">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each Q4-22 Warrant has an exercise
              price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_8534663d54194e6e8359b75f4615b032" contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">3.28</ix:nonFraction> per share, becomes exercisable <ix:nonNumeric name="erna:ClassOfWarrantOrRightsExercisableTerm" id="Fact_6b7096bda34041278445eea3543cec94" contextRef="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorOneMember" format="ixt-sec:durwordsen">six months</ix:nonNumeric> following the closing of the Q4-22 PIPE Transaction, expires <span style="-sec-ix-hidden:Fact_ead7f34b09d749a6b4ac3742e9967755">five-and-one-half</span>
              years from the date of issuance and is subject to customary adjustments. Certain of the Q4-22 Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed <ix:nonFraction name="erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="Fact_c7790281356645a9a5aed3692714cfde" contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorOneMember" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">4.99</ix:nonFraction>% immediately after exercise thereof, subject to increase to <ix:nonFraction name="erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="Fact_515c3c3edefa44c09689009781e74556" contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember_RangeAxis_MaximumMember" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">9.99</ix:nonFraction>% at the option of the holder.</div>
</ix:continuation>
            <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc9" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc10">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></div>

          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc10" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc11">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc11" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc12">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
          </div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc12" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc13">
<div style="display:none;"><br /></div>
<div style="text-indent: 27pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;">The Q4-22 Warrants meet the criteria for equity
              classification.</div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc13" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc14">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc14" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc15">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;">Q1-22 Private Placement</span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc15" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc16">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc16" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc17">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On March 6, 2022, the Company entered into the Q1-22 Purchase Agreement with the
            Q1-22 PIPE Investor for the Q1-22 PIPE Transaction, pursuant to which, the Company issued to the Q1-22 PIPE Investor approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_d158361e17204c3180180942639ee0f2" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt:num-dot-decimal">343,000</ix:nonFraction>
            units, each unit consisting of (i) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_f78eaedc67bf482ead23b0289517b2f6" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of the Company&#8217;s common stock (or, in lieu thereof, one Q1-22 Pre-Funded Warrant to
            purchase one share of common stock) and (ii) one warrant Q1-22&#160; Common Warrant to purchase <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_59e75f9e094043a2bd1d45f5a8f6a220" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of common stock, for an
            aggregate gross purchase price of approximately $<ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" id="Fact_598138eda4204a4eb62f3d66891f8732" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">12.0</ix:nonFraction> million (the &#8220;Subscription Amount&#8221;). The Q1-22 PIPE Transaction closed on March
            9, 2022. Pursuant to the Q1-22 Purchase Agreement, the Company was prohibited from issuing equity in variable rate transactions for a period of <ix:nonNumeric name="erna:VariableRateTransactionsPeriod" id="Fact_251bf9075f2e40a09a8583849ae94f30" contextRef="c20220306to20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" format="ixt-sec:durwordsen">one-year</ix:nonNumeric>
            following consummation of the Q1-22 PIPE Transaction, including issuing equity under the Second Purchase Agreement, which is discussed below.</div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc17" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc18">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
          </div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc18" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc19">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each Q1-22 Pre-Funded Warrant had an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_1c12c15f3d1046e4a79336a1965c6498" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">0.10</ix:nonFraction> per share of common stock, was immediately exercisable, could be exercised at any time, had no expiration date and was subject to customary
              adjustments. The Q1-22 Pre-Funded Warrants could not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed <ix:nonFraction name="erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="Fact_d6f0a0c6012e4715b38beb26d2b3ca8e" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">9.99</ix:nonFraction>% immediately after exercise thereof.&#160; Upon the closing of the Q1-22 PIPE Transaction, the Company issued <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_34d307abf12442729c6e25fd606a6ccd" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">275,000</ix:nonFraction> shares of common stock, approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_5c57130310e8458a86316ccfdf7a7d90" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">68,000</ix:nonFraction> Q1-22 Pre-Funded
              Warrants and approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_219bcd9069d7427ab63112b686cd5777" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt:num-dot-decimal">343,000</ix:nonFraction> Q1-22 Common Warrants.</div>
</ix:continuation>
            <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc19" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc20">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></div>

          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc20" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc21">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc21" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc22">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
              </span> </div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc22" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc23">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <a id="z_Hlk118110996"></a><ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc23" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc24">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each Q1-22 Common Warrant has an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_92dcae471db84d328e76a6397ab126b3" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">38.20</ix:nonFraction> per share, became exercisable <ix:nonNumeric name="erna:ClassOfWarrantOrRightsExercisableTerm" id="Fact_5d5fd8762df04a158d3b01f692a3ef9a" contextRef="c20220306to20220306_InvestmentTypeAxis_PIPEInvestorMember" format="ixt-sec:durwordsen">six months</ix:nonNumeric>
              following the closing of the Q1-22 PIPE Transaction, expires <span style="-sec-ix-hidden:Fact_d45bfc25257042c4abeb3af3c960c760">five-and-one-half</span> years from the date of issuance and is subject to
              customary adjustments. The Q1-22 Common Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed <ix:nonFraction name="erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="Fact_15cfa72df4a144d49aff57a025a06ee3" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">4.99</ix:nonFraction>% immediately after exercise thereof, subject to increase to <ix:nonFraction name="erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="Fact_36353374c5884c169d6a3d338ab86f0f" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">9.99</ix:nonFraction>%
              at the option of the holder.</div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc24" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc25">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc25" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc26">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
            </span> </div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc26" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc27">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc27" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc28">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Q1-22 Common Warrants and Q1-22 Pre-Funded Warrants were accounted for as liabilities under ASC 815-40, as these warrants provide for a cashless settlement provision
            that does not meet the requirements of the indexation guidance under ASC 815-40.&#160; These warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of
            operations.&#160; (See Note 5 for more information related to changes in fair value.) Upon exercise of the Q1-22 Common Warrants and Q1-22 Pre-Funded Warrants, the fair value on the exercise date is reclassified from warrant liabilities to equity.</div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc28" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc29">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc29" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc30">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
            </span> </div>
</ix:continuation>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-30</span></div>

            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

            <div style="width: 100%;" class="BRPFPageHeader">
              <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
              </div>

            </div>

          </div>

          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc30" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc31">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc31" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc32">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The fair values of the Q1-22 Common Warrants and the
              Q1-22 Pre-Funded Warrants at the issuance date totaled $<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_601b09d8a7d5453f9be0ba42bdd1b22e" contextRef="c20220306to20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">12.6</ix:nonFraction> million in the aggregate, which was $<ix:nonFraction name="erna:OverSubscriptionAmountReceived" id="Fact_ee92837a41cb4f6c8f488fe6cc49cbbc" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million more than the Subscription Amount.&#160; The excess $<ix:nonFraction name="erna:OverSubscriptionAmountReceived" id="Fact_02789ab4296745c080b40a3dc2002efe" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million represents an inducement to the Q1-22 PIPE Investor to enter into the Q1-22 PIPE Transaction and was recorded in warrant liabilities expense in the accompanying
              consolidated statement of operations.<br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc32" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc33">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
            </div>
</ix:continuation>
          </div>

          <a id="z_Hlk118110988"></a><ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc33" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc34">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On July 12, 2022, the Q1-22 PIPE Investor exercised its <ix:nonFraction name="erna:ClassOfWarrantOrRightExercised" id="Fact_8645794c5537420b811119543502dded" contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt:num-dot-decimal">68,000</ix:nonFraction> Q1-22 Pre-Funded Warrants at an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_db5a3a599a0949a8a8d8a1e5b26bb808" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">0.10</ix:nonFraction> per share
            for an aggregate exercise price of approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" id="Fact_ff0bd6a23cd94a16a65a719a915a8e28" contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">7,000</ix:nonFraction>, in cash. The Company issued 68,000 shares of common stock to the Q1-22 PIPE
            Investor on July 14, 2022 upon receipt of the cash proceeds and reclassified approximately $<ix:nonFraction name="erna:ClassOfWarrantOrRightExercised" id="Fact_2452b5f23c3242b9bc8357340ecf75f9" contextRef="c20220714to20220714_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.7</ix:nonFraction> million of the fair value of the
            exercised warrants as of the exercise date from warrant liabilities to equity. Subsequent to the exercise, no Q1-22 Pre-Funded Warrants remained outstanding.</div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc34" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc35">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc35" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc36">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
            </span> </div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc36" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc37">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc37" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc38">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Company incurred fees of approximately $<ix:nonFraction name="erna:TransactionFeesPayable" id="Fact_39d4a67ab2f5453297d524ec2b0ff9f7" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.0</ix:nonFraction> million
            through December 31, 2022 related to the Q1-22 PIPE Transaction, which were allocated to the fair value of the Q1-22 Warrants and the Q1-22 Pre-Funded Warrants and recorded in other expense, net on the accompanying consolidated statement of
            operations.</div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc38" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc39">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc39" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc40">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
            </span> </div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc40" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc41">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc41" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc42">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">In connection with the Q1-22 PIPE Transaction, the Company and the Q1-22 PIPE Investor also entered into a registration rights agreement, dated March
            6, 2022, pursuant to which the Company agreed to prepare and file a registration statement with the SEC no later than <ix:nonNumeric name="erna:AggregateCalendarDays" id="Fact_135822312151432c9c2df34b7f900ab1" contextRef="c20220306to20220306_InvestmentTypeAxis_PIPEInvestorMember" format="ixt-sec:durday">15</ix:nonNumeric> days
            following the filing date of the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021 (the &#8220;2021 Annual Report&#8221;) to register the resale of the shares of common stock included in the Units and the shares of common stock
            issuable upon exercise of the Q1-22 Pre-Funded Warrants and the Q1-22 Common Warrants. The Company agreed to use its best efforts to have such registration statement declared effective as promptly as possible after the filing thereof, subject
            to certain specified penalties if timely effectiveness were not achieved.&#160; The Company filed the 2021 Annual Report on April 15, 2022 and the registration statement on April 29, 2022.&#160; The resale registration statement became effective on May
            11, 2022.</div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc42" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc43">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc43" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc44">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
            </span> </div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc44" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc45">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc45" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc46">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">Pursuant to the registration rights agreement, the Company is obligated to pay the Q1-22 PIPE Investor liquidated damages equal to <ix:nonFraction name="erna:ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" id="Fact_c54b0d19fcac4015a04007f5a15d3781" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">2</ix:nonFraction>% of the Subscription Amount per month, with a maximum aggregate payment of <ix:nonFraction name="erna:ObligationToPayLiquidatedDamagesPercentage" id="Fact_2faba044191541c6bec3802995796360" contextRef="c20221231_InvestmentTypeAxis_PIPEInvestorMember_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">12</ix:nonFraction>% of the Subscription Amount, in the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered for resale thereunder
            for more than a specified period of time.</div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc46" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc47">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc47" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc48">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
            </span> </div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc48" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc49">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc49" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc50">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">On May 24, 2022, the Company notified the Q1-22 PIPE Investor that it was not able to use the registration agreement because the Company had not
            timely filed its Quarterly Report on Form 10-Q (the &#8220;Q1 2022 10-Q&#8221;) with the SEC, and that the Q1-22 PIPE Investor could not use the registration statement to resell the securities registered thereunder until the Company filed the Q1 2022
            10-Q.&#160; Because of the Q1-22 PIPE&#160; Investor&#8217;s inability to use the registration statement, the Company accrued $<ix:nonFraction name="us-gaap:LossContingencyEstimateOfPossibleLoss" id="Fact_a44f0350da44468cb9d3a1a1e9f8ba5e" contextRef="c20221231_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million during
            2022 for the contingent loss the Company incurred as liquidated damages as a result of the late Q1 2022 10Q filing, which is recorded in other expense, net for the year ended December 31, 2022 in the accompanying consolidated statements of
            operations.&#160; The Company paid such $<ix:nonFraction name="us-gaap:LossContingencyDamagesPaidValue" id="Fact_ffa50ea0e1ac4067ab795f0079db7a51" contextRef="c20220601to20220630_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million liquidated damages payment in June 2022.</div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc50" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc51">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc51" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc52">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc52" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc53">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">On June 30, 2022, the Company filed its Q1 2022 10-Q along
            with an amended Annual Report on Form 10-K/A for the year ended December 31, 2021, and on July 1, 2022, the Company provided its notice to the Q1-22 PIPE Investor that it could resume use of the resale registration statement.</div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc53" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc54">
<div><br />
            </div>
</ix:continuation>
          </div>


          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc54" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc55"><ix:nonNumeric name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="Text_be9dff19f7964586a75f66027ef892fa" contextRef="c20220101to20221231" escape="true" continuedAt="Text_d6c708c687bf49fd99c10c7d6f43e4ac1">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">The following table shows the Company&#8217;s warrant
            activity for the year ended December 31, 2022 (in thousands except for per-share data):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc55" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc56"><ix:continuation id="Text_d6c708c687bf49fd99c10c7d6f43e4ac1" continuedAt="Text_d6c708c687bf49fd99c10c7d6f43e4ac2">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
          </div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc56" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc57"><ix:continuation id="Text_d6c708c687bf49fd99c10c7d6f43e4ac2">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 2022</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Pre-Funded</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">November 2022</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Balance as of January 1, 2022</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_ddee430b7c2c400da5811fd4d8aad0c4" contextRef="c20211231_ClassOfWarrantOrRightAxis_March2022WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_9a6a30b1c3fb4632ac9f1cd891004967" contextRef="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_5c4083057cdb479fa6716d83bd32daee" contextRef="c20211231_ClassOfWarrantOrRightAxis_November2022WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_5a09a18f59ce420f840ac40329681565" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Granted</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ClassOfWarrantOrRightGrantsInPeriod" id="Fact_6790011230ad4af783043293a9fa717c" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_March2022WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">343</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ClassOfWarrantOrRightGrantsInPeriod" id="Fact_af7cc0a77f7142649db73575e1c1c35e" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">68</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ClassOfWarrantOrRightGrantsInPeriod" id="Fact_8386e74f116e4135a056c7e60aad84e9" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_November2022WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">4,370</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ClassOfWarrantOrRightGrantsInPeriod" id="Fact_6eb319846652495997d523f96ecb1327" contextRef="c20220101to20221231" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">4,781</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Exercised</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ClassOfWarrantOrRightExercisedInPeriod" id="Fact_249c7af14dda4593a7c291ffa7fe5b6d" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_March2022WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:ClassOfWarrantOrRightExercisedInPeriod" id="Fact_68b49594ace047a6ac348c8c2fc36eec" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">68</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ClassOfWarrantOrRightExercisedInPeriod" id="Fact_2534898dc02441d399275063fd38c4b0" contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_November2022WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:ClassOfWarrantOrRightExercisedInPeriod" id="Fact_0c91df92f1c846c89cc474847f7c37ae" contextRef="c20220101to20221231" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">68</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Balance as of December 31, 2022</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_7176e1eb04034b57ab4c6572786fd508" contextRef="c20221231_ClassOfWarrantOrRightAxis_March2022WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">343</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_48dfdfc40bb947378439f3fff1635f84" contextRef="c20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_10782c3233174a73bd860f2d636b78e2" contextRef="c20221231_ClassOfWarrantOrRightAxis_November2022WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">4,370</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_9c5e3ed8a9fd4a60b49c132e1c299417" contextRef="c20221231" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">4,713</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc57" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc58">
<div><br />
            </div>
</ix:continuation>
          </div>

          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc58" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc59">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As of December 31, 2022, the weighted average remaining
              contractual life of the warrants outstanding was <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Fact_361203a64dc943dba28bcaece5872d36" contextRef="c20221231_ClassOfWarrantOrRightAxis_WarrantMember" format="ixt-sec:duryear">5.37</ix:nonNumeric> years and the weighted average exercise price was $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_aa77d2416d2143a28723480de3521909" contextRef="c20221231_ClassOfWarrantOrRightAxis_WarrantMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">5.82</ix:nonFraction>.</div>
</ix:continuation>
          </div>

          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc59" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc60">
<div><br />
            </div>
</ix:continuation>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-31</span></div>

              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

              <div style="width: 100%;" class="BRPFPageHeader">
                <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
                </div>

              </div>

            </div>

          </div>

        </div>

        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc60" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc61">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Equity Line Offerings</div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc61" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc62">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc62" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc63">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">On April 26, 2021, the Company entered into a common stock purchase agreement (the &#8220;First Purchase
            Agreement&#8221;) an investment group (the &#8220;Investment Group&#8221;), which provided that the Company could offer to the Investment Group up to an aggregate o</span>f $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_f7004cff091844f8b82413345b014776" contextRef="c20210426to20210426_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember_TypeOfArrangementAxis_FirstPurchaseAgreementMember" unitRef="U001" decimals="-6" scale="6" format="ixt:num-dot-decimal">20</ix:nonFraction> million of common stock over a 36-month period commencing after May 10, 2021, the date that a registration statement covering the resale of shares of common stock issued under the First
          Purchase Agreement was declared effective by the SEC. As of December 31, 2022, the Company had issued and sold an aggregate of approximately <ix:nonFraction name="us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" id="Fact_3776e05ae3fc446c92aeb0dd9a04f296" contextRef="c20210426to20210426_LegalEntityAxis_LincolnParkCapitalFundLLCMember_TypeOfArrangementAxis_FirstPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">56,000</ix:nonFraction>
          shares of common stock to the Investment Group pursuant to the First Purchase Agreement, resulting in gross proceeds of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" id="Fact_517ebba79d0447d187cdff1aade0d82f" contextRef="c20210426to20210426_TypeOfArrangementAxis_FirstPurchaseAgreementMember" unitRef="U001" decimals="-6" scale="6" format="ixt:num-dot-decimal">20</ix:nonFraction> million.</span></div>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc63" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc64">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation>
    </div>

    <div>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc64" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc65">
<div style="display:none;"><br /></div>
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">On May 26, 2021, the Company entered into a second common stock purchase agreement (the &#8220;Second
          Purchase Agreement&#8221;) with the Investment Group, which provides that the Company may offer to the Investment Group up to an aggregate of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_bfc43931724e4d94ab577972ca1f1ac6" contextRef="c20210526to20210526_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember" unitRef="U001" decimals="-6" scale="6" format="ixt:num-dot-decimal">40</ix:nonFraction>
          million of common stock over a 36-month period commencing after June 4, 2021, the date that a registration statement covering the resale of shares of common stock issued under the Second Purchase Agreement was declared effective by the SEC. As of
          December 31, 2022, the Company had issued and sold an aggregate of approximately <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" id="Fact_a26cdd7ddc6e424086ea65845239e1fa" contextRef="c20210526to20210526_TypeOfArrangementAxis_SecondPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">121,000</ix:nonFraction> shares of common stock to the Investment
          Group pursuant to the Second Purchase Agreement, resulting in gross proceeds of approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" id="Fact_a2a217e506034194871d13c87ab1a4ae" contextRef="c20210526to20210526_TypeOfArrangementAxis_SecondPurchaseAgreementMember" unitRef="U001" decimals="-6" scale="6" format="ixt:num-dot-decimal">34</ix:nonFraction> million. As of December 31, 2022,
          there were approximately <ix:nonFraction name="erna:SaleOfStockNumberOfSharesToIssuedInTransaction" id="Fact_d739276be7334d2495de107f20fd5a7e" contextRef="c20220101to20221231_TypeOfArrangementAxis_SecondPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">22,000</ix:nonFraction> shares remaining to be sold under the Second Purchase Agreement.</span> </div>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc65" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc66">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc66" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc67">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Under the Second Purchase Agreement, the Company may direct the Investment Group to purchase up to <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_4a99e8ef52a04538b88a5272c36fb1e6" contextRef="c20210426_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">3,000</ix:nonFraction> shares of common stock on any business day (the &#8220;Regular Purchase&#8221;), which amount may be increased up to <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_1efb4b4a98fc4a5688a4ea26720c791b" contextRef="c20221231_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">6,000</ix:nonFraction> shares based on the closing price of the common stock, provided that&#160; the Investment Group&#8217;s maximum commitment in any single Regular Purchase
          may not exceed $<ix:nonFraction name="erna:CommitmentAmountToMeetAnySingleRegularPurchase" id="Fact_e5b6deba9b634ead95e94c64b67dd776" contextRef="c20210426_RangeAxis_MaximumMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction> million. The purchase price per share for each such Regular Purchase is based off of the common stock&#8217;s market
          immediately preceding the time of sale.<br />
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc67" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc68">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc68" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc69">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Second Purchase Agreement also prohibits the Company from directing the Investment Group to purchase any shares of common
          stock if those shares, when aggregated with all other shares of common stock then beneficially owned by the Investment Group and its affiliates, would result in the Investment Group and its affiliates having beneficial ownership, at any single
          point in time, of more than <ix:nonFraction name="erna:BeneficialOwnershipPercentageOnTotalOutstandingShares" id="Fact_6527dd1fe4984164851a4eb8ca97cbdb" contextRef="c20210426_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">4.99</ix:nonFraction>% of the then total outstanding shares of common stock. The Company has the right to terminate the
          Second Purchase Agreement at any time, at no cost or penalty.</div>
</ix:continuation>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc69" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc70">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc70" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc71">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Actual sales of shares of common stock to the Investment Group under the Second Purchase Agreement depend on a variety of
          factors to be determined by us from time to time, including, among others, market conditions, the trading price of the common stock and determinations by the Company as to the appropriate sources of funding for the Company and its operations.<br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc71" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc72">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc72" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc73">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Pursuant to the Q1-22 Purchase Agreement in respect of the Q1-22 PIPE Transaction, the Company was prohibited from issuing additional shares under the Second Purchase Agreement for a period of one-year
            immediately following the closing of the Q1-22 PIPE Transaction.</span> </div>
</ix:continuation>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc73" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc74">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc74" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc75">
<div style="font-style: italic;">Merger </div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc75" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc76">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc76" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc77">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Under the terms of the Merger Agreement (see Notes 1 and 4), on March 25, 2021, the Company issued shares of common stock to
          the equity holders of Eterna LLC. The <ix:nonFraction name="us-gaap:SharesIssued" id="Fact_8a2d69153d344bae9b74af4ce407d378" contextRef="c20210325_StatementClassOfStockAxis_CommonClassAMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">87,000</ix:nonFraction> Class A units of Eterna LLC were converted into approximately <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" id="Fact_9e22995c1e034e2ab149958394f19a68" contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassAMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">1,114,000</ix:nonFraction> shares of common stock; the <ix:nonFraction name="us-gaap:SharesIssued" id="Fact_dba32cf8775b4da594abed3a630d8765" contextRef="c20210325_StatementClassOfStockAxis_CommonClassBMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">15,000,000</ix:nonFraction>
          Class B units were converted into approximately <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" id="Fact_c8d2fec43e5344feb1db55e0861a5c82" contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassBMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">126,000</ix:nonFraction> shares of common stock; the <ix:nonFraction name="us-gaap:SharesIssued" id="Fact_801ddb34b7324c2f8460b08e49af829e" contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction> Class C units were converted into approximately <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" id="Fact_c1d1cfe24ff74ac89f36ce2c7eb689e2" contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassCMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">84,000</ix:nonFraction>
          shares of common stock; approximately <ix:nonFraction name="us-gaap:SharesIssued" id="Fact_aca1de23f8894135b560e06134189047" contextRef="c20210325_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">630,000</ix:nonFraction> shares of common units were converted into approximately <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" id="Fact_4decfe9df21744e2a4216444858eb400" contextRef="c20210325to20210325_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">31,000</ix:nonFraction> shares of common stock, and <ix:nonFraction name="erna:ClassOfWarrantOrRightIssued" id="Fact_d735ea58fe394955ae40c86f6122ec14" contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">10,500,000</ix:nonFraction>
          rights options were converted into approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_fd8d98cb8d914fc4a114ea75d5cc3154" contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">591,000</ix:nonFraction> shares of common stock.&#160; The Company also issued approximately <ix:nonFraction name="erna:StockIssuedDuringPeriodSharesAcquisitions1" id="Fact_0bd53fadc0574da29ff7c3fa7668f007" contextRef="c20210325to20210325" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">53,000</ix:nonFraction> shares of common stock to the Financial Advisor pursuant to the Merger Agreement.</div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc77" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc78">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc78" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc79">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Acquisition</div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc79" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc80">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc80" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc81">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Under the terms of the Novellus Acquisition (see Notes 1 and 4), on July 16, 2021, the Company issued approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" id="Fact_79d775385251499fb1b6bf96087c102a" contextRef="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">351,000</ix:nonFraction> shares of common stock, of which approximately <ix:nonFraction name="erna:StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" id="Fact_4e4948aeac794667accdc05ac3a0499d" contextRef="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">182,000</ix:nonFraction>
          shares are unrestricted and approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="Fact_d1f23cbd1d7f4c128705220096defef4" contextRef="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">169,000</ix:nonFraction> shares are subject to a <ix:nonNumeric name="erna:EachLockUpAgreementExtendsTerm" id="Fact_37278f3a5b2048a38a07bef19531f4ae" contextRef="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember" format="ixt-sec:durwordsen">three-year</ix:nonNumeric> lockup agreement, provided that up to <ix:nonFraction name="erna:PercentageOfCommonStockSubjectToLockUpAgreement" id="Fact_5583be9459624b84bb8e25f83054b918" contextRef="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">75</ix:nonFraction>% of the shares of common
          stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock on the principal market for the common stock exceeds specified thresholds.</div>
</ix:continuation>
        <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc81" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc82">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc82" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc83">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> Cumulative Convertible Preferred Stock </span></div>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc83" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc84">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc84" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc85">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">As a result of the Merger, the Company has authorized <ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_f7ca598309e14ab49087af7b892b3419" contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_919b660f978d472789f00d9e0bc03c7d" contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_5c5d8b77706a4209a10526552053a391" contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">156,000</ix:nonFraction></ix:nonFraction></ix:nonFraction> shares of preferred stock, all of which is designated as Series A Cumulative Convertible Preferred Stock (the &#8220;Series A Preferred Stock&#8221;), and all of which were issued and
        outstanding as of December 31, 2022.</div>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc85" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc86">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-32</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>

      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc86" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc87">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Series A Preferred Stock provides for a cumulative annual dividend of $<ix:nonFraction name="us-gaap:DividendsPayableAmountPerShare" id="Fact_52def56ee6fc4583afe61d8d9a5163dc" contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">0.10</ix:nonFraction> per share, payable in semi-annual installments in June and December. Dividends may be paid in cash or with shares of common stock.<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company paid approximately $<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_0bf1c3913a3f4bbc92f53ffe6e8fc449" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">16,000</ix:nonFraction> in cash for payment of dividends during the year ended December 31, 2022</span>.</span> The Company paid approximately $<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_bbfaa7d1f02747478c7d87882a6afae0" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">8,000</ix:nonFraction> in cash and issued approximately <ix:nonFraction name="us-gaap:PreferredStockDividendsShares" id="Fact_a6adea1deec84bb290023605f054bf2f" contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">10</ix:nonFraction> shares of common stock for payment of dividends during the
        year ended December 31, 2021.</div>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc87" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc88">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc88" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc89">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Series A Preferred Stock has no voting rights and has a $<ix:nonFraction name="us-gaap:PreferredStockLiquidationPreference" id="Fact_2cefb91d99ee4333ab661e744bb53b0c" contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.00</ix:nonFraction> per share liquidation preference over common stock. The registered holder has the right at any time to convert shares of Series A Preferred Stock into that number of shares of common
        stock that equals the number of shares of Series A Preferred Stock that are surrendered for conversion divided by the conversion rate.&#160; At December 31, 2022, the conversion rate was <ix:nonFraction name="us-gaap:PreferredStockConvertibleConversionRatio" id="Fact_fd9048399b8f4ce5a5d1d9879b8a5199" contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U005" decimals="4" scale="0" format="ixt:num-dot-decimal">23.9988</ix:nonFraction> and, based on that conversion rate, one share of Series A Convertible Preferred Stock would have converted into approximately <ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" id="Fact_9314ce700ef44f5c8a0ad29b1cb2e9b8" contextRef="c20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="2" scale="0" format="ixt:num-dot-decimal">0.04</ix:nonFraction> shares of common stock, and all the outstanding shares of the Series A Convertible Preferred Stock would have converted into approximately <ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" id="Fact_4ea41a52c4044d6d84215f43648af106" contextRef="c20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">6,000</ix:nonFraction> shares of common stock in the aggregate. There were <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" id="Fact_fb2359418eb742759e6bd571dfb38380" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" id="Fact_279c5c69f312489782e1d65e514cb5a6" contextRef="c20210101to20211231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>
        conversions during the years ended December 31, 2022 and 2021. There is no mandatory conversion term, date or any redemption features associated with the Series A Preferred Stock. The conversion rate will adjust under the following circumstances:</div>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc89" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc90">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc90" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc91">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">1.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">If the Company (a) pays a dividend or makes a distribution in shares of its common stock, (b) subdivides its outstanding shares of common stock into a greater number of shares, (c) combines its outstanding
                shares of common stock into a smaller number of shares, or (d) issues by reclassification of its shares of common stock any shares of its common stock (other than a change in par value, or from par value to no par value, or from no par
                value to par value), then the conversion rate in effect immediately prior to the applicable event will be adjusted so that the holders of the Series A Convertible Preferred Stock will be entitled to receive the number of shares of common
                stock which they would have owned or have been entitled to receive immediately following the happening of the event, had the Series A Convertible Preferred Stock been converted immediately prior to the record or effective date of the
                applicable event.</div>
            </td>

  </tr>


</table>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc91" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc92">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc92" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc93">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">2.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">If the outstanding shares of the Company&#8217;s common stock are reclassified (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result of a
                subdivision, combination or stock dividend), or if the Company consolidates with or merge into another corporation and the Company is not the surviving entity, or if the Company sells all or substantially all of its property, assets,
                business and goodwill, then the holders of the Series A Convertible Preferred Stock will thereafter be entitled upon conversion to the kind and amount of shares of stock or other equity securities, or other property or assets which would
                have been receivable by such holders upon such reclassification, consolidation, merger or sale, if the Series A Convertible Preferred Stock had been converted immediately prior thereto.</div>
            </td>

  </tr>


</table>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc93" continuedAt="Text_8b2b07c46750476a86e4775f49a46dfc94">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_8b2b07c46750476a86e4775f49a46dfc94">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">3.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">If the Company issues common stock without consideration or for a consideration per share less than the then applicable Equivalent Preference Amount (as defined below), then the Equivalent Preference Amount
                will immediately be reduced to the amount determined by dividing (A) an amount equal to the sum of (1) the number of shares of common stock outstanding immediately prior to such issuance multiplied by the Equivalent Preference Amount in
                effect immediately prior to such issuance and (2) the consideration, if any, received by the Company upon such issuance, by (B) the total number of shares of common stock outstanding immediately after such issuance. The &#8220;Equivalent
                Preference Amount&#8221; is the value that results when the liquidation preference of one share of Series A Convertible Preferred Stock (which is $<ix:nonFraction name="us-gaap:PreferredStockLiquidationPreference" id="Fact_d01734687aa2453688344c89047a4672" contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.00</ix:nonFraction>)
                is multiplied by the conversion rate in effect at that time; thus the conversion rate applicable after the adjustment in the Equivalent Preference Amount as described herein will be the figure that results when the adjusted Equivalent
                Preference Amount is divided by the liquidation preference of one share of Series A Convertible Preferred Stock.</div>
            </td>

  </tr>


</table>
</ix:continuation>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:IncomeTaxDisclosureTextBlock" id="Text_5e8fbae6b1184b969719cbe3a9c28eb5" contextRef="c20220101to20221231" escape="true" continuedAt="Text_c89dba22789549f281faed2738e60ae21">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 35.9pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">16)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Income Taxes</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_c89dba22789549f281faed2738e60ae21" continuedAt="Text_c89dba22789549f281faed2738e60ae22">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae22" continuedAt="Text_c89dba22789549f281faed2738e60ae23"><ix:nonNumeric name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="Text_a3f4ee5e0f204eb396b5a3cc7b336925" contextRef="c20220101to20221231" escape="true" continuedAt="Text_715695bf570f4f8b813d7bb9601db9101">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Loss before income taxes consist of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae23" continuedAt="Text_c89dba22789549f281faed2738e60ae24"><ix:continuation id="Text_715695bf570f4f8b813d7bb9601db9101" continuedAt="Text_715695bf570f4f8b813d7bb9601db9102">
<div><br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae24" continuedAt="Text_c89dba22789549f281faed2738e60ae25"><ix:continuation id="Text_715695bf570f4f8b813d7bb9601db9102">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td valign="bottom" colspan="7" style="vertical-align: top; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ended December 31,</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td valign="bottom" colspan="3" style="vertical-align: top; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2022</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="3" style="vertical-align: top; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top;"><span style="font-weight: bold;">&#160;<span style="font-style: italic;">(in thousands)</span></span><br />
              </td>

    <td valign="bottom" colspan="3" rowspan="1" style="vertical-align: bottom; text-align: center; text-indent: 9pt; font-weight: bold; white-space: nowrap;"><br />
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-indent: 9pt; font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;"><br />
              </td>

    <td valign="bottom" colspan="3" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; white-space: nowrap;"><br />
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Domestic</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" id="Fact_59392ae40e7446ebab90a0daae31253b" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,513</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" id="Fact_396a2c22843d40ad8e8e20dce508f2c7" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">122,476</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Foreign</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" id="Fact_3d27e6dace4a400ab7c45d03c60b3203" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">21</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" id="Fact_2e9ea2b84bf94df0a41ab3f6d853b8ab" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total loss before income taxes</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_ebd3c525c17f489fbd38f474675d9213" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,534</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_8a2bdba9582d41439204b8990e398cb3" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">122,481</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
        </div>

      <ix:continuation id="Text_c89dba22789549f281faed2738e60ae25" continuedAt="Text_c89dba22789549f281faed2738e60ae26">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-33</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
          </div>

        </div>

      </div>


      <ix:continuation id="Text_c89dba22789549f281faed2738e60ae26" continuedAt="Text_c89dba22789549f281faed2738e60ae27"><ix:nonNumeric name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="Text_d7cc4244179e400cafb6c5f814b5ad21" contextRef="c20220101to20221231" escape="true" continuedAt="Text_bebfa4d6f38f4f38b5e4002690a1f9fc1">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">For each of the years ended December 31, 2022 and 2021, current tax provisions and current deferred tax provisions were
        recorded as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_c89dba22789549f281faed2738e60ae27" continuedAt="Text_c89dba22789549f281faed2738e60ae28"><ix:continuation id="Text_bebfa4d6f38f4f38b5e4002690a1f9fc1" continuedAt="Text_bebfa4d6f38f4f38b5e4002690a1f9fc2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_c89dba22789549f281faed2738e60ae28" continuedAt="Text_c89dba22789549f281faed2738e60ae29"><ix:continuation id="Text_bebfa4d6f38f4f38b5e4002690a1f9fc2">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="6">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Years ended December 31,</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Current Tax Provision</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Federal<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="Fact_ea98f0814498471786f6c7cca18f2987" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="Fact_8cc2f1c7ff814b179d1132bc45a8a1fc" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">State<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="Fact_8ad889ddc4e84ec084741eff76bcb1f0" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="Fact_7185b4de95a0480fbb43542b71423948" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
              <div style="margin-left: 9pt;">Foreign <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" id="Fact_af462f0cbde54e4f9683fefd3052d695" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" id="Fact_4e4e429ce5a54d1ba482ad694b799743" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" id="Fact_7769f449ab1e4f6f950f197f008cacda" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" id="Fact_d18a46096b99468085bb3d8a73c0ee8f" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Deferred Tax Provision<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Federal<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="Fact_85498d73c9384a16bb0ceb86ffb6e177" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">6,851</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="Fact_0c83d7b3936f45bbadc303b345231a22" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5,840</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">State<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="Fact_f2bc8ee654f24691890fd41f606d5d48" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,602</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="Fact_6ee82fd7bf9d477a91340ac9629fa697" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,414</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
              <div style="margin-left: 9pt;">Foreign <br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">(<ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" id="Fact_397c920bc99c48eebb4fd1798f6f7901" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">187</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" id="Fact_04cd743a21034090bdb0115a03e99314" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_6259991b364549dbaa2898ec9bc89106" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">8,640</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_d77e85e13aa14013a5d51dea43af84da" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">7,255</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0);">Change in valuation allowance</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1"><ix:nonFraction name="erna:EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" id="Fact_777799ccf5264d72912e47661d49c587" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,681</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" id="Fact_213d293f40294767b27402270c139ee0" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,314</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Total tax provision for income taxes</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_7fb1a268c54f411ab9d6bdd64c286f36" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">45</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_eb4bdb8dedea4831a6921e14a7f5fd83" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">64</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_c89dba22789549f281faed2738e60ae29" continuedAt="Text_c89dba22789549f281faed2738e60ae210">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_c89dba22789549f281faed2738e60ae210" continuedAt="Text_c89dba22789549f281faed2738e60ae211"><ix:nonNumeric name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="Text_ef8831b411254551aae495607bc6a985" contextRef="c20220101to20221231" escape="true" continuedAt="Text_657921674da24b3aa86e90ccb1e626261">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Deferred tax assets and liabilities
        consist of the effects of temporary differences as shown in the table below (in thousands). Deferred tax assets have been fully reserved by a valuation allowance since it is more likely than not that such tax benefits will not be realized.</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_c89dba22789549f281faed2738e60ae211" continuedAt="Text_c89dba22789549f281faed2738e60ae212"><ix:continuation id="Text_657921674da24b3aa86e90ccb1e626261" continuedAt="Text_657921674da24b3aa86e90ccb1e626262">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_657921674da24b3aa86e90ccb1e626262"><ix:continuation id="Text_c89dba22789549f281faed2738e60ae212" continuedAt="Text_c89dba22789549f281faed2738e60ae213">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="6">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31,</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred Tax Assets:</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Net operating losses</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" id="Fact_be572ce6cd4e452e9b27939a1a28ad03" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,382</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" id="Fact_867a178c9eb24c978d35415c5fca0519" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,457</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Foreign net operating losses<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" id="Fact_017a0901081e47428288099a10e5f3d4" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">782</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" id="Fact_1420e7f8c51d4b53b2203b8ef9431318" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">595</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">&#160;&#160;&#160; Stock compensation</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" id="Fact_d35d87cd3f7d42129ae20b431985bef3" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,173</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" id="Fact_4fb2815f45a14caca08c8d2eb0a87217" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,312</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">&#160; &#160; In-process research and development</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" id="Fact_a123899d570746c583c19bc00f2860d5" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,233</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" id="Fact_eacd34ed666d4a9c9933a50c9febdc3c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">&#160;&#160;&#160; Capitalized rearch and development expenses</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" id="Fact_120e3d6359574b6da453c8798f23eaa9" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,502</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" id="Fact_2bee8d3fc84b4e2597c01026cfc2c9af" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">R&amp;D credit carryforwards</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" id="Fact_e5c9b0d259844bfb8177087dbcef95b1" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">517</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" id="Fact_3ccd32feda43419fb8a68a5e74ff0329" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">288</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Compensation accrual</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" id="Fact_98d134a9251546e09a3b31a5baf271dd" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">81</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" id="Fact_bd6c7564f0114fde8b5de855a565c6fd" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">30</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: 9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" rowspan="1">ROU Liabilities<br />
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:DeferredTaxAssetsRightOfUseLiabilities" id="Fact_8ad19b786a4343b2880ed86813edba8c" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">334</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:DeferredTaxAssetsRightOfUseLiabilities" id="Fact_526aea83e4a741bdbfbf024e81ee2134" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">706</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">&#160;&#160;&#160; Other<br />
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" id="Fact_43df09c6621347ba878f7bc5b22e5436" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">549</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" id="Fact_35a88a8f99da443b97ca76002fdfb07a" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total gross deferred tax assets</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" id="Fact_652142c9712743cebfbaf2aa53d9e1c2" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,553</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" id="Fact_ce13051d3d044cffad8fcaadde55f9d6" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,388</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Valuation allowance</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" id="Fact_06d79b3334ec43e881433ce41cca31a3" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,157</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" id="Fact_dc82b7498a334730a2307a72c5bd4df3" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,467</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax assets</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" id="Fact_c74e222a23174a83a37ded988be7458b" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">396</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" id="Fact_074a9ce39fad4c0ca9a36fe76c246fc7" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">921</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred Tax Liabilities:</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Fixed assets</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" id="Fact_6bb84d197a034542a6123984e4857a4d" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" id="Fact_0447864f8ea24f5fa8beea561b253713" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">168</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
                <div style="margin-left: 9pt;">ROU Assets<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:DeferredTaxAssetsRightOfUseAssets" id="Fact_5ff0170ad28a4a35b3c2b53b8c6bf821" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">291</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:DeferredTaxAssetsRightOfUseAssets" id="Fact_0372b20819af4b77ab6d45f0cf11200f" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">666</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Intangibles - goodwill</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" id="Fact_55a0765a9dcf4f8f8dbc7610ef149624" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">160</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" id="Fact_d2e6e3c929db4465ae17a3a641f4ccae" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">112</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total deferred tax liabilities</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" id="Fact_3d82a1ed4df44072bf6a0742ab19eb83" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">461</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" id="Fact_276affcd755042d88425029933107bb2" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">946</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred taxes</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" id="Fact_e4f4d3c0fab54077a34a1e8fa26ede5f" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">65</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" id="Fact_6de707a0f8104979bdecef0698526bcb" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>
         </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_c89dba22789549f281faed2738e60ae213" continuedAt="Text_c89dba22789549f281faed2738e60ae214">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>
</ix:continuation>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae214" continuedAt="Text_c89dba22789549f281faed2738e60ae215"><ix:nonNumeric name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="Text_b153d71df5ac49be98073b30e08b0673" contextRef="c20220101to20221231" escape="true" continuedAt="Text_77c7175d668f4ef3a9e2e441bf8899f81">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">The






          reconciliation of computed expected income taxes to effective income taxes by applying the federal statutory rate of <ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_ff19066ae3f542768d820b853a686e08" contextRef="c20210101to20211231" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_a71f2e69a0cf4b9995fe8dd1da4aeed5" contextRef="c20220101to20221231" unitRef="U005" decimals="2" scale="-2" format="ixt:num-dot-decimal">21</ix:nonFraction></ix:nonFraction>% is as
          follows:</div>
</ix:nonNumeric></ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae215" continuedAt="Text_c89dba22789549f281faed2738e60ae216"><ix:continuation id="Text_77c7175d668f4ef3a9e2e441bf8899f81" continuedAt="Text_77c7175d668f4ef3a9e2e441bf8899f82">
<div style="display:none;"><br /></div>
<div style="text-indent: 27pt;">&#160;<br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_77c7175d668f4ef3a9e2e441bf8899f82"><ix:continuation id="Text_c89dba22789549f281faed2738e60ae216" continuedAt="Text_c89dba22789549f281faed2738e60ae217">
<div style="display:none;"><br /></div>
<div style="text-indent: 18pt;">
          <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" rowspan="1" style="vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31,</div>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;"> 2022</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;"> 2021</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tax at federal income tax rate</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_8fd107d9e8334fcda6c210a53219d591" contextRef="c20220101to20221231" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">21.00</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-indent: 9pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><br />
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_3b38cae563f4453396c965389a24b7fe" contextRef="c20210101to20211231" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">21.00</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State income tax, net of federal tax</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" id="Fact_990bc5b6cfa34c72b32072843715afb7" contextRef="c20220101to20221231" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">6.52</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" id="Fact_06f27729275f473ba57605cdfecac5cc" contextRef="c20210101to20211231" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">1.15</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">%</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;Foreign tax differential</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" id="Fact_414cac87c99e4f5ea9b58979d989f3ae" contextRef="c20220101to20221231" unitRef="U005" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">%)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" id="Fact_78c12c88124142baa08052b81ea54062" contextRef="c20210101to20211231" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.00</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">% <br />
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-deductible expenses/excludable items</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" id="Fact_195f9793309149bc8582284b442cba91" contextRef="c20220101to20221231" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">6.09</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" id="Fact_008990e5cdc6453589bd4ed68c351169" contextRef="c20210101to20211231" unitRef="U005" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">16.30</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">%)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in valuation allowance</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" id="Fact_ecd5e668620a4f7eb8e1ff3e0bdb4f90" contextRef="c20220101to20221231" unitRef="U005" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">35.38</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">%)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" id="Fact_217ae9f421f94fbb9755c370186e152b" contextRef="c20210101to20211231" unitRef="U005" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">5.97</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">%)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Credits</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" id="Fact_707366dab331461b9dfb132eb6a551fa" contextRef="c20220101to20221231" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.98</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" id="Fact_72f568cf07f74288aff44860996fa9fc" contextRef="c20210101to20211231" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.23</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">%</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">Uncertain tax positions<br />
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">(<ix:nonFraction name="erna:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" id="Fact_390ba8fe08554ea0a05f1782c3edfac5" contextRef="c20220101to20221231" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.49</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">%)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;"><ix:nonFraction name="erna:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" id="Fact_e29ade52f6314861b415c26b154d6f98" contextRef="c20210101to20211231" unitRef="U005" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">0.00</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" id="Fact_d3bf84ccb7ce4de4b952fd05163b1b7d" contextRef="c20220101to20221231" unitRef="U005" decimals="4" scale="-2" format="ixt:num-dot-decimal">1.11</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" id="Fact_8d9b6c2a5b1b458bb952eb3222f653af" contextRef="c20210101to20211231" unitRef="U005" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">0.16</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">%)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Provision for income taxes</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" id="Fact_51c84c79cbec46d2bcd6bae8f3e923fe" contextRef="c20220101to20221231" unitRef="U005" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">0.18</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" id="Fact_494736ddd45445caaf826cfe81589a7d" contextRef="c20210101to20211231" unitRef="U005" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">0.05</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">%)</td>

  </tr>


</table>
          </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae217" continuedAt="Text_c89dba22789549f281faed2738e60ae218">
<div style="display:none;"><br /></div>
<div style="text-indent: 18pt;"> &#160;</div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-34</span></div>

          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="BRPFPageHeader">
            <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
            </div>

          </div>

        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
          <ix:continuation id="Text_c89dba22789549f281faed2738e60ae218" continuedAt="Text_c89dba22789549f281faed2738e60ae219">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The net increase in the total valuation allowance for the year ended December 31, 2022 was an increase of approximately $<ix:nonFraction name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" id="Fact_abd38b3a9b504b4286753bca9b9235f6" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">8.8</ix:nonFraction>
              million. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets
              is dependent upon the generation of future taxable income during periods in which those temporary difference become deductible. Management considered the scheduled reversal of deferred tax liabilities, projected future taxable income and
              planning strategies in making this assessment.&#160; Based on the level of historical operating results and projections for the taxable income for the future, management has determined that it is more likely than not that the deferred taxes assets
              will not be utilized. Accordingly, the Company has recorded a full valuation allowance. The net deferred tax liability represents an indefinite life intangible liability related to tax deductible goodwill, partially offset by an indefinite
              life deferred tax asset.</span> </div>
</ix:continuation>
          <ix:continuation id="Text_c89dba22789549f281faed2738e60ae219" continuedAt="Text_c89dba22789549f281faed2738e60ae220">
<div><br />
          </div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae220" continuedAt="Text_c89dba22789549f281faed2738e60ae221">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">At December 31, 2022 and 2021, the Company has available net operating loss (&#8220;NOL&#8221;) carryforwards of approximately $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_1ccf37d2860740898966fa4bd6ab45b5" contextRef="c20221231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">35.6</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_15e6ee6726ba4667ae031d1ca6c773f4" contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">20.7</ix:nonFraction> million for
          federal income tax purposes, respectively, of which approximately $<ix:nonFraction name="erna:TaxCutsAndJobsActOperatingLossCarryforwards" id="Fact_5bd816b074a84402868ae388ac3c175e" contextRef="c20221231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">35.6</ix:nonFraction> million can be carried forward indefinitely. The Company has
          available $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_54b7d8830fa747c49016c76cc984dae7" contextRef="c20221231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">28.8</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_07c6b3fcc1d245be8f8f47a1961857d6" contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">20.7</ix:nonFraction>
          million state NOLs for the years ended December 31, 2022 and 2021, respectively, which begin to expire in <ix:nonNumeric name="erna:OperatingLossCarryforwardsExpirationYear" id="Fact_c5542fec165249b78aee6c6c3ec8e0b5" contextRef="c20220101to20221231">2041</ix:nonNumeric>. The Company also has
          foreign NOL carryforwards of approximately $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_5f00c8d37242483e948863eac8d333f1" contextRef="c20221231_IncomeTaxAuthorityAxis_ForeignCountryMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.3</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_0ff588c692274c32b3ecc58f9e16fb34" contextRef="c20211231_IncomeTaxAuthorityAxis_ForeignCountryMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.8</ix:nonFraction> million for the years ended December 31, 2022 and 2021, respectively, which carry forward indefinitely. Section 382 of the Internal Revenue Code (&#8220;IRC&#8221;) imposes limits on
          the ability to use NOL carryforwards that existed prior to a change in control to offset future taxable income. Such limitations would reduce, potentially significantly, the gross deferred tax assets disclosed in the table above related to the
          NOL carryforwards.&#160; The Company continues to disclose the NOL carryforwards at their original amount in the table above as no potential limitation has been quantified. The Company has also established a full valuation allowance for all deferred
          tax assets, including the NOL carryforwards, since the Company could not conclude that it was more likely than not able to generate future taxable income to realize these assets.&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae221" continuedAt="Text_c89dba22789549f281faed2738e60ae222">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae222" continuedAt="Text_c89dba22789549f281faed2738e60ae223">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">At December 31, 2022 and 2021 the Company has federal and state income tax credit carryforwards of approximately $<ix:nonFraction name="us-gaap:TaxCreditCarryforwardAmount" id="Fact_6599c7249ade4da1a3ee17da5ea32138" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:TaxCreditCarryforwardAmount" id="Fact_2d72dd45f16a4b35a80d450b93079ab1" contextRef="c20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million,
          respectively. The credits begin to expire in <ix:nonNumeric name="erna:TaxCreditCarryforwardExpirationYear" id="Fact_feb28f42dd9943988b6465d9700bab04" contextRef="c20220101to20221231">2041</ix:nonNumeric>.</div>
</ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae223" continuedAt="Text_c89dba22789549f281faed2738e60ae224">
<div><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae224" continuedAt="Text_c89dba22789549f281faed2738e60ae225">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">In accordance with authoritative guidance, the impact of an uncertain income tax position on the income tax return must be
          recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. <ix:nonNumeric name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="Text_415d751357954ea8bbe74b54f23b1d54" contextRef="c20220101to20221231" escape="true" continuedAt="Text_9fb2aa35116548f1b8f843c7bc77ba251"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The following table summarizes amounts the
          Company recorded for uncertain tax positions as of December 31, 2022 and 2021 (in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
        <ix:continuation id="Text_9fb2aa35116548f1b8f843c7bc77ba251" continuedAt="Text_9fb2aa35116548f1b8f843c7bc77ba252"><ix:continuation id="Text_c89dba22789549f281faed2738e60ae225" continuedAt="Text_c89dba22789549f281faed2738e60ae226">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"> <br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9fb2aa35116548f1b8f843c7bc77ba252"><ix:continuation id="Text_c89dba22789549f281faed2738e60ae226" continuedAt="Text_c89dba22789549f281faed2738e60ae227">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">
          <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                  <div style="text-align: center; font-weight: bold;"> 2022<br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                  <div style="text-align: center; font-weight: bold;">2021<br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Beginning balance of uncertain tax positions</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" id="Fact_624a5ed1c17b4778afec7205c5cbe4c2" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" id="Fact_2ed9e194e4ac48a5962fbef53a92bc2a" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Additions based on current year&#8217;s tax positions</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" id="Fact_88dacb737b034656913c4a350a08aceb" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">45</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" id="Fact_40dace3b9f5841dc80957ec6c7d8292c" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Net changes based on prior year&#8217;s tax positions</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" id="Fact_ecf7de88742049cc81433c34a4890085" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">76</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" id="Fact_92622bbeac924a0e9c9517fa661cedcf" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Ending balance of uncertain tax positions</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" id="Fact_cf12dc1d118d49ddb44cef0cbb5b1ce0" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">121</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" id="Fact_f694e8fd54144272a7da0585772b4f00" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
           </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae227" continuedAt="Text_c89dba22789549f281faed2738e60ae228">
<div><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae228" continuedAt="Text_c89dba22789549f281faed2738e60ae229">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">It
          is reasonably possible that unrecognized tax benefits may increase or decrease within the next twelve months due to tax examination changes, expiration of statute of limitations, or changes in tax law.&#160; The Company does not anticipate any
          significant changes to unrecognized tax benefits over the next 12 months. </div>
</ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae229" continuedAt="Text_c89dba22789549f281faed2738e60ae230">
<div> <br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae230" continuedAt="Text_c89dba22789549f281faed2738e60ae231">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The Company recognizes interest and penalties related to unrecognized tax positions within the income tax expense line in the
          accompanying consolidated statements of operations. There were <ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_e65c42ca21ce47dba118855aa3f003e7" contextRef="c20211231" unitRef="U001" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_80412a4e63734e999792a1d23ffcd1be" contextRef="c20221231" unitRef="U001" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> accrued interest and penalties associated with uncertain tax
          positions as of December 31, 2022 or December 31, 2021.</div>
</ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae231" continuedAt="Text_c89dba22789549f281faed2738e60ae232">
<div><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae232" continuedAt="Text_c89dba22789549f281faed2738e60ae233">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The Company is subject to U.S. federal, state, and foreign income tax. The Company&#8217;s income tax returns are subject to
          examination by the relevant taxing authorities. As of December 31, 2022, the <span style="-sec-ix-hidden:Fact_f5787a4f89d441eb816e0f3918c8cfa1">2019 &#8211; 2022</span> tax years remain subject to examination in
          the U.S. federal tax, various state, and foreign tax jurisdictions. The Company is not currently under examination by federal state, or foreign jurisdictions.</div>
</ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae233" continuedAt="Text_c89dba22789549f281faed2738e60ae234">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_c89dba22789549f281faed2738e60ae234">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;) was enacted into law. Among other changes to the tax code, the IRA imposes a 1% excise tax on
            certain repurchases of corporate stock by certain publicly traded corporations. The 1% stock buyback tax applies to redemptions by domestic corporations occurring in taxable years beginning after December 31, 2022.&#160; A number of exceptions to
            the stock buyback tax are available including exceptions to certain reorganizations. However, while these exceptions may be helpful in limiting the application of the stock buyback tax in situations in which it was not intended to apply, more
            guidance will be necessary for taxpayers to analyze the potential application of these exceptions and whether they will be able to rely upon them.<br />
          </span></div>
</ix:continuation>
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
        <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">F-35</span></div>

          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="BRPFPageHeader">
            <div><a href="#TABLEOFCONTENTS"><span style="font-style: italic; font-size: 8pt;">Table of Contents</span></a><br />
            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <!--PROfilePageNumberReset%Num%36%F-%%-->
    <div>
      <ix:nonNumeric name="us-gaap:SubsequentEventsTextBlock" id="Text_70b25e83691d4a44b87beca2cb618a2c" contextRef="c20220101to20221231" escape="true" continuedAt="Text_8b66512cf7d04a55b3041612bf4765231">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 35.9pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">17)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Subsequent Event</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:continuation id="Text_8b66512cf7d04a55b3041612bf4765231" continuedAt="Text_8b66512cf7d04a55b3041612bf4765232">
<div>&#160;
        </div>
</ix:continuation>
<div>
          <ix:continuation id="Text_8b66512cf7d04a55b3041612bf4765232" continuedAt="Text_8b66512cf7d04a55b3041612bf4765233">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Cell Customization and License Agreement</span> </div>
</ix:continuation>
          <ix:continuation id="Text_8b66512cf7d04a55b3041612bf4765233" continuedAt="Text_8b66512cf7d04a55b3041612bf4765234">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br />
            </span></div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_8b66512cf7d04a55b3041612bf4765234">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">O<span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">n February 21, 2023, the Company and Lineage Cell Therapeutics, Inc. (&#8220;Lineage&#8221;) entered into an exclusive option and license agreement (the &#8220;Lineage Agreement&#8221;), pursuant to which, Lineage
            may request prior to August 22, 2023 that the Company develops for, and delivers to, Lineage certain induced pluripotent stem cell lines, which Lineage would use to evaluate the possible development of cell transplant therapies for treatment of
            diseases of the central nervous system in humans, excluding ophthalmologic indications, (b) diseases and conditions of the peripheral nervous system, (c) psychiatric, respiratory, musculoskeletal, and hematological diseases, disorders, and
            conditions, and (d) cancer.&#160; The Lineage Agreement also provides Lineage with the option to obtain an exclusive sublicense to certain related technology for preclinical, clinical and commercial purposes, which would permit Lineage to sublicense
            such intellectual property, subject to payment of certain sublicense royalty fees.&#160; Lineage has six months from our delivery to Lineage of such induced pluripotent stem cell lines to exercise such option, and upon any such exercise, Lineage
            would agree to use its commercially reasonable efforts to exploit and make commercially available one or more licensed products derived from such induced pluripotent stem cell lines in accordance with the Lineage Agreement. Upon entry into the
            Lineage Agreement, Lineage paid the Company a $<ix:nonFraction name="erna:ProceedsFromOptionAndLicenseAgreement" id="Fact_b632e2ba91c244f1bc208bd8fd784dd4" contextRef="c20230221to20230221_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">250,000</ix:nonFraction> non-refundable up-front payment.&#160; We are also entitled to certain cell line
            customization fees with respect to cell lines that Lineage may request that we develop for Lineage, and royalty payments with respect to any such licensed products, certain sublicense fees and certain milestone payments under the Lineage
            Agreements</span>.</div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      </div>

      <div><br />
      </div>

      <div style="text-align: center;"><br />
      </div>

    </div>

    <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">F-36</span></div>

    <div style="text-align: center;" class="BRPFPageNumberArea">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;"> </span></div>

  </div>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>brhc10049677_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 3.1</font><br>
  </div>
  <br>
  <div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">THIS COMPOSITE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ARKO CORP. (THE &#8220;CORPORATION&#8221;) REFLECTS THE PROVISIONS OF THE CORPORATION&#8217;S CERTIFICATE OF
      INCORPORATION AND ALL AMENDMENTS THERETO FILED WITH THE DELAWARE SECRETARY OF STATE THEREAFTER ON OR PRIOR TO OCTOBER 17, 2022, BUT IS NOT AN AMENDMENT AND/OR RESTATEMENT THEREOF.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">COMPOSITE</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RESTATED CERTIFICATE</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OF</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INCORPORATION</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Eterna Therapeutics Inc., a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows:</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1. The name of the corporation is Eterna Therapeutics Inc. The corporation was originally incorporated under the name Alroy
      Industries, Inc. The original certificate of incorporation of the corporation was filed with the Secretary of State of the State of Delaware on April 13, 1984 (the &#8220;Original Certificate&#8221;). The Original Certificate was amended and restated by a
      restated certificate of incorporation of the corporation filed with the Secretary of State of the State of Delaware on June 14, 1991 (the &#8220;Amended and Restated Certificate&#8221;).</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2. This Restated Certificate of Incorporation was duly adopted in accordance with Section 245 of the General Corporation Law of
      Delaware.</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3. Pursuant to Section 245(c) of the General Corporation Law of Delaware, this Restated Certificate of Incorporation only restates
      and integrates and does not further amend the provisions of the Amended and Restated Certificate as heretofore amended or supplemented, and there is no discrepancy between those provisions and the provisions of this Restated Certificate of
      Incorporation.</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4. The text of the Amended and Restated Certificate as heretofore amended or supplemented is hereby restated to read in its entirety
      as follows:</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE I</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The name of the corporation (the &#8220;Corporation&#8221;) is Eterna Therapeutics Inc.</div>
    <div style="text-align: left; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE II</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The address of the corporation&#8217;s registered office in the State of Delaware is 1209 Orange Street, in the City of Wilmington, county
      of New Castle, Delaware. The name of the Corporation&#8217;s registered agent at such address is The Corporation Trust Company.</div>
    <div style="text-align: left; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE III</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The nature of the business or purpose to be conducted or promoted is to be engaged in any lawful act or activity for which
      corporations may be organized under the General Corporation Law of the State of Delaware.</div>
    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE IV</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;The total number of shares of stock which the Corporation shall have
        authority to issue is 101,000,000 shares, of which 100,000,000 shares shall be Common Stock, par value $.005 per share, and 1,000,000 shall be Preferred Stock, par value $.005 per share</font>.&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(a)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Series A Preferred Stock</u></font>. This corporation is
      authorized to issue a series of Preferred Stock designated &#8220;Series A Convertible Preferred Stock&#8221; consisting of 156,112 shares.</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Dividend Rights</u></font>.</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(i)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Rights to Cash Dividends.</u></font>&#160;In the absence of any
      action pursuant to part (ii) of this subdivision (a)(l), the holders of the Series A Preferred shall be entitled to receive cumulative dividends of ten cents per share per annum, payable semiannually in equal installments of five cents per share on
      December 1 and June 1 of each year. The dividends so payable on any December 1 or June 1 will be paid by check or draft to the person (the &#8220;Registered Holder&#8221;) in whose name the Series A Preferred is registered as of the close of business on November
      15 or May 15 next preceding the interest payment date (whether or not a business day), at such person&#8217;s address as it appears on the registration books of the Corporation.</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>(ii)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Rights to Stock Dividends.</u></font>&#160;At the Corporation&#8217;s option, the Corporation may declare and pay a dividend for any dividend payment date(s) in the form of its common
      stock, $.005 par value per share (the &#8220;Common Stock&#8221;), such stock dividend to be in lieu of the dividend provided for by part (i) of this subdivision (a)(l). To determine the amount of Common Stock to be issued as a substitute dividend on the Series
      A Preferred, the Common Stock will be valued at its market value. Market value is defined for this purpose as the average closing bid price for the twentieth through eleventh trading days preceding the date on which interest is due.</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Voting Rights</u></font>. The Series A Preferred shall have
      no voting rights.</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Rights on Liquidation, Dissolution and Winding Up</u></font>.
      Upon liquidation, dissolution and winding up, each share of the Series A Preferred shall have preference over the Common Stock to the extent of $1.00 per share, but shall not otherwise be entitled to share in the proceeds of any liquidation,
      dissolution or winding up. The preference or subordination of the rights of the Series A Preferred with respect to any other class of stock, or any other series of preferred stock, shall be as stated in the instrument defining the rights of such
      other class or series. Neither the merger or consolidation of the Corporation into or with any other corporation or any other corporation into or with the Corporation, nor a sale, transfer or lease of all or any part of the assets of the Corporation,
      shall be deemed to be a liquidation, dissolution or winding up of the Corporation within the meaning of this subdivision (3).</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(4)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Conversion Rights</u></font>. Commencing on the date of the
      issuance of the Series A Preferred, the Series A Preferred shall at any time be convertible at the option of the holder thereof into duly authorized, validly issued, fully paid and nonassessable shares of Common Stock at a conversion rate (the
      &#8220;Conversion Rate&#8221;) as set forth below (subject to adjustment as provided in subdivision (5) hereof).</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(i) The Registered Holder shall have the right at any time to convert shares of Series A Preferred into that number of fully paid
      and nonassessable shares of Common Stock of the Corporation that equals the number of shares of Series A Preferred that are surrendered for conversion divided by the Conversion Rate. The Conversion Rate shall initially be 100%, and shall be subject
      to adjustment pursuant to subdivision (5) hereof. Upon the surrender of the Series A Preferred accompanied by the written request for conversion from the Registered Holder, the Corporation shall issue and deliver to such Registered Holder
      certificates evidencing such shares of Common Stock.</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(ii) In order to exercise the conversion privileges, the Registered Holder shall surrender the Series A Preferred to the
      Corporation at its principal address, accompanied by written notice to the Corporation that such holder elects to convert all or a portion of the same. Such notice shall also state the name or names (with address) in which the certificate or
      certificates for shares of Common Stock and any re-issued Series A Preferred shall be issued upon such conversion. As promptly as practicable after the receipt of such notice and surrender of the Series A Preferred, the Corporation shall issue and
      deliver to such holder, or to his assignee or assignees on his written order, a certificate or certificates for the number of full shares of Common Stock and any re-issued Series A Preferred issuable upon the conversion of the Series A Preferred.
      Such conversion shall be deemed to have been effected at the close of business of the first business day after the date on which such notice shall have been received by the Corporation and such Series A Preferred shall have been surrendered.</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(iii) No fractional shares shall be issued upon conversion of the Series A Preferred and any portion of the same which would
      otherwise be convertible into a fractional share shall be paid in cash in the amount of the liquidation preference of the fractional share. No payment or adjustment shall be made upon any conversion on account of any cash dividends on the Common
      Stock issued upon such conversion.</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(5)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Adjustments to Conversion Rate.</u></font></div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Conversion Rate shall be subject to adjustment as provided in this subdivision (5).</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(i) In case the Corporation shall (A) pay a dividend, or make a distribution, in shares of its Common Stock (the &#8220;Shares&#8221;), (B)
      subdivide its outstanding Shares into a greater number of Shares, (C) combine its outstanding Shares into a smaller number of Shares, or (D) issue by reclassification of its Shares any shares of Common Stock of the Corporation (other than a change in
      par value, or from par value to no par value, or from no par value to par value), the Conversion Rate in effect immediately prior thereto shall be adjusted so that the Registered Holder shall be entitled to receive the number of Shares which he would
      have owned or have been entitled to receive immediately following the happening of any of the events described above, had the Series A Preferred been converted immediately prior to the record or effective date thereof.</div>
    <div style="text-align: left; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">An adjustment made pursuant to subparts (i)(A)-(D) above shall become effective immediately after the record date in the case of a
      dividend or distribution in Shares and shall become effective immediately after the effective date in the case of a subdivision, combination or reclassification. If, as a result of an adjustment made pursuant to this paragraph, the Registered Holder
      shall become entitled to receive shares of two or more classes of Common Stock of the Corporation, the Board of Directors (whose determination shall be conclusive and shall be evidenced by a resolution) shall determine the allocation of the adjusted
      Conversion Rate between or among the shares of such classes of Common Stock.</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(ii) In case of any reclassification of the outstanding Shares (other than a change in par value, or from par value to no par
      value, or from no par value to par value, or as a result of a subdivision, combination or stock dividend), or in case of any consolidation of the Corporation with, or merger of the Corporation into, another corporation wherein the Corporation is not
      the surviving entity, or in case of any sale of all, or substantially all, of the property, assets, business and goodwill of the Corporation, the Corporation, or such successor or purchasing corporation, as the case may be, shall provide, by a
      written instrument delivered to the Registered Holder, that the Registered Holder shall thereafter be entitled upon conversion to the kind and amount of shares of stock or other equity securities, or other property or assets which would have been
      receivable by such Registered Holder upon such reclassification, consolidation, merger or sale, if the Series A Preferred had been converted immediately prior thereto. Such corporation, which thereafter shall be deemed to be the &#8220;Corporation&#8221; for
      purposes of the Series A Preferred, shall provide in such written instrument for adjustments to the Conversion Rate which shall be as nearly equivalent as may be practicable to the adjustments provided for in this subdivision (5).</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(iii)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Common Stock Issued at Less Than the Conversion Price</u></font>.
      If the Corporation shall issue any Common Stock without consideration or for a consideration per share less than the then applicable Equivalent Preference Amount, the Equivalent Preference Amount shall immediately be reduced to the amount determined
      by dividing (A) an amount equal to the sum of (1) the number of shares of Common Stock outstanding immediately prior to such issuance multiplied by the Equivalent Preference Amount in effect immediately prior to such issuance and (2) the
      consideration, if any, received by the Corporation upon such issuance, by (B) the total number of shares of Common Stock outstanding immediately after such issuance. The Equivalent Preference Amount at any time shall be the value that results when
      the liquidation preference of one share of Series A Preferred is multiplied by the Conversion Rate in effect at that time; thus the Conversion Rate applicable after the adjustment in the Equivalent Preference Amount provided by this part (iii) shall
      be the figure that results when the adjusted Equivalent Preference Amount is divided by the liquidation preference of one share of Series A Preferred.</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the purpose of determining the date on which an adjustment to the Conversion Rate pursuant to this part (iii) shall take effect,
      the Conversion Rate shall be adjusted as of the earlier of (x) the date, if any, on which the Corporation shall enter into a firm contract for the issuance of such shares of Common Stock, or securities convertible into or exchangeable or exercisable
      for shares of Common Stock, or (y) the date of actual issuance of such shares of Common Stock or such other securities.</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the purposes of any adjustment of the Conversion Rate pursuant to this part (iii), the following provisions shall also be
      applicable:</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 104.05pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(A)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Cash</u></font>. In the case of the issuance of Common Stock
      for cash, the amount of the consideration received by the Corporation shall be deemed to be the amount of the cash proceeds received by the Corporation for such Common Stock before deducting therefrom any discounts, commissions, taxes or other
      expenses allowed, paid or incurred by the Corporation for any underwriting or otherwise in connection with the issuance and sale thereof.</div>
    <div style="text-align: justify; text-indent: 104.05pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 104.05pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(B)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Consideration Other Than Cash</u></font>. In the case of the
      issuance of Common Stock (otherwise than upon the conversion of shares of capital stock or other securities of the Corporation) for a consideration in whole or in part other than cash, including securities acquired in exchange therefor (other than
      securities by their terms so exchangeable), the consideration other than cash shall be deemed to be the fair value thereof as determined by the Board of Directors, irrespective of any accounting treatment; provided that such fair value as determined
      by the Board of Directors shall not exceed the aggregate current market price of the shares of Common Stock being issued as of the date the Board of Directors authorizes the issuance of such shares.</div>
    <div style="text-align: left; text-indent: 104.05pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 104.05pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(C)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Options and Convertible Securities</u></font>. In the case
      of the issuance of (x) options, warrants or other rights to purchase or acquire Common Stock (whether or not at the time exercisable), (y) securities by their terms convertible into or exchangeable for Common Stock (whether or not at the time so
      convertible or exchangeable) or (z) options, warrants or rights to purchase such convertible or exchangeable securities (whether or not at the time exercisable):</div>
    <div style="text-align: justify; text-indent: 104.05pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1) the aggregate maximum number of shares of Common Stock deliverable upon exercise of such options, warrants or other rights to
      purchase or acquire Common Stock shall be deemed to have been issued at the time such options, warrants or rights were issued and for a consideration equal to the consideration (determined in the manner provided in subparts (A) and (B) above), if
      any, received by the Corporation upon the issuance of such options, warrants or rights plus the minimum purchase price provided in such options, warrants or rights for the Common Stock covered thereby;</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2) the aggregate maximum number of shares of Common Stock deliverable upon conversion of or in exchange for any such convertible
      or exchangeable securities, or upon the exercise of options, warrants or other rights to purchase or acquire such convertible or exchangeable securities and the subsequent conversion or exchange thereof, shall be deemed to have been issued at the
      time such securities were issued or such options, warrants or rights were issued and for a consideration equal to the consideration, if any, received by the Corporation for any such securities and related options, warrants or rights (excluding any
      cash received on account of accrued interest or accrued dividends), plus the additional consideration (determined in the manner provided in subparts (A) and (B) above), if any, to be received by the Corporation upon the conversion or exchange of such
      securities, or upon the exercise of any related options, warrants or rights to purchase or acquire such convertible or exchangeable securities and the subsequent conversion or exchange thereof.</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3) on any change in the number of shares of Common Stock deliverable upon exercise of any such options, warrants or rights or
      conversion or exchange of such convertible or exchangeable securities or any change in the consideration to be received by the Corporation upon such exercise, conversion or exchange (the &#8220;Change in Number or Consideration&#8221;), including, but not
      limited to, a change resulting from the anti-dilution provisions thereof, the Conversion Rate as then in effect shall forthwith be readjusted to such Conversion Rate as would have been obtained had an adjustment been made upon the issuance of such
      options, warrants or rights not exercised prior to the Change in Number or Consideration, or of such convertible or exchangeable securities not converted or exchanged prior to the Change in Number or Consideration, upon the basis of the Change in
      Number or Consideration;</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(4) on the expiration or cancellation of any such options, warrants or rights, or the termination of the right to convert or
      exchange such convertible or exchangeable securities, if the Conversion Rate shall have been adjusted upon the issuance thereof, the Conversion Rate shall forthwith be readjusted to such Conversion Rate as would have been obtained had an adjustment
      been made upon the issuance of such options, warrants, rights or such convertible or exchangeable securities on the basis of the issuance of only the number of shares of Common Stock actually issued upon the exercise of such options, warrants or
      rights, or upon the conversion or exchange of such convertible or exchangeable securities; and</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(5) if the Conversion Rate shall have been adjusted upon the issuance of any such options, warrants, rights or convertible or
      exchangeable securities, no further adjustment of the Conversion Rate shall be made for the actual issuance of Common Stock upon the exercise, conversion or exchange thereof.</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(iv) Whenever the Conversion Rate shall be adjusted as herein provided, the Corporation shall compute the adjusted Conversion Rate
      in accordance with such provisions and shall prepare a certificate signed by its President, any Vice-President or the Chief Financial Officer setting forth the adjusted Conversion Rate and showing in reasonable detail the facts upon which such
      adjustment was based and shall mail such certificate to the Registered Holders of the Series A Preferred.</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(6)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Reservation of Shares</u></font>. The Corporation shall at
      all times reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the conversion of the Series A Preferred, such number of shares as shall from time to time be sufficient to effect the
      conversion of all shares of Series A Preferred from time to time outstanding, and, if at any time the number of shares of Common Stock remaining unissued are not sufficient to permit the conversion of all the then-outstanding shares of Series A
      Preferred, the Corporation shall take such action as is necessary to increase the authorized amount of Common Stock to such number of shares as shall be sufficient for such purposes.</div>
    <div style="text-align: left; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(b)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Other Series or Classes of Preferred Stock</u></font>. Shares
      of an additional Preferred Stock may be issued from time to time in one or more series, each such series to have such distinctive designation or title as may be stated and expressed in this Article IV or as may be fixed by the Board of Directors
      prior to the issuance of any shares thereof. Each such series of Preferred Stock shall have such voting powers, full or limited, or no voting powers, and such designations, preferences and such relative, participating, optional or other special
      rights (including, without limitation, the right to convert the shares of such Preferred Stock into shares of the Corporation&#8217;s Common Stock at such rate and upon such terms and conditions as may be fixed by the Corporation&#8217;s Board of Directors),
      with such qualifications, limitations, or restrictions of such preferences or rights as shall be stated and expressed in this Article IV or in the resolution or resolutions providing for the issue of such series of Preferred Stock as may be adopted
      from time to time by the Board of Directors prior to the issuance of any shares thereof, in accordance with the laws of the State of Delaware.</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Except as may be otherwise provided in this Article IV or in the resolution or resolutions providing for the issue of a particular
      series, the Board of Directors may from time to time increase the number of shares of any series already created by providing that any unissued shares of Preferred Stock shall constitute part of such series, or may decrease (but not below the number
      of shares thereof then outstanding) the number of shares of any series already created by providing that any unissued shares previously assigned to such series shall no longer constitute part thereof.</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">All shares of Preferred Stock of all series shall be of equal rank and be identical in all respects except in respect to the
      particulars which may be fixed by the Board of Directors as provided in this Article IV.</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(c)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Common Stock</u></font>.</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1) After the requirements with respect to the preferential dividends of the Preferred Stock shall be met, and after the
      Corporation shall have complied with all of the requirements, if any, with respect to the setting aside of sums for redemption, the holders of Common Stock shall be entitled to receive such dividends as may be declared from time to time by the Board
      of Directors.</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2) After distribution in full of the preferential amounts required to be distributed to the holders of the Preferred Stock and to
      the holders of any class of stock of the Corporation ranking as to distribution of assets senior to the Common Stock, in the event of voluntary or involuntary liquidation or dissolution or winding-up of the Corporation, the holders of the Common
      Stock shall be entitled to receive all of the remaining assets of the Corporation, tangible and intangible, of whatever kind available to distribution to stockholders ratably in proportion to the number of shares of Common Stock held by them,
      respectively.</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3) Each holder of record of Common Stock shall have the right to vote each share of Common Stock standing in his name on the
      record books of the Corporation. Except as otherwise provided herein or in any Certificate of Designations, Preferences and Rights of Preferred Stock filed in the Office of the Secretary of State of the State of Delaware, or otherwise as required by
      law, the holders of Preferred Stock and the holders of Common Stock shall vote together as one class on all matters.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Effective immediately upon the effectiveness of the Certificate of Amendment adding this paragraph to Article IV of this
        Certificate of Incorporation on October 16, 2022 at 11:59 p.m. Eastern Time (the &#8220;Effective Time&#8221;), each ten (10) to twenty (20) shares of Common Stock that are issued and outstanding immediately prior to the Effective Time shall be reclassified
        and combined into one (1) validly issued, fully paid and non-assessable share of Common Stock, with the exact ratio within such range to be determined by the Board of Directors prior to the Effective Time and publicly announced by the Corporation,
        subject to the treatment of fractional share interests as described below (the &#8220;Reverse Stock Split&#8221;). The Reverse Stock Split shall occur automatically without any further action by the Corporation or its stockholders and whether or not any
        certificate representing such shares immediately prior to the Effective Time (the &#8220;Old Certificate&#8221;) is surrendered to the Corporation. The Reverse Stock Split shall also apply to any outstanding securities or rights convertible into, or
        exchangeable or exercisable for, Common Stock. The Reverse Stock Split shall be effected on a certificate-by-certificate basis and no fractional shares shall be issued upon the reclassification and combination. In lieu of any fractional shares to
        which the holder would otherwise be entitled, the Corporation shall pay an amount of cash equal to the product of (i) the fractional share to which the holder would otherwise be entitled and (ii) the then fair value of a share as determined in good
        faith by the Board of Directors. Following the Effective Time, each Old Certificate shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the Old Certificate shall have been
        reclassified and combined, subject to the elimination of fractional share interests as described above, until such time as such Old Certificate has been surrendered to the Corporation.</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE V</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation is to have perpetual existence.</div>
    <div style="text-align: left; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE VI</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Board of Directors is authorized to make, alter or repeal the Bylaws of the Corporation, to fix the amount reserved as working
      capital, and to authorize and cause to be executed, mortgages and liens without limit as to the amount upon the property and franchise of this corporation.</div>
    <div style="text-align: left; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">With the consent in writing, and pursuant to a vote of the holders of a majority of the capital stock issued and outstanding, the
      Directors shall have the authority to dispose, in any manner, of the whole property of the Corporation.</div>
    <div style="text-align: left; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE VII</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation shall indemnify, in the manner and to the full extent permitted by law, any person (or the estate of any person) who
      was or is a party, or is threatened to be made a party to, any threatened, pending or completed action, suit or proceeding, whether or not by or in the right of the Corporation, and whether civil, criminal, administrative, investigative or otherwise,
      by reason of the fact that such person is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint
      venture, trust or other enterprise. Where required by law, the indemnification provided for herein shall be made only as authorized in the specific case upon a determination in the manner provided by law, that indemnification of the director,
      officer, employee or agent is proper under the circumstances. The Corporation may, to the full extent permitted by law, purchase and maintain insurance on behalf of any such person against any liability which may be asserted against him. To the full
      extent permitted by law, the indemnification provided herein shall include expenses (including attorneys&#8217; fees) in any action, suit or proceeding, or in connection with any appeal therein, judgments, fines and amounts paid in settlement, and in the
      manner provided by law any such expenses may be paid by the Corporation in advance of the final disposition of such action, suit or proceeding. The indemnification provided herein shall not be deemed to limit the right of the Corporation to indemnify
      any other person for any such expense to the full extent permitted by law, nor shall it be deemed exclusive of any other rights to which any person seeking indemnification from the Corporation may be entitled under any agreement, vote of stockholders
      or disinterested directors or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office.</div>
    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">To the extent permitted by law, no director of the Corporation shall be liable to the Corporation or its stockholders for monetary
      damages for breach of fiduciary duty as a director, except for liability (i) for any breach of the director&#8217;s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct
      or a knowing violation of law; (iii) under section 174 of the Delaware General Corporation Law; or (iv) for any transaction from which the director derived an improper personal benefit.</div>
    <div style="text-align: left; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE VIII</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation reserves the right to amend, alter, change or repeal any provision contained in this Certificate of Incorporation in
      the manner now or hereafter prescribed by law.</div>
    <div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE IX</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">A.&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Number, Election and Term of Directors</u></font>. The number of
      Directors of the Corporation shall be fixed from time to time by or pursuant to the By-laws. Each director who is serving as a director on the date of this Amendment (October 20, 2005) shall hold office until the next annual meeting of stockholders
      after such date and until his or her successor has been duly elected and qualified, notwithstanding that such director may have been elected for a term that extended beyond the date of such next annual meeting of stockholders. At each annual meeting
      of stockholders after the date of this Amendment (October 20, 2005), the Directors elected at such annual meeting shall hold office for a term expiring at the next annual meeting of stockholders to be held in the year following the year of their
      election, with the members to hold office until their successors are elected and qualified.</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">B.&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Newly Created Directorship and Vacancies</u></font>. Newly
      created directorships resulting from any increase in the number of Directors and any vacancies on the Board of Directors resulting from the death, resignation, disqualification, or removal of a director shall be filled solely by the affirmative vote
      of the majority of the remaining Directors then in office, even though less than a quorum of the Board of Directors. Any Director elected (a) to fill any vacancy resulting from the death, resignation, disqualification or removal of a Director shall
      hold office for the remainder of the full term of the Director whose death, resignation, disqualification or removal created such vacancy or (b) to fill any vacancy resulting from a newly created directorship shall hold office until the next annual
      meeting of stockholders and, in each case, until such Director&#8217;s successors shall have become elected and qualified. No decrease in the number of Directors constituting the Board of Directors shall shorten the term of any incumbent Director.</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">C.&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Removal</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160;</font>Subject to the rights of any Preferred Stock to elect directors under specified circumstances, any director may be removed from office, with or without cause, and only by the affirmative vote of the
      holders of 80% of the combined voting power of the then outstanding shares of stock entitled to vote generally in the election of directors, voting together as a single class.</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE X</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or
      special meeting of such holders and may not be effected by any consent in writing by such holders. Except as otherwise required by law and subject to the rights of the holders of Preferred Stock, special meetings of stockholders of the Corporation
      may be called only by the Board of Directors pursuant to a resolution approved by a majority of the entire Board of Directors. Notwithstanding anything contained in this Restated Certificate of Incorporation to the contrary, the affirmative vote of
      the holders of at least 80% of the voting power of all shares of the Corporation entitled to vote generally in the election of directors, voting together as a single class, shall be required to after, amend, adopt any provision inconsistent with or
      repeal this Article X.</div>
    <div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE XI</div>
    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(a) Except as otherwise provided in this Article XI, no purchase by the Corporation from any Controlling Person (as hereinafter
      defined) of shares of any stock of the Corporation owned by such Controlling Person shall be made at a price exceeding the average price paid by such Controlling Person for all shares of stock of the Corporation acquired by such Controlling Person
      during the two-year period preceding the date of such proposed purchase unless such purchase is approved by the affirmative vote of not less than a majority of the voting power of the shares of stock of the Corporation entitled to vote held by
      Disinterested Stockholders (as hereinafter defined).</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(b) The provisions of this Article XI shall not apply to (i) any offer to purchase made by the Corporation which is made on the same
      terms and conditions to the holders of all shares of stock of the Corporation, (ii) any purchase by the Corporation of shares owned by a Controlling Person occurring after the end of two years following the date of the last acquisition by such
      Controlling Person of stock of the Corporation, (iii) any transaction which may be deemed to be a purchase by the Corporation of shares of its stock which is made in accordance with the terms of any stock option or other employee benefit plan now or
      hereafter maintained by the Corporation, or (iv) any purchase by the Corporation of shares of its stock at prevailing market prices pursuant to a stock repurchase program.</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(c) This Article XI shall not be amended without the affirmative vote of not less than a majority of the stock of the Corporation
      entitled to vote thereon; provided, however, that if, at the time of such vote, there shall be one or more Controlling Persons, such affirmative vote shall include the affirmative vote in favor of such amendment of not less than a majority of the
      voting power of the shares of stock of the Corporation entitled to vote thereon held by Disinterested Stockholders.</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(d) For purposes of this Article XI: (i) the term &#8220;Controlling Person&#8221; means any individual, corporation, partnership, trust,
      association or other organization or entity (including any group formed for the purpose of acquiring, voting or holding securities of the Corporation) which either directly, or indirectly through one or more intermediaries, owns, beneficially or of
      record, or controls by agreement, voting trust or otherwise, at least 10% of the voting power of the stock of the Corporation, and such term also includes any corporation, partnership, trust, association or other organization or entity in which one
      or more Controlling Persons have the power, through the ownership of voting securities, by contract, or otherwise, to influence significantly any of the management, activities or policies of such corporation, partnership, trust, association, other
      organization or entity and (ii) the term &#8220;Disinterested Stockholders&#8221; means those holders of the stock of the Corporation entitled to vote on any matter, none of which is a &#8220;Controlling Person.&#8221;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Corporation has caused this Restated Certificate of Incorporation to be duly executed by its authorized
      officer this 9th day of August, 2013.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.16
<SEQUENCE>3
<FILENAME>brhc10049677_ex10-16.htm
<DESCRIPTION>EXHIBIT 10.16
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;"> Exhibit 10.16</font><br>
    </div>
    <div style="text-align: center;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div>
      <div style="text-align: center; font-weight: bold;"><u>SUBLEASE AGREEMENT</u></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">THIS SUBLEASE AGREEMENT (&#8220;<u>Sublease</u>&#8221;) is made and entered into effective as of the <u>18</u> day of <u>October</u>, 2022 (the &#8220;<u>Effective Date</u>&#8221;), by and between <font style="font-weight: bold;">E.R. SQUIBB &amp; SONS, L.L.C.</font>, a Delaware limited liability company (&#8220;<u>Sublessor</u>&#8221;), and <font style="font-weight: bold;">ETERNA THERAPEUTICS INC.</font>, a Delaware corporation, formerly known as Brooklyn
        Immunotherapeutics, Inc. (&#8220;<u>Sublessee</u>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: center;"><u>R E C I T A L S</u>:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="DocXGoBackHere"></a>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;DW Propco EF, LLC, a Delaware limited liability company (&#8220;<u>Landlord</u>&#8221;), as landlord, and Sublessor, as tenant, have made and entered into that certain
        Lease dated as of July 31, 2020 (the &#8220;<u>Original Lease</u>&#8221;), as amended by that certain First Amendment to Lease dated March 15, 2021 (the &#8220;<u>First Amendment</u>;&#8221; the Original Lease, as amended by the First Amendment, being hereafter referred
        to as the &#8220;<u>Primary Lease</u>&#8221;), which Primary Lease provides for the lease and demise by Landlord to Sublessor of those certain premises located in the building currently under construction at 250 Water Street, Somerville, Massachusetts (the &#8220;<u>Building</u>&#8221;)




        and more particularly described in the Primary Lease, but which are generally described as consisting of (i) portions of the first (1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup>) floor of the Building
        containing approximately 19,856 RSF in the aggregate, (ii) the entire rentable area of the second (2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup>), third (3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup>), fourth (4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>), fifth (5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>), sixth (6<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>), seventh (7<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>), eighth (8<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) and ninth (9<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) floors of the Building, and (ii) certain rentable area on the penthouse level 1 of the Building (the &#8220;<u>Primary
          Leased Premises</u>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A true and correct copy of the Primary Lease (with confidential portions redacted) is attached hereto as <u>Exhibit &#8220;A&#8221;</u> and made a part hereof for all purposes.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Sublessor desires to sublease to Sublessee the below-described portion of the Primary Leased Premises, and Sublessee desires to accept and sublease the same, all upon and subject to the
        terms and conditions set forth hereinbelow.</div>
      <div>&#160;</div>
      <div style="text-align: center;"><u>A G R E E M E N T</u>:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">NOW, THEREFORE, for and in consideration of the above and foregoing premises and in consideration of the mutual terms, conditions, covenants and agreements herein contained, and for other good and
        valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each of the parties hereto, Sublessor and Sublessee hereby covenant and agree as follows:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Demise and Description of Premises</u>.&#160; Sublessor hereby subleases to Sublessee, and Sublessee hereby subleases from Sublessor, upon and subject to the terms, limitations and
        conditions set forth herein and in the Primary Lease, that portion (the &#8220;<u>Premises</u>&#8221;) of the Primary Leased Premises consisting of approximately 45,500 square feet of rentable area located on the ninth (9<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) floor of the Building, which Premises is more particularly described on <u>Exhibit &#8220;B&#8221;</u> attached hereto and made a part hereof for all purposes.&#160; Sublessor and Sublessee hereby stipulate that the
        Premises contain 45,500 square feet of rentable area and that the Sublease Rent hereunder shall not be subject to change based on any remeasurement of the Premises.&#160; Sublessee acknowledges that the Primary Leased Premises are subject to
        remeasurement pursuant to the process described in Paragraph 3.5 of Exhibit B to the Original Lease.&#160; Within thirty (30) days of such remeasurement, Sublessor shall advise Sublessee and the terms hereunder that are based on the square footage of
        the Premises (including, without limitation, Sublessor&#8217;s Share of Operating Expenses, but specifically excluding Sublease Rent) shall be updated accordingly.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Term: Surrender</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Term</u>.&#160; Subject to the early termination rights set forth in Section 2(C) hereof and to the renewal option set forth in Section 2(D) hereof, the term (&#8220;<u>Term</u>&#8221;) shall
        commence on the date that is the later of the date of receipt of Landlord&#8217;s consent hereto (which shall be in such form as is reasonably acceptable to each of Sublessor and Sublessee and the date the Premises are delivered to Sublessee (the &#8220;<u>Sublease



          Commencement Date</u>&#8221;) and ending at 11:59 p.m. (Boston, Massachusetts time) on the date that is the day immediately preceding the ten (10) year anniversary of the Sublease Rent Commencement Date (as defined below) (the &#8220;<u>Expiration Date</u>&#8221;),



        or at such earlier date as this Sublease may be terminated pursuant to the terms of this Sublease.&#160; Notwithstanding the preceding sentence, this Sublease will automatically terminate upon the expiration or termination for any reason of the Primary
        Lease.&#160; As used herein, the term &#8220;<u>Sublease Rent Commencement Date</u>&#8221; shall mean the date that is the earlier to occur of (i) the date that Sublessee, or any person occupying any of the Premises with Sublessee&#8217;s permission, commences business
        operations from the Premises or (ii) the date that is the one (1) year anniversary of the later to occur of (A) the Effective Date of this Sublease or (B) the date that Sublessor obtains Landlord&#8217;s consent with respect to this Sublease.&#160;
        Notwithstanding the foregoing to the contrary, Sublessee acknowledges that pursuant to the terms of the Primary Lease, Sublessor has the right to contract the Primary Leased Premises by the Premises on a date that is the later to occur of (i) the
        tenth (10<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) anniversary of the Commencement Date of the Initial Premises (as defined in the First Amendment) Commencement Date (as defined in the Original Lease) and
        (ii) the tenth (10<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) anniversary of the Ninth Floor Commencement (as defined in the First Amendment) (such later date being the &#8220;<u>Contraction Date</u>&#8221;).&#160; As of the
        Effective Date hereof, Sublessor estimates that the Contraction Date will occur on or about November 1, 2032, however, upon Sublessee&#8217;s written request following the Sublease Rent Commencement Date, Sublessor shall verify the actual date that the
        Contraction Date would occur if Sublessor exercises its contraction option.&#160; Notwithstanding the foregoing or anything else to the contrary herein, in no event shall the Contraction Date occur earlier than the seven-year anniversary of the Sublease
        Rent Commencement Date.&#160; In the event Sublessor exercises such contraction option with respect to the Premises and the Contraction Date will occur prior to the Expiration Date, then Sublessor shall provide written notice to Sublessee (which such
        written notice to Sublessee shall be delivered no later than thirty (30) days following the date that Sublessor delivered written notice to Landlord of its election to exercise such contraction option) and the Expiration Date shall be accelerated
        to be the day immediately preceding the Contraction Date.&#160; Promptly following the Sublease Commencement Date, but no more than ten (10) business days following such date, Sublessor may prepare and deliver to Sublessee a written certificate
        specifying only the actual Sublease Commencement Date and Expiration Date, which Sublessee shall acknowledge by executing a copy and returning it to Sublessor.&#160; If Sublessee fails to sign and return the certificate to Sublessor, or to notify
        Sublessor of Sublessee&#8217;s objection(s) to the form of certificate, within ten (10) business days of its receipt from Sublessor, the certificate as sent by Sublessor shall be deemed to have correctly set forth the Sublease Commencement Date,
        Expiration Date and the other matters addressed in the certificate.&#160; Failure of Sublessor to send the certificate or of the Sublessee to return the certificate shall have no effect on the Sublease Commencement Date or the Expiration Date and shall
        not be a default hereunder.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;">
        <div>If the Primary Lease terminates as a result of a default or breach by Sublessor or Sublessee under this Sublease and/or the Primary Lease, then the defaulting party shall be liable to the non- defaulting party for the actual and direct damage
          suffered as a result of such termination or forfeiture, it being agreed that such actual and direct damage suffered by Sublessee shall include, without limitation, the unamortized balance as of such termination of Sublessee&#8217;s actual out-of-pocket
          costs incurred in excess of the Sublessee Allowance (as defined in Exhibit C attached hereto) with respect to the construction of the Sublessee Improvements (as defined in Exhibit C attached hereto) (as such amounts are amortized on a
          straight-line basis over a 10-year period commencing on the Sublease Rent Commencement Date).</div>
        <div> <br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">B.&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>End of Term</u>.&#160; Upon the expiration or termination of this Sublease, Sublessee must:&#160; (i) surrender to Sublessor any keys, electronic ID cards, and other access devices to the
        Premises at the place then fixed hereunder for payment of rent and other charges hereunder to Sublessor or such other place designated by Sublessor; (ii) remove all of Sublessee&#8217;s trade fixtures and other personal property from the Premises; (iii)
        remove any alterations performed by Sublessee in the Premises pursuant to the terms of the Sublease, if either (I) Sublessor specified in writing during its review of plans and specifications for the alterations that such alterations would need to
        be removed by Sublessee upon the expiration of this Sublease or (II) in accordance with the Primary Lease, Landlord requires the removal of the same upon the expiration or earlier termination of the Primary Lease, provided during Sublessor&#8217;s review
        of plans and specifications, Sublessor shall promptly following receipt submit such plans and specifications to Landlord and solicit whether such alterations must be removed (provided if Sublessor fails to solicit such feedback from Landlord and
        Landlord fails to state whether the alterations need to be removed, then Sublessee shall not be obligated to remove such alterations); (iv) surrender the Premises in &#8220;broom clean&#8221; condition and in compliance with the terms and conditions of the
        Primary Lease pertaining to surrender of the Premises, including, without limitation, in accordance with Section 10.6 of the Primary Lease; (v) except for reasonable wear and tear and (subject to the provisions of Article 12 of the Primary Lease)
        damage by casualty or taking, surrender the Premises and fixtures in the same condition in which Sublessee received them; and (vi) if during the Term any portion of the Premises was used by Sublessee for laboratory purposes or any portion of the
        Premises or Tenant&#8217;s Appurtenant Areas (as defined in the Primary Lease) was used by Sublessee for the storage, processing, use, or disposal of Hazardous Substances (as defined in the Primary Lease) (other than Customary Office Materials (as
        defined in the Primary Lease)) in compliance with applicable Environmental Laws (as defined in the Primary Lease)), (I) remove all Hazardous Substances from the Premises and any such Tenant&#8217;s Appurtenant Areas in accordance with applicable
        Environmental Laws prior to Tenant&#8217;s surrender of the Premises; and (II) at least sixty (60) days prior to Sublessee&#8217;s surrender of possession of any part of the Premises, provide Sublessor with a Decommissioning Report (as defined in the Primary
        Lease) prepared by an independent third party state-certified professional with appropriate expertise pursuant to the process set forth in Section 10.6(b) of the Primary Lease.&#160; As part of Sublessee&#8217;s surrender obligation, Sublessee shall be
        required to provide a Decommissioning Report to Sublessor pursuant to the process set forth in Section 10.6(b) of the Primary Lease.&#160; If Sublessee fails to perform its surrender obligations under this Section 2(B), without limiting any other right
        or remedy of Sublessor, Sublessor may perform such obligations at Sublessee&#8217;s expense, and Sublessee shall promptly reimburse Sublessor within thirty (30) days following written demand for all reasonable, out-of-pocket costs and expenses incurred
        by Sublessor in connection with such work, together with a 5% administrative fee for Sublessor&#8217;s efforts to undertake such work (which written demand shall be accompanied by reasonable back-up documentation evidencing such costs incurred by
        Landlord).&#160; Notwithstanding anything herein to the contrary, Sublessor has reviewed the proposed test-fit attached hereto as <u>Exhibit &#8220;E&#8221;</u> for the initial Sublessee Improvements contemplated in <u>Exhibit &#8220;C&#8221;</u> and Sublessor confirms that
        it will not require the removal of any of the Sublessee Improvements shown therein; provided, however, Sublessee acknowledges that in accordance with the Primary Lease Landlord may identify for removal any of the improvements shown in <u>Exhibit
          &#8220;E&#8221;</u> and, if Landlord so requires their removal, then Sublessor may require Sublessee, at its sole cost and expense, to remove the same at the expiration or earlier termination of the Sublease.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">In the event of holdover, Sublessee will be obligated to pay each month (pro-rated on the basis of a three hundred sixty-five (365) day calendar year for any partial month) during the holdover
        period a monthly installment of Sublease Rent equal to (A) for the initial sixty (60) days of such holdover period, 150% of the monthly installment of Sublease Rent required to be paid upon the expiration or earlier termination of this Sublease and
        (B) if such holdover period is longer than sixty (60) days, then commencing on the sixty-first (61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup>) day of such holdover period and continuing for the duration of
        such holdover period, 200% of the monthly installment of Sublease Rent required to be paid upon the expiration or earlier termination of this Sublease.&#160; No holding over by Sublessee shall extend the Term.&#160; If Sublessee remains in possession beyond
        the expiration of the Term, Sublessee will indemnify, defend, and hold Sublessor harmless against any and all losses, liabilities, damages, costs, and/or expenses (including attorneys&#8217; fees and costs of litigation), or any claim therefor, (a)
        sustained by Sublessor by reason of such holding over to the extent such holdover period extends for more than ninety (90) days after the expiration or earlier termination of this Sublease, (b) incurred by Sublessor in connection with the exercise
        by Sublessor of its remedies against Sublessee to the extent such holdover period extends for more than ninety (90) days after the expiration or earlier termination of this Sublease, and/or (c) claimed by Landlord pursuant to the Primary Lease (it
        being agreed that there shall be no 90-day grace period with respect to claims under this clause (c)).&#160; The foregoing indemnity shall survive the expiration or earlier termination of this Sublease.&#160; In the event this Sublease has not expired or
        otherwise been terminated, then during the final 18-months of the term of the Primary Lease, Sublessee may provide a written inquiry to Sublessor requesting copies of any notices that Sublessor received from Landlord pursuant to Section 14.8 of the
        Primary Lease and, promptly following such written inquiry, Sublessor shall provide copies to Sublessee of any such notices that is has previously received.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Sublessor Termination Right</u>.&#160; Sublessor shall have the right to send Sublessee irrevocable written notice (the &#8220;<u>Cancellation Notice</u>&#8221;) that Sublessor has elected to
        terminate this Sublease, effective on the seven (7) year anniversary of the Sublease Rent Commencement Date (such date being the &#8220;<u>Cancellation Date</u>&#8221;), by delivering the Cancellation Notice to Sublessee on or before the last day of the
        sixty-sixth (66<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) full calendar month following the Sublease Rent Commencement Date (&#8220;<u>Cancellation Option</u>&#8221;).&#160; If Sublessor elects to terminate this Sublease
        pursuant to this <u>Section 2(C)</u>, Sublessor shall pay to Sublessee a termination fee equal to the unamortized balance as of the Cancellation Date of Sublessee&#8217;s actual out-of-pocket hard and soft construction costs incurred in excess of the
        Sublessee Allowance (as defined in <u>Exhibit C</u> attached hereto) with respect to the construction of the Sublessee Improvements (as defined in <u>Exhibit C</u> attached hereto) (as such amounts are amortized on a straight-line basis over a
        10-year period commencing on the Sublease Rent Commencement Date) (collectively, the &#8220;<u>Termination Fee</u>&#8221;).&#160; One-half of the Termination Fee shall be payable within thirty (30) days after Sublessor&#8217;s delivery of the Cancellation Notice and the
        second half of the Termination Fee shall be payable on or prior to the Cancellation Date.&#160; No later than ninety (90) days following the Sublease Rent Commencement Date, Sublessee shall furnish Sublessor a calculation (which shall include
        documentation supporting the costs incurred by Sublessee) with respect to the Termination Fee based on the final hard and soft construction costs over the Sublessee Allowance incurred by Sublessee with respect to the Sublessee Improvements.&#160;
        Thereafter, Sublessor shall have a period of sixty (60) days (the &#8220;<u>Verification Period</u>&#8221;) to verify and/or object to the proposed calculation of the Termination Fee.&#160; In the event Sublessee fails to timely deliver the calculation of the
        Termination Fee, then it shall be deemed that Sublessee did not incur any costs in excess of the Sublessee Allowance so that there is no Termination Fee.&#160; In the event Sublessor objects to the calculation of the Termination Fee, then the parties
        shall meet and confer in good faith to discuss the Sublessor&#8217;s objections and a recalculation of the Termination Fee, and in the event Sublessor and Sublessee fail to reach an agreement on the Termination Fee within thirty (30) days after the
        expiration of the Verification Period, then the matter shall be submitted, upon the demand of either party, to the office of the American Arbitration Association in Boston, with a request for arbitration in accordance with the expedited commercial
        arbitration rules of the Association by a single arbitrator who shall be a licensed real estate broker with at least ten (10) years&#8217; experience in the leasing of 50,000 or more square feet of floor area in buildings similar in character and
        location to the Building, and who shall not be affiliated with either Sublessor or Sublessee and has not worked for either party or its affiliates at any time during the prior five (5) years, whose decision shall be conclusive and binding on the
        parties.&#160; Except as otherwise expressly set forth in this Sublease, Sublessor and Sublessee shall be relieved of all obligations accruing under this Sublease after the Cancellation Date, but not any obligations accruing under this Sublease prior to
        the effective date of such termination.&#160; If Sublessor does not give the Cancellation Notice within the period set forth above, Sublessor&#8217;s right to terminate this Sublease as provided herein shall automatically terminate.&#160; Time is of the essence as
        to the giving of the Cancellation Notice.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Renewal Option</u>.&#160; Provided that as of the time of the giving of the Extension Notice and the Commencement Date of the Extension Term, (i) Sublessee is either the Sublessee
        originally named herein or a Permitted Transferee (as defined in Section 13 below), (ii) Sublessee actually occupies all of the Premises initially demised under this Lease and any space added to the Premises, (iii) no event of default (past
        applicable notice and cure periods) under this Sublease shall exist, and (iv) Sublessor, in its sole and absolute discretion, has elected not to utilize the Premises following the expiration of the initial Term of this Sublease; then Sublessee
        shall have the right to extend the Term of this Sublease for an additional term that will extend through the date that is sixty (60) days prior to the date that the Initial Term of the Primary Term is scheduled to expire as set forth in Section 1.5
        of the Primary Lease (such additional term is hereinafter called the &#8220;<u>Extension Term</u>&#8221;) commencing on the day following the expiration of the original Term of this Sublease (hereinafter referred to as the &#8220;<u>Commencement Date of the
          Extension Term</u>&#8221;).&#160; Sublessee shall give Sublessor notice (hereinafter called the &#8220;<u>Extension Notice</u>&#8221;) of its election to extend the Term of the Sublease at least eighteen (18) months, but not more than twenty-four (24) months, prior to
        the scheduled expiration date of the original Term of the Sublease.&#160; Notwithstanding the foregoing to the contrary, Sublessor shall have the right at any time prior to Sublessee&#8217;s delivery of the Extension Notice or within sixty (60) days following
        Sublessee&#8217;s delivery of the Extension Notice in which to provide Sublessee with written notice (the &#8220;Renewal Option Void Notice&#8221;) to advise Sublessee that Sublessor has elected, in its sole discretion, to commence to utilize the Premises following
        the expiration of the initial Term of this Sublease.&#160; In the event Sublessor delivers a Renewal Option Void Notice, then this Section 2(D) shall thereafter be deemed null and void and of no further force or effect and, if Sublessee had previously
        delivered an Extension Notice, then such Extension Notice shall be deemed withdrawn and of no further force or effect such that the Term of the Sublease shall expire as of the Term originally contemplated in Section 2(A) of this Sublease.&#160;
        Notwithstanding the foregoing to the contrary, Sublessee&#8217;s renewal option set forth herein is subject to Sublessor&#8217;s termination right set forth in the immediately preceding subparagraph C.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">The Sublease Rent payable by Sublessee to Sublessor during the Extension Term shall be the then prevailing market rate for comparable laboratory/office space in the Cambridge, MA area and
        comparable buildings in the vicinity of the Building, taking into account the size of the Premises, the length of the renewal term, market escalations and the credit of Sublessee.&#160; The Sublease Rent shall not be reduced by reason of any costs or
        expenses saved by Sublessor by reason of Sublessor&#8217;s not having to find a new subtenant for such premises (including, without limitation, brokerage commissions, costs of improvements, rent concessions or lost rental income during any vacancy
        period).&#160; In the event Sublessor and Sublessee fail to reach an agreement on such rental rate and execute the Amendment (defined below) at least twelve (12) months prior to the expiration of the Sublease, then Sublessee&#8217;s exercise of this renewal
        option shall be deemed withdrawn and the Lease shall terminate on its original expiration date.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The determination of Sublease Rent does not reduce the Sublessee&#8217;s obligation to pay or reimburse Sublessor for Additional Rent and other reimbursable items as set forth in the Sublease, and
        Sublessee shall reimburse and pay Sublessor as set forth in the Sublease with respect to such Additional Rent and other items with respect to the Premises during the Extension Term.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Except for the Sublease Rent as determined above, Sublessee&#8217;s occupancy of the Premises during the Extension Term shall be on the same terms and conditions as are in effect immediately prior to the
        expiration of the initial Term of the Sublease; provided, however, Sublessee shall have no further right to any allowances, credits or abatements or any options to expand, contract, terminate, renew or extend the Lease.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If Sublessee does not give the Extension Notice within the period set forth above, Sublessee&#8217;s right to extend the Term shall automatically terminate.&#160; Time is of the essence as to the giving of
        the Extension Notice.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Sublessor shall have no obligation to refurbish or otherwise improve the Premises for the Extension Term.&#160; The Premises shall be tendered on the Commencement Date of the Extension Term in &#8220;as-is&#8221;
        condition.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If the Lease is extended for the Extension Term, then Sublessor shall prepare and Sublessee shall execute an amendment to the Lease confirming the extension of the Lease Term and the other
        provisions applicable thereto (the &#8220;<u>Amendment</u>&#8221;).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">If Sublessee exercises its right to extend the term of the Lease for the Extension Term pursuant to this Section 2(D), the term &#8220;Term&#8221; as used in the Sublease, shall be construed to include, when
        practicable, the Extension Term.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Sublease Rent</u>.&#160; Commencing on the Sublease Rent Commencement Date and continuing throughout the Term of this Sublease, Sublessee must pay to Sublessor as base rent (the &#8220;<u>Sublease



          Rent</u>&#8221;) for the Premises the following sums during the respective periods set forth below:</div>
      <div>&#160;
        <table cellspacing="0" cellpadding="1" border="0" id="z61553e64fbfb44de9970e185cc62da42" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 34.51%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div style="text-align: center;">Period</div>
              </td>
              <td style="width: 35.02%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div style="text-align: center;">Sublease Rental</div>
                <div style="text-align: center;">Rate/RSF/annum</div>
              </td>
              <td style="width: 30.26%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div style="text-align: center;">Monthly Installments of</div>
                <div style="text-align: center;">Sublease Rent</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.51%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;">Months 1 &#8211; 12</div>
              </td>
              <td style="width: 35.02%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;">$120.00, plus NNN*</div>
              </td>
              <td style="width: 30.26%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; color: rgb(0, 0, 0);">$455,000.00</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.51%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify;">Months 13 &#8211; 24</div>
              </td>
              <td style="width: 35.02%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify;">$123.60, plus NNN*</div>
              </td>
              <td style="width: 30.26%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify; color: rgb(0, 0, 0);">$468,650.00</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.51%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;">Months 25 &#8211; 36</div>
              </td>
              <td style="width: 35.02%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;">$127.31, plus NNN*</div>
              </td>
              <td style="width: 30.26%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; color: rgb(0, 0, 0);">$482,717.08</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.51%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify;">Months 37 &#8211; 48</div>
              </td>
              <td style="width: 35.02%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify;">$131.13, plus NNN*</div>
              </td>
              <td style="width: 30.26%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify; color: rgb(0, 0, 0);">$497,201.25</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.51%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;">Months 49 &#8211; 60</div>
              </td>
              <td style="width: 35.02%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;">$135.06, plus NNN*</div>
              </td>
              <td style="width: 30.26%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; color: rgb(0, 0, 0);">$512,102.50</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.51%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify;">Months 61 &#8211; 72</div>
              </td>
              <td style="width: 35.02%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify;">$139.11, plus NNN*</div>
              </td>
              <td style="width: 30.26%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify; color: rgb(0, 0, 0);">$527,458.75</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.51%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;">Months 73 &#8211; 84</div>
              </td>
              <td style="width: 35.02%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;">$143.28, plus NNN*</div>
              </td>
              <td style="width: 30.26%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; color: rgb(0, 0, 0);">$543,270.00</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.51%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify;">Months 85 &#8211; 96</div>
              </td>
              <td style="width: 35.02%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify;">$147.58, plus NNN*</div>
              </td>
              <td style="width: 30.26%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify; color: rgb(0, 0, 0);">$559,574.17</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.51%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;">Months 97 &#8211; 108</div>
              </td>
              <td style="width: 35.02%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;">$152.01, plus NNN*</div>
              </td>
              <td style="width: 30.26%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; color: rgb(0, 0, 0);">$576,371.25</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.51%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify;">Months 109 &#8211; Expiration Date</div>
              </td>
              <td style="width: 35.02%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify;">$156.57, plus NNN*</div>
              </td>
              <td style="width: 30.26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">$593,661.25</div>
              </td>
            </tr>
            <tr>
              <td style="width: 99.8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="3">
                <div style="text-align: justify;">*NNN = Sublessor&#8217;s Share of Operating Expenses</div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">The Sublease Rent must be paid in lawful money of the United State of America, at the office of Sublessor, at least five (5) days prior to the first day of each calendar month during the Term,
        commencing on the Sublease Rent Commencement Date, without demand, abatement, deduction or set-off.&#160; The Sublease Rent must be paid to Sublessor at Sublessor&#8217;s address as provided on the signature page of this Sublease or to such other person or at
        such other address as Sublessor may from time to time designate in writing.&#160; Sublessor may, at its option, bill Sublessee for Sublease Rent, but no delay or failure by Sublessor in providing such a bill will relieve Sublessee from the obligation to
        pay the Sublease Rent on the first day of each month as provided herein.&#160; All payments must be in the form of a check or a wire transfer unless otherwise agreed by Sublessor, except that payment by check will not be deemed made if the check is not
        duly honored with good funds.&#160; If any such check is ever returned for lack of sufficient funds or is otherwise not duly honored with good funds, then Sublessor may thereafter require, upon written notice thereof to Sublessee, that all future
        payments of Sublease Rent or other charges under this Sublease be made in cash or cash equivalent mode or a wire transfer.&#160; In addition to the Sublease Rent and any other sums or amounts required to be paid by Sublessee to Sublessor pursuant to
        this Sublease, Sublessee must also pay to Sublessor, concurrently with the payments of such Sublease Rent or other charges, the amount of any applicable sales, use or excise tax, rent tax or other tax with respect thereto (other than any general
        income tax payable by Sublessor with respect thereto) as the same may be levied, imposed or assessed by any federal, state, commonwealth, county or municipal government entity or agency.&#160; The obligation of Sublessee to pay Sublease Rent and other
        sums to Sublessor and the obligations under this Sublease are independent obligations.&#160; If the Term of this Sublease commences or ends at any time other than the first day of a calendar year, then Sublease Rent will be prorated for such year
        according to the number of days of the Term in such year.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Additional Rent</u>.&#160; In addition to the Sublease Rent provided in <u>Section 3</u> of this Sublease, commencing on the Sublease Rent Commencement Date, Sublessee must also pay to
        Sublessor all Taxes (as defined in the Primary Lease), Operating Expenses (as defined in the Primary Lease), Separately Reimbursable Utilities (as defined in the Primary Lease) and any other rent or other charges payable by Sublessor pursuant to
        the Primary Lease for the Premises, and all such other sums of money becoming due and payable by Sublessor to Landlord under the Primary Lease and relating to the Premises (&#8220;<u>Additional Rent</u>&#8221;).&#160; Sublease Rent and all Additional Rent are
        sometimes collectively referred to in this Sublease as &#8220;<u>Rent</u>.&#8221; Pursuant to Section 4.2(b) of the Primary Lease, after the end of each calendar year, Landlord is required to deliver to Sublessor a Reconciliation Statement of the actual
        Operating Expenses and Taxes for the prior calendar year and thereafter Sublessor shall either pay to Landlord any underpayment of Operating Expenses or Taxes or Landlord shall credit to Sublessor any overpayment of Operating Expenses or Taxes for
        the prior calendar year.&#160; Promptly following Sublessor&#8217;s receipt of the Reconciliation Statement from Landlord, Sublessor shall deliver the same to Sublessee and Sublessor and Sublessee shall thereafter make a similar reconciliation payment to each
        other based on Operating Expenses and Taxes for the Premises (i.e., Sublessee shall pay to Sublessor any amounts that it underpaid for Operating Expenses and/or Taxes for the prior calendar year or Sublessor shall credit to Sublessee any
        overpayment made by Sublessee of Operating Expenses and Taxes for the prior calendar year).&#160; Notwithstanding anything herein to the contrary, Operating Expenses shall exclude any costs or expenses incurred by Landlord relating to a service that is
        only allocable or provided to the portion of the Primary Leased Premises exclusively used by Sublessor (i.e., being the portion of the Primary Leased Premises other than the Premises or any common areas (e.g., parking areas, loading docks, lobbies,
        etc.)).&#160; For the avoidance of doubt, the preceding sentence does not exclude from Operating Expenses any costs incurred by Landlord with respect to the repair, maintenance or replacement of any base Building systems or equipment that serve the
        Building generally.&#160; All Rent must be paid without notice, demand, abatement, deduction or setoff, except as otherwise expressly provided in this Sublease.&#160; All amounts of Rent not paid by Sublessee when due shall bear interest from the date due
        until the date paid at the same rates of interest, and subject to the same late fees, penalties, or charges, if any, provided for in the Primary Lease.&#160; EXCEPT TO THE EXTENT SUBLESSOR IS ENTITLED TO ANY SUCH ABATEMENT UNDER THE PRIMARY LEASE (BUT
        ONLY TO THE EXTENT SUCH ABATEMENT APPLIES TO THE PREMISES BEING SUBLET BY SUBLESSEE HEREUNDER) AND ACTUALLY RECEIVES SUCH ABATEMENT FROM LANDLORD WITH RESPECT TO THE PREMISES BEING SUBLET BY SUBLESSEE, SUBLESSEE WILL CONTINUE TO PAY THE RENT AND
        OTHER CHARGES DUE AND PAYABLE BY SUBLESSEE HEREUNDER WITHOUT ABATEMENT, SET OFF OR DEDUCTION, NOTWITHSTANDING ANY BREACH OR ALLEGED BREACH BY SUBLESSOR OF SUBLESSOR&#8217;S DUTIES OR OBLIGATIONS HEREUNDER, WHETHER EXPRESS OR IMPLIED.&#160; Notwithstanding the
        preceding sentence to the contrary, in no event shall Sublessee be entitled to an offset, reduction or abatement of rent payable hereunder if Sublessor receives an offset, reduction or abatement of rent payable by it under the Primary Lease as a
        result of exercising its self-help rights or as a result of any failure of Landlord to disburse the tenant improvement allowance payable to Sublessor; provided, however, Sublessee shall have those certain offset rights set forth in <u>Paragraph
          (a)(x)</u> of the work letter attached hereto as <u>Exhibit &#8220;C&#8221;</u> in the event Sublessor fails to disburse the Sublessee Improvement Allowance.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Security Deposit</u>.&#160; Within two (2) business days after the date of receipt of Landlord&#8217;s consent hereto, Sublessee must deliver to Sublessor a security deposit in the form of a
        Letter of Credit in the amount of Four Million Ninety-Five Thousand Dollars ($4,095,000.00) (the &#8220;<u>Security Deposit</u>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Letter of Credit shall be in form and substance as set forth in <u>Exhibit D</u> attached hereto or otherwise satisfactory to Sublessor in its reasonable discretion, from a bank acceptable to
        Sublessor in Sublessor&#8217;s reasonable determination in the initial amount of the Security Deposit, as security for the performance of the provisions hereof by Sublessee, if applicable.&#160; At a minimum the Letter of Credit shall provide for the
        following:&#160; (i) it shall terminate no sooner than thirty days following the actual expiration date of the Term, or, if it shall terminate earlier, the Letter of Credit shall provide that it will automatically renew or be replaced annually unless
        Sublessor (the beneficiary thereof) is notified in writing by the issuer at least thirty (30) days prior to the expiry date that the Letter of Credit will not be renewed or replaced; and if Sublessor is so notified of such
        non-renewal/non-replacement, Sublessor (the beneficiary thereof) shall have the right to draw the full amount of such Letter of Credit prior to such earlier expiry date and the amounts so drawn shall be held by Sublessor as a Security Deposit, and
        applied and disbursed in accordance with the terms of the next following paragraph; (b) it shall be irrevocable, and (c) it shall be transferable in whole (but not partially) to any successor to Sublessor&#8217;s interest under this Lease.&#160; If at any
        time during the Lease Term the bank or financial institution that issues the letter of credit is declared insolvent, or is placed into receivership by the Federal Deposit Insurance Corporation or any other governmental or quasi-governmental
        institution, or if there is a material adverse change in the financial or business condition of the bank or financial institution from the date of the Lease as reasonably determined by Sublessor, then following written notice from Sublessor,
        Sublessee shall have ten (10) business days to replace the Letter of Credit with a new letter of credit from a bank or financial institution acceptable to Sublessor in Sublessor&#8217;s reasonable discretion.&#160; If Sublessee does not replace the Letter of
        Credit with a new letter of credit from a bank or financial institution acceptable to Sublessor within such ten (10) business day period, then notwithstanding anything in the Sublease to the contrary, Sublessee shall be in default, and Sublessor
        shall have the right to draw upon the Letter of Credit for the full amount of the Letter of Credit and retain and apply such amounts pursuant to this <u>Section 5</u>.&#160; Provided no event of default (past applicable notice and cure periods) by the
        Sublessee occurs during the initial thirty-six (36) month period following the Sublease Rent Commencement Date, then the amount of the Letter of Credit shall be reduced on the first day of the thirty-seventh (37th) month following the Sublease Rent
        Commencement Date by the sum of $1,365,000.00 so that the Letter of Credit deposited with Sublessor thereafter shall be in the sum of $2,730,000.00.&#160; Provided no event of default (past applicable notice and cure periods) by the Sublessee occurs
        during the initial eighty-four (84) month period following the Sublease Rent Commencement Date, then the amount of the Letter of Credit shall be reduced on the first day of the eighty-fifth (85th) month of following the Sublease Rent Commencement
        Date by the sum of $910,000.00 so that the Letter of Credit deposited with Sublessor thereafter shall be in the sum of $1,820,000.00.&#160; Sublessor agrees to authorize such reduction, to the extent permitted, in writing to the issuer of the Letter of
        Credit.&#160; Notwithstanding the foregoing, in the event a default (past applicable notice and cure periods) by the Sublessee prior to the reduction periods above, there shall be no reduction (or further reduction) in the Security Deposit.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">If Sublessee defaults, beyond applicable notice and cure periods, with respect to any provision of this Sublease, including, without limitation, the provisions relating to the payment of rent or
        the cleaning of the Premises upon the termination of this Lease, or amounts which Sublessor may be entitled to recover under applicable laws, Sublessor may draw down the Letter of Credit and use, apply or retain such portion of the proceeds from
        the Letter of Credit as may be necessary (i) for the payment of any rent or any other sum in default, (ii) for the payment of any other amount which Sublessor may, in accordance with the terms of this Sublease, spend or become obligated to spend by
        reason of Sublessee&#8217;s default hereunder, or (iii) to compensate Sublessor, in accordance with the terms of this Sublease, for any other loss or damage which Sublessor may suffer by reason of Sublessee&#8217;s default hereunder, including, without
        limitation, costs and reasonable attorneys&#8217; fees incurred by Sublessor to recover possession of the Premises following a default by Sublessee hereunder.&#160; The use or application of the proceeds from the Letter of Credit or any portion thereof shall
        not prevent Sublessor from exercising any other right or remedy provided hereunder or under any Law and shall not be construed as liquidated damages.&#160; In the event Sublessor draws down the Letter of Credit pursuant to the terms of this Lease,
        Sublessor shall not be required to keep the proceeds of the Letter of Credit separate from its general funds and Sublessee shall not be entitled to interest thereon.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">If any portion of the Letter of Credit is so used or applied, Sublessee shall, upon demand therefor, amend the Letter of Credit, provide an additional letter of credit (meeting all of the
        requirements of the Letter of Credit set forth above) or deposit cash with Sublessor, in each such case in an amount sufficient to restore the Security Deposit within ten (10) business days to the appropriate amount, as determined hereunder.&#160; The
        Security Deposit or any balance thereof not otherwise applied as provided herein shall be returned to Sublessee (or, at Sublessor&#8217;s option, to the last assignee of Sublessee&#8217;s interest hereunder) within thirty (30) days following the expiration or
        sooner termination of this Sublease.&#160; Sublessee hereby waives all provisions of law, now or hereafter in force, which provide that Sublessor may claim from a security deposit only those sums reasonably necessary to remedy defaults in the payment of
        rent, to repair damage caused by Sublessee or to clean the Premises, it being agreed that Sublessor may, in addition, claim those sums reasonably necessary, in accordance with the terms of this Sublease, to compensate Sublessor for any other loss
        or damage, foreseeable or unforeseeable, caused by the act or omission of Sublessee.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">6.&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Acceptance and Use of the Premises</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Acceptance of Premises</u>.&#160; Except for Sublessor performing the Sublessor Work (as more particularly set forth in <u>Section 18(V)</u> below), Sublessee accepts the Premises in its
        present, <font style="font-weight: bold;">&#8220;AS-IS, WHERE IS&#8221;</font> condition and with all faults; provided, however, subject to the terms and conditions of the Work Letter attached hereto as <u>Exhibit C</u>, Sublessor agrees to provide Sublessee
        with a Sublessee Improvement Allowance of up to $190.00 per square foot of rentable area in the Premises (the &#8220;<u>Sublessee Improvement Allowance</u>&#8221;) for the purpose of constructing improvements to the Premises pursuant to the terms of <u>Exhibit



          C</u> attached hereto.&#160; By occupying the Premises, Sublessee: (a) acknowledges that Sublessee has had full opportunity to examine the Premises and is fully informed, independently of Sublessor or any employee, agent, representative, shareholder,
        officer or director of Sublessor, as to the character, construction and structure of the Premises; (b) acknowledges that neither Sublessor nor any of Sublessor&#8217;s employees, agents, representatives, shareholders, officers or directors, has made any
        representations, warranties or promises with respect to the Premises, including without limitation any representation or warranty as to fitness thereof for any purpose; (c) accepts the Premises in an <font style="font-weight: bold;">&#8220;AS-IS, WHERE
          IS&#8221;</font> condition and acknowledges that the Premises comply with all requirements imposed upon Sublessor under this Sublease; and (d) acknowledges and agrees that the Premises are subject to the limitations, encumbrances, and other matters
        described in the Primary Lease.&#160; Sublessee acknowledges that Landlord is currently performing certain Base Building Work (as defined in the Primary Lease) and that Sublessor has no liability or obligation to perform any such Base Building Work;
        provided, however, upon written notice from Sublessee, Sublessor shall diligently enforce any and all rights Sublessor may have under the Primary Lease with respect to the Base Building Work in the Premises.&#160; In no event shall Sublessor have any
        liability to Sublessee in the event there are any delays on the part of Landlord to complete the Base Building Work, except to the extent such delays are due to a default by Sublessor under the Primary Lease.&#160; In no event shall Sublessee interfere
        with or otherwise cause any delays in the completion of the Base Building Work by Landlord.&#160; Sublessee acknowledges that Sublessor is performing certain Sublessor Work, as more particularly set forth in <u>Exhibit &#8220;F&#8221;</u> and Sublessee shall not
        interfere with such Sublessor Work.&#160; Notwithstanding the foregoing to the contrary, in the event Sublessee becomes aware of any latent defect (as such term is defined in <u>Section 10.3</u> of <u>Exhibit B</u> of the Primary Lease) with respect
        to the Premises, Sublessee shall notify Sublessor of such within the applicable time periods set forth in <u>Section 10.3</u> of <u>Exhibit B</u> of the Primary Lease in order to enable Sublessor to timely notify Landlord of the same and
        Sublessor shall diligently enforce the provisions of such <u>Section 10.3</u> for the benefit of Sublessee and the Premises.&#160; Notwithstanding the foregoing to the contrary, Sublessee shall not be required to investigate or otherwise inspect the
        physical condition of the Premises.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Maintenance of Premises</u>.&#160; Sublessee must maintain the Premises in good condition and repair and in all respects in compliance with all obligations of Sublessor as tenant under the
        Primary Lease.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">C.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Use of Premises</u>.&#160; The Premises may be used by Sublessee only for the uses permitted under the Primary Lease and for no other use or purpose.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">D.&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Intentionally Omitted</u>.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">7.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Relationship to Primary Lease</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Obligations and Provisions Under Primary Lease</u>.&#160; Sublessee hereby assumes and agrees to perform all obligations of Sublessor as tenant under the Primary Lease relating to the
        Premises (to the extent such obligations are not otherwise redacted from the copy of the Primary Lease attached hereto as Exhibit &#8220;A&#8221;), and Sublessee agrees to abide by and comply with all of the provisions of the Primary Lease during the Term of
        this Sublease, except that: (i) the payment of rent and other charges by Sublessee will be replaced by the provisions of <u>Sections 3</u> and <u>4</u> of this Sublease; and (ii) the following provisions of the Primary Lease will not be
        applicable:<font style="font-weight: bold;">&#160;</font>(a) Sublessee will have no right to any preferential option under the Primary Lease, including, without limitation, any rights or options to expand, renew, extend, or terminate (notwithstanding
        the availability of any such options under the Primary Lease), (b) Sublessee will have no right to any allowances or credits (except to the extent of the Sublessee Improvement Allowance being provided to Sublessee in accordance with Section 6(A) of
        this Sublease, which shall be disbursed in accordance with Exhibit &#8220;C&#8221; attached hereto and, except to the extent provided for in Section 4.2(b) of the Primary Lease); (c) Sublessee will have no right to perform alterations or make improvements to
        the Premises, without Sublessor&#8217;s prior written consent, which shall not be unreasonably withheld, conditioned or delayed (however, Sublessor&#8217;s prior consent shall not be required for any like-kind replacements (e.g., replacing a supplemental HVAC
        unit with a similar sized supplemental HVAC unit)), or without Landlord&#8217;s prior written consent as and to the extent required by the Primary Lease; and (d) except as otherwise expressly set forth in Sections 4 and 8 of this Sublease and Paragraph
        (a)(x) of the work letter attached hereto as Exhibit &#8220;C&#8221;, Sublessee will have no claims or rights of offset or abatement against Rent for any reason, including, without limitation, as a result of the failure of any utility or service, the
        interference with Sublessee&#8217;s use or access to the Premises, casualty or condemnation, unless Sublessor receives a corresponding offset or abatement from Landlord.&#160; In addition, the redacted portions of the Primary Lease and the following sections
        of the Primary Lease shall not be applicable to this Sublease: (I) with respect to the Original Lease: <u>Sections 1.5</u>, <u>1.6</u>, <u>1.9</u>, <u>1.10</u>, <u>1.12</u>, <u>1.13</u>, <u>1.15</u>, <u>2.2(b)</u>, <u>2.2(d)</u>, <u>2.2(e)</u>,
        <u>2.2(f)</u>, <u>2.2(g)</u>, <u>2.2(h)</u>, <u>2.2(i)</u>, <u>2.2(j)</u>, <u>3.1</u>, <u>3.2</u>, <u>3.3</u>, <u>3.4</u>, <u>3.5</u>, <u>4.1</u>, <u>4.4</u>, the second grammatical paragraph of <u>Section 7.1</u>, <u>11.1</u>, <u>11.2</u>,
        <u>11.3</u>, <u>11.4</u>, <u>14.6</u>, the second grammatical paragraph of <u>14.8</u>, <u>16.2(b)</u>, the second sentence of <u>16.4(a)</u>, <u>16.6(a)</u> (except for the first sentence), <u>Exhibit A-4</u>, <u>Exhibit B</u> (except as
        expressly incorporated in the Work Letter attached hereto as <u>Exhibit C</u>), <u>Exhibit D-1</u>, <u>Exhibit D-2</u>, <u>Exhibit D-3</u>, and <u>Exhibit I</u> and (II) with respect to the First Amendment: <u>Sections 1</u>, <u>2</u>, <u>3</u>,
        <u>4(b)</u>, <u>4(c)</u>, <u>4(d)</u>, <u>4(e)</u>, <u>4(f)</u>, <u>4(g)</u>, <u>4(h)</u>, and <u>5</u>.&#160; Sublessee hereby acknowledges that Sublessee has read and is familiar with the terms and conditions of the Primary Lease (not including
        any redacted provisions), and Sublessee further hereby acknowledges and agrees that, except as otherwise set forth in this Sublease, (x) this Sublease is and shall be and remain expressly subject to all of the terms and conditions of the Primary
        Lease, and (y) except as otherwise specifically set forth in this Sublease, Sublessor expressly retains and reserves all rights and benefits applicable to Sublessor as tenant under the Primary Lease.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Incorporation of Primary Lease</u>.&#160; Except as specifically excluded in this Sublease from application to Sublessee or Sublessor, as applicable, the provisions of the Primary Lease,
        to the extent that they apply to the Premises hereunder and do not conflict with specific provisions contained in this Sublease, are fully incorporated into this Sublease.&#160; In the event of any conflict between the provisions of the Primary Lease
        and the provisions contained in this Sublease, the provisions of this Sublease will be controlling as between Sublessor and Sublessee.&#160; Sublessee hereby agrees to be bound to Sublessor by, and to comply with all of the terms and conditions of, the
        Primary Lease and to assume toward Sublessor and perform all of the covenants, obligations and responsibilities that Sublessor by the Primary Lease assumes toward the Landlord, but only to the extent the same are applicable to the Premises
        hereunder.&#160; <font style="font-weight: bold;">TO THE EXTENT ALLOWED BY LAW,</font>&#160;<font style="font-weight: bold;">SUBLESSEE HEREBY AGREES TO INDEMNIFY, DEFEND (WITH COUNSEL APPROVED IN ADVANCE IN WRITING BY SUBLESSOR) AND HOLD HARMLESS SUBLESSOR,
          AND SUBLESSOR&#8217;S AGENTS, FROM AND AGAINST ANY AND ALL CLAIMS, LIABILITIES, CAUSES OF ACTION, LOSSES, DAMAGES, COSTS AND EXPENSES ARISING FROM (i) RESULTING FROM SUBLESSEE&#8217;S USE OR OCCUPANCY OF THE PREMISES, OR (ii) ANY PERSONAL OR BODILY INJURY TO
          PERSONS OR DAMAGE TO PROPERTY TO THE EXTENT THAT SUCH DAMAGE OR INJURY WAS CAUSED, EITHER PROXIMATELY OR REMOTELY, BY ANY ACT OR OMISSION, WHETHER NEGLIGENT OR NOT, OF SUBLESSEE OR ANY OF SUBLESSEE&#8217;S AGENTS, SERVANTS, EMPLOYEES, CONTRACTORS,
          CUSTOMERS, GUESTS, OR INVITEES OR OF ANY OTHER PERSON ENTERING ONTO THE PREMISES UNDER OR WITH THE EXPRESS OR IMPLIED INVITATION OF SUBLESSEE.&#160; SUBLESSEE&#8217;S OBLIGATIONS OF INDEMNIFICATION PURSUANT TO THIS <u>SECTION 7(B)</u> WILL SURVIVE THE
          EXPIRATION OR EARLIER TERMINATION OF THIS SUBLEASE.</font></div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Definition of Landlord</u>.&#160; With respect to this Sublease, Sublessee hereby agrees that all references to &#8220;Landlord&#8221; in the Primary Lease are deemed to be solely references to the
        Landlord for purposes of: (i) any provisions dealing with work to be performed or services or statements to be furnished by the Landlord pursuant to the Primary Lease; (ii) the obligations and liabilities imposed upon, allocated to, or assumed by
        the Landlord under the Primary Lease, including, without limitation, representations made and indemnities granted by Landlord under the Primary Lease;<font style="font-weight: bold;">&#160;</font>(iii) Sublessor shall not be obligated to perform or
        provide for any improvements or alterations, including casualty and condemnation restoration obligations; (iv) Landlord insurance obligations under the Primary Lease; (v) the execution or delivery of any estoppel or non-disturbance agreements; or
        (vi) the provision of any reconciliation statement or participation in any audit (it being agreed that in the event Sublessor elects not to audit Operating Expenses for any given calendar year pursuant to its audit rights under the Primary Lease,
        then Sublessee shall have the right to provide a written request to Sublessor that it exercise its audit rights under the Primary Lease for Sublessee&#8217;s benefit and, in such case, Sublessee shall reimburse Sublessor for any reasonable and actual
        out-of-pocket costs and expenses incurred in the conduct of such audit).&#160; In addition, all references to &#8220;Landlord&#8221; in the Primary Lease are deemed to be references to both Sublessor and Landlord with respect to: (a) all provisions requiring the
        consent of Landlord; (b) all provisions requiring notice to the Landlord; (c) all rights and remedies that may be exercised by Landlord under the Primary Lease; and (d) all waivers, indemnities and limitations of liability in favor of Landlord
        under the Primary Lease.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">8.&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Services and Other Rights</u>.&#160; Notwithstanding anything herein contained to the contrary, Sublessee hereby acknowledges and agrees that the only services or other rights that
        Sublessee is entitled to under this Sublease are those to which Sublessor is entitled under the Primary Lease, and Sublessee hereby agrees that Sublessee will look solely to Landlord under the Primary Lease for all such services and other rights
        and that Sublessor is not responsible therefor; provided that Sublessor shall use commercially reasonable efforts to cause Landlord to comply with such obligations under the Primary Lease.&#160; Sublessee shall pay all charges and costs for the
        utilities or services consumed at or attributable to the Premises under the Primary Lease.&#160; In the event the Premises are not separately metered or submetered, Sublessee shall install separate meters or submeters (based on specifications to be
        provided by Sublessor) in order to measure the utilities utilized in the Premises.&#160; Notwithstanding anything herein to the contrary, if there is an interruption or cessation of water, sewer, gas, or electricity service to the Premises due to (i)
        Sublessor&#8217;s negligence or willful misconduct, (ii) Sublessor&#8217;s failure to perform any other covenant or provision of the Primary Lease or this Sublease on its part required to be performed, or (iii) the performance of any work in or about the
        Building by Sublessor or its employees or agents, and such interruption or cessation results in the Premises being unusable by Sublessee for the conduct of Sublessee&#8217;s business, then Sublease Rent shall be abated commencing on that date which is
        three (3) consecutive business days following the date Sublessee delivers written notice to Sublessor of such interruption and continuing until either such service to the Premises is restored or such earlier date as the Premises is again usable for
        the conduct of Sublessee&#8217;s business.&#160; If, however, Sublessee reoccupies any portion of the Premises during such abatement period, the Sublease Rent allocable to such reoccupied portion, based on the proportion that the rentable area of such
        reoccupied portion of the Premises bears to the total rentable area of the Premises, shall be payable by Tenant from the date Tenant reoccupies such portion of the Premises.&#160; Such right to abate Sublease Rent shall be Tenant&#8217;s sole and exclusive
        remedy at law or in equity in the event of any such interruption or cessation of a utility service to the Premises.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exculpation</u>.&#160; Sublessee hereby acknowledges and agrees that Sublessor is not responsible for any repairs to the Premises, nor will Sublessor, nor any of Sublessor&#8217;s partners,
        officers, directors, shareholders, agents, employees or representatives, be liable for any of the following:&#160; (i) any of the Landlord&#8217;s obligations under the Primary Lease; (ii) any interruption in utilities or services to the Premises; (iii) any
        loss of or damage to any property of Sublessee or of Sublessee&#8217;s employees, agents, customers, guests or invitees (whether by theft or otherwise); (iv) the failure of Landlord to perform any obligation of Landlord under the Primary Lease; or (v)
        any damage or disturbance caused by others.&#160; Neither Sublessor nor any of Sublessor&#8217;s partners, officers, directors, shareholders, employees, agents or representatives has any personal liability under this Sublease.&#160; Under no circumstances
        whatsoever shall Sublessor ever be liable for punitive, consequential or special damages under this Sublease, and Sublessee waives any rights it may have to such damages under this Sublease in the event of a breach or default by Sublessor or
        Landlord under this Sublease.&#160; Under no circumstances whatsoever shall either Sublessee or Sublessor ever be liable for punitive, consequential or special damages under this Sublease, except for Sublessee&#8217;s liability for consequential damages
        pursuant to <u>Section 2.B</u> of this Sublease.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">10.&#160;&#160;&#160;&#160;&#160;&#160; <u>Default Under Primary Lease</u>.&#160; No default of Landlord under the Primary Lease will affect this Sublease or waive or defer the performance of any of Sublessee&#8217;s obligations
        hereunder and Sublessee agrees that Sublessor will not be liable for any costs or damages, nor responsible for any reimbursement.&#160; However, in the event of any such default or failure by Landlord, Sublessor agrees, upon Sublessor&#8217;s receipt of
        written notice thereof from Sublessee, and at Sublessor&#8217;s expense, to make demand (i.e., which shall be limited to providing a written notice to Landlord) upon Landlord to perform Landlord&#8217;s obligations under the Primary Lease in accordance with
        the terms of the Primary Lease (but without obligation of Sublessor to take any other action or incur any expense to enforce Landlord&#8217;s obligations under the Primary Lease).&#160; The terms of <u>Section 18(F)</u> below shall be applicable with respect
        to any disputes between Sublessor and Sublessee with respect to this Sublease.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">11.&#160;&#160;&#160;&#160;&#160;&#160; <u>Insurance</u>.&#160; Sublessee must obtain and maintain in force and effect with respect to the Premises, throughout the entire Term of this Sublease, any and all insurance required to be
        maintained by the &#8220;tenant&#8221; pursuant to the terms of the Primary Lease.&#160; It is agreed that any and all insurance required to be maintained by Sublessee pursuant to the terms of the Primary Lease (as incorporated herein and assumed by Sublessee
        hereunder) must: (i) name Sublessor, each leasehold mortgagee holding a leasehold mortgage on this Sublease or the Premises or any part thereof, and Landlord as additional loss payees with respect to all property insurance; (ii) contain waivers of
        subrogation applicable to each of Sublessor, each aforesaid leasehold mortgagee and Landlord; (iii) include a standard mortgage clause in favor of each aforesaid leasehold mortgagee;&#160; (iv) name Sublessor, each aforesaid leasehold mortgagee and
        Landlord as additional insureds with respect to liability insurance; and (v) require at least thirty (30) days&#8217; advance written notice to Sublessor, Landlord and any applicable mortgagee prior to the cancellation or modification of any such
        insurance.&#160; In addition to, and to the extent not already required by, the insurance requirements outlined in the Primary Lease, Sublessee will keep in full force and effect fire, extended coverage, and vandalism and malicious mischief insurance,
        insuring the personal property, furniture, furnishings, fixtures, materials, equipment and supplies belonging to Sublessee located on the Premises for not less than the actual replacement value thereof, and such other insurance as Landlord or the
        Sublessor may reasonably require.&#160; All insurance policies required to be maintained by Sublessee hereunder must be written by insurance companies reasonably satisfactory to Sublessor and Landlord.&#160; True, correct and complete copies of all such
        insurance policies (or certificates thereof in form and content reasonably satisfactory to Sublessor and Landlord), evidencing that all such insurance policies required to be obtained and maintained by Sublessee hereunder have been obtained and
        paid for, must be provided to Sublessor, Landlord and any applicable mortgagees concurrently with the execution of this Sublease and thereafter at least thirty (30) days prior to the expiration date of any then-existing policies.&#160; Without limiting
        any other waivers of &#8220;tenant&#8221; under the Lease that are imputed to Sublessee pursuant to the terms of this Sublease, Sublessee, on behalf of itself and its insurer, hereby waives any and all rights of recovery against Landlord and Sublessor, for any
        loss or damage that may occur to the Premises, or any improvements thereto, or any of Sublessee&#8217;s personal property located therein, which losses could be insured against under the insurance required of Sublessee pursuant to this <u>Section 11</u>,
        regardless of cause or origin, including negligence, but not to the extent such loss or damage is caused by the gross negligence or willful misconduct of Landlord or Sublessor.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">12.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Limitation of Liability</u>.&#160; Notwithstanding any provision of the Primary Lease to the contrary, neither Landlord nor Sublessor, nor any of Sublessor&#8217;s partners, officers,
        directors, shareholders, agents, employees or representatives, shall be liable to Sublessee, or any of Sublessee&#8217;s agents, employees, servants, customers, guests or invitees, for any damage to persons or property due to the condition, design, or
        any defect in the Premises or its mechanical systems that may exist on the Sublease Commencement Date or that may subsequently occur.&#160; Sublessee, with respect to itself and its agents, employees, servants, customers, guests and invitees, hereby
        expressly assumes all risks of damage to persons and property, either proximate or remote, by reason of the present or future condition of the Premises.&#160; Notwithstanding anything herein to the contrary, Sublessor shall not be responsible for, and
        Sublessee releases and discharges Sublessor from, and Sublessee further waives any right of recovery from Sublessor for, any loss for or from business interruption or loss of use of the Premises suffered by Sublessor in connection with Sublessee&#8217;s
        use or occupancy of the Premises, <font style="font-weight: bold;">EVEN IF SUCH LOSS IS CAUSED SOLELY OR IN PART BY THE NEGLIGENCE OF SUBLESSOR AND/OR LANDLORD.</font></div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Assignment and Subletting</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">A.&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Sublessor&#8217;s and Landlord&#8217;s Consent Required</u>.&#160; Except for a Permitted Transfer (as defined below), Sublessee shall not transfer, or permit the transfer of, all or any part of
        the Premises or of its interest in this Sublease to any other entity, whether by sale, assignment, mortgage, sublease, license, transfer, operation of law (including, without limitation by merger, consolidation, sale or other transfer of all or
        substantially all of the stock or business and assets of Sublessee, or otherwise) or act of Sublessee, subtenant, or any other party acting under or through Sublessee (each a &#8220;<u>Transfer</u>&#8221; to a &#8220;<u>Transferee</u>&#8221;) without both Sublessor&#8217;s
        prior written consent as provided in <u>Section 13(C)</u> below and Landlord&#8217;s consent under the Primary Lease.&#160; For the avoidance of doubt, a Transfer shall include, without limitation, any transfer or sale of a controlling interest in Sublessee,
        whether by sale of its capital stock or otherwise.&#160; Consent to one Transfer shall not imply consent to any other Transfer or waive the consent requirement as to any other Transfer.&#160; As used herein, the term &#8220;<u>Third Party</u>&#8221; shall mean any party
        other than a Permitted Transferee (as defined below).&#160; Any attempted Transfer without having received the required Sublessor consent hereunder or Landlord consent under the Primary Lease shall be void at the election of Sublessor.&#160; Any entity to
        which a Transfer is made is a &#8220;<u>Transferee</u>&#8221;.&#160; Notwithstanding anything to the contrary herein, if and so long as the shares of Sublessee or Sublessee&#8217;s direct or indirect parent company are traded on a nationally recognized stock exchange,
        any public offering of such shares on such exchange or any subsequent sale of such shares on such exchange shall not be deemed a Transfer for purposes of this <u>Section 13</u>.&#160; Sublessee acknowledges that the covenants contained in this <u>Section



          13</u> are material to the transaction contained herein and that Sublessor shall have, in addition to any other rights and remedies available under this Sublease or at law, the right to seek injunctive relief and/or specific performance in order
        to enforce such covenants.&#160; Any Transfer by Sublessee shall also be in accordance with and subject to the terms of the Primary Lease.&#160; Notwithstanding any such Transfer, Sublessee shall remain primarily liable and shall continue to make all rental
        payments and all other payments that may become due and payable hereunder to Sublessor in a timely manner.&#160; Without limiting any other reasonable basis in which Sublessor may withhold its consent to any proposed sublease or assignment, it is hereby
        agreed that is shall be reasonable for Sublessor to withhold its consent to any proposed sublease or assignment to a Competitor (as defined below), subject to the provisions of the second paragraph of <u>Section 13(B)</u> hereinbelow.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Permitted Transfers</u>.&#160; Subject to the Sublessor&#8217;s right to terminate this Sublease in the event of a Permitted Transfer (as defined below) to a Competitor (as defined below),
        provided no event of default has occurred and is continuing under this Sublease, upon prior written notice to Sublessor and Landlord (except to the extent prohibited by applicable securities or other laws or regulations or confidentiality
        requirements in any applicable agreements, in which event such notice shall be given following such Permitted Transfer, and Sublessee shall use commercially reasonable efforts to provide such notice no later than fifteen (15) days after the
        effective date of such Permitted Transfer, but in any event such notice shall be provided no later than thirty (30) days after the effective date of such Permitted Transfer), Sublessee may, without Sublessor&#8217;s prior written consent (but Sublessee
        shall still be required to obtain Landlord&#8217;s consent under the Primary Lease), assign this Sublease to an entity into which Sublessee is merged or consolidated or assign this Sublease or sublease the Premises to an entity to which substantially all
        of Sublessee&#8217;s assets are transferred or to an entity that is controlling, controlled by or commonly controlled with Sublessee (any such sublease or assignment being a &#8220;<u>Permitted Transfer</u>&#8221; and any assignee or sublessee pursuant to a
        Permitted Transfer is referred to herein as a &#8220;<u>Permitted Transferee</u>&#8221;), provided (i) such merger, consolidation, or transfer of assets is for a good faith business purpose and not principally for the purpose of transferring Sublessee&#8217;s
        sublease estate and (ii) the assignee or successor entity has a tangible net worth, calculated in accordance with generally accepted accounting principles (and evidenced by financial statements in form reasonably satisfactory to Sublessor and
        Landlord) at least equal to the tangible net worth of Sublessee immediately prior to such merger, consolidation, or transfer.&#160; In connection with any Permitted Transfer, Sublessee shall provide a written certification as to whether the assignee or
        sublessee is a Competitor.&#160; In the event Sublessee desires an updated Competitor list from Sublessor, then Sublessee shall have the right (but not the obligation) to provide Sublessor with a Marketing Notice (as defined below) prior to any
        contemplated Permitted Transfer in order to have Sublessor provide its updated Competitor list.&#160; The term &#8220;controlled by&#8221; or &#8220;commonly controlled with&#8221;&#160; or &#8220;controlling&#8221; shall mean the possession, direct or indirect, of the power to direct or cause
        the direction of the management and policies of such controlled person or entity; the ownership, directly or indirectly, of at least fifty-one percent (51%) of the voting securities of, or possession of the right to vote, in the ordinary direction
        of its affairs, at least fifty-one percent (51%) of the voting interest in, any person or entity shall be presumed to constitute such control.&#160; For the avoidance of doubt, Sublessee shall be required to obtain Landlord&#8217;s consent with respect to any
        Permitted Transfer.&#160; In the event of any Permitted Transfer to an entity that is a Competitor, then, at Sublessor&#8217;s option, Sublessor shall have the right to terminate this Sublease following such Permitted Transfer by providing written notice to
        Sublessee, with the termination date being the earlier of the effective date of the proposed Permitted Transfer or thirty (30) days following the date that Sublessor delivers such termination notice to Sublessee.&#160; In the event Sublessor delivers
        such termination notice to Sublessee, Sublessee may, at its option, rescind such Permitted Transfer within five (5) business days of receipt, and the Sublease shall continue unmodified between Sublessor and Sublessee.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 31.5pt;">As used herein, the term &#8220;<u>Competitor</u>&#8221; shall mean (i) Merck &amp; Co., (ii) Novartis, (iii) AbbVie Inc., (iv) Genentech, and (v) up to an additional three (3) entities named by Sublessor
        from time to time.&#160; &#8220;Competitor&#8221; shall include any subsidiary, affiliate, or parent company of any of the foregoing.&#160; In the event Sublessee anticipates that it will market the Premises for sublease or market the Sublease for a potential assignment
        of the Sublease, then Sublessee shall use reasonable efforts to provide Sublessor with written notice (the &#8220;<u>Marketing Notice</u>&#8221;) of the anticipated marketing of the Premises, which such Marketing Notice shall request that Sublessor update its
        Competitor list.&#160; Within thirty (30) days of Sublessor&#8217;s receipt of the Marketing Notice, Sublessor shall have the right to update the Competitor list by naming and/or changing the names of the three (3) entities contemplated in clause (v) of the
        first sentence of this grammatical paragraph.&#160; Thereafter, any update to the Competitor list shall be effective for the next 12-month period (i.e., Sublessor shall not have the right to further update the list during the 12-month period immediately
        following the date that Sublessor delivered the updated list to Sublessee).&#160; In the event Sublessee failed to deliver a Marketing Notice to Sublessor, then Sublessee acknowledges that Sublessor shall have the right to update the Competitor list at
        any time, including, without limitation, after Sublessee has delivered its request for Sublessor&#8217;s consent with respect to a proposed sublease or assignment (i.e., it being agreed that in such case Sublessor shall have the right to identify the
        proposed subtenant or assignee in any such Competitor list update).&#160; In the event Sublessor fails to respond or update the Competitor list within thirty (30) days of Sublessee&#8217;s Marketing Notice, Sublessor shall be deemed to have waived its right
        to update the Competitor list for the next 12-month period.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 31.5pt;">In addition, as ancillary to Sublessee&#8217;s conduct of business in the Premises, any license, desk sharing, or other occupancy agreement entered into by the Sublessee for the use or occupancy of a
        portion or portions of the Premises by under a so-called &#8220;desk sharing&#8221; arrangement by Sublessee Business Parties (each such desk or office space user a &#8220;<u>Desk Space User</u>&#8221;)&#160; for the permitted uses in accordance with the provisions of <u>Section



          6(C)</u> of this Sublease (&#8220;<u>Desk Sharing Arrangements</u>&#8221;) shall not require the consent of Sublessor (however, this paragraph shall not relieve Sublessee&#8217;s obligation to obtain Landlord&#8217;s consent under the Primary Lease); provided that (A)
        such Desk Space Users do not use or occupy more than twenty-five percent (25%) of the Premises rentable area in the aggregate and such Desk Space Users shall remain Sublessee Business Parties (as defined below) of the Sublessee; (B) in no event
        shall the use of any portion of the Premises by any Desk Space User create or be deemed to create any right, title or interest of such party in any portion of the Premises or the Sublease; (C) such &#8220;desk sharing&#8221; arrangement shall terminate
        automatically upon the termination of this Sublease; (D) Sublessee shall receive no rent or other payment or consideration for the use or occupancy of any space in the Premises by any Desk Space User in excess of an allocable share of the Rent
        payable by Sublessee under this Sublease; (E) prior to the commencement of such occupancy by a Desk Space User, Sublessee provides an insurance certificate, reasonably acceptable to Sublessor, evidencing the insurance coverages required to be
        maintained under this Sublease identifying each such Desk Space User; (F) if requested by Sublessor, Sublessee will provide reasonable evidence to Sublessor that such arrangement is in fact a Desk Sharing Arrangement in accordance with this
        paragraph; and (G) the Desk Sharing Arrangement complies with all other provisions of this Lease (including, without limitation, this <u>Section 13</u>), does not alter Sublessor&#8217;s rights under this Sublease, does not impose any additional
        obligation on Sublessor, and the transaction is not part of a series of transfers that, when taken together, avoids the restrictions on Transfers to a Third Party under this <u>Section 13</u> (such as a sublease or assignment to a Desk Space User
        that is thereafter acquired by a Third Party who would not qualify as a Sublessee Business Party).&#160; Without limiting the generality of the foregoing, the proposed particular use of the Premises by any such Desk Space User shall not be reasonably
        incompatible with a first-class mixed-use multi-tenant laboratory/office building (e.g., shall not be a governmental agency or a non-profit organization), taking into account the existing tenants and use mix at the Building, and such Desk Space
        User shall not have a business reputation that is reasonably unsatisfactory to Sublessor (e.g., a current or recent criminal conviction or investigation), and the Desk Space User&#8217;s proposed occupancy shall not result in a use of any portion of the
        Premises that is open to the general public on a walk-in basis.&#160; As used herein, &#8220;Sublessee Business Party&#8221; shall mean any persons or entities with whom Sublessee has an ongoing business relationship other than as tenants or occupants of the
        Premises, for so long as such relationship exists (such as, by way of example, Sublessee&#8217;s auditors, Sublessee&#8217;s clients and Sublessee&#8217;s joint venturers); provided, however, in no event shall a Competitor be permitted to be a Sublessee Business
        Party.&#160; In the event Sublessee desires an updated Competitor list from Sublessor, then Sublessee shall have the right (but not the obligation) to provide Sublessor with a Marketing Notice (as defined below) prior to any contemplated Desk Sharing
        Arrangement in order to have Sublessor provide its updated Competitor list.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Consent Procedures</u>.&#160; Sublessee&#8217;s request for Sublessor&#8217;s consent to any assignment or sublease for which Sublessor&#8217;s consent is required under this <u>Section 13</u> shall be
        made at least thirty (30) days prior to the effective date of the proposed Transfer, describe the details of the proposed Transfer, including the name, business and financial condition of the prospective Transferee, and the financial terms of the
        proposed Transfer (e.g., payments in consideration of the proposed Transfer, term, rent, construction, and security deposit), and Sublessee shall also provide any other information in Sublessee&#8217;s possession (or reasonably obtainable from the
        proposed Transferee) Sublessor reasonably deems relevant, including without limitation the proposed form of Transfer documentation (which shall be substantially in final form, Sublessor acknowledging that Sublessee and the proposed Transferee may
        still be in the process of negotiating the final form of documents, provided that Sublessor shall have the right to approve the final form of Transfer documentation).&#160; Sublessor shall not unreasonably withhold, condition or delay (beyond the
        Sublease Response Period, as defined below) its consent to any assignment or subletting of the Premises.&#160; For the avoidance of doubt, in no event shall Sublessor have any recapture rights in connection with a request for consent to any assignment
        or subletting of the Premises under the terms of this Sublease (however, Sublessor does have the recapture right set forth in the first paragraph of this <u>Section 13(B)</u> in the event of a Permitted Transfer to an entity that is a
        Competitor).&#160; As used herein, the &#8220;<u>Sublease Response Period</u>&#8221; means the period starting on the date that Sublessor receives Sublessee&#8217;s written request for consent with all information required herein and ending on the date that is fifteen
        (15) business days thereafter; provided, however, if within such fifteen (15) business day period Sublessor requests any additional information regarding the proposed Transferee or the proposed Transfer consistent with the information required to
        be provided above, then the Sublease Response Period shall be the later of (i) such original fifteen (15) business day period or (ii) five (5) business days following Sublessor&#8217;s receipt of such additional information.&#160; If Sublessor fails to
        approve or disapprove a proposed assignment or subletting of the Premises within the Sublease Response Period, and such failure continues for a further five (5) business days after Sublessee&#8217;s written notice to Sublessor of such failure (which
        notice shall bear the legend &#8220;<font style="font-style: italic;"><u>Second Notice: Failure by Sublessor to respond in accordance with Section 13(C) of the Sublease within five (5) business days shall constitute Sublessor&#8217;s deemed approval of the
            [assignment/sublease] described herein</u></font>&#8221;, then such failure shall constitute Sublessor&#8217;s deemed consent to the proposed assignment or sublease of the Premises for purposes hereof, provided that any such deemed consent shall not
        relieve Sublessee of its obligations hereunder (including the obligation to obtain Landlord&#8217;s consent under the Primary Lease) or adversely affect Sublessor&#8217;s rights set forth herein.&#160; Without limiting any other basis in which Sublessor may
        withhold its consent, it shall not be deemed unreasonable for Sublessor to deny consent for the following reasons, among others:&#160; (i) the business of the proposed Transferee or the proposed use of the Premises is inconsistent with the permitted
        uses contemplated in <u>Section 6(C)</u> of this Sublease; (ii) the net worth and financial condition of any proposed assignee or subtenant is not reasonably satisfactory to Sublessor, taking into account the then remaining obligations under this
        Sublease (in the case of an assignment) or under the sublease (in the case of a sublease) and Sublessee&#8217;s then net worth and financial condition; (iii) any Event of Default shall then exist (beyond any applicable notice or cure period), (iv) the
        Transferee&#8217;s proposed particular use of the Premises is reasonably incompatible with a first-class mixed-use multi-tenant laboratory/office building (e.g., shall not be a governmental agency or a non-profit organization), taking into account the
        existing tenants and use mix at the Building, or the Transferee&#8217;s business reputation is reasonably unsatisfactory to Sublessor (e.g., a current or recent criminal conviction or investigation), or the Transferee&#8217;s proposed occupancy would result in
        a use of any portion of the Premises that is open to the general public on a walk-in basis, or such proposed particular use is not approved by Landlord under the Primary Lease, (v) during the preceding five (5) year period, the Transferee or its
        affiliate has filed a petition for insolvency or for appointment of a receiver, trustee or assignee or for adjudication, reorganization or arrangement under any bankruptcy act, or if any similar petition has been filed against such Transferee or
        affiliates, or (vi) the Transfer in question would result in a violation of the Project Documents (as defined in the Primary Lease) or any Applicable Legal Requirement (including without limitation any Legal Requirement governing contracts or
        agreements with so-called &#8220;prohibited persons&#8221; under the laws, rules and regulations promulgated by the Office of Foreign Asset Control in the United States Department of the Treasury or any Legal Requirement under the Employee Retirement Income
        Security Act of 1974, as amended) (as defined in the Primary Lease).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Sharing of Transfer Profits.</u>&#160; Sublessee shall pay to Sublessor, as additional Rent, fifty percent (50%) of the Profits (as defined below) arising from any Transfer (other than a
        Permitted Transfer) as and when received by Sublessee, unless, while a monetary or material non-monetary Event of Default exists (beyond any applicable notice or cure period as provided herein), Sublessor notifies Sublessee and the Transferee that
        the Transferee shall pay Sublessor&#8217;s share of the Profits directly to Sublessor (in which case the share of the Profits received by Sublessor shall be credited against the rent to be paid by Sublessee hereunder, which may include without
        limitation, Sublessee&#8217;s obligation hereunder to pay such share of the Profits).&#160; &#8220;<u>Profits</u>&#8221; means (a) all rent, fees and other consideration paid for or in respect of the Transfer (excluding the fair market value of personal property
        purchased from Sublessee by such Transferee, but including consideration in excess of the fair market value of personal property and fees in excess of reasonable amounts under collateral agreements, the intent being to prohibit Sublessee from
        shifting occupancy costs to collateral agreements), less (b) the sum of (i) the Rent and other sums payable under this Sublease (or if the Transfer is a sublease of part of the Premises, allocable to the subleased premises) and (ii) all reasonable
        and customary costs and expenses directly incurred by Sublessee in connection with such Transfer, including without limitation, all reasonable real estate broker&#8217;s commissions, reasonable legal fees, customary costs attributable to marketing
        downtime, free rent, and costs of renovation or construction of subtenant improvements in the applicable space required by the Transfer for the applicable space (with the costs of such improvements to be amortized on a straight-line basis over the
        applicable term of the Transfer transaction).&#160; Sublessee shall give Sublessor a written statement certifying all amounts to be paid from any Transfer (including any collateral agreements) within thirty (30) days after the transfer agreement is
        signed and from time to time thereafter on Sublessor&#8217;s request, and Sublessor may inspect Sublessee&#8217;s books and records to verify the accuracy of such statements, subject to Sublessor&#8217;s execution of a confidentiality agreement reasonably supplied
        by Sublessor and reasonably acceptable to Sublessee.&#160; On written request, Sublessee shall promptly furnish to Sublessor copies of all Transfer documents, certified by Sublessee to be complete, true and correct.&#160; The provisions of this Section shall
        survive the expiration or earlier termination of the Sublease.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Release.</u>&#160; Notwithstanding any Transfer (whether a Permitted Transfer or a Transfer to a Third Party, and whether or not the same is consented to), the liability of Sublessee
        to Sublessor for all obligations under this Lease shall remain direct and primary (and not as guarantor or surety) for the remainder of the Term then existing as of the date of the Transfer and any extensions thereof to the extent such extension is
        as a result of an exercise of a renewal option set forth in the Sublease existing at the time of such Transfer (it being agreed that any amendment to the Sublease between an assignee of the Sublessee and Sublessor made after the assignment shall
        not be binding on Sublessee unless and only to the extent that Sublessor is required to enter into such amendment as a result of the assignee exercising rights set forth in the Sublease in effect at the time of such Transfer [e.g., to the extent
        such amendment exercising such rights have extraneous terms not set forth in this Sublease, such terms shall not be binding upon Sublessee]) and Sublessee shall not be relieved of any liability hereunder as a result of any such Transfer.&#160; Any
        Transferee shall be jointly and severally liable with Sublessee (except in connection with a release of Sublessee in accordance with requirements expressly set forth below following Sublessee&#8217;s strict satisfaction of such requirements) to Sublessor
        for the performance of all of Sublessee&#8217;s covenants under this Lease; provided, however, in connection with a sublease of less than all of the Premises, such joint and several liability of the subtenant shall only extend to the proportionate share
        that applicable subleased premises bears to the total Premises (unless a greater proportion of the obligations are assumed pursuant to the applicable sublease Transfer instrument); and such Transferee shall, upon Sublessor&#8217;s request, execute and
        deliver such customary instruments as Sublessor reasonably requests in confirmation thereof provided however that failure of such Transferee to execute the same shall not relieve such Transferee of any liability hereunder.&#160; Sublessee hereby
        irrevocably authorizes Sublessor, upon the occurrence of an Event of Default that continues beyond any applicable notice or cure period as provided herein, if any, to collect rent directly from any Transferee (and upon notice any Transferee shall
        pay directly to Sublessor) and apply the net amount collected to the Rent and other charges reserved under this Lease.&#160; No Transfer (whether or not consented to by Sublessor, and whether or not such consent is required) shall be deemed a waiver of
        the provisions of this <u>Section 13</u>, or the acceptance of the Transferee as a tenant, or a release of Sublessee from direct and primary liability for the performance of all of the covenants of this Lease.&#160; The consent by Sublessor to any
        Transfer shall not relieve Sublessee or any Transferee from the obligation of obtaining the express consent of Sublessor to any modification of such Transfer or a further Transfer by Sublessee or such Transferee.&#160; Notwithstanding anything to the
        contrary in the documents effecting the Transfer, Sublessor&#8217;s consent shall not alter in any manner whatsoever the terms of this Lease, to which any Transfer at all times shall be subject and subordinate.&#160; Notwithstanding anything herein to the
        contrary, in connection with a request for Sublessor&#8217;s consent to an assignment of the Sublease to a Third Party in accordance with the terms of this <u>Section 13</u>, Sublessee shall have the one-time right to request a release of the original
        Sublessee under this Sublease in accordance with the following terms.&#160; Without limiting any of the approval criteria for the proposed assignment of the Sublease as set forth above in this <u>Section 13</u>, if Sublessor approves such assignment,
        then any such request for release shall be approved by Sublessor only so long as (i) each of the Financial Criteria (as defined below) with respect to the assignee under such assignment is equal to or greater than each respective corresponding
        Financial Criteria of both Sublessor and Original Guarantor (as defined in the Primary Lease) as of the effective date of the Primary Lease and (ii) the assignee under such assignment assumes all of Sublessee&#8217;s obligations under the Sublease.&#160; Any
        such release of Sublessee, if applicable, granted strictly in accordance with the foregoing shall be effective on the date of such assignment of the Sublease and shall be applicable solely with respect to matters first arising from and after the
        effective date of such release.&#160; As used herein, the &#8220;<u>Financial Criteria</u>&#8221; of an entity shall mean each of the following metrics with respect to such entity: (A) the credit rating with Standard &amp; Poor&#8217;s (or, if Standard &amp; Poor&#8217;s
        ceases to exist, the equivalent credit rating with such other nationally recognized debt rating service as is reasonably identified by Sublessee) and (B) the market capitalization based on market valuations on the New York Stock Exchange.&#160; The
        parties hereto acknowledge and agree that the Financial Criteria of Original Guarantor as of the effective date of the Primary Lease are as follows: (A) a credit rating with Standard &amp; Poor&#8217;s of A+ and (B) a market capitalization (based on the
        New York Stock Exchange valuations) equal to $132,300,000,000.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of Documents, Etc.</u>&#160; Within ten (10) business days after the final execution of the documents for any Transfer for which Sublessee has received Sublessor&#8217;s consent
        hereunder or for any Permitted Transfer, Sublessee shall deliver to Sublessor (i) a true and complete copy of the fully executed instrument or instruments evidencing such Transfer and (ii) a written agreement of the Transferee agreeing with
        Sublessor to perform and observe all of the terms, covenants, and conditions of this Lease undertaken by such Transferee under such Transfer documents (i.e., such written agreement shall not obligate such Transferee to assume any obligations under
        the Sublease that are greater obligations than those obligations that such Transferee has undertaken in the Transfer documents).&#160; Sublessee shall pay to Sublessor, as Additional Rent, all reasonable third party costs incurred by Sublessor
        (including, without limitation, reasonable attorneys&#8217; fees, not to exceed $2,500.00) in reviewing any proposed Transfer (estimates for which Sublessor shall provide if requested by Sublessee after submitting the applicable Transfer documents to
        Sublessor for review), whether or not any such proposed Transfer is consummated by Sublessee pursuant to the provisions of this <u>Section 13</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Parking</u>.&#160; During the Term Sublessee will have a nonexclusive right to use up to its pro rata share (based on a ratio equal to the total rentable square foot in the Premises
        divided by the total rentable square feet in the Primary Leased Premises) of the parking spaces (the &#8220;<u>Sublessee&#8217;s Parking Spaces</u>&#8221;) allocated to Sublessor under <u>Section 2.2(b)</u> of the Primary Lease, at the then current market parking
        rate for such parking spaces (which such parking rent shall be payable at the same time that Sublessor is required to pay the parking charges under the Primary Lease with respect to its parking spaces) (the &#8220;Parking Rent&#8221;), as such parking rate
        shall be determined by Landlord from time to time or the operator of the Building&#8217;s parking facility throughout the Term.&#160; Notwithstanding the foregoing to the contrary, throughout the Term (as the same may be extended), Sublessee shall be required
        to pay the Parking Rent each month for all of the Sublessee&#8217;s Parking Spaces regardless of if Sublessee is actually using any or all of the Sublessee&#8217;s Parking Spaces and Sublessee shall have no right to surrender any Sublessee&#8217;s Parking Spaces.&#160;
        Sublessee&#8217;s use of such parking spaces is subject to the terms and conditions of the Primary Lease.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">15.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Brokers</u>.&#160; Sublessor and Sublessee agree and represent to one another that no finder or broker has been involved in the procurement, negotiation or execution of this Sublease,
        except for Rise 73 (as Sublessee&#8217;s representative) and Cushman &amp; Wakefield (as Sublessor&#8217;s representative (&#8220;<u>Brokers</u>&#8221;), and that Brokers are the only brokers entitled to a fee or commission for the procurement, negotiation or execution of
        this Sublease (which Broker&#8217;s commission will be paid by Sublessor pursuant to a separate commission agreement between Sublessor and each such Broker).&#160; <font style="font-weight: bold;">SUBLESSOR AND SUBLESSEE HEREBY AGREE TO DEFEND, INDEMNIFY AND
          HOLD EACH OTHER HARMLESS AGAINST ANY LOSS, CLAIM, EXPENSE OR LIABILITY WITH RESPECT TO ANY COMMISSIONS OR BROKERAGE FEES (EXCEPT AS OTHERWISE SET FORTH IN THE IMMEDIATELY PRECEDING SENTENCE) CLAIMED ON ACCOUNT OF THE EXECUTION AND/OR RENEWAL OF
          THIS SUBLEASE OR THE EXPANSION OF THE PREMISES DUE TO ANY ACTION OF THE INDEMNIFYING PARTY.&#160; THE OBLIGATIONS OF INDEMNITY SET FORTH IN THIS <u>SECTION 15</u> WILL SURVIVE THE EXPIRATION OR EARLIER TERMINATION OF THIS SUBLEASE.</font></div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">16.&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Sublessee Improvements</u>.&#160; Sublessee will be responsible for the construction of all improvements (the &#8220;<u>Sublessee Improvements</u>&#8221;) to be made to the Premises in
        accordance with&#160; <u>Exhibit C</u> attached hereto and made a part hereof for all purposes; provided, however, such construction will be subject to the terms and conditions of the Primary Lease (including, without limitation, <u>Exhibit B</u>
        attached thereto such that Sublessee shall be required to comply with the requirements of the TI Work (as defined in the Primary Lease) in connection with its completion of the Sublessee Improvements).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">17.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Default and Remedies</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Event of Default</u>.&#160; The occurrence of any one or more of the following events will constitute an event of default (&#8220;<u>Event of Default</u>&#8221;) by Sublessee under this Sublease:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the failure of Sublessee to pay any installment of Sublease Rent, Additional Rent or other charge or money obligation due under this Sublease when due and such default continues for
        five (5) business days after written notice from Sublessor of such failure, provided that such notice and cure period shall not apply after the first (1st) two (2) occasions during any consecutive twelve-(12)-month period in which a default notice
        for such a failure is given to Sublessee;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the failure of Sublessee to perform, comply with or observe any agreement, covenant or obligation of Sublessee under this Sublease other than the payment of Rent or other monetary
        amounts, and such failure continues for a period of the lesser of (I) the stated time period to comply in the Lease or (II) thirty (30) days after written notice thereof to Sublessee, provided, however, that such period shall be reasonably extended
        in the case of any such non-monetary default that cannot be cured within such period (but in any event shall not exceed ninety (90) days in the aggregate) only if the matter complained of can be cured, Tenant begins promptly and thereafter
        diligently completes the cure, and Tenant gives Landlord notice of such intent to cure within ten (10) days after notice of such default);</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the making by Sublessee of any assignment for the benefit of Sublessee&#8217;s creditors;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; the institution in a court of competent jurisdiction of bankruptcy proceedings against Sublessee or any of Sublessee&#8217;s shareholders, or for the appointment of a receiver of the
        property of Sublessee, provided that such proceedings are not dismissed, and any receiver, trustee, or liquidator appointed therein is not discharged, within thirty (30) days after the institution of said proceedings; or</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the occurrence of any default or Event of Default as defined under the Primary Lease with respect to the Sublessee or the Premises.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Remedies</u>.&#160; Upon the occurrence of an Event of Default, Sublessor, in addition to any and all other rights and remedies available to Sublessor at law or in equity and in addition
        to all other rights or remedies reserved herein, will have the option to pursue any one or more of the following remedies without any notice or demand whatsoever and without releasing Sublessee from any obligation under this Sublease (except in the
        case of a termination of the Sublease):</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Sublessor may enter the Premises without terminating this Sublease and may perform any covenant or agreement or cure any condition creating or giving rise to a default or Event of
        Default under this Sublease or under the Primary Lease, and Sublessee agrees to pay to Sublessor on demand, as Additional Rent, the amount expended by Sublessor in performing such covenants or agreements or satisfying or observing such condition.&#160;
        Sublessor, and Sublessor&#8217;s agents, representatives and employees, will have the right to enter the Premises in the exercise of such rights and such entry and such performance will not terminate this Sublease or constitute an eviction of Sublessee;
        or</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;At Sublessor&#8217;s sole option, Sublessor may terminate this Sublease by written notice thereof to Sublessee or Sublessor may terminate Sublessee&#8217;s right of possession to the Premises,
        without terminating this Sublease.&#160; In either such event, Sublessee must surrender (in accordance with the terms and conditions of this Sublease) possession of and vacate the Premises immediately and must deliver possession thereof to Sublessor,
        and Sublessor may, to the extent permitted by applicable law, enter the Premises, in whole or in part, with process of law, to change any and all door locks, to deny Sublessee access to the Premises and to expel or remove Sublessee and any other
        person, firm or corporation who may be occupying the Premises or any part thereof and remove any and all property therefrom, using such lawful force as may be necessary.&#160; Upon either Sublessor&#8217;s termination of this Sublease or termination of
        Sublessee&#8217;s right of possession to the Premises without terminating this Sublease, as provided herein, Sublessor will in either such event be entitled to recovery from Sublessee all damages to which Sublessor may be entitled hereunder or at law by
        virtue thereof, including (without limitation) all costs and losses incurred by Sublessor as a result of the Event of Default by Sublessee hereunder and any expenses which Sublessor may incur in effecting compliance with Sublessee&#8217;s obligations
        under this Sublease, all of which sums Sublessee agrees to reimburse to Sublessor on demand.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Termination or Waiver</u>.&#160; Institution of a forcible detainer action to re-enter the Premises will not be construed to be an election by Sublessor to terminate this Sublease.&#160;
        Sublessor may collect and receive any Rent due from Sublessee and the payment thereof shall not constitute a waiver of or affect any notice or demand given, suit instituted, or judgment obtained by Sublessor, or be held or deemed to waive or alter
        the rights or remedies which Sublessor may have at law or in equity or by virtue of this Sublease at the time of such payment.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Remedies Non-exclusive</u>.&#160; All rights and remedies of Sublessor enumerated in this Sublease are cumulative and will not exclude any other right or remedy allowed by law.&#160; All such
        rights and remedies may be exercised and enforced concurrently, whenever and as often as necessary.<font style="color: #000000;">&#160;</font>Sublessor shall have each of the rights and remedies of the Landlord under the Primary Lease in the event of
        Sublessee&#8217;s default hereunder.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">18.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Miscellaneous Provisions</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Governing Law and Forum</u>.&#160; THIS SUBLEASE WILL BE GOVERNED BY AND CONSTRUED UNDER AND IN ACCORDANCE WITH THE LAWS OF THE JURISDICTION IN WHICH THE PREMISES ARE LOCATED.&#160; BY
        EXECUTING THIS SUBLEASE, EACH PARTY HERETO EXPRESSLY (a) CONSENTS AND SUBMITS TO PERSONAL JURISDICTION CONSISTENT WITH THE PREVIOUS SENTENCE, (b) WAIVES TO THE FULLEST EXTENT PERMITTED BY LAW, ANY CLAIM OR DEFENSE THAT SUCH VENUE IS NOT PROPER OR
        CONVENIENT AND (c) CONSENTS TO SERVICE OF PROCESS IN ANY MANNER AUTHORIZED BY MASSACHUSETTS LAW.&#160; ANY FINAL JUDGMENT ENTERED IN AN ACTION BROUGHT HEREUNDER SHALL BE CONCLUSIVE AND BINDING UPON THE PARTIES HERETO.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Parties Bound</u>.&#160; This Sublease will be binding on and inure to the benefit of each of the parties hereto and their respective successors and permitted assigns.&#160; Notwithstanding
        anything to the contrary set forth herein, it is hereby agreed that Sublessor has the right to assign, transfer, pledge or otherwise convey any interest of Sublessor in the Premises, the Primary Lease and/or this Sublease, and Sublessee agrees that
        in the event of any such transfer, Sublessor will automatically be released from all liability under this Sublease accruing from and after the date of such transfer of interest by Sublessor, and Sublessee agrees to thereupon look solely to the
        transferee for the performance of Sublessor&#8217;s obligations hereunder accruing from and after the date of such transfer of interest by Sublessor.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">C.&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Partial Invalidity</u>.&#160; In case any one or more of the provisions contained in this Sublease is for any reason be held to be invalid, illegal, or unenforceable in any respect,
        such invalidity, illegality, or unenforceability will not affect any other provisions hereof and this Sublease will be construed as if such invalid, illegal, or unenforceable provisions had never been included herein.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Prior Agreements Superseded</u>.&#160; This Sublease constitutes the sole and entire agreement of the parties with respect to the subject matter hereof and supersedes any prior
        understandings or written or oral agreement between the parties respecting such subject matter.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">E.&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <u>Disclaimer of Warranty</u>.&#160; SUBLESSEE HEREBY EXPRESSLY DISCLAIMS ANY IMPLIED WARRANTY THAT THE PREMISES ARE SUITABLE FOR SUBLESSEE&#8217;S INTENDED PURPOSE, AND SUBLESSEE&#8217;S OBLIGATION TO
        PAY RENT AND OTHER CHARGES HEREUNDER IS NOT DEPENDENT UPON THE CONDITION OF THE PREMISES OR THE PERFORMANCE BY SUBLESSOR OF ANY OBLIGATIONS HEREUNDER.&#160; EXCEPT AS OTHERWISE EXPRESSLY PROVIDED HEREIN, SUBLESSEE WILL CONTINUE TO PAY THE RENT AND OTHER
        CHARGES DUE AND PAYABLE BY SUBLESSEE HEREUNDER WITHOUT ABATEMENT, SET OFF OR DEDUCTION, NOTWITHSTANDING ANY BREACH OR ALLEGED BREACH BY SUBLESSOR OF SUBLESSOR&#8217;S DUTIES OR OBLIGATIONS HEREUNDER, WHETHER EXPRESS OR IMPLIED.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Attorneys&#8217; Fees</u>.&#160; If any legal action or any arbitration or other proceeding is brought for the enforcement of this Sublease, or because of an alleged dispute, breach, default or
        misrepresentation in connection with any of the provisions of this Sublease, the successful or prevailing party shall be entitled to recover reasonable attorneys&#8217; fees and other costs incurred in that action or proceeding, in addition to any other
        relief to which it may be entitled. For the purposes of this Sublease, the term &#8220;prevailing party&#8221; shall mean the party who obtains substantially the relief desired, whether by dismissal, default, summary judgment, settlement or otherwise.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">G.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Counterparts</u>.&#160; To facilitate execution of this Sublease, this Sublease may be executed in one or more counterparts as may be convenient or required, and an executed copy of this
        Sublease delivered by facsimile will have the effect of an original, executed instrument.&#160; All counterparts of this Sublease will collectively constitute a single instrument; but, in making proof of this Sublease, it will not be necessary to
        produce or account for more than one such counterpart.&#160; It will not be necessary for the signature of, or on behalf of, each party hereto, or that the signature of all persons required to bind any such party, appear on each counterpart of this
        Sublease.&#160; Each signature page to any counterpart of this Sublease may be detached from such counterpart without impairing the legal effect of the signatures thereon and thereafter attached to another counterpart of this Sublease identical thereto
        except having attached to it additional signature pages.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">H.&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>No Offer</u>.&#160; The submission of this Sublease to Sublessee should not be construed as an offer, nor will Sublessee have any rights hereunder or to the Premises, unless and until
        Sublessor has executed a copy of this Sublease and delivered the same to Sublessee.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">I.&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <u>Time of Essence</u>.&#160; Time is of the essence in this Sublease.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">J.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Survival of Sublessee Obligations</u>.&#160; With respect to any obligations of either Sublessor or Sublessee that are expressly stated to survive past the expiration or earlier
        termination of the Sublease, such obligations will survive the expiration or earlier termination of this Sublease.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">K.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Only Sublessor/Sublessee Relationship</u>.&#160; Nothing contained in this Sublease will be deemed or construed by the parties hereto or by any third party to create the relationship of
        principal and agent, partnership, joint venture or any association between Sublessor and Sublessee, it being expressly understood and agreed that nothing contained in this Sublease will be deemed to create any relationship between Sublessor and
        Sublessee other than the relationship of sublessor and sublessee.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">L.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Headings: Miscellaneous</u>.&#160; The captions and/or headings of the several articles, paragraphs and sections contained herein are for convenience only and do not define, limit or
        construe the contents of such articles, paragraphs or sections.&#160; Any reference herein to an article, paragraph or section shall mean and refer to an article, paragraph or section of this Sublease unless otherwise expressly specified herein.&#160; This
        Sublease may not be amended or modified by any act or conduct of the parties or by oral agreements unless reduced and agreed to in writing signed by both Sublessor and Sublessee.&#160; No waiver of any of the terms of this Sublease will be binding upon
        Sublessor unless reduced to writing and signed by Sublessor.&#160; Neither Sublessor&#8217;s failure to enforce or require strict performance of any provision of this Sublease, nor Sublessor&#8217;s acceptance of Rent or other charges with knowledge of a breach,
        default or Event of Default hereunder, will be a waiver of such breach, default or Event of Default or any future breach, default or Event of Default hereunder.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">26</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">M.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>.&#160; Any notice under this Sublease must be in writing, and must be given or served by (i) personal delivery via a recognized independent courier service (providing
        reasonable proof of such delivery), (ii) depositing the same in the United States mail, postage prepaid, certified mail, return receipt requested, in either such event addressed to the party to be notified at the address stated in this Sublease
        hereinbelow or such other address in the continental United States of which notice has been given to the other party in the manner provided herein, or (iii) via facsimile to the respective fax numbers of the parties hereto as set forth hereinbelow,
        with either electronic or telephonic verification of receipt, so long as the original of the facsimile notice is deposited in the United States mail within three (3) days thereafter.&#160; Notice by personal delivery or via courier will be effective
        upon receipt, notice by mail will be effective upon deposit in the United States mail in the manner described above and notice by facsimile shall be effective upon electronic or telephonic verification of receipt.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">N.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Interpretation</u>.&#160; When used herein, the singular includes the plural and the plural the singular, and words importing any gender include the other gender.&#160; The terms and
        conditions of this Sublease represent the result of negotiations between Sublessor and Sublessee, each of which were represented and/or had the opportunity to be represented by independent counsel and neither of which has acted under compulsion or
        duress; consequently, the normal rule of construction that any ambiguity be resolved against the drafting party will not apply to the interpretation of this Sublease or of any exhibits, addenda or amendments hereto.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">O.&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Exhibits</u>.&#160; All exhibits attached to this Sublease are deemed to be incorporated in this Sublease as if fully set forth hereinabove.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">P.&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <u>Holidays</u>.&#160; If the date upon which any of the duties or obligations hereunder to be performed occurs on a Saturday, Sunday or legal holiday, then, provided that performance of
        such obligation is not earlier required under the Primary Lease, the due date for performance of any duty or obligation will thereupon be automatically extended to the next succeeding business day.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">Q.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Authority</u>.&#160; The individual executing this Sublease on behalf of Sublessee represents and warrants to Sublessor that Sublessee has full right and authority to enter into this
        Sublease and performance obligations hereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">R.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Entry by Sublessor</u>.&#160; Upon at least two (2) business days&#8217; prior notice (except in the event of an emergency, when no such notice shall be required) to Sublessee, Sublessor and
        its representatives will have the right, at all reasonable times, to enter upon the Premises for the purpose of examining and inspecting the same; provided, however, this section will not be construed as imposing any obligation upon Sublessor to
        inspect the Premises.&#160; Notwithstanding the foregoing, and for the avoidance of doubt, in no event does Sublessor have to give Sublessee any notice in order to access the common corridor on the ninth (9<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) floor in order to access the ninth (9<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) floor terrace; it being acknowledged that Sublessor shall have unrestricted
        access to such corridor and terrace.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">27</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">S.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Waiver of Jury Trial</u>.&#160; <font style="font-weight: bold;">IT IS AGREED BY AND BETWEEN SUBLESSOR AND SUBLESSEE THAT THE RESPECTIVE PARTIES HERETO WILL AND THEY HEREBY DO,
          TO THE EXTENT PERMITTED BY APPLICABLE LAW, WAIVE TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM BROUGHT BY EITHER OF THE PARTIES HERETO AGAINST THE OTHER ON ANY MATTERS ARISING OUT OF OR IN ANY WAY CONNECTED WITH THIS SUBLEASE, THE
          RELATIONSHIP OF SUBLESSOR AND SUBLESSEE, OR SUBLESSEE&#8217;S USE OR OCCUPANCY OF THE PREMISES.&#160; SUBLESSEE FURTHER AGREES THAT, TO THE EXTENT PERMITTED BY APPLICABLE LAW, SUBLESSEE WILL NOT IMPOSE ANY COUNTERCLAIM (OTHER THAN ANY MANDATORY
          COUNTERCLAIM) IN A SUMMARY PROCEEDING OR IN ANY ACTION BASED ON NON-PAYMENT OF RENT OR ANY OTHER PAYMENT REQUIRED BY SUBLESSEE HEREUNDER.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">T.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Defined Terms</u>.&#160; Unless otherwise specifically defined in this Sublease, capitalized terms utilized in this Sublease will have the meaning ascribed to such terms in the Primary
        Lease.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">U.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">&#160;</font><u>Contingency</u>.&#160; This Sublease is expressly contingent upon the consent of the Landlord being obtained in form and substance satisfactory to
        Sublessor.&#160; In the event Landlord fails to give its consent, this Sublease shall be void and the parties shall have no further rights or obligations hereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">V.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Ninth Floor Terrace</u>.&#160; Sublessee acknowledges that there is a terrace on the Ninth Floor of the Building (the &#8220;<u>Ninth Floor Terrace</u>&#8221;) and that the Ninth Floor Terrace is
        expressly excluded from the Premises.&#160; In addition, Sublessor, at its cost and expense, shall perform certain work more particularly described in Exhibit &#8220;F&#8221; attached hereto (the &#8220;<u>Sublessor Work</u>&#8221;), which includes the design and construction
        of a corridor/elevator lobby on the Ninth Floor and certain other related work such as the construction of additional restrooms on the Ninth Floor and storage rooms for Sublessor&#8217;s exclusive use.&#160; The storage rooms and restrooms being constructed
        as part of the Sublessor Work shall not be considered part of the Premises (such areas being the &#8220;<u>Sublessor&#8217;s Ninth Floor Areas</u>&#8221;).&#160; The corridor/elevator lobby being constructed as part of the Sublessor Work is considered a common element
        available for the common use of Sublessor and Sublessee.&#160; Sublessee acknowledges and agrees that at all times and without any notice to Sublessee, Sublessor shall have free access to the Ninth Floor Terrace as well as the Sublessor&#8217;s Ninth Floor
        Areas (and the Ninth Floor elevator lobby/corridors so that such Ninth Floor Terrace can be accessed) in order to access and utilize the Ninth Floor Terrace.&#160; Upon prior written notice and subject to Sublessor&#8217;s scheduling protocols and subject to
        availability, Sublessee shall have the right to utilize the Ninth Floor Terrace for up to four (4) days in each calendar year of the Term, at no additional cost or charge.&#160; Sublessee shall be required to clean the Ninth Floor Terrace after its use
        and shall repair any damage to the Ninth Floor Terrace (or the furniture therein) to the extent caused by Sublessee&#8217;s access and/or use of the Ninth Floor Terrace.&#160; Sublessor shall have access to the Ninth Floor in order to perform the Sublessor
        Work.&#160; Sublessor and Sublessee shall cause their respective contractors to cooperate with each other in order to minimize any interference with the Sublessor Work being performed on the Ninth Floor and the Sublessee Improvements being performed by
        Sublessee on the Ninth Floor; provided, however, in the event Sublessee requires the Sublessor to temporarily cease performing the Sublessor Work on the Ninth Floor because the Sublessee Improvements cannot proceed, then Sublessor shall cause its
        contractors to temporarily cease performing such work on the Ninth Floor (it being agreed that Sublessee&#8217;s right to request Sublessor to temporarily cease work shall only apply to the Sublessor Work being performed on the Ninth Floor, not other
        parts of the Building), provided, such temporary cessation shall be limited to that period of time where both Sublessor&#8217;s Work and Sublessee&#8217;s Improvements are not able to be performed concurrently.&#160; Sublessee acknowledges that in no event shall
        Sublessor be in default hereunder if it is unable to timely complete the Sublessor Work due to Sublessee causing Sublessor to temporarily cease performing such work.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">28</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">W.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Environmental</u>.&#160; Sublessee agrees not to cause or permit any <u>&#8220;Hazardous Materials</u>&#8221; as defined in this Sublease to be brought upon, stored, used, handled, generated,
        released or disposed of on, in, under or about the Premises by Sublessee, its agents, employees, subtenants, assignees, licensees, contractors or invitees (collectively, &#8220;<u>Sublessee&#8217;s Parties</u>&#8221;), except in accordance with all applicable local,
        state and federal laws.&#160; Concurrently with the execution of this Sublease and annually thereafter, within thirty (30) days of written request from Sublessor (which request shall not be made more than once annually, unless required in by Landlord,
        or to satisfy Applicable Legal Requirements or an Event of Default is continuing), Sublessee agrees to complete and deliver to Sublessor an environmental questionnaire in a reasonable form to be supplied by Sublessor.&#160; In addition to and not in
        replacement of Sublessor&#8217;s obligation in the immediately preceding sentence, Sublessee shall deliver to Sublessor a list identifying each type of Hazardous Material (other than Customary Office Materials&#160; used in accordance with Applicable Legal
        Requirements ), including the types and amounts, being or to be generated, produced, brought upon, used, stored, treated or disposed of by or on behalf of Subtenant in or about or on the Premises, the Building, or the Property (a &#8220;<u>Hazardous
          Substances List</u>&#8221;) within thirty (30) days of the effective date of this Sublease and within sixty (60) days of any material change to such Hazardous Substances List.&#160; For illustrative purposes, a &#8220;material change&#8221; shall include, without
        limitation, the introduction of a new category or classification of Hazardous Materials.&#160; In addition, Sublessee shall timely furnish all disclosures required pursuant to the terms of the Primary Lease as it relates to Hazardous Materials.&#160; Upon
        the expiration or earlier termination of this Sublease, Sublessee agrees to promptly remove from the Premises, at its sole cost and expense, any and all Hazardous Materials, including any equipment or systems containing Hazardous Materials which
        are installed, brought upon, stored, used, generated or released upon, in, under or about the Premises or any portion thereof by Sublessee or any of the Sublessee&#8217;s Parties.&#160; To the fullest extent permitted by law, Sublessee agrees to promptly
        indemnify, protect, defend and hold harmless Sublessor and Sublessor&#8217;s partners, officers, directors, employees, agents, successors and assigns (collectively, &#8220;<u>Sublessor Indemnified Parties</u>&#8221;) from and against any and all claims, damages,
        judgments, suits, causes of action, losses, liabilities, penalties, fines, expenses and costs (including, without limitation, clean-up, removal, remediation and restoration costs, sums paid in settlement of claims, attorneys&#8217; fees, consultant fees
        and expert fees and court costs) which arise or result from the presence of Hazardous Materials on, in, under or about the Premises and which are caused or permitted by Sublessee or any of the Sublessee&#8217;s Parties.&#160; Sublessee agrees to promptly
        notify Sublessor of any release of Hazardous Materials in the Premises which Sublessee becomes aware of during the Term of this Sublease, whether caused by Sublessee or any other persons or entities.&#160; In the event of any release of Hazardous
        Materials caused or permitted by Sublessee or any of the Sublessee&#8217;s Parties, Sublessor shall have the right, but not the obligation, to cause Sublessee to immediately take all steps Sublessor deems necessary or appropriate to remediate such
        release and prevent any similar future release to the satisfaction of Sublessor or Landlord.&#160; At all times during the Term of this Sublease upon at least twenty-four (24) hours prior written notice to Sublessee, provided Sublessee shall have the
        right to have a representative of Sublessee accompany Sublessor, Sublessor will have the right, but not the obligation, to enter upon the Premises to inspect, investigate, sample and/or monitor the Premises to determine if Sublessee is in
        compliance with the terms of this Sublease regarding Hazardous Materials.&#160; As used in this Sublease, the term &#8220;<u>Hazardous Materials</u>&#8221; shall mean and include any hazardous or toxic materials, substances or wastes as now or hereafter designated
        under any law, statute, ordinance, rule, regulation, order or ruling of any agency of the Commonwealth of Massachusetts, the United States Government or any local governmental authority, including, without limitation, asbestos, petroleum, petroleum
        hydrocarbons and petroleum based products, urea formaldehyde foam insulation, polychlorinated biphenyls, and freon and other chlorofluorocarbons.&#160; The provisions of this paragraph will survive the expiration or earlier termination of this
        Sublease.&#160; This <u>Section 18(W)</u> shall be in addition to the requirements of the Primary Lease regarding Hazardous Substances.&#160; Sublessee shall also comply with all of the obligations and make all required disclosures with respect to Hazardous
        Substances caused, permitted, generated or introduced by Sublessee or any of the Sublessee&#8217;s Parties as outlined in the Primary Lease.&#160; If any transportation to or from, or any storage, use or disposal of Hazardous Materials on or about, the
        Premises, or any other portion of the Building, the Building Site, or the Project by Sublessor or Sublessor&#8217;s agents or contractors results in any unpermitted release of or contamination by Hazardous Substances to the air, surfaces, soil or surface
        or ground water at the Property, or any loss or damage to person or property, Sublessor hereby agrees to indemnify, defend, and hold Sublessee and Sublessee&#8217;s partners, shareholders, members, managers, officers, directors, agents, servants, and
        employees harmless from and against any and all claims, damages, losses, penalties, costs, expenses and fees (including reasonable attorneys&#8217; fees) arising in whole or in part out of any such occurrence. Such indemnity, defense, and hold harmless
        obligations of Sublessor shall survive the expiration of the Term or earlier termination of this Sublease.&#160; For purposes of this <u>Section 18(W)</u>, the term &#8220;Premises&#8221; shall specifically be deemed to include the Sublessee Fire Control Area
        (defined in <u>Section 18(CC)</u> below) in addition to the loading dock areas utilized by Sublessee pursuant to <u>Section 18(Y)</u> below).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">29</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">X.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Force Majeure</u>.&#160; Any prevention, delay or stoppage due to strikes, lockouts, labor disputes, acts of God, acts of war, terrorism, terrorist activities, inability to obtain
        services, labor, or materials or reasonable substitutes therefore, governmental actions, civil commotions, fire, flood, earthquake or other casualty, any restrictions, shutdowns, closures, or shortages or other delays related to COVID-19 or any
        similar viruses, epidemics or pandemics, and other causes beyond the reasonable control of the party obligated to perform, except with respect to the obligations imposed with regard to Sublease Rent and other charges to be paid by Sublessee
        pursuant to this Sublease or Sublessee&#8217;s obligation to timely surrender the Premises (unless Sublessee is unable to timely surrender the Premises solely as a result of governmental mandates that are generally applicable to all parties that prevent
        Sublessee from retaining any third party from accessing the Premises to remove Sublessee&#8217;s personal property and/or any alterations required to be removed pursuant to the terms of this Sublease or the Primary Lease) or Sublessor&#8217;s obligations to
        pay any sums or amounts to Sublessee (collectively, a &#8220;<u>Force Majeure</u>&#8221;), notwithstanding anything to the contrary contained in this Sublease, shall excuse the performance of such party for a period equal to any such prevention, delay or
        stoppage and, therefore, if this Sublease specifies a time period for performance of an obligation of either party, that time period shall be extended by the period of any delay in such party&#8217;s performance caused by a Force Majeure.&#160;
        Notwithstanding anything to the contrary in this Sublease, in no event will any Force Majeure event excuse the Sublessee&#8217;s or the Sublessor&#8217;s obligation to pay rent or other amounts.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">30</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">Y.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Loading Dock/Fire Control Areas/PPE Elevator</u>.&#160; Sublessee acknowledges that from time to time Sublessor may designate an elevator and/or one (1) of the loading docks for the
        exclusive use of Sublessor and in such case Sublessee shall have no rights or obligations with respect thereto.&#160; In addition, except as set forth in <u>Section 18(CC)</u> below, in no event does Sublessor guaranty any specific fire control area
        capacity.&#160; In the event Sublessor elects to retain a loading dock manager, then Sublessee shall reimburse Sublessor for a pro rata share (based on a fraction equal to the rentable area of the Premises divided by the rentable area of the Primary
        Leased Premises) for all reasonable third-party costs incurred by Sublessor in connection with such loading dock manager.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">Z.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Sublessor&#8217;s Representations, Warranties and Covenants</u>.&#160; <font style="color: #000000;">Sublessor</font> represents and warrants to Sublessee as follows: (i) <font style="color: #000000;">Sublessor</font> has delivered to Sublessee a full and complete redacted copy of the <font style="color: #000000;">Primary Lease </font>and any amendments thereto; (ii) as of the Effective Date hereof, the <font style="color: #000000;">Primary Lease </font>is in full force and effect in accordance with, and subject to, all terms, covenants, conditions and agreements contained therein, and the <font style="color: #000000;">Primary Lease </font>has not
        been modified, amended or supplemented except as disclosed to Sublessee herein; (iii) as of the Effective Date hereof, there are no other agreements between Sublessor and Landlord relating to the leasing, use, and occupancy of the Premises, (iv)
        Sublessor has no actual knowledge of any default of Landlord under the Primary Lease; and (v) Sublessor has received no default notice from Landlord under the <font style="color: #000000;">Primary Lease that remains uncured as of the Effective
          Date hereof </font>and Sublessor has no knowledge of any fact or circumstance which, with the giving of notice, passage of time, or both, would constitute an event of default under the Primary Lease.&#160; Sublessor covenants with Sublessee as
        follows: (I) Sublessor shall timely perform all of Sublessor&#8217;s obligations under the Primary Lease and shall not amend or voluntarily cancel or surrender the <font style="color: #000000;">Primary Lease (or any portion thereof)</font>, except in
        connection with Sublessor&#8217;s rights under the Primary Lease (e.g., it being agreed that Sublessor reserves the right to exercise its contraction right under the Lease in order to terminate the Primary Lease as to the Premises as contemplated in <u>Section



          2(A)</u> of this Sublease) and except for items that will not materially adversely affect Sublessee&#8217;s rights, remedies and obligations, including Sublessee&#8217;s monetary obligations, hereunder, without the Sublessee&#8217;s prior written consent, which
        may be withheld by Sublessee in its sole and absolute discretion; and (II) as long as Sublessee shall pay the rent due hereunder and shall duly perform all of the terms, covenants and conditions of this Sublease on its part to be performed and
        observed, Sublessee shall peaceably and quietly have, hold and enjoy the Premises during the term of the Sublease without molestation or hindrance by Sublessor, subject to the terms, provisions and conditions of the Primary Lease and this Sublease.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">31</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">AA.&#160;&#160;&#160;&#160; &#160;&#160; <u>Generator</u>.&#160; Sublessor is in the process of installing a generator for its own use (the &#8220;<u>Sublessor&#8217;s Generator</u>&#8221;).&#160; Sublessee has requested the ability to connect to
        Sublessor&#8217;s Generator.&#160; Sublessor&#8217;s sole obligation for providing backup generator power to Sublessee shall be: (i) to permit Sublessee, at its sole cost and expense, to connect to Sublessor&#8217;s Generator for up to the maximum amount of backup power
        capacity reflected in the services matrix attached hereto as <u>Exhibit &#8220;G&#8221;</u> (the &#8220;<u>Services Matrix</u>&#8221;) and (ii) to contract with a third party to maintain the Sublessor&#8217;s Generator as per the manufacturer&#8217;s standard maintenance
        guidelines.&#160; Any work to connect the Premises to the Sublessor&#8217;s Generator shall be subject to Sublessor&#8217;s prior review and approval, such approval not to be unreasonably withheld, conditioned or delayed.&#160; Sublessor shall have no obligation to
        provide Sublessee with operational life safety generators or back-up power or to supervise, oversee or confirm that the third party maintaining the life safety generator is maintaining the generator as per the manufacturer&#8217;s standard guidelines or
        otherwise.&#160; During any period of replacement, repair or maintenance of the Sublessor&#8217;s Generator when the Sublessor Generator is not operational, including any delays thereto due to the inability to obtain parts or replacement equipment, Sublessor
        shall have no obligation to provide Sublessee with an alternative life safety generator or generators or alternative sources of back-up power.&#160; Sublessee expressly acknowledges and agrees that Sublessor does not guaranty that such Sublessor&#8217;s
        Generator will be operational at all times or that emergency power will be available to the Premises when needed.&#160; Sublessee agrees to reimburse Sublessor, upon demand, for its pro rata share (measured based on a fraction equal to the total
        capacity available for Sublessee as reflected in the Services Matrix divided by the total capacity of the Sublessor&#8217;s Generator) of all costs associated with the maintenance, repair, operation (including, without limitation, fuel costs) and
        replacement of the Sublessor&#8217;s Generator.&#160; To the fullest extent permitted by law, Sublessee agrees to promptly indemnify, protect, defend and hold harmless Sublessor and Sublessor&#8217;s partners, officers, directors, employees, agents, successors and
        assigns (collectively, &#8220;Sublessor Indemnified Parties&#8221;) from and against any and all claims, damages, judgments, suits, causes of action, losses, liabilities, penalties, fines, expenses and costs (including, without limitation, clean-up, removal,
        remediation and restoration costs, sums paid in settlement of claims, attorneys&#8217; fees, consultant fees and expert fees and court costs) which arise or result from Sublessee&#8217;s use and/or operation of Sublessor&#8217;s Generator.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">BB.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Services</u>.&#160; Sublessee has requested that Sublessor provide certain services to the Premises as reflected in the Services Matrix.&#160; Sublessor shall use reasonable efforts to provide
        Sublessee with the services reflected in the Services Matrix.&#160; As a condition to Sublessor providing Sublessee with such services, Sublessee, at its sole cost and expense, shall be required to install a submeter or measuring device in order to
        measure Sublessee&#8217;s usage of such services.&#160; Based on the amount of services utilized by Sublessee as measured pursuant to such submeters or measuring devices, Sublessee shall reimburse Sublessor within thirty (30) days of receipt of an invoice for
        all costs incurred by Sublessor in providing such services to Sublessee.&#160; Notwithstanding anything herein to the contrary, except as set forth below, Sublessor shall not be liable for, and Sublessee shall not be entitled to, any damages, abatement
        or reduction of rent, or other liability by reason of any failure to furnish any services described in the Services Matrix for any reason, including, without limitation, when caused by accident, breakage, water leakage, flooding, repairs,
        alterations or other improvements to the Building, strikes, lockouts or other labor disturbances or labor disputes of any character, governmental regulation, moratorium or other governmental action, inability to obtain services, or any other cause
        beyond Sublessor&#8217;s control.&#160; No such failure, stoppage or interruption of any such service shall be construed as an eviction of Sublessee, nor shall the same relieve Sublessee from any obligation to perform any covenant or agreement under this
        Sublease.&#160; In the event of any failure, stoppage or interruption thereof, Sublessor shall use reasonable efforts to attempt to restore all services promptly.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">Notwithstanding anything herein to the contrary, if there is an interruption or cessation of the services to be provided by Sublessor to Sublessee as reflected in the Services Matrix and such interruption or
        cessation is due to (i) Sublessor&#8217;s negligence or willful misconduct, (ii) Sublessor&#8217;s failure to perform any other covenant or provision of the Primary Lease or this Sublease on its part required to be performed, or (iii) the performance of any
        work in or about the Building by Sublessor or its employees or agents, and such interruption or cessation results in the Premises being unusable by Sublessee for the conduct of Sublessee&#8217;s business, then Sublease Rent shall be abated commencing on
        that date which is three (3) consecutive business days following the date Sublessee delivers written notice to Sublessor of such interruption and continuing until either such service to the Premises is restored or such earlier date as the Premises
        is again usable for the conduct of Sublessee&#8217;s business.&#160; Such right to abate Sublease Rent shall be Sublessee&#8217;s sole and exclusive remedy at law or in equity in the event of any such interruption or cessation of a service to be provided to
        Sublessee as reflected in the Services Matrix.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">32</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">CC.&#160;&#160;&#160;&#160;&#160;&#160; <u>Fire Control Area</u>.&#160; Sublessee acknowledges that the first (1st) floor of the Building has a total of four (4) fire control areas and that three (3) of such fire control areas are
        for the exclusive use of Sublessor.&#160; With respect to the fourth (4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) fire control area on the first floor, Sublessee shall have the rights to utilize that portion of
        such fourth (4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) area as depicted in <u>Exhibit &#8220;H&#8221;</u> attached hereto and incorporated herein for all purposes (the &#8220;<u>Sublessee Fire Control Area</u>&#8221;).&#160; Except
        with respect to the Sublessor Work as it relates to the Sublessee Fire Control Area, Sublessee acknowledges that the Sublessee Fire Control Area is delivered to Sublessee in its as-is condition and that Sublessor shall have no obligation to make
        any improvements thereto.&#160; Sublessor, at its sole cost and expense, shall be required to make any and all improvements to separate the Sublessee Fire Control Area from the remainder of the fourth (4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) fire control area as further described in <u>Exhibit &#8220;F&#8221;</u> attached hereto; provided, however, any such improvements shall be subject to written approval of Landlord.&#160; Sublessee shall comply with all
        applicable laws and legal requirements in connection with its use of the Sublessee Fire Control Area and such areas shall be considered part of the Premises.&#160; Sublessee acknowledges that Sublessor, Landlord, and/or additional of Sublessor&#8217;s
        sublessees shall have the right to utilize the fourth (4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) fire control area in common with Sublessee and that in no event shall Sublessee utilize more than two
        hundred forty (240) gallons of the permitted capacity with respect to the fourth (4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) fire control area on the first floor of the Building.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">DD.&#160;&#160;&#160;&#160;&#160;&#160; <u>Acid Neutralization System</u>.&#160; Sublessee acknowledges that there is an acid neutralization system in the Building.&#160; Subject to Sublessee complying with the reasonable rules and
        protocols imposed by Sublessor and Landlord (specifically including, but not limited to, any list of prohibited discharges provided), Sublessee shall have the right to utilize such system; provided, however, before utilizing such system, Sublessee
        shall be required to provide a list of all substances that Sublessee plans to introduce into such system and provide such other information and disclosures as may be requested by Sublessor and/or Landlord.&#160; Sublessee shall comply with all
        applicable laws and legal requirements in connection with its use of the acid neutralization system.&#160; In connection with Sublessee&#8217;s use of the acid neutralization system, Sublessee shall reimburse Landlord for Sublessee&#8217;s Acid System Share of all
        costs incurred to operate, maintain, repair and/or replace the acid neutralization system.&#160; As used herein, the term &#8220;<u>Sublessee&#8217;s Acid System Share</u>&#8221; shall mean a percentage derived from dividing the total Sublessee connection points to the
        acid neutralization system by the total aggregate amount of connection points of Sublessor and Sublessee to the acid neutralization system.&#160; For example, if Sublessee had ten (10) connection points to the acid neutralization system and Sublessor
        had ninety (90) connection points, then the Sublessee&#8217;s Acid System Share would equal 10% (i.e., 10/100).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">33</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">EE.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Contractor Coordination</u>.&#160; The parties acknowledge that Sublessor is currently in the process of performing its initial tenant improvements to certain portions of the Primary
        Leased Premises (the &#8220;<u>Sublessor Initial TI Work</u>&#8221;) and that such Sublessor Initial TI Work shall be occurring concurrently with Sublessee&#8217;s construction of the Sublessee Improvements.&#160; Each party agrees to use reasonable efforts to cause
        their respective contractors to coordinate with each other in order to minimize any interference with each respective party&#8217;s ongoing construction.&#160; During construction of the Sublessee Improvements, upon Sublessee&#8217;s written request, Sublessor
        agrees to permit Sublessee to utilize a portion of the Eighth Floor reasonably designated by Sublessor as a construction laydown area in connection with the Sublessee&#8217;s construction of the Sublesee Improvements.&#160; Sublessee acknowledges that
        Sublessor is also concurrently utilizing the Eighth Floor as its construction laydown area so Sublessor may require Sublessee, at its cost, to erect temporary fencing in order to separate the Sublessee&#8217;s construction laydown area on the Eighth
        Floor.&#160; Notwithstanding the foregoing to the contrary, in the event Sublessor desires to commence construction on the Eighth Floor either for purposes of occupying the floor or in connection with an executed or prospective sublease, then Sublessor
        shall have the right to send Sublessee written notice and thereafter within sixty (60) days following receipt of such notice, Sublessee shall remove all of its property and equipment from the Eighth Floor and shall have no further rights with
        respect to the Eighth Floor.&#160; As of the Sublease Rent Commencement Date, Sublessee acknowledges that it shall have no further rights to utilize the Eighth Floor as a construction laydown area.</div>
      <div>&#160;</div>
      <div style="text-align: center;">[<font style="font-style: italic;">Signature Page Follows</font>]</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">34</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%A-%%-->
      <div style="text-align: justify; text-indent: 36pt;">IN WITNESS WHEREOF, the parties hereto have caused this Sublease to be executed by their respective duly authorized representatives, effective as of the date first hereinabove written.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z34d19c5a93b64764b07990eadd7b0564" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div><u>SUBLESSOR</u>:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" colspan="2" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="font-weight: bold;">E.R. SQUIBB &amp; SONS, L.L.C.,</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="font-weight: bold;">a Delaware limited liability company</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div style="font-weight: bold;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid black;">
              <div style="font-weight: bold;">/s/ Bruce Mayer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div style="font-weight: bold;">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid black;">
              <div style="font-weight: bold; margin-left: 9pt;">Bruce Mayer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div style="font-weight: bold;">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid black;">
              <div style="font-weight: bold; margin-left: 9pt;">Sr. Director Global Real Estate</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid black;">
              <div style="font-weight: bold; margin-left: 9pt;">Authorized Signatory</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 7%; vertical-align: top; padding-bottom: 2px;">
              <div>Address:</div>
            </td>
            <td style="width: 43%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
            <td style="width: 7%; vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
            <td style="width: 7%; vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
            <td style="width: 43%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: center;">[remainder&#160; of page intentionally left blank]</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">A-1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <table cellspacing="0" cellpadding="0" border="0" id="zb2eb9798247e44df90a649db4d36b5f4" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div><u>SUBLESSEE:</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="font-weight: bold;">ETERNA THERAPEUTICS, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="font-weight: bold;">a Delaware corporation, formerly known as Brooklyn Immunotherapeutics, Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>By:</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid black;">
              <div>/s/ Matthew Angel</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid black;">
              <div style="margin-left: 9pt;">Matthew Angel</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid black;">
              <div style="margin-left: 9pt;">CEO</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 7%; vertical-align: top;">
              <div>Address:</div>
            </td>
            <td style="width: 43%; vertical-align: top; border-bottom: 2px solid black;">
              <div>10531 4S Commons Dr.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 7%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top; border-bottom: 2px solid black;">
              <div>Suite 1660550</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 7%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top; border-bottom: 2px solid black;">
              <div>San Diego, CA 92127</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify;">List of Exhibits:</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="z88c9b1314436497aafa38e73421af4e6" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 8%;">Exhibit &#8220;A&#8221;</td>
              <td style="width: 7%; text-align: center;">=</td>
              <td style="width: 85%;">Copy of Primary Lease</td>
            </tr>
            <tr>
              <td style="width: 8%;">Exhibit &#8220;B&#8221;</td>
              <td style="width: 7%; text-align: center;">=</td>
              <td style="width: 85%;">Description of Premises</td>
            </tr>
            <tr>
              <td style="width: 8%;">Exhibit &#8220;C&#8221;</td>
              <td style="width: 7%; text-align: center;">=</td>
              <td style="width: 85%;">Work Letter</td>
            </tr>
            <tr>
              <td style="width: 8%;">Exhibit &#8220;D&#8221;</td>
              <td style="width: 7%; text-align: center;">=</td>
              <td style="width: 85%;">
                <div>Form of Letter of Credit</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8%;">Exhibit &#8220;E&#8221;</td>
              <td style="width: 7%; text-align: center;">=</td>
              <td style="width: 85%;">Initial Test Fit</td>
            </tr>
            <tr>
              <td style="width: 8%;">Exhibit &#8220;F&#8221;</td>
              <td style="width: 7%; text-align: center;">=</td>
              <td style="width: 85%;">Sublessor Work</td>
            </tr>
            <tr>
              <td style="width: 8%;">Exhibit &#8220;G&#8221;</td>
              <td style="width: 7%; text-align: center;">=</td>
              <td style="width: 85%;">Services Matrix</td>
            </tr>
            <tr>
              <td style="width: 8%;">Exhibit &#8220;H&#8221;</td>
              <td style="width: 7%; text-align: center;">=</td>
              <td style="width: 85%;">Sublessee Fire Control Area</td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%A - % %-->
      <div style="text-align: center;">EXHIBIT &#8220;A&#8221;</div>
      <div style="text-align: center;">Copy of Primary Lease</div>
      <div><br>
      </div>
      <div style="text-align: center;">[attached]</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">A - 1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%B - % %-->
      <div style="text-align: center;">EXHIBIT &#8220;B&#8221;</div>
      <div style="text-align: center;">Description of Premises</div>
      <div><br>
      </div>
      <div style="text-align: center;"><img width="616" height="306" src="image01.jpg"></div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">B - 1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%C-1 - % %-->
      <div style="text-align: center;">EXHIBIT &#8220;C&#8221;</div>
      <div style="text-align: center;">Work Letter</div>
      <div><br>
      </div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Sublessee Improvements; Sublessee Improvement Allowance</u>.&#160; The leasehold improvements to be constructed by Sublessee (the &#8220;<u>Sublessee Improvements</u>&#8221;), at Sublessee&#8217;s sole
        cost and expense (except for the Sublessee Improvement Allowance, as specified in <u>Section 6(A)</u> of this Sublease), shall be constructed in accordance with the SI Construction Documents to be submitted by Sublessee and reviewed and approved
        by Sublessor in accordance with the provisions of <u>Paragraph (b)</u> of this <u>Exhibit C</u> and by Landlord in accordance with the process set forth in the work letter attached as Exhibit B to the Primary Lease as it relates to Landlord&#8217;s
        review and approval with respect to the TIW Construction Documents.&#160; Notwithstanding anything herein to the contrary, Sublessee acknowledges that in connection with design of the Sublessee Improvements and the preparation of the SI Construction
        Documents and the construction and the construction of the Sublessee Improvements that Sublessee shall be required to comply with all of the requirements, processes, rules and restrictions that relate to the TI Work in Exhibit B of the Primary
        Lease.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Sublessor shall have no obligation to construct or to pay for the construction of the Sublessee Improvements.&#160; However, Sublessor agrees to contribute toward the cost of construction of the
        Sublessee Improvements the cash sum of up to the Sublessee Improvement Allowance (as defined in <u>Section 6(A)</u> of this Sublease).&#160; Notwithstanding anything in this Sublease or in this Work Letter to the contrary, Sublessee Improvement
        Allowance shall be used only for the construction of the Sublessee Improvements, and if construction of the Sublessee Improvements is not Substantially Completed (defined below) by December 1, 2023 (the &#8220;<u>Construction Termination Date</u>&#8221;),
        then, other than with respect to the Final Retainage (as defined below), Sublessor&#8217;s obligation to provide any portion of the Sublessee Improvement Allowance shall, with regard to reimbursement of costs for which a Disbursement Request has not been
        made by the Construction Termination Date, terminate and become null and void, and Sublessee shall be deemed to have waived its rights in and to said portion of the Sublessee Improvement Allowance.&#160; With respect to the Final Retainage, Sublessee
        shall submit the Disbursement Request for such Final Retainage no later than March 1, 2024, otherwise Sublessee shall forfeit the right to receive such Final Retainage from Sublessor.&#160; The Sublessee Improvement Allowance will be reduced by a
        coordination fee/construction management fee that is required to be paid by Sublessor to Landlord under the Prime Lease to the extent it relates to the Sublessee Improvements.&#160; In addition to the coordination fee/construction management fee payable
        pursuant to the preceding sentence, the Sublessee Improvement Allowance will also be reduced by an amount equal to one percent (1%) of the total Sublessee Improvement Allowance (the &#8220;<u>Sublessor Oversight Fee</u>&#8221;), which such Sublessor Oversight
        Fee shall be paid to Sublessor with respect to any consulting or architectural fees incurred by Sublessor and/or for any oversight/coordination by Sublessor&#8217;s employees.&#160; The hard and soft construction costs that may be reimbursed from the
        Sublessee Improvement Allowance shall include only the following:&#160; costs of labor, equipment, supplies and materials furnished for construction of the Sublessee Improvements; governmental fees and charges for required permits, plan checks, and
        inspections for the Sublessee Improvements; charges of Sublessee&#8217;s design professionals; and charges of Sublessor&#8217;s design professionals for review of plans and monitoring of construction or installation of the Sublessee Improvements.&#160; No other
        costs, fees or expenses of the Sublessee Improvements shall be reimbursable out of the Sublessee Improvement Allowance.&#160; If the actual cost of the Sublessee Improvements is less than the Sublessee Improvement Allowance, then Sublessee shall not
        receive any credit whatsoever for the difference between the actual cost of the Sublessee Improvements and Sublessee Improvement Allowance.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">C-1 - 1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">Sublessor shall disburse the Sublessee Improvement Allowance in accordance with the disbursement procedures set forth below:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(i)&#160; &#160; &#160; &#160; &#160; Disbursements shall be made in periodic progress payments (which shall not occur more frequently than once per month) based on Disbursement Requests (defined below) delivered to
        Sublessor not more often than thirty (30) days following the previously delivered Disbursement Request.&#160; Except for the final disbursement of the Sublessee Improvement Allowance as described in Paragraph (a)(ix), in no event will monthly
        disbursements exceed ninety percent (90%) of the amount requested in a Disbursement Request.&#160; In the event the Construction Estimate (as defined below) exceeds the amount of the Sublessee Improvement Allowance, Sublessor and Sublessee shall make
        each monthly payment of the Disbursement Requests pro rata according to the following percentages: (a) Sublessor shall pay a percentage equal to the Sublessee Improvement Allowance divided by the Construction Estimate and (b) Sublessee shall pay
        the remaining sum.&#160; Notwithstanding anything to the contrary herein, once Sublessor has disbursed a total of ninety percent (90%) of the Sublessee Improvement Allowance, then Sublessor shall retain the final ten percent (10%) (such amount being the
        &#8220;<u>Final Retainage</u>&#8221;) and shall disburse the same only when the Final Disbursement Conditions (as defined below) have been satisfied in full.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(ii)&#160; &#160; &#160; &#160; Sublessee shall have given Sublessor a written request for any desired disbursement (a &#8220;<u>Disbursement Request</u>&#8221;), specifying the amount of the requested disbursement and
        accompanied by a written statement by Sublessee describing the expenses to be paid from such disbursement and paid invoices reflecting that Sublessee has already paid such sums to its contractors.</div>
      <div style="text-align: justify; text-indent: 72pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(iii)&#160; &#160;&#160;&#160; &#160; Sublessee and its architect shall both confirm by signature to Sublessor their consent and approval of the amounts requested in the Disbursement Request and the completion of the
        Sublessee Improvements for which such Disbursement Request relates and such evidence shall be supplied to Sublessor.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(iv)&#160; &#160; &#160; &#160; Sublessee shall have delivered to Sublessor (A) evidence satisfactory to Sublessor in its reasonable judgment (which may include, without limitation, lien waivers or partial waivers, as
        appropriate) demonstrating that the amount of the requested disbursement is for permissible costs for work theretofore performed and for which no previous disbursement from the Sublessee Improvement Allowance was made, (B) evidence satisfactory to
        Sublessor in its reasonable judgment (which for the purposes of this clause (B) it shall be deemed satisfactory if Sublessor is supplied with lien waivers or partial waivers, as appropriate) that all previous disbursements from the Sublessee
        Improvement Allowance have been properly applied to pay for those costs for which such previous disbursements were made and that to the extent required Sublessee has made its pro rata share of payments in connection with each disbursement request
        as set forth in item (i) above, (C) such evidence as Sublessor may reasonably require (which may include an inspection by Sublessor or its representative) to verify that the subject of any such Disbursement Request and any other work has been
        completed, and (D) all evidence that is required to be submitted by Sublessor to Landlord under Exhibit B in connection with a requisition of the TI Allowance.&#160; Sublessor agrees that if the Landlord requests any additional information or
        documentation, then Sublessee shall provide such additional information or documentation upon request.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">C-2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(v)&#160; &#160; &#160;&#160; &#160;&#160; On or before the date on which Sublessee desires Sublessor to make a disbursement (which shall be at least forty-five (45) days after all requirements of (a)(i) to (iv) have been
        delivered to Sublessor), Sublessor shall make the requested disbursement to Sublessee; provided, however, Sublessee acknowledges that Sublessor may delay the disbursement in the event Sublessee has failed to provide all information and
        documentation that may be required or requested by Landlord pursuant to the terms of the Primary Lease for it to make a disbursements of the TI Allowance.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(vi)&#160; &#160; &#160; &#160;&#160; There shall be no event of default by Sublessee under the Sublease beyond any applicable notice and cure periods provided for in the Lease.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(vii)&#160; &#160; &#160;&#160; Sublessor shall not have any responsibility to Sublessee (A) to see that any work for which reimbursement is requested hereunder is constructed in accordance with applicable plans and
        specifications, or that such work will be completed, or that sufficient funds (above and beyond the Sublessee Improvement Allowance) are available for completion, (B) for mechanics&#8217; liens or claims by contractors, subcontractors, materialmen or any
        others hired by Sublessee to do work in the Premises, subject to Sublessor&#8217;s obligations hereunder to disburse the Sublessee Improvement Allowance, or (C) Sublessor shall not be required to disburse funds in excess of the Sublessee Improvement
        Allowance.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(viii)&#160; &#160;&#160; All conditions to Sublessor&#8217;s obligation to disburse the Sublessee Improvement Allowance are for the exclusive benefit of Sublessor.&#160; Any or all such conditions may be waived or relaxed
        at any time or times by Sublessor, at its sole and exclusive option.&#160; No such waiver or relaxation in any particular instance shall affect Sublessor&#8217;s discretion in dealing with any such condition in any other instance.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(ix)&#160; &#160; &#160;&#160; Except for the final disbursement of the Sublessee Improvement Allowance, in no event will monthly disbursements exceed ninety percent (90%) of the amount requested in a Disbursement
        Request. At the time of Substantial Completion and upon satisfaction of the Final Disbursement Conditions (as defined below), Sublessor shall disburse the final ten percent (10%) of the Sublessee Improvement Allowance that Sublessee or Sublessee&#8217;s
        contractor is otherwise entitled to have disbursed hereunder.&#160; The &#8220;<u>Final Disbursement Conditions</u>&#8221; shall mean the following: (i) the Sublessee Improvements shall have been completed in accordance with the SI Construction Documents (as
        hereinafter defined); (ii) Sublessee shall have delivered to Sublessor satisfactory evidence that all mechanics&#8217; lien rights of all contractors, suppliers, subcontractors, or materialmen furnishing labor, supplies or materials in the construction
        or installation of the Sublessee Improvements have been unconditionally waived, released, or extinguished; (iii) Sublessee shall have delivered to Sublessor paid receipts or other written evidence satisfactorily substantiating the actual amount of
        the construction costs of the Sublessee Improvements; (iv) Sublessee shall have delivered to Sublessor a final certificate of occupancy for the Premises; (v) Sublessee shall not then be in default of any of the provisions of the Lease; (vi)
        Sublessee shall have occupied and opened for business at the Premises; (vii) Sublessee shall have delivered to Sublessor a complete set of the final &#8220;as built&#8221; plans and specifications conforming to the SI Construction Documents (defined below) in
        both hard copy and CAD format; and (viii) Sublessee shall have delivered to Sublessor copies of all warranties from contractors and suppliers relating to the Sublessee Improvements.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">C-3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the extent that Sublessor fails to pay from the Sublessee Improvement Allowance amounts due to Sublessee in accordance with the terms hereof, and such amounts remain unpaid for
        thirty-five (35) days after notice from Sublessee, and Sublessor has not disputed that the Disbursement Request (including all applicable documentation required hereunder) has been properly and timely submitted hereunder prior to the expiration of
        such thirty-five (35) day period, then without limiting Sublessee&#8217;s other remedies under the Lease, Sublessee may, after Sublessor&#8217;s failure to pay such amounts within five (5) business days after Sublessee&#8217;s delivery of a second notice from
        Sublessee delivered after the expiration of such 35-day period (with such second notice providing in bold, all-capital typeface at the top of such notice that &#8220;SUBLESSOR&#8217;S FAILURE TO MAKE THE REQUESTED DISBURSEMENTS REQUESTED IN CONNECTION WITH THE
        ENCLOSED DISBURSEMENT REQUEST MAY RESULT IN SUBLESSEE BEING PERMITTED TO OFFSET RENT DUE UNDER THE SUBLEASE&#8221;), deduct the amount thereof from the Sublease Rent next due and owing under the Sublease (the &#8220;<u>Offset Amount</u>&#8221;).&#160; Notwithstanding the
        foregoing, if during either the 35-day or 5-day period set forth above, Sublessor delivers notice to Sublessee that Sublessor has a good-faith dispute as to any portion of the amounts claimed to be due or that Sublessee has failed to submit a
        complete Disbursement Request with all information required under the Sublease and/or Primary Lease (the &#8220;<u>Allowance Dispute Notice</u>&#8221;), Sublessee shall have no right to offset the Offset Amount (or such portion thereof that is the subject of
        such a good-faith dispute) against rent unless and until Sublessee initiates an arbitration procedure in accordance with the terms of this Paragraph in order to determine whether Sublessee has satisfied all requirements set forth in this <u>Exhibit



          C</u> in order to be entitled to the requested disbursement.&#160; In the event Sublessee claims that Sublessee has satisfied all of the requirements in order to receive a disbursement from the Sublessee&#8217;s Improvement Allowance or disputes Sublessor&#8217;s
        notion of a good-faith dispute, and, therefore, that Sublessor&#8217;s Allowance Dispute Notice is not correct, then Sublessee shall send Sublessor a written notice within thirty (30) days of Sublessor&#8217;s issuance of such Allowance Dispute Notice (the &#8220;<u>Offset



          Dispute Notice</u>&#8221;), specifying the grounds on which Sublessee asserts that the Allowance Dispute Notice was factually incorrect (provided, however, Sublessee shall only be permitted to rely upon materials and documentation furnished to
        Sublessor prior to the date that Sublessor issued the applicable Allowance Dispute Notice) and electing to have the dispute resolved by arbitration as hereinbelow provided (the &#8220;<u>Expedited Arbitration</u>&#8221;).&#160; In the Offset Dispute Notice,
        Sublessee shall designate an arbitrator of its selection who meets the qualifications provided below.&#160; Within fifteen (15) business days after receipt of the Offset Dispute Notice, Sublessor shall notify Sublessee of its selection of an arbitrator
        who meets the qualifications provided below.&#160; Sublessor&#8217;s and Sublessee&#8217;s arbitrators shall then select a third, neutral arbitrator who meets the qualifications provided below.&#160; The Expedited Arbitration shall be held at such neutral arbitrator&#8217;s
        office.&#160; Each of the arbitrators shall (1) have at least ten (10) years&#8217; experience as a real estate attorney representing landlords or tenants in the leasing of Class A office buildings in the greater Boston, Massachusetts area and (2) not have
        represented Sublessor or Sublessee during the preceding five (5) years.&#160; The Expedited Arbitration shall be held on a mutually agreeable date which shall be no less than thirty (30) days and no more than sixty (60) days after Sublessor&#8217;s receipt of
        the Offset Dispute Notice.&#160; The Expedited Arbitration shall be conducted in accordance with the rules of the American Arbitration Association and the scope of the arbitrators&#8217; inquiry and determination shall be strictly limited to whether
        Sublessor&#8217;s Dispute Notice was factually correct based on the documentation and information furnished by Sublessee at the time that Sublessor provided such Sublessor&#8217;s Allowance Dispute Notice.&#160; The determination of the majority of the arbitrators
        shall be conclusive and binding upon the parties and shall be made within five (5) business days after completion of the hearing.&#160; Each party shall pay for the fees and expenses of their respective arbitrator and the parties shall equally split the
        fees and expenses of the third arbitrator.&#160; In the event the arbitrators find that Sublessor&#8217;s Allowance Dispute Notice was factually incorrect as set forth herein, Sublessee may proceed with the proposed offset against future rent for the Offset
        Amount; provided, however, if Sublessor subsequently disburses such Offset Amount to Sublessee then Sublessee shall not have the right to offset with respect to such Offset Amount.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">C-4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Preparation and Review of Plans for Sublessee Improvements</u>.&#160; Sublessee shall retain an architect (the &#8220;<u>Space Planner</u>&#8221;), which such Space Planner shall be subject to
        Sublessor&#8217;s approval, and the Space Planner has prepared (or will prepare) certain plans, drawings and specifications (the &#8220;<u>Temporary Plans</u>&#8221;) for the construction of the Sublessee Improvements in the Premises to be installed in the Premises
        by a general contractor selected by Sublessee pursuant to this Work Letter.&#160; Sublessee shall deliver the Temporary Plans to Sublessor and Landlord for their review and approval.&#160; Sublessor shall have fifteen (15) business days after Sublessor&#8217;s
        receipt of the proposed Temporary Plans to review the same and notify Sublessee in writing of any comments or required changes, or to otherwise give its approval or disapproval of such proposed Temporary Plans.&#160; In addition, Sublessee acknowledges
        that Landlord shall have the time period set forth in <u>Exhibit B</u> to the Primary Lease for review of the TIW Construction Documents in connection with its review of the Temporary Plans.&#160; If Sublessor fails to give written comments to or
        approve the Temporary Plans within such fifteen (15) business day period, then Sublessee shall provide a second written notice (the &#8220;<u>Temporary Plans Notice</u>&#8221;), which shall provide in bold, all-capital letters at the top of such notice as
        follows: &#8220;IF SUBLESSOR FAILS TO GIVE WRITTEN COMMENTS TO OR APPROVE THE PROPOSED TEMPORARY PLANS WITHIN FIVE (5) BUSINESS DAYS AFTER RECEIPT OF THIS WRITTEN NOTICE, THEN SUBLESSOR SHALL BE DEEMED TO HAVE APPROVED THE PROPOSED TEMPORARY PLANS.&#8221;&#160; If
        Sublessor fails to give written comments to or approve the Temporary Plans within five (5) business days after receipt of the Temporary Plans Notice, then Sublessor shall be deemed to have approved the Temporary Plans as submitted.&#160; Sublessee shall
        have ten (10) business days following its receipt of Sublessor&#8217;s and/or Landlord&#8217;s comments and objections to redraw the proposed Temporary Plans in compliance with Sublessor&#8217;s request and to resubmit the same for Sublessor&#8217;s final review and
        approval or comment within ten (10) business days of Sublessor&#8217;s receipt of such revised plans.&#160; Such process shall be repeated until such time as final approval by Sublessor and Landlord of the proposed Temporary Plans has been obtained.&#160; Once
        Sublessor and Landlord have each approved the Temporary Plans, the approved Temporary Plans shall thereafter for the basis to prepare construction drawings for the Sublessee Improvements, which such construction drawings are hereafter referred to
        as the &#8220;<u>SI Construction Documents</u>&#8221;.&#160; The SI Construction Documents shall include the complete and final layout, plans and specifications for the Premises showing all doors, light fixtures, electrical outlets, telephone outlets, wall
        coverings, plumbing improvements (if any), data systems wiring, floor coverings, wall coverings, painting, any other improvements to the Premises beyond the shell and core improvements provided by Sublessor and any demolition of existing
        improvements in the Premises.&#160; The improvements shown in the SI Construction Documents shall (i) utilize first class building materials and methods of construction, (ii) be compatible with the shell and core improvements and the design,
        construction and equipment of the Premises, and (iii) comply with all applicable laws, rules, regulations, codes and ordinances.&#160; Sublessee, using the Space Planner, shall prepare or cause to be prepared and submitted the SI Construction Documents,
        concurrently, and in each case by receipted courier or delivery service, to Sublessor&#8217;s construction representative (&#8220;<u>Sublessor&#8217;s Construction Representative</u>&#8221;), and Sublessor&#8217;s offices for Sublessor&#8217;s review and approval, which shall be
        consistent with the description of the Sublessee Improvements set forth in the Temporary Plans.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">C-5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">Each set of proposed SI Construction Documents furnished by Sublessee shall include at least two (2) sets of prints.&#160; The SI Construction Documents shall be compatible with the design,
        construction, and equipment of the Building, and shall be capable of logical measurement and construction.&#160; Unless Sublessor shall otherwise agree in writing, the SI Construction Documents shall be signed/stamped by the Space Planner, and shall
        include (to the extent relevant or applicable) such additional plans reasonably requested by Sublessor related to the Sublessee Improvements, including, without limitation, any and all additional plans related to Sublessee&#8217;s specific use of the
        Premises, or as may be required by local city ordinance or building code.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Sublessee shall submit all SI Construction Documents concurrently to Sublessor&#8217;s construction representative and offices, as designated above, for Sublessor&#8217;s review and approval and to Landlord
        for Landlord&#8217;s review and approval in accordance with the process set forth in <u>Exhibit B</u> as it relates to the review and approval of the TIW Construction Documents.&#160; Sublessor shall have fifteen (15) business days after Sublessor&#8217;s receipt
        of the proposed SI Construction Documents to review the same and notify Sublessee in writing of any comments or required changes, or to otherwise give its approval or disapproval of such proposed SI Construction Documents.&#160; If Sublessor fails to
        give written comments to or approve the SI Construction Documents Plans within such fifteen (15) business day period, then Sublessee shall provide a second written notice (the &#8220;<u>SI Construction Documents Notice</u>&#8221;), which shall provide in bold,
        all-capital letters at the top of such notice as follows: &#8220;IF SUBLESSOR FAILS TO GIVE WRITTEN COMMENTS TO OR APPROVE THE PROPOSED SI CONSTRUCTION DRAWINGS WITHIN FIVE (5) BUSINESS DAYS AFTER RECEIPT OF THIS WRITTEN NOTICE, THEN SUBLESSOR SHALL BE
        DEEMED TO HAVE APPROVED THE PROPOSED SI CONSTRUCTION DRAWINGS.&#8221;&#160; If Sublessor fails to give written comments to or approve the SI Construction Drawings within five (5) business days after receipt of the SI Construction Drawings Notice, then
        Sublessor shall be deemed to have approved the SI Construction Drawings as submitted.&#160; Sublessee shall have ten (10) business days following its receipt of Sublessor&#8217;s and/or Landlord&#8217;s comments and objections to redraw the proposed SI Construction
        Documents in compliance with Sublessor&#8217;s request and to resubmit the same for Sublessor&#8217;s final review and approval or comment within five (5) business days of Sublessor&#8217;s receipt of such revised plans.&#160; Such process shall be repeated as necessary
        until final approval by Sublessor and Landlord of the proposed SI Construction Documents has been obtained.&#160; Sublessor may at any time by written notice given in accordance with the notice provisions of the Lease change the name and/or address of
        the designated Sublessor&#8217;s construction representative to receive plans delivered by Sublessee to Sublessor.&#160; In the event that Sublessee disagrees with any of the changes to the proposed SI Construction Documents required by Sublessor, then
        Sublessor and Sublessee shall consult with respect thereto and each party shall use all reasonable efforts to promptly resolve any disputed elements of such proposed SI Construction Documents.&#160; If such SI Construction Documents are not resolved by
        Sublessor and Sublessee, then Sublessee shall accept Sublessor&#8217;s and/or Landlord&#8217;s final changes to the proposed SI Construction Documents.&#160; For purposes hereof, &#8220;business days&#8221; shall be all calendar days except Saturdays and Sundays and holidays
        observed by national banks in the State in which the Premises are situated.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">C-6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">Notwithstanding the preceding provisions of this <u>Paragraph (b)</u>, under no circumstances whatsoever shall (i) any combustible materials be utilized above finished ceiling or in any concealed
        space, (ii) any structural load, temporary or permanent, be placed or exerted on any part of the Building without the prior written approval of Sublessor, or (iii) any holes be cut or drilled in any part of the roof or other portion of the Building
        shell without the prior written approval of Sublessor.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">In the event that Sublessee proposes any changes to the SI Construction Documents (or any portion thereof) after the same have been approved by Sublessor and Landlord, Sublessor shall not
        unreasonably withhold its consent to any such changes, provided the changes do not, in Sublessor&#8217;s reasonable opinion, adversely affect the Building structure, systems, or equipment, or the external appearance of the Premises.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">As soon as the SI Construction Documents (or a portion thereof sufficient to permit commencement of construction or installation of the Sublessee Improvements, if Sublessee elects to proceed with a
        &#8220;fast track&#8221; construction) are mutually agreed upon, Sublessee shall use diligent efforts to obtain all required permits, authorizations, and licenses from appropriate governmental authorities for construction of the Sublessee Improvements (or such
        portion thereof, as applicable).&#160; Sublessee shall be solely responsible for obtaining any business or other license or permit required for the conduct of its business at the Premises.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The parties acknowledge and agree that all plans, specifications, drawings, etc. set forth in this <u>Paragraph (b)</u> shall be submitted by Sublessor to Landlord promptly upon receipt (i.e.,
        Sublessor shall deliver the same within 3 business days), such that Sublessor and Landlord may review such materials simultaneously.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Construction of the Sublessee Improvements</u>.&#160; Construction or installation of the Sublessee Improvements shall be performed by a general contractor that is approved by both
        Sublessor (not to be unreasonably withheld, conditioned or delayed so long as such contractor is approved by Landlord) and Landlord (the &#8220;<u>Sublessee&#8217;s Contractor</u>&#8221;).&#160; Sublessor hereby approves of Wise as Sublessee&#8217;s contractor.&#160; Any attempt to
        change the Sublessee&#8217;s Contractor shall be subject to Sublessor&#8217;s prior written approval, which may be withheld in Sublessor&#8217;s sole and absolute discretion.&#160; The mechanical, electrical, and plumbing engineer to be utilized by Sublessee shall be
        subject to Sublessor&#8217;s prior written approval.&#160; The construction contract to be negotiated and entered into by and between the Sublessee&#8217;s Contractor and Sublessee shall be submitted to Sublessor for its review and approval.&#160; Each such contract
        shall (i) obligate Sublessee&#8217;s Contractor to comply with all rules and regulations of Sublessor and Landlord relating to construction activities in the Building, (ii) name Sublessor and Landlord as an additional indemnitee under the provisions of
        the contract whereby the Sublessee&#8217;s Contractor holds Sublessee harmless from and against any and all claims, damages, losses, liabilities and expenses arising out of or resulting from the performance of such work, (iii) name Sublessor and Landlord
        as a beneficiary of (and a party entitled to enforce) all of the warranties of the Sublessee&#8217;s Contractor with respect to the work performed thereunder and the obligation of the Sublessee&#8217;s Contractor to replace defective materials and correct
        defective workmanship for a period of not less than one (1) year following final completion of the work under such contract, and (iv) evidence the agreement of the Sublessee&#8217;s Contractor that the provisions of this Sublease and the Primary Lease
        shall control over the provisions of the contract with respect to distribution or use of insurance proceeds, in the event of a casualty during construction.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">C-7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">Prior to commencement of construction of the Sublessee Improvements, Sublessee&#8217;s Contractor shall provide Sublessee with an estimate of the total cost to construct and install the Sublessee
        Improvements (the &#8220;<u>Construction Estimate</u>&#8221;).&#160; In the event there is any material change order (i.e., having an impact of at least $50,000), then Sublessee shall provide Sublessor with an updated Construction Estimate in order for Sublessor to
        be able to recalculate the pari passu disbursement percentage in clause (i) of the disbursement procedures set forth in Paragraph (a) above.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Sublessee acknowledges and understands that all roof penetrations involved in the construction of the Sublessee Improvements must be performed by the Landlord&#8217;s roofing contractor.&#160; All costs, fees
        and expenses incurred with such contractor in performing such work shall be a cost of the Sublessee Improvements, payable in accordance with the provisions of this <u>Exhibit C</u>.&#160; Sublessee or Sublessee&#8217;s Contractor shall be responsible for all
        water, gas, electricity, sewer or other utilities used or consumed at the Premises during the construction of the Sublessee Improvements.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Sublessee specifically agrees to carry, or cause the Sublessee&#8217;s Contractor to carry, during all such times as the Sublessee&#8217;s work is being performed, insurance consistent with the insurance
        requirements set forth in the Primary Lease.&#160; Sublessee shall not commence construction of the Sublessee Improvements until Sublessor and Landlord have each issued to Sublessee a written authorization to proceed with construction after Sublessee
        has delivered to Sublessor&#8217;s construction representative and Landlord (i) certificates of the insurance policies described above, (ii) copies of all permits required for construction of the Sublessee Improvements and a copy of the permitted SI
        Construction Documents as approved by the appropriate governmental agency, and (iii) a copy of each signed construction contract for the Sublessee Improvements (a copy of each subsequently signed contract shall be forwarded to Sublessor&#8217;s
        construction representative without request or demand, promptly after execution thereof and prior to the performance of any work thereunder).&#160; All of the construction work shall be the responsibility of and supervised by Sublessee.&#160; Sublessee
        acknowledges that during construction of the Sublessee Improvements that the Landlord may concurrently be performing Base Building Work (as defined in the Primary Lease) and Sublessor may concurrently be performing TI Work (as defined in the
        Primary Lease) and that Sublessee shall cause its contractors to work in harmony and to not disturb the progress of such Base Building Work and/or TI Work.</div>
      <div style="text-align: justify; text-indent: 36pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">C-8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Requirements for Sublessee&#8217;s Work</u>.&#160; All of Sublessee&#8217;s construction with respect to the Premises shall be performed in substantial compliance with this <u>Exhibit C</u>
        (and in compliance with <u>Exhibit B</u> to the Primary Lease) and the SI Construction Documents therefor previously approved in writing by Sublessor (and any changes thereto approved by Sublessor as herein provided), and in a good and workmanlike
        manner, utilizing only new materials.&#160; All such work shall be performed by Sublessee in strict compliance with all applicable building codes, regulations and all other legal requirements.&#160; All materials utilized in the construction of Sublessee&#8217;s
        work must be confined to within the Premises or to a dumpster for Sublessee&#8217;s exclusive use and to be maintained by Sublessee in a location mutually agreeable to Sublessor and Sublessee (it being agreed that all costs associated with such dedicated
        dumpster for Sublessee&#8217;s exclusive use to be maintained during the course of the Sublessee Improvements shall be at Sublessee&#8217;s sole cost and expense).&#160; All trash and construction debris not located wholly within the Premises or deposited in the
        aforementioned dumpster must be removed each day from the Building at the sole cost and expense of Sublessee.&#160; Sublessor shall have the right at all times to monitor the work for compliance with the requirements of this <u>Exhibit C</u>.&#160; If
        Sublessor determines that any such requirements are not being strictly complied with, Sublessor may immediately require the cessation of all work being performed in or around the Premises or the Building until such time as Sublessor is satisfied
        that the applicable requirements will be observed.&#160; Any approval given by Sublessor with respect to Sublessee&#8217;s construction or the Temporary Plans or SI Construction Documents therefor, and/or any monitoring of Sublessee&#8217;s work by Sublessor, shall
        not make Sublessor liable or responsible in any way for the condition, quality or function of such matters or constitute any undertaking, warranty or representation by Sublessor with respect to any of such matters.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Liens; Indemnification</u>.&#160; Sublessee shall have no authority to place any lien upon the Premises, or the Building, or any portion thereof or interest therein, nor shall
        Sublessee have any authority in any way to bind Sublessor, and any attempt to do so shall be void and of no effect.&#160; If, because of any actual or alleged act or omission of Sublessee, or Sublessee&#8217;s Contractor, or any subcontractors or materialmen,
        any lien, affidavit, charge or order for the payment of money shall be filed against Sublessor, the Premises, the Building, or any portion thereof or interest therein, whether or not such lien, affidavit, charge or order is valid or enforceable,
        Sublessee shall, at its sole cost and expense, cause the same to be discharged of record by payment, bonding or otherwise no later than fifteen (15) days after notice to Sublessee of the filing thereof, but in any event prior to the foreclosure
        thereof.&#160; With respect to the contract for labor or materials for construction of the Sublessee Improvements, Sublessee acts as principal and not as the agent of Sublessor.&#160; Sublessor expressly disclaims liability for the cost of labor performed
        for or supplies or materials furnished to Sublessee.&#160; Sublessor may post one or more &#8220;notices of non-responsibility&#8221; for Sublessee&#8217;s work on the Building.&#160; No contractor of Sublessee is intended to be a third-party beneficiary with respect to the
        Sublessee Improvement Allowance, or the agreement of Sublessor to make such Sublessee Improvement Allowance available for payment of or reimbursement for the costs of construction of the Sublessee Improvements.&#160; Sublessee agrees to indemnify,
        defend and hold Sublessor, the Premises and the Project, harmless from all claims (including all costs and expenses of defending against such claims) arising or alleged to arise from any act or omission of Sublessee or Sublessee&#8217;s agents,
        employees, contractor, subcontractors, suppliers, materialmen, architects, designers, surveyors, engineers, consultants, laborers, or invitees, or arising from any bodily injury or property damage occurring or alleged to have occurred incident to
        any of the work to be performed by Sublessee or its contractors or subcontractors with respect to the Premises.&#160; Any default by Sublessee under this <u>Exhibit C</u> shall constitute a default by Sublessee under the Sublease for all purposes.&#160;
        Additionally, any approval given by Sublessor with respect to the Sublessee Improvements or the SI Construction Documents and/or any monitoring of the construction of the Sublessee Improvements by Sublessor shall not make Sublessor liable or
        responsible in any way for the condition, quality or function of such matters or constitute any undertaking, warranty or representation by Sublessor with respect to any such matters.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">C-9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Substantial Completion</u>.&#160; &#8220;<u>Substantial Completion</u>&#8221; (or any grammatical variant thereof) of construction of the Sublessee Improvements shall be defined as both the date
        upon which (i) Sublessor&#8217;s Construction Representative (or other consultant engaged by Sublessor) determines that the Sublessee Improvements have been substantially completed in accordance with the SI Construction Documents, and (ii) a temporary
        certificate of occupancy (or its equivalent) is issued for the Premises by the appropriate governmental authority.&#160; After the completion of the Sublessee Improvements, Sublessee shall, upon demand, execute and deliver to Sublessor a letter of
        acceptance of improvements performed on the Premises.&#160; The failure of Sublessee to take possession of or to occupy the Premises shall not serve to relieve Sublessee of obligations arising on the Sublease Rent Commencement Date or delay the payment
        of rent by Sublessee.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">C-10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%D-%%-->
      <div style="text-align: center;">EXHIBIT &#8220;D&#8221;</div>
      <div style="text-align: center;">Form of Letter of Credit</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">[BANK]</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zc6341697e9734f43bc589c7c9deabb24" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 45%; vertical-align: top;">
              <div>BENEFICIARY:</div>
            </td>
            <td style="width: 10%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div>APPLICANT</div>
            </td>
          </tr>
          <tr>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
            <td style="width: 10%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 45%; vertical-align: top;">
              <div>E.R. SQUIBB &amp; SONS, L.L.C.</div>
            </td>
            <td style="width: 10%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div>ETERNA THERAPEUTICS, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 10%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="vertical-align: top; padding-bottom: 2px;" colspan="2">
              <div>a Delaware corporation, formerly known as Brooklyn Immunotherapeutics, Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 10%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
            <td style="width: 10%; vertical-align: top; padding-bottom: 2px;" colspan="1" rowspan="1">&#160;</td>
            <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 45%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 10%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
            <td style="width: 10%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div>AMOUNT:&#160; USD $_____________ (__________________ AND 00/100 DOLLARS)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
            <td style="width: 10%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>Ladies and Gentlemen:</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">We hereby issue this Irrevocable Standby Letter of Credit No. ______________ (&#8220;Letter of Credit&#8221;) in your favor for the account of ETERNA THERAPEUTICS, INC., a Delaware corporation, formerly known
        as Brooklyn Immunotherapeutics, Inc.<font style="font-weight: bold;">&#160;</font>(&#8220;Tenant&#8221;) for a sum not to exceed an aggregate amount of $________________ effective immediately and expiring at our office at _______________________________________ on
        ________________________ (&#8220;Expiry Date&#8221;).&#160; Notwithstanding anything herein to the contrary, this Letter of Credit shall automatically renew on a year-to-year basis, the first such renewal commencing on the day immediately following the Expiry Date
        unless we notify you (Beneficiary) in writing at least thirty (30) days prior to the Expiry Date (or the applicable subsequent Expiry Date, following any such renewal) that we will not renew this Letter of Credit.&#160; Partial Drawings are permitted
        hereunder, and each drawing under this Letter of Credit shall permanently reduce the face amount of this Letter of Credit by the amount of such drawing.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">We undertake that drawings under this Letter of Credit will be duly honored upon presentation to us at our office indicated above on any Business Day (as defined below) on or before the Expiry Date
        of your sight draft(s) drawn on us, bearing the clause: &#8220;Drawn under _________________ Irrevocable Standby Letter of Credit No. _____________&#8221;, together with a statement in the form of Annex A (as stated below) purportedly executed by your
        authorized officer and regardless of whether Sublessee disputes the content of such statement.&#160; Payment will be made hereunder not later than 1:00 p.m. Eastern Standard time on the third Business Day (as defined below) following the date such
        demand for payment is presented as aforesaid.&#160; Payment of any amount drawn under this Letter of Credit will be made in immediately available funds by wire transfer to such account as you shall specify or in such other manner as you specify in the
        sight draft presented to us with respect to such payment.&#160; For purposes of this Letter of Credit, the&#160; term &#8220;Business Day&#8221; shall mean a day upon which banks in Boston, Massachusetts are open for commercial business.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">D-1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">This Letter of Credit is transferable or assignable, with notice to, but without permission or approval of ______________ Bank, in full and not in part.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">This Letter of Credit sets forth in full the terms of our undertaking and such undertaking shall not in any way be modified, amended or amplified by reference to any document or instrument referred
        to herein or in which this Letter of Credit is referred to or to which this Letter of Credit relates and any such reference shall not be deemed to incorporate herein by reference to any document or instrument.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">Except as stated herein, this undertaking is not subject to any condition or qualification.&#160; Our obligations under this Letter of Credit shall be the individual obligation of _______________ Bank,
        in no way contingent upon reimbursement with respect thereto.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">This Letter of Credit is subject to the Uniform Customs and Practice for Documentary Credits (1993 Revision) International Chamber of Commerce Publication No. 500 (&#8220;ISP 98&#8221;) and, to the extent not
        inconsistent with the ISP 98, the laws of the State of Massachusetts.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">D-2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">ANNEX A</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">CERTIFICATE RELATING TO _______________ BANK</div>
      <div style="text-align: center; font-weight: bold;">IRREVOCABLE LETTER OF CREDIT NO. _______</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">____________________________, a ____________________ (&#8220;Sublessor&#8221;) hereby requests payment of ____________ United States Dollars (U.S. $__________) pursuant to Letter of Credit No. ___________
        (&#8220;Letter of Credit&#8221;) dated _______________.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">In connection with such request, the Sublessor hereby certifies that either (i) ________________ (&#8220;Sublessee&#8221;) has not complied with the terms and conditions of that certain Sublease Agreement
        dated ______________, 2022, entered into by and between _______________________, as landlord, and ______________________, a _______________, as tenant, or (ii) Sublessor has received written notice that the Letter of Credit will not be renewed.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z500c846f86df4336bd443bb32b781076" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="font-weight: bold;"><u>&#8220;SUBLESSOR&#8221;</u></div>
            </td>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 7%; vertical-align: top; padding-bottom: 2px;">
              <div style="font-weight: bold;">By:</div>
            </td>
            <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 58%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; vertical-align: top; padding-bottom: 2px;">
              <div style="font-weight: bold;">Name:</div>
            </td>
            <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 58%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; vertical-align: top; padding-bottom: 2px;">
              <div style="font-weight: bold;">Title:</div>
            </td>
            <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 58%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
            <td style="width: 58%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>Dated:___________________, 20___</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">D-3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%E-%%-->
      <div style="text-align: center;">EXHIBIT &#8220;E&#8221;</div>
      <div style="text-align: center;">Initial Test-Fit</div>
      <div><br>
      </div>
      <div style="text-align: center;"><img src="image06.jpg"></div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">E-1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%F-%%-->
      <div style="text-align: center;">EXHIBIT &#8220;F&#8221;</div>
      <div style="text-align: center;">Sublessor Work</div>
      <div><br>
      </div>
      <div style="text-align: center;"><img src="image04.jpg"></div>
      <div><br>
      </div>
      <div style="text-align: center;"><img src="image05.jpg"></div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">F-1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%G-%%-->
      <div style="text-align: center;">EXHIBIT &#8220;G&#8221;</div>
      <div style="text-align: center;">Services Matrix</div>
      <div><br>
      </div>
      <div style="text-align: center;"><img src="image03.jpg"></div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">G-1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%H-%%-->
      <div style="text-align: center;">EXHIBIT &#8220;H&#8221;</div>
      <div style="text-align: center;">Sublessee Fire Control Area</div>
      <div><br>
      </div>
      <div style="text-align: center;"><img src="image02.jpg"></div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <div style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">H-1</font></div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21
<SEQUENCE>4
<FILENAME>brhc10049677_ex10-21.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%2%-%-%-->
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right;"><font style="font-weight: bold;">&#160;Exhibit 10.21</font><br>
      </div>
      <div> <br>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>LEASE TERMINATION AGREEMENT</u></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Lease Termination Agreement (this &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;) is entered into as of the 30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>
        day of November, 2022, by and between TORREY PINES SCIENCE CENTER LIMITED PARTNERSHIP, a Delaware limited partnership (&#8220;<font style="font-weight: bold;">Landlord</font>&#8221;), and ETERNA THERAPEUTICS INC., a Delaware corporation (&#8220;<font style="font-weight: bold;">Tenant</font>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: center;"><u>R E C I T A L S </u>:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Landlord and Tenant (formerly known as Brooklyn Immunotherapeutics, Inc.)<font style="font-weight: bold;">&#160;</font>entered into that certain Lease dated March 29, 2022 (the &#8220;<font style="font-weight: bold;">Lease</font>&#8221;), whereby Landlord leased to Tenant, and Tenant leased from Landlord, that certain space consisting of 5,193 rentable square feet and located on the first (1st) floor of that certain building located at
        10355 Science Center Drive, San Diego, California 92121 (&#8220;<font style="font-weight: bold;">Building</font>&#8221;), more particularly described in the Lease (the &#8220;<font style="font-weight: bold;">Premises</font>&#8221;).&#160; A copy of the Lease is attached hereto
        as <font style="font-weight: bold;"><u>Exhibit A</u></font> and is incorporated herein by this reference.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Tenant and Landlord desire to enter into this Agreement in order to terminate the Lease and to release one another from their respective obligations thereunder, except as otherwise
        provided herein.</div>
      <div>&#160;</div>
      <div style="text-align: center;"><u>A G R E E M E N T </u>:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">NOW, THEREFORE, in consideration of the foregoing recitals and the conditions and the covenants hereinafter contained, and for other consideration hereinafter set forth, the receipt and sufficiency
        of which are hereby acknowledged, Landlord and Tenant hereby agree as follows.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Effectiveness of this Lease Termination Agreement</u></font>.&#160; Notwithstanding anything to the contrary contained in this Agreement, this Agreement
        shall not be effective until Landlord enters into a new lease with &#8220;Salk Institute for Biological Studies, a California nonprofit corporation&#8221; (&#8220;<font style="font-weight: bold;">Salk</font>&#8221;) for the Premises, in a form acceptable to Landlord in
        its sole and absolute discretion (the &#8220;<font style="font-weight: bold;">Salk Lease Agreement</font>&#8221;).&#160; In the event Landlord does not enter into the Salk Lease Agreement on or before January 31, 2023, this Agreement shall terminate and be of no
        further force nor effect, and Landlord shall return the Termination Fee (defined below) to the extent paid to Landlord by Tenant.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Termination of the Lease</u></font>.&#160; Following the full execution and delivery of the Salk Lease Agreement by Landlord and Salk, Landlord shall
        deliver written notice to Tenant (the &#8220;<font style="font-weight: bold;">Termination Notice</font>&#8221;) and the Lease shall terminate and be of no further force or effect as of 11:59 P.M. on February 28, 2023 (&#8220;<font style="font-weight: bold;">Termination



          Date</font>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Surrender of Premises</u></font>.&#160; Tenant hereby agrees to vacate the Premises and surrender and deliver exclusive possession of the Premises to
        Landlord on or before the Termination Date in accordance with the provisions of the Lease, including without limitation <u>Sections 5.3.3</u> and <u>15.4</u>.</div>
      <div style="text-align: justify; text-indent: 36pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 40.38%; vertical-align: bottom; font-size: 8pt;"><br>
                </td>
                <td style="width: 20%; vertical-align: bottom; font-size: 8pt; text-align: center;"></td>
                <td style="width: 40.38%; vertical-align: bottom; font-size: 8pt;">
                  <div style="text-align: right;">HCP, INC.</div>
                  <div style="text-align: right;">[10355 Science Center Drive]</div>
                  <div style="text-align: right;">[Eterna Therapeutics Inc.]</div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%-%-%-->
      <div style="text-align: justify; text-indent: 36pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Consideration to Landlord</u></font>.&#160; In consideration for Landlord&#8217;s execution of this Agreement, Tenant shall deliver to Landlord the sum of One
        Hundred Thousand and 00/100 Dollars ($100,000.00), which amount represents certain costs of Landlord with respect to reletting the Premises to Salk (the &#8220;<font style="font-weight: bold;">Termination Fee</font>&#8221;).&#160; The Termination Fee shall be paid
        to Landlord as follows:&#160; (i) Forty-Six Thousand and 00/100 Dollars ($46,000.00) shall be paid to Landlord within five (5) business days following Landlord&#8217;s delivery to Tenant of the Termination Notice, and (ii) Fifty-Four Thousand and 00/100
        Dollars ($54,000.00) shall be paid to Landlord on or before the Termination Date.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Return of Security Deposit to Tenant</u></font>.&#160; Landlord and Tenant hereby acknowledge that, in accordance with <u>Article 21</u> of the Lease,
        Tenant has previously delivered to Landlord the total sum of Fifty-Four Thousand Six Hundred Eight and 24/100 Dollars ($54,608.24) as the Security Deposit for the faithful performance by Tenant of the terms, covenants and conditions of the Lease.&#160;
        Pursuant to such <u>Article 21</u>, any unapplied portion of the Security Deposit shall be returned to Tenant within sixty (60) days following the Termination Date.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Release of Liability</u></font>.&#160; Except as with respect to all obligation set forth in the Lease that survive the termination of the Lease,
        including, without limitation, Tenant&#8217;s indemnity obligations, and except as provided in <u>Articles 4, 5, 7 and 8</u> hereof, and conditioned on the performance by the parties of the provisions of this Agreement:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Landlord and Tenant shall, as of the Termination Date, be fully and unconditionally released and discharged from their respective obligations arising after the Termination Date from or
        connected with the provisions of the Lease, specifically including, without limitation, any right Tenant may have to audit or review Landlord&#8217;s books or records or to contest any &#8220;Operating Expenses,&#8221; as that term is defined in the Lease, billed to
        Tenant under the Lease; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; this Agreement shall fully and finally settle all demands, charges, claims, accounts or causes of action of any nature, including, without limitation, both known and unknown claims and
        causes of action that may arise out of or in connection with the obligations of the parties under the Lease after the Termination Date.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Each of the parties expressly waives the provisions of California Civil Code Section 1542, which provides:</div>
      <div>&#160;</div>
      <div style="text-align: justify; margin-right: 72pt; margin-left: 72pt;">&#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT&#160; THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND
        THAT, IF KNOWN BY HIM OR HER WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#8221;</div>
      <div style="text-align: justify; margin-right: 72pt; margin-left: 72pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 40.38%; vertical-align: bottom; font-size: 8pt;"><br>
                </td>
                <td style="width: 20%; vertical-align: bottom; font-size: 8pt; text-align: center;"><font style="font-weight: normal; font-style: normal;">-2-</font></td>
                <td style="width: 40.38%; vertical-align: bottom; font-size: 8pt;">
                  <div style="text-align: right;">HCP, INC.</div>
                  <div style="text-align: right;">[10355 Science Center Drive]</div>
                  <div style="text-align: right;">[Eterna Therapeutics Inc.]</div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">Each party acknowledges that it has received the advice of legal counsel with respect to the aforementioned waiver and understands the terms thereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Representations of Tenant</u></font>.&#160; Tenant represents and warrants to Landlord that (a) Tenant has not heretofore assigned or sublet all or any
        portion of its interest in the Lease; (b) no other person, firm or entity has any right, title or interest in the Lease; (c) Tenant has the full right, legal power and actual authority to enter into this Agreement and to terminate the Lease without
        the consent of any person, firm or entity; and (d) Tenant has the full right, legal power and actual authority to bind Tenant to the terms and conditions hereof. Tenant further represents and warrants to Landlord that as of the date hereof there
        are no, and as of the Termination Date there shall not be any, mechanic&#8217;s liens or other liens encumbering all or any portion of the Premises, by virtue of any act or omission on the part of Tenant, its predecessors, contractors, agents, employees,
        successors or assigns. Notwithstanding the termination of the Lease and the release of liability provided for herein, the representations and warranties set forth in this <u>Article 7</u> shall survive the Termination Date and Tenant shall be
        liable to Landlord for any inaccuracy or any breach thereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Continuing Liability</u></font>.&#160; Notwithstanding the termination of the Lease and the release of liability provided for herein, Tenant shall remain
        liable, with respect to the period of its tenancy prior to the Termination Date, for the performance of all of its obligations under the Lease (including, without limitation, Tenant&#8217;s payment of reconciliation of Operating Expenses [provided such
        reconciliation shall not exceed $10,000.00 in Landlord&#8217;s favor]) and Landlord shall have all the rights and remedies with respect to such obligations as set forth in the Lease. In the event that Tenant retains possession of the Premises or any part
        thereof after the Termination Date, then the provisions of <u>Article 16</u> of the Original Lease shall apply.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Landlord Entry</u></font>. In accordance with <u>Article 27</u> of the Lease, Landlord and Landlord&#8217;s representatives, contractors and agents, may,
        after Landlord&#8217;s delivery of the Termination Notice to Tenant but prior to the Termination Date, enter the Premises in order to perform any alterations and improvements and/or install any furniture fixtures and equipment therein.&#160; Landlord&#8217;s (and
        its representatives, contractors and agents) entry into the Premises prior to the Termination Date pursuant to the terms of this <u>Article 9</u> shall be deemed to mean that the Premises were in the condition required for surrender in accordance
        with the provisions of the Lease, except that, Tenant shall remain liable for removing its personal property from the Premises on or before the Termination Date.&#160; Except to the extent that Landlord can reasonably demonstrate that the damage was
        actually caused by Tenant, its employees or agents, Tenant shall not be liable, and Landlord indemnifies Tenant, for any damage to the Premises or Tenant&#8217;s personal property (including, its furniture, fixture and equipment) located in the Premises
        that occurs after the date that Landlord first enters the Premises pursuant to the terms of this <u>Article 9</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Attorneys&#8217; Fees</u></font>.&#160; Should any dispute arise between the parties hereto or their legal representatives, successors and assigns concerning
        any provision of this Agreement or the rights and duties of any person in relation thereto, the party prevailing in such dispute shall be entitled, in addition to such other relief that may be granted, to recover reasonable attorneys&#8217; fees and
        legal costs in connection with such dispute.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Governing Law</u></font>.&#160; This Agreement shall be governed and construed under the laws of the State of California.</div>
      <div style="text-align: justify; text-indent: 36pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 40.38%; vertical-align: bottom; font-size: 8pt;"><br>
                </td>
                <td style="width: 20%; vertical-align: bottom; font-size: 8pt; text-align: center;"><font style="font-weight: normal; font-style: normal;">-3-</font></td>
                <td style="width: 40.38%; vertical-align: bottom; font-size: 8pt;">
                  <div style="text-align: right;">HCP, INC.</div>
                  <div style="text-align: right;">[10355 Science Center Drive]</div>
                  <div style="text-align: right;">[Eterna Therapeutics Inc.]</div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Counterparts; Signatures</u></font>.&#160; This Agreement may be executed in counterparts, each of which shall be deemed an original, but such
        counterparts, when taken together, shall constitute one agreement.&#160; <font style="color: #000000;">Signatures of the parties transmitted by telefacsimile or electronic mail PDF format shall be deemed to constitute originals and may be relied upon,
          for all purposes, as binding the transmitting party hereto.&#160; The parties intend to be bound by the signatures transmitted by telefacsimile or electronic mail PDF format, are aware that the other party will rely on such signature, and hereby waive
          any defenses to the enforcement of the terms of this Agreement based on the form of signature.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Binding Effect</u></font>.&#160; This Agreement shall inure to the benefit of, and shall be binding upon, the parties hereto and their respective legal
        representatives, successors and assigns.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Time of the Essence</u></font>.&#160; Time is of the essence of this Agreement and the provisions contained herein.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Further Assurances</u></font>.&#160; Landlord and Tenant hereby agree to execute such further documents or instruments as may be necessary or appropriate
        to carry out the intention of this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Voluntary Agreement</u></font>.&#160; The parties have read this Agreement and mutual release as contained herein, and on the advice of counsel they
        have freely and voluntarily entered into this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: center;">[signature page to follow]</div>
      <div style="text-align: center;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 40.38%; vertical-align: bottom; font-size: 8pt;"><br>
                </td>
                <td style="width: 20%; vertical-align: bottom; font-size: 8pt; text-align: center;"><font style="font-weight: normal; font-style: normal;">-4-</font></td>
                <td style="width: 40.38%; vertical-align: bottom; font-size: 8pt;">
                  <div style="text-align: right;">HCP, INC.</div>
                  <div style="text-align: right;">[10355 Science Center Drive]</div>
                  <div style="text-align: right;">[Eterna Therapeutics Inc.]</div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">IN WITNESS WHEREOF, Landlord and Tenant have executed this Agreement as of the day and year first above written.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zc07cf875d7fb44a38bdb0ee8eb5bf3d5" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 95%; vertical-align: top;">
              <div>&#8220;LANDLORD&#8221;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 95%; vertical-align: top;">
              <div>TORREY PINES SCIENCE CENTER LIMITED PARTNERSHIP,</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 95%; vertical-align: top;">
              <div>a Delaware limited partnership</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 42%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="margin-left: 18pt;">/s/ Michael Dorris</div>
            </td>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="1" style="width: 10%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>Its:</div>
            </td>
            <td style="width: 34%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Senior Vice President</div>
            </td>
            <td style="width: 53%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z03e236af05074cf597b793f291d3423a" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="vertical-align: top;">
              <div>&#8220;TENANT&#8221;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
            <td rowspan="1" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="vertical-align: top;">
              <div>ETERNA THERAPEUTICS INC.,</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="vertical-align: top;">
              <div>a Delaware corporation</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
            <td rowspan="1" style="vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 42%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/ Andrew Jackson</div>
            </td>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="1" style="width: 10%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>Its:</div>
            </td>
            <td style="width: 34%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>CFO</div>
            </td>
            <td style="width: 53%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 42%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 10%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>Its:</div>
            </td>
            <td style="width: 34%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 53%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 40.38%; vertical-align: bottom; font-size: 8pt;"><br>
                </td>
                <td style="width: 20%; vertical-align: bottom; font-size: 8pt; text-align: center;"><font style="font-weight: normal; font-style: normal;">-5-</font></td>
                <td style="width: 40.38%; vertical-align: bottom; font-size: 8pt;">
                  <div style="text-align: right;">HCP, INC.</div>
                  <div style="text-align: right;">[10355 Science Center Drive]</div>
                  <div style="text-align: right;">[Eterna Therapeutics Inc.]</div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>EXHIBIT A</u></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;"><u>THE LEASE</u></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">[ATTACHED]</div>
      <div style="text-align: center; font-weight: bold;">
        <div><br>
        </div>
        <br>
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 40.38%; vertical-align: bottom; font-size: 8pt;"><br>
                </td>
                <td style="width: 20%; vertical-align: bottom; font-size: 8pt; text-align: center;">
                  <div>Exhibit A<br>
                  </div>
                  <div>-1-<br>
                  </div>
                </td>
                <td style="width: 40.38%; vertical-align: bottom; font-size: 8pt;">
                  <div style="text-align: right;">HCP, INC.</div>
                  <div style="text-align: right;">[10355 Science Center Drive]</div>
                  <div style="text-align: right;">[Eterna Therapeutics Inc.]</div>
                </td>
              </tr>

          </table>
        </div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22
<SEQUENCE>5
<FILENAME>brhc10049677_ex10-22.htm
<DESCRIPTION>EXHIBIT 10.22
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div>
        <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.22</font><br>
        </div>
        <div>&#160;</div>
        <div style="text-align: center; margin-right: 63.35pt; margin-left: 62.1pt; font-weight: bold;"><u>FIRST AMENDMENT TO LEASE TERMINATION AGREEMENT</u></div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 5.8pt; margin-left: 5pt;">This First Amendment to Lease Termination Agreement (this &#8220;<font style="font-weight: bold;">First Amendment</font>&#8221;) is entered into as of the 29<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day of December, 2022, by and between TORREY PINES SCIENCE CENTER LIMITED PARTNERSHIP, a Delaware limited partnership (&#8220;<font style="font-weight: bold;">Landlord</font>&#8221;),


          and ETERNA THERAPEUTICS INC., a Delaware corporation (&#8220;<font style="font-weight: bold;">Tenant</font>&#8221;).</div>
        <div><br>
        </div>
        <div style="text-align: center; margin-right: 63.25pt; margin-left: 62.1pt;"><u>R E</u>&#160;<u>C I</u>&#160;<u>T A</u>&#160;<u>L S</u> :</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 6.05pt; margin-left: 5pt;">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Landlord and Tenant (formerly known as Brooklyn Immunotherapeutics, Inc.) entered into that certain Lease dated March 29, 2022 (the &#8220;<font style="font-weight: bold;">Lease</font>&#8221;), whereby Landlord leased to Tenant, and Tenant leased from Landlord, that certain space consisting of 5,193 rentable square feet and located on the first (1st) floor of that certain building located at
          10355 Science Center Drive, San Diego, California 92121 (&#8220;<font style="font-weight: bold;">Building</font>&#8221;), more particularly described in the Lease (the &#8220;<font style="font-weight: bold;">Premises</font>&#8221;). A copy of the Lease is attached
          hereto as <font style="font-weight: bold;"><u>Exhibit A</u>&#160;</font>and is incorporated herein by this reference.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 6.3pt; margin-left: 5pt;">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Landlord and Tenant entered into that certain Lease Termination Agreement dated November 30, 2022 (the &#8220;<font style="font-weight: bold;">Termination




            Agreement</font>&#8221;), whereby Landlord and Tenant agreed, subject to the terms and conditions set forth in the Termination Agreement, to terminate the Lease as of the &#8220;Termination Date,&#8221; as that term is defined in the Termination Agreement
          (subject to <u>Section 2</u>, below).</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 6.45pt; margin-left: 5pt;">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Tenant and Landlord desire to enter into this First Amendment in order to amend the Termination Date.</div>
        <div><br>
        </div>
        <div style="text-align: center; margin-right: 63.35pt; margin-left: 62.05pt;"><u>A</u>&#160;<u>G</u>&#160;<u>R</u>&#160;<u>E</u>&#160;<u>E</u>&#160;<u>M</u>&#160;<u>E</u>&#160;<u>N</u>&#160;<u>T</u> :</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 6.35pt; margin-left: 5pt;">NOW, THEREFORE, in consideration of the foregoing recitals and the conditions and the covenants hereinafter contained, and for other consideration
          hereinafter set forth, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant hereby agree as follows.<br>
          <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 6.4pt; margin-left: 5pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Capitalized Terms</u></font>. All capitalized terms used herein shall have the same respective meanings as
          are given such terms in the Termination Agreement, unless expressly provided otherwise in this First Amendment.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Termination of the Lease</u></font>. Notwithstanding anything set forth in the Termination Agreement to the contrary, the
          Termination Date shall be 11:59 P.M. on January 31, 2023.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Governing Law</u></font>. This First Amendment shall be governed and construed under the laws of the State of California.</div>
        <div>&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="width: 100%;" class="BRPFPageFooter">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 33%; vertical-align: top;" colspan="1">&#160;</td>
                  <td style="width: 34%; vertical-align: top;" colspan="1">&#160;</td>
                  <td style="width: 33%; vertical-align: top;">
                    <div style="text-align: right; font-size: 8pt;">HCP, INC.</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 33%; vertical-align: top;" colspan="1">&#160;</td>
                  <td style="width: 34%; vertical-align: bottom; text-align: center; font-size: 8pt;" colspan="1"></td>
                  <td style="width: 33%; vertical-align: top;">
                    <div style="text-align: right; font-size: 8pt;">[10355 Science Center Drive] </div>
                    <div style="text-align: right; font-size: 8pt;">[Eterna Therapeutics Inc.]</div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%2%-%-%-->
        <div style="text-align: justify; text-indent: 45pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Counterparts; Signatures</u></font>. This First Amendment may be executed in counterparts, each of which shall be deemed an original, but such
          counterparts, when taken together, shall constitute one First Amendment. Signatures of the parties transmitted by telefacsimile or electronic mail PDF format shall be deemed to constitute originals and may be relied upon, for all purposes, as
          binding the transmitting party hereto. The parties intend to be bound by the signatures transmitted by telefacsimile or electronic mail PDF format, are aware that the other party will rely on such signature, and hereby waive any defenses to the
          enforcement of the terms of this First Amendment based on the form of signature.</div>
      </div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Binding Effect</u></font>. This First Amendment shall inure to the benefit of, and shall be binding upon, the parties hereto and
        their respective legal representatives, successors and assigns.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Time of the Essence</u></font>. Time is of the essence of this First Amendment and the provisions contained herein.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt;">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Further Assurances</u></font>. Landlord and Tenant hereby agree to execute such further documents or instruments as may be
        necessary or appropriate to carry out the intention of this First Amendment.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt;">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Voluntary Agreement</u></font>. The parties have read this First Amendment and mutual release as contained herein, and on the
        advice of counsel they have freely and voluntarily entered into this First Amendment.</div>
      <div>&#160;</div>
      <div style="text-align: center; margin-right: 63.1pt; margin-left: 62.1pt;">[signature page to follow]</div>
      <div style="text-align: center; margin-right: 63.1pt; margin-left: 62.1pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 33%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 34%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 33%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">HCP, INC.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 33%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 34%; vertical-align: bottom; text-align: center; font-size: 8pt;" colspan="1"><font style="font-weight: normal; font-style: normal;">-2-</font></td>
                <td style="width: 33%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">[10355 Science Center Drive] </div>
                  <div style="text-align: right; font-size: 8pt;">[Eterna Therapeutics Inc.]</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-indent: 36pt; margin-left: 5pt;">IN WITNESS WHEREOF, Landlord and Tenant have executed this First Amendment as of the day and year first above written.</div>
        <div style="text-indent: 36pt; margin-left: 5pt;"> <br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0d234aa393784cbda9ef5d518eb86699">

            <tr>
              <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
              <td colspan="3" style="vertical-align: top;">
                <div>&#8220;LANDLORD&#8221;</div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
              <td colspan="3" style="vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
              <td colspan="3" style="vertical-align: top;">
                <div>TORREY PINES SCIENCE CENTER LIMITED PARTNERSHIP,</div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
              <td colspan="3" style="vertical-align: top;">
                <div>a Delaware limited partnership</div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
              <td colspan="3" style="vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                <div>By</div>
              </td>
              <td style="width: 44%; vertical-align: top; border-bottom: 2px solid black;">
                <div>:/s/ Michael Dorris</div>
              </td>
              <td style="width: 48%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td colspan="2" style="vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 10%; vertical-align: top; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                <div>
                  <div>Its:</div>
                </div>
              </td>
              <td style="width: 34%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>Senior Vice President</div>
              </td>
              <td style="width: 53%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
              <td colspan="3" rowspan="1" style="width: 3%; vertical-align: top;">
                <div>&#8220;TENANT&#8221;</div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
              <td colspan="3" rowspan="1" style="width: 3%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
              <td colspan="3" style="vertical-align: top;">
                <div>ETERNA THERAPEUTICS INC.,</div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
              <td colspan="3" style="vertical-align: top;">
                <div>a Delaware corporation</div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td colspan="2" style="vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                <div>By:</div>
              </td>
              <td style="width: 44%; vertical-align: top; border-bottom: 2px solid black;">
                <div>/s/ Andrew Jackson</div>
              </td>
              <td style="width: 48%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td colspan="2" style="vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 10%; vertical-align: top; padding-bottom: 2px;"><br>
                </td>
                <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                  <div>
                    <div>Its:</div>
                  </div>
                </td>
                <td style="width: 34%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div>Chief Financial Officer</div>
                  </div>
                </td>
                <td style="width: 53%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              </tr>

          </table>
        </div>
        <div>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                  <div>By:</div>
                </td>
                <td style="width: 44%; vertical-align: top; border-bottom: 2px solid black;">
                  <div><br>
                  </div>
                </td>
                <td style="width: 53%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                <td style="width: 3%; vertical-align: top;">&#160;</td>
                <td colspan="2" style="vertical-align: top;">&#160;</td>
              </tr>

          </table>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 10%; vertical-align: top; padding-bottom: 2px;"><br>
                </td>
                <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                  <div>
                    <div>Its:</div>
                  </div>
                </td>
                <td style="width: 34%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div><br>
                    </div>
                  </div>
                </td>
                <td style="width: 53%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              </tr>

          </table>
        </div>
        <div> <br>
        </div>
        <div> <br>
        </div>
        <div>
          <div style="width: 100%;" class="BRPFPageFooter">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 33%; vertical-align: top;" colspan="1">&#160;</td>
                  <td style="width: 34%; vertical-align: top;" colspan="1">&#160;</td>
                  <td style="width: 33%; vertical-align: top;">
                    <div style="text-align: right; font-size: 8pt;">HCP, INC.</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 33%; vertical-align: top;" colspan="1">&#160;</td>
                  <td style="width: 34%; vertical-align: bottom; text-align: center; font-size: 8pt;" colspan="1"><font style="font-weight: normal; font-style: normal;">-3-</font></td>
                  <td style="width: 33%; vertical-align: top;">
                    <div style="text-align: right; font-size: 8pt;">[10355 Science Center Drive] </div>
                    <div style="text-align: right; font-size: 8pt;">[Eterna Therapeutics Inc.]</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>6
<FILENAME>brhc10049677_ex21-1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: #000000; font-weight: bold;">EXHIBIT 21.1</div>
      <div>&#160;</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">SUBSIDIARIES OF THE REGISTRANT</div>
      <div style="color: #000000;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z17040d71d50b4faf9467634c5b081b4f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td nowrap="nowrap" style="width: 49%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Subsidiary</div>
            </td>
            <td nowrap="nowrap" colspan="1" style="width: 2%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td nowrap="nowrap" style="width: 49%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold;">State Or Country of Organization</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: justify; text-indent: -12pt; margin-left: 12pt; color: rgb(0, 0, 0);">Eterna Therapeutics LLC</div>
            </td>
            <td colspan="1" style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: justify; color: rgb(0, 0, 0);">Delaware</div>
            </td>
          </tr>

      </table>
      <div style="color: #000000;"> <br>
      </div>
      <div style="color: #000000;">*Pursuant to Item 601(b)(21)(ii) of Regulation S-K, the names of other subsidiaries of the registrant are omitted because, considered in the aggregate, they would not constitute a significant subsidiary as of the end of
        the year covered by this report.</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>brhc10049677_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; color: #000000; font-weight: bold;">EXHIBIT 23.1</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
    <div><br>
    </div>
    <div style="text-align: justify;">We have issued our report dated March 20, 2023, with respect to the consolidated financial statements included in the Annual Report of Eterna Therapeutics Inc. on Form 10-K for the year ended December 31, 2022.&#160; We
      consent to the incorporation by reference of said report in the Registration Statements of Eterna Therapeutics Inc. on Forms S-1 (File No. 333-261185 and File No. 333-256570), on Form S-3 (File No. 333-264585) and on Forms S-8 (File No. 333-260200
      and File No. 333-256760).</div>
    <div><br>
    </div>
    <div>/s/ Grant Thornton LLP</div>
    <div> <br>
    </div>
    <div>New York, New York</div>
    <div>March 20, 2023</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>8
<FILENAME>brhc10049677_ex23-2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: #000000; font-weight: bold;">EXHIBIT 23.2</div>
      <div style="color: #000000;"> <br>
      </div>
      <div style="color: #000000;">
        <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><u>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM&#8217;S CONSENT</u></div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">We consent to the incorporation by reference in the Registration Statement of Eterna
            Therapeutics Inc. (formerly known as Brooklyn ImmunoTherapeutics, Inc.) on Form S-8 (File No. 333-260200 and File No. 333-256760) and Form S-3 (File No. </font><font style="font-size: 10pt; font-family: 'Times New Roman';">333-264585</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">) of our report dated April 15, 2022, except for Note 3, Restatement of Previously Reported Information and Note 15, Income Taxes, as to which the date is June 30, 2022,
            which includes an explanatory paragraph as to the Company&#8217;s ability to continue as a going concern, with respect to our audit of the consolidated financial statements of Eterna Therapeutics Inc. (formerly known as Brooklyn ImmunoTherapeutics,
            Inc.)</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">as of December 31, 2021 and for the year ended
            December 31, 2021, which report is included in this Annual Report on Form 10-K of Eterna Therapeutics Inc. (formerly known as Brooklyn ImmunoTherapeutics, Inc.)</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">for the year ended December 31, 2022. We were dismissed as auditors on April 15, 2022 and, accordingly, we have not performed any
            audit or review procedures with respect to any financial statements appearing in such Prospectus for the periods after the date of our dismissal.</font></div>
        <div><br>
        </div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Marcum <font style="font-size: 10pt; font-family: 'Times New Roman'; font-variant: small-caps;">llp</font></div>
        <div><br>
        </div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Marcum <font style="font-size: 10pt; font-family: 'Times New Roman'; font-variant: small-caps;">llp</font></div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">New York, NY</div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">March 20, 2023</div>
      </div>
      <div style="color: #000000;"> <br>
      </div>
      <div style="color: #000000;"> <br>
      </div>
      <div style="color: #000000;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>9
<FILENAME>brhc10049677_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; color: #000000; font-weight: bold;">EXHIBIT 31.1</div>
    <div style="text-align: center; color: #000000; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15(d)-14(a), AS ADOPTED PURSUANT TO</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div>&#160;</div>
    <div style="color: #000000;">I, Matthew Angel, certify that:</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt; color: #000000;">1. I have reviewed this annual report on Form 10-K of Eterna Therapeutics Inc. (the &#8220;Company&#8221;);</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt; color: #000000;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under
      which such statements were made, not misleading with respect to the period covered by this report;</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt; color: #000000;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and
      cash flows of the registrant as of, and for, the periods presented in this report;</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt; color: #000000;">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
      internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zb0b424393b5f4b5bafa26495a60c2d7c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(a)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
              including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z32b89176b79d434eb36cf9b53dfbae8f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(b)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability
              of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zeb1da8ee27db4e5aac8c50db9d15f25a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(c)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end
              of the period covered by this report based on such evaluation; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9fc1266a833a414e80df091db6c6c839" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(d)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the
              case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt; color: #000000;">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee
      of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za5c81362c3e94c10b4d4d62dccab539b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(a)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record,
              process, summarize and report financial information; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7296fae57f584350ae24a5045abd5e74" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.45pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(b)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
          </td>
        </tr>

    </table>
    <div style="color: #000000;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="za3bfb13c43084a29855a820aedef246b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 48%; vertical-align: top; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">Dated: March 20, 2023</div>
          </td>
          <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s<font style="font-style: italic;">/&#160;</font><font style="font-style: italic; font-variant: small-caps;">Matthew Angel</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 48%; vertical-align: top;">&#160;</td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Matthew Angel</div>
          </td>
        </tr>
        <tr>
          <td style="width: 48%; vertical-align: top;">&#160;</td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Chief Executive Officer and President</div>
          </td>
        </tr>
        <tr>
          <td style="width: 48%; vertical-align: top;">&#160;</td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Eterna Therapeutics Inc.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>10
<FILENAME>brhc10049677_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: #000000; font-weight: bold;">EXHIBIT 31.2</div>
      <div style="text-align: center; color: #000000; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; color: #000000; font-weight: bold;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15(d)-14(a), AS ADOPTED PURSUANT TO</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div>&#160;</div>
      <div style="color: #000000;">I, Andrew Jackson, certify that:</div>
      <div>&#160;</div>
      <div style="text-indent: 24.5pt; color: #000000;">1. I have reviewed this annual report on Form 10-K of Eterna Therapeutics Inc. (the &#8220;Company&#8221;);</div>
      <div>&#160;</div>
      <div style="text-indent: 24.5pt; color: #000000;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
        under which such statements were made, not misleading with respect to the period covered by this report;</div>
      <div>&#160;</div>
      <div style="text-indent: 24.5pt; color: #000000;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and
        cash flows of the registrant as of, and for, the periods presented in this report;</div>
      <div>&#160;</div>
      <div style="text-indent: 24.5pt; color: #000000;">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
        internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f1760b6e26b4338a417f910cfd17cb3">

          <tr>
            <td style="width: 42.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
                including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcf90d67599754c399ab00c5de2b4f336">

          <tr>
            <td style="width: 42.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the
                reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdf5152e2eb504edfab348c7a012bc5d9">

          <tr>
            <td style="width: 42.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end
                of the period covered by this report based on such evaluation; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd9125c8d42244d87b376e5e09c5f0cc2">

          <tr>
            <td style="width: 42.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">(d)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in
                the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-indent: 24.5pt; color: #000000;">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit
        committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z97705b1a27454901a498070ca1f2fb2b">

          <tr>
            <td style="width: 42.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record,
                process, summarize and report financial information; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za46c45c96993432882dfa93aaf1b4fc6">

          <tr>
            <td style="width: 42.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
            </td>
          </tr>

      </table>
      <div style="color: #000000;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze7286960fe864aa0b089964286b52794">

          <tr>
            <td style="width: 48%; vertical-align: top; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0);">Dated: March 20, 2023</div>
            </td>
            <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/&#160;<font style="font-style: italic; font-variant: small-caps;">Andrew Jackson</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Andrew Jackson.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Chief Financial Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Eterna Therapeutics Inc.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>11
<FILENAME>brhc10049677_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; color: #000000; font-weight: bold;">EXHIBIT 32.1</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt; color: #000000;">In connection with the Annual Report of Eterna Therapeutics Inc. (the &#8220;Registrant&#8221;) on Form 10-K for the year ended December&#160;31, 2022 (the &#8220;Report&#8221;), I, Matthew Angel, Chief Executive Officer and
      President of the Registrant, do hereby certify, pursuant to 18&#160;U.S.C.&#160;&#167;1350, as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt; color: #000000;">(1) the Report, as filed with the Securities and Exchange Commission, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt; color: #000000;">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</div>
    <div style="color: #000000;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za5078a8e10ea478b8e170c2a687b52a8">

        <tr>
          <td style="width: 48%; vertical-align: top; padding-bottom: 2px;">
            <div style="color: rgb(0, 0, 0);">Dated: March 20, 2023</div>
          </td>
          <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/&#160;<font style="font-style: italic; font-variant: small-caps;">Matthew Angel</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 48%; vertical-align: top;">&#160;</td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Matthew Angel</div>
          </td>
        </tr>
        <tr>
          <td style="width: 48%; vertical-align: top;">&#160;</td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Chief Executive Officer and President</div>
          </td>
        </tr>
        <tr>
          <td style="width: 48%; vertical-align: top;">&#160;</td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Eterna Therapeutics Inc.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
  </div>
  <div><br>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"><br>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>12
<FILENAME>brhc10049677_ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: #000000; font-weight: bold;">EXHIBIT 32.2</div>
      <div><br>
      </div>
      <div style="text-align: center; color: #000000; font-weight: bold;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div>&#160;</div>
      <div style="text-indent: 24.5pt; color: #000000;">In connection with the Annual Report of Eterna Therapeutics Inc. (the &#8220;Registrant&#8221;) on Form 10-K for the year ended December&#160;31, 2022 (the &#8220;Report&#8221;), I, Andrew Jackson, Chief Financial Officer of the
        Registrant, do hereby certify, pursuant to 18&#160;U.S.C.&#160;&#167;1350, as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:</div>
      <div>&#160;</div>
      <div style="text-indent: 24.5pt; color: #000000;">(1) the Report, as filed with the Securities and Exchange Commission, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
      <div>&#160;</div>
      <div style="text-indent: 24.5pt; color: #000000;">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</div>
      <div style="color: #000000;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1e18f0f2dcc14f3897804605379c36a9">

          <tr>
            <td style="width: 48%; vertical-align: top; padding-bottom: 2px;">
              <div style="color: #000000;">Dated: March 20, 2023</div>
            </td>
            <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">/s/&#160;<font style="font-variant: small-caps;">Andrew Jackson</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-align: center; color: #000000; font-size: 8pt; font-weight: bold;">Andrew Jackson</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-align: center; color: #000000; font-size: 8pt; font-weight: bold;">Chief Financial Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-align: center; color: #000000; font-size: 8pt; font-weight: bold;">Eterna Therapeutics Inc.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
    </div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>erna-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.2.1.5134 Broadridge-->
<xs:schema targetNamespace="http://eternatx.com/20221231" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:erna="http://eternatx.com/20221231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="erna-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="erna-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="erna-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="erna-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://eternatx.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>010000 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <!--Parent Role: CONSOLIDATED BALANCE SHEETS-->
        <link:definition>010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
        <link:definition>020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity" id="ConsolidatedStatementsOfMembersStockholdersEquity">
        <link:definition>030000 - Statement - CONSOLIDATED STATEMENTS OF MEMBERS'/STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations" id="OrganizationAndDescriptionOfBusinessOperations">
        <link:definition>060100 - Disclosure - Organization and Description of Business Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LiquidityAndCapitalResources" id="LiquidityAndCapitalResources">
        <link:definition>060200 - Disclosure - Liquidity and Capital Resources</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies">
        <link:definition>060300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactions" id="MergerDispositionAndAcquisitionTransactions">
        <link:definition>060400 - Disclosure - Merger, Disposition and Acquisition Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/FairValueOfFinancialInstruments" id="FairValueOfFinancialInstruments">
        <link:definition>060500 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
        <link:definition>060600 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/Leases" id="Leases">
        <link:definition>060700 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwill" id="InprocessResearchDevelopmentAndGoodwill">
        <link:definition>060800 - Disclosure - In-Process Research &amp; Development and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>060900 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/AccruedExpenses" id="AccruedExpenses">
        <link:definition>061000 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/Debt" id="Debt">
        <link:definition>061100 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>061200 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasicAndDilutedLossPerCommonShare" id="BasicAndDilutedLossPerCommonShare">
        <link:definition>061300 - Disclosure - Basic and Diluted Loss per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensation" id="StockbasedCompensation">
        <link:definition>061400 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrants" id="EquityAndWarrants">
        <link:definition>061500 - Disclosure - Equity and Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>061600 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/SubsequentEvent" id="SubsequentEvent">
        <link:definition>061700 - Disclosure - Subsequent Event</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies">
        <!--Parent Role: Basis of Accounting Presentation and Summary of Significant Accounting Policies-->
        <link:definition>070300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsTables" id="MergerDispositionAndAcquisitionTransactionsTables">
        <!--Parent Role: Merger, Disposition and Acquisition Transactions-->
        <link:definition>080400 - Disclosure - Merger, Disposition and Acquisition Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsTables" id="FairValueOfFinancialInstrumentsTables">
        <!--Parent Role: Fair Value of Financial Instruments-->
        <link:definition>080500 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
        <!--Parent Role: Property and Equipment-->
        <link:definition>080600 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesTables" id="LeasesTables">
        <!--Parent Role: Leases-->
        <link:definition>080700 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
        <!--Parent Role: Accrued Expenses-->
        <link:definition>081000 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasicAndDilutedLossPerCommonShareTables" id="BasicAndDilutedLossPerCommonShareTables">
        <!--Parent Role: Basic and Diluted Loss per Common Share-->
        <link:definition>081300 - Disclosure - Basic and Diluted Loss per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationTables" id="StockbasedCompensationTables">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>081400 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrantsTables" id="EquityAndWarrantsTables">
        <!--Parent Role: Equity and Warrants-->
        <link:definition>081500 - Disclosure - Equity and Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
        <!--Parent Role: Income Taxes-->
        <link:definition>081600 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails" id="OrganizationAndDescriptionOfBusinessOperationsDetails">
        <!--Parent Role: Organization and Description of Business Operations-->
        <link:definition>090100 - Disclosure - Organization and Description of Business Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LiquidityAndCapitalResourcesDetails" id="LiquidityAndCapitalResourcesDetails">
        <!--Parent Role: Liquidity and Capital Resources-->
        <link:definition>090200 - Disclosure - Liquidity and Capital Resources (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesBasisOfAccountingPresentationDetails" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesBasisOfAccountingPresentationDetails">
        <!--Parent Role: Basis of Accounting Presentation and Summary of Significant Accounting Policies-->
        <link:definition>090300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Basis of Accounting Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails">
        <!--Parent Role: Basis of Accounting Presentation and Summary of Significant Accounting Policies-->
        <link:definition>090302 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, October 2022 Reverse Stock Split (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails">
        <!--Parent Role: Basis of Accounting Presentation and Summary of Significant Accounting Policies-->
        <link:definition>090306 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
        <!--Parent Role: Basis of Accounting Presentation and Summary of Significant Accounting Policies-->
        <link:definition>090308 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails">
        <!--Parent Role: Basis of Accounting Presentation and Summary of Significant Accounting Policies-->
        <link:definition>090310 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails">
        <!--Parent Role: Basis of Accounting Presentation and Summary of Significant Accounting Policies-->
        <link:definition>090312 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Recent Accounting Standards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails" id="MergerDispositionAndAcquisitionTransactionsMergerDetails">
        <!--Parent Role: Merger, Disposition and Acquisition Transactions-->
        <link:definition>090400 - Disclosure - Merger, Disposition and Acquisition Transactions, Merger (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" id="MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails">
        <!--Parent Role: Merger, Disposition and Acquisition Transactions-->
        <link:definition>090402 - Disclosure - Merger, Disposition and Acquisition Transactions, Fair Value of Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails" id="MergerDispositionAndAcquisitionTransactionsDispositionDetails">
        <!--Parent Role: Merger, Disposition and Acquisition Transactions-->
        <link:definition>090404 - Disclosure - Merger, Disposition and Acquisition Transactions, Disposition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" id="MergerDispositionAndAcquisitionTransactionsAcquisitionDetails">
        <!--Parent Role: Merger, Disposition and Acquisition Transactions-->
        <link:definition>090408 - Disclosure - Merger, Disposition and Acquisition Transactions, Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" id="MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails">
        <!--Parent Role: Merger, Disposition and Acquisition Transactions-->
        <link:definition>090410 - Disclosure - Merger, Disposition and Acquisition Transactions, Investment in NoveCite (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" id="FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails">
        <!--Parent Role: Fair Value of Financial Instruments-->
        <link:definition>090504 - Disclosure - Fair Value of Financial Instruments, Liabilities Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" id="FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails">
        <!--Parent Role: Fair Value of Financial Instruments-->
        <link:definition>090506 - Disclosure - Fair Value of Financial Instruments, Changes in Warrant Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/PropertyAndEquipmentDetails" id="PropertyAndEquipmentDetails">
        <!--Parent Role: Property and Equipment-->
        <link:definition>090600 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesOperatingLeaseDetails" id="LeasesOperatingLeaseDetails">
        <!--Parent Role: Leases-->
        <link:definition>090700 - Disclosure - Leases, Operating Lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails" id="LeasesNetOperatingLeaseExpensesDetails">
        <!--Parent Role: Leases-->
        <link:definition>090702 - Disclosure - Leases, Net Operating Lease Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" id="LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails">
        <!--Parent Role: Leases-->
        <link:definition>090704 - Disclosure - Leases, Operating Lease Right-of-use Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" id="LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails">
        <!--Parent Role: Leases-->
        <link:definition>090706 - Disclosure - Leases, Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesSubleaseAgreementDetails" id="LeasesSubleaseAgreementDetails">
        <!--Parent Role: Leases-->
        <link:definition>090708 - Disclosure - Leases, Sublease Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" id="LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01">
        <!--Parent Role: Leases, Maturities of Operating Lease Liabilities (Details)-->
        <link:definition>090708 - Disclosure - LEASES, Maturities of Operating Lease Liabilities (Details) CALC 01</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwillDetails" id="InprocessResearchDevelopmentAndGoodwillDetails">
        <!--Parent Role: In-Process Research & Development and Goodwill-->
        <link:definition>090800 - Disclosure - In-Process Research &amp; Development and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/RelatedPartyTransactionsDetails" id="RelatedPartyTransactionsDetails">
        <!--Parent Role: Related Party Transactions-->
        <link:definition>090900 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/AccruedExpensesDetails" id="AccruedExpensesDetails">
        <!--Parent Role: Accrued Expenses-->
        <link:definition>091000 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/DebtDetails" id="DebtDetails">
        <!--Parent Role: Debt-->
        <link:definition>091100 - Disclosure - Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails" id="CommitmentsAndContingenciesLegalMattersDetails">
        <!--Parent Role: Commitments and Contingencies-->
        <link:definition>091200 - Disclosure - Commitments and Contingencies, Legal Matters (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails" id="CommitmentsAndContingenciesLicensingAgreementsDetails">
        <!--Parent Role: Commitments and Contingencies-->
        <link:definition>091202 - Disclosure - Commitments and Contingencies, Licensing Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails" id="CommitmentsAndContingenciesRoyaltyAgreementsDetails">
        <!--Parent Role: Commitments and Contingencies-->
        <link:definition>091204 - Disclosure - Commitments and Contingencies, Royalty Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails" id="CommitmentsAndContingenciesRetirementSavingsPlanDetails">
        <!--Parent Role: Commitments and Contingencies-->
        <link:definition>091206 - Disclosure - Commitments and Contingencies, Retirement Savings Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails" id="BasicAndDilutedLossPerCommonShareDetails">
        <!--Parent Role: Basic and Diluted Loss per Common Share-->
        <link:definition>091300 - Disclosure - Basic and Diluted Loss per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails" id="StockbasedCompensationEquityIncentivePlansDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091400 - Disclosure - Stock-Based Compensation, Equity Incentive Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails" id="StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091402 - Disclosure - Stock-Based Compensation, Weighted-Average Assumptions Used for Grants Issued (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails" id="StockbasedCompensationStockOptionActivityDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091404 - Disclosure - Stock-Based Compensation, Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails" id="StockbasedCompensationSummaryOfStockOptionsDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091406 - Disclosure - Stock-Based Compensation, Summary of Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationRsusDetails" id="StockbasedCompensationRsusDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091408 - Disclosure - Stock-Based Compensation, RSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails" id="StockbasedCompensationNumberOfRsusVestedAndSettledDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091410 - Disclosure - Stock-Based Compensation, Number of RSUs Vested and Settled (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails" id="StockbasedCompensationRestrictedStockDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091412 - Disclosure - Stock-Based Compensation, Restricted Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails" id="StockbasedCompensationStockbasedCompensationExpenseDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091414 - Disclosure - Stock-Based Compensation, Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails" id="EquityAndWarrantsPrivatePlacementOfEquityDetails">
        <!--Parent Role: Equity and Warrants-->
        <link:definition>091500 - Disclosure - Equity and Warrants, Private Placement of Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails" id="EquityAndWarrantsWarrantsActivityDetails">
        <!--Parent Role: Equity and Warrants-->
        <link:definition>091502 - Disclosure - Equity and Warrants,Warrants activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails" id="EquityAndWarrantsEquityLineOfferingsDetails">
        <!--Parent Role: Equity and Warrants-->
        <link:definition>091504 - Disclosure - Equity and Warrants, Equity Line Offerings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrantsMergerDetails" id="EquityAndWarrantsMergerDetails">
        <!--Parent Role: Equity and Warrants-->
        <link:definition>091508 - Disclosure - Equity and Warrants, Merger (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails" id="EquityAndWarrantsAcquisitionDetails">
        <!--Parent Role: Equity and Warrants-->
        <link:definition>091510 - Disclosure - Equity and Warrants, Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails" id="EquityAndWarrantsCumulativeConvertiblePreferredStockDetails">
        <!--Parent Role: Equity and Warrants-->
        <link:definition>091512 - Disclosure - Equity and Warrants, Cumulative Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails" id="IncomeTaxesLossBeforeIncomeTaxesDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091600 - Disclosure - Income Taxes, Loss before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails" id="IncomeTaxesComponentsOfIncomeTaxProvisionDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091602 - Disclosure - Income Taxes, Components of Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" id="IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091604 - Disclosure - Income Taxes, Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" id="IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091606 - Disclosure - Income Taxes, Reconciliation of Computed Expected Income Taxes to Effective Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails" id="IncomeTaxesUncertainTaxPositionsDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091608 - Disclosure - Income Taxes, Uncertain Tax Positions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/SubsequentEventDetails" id="SubsequentEventDetails">
        <!--Parent Role: Subsequent Event-->
        <link:definition>091700 - Disclosure - Subsequent Event (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="PercentageOfCommonStockSubjectToLockUpAgreement" id="erna_PercentageOfCommonStockSubjectToLockUpAgreement" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" id="erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NovellusTherapeuticsLimitedMember" id="erna_NovellusTherapeuticsLimitedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EachLockUpAgreementExtendsTerm" id="erna_EachLockUpAgreementExtendsTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" id="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PurchaseAgreementMember" id="erna_PurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="FirstPurchaseAgreementMember" id="erna_FirstPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PrivatePlacementOfferingsAbstract" id="erna_PrivatePlacementOfferingsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SaleOfStockNumberOfSharesToIssuedInTransaction" id="erna_SaleOfStockNumberOfSharesToIssuedInTransaction" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" id="erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BeneficialOwnershipPercentageOnTotalOutstandingShares" id="erna_BeneficialOwnershipPercentageOnTotalOutstandingShares" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="LincolnParkCapitalFundLLCMember" id="erna_LincolnParkCapitalFundLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CommitmentAmountToMeetAnySingleRegularPurchase" id="erna_CommitmentAmountToMeetAnySingleRegularPurchase" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="SecondPurchaseAgreementMember" id="erna_SecondPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PIPEInvestorOneMember" id="erna_PIPEInvestorOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PrivatePlacementOfEquityAbstract" id="erna_PrivatePlacementOfEquityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfWarrantsInEachUnit" id="erna_NumberOfWarrantsInEachUnit" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ClassOfWarrantOrRightsExercisableTerm" id="erna_ClassOfWarrantOrRightsExercisableTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ObligationToPayLiquidatedDamagesPercentage" id="erna_ObligationToPayLiquidatedDamagesPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="OverSubscriptionAmountReceived" id="erna_OverSubscriptionAmountReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ClassOfWarrantOrRightExercised" id="erna_ClassOfWarrantOrRightExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CommonWarrantsOneMember" id="erna_CommonWarrantsOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CommonWarrantsMember" id="erna_CommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" id="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PreFundedWarrantsMember" id="erna_PreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="UnitPriceOfWarrants" id="erna_UnitPriceOfWarrants" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="TransactionFeesPayable" id="erna_TransactionFeesPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="PIPEInvestorMember" id="erna_PIPEInvestorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AggregateCalendarDays" id="erna_AggregateCalendarDays" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="VariableRateTransactionsPeriod" id="erna_VariableRateTransactionsPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="GainLossOnDisposalOfFixedAssets" id="erna_GainLossOnDisposalOfFixedAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="RemainingNetBookValueOfFixedAssets" id="erna_RemainingNetBookValueOfFixedAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="ExacisOptionAgreementAbstract" id="erna_ExacisOptionAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MonthlyMasterServicesAgreementFeesPayable" id="erna_MonthlyMasterServicesAgreementFeesPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ReimburseCostsIncurredOrPaid" id="erna_ReimburseCostsIncurredOrPaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NoticePeriodForSupersedingTerminationProvisions" id="erna_NoticePeriodForSupersedingTerminationProvisions" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RemainingLicenseFeeObligation" id="erna_RemainingLicenseFeeObligation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="RelatedPartyTransactionPeriodicFeesPaymentAmount" id="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NumberOfMonthlyInstallmentsForFeesPayable" id="erna_NumberOfMonthlyInstallmentsForFeesPayable" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" id="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="NoticePeriodForFirstTerminationOfContract" id="erna_NoticePeriodForFirstTerminationOfContract" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MasterServiceAgreementInitialFeesPayable" id="erna_MasterServiceAgreementInitialFeesPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="AgreedWaivePayment" id="erna_AgreedWaivePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="Q422PIPETransactionAbstract" id="erna_Q422PIPETransactionAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ExacisBiotherapeuticsIncMember" id="erna_ExacisBiotherapeuticsIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="InitialLicenseFeeObligation" id="erna_InitialLicenseFeeObligation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="FactorBioscienceIncMember" id="erna_FactorBioscienceIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PaymentOfOptionFee" id="erna_PaymentOfOptionFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="BasisOfPresentationAbstract" id="erna_BasisOfPresentationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" id="erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" id="erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" id="erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CommonUnitsMember" id="erna_CommonUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MembershipEquityMember" id="erna_MembershipEquityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" id="erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodSharesInLieuOfDividends" id="erna_StockIssuedDuringPeriodSharesInLieuOfDividends" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodSharesAcquisitions2" id="erna_StockIssuedDuringPeriodSharesAcquisitions2" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValueAcquisitions2" id="erna_StockIssuedDuringPeriodValueAcquisitions2" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodValueAcquisitions1" id="erna_StockIssuedDuringPeriodValueAcquisitions1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodValueStockPurchaseAgreement" id="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="StockIssuedDuringPeriodValueInLieuOfDividends" id="erna_StockIssuedDuringPeriodValueInLieuOfDividends" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodSharesAcquisitions1" id="erna_StockIssuedDuringPeriodSharesAcquisitions1" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodSharesStockPurchaseAgreement" id="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ReverseStockSplitAbstract" id="erna_ReverseStockSplitAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" id="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NumberOfSharesConsideredAsFractionalInReverseStock" id="erna_NumberOfSharesConsideredAsFractionalInReverseStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WarrantLiabilitiesExpense" id="erna_WarrantLiabilitiesExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="LossOnNonControllingInvestment" id="erna_LossOnNonControllingInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ExpensesPaidInConnectionWithPrivateOffering" id="erna_ExpensesPaidInConnectionWithPrivateOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PaymentsOfPaycheckProtectionProgramLoan" id="erna_PaymentsOfPaycheckProtectionProgramLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PaymentsToAcquireProductiveAssetsNet" id="erna_PaymentsToAcquireProductiveAssetsNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="IssuanceOfCommonStockForAssetAcquisition" id="erna_IssuanceOfCommonStockForAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" id="erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" id="erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="UnpaidFeesIncurredInConnectionWithPrivateOffering" id="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ConversionOfWarrantLiabilityToEquity" id="erna_ConversionOfWarrantLiabilityToEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ResearchAndDevelopmentInProcessAssetAcquisition" id="erna_ResearchAndDevelopmentInProcessAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" id="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="CashPaidDuringThePeriodForAbstract" id="erna_CashPaidDuringThePeriodForAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" id="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="InitialMeasurementOfFinanceLeaseLiabilities" id="erna_InitialMeasurementOfFinanceLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="IncreaseDecreaseInOperatingLeaseLiabilities" id="erna_IncreaseDecreaseInOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" id="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="GainOnTerminationOfLease" id="erna_GainOnTerminationOfLease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="GainLossOnForgivenessOfPaycheckProtectionProgramLoan" id="erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="IssuanceOfCommonStockForSeriesAPreferredStockDividend" id="erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ProceedsFromIssuanceOfCommonStockToLincolnPark" id="erna_ProceedsFromIssuanceOfCommonStockToLincolnPark" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" id="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="AreaOfSubleaseSpaceCurrentlyRented" id="erna_AreaOfSubleaseSpaceCurrentlyRented" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="PercentageOfAdditionalRightsOffering" id="erna_PercentageOfAdditionalRightsOffering" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" id="erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="NTNBuzztimeIncMember" id="erna_NTNBuzztimeIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ProFormaFairValueAdjustmentToAssetsMember" id="erna_ProFormaFairValueAdjustmentToAssetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PurchasePriceAllocationMember" id="erna_PurchasePriceAllocationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ProceedsFromSaleOfRights" id="erna_ProceedsFromSaleOfRights" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" id="erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BeneficialHoldersContractualCommitmentsToInvest" id="erna_BeneficialHoldersContractualCommitmentsToInvest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" id="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OperatingLeaseAssestAbstract" id="erna_OperatingLeaseAssestAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="WriteOffOfOperatingLeaseRightOfUseAsset" id="erna_WriteOffOfOperatingLeaseRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="RemeasurementOfOperatingLeaseRightOfUseAsset" id="erna_RemeasurementOfOperatingLeaseRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="InitialMeasurementOfOperatingLeaseROUAssets" id="erna_InitialMeasurementOfOperatingLeaseROUAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ReclassificationFromFixedAssetsToRightOfUseAsset" id="erna_ReclassificationFromFixedAssetsToRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="PrincipalPaymentsOnOperatingLeaseLiabilities" id="erna_PrincipalPaymentsOnOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="InitialMeasurementOfOperatingLeaseLiabilities" id="erna_InitialMeasurementOfOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="RemeasurementOfOperatingLeaseLiability" id="erna_RemeasurementOfOperatingLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="WriteOffOfOperatingLeaseLiability" id="erna_WriteOffOfOperatingLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NumberOfAwardsVestedAndSettledAbstract" id="erna_NumberOfAwardsVestedAndSettledAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CommonStockWithheldToCoverTaxes" id="erna_CommonStockWithheldToCoverTaxes" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EquityIncentivePlan2020Member" id="erna_EquityIncentivePlan2020Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="InducementPlan2021Member" id="erna_InducementPlan2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfSharesOfCommonStockOutstanding" id="erna_PercentageOfSharesOfCommonStockOutstanding" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NonQualifiedStockOptionMember" id="erna_NonQualifiedStockOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="IncentiveStockOptionsMember" id="erna_IncentiveStockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="BrooklynPaycheckProtectionProgramMember" id="erna_BrooklynPaycheckProtectionProgramMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PaycheckProtectionProgramLoanMember" id="erna_PaycheckProtectionProgramLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PaycheckProtectionProgramMember" id="erna_PaycheckProtectionProgramMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DebtInstrumentAbstract" id="erna_DebtInstrumentAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PaymentOfAccruedAndUnpaidInterest" id="erna_PaymentOfAccruedAndUnpaidInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PerformanceBasedStockOptionMember" id="erna_PerformanceBasedStockOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TimeBasedStockOptionMember" id="erna_TimeBasedStockOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AccruedPrivatePlacementInPublicEquityCurrent" id="erna_AccruedPrivatePlacementInPublicEquityCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="AccruedClinicalCurrent" id="erna_AccruedClinicalCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="NumberOfBoardSeats" id="erna_NumberOfBoardSeats" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NoveCiteINCMember" id="erna_NoveCiteINCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CitiusPharmaceuticalsIncMember" id="erna_CitiusPharmaceuticalsIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ReverseStockSplitPolicyTextBlock" id="erna_ReverseStockSplitPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="LIQUIDITYANDCAPITALRESOURCESAbstract" id="erna_LIQUIDITYANDCAPITALRESOURCESAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LiquidityAndCapitalResourcesTextBlock" id="erna_LiquidityAndCapitalResourcesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" id="erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfInLicensedPortfolioPatents" id="erna_NumberOfInLicensedPortfolioPatents" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AggregateIntrinsicValueAbstract" id="erna_AggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DispositionAbstract" id="erna_DispositionAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ProceedsFromDispositionAbstract" id="erna_ProceedsFromDispositionAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" id="erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" id="erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" id="erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" id="erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="NTNBusinessMember" id="erna_NTNBusinessMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" id="erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PercentageOfDiscountOnFairValueOfRestrictedShares" id="erna_PercentageOfDiscountOnFairValueOfRestrictedShares" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EscrowShares" id="erna_EscrowShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" id="erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodRestrictedSharesAcquisitions" id="erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AssetAcquisitionRestrictedSharesSharePrice" id="erna_AssetAcquisitionRestrictedSharesSharePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="AssetAcquisitionFairValueOfConsiderationPaid" id="erna_AssetAcquisitionFairValueOfConsiderationPaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="AssetAcquisitionSharePrice" id="erna_AssetAcquisitionSharePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="LockUpPeriodForRestrictedShares" id="erna_LockUpPeriodForRestrictedShares" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AcquisitionAgreementNonCompetitivePeriod" id="erna_AcquisitionAgreementNonCompetitivePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AssetAcquisitionUnrestrictedSharesSharePrice" id="erna_AssetAcquisitionUnrestrictedSharesSharePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="LicenseAgreementAbstract" id="erna_LicenseAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ProceedsFromOptionAndLicenseAgreement" id="erna_ProceedsFromOptionAndLicenseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="LegalMattersAbstract" id="erna_LegalMattersAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LitigationSettlementAmountPayable" id="erna_LitigationSettlementAmountPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="InvestorRoyaltyAgreementMember" id="erna_InvestorRoyaltyAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RoyaltyAgreementsAbstract" id="erna_RoyaltyAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" id="erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="LossContingencyPercentageOfRoyaltyPayable" id="erna_LossContingencyPercentageOfRoyaltyPayable" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" id="erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CollaboratorRoyaltyAgreementMember" id="erna_CollaboratorRoyaltyAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LicensingAgreementsAbstract" id="erna_LicensingAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfSublicenseFeePayableDuringRenewalTerm" id="erna_PercentageOfSublicenseFeePayableDuringRenewalTerm" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PercentageOfSublicenseFeePayableBeforeExpirationPeriod" id="erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="LicenseAgreementTerm" id="erna_LicenseAgreementTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="LicenseAgreementExtensionTerm" id="erna_LicenseAgreementExtensionTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ThresholdIncomeForAutomaticExtensionOfLicensePeriod" id="erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="UniversityOfSouthFloridaMember" id="erna_UniversityOfSouthFloridaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ExclusiveFactorLicenseAgreementMember" id="erna_ExclusiveFactorLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DefinedContributionPlanEmployeeContributionAtThresholdTwo" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" id="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RetirementPlan401KMember" id="erna_RetirementPlan401KMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DefinedContributionPlanEmployeeContributionAtThresholdOne" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="FutureLeasePaymentsSubleaseAgreementTableTextBlock" id="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" id="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ERSquibbSonsLLCMember" id="erna_ERSquibbSonsLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LeaseTerminationFeePayable" id="erna_LeaseTerminationFeePayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="LeaseTerminationFee" id="erna_LeaseTerminationFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" id="erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="SubleaseCost" id="erna_SubleaseCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="CostRelatedToIssuanceOfLetterOfCredit" id="erna_CostRelatedToIssuanceOfLetterOfCredit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="TenantImprovementAllowance" id="erna_TenantImprovementAllowance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="OperatingLeasesIncrementalBaseRentalPayment" id="erna_OperatingLeasesIncrementalBaseRentalPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="SubleaseCostForTenantImprovements" id="erna_SubleaseCostForTenantImprovements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="LesseeCommitmentToPurchaseProperty" id="erna_LesseeCommitmentToPurchaseProperty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="OperatingLeasesMonthlyBaseRent" id="erna_OperatingLeasesMonthlyBaseRent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="OperatingLeaseArea" id="erna_OperatingLeaseArea" type="dtr-types:areaItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="TenantImprovementAllowancePerRentableSquareFoot" id="erna_TenantImprovementAllowancePerRentableSquareFoot" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="MergerAbstract" id="erna_MergerAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ClassOfWarrantOrRightIssued" id="erna_ClassOfWarrantOrRightIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="LaboratoryAndManufacturingEquipmentMember" id="erna_LaboratoryAndManufacturingEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" id="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" id="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="DeferredTaxAssetsRightOfUseLiabilities" id="erna_DeferredTaxAssetsRightOfUseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="DeferredTaxAssetsRightOfUseAssets" id="erna_DeferredTaxAssetsRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" id="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="LiquidityAndCapitalResourcesTable" id="erna_LiquidityAndCapitalResourcesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LiquidityAndCapitalResourcesLineItems" id="erna_LiquidityAndCapitalResourcesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NewFacilityLeaseAbstract" id="erna_NewFacilityLeaseAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" id="erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OperatingLossCarryforwardsExpirationYear" id="erna_OperatingLossCarryforwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" id="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="IncomeTaxAbstract" id="erna_IncomeTaxAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TaxCreditCarryforwardExpirationYear" id="erna_TaxCreditCarryforwardExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="TaxCutsAndJobsActOperatingLossCarryforwards" id="erna_TaxCutsAndJobsActOperatingLossCarryforwards" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="ClassOfWarrantOrRightExercisedInPeriod" id="erna_ClassOfWarrantOrRightExercisedInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ClassOfWarrantOrRightGrantsInPeriod" id="erna_ClassOfWarrantOrRightGrantsInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="November2022WarrantsMember" id="erna_November2022WarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="March2022WarrantsMember" id="erna_March2022WarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CoronavirusAidReliefAndEconomicSecurityActMember" id="erna_CoronavirusAidReliefAndEconomicSecurityActMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>14
<FILENAME>erna-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.2.1.5134 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesComponentsOfIncomeTaxProvisionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesLossBeforeIncomeTaxesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationNumberOfRsusVestedAndSettledDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesSubleaseAgreementDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesSubleaseAgreementDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesNetOperatingLeaseExpensesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipmentDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#PropertyAndEquipmentDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="erna-20221231.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="erna-20221231.xsd#ConsolidatedStatementsOfOperations" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="erna-20221231.xsd#ConsolidatedBalanceSheets" />
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="RestrictedCashNoncurrent" xlink:title="RestrictedCashNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="RestrictedCashNoncurrent" xlink:title="calculation: Assets to RestrictedCashNoncurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="calculation: Assets to IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="Goodwill" xlink:title="calculation: Assets to Goodwill" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="EquityMethodInvestments" xlink:title="calculation: Assets to EquityMethodInvestments" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="calculation: Assets to PropertyPlantAndEquipmentNet" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="calculation: AssetsCurrent to PrepaidExpenseAndOtherAssetsCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="OtherReceivablesNetCurrent" xlink:title="calculation: AssetsCurrent to OtherReceivablesNetCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="Cash" xlink:title="calculation: AssetsCurrent to Cash" order="0.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="AssetsCurrent" xlink:title="calculation: Assets to AssetsCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OtherAssetsNoncurrent" xlink:title="calculation: Assets to OtherAssetsNoncurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="calculation: Assets to OperatingLeaseRightOfUseAsset" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="DueToRelatedPartiesNoncurrent" xlink:title="DueToRelatedPartiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="DueToRelatedPartiesNoncurrent" xlink:title="calculation: Liabilities to DueToRelatedPartiesNoncurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="DerivativeLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to DerivativeLiabilitiesNoncurrent" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="calculation: Liabilities to OperatingLeaseLiabilityNoncurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="DueToRelatedPartiesCurrent" xlink:title="DueToRelatedPartiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="DueToRelatedPartiesCurrent" xlink:title="calculation: LiabilitiesCurrent to DueToRelatedPartiesCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="OtherLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to OtherLiabilitiesCurrent" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="calculation: LiabilitiesCurrent to OperatingLeaseLiabilityCurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccountsPayableCurrent" xlink:title="calculation: LiabilitiesCurrent to AccountsPayableCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccruedLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to AccruedLiabilitiesCurrent" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LiabilitiesCurrent" xlink:title="calculation: Liabilities to LiabilitiesCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to OtherLiabilitiesNoncurrent" order="6.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="Liabilities" xlink:title="calculation: LiabilitiesAndStockholdersEquity to Liabilities" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="calculation: StockholdersEquity to RetainedEarningsAccumulatedDeficit" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="CommonStockValue" xlink:title="calculation: StockholdersEquity to CommonStockValue" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="PreferredStockValue" xlink:title="calculation: StockholdersEquity to PreferredStockValue" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="AdditionalPaidInCapital" xlink:title="calculation: StockholdersEquity to AdditionalPaidInCapital" order="3.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="StockholdersEquity" xlink:title="calculation: LiabilitiesAndStockholdersEquity to StockholdersEquity" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfOperations">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="PreferredStockDividendsAndOtherAdjustments" xlink:title="PreferredStockDividendsAndOtherAdjustments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="PreferredStockDividendsAndOtherAdjustments" xlink:title="calculation: NetIncomeLossAvailableToCommonStockholdersBasic to PreferredStockDividendsAndOtherAdjustments" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="IncomeTaxExpenseBenefit" xlink:title="calculation: NetIncomeLoss to IncomeTaxExpenseBenefit" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="LossOnNonControllingInvestment" xlink:title="calculation: NonoperatingIncomeExpense to LossOnNonControllingInvestment" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="WarrantLiabilitiesExpense" xlink:title="calculation: NonoperatingIncomeExpense to WarrantLiabilitiesExpense" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="calculation: NonoperatingIncomeExpense to DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="OtherNonoperatingIncomeExpense" xlink:title="calculation: NonoperatingIncomeExpense to OtherNonoperatingIncomeExpense" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="NonoperatingIncomeExpense" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to NonoperatingIncomeExpense" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="NoncashMergerRelatedCosts" xlink:title="calculation: OperatingExpenses to NoncashMergerRelatedCosts" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="GeneralAndAdministrativeExpense" xlink:title="calculation: OperatingExpenses to GeneralAndAdministrativeExpense" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:label="ResearchAndDevelopmentInProcess" xlink:title="ResearchAndDevelopmentInProcess" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="ResearchAndDevelopmentInProcess" xlink:title="calculation: OperatingExpenses to ResearchAndDevelopmentInProcess" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="calculation: OperatingExpenses to ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="ImpairmentOfOngoingProject" xlink:title="calculation: OperatingExpenses to ImpairmentOfOngoingProject" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="OperatingExpenses" xlink:title="calculation: OperatingIncomeLoss to OperatingExpenses" order="0.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="OperatingIncomeLoss" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to OperatingIncomeLoss" order="0.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="calculation: NetIncomeLoss to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="NetIncomeLoss" xlink:title="calculation: NetIncomeLossAvailableToCommonStockholdersBasic to NetIncomeLoss" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="PaymentsOfDividendsPreferredStockAndPreferenceStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfDividendsPreferredStockAndPreferenceStock" order="10.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:label="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:title="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to CashPaidForFractionalSharesInConnectionWithReverseStockSplit" order="6.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="11.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:label="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:title="ProceedsFromIssuanceOfCommonStockToLincolnPark" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromIssuanceOfCommonStockToLincolnPark" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromStockOptionsExercised" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromStockOptionsExercised" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromIssuanceOfCommonStock" order="12.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:label="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:title="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" order="7.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ExpensesPaidInConnectionWithPrivateOffering" xlink:label="ExpensesPaidInConnectionWithPrivateOffering" xlink:title="ExpensesPaidInConnectionWithPrivateOffering" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ExpensesPaidInConnectionWithPrivateOffering" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ExpensesPaidInConnectionWithPrivateOffering" order="0.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentsOfPaycheckProtectionProgramLoan" xlink:label="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="PaymentsOfPaycheckProtectionProgramLoan" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfPaycheckProtectionProgramLoan" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="ProceedsFromOtherEquity" xlink:title="ProceedsFromOtherEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromOtherEquity" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromOtherEquity" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="FinanceLeasePrincipalPayments" xlink:title="FinanceLeasePrincipalPayments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="FinanceLeasePrincipalPayments" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to FinanceLeasePrincipalPayments" order="9.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="RepaymentsOfNotesPayable" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to RepaymentsOfNotesPayable" order="1.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInFinancingActivities" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DepreciationDepletionAndAmortization" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DepreciationDepletionAndAmortization" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainLossOnDisposalOfFixedAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainLossOnDisposalOfFixedAssets" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:label="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:title="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" order="6.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="IncreaseDecreaseInDueToRelatedParties" xlink:title="IncreaseDecreaseInDueToRelatedParties" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInDueToRelatedParties" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInDueToRelatedParties" order="19.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="NoncashMergerRelatedCosts" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to NoncashMergerRelatedCosts" order="12.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="NetIncomeLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to NetIncomeLoss" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ResearchAndDevelopmentInProcessAssetAcquisition" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="OperatingLeaseImpairmentLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to OperatingLeaseImpairmentLoss" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ShareBasedCompensation" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="LossOnNonControllingInvestment" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to LossOnNonControllingInvestment" order="11.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainOnTerminationOfLease" xlink:label="GainOnTerminationOfLease" xlink:title="GainOnTerminationOfLease" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainOnTerminationOfLease" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainOnTerminationOfLease" order="9.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="18.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOperatingLeaseLiabilities" order="20.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to OperatingLeaseRightOfUseAssetAmortizationExpense" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="IncreaseDecreaseInOtherReceivables" xlink:title="IncreaseDecreaseInOtherReceivables" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherReceivables" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherReceivables" order="15.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherOperatingLiabilities" order="21.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="IncreaseDecreaseInOtherNoncurrentAssets" xlink:title="IncreaseDecreaseInOtherNoncurrentAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherNoncurrentAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherNoncurrentAssets" order="17.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="GainLossOnDispositionOfAssets1" xlink:title="GainLossOnDispositionOfAssets1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainLossOnDispositionOfAssets1" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainLossOnDispositionOfAssets1" order="13.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="WarrantLiabilitiesExpense" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to WarrantLiabilitiesExpense" order="10.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="16.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan" xlink:label="GainLossOnForgivenessOfPaycheckProtectionProgramLoan" xlink:title="GainLossOnForgivenessOfPaycheckProtectionProgramLoan" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainLossOnForgivenessOfPaycheckProtectionProgramLoan" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainLossOnForgivenessOfPaycheckProtectionProgramLoan" order="14.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ImpairmentOfOngoingProject" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ImpairmentOfOngoingProject" order="3.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInOperatingActivities" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:label="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="ProceedsFromSalesOfAssetsInvestingActivities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromSalesOfAssetsInvestingActivities" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromDivestitureOfBusinesses" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromDivestitureOfBusinesses" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentsToAcquireProductiveAssetsNet" xlink:label="PaymentsToAcquireProductiveAssetsNet" xlink:title="PaymentsToAcquireProductiveAssetsNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireProductiveAssetsNet" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireProductiveAssetsNet" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromSaleOfPropertyPlantAndEquipment" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInInvestingActivities" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="calculation: AssetAcquisitionFairValueOfConsiderationPaid to StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="CashAcquiredFromAcquisition" xlink:title="calculation: AssetAcquisitionFairValueOfConsiderationPaid to CashAcquiredFromAcquisition" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="calculation: AssetAcquisitionFairValueOfConsiderationPaid to StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="calculation: AssetAcquisitionFairValueOfConsiderationPaid to PaymentsToAcquireProductiveAssets" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="calculation: PropertyPlantAndEquipmentNet to PropertyPlantAndEquipmentGross" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="calculation: PropertyPlantAndEquipmentNet to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome" xlink:label="SubleaseIncome" xlink:title="SubleaseIncome" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="SubleaseIncome" xlink:title="calculation: LeaseCost to SubleaseIncome" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="OperatingLeaseCost" xlink:title="calculation: LeaseCost to OperatingLeaseCost" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="VariableLeaseCost" xlink:title="calculation: LeaseCost to VariableLeaseCost" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesSubleaseAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:title="calculation: SaleLeasebackTransactionsFutureMinimumSubleaseRentals to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" xlink:title="calculation: SaleLeasebackTransactionsFutureMinimumSubleaseRentals to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:title="calculation: SaleLeasebackTransactionsFutureMinimumSubleaseRentals to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:title="calculation: SaleLeasebackTransactionsFutureMinimumSubleaseRentals to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="OperatingLeaseLiability" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to OperatingLeaseLiability" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AccruedClinicalCurrent" xlink:label="AccruedClinicalCurrent" xlink:title="AccruedClinicalCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedClinicalCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedClinicalCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to EmployeeRelatedLiabilitiesCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AccruedPrivatePlacementInPublicEquityCurrent" xlink:label="AccruedPrivatePlacementInPublicEquityCurrent" xlink:title="AccruedPrivatePlacementInPublicEquityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedPrivatePlacementInPublicEquityCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedPrivatePlacementInPublicEquityCurrent" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedProfessionalFeesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedProfessionalFeesCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to OtherAccruedLiabilitiesCurrent" order="5.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="calculation: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonStockWithheldToCoverTaxes" xlink:label="CommonStockWithheldToCoverTaxes" xlink:title="CommonStockWithheldToCoverTaxes" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="CommonStockWithheldToCoverTaxes" xlink:title="calculation: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to CommonStockWithheldToCoverTaxes" order="1.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="calculation: DeferredIncomeTaxExpenseBenefit to DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="calculation: DeferredIncomeTaxExpenseBenefit to DeferredFederalIncomeTaxExpenseBenefit" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="DeferredForeignIncomeTaxExpenseBenefit" xlink:title="DeferredForeignIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="DeferredForeignIncomeTaxExpenseBenefit" xlink:title="calculation: DeferredIncomeTaxExpenseBenefit to DeferredForeignIncomeTaxExpenseBenefit" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="calculation: IncomeTaxExpenseBenefit to DeferredIncomeTaxExpenseBenefit" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="CurrentForeignTaxExpenseBenefit" xlink:title="CurrentForeignTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="CurrentForeignTaxExpenseBenefit" xlink:title="calculation: CurrentIncomeTaxExpenseBenefit to CurrentForeignTaxExpenseBenefit" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="CurrentFederalTaxExpenseBenefit" xlink:title="calculation: CurrentIncomeTaxExpenseBenefit to CurrentFederalTaxExpenseBenefit" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="calculation: CurrentIncomeTaxExpenseBenefit to CurrentStateAndLocalTaxExpenseBenefit" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="CurrentIncomeTaxExpenseBenefit" xlink:title="calculation: IncomeTaxExpenseBenefit to CurrentIncomeTaxExpenseBenefit" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:label="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:title="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:title="calculation: IncomeTaxExpenseBenefit to EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="DeferredTaxAssetsNet" xlink:title="DeferredTaxAssetsNet" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:title="DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsOperatingLossCarryforwardsForeign" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:label="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:title="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="DeferredTaxAssetsTaxDeferredExpenseOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxDeferredExpenseOther" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsInProcessResearchAndDevelopment" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DeferredTaxAssetsRightOfUseLiabilities" xlink:label="DeferredTaxAssetsRightOfUseLiabilities" xlink:title="DeferredTaxAssetsRightOfUseLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsRightOfUseLiabilities" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsRightOfUseLiabilities" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" order="9.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsNet" xlink:to="DeferredTaxAssetsGross" xlink:title="calculation: DeferredTaxAssetsNet to DeferredTaxAssetsGross" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="DeferredTaxAssetsValuationAllowance" xlink:title="DeferredTaxAssetsValuationAllowance" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsNet" xlink:to="DeferredTaxAssetsValuationAllowance" xlink:title="calculation: DeferredTaxAssetsNet to DeferredTaxAssetsValuationAllowance" order="1.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxLiabilities" xlink:to="DeferredTaxAssetsNet" xlink:title="calculation: DeferredTaxLiabilities to DeferredTaxAssetsNet" order="0.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:label="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:title="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DeferredTaxAssetsRightOfUseAssets" xlink:label="DeferredTaxAssetsRightOfUseAssets" xlink:title="DeferredTaxAssetsRightOfUseAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxAssetsRightOfUseAssets" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxAssetsRightOfUseAssets" order="0.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxLiabilities" xlink:to="DeferredIncomeTaxLiabilities" xlink:title="calculation: DeferredTaxLiabilities to DeferredIncomeTaxLiabilities" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="EffectiveIncomeTaxRateContinuingOperations" xlink:title="EffectiveIncomeTaxRateContinuingOperations" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:title="EffectiveIncomeTaxRateReconciliationTaxCredits" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationTaxCredits" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:title="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:title="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:label="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:title="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" order="5.0" weight="-1.0" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>15
<FILENAME>erna-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.2.1.5134 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://eternatx.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#SubsequentEventDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesUncertainTaxPositionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesComponentsOfIncomeTaxProvisionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesLossBeforeIncomeTaxesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsCumulativeConvertiblePreferredStockDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsAcquisitionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsMergerDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsMergerDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsEquityLineOfferingsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsWarrantsActivityDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsPrivatePlacementOfEquityDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationStockbasedCompensationExpenseDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationRestrictedStockDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationNumberOfRsusVestedAndSettledDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationRsusDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationRsusDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationSummaryOfStockOptionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationStockOptionActivityDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationEquityIncentivePlansDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasicAndDilutedLossPerCommonShareDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#CommitmentsAndContingenciesRetirementSavingsPlanDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#CommitmentsAndContingenciesRoyaltyAgreementsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#CommitmentsAndContingenciesLicensingAgreementsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#CommitmentsAndContingenciesLegalMattersDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/DebtDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#DebtDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#RelatedPartyTransactionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwillDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#InprocessResearchDevelopmentAndGoodwillDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesSubleaseAgreementDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesSubleaseAgreementDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesNetOperatingLeaseExpensesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesOperatingLeaseDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesOperatingLeaseDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipmentDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#PropertyAndEquipmentDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactionsDispositionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactionsMergerDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesBasisOfAccountingPresentationDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesBasisOfAccountingPresentationDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LiquidityAndCapitalResourcesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LiquidityAndCapitalResourcesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#OrganizationAndDescriptionOfBusinessOperationsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesTables" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsTables" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsTables" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationTables" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedLossPerCommonShareTables" xlink:type="simple" xlink:href="erna-20221231.xsd#BasicAndDilutedLossPerCommonShareTables" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="erna-20221231.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesTables" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesTables" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipmentTables" xlink:type="simple" xlink:href="erna-20221231.xsd#PropertyAndEquipmentTables" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsTables" xlink:type="simple" xlink:href="erna-20221231.xsd#FairValueOfFinancialInstrumentsTables" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsTables" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactionsTables" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://eternatx.com/role/SubsequentEvent" xlink:type="simple" xlink:href="erna-20221231.xsd#SubsequentEvent" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxes" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxes" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrants" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrants" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensation" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensation" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedLossPerCommonShare" xlink:type="simple" xlink:href="erna-20221231.xsd#BasicAndDilutedLossPerCommonShare" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="erna-20221231.xsd#CommitmentsAndContingencies" />
  <link:roleRef roleURI="http://eternatx.com/role/Debt" xlink:type="simple" xlink:href="erna-20221231.xsd#Debt" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpenses" xlink:type="simple" xlink:href="erna-20221231.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://eternatx.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="erna-20221231.xsd#RelatedPartyTransactions" />
  <link:roleRef roleURI="http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwill" xlink:type="simple" xlink:href="erna-20221231.xsd#InprocessResearchDevelopmentAndGoodwill" />
  <link:roleRef roleURI="http://eternatx.com/role/Leases" xlink:type="simple" xlink:href="erna-20221231.xsd#Leases" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipment" xlink:type="simple" xlink:href="erna-20221231.xsd#PropertyAndEquipment" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstruments" xlink:type="simple" xlink:href="erna-20221231.xsd#FairValueOfFinancialInstruments" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactions" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactions" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies" />
  <link:roleRef roleURI="http://eternatx.com/role/LiquidityAndCapitalResources" xlink:type="simple" xlink:href="erna-20221231.xsd#LiquidityAndCapitalResources" />
  <link:roleRef roleURI="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations" xlink:type="simple" xlink:href="erna-20221231.xsd#OrganizationAndDescriptionOfBusinessOperations" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="erna-20221231.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity" xlink:type="simple" xlink:href="erna-20221231.xsd#ConsolidatedStatementsOfMembersStockholdersEquity" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="erna-20221231.xsd#ConsolidatedStatementsOfOperations" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="erna-20221231.xsd#ConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="erna-20221231.xsd#ConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://eternatx.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="erna-20221231.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/DocumentAndEntityInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AssetsAbstract" xlink:title="definition: StatementLineItems to AssetsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="definition: StatementLineItems to LiabilitiesAndStockholdersEquityAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesCurrentAbstract" xlink:title="definition: StatementLineItems to LiabilitiesCurrentAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="DueToRelatedPartiesNoncurrent" xlink:title="DueToRelatedPartiesNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DueToRelatedPartiesNoncurrent" xlink:title="definition: StatementLineItems to DueToRelatedPartiesNoncurrent" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DerivativeLiabilitiesNoncurrent" xlink:title="definition: StatementLineItems to DerivativeLiabilitiesNoncurrent" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="definition: StatementLineItems to OperatingLeaseLiabilityNoncurrent" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="definition: StatementLineItems to OtherLiabilitiesNoncurrent" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Liabilities" xlink:title="definition: StatementLineItems to Liabilities" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CommitmentsAndContingencies" xlink:title="definition: StatementLineItems to CommitmentsAndContingencies" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquityAbstract" xlink:title="definition: StatementLineItems to StockholdersEquityAbstract" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="definition: StatementLineItems to LiabilitiesAndStockholdersEquity" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PreferredStockValue" xlink:title="definition: StatementLineItems to PreferredStockValue" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CommonStockValue" xlink:title="definition: StatementLineItems to CommonStockValue" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdditionalPaidInCapital" xlink:title="definition: StatementLineItems to AdditionalPaidInCapital" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="definition: StatementLineItems to RetainedEarningsAccumulatedDeficit" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquity" xlink:title="definition: StatementLineItems to StockholdersEquity" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AccountsPayableCurrent" xlink:title="definition: StatementLineItems to AccountsPayableCurrent" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AccruedLiabilitiesCurrent" xlink:title="definition: StatementLineItems to AccruedLiabilitiesCurrent" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="DueToRelatedPartiesCurrent" xlink:title="DueToRelatedPartiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DueToRelatedPartiesCurrent" xlink:title="definition: StatementLineItems to DueToRelatedPartiesCurrent" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="definition: StatementLineItems to OperatingLeaseLiabilityCurrent" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherLiabilitiesCurrent" xlink:title="definition: StatementLineItems to OtherLiabilitiesCurrent" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesCurrent" xlink:title="definition: StatementLineItems to LiabilitiesCurrent" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AssetsCurrentAbstract" xlink:title="definition: StatementLineItems to AssetsCurrentAbstract" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="RestrictedCashNoncurrent" xlink:title="RestrictedCashNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RestrictedCashNoncurrent" xlink:title="definition: StatementLineItems to RestrictedCashNoncurrent" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="definition: StatementLineItems to PropertyPlantAndEquipmentNet" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="definition: StatementLineItems to OperatingLeaseRightOfUseAsset" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Goodwill" xlink:title="definition: StatementLineItems to Goodwill" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="definition: StatementLineItems to IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="EquityMethodInvestments" xlink:title="definition: StatementLineItems to EquityMethodInvestments" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherAssetsNoncurrent" xlink:title="definition: StatementLineItems to OtherAssetsNoncurrent" order="30.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Assets" xlink:title="definition: StatementLineItems to Assets" order="31.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Cash" xlink:title="definition: StatementLineItems to Cash" order="32.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherReceivablesNetCurrent" xlink:title="definition: StatementLineItems to OtherReceivablesNetCurrent" order="33.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="definition: StatementLineItems to PrepaidExpenseAndOtherAssetsCurrent" order="34.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AssetsCurrent" xlink:title="definition: StatementLineItems to AssetsCurrent" order="35.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="36.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: StatementTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="definition: ClassOfStockDomain to SeriesAPreferredStockMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfOperations" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="definition: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquity" xlink:title="definition: StatementLineItems to StockholdersEquity" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesOutstanding" xlink:title="definition: StatementLineItems to SharesOutstanding" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:label="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:label="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueAcquisitions1" xlink:label="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="StockIssuedDuringPeriodValueAcquisitions1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueAcquisitions1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesAcquisitions1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountAcquisitions" xlink:label="PartnersCapitalAccountAcquisitions" xlink:title="PartnersCapitalAccountAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PartnersCapitalAccountAcquisitions" xlink:title="definition: StatementLineItems to PartnersCapitalAccountAcquisitions" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountUnitsAcquisitions" xlink:label="PartnersCapitalAccountUnitsAcquisitions" xlink:title="PartnersCapitalAccountUnitsAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PartnersCapitalAccountUnitsAcquisitions" xlink:title="definition: StatementLineItems to PartnersCapitalAccountUnitsAcquisitions" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueAcquisitions" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueAcquisitions" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesAcquisitions" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueStockOptionsExercised" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesStockOptionsExercised" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodValueStockPurchaseAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueStockPurchaseAgreement" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodSharesStockPurchaseAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesStockPurchaseAgreement" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueAcquisitions2" xlink:label="StockIssuedDuringPeriodValueAcquisitions2" xlink:title="StockIssuedDuringPeriodValueAcquisitions2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueAcquisitions2" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueAcquisitions2" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesAcquisitions2" xlink:label="StockIssuedDuringPeriodSharesAcquisitions2" xlink:title="StockIssuedDuringPeriodSharesAcquisitions2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions2" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesAcquisitions2" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" xlink:label="StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" xlink:title="StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" xlink:label="StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" xlink:title="StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="DividendsPreferredStockCash" xlink:title="DividendsPreferredStockCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DividendsPreferredStockCash" xlink:title="definition: StatementLineItems to DividendsPreferredStockCash" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="PreferredStockDividendsShares" xlink:title="PreferredStockDividendsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PreferredStockDividendsShares" xlink:title="definition: StatementLineItems to PreferredStockDividendsShares" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueInLieuOfDividends" xlink:label="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:title="StockIssuedDuringPeriodValueInLieuOfDividends" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueInLieuOfDividends" order="30.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:label="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:title="StockIssuedDuringPeriodSharesInLieuOfDividends" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesInLieuOfDividends" order="31.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:label="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" order="32.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:label="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="definition: StatementLineItems to SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" order="33.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="34.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="definition: StatementLineItems to NetIncomeLoss" order="35.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="36.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: StatementTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_MembershipEquityMember" xlink:label="MembershipEquityMember" xlink:title="MembershipEquityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="MembershipEquityMember" xlink:title="definition: EquityComponentDomain to MembershipEquityMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="PreferredStockMember" xlink:title="definition: EquityComponentDomain to PreferredStockMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="AdditionalPaidInCapitalMember" xlink:title="definition: EquityComponentDomain to AdditionalPaidInCapitalMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="RetainedEarningsMember" xlink:title="definition: EquityComponentDomain to RetainedEarningsMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: StatementTable to StatementClassOfStockAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="definition: ClassOfStockDomain to CommonClassAMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassBMember" xlink:title="definition: ClassOfStockDomain to CommonClassBMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassCMember" xlink:title="definition: ClassOfStockDomain to CommonClassCMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonUnitsMember" xlink:label="CommonUnitsMember" xlink:title="CommonUnitsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonUnitsMember" xlink:title="definition: ClassOfStockDomain to CommonUnitsMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="definition: ClassOfStockDomain to SeriesAPreferredStockMember" order="5.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LiquidityAndCapitalResources" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactions" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstruments" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipment" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/Leases" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwill" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/RelatedPartyTransactions" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpenses" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/Debt" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingencies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedLossPerCommonShare" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrants" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxes" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/SubsequentEvent" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipmentTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpensesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedLossPerCommonShareTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfInLicensedPortfolioPatents" xlink:label="NumberOfInLicensedPortfolioPatents" xlink:title="NumberOfInLicensedPortfolioPatents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfInLicensedPortfolioPatents" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfInLicensedPortfolioPatents" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestmentOwnershipPercentage" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain_2" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain_2" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="definition: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LiquidityAndCapitalResourcesDetails">
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LiquidityAndCapitalResourcesLineItems" xlink:label="LiquidityAndCapitalResourcesLineItems" xlink:title="LiquidityAndCapitalResourcesLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:label="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:title="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NewFacilityLeaseAbstract" xlink:label="NewFacilityLeaseAbstract" xlink:title="NewFacilityLeaseAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="NewFacilityLeaseAbstract" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to NewFacilityLeaseAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="AreaOfRealEstateProperty" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to AreaOfRealEstateProperty" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:label="LineOfCredit" xlink:title="LineOfCredit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="LineOfCredit" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to LineOfCredit" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="RestrictedCash" xlink:title="RestrictedCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="RestrictedCash" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to RestrictedCash" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="Cash" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to Cash" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to RetainedEarningsAccumulatedDeficit" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="NetIncomeLoss" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to NetIncomeLoss" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to NetCashProvidedByUsedInOperatingActivities" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to CommonStockParOrStatedValuePerShare" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_UnitPriceOfWarrants" xlink:label="UnitPriceOfWarrants" xlink:title="UnitPriceOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="UnitPriceOfWarrants" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to UnitPriceOfWarrants" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to StockRepurchaseProgramAuthorizedAmount1" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="ProceedsFromIssuanceOfWarrants" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to ProceedsFromIssuanceOfWarrants" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="ClassOfWarrantOrRightsExercisableTerm" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to ClassOfWarrantOrRightsExercisableTerm" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LiquidityAndCapitalResourcesTable" xlink:label="LiquidityAndCapitalResourcesTable" xlink:title="LiquidityAndCapitalResourcesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="LiquidityAndCapitalResourcesTable" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to LiquidityAndCapitalResourcesTable" order="19.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="InvestmentTypeAxis" xlink:title="definition: LiquidityAndCapitalResourcesTable to InvestmentTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember_2" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember_2" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="definition: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: LiquidityAndCapitalResourcesTable to ClassOfWarrantOrRightAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesBasisOfAccountingPresentationDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:label="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:title="PropertyPlantAndEquipmentNetByTypeAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentNetByTypeAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentUsefulLife" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="definition: PropertyPlantAndEquipmentLineItems to ScheduleOfPropertyPlantAndEquipmentTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="definition: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LaboratoryAndManufacturingEquipmentMember" xlink:label="LaboratoryAndManufacturingEquipmentMember" xlink:title="LaboratoryAndManufacturingEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LaboratoryAndManufacturingEquipmentMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to LaboratoryAndManufacturingEquipmentMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerEquipmentMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to ComputerEquipmentMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:title="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="definition: NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems to NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="IncomeTaxesReceivable" xlink:title="IncomeTaxesReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="IncomeTaxesReceivable" xlink:title="definition: NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems to IncomeTaxesReceivable" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:title="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:title="definition: NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems to NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="definition: NewAccountingPronouncementsOrChangeInAccountingPrincipleTable to UnusualOrInfrequentItemAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain_2" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain_2" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CoronavirusAidReliefAndEconomicSecurityActMember" xlink:label="CoronavirusAidReliefAndEconomicSecurityActMember" xlink:title="CoronavirusAidReliefAndEconomicSecurityActMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="CoronavirusAidReliefAndEconomicSecurityActMember" xlink:title="definition: UnusualOrInfrequentItemDomain to CoronavirusAidReliefAndEconomicSecurityActMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodSharesIssuedForServices" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="BusinessAcquisitionSharePrice" xlink:title="BusinessAcquisitionSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionSharePrice" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionSharePrice" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="CommonStockSharesOutstanding" xlink:title="definition: BusinessAcquisitionLineItems to CommonStockSharesOutstanding" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="Goodwill" xlink:title="definition: BusinessAcquisitionLineItems to Goodwill" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:label="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="definition: BusinessAcquisitionLineItems to ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BeneficialHoldersContractualCommitmentsToInvest" xlink:label="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="BeneficialHoldersContractualCommitmentsToInvest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="definition: BusinessAcquisitionLineItems to BeneficialHoldersContractualCommitmentsToInvest" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfAdditionalRightsOffering" xlink:label="PercentageOfAdditionalRightsOffering" xlink:title="PercentageOfAdditionalRightsOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfAdditionalRightsOffering" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfAdditionalRightsOffering" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProceedsFromSaleOfRights" xlink:label="ProceedsFromSaleOfRights" xlink:title="ProceedsFromSaleOfRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ProceedsFromSaleOfRights" xlink:title="definition: BusinessAcquisitionLineItems to ProceedsFromSaleOfRights" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="Goodwill" xlink:title="definition: BusinessAcquisitionLineItems to Goodwill" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="16.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:label="NonrecurringAdjustmentAxis" xlink:title="NonrecurringAdjustmentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="NonrecurringAdjustmentAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to NonrecurringAdjustmentAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="NonrecurringAdjustmentDomain" xlink:title="NonrecurringAdjustmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="NonrecurringAdjustmentAxis" xlink:to="NonrecurringAdjustmentDomain" xlink:title="definition: NonrecurringAdjustmentAxis to NonrecurringAdjustmentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="NonrecurringAdjustmentDomain_2" xlink:title="NonrecurringAdjustmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="NonrecurringAdjustmentAxis" xlink:to="NonrecurringAdjustmentDomain_2" xlink:title="definition: NonrecurringAdjustmentAxis to NonrecurringAdjustmentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProFormaFairValueAdjustmentToAssetsMember" xlink:label="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="ProFormaFairValueAdjustmentToAssetsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NonrecurringAdjustmentDomain" xlink:to="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="definition: NonrecurringAdjustmentDomain to ProFormaFairValueAdjustmentToAssetsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PurchasePriceAllocationMember" xlink:label="PurchasePriceAllocationMember" xlink:title="PurchasePriceAllocationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NonrecurringAdjustmentDomain" xlink:to="PurchasePriceAllocationMember" xlink:title="definition: NonrecurringAdjustmentDomain to PurchasePriceAllocationMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TradeNamesMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TradeNamesMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DispositionAbstract" xlink:label="DispositionAbstract" xlink:title="DispositionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DispositionAbstract" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DispositionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:label="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProceedsFromDispositionAbstract" xlink:label="ProceedsFromDispositionAbstract" xlink:title="ProceedsFromDispositionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="ProceedsFromDispositionAbstract" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to ProceedsFromDispositionAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationTransactionCosts" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:label="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:label="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationLeaseLiability" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:label="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:label="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:label="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="DisposalGroupIncludingDiscontinuedOperationGoodwill1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationGoodwill1" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationOtherAssets" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="25.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis to DisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2" xlink:title="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis to DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NTNBusinessMember" xlink:label="NTNBusinessMember" xlink:title="NTNBusinessMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="NTNBusinessMember" xlink:title="definition: DisposalGroupsIncludingDiscontinuedOperationsNameDomain to NTNBusinessMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TradeNamesMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TradeNamesMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestmentOwnershipPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodSharesAcquisitions" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodValueAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodValueAcquisitions" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AssetAcquisitionSharePrice" xlink:label="AssetAcquisitionSharePrice" xlink:title="AssetAcquisitionSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AssetAcquisitionSharePrice" xlink:title="definition: BusinessAcquisitionLineItems to AssetAcquisitionSharePrice" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodValueNewIssues" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodValueNewIssues" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EscrowShares" xlink:label="EscrowShares" xlink:title="EscrowShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EscrowShares" xlink:title="definition: BusinessAcquisitionLineItems to EscrowShares" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AcquisitionAgreementNonCompetitivePeriod" xlink:label="AcquisitionAgreementNonCompetitivePeriod" xlink:title="AcquisitionAgreementNonCompetitivePeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AcquisitionAgreementNonCompetitivePeriod" xlink:title="definition: BusinessAcquisitionLineItems to AcquisitionAgreementNonCompetitivePeriod" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodSharesIssuedForServices" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EachLockUpAgreementExtendsTerm" xlink:label="EachLockUpAgreementExtendsTerm" xlink:title="EachLockUpAgreementExtendsTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EachLockUpAgreementExtendsTerm" xlink:title="definition: BusinessAcquisitionLineItems to EachLockUpAgreementExtendsTerm" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfCommonStockSubjectToLockUpAgreement" xlink:label="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="PercentageOfCommonStockSubjectToLockUpAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfCommonStockSubjectToLockUpAgreement" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentsToAcquireProductiveAssetsNet" xlink:label="PaymentsToAcquireProductiveAssetsNet" xlink:title="PaymentsToAcquireProductiveAssetsNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireProductiveAssetsNet" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireProductiveAssetsNet" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LockUpPeriodForRestrictedShares" xlink:label="LockUpPeriodForRestrictedShares" xlink:title="LockUpPeriodForRestrictedShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="LockUpPeriodForRestrictedShares" xlink:title="definition: BusinessAcquisitionLineItems to LockUpPeriodForRestrictedShares" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AssetAcquisitionUnrestrictedSharesSharePrice" xlink:label="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="AssetAcquisitionUnrestrictedSharesSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="definition: BusinessAcquisitionLineItems to AssetAcquisitionUnrestrictedSharesSharePrice" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodRestrictedSharesAcquisitions" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AssetAcquisitionRestrictedSharesSharePrice" xlink:label="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="AssetAcquisitionRestrictedSharesSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="definition: BusinessAcquisitionLineItems to AssetAcquisitionRestrictedSharesSharePrice" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:label="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="PercentageOfDiscountOnFairValueOfRestrictedShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfDiscountOnFairValueOfRestrictedShares" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireProductiveAssets" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="CashAcquiredFromAcquisition" xlink:title="definition: BusinessAcquisitionLineItems to CashAcquiredFromAcquisition" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="definition: BusinessAcquisitionLineItems to AssetAcquisitionFairValueOfConsiderationPaid" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="PaymentsToAcquireInvestments" xlink:title="PaymentsToAcquireInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireInvestments" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireInvestments" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="definition: BusinessAcquisitionLineItems to ResearchAndDevelopmentInProcessAssetAcquisition" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="26.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain_2" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain_2" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="definition: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="AssetAcquisitionAxis" xlink:title="AssetAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="AssetAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to AssetAcquisitionAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="AssetAcquisitionDomain" xlink:title="AssetAcquisitionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AssetAcquisitionAxis" xlink:to="AssetAcquisitionDomain" xlink:title="definition: AssetAcquisitionAxis to AssetAcquisitionDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="AssetAcquisitionDomain_2" xlink:title="AssetAcquisitionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AssetAcquisitionAxis" xlink:to="AssetAcquisitionDomain_2" xlink:title="definition: AssetAcquisitionAxis to AssetAcquisitionDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="definition: AssetAcquisitionDomain to NovellusTherapeuticsLimitedMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RelatedPartyTransactionsByRelatedPartyAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:label="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="definition: RelatedPartyDomain to ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract" xlink:label="InvestmentsAbstract" xlink:title="InvestmentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="InvestmentsAbstract" xlink:title="definition: BusinessAcquisitionLineItems to InvestmentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestmentOwnershipPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="MinorityInterestOwnershipPercentageByParent" xlink:title="MinorityInterestOwnershipPercentageByParent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="MinorityInterestOwnershipPercentageByParent" xlink:title="definition: BusinessAcquisitionLineItems to MinorityInterestOwnershipPercentageByParent" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfBoardSeats" xlink:label="NumberOfBoardSeats" xlink:title="NumberOfBoardSeats" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBoardSeats" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBoardSeats" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestments" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestments" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestmentRealizedGainLossOnDisposal" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain_2" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain_2" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="definition: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="OwnershipAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to OwnershipAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="definition: OwnershipAxis to OwnershipDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain_2" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain_2" xlink:title="definition: OwnershipAxis to OwnershipDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CitiusPharmaceuticalsIncMember" xlink:label="CitiusPharmaceuticalsIncMember" xlink:title="CitiusPharmaceuticalsIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OwnershipDomain" xlink:to="CitiusPharmaceuticalsIncMember" xlink:title="definition: OwnershipDomain to CitiusPharmaceuticalsIncMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiabilityAbstract" xlink:label="FairValueNetAssetLiabilityAbstract" xlink:title="FairValueNetAssetLiabilityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueNetAssetLiabilityAbstract" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueNetAssetLiabilityAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="LiabilitiesFairValueDisclosureAbstract" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to LiabilitiesFairValueDisclosureAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="LiabilitiesFairValueDisclosure" xlink:title="LiabilitiesFairValueDisclosure" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="LiabilitiesFairValueDisclosure" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to LiabilitiesFairValueDisclosure" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="ProceedsFromIssuanceOfWarrants" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to ProceedsFromIssuanceOfWarrants" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="ClassOfWarrantOrRightOutstanding" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to ClassOfWarrantOrRightOutstanding" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel1Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel1Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByLiabilityClassAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByLiabilityClassAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="definition: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" xlink:title="definition: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to DerivativeFinancialInstrumentsLiabilitiesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="InvestmentTypeAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to InvestmentTypeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember_2" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember_2" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="definition: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="OverSubscriptionAmountReceived" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to OverSubscriptionAmountReceived" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to StockRepurchaseProgramAuthorizedAmount1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="LiabilitiesFairValueAdjustment" xlink:title="LiabilitiesFairValueAdjustment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="LiabilitiesFairValueAdjustment" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to LiabilitiesFairValueAdjustment" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="ProceedsFromWarrantExercises" xlink:title="ProceedsFromWarrantExercises" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="ProceedsFromWarrantExercises" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to ProceedsFromWarrantExercises" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:label="PropertyPlantAndEquipmentGrossAbstract" xlink:title="PropertyPlantAndEquipmentGrossAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentGrossAbstract" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentGrossAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentGross" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="definition: PropertyPlantAndEquipmentLineItems to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentNet" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="GainLossOnDisposalOfFixedAssets" xlink:title="definition: PropertyPlantAndEquipmentLineItems to GainLossOnDisposalOfFixedAssets" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RemainingNetBookValueOfFixedAssets" xlink:label="RemainingNetBookValueOfFixedAssets" xlink:title="RemainingNetBookValueOfFixedAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="RemainingNetBookValueOfFixedAssets" xlink:title="definition: PropertyPlantAndEquipmentLineItems to RemainingNetBookValueOfFixedAssets" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="definition: PropertyPlantAndEquipmentLineItems to ProceedsFromSaleOfPropertyPlantAndEquipment" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="Depreciation" xlink:title="definition: PropertyPlantAndEquipmentLineItems to Depreciation" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="definition: PropertyPlantAndEquipmentLineItems to ScheduleOfPropertyPlantAndEquipmentTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="definition: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="EquipmentMember" xlink:title="EquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="EquipmentMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to EquipmentMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerEquipmentMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to ComputerEquipmentMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesOperatingLeaseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseDescriptionAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LesseeCommitmentToPurchaseProperty" xlink:label="LesseeCommitmentToPurchaseProperty" xlink:title="LesseeCommitmentToPurchaseProperty" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeCommitmentToPurchaseProperty" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeCommitmentToPurchaseProperty" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="DepositsAssetsNoncurrent" xlink:title="DepositsAssetsNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="DepositsAssetsNoncurrent" xlink:title="definition: LesseeLeaseDescriptionLineItems to DepositsAssetsNoncurrent" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseRightOfUseAsset" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiability" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseLiability" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLeaseArea" xlink:label="OperatingLeaseArea" xlink:title="OperatingLeaseArea" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseArea" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseArea" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseTermOfContract" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseTermOfContract" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialMeasurementOfOperatingLeaseROUAssets" xlink:label="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="InitialMeasurementOfOperatingLeaseROUAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="definition: LesseeLeaseDescriptionLineItems to InitialMeasurementOfOperatingLeaseROUAssets" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialMeasurementOfOperatingLeaseLiabilities" xlink:label="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="InitialMeasurementOfOperatingLeaseLiabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="definition: LesseeLeaseDescriptionLineItems to InitialMeasurementOfOperatingLeaseLiabilities" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseImpairmentLoss" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseImpairmentLoss" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LeaseTerminationFeePayable" xlink:label="LeaseTerminationFeePayable" xlink:title="LeaseTerminationFeePayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseTerminationFeePayable" xlink:title="definition: LesseeLeaseDescriptionLineItems to LeaseTerminationFeePayable" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LeaseTerminationFee" xlink:label="LeaseTerminationFee" xlink:title="LeaseTerminationFee" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseTerminationFee" xlink:title="definition: LesseeLeaseDescriptionLineItems to LeaseTerminationFee" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="IncreaseDecreaseInOperatingLeaseLiability" xlink:title="IncreaseDecreaseInOperatingLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="IncreaseDecreaseInOperatingLeaseLiability" xlink:title="definition: LesseeLeaseDescriptionLineItems to IncreaseDecreaseInOperatingLeaseLiability" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" xlink:label="LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" xlink:title="LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" xlink:title="definition: LesseeLeaseDescriptionLineItems to LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="AreaOfRealEstateProperty" xlink:title="definition: LesseeLeaseDescriptionLineItems to AreaOfRealEstateProperty" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="LesseeOperatingLeaseRenewalTerm" xlink:title="LesseeOperatingLeaseRenewalTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseRenewalTerm" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseRenewalTerm" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:label="LineOfCredit" xlink:title="LineOfCredit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LineOfCredit" xlink:title="definition: LesseeLeaseDescriptionLineItems to LineOfCredit" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLeasesMonthlyBaseRent" xlink:label="OperatingLeasesMonthlyBaseRent" xlink:title="OperatingLeasesMonthlyBaseRent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeasesMonthlyBaseRent" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeasesMonthlyBaseRent" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLeasesIncrementalBaseRentalPayment" xlink:label="OperatingLeasesIncrementalBaseRentalPayment" xlink:title="OperatingLeasesIncrementalBaseRentalPayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeasesIncrementalBaseRentalPayment" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeasesIncrementalBaseRentalPayment" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TenantImprovementAllowancePerRentableSquareFoot" xlink:label="TenantImprovementAllowancePerRentableSquareFoot" xlink:title="TenantImprovementAllowancePerRentableSquareFoot" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="TenantImprovementAllowancePerRentableSquareFoot" xlink:title="definition: LesseeLeaseDescriptionLineItems to TenantImprovementAllowancePerRentableSquareFoot" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TenantImprovementAllowance" xlink:label="TenantImprovementAllowance" xlink:title="TenantImprovementAllowance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="TenantImprovementAllowance" xlink:title="definition: LesseeLeaseDescriptionLineItems to TenantImprovementAllowance" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SubleaseCost" xlink:label="SubleaseCost" xlink:title="SubleaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="SubleaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to SubleaseCost" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SubleaseCostForTenantImprovements" xlink:label="SubleaseCostForTenantImprovements" xlink:title="SubleaseCostForTenantImprovements" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="SubleaseCostForTenantImprovements" xlink:title="definition: LesseeLeaseDescriptionLineItems to SubleaseCostForTenantImprovements" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CostRelatedToIssuanceOfLetterOfCredit" xlink:label="CostRelatedToIssuanceOfLetterOfCredit" xlink:title="CostRelatedToIssuanceOfLetterOfCredit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="CostRelatedToIssuanceOfLetterOfCredit" xlink:title="definition: LesseeLeaseDescriptionLineItems to CostRelatedToIssuanceOfLetterOfCredit" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeLeaseDescriptionTable" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeLeaseDescriptionTable" order="25.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: LesseeLeaseDescriptionTable to RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ERSquibbSonsLLCMember" xlink:label="ERSquibbSonsLLCMember" xlink:title="ERSquibbSonsLLCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="ERSquibbSonsLLCMember" xlink:title="definition: RelatedPartyDomain to ERSquibbSonsLLCMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgingPurposeAxis" xlink:label="PledgingPurposeAxis" xlink:title="PledgingPurposeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LesseeLeaseDescriptionTable" xlink:to="PledgingPurposeAxis" xlink:title="definition: LesseeLeaseDescriptionTable to PledgingPurposeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgingPurposeDomain" xlink:label="PledgingPurposeDomain" xlink:title="PledgingPurposeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PledgingPurposeAxis" xlink:to="PledgingPurposeDomain" xlink:title="definition: PledgingPurposeAxis to PledgingPurposeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgingPurposeDomain" xlink:label="PledgingPurposeDomain_2" xlink:title="PledgingPurposeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PledgingPurposeAxis" xlink:to="PledgingPurposeDomain_2" xlink:title="definition: PledgingPurposeAxis to PledgingPurposeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember" xlink:label="LetterOfCreditMember" xlink:title="LetterOfCreditMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PledgingPurposeDomain" xlink:to="LetterOfCreditMember" xlink:title="definition: PledgingPurposeDomain to LetterOfCreditMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LesseeLeaseDescriptionTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: LesseeLeaseDescriptionTable to SubsequentEventTypeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="BalanceSheetLocationAxis" xlink:title="BalanceSheetLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LesseeLeaseDescriptionTable" xlink:to="BalanceSheetLocationAxis" xlink:title="definition: LesseeLeaseDescriptionTable to BalanceSheetLocationAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="BalanceSheetLocationDomain" xlink:title="BalanceSheetLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BalanceSheetLocationAxis" xlink:to="BalanceSheetLocationDomain" xlink:title="definition: BalanceSheetLocationAxis to BalanceSheetLocationDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="BalanceSheetLocationDomain_2" xlink:title="BalanceSheetLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BalanceSheetLocationAxis" xlink:to="BalanceSheetLocationDomain_2" xlink:title="definition: BalanceSheetLocationAxis to BalanceSheetLocationDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="OtherNoncurrentAssetsMember" xlink:title="OtherNoncurrentAssetsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BalanceSheetLocationDomain" xlink:to="OtherNoncurrentAssetsMember" xlink:title="definition: BalanceSheetLocationDomain to OtherNoncurrentAssetsMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesSubleaseAgreementDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwillDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="RelatedPartyTransactionLineItems" xlink:title="RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:label="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:title="RelatedPartyTransactionDueFromToRelatedPartyAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:title="definition: RelatedPartyTransactionLineItems to RelatedPartyTransactionDueFromToRelatedPartyAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ExacisOptionAgreementAbstract" xlink:label="ExacisOptionAgreementAbstract" xlink:title="ExacisOptionAgreementAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ExacisOptionAgreementAbstract" xlink:title="definition: RelatedPartyTransactionLineItems to ExacisOptionAgreementAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_Q422PIPETransactionAbstract" xlink:label="Q422PIPETransactionAbstract" xlink:title="Q422PIPETransactionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="Q422PIPETransactionAbstract" xlink:title="definition: RelatedPartyTransactionLineItems to Q422PIPETransactionAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="definition: RelatedPartyTransactionLineItems to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="definition: RelatedPartyTransactionLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_UnitPriceOfWarrants" xlink:label="UnitPriceOfWarrants" xlink:title="UnitPriceOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="UnitPriceOfWarrants" xlink:title="definition: RelatedPartyTransactionLineItems to UnitPriceOfWarrants" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="definition: RelatedPartyTransactionLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ProceedsFromIssuanceOfWarrants" xlink:title="definition: RelatedPartyTransactionLineItems to ProceedsFromIssuanceOfWarrants" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ClassOfWarrantOrRightsExercisableTerm" xlink:title="definition: RelatedPartyTransactionLineItems to ClassOfWarrantOrRightsExercisableTerm" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="definition: RelatedPartyTransactionLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentOfOptionFee" xlink:label="PaymentOfOptionFee" xlink:title="PaymentOfOptionFee" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="PaymentOfOptionFee" xlink:title="definition: RelatedPartyTransactionLineItems to PaymentOfOptionFee" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_MasterServiceAgreementInitialFeesPayable" xlink:label="MasterServiceAgreementInitialFeesPayable" xlink:title="MasterServiceAgreementInitialFeesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="MasterServiceAgreementInitialFeesPayable" xlink:title="definition: RelatedPartyTransactionLineItems to MasterServiceAgreementInitialFeesPayable" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfMonthlyInstallmentsForFeesPayable" xlink:label="NumberOfMonthlyInstallmentsForFeesPayable" xlink:title="NumberOfMonthlyInstallmentsForFeesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="NumberOfMonthlyInstallmentsForFeesPayable" xlink:title="definition: RelatedPartyTransactionLineItems to NumberOfMonthlyInstallmentsForFeesPayable" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:label="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:title="RelatedPartyTransactionPeriodicFeesPaymentAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:title="definition: RelatedPartyTransactionLineItems to RelatedPartyTransactionPeriodicFeesPaymentAmount" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialLicenseFeeObligation" xlink:label="InitialLicenseFeeObligation" xlink:title="InitialLicenseFeeObligation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="InitialLicenseFeeObligation" xlink:title="definition: RelatedPartyTransactionLineItems to InitialLicenseFeeObligation" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_MonthlyMasterServicesAgreementFeesPayable" xlink:label="MonthlyMasterServicesAgreementFeesPayable" xlink:title="MonthlyMasterServicesAgreementFeesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="MonthlyMasterServicesAgreementFeesPayable" xlink:title="definition: RelatedPartyTransactionLineItems to MonthlyMasterServicesAgreementFeesPayable" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:label="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:title="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:title="definition: RelatedPartyTransactionLineItems to DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoticePeriodForFirstTerminationOfContract" xlink:label="NoticePeriodForFirstTerminationOfContract" xlink:title="NoticePeriodForFirstTerminationOfContract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="NoticePeriodForFirstTerminationOfContract" xlink:title="definition: RelatedPartyTransactionLineItems to NoticePeriodForFirstTerminationOfContract" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoticePeriodForSupersedingTerminationProvisions" xlink:label="NoticePeriodForSupersedingTerminationProvisions" xlink:title="NoticePeriodForSupersedingTerminationProvisions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="NoticePeriodForSupersedingTerminationProvisions" xlink:title="definition: RelatedPartyTransactionLineItems to NoticePeriodForSupersedingTerminationProvisions" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AgreedWaivePayment" xlink:label="AgreedWaivePayment" xlink:title="AgreedWaivePayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="AgreedWaivePayment" xlink:title="definition: RelatedPartyTransactionLineItems to AgreedWaivePayment" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="definition: RelatedPartyTransactionLineItems to ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RemainingLicenseFeeObligation" xlink:label="RemainingLicenseFeeObligation" xlink:title="RemainingLicenseFeeObligation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="RemainingLicenseFeeObligation" xlink:title="definition: RelatedPartyTransactionLineItems to RemainingLicenseFeeObligation" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ReimburseCostsIncurredOrPaid" xlink:label="ReimburseCostsIncurredOrPaid" xlink:title="ReimburseCostsIncurredOrPaid" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ReimburseCostsIncurredOrPaid" xlink:title="definition: RelatedPartyTransactionLineItems to ReimburseCostsIncurredOrPaid" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="definition: RelatedPartyTransactionLineItems to ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="24.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_FactorBioscienceIncMember" xlink:label="FactorBioscienceIncMember" xlink:title="FactorBioscienceIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="FactorBioscienceIncMember" xlink:title="definition: RelatedPartyDomain to FactorBioscienceIncMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ExacisBiotherapeuticsIncMember" xlink:label="ExacisBiotherapeuticsIncMember" xlink:title="ExacisBiotherapeuticsIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="ExacisBiotherapeuticsIncMember" xlink:title="definition: RelatedPartyDomain to ExacisBiotherapeuticsIncMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="InvestmentTypeAxis" xlink:title="definition: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to InvestmentTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember_2" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember_2" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="definition: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to ClassOfWarrantOrRightAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpensesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/DebtDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DebtInstrumentAbstract" xlink:label="DebtInstrumentAbstract" xlink:title="DebtInstrumentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentAbstract" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableCurrent" xlink:label="LoansPayableCurrent" xlink:title="LoansPayableCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LoansPayableCurrent" xlink:title="definition: DebtInstrumentLineItems to LoansPayableCurrent" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="RepaymentsOfNotesPayable" xlink:title="definition: DebtInstrumentLineItems to RepaymentsOfNotesPayable" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentOfAccruedAndUnpaidInterest" xlink:label="PaymentOfAccruedAndUnpaidInterest" xlink:title="PaymentOfAccruedAndUnpaidInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="PaymentOfAccruedAndUnpaidInterest" xlink:title="definition: DebtInstrumentLineItems to PaymentOfAccruedAndUnpaidInterest" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentFaceAmount" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentFaceAmount" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentInterestRateStatedPercentage" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="GainsLossesOnExtinguishmentOfDebt" xlink:title="definition: DebtInstrumentLineItems to GainsLossesOnExtinguishmentOfDebt" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebt" xlink:title="definition: DebtInstrumentLineItems to LongTermDebt" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: DebtInstrumentTable to DebtInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaycheckProtectionProgramLoanMember" xlink:label="PaycheckProtectionProgramLoanMember" xlink:title="PaycheckProtectionProgramLoanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="PaycheckProtectionProgramLoanMember" xlink:title="definition: DebtInstrumentNameDomain to PaycheckProtectionProgramLoanMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaycheckProtectionProgramMember" xlink:label="PaycheckProtectionProgramMember" xlink:title="PaycheckProtectionProgramMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="PaycheckProtectionProgramMember" xlink:title="definition: DebtInstrumentNameDomain to PaycheckProtectionProgramMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BrooklynPaycheckProtectionProgramMember" xlink:label="BrooklynPaycheckProtectionProgramMember" xlink:title="BrooklynPaycheckProtectionProgramMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="BrooklynPaycheckProtectionProgramMember" xlink:title="definition: DebtInstrumentNameDomain to BrooklynPaycheckProtectionProgramMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LicensingAgreementsAbstract" xlink:label="LicensingAgreementsAbstract" xlink:title="LicensingAgreementsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LicensingAgreementsAbstract" xlink:title="definition: LossContingenciesLineItems to LicensingAgreementsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LicenseAgreementTerm" xlink:label="LicenseAgreementTerm" xlink:title="LicenseAgreementTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LicenseAgreementTerm" xlink:title="definition: LossContingenciesLineItems to LicenseAgreementTerm" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LicenseAgreementExtensionTerm" xlink:label="LicenseAgreementExtensionTerm" xlink:title="LicenseAgreementExtensionTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LicenseAgreementExtensionTerm" xlink:title="definition: LossContingenciesLineItems to LicenseAgreementExtensionTerm" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod" xlink:label="ThresholdIncomeForAutomaticExtensionOfLicensePeriod" xlink:title="ThresholdIncomeForAutomaticExtensionOfLicensePeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="ThresholdIncomeForAutomaticExtensionOfLicensePeriod" xlink:title="definition: LossContingenciesLineItems to ThresholdIncomeForAutomaticExtensionOfLicensePeriod" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod" xlink:label="PercentageOfSublicenseFeePayableBeforeExpirationPeriod" xlink:title="PercentageOfSublicenseFeePayableBeforeExpirationPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="PercentageOfSublicenseFeePayableBeforeExpirationPeriod" xlink:title="definition: LossContingenciesLineItems to PercentageOfSublicenseFeePayableBeforeExpirationPeriod" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfSublicenseFeePayableDuringRenewalTerm" xlink:label="PercentageOfSublicenseFeePayableDuringRenewalTerm" xlink:title="PercentageOfSublicenseFeePayableDuringRenewalTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="PercentageOfSublicenseFeePayableDuringRenewalTerm" xlink:title="definition: LossContingenciesLineItems to PercentageOfSublicenseFeePayableDuringRenewalTerm" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LossContingencyPercentageOfRoyaltyPayable" xlink:label="LossContingencyPercentageOfRoyaltyPayable" xlink:title="LossContingencyPercentageOfRoyaltyPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyPercentageOfRoyaltyPayable" xlink:title="definition: LossContingenciesLineItems to LossContingencyPercentageOfRoyaltyPayable" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LossContingenciesLineItems" xlink:to="LossContingenciesTable" xlink:title="definition: LossContingenciesLineItems to LossContingenciesTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="LegalEntityAxis" xlink:title="definition: LossContingenciesTable to LegalEntityAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="definition: LegalEntityAxis to EntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="EntityDomain_2" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LegalEntityAxis" xlink:to="EntityDomain_2" xlink:title="definition: LegalEntityAxis to EntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_UniversityOfSouthFloridaMember" xlink:label="UniversityOfSouthFloridaMember" xlink:title="UniversityOfSouthFloridaMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityDomain" xlink:to="UniversityOfSouthFloridaMember" xlink:title="definition: EntityDomain to UniversityOfSouthFloridaMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: LossContingenciesTable to TypeOfArrangementAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ExclusiveFactorLicenseAgreementMember" xlink:label="ExclusiveFactorLicenseAgreementMember" xlink:title="ExclusiveFactorLicenseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="ExclusiveFactorLicenseAgreementMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to ExclusiveFactorLicenseAgreementMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RoyaltyAgreementsAbstract" xlink:label="RoyaltyAgreementsAbstract" xlink:title="RoyaltyAgreementsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="RoyaltyAgreementsAbstract" xlink:title="definition: LossContingenciesLineItems to RoyaltyAgreementsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LossContingencyPercentageOfRoyaltyPayable" xlink:label="LossContingencyPercentageOfRoyaltyPayable" xlink:title="LossContingencyPercentageOfRoyaltyPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyPercentageOfRoyaltyPayable" xlink:title="definition: LossContingenciesLineItems to LossContingencyPercentageOfRoyaltyPayable" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" xlink:label="PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" xlink:title="PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" xlink:title="definition: LossContingenciesLineItems to PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:label="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="definition: LossContingenciesLineItems to PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LossContingenciesLineItems" xlink:to="LossContingenciesTable" xlink:title="definition: LossContingenciesLineItems to LossContingenciesTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: LossContingenciesTable to TypeOfArrangementAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InvestorRoyaltyAgreementMember" xlink:label="InvestorRoyaltyAgreementMember" xlink:title="InvestorRoyaltyAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="InvestorRoyaltyAgreementMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to InvestorRoyaltyAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CollaboratorRoyaltyAgreementMember" xlink:label="CollaboratorRoyaltyAgreementMember" xlink:title="CollaboratorRoyaltyAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="CollaboratorRoyaltyAgreementMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to CollaboratorRoyaltyAgreementMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="DefinedContributionPlanDisclosureLineItems" xlink:title="DefinedContributionPlanDisclosureLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanAbstract" xlink:label="DefinedContributionPlanAbstract" xlink:title="DefinedContributionPlanAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanAbstract" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:label="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:title="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:label="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:title="DefinedContributionPlanEmployeeContributionAtThresholdOne" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanEmployeeContributionAtThresholdOne" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:label="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:title="DefinedContributionPlanEmployeeContributionAtThresholdTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanEmployeeContributionAtThresholdTwo" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:title="DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="DefinedContributionPlanTable" xlink:title="DefinedContributionPlanTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanTable" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis" xlink:label="RetirementPlanNameAxis" xlink:title="RetirementPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DefinedContributionPlanTable" xlink:to="RetirementPlanNameAxis" xlink:title="definition: DefinedContributionPlanTable to RetirementPlanNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="RetirementPlanNameDomain" xlink:title="RetirementPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RetirementPlanNameAxis" xlink:to="RetirementPlanNameDomain" xlink:title="definition: RetirementPlanNameAxis to RetirementPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="RetirementPlanNameDomain_2" xlink:title="RetirementPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RetirementPlanNameAxis" xlink:to="RetirementPlanNameDomain_2" xlink:title="definition: RetirementPlanNameAxis to RetirementPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RetirementPlan401KMember" xlink:label="RetirementPlan401KMember" xlink:title="RetirementPlan401KMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RetirementPlanNameDomain" xlink:to="RetirementPlan401KMember" xlink:title="definition: RetirementPlanNameDomain to RetirementPlan401KMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DefinedContributionPlanTable" xlink:to="RangeAxis" xlink:title="definition: DefinedContributionPlanTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DefinedContributionPlanTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: DefinedContributionPlanTable to SubsequentEventTypeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareDilutedOtherDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to EarningsPerShareDilutedOtherDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="definition: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain_2" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain_2" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to WarrantMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="ConvertiblePreferredStockMember" xlink:title="ConvertiblePreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="ConvertiblePreferredStockMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to ConvertiblePreferredStockMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to RestrictedStockUnitsRSUMember" order="4.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfSharesOfCommonStockOutstanding" xlink:label="PercentageOfSharesOfCommonStockOutstanding" xlink:title="PercentageOfSharesOfCommonStockOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="PercentageOfSharesOfCommonStockOutstanding" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to PercentageOfSharesOfCommonStockOutstanding" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="definition: PlanNameAxis to PlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain_2" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain_2" xlink:title="definition: PlanNameAxis to PlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EquityIncentivePlan2020Member" xlink:label="EquityIncentivePlan2020Member" xlink:title="EquityIncentivePlan2020Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="EquityIncentivePlan2020Member" xlink:title="definition: PlanNameDomain to EquityIncentivePlan2020Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InducementPlan2021Member" xlink:label="InducementPlan2021Member" xlink:title="InducementPlan2021Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="InducementPlan2021Member" xlink:title="definition: PlanNameDomain to InducementPlan2021Member" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IncentiveStockOptionsMember" xlink:label="IncentiveStockOptionsMember" xlink:title="IncentiveStockOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EmployeeStockOptionMember" xlink:to="IncentiveStockOptionsMember" xlink:title="definition: EmployeeStockOptionMember to IncentiveStockOptionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NonQualifiedStockOptionMember" xlink:label="NonQualifiedStockOptionMember" xlink:title="NonQualifiedStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EmployeeStockOptionMember" xlink:to="NonQualifiedStockOptionMember" xlink:title="definition: EmployeeStockOptionMember to NonQualifiedStockOptionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="6.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AggregateIntrinsicValueAbstract" xlink:label="AggregateIntrinsicValueAbstract" xlink:title="AggregateIntrinsicValueAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AggregateIntrinsicValueAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AggregateIntrinsicValueAbstract" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="19.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TimeBasedStockOptionMember" xlink:label="TimeBasedStockOptionMember" xlink:title="TimeBasedStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EmployeeStockOptionMember" xlink:to="TimeBasedStockOptionMember" xlink:title="definition: EmployeeStockOptionMember to TimeBasedStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PerformanceBasedStockOptionMember" xlink:label="PerformanceBasedStockOptionMember" xlink:title="PerformanceBasedStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EmployeeStockOptionMember" xlink:to="PerformanceBasedStockOptionMember" xlink:title="definition: EmployeeStockOptionMember to PerformanceBasedStockOptionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationRsusDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="13.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfAwardsVestedAndSettledAbstract" xlink:label="NumberOfAwardsVestedAndSettledAbstract" xlink:title="NumberOfAwardsVestedAndSettledAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="NumberOfAwardsVestedAndSettledAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to NumberOfAwardsVestedAndSettledAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonStockWithheldToCoverTaxes" xlink:label="CommonStockWithheldToCoverTaxes" xlink:title="CommonStockWithheldToCoverTaxes" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="CommonStockWithheldToCoverTaxes" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to CommonStockWithheldToCoverTaxes" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="6.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:label="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="IncomeStatementLocationAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to IncomeStatementLocationAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain_2" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain_2" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PrivatePlacementOfEquityAbstract" xlink:label="PrivatePlacementOfEquityAbstract" xlink:title="PrivatePlacementOfEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="PrivatePlacementOfEquityAbstract" xlink:title="definition: SubsidiarySaleOfStockLineItems to PrivatePlacementOfEquityAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="definition: SubsidiarySaleOfStockLineItems to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="definition: SubsidiarySaleOfStockLineItems to StockRepurchaseProgramAuthorizedAmount1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ProceedsFromIssuanceOfWarrants" xlink:title="definition: SubsidiarySaleOfStockLineItems to ProceedsFromIssuanceOfWarrants" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_VariableRateTransactionsPeriod" xlink:label="VariableRateTransactionsPeriod" xlink:title="VariableRateTransactionsPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="VariableRateTransactionsPeriod" xlink:title="definition: SubsidiarySaleOfStockLineItems to VariableRateTransactionsPeriod" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_UnitPriceOfWarrants" xlink:label="UnitPriceOfWarrants" xlink:title="UnitPriceOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="UnitPriceOfWarrants" xlink:title="definition: SubsidiarySaleOfStockLineItems to UnitPriceOfWarrants" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfWarrantsInEachUnit" xlink:label="NumberOfWarrantsInEachUnit" xlink:title="NumberOfWarrantsInEachUnit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="NumberOfWarrantsInEachUnit" xlink:title="definition: SubsidiarySaleOfStockLineItems to NumberOfWarrantsInEachUnit" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:label="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightsExercisableTerm" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightsExercisableTerm" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="definition: SubsidiarySaleOfStockLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightExercised" xlink:label="ClassOfWarrantOrRightExercised" xlink:title="ClassOfWarrantOrRightExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightExercised" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightExercised" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="definition: SubsidiarySaleOfStockLineItems to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="OverSubscriptionAmountReceived" xlink:title="definition: SubsidiarySaleOfStockLineItems to OverSubscriptionAmountReceived" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:label="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="definition: SubsidiarySaleOfStockLineItems to ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ObligationToPayLiquidatedDamagesPercentage" xlink:label="ObligationToPayLiquidatedDamagesPercentage" xlink:title="ObligationToPayLiquidatedDamagesPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ObligationToPayLiquidatedDamagesPercentage" xlink:title="definition: SubsidiarySaleOfStockLineItems to ObligationToPayLiquidatedDamagesPercentage" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TransactionFeesPayable" xlink:label="TransactionFeesPayable" xlink:title="TransactionFeesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="TransactionFeesPayable" xlink:title="definition: SubsidiarySaleOfStockLineItems to TransactionFeesPayable" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AggregateCalendarDays" xlink:label="AggregateCalendarDays" xlink:title="AggregateCalendarDays" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="AggregateCalendarDays" xlink:title="definition: SubsidiarySaleOfStockLineItems to AggregateCalendarDays" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="LossContingencyEstimateOfPossibleLoss" xlink:title="LossContingencyEstimateOfPossibleLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="LossContingencyEstimateOfPossibleLoss" xlink:title="definition: SubsidiarySaleOfStockLineItems to LossContingencyEstimateOfPossibleLoss" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="LossContingencyDamagesPaidValue" xlink:title="LossContingencyDamagesPaidValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="LossContingencyDamagesPaidValue" xlink:title="definition: SubsidiarySaleOfStockLineItems to LossContingencyDamagesPaidValue" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="definition: SubsidiarySaleOfStockLineItems to WarrantsAndRightsOutstandingTerm" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="definition: SubsidiarySaleOfStockLineItems to SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="23.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="InvestmentTypeAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to InvestmentTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember_2" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember_2" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PIPEInvestorOneMember" xlink:label="PIPEInvestorOneMember" xlink:title="PIPEInvestorOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorOneMember" xlink:title="definition: InvestmentTypeCategorizationMember to PIPEInvestorOneMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="definition: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to ClassOfWarrantOrRightAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="WarrantMember" xlink:title="definition: ClassOfWarrantOrRightDomain to WarrantMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsOneMember" xlink:label="CommonWarrantsOneMember" xlink:title="CommonWarrantsOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="WarrantMember" xlink:to="CommonWarrantsOneMember" xlink:title="definition: WarrantMember to CommonWarrantsOneMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="WarrantMember" xlink:to="CommonWarrantsMember" xlink:title="definition: WarrantMember to CommonWarrantsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="WarrantMember" xlink:to="PreFundedWarrantsMember" xlink:title="definition: WarrantMember to PreFundedWarrantsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to StatementEquityComponentsAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="RangeAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to RangeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="ClassOfWarrantOrRightLineItems" xlink:title="ClassOfWarrantOrRightLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="definition: ClassOfWarrantOrRightLineItems to WarrantsAndRightsNoteDisclosureAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightOutstanding" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightOutstanding" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightGrantsInPeriod" xlink:label="ClassOfWarrantOrRightGrantsInPeriod" xlink:title="ClassOfWarrantOrRightGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightGrantsInPeriod" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightGrantsInPeriod" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightExercisedInPeriod" xlink:label="ClassOfWarrantOrRightExercisedInPeriod" xlink:title="ClassOfWarrantOrRightExercisedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightExercisedInPeriod" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightExercisedInPeriod" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="ClassOfWarrantOrRightTable" xlink:title="ClassOfWarrantOrRightTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightTable" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ClassOfWarrantOrRightTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: ClassOfWarrantOrRightTable to ClassOfWarrantOrRightAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="WarrantMember" xlink:title="definition: ClassOfWarrantOrRightDomain to WarrantMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_March2022WarrantsMember" xlink:label="March2022WarrantsMember" xlink:title="March2022WarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="WarrantMember" xlink:to="March2022WarrantsMember" xlink:title="definition: WarrantMember to March2022WarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="WarrantMember" xlink:to="PreFundedWarrantsMember" xlink:title="definition: WarrantMember to PreFundedWarrantsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_November2022WarrantsMember" xlink:label="November2022WarrantsMember" xlink:title="November2022WarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="WarrantMember" xlink:to="November2022WarrantsMember" xlink:title="definition: WarrantMember to November2022WarrantsMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PrivatePlacementOfferingsAbstract" xlink:label="PrivatePlacementOfferingsAbstract" xlink:title="PrivatePlacementOfferingsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="PrivatePlacementOfferingsAbstract" xlink:title="definition: SubsidiarySaleOfStockLineItems to PrivatePlacementOfferingsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="definition: SubsidiarySaleOfStockLineItems to ProceedsFromIssuanceOfCommonStock" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:label="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:title="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:title="definition: SubsidiarySaleOfStockLineItems to NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" xlink:label="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" xlink:title="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" xlink:title="definition: SubsidiarySaleOfStockLineItems to NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="CommonStockSharesAuthorized" xlink:title="definition: SubsidiarySaleOfStockLineItems to CommonStockSharesAuthorized" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommitmentAmountToMeetAnySingleRegularPurchase" xlink:label="CommitmentAmountToMeetAnySingleRegularPurchase" xlink:title="CommitmentAmountToMeetAnySingleRegularPurchase" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="CommitmentAmountToMeetAnySingleRegularPurchase" xlink:title="definition: SubsidiarySaleOfStockLineItems to CommitmentAmountToMeetAnySingleRegularPurchase" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BeneficialOwnershipPercentageOnTotalOutstandingShares" xlink:label="BeneficialOwnershipPercentageOnTotalOutstandingShares" xlink:title="BeneficialOwnershipPercentageOnTotalOutstandingShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="BeneficialOwnershipPercentageOnTotalOutstandingShares" xlink:title="definition: SubsidiarySaleOfStockLineItems to BeneficialOwnershipPercentageOnTotalOutstandingShares" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="definition: SubsidiarySaleOfStockLineItems to SaleOfStockNumberOfSharesIssuedInTransaction" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="ProceedsFromIssuanceOrSaleOfEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="definition: SubsidiarySaleOfStockLineItems to ProceedsFromIssuanceOrSaleOfEquity" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesToIssuedInTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:title="definition: SubsidiarySaleOfStockLineItems to SaleOfStockNumberOfSharesToIssuedInTransaction" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="definition: SubsidiarySaleOfStockLineItems to SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="11.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to TypeOfArrangementAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PurchaseAgreementMember" xlink:label="PurchaseAgreementMember" xlink:title="PurchaseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="PurchaseAgreementMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to PurchaseAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_FirstPurchaseAgreementMember" xlink:label="FirstPurchaseAgreementMember" xlink:title="FirstPurchaseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PurchaseAgreementMember" xlink:to="FirstPurchaseAgreementMember" xlink:title="definition: PurchaseAgreementMember to FirstPurchaseAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SecondPurchaseAgreementMember" xlink:label="SecondPurchaseAgreementMember" xlink:title="SecondPurchaseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PurchaseAgreementMember" xlink:to="SecondPurchaseAgreementMember" xlink:title="definition: PurchaseAgreementMember to SecondPurchaseAgreementMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="LegalEntityAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to LegalEntityAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="definition: LegalEntityAxis to EntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="EntityDomain_2" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LegalEntityAxis" xlink:to="EntityDomain_2" xlink:title="definition: LegalEntityAxis to EntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LincolnParkCapitalFundLLCMember" xlink:label="LincolnParkCapitalFundLLCMember" xlink:title="LincolnParkCapitalFundLLCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityDomain" xlink:to="LincolnParkCapitalFundLLCMember" xlink:title="definition: EntityDomain to LincolnParkCapitalFundLLCMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="RangeAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsMergerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_MergerAbstract" xlink:label="MergerAbstract" xlink:title="MergerAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="MergerAbstract" xlink:title="definition: ClassOfStockLineItems to MergerAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="SharesIssued" xlink:title="SharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SharesIssued" xlink:title="definition: ClassOfStockLineItems to SharesIssued" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="ConversionOfStockSharesConverted1" xlink:title="ConversionOfStockSharesConverted1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ConversionOfStockSharesConverted1" xlink:title="definition: ClassOfStockLineItems to ConversionOfStockSharesConverted1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightIssued" xlink:label="ClassOfWarrantOrRightIssued" xlink:title="ClassOfWarrantOrRightIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightIssued" xlink:title="definition: ClassOfStockLineItems to ClassOfWarrantOrRightIssued" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: ClassOfStockLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="definition: ClassOfStockLineItems to StockIssuedDuringPeriodSharesAcquisitions1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ClassOfStockLineItems" xlink:to="ScheduleOfStockByClassTable" xlink:title="definition: ClassOfStockLineItems to ScheduleOfStockByClassTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: ScheduleOfStockByClassTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: ScheduleOfStockByClassTable to StatementClassOfStockAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="definition: ClassOfStockDomain to CommonClassAMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassBMember" xlink:title="definition: ClassOfStockDomain to CommonClassBMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassCMember" xlink:title="definition: ClassOfStockDomain to CommonClassCMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfStockByClassTable to BusinessAcquisitionAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: ClassOfStockLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="definition: ClassOfStockLineItems to StockIssuedDuringPeriodSharesAcquisitions" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="definition: ClassOfStockLineItems to StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="definition: ClassOfStockLineItems to StockIssuedDuringPeriodSharesIssuedForServices" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EachLockUpAgreementExtendsTerm" xlink:label="EachLockUpAgreementExtendsTerm" xlink:title="EachLockUpAgreementExtendsTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="EachLockUpAgreementExtendsTerm" xlink:title="definition: ClassOfStockLineItems to EachLockUpAgreementExtendsTerm" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfCommonStockSubjectToLockUpAgreement" xlink:label="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="PercentageOfCommonStockSubjectToLockUpAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="definition: ClassOfStockLineItems to PercentageOfCommonStockSubjectToLockUpAgreement" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ClassOfStockLineItems" xlink:to="ScheduleOfStockByClassTable" xlink:title="definition: ClassOfStockLineItems to ScheduleOfStockByClassTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfStockByClassTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to NovellusTherapeuticsLimitedMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: ScheduleOfStockByClassTable to RelatedPartyTransactionsByRelatedPartyAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:label="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="definition: RelatedPartyDomain to ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfStockByClassTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:label="FeaturesOfConvertiblePreferredStockAbstract" xlink:title="FeaturesOfConvertiblePreferredStockAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="FeaturesOfConvertiblePreferredStockAbstract" xlink:title="definition: ClassOfStockLineItems to FeaturesOfConvertiblePreferredStockAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PreferredStockSharesAuthorized" xlink:title="definition: ClassOfStockLineItems to PreferredStockSharesAuthorized" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PreferredStockSharesIssued" xlink:title="definition: ClassOfStockLineItems to PreferredStockSharesIssued" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PreferredStockSharesOutstanding" xlink:title="definition: ClassOfStockLineItems to PreferredStockSharesOutstanding" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare" xlink:label="DividendsPayableAmountPerShare" xlink:title="DividendsPayableAmountPerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="DividendsPayableAmountPerShare" xlink:title="definition: ClassOfStockLineItems to DividendsPayableAmountPerShare" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="DividendsPreferredStockCash" xlink:title="DividendsPreferredStockCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="DividendsPreferredStockCash" xlink:title="definition: ClassOfStockLineItems to DividendsPreferredStockCash" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="PreferredStockDividendsShares" xlink:title="PreferredStockDividendsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PreferredStockDividendsShares" xlink:title="definition: ClassOfStockLineItems to PreferredStockDividendsShares" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="PreferredStockLiquidationPreference" xlink:title="PreferredStockLiquidationPreference" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PreferredStockLiquidationPreference" xlink:title="definition: ClassOfStockLineItems to PreferredStockLiquidationPreference" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionRatio" xlink:label="PreferredStockConvertibleConversionRatio" xlink:title="PreferredStockConvertibleConversionRatio" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PreferredStockConvertibleConversionRatio" xlink:title="definition: ClassOfStockLineItems to PreferredStockConvertibleConversionRatio" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="ConvertiblePreferredStockSharesIssuedUponConversion" xlink:title="ConvertiblePreferredStockSharesIssuedUponConversion" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ConvertiblePreferredStockSharesIssuedUponConversion" xlink:title="definition: ClassOfStockLineItems to ConvertiblePreferredStockSharesIssuedUponConversion" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="PreferredStockConvertibleSharesIssuable" xlink:title="PreferredStockConvertibleSharesIssuable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PreferredStockConvertibleSharesIssuable" xlink:title="definition: ClassOfStockLineItems to PreferredStockConvertibleSharesIssuable" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="definition: ClassOfStockLineItems to StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ClassOfStockLineItems" xlink:to="ScheduleOfStockByClassTable" xlink:title="definition: ClassOfStockLineItems to ScheduleOfStockByClassTable" order="13.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: ScheduleOfStockByClassTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: ScheduleOfStockByClassTable to StatementClassOfStockAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="definition: ClassOfStockDomain to SeriesAPreferredStockMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="OperatingLossCarryforwardsLineItems" xlink:title="OperatingLossCarryforwardsLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IncomeTaxAbstract" xlink:label="IncomeTaxAbstract" xlink:title="IncomeTaxAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="IncomeTaxAbstract" xlink:title="definition: OperatingLossCarryforwardsLineItems to IncomeTaxAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="definition: OperatingLossCarryforwardsLineItems to ValuationAllowanceDeferredTaxAssetChangeInAmount" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwards" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwards" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TaxCutsAndJobsActOperatingLossCarryforwards" xlink:label="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:title="TaxCutsAndJobsActOperatingLossCarryforwards" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:title="definition: OperatingLossCarryforwardsLineItems to TaxCutsAndJobsActOperatingLossCarryforwards" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="TaxCreditCarryforwardAmount" xlink:title="TaxCreditCarryforwardAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="TaxCreditCarryforwardAmount" xlink:title="definition: OperatingLossCarryforwardsLineItems to TaxCreditCarryforwardAmount" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLossCarryforwardsExpirationYear" xlink:label="OperatingLossCarryforwardsExpirationYear" xlink:title="OperatingLossCarryforwardsExpirationYear" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsExpirationYear" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsExpirationYear" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TaxCreditCarryforwardExpirationYear" xlink:label="TaxCreditCarryforwardExpirationYear" xlink:title="TaxCreditCarryforwardExpirationYear" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="TaxCreditCarryforwardExpirationYear" xlink:title="definition: OperatingLossCarryforwardsLineItems to TaxCreditCarryforwardExpirationYear" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="definition: OperatingLossCarryforwardsLineItems to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OpenTaxYear" xlink:label="OpenTaxYear" xlink:title="OpenTaxYear" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OpenTaxYear" xlink:title="definition: OperatingLossCarryforwardsLineItems to OpenTaxYear" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="OperatingLossCarryforwardsTable" xlink:title="OperatingLossCarryforwardsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsTable" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsTable" order="10.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="OperatingLossCarryforwardsTable" xlink:to="IncomeTaxAuthorityAxis" xlink:title="definition: OperatingLossCarryforwardsTable to IncomeTaxAuthorityAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain" xlink:title="definition: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain_2" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain_2" xlink:title="definition: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="DomesticCountryMember" xlink:title="DomesticCountryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="DomesticCountryMember" xlink:title="definition: IncomeTaxAuthorityDomain to DomesticCountryMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="StateAndLocalJurisdictionMember" xlink:title="definition: IncomeTaxAuthorityDomain to StateAndLocalJurisdictionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="ForeignCountryMember" xlink:title="ForeignCountryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="ForeignCountryMember" xlink:title="definition: IncomeTaxAuthorityDomain to ForeignCountryMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LicenseAgreementAbstract" xlink:label="LicenseAgreementAbstract" xlink:title="LicenseAgreementAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="LicenseAgreementAbstract" xlink:title="definition: SubsequentEventLineItems to LicenseAgreementAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProceedsFromOptionAndLicenseAgreement" xlink:label="ProceedsFromOptionAndLicenseAgreement" xlink:title="ProceedsFromOptionAndLicenseAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ProceedsFromOptionAndLicenseAgreement" xlink:title="definition: SubsequentEventLineItems to ProceedsFromOptionAndLicenseAgreement" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SubsequentEventLineItems" xlink:to="SubsequentEventTable" xlink:title="definition: SubsequentEventLineItems to SubsequentEventTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: SubsequentEventTable to SubsequentEventTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>16
<FILENAME>erna-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.2.1.5134 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AreaOfRealEstateProperty_lbl" xml:lang="en-US" id="us-gaap_AreaOfRealEstateProperty_lbl">Area of office and laboratory space</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AreaOfRealEstateProperty" xlink:to="us-gaap_AreaOfRealEstateProperty_lbl" xlink:title="label: AreaOfRealEstateProperty to us-gaap_AreaOfRealEstateProperty_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AreaOfRealEstateProperty_lbl1" xml:lang="en-US" id="us-gaap_AreaOfRealEstateProperty_lbl1">Area of premises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AreaOfRealEstateProperty" xlink:to="us-gaap_AreaOfRealEstateProperty_lbl1" xlink:title="label: AreaOfRealEstateProperty to us-gaap_AreaOfRealEstateProperty_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US" id="us-gaap_AwardTypeAxis_lbl">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:title="label: AwardTypeAxis to us-gaap_AwardTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xml:lang="en-US" id="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:title="label: ArrangementsAndNonarrangementTransactionsMember to us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" id="us-gaap_AccountingPoliciesAbstract_lbl">Basis of Accounting Presentation and Summary of Significant Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:title="label: AccountingPoliciesAbstract to us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent_lbl">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:title="label: AccountsPayableCurrent to us-gaap_AccountsPayableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent_lbl1">Accounts Payable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl1" xlink:title="label: AccountsPayableCurrent to us-gaap_AccountsPayableCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedProfessionalFeesCurrent_lbl">Legal fees and related</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:title="label: AccruedProfessionalFeesCurrent to us-gaap_AccruedProfessionalFeesCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl">Accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl1">Total accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl2" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl2">Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl">Less accumulated depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapital_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl1">Additional Paid in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl1" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl1">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl">Stock based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl">Stock based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl1">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl2" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl2">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl2" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesNameDomain_lbl">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:title="label: AntidilutiveSecuritiesNameDomain to us-gaap_AntidilutiveSecuritiesNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl">Total potential common shares excluded from computation (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:label="AssetAcquisitionTableTextBlock" xlink:title="AssetAcquisitionTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_AssetAcquisitionTableTextBlock_lbl">Fair Value of Asset Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionTableTextBlock" xlink:to="us-gaap_AssetAcquisitionTableTextBlock_lbl" xlink:title="label: AssetAcquisitionTableTextBlock to us-gaap_AssetAcquisitionTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="AssetAcquisitionAxis" xlink:title="AssetAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionAxis_lbl" xml:lang="en-US" id="us-gaap_AssetAcquisitionAxis_lbl">Asset Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionAxis_lbl" xlink:title="label: AssetAcquisitionAxis to us-gaap_AssetAcquisitionAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="AssetAcquisitionDomain" xlink:title="AssetAcquisitionDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionDomain_lbl" xml:lang="en-US" id="us-gaap_AssetAcquisitionDomain_lbl">Asset Acquisition [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionDomain" xlink:to="us-gaap_AssetAcquisitionDomain_lbl" xlink:title="label: AssetAcquisitionDomain to us-gaap_AssetAcquisitionDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl1">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl1" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:label="AssetsAndLiabilitiesLesseeAbstract" xlink:title="AssetsAndLiabilitiesLesseeAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl">Assets and Liabilities, Lessee [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAndLiabilitiesLesseeAbstract" xlink:to="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" xlink:title="label: AssetsAndLiabilitiesLesseeAbstract to us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Assets_lbl" xml:lang="en-US" id="us-gaap_Assets_lbl">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl" xlink:title="label: Assets to us-gaap_Assets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Assets_lbl1" xml:lang="en-US" id="us-gaap_Assets_lbl1">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl1" xlink:title="label: Assets to us-gaap_Assets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl1">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl1" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl1">Assets, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl1" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl">Carrying value of assets sold [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xlink:title="label: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="BalanceSheetLocationDomain" xlink:title="BalanceSheetLocationDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BalanceSheetLocationDomain_lbl" xml:lang="en-US" id="us-gaap_BalanceSheetLocationDomain_lbl">Balance Sheet Location [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl" xlink:title="label: BalanceSheetLocationDomain to us-gaap_BalanceSheetLocationDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="BalanceSheetLocationAxis" xlink:title="BalanceSheetLocationAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US" id="us-gaap_BalanceSheetLocationAxis_lbl">Balance Sheet Location [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xlink:title="label: BalanceSheetLocationAxis to us-gaap_BalanceSheetLocationAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:title="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" id="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl">Basis of Accounting Presentation and Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xlink:title="label: BasisOfPresentationAndSignificantAccountingPoliciesTextBlock to us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl">Basis of Accounting Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:title="label: BasisOfAccountingPolicyPolicyTextBlock to us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xlink:title="label: BasisOfAccountingPolicyPolicyTextBlock to us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl">Intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl">Accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl">Accounts payable, accrued liabilities and other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl">Prepaid expense and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAxis_lbl">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:title="label: BusinessAcquisitionAxis to us-gaap_BusinessAcquisitionAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="BusinessAcquisitionSharePrice" xlink:title="BusinessAcquisitionSharePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionSharePrice_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionSharePrice_lbl">Closing price of common stock (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:title="label: BusinessAcquisitionSharePrice to us-gaap_BusinessAcquisitionSharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionSharePrice_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionSharePrice_lbl1">Business Acquisition, Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl1" xlink:title="label: BusinessAcquisitionSharePrice to us-gaap_BusinessAcquisitionSharePrice_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAcquireeDomain_lbl">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:title="label: BusinessAcquisitionAcquireeDomain to us-gaap_BusinessAcquisitionAcquireeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationsAbstract_lbl">Merger, Disposition and Acquisition Transactions [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:title="label: BusinessCombinationsAbstract to us-gaap_BusinessCombinationsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionLineItems_lbl">Business Acquisition [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:title="label: BusinessAcquisitionLineItems to us-gaap_BusinessAcquisitionLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl">Number of common stock issued in exchange of membership interests (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:title="label: BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued to us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1" xlink:title="label: BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued to us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl">Percentage of outstanding common stock received by members and financial adviser</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl">Total consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityTransactionCosts to us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1">Purchase price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityTransactionCosts to us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract_lbl">Acquisitions [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract_lbl1">Description of Business [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract_lbl1" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract_lbl2" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract_lbl2">Merger Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract_lbl2" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl">Net assets acquired, excluding goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl">Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:label="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:title="CashAndCashEquivalentsAtCarryingValueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl">Cash and Cash Equivalents [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl" xlink:title="label: CashAndCashEquivalentsAtCarryingValueAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl1">Cash and Cash Equivalents, at Carrying Value [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl1" xlink:title="label: CashAndCashEquivalentsAtCarryingValueAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2">Total Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl3" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl3">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl3" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl">Net (decrease) increase in cash, cash equivalents and restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Cash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_Cash_lbl" xml:lang="en-US" id="us-gaap_Cash_lbl">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Cash" xlink:to="us-gaap_Cash_lbl" xlink:title="label: Cash to us-gaap_Cash_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Cash_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Cash_lbl1" xml:lang="en-US" id="us-gaap_Cash_lbl1">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Cash" xlink:to="us-gaap_Cash_lbl1" xlink:title="label: Cash to us-gaap_Cash_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_CashAcquiredFromAcquisition_lbl" xml:lang="en-US" id="us-gaap_CashAcquiredFromAcquisition_lbl">Cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:title="label: CashAcquiredFromAcquisition to us-gaap_CashAcquiredFromAcquisition_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAcquiredFromAcquisition_lbl1" xml:lang="en-US" id="us-gaap_CashAcquiredFromAcquisition_lbl1">Cash Acquired from Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl1" xlink:title="label: CashAcquiredFromAcquisition to us-gaap_CashAcquiredFromAcquisition_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="CashEquivalentsAtCarryingValue" xlink:title="CashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="us-gaap_CashEquivalentsAtCarryingValue_lbl">Cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:title="label: CashEquivalentsAtCarryingValue to us-gaap_CashEquivalentsAtCarryingValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US" id="us-gaap_CashEquivalentsAtCarryingValue_lbl1">Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl1" xlink:title="label: CashEquivalentsAtCarryingValue to us-gaap_CashEquivalentsAtCarryingValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:title="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl">Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:title="label: CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy to us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl1">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl1" xlink:title="label: CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy to us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl">Supplemental disclosure of non-cash investing and financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl">Warrants exercisable (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1">Number of rights options converted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightAxis_lbl">Class of Warrant or Right [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:title="label: ClassOfWarrantOrRightAxis to us-gaap_ClassOfWarrantOrRightAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="ClassOfWarrantOrRightLineItems" xlink:title="ClassOfWarrantOrRightLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightLineItems_lbl">Class of Warrant or Right [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:title="label: ClassOfWarrantOrRightLineItems to us-gaap_ClassOfWarrantOrRightLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockLineItems_lbl">Class of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:title="label: ClassOfStockLineItems to us-gaap_ClassOfStockLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl">Number of common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="ClassOfWarrantOrRightTable" xlink:title="ClassOfWarrantOrRightTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightTable_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightTable_lbl">Class of Warrant or Right [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:title="label: ClassOfWarrantOrRightTable to us-gaap_ClassOfWarrantOrRightTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl">Warrant exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:title="label: ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1">Warrant exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" xlink:title="label: ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightDomain_lbl">Class of Warrant or Right [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:title="label: ClassOfWarrantOrRightDomain to us-gaap_ClassOfWarrantOrRightDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightOutstanding_lbl">Warrants outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:title="label: ClassOfWarrantOrRightOutstanding to us-gaap_ClassOfWarrantOrRightOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ClassOfWarrantOrRightOutstanding_lbl1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightOutstanding_lbl1">Beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl1" xlink:title="label: ClassOfWarrantOrRightOutstanding to us-gaap_ClassOfWarrantOrRightOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ClassOfWarrantOrRightOutstanding_lbl2" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightOutstanding_lbl2">Ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl2" xlink:title="label: ClassOfWarrantOrRightOutstanding to us-gaap_ClassOfWarrantOrRightOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl">Commitments and Contingencies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureAbstract to us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="CommitmentsAndContingenciesPolicyTextBlock" xlink:title="CommitmentsAndContingenciesPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl">Commitment and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:title="label: CommitmentsAndContingenciesPolicyTextBlock to us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl1">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl1" xlink:title="label: CommitmentsAndContingenciesPolicyTextBlock to us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingencies_lbl">Commitments and contingencies (Note 12)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:title="label: CommitmentsAndContingencies to us-gaap_CommitmentsAndContingencies_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember_lbl1" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl1">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonClassCMember_lbl" xml:lang="en-US" id="us-gaap_CommonClassCMember_lbl">Class C [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:title="label: CommonClassCMember to us-gaap_CommonClassCMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassCMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonClassCMember_lbl1" xml:lang="en-US" id="us-gaap_CommonClassCMember_lbl1">Common Class C [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl1" xlink:title="label: CommonClassCMember to us-gaap_CommonClassCMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassCMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonClassCMember_lbl2" xml:lang="en-US" id="us-gaap_CommonClassCMember_lbl2">Common Class C [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl2" xlink:title="label: CommonClassCMember to us-gaap_CommonClassCMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonClassAMember_lbl" xml:lang="en-US" id="us-gaap_CommonClassAMember_lbl">Class A [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:title="label: CommonClassAMember to us-gaap_CommonClassAMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonClassAMember_lbl1" xml:lang="en-US" id="us-gaap_CommonClassAMember_lbl1">Common Class A [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl1" xlink:title="label: CommonClassAMember to us-gaap_CommonClassAMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonClassAMember_lbl2" xml:lang="en-US" id="us-gaap_CommonClassAMember_lbl2">Common Class A [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl2" xlink:title="label: CommonClassAMember to us-gaap_CommonClassAMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonClassBMember_lbl" xml:lang="en-US" id="us-gaap_CommonClassBMember_lbl">Class B [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:title="label: CommonClassBMember to us-gaap_CommonClassBMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonClassBMember_lbl1" xml:lang="en-US" id="us-gaap_CommonClassBMember_lbl1">Common Class B [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl1" xlink:title="label: CommonClassBMember to us-gaap_CommonClassBMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonClassBMember_lbl2" xml:lang="en-US" id="us-gaap_CommonClassBMember_lbl2">Common Class B [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl2" xlink:title="label: CommonClassBMember to us-gaap_CommonClassBMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl">Common stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl">Common stock, $0.005 par value, 100,000 shares authorized at December 31, 2022 and 2021; 5,127 and 2,601 issued and outstanding at December 31, 2022 and 2021, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl">Common stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl">Number of shares authorized to sale in regular purchase (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl1">Common stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding_lbl">Common stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:title="label: CommonStockSharesOutstanding to us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding_lbl1">Number of shares of common stock owned by stockholders immediately before the Merger (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl1" xlink:title="label: CommonStockSharesOutstanding to us-gaap_CommonStockSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:title="label: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" id="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl">Components of Income Tax Provision [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:title="label: ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xml:lang="en-US" id="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:title="label: ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US" id="us-gaap_ComputerEquipmentMember_lbl">Computer Equipment and Programs [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:title="label: ComputerEquipmentMember to us-gaap_ComputerEquipmentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComputerEquipmentMember_lbl1" xml:lang="en-US" id="us-gaap_ComputerEquipmentMember_lbl1">Computer Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl1" xlink:title="label: ComputerEquipmentMember to us-gaap_ComputerEquipmentMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="ConcentrationRiskCreditRisk" xlink:title="ConcentrationRiskCreditRisk" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US" id="us-gaap_ConcentrationRiskCreditRisk_lbl">Concentration of Credit Risk</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:title="label: ConcentrationRiskCreditRisk to us-gaap_ConcentrationRiskCreditRisk_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConcentrationRiskCreditRisk_lbl1" xml:lang="en-US" id="us-gaap_ConcentrationRiskCreditRisk_lbl1">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl1" xlink:title="label: ConcentrationRiskCreditRisk to us-gaap_ConcentrationRiskCreditRisk_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="ConversionOfStockSharesConverted1" xlink:title="ConversionOfStockSharesConverted1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US" id="us-gaap_ConversionOfStockSharesConverted1_lbl">Number of shares converted to common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:title="label: ConversionOfStockSharesConverted1 to us-gaap_ConversionOfStockSharesConverted1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConversionOfStockSharesConverted1_lbl1" xml:lang="en-US" id="us-gaap_ConversionOfStockSharesConverted1_lbl1">Conversion of Stock, Shares Converted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl1" xlink:title="label: ConversionOfStockSharesConverted1 to us-gaap_ConversionOfStockSharesConverted1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="ConvertiblePreferredStockMember" xlink:title="ConvertiblePreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="us-gaap_ConvertiblePreferredStockMember_lbl">Preferred Stock Converted into Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:title="label: ConvertiblePreferredStockMember to us-gaap_ConvertiblePreferredStockMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="ConvertiblePreferredStockSharesIssuedUponConversion" xlink:title="ConvertiblePreferredStockSharesIssuedUponConversion" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xml:lang="en-US" id="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl">Each preferred stock converted into common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:title="label: ConvertiblePreferredStockSharesIssuedUponConversion to us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:title="label: CurrentStateAndLocalTaxExpenseBenefit to us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_CurrentFederalTaxExpenseBenefit_lbl">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:title="label: CurrentFederalTaxExpenseBenefit to us-gaap_CurrentFederalTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1">Current Federal Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xlink:title="label: CurrentFederalTaxExpenseBenefit to us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="CurrentForeignTaxExpenseBenefit" xlink:title="CurrentForeignTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_CurrentForeignTaxExpenseBenefit_lbl">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:title="label: CurrentForeignTaxExpenseBenefit to us-gaap_CurrentForeignTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentForeignTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentForeignTaxExpenseBenefit_lbl1">Current Foreign Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl1" xlink:title="label: CurrentForeignTaxExpenseBenefit to us-gaap_CurrentForeignTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl">Current income tax provision</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:title="label: CurrentIncomeTaxExpenseBenefit to us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1">Current Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xlink:title="label: CurrentIncomeTaxExpenseBenefit to us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl">Current Tax Provision [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:title="label: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:title="label: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US" id="us-gaap_CustomerRelationshipsMember_lbl">Customers [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:title="label: CustomerRelationshipsMember to us-gaap_CustomerRelationshipsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CustomerRelationshipsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CustomerRelationshipsMember_lbl1" xml:lang="en-US" id="us-gaap_CustomerRelationshipsMember_lbl1">Customer Relationships [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl1" xlink:title="label: CustomerRelationshipsMember to us-gaap_CustomerRelationshipsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_DebtDisclosureAbstract_lbl">Debt [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:title="label: DebtDisclosureAbstract to us-gaap_DebtDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentTable_lbl">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:title="label: DebtInstrumentTable to us-gaap_DebtInstrumentTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_DebtDisclosureTextBlock_lbl">Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:title="label: DebtDisclosureTextBlock to us-gaap_DebtDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentAxis_lbl">Debt Instrument [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:title="label: DebtInstrumentAxis to us-gaap_DebtInstrumentAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentLineItems_lbl">Debt Instrument [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:title="label: DebtInstrumentLineItems to us-gaap_DebtInstrumentLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount_lbl">Principal amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentFaceAmount_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount_lbl1">Debt Instrument, Face Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl1" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl">Interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentNameDomain_lbl">Debt Instrument, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" xlink:title="label: DebtInstrumentNameDomain to us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="DeferredTaxLiabilitiesNetAbstract" xlink:title="DeferredTaxLiabilitiesNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl">Deferred Tax Liabilities: [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:title="label: DeferredTaxLiabilitiesNetAbstract to us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl1">Deferred Tax Liabilities, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl1" xlink:title="label: DeferredTaxLiabilitiesNetAbstract to us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredFederalIncomeTaxExpenseBenefit to us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredFederalIncomeTaxExpenseBenefit to us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="DeferredForeignIncomeTaxExpenseBenefit" xlink:title="DeferredForeignIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredForeignIncomeTaxExpenseBenefit to us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl1">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredForeignIncomeTaxExpenseBenefit to us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxLiabilities_lbl">Total deferred tax liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:title="label: DeferredIncomeTaxLiabilities to us-gaap_DeferredIncomeTaxLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxLiabilities_lbl1">Deferred Tax Liabilities, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xlink:title="label: DeferredIncomeTaxLiabilities to us-gaap_DeferredIncomeTaxLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl">Deferred Tax Provision [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:title="label: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:title="label: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl">Deferred Income tax provision</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1">Deferred Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredStateAndLocalIncomeTaxExpenseBenefit to us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredStateAndLocalIncomeTaxExpenseBenefit to us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="DeferredTaxAssetsNetAbstract" xlink:title="DeferredTaxAssetsNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsNetAbstract_lbl">Deferred Tax Assets: [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:title="label: DeferredTaxAssetsNetAbstract to us-gaap_DeferredTaxAssetsNetAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsNetAbstract_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsNetAbstract_lbl1">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl1" xlink:title="label: DeferredTaxAssetsNetAbstract to us-gaap_DeferredTaxAssetsNetAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl">Foreign net operating losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwardsForeign to us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="DeferredTaxAssetsNet" xlink:title="DeferredTaxAssetsNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsNet_lbl">Net deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:title="label: DeferredTaxAssetsNet to us-gaap_DeferredTaxAssetsNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsNet_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsNet_lbl1">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl1" xlink:title="label: DeferredTaxAssetsNet to us-gaap_DeferredTaxAssetsNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGross_lbl">Total gross deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:title="label: DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsGross_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGross_lbl1">Deferred Tax Assets, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl1" xlink:title="label: DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl">In-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:title="label: DeferredTaxAssetsInProcessResearchAndDevelopment to us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl1">Deferred Tax Assets, in Process Research and Development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl1" xlink:title="label: DeferredTaxAssetsInProcessResearchAndDevelopment to us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_lbl">Compensation accrual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_lbl" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:title="DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl">R&amp;D credit carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:title="label: DeferredTaxAssetsTaxCreditCarryforwardsResearch to us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl">Stock compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="DeferredTaxAssetsTaxDeferredExpenseOther" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseOther to us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl1">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl1" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseOther to us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilities_lbl">Net deferred taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:title="label: DeferredTaxLiabilities to us-gaap_DeferredTaxLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilities_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilities_lbl1">Deferred Tax Liabilities, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl1" xlink:title="label: DeferredTaxLiabilities to us-gaap_DeferredTaxLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="DeferredTaxAssetsValuationAllowance" xlink:title="DeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsValuationAllowance_lbl">Valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:title="label: DeferredTaxAssetsValuationAllowance to us-gaap_DeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1" xlink:title="label: DeferredTaxAssetsValuationAllowance to us-gaap_DeferredTaxAssetsValuationAllowance_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:label="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:title="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl">Intangibles - goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl" xlink:title="label: DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill to us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl1">Deferred Tax Liabilities, Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl1" xlink:title="label: DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill to us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl">Fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:title="label: DeferredTaxLiabilitiesPropertyPlantAndEquipment to us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" xlink:title="label: DeferredTaxLiabilitiesPropertyPlantAndEquipment to us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanAbstract" xlink:label="DefinedContributionPlanAbstract" xlink:title="DefinedContributionPlanAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DefinedContributionPlanAbstract_lbl" xml:lang="en-US" id="us-gaap_DefinedContributionPlanAbstract_lbl">Defined Contribution Plan [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanAbstract" xlink:to="us-gaap_DefinedContributionPlanAbstract_lbl" xlink:title="label: DefinedContributionPlanAbstract to us-gaap_DefinedContributionPlanAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="DefinedContributionPlanTable" xlink:title="DefinedContributionPlanTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DefinedContributionPlanTable_lbl" xml:lang="en-US" id="us-gaap_DefinedContributionPlanTable_lbl">Defined Contribution Plan [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanTable" xlink:to="us-gaap_DefinedContributionPlanTable_lbl" xlink:title="label: DefinedContributionPlanTable to us-gaap_DefinedContributionPlanTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="DefinedContributionPlanDisclosureLineItems" xlink:title="DefinedContributionPlanDisclosureLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xml:lang="en-US" id="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl">Defined Contribution Plan Disclosure [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xlink:title="label: DefinedContributionPlanDisclosureLineItems to us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:title="DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl" xml:lang="en-US" id="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl">Maximum employer matching contribution</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl" xlink:title="label: DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent to us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl1" xml:lang="en-US" id="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl1">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl1" xlink:title="label: DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent to us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="DepositsAssetsNoncurrent" xlink:title="DepositsAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US" id="us-gaap_DepositsAssetsNoncurrent_lbl">Security deposit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:title="label: DepositsAssetsNoncurrent to us-gaap_DepositsAssetsNoncurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl1" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl1">Depreciation, Depletion and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Depreciation_lbl" xml:lang="en-US" id="us-gaap_Depreciation_lbl">Depreciation expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:title="label: Depreciation to us-gaap_Depreciation_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl" xml:lang="en-US" id="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl">Warrant Liabilities [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:to="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl" xlink:title="label: DerivativeFinancialInstrumentsLiabilitiesMember to us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="us-gaap_DerivativeLiabilitiesNoncurrent_lbl">Warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xlink:title="label: DerivativeLiabilitiesNoncurrent to us-gaap_DerivativeLiabilitiesNoncurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:label="DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:title="DerivativesMethodsOfAccountingNonhedgingDerivatives" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives_lbl" xml:lang="en-US" id="us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives_lbl">Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:to="us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives_lbl" xlink:title="label: DerivativesMethodsOfAccountingNonhedgingDerivatives to us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl">Stock-Based Compensation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:label="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="DisposalGroupIncludingDiscontinuedOperationGoodwill1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationGoodwill1 to us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationGoodwill1 to us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl">Intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationIntangibleAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationIntangibleAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl">Prepaids and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:label="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationDeferredRevenue to us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:label="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment to us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment to us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities to us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities to us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents to us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents to us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl">Other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities to us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl">Accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet to us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet to us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationOtherAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationOtherAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl">Disposal Group Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" xlink:title="label: DisposalGroupsIncludingDiscontinuedOperationsNameDomain to us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl">Loss on sale of NTN assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl" xlink:title="label: DisposalGroupNotDiscontinuedOperationGainLossOnDisposal to us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl1">Total loss on sale of assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl1" xlink:title="label: DisposalGroupNotDiscontinuedOperationGainLossOnDisposal to us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare" xlink:label="DividendsPayableAmountPerShare" xlink:title="DividendsPayableAmountPerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsPayableAmountPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DividendsPayableAmountPerShare_lbl" xml:lang="en-US" id="us-gaap_DividendsPayableAmountPerShare_lbl">Cumulative annual dividend payable per share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsPayableAmountPerShare" xlink:to="us-gaap_DividendsPayableAmountPerShare_lbl" xlink:title="label: DividendsPayableAmountPerShare to us-gaap_DividendsPayableAmountPerShare_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="DividendsPreferredStockCash" xlink:title="DividendsPreferredStockCash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsPreferredStockCash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DividendsPreferredStockCash_lbl" xml:lang="en-US" id="us-gaap_DividendsPreferredStockCash_lbl">Dividend paid in cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash_lbl" xlink:title="label: DividendsPreferredStockCash to us-gaap_DividendsPreferredStockCash_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsPreferredStockCash_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DividendsPreferredStockCash_lbl1" xml:lang="en-US" id="us-gaap_DividendsPreferredStockCash_lbl1">Cash dividends to Series A preferred stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash_lbl1" xlink:title="label: DividendsPreferredStockCash to us-gaap_DividendsPreferredStockCash_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsPreferredStockCash_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DividendsPreferredStockCash_lbl2" xml:lang="en-US" id="us-gaap_DividendsPreferredStockCash_lbl2">Dividends, Preferred Stock, Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash_lbl2" xlink:title="label: DividendsPreferredStockCash to us-gaap_DividendsPreferredStockCash_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="DomesticCountryMember" xlink:title="DomesticCountryMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US" id="us-gaap_DomesticCountryMember_lbl">Federal [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:title="label: DomesticCountryMember to us-gaap_DomesticCountryMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DomesticCountryMember_lbl1" xml:lang="en-US" id="us-gaap_DomesticCountryMember_lbl1">Domestic Tax Authority [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl1" xlink:title="label: DomesticCountryMember to us-gaap_DomesticCountryMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="DueToRelatedPartiesNoncurrent" xlink:title="DueToRelatedPartiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DueToRelatedPartiesNoncurrent_lbl" xml:lang="en-US" id="us-gaap_DueToRelatedPartiesNoncurrent_lbl">Due to related party, non-current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DueToRelatedPartiesNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent_lbl" xlink:title="label: DueToRelatedPartiesNoncurrent to us-gaap_DueToRelatedPartiesNoncurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="DueToRelatedPartiesCurrent" xlink:title="DueToRelatedPartiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US" id="us-gaap_DueToRelatedPartiesCurrent_lbl">Due to related party, current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:title="label: DueToRelatedPartiesCurrent to us-gaap_DueToRelatedPartiesCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="EarningsPerSharePolicyTextBlock" xlink:title="EarningsPerSharePolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_EarningsPerSharePolicyTextBlock_lbl">Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:title="label: EarningsPerSharePolicyTextBlock to us-gaap_EarningsPerSharePolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerSharePolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerSharePolicyTextBlock_lbl1">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl1" xlink:title="label: EarningsPerSharePolicyTextBlock to us-gaap_EarningsPerSharePolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareDilutedOtherDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl">Anti-dilutive Securities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl" xlink:title="label: EarningsPerShareDilutedOtherDisclosuresAbstract to us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic_lbl">Net loss per common share - basic (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic_lbl1">Earnings Per Share, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareDiluted_lbl">Net loss per common share - diluted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:title="label: EarningsPerShareDiluted to us-gaap_EarningsPerShareDiluted_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl">Basic and Diluted Loss per Common Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareAbstract_lbl">Basic and Diluted Loss per Common Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:title="label: EarningsPerShareAbstract to us-gaap_EarningsPerShareAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl">Federal statutory tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:title="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent to us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl">Change in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance to us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance to us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:title="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl">Foreign tax differential</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential to us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl1">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential to us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl">Non-deductible expenses/excludable items</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationNondeductibleExpense to us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl">State income tax, net of federal tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes to us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="EffectiveIncomeTaxRateContinuingOperations" xlink:title="EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl">Total tax provision for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:title="label: EffectiveIncomeTaxRateContinuingOperations to us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" xlink:title="label: EffectiveIncomeTaxRateContinuingOperations to us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:title="EffectiveIncomeTaxRateReconciliationTaxCredits" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl">Credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationTaxCredits to us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" id="us-gaap_EmployeeStockOptionMember_lbl">Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:title="label: EmployeeStockOptionMember to us-gaap_EmployeeStockOptionMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl">Weighted average remaining requisite service period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl">Unamortized stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl">Accrued compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="EquipmentMember" xlink:title="EquipmentMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquipmentMember_lbl" xml:lang="en-US" id="us-gaap_EquipmentMember_lbl">Laboratory and Manufacturing Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:title="label: EquipmentMember to us-gaap_EquipmentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquipmentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquipmentMember_lbl1" xml:lang="en-US" id="us-gaap_EquipmentMember_lbl1">Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl1" xlink:title="label: EquipmentMember to us-gaap_EquipmentMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl">Percentage of total outstanding equity interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:title="label: EquityMethodInvestmentOwnershipPercentage to us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1">Ownership percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xlink:title="label: EquityMethodInvestmentOwnershipPercentage to us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl">Losses on investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xlink:title="label: EquityMethodInvestmentRealizedGainLossOnDisposal to us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="us-gaap_EquityComponentDomain_lbl">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xlink:title="label: EquityComponentDomain to us-gaap_EquityComponentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestments_lbl">Investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" xlink:title="label: EquityMethodInvestments to us-gaap_EquityMethodInvestments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_EquityMethodInvestments_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestments_lbl1">Investment in non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl1" xlink:title="label: EquityMethodInvestments to us-gaap_EquityMethodInvestments_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestments_lbl2" xml:lang="en-US" id="us-gaap_EquityMethodInvestments_lbl2">Equity Method Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl2" xlink:title="label: EquityMethodInvestments to us-gaap_EquityMethodInvestments_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:label="FeaturesOfConvertiblePreferredStockAbstract" xlink:title="FeaturesOfConvertiblePreferredStockAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl" xml:lang="en-US" id="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl">Cumulative Convertible Preferred Stock [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl" xlink:title="label: FeaturesOfConvertiblePreferredStockAbstract to us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl1" xml:lang="en-US" id="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl1">Features of Convertible Preferred Stock [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl1" xlink:title="label: FeaturesOfConvertiblePreferredStockAbstract to us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiabilityAbstract" xlink:label="FairValueNetAssetLiabilityAbstract" xlink:title="FairValueNetAssetLiabilityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueNetAssetLiabilityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueNetAssetLiabilityAbstract_lbl" xml:lang="en-US" id="us-gaap_FairValueNetAssetLiabilityAbstract_lbl">Fair Value Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueNetAssetLiabilityAbstract" xlink:to="us-gaap_FairValueNetAssetLiabilityAbstract_lbl" xlink:title="label: FairValueNetAssetLiabilityAbstract to us-gaap_FairValueNetAssetLiabilityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueByLiabilityClassAxis_lbl" xml:lang="en-US" id="us-gaap_FairValueByLiabilityClassAxis_lbl">Liability Class [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:title="label: FairValueByLiabilityClassAxis to us-gaap_FairValueByLiabilityClassAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_FairValueDisclosuresAbstract_lbl">Fair Value of Financial Instruments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:title="label: FairValueDisclosuresAbstract to us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl">Liabilities Measured at Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" id="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:title="label: FairValueByFairValueHierarchyLevelAxis to us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl">Fair value at March 9, 2022 (issuance date)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1">Warrants fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl">Fair value, end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1">Fair value, beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" id="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:title="label: FairValueMeasurementsFairValueHierarchyDomain to us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl">Fair Value by Liability Class [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xlink:title="label: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock_lbl">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:title="label: FairValueDisclosuresTextBlock to us-gaap_FairValueDisclosuresTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock_lbl1">Fair Value Disclosures [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl1" xlink:title="label: FairValueDisclosuresTextBlock to us-gaap_FairValueDisclosuresTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="FairValueOfFinancialInstrumentsPolicy" xlink:title="FairValueOfFinancialInstrumentsPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" id="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:title="label: FairValueOfFinancialInstrumentsPolicy to us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xml:lang="en-US" id="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xlink:title="label: FairValueOfFinancialInstrumentsPolicy to us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US" id="us-gaap_FairValueInputsLevel1Member_lbl">Level 1 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:title="label: FairValueInputsLevel1Member to us-gaap_FairValueInputsLevel1Member_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US" id="us-gaap_FairValueInputsLevel2Member_lbl">Level 2 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:title="label: FairValueInputsLevel2Member to us-gaap_FairValueInputsLevel2Member_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" id="us-gaap_FairValueInputsLevel3Member_lbl">Level 3 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:title="label: FairValueInputsLevel3Member to us-gaap_FairValueInputsLevel3Member_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl">Changes in Fair Value of Warrant Liabilities [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xlink:title="label: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="FinanceLeasePrincipalPayments" xlink:title="FinanceLeasePrincipalPayments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FinanceLeasePrincipalPayments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_FinanceLeasePrincipalPayments_lbl" xml:lang="en-US" id="us-gaap_FinanceLeasePrincipalPayments_lbl">Principal payments on finance leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FinanceLeasePrincipalPayments" xlink:to="us-gaap_FinanceLeasePrincipalPayments_lbl" xlink:title="label: FinanceLeasePrincipalPayments to us-gaap_FinanceLeasePrincipalPayments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FinanceLeasePrincipalPayments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FinanceLeasePrincipalPayments_lbl1" xml:lang="en-US" id="us-gaap_FinanceLeasePrincipalPayments_lbl1">Finance Lease, Principal Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FinanceLeasePrincipalPayments" xlink:to="us-gaap_FinanceLeasePrincipalPayments_lbl1" xlink:title="label: FinanceLeasePrincipalPayments to us-gaap_FinanceLeasePrincipalPayments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:title="label: FiniteLivedIntangibleAssetsMajorClassNameDomain to us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:title="label: FiniteLivedIntangibleAssetsByMajorClassAxis to us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="ForeignCountryMember" xlink:title="ForeignCountryMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US" id="us-gaap_ForeignCountryMember_lbl">Foreign [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" xlink:title="label: ForeignCountryMember to us-gaap_ForeignCountryMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ForeignCountryMember_lbl1" xml:lang="en-US" id="us-gaap_ForeignCountryMember_lbl1">Foreign Tax Authority [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl1" xlink:title="label: ForeignCountryMember to us-gaap_ForeignCountryMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="GainLossOnDispositionOfAssets1" xlink:title="GainLossOnDispositionOfAssets1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_GainLossOnDispositionOfAssets1_lbl" xml:lang="en-US" id="us-gaap_GainLossOnDispositionOfAssets1_lbl">Loss on sale of NTN assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:title="label: GainLossOnDispositionOfAssets1 to us-gaap_GainLossOnDispositionOfAssets1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GainLossOnDispositionOfAssets1_lbl1" xml:lang="en-US" id="us-gaap_GainLossOnDispositionOfAssets1_lbl1">Gain (Loss) on Disposition of Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl1" xlink:title="label: GainLossOnDispositionOfAssets1 to us-gaap_GainLossOnDispositionOfAssets1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US" id="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl">Gain on extinguishment of debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:title="label: GainsLossesOnExtinguishmentOfDebt to us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" xml:lang="en-US" id="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" xlink:title="label: GainsLossesOnExtinguishmentOfDebt to us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpense_lbl">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:title="label: GeneralAndAdministrativeExpense to us-gaap_GeneralAndAdministrativeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GeneralAndAdministrativeExpense_lbl1" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpense_lbl1">General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl1" xlink:title="label: GeneralAndAdministrativeExpense to us-gaap_GeneralAndAdministrativeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpenseMember_lbl">General and Administrative [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:title="label: GeneralAndAdministrativeExpenseMember to us-gaap_GeneralAndAdministrativeExpenseMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:title="GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:title="label: GoodwillAndIntangibleAssetsGoodwillPolicy to us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl1">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl1" xlink:title="label: GoodwillAndIntangibleAssetsGoodwillPolicy to us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl">In-Process Research &amp; Development and Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureTextBlock to us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureTextBlock to us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_Goodwill_lbl" xml:lang="en-US" id="us-gaap_Goodwill_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Goodwill_lbl1" xml:lang="en-US" id="us-gaap_Goodwill_lbl1">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl1" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl">In-Process Research &amp; Development and Goodwill [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureAbstract to us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOfOngoingProject_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ImpairmentOfOngoingProject_lbl" xml:lang="en-US" id="us-gaap_ImpairmentOfOngoingProject_lbl">Non-cash impairment charges</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOfOngoingProject" xlink:to="us-gaap_ImpairmentOfOngoingProject_lbl" xlink:title="label: ImpairmentOfOngoingProject to us-gaap_ImpairmentOfOngoingProject_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOfOngoingProject_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ImpairmentOfOngoingProject_lbl1" xml:lang="en-US" id="us-gaap_ImpairmentOfOngoingProject_lbl1">Impairment of in-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOfOngoingProject" xlink:to="us-gaap_ImpairmentOfOngoingProject_lbl1" xlink:title="label: ImpairmentOfOngoingProject to us-gaap_ImpairmentOfOngoingProject_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="InProcessResearchAndDevelopmentPolicy" xlink:title="InProcessResearchAndDevelopmentPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl" xml:lang="en-US" id="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl">IPR&amp;D</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InProcessResearchAndDevelopmentPolicy" xlink:to="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl" xlink:title="label: InProcessResearchAndDevelopmentPolicy to us-gaap_InProcessResearchAndDevelopmentPolicy_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl1" xml:lang="en-US" id="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl1">In Process Research and Development, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InProcessResearchAndDevelopmentPolicy" xlink:to="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl1" xlink:title="label: InProcessResearchAndDevelopmentPolicy to us-gaap_InProcessResearchAndDevelopmentPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementLocationAxis_lbl">Income Statement Location [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:title="label: IncomeStatementLocationAxis to us-gaap_IncomeStatementLocationAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureAbstract_lbl">Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:title="label: IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl">Loss before income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementLocationDomain_lbl">Income Statement Location [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" xlink:title="label: IncomeStatementLocationDomain to us-gaap_IncomeStatementLocationDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityAxis_lbl">Income Tax Authority [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:title="label: IncomeTaxAuthorityAxis to us-gaap_IncomeTaxAuthorityAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl">Domestic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl">Loss before Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl1">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl1" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xlink:title="label: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureTextBlock_lbl">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:title="label: IncomeTaxDisclosureTextBlock to us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureTextBlock_lbl1">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xlink:title="label: IncomeTaxDisclosureTextBlock to us-gaap_IncomeTaxDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementAbstract_lbl">CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:title="label: IncomeStatementAbstract to us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xlink:title="label: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl">Disposal Group Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xlink:title="label: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis to us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityDomain_lbl">Income Tax Authority [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:title="label: IncomeTaxAuthorityDomain to us-gaap_IncomeTaxAuthorityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl">Provision for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl1">Total tax provision for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl2" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl2">Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl2" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl">Reconciliation of Computed Expected Income Taxes to Effective Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxesPaidNet_lbl">Income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:title="label: IncomeTaxesPaidNet to us-gaap_IncomeTaxesPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxesPaidNet_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxesPaidNet_lbl1">Income Taxes Paid, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl1" xlink:title="label: IncomeTaxesPaidNet to us-gaap_IncomeTaxesPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="IncomeTaxesReceivable" xlink:title="IncomeTaxesReceivable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_IncomeTaxesReceivable_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxesReceivable_lbl">Payroll tax refunds included in other receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesReceivable" xlink:to="us-gaap_IncomeTaxesReceivable_lbl" xlink:title="label: IncomeTaxesReceivable to us-gaap_IncomeTaxesReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxesReceivable_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxesReceivable_lbl1">Income Taxes Receivable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesReceivable" xlink:to="us-gaap_IncomeTaxesReceivable_lbl1" xlink:title="label: IncomeTaxesReceivable to us-gaap_IncomeTaxesReceivable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock_lbl">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:title="label: IncomeTaxPolicyTextBlock to us-gaap_IncomeTaxPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock_lbl1">Income Tax, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xlink:title="label: IncomeTaxPolicyTextBlock to us-gaap_IncomeTaxPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="IncreaseDecreaseInOtherNoncurrentAssets" xlink:title="IncreaseDecreaseInOtherNoncurrentAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl">Other non-current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:title="label: IncreaseDecreaseInOtherNoncurrentAssets to us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl1">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl1" xlink:title="label: IncreaseDecreaseInOtherNoncurrentAssets to us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="IncreaseDecreaseInOperatingLeaseLiability" xlink:title="IncreaseDecreaseInOperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl">Decrease in lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:title="label: IncreaseDecreaseInOperatingLeaseLiability to us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="IncreaseDecreaseInDueToRelatedParties" xlink:title="IncreaseDecreaseInDueToRelatedParties" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl">Due to related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDueToRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xlink:title="label: IncreaseDecreaseInDueToRelatedParties to us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="IncreaseDecreaseInOtherReceivables" xlink:title="IncreaseDecreaseInOtherReceivables" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherReceivables_lbl">Other receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xlink:title="label: IncreaseDecreaseInOtherReceivables to us-gaap_IncreaseDecreaseInOtherReceivables_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1">Increase (Decrease) in Other Receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" xlink:title="label: IncreaseDecreaseInOtherReceivables to us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl">Other liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:title="label: IncreaseDecreaseInOtherOperatingLiabilities to us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInOtherOperatingLiabilities to us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:title="label: IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US" id="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl">In-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:title="label: IndefiniteLivedIntangibleAssetsExcludingGoodwill to us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" xml:lang="en-US" id="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" xlink:title="label: IndefiniteLivedIntangibleAssetsExcludingGoodwill to us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl">Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestPaidNet_lbl1" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl1">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl1" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentTypeCategorizationMember_lbl" xml:lang="en-US" id="us-gaap_InvestmentTypeCategorizationMember_lbl">Investments [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:title="label: InvestmentTypeCategorizationMember to us-gaap_InvestmentTypeCategorizationMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US" id="us-gaap_InvestmentTypeAxis_lbl">Investment Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" xlink:title="label: InvestmentTypeAxis to us-gaap_InvestmentTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract" xlink:label="InvestmentsAbstract" xlink:title="InvestmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsAbstract_lbl" xml:lang="en-US" id="us-gaap_InvestmentsAbstract_lbl">Investments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsAbstract" xlink:to="us-gaap_InvestmentsAbstract_lbl" xlink:title="label: InvestmentsAbstract to us-gaap_InvestmentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeasesTextBlock_lbl">Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:title="label: LesseeOperatingLeasesTextBlock to us-gaap_LesseeOperatingLeasesTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="LesseeLeasesPolicyTextBlock" xlink:title="LesseeLeasesPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeLeasesPolicyTextBlock_lbl">Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:title="label: LesseeLeasesPolicyTextBlock to us-gaap_LesseeLeasesPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeasesPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_LesseeLeasesPolicyTextBlock_lbl1">Lessee, Leases [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl1" xlink:title="label: LesseeLeasesPolicyTextBlock to us-gaap_LesseeLeasesPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl">2027</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFive to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl1">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearTwo to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="LesseeOperatingLeaseRenewalTerm" xlink:title="LesseeOperatingLeaseRenewalTerm" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl">Extension term of sublease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:title="label: LesseeOperatingLeaseRenewalTerm to us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl1">Lessee, Operating Lease, Renewal Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl1" xlink:title="label: LesseeOperatingLeaseRenewalTerm to us-gaap_LesseeOperatingLeaseRenewalTerm_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseTermOfContract_lbl">Term of sublease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:title="label: LesseeOperatingLeaseTermOfContract to us-gaap_LesseeOperatingLeaseTermOfContract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseTermOfContract_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseTermOfContract_lbl1">Lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl1" xlink:title="label: LesseeOperatingLeaseTermOfContract to us-gaap_LesseeOperatingLeaseTermOfContract_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseTermOfContract_lbl2" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseTermOfContract_lbl2">Lessee, Operating Lease, Term of Contract</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl2" xlink:title="label: LesseeOperatingLeaseTermOfContract to us-gaap_LesseeOperatingLeaseTermOfContract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFour to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearThree to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl">Less: Imputed interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeaseDescriptionTable_lbl" xml:lang="en-US" id="us-gaap_LesseeLeaseDescriptionTable_lbl">Lessee, Lease, Description [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:title="label: LesseeLeaseDescriptionTable to us-gaap_LesseeLeaseDescriptionTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl">Maturities of Operating Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityMaturityTableTextBlock to us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xml:lang="en-US" id="us-gaap_LesseeLeaseDescriptionLineItems_lbl">Lessee, Lease, Description [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:title="label: LesseeLeaseDescriptionLineItems to us-gaap_LesseeLeaseDescriptionLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl">Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" xlink:title="label: LesseeOperatingLeaseDescriptionAbstract to us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl1">Lessee, Operating Lease, Description [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl1" xlink:title="label: LesseeOperatingLeaseDescriptionAbstract to us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl">Total payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US" id="us-gaap_LeaseCostAbstract_lbl">Net Operating Lease Expense [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl" xlink:title="label: LeaseCostAbstract to us-gaap_LeaseCostAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LeaseCost_lbl" xml:lang="en-US" id="us-gaap_LeaseCost_lbl">Total lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:title="label: LeaseCost to us-gaap_LeaseCost_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCost_lbl1" xml:lang="en-US" id="us-gaap_LeaseCost_lbl1">Lease, Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost_lbl1" xlink:title="label: LeaseCost to us-gaap_LeaseCost_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LeaseCostTableTextBlock_lbl">Net Operating Lease Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:title="label: LeaseCostTableTextBlock to us-gaap_LeaseCostTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl1" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl1">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeasesAbstract_lbl" xml:lang="en-US" id="us-gaap_LeasesAbstract_lbl">Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:title="label: LeasesAbstract to us-gaap_LeasesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember" xlink:label="LetterOfCreditMember" xlink:title="LetterOfCreditMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LetterOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LetterOfCreditMember_lbl" xml:lang="en-US" id="us-gaap_LetterOfCreditMember_lbl">Letter of Credit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LetterOfCreditMember" xlink:to="us-gaap_LetterOfCreditMember_lbl" xlink:title="label: LetterOfCreditMember to us-gaap_LetterOfCreditMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="LiabilitiesFairValueAdjustment" xlink:title="LiabilitiesFairValueAdjustment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesFairValueAdjustment_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueAdjustment_lbl">Change in fair value of warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueAdjustment" xlink:to="us-gaap_LiabilitiesFairValueAdjustment_lbl" xlink:title="label: LiabilitiesFairValueAdjustment to us-gaap_LiabilitiesFairValueAdjustment_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="LiabilitiesFairValueDisclosure" xlink:title="LiabilitiesFairValueDisclosure" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueDisclosure_lbl">Liabilities, fair value disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:title="label: LiabilitiesFairValueDisclosure to us-gaap_LiabilitiesFairValueDisclosure_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesFairValueDisclosure_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueDisclosure_lbl1">Liabilities, Fair Value Disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl1" xlink:title="label: LiabilitiesFairValueDisclosure to us-gaap_LiabilitiesFairValueDisclosure_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl">Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:title="label: LiabilitiesFairValueDisclosureAbstract to us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl">Liabilities transferred upon sale [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xlink:title="label: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1">Liabilities and Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl">Total liabilities and stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl1">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Liabilities_lbl" xml:lang="en-US" id="us-gaap_Liabilities_lbl">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Liabilities_lbl1" xml:lang="en-US" id="us-gaap_Liabilities_lbl1">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl1" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl1">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl1" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:label="LineOfCredit" xlink:title="LineOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCredit_lbl" xml:lang="en-US" id="us-gaap_LineOfCredit_lbl">Letter of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:title="label: LineOfCredit to us-gaap_LineOfCredit_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="LitigationSettlementAmountAwardedToOtherParty" xlink:title="LitigationSettlementAmountAwardedToOtherParty" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xml:lang="en-US" id="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl">Litigation settlement, amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationSettlementAmountAwardedToOtherParty" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xlink:title="label: LitigationSettlementAmountAwardedToOtherParty to us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableCurrent" xlink:label="LoansPayableCurrent" xlink:title="LoansPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LoansPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LoansPayableCurrent_lbl" xml:lang="en-US" id="us-gaap_LoansPayableCurrent_lbl">Loans payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LoansPayableCurrent" xlink:to="us-gaap_LoansPayableCurrent_lbl" xlink:title="label: LoansPayableCurrent to us-gaap_LoansPayableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LoansPayableCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LoansPayableCurrent_lbl1" xml:lang="en-US" id="us-gaap_LoansPayableCurrent_lbl1">Loans Payable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LoansPayableCurrent" xlink:to="us-gaap_LoansPayableCurrent_lbl1" xlink:title="label: LoansPayableCurrent to us-gaap_LoansPayableCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebt_lbl" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl">Term loan amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebt_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl1">Long-Term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl1" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="LossContingencyDamagesPaidValue" xlink:title="LossContingencyDamagesPaidValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyDamagesPaidValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyDamagesPaidValue_lbl" xml:lang="en-US" id="us-gaap_LossContingencyDamagesPaidValue_lbl">Liquidated damages payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesPaidValue" xlink:to="us-gaap_LossContingencyDamagesPaidValue_lbl" xlink:title="label: LossContingencyDamagesPaidValue to us-gaap_LossContingencyDamagesPaidValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingenciesLineItems_lbl" xml:lang="en-US" id="us-gaap_LossContingenciesLineItems_lbl">Loss Contingencies [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl" xlink:title="label: LossContingenciesLineItems to us-gaap_LossContingenciesLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingenciesTable_lbl" xml:lang="en-US" id="us-gaap_LossContingenciesTable_lbl">Loss Contingencies [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" xlink:title="label: LossContingenciesTable to us-gaap_LossContingenciesTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="LossContingencyEstimateOfPossibleLoss" xlink:title="LossContingencyEstimateOfPossibleLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" xml:lang="en-US" id="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl">Estimated contingent loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyEstimateOfPossibleLoss" xlink:to="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" xlink:title="label: LossContingencyEstimateOfPossibleLoss to us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:title="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xml:lang="en-US" id="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl">Merger, Disposition and Acquisition Transactions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xlink:title="label: MergersAcquisitionsAndDispositionsDisclosuresTextBlock to us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="MinorityInterestOwnershipPercentageByParent" xlink:title="MinorityInterestOwnershipPercentageByParent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl">Ownership percentage by Citius</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:title="label: MinorityInterestOwnershipPercentageByParent to us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:label="NonrecurringAdjustmentAxis" xlink:title="NonrecurringAdjustmentAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonrecurringAdjustmentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonrecurringAdjustmentAxis_lbl" xml:lang="en-US" id="us-gaap_NonrecurringAdjustmentAxis_lbl">Nonrecurring Adjustment [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonrecurringAdjustmentAxis" xlink:to="us-gaap_NonrecurringAdjustmentAxis_lbl" xlink:title="label: NonrecurringAdjustmentAxis to us-gaap_NonrecurringAdjustmentAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="NonrecurringAdjustmentDomain" xlink:title="NonrecurringAdjustmentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonrecurringAdjustmentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonrecurringAdjustmentDomain_lbl" xml:lang="en-US" id="us-gaap_NonrecurringAdjustmentDomain_lbl">Nonrecurring Adjustment [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonrecurringAdjustmentDomain" xlink:to="us-gaap_NonrecurringAdjustmentDomain_lbl" xlink:title="label: NonrecurringAdjustmentDomain to us-gaap_NonrecurringAdjustmentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl">Cash flows from financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl">Net cash used in investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl">Net cash provided by financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl">Cash flows from investing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Cash flows from operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl1">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLoss_lbl2" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl2">Net Income (Loss) Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl2" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl">Net loss attributable to common stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasic to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl1">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl1" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasic to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl">Recent Accounting Standards [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xlink:title="label: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl1">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl1" xlink:title="label: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:title="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xlink:title="label: NewAccountingPronouncementsOrChangeInAccountingPrincipleTable to us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:title="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:title="label: NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems to us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl">Recent Accounting Standards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:label="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:title="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_lbl" xml:lang="en-US" id="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_lbl">Common stock, shares issued in consideration for purchase commitment (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_lbl" xlink:title="label: NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1 to us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashMergerRelatedCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_NoncashMergerRelatedCosts_lbl" xml:lang="en-US" id="us-gaap_NoncashMergerRelatedCosts_lbl">Transaction costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashMergerRelatedCosts" xlink:to="us-gaap_NoncashMergerRelatedCosts_lbl" xlink:title="label: NoncashMergerRelatedCosts to us-gaap_NoncashMergerRelatedCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashMergerRelatedCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncashMergerRelatedCosts_lbl1" xml:lang="en-US" id="us-gaap_NoncashMergerRelatedCosts_lbl1">Transaction costs - shares to Financial Advisor</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashMergerRelatedCosts" xlink:to="us-gaap_NoncashMergerRelatedCosts_lbl1" xlink:title="label: NoncashMergerRelatedCosts to us-gaap_NoncashMergerRelatedCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashMergerRelatedCosts_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncashMergerRelatedCosts_lbl2" xml:lang="en-US" id="us-gaap_NoncashMergerRelatedCosts_lbl2">Noncash Merger Related Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashMergerRelatedCosts" xlink:to="us-gaap_NoncashMergerRelatedCosts_lbl2" xlink:title="label: NoncashMergerRelatedCosts to us-gaap_NoncashMergerRelatedCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl">Total other income (expenses), net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl1" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl1">Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US" id="us-gaap_NumberOfOperatingSegments_lbl">Number of operating segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" xlink:title="label: NumberOfOperatingSegments to us-gaap_NumberOfOperatingSegments_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OpenTaxYear" xlink:label="OpenTaxYear" xlink:title="OpenTaxYear" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OpenTaxYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OpenTaxYear_lbl" xml:lang="en-US" id="us-gaap_OpenTaxYear_lbl">Open tax year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OpenTaxYear" xlink:to="us-gaap_OpenTaxYear_lbl" xlink:title="label: OpenTaxYear to us-gaap_OpenTaxYear_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_OperatingLeaseImpairmentLoss_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseImpairmentLoss_lbl">Impairment of ROU asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl" xlink:title="label: OperatingLeaseImpairmentLoss to us-gaap_OperatingLeaseImpairmentLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseImpairmentLoss_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseImpairmentLoss_lbl1">Impairment of right-of-use asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl1" xlink:title="label: OperatingLeaseImpairmentLoss to us-gaap_OperatingLeaseImpairmentLoss_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseImpairmentLoss_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseImpairmentLoss_lbl2">Impairment of ROU asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl2" xlink:title="label: OperatingLeaseImpairmentLoss to us-gaap_OperatingLeaseImpairmentLoss_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl">Weighted average discount rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:title="label: OperatingLeaseWeightedAverageDiscountRatePercent to us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl">Weighted average remaining lease term (years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:title="label: OperatingLeaseWeightedAverageRemainingLeaseTerm1 to us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl">Operating lease liabilities, non-current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1">Less non-current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl">Amortization of right-of-use asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:title="label: OperatingLeaseRightOfUseAssetAmortizationExpense to us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1">Amortization of operating lease ROU assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1" xlink:title="label: OperatingLeaseRightOfUseAssetAmortizationExpense to us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" xlink:title="label: OperatingLeaseRightOfUseAssetAmortizationExpense to us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl">Operating lease liabilities, current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl1">Current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl2">Operating Lease, Liability, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="OperatingLeaseLiabilityAbstract" xlink:title="OperatingLeaseLiabilityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityAbstract_lbl">Operating Lease, Liability [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:title="label: OperatingLeaseLiabilityAbstract to us-gaap_OperatingLeaseLiabilityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl">Maturities of Operating Lease Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:title="label: OperatingLeaseLiabilitiesPaymentsDueAbstract to us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl">Total operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_OperatingLeaseLiability_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl1">Operating lease liabilities, Beginning</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl1" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_OperatingLeaseLiability_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl2">Operating lease liabilities, Ending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl2" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiability_lbl3" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl3">Lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl3" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl">Right-of-use assets - operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl1">Operating lease ROU assets, Beginning</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl2">Operating lease ROU assets, Ending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl2" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl3" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl3">ROU asset balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl3" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl3" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl4" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl4">Operating Lease, Right-of-Use Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl4" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseCost_lbl">Operating lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:title="label: OperatingLeaseCost to us-gaap_OperatingLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl1">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl1" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract_lbl">Operating expenses:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:title="label: OperatingExpensesAbstract to us-gaap_OperatingExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingExpensesAbstract_lbl1" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract_lbl1">Operating Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl1" xlink:title="label: OperatingExpensesAbstract to us-gaap_OperatingExpensesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" id="us-gaap_OperatingExpenses_lbl">Total operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:title="label: OperatingExpenses to us-gaap_OperatingExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingExpenses_lbl1" xml:lang="en-US" id="us-gaap_OperatingExpenses_lbl1">Operating Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl1" xlink:title="label: OperatingExpenses to us-gaap_OperatingExpenses_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="OperatingLossCarryforwardsLineItems" xlink:title="OperatingLossCarryforwardsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US" id="us-gaap_OperatingLossCarryforwardsLineItems_lbl">Operating Loss Carryforwards [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:title="label: OperatingLossCarryforwardsLineItems to us-gaap_OperatingLossCarryforwardsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US" id="us-gaap_OperatingLossCarryforwards_lbl">Operating loss carry forward</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:title="label: OperatingLossCarryforwards to us-gaap_OperatingLossCarryforwards_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="OperatingLossCarryforwardsTable" xlink:title="OperatingLossCarryforwardsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US" id="us-gaap_OperatingLossCarryforwardsTable_lbl">Operating Loss Carryforwards [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:title="label: OperatingLossCarryforwardsTable to us-gaap_OperatingLossCarryforwardsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl">Organization and Description of Business Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl">Organization and Description of Business Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="OtherNoncurrentAssetsMember" xlink:title="OtherNoncurrentAssetsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNoncurrentAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherNoncurrentAssetsMember_lbl" xml:lang="en-US" id="us-gaap_OtherNoncurrentAssetsMember_lbl">Other Assets [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNoncurrentAssetsMember" xlink:to="us-gaap_OtherNoncurrentAssetsMember_lbl" xlink:title="label: OtherNoncurrentAssetsMember to us-gaap_OtherNoncurrentAssetsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNoncurrentAssetsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherNoncurrentAssetsMember_lbl1" xml:lang="en-US" id="us-gaap_OtherNoncurrentAssetsMember_lbl1">Other Noncurrent Assets [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNoncurrentAssetsMember" xlink:to="us-gaap_OtherNoncurrentAssetsMember_lbl1" xlink:title="label: OtherNoncurrentAssetsMember to us-gaap_OtherNoncurrentAssetsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherReceivablesNetCurrent_lbl">Other receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:title="label: OtherReceivablesNetCurrent to us-gaap_OtherReceivablesNetCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherReceivablesNetCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherReceivablesNetCurrent_lbl1">Other Receivables, Net, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl1" xlink:title="label: OtherReceivablesNetCurrent to us-gaap_OtherReceivablesNetCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl1">Other Assets, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpensesAbstract" xlink:label="OtherExpensesAbstract" xlink:title="OtherExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherExpensesAbstract_lbl" xml:lang="en-US" id="us-gaap_OtherExpensesAbstract_lbl">Other income (expenses):</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherExpensesAbstract" xlink:to="us-gaap_OtherExpensesAbstract_lbl" xlink:title="label: OtherExpensesAbstract to us-gaap_OtherExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherExpensesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherExpensesAbstract_lbl1" xml:lang="en-US" id="us-gaap_OtherExpensesAbstract_lbl1">Other Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherExpensesAbstract" xlink:to="us-gaap_OtherExpensesAbstract_lbl1" xlink:title="label: OtherExpensesAbstract to us-gaap_OtherExpensesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherLiabilitiesCurrent_lbl">Other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:title="label: OtherLiabilitiesCurrent to us-gaap_OtherLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherLiabilitiesCurrent_lbl1">Other Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl1" xlink:title="label: OtherLiabilitiesCurrent to us-gaap_OtherLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl">Other liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl1">Other Liabilities, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpense_lbl">Other (expense) income, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:title="label: OtherNonoperatingIncomeExpense to us-gaap_OtherNonoperatingIncomeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherNonoperatingIncomeExpense_lbl1" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpense_lbl1">Other Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl1" xlink:title="label: OtherNonoperatingIncomeExpense to us-gaap_OtherNonoperatingIncomeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1">Other Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgingPurposeDomain" xlink:label="PledgingPurposeDomain" xlink:title="PledgingPurposeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PledgingPurposeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PledgingPurposeDomain_lbl" xml:lang="en-US" id="us-gaap_PledgingPurposeDomain_lbl">Pledging Purpose [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PledgingPurposeDomain" xlink:to="us-gaap_PledgingPurposeDomain_lbl" xlink:title="label: PledgingPurposeDomain to us-gaap_PledgingPurposeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgingPurposeAxis" xlink:label="PledgingPurposeAxis" xlink:title="PledgingPurposeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PledgingPurposeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PledgingPurposeAxis_lbl" xml:lang="en-US" id="us-gaap_PledgingPurposeAxis_lbl">Pledging Purpose [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PledgingPurposeAxis" xlink:to="us-gaap_PledgingPurposeAxis_lbl" xlink:title="label: PledgingPurposeAxis to us-gaap_PledgingPurposeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountUnitsAcquisitions" xlink:label="PartnersCapitalAccountUnitsAcquisitions" xlink:title="PartnersCapitalAccountUnitsAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl" xml:lang="en-US" id="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl">Issuance of common stock to Eterna LLC members (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnersCapitalAccountUnitsAcquisitions" xlink:to="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl" xlink:title="label: PartnersCapitalAccountUnitsAcquisitions to us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1" xml:lang="en-US" id="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1">Partners' Capital Account, Units, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnersCapitalAccountUnitsAcquisitions" xlink:to="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1" xlink:title="label: PartnersCapitalAccountUnitsAcquisitions to us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountAcquisitions" xlink:label="PartnersCapitalAccountAcquisitions" xlink:title="PartnersCapitalAccountAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PartnersCapitalAccountAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PartnersCapitalAccountAcquisitions_lbl" xml:lang="en-US" id="us-gaap_PartnersCapitalAccountAcquisitions_lbl">Issuance of common stock to Eterna LLC members</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnersCapitalAccountAcquisitions" xlink:to="us-gaap_PartnersCapitalAccountAcquisitions_lbl" xlink:title="label: PartnersCapitalAccountAcquisitions to us-gaap_PartnersCapitalAccountAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PartnersCapitalAccountAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PartnersCapitalAccountAcquisitions_lbl1" xml:lang="en-US" id="us-gaap_PartnersCapitalAccountAcquisitions_lbl1">Partners' Capital Account, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnersCapitalAccountAcquisitions" xlink:to="us-gaap_PartnersCapitalAccountAcquisitions_lbl1" xlink:title="label: PartnersCapitalAccountAcquisitions to us-gaap_PartnersCapitalAccountAcquisitions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US" id="us-gaap_PayablesAndAccrualsAbstract_lbl">Accrued Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:title="label: PayablesAndAccrualsAbstract to us-gaap_PayablesAndAccrualsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl">Payroll tax remitted on net share settlement of equity awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:title="label: PaymentsRelatedToTaxWithholdingForShareBasedCompensation to us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xlink:title="label: PaymentsRelatedToTaxWithholdingForShareBasedCompensation to us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="PaymentsOfDividendsPreferredStockAndPreferenceStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl">Dividends paid to Series A preferred shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:to="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl" xlink:title="label: PaymentsOfDividendsPreferredStockAndPreferenceStock to us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1">Payments of Ordinary Dividends, Preferred Stock and Preference Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:to="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1" xlink:title="label: PaymentsOfDividendsPreferredStockAndPreferenceStock to us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="PaymentsToAcquireInvestments" xlink:title="PaymentsToAcquireInvestments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireInvestments_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireInvestments_lbl">Less amount of cash paid for NoveCite investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:title="label: PaymentsToAcquireInvestments to us-gaap_PaymentsToAcquireInvestments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireInvestments_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireInvestments_lbl1">Payments to Acquire Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl1" xlink:title="label: PaymentsToAcquireInvestments to us-gaap_PaymentsToAcquireInvestments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl">Purchase of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireProductiveAssets_lbl">Cash paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:title="label: PaymentsToAcquireProductiveAssets to us-gaap_PaymentsToAcquireProductiveAssets_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PlanNameDomain_lbl" xml:lang="en-US" id="us-gaap_PlanNameDomain_lbl">Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" xlink:title="label: PlanNameDomain to us-gaap_PlanNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PlanNameAxis_lbl" xml:lang="en-US" id="us-gaap_PlanNameAxis_lbl">Plan Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:title="label: PlanNameAxis to us-gaap_PlanNameAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="PreferredStockConvertibleSharesIssuable" xlink:title="PreferredStockConvertibleSharesIssuable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockConvertibleSharesIssuable_lbl" xml:lang="en-US" id="us-gaap_PreferredStockConvertibleSharesIssuable_lbl">Aggregate preferred stock to be convert into common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockConvertibleSharesIssuable" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable_lbl" xlink:title="label: PreferredStockConvertibleSharesIssuable to us-gaap_PreferredStockConvertibleSharesIssuable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockMember_lbl" xml:lang="en-US" id="us-gaap_PreferredStockMember_lbl">Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:title="label: PreferredStockMember to us-gaap_PreferredStockMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="PreferredStockLiquidationPreferenceValue" xlink:title="PreferredStockLiquidationPreferenceValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xml:lang="en-US" id="us-gaap_PreferredStockLiquidationPreferenceValue_lbl">Preferred stock, liquidation preference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xlink:title="label: PreferredStockLiquidationPreferenceValue to us-gaap_PreferredStockLiquidationPreferenceValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="PreferredStockDividendsShares" xlink:title="PreferredStockDividendsShares" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockDividendsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockDividendsShares_lbl" xml:lang="en-US" id="us-gaap_PreferredStockDividendsShares_lbl">Shares issued for payment of dividends (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendsShares" xlink:to="us-gaap_PreferredStockDividendsShares_lbl" xlink:title="label: PreferredStockDividendsShares to us-gaap_PreferredStockDividendsShares_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockDividendsShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockDividendsShares_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockDividendsShares_lbl1">Cash dividends to Series A preferred stockholders (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendsShares" xlink:to="us-gaap_PreferredStockDividendsShares_lbl1" xlink:title="label: PreferredStockDividendsShares to us-gaap_PreferredStockDividendsShares_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="PreferredStockDividendsAndOtherAdjustments" xlink:title="PreferredStockDividendsAndOtherAdjustments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" xml:lang="en-US" id="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl">Series A preferred stock dividend</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendsAndOtherAdjustments" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" xlink:title="label: PreferredStockDividendsAndOtherAdjustments to us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1">Preferred Stock Dividends and Other Adjustments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendsAndOtherAdjustments" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1" xlink:title="label: PreferredStockDividendsAndOtherAdjustments to us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionRatio" xlink:label="PreferredStockConvertibleConversionRatio" xlink:title="PreferredStockConvertibleConversionRatio" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockConvertibleConversionRatio_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockConvertibleConversionRatio_lbl" xml:lang="en-US" id="us-gaap_PreferredStockConvertibleConversionRatio_lbl">Preferred stock, conversion rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockConvertibleConversionRatio" xlink:to="us-gaap_PreferredStockConvertibleConversionRatio_lbl" xlink:title="label: PreferredStockConvertibleConversionRatio to us-gaap_PreferredStockConvertibleConversionRatio_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl">Preferred stock series A, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl1">Preferred stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl1" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl">Preferred stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl">Preferred stock Series A, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl1">Preferred stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl">Preferred stock, $0.005 par value, 1,000 shares authorized, 156 designated and outstanding of Series A convertible preferred stock at December 31, 2022 and 2021, $156 liquidation preference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockValue_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl1">Preferred Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl1" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl">Preferred stock series A, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl1">Preferred stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="PreferredStockLiquidationPreference" xlink:title="PreferredStockLiquidationPreference" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockLiquidationPreference_lbl" xml:lang="en-US" id="us-gaap_PreferredStockLiquidationPreference_lbl">Preferred stock, liquidation preference per share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockLiquidationPreference" xlink:to="us-gaap_PreferredStockLiquidationPreference_lbl" xlink:title="label: PreferredStockLiquidationPreference to us-gaap_PreferredStockLiquidationPreference_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:title="label: PrepaidExpenseAndOtherAssetsCurrent to us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1">Prepaid Expense and Other Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xlink:title="label: PrepaidExpenseAndOtherAssetsCurrent to us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLeasePayments" xlink:label="ProceedsFromLeasePayments" xlink:title="ProceedsFromLeasePayments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromLeasePayments_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromLeasePayments_lbl">Sublease payments received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromLeasePayments" xlink:to="us-gaap_ProceedsFromLeasePayments_lbl" xlink:title="label: ProceedsFromLeasePayments to us-gaap_ProceedsFromLeasePayments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromLeasePayments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromLeasePayments_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromLeasePayments_lbl1">Proceeds from Lease Payment, Operating Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromLeasePayments" xlink:to="us-gaap_ProceedsFromLeasePayments_lbl1" xlink:title="label: ProceedsFromLeasePayments to us-gaap_ProceedsFromLeasePayments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="ProceedsFromWarrantExercises" xlink:title="ProceedsFromWarrantExercises" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromWarrantExercises_lbl">Exercise of Q1-22 pre-funded warrants (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:title="label: ProceedsFromWarrantExercises to us-gaap_ProceedsFromWarrantExercises_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromWarrantExercises_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromWarrantExercises_lbl1">Proceeds from Warrant Exercises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl1" xlink:title="label: ProceedsFromWarrantExercises to us-gaap_ProceedsFromWarrantExercises_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:label="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="ProceedsFromSalesOfAssetsInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl">Purchase of NTN, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfAssetsInvestingActivities" xlink:to="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl" xlink:title="label: ProceedsFromSalesOfAssetsInvestingActivities to us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1">Proceeds from Sales of Assets, Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfAssetsInvestingActivities" xlink:to="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1" xlink:title="label: ProceedsFromSalesOfAssetsInvestingActivities to us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:label="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl">Sale of rights, title and interest in and to the assets relating to the business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl" xlink:title="label: ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets to us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1">Proceeds from Sales of Business, Affiliate and Productive Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1" xlink:title="label: ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets to us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl">Proceeds from the sale of NTN assets, net of cash disposed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDivestitureOfBusinesses" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:title="label: ProceedsFromDivestitureOfBusinesses to us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl">Proceeds from sale of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:title="label: ProceedsFromIssuanceOfCommonStock to us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1">Proceeds from issuance of common stock and warrants in connection with private offerings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xlink:title="label: ProceedsFromIssuanceOfCommonStock to us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="ProceedsFromOtherEquity" xlink:title="ProceedsFromOtherEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromOtherEquity_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromOtherEquity_lbl">Proceeds from sale of members' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromOtherEquity" xlink:to="us-gaap_ProceedsFromOtherEquity_lbl" xlink:title="label: ProceedsFromOtherEquity to us-gaap_ProceedsFromOtherEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromOtherEquity_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromOtherEquity_lbl1">Proceeds from Other Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromOtherEquity" xlink:to="us-gaap_ProceedsFromOtherEquity_lbl1" xlink:title="label: ProceedsFromOtherEquity to us-gaap_ProceedsFromOtherEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfWarrants_lbl">Proceeds from issuance of warrants to purchase of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:title="label: ProceedsFromIssuanceOfWarrants to us-gaap_ProceedsFromIssuanceOfWarrants_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1">Aggregate exercise price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" xlink:title="label: ProceedsFromIssuanceOfWarrants to us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOfWarrants_lbl2" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfWarrants_lbl2">Proceeds from issuance of warrants to purchase of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl2" xlink:title="label: ProceedsFromIssuanceOfWarrants to us-gaap_ProceedsFromIssuanceOfWarrants_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="ProceedsFromIssuanceOrSaleOfEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl">Gross proceeds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:title="label: ProceedsFromIssuanceOrSaleOfEquity to us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl1">Proceeds from Issuance or Sale of Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl1" xlink:title="label: ProceedsFromIssuanceOrSaleOfEquity to us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl">Proceeds from sales of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:title="label: ProceedsFromSaleOfPropertyPlantAndEquipment to us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl1">Proceeds from the sale of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl1" xlink:title="label: ProceedsFromSaleOfPropertyPlantAndEquipment to us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromStockOptionsExercised_lbl">Proceeds from the exercise of stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:title="label: ProceedsFromStockOptionsExercised to us-gaap_ProceedsFromStockOptionsExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromStockOptionsExercised_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromStockOptionsExercised_lbl1">Proceeds from Stock Options Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl1" xlink:title="label: ProceedsFromStockOptionsExercised to us-gaap_ProceedsFromStockOptionsExercised_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl">Estimated useful life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1">Property, Plant and Equipment, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:title="label: PropertyPlantAndEquipmentDisclosureTextBlock to us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentLineItems_lbl">Property, Plant and Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:title="label: PropertyPlantAndEquipmentLineItems to us-gaap_PropertyPlantAndEquipmentLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="PropertyPlantAndEquipmentTextBlock" xlink:title="PropertyPlantAndEquipmentTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl">Schedule of Property, Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:title="label: PropertyPlantAndEquipmentTextBlock to us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl">Long-Lived Tangible Asset [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:title="label: PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentAbstract_lbl">Property and Equipment [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentAbstract to us-gaap_PropertyPlantAndEquipmentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl1">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl2" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl2">Property, Plant and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl2" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross_lbl">Property and equipment, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:title="label: PropertyPlantAndEquipmentPolicyTextBlock to us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1" xlink:title="label: PropertyPlantAndEquipmentPolicyTextBlock to us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:label="PropertyPlantAndEquipmentGrossAbstract" xlink:title="PropertyPlantAndEquipmentGrossAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGrossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentGrossAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGrossAbstract_lbl">Property, Plant and Equipment, Gross [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentGrossAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentGrossAbstract to us-gaap_PropertyPlantAndEquipmentGrossAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl">Long-Lived Tangible Asset [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:title="label: PropertyPlantAndEquipmentTypeDomain to us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:label="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:title="PropertyPlantAndEquipmentNetByTypeAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl">Property and Equipment [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentNetByTypeAbstract to us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl1">Property, Plant and Equipment, Net, by Type [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl1" xlink:title="label: PropertyPlantAndEquipmentNetByTypeAbstract to us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:title="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xml:lang="en-US" id="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xlink:title="label: ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward to us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="RelatedPartyTransactionsAbstract" xlink:title="RelatedPartyTransactionsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionsAbstract_lbl">Related Party Transactions [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:title="label: RelatedPartyTransactionsAbstract to us-gaap_RelatedPartyTransactionsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="RelatedPartyTransactionLineItems" xlink:title="RelatedPartyTransactionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionLineItems_lbl">Related Party Transaction [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:title="label: RelatedPartyTransactionLineItems to us-gaap_RelatedPartyTransactionLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:label="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:title="RelatedPartyTransactionDueFromToRelatedPartyAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract_lbl">Related Party Transaction [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract_lbl" xlink:title="label: RelatedPartyTransactionDueFromToRelatedPartyAbstract to us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="RelatedPartyTransactionsDisclosureTextBlock" xlink:title="RelatedPartyTransactionsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl">Related Party Transactions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:title="label: RelatedPartyTransactionsDisclosureTextBlock to us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyDomain_lbl">Related Party [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl" xlink:title="label: RelatedPartyDomain to us-gaap_RelatedPartyDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl">Related Party [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:title="label: RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US" id="us-gaap_RepaymentsOfNotesPayable_lbl">Principal payments on notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:title="label: RepaymentsOfNotesPayable to us-gaap_RepaymentsOfNotesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RepaymentsOfNotesPayable_lbl1" xml:lang="en-US" id="us-gaap_RepaymentsOfNotesPayable_lbl1">Principal payment of outstanding notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl1" xlink:title="label: RepaymentsOfNotesPayable to us-gaap_RepaymentsOfNotesPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RepaymentsOfNotesPayable_lbl2" xml:lang="en-US" id="us-gaap_RepaymentsOfNotesPayable_lbl2">Repayments of Notes Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl2" xlink:title="label: RepaymentsOfNotesPayable to us-gaap_RepaymentsOfNotesPayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseMember_lbl">Research and Development [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:title="label: ResearchAndDevelopmentExpenseMember to us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:label="ResearchAndDevelopmentInProcess" xlink:title="ResearchAndDevelopmentInProcess" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentInProcess_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentInProcess_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentInProcess_lbl">In-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcess" xlink:to="us-gaap_ResearchAndDevelopmentInProcess_lbl" xlink:title="label: ResearchAndDevelopmentInProcess to us-gaap_ResearchAndDevelopmentInProcess_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="ResearchAndDevelopmentExpensePolicy" xlink:title="ResearchAndDevelopmentExpensePolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl">Research and Development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:title="label: ResearchAndDevelopmentExpensePolicy to us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1" xlink:title="label: ResearchAndDevelopmentExpensePolicy to us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl">Research and development expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xlink:title="label: ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost to us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl1" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl1">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl1" xlink:title="label: ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost to us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl2" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl2">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl2" xlink:title="label: ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost to us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember_lbl">RSUs [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestrictedStockUnitsRSUMember_lbl1" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember_lbl1">Restricted Common Units [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl1" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedStockUnitsRSUMember_lbl2" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember_lbl2">RSU [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl2" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US" id="us-gaap_RestrictedStockMember_lbl">Restricted Common Shares [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:title="label: RestrictedStockMember to us-gaap_RestrictedStockMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="RestrictedCashCurrent" xlink:title="RestrictedCashCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestrictedCashCurrent_lbl" xml:lang="en-US" id="us-gaap_RestrictedCashCurrent_lbl">Restricted Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl" xlink:title="label: RestrictedCashCurrent to us-gaap_RestrictedCashCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedCashCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedCashCurrent_lbl1" xml:lang="en-US" id="us-gaap_RestrictedCashCurrent_lbl1">Restricted Cash, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl1" xlink:title="label: RestrictedCashCurrent to us-gaap_RestrictedCashCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="RestrictedCash" xlink:title="RestrictedCash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestrictedCash_lbl" xml:lang="en-US" id="us-gaap_RestrictedCash_lbl">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl" xlink:title="label: RestrictedCash to us-gaap_RestrictedCash_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedCash_lbl1" xml:lang="en-US" id="us-gaap_RestrictedCash_lbl1">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl1" xlink:title="label: RestrictedCash to us-gaap_RestrictedCash_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="RestrictedCashNoncurrent" xlink:title="RestrictedCashNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestrictedCashNoncurrent_lbl" xml:lang="en-US" id="us-gaap_RestrictedCashNoncurrent_lbl">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent_lbl" xlink:title="label: RestrictedCashNoncurrent to us-gaap_RestrictedCashNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedCashNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_RestrictedCashNoncurrent_lbl1">Restricted Cash, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent_lbl1" xlink:title="label: RestrictedCashNoncurrent to us-gaap_RestrictedCashNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1">Retained Earnings (Accumulated Deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl">Accumulated Deficit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsMember_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl1">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl1" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis" xlink:label="RetirementPlanNameAxis" xlink:title="RetirementPlanNameAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetirementPlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetirementPlanNameAxis_lbl" xml:lang="en-US" id="us-gaap_RetirementPlanNameAxis_lbl">Retirement Plan Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetirementPlanNameAxis" xlink:to="us-gaap_RetirementPlanNameAxis_lbl" xlink:title="label: RetirementPlanNameAxis to us-gaap_RetirementPlanNameAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="RetirementPlanNameDomain" xlink:title="RetirementPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetirementPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetirementPlanNameDomain_lbl" xml:lang="en-US" id="us-gaap_RetirementPlanNameDomain_lbl">Retirement Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetirementPlanNameDomain" xlink:to="us-gaap_RetirementPlanNameDomain_lbl" xlink:title="label: RetirementPlanNameDomain to us-gaap_RetirementPlanNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome" xlink:label="SubleaseIncome" xlink:title="SubleaseIncome" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubleaseIncome_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_SubleaseIncome_lbl" xml:lang="en-US" id="us-gaap_SubleaseIncome_lbl">Sublease income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl" xlink:title="label: SubleaseIncome to us-gaap_SubleaseIncome_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubleaseIncome_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubleaseIncome_lbl1" xml:lang="en-US" id="us-gaap_SubleaseIncome_lbl1">Sublease Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl1" xlink:title="label: SubleaseIncome to us-gaap_SubleaseIncome_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl">Warrant expiration term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1">Stock based compensation stock option term period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl">Options vested and exercisable, weighted average remaining contractual life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl">Number of accelerated vesting stock option (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl">Expected term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl">Incremental fair value of stock options recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl">Weighted-average remaining contractual life, outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US" id="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl">Common stock issued and sold during period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:title="label: SaleOfStockNumberOfSharesIssuedInTransaction to us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1" xml:lang="en-US" id="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1" xlink:title="label: SaleOfStockNumberOfSharesIssuedInTransaction to us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:title="ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl">Uncertain Tax Positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:title="label: ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock to us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl">Summarizes of RSU Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:title="label: ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock to us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:title="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl">Tangible and Intangible Assets Acquired And Liabilities Assumed, Based on Estimated Fair Values</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:title="label: ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock to us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl">Weighted-Average Assumptions Used for Grants Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:title="label: ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl">Summarizes of Stock Option Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:title="label: ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock to us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl">Loss before Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:title="label: ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock to us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1" xlink:title="label: ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock to us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl">Income Tax Provision</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:title="label: ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock to us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:title="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl">Changes in Warrant Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xlink:title="label: ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock to us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl1">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl1" xlink:title="label: ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock to us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl">Reconciliation of Computed Expected Income Taxes to Effective Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:title="label: ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xlink:title="label: ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl">Deferred Tax Assets and Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:title="label: ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl">Computation of Diluted Net Loss per Common Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTable to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl">Stock-Based Compensation Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:title="label: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock to us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:title="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl">Disposition Details</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xlink:title="label: ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock to us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:title="label: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl">Property, Plant and Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:title="label: ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl">Warrant activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:title="label: ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock to us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl1">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl1" xlink:title="label: ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock to us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfStockByClassTable_lbl">Schedule of Stock by Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:title="label: ScheduleOfStockByClassTable to us-gaap_ScheduleOfStockByClassTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="SegmentReportingPolicyPolicyTextBlock" xlink:title="SegmentReportingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl">Segment Reporting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:title="label: SegmentReportingPolicyPolicyTextBlock to us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xlink:title="label: SegmentReportingPolicyPolicyTextBlock to us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingAbstract_lbl">Segment Reporting [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:title="label: SegmentReportingAbstract to us-gaap_SegmentReportingAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US" id="us-gaap_SeriesAPreferredStockMember_lbl">Series A Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:title="label: SeriesAPreferredStockMember to us-gaap_SeriesAPreferredStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SeriesAPreferredStockMember_lbl1" xml:lang="en-US" id="us-gaap_SeriesAPreferredStockMember_lbl1">Series A Cumulative Convertible Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl1" xlink:title="label: SeriesAPreferredStockMember to us-gaap_SeriesAPreferredStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl">Cancelled (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl">Cancelled (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl">Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl">Weighted Average Fair Value Per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl">Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:label="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl">Stock-Based Compensation Expense [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:to="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl" xlink:title="label: ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract to us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:to="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1" xlink:title="label: ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract to us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl">Weighted Average Exercise Price per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl">Stock-based Compensation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl">Outstanding Restricted Stock Units [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl">Weighted Average Fair Value Per Share, Ending balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1">Weighted Average Fair Value Per Share, Beginning balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl">Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl">Number of RSUs cancelled (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1">Cancelled (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl2">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl1">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl1" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl">Number of stock units awards outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1">Restricted stock units outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2">Outstanding, Ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl3" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl3" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl3">Outstanding, Beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl3" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl">RSUs vested (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1">Released (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl">Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl">Weightage-Average Assumptions Used for Stock Options Granted [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl">Released (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl">Number of common stock shares to be issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl">Stock-based compensation shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl">Weighted average volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl">Weighted average risk-free rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl">Dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl">Options vested and exercisable, aggregate intrinsic value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl">Outstanding, beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1">Outstanding, ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl">Options vested and exercisable, Weighted average exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl">Options vested and exercisable, Outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl">Stock option outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1">Outstanding, beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2">Outstanding, ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl">Outstanding, ending balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1">Outstanding, beginning balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl">Cancelled (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl">Number of Option Share [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl">Options Vested and Exercisable [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl">Award Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract_lbl">Weighted Average Remaining Contractual Life [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract_lbl" xlink:title="label: ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract to us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl">Number of shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:title="label: ShareBasedCompensationOptionAndIncentivePlansPolicy to us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1" xlink:title="label: ShareBasedCompensationOptionAndIncentivePlansPolicy to us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl1">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesOutstanding_lbl2" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl2">Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl2" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="SharesIssued" xlink:title="SharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharesIssued_lbl" xml:lang="en-US" id="us-gaap_SharesIssued_lbl">Number of shares issued in merger agreement (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xlink:title="label: SharesIssued to us-gaap_SharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesIssued_lbl1" xml:lang="en-US" id="us-gaap_SharesIssued_lbl1">Shares, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssued" xlink:to="us-gaap_SharesIssued_lbl1" xlink:title="label: SharesIssued to us-gaap_SharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US" id="us-gaap_StateAndLocalJurisdictionMember_lbl">State [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:title="label: StateAndLocalJurisdictionMember to us-gaap_StateAndLocalJurisdictionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StateAndLocalJurisdictionMember_lbl1" xml:lang="en-US" id="us-gaap_StateAndLocalJurisdictionMember_lbl1">State and Local Jurisdiction [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl1" xlink:title="label: StateAndLocalJurisdictionMember to us-gaap_StateAndLocalJurisdictionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfFinancialPositionAbstract_lbl">CONSOLIDATED BALANCE SHEETS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:title="label: StatementOfFinancialPositionAbstract to us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="us-gaap_StatementEquityComponentsAxis_lbl">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:title="label: StatementEquityComponentsAxis to us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="us-gaap_StatementLineItems_lbl">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:title="label: StatementLineItems to us-gaap_StatementLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfCashFlowsAbstract_lbl">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:title="label: StatementOfCashFlowsAbstract to us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementTable_lbl" xml:lang="en-US" id="us-gaap_StatementTable_lbl">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:title="label: StatementTable to us-gaap_StatementTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfStockholdersEquityAbstract_lbl">CONSOLIDATED STATEMENTS OF MEMBERS'/STOCKHOLDERS' EQUITY [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:title="label: StatementOfStockholdersEquityAbstract to us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl">Gross proceeds received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:title="label: StockRepurchaseProgramAuthorizedAmount1 to us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1">Aggregate gross purchase price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1" xlink:title="label: StockRepurchaseProgramAuthorizedAmount1 to us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl2" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl2">Aggregate gross purchase price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl2" xlink:title="label: StockRepurchaseProgramAuthorizedAmount1 to us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1" xlink:label="StockIssued1" xlink:title="StockIssued1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssued1_lbl" xml:lang="en-US" id="us-gaap_StockIssued1_lbl">Issuance of common stock for business combination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:title="label: StockIssued1 to us-gaap_StockIssued1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssued1_lbl1" xml:lang="en-US" id="us-gaap_StockIssued1_lbl1">Stock Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssued1" xlink:to="us-gaap_StockIssued1_lbl1" xlink:title="label: StockIssued1 to us-gaap_StockIssued1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl">Number of shares converted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:title="label: StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities to us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl">Private placement (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:title="label: StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased to us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl">Issuance of common stock from vested restricted stock units (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1">Restricted stock replaced during the period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl">Acquisition of common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions to us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1">Issuance of common stock to Financial Advisor upon consummation of merger (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions to us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl">Lock-up agreements shares received in acquisition (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:title="label: StockIssuedDuringPeriodSharesIssuedForServices to us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1">Lock-up agreements common shares received in acquisition (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesIssuedForServices to us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl2" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl2">Number of common stock issued as compensation for services (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesIssuedForServices to us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl">Common stock issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl">Fair value of shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:title="label: StockIssuedDuringPeriodValueNewIssues to us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl">Issuance of common stock from the exercise of stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:title="label: StockIssuedDuringPeriodValueStockOptionsExercised to us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl1">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl1" xlink:title="label: StockIssuedDuringPeriodValueStockOptionsExercised to us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl">Acquisition agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions to us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1">Issuance of common stock to Financial Advisor upon consummation of merger</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions to us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions to us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl">Issuance of common stock from the exercise of stock options (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:title="label: StockIssuedDuringPeriodSharesStockOptionsExercised to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesStockOptionsExercised to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl">Issuance of common stock from vested restricted stock units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl">Total stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl1">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl2">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquity_lbl3" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl3">Stockholders' Equity Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl3" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl">Stock conversion ratio</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:title="label: StockholdersEquityNoteStockSplitConversionRatio1 to us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl1">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl1" xlink:title="label: StockholdersEquityNoteStockSplitConversionRatio1 to us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl">Equity and Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl">Stockholders' equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl1">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl1" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteAbstract_lbl">Equity and Warrants [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:title="label: StockholdersEquityNoteAbstract to us-gaap_StockholdersEquityNoteAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="SubsequentEventsTextBlock" xlink:title="SubsequentEventsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventsTextBlock_lbl">Subsequent Events</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:title="label: SubsequentEventsTextBlock to us-gaap_SubsequentEventsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SubsequentEventsTextBlock_lbl1">Subsequent Events [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl1" xlink:title="label: SubsequentEventsTextBlock to us-gaap_SubsequentEventsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTable_lbl">Subsequent Event [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:title="label: SubsequentEventTable to us-gaap_SubsequentEventTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeDomain_lbl">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" xlink:title="label: SubsequentEventTypeDomain to us-gaap_SubsequentEventTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventMember_lbl">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:title="label: SubsequentEventMember to us-gaap_SubsequentEventMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeAxis_lbl">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:title="label: SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventLineItems_lbl">Subsequent Event [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:title="label: SubsequentEventLineItems to us-gaap_SubsequentEventLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventsAbstract_lbl">Subsequent Event [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:title="label: SubsequentEventsAbstract to us-gaap_SubsequentEventsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US" id="us-gaap_SubsidiarySaleOfStockLineItems_lbl">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:title="label: SubsidiarySaleOfStockLineItems to us-gaap_SubsidiarySaleOfStockLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US" id="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:title="label: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl">Supplemental disclosures of cash flow information:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl1">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="TaxCreditCarryforwardAmount" xlink:title="TaxCreditCarryforwardAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TaxCreditCarryforwardAmount_lbl" xml:lang="en-US" id="us-gaap_TaxCreditCarryforwardAmount_lbl">Federal and state income tax credit carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:title="label: TaxCreditCarryforwardAmount to us-gaap_TaxCreditCarryforwardAmount_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TradeNamesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TradeNamesMember_lbl" xml:lang="en-US" id="us-gaap_TradeNamesMember_lbl">Trade Names [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradeNamesMember" xlink:to="us-gaap_TradeNamesMember_lbl" xlink:title="label: TradeNamesMember to us-gaap_TradeNamesMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US" id="us-gaap_TypeOfArrangementAxis_lbl">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:title="label: TypeOfArrangementAxis to us-gaap_TypeOfArrangementAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl">Accrued interest and penalties related to uncertain tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:title="UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl">Net changes based on prior year's tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:title="label: UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions to us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:title="UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl">Additions based on current year's tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:title="label: UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions to us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="UnrecognizedTaxBenefits" xlink:title="UnrecognizedTaxBenefits" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefits_lbl">Beginning balance of uncertain tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:title="label: UnrecognizedTaxBenefits to us-gaap_UnrecognizedTaxBenefits_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_UnrecognizedTaxBenefits_lbl1" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefits_lbl1">Ending balance of uncertain tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl1" xlink:title="label: UnrecognizedTaxBenefits to us-gaap_UnrecognizedTaxBenefits_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefits_lbl2" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefits_lbl2">Unrecognized Tax Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl2" xlink:title="label: UnrecognizedTaxBenefits to us-gaap_UnrecognizedTaxBenefits_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnusualOrInfrequentItemAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnusualOrInfrequentItemAxis_lbl" xml:lang="en-US" id="us-gaap_UnusualOrInfrequentItemAxis_lbl">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="us-gaap_UnusualOrInfrequentItemAxis_lbl" xlink:title="label: UnusualOrInfrequentItemAxis to us-gaap_UnusualOrInfrequentItemAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnusualOrInfrequentItemDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnusualOrInfrequentItemDomain_lbl" xml:lang="en-US" id="us-gaap_UnusualOrInfrequentItemDomain_lbl">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="us-gaap_UnusualOrInfrequentItemDomain_lbl" xlink:title="label: UnusualOrInfrequentItemDomain to us-gaap_UnusualOrInfrequentItemDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UseOfEstimates_lbl1" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl1">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl1" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US" id="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl">Increase in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:title="label: ValuationAllowanceDeferredTaxAssetChangeInAmount to us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl1" xml:lang="en-US" id="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl1">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl1" xlink:title="label: ValuationAllowanceDeferredTaxAssetChangeInAmount to us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VariableLeaseCost_lbl" xml:lang="en-US" id="us-gaap_VariableLeaseCost_lbl">Variable lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" xlink:title="label: VariableLeaseCost to us-gaap_VariableLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantMember_lbl" xml:lang="en-US" id="us-gaap_WarrantMember_lbl">Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:title="label: WarrantMember to us-gaap_WarrantMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US" id="us-gaap_WarrantsAndRightsOutstandingTerm_lbl">Warrants outstanding weighted average contractual life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:title="label: WarrantsAndRightsOutstandingTerm to us-gaap_WarrantsAndRightsOutstandingTerm_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl">Warrant Activity Abstract</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:title="label: WarrantsAndRightsNoteDisclosureAbstract to us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl">Weighted average shares outstanding - diluted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:title="label: WeightedAverageNumberOfDilutedSharesOutstanding to us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl">Weighted average shares outstanding - basic (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:title="label: WeightedAverageNumberOfSharesOutstandingBasic to us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:label xlink:type="resource" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_EquityMethodInvesteeNameDomain_lbl" xml:lang="en-US" id="srt_EquityMethodInvesteeNameDomain_lbl">Investment, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl" xlink:title="label: EquityMethodInvesteeNameDomain to srt_EquityMethodInvesteeNameDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_EquityMethodInvesteeNameDomain_lbl1" xml:lang="en-US" id="srt_EquityMethodInvesteeNameDomain_lbl1">Investment, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl1" xlink:title="label: EquityMethodInvesteeNameDomain to srt_EquityMethodInvesteeNameDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MaximumMember_lbl" xml:lang="en-US" id="srt_MaximumMember_lbl">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:title="label: MaximumMember to srt_MaximumMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MinimumMember_lbl" xml:lang="en-US" id="srt_MinimumMember_lbl">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:title="label: MinimumMember to srt_MinimumMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipDomain_lbl" xml:lang="en-US" id="srt_OwnershipDomain_lbl">Ownership [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl" xlink:title="label: OwnershipDomain to srt_OwnershipDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipAxis_lbl" xml:lang="en-US" id="srt_OwnershipAxis_lbl">Ownership [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:title="label: OwnershipAxis to srt_OwnershipAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_RangeAxis_lbl" xml:lang="en-US" id="srt_RangeAxis_lbl">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:title="label: RangeAxis to srt_RangeAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeAxis_lbl1" xml:lang="en-US" id="srt_RangeAxis_lbl1">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis_lbl1" xlink:title="label: RangeAxis to srt_RangeAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:label xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeMember_lbl" xml:lang="en-US" id="srt_RangeMember_lbl">Statistical Measurement [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="srt_RangeMember_lbl" xlink:title="label: RangeMember to srt_RangeMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US" id="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl">Investment, Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:title="label: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl1" xml:lang="en-US" id="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl1">Investment, Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl1" xlink:title="label: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="DocumentAnnualReport" xlink:title="DocumentAnnualReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentAnnualReport_lbl" xml:lang="en-US" id="dei_DocumentAnnualReport_lbl">Document Annual Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:title="label: DocumentAnnualReport to dei_DocumentAnnualReport_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentTransitionReport_lbl" xml:lang="en-US" id="dei_DocumentTransitionReport_lbl">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:title="label: DocumentTransitionReport to dei_DocumentTransitionReport_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:label xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" id="dei_EntityInteractiveDataCurrent_lbl">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:title="label: EntityInteractiveDataCurrent to dei_EntityInteractiveDataCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="IcfrAuditorAttestationFlag" xlink:title="IcfrAuditorAttestationFlag" />
    <link:label xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US" id="dei_IcfrAuditorAttestationFlag_lbl">ICFR Auditor Attestation Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:title="label: IcfrAuditorAttestationFlag to dei_IcfrAuditorAttestationFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:label xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LegalEntityAxis_lbl" xml:lang="en-US" id="dei_LegalEntityAxis_lbl">Legal Entity [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:title="label: LegalEntityAxis to dei_LegalEntityAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:label xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityDomain_lbl" xml:lang="en-US" id="dei_EntityDomain_lbl">Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityDomain" xlink:to="dei_EntityDomain_lbl" xlink:title="label: EntityDomain to dei_EntityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate_lbl">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer" />
    <link:label xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US" id="dei_EntityWellKnownSeasonedIssuer_lbl">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:title="label: EntityWellKnownSeasonedIssuer to dei_EntityWellKnownSeasonedIssuer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers" />
    <link:label xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US" id="dei_EntityVoluntaryFilers_lbl">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:title="label: EntityVoluntaryFilers to dei_EntityVoluntaryFilers_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" id="dei_EntityCurrentReportingStatus_lbl">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:title="label: EntityCurrentReportingStatus to dei_EntityCurrentReportingStatus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityShellCompany_lbl" xml:lang="en-US" id="dei_EntityShellCompany_lbl">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:title="label: EntityShellCompany to dei_EntityShellCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="dei_EntityFilerCategory_lbl">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:title="label: EntityFilerCategory to dei_EntityFilerCategory_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:label xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntitySmallBusiness_lbl" xml:lang="en-US" id="dei_EntitySmallBusiness_lbl">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:title="label: EntitySmallBusiness to dei_EntitySmallBusiness_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="EntityPublicFloat" xlink:title="EntityPublicFloat" />
    <link:label xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityPublicFloat_lbl" xml:lang="en-US" id="dei_EntityPublicFloat_lbl">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:title="label: EntityPublicFloat to dei_EntityPublicFloat_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="dei_EntityCommonStockSharesOutstanding_lbl">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:title="label: EntityCommonStockSharesOutstanding to dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="AuditorName" xlink:title="AuditorName" />
    <link:label xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AuditorName_lbl" xml:lang="en-US" id="dei_AuditorName_lbl">Auditor Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AuditorName" xlink:to="dei_AuditorName_lbl" xlink:title="label: AuditorName to dei_AuditorName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="AuditorLocation" xlink:title="AuditorLocation" />
    <link:label xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AuditorLocation_lbl" xml:lang="en-US" id="dei_AuditorLocation_lbl">Auditor Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:title="label: AuditorLocation to dei_AuditorLocation_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="AuditorFirmId" xlink:title="AuditorFirmId" />
    <link:label xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AuditorFirmId_lbl" xml:lang="en-US" id="dei_AuditorFirmId_lbl">Auditor Firm ID</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:title="label: AuditorFirmId to dei_AuditorFirmId_lbl" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfCommonStockSubjectToLockUpAgreement" xlink:label="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="PercentageOfCommonStockSubjectToLockUpAgreement" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl" xml:lang="en-US" id="erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl">The percentage of shares of common stock subject to the lock-up agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:to="erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl" xlink:title="label: PercentageOfCommonStockSubjectToLockUpAgreement to erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1" xml:lang="en-US" id="erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1">Percentage of Common Stock Subject to Lock-up Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:to="erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1" xlink:title="label: PercentageOfCommonStockSubjectToLockUpAgreement to erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2" xml:lang="en-US" id="erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2">Percentage of common stock subject to the lock-up agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:to="erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2" xlink:title="label: PercentageOfCommonStockSubjectToLockUpAgreement to erna_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl">Number of shares of stock issued without any restrictions during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:to="erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesAcquisitions to erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1">Stock Issued During Period, Unrestricted Shares, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:to="erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesAcquisitions to erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2">Unrestricted shares, issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:to="erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesAcquisitions to erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:label xlink:type="resource" xlink:label="erna_NovellusTherapeuticsLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NovellusTherapeuticsLimitedMember_lbl" xml:lang="en-US" id="erna_NovellusTherapeuticsLimitedMember_lbl">The name of company involved in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusTherapeuticsLimitedMember" xlink:to="erna_NovellusTherapeuticsLimitedMember_lbl" xlink:title="label: NovellusTherapeuticsLimitedMember to erna_NovellusTherapeuticsLimitedMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NovellusTherapeuticsLimitedMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NovellusTherapeuticsLimitedMember_lbl1" xml:lang="en-US" id="erna_NovellusTherapeuticsLimitedMember_lbl1">Novellus Therapeutics Limited [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusTherapeuticsLimitedMember" xlink:to="erna_NovellusTherapeuticsLimitedMember_lbl1" xlink:title="label: NovellusTherapeuticsLimitedMember to erna_NovellusTherapeuticsLimitedMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NovellusTherapeuticsLimitedMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NovellusTherapeuticsLimitedMember_lbl2" xml:lang="en-US" id="erna_NovellusTherapeuticsLimitedMember_lbl2">Novellus, Ltd. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusTherapeuticsLimitedMember" xlink:to="erna_NovellusTherapeuticsLimitedMember_lbl2" xlink:title="label: NovellusTherapeuticsLimitedMember to erna_NovellusTherapeuticsLimitedMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EachLockUpAgreementExtendsTerm" xlink:label="EachLockUpAgreementExtendsTerm" xlink:title="EachLockUpAgreementExtendsTerm" />
    <link:label xlink:type="resource" xlink:label="erna_EachLockUpAgreementExtendsTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_EachLockUpAgreementExtendsTerm_lbl" xml:lang="en-US" id="erna_EachLockUpAgreementExtendsTerm_lbl">The period of lock-up agreement extend term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EachLockUpAgreementExtendsTerm" xlink:to="erna_EachLockUpAgreementExtendsTerm_lbl" xlink:title="label: EachLockUpAgreementExtendsTerm to erna_EachLockUpAgreementExtendsTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_EachLockUpAgreementExtendsTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_EachLockUpAgreementExtendsTerm_lbl1" xml:lang="en-US" id="erna_EachLockUpAgreementExtendsTerm_lbl1">Each Lock-up Agreement Extends Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EachLockUpAgreementExtendsTerm" xlink:to="erna_EachLockUpAgreementExtendsTerm_lbl1" xlink:title="label: EachLockUpAgreementExtendsTerm to erna_EachLockUpAgreementExtendsTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_EachLockUpAgreementExtendsTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_EachLockUpAgreementExtendsTerm_lbl2" xml:lang="en-US" id="erna_EachLockUpAgreementExtendsTerm_lbl2">Each lock-up agreement extend term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EachLockUpAgreementExtendsTerm" xlink:to="erna_EachLockUpAgreementExtendsTerm_lbl2" xlink:title="label: EachLockUpAgreementExtendsTerm to erna_EachLockUpAgreementExtendsTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:label="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" />
    <link:label xlink:type="resource" xlink:label="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl" xml:lang="en-US" id="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl">Person with designation of chairman of the board of directors, chief executive officer and president.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:to="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl" xlink:title="label: ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember to erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl1" xml:lang="en-US" id="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl1">Chairman of the Board of Directors Chief Executive Officer and President [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:to="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl1" xlink:title="label: ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember to erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl2" xml:lang="en-US" id="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl2">Chair of the Board of Directors, Chief Executive Officer and President [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:to="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl2" xlink:title="label: ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember to erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl2" />
    <link:label xlink:type="resource" xlink:label="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl3" xml:lang="en-US" id="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl3">Chairman of the Board of Directors, Chief Executive Officer and President [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:to="erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl3" xlink:title="label: ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember to erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl3" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PurchaseAgreementMember" xlink:label="PurchaseAgreementMember" xlink:title="PurchaseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="erna_PurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PurchaseAgreementMember_lbl" xml:lang="en-US" id="erna_PurchaseAgreementMember_lbl">Information about purchase agreement between the entities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseAgreementMember" xlink:to="erna_PurchaseAgreementMember_lbl" xlink:title="label: PurchaseAgreementMember to erna_PurchaseAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PurchaseAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PurchaseAgreementMember_lbl1" xml:lang="en-US" id="erna_PurchaseAgreementMember_lbl1">Purchase Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseAgreementMember" xlink:to="erna_PurchaseAgreementMember_lbl1" xlink:title="label: PurchaseAgreementMember to erna_PurchaseAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PurchaseAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PurchaseAgreementMember_lbl2" xml:lang="en-US" id="erna_PurchaseAgreementMember_lbl2">Purchase Agreements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseAgreementMember" xlink:to="erna_PurchaseAgreementMember_lbl2" xlink:title="label: PurchaseAgreementMember to erna_PurchaseAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_FirstPurchaseAgreementMember" xlink:label="FirstPurchaseAgreementMember" xlink:title="FirstPurchaseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="erna_FirstPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_FirstPurchaseAgreementMember_lbl" xml:lang="en-US" id="erna_FirstPurchaseAgreementMember_lbl">Information about purchase agreement between the entities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FirstPurchaseAgreementMember" xlink:to="erna_FirstPurchaseAgreementMember_lbl" xlink:title="label: FirstPurchaseAgreementMember to erna_FirstPurchaseAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_FirstPurchaseAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_FirstPurchaseAgreementMember_lbl1" xml:lang="en-US" id="erna_FirstPurchaseAgreementMember_lbl1">First Purchase Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FirstPurchaseAgreementMember" xlink:to="erna_FirstPurchaseAgreementMember_lbl1" xlink:title="label: FirstPurchaseAgreementMember to erna_FirstPurchaseAgreementMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PrivatePlacementOfferingsAbstract" xlink:label="PrivatePlacementOfferingsAbstract" xlink:title="PrivatePlacementOfferingsAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_PrivatePlacementOfferingsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PrivatePlacementOfferingsAbstract_lbl1" xml:lang="en-US" id="erna_PrivatePlacementOfferingsAbstract_lbl1">Private Placement Offerings [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrivatePlacementOfferingsAbstract" xlink:to="erna_PrivatePlacementOfferingsAbstract_lbl1" xlink:title="label: PrivatePlacementOfferingsAbstract to erna_PrivatePlacementOfferingsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesToIssuedInTransaction" />
    <link:label xlink:type="resource" xlink:label="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl" xml:lang="en-US" id="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl">The number of shares to be issued by the subsidiary or equity method investee per stock transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:to="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl" xlink:title="label: SaleOfStockNumberOfSharesToIssuedInTransaction to erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl1" xml:lang="en-US" id="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl1">Sale of Stock, Number of Shares to Issued in Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:to="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl1" xlink:title="label: SaleOfStockNumberOfSharesToIssuedInTransaction to erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl2" xml:lang="en-US" id="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl2">Number of remaining shares to be sold (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:to="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl2" xlink:title="label: SaleOfStockNumberOfSharesToIssuedInTransaction to erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" xlink:label="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" xlink:title="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" />
    <link:label xlink:type="resource" xlink:label="erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl" xml:lang="en-US" id="erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl">The number of further shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" xlink:to="erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl" xlink:title="label: NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1 to erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl1" xml:lang="en-US" id="erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl1">Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Further Shares Issued1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" xlink:to="erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl1" xlink:title="label: NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1 to erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl2" xml:lang="en-US" id="erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl2">Number of shares remaining to be sold in purchase commitment (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" xlink:to="erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl2" xlink:title="label: NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1 to erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BeneficialOwnershipPercentageOnTotalOutstandingShares" xlink:label="BeneficialOwnershipPercentageOnTotalOutstandingShares" xlink:title="BeneficialOwnershipPercentageOnTotalOutstandingShares" />
    <link:label xlink:type="resource" xlink:label="erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl" xml:lang="en-US" id="erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl">The equity interest of shareholders, partners or other equity holders in consolidated entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialOwnershipPercentageOnTotalOutstandingShares" xlink:to="erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl" xlink:title="label: BeneficialOwnershipPercentageOnTotalOutstandingShares to erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl1" xml:lang="en-US" id="erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl1">Beneficial Ownership Percentage on Total Outstanding Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialOwnershipPercentageOnTotalOutstandingShares" xlink:to="erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl1" xlink:title="label: BeneficialOwnershipPercentageOnTotalOutstandingShares to erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl2" xml:lang="en-US" id="erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl2">Beneficial ownership percentage on total outstanding shares that prohibits company to direct share purchases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialOwnershipPercentageOnTotalOutstandingShares" xlink:to="erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl2" xlink:title="label: BeneficialOwnershipPercentageOnTotalOutstandingShares to erna_BeneficialOwnershipPercentageOnTotalOutstandingShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LincolnParkCapitalFundLLCMember" xlink:label="LincolnParkCapitalFundLLCMember" xlink:title="LincolnParkCapitalFundLLCMember" />
    <link:label xlink:type="resource" xlink:label="erna_LincolnParkCapitalFundLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LincolnParkCapitalFundLLCMember_lbl" xml:lang="en-US" id="erna_LincolnParkCapitalFundLLCMember_lbl">Name of entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LincolnParkCapitalFundLLCMember" xlink:to="erna_LincolnParkCapitalFundLLCMember_lbl" xlink:title="label: LincolnParkCapitalFundLLCMember to erna_LincolnParkCapitalFundLLCMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LincolnParkCapitalFundLLCMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LincolnParkCapitalFundLLCMember_lbl1" xml:lang="en-US" id="erna_LincolnParkCapitalFundLLCMember_lbl1">Lincoln Park Capital Fund, LLC [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LincolnParkCapitalFundLLCMember" xlink:to="erna_LincolnParkCapitalFundLLCMember_lbl1" xlink:title="label: LincolnParkCapitalFundLLCMember to erna_LincolnParkCapitalFundLLCMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LincolnParkCapitalFundLLCMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LincolnParkCapitalFundLLCMember_lbl2" xml:lang="en-US" id="erna_LincolnParkCapitalFundLLCMember_lbl2">Lincoln Park [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LincolnParkCapitalFundLLCMember" xlink:to="erna_LincolnParkCapitalFundLLCMember_lbl2" xlink:title="label: LincolnParkCapitalFundLLCMember to erna_LincolnParkCapitalFundLLCMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommitmentAmountToMeetAnySingleRegularPurchase" xlink:label="CommitmentAmountToMeetAnySingleRegularPurchase" xlink:title="CommitmentAmountToMeetAnySingleRegularPurchase" />
    <link:label xlink:type="resource" xlink:label="erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl" xml:lang="en-US" id="erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl">The amount of purchase price or commitment amount to meet any single regular purchase in share purchase transaction on any business day.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentAmountToMeetAnySingleRegularPurchase" xlink:to="erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl" xlink:title="label: CommitmentAmountToMeetAnySingleRegularPurchase to erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl1" xml:lang="en-US" id="erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl1">Commitment Amount to Meet any Single Regular Purchase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentAmountToMeetAnySingleRegularPurchase" xlink:to="erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl1" xlink:title="label: CommitmentAmountToMeetAnySingleRegularPurchase to erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl2" xml:lang="en-US" id="erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl2">Maximum commitment in any single regular purchase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentAmountToMeetAnySingleRegularPurchase" xlink:to="erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl2" xlink:title="label: CommitmentAmountToMeetAnySingleRegularPurchase to erna_CommitmentAmountToMeetAnySingleRegularPurchase_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SecondPurchaseAgreementMember" xlink:label="SecondPurchaseAgreementMember" xlink:title="SecondPurchaseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="erna_SecondPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SecondPurchaseAgreementMember_lbl" xml:lang="en-US" id="erna_SecondPurchaseAgreementMember_lbl">Information about second purchase agreement between the entities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecondPurchaseAgreementMember" xlink:to="erna_SecondPurchaseAgreementMember_lbl" xlink:title="label: SecondPurchaseAgreementMember to erna_SecondPurchaseAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SecondPurchaseAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SecondPurchaseAgreementMember_lbl1" xml:lang="en-US" id="erna_SecondPurchaseAgreementMember_lbl1">Second Purchase Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecondPurchaseAgreementMember" xlink:to="erna_SecondPurchaseAgreementMember_lbl1" xlink:title="label: SecondPurchaseAgreementMember to erna_SecondPurchaseAgreementMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PIPEInvestorOneMember" xlink:label="PIPEInvestorOneMember" xlink:title="PIPEInvestorOneMember" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PIPEInvestorOneMember_lbl" xml:lang="en-US" id="erna_PIPEInvestorOneMember_lbl">A private investment in public equity, often called a PIPE deal, involves the selling of publicly traded common shares or some form of preferred stock or convertible security to private investors. It is an allocation of shares in a public company not through a public offering in a stock exchange. PIPE deals are part of the primary market. In the U.S., a PIPE offering may be registered with the Securities and Exchange Commission on a registration statement or may be completed as an unregistered private placement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorOneMember" xlink:to="erna_PIPEInvestorOneMember_lbl" xlink:title="label: PIPEInvestorOneMember to erna_PIPEInvestorOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PIPEInvestorOneMember_lbl1" xml:lang="en-US" id="erna_PIPEInvestorOneMember_lbl1">PIPE Investor One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorOneMember" xlink:to="erna_PIPEInvestorOneMember_lbl1" xlink:title="label: PIPEInvestorOneMember to erna_PIPEInvestorOneMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorOneMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PIPEInvestorOneMember_lbl2" xml:lang="en-US" id="erna_PIPEInvestorOneMember_lbl2">Q4-22 PIPE Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorOneMember" xlink:to="erna_PIPEInvestorOneMember_lbl2" xlink:title="label: PIPEInvestorOneMember to erna_PIPEInvestorOneMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PrivatePlacementOfEquityAbstract" xlink:label="PrivatePlacementOfEquityAbstract" xlink:title="PrivatePlacementOfEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_PrivatePlacementOfEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PrivatePlacementOfEquityAbstract_lbl1" xml:lang="en-US" id="erna_PrivatePlacementOfEquityAbstract_lbl1">Private Placement of Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="erna_PrivatePlacementOfEquityAbstract_lbl1" xlink:title="label: PrivatePlacementOfEquityAbstract to erna_PrivatePlacementOfEquityAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PrivatePlacementOfEquityAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PrivatePlacementOfEquityAbstract_lbl2" xml:lang="en-US" id="erna_PrivatePlacementOfEquityAbstract_lbl2">Private Placement of Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="erna_PrivatePlacementOfEquityAbstract_lbl2" xlink:title="label: PrivatePlacementOfEquityAbstract to erna_PrivatePlacementOfEquityAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfWarrantsInEachUnit" xlink:label="NumberOfWarrantsInEachUnit" xlink:title="NumberOfWarrantsInEachUnit" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfWarrantsInEachUnit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NumberOfWarrantsInEachUnit_lbl" xml:lang="en-US" id="erna_NumberOfWarrantsInEachUnit_lbl">Number of warrant consist in each unit.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfWarrantsInEachUnit" xlink:to="erna_NumberOfWarrantsInEachUnit_lbl" xlink:title="label: NumberOfWarrantsInEachUnit to erna_NumberOfWarrantsInEachUnit_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfWarrantsInEachUnit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NumberOfWarrantsInEachUnit_lbl1" xml:lang="en-US" id="erna_NumberOfWarrantsInEachUnit_lbl1">Number of warrants in each unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfWarrantsInEachUnit" xlink:to="erna_NumberOfWarrantsInEachUnit_lbl1" xlink:title="label: NumberOfWarrantsInEachUnit to erna_NumberOfWarrantsInEachUnit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightsExercisableTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ClassOfWarrantOrRightsExercisableTerm_lbl" xml:lang="en-US" id="erna_ClassOfWarrantOrRightsExercisableTerm_lbl">Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightsExercisableTerm" xlink:to="erna_ClassOfWarrantOrRightsExercisableTerm_lbl" xlink:title="label: ClassOfWarrantOrRightsExercisableTerm to erna_ClassOfWarrantOrRightsExercisableTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightsExercisableTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ClassOfWarrantOrRightsExercisableTerm_lbl1" xml:lang="en-US" id="erna_ClassOfWarrantOrRightsExercisableTerm_lbl1">Class of Warrant or Rights Exercisable Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightsExercisableTerm" xlink:to="erna_ClassOfWarrantOrRightsExercisableTerm_lbl1" xlink:title="label: ClassOfWarrantOrRightsExercisableTerm to erna_ClassOfWarrantOrRightsExercisableTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightsExercisableTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ClassOfWarrantOrRightsExercisableTerm_lbl2" xml:lang="en-US" id="erna_ClassOfWarrantOrRightsExercisableTerm_lbl2">Warrant exercisable term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightsExercisableTerm" xlink:to="erna_ClassOfWarrantOrRightsExercisableTerm_lbl2" xlink:title="label: ClassOfWarrantOrRightsExercisableTerm to erna_ClassOfWarrantOrRightsExercisableTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ObligationToPayLiquidatedDamagesPercentage" xlink:label="ObligationToPayLiquidatedDamagesPercentage" xlink:title="ObligationToPayLiquidatedDamagesPercentage" />
    <link:label xlink:type="resource" xlink:label="erna_ObligationToPayLiquidatedDamagesPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ObligationToPayLiquidatedDamagesPercentage_lbl" xml:lang="en-US" id="erna_ObligationToPayLiquidatedDamagesPercentage_lbl">Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages percentage of aggregate payment on Subscription Amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentage" xlink:to="erna_ObligationToPayLiquidatedDamagesPercentage_lbl" xlink:title="label: ObligationToPayLiquidatedDamagesPercentage to erna_ObligationToPayLiquidatedDamagesPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ObligationToPayLiquidatedDamagesPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ObligationToPayLiquidatedDamagesPercentage_lbl1" xml:lang="en-US" id="erna_ObligationToPayLiquidatedDamagesPercentage_lbl1">Obligation to Pay Liquidated Damages Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentage" xlink:to="erna_ObligationToPayLiquidatedDamagesPercentage_lbl1" xlink:title="label: ObligationToPayLiquidatedDamagesPercentage to erna_ObligationToPayLiquidatedDamagesPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ObligationToPayLiquidatedDamagesPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ObligationToPayLiquidatedDamagesPercentage_lbl2" xml:lang="en-US" id="erna_ObligationToPayLiquidatedDamagesPercentage_lbl2">Obligated to pay liquidated damages percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentage" xlink:to="erna_ObligationToPayLiquidatedDamagesPercentage_lbl2" xlink:title="label: ObligationToPayLiquidatedDamagesPercentage to erna_ObligationToPayLiquidatedDamagesPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:label xlink:type="resource" xlink:label="erna_OverSubscriptionAmountReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_OverSubscriptionAmountReceived_lbl" xml:lang="en-US" id="erna_OverSubscriptionAmountReceived_lbl">Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OverSubscriptionAmountReceived" xlink:to="erna_OverSubscriptionAmountReceived_lbl" xlink:title="label: OverSubscriptionAmountReceived to erna_OverSubscriptionAmountReceived_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_OverSubscriptionAmountReceived_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OverSubscriptionAmountReceived_lbl1" xml:lang="en-US" id="erna_OverSubscriptionAmountReceived_lbl1">Over-Subscription Amount Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OverSubscriptionAmountReceived" xlink:to="erna_OverSubscriptionAmountReceived_lbl1" xlink:title="label: OverSubscriptionAmountReceived to erna_OverSubscriptionAmountReceived_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_OverSubscriptionAmountReceived_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_OverSubscriptionAmountReceived_lbl2" xml:lang="en-US" id="erna_OverSubscriptionAmountReceived_lbl2">Over-subscription amount received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OverSubscriptionAmountReceived" xlink:to="erna_OverSubscriptionAmountReceived_lbl2" xlink:title="label: OverSubscriptionAmountReceived to erna_OverSubscriptionAmountReceived_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightExercised" xlink:label="ClassOfWarrantOrRightExercised" xlink:title="ClassOfWarrantOrRightExercised" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ClassOfWarrantOrRightExercised_lbl" xml:lang="en-US" id="erna_ClassOfWarrantOrRightExercised_lbl">Number of warrants or rights exercised during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercised" xlink:to="erna_ClassOfWarrantOrRightExercised_lbl" xlink:title="label: ClassOfWarrantOrRightExercised to erna_ClassOfWarrantOrRightExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ClassOfWarrantOrRightExercised_lbl1" xml:lang="en-US" id="erna_ClassOfWarrantOrRightExercised_lbl1">Class of Warrant or Right Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercised" xlink:to="erna_ClassOfWarrantOrRightExercised_lbl1" xlink:title="label: ClassOfWarrantOrRightExercised to erna_ClassOfWarrantOrRightExercised_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightExercised_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_ClassOfWarrantOrRightExercised_lbl2" xml:lang="en-US" id="erna_ClassOfWarrantOrRightExercised_lbl2">Warrants exercised (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercised" xlink:to="erna_ClassOfWarrantOrRightExercised_lbl2" xlink:title="label: ClassOfWarrantOrRightExercised to erna_ClassOfWarrantOrRightExercised_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsOneMember" xlink:label="CommonWarrantsOneMember" xlink:title="CommonWarrantsOneMember" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CommonWarrantsOneMember_lbl" xml:lang="en-US" id="erna_CommonWarrantsOneMember_lbl">A common warrant represents the right to purchase a company's stock at a specific price and at a specific date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsOneMember" xlink:to="erna_CommonWarrantsOneMember_lbl" xlink:title="label: CommonWarrantsOneMember to erna_CommonWarrantsOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CommonWarrantsOneMember_lbl1" xml:lang="en-US" id="erna_CommonWarrantsOneMember_lbl1">Common Warrants One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsOneMember" xlink:to="erna_CommonWarrantsOneMember_lbl1" xlink:title="label: CommonWarrantsOneMember to erna_CommonWarrantsOneMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsOneMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_CommonWarrantsOneMember_lbl2" xml:lang="en-US" id="erna_CommonWarrantsOneMember_lbl2">Q4-22 Common Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsOneMember" xlink:to="erna_CommonWarrantsOneMember_lbl2" xlink:title="label: CommonWarrantsOneMember to erna_CommonWarrantsOneMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CommonWarrantsMember_lbl" xml:lang="en-US" id="erna_CommonWarrantsMember_lbl">A common warrant represents the right to purchase a company's stock at a specific price and at a specific date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="erna_CommonWarrantsMember_lbl" xlink:title="label: CommonWarrantsMember to erna_CommonWarrantsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CommonWarrantsMember_lbl1" xml:lang="en-US" id="erna_CommonWarrantsMember_lbl1">Common Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="erna_CommonWarrantsMember_lbl1" xlink:title="label: CommonWarrantsMember to erna_CommonWarrantsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_CommonWarrantsMember_lbl2" xml:lang="en-US" id="erna_CommonWarrantsMember_lbl2">Common Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="erna_CommonWarrantsMember_lbl2" xlink:title="label: CommonWarrantsMember to erna_CommonWarrantsMember_lbl2" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsMember_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_CommonWarrantsMember_lbl3" xml:lang="en-US" id="erna_CommonWarrantsMember_lbl3">Q1-22 Common Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="erna_CommonWarrantsMember_lbl3" xlink:title="label: CommonWarrantsMember to erna_CommonWarrantsMember_lbl3" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:label="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" />
    <link:label xlink:type="resource" xlink:label="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" xml:lang="en-US" id="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl">Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages equal to the Subscription Amount per month.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:to="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" xlink:title="label: ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth to erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" xml:lang="en-US" id="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1">Obligation to Pay Liquidated Damages Percentage on Subscription Amount per Month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:to="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" xlink:title="label: ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth to erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2" xml:lang="en-US" id="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2">Obligation to pay liquidated damages per month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:to="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2" xlink:title="label: ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth to erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:label xlink:type="resource" xlink:label="erna_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PreFundedWarrantsMember_lbl" xml:lang="en-US" id="erna_PreFundedWarrantsMember_lbl">A pre-funded warrant that allows the warrant holder to purchase a specified number of a company's securities at a nominal exercise price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreFundedWarrantsMember" xlink:to="erna_PreFundedWarrantsMember_lbl" xlink:title="label: PreFundedWarrantsMember to erna_PreFundedWarrantsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PreFundedWarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PreFundedWarrantsMember_lbl1" xml:lang="en-US" id="erna_PreFundedWarrantsMember_lbl1">Pre-funded Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreFundedWarrantsMember" xlink:to="erna_PreFundedWarrantsMember_lbl1" xlink:title="label: PreFundedWarrantsMember to erna_PreFundedWarrantsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PreFundedWarrantsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PreFundedWarrantsMember_lbl2" xml:lang="en-US" id="erna_PreFundedWarrantsMember_lbl2">Pre-funded Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreFundedWarrantsMember" xlink:to="erna_PreFundedWarrantsMember_lbl2" xlink:title="label: PreFundedWarrantsMember to erna_PreFundedWarrantsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_UnitPriceOfWarrants" xlink:label="UnitPriceOfWarrants" xlink:title="UnitPriceOfWarrants" />
    <link:label xlink:type="resource" xlink:label="erna_UnitPriceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_UnitPriceOfWarrants_lbl" xml:lang="en-US" id="erna_UnitPriceOfWarrants_lbl">Exercise price of prefunded and common warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnitPriceOfWarrants" xlink:to="erna_UnitPriceOfWarrants_lbl" xlink:title="label: UnitPriceOfWarrants to erna_UnitPriceOfWarrants_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_UnitPriceOfWarrants_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_UnitPriceOfWarrants_lbl1" xml:lang="en-US" id="erna_UnitPriceOfWarrants_lbl1">Unit Price of Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnitPriceOfWarrants" xlink:to="erna_UnitPriceOfWarrants_lbl1" xlink:title="label: UnitPriceOfWarrants to erna_UnitPriceOfWarrants_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_UnitPriceOfWarrants_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_UnitPriceOfWarrants_lbl2" xml:lang="en-US" id="erna_UnitPriceOfWarrants_lbl2">Unit price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnitPriceOfWarrants" xlink:to="erna_UnitPriceOfWarrants_lbl2" xlink:title="label: UnitPriceOfWarrants to erna_UnitPriceOfWarrants_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:label="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl" xml:lang="en-US" id="erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl">Percentage of securities that would be issuable upon the exercise of warrants or rights.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:to="erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl" xlink:title="label: ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights to erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1" xml:lang="en-US" id="erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1">Class of Warrant or Right Percent of Securities that Would be Issuable Upon Exercise of Warrants or Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:to="erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1" xlink:title="label: ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights to erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2" xml:lang="en-US" id="erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2">Percentage of warrants exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:to="erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2" xlink:title="label: ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights to erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TransactionFeesPayable" xlink:label="TransactionFeesPayable" xlink:title="TransactionFeesPayable" />
    <link:label xlink:type="resource" xlink:label="erna_TransactionFeesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_TransactionFeesPayable_lbl" xml:lang="en-US" id="erna_TransactionFeesPayable_lbl">Fees incurred related to PIPE transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesPayable" xlink:to="erna_TransactionFeesPayable_lbl" xlink:title="label: TransactionFeesPayable to erna_TransactionFeesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_TransactionFeesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_TransactionFeesPayable_lbl1" xml:lang="en-US" id="erna_TransactionFeesPayable_lbl1">Transaction Fees Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesPayable" xlink:to="erna_TransactionFeesPayable_lbl1" xlink:title="label: TransactionFeesPayable to erna_TransactionFeesPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_TransactionFeesPayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_TransactionFeesPayable_lbl2" xml:lang="en-US" id="erna_TransactionFeesPayable_lbl2">Transaction fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesPayable" xlink:to="erna_TransactionFeesPayable_lbl2" xlink:title="label: TransactionFeesPayable to erna_TransactionFeesPayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PIPEInvestorMember_lbl" xml:lang="en-US" id="erna_PIPEInvestorMember_lbl">A private investment in public equity, often called a PIPE deal, involves the selling of publicly traded common shares or some form of preferred stock or convertible security to private investors. It is an allocation of shares in a public company not through a public offering in a stock exchange. PIPE deals are part of the primary market. In the U.S., a PIPE offering may be registered with the Securities and Exchange Commission on a registration statement or may be completed as an unregistered private placement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="erna_PIPEInvestorMember_lbl" xlink:title="label: PIPEInvestorMember to erna_PIPEInvestorMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PIPEInvestorMember_lbl1" xml:lang="en-US" id="erna_PIPEInvestorMember_lbl1">PIPE Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="erna_PIPEInvestorMember_lbl1" xlink:title="label: PIPEInvestorMember to erna_PIPEInvestorMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PIPEInvestorMember_lbl2" xml:lang="en-US" id="erna_PIPEInvestorMember_lbl2">PIPE Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="erna_PIPEInvestorMember_lbl2" xlink:title="label: PIPEInvestorMember to erna_PIPEInvestorMember_lbl2" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorMember_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_PIPEInvestorMember_lbl3" xml:lang="en-US" id="erna_PIPEInvestorMember_lbl3">Q1-22 PIPE Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="erna_PIPEInvestorMember_lbl3" xlink:title="label: PIPEInvestorMember to erna_PIPEInvestorMember_lbl3" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AggregateCalendarDays" xlink:label="AggregateCalendarDays" xlink:title="AggregateCalendarDays" />
    <link:label xlink:type="resource" xlink:label="erna_AggregateCalendarDays_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AggregateCalendarDays_lbl" xml:lang="en-US" id="erna_AggregateCalendarDays_lbl">In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified aggregate calendar days (which need not be consecutive calendar days) during any 12-month period for resale in in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateCalendarDays" xlink:to="erna_AggregateCalendarDays_lbl" xlink:title="label: AggregateCalendarDays to erna_AggregateCalendarDays_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AggregateCalendarDays_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AggregateCalendarDays_lbl1" xml:lang="en-US" id="erna_AggregateCalendarDays_lbl1">Aggregate Calendar Days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateCalendarDays" xlink:to="erna_AggregateCalendarDays_lbl1" xlink:title="label: AggregateCalendarDays to erna_AggregateCalendarDays_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AggregateCalendarDays_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AggregateCalendarDays_lbl2" xml:lang="en-US" id="erna_AggregateCalendarDays_lbl2">Aggregate calendar days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateCalendarDays" xlink:to="erna_AggregateCalendarDays_lbl2" xlink:title="label: AggregateCalendarDays to erna_AggregateCalendarDays_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_VariableRateTransactionsPeriod" xlink:label="VariableRateTransactionsPeriod" xlink:title="VariableRateTransactionsPeriod" />
    <link:label xlink:type="resource" xlink:label="erna_VariableRateTransactionsPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_VariableRateTransactionsPeriod_lbl" xml:lang="en-US" id="erna_VariableRateTransactionsPeriod_lbl">Pursuant to the Purchase Agreement, the Company is prohibited from issuing equity in variable rate transactions for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateTransactionsPeriod" xlink:to="erna_VariableRateTransactionsPeriod_lbl" xlink:title="label: VariableRateTransactionsPeriod to erna_VariableRateTransactionsPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_VariableRateTransactionsPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_VariableRateTransactionsPeriod_lbl1" xml:lang="en-US" id="erna_VariableRateTransactionsPeriod_lbl1">Variable Rate Transactions Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateTransactionsPeriod" xlink:to="erna_VariableRateTransactionsPeriod_lbl1" xlink:title="label: VariableRateTransactionsPeriod to erna_VariableRateTransactionsPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_VariableRateTransactionsPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_VariableRateTransactionsPeriod_lbl2" xml:lang="en-US" id="erna_VariableRateTransactionsPeriod_lbl2">Variable rate transaction period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateTransactionsPeriod" xlink:to="erna_VariableRateTransactionsPeriod_lbl2" xlink:title="label: VariableRateTransactionsPeriod to erna_VariableRateTransactionsPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnDisposalOfFixedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_GainLossOnDisposalOfFixedAssets_lbl" xml:lang="en-US" id="erna_GainLossOnDisposalOfFixedAssets_lbl">Amount of gain (loss) on sale or disposal of fixed assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="erna_GainLossOnDisposalOfFixedAssets_lbl" xlink:title="label: GainLossOnDisposalOfFixedAssets to erna_GainLossOnDisposalOfFixedAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnDisposalOfFixedAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_GainLossOnDisposalOfFixedAssets_lbl1" xml:lang="en-US" id="erna_GainLossOnDisposalOfFixedAssets_lbl1">Gain (Loss) on Disposal of Fixed Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="erna_GainLossOnDisposalOfFixedAssets_lbl1" xlink:title="label: GainLossOnDisposalOfFixedAssets to erna_GainLossOnDisposalOfFixedAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnDisposalOfFixedAssets_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_GainLossOnDisposalOfFixedAssets_lbl2" xml:lang="en-US" id="erna_GainLossOnDisposalOfFixedAssets_lbl2">Loss on disposal of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="erna_GainLossOnDisposalOfFixedAssets_lbl2" xlink:title="label: GainLossOnDisposalOfFixedAssets to erna_GainLossOnDisposalOfFixedAssets_lbl2" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnDisposalOfFixedAssets_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_GainLossOnDisposalOfFixedAssets_lbl3" xml:lang="en-US" id="erna_GainLossOnDisposalOfFixedAssets_lbl3">Loss on disposal of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="erna_GainLossOnDisposalOfFixedAssets_lbl3" xlink:title="label: GainLossOnDisposalOfFixedAssets to erna_GainLossOnDisposalOfFixedAssets_lbl3" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RemainingNetBookValueOfFixedAssets" xlink:label="RemainingNetBookValueOfFixedAssets" xlink:title="RemainingNetBookValueOfFixedAssets" />
    <link:label xlink:type="resource" xlink:label="erna_RemainingNetBookValueOfFixedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_RemainingNetBookValueOfFixedAssets_lbl" xml:lang="en-US" id="erna_RemainingNetBookValueOfFixedAssets_lbl">Amount after depreciation of long-lived, physical assets used to produce goods and services and not intended for resale.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingNetBookValueOfFixedAssets" xlink:to="erna_RemainingNetBookValueOfFixedAssets_lbl" xlink:title="label: RemainingNetBookValueOfFixedAssets to erna_RemainingNetBookValueOfFixedAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_RemainingNetBookValueOfFixedAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RemainingNetBookValueOfFixedAssets_lbl1" xml:lang="en-US" id="erna_RemainingNetBookValueOfFixedAssets_lbl1">Remaining Net Book Value of Fixed Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingNetBookValueOfFixedAssets" xlink:to="erna_RemainingNetBookValueOfFixedAssets_lbl1" xlink:title="label: RemainingNetBookValueOfFixedAssets to erna_RemainingNetBookValueOfFixedAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RemainingNetBookValueOfFixedAssets_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_RemainingNetBookValueOfFixedAssets_lbl2" xml:lang="en-US" id="erna_RemainingNetBookValueOfFixedAssets_lbl2">Net book value of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingNetBookValueOfFixedAssets" xlink:to="erna_RemainingNetBookValueOfFixedAssets_lbl2" xlink:title="label: RemainingNetBookValueOfFixedAssets to erna_RemainingNetBookValueOfFixedAssets_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ExacisOptionAgreementAbstract" xlink:label="ExacisOptionAgreementAbstract" xlink:title="ExacisOptionAgreementAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_ExacisOptionAgreementAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ExacisOptionAgreementAbstract_lbl1" xml:lang="en-US" id="erna_ExacisOptionAgreementAbstract_lbl1">Exacis Option Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExacisOptionAgreementAbstract" xlink:to="erna_ExacisOptionAgreementAbstract_lbl1" xlink:title="label: ExacisOptionAgreementAbstract to erna_ExacisOptionAgreementAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_MonthlyMasterServicesAgreementFeesPayable" xlink:label="MonthlyMasterServicesAgreementFeesPayable" xlink:title="MonthlyMasterServicesAgreementFeesPayable" />
    <link:label xlink:type="resource" xlink:label="erna_MonthlyMasterServicesAgreementFeesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_MonthlyMasterServicesAgreementFeesPayable_lbl" xml:lang="en-US" id="erna_MonthlyMasterServicesAgreementFeesPayable_lbl">The monthly master service agreement ("MSA") fees payable to related party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MonthlyMasterServicesAgreementFeesPayable" xlink:to="erna_MonthlyMasterServicesAgreementFeesPayable_lbl" xlink:title="label: MonthlyMasterServicesAgreementFeesPayable to erna_MonthlyMasterServicesAgreementFeesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_MonthlyMasterServicesAgreementFeesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_MonthlyMasterServicesAgreementFeesPayable_lbl1" xml:lang="en-US" id="erna_MonthlyMasterServicesAgreementFeesPayable_lbl1">Monthly Master Services Agreement Fees Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MonthlyMasterServicesAgreementFeesPayable" xlink:to="erna_MonthlyMasterServicesAgreementFeesPayable_lbl1" xlink:title="label: MonthlyMasterServicesAgreementFeesPayable to erna_MonthlyMasterServicesAgreementFeesPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_MonthlyMasterServicesAgreementFeesPayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_MonthlyMasterServicesAgreementFeesPayable_lbl2" xml:lang="en-US" id="erna_MonthlyMasterServicesAgreementFeesPayable_lbl2">Monthly master services agreement fees payable initial 12-month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MonthlyMasterServicesAgreementFeesPayable" xlink:to="erna_MonthlyMasterServicesAgreementFeesPayable_lbl2" xlink:title="label: MonthlyMasterServicesAgreementFeesPayable to erna_MonthlyMasterServicesAgreementFeesPayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ReimburseCostsIncurredOrPaid" xlink:label="ReimburseCostsIncurredOrPaid" xlink:title="ReimburseCostsIncurredOrPaid" />
    <link:label xlink:type="resource" xlink:label="erna_ReimburseCostsIncurredOrPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ReimburseCostsIncurredOrPaid_lbl" xml:lang="en-US" id="erna_ReimburseCostsIncurredOrPaid_lbl">The amount reimburse for costs already incurred or paid.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReimburseCostsIncurredOrPaid" xlink:to="erna_ReimburseCostsIncurredOrPaid_lbl" xlink:title="label: ReimburseCostsIncurredOrPaid to erna_ReimburseCostsIncurredOrPaid_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ReimburseCostsIncurredOrPaid_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ReimburseCostsIncurredOrPaid_lbl1" xml:lang="en-US" id="erna_ReimburseCostsIncurredOrPaid_lbl1">Reimburse Costs Incurred or Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReimburseCostsIncurredOrPaid" xlink:to="erna_ReimburseCostsIncurredOrPaid_lbl1" xlink:title="label: ReimburseCostsIncurredOrPaid to erna_ReimburseCostsIncurredOrPaid_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ReimburseCostsIncurredOrPaid_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ReimburseCostsIncurredOrPaid_lbl2" xml:lang="en-US" id="erna_ReimburseCostsIncurredOrPaid_lbl2">Reimburse costs incurred or paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReimburseCostsIncurredOrPaid" xlink:to="erna_ReimburseCostsIncurredOrPaid_lbl2" xlink:title="label: ReimburseCostsIncurredOrPaid to erna_ReimburseCostsIncurredOrPaid_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoticePeriodForSupersedingTerminationProvisions" xlink:label="NoticePeriodForSupersedingTerminationProvisions" xlink:title="NoticePeriodForSupersedingTerminationProvisions" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodForSupersedingTerminationProvisions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NoticePeriodForSupersedingTerminationProvisions_lbl" xml:lang="en-US" id="erna_NoticePeriodForSupersedingTerminationProvisions_lbl">The Master Services Agreement (or "MSA") contains customary confidentiality provisions and representations and warranties of the parties, and the Master Services Agreement (or "MSA") may be terminated by ether party prior notice, subject to any superseding termination provisions contained in a particular work order, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForSupersedingTerminationProvisions" xlink:to="erna_NoticePeriodForSupersedingTerminationProvisions_lbl" xlink:title="label: NoticePeriodForSupersedingTerminationProvisions to erna_NoticePeriodForSupersedingTerminationProvisions_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodForSupersedingTerminationProvisions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NoticePeriodForSupersedingTerminationProvisions_lbl1" xml:lang="en-US" id="erna_NoticePeriodForSupersedingTerminationProvisions_lbl1">Notice Period for Superseding Termination Provisions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForSupersedingTerminationProvisions" xlink:to="erna_NoticePeriodForSupersedingTerminationProvisions_lbl1" xlink:title="label: NoticePeriodForSupersedingTerminationProvisions to erna_NoticePeriodForSupersedingTerminationProvisions_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodForSupersedingTerminationProvisions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NoticePeriodForSupersedingTerminationProvisions_lbl2" xml:lang="en-US" id="erna_NoticePeriodForSupersedingTerminationProvisions_lbl2">Notice period for superseding termination provisions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForSupersedingTerminationProvisions" xlink:to="erna_NoticePeriodForSupersedingTerminationProvisions_lbl2" xlink:title="label: NoticePeriodForSupersedingTerminationProvisions to erna_NoticePeriodForSupersedingTerminationProvisions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RemainingLicenseFeeObligation" xlink:label="RemainingLicenseFeeObligation" xlink:title="RemainingLicenseFeeObligation" />
    <link:label xlink:type="resource" xlink:label="erna_RemainingLicenseFeeObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_RemainingLicenseFeeObligation_lbl" xml:lang="en-US" id="erna_RemainingLicenseFeeObligation_lbl">The amount of remaining license fee obligation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingLicenseFeeObligation" xlink:to="erna_RemainingLicenseFeeObligation_lbl" xlink:title="label: RemainingLicenseFeeObligation to erna_RemainingLicenseFeeObligation_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_RemainingLicenseFeeObligation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RemainingLicenseFeeObligation_lbl1" xml:lang="en-US" id="erna_RemainingLicenseFeeObligation_lbl1">Remaining License Fee Obligation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingLicenseFeeObligation" xlink:to="erna_RemainingLicenseFeeObligation_lbl1" xlink:title="label: RemainingLicenseFeeObligation to erna_RemainingLicenseFeeObligation_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RemainingLicenseFeeObligation_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_RemainingLicenseFeeObligation_lbl2" xml:lang="en-US" id="erna_RemainingLicenseFeeObligation_lbl2">Remaining license fee obligation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingLicenseFeeObligation" xlink:to="erna_RemainingLicenseFeeObligation_lbl2" xlink:title="label: RemainingLicenseFeeObligation to erna_RemainingLicenseFeeObligation_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:label="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:title="RelatedPartyTransactionPeriodicFeesPaymentAmount" />
    <link:label xlink:type="resource" xlink:label="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl" xml:lang="en-US" id="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl">The amount of required periodic fees payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:to="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl" xlink:title="label: RelatedPartyTransactionPeriodicFeesPaymentAmount to erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl1" xml:lang="en-US" id="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl1">Related Party Transaction, Periodic Fees Payment, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:to="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl1" xlink:title="label: RelatedPartyTransactionPeriodicFeesPaymentAmount to erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl2" xml:lang="en-US" id="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl2">Monthly installment fees amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:to="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl2" xlink:title="label: RelatedPartyTransactionPeriodicFeesPaymentAmount to erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfMonthlyInstallmentsForFeesPayable" xlink:label="NumberOfMonthlyInstallmentsForFeesPayable" xlink:title="NumberOfMonthlyInstallmentsForFeesPayable" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl" xml:lang="en-US" id="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl">The number of equal monthly installments for initial fees payable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfMonthlyInstallmentsForFeesPayable" xlink:to="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl" xlink:title="label: NumberOfMonthlyInstallmentsForFeesPayable to erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl1" xml:lang="en-US" id="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl1">Number of Monthly Installments for Fees Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfMonthlyInstallmentsForFeesPayable" xlink:to="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl1" xlink:title="label: NumberOfMonthlyInstallmentsForFeesPayable to erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl2" xml:lang="en-US" id="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl2">Number of monthly installments for fees payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfMonthlyInstallmentsForFeesPayable" xlink:to="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl2" xlink:title="label: NumberOfMonthlyInstallmentsForFeesPayable to erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:label="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:title="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" />
    <link:label xlink:type="resource" xlink:label="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl" xml:lang="en-US" id="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl">Amount of deposit paid which will be applied to the last month of the first work order.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:to="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl" xlink:title="label: DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder to erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl1" xml:lang="en-US" id="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl1">Deposit Paid to be Applied to Last Month of First Work Order</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:to="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl1" xlink:title="label: DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder to erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl2" xml:lang="en-US" id="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl2">Deposit paid to be applied to last month of first work order</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:to="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl2" xlink:title="label: DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder to erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoticePeriodForFirstTerminationOfContract" xlink:label="NoticePeriodForFirstTerminationOfContract" xlink:title="NoticePeriodForFirstTerminationOfContract" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodForFirstTerminationOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NoticePeriodForFirstTerminationOfContract_lbl" xml:lang="en-US" id="erna_NoticePeriodForFirstTerminationOfContract_lbl">The Company may terminate the first work under the MSA on or after the second anniversary of the date of the MSA, subject to providing Factor with prior notice, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForFirstTerminationOfContract" xlink:to="erna_NoticePeriodForFirstTerminationOfContract_lbl" xlink:title="label: NoticePeriodForFirstTerminationOfContract to erna_NoticePeriodForFirstTerminationOfContract_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodForFirstTerminationOfContract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NoticePeriodForFirstTerminationOfContract_lbl1" xml:lang="en-US" id="erna_NoticePeriodForFirstTerminationOfContract_lbl1">Notice Period for First Termination of Contract</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForFirstTerminationOfContract" xlink:to="erna_NoticePeriodForFirstTerminationOfContract_lbl1" xlink:title="label: NoticePeriodForFirstTerminationOfContract to erna_NoticePeriodForFirstTerminationOfContract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodForFirstTerminationOfContract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NoticePeriodForFirstTerminationOfContract_lbl2" xml:lang="en-US" id="erna_NoticePeriodForFirstTerminationOfContract_lbl2">Notice period for first termination of contract</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForFirstTerminationOfContract" xlink:to="erna_NoticePeriodForFirstTerminationOfContract_lbl2" xlink:title="label: NoticePeriodForFirstTerminationOfContract to erna_NoticePeriodForFirstTerminationOfContract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_MasterServiceAgreementInitialFeesPayable" xlink:label="MasterServiceAgreementInitialFeesPayable" xlink:title="MasterServiceAgreementInitialFeesPayable" />
    <link:label xlink:type="resource" xlink:label="erna_MasterServiceAgreementInitialFeesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_MasterServiceAgreementInitialFeesPayable_lbl" xml:lang="en-US" id="erna_MasterServiceAgreementInitialFeesPayable_lbl">The amount agreed to pay an initial fee under Master Services Agreement (or "MSA").</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MasterServiceAgreementInitialFeesPayable" xlink:to="erna_MasterServiceAgreementInitialFeesPayable_lbl" xlink:title="label: MasterServiceAgreementInitialFeesPayable to erna_MasterServiceAgreementInitialFeesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_MasterServiceAgreementInitialFeesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_MasterServiceAgreementInitialFeesPayable_lbl1" xml:lang="en-US" id="erna_MasterServiceAgreementInitialFeesPayable_lbl1">Master Service Agreement, Initial Fees Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MasterServiceAgreementInitialFeesPayable" xlink:to="erna_MasterServiceAgreementInitialFeesPayable_lbl1" xlink:title="label: MasterServiceAgreementInitialFeesPayable to erna_MasterServiceAgreementInitialFeesPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_MasterServiceAgreementInitialFeesPayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_MasterServiceAgreementInitialFeesPayable_lbl2" xml:lang="en-US" id="erna_MasterServiceAgreementInitialFeesPayable_lbl2">Master services agreement, initial fees payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MasterServiceAgreementInitialFeesPayable" xlink:to="erna_MasterServiceAgreementInitialFeesPayable_lbl2" xlink:title="label: MasterServiceAgreementInitialFeesPayable to erna_MasterServiceAgreementInitialFeesPayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AgreedWaivePayment" xlink:label="AgreedWaivePayment" xlink:title="AgreedWaivePayment" />
    <link:label xlink:type="resource" xlink:label="erna_AgreedWaivePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AgreedWaivePayment_lbl" xml:lang="en-US" id="erna_AgreedWaivePayment_lbl">The amount agreed to waive payment as per waiver agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreedWaivePayment" xlink:to="erna_AgreedWaivePayment_lbl" xlink:title="label: AgreedWaivePayment to erna_AgreedWaivePayment_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AgreedWaivePayment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AgreedWaivePayment_lbl1" xml:lang="en-US" id="erna_AgreedWaivePayment_lbl1">Agreed Waive Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreedWaivePayment" xlink:to="erna_AgreedWaivePayment_lbl1" xlink:title="label: AgreedWaivePayment to erna_AgreedWaivePayment_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AgreedWaivePayment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AgreedWaivePayment_lbl2" xml:lang="en-US" id="erna_AgreedWaivePayment_lbl2">Agreed waive payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreedWaivePayment" xlink:to="erna_AgreedWaivePayment_lbl2" xlink:title="label: AgreedWaivePayment to erna_AgreedWaivePayment_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_Q422PIPETransactionAbstract" xlink:label="Q422PIPETransactionAbstract" xlink:title="Q422PIPETransactionAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_Q422PIPETransactionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_Q422PIPETransactionAbstract_lbl1" xml:lang="en-US" id="erna_Q422PIPETransactionAbstract_lbl1">Q4-22 PIPE Transaction [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Q422PIPETransactionAbstract" xlink:to="erna_Q422PIPETransactionAbstract_lbl1" xlink:title="label: Q422PIPETransactionAbstract to erna_Q422PIPETransactionAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ExacisBiotherapeuticsIncMember" xlink:label="ExacisBiotherapeuticsIncMember" xlink:title="ExacisBiotherapeuticsIncMember" />
    <link:label xlink:type="resource" xlink:label="erna_ExacisBiotherapeuticsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ExacisBiotherapeuticsIncMember_lbl" xml:lang="en-US" id="erna_ExacisBiotherapeuticsIncMember_lbl">A Delaware corporation the company entered into Option Agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExacisBiotherapeuticsIncMember" xlink:to="erna_ExacisBiotherapeuticsIncMember_lbl" xlink:title="label: ExacisBiotherapeuticsIncMember to erna_ExacisBiotherapeuticsIncMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ExacisBiotherapeuticsIncMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ExacisBiotherapeuticsIncMember_lbl1" xml:lang="en-US" id="erna_ExacisBiotherapeuticsIncMember_lbl1">Exacis Biotherapeutics, Inc. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExacisBiotherapeuticsIncMember" xlink:to="erna_ExacisBiotherapeuticsIncMember_lbl1" xlink:title="label: ExacisBiotherapeuticsIncMember to erna_ExacisBiotherapeuticsIncMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ExacisBiotherapeuticsIncMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ExacisBiotherapeuticsIncMember_lbl2" xml:lang="en-US" id="erna_ExacisBiotherapeuticsIncMember_lbl2">Exacis Biotherapeutics, Inc. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExacisBiotherapeuticsIncMember" xlink:to="erna_ExacisBiotherapeuticsIncMember_lbl2" xlink:title="label: ExacisBiotherapeuticsIncMember to erna_ExacisBiotherapeuticsIncMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialLicenseFeeObligation" xlink:label="InitialLicenseFeeObligation" xlink:title="InitialLicenseFeeObligation" />
    <link:label xlink:type="resource" xlink:label="erna_InitialLicenseFeeObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InitialLicenseFeeObligation_lbl" xml:lang="en-US" id="erna_InitialLicenseFeeObligation_lbl">The amount of initial license fees required to pay including non-refundable fee.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialLicenseFeeObligation" xlink:to="erna_InitialLicenseFeeObligation_lbl" xlink:title="label: InitialLicenseFeeObligation to erna_InitialLicenseFeeObligation_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InitialLicenseFeeObligation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InitialLicenseFeeObligation_lbl1" xml:lang="en-US" id="erna_InitialLicenseFeeObligation_lbl1">Initial License Fee Obligation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialLicenseFeeObligation" xlink:to="erna_InitialLicenseFeeObligation_lbl1" xlink:title="label: InitialLicenseFeeObligation to erna_InitialLicenseFeeObligation_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InitialLicenseFeeObligation_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InitialLicenseFeeObligation_lbl2" xml:lang="en-US" id="erna_InitialLicenseFeeObligation_lbl2">Initial license fees obligation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialLicenseFeeObligation" xlink:to="erna_InitialLicenseFeeObligation_lbl2" xlink:title="label: InitialLicenseFeeObligation to erna_InitialLicenseFeeObligation_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_FactorBioscienceIncMember" xlink:label="FactorBioscienceIncMember" xlink:title="FactorBioscienceIncMember" />
    <link:label xlink:type="resource" xlink:label="erna_FactorBioscienceIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_FactorBioscienceIncMember_lbl" xml:lang="en-US" id="erna_FactorBioscienceIncMember_lbl">A corporation the company entered into agreement to provide the Company with MRNA cell engineering research support services, including access to certain facilities, equipment, materials and training, and the Company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FactorBioscienceIncMember" xlink:to="erna_FactorBioscienceIncMember_lbl" xlink:title="label: FactorBioscienceIncMember to erna_FactorBioscienceIncMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_FactorBioscienceIncMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_FactorBioscienceIncMember_lbl1" xml:lang="en-US" id="erna_FactorBioscienceIncMember_lbl1">Factor Bioscience Inc. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FactorBioscienceIncMember" xlink:to="erna_FactorBioscienceIncMember_lbl1" xlink:title="label: FactorBioscienceIncMember to erna_FactorBioscienceIncMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_FactorBioscienceIncMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_FactorBioscienceIncMember_lbl2" xml:lang="en-US" id="erna_FactorBioscienceIncMember_lbl2">Factor Bioscience Inc. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FactorBioscienceIncMember" xlink:to="erna_FactorBioscienceIncMember_lbl2" xlink:title="label: FactorBioscienceIncMember to erna_FactorBioscienceIncMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentOfOptionFee" xlink:label="PaymentOfOptionFee" xlink:title="PaymentOfOptionFee" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentOfOptionFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PaymentOfOptionFee_lbl" xml:lang="en-US" id="erna_PaymentOfOptionFee_lbl">Payment of option fee related to licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfOptionFee" xlink:to="erna_PaymentOfOptionFee_lbl" xlink:title="label: PaymentOfOptionFee to erna_PaymentOfOptionFee_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentOfOptionFee_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PaymentOfOptionFee_lbl1" xml:lang="en-US" id="erna_PaymentOfOptionFee_lbl1">Payment of Option Fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfOptionFee" xlink:to="erna_PaymentOfOptionFee_lbl1" xlink:title="label: PaymentOfOptionFee to erna_PaymentOfOptionFee_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentOfOptionFee_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PaymentOfOptionFee_lbl2" xml:lang="en-US" id="erna_PaymentOfOptionFee_lbl2">Payment of option fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfOptionFee" xlink:to="erna_PaymentOfOptionFee_lbl2" xlink:title="label: PaymentOfOptionFee to erna_PaymentOfOptionFee_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BasisOfPresentationAbstract" xlink:label="BasisOfPresentationAbstract" xlink:title="BasisOfPresentationAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_BasisOfPresentationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_BasisOfPresentationAbstract_lbl1" xml:lang="en-US" id="erna_BasisOfPresentationAbstract_lbl1">Basis of Presentation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfPresentationAbstract" xlink:to="erna_BasisOfPresentationAbstract_lbl1" xlink:title="label: BasisOfPresentationAbstract to erna_BasisOfPresentationAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_BasisOfPresentationAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_BasisOfPresentationAbstract_lbl2" xml:lang="en-US" id="erna_BasisOfPresentationAbstract_lbl2">Basis of Presentation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfPresentationAbstract" xlink:to="erna_BasisOfPresentationAbstract_lbl2" xlink:title="label: BasisOfPresentationAbstract to erna_BasisOfPresentationAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" xlink:label="StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" xlink:title="StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl">Aggregate value of issuance of common stock from exercise of pre-funded warrants issued during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" xlink:to="erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl" xlink:title="label: StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants to erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl1">Stock Issued During Period Value Exercise of Pre-funded Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" xlink:to="erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl1" xlink:title="label: StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants to erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl2">Issuance of common stock from exercise of pre-funded warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" xlink:to="erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl2" xlink:title="label: StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants to erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" xlink:label="StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" xlink:title="StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl">Total number of shares issued during the period, including exercise of pre-funded warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" xlink:to="erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl" xlink:title="label: StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants to erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl1">Stock Issued During Period Shares Exercise of Pre-funded Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" xlink:to="erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants to erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl2">Issuance of common stock from exercise of pre-funded warrants (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" xlink:to="erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants to erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl">Value of stock issued common stock and prefunded warrants in connection with private offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xlink:title="label: StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1">Stock Issued During Period Value of Common Stock and Prefunded Warrants in Connection with Private Offering Net of Offering Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xlink:title="label: StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2">Issuance of common stock and pre-funded warrants in connection with March 2022 private offering, net.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2" xlink:title="label: StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl">Shares of stock issued common stock and prefunded warrants in connection with public offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl" xlink:title="label: StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl1">Stock Issued During Period Shares of Common Stock and Prefunded Warrants in Connection with Public Offering Net of Offering Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl2">Issuance of common stock and pre-funded warrants in connection with March 2022 private offering, net. (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonUnitsMember" xlink:label="CommonUnitsMember" xlink:title="CommonUnitsMember" />
    <link:label xlink:type="resource" xlink:label="erna_CommonUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CommonUnitsMember_lbl" xml:lang="en-US" id="erna_CommonUnitsMember_lbl">Classification of common stock that has different rights than provided to common units, representing ownership interest in a corporation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonUnitsMember" xlink:to="erna_CommonUnitsMember_lbl" xlink:title="label: CommonUnitsMember to erna_CommonUnitsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CommonUnitsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CommonUnitsMember_lbl1" xml:lang="en-US" id="erna_CommonUnitsMember_lbl1">Common Units [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonUnitsMember" xlink:to="erna_CommonUnitsMember_lbl1" xlink:title="label: CommonUnitsMember to erna_CommonUnitsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CommonUnitsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_CommonUnitsMember_lbl2" xml:lang="en-US" id="erna_CommonUnitsMember_lbl2">Common [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonUnitsMember" xlink:to="erna_CommonUnitsMember_lbl2" xlink:title="label: CommonUnitsMember to erna_CommonUnitsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_MembershipEquityMember" xlink:label="MembershipEquityMember" xlink:title="MembershipEquityMember" />
    <link:label xlink:type="resource" xlink:label="erna_MembershipEquityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_MembershipEquityMember_lbl" xml:lang="en-US" id="erna_MembershipEquityMember_lbl">Equity membership interest in entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MembershipEquityMember" xlink:to="erna_MembershipEquityMember_lbl" xlink:title="label: MembershipEquityMember to erna_MembershipEquityMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_MembershipEquityMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_MembershipEquityMember_lbl1" xml:lang="en-US" id="erna_MembershipEquityMember_lbl1">Membership Equity [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MembershipEquityMember" xlink:to="erna_MembershipEquityMember_lbl1" xlink:title="label: MembershipEquityMember to erna_MembershipEquityMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_MembershipEquityMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_MembershipEquityMember_lbl2" xml:lang="en-US" id="erna_MembershipEquityMember_lbl2">Membership Equity [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MembershipEquityMember" xlink:to="erna_MembershipEquityMember_lbl2" xlink:title="label: MembershipEquityMember to erna_MembershipEquityMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl">Value of stock issued common stock and warrants in connection with private offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xlink:title="label: StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1">Stock Issued During Period Value 0f Common Stock and Warrants in Connection with Private Offering Net of Offering Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xlink:title="label: StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2">Issuance of common stock and warrants in connection with November 2022 private offering, net.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2" xlink:title="label: StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl">Shares of stock issued common stock and warrants in connection with private offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xlink:title="label: StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1">Stock Issued During Period Shares of Common Stock and Warrants in Connection with Private Offering Net of Offering Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2">Issuance of common stock and warrants in connection with November 2022 private offering, net. (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl">Equity impact of the shares of new stock issued of preferred stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl" xlink:title="label: StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders to erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1">Stock Issued During Period, Shares, New Issues of Preferred Stock, Retained by Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders to erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2">Issuance of Series A preferred stock retained by NTN stockholders (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders to erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl">Equity impact of the value of new stock issued of preferred stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl" xlink:title="label: StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders to erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1">Stock Issued During Period, Value, New Issues of Preferred Stock, Retained by Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xlink:title="label: StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders to erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2">Issuance of Series A preferred stock retained by NTN stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xlink:title="label: StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders to erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:label="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:title="StockIssuedDuringPeriodSharesInLieuOfDividends" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl">Number of shares issued during the period in lieu of dividends to be paid.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:to="erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl" xlink:title="label: StockIssuedDuringPeriodSharesInLieuOfDividends to erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl1">Stock Issued During Period, Shares, in Lieu of Dividends</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:to="erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesInLieuOfDividends to erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl2">Issuance of common stock in lieu of cash dividend to Series A convertible preferred stockholders (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:to="erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesInLieuOfDividends to erna_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:label="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" />
    <link:label xlink:type="resource" xlink:label="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" xml:lang="en-US" id="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl">Number of shares Forfeiture of unvested restricted stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:to="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" xlink:title="label: SharesIssuedSharesForfeitureOfUnvestedRestrictedStock to erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" xml:lang="en-US" id="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1">Shares Issued, Shares, Forfeiture of unvested restricted stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:to="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" xlink:title="label: SharesIssuedSharesForfeitureOfUnvestedRestrictedStock to erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2" xml:lang="en-US" id="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2">Forfeiture of unvested restricted stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:to="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2" xlink:title="label: SharesIssuedSharesForfeitureOfUnvestedRestrictedStock to erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesAcquisitions2" xlink:label="StockIssuedDuringPeriodSharesAcquisitions2" xlink:title="StockIssuedDuringPeriodSharesAcquisitions2" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl">Number of shares of stock issued during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions2" xlink:to="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions2 to erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl1">Stock Issued During Period, Shares, Acquisitions2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions2" xlink:to="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions2 to erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl2">Issuance of common stock in connection with the acquisition of Novellus, Inc. (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions2" xlink:to="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions2 to erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueAcquisitions2" xlink:label="StockIssuedDuringPeriodValueAcquisitions2" xlink:title="StockIssuedDuringPeriodValueAcquisitions2" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl">Value of stock issued pursuant to acquisitions during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions2" xlink:to="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions2 to erna_StockIssuedDuringPeriodValueAcquisitions2_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl1">Stock Issued During Period, Value, Acquisitions2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions2" xlink:to="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl1" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions2 to erna_StockIssuedDuringPeriodValueAcquisitions2_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl2">Issuance of common stock in connection with the acquisition of Novellus, Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions2" xlink:to="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl2" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions2 to erna_StockIssuedDuringPeriodValueAcquisitions2_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueAcquisitions1" xlink:label="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="StockIssuedDuringPeriodValueAcquisitions1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueAcquisitions1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValueAcquisitions1_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueAcquisitions1_lbl">Value of stock issued pursuant to acquisitions during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions1" xlink:to="erna_StockIssuedDuringPeriodValueAcquisitions1_lbl" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions1 to erna_StockIssuedDuringPeriodValueAcquisitions1_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueAcquisitions1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValueAcquisitions1_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueAcquisitions1_lbl1">Stock Issued During Period, Value, Acquisitions1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions1" xlink:to="erna_StockIssuedDuringPeriodValueAcquisitions1_lbl1" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions1 to erna_StockIssuedDuringPeriodValueAcquisitions1_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueAcquisitions1_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValueAcquisitions1_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueAcquisitions1_lbl2">Common stock to be retained by NTN stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions1" xlink:to="erna_StockIssuedDuringPeriodValueAcquisitions1_lbl2" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions1 to erna_StockIssuedDuringPeriodValueAcquisitions1_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodValueStockPurchaseAgreement" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl">Equity impact of the value of stock that has been issued in a stock purchase agreement during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:to="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl" xlink:title="label: StockIssuedDuringPeriodValueStockPurchaseAgreement to erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1">Stock Issued During Period, Value, Stock Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:to="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1" xlink:title="label: StockIssuedDuringPeriodValueStockPurchaseAgreement to erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl2">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:to="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl2" xlink:title="label: StockIssuedDuringPeriodValueStockPurchaseAgreement to erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:label="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" />
    <link:label xlink:type="resource" xlink:label="erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl" xml:lang="en-US" id="erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl">Amount of decrease (increase) in additional paid in capital (APIC) for the increase in redemption of temporary equity as the result of a triggering event associated with the temporary equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:to="erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity to erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1" xml:lang="en-US" id="erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1">Adjustments to Additional Paid in Capital, Elimination Historical Member Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:to="erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity to erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2" xml:lang="en-US" id="erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2">Elimination of Eterna LLC's historical members' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:to="erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity to erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueInLieuOfDividends" xlink:label="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:title="StockIssuedDuringPeriodValueInLieuOfDividends" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl">Value of stock issued during the period in Lieu of Dividends to be paid.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:to="erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl" xlink:title="label: StockIssuedDuringPeriodValueInLieuOfDividends to erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl1">Stock Issued During Period, Value, in Lieu of Dividends</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:to="erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl1" xlink:title="label: StockIssuedDuringPeriodValueInLieuOfDividends to erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl2">Issuance of common stock in lieu of cash dividend to Series A convertible preferred stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:to="erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl2" xlink:title="label: StockIssuedDuringPeriodValueInLieuOfDividends to erna_StockIssuedDuringPeriodValueInLieuOfDividends_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:label="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl">Value of stock issued pursuant to rights offering membership units during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:to="erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl" xlink:title="label: StockIssuedDuringPeriodValueRightsOfferingMembershipUnits to erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1">Stock Issued During Period, Value, Rights Offering Membership Units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:to="erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1" xlink:title="label: StockIssuedDuringPeriodValueRightsOfferingMembershipUnits to erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2">Brooklyn rights offerings membership units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:to="erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2" xlink:title="label: StockIssuedDuringPeriodValueRightsOfferingMembershipUnits to erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl">Number of shares of stock issued during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions1" xlink:to="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions1 to erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl1">Stock Issued During Period, Shares, Acquisitions1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions1" xlink:to="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions1 to erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl2">Common stock to be retained by NTN stockholders (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions1" xlink:to="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions1 to erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl2" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl3" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl3">Stock issued, shares, acquisition (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions1" xlink:to="erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl3" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions1 to erna_StockIssuedDuringPeriodSharesAcquisitions1_lbl3" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodSharesStockPurchaseAgreement" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl">Number of shares that have been issued in a stock purchase agreement during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:to="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl" xlink:title="label: StockIssuedDuringPeriodSharesStockPurchaseAgreement to erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1">Stock Issued During Period, Shares, Stock Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:to="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesStockPurchaseAgreement to erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl2">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:to="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesStockPurchaseAgreement to erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:label="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl">Value of stock related to Forfeiture of unvested restricted stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:to="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" xlink:title="label: StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock to erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1">Stock Issued During Period, Value, Forfeiture of Unvested Restricted Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:to="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" xlink:title="label: StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock to erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2">Forfeiture of unvested restricted stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:to="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2" xlink:title="label: StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock to erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ReverseStockSplitAbstract" xlink:label="ReverseStockSplitAbstract" xlink:title="ReverseStockSplitAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_ReverseStockSplitAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ReverseStockSplitAbstract_lbl1" xml:lang="en-US" id="erna_ReverseStockSplitAbstract_lbl1">Reverse Stock-Split [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReverseStockSplitAbstract" xlink:to="erna_ReverseStockSplitAbstract_lbl1" xlink:title="label: ReverseStockSplitAbstract to erna_ReverseStockSplitAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:label="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:title="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" />
    <link:label xlink:type="resource" xlink:label="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl" xml:lang="en-US" id="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl">Amount of cash outflow for fractional shares in connection with reverse stock split.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:to="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl" xlink:title="label: CashPaidForFractionalSharesInConnectionWithReverseStockSplit to erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl1" xml:lang="en-US" id="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl1">Cash Paid for Fractional Shares in Connection with Reverse Stock Split</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:to="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl1" xlink:title="label: CashPaidForFractionalSharesInConnectionWithReverseStockSplit to erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl2" xml:lang="en-US" id="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl2">Amount paid for fractional share in connection with reverse stock split</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:to="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl2" xlink:title="label: CashPaidForFractionalSharesInConnectionWithReverseStockSplit to erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl2" />
    <link:label xlink:type="resource" xlink:label="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl3" xml:lang="en-US" id="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl3">Cash paid for fractional shares in connection with reverse stock split</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:to="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl3" xlink:title="label: CashPaidForFractionalSharesInConnectionWithReverseStockSplit to erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl3" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfSharesConsideredAsFractionalInReverseStock" xlink:label="NumberOfSharesConsideredAsFractionalInReverseStock" xlink:title="NumberOfSharesConsideredAsFractionalInReverseStock" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl" xml:lang="en-US" id="erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl">Number of shares considered as fractional in reverse stock split.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfSharesConsideredAsFractionalInReverseStock" xlink:to="erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl" xlink:title="label: NumberOfSharesConsideredAsFractionalInReverseStock to erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl1" xml:lang="en-US" id="erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl1">Number of Shares Considered as Fractional in Reverse Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfSharesConsideredAsFractionalInReverseStock" xlink:to="erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl1" xlink:title="label: NumberOfSharesConsideredAsFractionalInReverseStock to erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl2" xml:lang="en-US" id="erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl2">Number of fractional shares considered in reverse stock split (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfSharesConsideredAsFractionalInReverseStock" xlink:to="erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl2" xlink:title="label: NumberOfSharesConsideredAsFractionalInReverseStock to erna_NumberOfSharesConsideredAsFractionalInReverseStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:label xlink:type="resource" xlink:label="erna_WarrantLiabilitiesExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_WarrantLiabilitiesExpense_lbl" xml:lang="en-US" id="erna_WarrantLiabilitiesExpense_lbl">Amount of expenses related to warrant liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="erna_WarrantLiabilitiesExpense_lbl" xlink:title="label: WarrantLiabilitiesExpense to erna_WarrantLiabilitiesExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_WarrantLiabilitiesExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_WarrantLiabilitiesExpense_lbl1" xml:lang="en-US" id="erna_WarrantLiabilitiesExpense_lbl1">Warrant Liabilities Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="erna_WarrantLiabilitiesExpense_lbl1" xlink:title="label: WarrantLiabilitiesExpense to erna_WarrantLiabilitiesExpense_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_WarrantLiabilitiesExpense_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_WarrantLiabilitiesExpense_lbl2" xml:lang="en-US" id="erna_WarrantLiabilitiesExpense_lbl2">Change in fair value of warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="erna_WarrantLiabilitiesExpense_lbl2" xlink:title="label: WarrantLiabilitiesExpense to erna_WarrantLiabilitiesExpense_lbl2" />
    <link:label xlink:type="resource" xlink:label="erna_WarrantLiabilitiesExpense_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_WarrantLiabilitiesExpense_lbl3" xml:lang="en-US" id="erna_WarrantLiabilitiesExpense_lbl3">Gain on warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="erna_WarrantLiabilitiesExpense_lbl3" xlink:title="label: WarrantLiabilitiesExpense to erna_WarrantLiabilitiesExpense_lbl3" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:label xlink:type="resource" xlink:label="erna_LossOnNonControllingInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LossOnNonControllingInvestment_lbl" xml:lang="en-US" id="erna_LossOnNonControllingInvestment_lbl">Amount of loss on non-controlling investment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="erna_LossOnNonControllingInvestment_lbl" xlink:title="label: LossOnNonControllingInvestment to erna_LossOnNonControllingInvestment_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LossOnNonControllingInvestment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LossOnNonControllingInvestment_lbl1" xml:lang="en-US" id="erna_LossOnNonControllingInvestment_lbl1">Loss on Non-controlling Investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="erna_LossOnNonControllingInvestment_lbl1" xlink:title="label: LossOnNonControllingInvestment to erna_LossOnNonControllingInvestment_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LossOnNonControllingInvestment_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_LossOnNonControllingInvestment_lbl2" xml:lang="en-US" id="erna_LossOnNonControllingInvestment_lbl2">Loss on non-controlling investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="erna_LossOnNonControllingInvestment_lbl2" xlink:title="label: LossOnNonControllingInvestment to erna_LossOnNonControllingInvestment_lbl2" />
    <link:label xlink:type="resource" xlink:label="erna_LossOnNonControllingInvestment_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LossOnNonControllingInvestment_lbl3" xml:lang="en-US" id="erna_LossOnNonControllingInvestment_lbl3">Loss on non-controlling investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="erna_LossOnNonControllingInvestment_lbl3" xlink:title="label: LossOnNonControllingInvestment to erna_LossOnNonControllingInvestment_lbl3" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ExpensesPaidInConnectionWithPrivateOffering" xlink:label="ExpensesPaidInConnectionWithPrivateOffering" xlink:title="ExpensesPaidInConnectionWithPrivateOffering" />
    <link:label xlink:type="resource" xlink:label="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl" xml:lang="en-US" id="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl">The amount of expenses paid in connection with private offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpensesPaidInConnectionWithPrivateOffering" xlink:to="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl" xlink:title="label: ExpensesPaidInConnectionWithPrivateOffering to erna_ExpensesPaidInConnectionWithPrivateOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl1" xml:lang="en-US" id="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl1">Expenses Paid In Connection with Private Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpensesPaidInConnectionWithPrivateOffering" xlink:to="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl1" xlink:title="label: ExpensesPaidInConnectionWithPrivateOffering to erna_ExpensesPaidInConnectionWithPrivateOffering_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl2" xml:lang="en-US" id="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl2">Expenses paid in connection with private offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpensesPaidInConnectionWithPrivateOffering" xlink:to="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl2" xlink:title="label: ExpensesPaidInConnectionWithPrivateOffering to erna_ExpensesPaidInConnectionWithPrivateOffering_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentsOfPaycheckProtectionProgramLoan" xlink:label="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="PaymentsOfPaycheckProtectionProgramLoan" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentsOfPaycheckProtectionProgramLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PaymentsOfPaycheckProtectionProgramLoan_lbl" xml:lang="en-US" id="erna_PaymentsOfPaycheckProtectionProgramLoan_lbl">The amount of cash outflow for payment of paycheck protection program loans.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfPaycheckProtectionProgramLoan" xlink:to="erna_PaymentsOfPaycheckProtectionProgramLoan_lbl" xlink:title="label: PaymentsOfPaycheckProtectionProgramLoan to erna_PaymentsOfPaycheckProtectionProgramLoan_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentsOfPaycheckProtectionProgramLoan_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PaymentsOfPaycheckProtectionProgramLoan_lbl1" xml:lang="en-US" id="erna_PaymentsOfPaycheckProtectionProgramLoan_lbl1">Payments of Paycheck Protection Program Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfPaycheckProtectionProgramLoan" xlink:to="erna_PaymentsOfPaycheckProtectionProgramLoan_lbl1" xlink:title="label: PaymentsOfPaycheckProtectionProgramLoan to erna_PaymentsOfPaycheckProtectionProgramLoan_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentsOfPaycheckProtectionProgramLoan_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_PaymentsOfPaycheckProtectionProgramLoan_lbl2" xml:lang="en-US" id="erna_PaymentsOfPaycheckProtectionProgramLoan_lbl2">Repayment of NTN's PPP loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfPaycheckProtectionProgramLoan" xlink:to="erna_PaymentsOfPaycheckProtectionProgramLoan_lbl2" xlink:title="label: PaymentsOfPaycheckProtectionProgramLoan to erna_PaymentsOfPaycheckProtectionProgramLoan_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentsToAcquireProductiveAssetsNet" xlink:label="PaymentsToAcquireProductiveAssetsNet" xlink:title="PaymentsToAcquireProductiveAssetsNet" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentsToAcquireProductiveAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PaymentsToAcquireProductiveAssetsNet_lbl" xml:lang="en-US" id="erna_PaymentsToAcquireProductiveAssetsNet_lbl">The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets excluding cash acquired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssetsNet" xlink:to="erna_PaymentsToAcquireProductiveAssetsNet_lbl" xlink:title="label: PaymentsToAcquireProductiveAssetsNet to erna_PaymentsToAcquireProductiveAssetsNet_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentsToAcquireProductiveAssetsNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PaymentsToAcquireProductiveAssetsNet_lbl1" xml:lang="en-US" id="erna_PaymentsToAcquireProductiveAssetsNet_lbl1">Cash paid, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssetsNet" xlink:to="erna_PaymentsToAcquireProductiveAssetsNet_lbl1" xlink:title="label: PaymentsToAcquireProductiveAssetsNet to erna_PaymentsToAcquireProductiveAssetsNet_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentsToAcquireProductiveAssetsNet_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_PaymentsToAcquireProductiveAssetsNet_lbl2" xml:lang="en-US" id="erna_PaymentsToAcquireProductiveAssetsNet_lbl2">Purchase of Novellus, net of common stock issued and cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssetsNet" xlink:to="erna_PaymentsToAcquireProductiveAssetsNet_lbl2" xlink:title="label: PaymentsToAcquireProductiveAssetsNet to erna_PaymentsToAcquireProductiveAssetsNet_lbl2" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentsToAcquireProductiveAssetsNet_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_PaymentsToAcquireProductiveAssetsNet_lbl3" xml:lang="en-US" id="erna_PaymentsToAcquireProductiveAssetsNet_lbl3">Cash paid, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssetsNet" xlink:to="erna_PaymentsToAcquireProductiveAssetsNet_lbl3" xlink:title="label: PaymentsToAcquireProductiveAssetsNet to erna_PaymentsToAcquireProductiveAssetsNet_lbl3" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IssuanceOfCommonStockForAssetAcquisition" xlink:label="IssuanceOfCommonStockForAssetAcquisition" xlink:title="IssuanceOfCommonStockForAssetAcquisition" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockForAssetAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_IssuanceOfCommonStockForAssetAcquisition_lbl" xml:lang="en-US" id="erna_IssuanceOfCommonStockForAssetAcquisition_lbl">The issuance of common stock for asset acquisition in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockForAssetAcquisition" xlink:to="erna_IssuanceOfCommonStockForAssetAcquisition_lbl" xlink:title="label: IssuanceOfCommonStockForAssetAcquisition to erna_IssuanceOfCommonStockForAssetAcquisition_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockForAssetAcquisition_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_IssuanceOfCommonStockForAssetAcquisition_lbl1" xml:lang="en-US" id="erna_IssuanceOfCommonStockForAssetAcquisition_lbl1">Issuance of Common Stock for Asset Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockForAssetAcquisition" xlink:to="erna_IssuanceOfCommonStockForAssetAcquisition_lbl1" xlink:title="label: IssuanceOfCommonStockForAssetAcquisition to erna_IssuanceOfCommonStockForAssetAcquisition_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockForAssetAcquisition_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_IssuanceOfCommonStockForAssetAcquisition_lbl2" xml:lang="en-US" id="erna_IssuanceOfCommonStockForAssetAcquisition_lbl2">Issuance of common Stock for Novellus acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockForAssetAcquisition" xlink:to="erna_IssuanceOfCommonStockForAssetAcquisition_lbl2" xlink:title="label: IssuanceOfCommonStockForAssetAcquisition to erna_IssuanceOfCommonStockForAssetAcquisition_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:label="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:title="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" />
    <link:label xlink:type="resource" xlink:label="erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl" xml:lang="en-US" id="erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl">The fair value of preferred stock issued in a reverse merger transaction in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:to="erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl" xlink:title="label: NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger to erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1" xml:lang="en-US" id="erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1">Noncash or Part Noncash Acquisition, Preferred Shares Issued in Connection with Reverse Merger</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:to="erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1" xlink:title="label: NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger to erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2" xml:lang="en-US" id="erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2">Preferred shares issued in connection with reverse merger</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:to="erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2" xlink:title="label: NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger to erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" xlink:label="InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" xlink:title="InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl" xml:lang="en-US" id="erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl">The fair value of Initial measurement of ROU assets and operating lease liabilities in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" xlink:to="erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl" xlink:title="label: InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities to erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl1" xml:lang="en-US" id="erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl1">Initial Measurement of Right of Use Assets and Operating Lease Labilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" xlink:to="erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl1" xlink:title="label: InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities to erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl2" xml:lang="en-US" id="erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl2">Initial measurement of ROU assets and operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" xlink:to="erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl2" xlink:title="label: InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities to erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:label="UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:title="UnpaidFeesIncurredInConnectionWithPrivateOffering" />
    <link:label xlink:type="resource" xlink:label="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl" xml:lang="en-US" id="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl">Value of unpaid fees incurred in connection with private offering.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:to="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl" xlink:title="label: UnpaidFeesIncurredInConnectionWithPrivateOffering to erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl1" xml:lang="en-US" id="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl1">Unpaid Fees Incurred in Connection with Private Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:to="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl1" xlink:title="label: UnpaidFeesIncurredInConnectionWithPrivateOffering to erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl2" xml:lang="en-US" id="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl2">Unpaid fees incurred in connection with private offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:to="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl2" xlink:title="label: UnpaidFeesIncurredInConnectionWithPrivateOffering to erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ConversionOfWarrantLiabilityToEquity" xlink:label="ConversionOfWarrantLiabilityToEquity" xlink:title="ConversionOfWarrantLiabilityToEquity" />
    <link:label xlink:type="resource" xlink:label="erna_ConversionOfWarrantLiabilityToEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ConversionOfWarrantLiabilityToEquity_lbl" xml:lang="en-US" id="erna_ConversionOfWarrantLiabilityToEquity_lbl">The conversion of warrant liability to equity in non-cash investing and financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConversionOfWarrantLiabilityToEquity" xlink:to="erna_ConversionOfWarrantLiabilityToEquity_lbl" xlink:title="label: ConversionOfWarrantLiabilityToEquity to erna_ConversionOfWarrantLiabilityToEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ConversionOfWarrantLiabilityToEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ConversionOfWarrantLiabilityToEquity_lbl1" xml:lang="en-US" id="erna_ConversionOfWarrantLiabilityToEquity_lbl1">Conversion of Warrant Liability to Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConversionOfWarrantLiabilityToEquity" xlink:to="erna_ConversionOfWarrantLiabilityToEquity_lbl1" xlink:title="label: ConversionOfWarrantLiabilityToEquity to erna_ConversionOfWarrantLiabilityToEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:label xlink:type="resource" xlink:label="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" xml:lang="en-US" id="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl">The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xml:lang="en-US" id="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1">Research and Development in Process, Asset Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" xml:lang="en-US" id="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2">In-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" />
    <link:label xlink:type="resource" xlink:label="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl3" xml:lang="en-US" id="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl3">In-process R&amp;D acquired in Novellus asset acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl3" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl3" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:label="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:title="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl" xml:lang="en-US" id="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl">Amount of gain (loss) on remeasurement of right-of-use asset obtained in exchange for operating lease liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:to="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl" xlink:title="label: GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset to erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl1" xml:lang="en-US" id="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl1">Gain (Loss) on Remeasurement of Operating Lease Liability and Right-of-Use-Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:to="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl1" xlink:title="label: GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset to erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl2" xml:lang="en-US" id="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl2">Gain on remeasurement of operating lease liability and right-of-use-asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:to="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl2" xlink:title="label: GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset to erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CashPaidDuringThePeriodForAbstract" xlink:label="CashPaidDuringThePeriodForAbstract" xlink:title="CashPaidDuringThePeriodForAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_CashPaidDuringThePeriodForAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CashPaidDuringThePeriodForAbstract_lbl1" xml:lang="en-US" id="erna_CashPaidDuringThePeriodForAbstract_lbl1">Cash Paid During the Period for [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="erna_CashPaidDuringThePeriodForAbstract_lbl1" xlink:title="label: CashPaidDuringThePeriodForAbstract to erna_CashPaidDuringThePeriodForAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CashPaidDuringThePeriodForAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_CashPaidDuringThePeriodForAbstract_lbl2" xml:lang="en-US" id="erna_CashPaidDuringThePeriodForAbstract_lbl2">Cash paid during the period for:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="erna_CashPaidDuringThePeriodForAbstract_lbl2" xlink:title="label: CashPaidDuringThePeriodForAbstract to erna_CashPaidDuringThePeriodForAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:label="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:title="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl1" xml:lang="en-US" id="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl1">Reconciliation of Cash Cash Equivalents and Restricted Cash in Condensed Consolidated Statements Of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:to="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl1" xlink:title="label: ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract to erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl2" xml:lang="en-US" id="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl2">Reconciliation of cash, cash equivalents and restricted cash at end of period:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:to="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl2" xlink:title="label: ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract to erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialMeasurementOfFinanceLeaseLiabilities" xlink:label="InitialMeasurementOfFinanceLeaseLiabilities" xlink:title="InitialMeasurementOfFinanceLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl" xml:lang="en-US" id="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl">The fair value of initial measurement of finance lease liabilities in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfFinanceLeaseLiabilities" xlink:to="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl" xlink:title="label: InitialMeasurementOfFinanceLeaseLiabilities to erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl1" xml:lang="en-US" id="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl1">Initial Measurement of Finance Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfFinanceLeaseLiabilities" xlink:to="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl1" xlink:title="label: InitialMeasurementOfFinanceLeaseLiabilities to erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl2" xml:lang="en-US" id="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl2">Initial measurement of finance lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfFinanceLeaseLiabilities" xlink:to="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl2" xlink:title="label: InitialMeasurementOfFinanceLeaseLiabilities to erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xml:lang="en-US" id="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl">The increase (decrease) during the reporting period in the operating lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:title="label: IncreaseDecreaseInOperatingLeaseLiabilities to erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" xml:lang="en-US" id="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInOperatingLeaseLiabilities to erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2" xml:lang="en-US" id="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2">Operating lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2" xlink:title="label: IncreaseDecreaseInOperatingLeaseLiabilities to erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:label="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:title="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl" xml:lang="en-US" id="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl">Amount of cash flows from issuance of common stock from exercise of pre-funded warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:to="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl" xlink:title="label: IssuanceOfCommonStockFromExerciseOfPreFundedWarrants to erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl1" xml:lang="en-US" id="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl1">Issuance of Common Stock from Exercise of Pre-funded Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:to="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl1" xlink:title="label: IssuanceOfCommonStockFromExerciseOfPreFundedWarrants to erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl2" xml:lang="en-US" id="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl2">Issuance of common stock from exercise of pre-funded warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:to="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl2" xlink:title="label: IssuanceOfCommonStockFromExerciseOfPreFundedWarrants to erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainOnTerminationOfLease" xlink:label="GainOnTerminationOfLease" xlink:title="GainOnTerminationOfLease" />
    <link:label xlink:type="resource" xlink:label="erna_GainOnTerminationOfLease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_GainOnTerminationOfLease_lbl" xml:lang="en-US" id="erna_GainOnTerminationOfLease_lbl">Amount of gain on termination of lease before expiration of lease term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnTerminationOfLease" xlink:to="erna_GainOnTerminationOfLease_lbl" xlink:title="label: GainOnTerminationOfLease to erna_GainOnTerminationOfLease_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_GainOnTerminationOfLease_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_GainOnTerminationOfLease_lbl1" xml:lang="en-US" id="erna_GainOnTerminationOfLease_lbl1">Gain on Termination of Lease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnTerminationOfLease" xlink:to="erna_GainOnTerminationOfLease_lbl1" xlink:title="label: GainOnTerminationOfLease to erna_GainOnTerminationOfLease_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_GainOnTerminationOfLease_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_GainOnTerminationOfLease_lbl2" xml:lang="en-US" id="erna_GainOnTerminationOfLease_lbl2">Gain on lease termination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnTerminationOfLease" xlink:to="erna_GainOnTerminationOfLease_lbl2" xlink:title="label: GainOnTerminationOfLease to erna_GainOnTerminationOfLease_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan" xlink:label="GainLossOnForgivenessOfPaycheckProtectionProgramLoan" xlink:title="GainLossOnForgivenessOfPaycheckProtectionProgramLoan" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl" xml:lang="en-US" id="erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl">Amount of gain (loss) on forgiveness of PPP loan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnForgivenessOfPaycheckProtectionProgramLoan" xlink:to="erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl" xlink:title="label: GainLossOnForgivenessOfPaycheckProtectionProgramLoan to erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl1" xml:lang="en-US" id="erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl1">Gain (Loss) on Forgiveness of Paycheck Protection Program Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnForgivenessOfPaycheckProtectionProgramLoan" xlink:to="erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl1" xlink:title="label: GainLossOnForgivenessOfPaycheckProtectionProgramLoan to erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl2" xml:lang="en-US" id="erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl2">Gain on forgiveness of PPP loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnForgivenessOfPaycheckProtectionProgramLoan" xlink:to="erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl2" xlink:title="label: GainLossOnForgivenessOfPaycheckProtectionProgramLoan to erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend" xlink:label="IssuanceOfCommonStockForSeriesAPreferredStockDividend" xlink:title="IssuanceOfCommonStockForSeriesAPreferredStockDividend" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl" xml:lang="en-US" id="erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl">The fair value of issuance of common stock for Series A preferred stock dividend in non-cash investing and financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockForSeriesAPreferredStockDividend" xlink:to="erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl" xlink:title="label: IssuanceOfCommonStockForSeriesAPreferredStockDividend to erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl1" xml:lang="en-US" id="erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl1">Issuance of Common Stock for Series A Preferred Stock Dividend</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockForSeriesAPreferredStockDividend" xlink:to="erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl1" xlink:title="label: IssuanceOfCommonStockForSeriesAPreferredStockDividend to erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl2" xml:lang="en-US" id="erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl2">Issuance of common stock for Series A preferred stock dividend</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockForSeriesAPreferredStockDividend" xlink:to="erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl2" xlink:title="label: IssuanceOfCommonStockForSeriesAPreferredStockDividend to erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:label="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:title="ProceedsFromIssuanceOfCommonStockToLincolnPark" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl" xml:lang="en-US" id="erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl">The cash inflow from the proceeds from issuance of common stock to Lincoln Park to the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:to="erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl" xlink:title="label: ProceedsFromIssuanceOfCommonStockToLincolnPark to erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl1" xml:lang="en-US" id="erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl1">Proceeds From Issuance of Common Stock to Lincoln Park</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:to="erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl1" xlink:title="label: ProceedsFromIssuanceOfCommonStockToLincolnPark to erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl2" xml:lang="en-US" id="erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl2">Net proceeds of common stock issued to Lincoln Park</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:to="erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl2" xlink:title="label: ProceedsFromIssuanceOfCommonStockToLincolnPark to erna_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl1" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl1">Sale Leaseback Transactions, Future Minimum Sublease Rentals, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl1" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl2" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl2">Future Lease Payments, Sublease Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl2" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:label="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:title="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl" xml:lang="en-US" id="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl">Percentage of increase in annual lease payment for subleases for each year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:to="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl" xlink:title="label: PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments to erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl1" xml:lang="en-US" id="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl1">Percentage of Lessee Sublease, Increase In Annual Lease Rent Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:to="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl1" xlink:title="label: PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments to erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl2" xml:lang="en-US" id="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl2">Percentage of annual rent increase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:to="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl2" xlink:title="label: PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments to erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl">Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl1" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl1">Sale Leaseback Transactions, Future Minimum Sublease Rentals, Next Twelve Months</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl1" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl2" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl2">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl2" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl">Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl1" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl1">Sale Leaseback Transactions, Future Minimum Sublease Rentals, within Two Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl1" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl2" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl2">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl2" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AreaOfSubleaseSpaceCurrentlyRented" xlink:label="AreaOfSubleaseSpaceCurrentlyRented" xlink:title="AreaOfSubleaseSpaceCurrentlyRented" />
    <link:label xlink:type="resource" xlink:label="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl" xml:lang="en-US" id="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl">The subleases rentable area for properties currently rented.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AreaOfSubleaseSpaceCurrentlyRented" xlink:to="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl" xlink:title="label: AreaOfSubleaseSpaceCurrentlyRented to erna_AreaOfSubleaseSpaceCurrentlyRented_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl1" xml:lang="en-US" id="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl1">Area of Sublease, Space Currently Rented</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AreaOfSubleaseSpaceCurrentlyRented" xlink:to="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl1" xlink:title="label: AreaOfSubleaseSpaceCurrentlyRented to erna_AreaOfSubleaseSpaceCurrentlyRented_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl2" xml:lang="en-US" id="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl2">Currently rented area</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AreaOfSubleaseSpaceCurrentlyRented" xlink:to="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl2" xlink:title="label: AreaOfSubleaseSpaceCurrentlyRented to erna_AreaOfSubleaseSpaceCurrentlyRented_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl">Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl1" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl1">Sale Leaseback Transactions, Future Minimum Sublease Rentals, within Four Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl1" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl2" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl2">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl2" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl">Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl1" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl1">Sale Leaseback Transactions, Future Minimum Sublease Rentals, within Three Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl1" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl2" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl2">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl2" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl">Amount of minimum sublease rentals to be received by the seller-lessee for sale-leaseback transactions accounted for using the deposit method or as a financing.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentals to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl1" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl1">Sale Leaseback Transactions, Future Minimum Sublease Rentals</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl1" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentals to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl2" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl2">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl2" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentals to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfAdditionalRightsOffering" xlink:label="PercentageOfAdditionalRightsOffering" xlink:title="PercentageOfAdditionalRightsOffering" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfAdditionalRightsOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PercentageOfAdditionalRightsOffering_lbl" xml:lang="en-US" id="erna_PercentageOfAdditionalRightsOffering_lbl">Percentage of additional right offering made by the entity for unit holders.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfAdditionalRightsOffering" xlink:to="erna_PercentageOfAdditionalRightsOffering_lbl" xlink:title="label: PercentageOfAdditionalRightsOffering to erna_PercentageOfAdditionalRightsOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfAdditionalRightsOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PercentageOfAdditionalRightsOffering_lbl1" xml:lang="en-US" id="erna_PercentageOfAdditionalRightsOffering_lbl1">Percentage of Additional Rights Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfAdditionalRightsOffering" xlink:to="erna_PercentageOfAdditionalRightsOffering_lbl1" xlink:title="label: PercentageOfAdditionalRightsOffering to erna_PercentageOfAdditionalRightsOffering_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfAdditionalRightsOffering_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PercentageOfAdditionalRightsOffering_lbl2" xml:lang="en-US" id="erna_PercentageOfAdditionalRightsOffering_lbl2">Percentage of additional rights offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfAdditionalRightsOffering" xlink:to="erna_PercentageOfAdditionalRightsOffering_lbl2" xlink:title="label: PercentageOfAdditionalRightsOffering to erna_PercentageOfAdditionalRightsOffering_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" />
    <link:label xlink:type="resource" xlink:label="erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl" xml:lang="en-US" id="erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl">The amount of software development costs recognized as of the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:to="erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts to erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1" xml:lang="en-US" id="erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Software Development Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:to="erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts to erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2" xml:lang="en-US" id="erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2">Software development costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:to="erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts to erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:label xlink:type="resource" xlink:label="erna_NTNBuzztimeIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NTNBuzztimeIncMember_lbl" xml:lang="en-US" id="erna_NTNBuzztimeIncMember_lbl">Name of acquiree entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBuzztimeIncMember" xlink:to="erna_NTNBuzztimeIncMember_lbl" xlink:title="label: NTNBuzztimeIncMember to erna_NTNBuzztimeIncMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NTNBuzztimeIncMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NTNBuzztimeIncMember_lbl1" xml:lang="en-US" id="erna_NTNBuzztimeIncMember_lbl1">NTN Buzztime, Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBuzztimeIncMember" xlink:to="erna_NTNBuzztimeIncMember_lbl1" xlink:title="label: NTNBuzztimeIncMember to erna_NTNBuzztimeIncMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NTNBuzztimeIncMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NTNBuzztimeIncMember_lbl2" xml:lang="en-US" id="erna_NTNBuzztimeIncMember_lbl2">NTN Buzztime, Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBuzztimeIncMember" xlink:to="erna_NTNBuzztimeIncMember_lbl2" xlink:title="label: NTNBuzztimeIncMember to erna_NTNBuzztimeIncMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProFormaFairValueAdjustmentToAssetsMember" xlink:label="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="ProFormaFairValueAdjustmentToAssetsMember" />
    <link:label xlink:type="resource" xlink:label="erna_ProFormaFairValueAdjustmentToAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ProFormaFairValueAdjustmentToAssetsMember_lbl" xml:lang="en-US" id="erna_ProFormaFairValueAdjustmentToAssetsMember_lbl">Fair value adjustment to acquisition-date assets reported in proforma information.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProFormaFairValueAdjustmentToAssetsMember" xlink:to="erna_ProFormaFairValueAdjustmentToAssetsMember_lbl" xlink:title="label: ProFormaFairValueAdjustmentToAssetsMember to erna_ProFormaFairValueAdjustmentToAssetsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ProFormaFairValueAdjustmentToAssetsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ProFormaFairValueAdjustmentToAssetsMember_lbl1" xml:lang="en-US" id="erna_ProFormaFairValueAdjustmentToAssetsMember_lbl1">Pro Forma Fair Value Adjustment to Assets [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProFormaFairValueAdjustmentToAssetsMember" xlink:to="erna_ProFormaFairValueAdjustmentToAssetsMember_lbl1" xlink:title="label: ProFormaFairValueAdjustmentToAssetsMember to erna_ProFormaFairValueAdjustmentToAssetsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ProFormaFairValueAdjustmentToAssetsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ProFormaFairValueAdjustmentToAssetsMember_lbl2" xml:lang="en-US" id="erna_ProFormaFairValueAdjustmentToAssetsMember_lbl2">Fair Value Adjustment to Assets [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProFormaFairValueAdjustmentToAssetsMember" xlink:to="erna_ProFormaFairValueAdjustmentToAssetsMember_lbl2" xlink:title="label: ProFormaFairValueAdjustmentToAssetsMember to erna_ProFormaFairValueAdjustmentToAssetsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PurchasePriceAllocationMember" xlink:label="PurchasePriceAllocationMember" xlink:title="PurchasePriceAllocationMember" />
    <link:label xlink:type="resource" xlink:label="erna_PurchasePriceAllocationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PurchasePriceAllocationMember_lbl" xml:lang="en-US" id="erna_PurchasePriceAllocationMember_lbl">Purchase price allocation of acquisition-date assets and liability assumed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchasePriceAllocationMember" xlink:to="erna_PurchasePriceAllocationMember_lbl" xlink:title="label: PurchasePriceAllocationMember to erna_PurchasePriceAllocationMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PurchasePriceAllocationMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PurchasePriceAllocationMember_lbl1" xml:lang="en-US" id="erna_PurchasePriceAllocationMember_lbl1">Purchase Price Allocation [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchasePriceAllocationMember" xlink:to="erna_PurchasePriceAllocationMember_lbl1" xlink:title="label: PurchasePriceAllocationMember to erna_PurchasePriceAllocationMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PurchasePriceAllocationMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PurchasePriceAllocationMember_lbl2" xml:lang="en-US" id="erna_PurchasePriceAllocationMember_lbl2">Purchase Price Allocation [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchasePriceAllocationMember" xlink:to="erna_PurchasePriceAllocationMember_lbl2" xlink:title="label: PurchasePriceAllocationMember to erna_PurchasePriceAllocationMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProceedsFromSaleOfRights" xlink:label="ProceedsFromSaleOfRights" xlink:title="ProceedsFromSaleOfRights" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromSaleOfRights_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ProceedsFromSaleOfRights_lbl" xml:lang="en-US" id="erna_ProceedsFromSaleOfRights_lbl">The cash inflow from the sale of rights during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRights" xlink:to="erna_ProceedsFromSaleOfRights_lbl" xlink:title="label: ProceedsFromSaleOfRights to erna_ProceedsFromSaleOfRights_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromSaleOfRights_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ProceedsFromSaleOfRights_lbl1" xml:lang="en-US" id="erna_ProceedsFromSaleOfRights_lbl1">Proceeds From Sale Of Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRights" xlink:to="erna_ProceedsFromSaleOfRights_lbl1" xlink:title="label: ProceedsFromSaleOfRights to erna_ProceedsFromSaleOfRights_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromSaleOfRights_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ProceedsFromSaleOfRights_lbl2" xml:lang="en-US" id="erna_ProceedsFromSaleOfRights_lbl2">Proceeds from right offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRights" xlink:to="erna_ProceedsFromSaleOfRights_lbl2" xlink:title="label: ProceedsFromSaleOfRights to erna_ProceedsFromSaleOfRights_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:label="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" />
    <link:label xlink:type="resource" xlink:label="erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl" xml:lang="en-US" id="erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl">Amount of cash and cash equivalents obligated to maintain under merger agreement on balance sheet at the effective time of the merger.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:to="erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl" xlink:title="label: ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement to erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1" xml:lang="en-US" id="erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1">Obligated to Maintain Cash and Cash Equivalents Under Merger Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:to="erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1" xlink:title="label: ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement to erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2" xml:lang="en-US" id="erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2">Cash and cash equivalents obligated to have under merger agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:to="erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2" xlink:title="label: ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement to erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BeneficialHoldersContractualCommitmentsToInvest" xlink:label="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="BeneficialHoldersContractualCommitmentsToInvest" />
    <link:label xlink:type="resource" xlink:label="erna_BeneficialHoldersContractualCommitmentsToInvest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_BeneficialHoldersContractualCommitmentsToInvest_lbl" xml:lang="en-US" id="erna_BeneficialHoldersContractualCommitmentsToInvest_lbl">Amount of contractual commitment made by beneficial holders to invest in the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialHoldersContractualCommitmentsToInvest" xlink:to="erna_BeneficialHoldersContractualCommitmentsToInvest_lbl" xlink:title="label: BeneficialHoldersContractualCommitmentsToInvest to erna_BeneficialHoldersContractualCommitmentsToInvest_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_BeneficialHoldersContractualCommitmentsToInvest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_BeneficialHoldersContractualCommitmentsToInvest_lbl1" xml:lang="en-US" id="erna_BeneficialHoldersContractualCommitmentsToInvest_lbl1">Beneficial Holders Contractual Commitments To Invest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialHoldersContractualCommitmentsToInvest" xlink:to="erna_BeneficialHoldersContractualCommitmentsToInvest_lbl1" xlink:title="label: BeneficialHoldersContractualCommitmentsToInvest to erna_BeneficialHoldersContractualCommitmentsToInvest_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_BeneficialHoldersContractualCommitmentsToInvest_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_BeneficialHoldersContractualCommitmentsToInvest_lbl2" xml:lang="en-US" id="erna_BeneficialHoldersContractualCommitmentsToInvest_lbl2">Beneficial holders contractual commitments to invest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialHoldersContractualCommitmentsToInvest" xlink:to="erna_BeneficialHoldersContractualCommitmentsToInvest_lbl2" xlink:title="label: BeneficialHoldersContractualCommitmentsToInvest to erna_BeneficialHoldersContractualCommitmentsToInvest_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:label="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:title="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" xml:lang="en-US" id="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1">Lessee Operating Lease Weighted Average Remaining Lease Term And Discount Rate Abstract [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" xlink:title="label: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2" xml:lang="en-US" id="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2">Weighted Average Remaining Lease Term and Discount Rate [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2" xlink:title="label: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLeaseAssestAbstract" xlink:label="OperatingLeaseAssestAbstract" xlink:title="OperatingLeaseAssestAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseAssestAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OperatingLeaseAssestAbstract_lbl1" xml:lang="en-US" id="erna_OperatingLeaseAssestAbstract_lbl1">Operating Lease, Asset [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseAssestAbstract" xlink:to="erna_OperatingLeaseAssestAbstract_lbl1" xlink:title="label: OperatingLeaseAssestAbstract to erna_OperatingLeaseAssestAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_WriteOffOfOperatingLeaseRightOfUseAsset" xlink:label="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:title="WriteOffOfOperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" id="erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl">Write-off of operating lease right-of-use asset due to lease termination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:to="erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl" xlink:title="label: WriteOffOfOperatingLeaseRightOfUseAsset to erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1" xml:lang="en-US" id="erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1">Write-off of Operating Lease Right-of-use Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:to="erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1" xlink:title="label: WriteOffOfOperatingLeaseRightOfUseAsset to erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2" xml:lang="en-US" id="erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2">Write off of ROU asset due to lease termination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:to="erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2" xlink:title="label: WriteOffOfOperatingLeaseRightOfUseAsset to erna_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RemeasurementOfOperatingLeaseRightOfUseAsset" xlink:label="RemeasurementOfOperatingLeaseRightOfUseAsset" xlink:title="RemeasurementOfOperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" id="erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl">Amount of remeasurement of operating lease right-of-use asset.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemeasurementOfOperatingLeaseRightOfUseAsset" xlink:to="erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl" xlink:title="label: RemeasurementOfOperatingLeaseRightOfUseAsset to erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl1" xml:lang="en-US" id="erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl1">Remeasurement of Operating Lease Right-of-use Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemeasurementOfOperatingLeaseRightOfUseAsset" xlink:to="erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl1" xlink:title="label: RemeasurementOfOperatingLeaseRightOfUseAsset to erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl2" xml:lang="en-US" id="erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl2">Remeasurement of ROU asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemeasurementOfOperatingLeaseRightOfUseAsset" xlink:to="erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl2" xlink:title="label: RemeasurementOfOperatingLeaseRightOfUseAsset to erna_RemeasurementOfOperatingLeaseRightOfUseAsset_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialMeasurementOfOperatingLeaseROUAssets" xlink:label="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="InitialMeasurementOfOperatingLeaseROUAssets" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl">The fair value of initial measurement of operating lease ROU assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseROUAssets" xlink:to="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl" xlink:title="label: InitialMeasurementOfOperatingLeaseROUAssets to erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl1" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl1">Initial Measurement of Operating Lease ROU Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseROUAssets" xlink:to="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl1" xlink:title="label: InitialMeasurementOfOperatingLeaseROUAssets to erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl2" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl2">Initial measurement of ROU asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseROUAssets" xlink:to="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl2" xlink:title="label: InitialMeasurementOfOperatingLeaseROUAssets to erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl2" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl3" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl3">Initial measurement of operating lease ROU assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseROUAssets" xlink:to="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl3" xlink:title="label: InitialMeasurementOfOperatingLeaseROUAssets to erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl3" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ReclassificationFromFixedAssetsToRightOfUseAsset" xlink:label="ReclassificationFromFixedAssetsToRightOfUseAsset" xlink:title="ReclassificationFromFixedAssetsToRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl" xml:lang="en-US" id="erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl">Amount of reclassification from fixed assets to right-of-use (ROU) assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReclassificationFromFixedAssetsToRightOfUseAsset" xlink:to="erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl" xlink:title="label: ReclassificationFromFixedAssetsToRightOfUseAsset to erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl1" xml:lang="en-US" id="erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl1">Reclassification from Fixed Assets to Right-of-use Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReclassificationFromFixedAssetsToRightOfUseAsset" xlink:to="erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl1" xlink:title="label: ReclassificationFromFixedAssetsToRightOfUseAsset to erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl2" xml:lang="en-US" id="erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl2">Reclassification from fixed assets to ROU assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReclassificationFromFixedAssetsToRightOfUseAsset" xlink:to="erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl2" xlink:title="label: ReclassificationFromFixedAssetsToRightOfUseAsset to erna_ReclassificationFromFixedAssetsToRightOfUseAsset_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:label="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:title="PrincipalPaymentsOnOperatingLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" xml:lang="en-US" id="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl">Principal payments on operating lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:to="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" xlink:title="label: PrincipalPaymentsOnOperatingLeaseLiabilities to erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" xml:lang="en-US" id="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1">Principal payments on operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:to="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" xlink:title="label: PrincipalPaymentsOnOperatingLeaseLiabilities to erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2" xml:lang="en-US" id="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2">Principal payments on operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:to="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2" xlink:title="label: PrincipalPaymentsOnOperatingLeaseLiabilities to erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialMeasurementOfOperatingLeaseLiabilities" xlink:label="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="InitialMeasurementOfOperatingLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl">The fair value of initial measurement of operating lease liabilities in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseLiabilities" xlink:to="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl" xlink:title="label: InitialMeasurementOfOperatingLeaseLiabilities to erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl1" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl1">Initial Measurement of Operating Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseLiabilities" xlink:to="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl1" xlink:title="label: InitialMeasurementOfOperatingLeaseLiabilities to erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl2" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl2">Initial measurement of operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseLiabilities" xlink:to="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl2" xlink:title="label: InitialMeasurementOfOperatingLeaseLiabilities to erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RemeasurementOfOperatingLeaseLiability" xlink:label="RemeasurementOfOperatingLeaseLiability" xlink:title="RemeasurementOfOperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="erna_RemeasurementOfOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_RemeasurementOfOperatingLeaseLiability_lbl" xml:lang="en-US" id="erna_RemeasurementOfOperatingLeaseLiability_lbl">Amount of remeasurement of operating lease liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemeasurementOfOperatingLeaseLiability" xlink:to="erna_RemeasurementOfOperatingLeaseLiability_lbl" xlink:title="label: RemeasurementOfOperatingLeaseLiability to erna_RemeasurementOfOperatingLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_RemeasurementOfOperatingLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RemeasurementOfOperatingLeaseLiability_lbl1" xml:lang="en-US" id="erna_RemeasurementOfOperatingLeaseLiability_lbl1">Remeasurment of lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemeasurementOfOperatingLeaseLiability" xlink:to="erna_RemeasurementOfOperatingLeaseLiability_lbl1" xlink:title="label: RemeasurementOfOperatingLeaseLiability to erna_RemeasurementOfOperatingLeaseLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RemeasurementOfOperatingLeaseLiability_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_RemeasurementOfOperatingLeaseLiability_lbl2" xml:lang="en-US" id="erna_RemeasurementOfOperatingLeaseLiability_lbl2">Remeasurement of lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemeasurementOfOperatingLeaseLiability" xlink:to="erna_RemeasurementOfOperatingLeaseLiability_lbl2" xlink:title="label: RemeasurementOfOperatingLeaseLiability to erna_RemeasurementOfOperatingLeaseLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_WriteOffOfOperatingLeaseLiability" xlink:label="WriteOffOfOperatingLeaseLiability" xlink:title="WriteOffOfOperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="erna_WriteOffOfOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_WriteOffOfOperatingLeaseLiability_lbl" xml:lang="en-US" id="erna_WriteOffOfOperatingLeaseLiability_lbl">Write-off of operating lease liability due to lease termination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseLiability" xlink:to="erna_WriteOffOfOperatingLeaseLiability_lbl" xlink:title="label: WriteOffOfOperatingLeaseLiability to erna_WriteOffOfOperatingLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_WriteOffOfOperatingLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_WriteOffOfOperatingLeaseLiability_lbl1" xml:lang="en-US" id="erna_WriteOffOfOperatingLeaseLiability_lbl1">Write- off of Operating Lease Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseLiability" xlink:to="erna_WriteOffOfOperatingLeaseLiability_lbl1" xlink:title="label: WriteOffOfOperatingLeaseLiability to erna_WriteOffOfOperatingLeaseLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_WriteOffOfOperatingLeaseLiability_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_WriteOffOfOperatingLeaseLiability_lbl2" xml:lang="en-US" id="erna_WriteOffOfOperatingLeaseLiability_lbl2">Write off of lease liability due to lease termination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseLiability" xlink:to="erna_WriteOffOfOperatingLeaseLiability_lbl2" xlink:title="label: WriteOffOfOperatingLeaseLiability to erna_WriteOffOfOperatingLeaseLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfAwardsVestedAndSettledAbstract" xlink:label="NumberOfAwardsVestedAndSettledAbstract" xlink:title="NumberOfAwardsVestedAndSettledAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfAwardsVestedAndSettledAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NumberOfAwardsVestedAndSettledAbstract_lbl1" xml:lang="en-US" id="erna_NumberOfAwardsVestedAndSettledAbstract_lbl1">Number of Awards Vested and Settled [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="erna_NumberOfAwardsVestedAndSettledAbstract_lbl1" xlink:title="label: NumberOfAwardsVestedAndSettledAbstract to erna_NumberOfAwardsVestedAndSettledAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfAwardsVestedAndSettledAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NumberOfAwardsVestedAndSettledAbstract_lbl2" xml:lang="en-US" id="erna_NumberOfAwardsVestedAndSettledAbstract_lbl2">Number of RSUs Vested and Settled [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="erna_NumberOfAwardsVestedAndSettledAbstract_lbl2" xlink:title="label: NumberOfAwardsVestedAndSettledAbstract to erna_NumberOfAwardsVestedAndSettledAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonStockWithheldToCoverTaxes" xlink:label="CommonStockWithheldToCoverTaxes" xlink:title="CommonStockWithheldToCoverTaxes" />
    <link:label xlink:type="resource" xlink:label="erna_CommonStockWithheldToCoverTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CommonStockWithheldToCoverTaxes_lbl" xml:lang="en-US" id="erna_CommonStockWithheldToCoverTaxes_lbl">The number of shares of common stock withheld to cover the withholding taxes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockWithheldToCoverTaxes" xlink:to="erna_CommonStockWithheldToCoverTaxes_lbl" xlink:title="label: CommonStockWithheldToCoverTaxes to erna_CommonStockWithheldToCoverTaxes_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CommonStockWithheldToCoverTaxes_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CommonStockWithheldToCoverTaxes_lbl1" xml:lang="en-US" id="erna_CommonStockWithheldToCoverTaxes_lbl1">Common Stock Withheld to Cover Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockWithheldToCoverTaxes" xlink:to="erna_CommonStockWithheldToCoverTaxes_lbl1" xlink:title="label: CommonStockWithheldToCoverTaxes to erna_CommonStockWithheldToCoverTaxes_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CommonStockWithheldToCoverTaxes_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_CommonStockWithheldToCoverTaxes_lbl2" xml:lang="en-US" id="erna_CommonStockWithheldToCoverTaxes_lbl2">Common stock withheld to cover taxes (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockWithheldToCoverTaxes" xlink:to="erna_CommonStockWithheldToCoverTaxes_lbl2" xlink:title="label: CommonStockWithheldToCoverTaxes to erna_CommonStockWithheldToCoverTaxes_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EquityIncentivePlan2020Member" xlink:label="EquityIncentivePlan2020Member" xlink:title="EquityIncentivePlan2020Member" />
    <link:label xlink:type="resource" xlink:label="erna_EquityIncentivePlan2020Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_EquityIncentivePlan2020Member_lbl" xml:lang="en-US" id="erna_EquityIncentivePlan2020Member_lbl">Share-based compensation equity incentive plan 2020.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityIncentivePlan2020Member" xlink:to="erna_EquityIncentivePlan2020Member_lbl" xlink:title="label: EquityIncentivePlan2020Member to erna_EquityIncentivePlan2020Member_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_EquityIncentivePlan2020Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_EquityIncentivePlan2020Member_lbl1" xml:lang="en-US" id="erna_EquityIncentivePlan2020Member_lbl1">Equity Incentive Plan 2020 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityIncentivePlan2020Member" xlink:to="erna_EquityIncentivePlan2020Member_lbl1" xlink:title="label: EquityIncentivePlan2020Member to erna_EquityIncentivePlan2020Member_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_EquityIncentivePlan2020Member_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_EquityIncentivePlan2020Member_lbl2" xml:lang="en-US" id="erna_EquityIncentivePlan2020Member_lbl2">2020 Equity Incentive Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityIncentivePlan2020Member" xlink:to="erna_EquityIncentivePlan2020Member_lbl2" xlink:title="label: EquityIncentivePlan2020Member to erna_EquityIncentivePlan2020Member_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InducementPlan2021Member" xlink:label="InducementPlan2021Member" xlink:title="InducementPlan2021Member" />
    <link:label xlink:type="resource" xlink:label="erna_InducementPlan2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InducementPlan2021Member_lbl" xml:lang="en-US" id="erna_InducementPlan2021Member_lbl">Share-based payment arrangement award inducement plan 2021.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InducementPlan2021Member" xlink:to="erna_InducementPlan2021Member_lbl" xlink:title="label: InducementPlan2021Member to erna_InducementPlan2021Member_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InducementPlan2021Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InducementPlan2021Member_lbl1" xml:lang="en-US" id="erna_InducementPlan2021Member_lbl1">Inducement Plan 2021 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InducementPlan2021Member" xlink:to="erna_InducementPlan2021Member_lbl1" xlink:title="label: InducementPlan2021Member to erna_InducementPlan2021Member_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InducementPlan2021Member_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InducementPlan2021Member_lbl2" xml:lang="en-US" id="erna_InducementPlan2021Member_lbl2">2021 Inducement Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InducementPlan2021Member" xlink:to="erna_InducementPlan2021Member_lbl2" xlink:title="label: InducementPlan2021Member to erna_InducementPlan2021Member_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfSharesOfCommonStockOutstanding" xlink:label="PercentageOfSharesOfCommonStockOutstanding" xlink:title="PercentageOfSharesOfCommonStockOutstanding" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSharesOfCommonStockOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PercentageOfSharesOfCommonStockOutstanding_lbl" xml:lang="en-US" id="erna_PercentageOfSharesOfCommonStockOutstanding_lbl">Percentage of common stock shares outstanding considered for equity number of shares under equity incentive plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSharesOfCommonStockOutstanding" xlink:to="erna_PercentageOfSharesOfCommonStockOutstanding_lbl" xlink:title="label: PercentageOfSharesOfCommonStockOutstanding to erna_PercentageOfSharesOfCommonStockOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSharesOfCommonStockOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PercentageOfSharesOfCommonStockOutstanding_lbl1" xml:lang="en-US" id="erna_PercentageOfSharesOfCommonStockOutstanding_lbl1">Percentage of Shares of Common Stock Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSharesOfCommonStockOutstanding" xlink:to="erna_PercentageOfSharesOfCommonStockOutstanding_lbl1" xlink:title="label: PercentageOfSharesOfCommonStockOutstanding to erna_PercentageOfSharesOfCommonStockOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSharesOfCommonStockOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PercentageOfSharesOfCommonStockOutstanding_lbl2" xml:lang="en-US" id="erna_PercentageOfSharesOfCommonStockOutstanding_lbl2">Percentage of number of shares of common stock outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSharesOfCommonStockOutstanding" xlink:to="erna_PercentageOfSharesOfCommonStockOutstanding_lbl2" xlink:title="label: PercentageOfSharesOfCommonStockOutstanding to erna_PercentageOfSharesOfCommonStockOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NonQualifiedStockOptionMember" xlink:label="NonQualifiedStockOptionMember" xlink:title="NonQualifiedStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="erna_NonQualifiedStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NonQualifiedStockOptionMember_lbl" xml:lang="en-US" id="erna_NonQualifiedStockOptionMember_lbl">Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionMember" xlink:to="erna_NonQualifiedStockOptionMember_lbl" xlink:title="label: NonQualifiedStockOptionMember to erna_NonQualifiedStockOptionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NonQualifiedStockOptionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NonQualifiedStockOptionMember_lbl1" xml:lang="en-US" id="erna_NonQualifiedStockOptionMember_lbl1">Non-qualified Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionMember" xlink:to="erna_NonQualifiedStockOptionMember_lbl1" xlink:title="label: NonQualifiedStockOptionMember to erna_NonQualifiedStockOptionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NonQualifiedStockOptionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NonQualifiedStockOptionMember_lbl2" xml:lang="en-US" id="erna_NonQualifiedStockOptionMember_lbl2">Nonqualified Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionMember" xlink:to="erna_NonQualifiedStockOptionMember_lbl2" xlink:title="label: NonQualifiedStockOptionMember to erna_NonQualifiedStockOptionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IncentiveStockOptionsMember" xlink:label="IncentiveStockOptionsMember" xlink:title="IncentiveStockOptionsMember" />
    <link:label xlink:type="resource" xlink:label="erna_IncentiveStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_IncentiveStockOptionsMember_lbl" xml:lang="en-US" id="erna_IncentiveStockOptionsMember_lbl">Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on incentive basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncentiveStockOptionsMember" xlink:to="erna_IncentiveStockOptionsMember_lbl" xlink:title="label: IncentiveStockOptionsMember to erna_IncentiveStockOptionsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_IncentiveStockOptionsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_IncentiveStockOptionsMember_lbl1" xml:lang="en-US" id="erna_IncentiveStockOptionsMember_lbl1">Incentive Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncentiveStockOptionsMember" xlink:to="erna_IncentiveStockOptionsMember_lbl1" xlink:title="label: IncentiveStockOptionsMember to erna_IncentiveStockOptionsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_IncentiveStockOptionsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_IncentiveStockOptionsMember_lbl2" xml:lang="en-US" id="erna_IncentiveStockOptionsMember_lbl2">Incentive Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncentiveStockOptionsMember" xlink:to="erna_IncentiveStockOptionsMember_lbl2" xlink:title="label: IncentiveStockOptionsMember to erna_IncentiveStockOptionsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl">The number of non-vested equity-based payment instruments, excluding stock (or unit) options expected to vest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl2" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl2">Balance expected to vest (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BrooklynPaycheckProtectionProgramMember" xlink:label="BrooklynPaycheckProtectionProgramMember" xlink:title="BrooklynPaycheckProtectionProgramMember" />
    <link:label xlink:type="resource" xlink:label="erna_BrooklynPaycheckProtectionProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_BrooklynPaycheckProtectionProgramMember_lbl" xml:lang="en-US" id="erna_BrooklynPaycheckProtectionProgramMember_lbl">Represents the Paycheck Protection Program for Brooklyn.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BrooklynPaycheckProtectionProgramMember" xlink:to="erna_BrooklynPaycheckProtectionProgramMember_lbl" xlink:title="label: BrooklynPaycheckProtectionProgramMember to erna_BrooklynPaycheckProtectionProgramMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_BrooklynPaycheckProtectionProgramMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_BrooklynPaycheckProtectionProgramMember_lbl1" xml:lang="en-US" id="erna_BrooklynPaycheckProtectionProgramMember_lbl1">Brooklyn Paycheck Protection Program [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BrooklynPaycheckProtectionProgramMember" xlink:to="erna_BrooklynPaycheckProtectionProgramMember_lbl1" xlink:title="label: BrooklynPaycheckProtectionProgramMember to erna_BrooklynPaycheckProtectionProgramMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_BrooklynPaycheckProtectionProgramMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_BrooklynPaycheckProtectionProgramMember_lbl2" xml:lang="en-US" id="erna_BrooklynPaycheckProtectionProgramMember_lbl2">Eterna Paycheck Protection Program [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BrooklynPaycheckProtectionProgramMember" xlink:to="erna_BrooklynPaycheckProtectionProgramMember_lbl2" xlink:title="label: BrooklynPaycheckProtectionProgramMember to erna_BrooklynPaycheckProtectionProgramMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaycheckProtectionProgramLoanMember" xlink:label="PaycheckProtectionProgramLoanMember" xlink:title="PaycheckProtectionProgramLoanMember" />
    <link:label xlink:type="resource" xlink:label="erna_PaycheckProtectionProgramLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PaycheckProtectionProgramLoanMember_lbl" xml:lang="en-US" id="erna_PaycheckProtectionProgramLoanMember_lbl">Name of the debt instrument.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaycheckProtectionProgramLoanMember" xlink:to="erna_PaycheckProtectionProgramLoanMember_lbl" xlink:title="label: PaycheckProtectionProgramLoanMember to erna_PaycheckProtectionProgramLoanMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PaycheckProtectionProgramLoanMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PaycheckProtectionProgramLoanMember_lbl1" xml:lang="en-US" id="erna_PaycheckProtectionProgramLoanMember_lbl1">Paycheck Protection Program Loan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaycheckProtectionProgramLoanMember" xlink:to="erna_PaycheckProtectionProgramLoanMember_lbl1" xlink:title="label: PaycheckProtectionProgramLoanMember to erna_PaycheckProtectionProgramLoanMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PaycheckProtectionProgramLoanMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PaycheckProtectionProgramLoanMember_lbl2" xml:lang="en-US" id="erna_PaycheckProtectionProgramLoanMember_lbl2">IRX Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaycheckProtectionProgramLoanMember" xlink:to="erna_PaycheckProtectionProgramLoanMember_lbl2" xlink:title="label: PaycheckProtectionProgramLoanMember to erna_PaycheckProtectionProgramLoanMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaycheckProtectionProgramMember" xlink:label="PaycheckProtectionProgramMember" xlink:title="PaycheckProtectionProgramMember" />
    <link:label xlink:type="resource" xlink:label="erna_PaycheckProtectionProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PaycheckProtectionProgramMember_lbl" xml:lang="en-US" id="erna_PaycheckProtectionProgramMember_lbl">Paycheck Protection Program [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaycheckProtectionProgramMember" xlink:to="erna_PaycheckProtectionProgramMember_lbl" xlink:title="label: PaycheckProtectionProgramMember to erna_PaycheckProtectionProgramMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PaycheckProtectionProgramMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PaycheckProtectionProgramMember_lbl1" xml:lang="en-US" id="erna_PaycheckProtectionProgramMember_lbl1">Paycheck Protection Program [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaycheckProtectionProgramMember" xlink:to="erna_PaycheckProtectionProgramMember_lbl1" xlink:title="label: PaycheckProtectionProgramMember to erna_PaycheckProtectionProgramMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PaycheckProtectionProgramMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PaycheckProtectionProgramMember_lbl2" xml:lang="en-US" id="erna_PaycheckProtectionProgramMember_lbl2">Eterna LLC Paycheck Protection Program [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaycheckProtectionProgramMember" xlink:to="erna_PaycheckProtectionProgramMember_lbl2" xlink:title="label: PaycheckProtectionProgramMember to erna_PaycheckProtectionProgramMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DebtInstrumentAbstract" xlink:label="DebtInstrumentAbstract" xlink:title="DebtInstrumentAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_DebtInstrumentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DebtInstrumentAbstract_lbl1" xml:lang="en-US" id="erna_DebtInstrumentAbstract_lbl1">Debt Instrument [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAbstract" xlink:to="erna_DebtInstrumentAbstract_lbl1" xlink:title="label: DebtInstrumentAbstract to erna_DebtInstrumentAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DebtInstrumentAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DebtInstrumentAbstract_lbl2" xml:lang="en-US" id="erna_DebtInstrumentAbstract_lbl2">Debt Instrument [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAbstract" xlink:to="erna_DebtInstrumentAbstract_lbl2" xlink:title="label: DebtInstrumentAbstract to erna_DebtInstrumentAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentOfAccruedAndUnpaidInterest" xlink:label="PaymentOfAccruedAndUnpaidInterest" xlink:title="PaymentOfAccruedAndUnpaidInterest" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentOfAccruedAndUnpaidInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PaymentOfAccruedAndUnpaidInterest_lbl" xml:lang="en-US" id="erna_PaymentOfAccruedAndUnpaidInterest_lbl">Amount of cash paid for accrued and unpaid interest related to notes payable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfAccruedAndUnpaidInterest" xlink:to="erna_PaymentOfAccruedAndUnpaidInterest_lbl" xlink:title="label: PaymentOfAccruedAndUnpaidInterest to erna_PaymentOfAccruedAndUnpaidInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentOfAccruedAndUnpaidInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PaymentOfAccruedAndUnpaidInterest_lbl1" xml:lang="en-US" id="erna_PaymentOfAccruedAndUnpaidInterest_lbl1">Payment of Accrued and Unpaid Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfAccruedAndUnpaidInterest" xlink:to="erna_PaymentOfAccruedAndUnpaidInterest_lbl1" xlink:title="label: PaymentOfAccruedAndUnpaidInterest to erna_PaymentOfAccruedAndUnpaidInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentOfAccruedAndUnpaidInterest_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PaymentOfAccruedAndUnpaidInterest_lbl2" xml:lang="en-US" id="erna_PaymentOfAccruedAndUnpaidInterest_lbl2">Payment of accrued and unpaid interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfAccruedAndUnpaidInterest" xlink:to="erna_PaymentOfAccruedAndUnpaidInterest_lbl2" xlink:title="label: PaymentOfAccruedAndUnpaidInterest to erna_PaymentOfAccruedAndUnpaidInterest_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl">The number of extended post-termination exercise period under the share-based compensation arrangements, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1">Share-based Compensation Arrangement By Share-based Payment Award, Extended Post-Termination, Exercise Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl2" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl2">Exercise period of extended post-termination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PerformanceBasedStockOptionMember" xlink:label="PerformanceBasedStockOptionMember" xlink:title="PerformanceBasedStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="erna_PerformanceBasedStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PerformanceBasedStockOptionMember_lbl" xml:lang="en-US" id="erna_PerformanceBasedStockOptionMember_lbl">Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on performance basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PerformanceBasedStockOptionMember" xlink:to="erna_PerformanceBasedStockOptionMember_lbl" xlink:title="label: PerformanceBasedStockOptionMember to erna_PerformanceBasedStockOptionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PerformanceBasedStockOptionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PerformanceBasedStockOptionMember_lbl1" xml:lang="en-US" id="erna_PerformanceBasedStockOptionMember_lbl1">Performance Based Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PerformanceBasedStockOptionMember" xlink:to="erna_PerformanceBasedStockOptionMember_lbl1" xlink:title="label: PerformanceBasedStockOptionMember to erna_PerformanceBasedStockOptionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TimeBasedStockOptionMember" xlink:label="TimeBasedStockOptionMember" xlink:title="TimeBasedStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="erna_TimeBasedStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_TimeBasedStockOptionMember_lbl" xml:lang="en-US" id="erna_TimeBasedStockOptionMember_lbl">Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on time basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TimeBasedStockOptionMember" xlink:to="erna_TimeBasedStockOptionMember_lbl" xlink:title="label: TimeBasedStockOptionMember to erna_TimeBasedStockOptionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_TimeBasedStockOptionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_TimeBasedStockOptionMember_lbl1" xml:lang="en-US" id="erna_TimeBasedStockOptionMember_lbl1">Time Based Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TimeBasedStockOptionMember" xlink:to="erna_TimeBasedStockOptionMember_lbl1" xlink:title="label: TimeBasedStockOptionMember to erna_TimeBasedStockOptionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AccruedPrivatePlacementInPublicEquityCurrent" xlink:label="AccruedPrivatePlacementInPublicEquityCurrent" xlink:title="AccruedPrivatePlacementInPublicEquityCurrent" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl" xml:lang="en-US" id="erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl">Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to private placement in public equity (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedPrivatePlacementInPublicEquityCurrent" xlink:to="erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl" xlink:title="label: AccruedPrivatePlacementInPublicEquityCurrent to erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl1" xml:lang="en-US" id="erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl1">Accrued Private Placement in Public Equity, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedPrivatePlacementInPublicEquityCurrent" xlink:to="erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl1" xlink:title="label: AccruedPrivatePlacementInPublicEquityCurrent to erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl2" xml:lang="en-US" id="erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl2">Q4-22 PIPE</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedPrivatePlacementInPublicEquityCurrent" xlink:to="erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl2" xlink:title="label: AccruedPrivatePlacementInPublicEquityCurrent to erna_AccruedPrivatePlacementInPublicEquityCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AccruedClinicalCurrent" xlink:label="AccruedClinicalCurrent" xlink:title="AccruedClinicalCurrent" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedClinicalCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AccruedClinicalCurrent_lbl" xml:lang="en-US" id="erna_AccruedClinicalCurrent_lbl">Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to clinical trail cost (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedClinicalCurrent" xlink:to="erna_AccruedClinicalCurrent_lbl" xlink:title="label: AccruedClinicalCurrent to erna_AccruedClinicalCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedClinicalCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AccruedClinicalCurrent_lbl1" xml:lang="en-US" id="erna_AccruedClinicalCurrent_lbl1">Accrued Clinical, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedClinicalCurrent" xlink:to="erna_AccruedClinicalCurrent_lbl1" xlink:title="label: AccruedClinicalCurrent to erna_AccruedClinicalCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedClinicalCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AccruedClinicalCurrent_lbl2" xml:lang="en-US" id="erna_AccruedClinicalCurrent_lbl2">Clinical</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedClinicalCurrent" xlink:to="erna_AccruedClinicalCurrent_lbl2" xlink:title="label: AccruedClinicalCurrent to erna_AccruedClinicalCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfBoardSeats" xlink:label="NumberOfBoardSeats" xlink:title="NumberOfBoardSeats" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfBoardSeats_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NumberOfBoardSeats_lbl" xml:lang="en-US" id="erna_NumberOfBoardSeats_lbl">Number of members of the company's management holds board seats on board of directors.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBoardSeats" xlink:to="erna_NumberOfBoardSeats_lbl" xlink:title="label: NumberOfBoardSeats to erna_NumberOfBoardSeats_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfBoardSeats_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NumberOfBoardSeats_lbl1" xml:lang="en-US" id="erna_NumberOfBoardSeats_lbl1">Number of Board Seats</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBoardSeats" xlink:to="erna_NumberOfBoardSeats_lbl1" xlink:title="label: NumberOfBoardSeats to erna_NumberOfBoardSeats_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfBoardSeats_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NumberOfBoardSeats_lbl2" xml:lang="en-US" id="erna_NumberOfBoardSeats_lbl2">Number of board seats</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBoardSeats" xlink:to="erna_NumberOfBoardSeats_lbl2" xlink:title="label: NumberOfBoardSeats to erna_NumberOfBoardSeats_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:label xlink:type="resource" xlink:label="erna_NoveCiteINCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NoveCiteINCMember_lbl" xml:lang="en-US" id="erna_NoveCiteINCMember_lbl">The name of company involved in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteINCMember" xlink:to="erna_NoveCiteINCMember_lbl" xlink:title="label: NoveCiteINCMember to erna_NoveCiteINCMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NoveCiteINCMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NoveCiteINCMember_lbl1" xml:lang="en-US" id="erna_NoveCiteINCMember_lbl1">NoveCite, INC. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteINCMember" xlink:to="erna_NoveCiteINCMember_lbl1" xlink:title="label: NoveCiteINCMember to erna_NoveCiteINCMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NoveCiteINCMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NoveCiteINCMember_lbl2" xml:lang="en-US" id="erna_NoveCiteINCMember_lbl2">NoveCite, INC. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteINCMember" xlink:to="erna_NoveCiteINCMember_lbl2" xlink:title="label: NoveCiteINCMember to erna_NoveCiteINCMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CitiusPharmaceuticalsIncMember" xlink:label="CitiusPharmaceuticalsIncMember" xlink:title="CitiusPharmaceuticalsIncMember" />
    <link:label xlink:type="resource" xlink:label="erna_CitiusPharmaceuticalsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CitiusPharmaceuticalsIncMember_lbl" xml:lang="en-US" id="erna_CitiusPharmaceuticalsIncMember_lbl">Represents Citius Pharmaceuticals, Inc. Ownership interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CitiusPharmaceuticalsIncMember" xlink:to="erna_CitiusPharmaceuticalsIncMember_lbl" xlink:title="label: CitiusPharmaceuticalsIncMember to erna_CitiusPharmaceuticalsIncMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CitiusPharmaceuticalsIncMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CitiusPharmaceuticalsIncMember_lbl1" xml:lang="en-US" id="erna_CitiusPharmaceuticalsIncMember_lbl1">Citius Pharmaceuticals, Inc. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CitiusPharmaceuticalsIncMember" xlink:to="erna_CitiusPharmaceuticalsIncMember_lbl1" xlink:title="label: CitiusPharmaceuticalsIncMember to erna_CitiusPharmaceuticalsIncMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ReverseStockSplitPolicyTextBlock" xlink:label="ReverseStockSplitPolicyTextBlock" xlink:title="ReverseStockSplitPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="erna_ReverseStockSplitPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ReverseStockSplitPolicyTextBlock_lbl" xml:lang="en-US" id="erna_ReverseStockSplitPolicyTextBlock_lbl">Disclosure of accounting policy for the reverse stock split during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReverseStockSplitPolicyTextBlock" xlink:to="erna_ReverseStockSplitPolicyTextBlock_lbl" xlink:title="label: ReverseStockSplitPolicyTextBlock to erna_ReverseStockSplitPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ReverseStockSplitPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ReverseStockSplitPolicyTextBlock_lbl1" xml:lang="en-US" id="erna_ReverseStockSplitPolicyTextBlock_lbl1">Reverse Stock Split [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReverseStockSplitPolicyTextBlock" xlink:to="erna_ReverseStockSplitPolicyTextBlock_lbl1" xlink:title="label: ReverseStockSplitPolicyTextBlock to erna_ReverseStockSplitPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ReverseStockSplitPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_ReverseStockSplitPolicyTextBlock_lbl2" xml:lang="en-US" id="erna_ReverseStockSplitPolicyTextBlock_lbl2">October 2022 Reverse Stock Split</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReverseStockSplitPolicyTextBlock" xlink:to="erna_ReverseStockSplitPolicyTextBlock_lbl2" xlink:title="label: ReverseStockSplitPolicyTextBlock to erna_ReverseStockSplitPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:label="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:title="LIQUIDITYANDCAPITALRESOURCESAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1" xml:lang="en-US" id="erna_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1">LIQUIDITY AND CAPITAL RESOURCES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:to="erna_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1" xlink:title="label: LIQUIDITYANDCAPITALRESOURCESAbstract to erna_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LiquidityAndCapitalResourcesTextBlock" xlink:label="LiquidityAndCapitalResourcesTextBlock" xlink:title="LiquidityAndCapitalResourcesTextBlock" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LiquidityAndCapitalResourcesTextBlock_lbl" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesTextBlock_lbl">The entire disclosure of liquidity and resource matters when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). going concern.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTextBlock" xlink:to="erna_LiquidityAndCapitalResourcesTextBlock_lbl" xlink:title="label: LiquidityAndCapitalResourcesTextBlock to erna_LiquidityAndCapitalResourcesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LiquidityAndCapitalResourcesTextBlock_lbl1" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesTextBlock_lbl1">Liquidity And Capital Resources [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTextBlock" xlink:to="erna_LiquidityAndCapitalResourcesTextBlock_lbl1" xlink:title="label: LiquidityAndCapitalResourcesTextBlock to erna_LiquidityAndCapitalResourcesTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LiquidityAndCapitalResourcesTextBlock_lbl2" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesTextBlock_lbl2">Liquidity and Capital Resources</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTextBlock" xlink:to="erna_LiquidityAndCapitalResourcesTextBlock_lbl2" xlink:title="label: LiquidityAndCapitalResourcesTextBlock to erna_LiquidityAndCapitalResourcesTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:label="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:title="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl" xml:lang="en-US" id="erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl">Tabular disclosure of the number RSUs vested and settled.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:to="erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl" xlink:title="label: ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock to erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl1" xml:lang="en-US" id="erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl1">Schedule of Restricted Stock Units Vested and Settled [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:to="erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl1" xlink:title="label: ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock to erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl2" xml:lang="en-US" id="erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl2">RSUs Vested and Settled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:to="erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl2" xlink:title="label: ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock to erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfInLicensedPortfolioPatents" xlink:label="NumberOfInLicensedPortfolioPatents" xlink:title="NumberOfInLicensedPortfolioPatents" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfInLicensedPortfolioPatents_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NumberOfInLicensedPortfolioPatents_lbl" xml:lang="en-US" id="erna_NumberOfInLicensedPortfolioPatents_lbl">The number of in-licensed portfolio patents covering key mRNA cell engineering technologies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInLicensedPortfolioPatents" xlink:to="erna_NumberOfInLicensedPortfolioPatents_lbl" xlink:title="label: NumberOfInLicensedPortfolioPatents to erna_NumberOfInLicensedPortfolioPatents_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfInLicensedPortfolioPatents_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NumberOfInLicensedPortfolioPatents_lbl1" xml:lang="en-US" id="erna_NumberOfInLicensedPortfolioPatents_lbl1">Number of In-licensed Portfolio Patents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInLicensedPortfolioPatents" xlink:to="erna_NumberOfInLicensedPortfolioPatents_lbl1" xlink:title="label: NumberOfInLicensedPortfolioPatents to erna_NumberOfInLicensedPortfolioPatents_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfInLicensedPortfolioPatents_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NumberOfInLicensedPortfolioPatents_lbl2" xml:lang="en-US" id="erna_NumberOfInLicensedPortfolioPatents_lbl2">Number of patents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInLicensedPortfolioPatents" xlink:to="erna_NumberOfInLicensedPortfolioPatents_lbl2" xlink:title="label: NumberOfInLicensedPortfolioPatents to erna_NumberOfInLicensedPortfolioPatents_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AggregateIntrinsicValueAbstract" xlink:label="AggregateIntrinsicValueAbstract" xlink:title="AggregateIntrinsicValueAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_AggregateIntrinsicValueAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AggregateIntrinsicValueAbstract_lbl1" xml:lang="en-US" id="erna_AggregateIntrinsicValueAbstract_lbl1">Aggregate Intrinsic Value [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueAbstract" xlink:to="erna_AggregateIntrinsicValueAbstract_lbl1" xlink:title="label: AggregateIntrinsicValueAbstract to erna_AggregateIntrinsicValueAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DispositionAbstract" xlink:label="DispositionAbstract" xlink:title="DispositionAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_DispositionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DispositionAbstract_lbl1" xml:lang="en-US" id="erna_DispositionAbstract_lbl1">Disposition [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DispositionAbstract" xlink:to="erna_DispositionAbstract_lbl1" xlink:title="label: DispositionAbstract to erna_DispositionAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProceedsFromDispositionAbstract" xlink:label="ProceedsFromDispositionAbstract" xlink:title="ProceedsFromDispositionAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromDispositionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ProceedsFromDispositionAbstract_lbl1" xml:lang="en-US" id="erna_ProceedsFromDispositionAbstract_lbl1">Proceeds from Disposition [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDispositionAbstract" xlink:to="erna_ProceedsFromDispositionAbstract_lbl1" xlink:title="label: ProceedsFromDispositionAbstract to erna_ProceedsFromDispositionAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromDispositionAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ProceedsFromDispositionAbstract_lbl2" xml:lang="en-US" id="erna_ProceedsFromDispositionAbstract_lbl2">Proceeds from sale [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDispositionAbstract" xlink:to="erna_ProceedsFromDispositionAbstract_lbl2" xlink:title="label: ProceedsFromDispositionAbstract to erna_ProceedsFromDispositionAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl">Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromCash to erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1">Disposal Group, Including Discontinued Operation, Proceeds from Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromCash to erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromCash to erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl">Amount of costs of the business disposal including legal, accounting, and other costs incurred to consummate the business disposition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationTransactionCosts to erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1">Disposal Group, Including Discontinued Operation, Transaction Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationTransactionCosts to erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2">Transaction costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationTransactionCosts to erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl">Aggregate proceeds received from interest on advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans to erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1">Disposal Group, Including Discontinued Operation, Proceeds from Interest on Advance/Loans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans to erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2">Interest on advance/loans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans to erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl">Aggregate proceeds received from assume advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans to erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1">Disposal Group, Including Discontinued Operation, Proceeds from Assume Advance/Loans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans to erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2">Assume advance/loans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans to erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl">Aggregate proceeds received from escrow deposits in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow to erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1">Disposal Group, Including Discontinued Operation, Proceeds from Escrow</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow to erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2">Escrow</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow to erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:label="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl">Amount classified as Obligations under finance leases attributable to disposal group held for sale or disposed of.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases to erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1">Disposal Group, Including Discontinued Operation, Obligations under finance leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases to erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2">Obligations under finance leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases to erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:label="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl">Amount classified as Lease liability attributable to disposal group held for sale or disposed of.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationLeaseLiability to erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1">Disposal Group, Including Discontinued Operation, Lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationLeaseLiability to erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2">Lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationLeaseLiability to erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl">Amount classified as software development cost attributable to disposal group held for sale or disposed of.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts to erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1">Disposal Group, Including Discontinued Operation, Software development costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts to erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2" xml:lang="en-US" id="erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2">Software development costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:to="erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts to erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NTNBusinessMember" xlink:label="NTNBusinessMember" xlink:title="NTNBusinessMember" />
    <link:label xlink:type="resource" xlink:label="erna_NTNBusinessMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NTNBusinessMember_lbl" xml:lang="en-US" id="erna_NTNBusinessMember_lbl">Name of the disposal group.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBusinessMember" xlink:to="erna_NTNBusinessMember_lbl" xlink:title="label: NTNBusinessMember to erna_NTNBusinessMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NTNBusinessMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NTNBusinessMember_lbl1" xml:lang="en-US" id="erna_NTNBusinessMember_lbl1">NTN Business [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBusinessMember" xlink:to="erna_NTNBusinessMember_lbl1" xlink:title="label: NTNBusinessMember to erna_NTNBusinessMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NTNBusinessMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NTNBusinessMember_lbl2" xml:lang="en-US" id="erna_NTNBusinessMember_lbl2">NTN Business [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBusinessMember" xlink:to="erna_NTNBusinessMember_lbl2" xlink:title="label: NTNBusinessMember to erna_NTNBusinessMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl">Value of stock issued with restrictions during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:to="erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesValueAcquisitions to erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1">Stock Issued During Period, Restricted Shares, Value, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:to="erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesValueAcquisitions to erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2">Restricted shares, value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:to="erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesValueAcquisitions to erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:label="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="PercentageOfDiscountOnFairValueOfRestrictedShares" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl" xml:lang="en-US" id="erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl">Percentage of discount on restricted shares, which was derived from the average discount rate between the Black Scholes and Finnerty valuation models.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:to="erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl" xlink:title="label: PercentageOfDiscountOnFairValueOfRestrictedShares to erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1" xml:lang="en-US" id="erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1">Percentage of Discount on Fair Value of Restricted Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:to="erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1" xlink:title="label: PercentageOfDiscountOnFairValueOfRestrictedShares to erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2" xml:lang="en-US" id="erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2">Percentage of discount on fair value restricted shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:to="erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2" xlink:title="label: PercentageOfDiscountOnFairValueOfRestrictedShares to erna_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EscrowShares" xlink:label="EscrowShares" xlink:title="EscrowShares" />
    <link:label xlink:type="resource" xlink:label="erna_EscrowShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_EscrowShares_lbl" xml:lang="en-US" id="erna_EscrowShares_lbl">Number of shares have been placed in escrow shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowShares" xlink:to="erna_EscrowShares_lbl" xlink:title="label: EscrowShares to erna_EscrowShares_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_EscrowShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_EscrowShares_lbl1" xml:lang="en-US" id="erna_EscrowShares_lbl1">Escrow Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowShares" xlink:to="erna_EscrowShares_lbl1" xlink:title="label: EscrowShares to erna_EscrowShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_EscrowShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_EscrowShares_lbl2" xml:lang="en-US" id="erna_EscrowShares_lbl2">Escrow shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowShares" xlink:to="erna_EscrowShares_lbl2" xlink:title="label: EscrowShares to erna_EscrowShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl">Value of stock issued without any restrictions during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:to="erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions to erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1">Stock Issued During Period, Unrestricted Shares, Value, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:to="erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions to erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2">Unrestricted shares, value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:to="erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions to erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl">Number of shares of stock issued with restrictions during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:to="erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesAcquisitions to erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1">Stock Issued During Period, Restricted Shares, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:to="erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesAcquisitions to erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2">Restricted shares, issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:to="erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesAcquisitions to erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AssetAcquisitionRestrictedSharesSharePrice" xlink:label="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="AssetAcquisitionRestrictedSharesSharePrice" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionRestrictedSharesSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AssetAcquisitionRestrictedSharesSharePrice_lbl" xml:lang="en-US" id="erna_AssetAcquisitionRestrictedSharesSharePrice_lbl">Price of a single share of a number of saleable stocks paid or offered with restrictions to be paid in asset acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionRestrictedSharesSharePrice" xlink:to="erna_AssetAcquisitionRestrictedSharesSharePrice_lbl" xlink:title="label: AssetAcquisitionRestrictedSharesSharePrice to erna_AssetAcquisitionRestrictedSharesSharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionRestrictedSharesSharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AssetAcquisitionRestrictedSharesSharePrice_lbl1" xml:lang="en-US" id="erna_AssetAcquisitionRestrictedSharesSharePrice_lbl1">Asset Acquisition, Restricted Shares, Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionRestrictedSharesSharePrice" xlink:to="erna_AssetAcquisitionRestrictedSharesSharePrice_lbl1" xlink:title="label: AssetAcquisitionRestrictedSharesSharePrice to erna_AssetAcquisitionRestrictedSharesSharePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionRestrictedSharesSharePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AssetAcquisitionRestrictedSharesSharePrice_lbl2" xml:lang="en-US" id="erna_AssetAcquisitionRestrictedSharesSharePrice_lbl2">Restricted shares, fair value per share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionRestrictedSharesSharePrice" xlink:to="erna_AssetAcquisitionRestrictedSharesSharePrice_lbl2" xlink:title="label: AssetAcquisitionRestrictedSharesSharePrice to erna_AssetAcquisitionRestrictedSharesSharePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl" xml:lang="en-US" id="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl">Amount of fair value of consideration paid in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl" xlink:title="label: AssetAcquisitionFairValueOfConsiderationPaid to erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" xml:lang="en-US" id="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl1">Asset Acquisition, Fair Value of Consideration Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" xlink:title="label: AssetAcquisitionFairValueOfConsiderationPaid to erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl2" xml:lang="en-US" id="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl2">Total fair value of consideration paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl2" xlink:title="label: AssetAcquisitionFairValueOfConsiderationPaid to erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AssetAcquisitionSharePrice" xlink:label="AssetAcquisitionSharePrice" xlink:title="AssetAcquisitionSharePrice" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AssetAcquisitionSharePrice_lbl" xml:lang="en-US" id="erna_AssetAcquisitionSharePrice_lbl">Price of a single share of a number of saleable stocks paid or offered to be paid in asset acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionSharePrice" xlink:to="erna_AssetAcquisitionSharePrice_lbl" xlink:title="label: AssetAcquisitionSharePrice to erna_AssetAcquisitionSharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionSharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AssetAcquisitionSharePrice_lbl1" xml:lang="en-US" id="erna_AssetAcquisitionSharePrice_lbl1">Asset Acquisition, Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionSharePrice" xlink:to="erna_AssetAcquisitionSharePrice_lbl1" xlink:title="label: AssetAcquisitionSharePrice to erna_AssetAcquisitionSharePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionSharePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AssetAcquisitionSharePrice_lbl2" xml:lang="en-US" id="erna_AssetAcquisitionSharePrice_lbl2">Share price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionSharePrice" xlink:to="erna_AssetAcquisitionSharePrice_lbl2" xlink:title="label: AssetAcquisitionSharePrice to erna_AssetAcquisitionSharePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LockUpPeriodForRestrictedShares" xlink:label="LockUpPeriodForRestrictedShares" xlink:title="LockUpPeriodForRestrictedShares" />
    <link:label xlink:type="resource" xlink:label="erna_LockUpPeriodForRestrictedShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LockUpPeriodForRestrictedShares_lbl" xml:lang="en-US" id="erna_LockUpPeriodForRestrictedShares_lbl">The period in which shares are locked-up, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LockUpPeriodForRestrictedShares" xlink:to="erna_LockUpPeriodForRestrictedShares_lbl" xlink:title="label: LockUpPeriodForRestrictedShares to erna_LockUpPeriodForRestrictedShares_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LockUpPeriodForRestrictedShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LockUpPeriodForRestrictedShares_lbl1" xml:lang="en-US" id="erna_LockUpPeriodForRestrictedShares_lbl1">Lock-up Period for Restricted Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LockUpPeriodForRestrictedShares" xlink:to="erna_LockUpPeriodForRestrictedShares_lbl1" xlink:title="label: LockUpPeriodForRestrictedShares to erna_LockUpPeriodForRestrictedShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LockUpPeriodForRestrictedShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LockUpPeriodForRestrictedShares_lbl2" xml:lang="en-US" id="erna_LockUpPeriodForRestrictedShares_lbl2">Lock-up period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LockUpPeriodForRestrictedShares" xlink:to="erna_LockUpPeriodForRestrictedShares_lbl2" xlink:title="label: LockUpPeriodForRestrictedShares to erna_LockUpPeriodForRestrictedShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AcquisitionAgreementNonCompetitivePeriod" xlink:label="AcquisitionAgreementNonCompetitivePeriod" xlink:title="AcquisitionAgreementNonCompetitivePeriod" />
    <link:label xlink:type="resource" xlink:label="erna_AcquisitionAgreementNonCompetitivePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AcquisitionAgreementNonCompetitivePeriod_lbl" xml:lang="en-US" id="erna_AcquisitionAgreementNonCompetitivePeriod_lbl">The Acquisition Agreement contains non-competition and non-solicitation provisions pursuant to which the Seller has agreed not to engage in certain competitive activities for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionAgreementNonCompetitivePeriod" xlink:to="erna_AcquisitionAgreementNonCompetitivePeriod_lbl" xlink:title="label: AcquisitionAgreementNonCompetitivePeriod to erna_AcquisitionAgreementNonCompetitivePeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AcquisitionAgreementNonCompetitivePeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AcquisitionAgreementNonCompetitivePeriod_lbl1" xml:lang="en-US" id="erna_AcquisitionAgreementNonCompetitivePeriod_lbl1">Acquisition Agreement, Non Competitive Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionAgreementNonCompetitivePeriod" xlink:to="erna_AcquisitionAgreementNonCompetitivePeriod_lbl1" xlink:title="label: AcquisitionAgreementNonCompetitivePeriod to erna_AcquisitionAgreementNonCompetitivePeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AcquisitionAgreementNonCompetitivePeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AcquisitionAgreementNonCompetitivePeriod_lbl2" xml:lang="en-US" id="erna_AcquisitionAgreementNonCompetitivePeriod_lbl2">Non-compete period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionAgreementNonCompetitivePeriod" xlink:to="erna_AcquisitionAgreementNonCompetitivePeriod_lbl2" xlink:title="label: AcquisitionAgreementNonCompetitivePeriod to erna_AcquisitionAgreementNonCompetitivePeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AssetAcquisitionUnrestrictedSharesSharePrice" xlink:label="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="AssetAcquisitionUnrestrictedSharesSharePrice" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl" xml:lang="en-US" id="erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl">Price of a single share of a number of saleable stocks paid or offered without any restrictions to be paid in asset acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:to="erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl" xlink:title="label: AssetAcquisitionUnrestrictedSharesSharePrice to erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1" xml:lang="en-US" id="erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1">Asset Acquisition, Unrestricted Shares, Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:to="erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1" xlink:title="label: AssetAcquisitionUnrestrictedSharesSharePrice to erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2" xml:lang="en-US" id="erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2">Unrestricted shares, fair value per share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:to="erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2" xlink:title="label: AssetAcquisitionUnrestrictedSharesSharePrice to erna_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LicenseAgreementAbstract" xlink:label="LicenseAgreementAbstract" xlink:title="LicenseAgreementAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_LicenseAgreementAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LicenseAgreementAbstract_lbl1" xml:lang="en-US" id="erna_LicenseAgreementAbstract_lbl1">License Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementAbstract" xlink:to="erna_LicenseAgreementAbstract_lbl1" xlink:title="label: LicenseAgreementAbstract to erna_LicenseAgreementAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LicenseAgreementAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LicenseAgreementAbstract_lbl2" xml:lang="en-US" id="erna_LicenseAgreementAbstract_lbl2">Cell Customization and License Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementAbstract" xlink:to="erna_LicenseAgreementAbstract_lbl2" xlink:title="label: LicenseAgreementAbstract to erna_LicenseAgreementAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProceedsFromOptionAndLicenseAgreement" xlink:label="ProceedsFromOptionAndLicenseAgreement" xlink:title="ProceedsFromOptionAndLicenseAgreement" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromOptionAndLicenseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ProceedsFromOptionAndLicenseAgreement_lbl" xml:lang="en-US" id="erna_ProceedsFromOptionAndLicenseAgreement_lbl">The cash inflow from exclusive option and license agreement as a non-refundable up-front payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromOptionAndLicenseAgreement" xlink:to="erna_ProceedsFromOptionAndLicenseAgreement_lbl" xlink:title="label: ProceedsFromOptionAndLicenseAgreement to erna_ProceedsFromOptionAndLicenseAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromOptionAndLicenseAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ProceedsFromOptionAndLicenseAgreement_lbl1" xml:lang="en-US" id="erna_ProceedsFromOptionAndLicenseAgreement_lbl1">Proceeds from Option and License Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromOptionAndLicenseAgreement" xlink:to="erna_ProceedsFromOptionAndLicenseAgreement_lbl1" xlink:title="label: ProceedsFromOptionAndLicenseAgreement to erna_ProceedsFromOptionAndLicenseAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromOptionAndLicenseAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ProceedsFromOptionAndLicenseAgreement_lbl2" xml:lang="en-US" id="erna_ProceedsFromOptionAndLicenseAgreement_lbl2">Proceeds from option and license agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromOptionAndLicenseAgreement" xlink:to="erna_ProceedsFromOptionAndLicenseAgreement_lbl2" xlink:title="label: ProceedsFromOptionAndLicenseAgreement to erna_ProceedsFromOptionAndLicenseAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LegalMattersAbstract" xlink:label="LegalMattersAbstract" xlink:title="LegalMattersAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_LegalMattersAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LegalMattersAbstract_lbl1" xml:lang="en-US" id="erna_LegalMattersAbstract_lbl1">Legal Matters [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalMattersAbstract" xlink:to="erna_LegalMattersAbstract_lbl1" xlink:title="label: LegalMattersAbstract to erna_LegalMattersAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LegalMattersAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LegalMattersAbstract_lbl2" xml:lang="en-US" id="erna_LegalMattersAbstract_lbl2">Legal Matters [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalMattersAbstract" xlink:to="erna_LegalMattersAbstract_lbl2" xlink:title="label: LegalMattersAbstract to erna_LegalMattersAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LitigationSettlementAmountPayable" xlink:label="LitigationSettlementAmountPayable" xlink:title="LitigationSettlementAmountPayable" />
    <link:label xlink:type="resource" xlink:label="erna_LitigationSettlementAmountPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LitigationSettlementAmountPayable_lbl" xml:lang="en-US" id="erna_LitigationSettlementAmountPayable_lbl">Amount payable to other party in judgment or settlement of litigation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationSettlementAmountPayable" xlink:to="erna_LitigationSettlementAmountPayable_lbl" xlink:title="label: LitigationSettlementAmountPayable to erna_LitigationSettlementAmountPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LitigationSettlementAmountPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LitigationSettlementAmountPayable_lbl1" xml:lang="en-US" id="erna_LitigationSettlementAmountPayable_lbl1">Litigation Settlement, Amount Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationSettlementAmountPayable" xlink:to="erna_LitigationSettlementAmountPayable_lbl1" xlink:title="label: LitigationSettlementAmountPayable to erna_LitigationSettlementAmountPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LitigationSettlementAmountPayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LitigationSettlementAmountPayable_lbl2" xml:lang="en-US" id="erna_LitigationSettlementAmountPayable_lbl2">Aggregate settlement amount payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationSettlementAmountPayable" xlink:to="erna_LitigationSettlementAmountPayable_lbl2" xlink:title="label: LitigationSettlementAmountPayable to erna_LitigationSettlementAmountPayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InvestorRoyaltyAgreementMember" xlink:label="InvestorRoyaltyAgreementMember" xlink:title="InvestorRoyaltyAgreementMember" />
    <link:label xlink:type="resource" xlink:label="erna_InvestorRoyaltyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InvestorRoyaltyAgreementMember_lbl" xml:lang="en-US" id="erna_InvestorRoyaltyAgreementMember_lbl">Arrangement other than collaborative applicable to investor royalty.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestorRoyaltyAgreementMember" xlink:to="erna_InvestorRoyaltyAgreementMember_lbl" xlink:title="label: InvestorRoyaltyAgreementMember to erna_InvestorRoyaltyAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InvestorRoyaltyAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InvestorRoyaltyAgreementMember_lbl1" xml:lang="en-US" id="erna_InvestorRoyaltyAgreementMember_lbl1">Investor Royalty Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestorRoyaltyAgreementMember" xlink:to="erna_InvestorRoyaltyAgreementMember_lbl1" xlink:title="label: InvestorRoyaltyAgreementMember to erna_InvestorRoyaltyAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InvestorRoyaltyAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InvestorRoyaltyAgreementMember_lbl2" xml:lang="en-US" id="erna_InvestorRoyaltyAgreementMember_lbl2">Investor Royalty Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestorRoyaltyAgreementMember" xlink:to="erna_InvestorRoyaltyAgreementMember_lbl2" xlink:title="label: InvestorRoyaltyAgreementMember to erna_InvestorRoyaltyAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RoyaltyAgreementsAbstract" xlink:label="RoyaltyAgreementsAbstract" xlink:title="RoyaltyAgreementsAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_RoyaltyAgreementsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RoyaltyAgreementsAbstract_lbl1" xml:lang="en-US" id="erna_RoyaltyAgreementsAbstract_lbl1">Royalty Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RoyaltyAgreementsAbstract" xlink:to="erna_RoyaltyAgreementsAbstract_lbl1" xlink:title="label: RoyaltyAgreementsAbstract to erna_RoyaltyAgreementsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RoyaltyAgreementsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_RoyaltyAgreementsAbstract_lbl2" xml:lang="en-US" id="erna_RoyaltyAgreementsAbstract_lbl2">Royalty Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RoyaltyAgreementsAbstract" xlink:to="erna_RoyaltyAgreementsAbstract_lbl2" xlink:title="label: RoyaltyAgreementsAbstract to erna_RoyaltyAgreementsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:label="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl" xml:lang="en-US" id="erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl">Percentage of additional royalty payable on gross sales by the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:to="erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl" xlink:title="label: PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales to erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1" xml:lang="en-US" id="erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1">Percentage of Payment Of Additional Royalty On Gross Sales</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:to="erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1" xlink:title="label: PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales to erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2" xml:lang="en-US" id="erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2">Percentage of payment of additional royalty on gross sales</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:to="erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2" xlink:title="label: PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales to erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LossContingencyPercentageOfRoyaltyPayable" xlink:label="LossContingencyPercentageOfRoyaltyPayable" xlink:title="LossContingencyPercentageOfRoyaltyPayable" />
    <link:label xlink:type="resource" xlink:label="erna_LossContingencyPercentageOfRoyaltyPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LossContingencyPercentageOfRoyaltyPayable_lbl" xml:lang="en-US" id="erna_LossContingencyPercentageOfRoyaltyPayable_lbl">Percentage of royalty payable from one party to another in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyPercentageOfRoyaltyPayable" xlink:to="erna_LossContingencyPercentageOfRoyaltyPayable_lbl" xlink:title="label: LossContingencyPercentageOfRoyaltyPayable to erna_LossContingencyPercentageOfRoyaltyPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LossContingencyPercentageOfRoyaltyPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LossContingencyPercentageOfRoyaltyPayable_lbl1" xml:lang="en-US" id="erna_LossContingencyPercentageOfRoyaltyPayable_lbl1">Loss contingency, Percentage of Royalty Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyPercentageOfRoyaltyPayable" xlink:to="erna_LossContingencyPercentageOfRoyaltyPayable_lbl1" xlink:title="label: LossContingencyPercentageOfRoyaltyPayable to erna_LossContingencyPercentageOfRoyaltyPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LossContingencyPercentageOfRoyaltyPayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LossContingencyPercentageOfRoyaltyPayable_lbl2" xml:lang="en-US" id="erna_LossContingencyPercentageOfRoyaltyPayable_lbl2">Percentage of royalty payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyPercentageOfRoyaltyPayable" xlink:to="erna_LossContingencyPercentageOfRoyaltyPayable_lbl2" xlink:title="label: LossContingencyPercentageOfRoyaltyPayable to erna_LossContingencyPercentageOfRoyaltyPayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" xlink:label="PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" xlink:title="PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl" xml:lang="en-US" id="erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl">Percentage of royalty payable equal to revenues generated from disposition of business.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" xlink:to="erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl" xlink:title="label: PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness to erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl1" xml:lang="en-US" id="erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl1">Percentage of Royalty Payable Equal to Revenues from Sale of Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" xlink:to="erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl1" xlink:title="label: PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness to erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl2" xml:lang="en-US" id="erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl2">Percentage of royalty receive equal to revenues from sale of business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" xlink:to="erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl2" xlink:title="label: PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness to erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CollaboratorRoyaltyAgreementMember" xlink:label="CollaboratorRoyaltyAgreementMember" xlink:title="CollaboratorRoyaltyAgreementMember" />
    <link:label xlink:type="resource" xlink:label="erna_CollaboratorRoyaltyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CollaboratorRoyaltyAgreementMember_lbl" xml:lang="en-US" id="erna_CollaboratorRoyaltyAgreementMember_lbl">Collaborative royalty arrangement in licensing deal with the company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaboratorRoyaltyAgreementMember" xlink:to="erna_CollaboratorRoyaltyAgreementMember_lbl" xlink:title="label: CollaboratorRoyaltyAgreementMember to erna_CollaboratorRoyaltyAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CollaboratorRoyaltyAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CollaboratorRoyaltyAgreementMember_lbl1" xml:lang="en-US" id="erna_CollaboratorRoyaltyAgreementMember_lbl1">Collaborator Royalty Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaboratorRoyaltyAgreementMember" xlink:to="erna_CollaboratorRoyaltyAgreementMember_lbl1" xlink:title="label: CollaboratorRoyaltyAgreementMember to erna_CollaboratorRoyaltyAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CollaboratorRoyaltyAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_CollaboratorRoyaltyAgreementMember_lbl2" xml:lang="en-US" id="erna_CollaboratorRoyaltyAgreementMember_lbl2">Collaborator Royalty Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaboratorRoyaltyAgreementMember" xlink:to="erna_CollaboratorRoyaltyAgreementMember_lbl2" xlink:title="label: CollaboratorRoyaltyAgreementMember to erna_CollaboratorRoyaltyAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LicensingAgreementsAbstract" xlink:label="LicensingAgreementsAbstract" xlink:title="LicensingAgreementsAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_LicensingAgreementsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LicensingAgreementsAbstract_lbl1" xml:lang="en-US" id="erna_LicensingAgreementsAbstract_lbl1">Licensing Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicensingAgreementsAbstract" xlink:to="erna_LicensingAgreementsAbstract_lbl1" xlink:title="label: LicensingAgreementsAbstract to erna_LicensingAgreementsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LicensingAgreementsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LicensingAgreementsAbstract_lbl2" xml:lang="en-US" id="erna_LicensingAgreementsAbstract_lbl2">Licensing Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicensingAgreementsAbstract" xlink:to="erna_LicensingAgreementsAbstract_lbl2" xlink:title="label: LicensingAgreementsAbstract to erna_LicensingAgreementsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfSublicenseFeePayableDuringRenewalTerm" xlink:label="PercentageOfSublicenseFeePayableDuringRenewalTerm" xlink:title="PercentageOfSublicenseFeePayableDuringRenewalTerm" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl" xml:lang="en-US" id="erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl">Percentage of sublicense fee payable by the company during renewal period as per "Exclusive Factor License Agreement".</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSublicenseFeePayableDuringRenewalTerm" xlink:to="erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl" xlink:title="label: PercentageOfSublicenseFeePayableDuringRenewalTerm to erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl1" xml:lang="en-US" id="erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl1">Percentage of Sublicense Fee Payable During Renewal Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSublicenseFeePayableDuringRenewalTerm" xlink:to="erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl1" xlink:title="label: PercentageOfSublicenseFeePayableDuringRenewalTerm to erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl2" xml:lang="en-US" id="erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl2">Percentage of sublicense fee payable by company during renewal term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSublicenseFeePayableDuringRenewalTerm" xlink:to="erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl2" xlink:title="label: PercentageOfSublicenseFeePayableDuringRenewalTerm to erna_PercentageOfSublicenseFeePayableDuringRenewalTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod" xlink:label="PercentageOfSublicenseFeePayableBeforeExpirationPeriod" xlink:title="PercentageOfSublicenseFeePayableBeforeExpirationPeriod" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl" xml:lang="en-US" id="erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl">Percentage of sublicense fee payable by the company before expiration date as per "Exclusive Factor License Agreement".</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSublicenseFeePayableBeforeExpirationPeriod" xlink:to="erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl" xlink:title="label: PercentageOfSublicenseFeePayableBeforeExpirationPeriod to erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl1" xml:lang="en-US" id="erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl1">Percentage of Sublicense Fee Payable Before Expiration Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSublicenseFeePayableBeforeExpirationPeriod" xlink:to="erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl1" xlink:title="label: PercentageOfSublicenseFeePayableBeforeExpirationPeriod to erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl2" xml:lang="en-US" id="erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl2">Percentage of sublicense fee payable by company before expiration date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSublicenseFeePayableBeforeExpirationPeriod" xlink:to="erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl2" xlink:title="label: PercentageOfSublicenseFeePayableBeforeExpirationPeriod to erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LicenseAgreementTerm" xlink:label="LicenseAgreementTerm" xlink:title="LicenseAgreementTerm" />
    <link:label xlink:type="resource" xlink:label="erna_LicenseAgreementTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LicenseAgreementTerm_lbl" xml:lang="en-US" id="erna_LicenseAgreementTerm_lbl">License agreement term in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementTerm" xlink:to="erna_LicenseAgreementTerm_lbl" xlink:title="label: LicenseAgreementTerm to erna_LicenseAgreementTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LicenseAgreementTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LicenseAgreementTerm_lbl1" xml:lang="en-US" id="erna_LicenseAgreementTerm_lbl1">License Agreement Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementTerm" xlink:to="erna_LicenseAgreementTerm_lbl1" xlink:title="label: LicenseAgreementTerm to erna_LicenseAgreementTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LicenseAgreementTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LicenseAgreementTerm_lbl2" xml:lang="en-US" id="erna_LicenseAgreementTerm_lbl2">License agreement term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementTerm" xlink:to="erna_LicenseAgreementTerm_lbl2" xlink:title="label: LicenseAgreementTerm to erna_LicenseAgreementTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LicenseAgreementExtensionTerm" xlink:label="LicenseAgreementExtensionTerm" xlink:title="LicenseAgreementExtensionTerm" />
    <link:label xlink:type="resource" xlink:label="erna_LicenseAgreementExtensionTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LicenseAgreementExtensionTerm_lbl" xml:lang="en-US" id="erna_LicenseAgreementExtensionTerm_lbl">The term of license agreement to be extendable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementExtensionTerm" xlink:to="erna_LicenseAgreementExtensionTerm_lbl" xlink:title="label: LicenseAgreementExtensionTerm to erna_LicenseAgreementExtensionTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LicenseAgreementExtensionTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LicenseAgreementExtensionTerm_lbl1" xml:lang="en-US" id="erna_LicenseAgreementExtensionTerm_lbl1">License Agreement Extension Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementExtensionTerm" xlink:to="erna_LicenseAgreementExtensionTerm_lbl1" xlink:title="label: LicenseAgreementExtensionTerm to erna_LicenseAgreementExtensionTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LicenseAgreementExtensionTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LicenseAgreementExtensionTerm_lbl2" xml:lang="en-US" id="erna_LicenseAgreementExtensionTerm_lbl2">License agreement extension term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementExtensionTerm" xlink:to="erna_LicenseAgreementExtensionTerm_lbl2" xlink:title="label: LicenseAgreementExtensionTerm to erna_LicenseAgreementExtensionTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod" xlink:label="ThresholdIncomeForAutomaticExtensionOfLicensePeriod" xlink:title="ThresholdIncomeForAutomaticExtensionOfLicensePeriod" />
    <link:label xlink:type="resource" xlink:label="erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl" xml:lang="en-US" id="erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl">Minimum threshold income from sublicenses to the factor patents for automatic extension of license period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ThresholdIncomeForAutomaticExtensionOfLicensePeriod" xlink:to="erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl" xlink:title="label: ThresholdIncomeForAutomaticExtensionOfLicensePeriod to erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl1" xml:lang="en-US" id="erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl1">Threshold Income for Automatic Extension of License Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ThresholdIncomeForAutomaticExtensionOfLicensePeriod" xlink:to="erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl1" xlink:title="label: ThresholdIncomeForAutomaticExtensionOfLicensePeriod to erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl2" xml:lang="en-US" id="erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl2">Threshold income for automatic extension of license period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ThresholdIncomeForAutomaticExtensionOfLicensePeriod" xlink:to="erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl2" xlink:title="label: ThresholdIncomeForAutomaticExtensionOfLicensePeriod to erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_UniversityOfSouthFloridaMember" xlink:label="UniversityOfSouthFloridaMember" xlink:title="UniversityOfSouthFloridaMember" />
    <link:label xlink:type="resource" xlink:label="erna_UniversityOfSouthFloridaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_UniversityOfSouthFloridaMember_lbl" xml:lang="en-US" id="erna_UniversityOfSouthFloridaMember_lbl">Legal entity involved in litigation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UniversityOfSouthFloridaMember" xlink:to="erna_UniversityOfSouthFloridaMember_lbl" xlink:title="label: UniversityOfSouthFloridaMember to erna_UniversityOfSouthFloridaMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_UniversityOfSouthFloridaMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_UniversityOfSouthFloridaMember_lbl1" xml:lang="en-US" id="erna_UniversityOfSouthFloridaMember_lbl1">University of South Florida [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UniversityOfSouthFloridaMember" xlink:to="erna_UniversityOfSouthFloridaMember_lbl1" xlink:title="label: UniversityOfSouthFloridaMember to erna_UniversityOfSouthFloridaMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_UniversityOfSouthFloridaMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_UniversityOfSouthFloridaMember_lbl2" xml:lang="en-US" id="erna_UniversityOfSouthFloridaMember_lbl2">University of South Florida [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UniversityOfSouthFloridaMember" xlink:to="erna_UniversityOfSouthFloridaMember_lbl2" xlink:title="label: UniversityOfSouthFloridaMember to erna_UniversityOfSouthFloridaMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ExclusiveFactorLicenseAgreementMember" xlink:label="ExclusiveFactorLicenseAgreementMember" xlink:title="ExclusiveFactorLicenseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="erna_ExclusiveFactorLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ExclusiveFactorLicenseAgreementMember_lbl" xml:lang="en-US" id="erna_ExclusiveFactorLicenseAgreementMember_lbl">Type of license agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExclusiveFactorLicenseAgreementMember" xlink:to="erna_ExclusiveFactorLicenseAgreementMember_lbl" xlink:title="label: ExclusiveFactorLicenseAgreementMember to erna_ExclusiveFactorLicenseAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ExclusiveFactorLicenseAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ExclusiveFactorLicenseAgreementMember_lbl1" xml:lang="en-US" id="erna_ExclusiveFactorLicenseAgreementMember_lbl1">Exclusive Factor License Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExclusiveFactorLicenseAgreementMember" xlink:to="erna_ExclusiveFactorLicenseAgreementMember_lbl1" xlink:title="label: ExclusiveFactorLicenseAgreementMember to erna_ExclusiveFactorLicenseAgreementMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:label="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:title="DefinedContributionPlanEmployeeContributionAtThresholdTwo" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl" xml:lang="en-US" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl">Percentage of employee contribution to the plan that is fully matched by the employer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:to="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl" xlink:title="label: DefinedContributionPlanEmployeeContributionAtThresholdTwo to erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl1" xml:lang="en-US" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl1">Defined Contribution Plan Employee Contribution At Threshold Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:to="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl1" xlink:title="label: DefinedContributionPlanEmployeeContributionAtThresholdTwo to erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl2" xml:lang="en-US" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl2">Deferred compensation matched by employer, next match</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:to="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl2" xlink:title="label: DefinedContributionPlanEmployeeContributionAtThresholdTwo to erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:label="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:title="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl" xml:lang="en-US" id="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl">Defined contribution plan, deferral percentage of employee on their pay on pre-tax basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:to="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl" xlink:title="label: DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis to erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl1" xml:lang="en-US" id="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl1">Defined Contribution Plan, Deferral Percent of Their Pay on Pre-tax Basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:to="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl1" xlink:title="label: DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis to erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl2" xml:lang="en-US" id="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl2">Employees contribution, deferral percentage of their pay on a pre-tax basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:to="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl2" xlink:title="label: DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis to erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl" xml:lang="en-US" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl">Percentage employer matches of the employee's percentage contribution in excess of certain percentage matched.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:to="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo to erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl1" xml:lang="en-US" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl1">Defined Contribution Plan Employer Matching Contribution Percent of Match Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:to="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl1" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo to erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl2" xml:lang="en-US" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl2">Employer matching contribution in excess of first 2%</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:to="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl2" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo to erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl" xml:lang="en-US" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl">Percentage employer matches of the employee's percentage contribution up to a certain percentage matched.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:to="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne to erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl1" xml:lang="en-US" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl1">Defined Contribution Plan Employer Matching Contribution Percent of Match One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:to="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl1" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne to erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl2" xml:lang="en-US" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl2">Employer matching contribution up to first 3%</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:to="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl2" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne to erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RetirementPlan401KMember" xlink:label="RetirementPlan401KMember" xlink:title="RetirementPlan401KMember" />
    <link:label xlink:type="resource" xlink:label="erna_RetirementPlan401KMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_RetirementPlan401KMember_lbl" xml:lang="en-US" id="erna_RetirementPlan401KMember_lbl">A defined-contribution retirement account which allows employees to save a portion of their salary in a tax-advantaged manner. The money earned in a 401(k) Plan is not taxed until after the employee retires, at which time their income will typically be lower than during their working years.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetirementPlan401KMember" xlink:to="erna_RetirementPlan401KMember_lbl" xlink:title="label: RetirementPlan401KMember to erna_RetirementPlan401KMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_RetirementPlan401KMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RetirementPlan401KMember_lbl1" xml:lang="en-US" id="erna_RetirementPlan401KMember_lbl1">Retirement Plan, 401K [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetirementPlan401KMember" xlink:to="erna_RetirementPlan401KMember_lbl1" xlink:title="label: RetirementPlan401KMember to erna_RetirementPlan401KMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RetirementPlan401KMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_RetirementPlan401KMember_lbl2" xml:lang="en-US" id="erna_RetirementPlan401KMember_lbl2">401K [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetirementPlan401KMember" xlink:to="erna_RetirementPlan401KMember_lbl2" xlink:title="label: RetirementPlan401KMember to erna_RetirementPlan401KMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:label="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:title="DefinedContributionPlanEmployeeContributionAtThresholdOne" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl" xml:lang="en-US" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl">Percentage of employee contribution to the plan that is fully matched by the employer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:to="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl" xlink:title="label: DefinedContributionPlanEmployeeContributionAtThresholdOne to erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl1" xml:lang="en-US" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl1">Defined Contribution Plan Employee Contribution at Threshold One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:to="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl1" xlink:title="label: DefinedContributionPlanEmployeeContributionAtThresholdOne to erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl2" xml:lang="en-US" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl2">Employee contribution threshold for matching percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:to="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl2" xlink:title="label: DefinedContributionPlanEmployeeContributionAtThresholdOne to erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:label="FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:title="FutureLeasePaymentsSubleaseAgreementTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl" xml:lang="en-US" id="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl">Tabular disclosure of future lease payments of sublease agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:to="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl" xlink:title="label: FutureLeasePaymentsSubleaseAgreementTableTextBlock to erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl1" xml:lang="en-US" id="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl1">Future Lease Payments, Sublease Agreement [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:to="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl1" xlink:title="label: FutureLeasePaymentsSubleaseAgreementTableTextBlock to erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl2" xml:lang="en-US" id="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl2">Future Lease Payments from Sublease Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:to="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl2" xlink:title="label: FutureLeasePaymentsSubleaseAgreementTableTextBlock to erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:label="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:title="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl">Tabular disclosure for lessee's operating lease right-of-use assets and liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:to="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" xlink:title="label: OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock to erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1">Operating Lease Right-of-use Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:to="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:title="label: OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock to erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2" xml:lang="en-US" id="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2">Operating Lease Right-of-use Assets and Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:to="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2" xlink:title="label: OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock to erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ERSquibbSonsLLCMember" xlink:label="ERSquibbSonsLLCMember" xlink:title="ERSquibbSonsLLCMember" />
    <link:label xlink:type="resource" xlink:label="erna_ERSquibbSonsLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ERSquibbSonsLLCMember_lbl" xml:lang="en-US" id="erna_ERSquibbSonsLLCMember_lbl">A Delaware limited liability company ("Sublessor"), for office, laboratory and research and development space (the "Premises").</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ERSquibbSonsLLCMember" xlink:to="erna_ERSquibbSonsLLCMember_lbl" xlink:title="label: ERSquibbSonsLLCMember to erna_ERSquibbSonsLLCMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ERSquibbSonsLLCMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ERSquibbSonsLLCMember_lbl1" xml:lang="en-US" id="erna_ERSquibbSonsLLCMember_lbl1">E.R. Squibb &amp; Sons, L.L.C. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ERSquibbSonsLLCMember" xlink:to="erna_ERSquibbSonsLLCMember_lbl1" xlink:title="label: ERSquibbSonsLLCMember to erna_ERSquibbSonsLLCMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ERSquibbSonsLLCMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ERSquibbSonsLLCMember_lbl2" xml:lang="en-US" id="erna_ERSquibbSonsLLCMember_lbl2">E.R. Squibb &amp; Sons, L.L.C. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ERSquibbSonsLLCMember" xlink:to="erna_ERSquibbSonsLLCMember_lbl2" xlink:title="label: ERSquibbSonsLLCMember to erna_ERSquibbSonsLLCMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LeaseTerminationFeePayable" xlink:label="LeaseTerminationFeePayable" xlink:title="LeaseTerminationFeePayable" />
    <link:label xlink:type="resource" xlink:label="erna_LeaseTerminationFeePayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LeaseTerminationFeePayable_lbl" xml:lang="en-US" id="erna_LeaseTerminationFeePayable_lbl">The amount of lease termination fees payable by the company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseTerminationFeePayable" xlink:to="erna_LeaseTerminationFeePayable_lbl" xlink:title="label: LeaseTerminationFeePayable to erna_LeaseTerminationFeePayable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LeaseTerminationFeePayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LeaseTerminationFeePayable_lbl1" xml:lang="en-US" id="erna_LeaseTerminationFeePayable_lbl1">Lease Termination Fee Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseTerminationFeePayable" xlink:to="erna_LeaseTerminationFeePayable_lbl1" xlink:title="label: LeaseTerminationFeePayable to erna_LeaseTerminationFeePayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LeaseTerminationFeePayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LeaseTerminationFeePayable_lbl2" xml:lang="en-US" id="erna_LeaseTerminationFeePayable_lbl2">Lease termination fee payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseTerminationFeePayable" xlink:to="erna_LeaseTerminationFeePayable_lbl2" xlink:title="label: LeaseTerminationFeePayable to erna_LeaseTerminationFeePayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LeaseTerminationFee" xlink:label="LeaseTerminationFee" xlink:title="LeaseTerminationFee" />
    <link:label xlink:type="resource" xlink:label="erna_LeaseTerminationFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LeaseTerminationFee_lbl" xml:lang="en-US" id="erna_LeaseTerminationFee_lbl">The amount of lease termination fees paid.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseTerminationFee" xlink:to="erna_LeaseTerminationFee_lbl" xlink:title="label: LeaseTerminationFee to erna_LeaseTerminationFee_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LeaseTerminationFee_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LeaseTerminationFee_lbl1" xml:lang="en-US" id="erna_LeaseTerminationFee_lbl1">Lease Termination Fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseTerminationFee" xlink:to="erna_LeaseTerminationFee_lbl1" xlink:title="label: LeaseTerminationFee to erna_LeaseTerminationFee_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LeaseTerminationFee_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LeaseTerminationFee_lbl2" xml:lang="en-US" id="erna_LeaseTerminationFee_lbl2">Lease termination fee paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseTerminationFee" xlink:to="erna_LeaseTerminationFee_lbl2" xlink:title="label: LeaseTerminationFee to erna_LeaseTerminationFee_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" xlink:label="LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" xlink:title="LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl">The amount of lease liability adjustment recognized as general and administrative expense.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" xlink:to="erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl" xlink:title="label: LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense to erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl1" xml:lang="en-US" id="erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl1">Lease Liability, Recognized as General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" xlink:to="erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl1" xlink:title="label: LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense to erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl2" xml:lang="en-US" id="erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl2">Lease liability adjustment recognized as general and administrative expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" xlink:to="erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl2" xlink:title="label: LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense to erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SubleaseCost" xlink:label="SubleaseCost" xlink:title="SubleaseCost" />
    <link:label xlink:type="resource" xlink:label="erna_SubleaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SubleaseCost_lbl" xml:lang="en-US" id="erna_SubleaseCost_lbl">Costs incurred in connection with sublease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseCost" xlink:to="erna_SubleaseCost_lbl" xlink:title="label: SubleaseCost to erna_SubleaseCost_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SubleaseCost_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SubleaseCost_lbl1" xml:lang="en-US" id="erna_SubleaseCost_lbl1">Sublease Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseCost" xlink:to="erna_SubleaseCost_lbl1" xlink:title="label: SubleaseCost to erna_SubleaseCost_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SubleaseCost_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SubleaseCost_lbl2" xml:lang="en-US" id="erna_SubleaseCost_lbl2">Sublease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseCost" xlink:to="erna_SubleaseCost_lbl2" xlink:title="label: SubleaseCost to erna_SubleaseCost_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CostRelatedToIssuanceOfLetterOfCredit" xlink:label="CostRelatedToIssuanceOfLetterOfCredit" xlink:title="CostRelatedToIssuanceOfLetterOfCredit" />
    <link:label xlink:type="resource" xlink:label="erna_CostRelatedToIssuanceOfLetterOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CostRelatedToIssuanceOfLetterOfCredit_lbl" xml:lang="en-US" id="erna_CostRelatedToIssuanceOfLetterOfCredit_lbl">Amount of bank fees related to issuance of letter of credit.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostRelatedToIssuanceOfLetterOfCredit" xlink:to="erna_CostRelatedToIssuanceOfLetterOfCredit_lbl" xlink:title="label: CostRelatedToIssuanceOfLetterOfCredit to erna_CostRelatedToIssuanceOfLetterOfCredit_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CostRelatedToIssuanceOfLetterOfCredit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CostRelatedToIssuanceOfLetterOfCredit_lbl1" xml:lang="en-US" id="erna_CostRelatedToIssuanceOfLetterOfCredit_lbl1">Cost Related to Issuance of Letter of Credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostRelatedToIssuanceOfLetterOfCredit" xlink:to="erna_CostRelatedToIssuanceOfLetterOfCredit_lbl1" xlink:title="label: CostRelatedToIssuanceOfLetterOfCredit to erna_CostRelatedToIssuanceOfLetterOfCredit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TenantImprovementAllowance" xlink:label="TenantImprovementAllowance" xlink:title="TenantImprovementAllowance" />
    <link:label xlink:type="resource" xlink:label="erna_TenantImprovementAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_TenantImprovementAllowance_lbl" xml:lang="en-US" id="erna_TenantImprovementAllowance_lbl">Amount of tenant improvement allowance to improvements of the Premises.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementAllowance" xlink:to="erna_TenantImprovementAllowance_lbl" xlink:title="label: TenantImprovementAllowance to erna_TenantImprovementAllowance_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_TenantImprovementAllowance_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_TenantImprovementAllowance_lbl1" xml:lang="en-US" id="erna_TenantImprovementAllowance_lbl1">Tenant Improvement Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementAllowance" xlink:to="erna_TenantImprovementAllowance_lbl1" xlink:title="label: TenantImprovementAllowance to erna_TenantImprovementAllowance_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_TenantImprovementAllowance_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_TenantImprovementAllowance_lbl2" xml:lang="en-US" id="erna_TenantImprovementAllowance_lbl2">Tenant improvement allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementAllowance" xlink:to="erna_TenantImprovementAllowance_lbl2" xlink:title="label: TenantImprovementAllowance to erna_TenantImprovementAllowance_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLeasesIncrementalBaseRentalPayment" xlink:label="OperatingLeasesIncrementalBaseRentalPayment" xlink:title="OperatingLeasesIncrementalBaseRentalPayment" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeasesIncrementalBaseRentalPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_OperatingLeasesIncrementalBaseRentalPayment_lbl" xml:lang="en-US" id="erna_OperatingLeasesIncrementalBaseRentalPayment_lbl">The total amount for base rental payments, as well as parking and traditional lease expenses including, certain taxes, operating expenses and utilities can be incremented.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesIncrementalBaseRentalPayment" xlink:to="erna_OperatingLeasesIncrementalBaseRentalPayment_lbl" xlink:title="label: OperatingLeasesIncrementalBaseRentalPayment to erna_OperatingLeasesIncrementalBaseRentalPayment_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeasesIncrementalBaseRentalPayment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OperatingLeasesIncrementalBaseRentalPayment_lbl1" xml:lang="en-US" id="erna_OperatingLeasesIncrementalBaseRentalPayment_lbl1">Operating Leases, Incremental Base Rental Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesIncrementalBaseRentalPayment" xlink:to="erna_OperatingLeasesIncrementalBaseRentalPayment_lbl1" xlink:title="label: OperatingLeasesIncrementalBaseRentalPayment to erna_OperatingLeasesIncrementalBaseRentalPayment_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeasesIncrementalBaseRentalPayment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_OperatingLeasesIncrementalBaseRentalPayment_lbl2" xml:lang="en-US" id="erna_OperatingLeasesIncrementalBaseRentalPayment_lbl2">Incremental base rental payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesIncrementalBaseRentalPayment" xlink:to="erna_OperatingLeasesIncrementalBaseRentalPayment_lbl2" xlink:title="label: OperatingLeasesIncrementalBaseRentalPayment to erna_OperatingLeasesIncrementalBaseRentalPayment_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SubleaseCostForTenantImprovements" xlink:label="SubleaseCostForTenantImprovements" xlink:title="SubleaseCostForTenantImprovements" />
    <link:label xlink:type="resource" xlink:label="erna_SubleaseCostForTenantImprovements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SubleaseCostForTenantImprovements_lbl" xml:lang="en-US" id="erna_SubleaseCostForTenantImprovements_lbl">Sublease cost for the architect to design the tenant improvements to the premises and for a project manager to manage the construction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseCostForTenantImprovements" xlink:to="erna_SubleaseCostForTenantImprovements_lbl" xlink:title="label: SubleaseCostForTenantImprovements to erna_SubleaseCostForTenantImprovements_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SubleaseCostForTenantImprovements_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SubleaseCostForTenantImprovements_lbl1" xml:lang="en-US" id="erna_SubleaseCostForTenantImprovements_lbl1">Sublease Cost for Tenant Improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseCostForTenantImprovements" xlink:to="erna_SubleaseCostForTenantImprovements_lbl1" xlink:title="label: SubleaseCostForTenantImprovements to erna_SubleaseCostForTenantImprovements_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SubleaseCostForTenantImprovements_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SubleaseCostForTenantImprovements_lbl2" xml:lang="en-US" id="erna_SubleaseCostForTenantImprovements_lbl2">Sublease cost for tenant improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseCostForTenantImprovements" xlink:to="erna_SubleaseCostForTenantImprovements_lbl2" xlink:title="label: SubleaseCostForTenantImprovements to erna_SubleaseCostForTenantImprovements_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LesseeCommitmentToPurchaseProperty" xlink:label="LesseeCommitmentToPurchaseProperty" xlink:title="LesseeCommitmentToPurchaseProperty" />
    <link:label xlink:type="resource" xlink:label="erna_LesseeCommitmentToPurchaseProperty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LesseeCommitmentToPurchaseProperty_lbl" xml:lang="en-US" id="erna_LesseeCommitmentToPurchaseProperty_lbl">The amount of property for which lessee committed to purchase.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeCommitmentToPurchaseProperty" xlink:to="erna_LesseeCommitmentToPurchaseProperty_lbl" xlink:title="label: LesseeCommitmentToPurchaseProperty to erna_LesseeCommitmentToPurchaseProperty_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LesseeCommitmentToPurchaseProperty_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LesseeCommitmentToPurchaseProperty_lbl1" xml:lang="en-US" id="erna_LesseeCommitmentToPurchaseProperty_lbl1">Lessee, Commitment to Purchase Property</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeCommitmentToPurchaseProperty" xlink:to="erna_LesseeCommitmentToPurchaseProperty_lbl1" xlink:title="label: LesseeCommitmentToPurchaseProperty to erna_LesseeCommitmentToPurchaseProperty_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LesseeCommitmentToPurchaseProperty_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LesseeCommitmentToPurchaseProperty_lbl2" xml:lang="en-US" id="erna_LesseeCommitmentToPurchaseProperty_lbl2">Commitment to purchase equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeCommitmentToPurchaseProperty" xlink:to="erna_LesseeCommitmentToPurchaseProperty_lbl2" xlink:title="label: LesseeCommitmentToPurchaseProperty to erna_LesseeCommitmentToPurchaseProperty_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLeasesMonthlyBaseRent" xlink:label="OperatingLeasesMonthlyBaseRent" xlink:title="OperatingLeasesMonthlyBaseRent" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeasesMonthlyBaseRent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_OperatingLeasesMonthlyBaseRent_lbl" xml:lang="en-US" id="erna_OperatingLeasesMonthlyBaseRent_lbl">The amount of rental expense payable per month for operating leases.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesMonthlyBaseRent" xlink:to="erna_OperatingLeasesMonthlyBaseRent_lbl" xlink:title="label: OperatingLeasesMonthlyBaseRent to erna_OperatingLeasesMonthlyBaseRent_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeasesMonthlyBaseRent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OperatingLeasesMonthlyBaseRent_lbl1" xml:lang="en-US" id="erna_OperatingLeasesMonthlyBaseRent_lbl1">Operating Leases, Monthly Base Rent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesMonthlyBaseRent" xlink:to="erna_OperatingLeasesMonthlyBaseRent_lbl1" xlink:title="label: OperatingLeasesMonthlyBaseRent to erna_OperatingLeasesMonthlyBaseRent_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeasesMonthlyBaseRent_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_OperatingLeasesMonthlyBaseRent_lbl2" xml:lang="en-US" id="erna_OperatingLeasesMonthlyBaseRent_lbl2">Monthly base rent payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesMonthlyBaseRent" xlink:to="erna_OperatingLeasesMonthlyBaseRent_lbl2" xlink:title="label: OperatingLeasesMonthlyBaseRent to erna_OperatingLeasesMonthlyBaseRent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLeaseArea" xlink:label="OperatingLeaseArea" xlink:title="OperatingLeaseArea" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseArea_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_OperatingLeaseArea_lbl" xml:lang="en-US" id="erna_OperatingLeaseArea_lbl">Area of leased property under operating lease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseArea" xlink:to="erna_OperatingLeaseArea_lbl" xlink:title="label: OperatingLeaseArea to erna_OperatingLeaseArea_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseArea_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OperatingLeaseArea_lbl1" xml:lang="en-US" id="erna_OperatingLeaseArea_lbl1">Operating Lease Area</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseArea" xlink:to="erna_OperatingLeaseArea_lbl1" xlink:title="label: OperatingLeaseArea to erna_OperatingLeaseArea_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseArea_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_OperatingLeaseArea_lbl2" xml:lang="en-US" id="erna_OperatingLeaseArea_lbl2">Operating lease area</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseArea" xlink:to="erna_OperatingLeaseArea_lbl2" xlink:title="label: OperatingLeaseArea to erna_OperatingLeaseArea_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TenantImprovementAllowancePerRentableSquareFoot" xlink:label="TenantImprovementAllowancePerRentableSquareFoot" xlink:title="TenantImprovementAllowancePerRentableSquareFoot" />
    <link:label xlink:type="resource" xlink:label="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl" xml:lang="en-US" id="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl">Amount of tenant improvement allowance per rentable square foot for the improvements of premises.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementAllowancePerRentableSquareFoot" xlink:to="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl" xlink:title="label: TenantImprovementAllowancePerRentableSquareFoot to erna_TenantImprovementAllowancePerRentableSquareFoot_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl1" xml:lang="en-US" id="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl1">Tenant Improvement Allowance, per Rentable Square Foot</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementAllowancePerRentableSquareFoot" xlink:to="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl1" xlink:title="label: TenantImprovementAllowancePerRentableSquareFoot to erna_TenantImprovementAllowancePerRentableSquareFoot_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl2" xml:lang="en-US" id="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl2">Tenant improvement allowance per rentable square foot</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementAllowancePerRentableSquareFoot" xlink:to="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl2" xlink:title="label: TenantImprovementAllowancePerRentableSquareFoot to erna_TenantImprovementAllowancePerRentableSquareFoot_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_MergerAbstract" xlink:label="MergerAbstract" xlink:title="MergerAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_MergerAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_MergerAbstract_lbl1" xml:lang="en-US" id="erna_MergerAbstract_lbl1">Merger [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAbstract" xlink:to="erna_MergerAbstract_lbl1" xlink:title="label: MergerAbstract to erna_MergerAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightIssued" xlink:label="ClassOfWarrantOrRightIssued" xlink:title="ClassOfWarrantOrRightIssued" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ClassOfWarrantOrRightIssued_lbl" xml:lang="en-US" id="erna_ClassOfWarrantOrRightIssued_lbl">Number of shares issued into which the class of warrant or right may be converted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightIssued" xlink:to="erna_ClassOfWarrantOrRightIssued_lbl" xlink:title="label: ClassOfWarrantOrRightIssued to erna_ClassOfWarrantOrRightIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ClassOfWarrantOrRightIssued_lbl1" xml:lang="en-US" id="erna_ClassOfWarrantOrRightIssued_lbl1">Class of Warrant or Right, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightIssued" xlink:to="erna_ClassOfWarrantOrRightIssued_lbl1" xlink:title="label: ClassOfWarrantOrRightIssued to erna_ClassOfWarrantOrRightIssued_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightIssued_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ClassOfWarrantOrRightIssued_lbl2" xml:lang="en-US" id="erna_ClassOfWarrantOrRightIssued_lbl2">Number of rights options issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightIssued" xlink:to="erna_ClassOfWarrantOrRightIssued_lbl2" xlink:title="label: ClassOfWarrantOrRightIssued to erna_ClassOfWarrantOrRightIssued_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LaboratoryAndManufacturingEquipmentMember" xlink:label="LaboratoryAndManufacturingEquipmentMember" xlink:title="LaboratoryAndManufacturingEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="erna_LaboratoryAndManufacturingEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LaboratoryAndManufacturingEquipmentMember_lbl" xml:lang="en-US" id="erna_LaboratoryAndManufacturingEquipmentMember_lbl">Tangible personal property used to produce goods and service.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaboratoryAndManufacturingEquipmentMember" xlink:to="erna_LaboratoryAndManufacturingEquipmentMember_lbl" xlink:title="label: LaboratoryAndManufacturingEquipmentMember to erna_LaboratoryAndManufacturingEquipmentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LaboratoryAndManufacturingEquipmentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LaboratoryAndManufacturingEquipmentMember_lbl1" xml:lang="en-US" id="erna_LaboratoryAndManufacturingEquipmentMember_lbl1">Laboratory and Manufacturing Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaboratoryAndManufacturingEquipmentMember" xlink:to="erna_LaboratoryAndManufacturingEquipmentMember_lbl1" xlink:title="label: LaboratoryAndManufacturingEquipmentMember to erna_LaboratoryAndManufacturingEquipmentMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LaboratoryAndManufacturingEquipmentMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LaboratoryAndManufacturingEquipmentMember_lbl2" xml:lang="en-US" id="erna_LaboratoryAndManufacturingEquipmentMember_lbl2">Laboratory and Manufacturing Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaboratoryAndManufacturingEquipmentMember" xlink:to="erna_LaboratoryAndManufacturingEquipmentMember_lbl2" xlink:title="label: LaboratoryAndManufacturingEquipmentMember to erna_LaboratoryAndManufacturingEquipmentMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl" xml:lang="en-US" id="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards excluding foreign purpose.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:to="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign to erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl1" xml:lang="en-US" id="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl1">Deferred Tax Assets, Operating Loss Carryforwards Excluding Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:to="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl1" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign to erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl2" xml:lang="en-US" id="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl2">Net operating losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:to="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl2" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign to erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:label="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:title="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl" xml:lang="en-US" id="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl">Amount of deferred tax assets attributable to taxable temporary differences from research and development costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:to="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl" xlink:title="label: DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts to erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl1" xml:lang="en-US" id="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl1">Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:to="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl1" xlink:title="label: DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts to erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl2" xml:lang="en-US" id="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl2">Capitalized research and development expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:to="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl2" xlink:title="label: DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts to erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DeferredTaxAssetsRightOfUseLiabilities" xlink:label="DeferredTaxAssetsRightOfUseLiabilities" xlink:title="DeferredTaxAssetsRightOfUseLiabilities" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl" xml:lang="en-US" id="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from right-of-use liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseLiabilities" xlink:to="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl" xlink:title="label: DeferredTaxAssetsRightOfUseLiabilities to erna_DeferredTaxAssetsRightOfUseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl1" xml:lang="en-US" id="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl1">Deferred Tax Assets Right Of Use Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseLiabilities" xlink:to="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl1" xlink:title="label: DeferredTaxAssetsRightOfUseLiabilities to erna_DeferredTaxAssetsRightOfUseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl2" xml:lang="en-US" id="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl2">ROU Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseLiabilities" xlink:to="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl2" xlink:title="label: DeferredTaxAssetsRightOfUseLiabilities to erna_DeferredTaxAssetsRightOfUseLiabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DeferredTaxAssetsRightOfUseAssets" xlink:label="DeferredTaxAssetsRightOfUseAssets" xlink:title="DeferredTaxAssetsRightOfUseAssets" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DeferredTaxAssetsRightOfUseAssets_lbl" xml:lang="en-US" id="erna_DeferredTaxAssetsRightOfUseAssets_lbl">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from right-of-use assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseAssets" xlink:to="erna_DeferredTaxAssetsRightOfUseAssets_lbl" xlink:title="label: DeferredTaxAssetsRightOfUseAssets to erna_DeferredTaxAssetsRightOfUseAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsRightOfUseAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DeferredTaxAssetsRightOfUseAssets_lbl1" xml:lang="en-US" id="erna_DeferredTaxAssetsRightOfUseAssets_lbl1">Deferred Tax Assets Right of Use Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseAssets" xlink:to="erna_DeferredTaxAssetsRightOfUseAssets_lbl1" xlink:title="label: DeferredTaxAssetsRightOfUseAssets to erna_DeferredTaxAssetsRightOfUseAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsRightOfUseAssets_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_DeferredTaxAssetsRightOfUseAssets_lbl2" xml:lang="en-US" id="erna_DeferredTaxAssetsRightOfUseAssets_lbl2">ROU Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseAssets" xlink:to="erna_DeferredTaxAssetsRightOfUseAssets_lbl2" xlink:title="label: DeferredTaxAssetsRightOfUseAssets to erna_DeferredTaxAssetsRightOfUseAssets_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:label="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:title="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to decrease in the valuation allowance for deferred tax assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:to="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount to erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl1" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl1">Effective Income Tax Rate Reconciliation, Decrease in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:to="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount to erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl2" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl2">Change in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:to="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl2" xlink:title="label: EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount to erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LiquidityAndCapitalResourcesTable" xlink:label="LiquidityAndCapitalResourcesTable" xlink:title="LiquidityAndCapitalResourcesTable" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LiquidityAndCapitalResourcesTable_lbl" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesTable_lbl">Disclosure of information about liquidity and capital resources.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="erna_LiquidityAndCapitalResourcesTable_lbl" xlink:title="label: LiquidityAndCapitalResourcesTable to erna_LiquidityAndCapitalResourcesTable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LiquidityAndCapitalResourcesTable_lbl1" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesTable_lbl1">Liquidity and Capital Resources [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="erna_LiquidityAndCapitalResourcesTable_lbl1" xlink:title="label: LiquidityAndCapitalResourcesTable to erna_LiquidityAndCapitalResourcesTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LiquidityAndCapitalResourcesLineItems" xlink:label="LiquidityAndCapitalResourcesLineItems" xlink:title="LiquidityAndCapitalResourcesLineItems" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LiquidityAndCapitalResourcesLineItems_lbl" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesLineItems_lbl">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="erna_LiquidityAndCapitalResourcesLineItems_lbl" xlink:title="label: LiquidityAndCapitalResourcesLineItems to erna_LiquidityAndCapitalResourcesLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LiquidityAndCapitalResourcesLineItems_lbl1" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesLineItems_lbl1">Liquidity and Capital Resources [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="erna_LiquidityAndCapitalResourcesLineItems_lbl1" xlink:title="label: LiquidityAndCapitalResourcesLineItems to erna_LiquidityAndCapitalResourcesLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NewFacilityLeaseAbstract" xlink:label="NewFacilityLeaseAbstract" xlink:title="NewFacilityLeaseAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_NewFacilityLeaseAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NewFacilityLeaseAbstract_lbl1" xml:lang="en-US" id="erna_NewFacilityLeaseAbstract_lbl1">New Facility Lease [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewFacilityLeaseAbstract" xlink:to="erna_NewFacilityLeaseAbstract_lbl1" xlink:title="label: NewFacilityLeaseAbstract to erna_NewFacilityLeaseAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:label="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:title="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1" xml:lang="en-US" id="erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1">Detailed information about Liquidity and Capital Resources [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1" xlink:title="label: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2" xml:lang="en-US" id="erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2">Liquidity and Capital Resources [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2" xlink:title="label: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLossCarryforwardsExpirationYear" xlink:label="OperatingLossCarryforwardsExpirationYear" xlink:title="OperatingLossCarryforwardsExpirationYear" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLossCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_OperatingLossCarryforwardsExpirationYear_lbl" xml:lang="en-US" id="erna_OperatingLossCarryforwardsExpirationYear_lbl">Expiration date of each operating loss carryforward included in operating loss carryforward, in YYYY format.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsExpirationYear" xlink:to="erna_OperatingLossCarryforwardsExpirationYear_lbl" xlink:title="label: OperatingLossCarryforwardsExpirationYear to erna_OperatingLossCarryforwardsExpirationYear_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLossCarryforwardsExpirationYear_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OperatingLossCarryforwardsExpirationYear_lbl1" xml:lang="en-US" id="erna_OperatingLossCarryforwardsExpirationYear_lbl1">Operating Loss Carryforwards, Expiration Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsExpirationYear" xlink:to="erna_OperatingLossCarryforwardsExpirationYear_lbl1" xlink:title="label: OperatingLossCarryforwardsExpirationYear to erna_OperatingLossCarryforwardsExpirationYear_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLossCarryforwardsExpirationYear_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_OperatingLossCarryforwardsExpirationYear_lbl2" xml:lang="en-US" id="erna_OperatingLossCarryforwardsExpirationYear_lbl2">Net operating loss carryforwards begin to expire</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsExpirationYear" xlink:to="erna_OperatingLossCarryforwardsExpirationYear_lbl2" xlink:title="label: OperatingLossCarryforwardsExpirationYear to erna_OperatingLossCarryforwardsExpirationYear_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:label="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:title="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to uncertain tax positions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:to="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent to erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl1" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl1">Effective Income Tax Rate Reconciliation Uncertain Tax Positions Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:to="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent to erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl2" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl2">Uncertain tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:to="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl2" xlink:title="label: EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent to erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IncomeTaxAbstract" xlink:label="IncomeTaxAbstract" xlink:title="IncomeTaxAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_IncomeTaxAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_IncomeTaxAbstract_lbl1" xml:lang="en-US" id="erna_IncomeTaxAbstract_lbl1">Income Tax [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAbstract" xlink:to="erna_IncomeTaxAbstract_lbl1" xlink:title="label: IncomeTaxAbstract to erna_IncomeTaxAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_IncomeTaxAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_IncomeTaxAbstract_lbl2" xml:lang="en-US" id="erna_IncomeTaxAbstract_lbl2">Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAbstract" xlink:to="erna_IncomeTaxAbstract_lbl2" xlink:title="label: IncomeTaxAbstract to erna_IncomeTaxAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TaxCreditCarryforwardExpirationYear" xlink:label="TaxCreditCarryforwardExpirationYear" xlink:title="TaxCreditCarryforwardExpirationYear" />
    <link:label xlink:type="resource" xlink:label="erna_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_TaxCreditCarryforwardExpirationYear_lbl" xml:lang="en-US" id="erna_TaxCreditCarryforwardExpirationYear_lbl">Expiration beginning year of the tax credit carryforward, in YYYY format.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCreditCarryforwardExpirationYear" xlink:to="erna_TaxCreditCarryforwardExpirationYear_lbl" xlink:title="label: TaxCreditCarryforwardExpirationYear to erna_TaxCreditCarryforwardExpirationYear_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_TaxCreditCarryforwardExpirationYear_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_TaxCreditCarryforwardExpirationYear_lbl1" xml:lang="en-US" id="erna_TaxCreditCarryforwardExpirationYear_lbl1">Tax Credit Carryforward Expiration Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCreditCarryforwardExpirationYear" xlink:to="erna_TaxCreditCarryforwardExpirationYear_lbl1" xlink:title="label: TaxCreditCarryforwardExpirationYear to erna_TaxCreditCarryforwardExpirationYear_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_TaxCreditCarryforwardExpirationYear_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_TaxCreditCarryforwardExpirationYear_lbl2" xml:lang="en-US" id="erna_TaxCreditCarryforwardExpirationYear_lbl2">Tax credits begin to expire</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCreditCarryforwardExpirationYear" xlink:to="erna_TaxCreditCarryforwardExpirationYear_lbl2" xlink:title="label: TaxCreditCarryforwardExpirationYear to erna_TaxCreditCarryforwardExpirationYear_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TaxCutsAndJobsActOperatingLossCarryforwards" xlink:label="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:title="TaxCutsAndJobsActOperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl" xml:lang="en-US" id="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl">Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws from effect of Tax Cuts and Jobs Act.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:to="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl" xlink:title="label: TaxCutsAndJobsActOperatingLossCarryforwards to erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl1" xml:lang="en-US" id="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl1">Tax Cuts and Jobs Act, Operating Loss Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:to="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl1" xlink:title="label: TaxCutsAndJobsActOperatingLossCarryforwards to erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl2" xml:lang="en-US" id="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl2">Net operating loss carryforwards under Tax Cuts and Jobs Act</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:to="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl2" xlink:title="label: TaxCutsAndJobsActOperatingLossCarryforwards to erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightExercisedInPeriod" xlink:label="ClassOfWarrantOrRightExercisedInPeriod" xlink:title="ClassOfWarrantOrRightExercisedInPeriod" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightExercisedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ClassOfWarrantOrRightExercisedInPeriod_lbl" xml:lang="en-US" id="erna_ClassOfWarrantOrRightExercisedInPeriod_lbl">Number of share warrants exercised during the current period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercisedInPeriod" xlink:to="erna_ClassOfWarrantOrRightExercisedInPeriod_lbl" xlink:title="label: ClassOfWarrantOrRightExercisedInPeriod to erna_ClassOfWarrantOrRightExercisedInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightExercisedInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ClassOfWarrantOrRightExercisedInPeriod_lbl1" xml:lang="en-US" id="erna_ClassOfWarrantOrRightExercisedInPeriod_lbl1">Class of Warrant or Right Exercised in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercisedInPeriod" xlink:to="erna_ClassOfWarrantOrRightExercisedInPeriod_lbl1" xlink:title="label: ClassOfWarrantOrRightExercisedInPeriod to erna_ClassOfWarrantOrRightExercisedInPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightExercisedInPeriod_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_ClassOfWarrantOrRightExercisedInPeriod_lbl2" xml:lang="en-US" id="erna_ClassOfWarrantOrRightExercisedInPeriod_lbl2">Exercised (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercisedInPeriod" xlink:to="erna_ClassOfWarrantOrRightExercisedInPeriod_lbl2" xlink:title="label: ClassOfWarrantOrRightExercisedInPeriod to erna_ClassOfWarrantOrRightExercisedInPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightGrantsInPeriod" xlink:label="ClassOfWarrantOrRightGrantsInPeriod" xlink:title="ClassOfWarrantOrRightGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl" xml:lang="en-US" id="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl">The number of grants made during the period on warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightGrantsInPeriod" xlink:to="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl" xlink:title="label: ClassOfWarrantOrRightGrantsInPeriod to erna_ClassOfWarrantOrRightGrantsInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl1" xml:lang="en-US" id="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl1">Class of Warrant or Right Grants in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightGrantsInPeriod" xlink:to="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl1" xlink:title="label: ClassOfWarrantOrRightGrantsInPeriod to erna_ClassOfWarrantOrRightGrantsInPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl2" xml:lang="en-US" id="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl2">Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightGrantsInPeriod" xlink:to="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl2" xlink:title="label: ClassOfWarrantOrRightGrantsInPeriod to erna_ClassOfWarrantOrRightGrantsInPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_November2022WarrantsMember" xlink:label="November2022WarrantsMember" xlink:title="November2022WarrantsMember" />
    <link:label xlink:type="resource" xlink:label="erna_November2022WarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_November2022WarrantsMember_lbl" xml:lang="en-US" id="erna_November2022WarrantsMember_lbl">Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="November2022WarrantsMember" xlink:to="erna_November2022WarrantsMember_lbl" xlink:title="label: November2022WarrantsMember to erna_November2022WarrantsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_November2022WarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_November2022WarrantsMember_lbl1" xml:lang="en-US" id="erna_November2022WarrantsMember_lbl1">November 2022 Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="November2022WarrantsMember" xlink:to="erna_November2022WarrantsMember_lbl1" xlink:title="label: November2022WarrantsMember to erna_November2022WarrantsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_March2022WarrantsMember" xlink:label="March2022WarrantsMember" xlink:title="March2022WarrantsMember" />
    <link:label xlink:type="resource" xlink:label="erna_March2022WarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_March2022WarrantsMember_lbl" xml:lang="en-US" id="erna_March2022WarrantsMember_lbl">Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="March2022WarrantsMember" xlink:to="erna_March2022WarrantsMember_lbl" xlink:title="label: March2022WarrantsMember to erna_March2022WarrantsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_March2022WarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_March2022WarrantsMember_lbl1" xml:lang="en-US" id="erna_March2022WarrantsMember_lbl1">March 2022 Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="March2022WarrantsMember" xlink:to="erna_March2022WarrantsMember_lbl1" xlink:title="label: March2022WarrantsMember to erna_March2022WarrantsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CoronavirusAidReliefAndEconomicSecurityActMember" xlink:label="CoronavirusAidReliefAndEconomicSecurityActMember" xlink:title="CoronavirusAidReliefAndEconomicSecurityActMember" />
    <link:label xlink:type="resource" xlink:label="erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl" xml:lang="en-US" id="erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl">Coronavirus Aid, Relief, and Economic Security Act (CARES Act).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoronavirusAidReliefAndEconomicSecurityActMember" xlink:to="erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl" xlink:title="label: CoronavirusAidReliefAndEconomicSecurityActMember to erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl1" xml:lang="en-US" id="erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl1">Coronavirus Aid Relief and Economic Security Act [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoronavirusAidReliefAndEconomicSecurityActMember" xlink:to="erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl1" xlink:title="label: CoronavirusAidReliefAndEconomicSecurityActMember to erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl2" xml:lang="en-US" id="erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl2">CARES Act [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoronavirusAidReliefAndEconomicSecurityActMember" xlink:to="erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl2" xlink:title="label: CoronavirusAidReliefAndEconomicSecurityActMember to erna_CoronavirusAidReliefAndEconomicSecurityActMember_lbl2" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>17
<FILENAME>erna-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.2.1.5134 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://eternatx.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#SubsequentEventDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesUncertainTaxPositionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesComponentsOfIncomeTaxProvisionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesLossBeforeIncomeTaxesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsCumulativeConvertiblePreferredStockDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsAcquisitionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsMergerDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsMergerDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsEquityLineOfferingsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsWarrantsActivityDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsPrivatePlacementOfEquityDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationStockbasedCompensationExpenseDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationRestrictedStockDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationNumberOfRsusVestedAndSettledDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationRsusDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationRsusDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationSummaryOfStockOptionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationStockOptionActivityDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationEquityIncentivePlansDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasicAndDilutedLossPerCommonShareDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#CommitmentsAndContingenciesRetirementSavingsPlanDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#CommitmentsAndContingenciesRoyaltyAgreementsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#CommitmentsAndContingenciesLicensingAgreementsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#CommitmentsAndContingenciesLegalMattersDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/DebtDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#DebtDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#RelatedPartyTransactionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwillDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#InprocessResearchDevelopmentAndGoodwillDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesSubleaseAgreementDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesSubleaseAgreementDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesNetOperatingLeaseExpensesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesOperatingLeaseDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesOperatingLeaseDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipmentDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#PropertyAndEquipmentDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactionsDispositionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactionsMergerDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesBasisOfAccountingPresentationDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesBasisOfAccountingPresentationDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LiquidityAndCapitalResourcesDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#LiquidityAndCapitalResourcesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails" xlink:type="simple" xlink:href="erna-20221231.xsd#OrganizationAndDescriptionOfBusinessOperationsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxesTables" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsTables" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrantsTables" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensationTables" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedLossPerCommonShareTables" xlink:type="simple" xlink:href="erna-20221231.xsd#BasicAndDilutedLossPerCommonShareTables" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="erna-20221231.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesTables" xlink:type="simple" xlink:href="erna-20221231.xsd#LeasesTables" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipmentTables" xlink:type="simple" xlink:href="erna-20221231.xsd#PropertyAndEquipmentTables" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsTables" xlink:type="simple" xlink:href="erna-20221231.xsd#FairValueOfFinancialInstrumentsTables" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsTables" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactionsTables" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://eternatx.com/role/SubsequentEvent" xlink:type="simple" xlink:href="erna-20221231.xsd#SubsequentEvent" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxes" xlink:type="simple" xlink:href="erna-20221231.xsd#IncomeTaxes" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrants" xlink:type="simple" xlink:href="erna-20221231.xsd#EquityAndWarrants" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensation" xlink:type="simple" xlink:href="erna-20221231.xsd#StockbasedCompensation" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedLossPerCommonShare" xlink:type="simple" xlink:href="erna-20221231.xsd#BasicAndDilutedLossPerCommonShare" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="erna-20221231.xsd#CommitmentsAndContingencies" />
  <link:roleRef roleURI="http://eternatx.com/role/Debt" xlink:type="simple" xlink:href="erna-20221231.xsd#Debt" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpenses" xlink:type="simple" xlink:href="erna-20221231.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://eternatx.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="erna-20221231.xsd#RelatedPartyTransactions" />
  <link:roleRef roleURI="http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwill" xlink:type="simple" xlink:href="erna-20221231.xsd#InprocessResearchDevelopmentAndGoodwill" />
  <link:roleRef roleURI="http://eternatx.com/role/Leases" xlink:type="simple" xlink:href="erna-20221231.xsd#Leases" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipment" xlink:type="simple" xlink:href="erna-20221231.xsd#PropertyAndEquipment" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstruments" xlink:type="simple" xlink:href="erna-20221231.xsd#FairValueOfFinancialInstruments" />
  <link:roleRef roleURI="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactions" xlink:type="simple" xlink:href="erna-20221231.xsd#MergerDispositionAndAcquisitionTransactions" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="erna-20221231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies" />
  <link:roleRef roleURI="http://eternatx.com/role/LiquidityAndCapitalResources" xlink:type="simple" xlink:href="erna-20221231.xsd#LiquidityAndCapitalResources" />
  <link:roleRef roleURI="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations" xlink:type="simple" xlink:href="erna-20221231.xsd#OrganizationAndDescriptionOfBusinessOperations" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="erna-20221231.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity" xlink:type="simple" xlink:href="erna-20221231.xsd#ConsolidatedStatementsOfMembersStockholdersEquity" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="erna-20221231.xsd#ConsolidatedStatementsOfOperations" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="erna-20221231.xsd#ConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="erna-20221231.xsd#ConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://eternatx.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="erna-20221231.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="DocumentAnnualReport" xlink:title="DocumentAnnualReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentAnnualReport" xlink:title="presentation: CoverAbstract to DocumentAnnualReport" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: CoverAbstract to CurrentFiscalYearEndDate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentTransitionReport" xlink:title="presentation: CoverAbstract to DocumentTransitionReport" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityWellKnownSeasonedIssuer" xlink:title="presentation: CoverAbstract to EntityWellKnownSeasonedIssuer" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityVoluntaryFilers" xlink:title="presentation: CoverAbstract to EntityVoluntaryFilers" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCurrentReportingStatus" xlink:title="presentation: CoverAbstract to EntityCurrentReportingStatus" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityInteractiveDataCurrent" xlink:title="presentation: CoverAbstract to EntityInteractiveDataCurrent" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFilerCategory" xlink:title="presentation: CoverAbstract to EntityFilerCategory" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntitySmallBusiness" xlink:title="presentation: CoverAbstract to EntitySmallBusiness" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="IcfrAuditorAttestationFlag" xlink:title="IcfrAuditorAttestationFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="IcfrAuditorAttestationFlag" xlink:title="presentation: CoverAbstract to IcfrAuditorAttestationFlag" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityShellCompany" xlink:title="presentation: CoverAbstract to EntityShellCompany" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="EntityPublicFloat" xlink:title="EntityPublicFloat" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityPublicFloat" xlink:title="presentation: CoverAbstract to EntityPublicFloat" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCommonStockSharesOutstanding" xlink:title="presentation: CoverAbstract to EntityCommonStockSharesOutstanding" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="AuditorFirmId" xlink:title="AuditorFirmId" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AuditorFirmId" xlink:title="presentation: CoverAbstract to AuditorFirmId" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="AuditorName" xlink:title="AuditorName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AuditorName" xlink:title="presentation: CoverAbstract to AuditorName" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="AuditorLocation" xlink:title="AuditorLocation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AuditorLocation" xlink:title="presentation: CoverAbstract to AuditorLocation" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="presentation: ClassOfStockDomain to SeriesAPreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: StatementTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="Cash" xlink:title="presentation: AssetsCurrentAbstract to Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="OtherReceivablesNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to OtherReceivablesNetCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to PrepaidExpenseAndOtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to AssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="RestrictedCashNoncurrent" xlink:title="RestrictedCashNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="RestrictedCashNoncurrent" xlink:title="presentation: AssetsAbstract to RestrictedCashNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: AssetsAbstract to PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: AssetsAbstract to OperatingLeaseRightOfUseAsset" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Goodwill" xlink:title="presentation: AssetsAbstract to Goodwill" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="presentation: AssetsAbstract to IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="EquityMethodInvestments" xlink:title="presentation: AssetsAbstract to EquityMethodInvestments" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OtherAssetsNoncurrent" xlink:title="presentation: AssetsAbstract to OtherAssetsNoncurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Assets" xlink:title="presentation: AssetsAbstract to Assets" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="AssetsAbstract" xlink:title="presentation: StatementLineItems to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccountsPayableCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="DueToRelatedPartiesCurrent" xlink:title="DueToRelatedPartiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="DueToRelatedPartiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to DueToRelatedPartiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OperatingLeaseLiabilityCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OtherLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OtherLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LiabilitiesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesCurrentAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="DueToRelatedPartiesNoncurrent" xlink:title="DueToRelatedPartiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="DueToRelatedPartiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to DueToRelatedPartiesNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="DerivativeLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to DerivativeLiabilitiesNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OperatingLeaseLiabilityNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OtherLiabilitiesNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="Liabilities" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to Liabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="CommitmentsAndContingencies" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to CommitmentsAndContingencies" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockValue" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockValue" xlink:title="presentation: StockholdersEquityAbstract to CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="AdditionalPaidInCapital" xlink:title="presentation: StockholdersEquityAbstract to AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: StockholdersEquityAbstract to RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="StockholdersEquity" xlink:title="presentation: StockholdersEquityAbstract to StockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesAndStockholdersEquity" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementLineItems to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfFinancialPositionAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesAuthorized" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesIssued" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesOutstanding" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="PreferredStockLiquidationPreferenceValue" xlink:title="PreferredStockLiquidationPreferenceValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockLiquidationPreferenceValue" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockLiquidationPreferenceValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityAbstract to CommonStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesAuthorized" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesAuthorized" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesIssued" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesIssued" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesOutstanding" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to StockholdersEquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfOperations">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="presentation: OperatingExpensesAbstract to ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="ImpairmentOfOngoingProject" xlink:title="presentation: OperatingExpensesAbstract to ImpairmentOfOngoingProject" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:label="ResearchAndDevelopmentInProcess" xlink:title="ResearchAndDevelopmentInProcess" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="ResearchAndDevelopmentInProcess" xlink:title="presentation: OperatingExpensesAbstract to ResearchAndDevelopmentInProcess" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="GeneralAndAdministrativeExpense" xlink:title="presentation: OperatingExpensesAbstract to GeneralAndAdministrativeExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="NoncashMergerRelatedCosts" xlink:title="presentation: OperatingExpensesAbstract to NoncashMergerRelatedCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="OperatingExpenses" xlink:title="presentation: OperatingExpensesAbstract to OperatingExpenses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingExpensesAbstract" xlink:title="presentation: IncomeStatementAbstract to OperatingExpensesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to OperatingIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpensesAbstract" xlink:label="OtherExpensesAbstract" xlink:title="OtherExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="presentation: OtherExpensesAbstract to DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="WarrantLiabilitiesExpense" xlink:title="presentation: OtherExpensesAbstract to WarrantLiabilitiesExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="LossOnNonControllingInvestment" xlink:title="presentation: OtherExpensesAbstract to LossOnNonControllingInvestment" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="OtherNonoperatingIncomeExpense" xlink:title="presentation: OtherExpensesAbstract to OtherNonoperatingIncomeExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="NonoperatingIncomeExpense" xlink:title="presentation: OtherExpensesAbstract to NonoperatingIncomeExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OtherExpensesAbstract" xlink:title="presentation: IncomeStatementAbstract to OtherExpensesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: IncomeStatementAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeStatementAbstract to IncomeTaxExpenseBenefit" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to NetIncomeLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="PreferredStockDividendsAndOtherAdjustments" xlink:title="PreferredStockDividendsAndOtherAdjustments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="PreferredStockDividendsAndOtherAdjustments" xlink:title="presentation: IncomeStatementAbstract to PreferredStockDividendsAndOtherAdjustments" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="presentation: IncomeStatementAbstract to NetIncomeLossAvailableToCommonStockholdersBasic" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareBasic" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareBasic" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareDiluted" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareDiluted" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfSharesOutstandingBasic" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfDilutedSharesOutstanding" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_MembershipEquityMember" xlink:label="MembershipEquityMember" xlink:title="MembershipEquityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="MembershipEquityMember" xlink:title="presentation: StatementEquityComponentsAxis to MembershipEquityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="CommonStockMember" xlink:title="presentation: StatementEquityComponentsAxis to CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="PreferredStockMember" xlink:title="presentation: StatementEquityComponentsAxis to PreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="AdditionalPaidInCapitalMember" xlink:title="presentation: StatementEquityComponentsAxis to AdditionalPaidInCapitalMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="RetainedEarningsMember" xlink:title="presentation: StatementEquityComponentsAxis to RetainedEarningsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: StatementTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="presentation: ClassOfStockDomain to CommonClassAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassBMember" xlink:title="presentation: ClassOfStockDomain to CommonClassBMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassCMember" xlink:title="presentation: ClassOfStockDomain to CommonClassCMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonUnitsMember" xlink:label="CommonUnitsMember" xlink:title="CommonUnitsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonUnitsMember" xlink:title="presentation: ClassOfStockDomain to CommonUnitsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="presentation: ClassOfStockDomain to SeriesAPreferredStockMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: StatementTable to StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquity" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:label="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:label="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueAcquisitions1" xlink:label="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="StockIssuedDuringPeriodValueAcquisitions1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueAcquisitions1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesAcquisitions1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountAcquisitions" xlink:label="PartnersCapitalAccountAcquisitions" xlink:title="PartnersCapitalAccountAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="PartnersCapitalAccountAcquisitions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to PartnersCapitalAccountAcquisitions" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountUnitsAcquisitions" xlink:label="PartnersCapitalAccountUnitsAcquisitions" xlink:title="PartnersCapitalAccountUnitsAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="PartnersCapitalAccountUnitsAcquisitions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to PartnersCapitalAccountUnitsAcquisitions" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueAcquisitions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueAcquisitions" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesAcquisitions" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueStockOptionsExercised" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesStockOptionsExercised" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodValueStockPurchaseAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueStockPurchaseAgreement" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodSharesStockPurchaseAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesStockPurchaseAgreement" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueAcquisitions2" xlink:label="StockIssuedDuringPeriodValueAcquisitions2" xlink:title="StockIssuedDuringPeriodValueAcquisitions2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueAcquisitions2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueAcquisitions2" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesAcquisitions2" xlink:label="StockIssuedDuringPeriodSharesAcquisitions2" xlink:title="StockIssuedDuringPeriodSharesAcquisitions2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesAcquisitions2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesAcquisitions2" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" xlink:label="StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" xlink:title="StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" xlink:label="StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" xlink:title="StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="DividendsPreferredStockCash" xlink:title="DividendsPreferredStockCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="DividendsPreferredStockCash" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to DividendsPreferredStockCash" order="26.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="PreferredStockDividendsShares" xlink:title="PreferredStockDividendsShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="PreferredStockDividendsShares" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to PreferredStockDividendsShares" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueInLieuOfDividends" xlink:label="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:title="StockIssuedDuringPeriodValueInLieuOfDividends" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueInLieuOfDividends" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:label="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:title="StockIssuedDuringPeriodSharesInLieuOfDividends" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesInLieuOfDividends" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:label="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:label="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" order="31.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="NetIncomeLoss" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to NetIncomeLoss" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity_2" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquity_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquity" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding_2" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="presentation: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfStockholdersEquityAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DepreciationDepletionAndAmortization" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ShareBasedCompensation" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to OperatingLeaseRightOfUseAssetAmortizationExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="OperatingLeaseImpairmentLoss" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to OperatingLeaseImpairmentLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:label="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:title="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ImpairmentOfOngoingProject" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ImpairmentOfOngoingProject" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ResearchAndDevelopmentInProcessAssetAcquisition" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnDisposalOfFixedAssets" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainLossOnDisposalOfFixedAssets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainOnTerminationOfLease" xlink:label="GainOnTerminationOfLease" xlink:title="GainOnTerminationOfLease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainOnTerminationOfLease" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainOnTerminationOfLease" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="WarrantLiabilitiesExpense" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to WarrantLiabilitiesExpense" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="LossOnNonControllingInvestment" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to LossOnNonControllingInvestment" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NoncashMergerRelatedCosts" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to NoncashMergerRelatedCosts" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="GainLossOnDispositionOfAssets1" xlink:title="GainLossOnDispositionOfAssets1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnDispositionOfAssets1" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainLossOnDispositionOfAssets1" order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan" xlink:label="GainLossOnForgivenessOfPaycheckProtectionProgramLoan" xlink:title="GainLossOnForgivenessOfPaycheckProtectionProgramLoan" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnForgivenessOfPaycheckProtectionProgramLoan" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainLossOnForgivenessOfPaycheckProtectionProgramLoan" order="13.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="IncreaseDecreaseInOtherReceivables" xlink:title="IncreaseDecreaseInOtherReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherReceivables" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="IncreaseDecreaseInOtherNoncurrentAssets" xlink:title="IncreaseDecreaseInOtherNoncurrentAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherNoncurrentAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherNoncurrentAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="IncreaseDecreaseInDueToRelatedParties" xlink:title="IncreaseDecreaseInDueToRelatedParties" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInDueToRelatedParties" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInDueToRelatedParties" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOperatingLeaseLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherOperatingLiabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to IncreaseDecreaseInOperatingCapitalAbstract" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetCashProvidedByUsedInOperatingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromSaleOfPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:label="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="ProceedsFromSalesOfAssetsInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromSalesOfAssetsInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentsToAcquireProductiveAssetsNet" xlink:label="PaymentsToAcquireProductiveAssetsNet" xlink:title="PaymentsToAcquireProductiveAssetsNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireProductiveAssetsNet" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireProductiveAssetsNet" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromDivestitureOfBusinesses" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromDivestitureOfBusinesses" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to NetCashProvidedByUsedInInvestingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromIssuanceOfCommonStock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ExpensesPaidInConnectionWithPrivateOffering" xlink:label="ExpensesPaidInConnectionWithPrivateOffering" xlink:title="ExpensesPaidInConnectionWithPrivateOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ExpensesPaidInConnectionWithPrivateOffering" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ExpensesPaidInConnectionWithPrivateOffering" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:label="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:title="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="FinanceLeasePrincipalPayments" xlink:title="FinanceLeasePrincipalPayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="FinanceLeasePrincipalPayments" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to FinanceLeasePrincipalPayments" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="PaymentsOfDividendsPreferredStockAndPreferenceStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfDividendsPreferredStockAndPreferenceStock" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:label="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:title="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to CashPaidForFractionalSharesInConnectionWithReverseStockSplit" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:label="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:title="ProceedsFromIssuanceOfCommonStockToLincolnPark" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromIssuanceOfCommonStockToLincolnPark" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="ProceedsFromOtherEquity" xlink:title="ProceedsFromOtherEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromOtherEquity" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromOtherEquity" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromStockOptionsExercised" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromStockOptionsExercised" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentsOfPaycheckProtectionProgramLoan" xlink:label="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="PaymentsOfPaycheckProtectionProgramLoan" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfPaycheckProtectionProgramLoan" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RepaymentsOfNotesPayable" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to RepaymentsOfNotesPayable" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to NetCashProvidedByUsedInFinancingActivities" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CashPaidDuringThePeriodForAbstract" xlink:label="CashPaidDuringThePeriodForAbstract" xlink:title="CashPaidDuringThePeriodForAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="InterestPaidNet" xlink:title="presentation: CashPaidDuringThePeriodForAbstract to InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="IncomeTaxesPaidNet" xlink:title="presentation: CashPaidDuringThePeriodForAbstract to IncomeTaxesPaidNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="CashPaidDuringThePeriodForAbstract" xlink:title="presentation: SupplementalCashFlowInformationAbstract to CashPaidDuringThePeriodForAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="SupplementalCashFlowInformationAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to SupplementalCashFlowInformationAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ConversionOfWarrantLiabilityToEquity" xlink:label="ConversionOfWarrantLiabilityToEquity" xlink:title="ConversionOfWarrantLiabilityToEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ConversionOfWarrantLiabilityToEquity" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to ConversionOfWarrantLiabilityToEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" xlink:label="InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" xlink:title="InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:label="UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:title="UnpaidFeesIncurredInConnectionWithPrivateOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to UnpaidFeesIncurredInConnectionWithPrivateOffering" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialMeasurementOfFinanceLeaseLiabilities" xlink:label="InitialMeasurementOfFinanceLeaseLiabilities" xlink:title="InitialMeasurementOfFinanceLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="InitialMeasurementOfFinanceLeaseLiabilities" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to InitialMeasurementOfFinanceLeaseLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend" xlink:label="IssuanceOfCommonStockForSeriesAPreferredStockDividend" xlink:title="IssuanceOfCommonStockForSeriesAPreferredStockDividend" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="IssuanceOfCommonStockForSeriesAPreferredStockDividend" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to IssuanceOfCommonStockForSeriesAPreferredStockDividend" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1" xlink:label="StockIssued1" xlink:title="StockIssued1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="StockIssued1" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to StockIssued1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IssuanceOfCommonStockForAssetAcquisition" xlink:label="IssuanceOfCommonStockForAssetAcquisition" xlink:title="IssuanceOfCommonStockForAssetAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="IssuanceOfCommonStockForAssetAcquisition" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to IssuanceOfCommonStockForAssetAcquisition" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:label="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:title="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:label="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:title="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="presentation: ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract to CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="RestrictedCashCurrent" xlink:title="RestrictedCashCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:to="RestrictedCashCurrent" xlink:title="presentation: ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract to RestrictedCashCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="presentation: ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LiquidityAndCapitalResources">
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:label="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:title="LIQUIDITYANDCAPITALRESOURCESAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LiquidityAndCapitalResourcesTextBlock" xlink:label="LiquidityAndCapitalResourcesTextBlock" xlink:title="LiquidityAndCapitalResourcesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:to="LiquidityAndCapitalResourcesTextBlock" xlink:title="presentation: LIQUIDITYANDCAPITALRESOURCESAbstract to LiquidityAndCapitalResourcesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:title="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactions">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:title="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to MergersAcquisitionsAndDispositionsDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstruments">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueDisclosuresTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipment">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to PropertyPlantAndEquipmentDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/Leases">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeasesTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwill">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/RelatedPartyTransactions">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="RelatedPartyTransactionsAbstract" xlink:title="RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="RelatedPartyTransactionsDisclosureTextBlock" xlink:title="RelatedPartyTransactionsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsAbstract" xlink:to="RelatedPartyTransactionsDisclosureTextBlock" xlink:title="presentation: RelatedPartyTransactionsAbstract to RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpenses">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/Debt">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtDisclosureTextBlock" xlink:title="presentation: DebtDisclosureAbstract to DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingencies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedLossPerCommonShare">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrants">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="StockholdersEquityNoteDisclosureTextBlock" xlink:title="presentation: StockholdersEquityNoteAbstract to StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxes">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxDisclosureTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/SubsequentEvent">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="SubsequentEventsTextBlock" xlink:title="SubsequentEventsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="SubsequentEventsTextBlock" xlink:title="presentation: SubsequentEventsAbstract to SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ReverseStockSplitPolicyTextBlock" xlink:label="ReverseStockSplitPolicyTextBlock" xlink:title="ReverseStockSplitPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ReverseStockSplitPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ReverseStockSplitPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="UseOfEstimates" xlink:title="presentation: AccountingPoliciesAbstract to UseOfEstimates" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:title="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:title="presentation: AccountingPoliciesAbstract to CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to PropertyPlantAndEquipmentPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:title="GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:title="presentation: AccountingPoliciesAbstract to GoodwillAndIntangibleAssetsGoodwillPolicy" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="InProcessResearchAndDevelopmentPolicy" xlink:title="InProcessResearchAndDevelopmentPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="InProcessResearchAndDevelopmentPolicy" xlink:title="presentation: AccountingPoliciesAbstract to InProcessResearchAndDevelopmentPolicy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="ResearchAndDevelopmentExpensePolicy" xlink:title="ResearchAndDevelopmentExpensePolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ResearchAndDevelopmentExpensePolicy" xlink:title="presentation: AccountingPoliciesAbstract to ResearchAndDevelopmentExpensePolicy" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="IncomeTaxPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to IncomeTaxPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="EarningsPerSharePolicyTextBlock" xlink:title="EarningsPerSharePolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="EarningsPerSharePolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to EarningsPerSharePolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="SegmentReportingPolicyPolicyTextBlock" xlink:title="SegmentReportingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SegmentReportingPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SegmentReportingPolicyPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="ConcentrationRiskCreditRisk" xlink:title="ConcentrationRiskCreditRisk" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ConcentrationRiskCreditRisk" xlink:title="presentation: AccountingPoliciesAbstract to ConcentrationRiskCreditRisk" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="FairValueOfFinancialInstrumentsPolicy" xlink:title="FairValueOfFinancialInstrumentsPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="FairValueOfFinancialInstrumentsPolicy" xlink:title="presentation: AccountingPoliciesAbstract to FairValueOfFinancialInstrumentsPolicy" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="LesseeLeasesPolicyTextBlock" xlink:title="LesseeLeasesPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="LesseeLeasesPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to LesseeLeasesPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="CommitmentsAndContingenciesPolicyTextBlock" xlink:title="CommitmentsAndContingenciesPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="CommitmentsAndContingenciesPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to CommitmentsAndContingenciesPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="presentation: AccountingPoliciesAbstract to ShareBasedCompensationOptionAndIncentivePlansPolicy" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:label="DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:title="DerivativesMethodsOfAccountingNonhedgingDerivatives" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:title="presentation: AccountingPoliciesAbstract to DerivativesMethodsOfAccountingNonhedgingDerivatives" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to NewAccountingPronouncementsPolicyPolicyTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:title="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:title="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:label="AssetAcquisitionTableTextBlock" xlink:title="AssetAcquisitionTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="AssetAcquisitionTableTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to AssetAcquisitionTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:title="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipmentTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="PropertyPlantAndEquipmentTextBlock" xlink:title="PropertyPlantAndEquipmentTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="PropertyPlantAndEquipmentTextBlock" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LeaseCostTableTextBlock" xlink:title="presentation: LeasesAbstract to LeaseCostTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:label="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:title="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:title="presentation: LeasesAbstract to OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:label="FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:title="FutureLeasePaymentsSubleaseAgreementTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:title="presentation: LeasesAbstract to FutureLeasePaymentsSubleaseAgreementTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpensesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to ScheduleOfAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedLossPerCommonShareTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:label="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:title="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="presentation: StockholdersEquityNoteAbstract to ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:title="ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="presentation: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="presentation: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfInLicensedPortfolioPatents" xlink:label="NumberOfInLicensedPortfolioPatents" xlink:title="NumberOfInLicensedPortfolioPatents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfInLicensedPortfolioPatents" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfInLicensedPortfolioPatents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EquityMethodInvestmentOwnershipPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LiquidityAndCapitalResourcesDetails">
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:label="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:title="LIQUIDITYANDCAPITALRESOURCESAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LiquidityAndCapitalResourcesTable" xlink:label="LiquidityAndCapitalResourcesTable" xlink:title="LiquidityAndCapitalResourcesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="presentation: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="presentation: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="InvestmentTypeAxis" xlink:title="presentation: LiquidityAndCapitalResourcesTable to InvestmentTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: LiquidityAndCapitalResourcesTable to ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LiquidityAndCapitalResourcesLineItems" xlink:label="LiquidityAndCapitalResourcesLineItems" xlink:title="LiquidityAndCapitalResourcesLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:label="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:title="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="Cash" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to RetainedEarningsAccumulatedDeficit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to NetIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to NetCashProvidedByUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to CommonStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_UnitPriceOfWarrants" xlink:label="UnitPriceOfWarrants" xlink:title="UnitPriceOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="UnitPriceOfWarrants" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to UnitPriceOfWarrants" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to StockRepurchaseProgramAuthorizedAmount1" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="ProceedsFromIssuanceOfWarrants" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to ProceedsFromIssuanceOfWarrants" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="ClassOfWarrantOrRightsExercisableTerm" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to ClassOfWarrantOrRightsExercisableTerm" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:title="presentation: LiquidityAndCapitalResourcesLineItems to DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NewFacilityLeaseAbstract" xlink:label="NewFacilityLeaseAbstract" xlink:title="NewFacilityLeaseAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewFacilityLeaseAbstract" xlink:to="AreaOfRealEstateProperty" xlink:title="presentation: NewFacilityLeaseAbstract to AreaOfRealEstateProperty" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:label="LineOfCredit" xlink:title="LineOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewFacilityLeaseAbstract" xlink:to="LineOfCredit" xlink:title="presentation: NewFacilityLeaseAbstract to LineOfCredit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="RestrictedCash" xlink:title="RestrictedCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewFacilityLeaseAbstract" xlink:to="RestrictedCash" xlink:title="presentation: NewFacilityLeaseAbstract to RestrictedCash" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="NewFacilityLeaseAbstract" xlink:title="presentation: LiquidityAndCapitalResourcesLineItems to NewFacilityLeaseAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="LiquidityAndCapitalResourcesLineItems" xlink:title="presentation: LiquidityAndCapitalResourcesTable to LiquidityAndCapitalResourcesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:to="LiquidityAndCapitalResourcesTable" xlink:title="presentation: LIQUIDITYANDCAPITALRESOURCESAbstract to LiquidityAndCapitalResourcesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesBasisOfAccountingPresentationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BasisOfPresentationAbstract" xlink:label="BasisOfPresentationAbstract" xlink:title="BasisOfPresentationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="presentation: BasisOfPresentationAbstract to StockholdersEquityNoteStockSplitConversionRatio1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="BasisOfPresentationAbstract" xlink:title="presentation: AccountingPoliciesAbstract to BasisOfPresentationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ReverseStockSplitAbstract" xlink:label="ReverseStockSplitAbstract" xlink:title="ReverseStockSplitAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAbstract" xlink:to="StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="presentation: ReverseStockSplitAbstract to StockholdersEquityNoteStockSplitConversionRatio1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:label="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:title="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAbstract" xlink:to="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:title="presentation: ReverseStockSplitAbstract to CashPaidForFractionalSharesInConnectionWithReverseStockSplit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfSharesConsideredAsFractionalInReverseStock" xlink:label="NumberOfSharesConsideredAsFractionalInReverseStock" xlink:title="NumberOfSharesConsideredAsFractionalInReverseStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAbstract" xlink:to="NumberOfSharesConsideredAsFractionalInReverseStock" xlink:title="presentation: ReverseStockSplitAbstract to NumberOfSharesConsideredAsFractionalInReverseStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ReverseStockSplitAbstract" xlink:title="presentation: AccountingPoliciesAbstract to ReverseStockSplitAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:label="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:title="CashAndCashEquivalentsAtCarryingValueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="CashEquivalentsAtCarryingValue" xlink:title="CashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="CashEquivalentsAtCarryingValue" xlink:title="presentation: CashAndCashEquivalentsAtCarryingValueAbstract to CashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="RestrictedCash" xlink:title="RestrictedCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="RestrictedCash" xlink:title="presentation: CashAndCashEquivalentsAtCarryingValueAbstract to RestrictedCash" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:title="presentation: AccountingPoliciesAbstract to CashAndCashEquivalentsAtCarryingValueAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LaboratoryAndManufacturingEquipmentMember" xlink:label="LaboratoryAndManufacturingEquipmentMember" xlink:title="LaboratoryAndManufacturingEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LaboratoryAndManufacturingEquipmentMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to LaboratoryAndManufacturingEquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerEquipmentMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to ComputerEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="presentation: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:label="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:title="PropertyPlantAndEquipmentNetByTypeAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="presentation: PropertyPlantAndEquipmentNetByTypeAbstract to PropertyPlantAndEquipmentUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:title="presentation: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentNetByTypeAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentLineItems" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="presentation: AccountingPoliciesAbstract to ScheduleOfPropertyPlantAndEquipmentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="NumberOfOperatingSegments" xlink:title="presentation: SegmentReportingAbstract to NumberOfOperatingSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SegmentReportingAbstract" xlink:title="presentation: AccountingPoliciesAbstract to SegmentReportingAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:title="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CoronavirusAidReliefAndEconomicSecurityActMember" xlink:label="CoronavirusAidReliefAndEconomicSecurityActMember" xlink:title="CoronavirusAidReliefAndEconomicSecurityActMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="CoronavirusAidReliefAndEconomicSecurityActMember" xlink:title="presentation: UnusualOrInfrequentItemDomain to CoronavirusAidReliefAndEconomicSecurityActMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="presentation: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="presentation: NewAccountingPronouncementsOrChangeInAccountingPrincipleTable to UnusualOrInfrequentItemAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:title="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="IncomeTaxesReceivable" xlink:title="IncomeTaxesReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="IncomeTaxesReceivable" xlink:title="presentation: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to IncomeTaxesReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="presentation: NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems to NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:title="presentation: NewAccountingPronouncementsOrChangeInAccountingPrincipleTable to NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:title="presentation: AccountingPoliciesAbstract to NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodSharesIssuedForServices" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="BusinessAcquisitionSharePrice" xlink:title="BusinessAcquisitionSharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionSharePrice" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionSharePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="CommonStockSharesOutstanding" xlink:title="presentation: BusinessCombinationDescriptionAbstract to CommonStockSharesOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="Goodwill" xlink:title="presentation: BusinessCombinationDescriptionAbstract to Goodwill" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:label="NonrecurringAdjustmentAxis" xlink:title="NonrecurringAdjustmentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="NonrecurringAdjustmentDomain" xlink:title="NonrecurringAdjustmentDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProFormaFairValueAdjustmentToAssetsMember" xlink:label="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="ProFormaFairValueAdjustmentToAssetsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonrecurringAdjustmentDomain" xlink:to="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="presentation: NonrecurringAdjustmentDomain to ProFormaFairValueAdjustmentToAssetsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PurchasePriceAllocationMember" xlink:label="PurchasePriceAllocationMember" xlink:title="PurchasePriceAllocationMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonrecurringAdjustmentDomain" xlink:to="PurchasePriceAllocationMember" xlink:title="presentation: NonrecurringAdjustmentDomain to PurchasePriceAllocationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonrecurringAdjustmentAxis" xlink:to="NonrecurringAdjustmentDomain" xlink:title="presentation: NonrecurringAdjustmentAxis to NonrecurringAdjustmentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="NonrecurringAdjustmentAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to NonrecurringAdjustmentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TradeNamesMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TradeNamesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="Goodwill" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to Goodwill" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:label="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="presentation: BusinessAcquisitionLineItems to ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BeneficialHoldersContractualCommitmentsToInvest" xlink:label="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="BeneficialHoldersContractualCommitmentsToInvest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="presentation: BusinessAcquisitionLineItems to BeneficialHoldersContractualCommitmentsToInvest" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfAdditionalRightsOffering" xlink:label="PercentageOfAdditionalRightsOffering" xlink:title="PercentageOfAdditionalRightsOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfAdditionalRightsOffering" xlink:title="presentation: BusinessAcquisitionLineItems to PercentageOfAdditionalRightsOffering" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProceedsFromSaleOfRights" xlink:label="ProceedsFromSaleOfRights" xlink:title="ProceedsFromSaleOfRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="ProceedsFromSaleOfRights" xlink:title="presentation: BusinessAcquisitionLineItems to ProceedsFromSaleOfRights" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NTNBusinessMember" xlink:label="NTNBusinessMember" xlink:title="NTNBusinessMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="NTNBusinessMember" xlink:title="presentation: DisposalGroupsIncludingDiscontinuedOperationsNameDomain to NTNBusinessMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis to DisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TradeNamesMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TradeNamesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DispositionAbstract" xlink:label="DispositionAbstract" xlink:title="DispositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:label="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="presentation: DispositionAbstract to ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProceedsFromDispositionAbstract" xlink:label="ProceedsFromDispositionAbstract" xlink:title="ProceedsFromDispositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProceedsFromDispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="presentation: ProceedsFromDispositionAbstract to DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProceedsFromDispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="presentation: ProceedsFromDispositionAbstract to DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProceedsFromDispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="presentation: ProceedsFromDispositionAbstract to DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProceedsFromDispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="presentation: ProceedsFromDispositionAbstract to DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="ProceedsFromDispositionAbstract" xlink:title="presentation: DispositionAbstract to ProceedsFromDispositionAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:label="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:label="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="DisposalGroupIncludingDiscontinuedOperationGoodwill1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationGoodwill1" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationOtherAssets" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="presentation: DispositionAbstract to AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:label="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:label="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:label="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="presentation: DispositionAbstract to LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="presentation: DispositionAbstract to DisposalGroupIncludingDiscontinuedOperationTransactionCosts" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="presentation: DispositionAbstract to DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DispositionAbstract" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DispositionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="presentation: BusinessCombinationsAbstract to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="presentation: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="presentation: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="AssetAcquisitionAxis" xlink:title="AssetAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="AssetAcquisitionDomain" xlink:title="AssetAcquisitionDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="presentation: AssetAcquisitionDomain to NovellusTherapeuticsLimitedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionAxis" xlink:to="AssetAcquisitionDomain" xlink:title="presentation: AssetAcquisitionAxis to AssetAcquisitionDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="AssetAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to AssetAcquisitionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:label="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="presentation: RelatedPartyDomain to ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RelatedPartyTransactionsByRelatedPartyAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EquityMethodInvestmentOwnershipPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodSharesAcquisitions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodValueAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodValueAcquisitions" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AssetAcquisitionSharePrice" xlink:label="AssetAcquisitionSharePrice" xlink:title="AssetAcquisitionSharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AssetAcquisitionSharePrice" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AssetAcquisitionSharePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodValueNewIssues" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodValueNewIssues" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EscrowShares" xlink:label="EscrowShares" xlink:title="EscrowShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EscrowShares" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EscrowShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AcquisitionAgreementNonCompetitivePeriod" xlink:label="AcquisitionAgreementNonCompetitivePeriod" xlink:title="AcquisitionAgreementNonCompetitivePeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AcquisitionAgreementNonCompetitivePeriod" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AcquisitionAgreementNonCompetitivePeriod" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodSharesIssuedForServices" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EachLockUpAgreementExtendsTerm" xlink:label="EachLockUpAgreementExtendsTerm" xlink:title="EachLockUpAgreementExtendsTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EachLockUpAgreementExtendsTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EachLockUpAgreementExtendsTerm" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfCommonStockSubjectToLockUpAgreement" xlink:label="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="PercentageOfCommonStockSubjectToLockUpAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PercentageOfCommonStockSubjectToLockUpAgreement" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentsToAcquireProductiveAssetsNet" xlink:label="PaymentsToAcquireProductiveAssetsNet" xlink:title="PaymentsToAcquireProductiveAssetsNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireProductiveAssetsNet" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireProductiveAssetsNet" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LockUpPeriodForRestrictedShares" xlink:label="LockUpPeriodForRestrictedShares" xlink:title="LockUpPeriodForRestrictedShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="LockUpPeriodForRestrictedShares" xlink:title="presentation: BusinessCombinationDescriptionAbstract to LockUpPeriodForRestrictedShares" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AssetAcquisitionUnrestrictedSharesSharePrice" xlink:label="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="AssetAcquisitionUnrestrictedSharesSharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AssetAcquisitionUnrestrictedSharesSharePrice" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodRestrictedSharesAcquisitions" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AssetAcquisitionRestrictedSharesSharePrice" xlink:label="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="AssetAcquisitionRestrictedSharesSharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AssetAcquisitionRestrictedSharesSharePrice" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:label="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="PercentageOfDiscountOnFairValueOfRestrictedShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PercentageOfDiscountOnFairValueOfRestrictedShares" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireProductiveAssets" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="CashAcquiredFromAcquisition" xlink:title="presentation: BusinessCombinationDescriptionAbstract to CashAcquiredFromAcquisition" order="18.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AssetAcquisitionFairValueOfConsiderationPaid" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="PaymentsToAcquireInvestments" xlink:title="PaymentsToAcquireInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireInvestments" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireInvestments" order="22.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="presentation: BusinessCombinationDescriptionAbstract to ResearchAndDevelopmentInProcessAssetAcquisition" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="presentation: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="presentation: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CitiusPharmaceuticalsIncMember" xlink:label="CitiusPharmaceuticalsIncMember" xlink:title="CitiusPharmaceuticalsIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipDomain" xlink:to="CitiusPharmaceuticalsIncMember" xlink:title="presentation: OwnershipDomain to CitiusPharmaceuticalsIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="presentation: OwnershipAxis to OwnershipDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="OwnershipAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to OwnershipAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract" xlink:label="InvestmentsAbstract" xlink:title="InvestmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="presentation: InvestmentsAbstract to EquityMethodInvestmentOwnershipPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="MinorityInterestOwnershipPercentageByParent" xlink:title="MinorityInterestOwnershipPercentageByParent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="MinorityInterestOwnershipPercentageByParent" xlink:title="presentation: InvestmentsAbstract to MinorityInterestOwnershipPercentageByParent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfBoardSeats" xlink:label="NumberOfBoardSeats" xlink:title="NumberOfBoardSeats" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="NumberOfBoardSeats" xlink:title="presentation: InvestmentsAbstract to NumberOfBoardSeats" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="EquityMethodInvestments" xlink:title="presentation: InvestmentsAbstract to EquityMethodInvestments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="presentation: InvestmentsAbstract to EquityMethodInvestmentRealizedGainLossOnDisposal" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="InvestmentsAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to InvestmentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel1Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel1Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="presentation: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to DerivativeFinancialInstrumentsLiabilitiesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="presentation: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByLiabilityClassAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByLiabilityClassAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="presentation: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="presentation: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="InvestmentTypeAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to InvestmentTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiabilityAbstract" xlink:label="FairValueNetAssetLiabilityAbstract" xlink:title="FairValueNetAssetLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="LiabilitiesFairValueDisclosure" xlink:title="LiabilitiesFairValueDisclosure" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="LiabilitiesFairValueDisclosure" xlink:title="presentation: LiabilitiesFairValueDisclosureAbstract to LiabilitiesFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: LiabilitiesFairValueDisclosureAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="presentation: LiabilitiesFairValueDisclosureAbstract to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="ProceedsFromIssuanceOfWarrants" xlink:title="presentation: LiabilitiesFairValueDisclosureAbstract to ProceedsFromIssuanceOfWarrants" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="ClassOfWarrantOrRightOutstanding" xlink:title="presentation: LiabilitiesFairValueDisclosureAbstract to ClassOfWarrantOrRightOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueNetAssetLiabilityAbstract" xlink:to="LiabilitiesFairValueDisclosureAbstract" xlink:title="presentation: FairValueNetAssetLiabilityAbstract to LiabilitiesFairValueDisclosureAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueNetAssetLiabilityAbstract" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueNetAssetLiabilityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="presentation: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="OverSubscriptionAmountReceived" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to OverSubscriptionAmountReceived" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to StockRepurchaseProgramAuthorizedAmount1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="LiabilitiesFairValueAdjustment" xlink:title="LiabilitiesFairValueAdjustment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="LiabilitiesFairValueAdjustment" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to LiabilitiesFairValueAdjustment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="ProceedsFromWarrantExercises" xlink:title="ProceedsFromWarrantExercises" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="ProceedsFromWarrantExercises" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to ProceedsFromWarrantExercises" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="EquipmentMember" xlink:title="EquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="EquipmentMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to EquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerEquipmentMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to ComputerEquipmentMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="presentation: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:label="PropertyPlantAndEquipmentGrossAbstract" xlink:title="PropertyPlantAndEquipmentGrossAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="GainLossOnDisposalOfFixedAssets" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to GainLossOnDisposalOfFixedAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RemainingNetBookValueOfFixedAssets" xlink:label="RemainingNetBookValueOfFixedAssets" xlink:title="RemainingNetBookValueOfFixedAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="RemainingNetBookValueOfFixedAssets" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to RemainingNetBookValueOfFixedAssets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to ProceedsFromSaleOfPropertyPlantAndEquipment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="Depreciation" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to Depreciation" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentGrossAbstract" xlink:title="presentation: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentGrossAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentLineItems" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to ScheduleOfPropertyPlantAndEquipmentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesOperatingLeaseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ERSquibbSonsLLCMember" xlink:label="ERSquibbSonsLLCMember" xlink:title="ERSquibbSonsLLCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="ERSquibbSonsLLCMember" xlink:title="presentation: RelatedPartyDomain to ERSquibbSonsLLCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: LesseeLeaseDescriptionTable to RelatedPartyTransactionsByRelatedPartyAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgingPurposeAxis" xlink:label="PledgingPurposeAxis" xlink:title="PledgingPurposeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgingPurposeDomain" xlink:label="PledgingPurposeDomain" xlink:title="PledgingPurposeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember" xlink:label="LetterOfCreditMember" xlink:title="LetterOfCreditMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PledgingPurposeDomain" xlink:to="LetterOfCreditMember" xlink:title="presentation: PledgingPurposeDomain to LetterOfCreditMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PledgingPurposeAxis" xlink:to="PledgingPurposeDomain" xlink:title="presentation: PledgingPurposeAxis to PledgingPurposeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="PledgingPurposeAxis" xlink:title="presentation: LesseeLeaseDescriptionTable to PledgingPurposeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: LesseeLeaseDescriptionTable to SubsequentEventTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="BalanceSheetLocationAxis" xlink:title="BalanceSheetLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="BalanceSheetLocationDomain" xlink:title="BalanceSheetLocationDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="OtherNoncurrentAssetsMember" xlink:title="OtherNoncurrentAssetsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetLocationDomain" xlink:to="OtherNoncurrentAssetsMember" xlink:title="presentation: BalanceSheetLocationDomain to OtherNoncurrentAssetsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetLocationAxis" xlink:to="BalanceSheetLocationDomain" xlink:title="presentation: BalanceSheetLocationAxis to BalanceSheetLocationDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="BalanceSheetLocationAxis" xlink:title="presentation: LesseeLeaseDescriptionTable to BalanceSheetLocationAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LesseeCommitmentToPurchaseProperty" xlink:label="LesseeCommitmentToPurchaseProperty" xlink:title="LesseeCommitmentToPurchaseProperty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LesseeCommitmentToPurchaseProperty" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LesseeCommitmentToPurchaseProperty" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="DepositsAssetsNoncurrent" xlink:title="DepositsAssetsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="DepositsAssetsNoncurrent" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to DepositsAssetsNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to OperatingLeaseRightOfUseAsset" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to OperatingLeaseLiability" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLeaseArea" xlink:label="OperatingLeaseArea" xlink:title="OperatingLeaseArea" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="OperatingLeaseArea" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to OperatingLeaseArea" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LesseeOperatingLeaseTermOfContract" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LesseeOperatingLeaseTermOfContract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialMeasurementOfOperatingLeaseROUAssets" xlink:label="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="InitialMeasurementOfOperatingLeaseROUAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to InitialMeasurementOfOperatingLeaseROUAssets" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialMeasurementOfOperatingLeaseLiabilities" xlink:label="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="InitialMeasurementOfOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to InitialMeasurementOfOperatingLeaseLiabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="OperatingLeaseImpairmentLoss" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to OperatingLeaseImpairmentLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LeaseTerminationFeePayable" xlink:label="LeaseTerminationFeePayable" xlink:title="LeaseTerminationFeePayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LeaseTerminationFeePayable" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LeaseTerminationFeePayable" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LeaseTerminationFee" xlink:label="LeaseTerminationFee" xlink:title="LeaseTerminationFee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LeaseTerminationFee" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LeaseTerminationFee" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="IncreaseDecreaseInOperatingLeaseLiability" xlink:title="IncreaseDecreaseInOperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="IncreaseDecreaseInOperatingLeaseLiability" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to IncreaseDecreaseInOperatingLeaseLiability" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" xlink:label="LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" xlink:title="LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="AreaOfRealEstateProperty" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to AreaOfRealEstateProperty" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract_2" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LesseeOperatingLeaseTermOfContract_2" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LesseeOperatingLeaseTermOfContract" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="LesseeOperatingLeaseRenewalTerm" xlink:title="LesseeOperatingLeaseRenewalTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LesseeOperatingLeaseRenewalTerm" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LesseeOperatingLeaseRenewalTerm" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:label="LineOfCredit" xlink:title="LineOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LineOfCredit" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LineOfCredit" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLeasesMonthlyBaseRent" xlink:label="OperatingLeasesMonthlyBaseRent" xlink:title="OperatingLeasesMonthlyBaseRent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="OperatingLeasesMonthlyBaseRent" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to OperatingLeasesMonthlyBaseRent" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLeasesIncrementalBaseRentalPayment" xlink:label="OperatingLeasesIncrementalBaseRentalPayment" xlink:title="OperatingLeasesIncrementalBaseRentalPayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="OperatingLeasesIncrementalBaseRentalPayment" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to OperatingLeasesIncrementalBaseRentalPayment" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TenantImprovementAllowancePerRentableSquareFoot" xlink:label="TenantImprovementAllowancePerRentableSquareFoot" xlink:title="TenantImprovementAllowancePerRentableSquareFoot" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="TenantImprovementAllowancePerRentableSquareFoot" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to TenantImprovementAllowancePerRentableSquareFoot" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TenantImprovementAllowance" xlink:label="TenantImprovementAllowance" xlink:title="TenantImprovementAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="TenantImprovementAllowance" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to TenantImprovementAllowance" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SubleaseCost" xlink:label="SubleaseCost" xlink:title="SubleaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="SubleaseCost" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to SubleaseCost" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SubleaseCostForTenantImprovements" xlink:label="SubleaseCostForTenantImprovements" xlink:title="SubleaseCostForTenantImprovements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="SubleaseCostForTenantImprovements" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to SubleaseCostForTenantImprovements" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CostRelatedToIssuanceOfLetterOfCredit" xlink:label="CostRelatedToIssuanceOfLetterOfCredit" xlink:title="CostRelatedToIssuanceOfLetterOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="CostRelatedToIssuanceOfLetterOfCredit" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to CostRelatedToIssuanceOfLetterOfCredit" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseDescriptionAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="LesseeLeaseDescriptionLineItems" xlink:title="presentation: LesseeLeaseDescriptionTable to LesseeLeaseDescriptionLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeLeaseDescriptionTable" xlink:title="presentation: LeasesAbstract to LesseeLeaseDescriptionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="OperatingLeaseCost" xlink:title="presentation: LeaseCostAbstract to OperatingLeaseCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome" xlink:label="SubleaseIncome" xlink:title="SubleaseIncome" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="SubleaseIncome" xlink:title="presentation: LeaseCostAbstract to SubleaseIncome" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="VariableLeaseCost" xlink:title="presentation: LeaseCostAbstract to VariableLeaseCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="LeaseCost" xlink:title="presentation: LeaseCostAbstract to LeaseCost" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LeaseCostAbstract" xlink:title="presentation: LeasesAbstract to LeaseCostAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:label="AssetsAndLiabilitiesLesseeAbstract" xlink:title="AssetsAndLiabilitiesLesseeAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLeaseAssestAbstract" xlink:label="OperatingLeaseAssestAbstract" xlink:title="OperatingLeaseAssestAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialMeasurementOfOperatingLeaseROUAssets" xlink:label="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="InitialMeasurementOfOperatingLeaseROUAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="presentation: OperatingLeaseAssestAbstract to InitialMeasurementOfOperatingLeaseROUAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseRightOfUseAssetAmortizationExpense" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseImpairmentLoss" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseImpairmentLoss" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RemeasurementOfOperatingLeaseRightOfUseAsset" xlink:label="RemeasurementOfOperatingLeaseRightOfUseAsset" xlink:title="RemeasurementOfOperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="RemeasurementOfOperatingLeaseRightOfUseAsset" xlink:title="presentation: OperatingLeaseAssestAbstract to RemeasurementOfOperatingLeaseRightOfUseAsset" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ReclassificationFromFixedAssetsToRightOfUseAsset" xlink:label="ReclassificationFromFixedAssetsToRightOfUseAsset" xlink:title="ReclassificationFromFixedAssetsToRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="ReclassificationFromFixedAssetsToRightOfUseAsset" xlink:title="presentation: OperatingLeaseAssestAbstract to ReclassificationFromFixedAssetsToRightOfUseAsset" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_WriteOffOfOperatingLeaseRightOfUseAsset" xlink:label="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:title="WriteOffOfOperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:title="presentation: OperatingLeaseAssestAbstract to WriteOffOfOperatingLeaseRightOfUseAsset" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset_2" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseRightOfUseAsset_2" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseRightOfUseAsset" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAndLiabilitiesLesseeAbstract" xlink:to="OperatingLeaseAssestAbstract" xlink:title="presentation: AssetsAndLiabilitiesLesseeAbstract to OperatingLeaseAssestAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="OperatingLeaseLiabilityAbstract" xlink:title="OperatingLeaseLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialMeasurementOfOperatingLeaseLiabilities" xlink:label="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="InitialMeasurementOfOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="presentation: OperatingLeaseLiabilityAbstract to InitialMeasurementOfOperatingLeaseLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:label="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:title="PrincipalPaymentsOnOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:title="presentation: OperatingLeaseLiabilityAbstract to PrincipalPaymentsOnOperatingLeaseLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RemeasurementOfOperatingLeaseLiability" xlink:label="RemeasurementOfOperatingLeaseLiability" xlink:title="RemeasurementOfOperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="RemeasurementOfOperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilityAbstract to RemeasurementOfOperatingLeaseLiability" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_WriteOffOfOperatingLeaseLiability" xlink:label="WriteOffOfOperatingLeaseLiability" xlink:title="WriteOffOfOperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="WriteOffOfOperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilityAbstract to WriteOffOfOperatingLeaseLiability" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability_2" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiability_2" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiability" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityNoncurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAndLiabilitiesLesseeAbstract" xlink:to="OperatingLeaseLiabilityAbstract" xlink:title="presentation: AssetsAndLiabilitiesLesseeAbstract to OperatingLeaseLiabilityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="AssetsAndLiabilitiesLesseeAbstract" xlink:title="presentation: LeasesAbstract to AssetsAndLiabilitiesLesseeAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:label="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:title="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="presentation: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="presentation: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to OperatingLeaseWeightedAverageDiscountRatePercent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to OperatingLeaseLiability" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="presentation: LeasesAbstract to OperatingLeaseLiabilitiesPaymentsDueAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesSubleaseAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AreaOfSubleaseSpaceCurrentlyRented" xlink:label="AreaOfSubleaseSpaceCurrentlyRented" xlink:title="AreaOfSubleaseSpaceCurrentlyRented" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="AreaOfSubleaseSpaceCurrentlyRented" xlink:title="presentation: LeasesAbstract to AreaOfSubleaseSpaceCurrentlyRented" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:label="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:title="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:title="presentation: LeasesAbstract to PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:title="presentation: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:title="presentation: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:title="presentation: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" xlink:title="presentation: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:title="presentation: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract to SaleLeasebackTransactionsFutureMinimumSubleaseRentals" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:title="presentation: LeasesAbstract to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLeasePayments" xlink:label="ProceedsFromLeasePayments" xlink:title="ProceedsFromLeasePayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="ProceedsFromLeasePayments" xlink:title="presentation: LeasesAbstract to ProceedsFromLeasePayments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" />
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwillDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="ImpairmentOfOngoingProject" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to ImpairmentOfOngoingProject" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="Goodwill" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to Goodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="RelatedPartyTransactionsAbstract" xlink:title="RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_FactorBioscienceIncMember" xlink:label="FactorBioscienceIncMember" xlink:title="FactorBioscienceIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="FactorBioscienceIncMember" xlink:title="presentation: RelatedPartyDomain to FactorBioscienceIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ExacisBiotherapeuticsIncMember" xlink:label="ExacisBiotherapeuticsIncMember" xlink:title="ExacisBiotherapeuticsIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="ExacisBiotherapeuticsIncMember" xlink:title="presentation: RelatedPartyDomain to ExacisBiotherapeuticsIncMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to RelatedPartyTransactionsByRelatedPartyAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="presentation: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="presentation: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="InvestmentTypeAxis" xlink:title="presentation: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to InvestmentTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to ClassOfWarrantOrRightAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="RelatedPartyTransactionLineItems" xlink:title="RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:label="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:title="RelatedPartyTransactionDueFromToRelatedPartyAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_MasterServiceAgreementInitialFeesPayable" xlink:label="MasterServiceAgreementInitialFeesPayable" xlink:title="MasterServiceAgreementInitialFeesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:to="MasterServiceAgreementInitialFeesPayable" xlink:title="presentation: RelatedPartyTransactionDueFromToRelatedPartyAbstract to MasterServiceAgreementInitialFeesPayable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfMonthlyInstallmentsForFeesPayable" xlink:label="NumberOfMonthlyInstallmentsForFeesPayable" xlink:title="NumberOfMonthlyInstallmentsForFeesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:to="NumberOfMonthlyInstallmentsForFeesPayable" xlink:title="presentation: RelatedPartyTransactionDueFromToRelatedPartyAbstract to NumberOfMonthlyInstallmentsForFeesPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:label="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:title="RelatedPartyTransactionPeriodicFeesPaymentAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:to="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:title="presentation: RelatedPartyTransactionDueFromToRelatedPartyAbstract to RelatedPartyTransactionPeriodicFeesPaymentAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InitialLicenseFeeObligation" xlink:label="InitialLicenseFeeObligation" xlink:title="InitialLicenseFeeObligation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:to="InitialLicenseFeeObligation" xlink:title="presentation: RelatedPartyTransactionDueFromToRelatedPartyAbstract to InitialLicenseFeeObligation" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_MonthlyMasterServicesAgreementFeesPayable" xlink:label="MonthlyMasterServicesAgreementFeesPayable" xlink:title="MonthlyMasterServicesAgreementFeesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:to="MonthlyMasterServicesAgreementFeesPayable" xlink:title="presentation: RelatedPartyTransactionDueFromToRelatedPartyAbstract to MonthlyMasterServicesAgreementFeesPayable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:label="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:title="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:to="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:title="presentation: RelatedPartyTransactionDueFromToRelatedPartyAbstract to DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoticePeriodForFirstTerminationOfContract" xlink:label="NoticePeriodForFirstTerminationOfContract" xlink:title="NoticePeriodForFirstTerminationOfContract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:to="NoticePeriodForFirstTerminationOfContract" xlink:title="presentation: RelatedPartyTransactionDueFromToRelatedPartyAbstract to NoticePeriodForFirstTerminationOfContract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoticePeriodForSupersedingTerminationProvisions" xlink:label="NoticePeriodForSupersedingTerminationProvisions" xlink:title="NoticePeriodForSupersedingTerminationProvisions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:to="NoticePeriodForSupersedingTerminationProvisions" xlink:title="presentation: RelatedPartyTransactionDueFromToRelatedPartyAbstract to NoticePeriodForSupersedingTerminationProvisions" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AgreedWaivePayment" xlink:label="AgreedWaivePayment" xlink:title="AgreedWaivePayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:to="AgreedWaivePayment" xlink:title="presentation: RelatedPartyTransactionDueFromToRelatedPartyAbstract to AgreedWaivePayment" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:to="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="presentation: RelatedPartyTransactionDueFromToRelatedPartyAbstract to ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RemainingLicenseFeeObligation" xlink:label="RemainingLicenseFeeObligation" xlink:title="RemainingLicenseFeeObligation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:to="RemainingLicenseFeeObligation" xlink:title="presentation: RelatedPartyTransactionDueFromToRelatedPartyAbstract to RemainingLicenseFeeObligation" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ReimburseCostsIncurredOrPaid" xlink:label="ReimburseCostsIncurredOrPaid" xlink:title="ReimburseCostsIncurredOrPaid" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:to="ReimburseCostsIncurredOrPaid" xlink:title="presentation: RelatedPartyTransactionDueFromToRelatedPartyAbstract to ReimburseCostsIncurredOrPaid" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionLineItems" xlink:to="RelatedPartyTransactionDueFromToRelatedPartyAbstract" xlink:title="presentation: RelatedPartyTransactionLineItems to RelatedPartyTransactionDueFromToRelatedPartyAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ExacisOptionAgreementAbstract" xlink:label="ExacisOptionAgreementAbstract" xlink:title="ExacisOptionAgreementAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentOfOptionFee" xlink:label="PaymentOfOptionFee" xlink:title="PaymentOfOptionFee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExacisOptionAgreementAbstract" xlink:to="PaymentOfOptionFee" xlink:title="presentation: ExacisOptionAgreementAbstract to PaymentOfOptionFee" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ExacisOptionAgreementAbstract" xlink:title="presentation: RelatedPartyTransactionLineItems to ExacisOptionAgreementAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_Q422PIPETransactionAbstract" xlink:label="Q422PIPETransactionAbstract" xlink:title="Q422PIPETransactionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Q422PIPETransactionAbstract" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="presentation: Q422PIPETransactionAbstract to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Q422PIPETransactionAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="presentation: Q422PIPETransactionAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_UnitPriceOfWarrants" xlink:label="UnitPriceOfWarrants" xlink:title="UnitPriceOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Q422PIPETransactionAbstract" xlink:to="UnitPriceOfWarrants" xlink:title="presentation: Q422PIPETransactionAbstract to UnitPriceOfWarrants" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Q422PIPETransactionAbstract" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="presentation: Q422PIPETransactionAbstract to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Q422PIPETransactionAbstract" xlink:to="ProceedsFromIssuanceOfWarrants" xlink:title="presentation: Q422PIPETransactionAbstract to ProceedsFromIssuanceOfWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Q422PIPETransactionAbstract" xlink:to="ClassOfWarrantOrRightsExercisableTerm" xlink:title="presentation: Q422PIPETransactionAbstract to ClassOfWarrantOrRightsExercisableTerm" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Q422PIPETransactionAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="presentation: Q422PIPETransactionAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionLineItems" xlink:to="Q422PIPETransactionAbstract" xlink:title="presentation: RelatedPartyTransactionLineItems to Q422PIPETransactionAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="RelatedPartyTransactionLineItems" xlink:title="presentation: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to RelatedPartyTransactionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsAbstract" xlink:to="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="presentation: RelatedPartyTransactionsAbstract to ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to EmployeeRelatedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedProfessionalFeesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedProfessionalFeesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AccruedClinicalCurrent" xlink:label="AccruedClinicalCurrent" xlink:title="AccruedClinicalCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedClinicalCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedClinicalCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AccruedPrivatePlacementInPublicEquityCurrent" xlink:label="AccruedPrivatePlacementInPublicEquityCurrent" xlink:title="AccruedPrivatePlacementInPublicEquityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedPrivatePlacementInPublicEquityCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedPrivatePlacementInPublicEquityCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to OtherAccruedLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedLiabilitiesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/DebtDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaycheckProtectionProgramLoanMember" xlink:label="PaycheckProtectionProgramLoanMember" xlink:title="PaycheckProtectionProgramLoanMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="PaycheckProtectionProgramLoanMember" xlink:title="presentation: DebtInstrumentNameDomain to PaycheckProtectionProgramLoanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaycheckProtectionProgramMember" xlink:label="PaycheckProtectionProgramMember" xlink:title="PaycheckProtectionProgramMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="PaycheckProtectionProgramMember" xlink:title="presentation: DebtInstrumentNameDomain to PaycheckProtectionProgramMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BrooklynPaycheckProtectionProgramMember" xlink:label="BrooklynPaycheckProtectionProgramMember" xlink:title="BrooklynPaycheckProtectionProgramMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="BrooklynPaycheckProtectionProgramMember" xlink:title="presentation: DebtInstrumentNameDomain to BrooklynPaycheckProtectionProgramMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DebtInstrumentAbstract" xlink:label="DebtInstrumentAbstract" xlink:title="DebtInstrumentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableCurrent" xlink:label="LoansPayableCurrent" xlink:title="LoansPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAbstract" xlink:to="LoansPayableCurrent" xlink:title="presentation: DebtInstrumentAbstract to LoansPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAbstract" xlink:to="RepaymentsOfNotesPayable" xlink:title="presentation: DebtInstrumentAbstract to RepaymentsOfNotesPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PaymentOfAccruedAndUnpaidInterest" xlink:label="PaymentOfAccruedAndUnpaidInterest" xlink:title="PaymentOfAccruedAndUnpaidInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAbstract" xlink:to="PaymentOfAccruedAndUnpaidInterest" xlink:title="presentation: DebtInstrumentAbstract to PaymentOfAccruedAndUnpaidInterest" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAbstract" xlink:to="DebtInstrumentFaceAmount" xlink:title="presentation: DebtInstrumentAbstract to DebtInstrumentFaceAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: DebtInstrumentAbstract to DebtInstrumentInterestRateStatedPercentage" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAbstract" xlink:to="GainsLossesOnExtinguishmentOfDebt" xlink:title="presentation: DebtInstrumentAbstract to GainsLossesOnExtinguishmentOfDebt" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAbstract" xlink:to="LongTermDebt" xlink:title="presentation: DebtInstrumentAbstract to LongTermDebt" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentAbstract" xlink:title="presentation: DebtInstrumentLineItems to DebtInstrumentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LegalMattersAbstract" xlink:label="LegalMattersAbstract" xlink:title="LegalMattersAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LitigationSettlementAmountPayable" xlink:label="LitigationSettlementAmountPayable" xlink:title="LitigationSettlementAmountPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="LitigationSettlementAmountPayable" xlink:title="presentation: LegalMattersAbstract to LitigationSettlementAmountPayable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="LitigationSettlementAmountAwardedToOtherParty" xlink:title="LitigationSettlementAmountAwardedToOtherParty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="LitigationSettlementAmountAwardedToOtherParty" xlink:title="presentation: LegalMattersAbstract to LitigationSettlementAmountAwardedToOtherParty" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="LegalMattersAbstract" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to LegalMattersAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_UniversityOfSouthFloridaMember" xlink:label="UniversityOfSouthFloridaMember" xlink:title="UniversityOfSouthFloridaMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityDomain" xlink:to="UniversityOfSouthFloridaMember" xlink:title="presentation: EntityDomain to UniversityOfSouthFloridaMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="presentation: LegalEntityAxis to EntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="LegalEntityAxis" xlink:title="presentation: LossContingenciesTable to LegalEntityAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ExclusiveFactorLicenseAgreementMember" xlink:label="ExclusiveFactorLicenseAgreementMember" xlink:title="ExclusiveFactorLicenseAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="ExclusiveFactorLicenseAgreementMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to ExclusiveFactorLicenseAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: LossContingenciesTable to TypeOfArrangementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LicensingAgreementsAbstract" xlink:label="LicensingAgreementsAbstract" xlink:title="LicensingAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LicenseAgreementTerm" xlink:label="LicenseAgreementTerm" xlink:title="LicenseAgreementTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="LicenseAgreementTerm" xlink:title="presentation: LicensingAgreementsAbstract to LicenseAgreementTerm" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LicenseAgreementExtensionTerm" xlink:label="LicenseAgreementExtensionTerm" xlink:title="LicenseAgreementExtensionTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="LicenseAgreementExtensionTerm" xlink:title="presentation: LicensingAgreementsAbstract to LicenseAgreementExtensionTerm" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod" xlink:label="ThresholdIncomeForAutomaticExtensionOfLicensePeriod" xlink:title="ThresholdIncomeForAutomaticExtensionOfLicensePeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="ThresholdIncomeForAutomaticExtensionOfLicensePeriod" xlink:title="presentation: LicensingAgreementsAbstract to ThresholdIncomeForAutomaticExtensionOfLicensePeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod" xlink:label="PercentageOfSublicenseFeePayableBeforeExpirationPeriod" xlink:title="PercentageOfSublicenseFeePayableBeforeExpirationPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="PercentageOfSublicenseFeePayableBeforeExpirationPeriod" xlink:title="presentation: LicensingAgreementsAbstract to PercentageOfSublicenseFeePayableBeforeExpirationPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfSublicenseFeePayableDuringRenewalTerm" xlink:label="PercentageOfSublicenseFeePayableDuringRenewalTerm" xlink:title="PercentageOfSublicenseFeePayableDuringRenewalTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="PercentageOfSublicenseFeePayableDuringRenewalTerm" xlink:title="presentation: LicensingAgreementsAbstract to PercentageOfSublicenseFeePayableDuringRenewalTerm" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LossContingencyPercentageOfRoyaltyPayable" xlink:label="LossContingencyPercentageOfRoyaltyPayable" xlink:title="LossContingencyPercentageOfRoyaltyPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="LossContingencyPercentageOfRoyaltyPayable" xlink:title="presentation: LicensingAgreementsAbstract to LossContingencyPercentageOfRoyaltyPayable" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesLineItems" xlink:to="LicensingAgreementsAbstract" xlink:title="presentation: LossContingenciesLineItems to LicensingAgreementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="LossContingenciesLineItems" xlink:title="presentation: LossContingenciesTable to LossContingenciesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="LossContingenciesTable" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to LossContingenciesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InvestorRoyaltyAgreementMember" xlink:label="InvestorRoyaltyAgreementMember" xlink:title="InvestorRoyaltyAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="InvestorRoyaltyAgreementMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to InvestorRoyaltyAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CollaboratorRoyaltyAgreementMember" xlink:label="CollaboratorRoyaltyAgreementMember" xlink:title="CollaboratorRoyaltyAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="CollaboratorRoyaltyAgreementMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to CollaboratorRoyaltyAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: LossContingenciesTable to TypeOfArrangementAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RoyaltyAgreementsAbstract" xlink:label="RoyaltyAgreementsAbstract" xlink:title="RoyaltyAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LossContingencyPercentageOfRoyaltyPayable" xlink:label="LossContingencyPercentageOfRoyaltyPayable" xlink:title="LossContingencyPercentageOfRoyaltyPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RoyaltyAgreementsAbstract" xlink:to="LossContingencyPercentageOfRoyaltyPayable" xlink:title="presentation: RoyaltyAgreementsAbstract to LossContingencyPercentageOfRoyaltyPayable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" xlink:label="PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" xlink:title="PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RoyaltyAgreementsAbstract" xlink:to="PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" xlink:title="presentation: RoyaltyAgreementsAbstract to PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:label="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RoyaltyAgreementsAbstract" xlink:to="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="presentation: RoyaltyAgreementsAbstract to PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesLineItems" xlink:to="RoyaltyAgreementsAbstract" xlink:title="presentation: LossContingenciesLineItems to RoyaltyAgreementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="LossContingenciesLineItems" xlink:title="presentation: LossContingenciesTable to LossContingenciesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="LossContingenciesTable" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to LossContingenciesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="DefinedContributionPlanTable" xlink:title="DefinedContributionPlanTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis" xlink:label="RetirementPlanNameAxis" xlink:title="RetirementPlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="RetirementPlanNameDomain" xlink:title="RetirementPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_RetirementPlan401KMember" xlink:label="RetirementPlan401KMember" xlink:title="RetirementPlan401KMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RetirementPlanNameDomain" xlink:to="RetirementPlan401KMember" xlink:title="presentation: RetirementPlanNameDomain to RetirementPlan401KMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RetirementPlanNameAxis" xlink:to="RetirementPlanNameDomain" xlink:title="presentation: RetirementPlanNameAxis to RetirementPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanTable" xlink:to="RetirementPlanNameAxis" xlink:title="presentation: DefinedContributionPlanTable to RetirementPlanNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanTable" xlink:to="RangeAxis" xlink:title="presentation: DefinedContributionPlanTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: DefinedContributionPlanTable to SubsequentEventTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="DefinedContributionPlanDisclosureLineItems" xlink:title="DefinedContributionPlanDisclosureLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanAbstract" xlink:label="DefinedContributionPlanAbstract" xlink:title="DefinedContributionPlanAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:label="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:title="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanAbstract" xlink:to="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:title="presentation: DefinedContributionPlanAbstract to DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanAbstract" xlink:to="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:title="presentation: DefinedContributionPlanAbstract to DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:label="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:title="DefinedContributionPlanEmployeeContributionAtThresholdOne" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanAbstract" xlink:to="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:title="presentation: DefinedContributionPlanAbstract to DefinedContributionPlanEmployeeContributionAtThresholdOne" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanAbstract" xlink:to="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:title="presentation: DefinedContributionPlanAbstract to DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:label="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:title="DefinedContributionPlanEmployeeContributionAtThresholdTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanAbstract" xlink:to="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:title="presentation: DefinedContributionPlanAbstract to DefinedContributionPlanEmployeeContributionAtThresholdTwo" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:title="DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanAbstract" xlink:to="DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:title="presentation: DefinedContributionPlanAbstract to DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanAbstract" xlink:title="presentation: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanTable" xlink:to="DefinedContributionPlanDisclosureLineItems" xlink:title="presentation: DefinedContributionPlanTable to DefinedContributionPlanDisclosureLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="DefinedContributionPlanTable" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to DefinedContributionPlanTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to WarrantMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="ConvertiblePreferredStockMember" xlink:title="ConvertiblePreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="ConvertiblePreferredStockMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to ConvertiblePreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to RestrictedStockUnitsRSUMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareDilutedOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="presentation: EarningsPerShareDilutedOtherDisclosuresAbstract to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to EarningsPerShareDilutedOtherDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EquityIncentivePlan2020Member" xlink:label="EquityIncentivePlan2020Member" xlink:title="EquityIncentivePlan2020Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="EquityIncentivePlan2020Member" xlink:title="presentation: PlanNameDomain to EquityIncentivePlan2020Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_InducementPlan2021Member" xlink:label="InducementPlan2021Member" xlink:title="InducementPlan2021Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="InducementPlan2021Member" xlink:title="presentation: PlanNameDomain to InducementPlan2021Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="presentation: PlanNameAxis to PlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IncentiveStockOptionsMember" xlink:label="IncentiveStockOptionsMember" xlink:title="IncentiveStockOptionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockOptionMember" xlink:to="IncentiveStockOptionsMember" xlink:title="presentation: EmployeeStockOptionMember to IncentiveStockOptionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NonQualifiedStockOptionMember" xlink:label="NonQualifiedStockOptionMember" xlink:title="NonQualifiedStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockOptionMember" xlink:to="NonQualifiedStockOptionMember" xlink:title="presentation: EmployeeStockOptionMember to NonQualifiedStockOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfSharesOfCommonStockOutstanding" xlink:label="PercentageOfSharesOfCommonStockOutstanding" xlink:title="PercentageOfSharesOfCommonStockOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="PercentageOfSharesOfCommonStockOutstanding" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to PercentageOfSharesOfCommonStockOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="presentation: ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AggregateIntrinsicValueAbstract" xlink:label="AggregateIntrinsicValueAbstract" xlink:title="AggregateIntrinsicValueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AggregateIntrinsicValueAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="presentation: AggregateIntrinsicValueAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AggregateIntrinsicValueAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:title="presentation: AggregateIntrinsicValueAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="AggregateIntrinsicValueAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to AggregateIntrinsicValueAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TimeBasedStockOptionMember" xlink:label="TimeBasedStockOptionMember" xlink:title="TimeBasedStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockOptionMember" xlink:to="TimeBasedStockOptionMember" xlink:title="presentation: EmployeeStockOptionMember to TimeBasedStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PerformanceBasedStockOptionMember" xlink:label="PerformanceBasedStockOptionMember" xlink:title="PerformanceBasedStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockOptionMember" xlink:to="PerformanceBasedStockOptionMember" xlink:title="presentation: EmployeeStockOptionMember to PerformanceBasedStockOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to AllocatedShareBasedCompensationExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationRsusDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfAwardsVestedAndSettledAbstract" xlink:label="NumberOfAwardsVestedAndSettledAbstract" xlink:title="NumberOfAwardsVestedAndSettledAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="presentation: NumberOfAwardsVestedAndSettledAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonStockWithheldToCoverTaxes" xlink:label="CommonStockWithheldToCoverTaxes" xlink:title="CommonStockWithheldToCoverTaxes" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="CommonStockWithheldToCoverTaxes" xlink:title="presentation: NumberOfAwardsVestedAndSettledAbstract to CommonStockWithheldToCoverTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="presentation: NumberOfAwardsVestedAndSettledAbstract to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="NumberOfAwardsVestedAndSettledAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to NumberOfAwardsVestedAndSettledAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to AllocatedShareBasedCompensationExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="presentation: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="IncomeStatementLocationAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to IncomeStatementLocationAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:label="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract to AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PIPEInvestorOneMember" xlink:label="PIPEInvestorOneMember" xlink:title="PIPEInvestorOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorOneMember" xlink:title="presentation: InvestmentTypeCategorizationMember to PIPEInvestorOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="presentation: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="presentation: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="InvestmentTypeAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to InvestmentTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsOneMember" xlink:label="CommonWarrantsOneMember" xlink:title="CommonWarrantsOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantMember" xlink:to="CommonWarrantsOneMember" xlink:title="presentation: WarrantMember to CommonWarrantsOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantMember" xlink:to="CommonWarrantsMember" xlink:title="presentation: WarrantMember to CommonWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantMember" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: WarrantMember to PreFundedWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="WarrantMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to WarrantMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="presentation: EquityComponentDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to StatementEquityComponentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="RangeAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PrivatePlacementOfEquityAbstract" xlink:label="PrivatePlacementOfEquityAbstract" xlink:title="PrivatePlacementOfEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="presentation: PrivatePlacementOfEquityAbstract to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="presentation: PrivatePlacementOfEquityAbstract to StockRepurchaseProgramAuthorizedAmount1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ProceedsFromIssuanceOfWarrants" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ProceedsFromIssuanceOfWarrants" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_VariableRateTransactionsPeriod" xlink:label="VariableRateTransactionsPeriod" xlink:title="VariableRateTransactionsPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="VariableRateTransactionsPeriod" xlink:title="presentation: PrivatePlacementOfEquityAbstract to VariableRateTransactionsPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_UnitPriceOfWarrants" xlink:label="UnitPriceOfWarrants" xlink:title="UnitPriceOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="UnitPriceOfWarrants" xlink:title="presentation: PrivatePlacementOfEquityAbstract to UnitPriceOfWarrants" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NumberOfWarrantsInEachUnit" xlink:label="NumberOfWarrantsInEachUnit" xlink:title="NumberOfWarrantsInEachUnit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="NumberOfWarrantsInEachUnit" xlink:title="presentation: PrivatePlacementOfEquityAbstract to NumberOfWarrantsInEachUnit" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:label="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightsExercisableTerm" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightsExercisableTerm" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="presentation: PrivatePlacementOfEquityAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightExercised" xlink:label="ClassOfWarrantOrRightExercised" xlink:title="ClassOfWarrantOrRightExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightExercised" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightExercised" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants_2" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ProceedsFromIssuanceOfWarrants_2" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ProceedsFromIssuanceOfWarrants" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="presentation: PrivatePlacementOfEquityAbstract to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="OverSubscriptionAmountReceived" xlink:title="presentation: PrivatePlacementOfEquityAbstract to OverSubscriptionAmountReceived" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:label="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ObligationToPayLiquidatedDamagesPercentage" xlink:label="ObligationToPayLiquidatedDamagesPercentage" xlink:title="ObligationToPayLiquidatedDamagesPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ObligationToPayLiquidatedDamagesPercentage" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ObligationToPayLiquidatedDamagesPercentage" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TransactionFeesPayable" xlink:label="TransactionFeesPayable" xlink:title="TransactionFeesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="TransactionFeesPayable" xlink:title="presentation: PrivatePlacementOfEquityAbstract to TransactionFeesPayable" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_AggregateCalendarDays" xlink:label="AggregateCalendarDays" xlink:title="AggregateCalendarDays" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="AggregateCalendarDays" xlink:title="presentation: PrivatePlacementOfEquityAbstract to AggregateCalendarDays" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="LossContingencyEstimateOfPossibleLoss" xlink:title="LossContingencyEstimateOfPossibleLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="LossContingencyEstimateOfPossibleLoss" xlink:title="presentation: PrivatePlacementOfEquityAbstract to LossContingencyEstimateOfPossibleLoss" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="LossContingencyDamagesPaidValue" xlink:title="LossContingencyDamagesPaidValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="LossContingencyDamagesPaidValue" xlink:title="presentation: PrivatePlacementOfEquityAbstract to LossContingencyDamagesPaidValue" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="presentation: PrivatePlacementOfEquityAbstract to WarrantsAndRightsOutstandingTerm" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="PrivatePlacementOfEquityAbstract" xlink:title="presentation: SubsidiarySaleOfStockLineItems to PrivatePlacementOfEquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="SubsidiarySaleOfStockLineItems" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to SubsidiarySaleOfStockLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="presentation: StockholdersEquityNoteAbstract to SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="ClassOfWarrantOrRightTable" xlink:title="ClassOfWarrantOrRightTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_March2022WarrantsMember" xlink:label="March2022WarrantsMember" xlink:title="March2022WarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantMember" xlink:to="March2022WarrantsMember" xlink:title="presentation: WarrantMember to March2022WarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantMember" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: WarrantMember to PreFundedWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_November2022WarrantsMember" xlink:label="November2022WarrantsMember" xlink:title="November2022WarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantMember" xlink:to="November2022WarrantsMember" xlink:title="presentation: WarrantMember to November2022WarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="WarrantMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to WarrantMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: ClassOfWarrantOrRightTable to ClassOfWarrantOrRightAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="ClassOfWarrantOrRightLineItems" xlink:title="ClassOfWarrantOrRightLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ClassOfWarrantOrRightOutstanding" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to ClassOfWarrantOrRightOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightGrantsInPeriod" xlink:label="ClassOfWarrantOrRightGrantsInPeriod" xlink:title="ClassOfWarrantOrRightGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ClassOfWarrantOrRightGrantsInPeriod" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to ClassOfWarrantOrRightGrantsInPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightExercisedInPeriod" xlink:label="ClassOfWarrantOrRightExercisedInPeriod" xlink:title="ClassOfWarrantOrRightExercisedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ClassOfWarrantOrRightExercisedInPeriod" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to ClassOfWarrantOrRightExercisedInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding_2" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ClassOfWarrantOrRightOutstanding_2" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to ClassOfWarrantOrRightOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="presentation: ClassOfWarrantOrRightLineItems to WarrantsAndRightsNoteDisclosureAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightTable" xlink:to="ClassOfWarrantOrRightLineItems" xlink:title="presentation: ClassOfWarrantOrRightTable to ClassOfWarrantOrRightLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="ClassOfWarrantOrRightTable" xlink:title="presentation: StockholdersEquityNoteAbstract to ClassOfWarrantOrRightTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PurchaseAgreementMember" xlink:label="PurchaseAgreementMember" xlink:title="PurchaseAgreementMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_FirstPurchaseAgreementMember" xlink:label="FirstPurchaseAgreementMember" xlink:title="FirstPurchaseAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PurchaseAgreementMember" xlink:to="FirstPurchaseAgreementMember" xlink:title="presentation: PurchaseAgreementMember to FirstPurchaseAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SecondPurchaseAgreementMember" xlink:label="SecondPurchaseAgreementMember" xlink:title="SecondPurchaseAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PurchaseAgreementMember" xlink:to="SecondPurchaseAgreementMember" xlink:title="presentation: PurchaseAgreementMember to SecondPurchaseAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="PurchaseAgreementMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to PurchaseAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to TypeOfArrangementAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LincolnParkCapitalFundLLCMember" xlink:label="LincolnParkCapitalFundLLCMember" xlink:title="LincolnParkCapitalFundLLCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityDomain" xlink:to="LincolnParkCapitalFundLLCMember" xlink:title="presentation: EntityDomain to LincolnParkCapitalFundLLCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="presentation: LegalEntityAxis to EntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="LegalEntityAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to LegalEntityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="RangeAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PrivatePlacementOfferingsAbstract" xlink:label="PrivatePlacementOfferingsAbstract" xlink:title="PrivatePlacementOfferingsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfferingsAbstract" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="presentation: PrivatePlacementOfferingsAbstract to ProceedsFromIssuanceOfCommonStock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:label="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:title="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfferingsAbstract" xlink:to="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:title="presentation: PrivatePlacementOfferingsAbstract to NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" xlink:label="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" xlink:title="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfferingsAbstract" xlink:to="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" xlink:title="presentation: PrivatePlacementOfferingsAbstract to NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfferingsAbstract" xlink:to="CommonStockSharesAuthorized" xlink:title="presentation: PrivatePlacementOfferingsAbstract to CommonStockSharesAuthorized" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_CommitmentAmountToMeetAnySingleRegularPurchase" xlink:label="CommitmentAmountToMeetAnySingleRegularPurchase" xlink:title="CommitmentAmountToMeetAnySingleRegularPurchase" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfferingsAbstract" xlink:to="CommitmentAmountToMeetAnySingleRegularPurchase" xlink:title="presentation: PrivatePlacementOfferingsAbstract to CommitmentAmountToMeetAnySingleRegularPurchase" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_BeneficialOwnershipPercentageOnTotalOutstandingShares" xlink:label="BeneficialOwnershipPercentageOnTotalOutstandingShares" xlink:title="BeneficialOwnershipPercentageOnTotalOutstandingShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfferingsAbstract" xlink:to="BeneficialOwnershipPercentageOnTotalOutstandingShares" xlink:title="presentation: PrivatePlacementOfferingsAbstract to BeneficialOwnershipPercentageOnTotalOutstandingShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfferingsAbstract" xlink:to="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="presentation: PrivatePlacementOfferingsAbstract to SaleOfStockNumberOfSharesIssuedInTransaction" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="ProceedsFromIssuanceOrSaleOfEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfferingsAbstract" xlink:to="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="presentation: PrivatePlacementOfferingsAbstract to ProceedsFromIssuanceOrSaleOfEquity" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesToIssuedInTransaction" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfferingsAbstract" xlink:to="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:title="presentation: PrivatePlacementOfferingsAbstract to SaleOfStockNumberOfSharesToIssuedInTransaction" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="PrivatePlacementOfferingsAbstract" xlink:title="presentation: SubsidiarySaleOfStockLineItems to PrivatePlacementOfferingsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="SubsidiarySaleOfStockLineItems" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to SubsidiarySaleOfStockLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="presentation: StockholdersEquityNoteAbstract to SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsMergerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="presentation: EquityComponentDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: ScheduleOfStockByClassTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="presentation: ClassOfStockDomain to CommonClassAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassBMember" xlink:title="presentation: ClassOfStockDomain to CommonClassBMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassCMember" xlink:title="presentation: ClassOfStockDomain to CommonClassCMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: ScheduleOfStockByClassTable to StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfStockByClassTable to BusinessAcquisitionAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_MergerAbstract" xlink:label="MergerAbstract" xlink:title="MergerAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="SharesIssued" xlink:title="SharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="SharesIssued" xlink:title="presentation: MergerAbstract to SharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="ConversionOfStockSharesConverted1" xlink:title="ConversionOfStockSharesConverted1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="ConversionOfStockSharesConverted1" xlink:title="presentation: MergerAbstract to ConversionOfStockSharesConverted1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ClassOfWarrantOrRightIssued" xlink:label="ClassOfWarrantOrRightIssued" xlink:title="ClassOfWarrantOrRightIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="ClassOfWarrantOrRightIssued" xlink:title="presentation: MergerAbstract to ClassOfWarrantOrRightIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: MergerAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="presentation: MergerAbstract to StockIssuedDuringPeriodSharesAcquisitions1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="MergerAbstract" xlink:title="presentation: ClassOfStockLineItems to MergerAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="ClassOfStockLineItems" xlink:title="presentation: ScheduleOfStockByClassTable to ClassOfStockLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="ScheduleOfStockByClassTable" xlink:title="presentation: StockholdersEquityNoteAbstract to ScheduleOfStockByClassTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to NovellusTherapeuticsLimitedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfStockByClassTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:label="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="presentation: RelatedPartyDomain to ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: ScheduleOfStockByClassTable to RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfStockByClassTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodSharesAcquisitions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodSharesIssuedForServices" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EachLockUpAgreementExtendsTerm" xlink:label="EachLockUpAgreementExtendsTerm" xlink:title="EachLockUpAgreementExtendsTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EachLockUpAgreementExtendsTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EachLockUpAgreementExtendsTerm" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_PercentageOfCommonStockSubjectToLockUpAgreement" xlink:label="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="PercentageOfCommonStockSubjectToLockUpAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PercentageOfCommonStockSubjectToLockUpAgreement" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: ClassOfStockLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="ClassOfStockLineItems" xlink:title="presentation: ScheduleOfStockByClassTable to ClassOfStockLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="ScheduleOfStockByClassTable" xlink:title="presentation: StockholdersEquityNoteAbstract to ScheduleOfStockByClassTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="presentation: EquityComponentDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: ScheduleOfStockByClassTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="presentation: ClassOfStockDomain to SeriesAPreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: ScheduleOfStockByClassTable to StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:label="FeaturesOfConvertiblePreferredStockAbstract" xlink:title="FeaturesOfConvertiblePreferredStockAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="PreferredStockSharesAuthorized" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to PreferredStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="PreferredStockSharesIssued" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to PreferredStockSharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="PreferredStockSharesOutstanding" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to PreferredStockSharesOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare" xlink:label="DividendsPayableAmountPerShare" xlink:title="DividendsPayableAmountPerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="DividendsPayableAmountPerShare" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to DividendsPayableAmountPerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="DividendsPreferredStockCash" xlink:title="DividendsPreferredStockCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="DividendsPreferredStockCash" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to DividendsPreferredStockCash" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="PreferredStockDividendsShares" xlink:title="PreferredStockDividendsShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="PreferredStockDividendsShares" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to PreferredStockDividendsShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="PreferredStockLiquidationPreference" xlink:title="PreferredStockLiquidationPreference" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="PreferredStockLiquidationPreference" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to PreferredStockLiquidationPreference" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionRatio" xlink:label="PreferredStockConvertibleConversionRatio" xlink:title="PreferredStockConvertibleConversionRatio" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="PreferredStockConvertibleConversionRatio" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to PreferredStockConvertibleConversionRatio" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="ConvertiblePreferredStockSharesIssuedUponConversion" xlink:title="ConvertiblePreferredStockSharesIssuedUponConversion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="ConvertiblePreferredStockSharesIssuedUponConversion" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to ConvertiblePreferredStockSharesIssuedUponConversion" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="PreferredStockConvertibleSharesIssuable" xlink:title="PreferredStockConvertibleSharesIssuable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="PreferredStockConvertibleSharesIssuable" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to PreferredStockConvertibleSharesIssuable" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="FeaturesOfConvertiblePreferredStockAbstract" xlink:title="presentation: ClassOfStockLineItems to FeaturesOfConvertiblePreferredStockAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="ClassOfStockLineItems" xlink:title="presentation: ScheduleOfStockByClassTable to ClassOfStockLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="ScheduleOfStockByClassTable" xlink:title="presentation: StockholdersEquityNoteAbstract to ScheduleOfStockByClassTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="presentation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="presentation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentFederalTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentFederalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentStateAndLocalTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="CurrentForeignTaxExpenseBenefit" xlink:title="CurrentForeignTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentForeignTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentForeignTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentIncomeTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentIncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="presentation: ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredFederalIncomeTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="DeferredForeignIncomeTaxExpenseBenefit" xlink:title="DeferredForeignIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredForeignIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredForeignIncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredIncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="presentation: ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:label="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:title="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:title="presentation: ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract to EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract to IncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="DeferredTaxAssetsNetAbstract" xlink:title="DeferredTaxAssetsNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsOperatingLossCarryforwardsForeign" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsInProcessResearchAndDevelopment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:label="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:title="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:title="DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DeferredTaxAssetsRightOfUseLiabilities" xlink:label="DeferredTaxAssetsRightOfUseLiabilities" xlink:title="DeferredTaxAssetsRightOfUseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsRightOfUseLiabilities" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsRightOfUseLiabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="DeferredTaxAssetsTaxDeferredExpenseOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsTaxDeferredExpenseOther" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsGross" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsGross" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="DeferredTaxAssetsValuationAllowance" xlink:title="DeferredTaxAssetsValuationAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsValuationAllowance" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsValuationAllowance" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="DeferredTaxAssetsNet" xlink:title="DeferredTaxAssetsNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsNet" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsNet" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxAssetsNetAbstract" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to DeferredTaxAssetsNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="DeferredTaxLiabilitiesNetAbstract" xlink:title="DeferredTaxLiabilitiesNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="presentation: DeferredTaxLiabilitiesNetAbstract to DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_DeferredTaxAssetsRightOfUseAssets" xlink:label="DeferredTaxAssetsRightOfUseAssets" xlink:title="DeferredTaxAssetsRightOfUseAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="DeferredTaxAssetsRightOfUseAssets" xlink:title="presentation: DeferredTaxLiabilitiesNetAbstract to DeferredTaxAssetsRightOfUseAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:label="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:title="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:title="presentation: DeferredTaxLiabilitiesNetAbstract to DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="DeferredIncomeTaxLiabilities" xlink:title="presentation: DeferredTaxLiabilitiesNetAbstract to DeferredIncomeTaxLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxLiabilitiesNetAbstract" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to DeferredTaxLiabilitiesNetAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxLiabilities" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to DeferredTaxLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:title="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:title="EffectiveIncomeTaxRateReconciliationTaxCredits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationTaxCredits" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:label="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:title="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:title="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="EffectiveIncomeTaxRateContinuingOperations" xlink:title="EffectiveIncomeTaxRateContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateContinuingOperations" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateContinuingOperations" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="OperatingLossCarryforwardsTable" xlink:title="OperatingLossCarryforwardsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="DomesticCountryMember" xlink:title="DomesticCountryMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="DomesticCountryMember" xlink:title="presentation: IncomeTaxAuthorityDomain to DomesticCountryMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="StateAndLocalJurisdictionMember" xlink:title="presentation: IncomeTaxAuthorityDomain to StateAndLocalJurisdictionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="ForeignCountryMember" xlink:title="ForeignCountryMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="ForeignCountryMember" xlink:title="presentation: IncomeTaxAuthorityDomain to ForeignCountryMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain" xlink:title="presentation: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsTable" xlink:to="IncomeTaxAuthorityAxis" xlink:title="presentation: OperatingLossCarryforwardsTable to IncomeTaxAuthorityAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="OperatingLossCarryforwardsLineItems" xlink:title="OperatingLossCarryforwardsLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_IncomeTaxAbstract" xlink:label="IncomeTaxAbstract" xlink:title="IncomeTaxAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="presentation: IncomeTaxAbstract to ValuationAllowanceDeferredTaxAssetChangeInAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="OperatingLossCarryforwards" xlink:title="presentation: IncomeTaxAbstract to OperatingLossCarryforwards" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TaxCutsAndJobsActOperatingLossCarryforwards" xlink:label="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:title="TaxCutsAndJobsActOperatingLossCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:title="presentation: IncomeTaxAbstract to TaxCutsAndJobsActOperatingLossCarryforwards" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="TaxCreditCarryforwardAmount" xlink:title="TaxCreditCarryforwardAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="TaxCreditCarryforwardAmount" xlink:title="presentation: IncomeTaxAbstract to TaxCreditCarryforwardAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_OperatingLossCarryforwardsExpirationYear" xlink:label="OperatingLossCarryforwardsExpirationYear" xlink:title="OperatingLossCarryforwardsExpirationYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="OperatingLossCarryforwardsExpirationYear" xlink:title="presentation: IncomeTaxAbstract to OperatingLossCarryforwardsExpirationYear" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_TaxCreditCarryforwardExpirationYear" xlink:label="TaxCreditCarryforwardExpirationYear" xlink:title="TaxCreditCarryforwardExpirationYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="TaxCreditCarryforwardExpirationYear" xlink:title="presentation: IncomeTaxAbstract to TaxCreditCarryforwardExpirationYear" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="presentation: IncomeTaxAbstract to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OpenTaxYear" xlink:label="OpenTaxYear" xlink:title="OpenTaxYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="OpenTaxYear" xlink:title="presentation: IncomeTaxAbstract to OpenTaxYear" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="IncomeTaxAbstract" xlink:title="presentation: OperatingLossCarryforwardsLineItems to IncomeTaxAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsTable" xlink:to="OperatingLossCarryforwardsLineItems" xlink:title="presentation: OperatingLossCarryforwardsTable to OperatingLossCarryforwardsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="OperatingLossCarryforwardsTable" xlink:title="presentation: IncomeTaxDisclosureAbstract to OperatingLossCarryforwardsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:title="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="UnrecognizedTaxBenefits" xlink:title="UnrecognizedTaxBenefits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="UnrecognizedTaxBenefits" xlink:title="presentation: ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward to UnrecognizedTaxBenefits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:title="UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:title="presentation: ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward to UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:title="UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:title="presentation: ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward to UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="UnrecognizedTaxBenefits_2" xlink:title="UnrecognizedTaxBenefits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="UnrecognizedTaxBenefits_2" xlink:title="presentation: ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward to UnrecognizedTaxBenefits" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:title="presentation: IncomeTaxDisclosureAbstract to ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: SubsequentEventTable to SubsequentEventTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_LicenseAgreementAbstract" xlink:label="LicenseAgreementAbstract" xlink:title="LicenseAgreementAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20221231.xsd#erna_ProceedsFromOptionAndLicenseAgreement" xlink:label="ProceedsFromOptionAndLicenseAgreement" xlink:title="ProceedsFromOptionAndLicenseAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicenseAgreementAbstract" xlink:to="ProceedsFromOptionAndLicenseAgreement" xlink:title="presentation: LicenseAgreementAbstract to ProceedsFromOptionAndLicenseAgreement" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="LicenseAgreementAbstract" xlink:title="presentation: SubsequentEventLineItems to LicenseAgreementAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventLineItems" xlink:title="presentation: SubsequentEventTable to SubsequentEventLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="SubsequentEventTable" xlink:title="presentation: SubsequentEventsAbstract to SubsequentEventTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image01.jpg
<TEXT>
begin 644 image01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +:!;P# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P $=I_\11_PK9?^?ZP_\$=I_P#$5K_:-+^K_P"1/LF5O^&FO^I1_P#*E_\
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MY[?^4ZP_^1Z/^%<:3_SV_P#*=8?_ "/1_:5/^O\ A@]DS+_X::_ZE'_RI?\
MVJC_ (::_P"I1_\ *E_]JK$\5Z%I6A:UIEB->TRS^V-M=;K0[20QKAL2%EC4
M!2P5><=2<X!QU_\ PKC2?^>W_E.L/_D>JECX12;6_K_D+V;,O_AIK_J4?_*E
M_P#:J/\ AIK_ *E'_P J7_VJM3_A7&D_\]O_ "G6'_R/1_PKC2?^>W_E.L/_
M )'J?[2I_P!?\,/V3,O_ (::_P"I1_\ *E_]JH_X::_ZE'_RI?\ VJM3_A7&
MD_\ /;_RG6'_ ,CT?\*XTG_GM_Y3K#_Y'H_M*G_7_#![)F7_ ,--?]2C_P"5
M+_[51_PTU_U*/_E2_P#M5:G_  KC2?\ GM_Y3K#_ .1Z/^%<:3_SV_\ *=8?
M_(]']I4_Z_X8/9,R_P#AIK_J4?\ RI?_ &JC_AIK_J4?_*E_]JK4_P"%<:3_
M ,]O_*=8?_(]'_"N-)_Y[?\ E.L/_D>C^TJ?]?\ #![)F7_PTU_U*/\ Y4O_
M +51_P --?\ 4H_^5+_[567>^&-.M_&5MI \0:-'%*I9H)=*L3,K Q 1YV#Y
MGWL5^7MT:NH_X5QI/_/;_P IUA_\CU4L?"*3?7U_R$J;,O\ X::_ZE'_ ,J7
M_P!JH_X::_ZE'_RI?_:JU/\ A7&D_P#/;_RG6'_R/1_PKC2?^>W_ )3K#_Y'
MJ?[2I_U_PP_9,R_^&FO^I1_\J7_VJC_AIK_J4?\ RI?_ &JM3_A7&D_\]O\
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MK#_Y'H_X5QI/_/;_ ,IUA_\ (]']I4_Z_P"&#V3,O_AIK_J4?_*E_P#:J/\
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M_P"5+_[51_PTU_U*/_E2_P#M5:G_  KC2?\ GM_Y3K#_ .1Z/^%<:3_SV_\
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MN>'[>_FU*QN9955G%GI=BJPL44F-LQ-\PSSTZC@5N?\ "N-)_P">W_E.L/\
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M9D%YI=BRS,$8B-<1+\QQQUZ'@TXYA"3LOZ_ 3IM%C_AIK_J4?_*E_P#:J/\
MAIK_ *E'_P J7_VJET3P+I-_9/+_ &WI^I8D*^=8:78*B\#Y3^Z?GG/7H1QZ
MZ?\ PKC2?^>W_E.L/_D>AYC33M_G_D'LF9?_  TU_P!2C_Y4O_M5'_#37_4H
M_P#E2_\ M5:G_"N-)_Y[?^4ZP_\ D>C_ (5QI/\ SV_\IUA_\CTO[2I_U_PP
M_9,R_P#AIK_J4?\ RI?_ &JC_AIK_J4?_*E_]JK4_P"%<:3_ ,]O_*=8?_(]
M'_"N-)_Y[?\ E.L/_D>C^TJ?]?\ #![)F7_PTU_U*/\ Y4O_ +51_P --?\
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M/_/;_P IUA_\CT?\*XTG_GM_Y3K#_P"1Z/[2I_U_PP>R9E_\--?]2C_Y4O\
M[51_PTU_U*/_ )4O_M5:G_"N-)_Y[?\ E.L/_D>N7\2^&-.TG5=/MH_$&C62
MW+;9$O=*L6>-=DC>9]Q/E)0)TZGKVJH8^$W9?K_D)TVC4_X::_ZE'_RI?_:J
M/^&FO^I1_P#*E_\ :JU/^%<:3_SV_P#*=8?_ "/1_P *XTG_ )[?^4ZP_P#D
M>I_M*G_7_##]DS+_ .&FO^I1_P#*E_\ :J/^&FO^I1_\J7_VJM3_ (5QI/\
MSV_\IUA_\CT?\*XTG_GM_P"4ZP_^1Z/[2I_U_P ,'LF9?_#37_4H_P#E2_\
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MD_\ ;;_T<]=C7R^(_C3]7^9UQ^%!1116(PHHHH **** "BBB@ HHHH ****
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M 4444 %> ?M-?\RM_P!O?_M&O?Z\ _::_P"96_[>_P#VC0!J?"O_ ))MI/\
MVV_]'/78UQWPK_Y)MI/_ &V_]'/78U\OB/XT_5_F=<?A04445B,**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$X7DDEH8GA?Q;XP^'\4LVBW$%WI+/YDR!1/;LV-H+8PT9Z=U)P,YQ7L'A?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M110 4444 %%%% !1110 4444 %%%% !7C_QY_P"0')_V"I__ $MT^O8*\?\
MCS_R Y/^P5/_ .ENGT :NC?ZF_\ ^PKJ'_I7-6C6=HW^IO\ _L*ZA_Z5S5HU
M\OB/XT_5_F=<?A04445B,**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK4HH!I/<X#6/ ]S+O<+%JJXX,I$%T./^>H&US[N#7(+IFH:'J:S:/J=UIVH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%%%%8C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(?\ T3K_ ,K=O7KM%'U##_R_B_\ ,/:2[GD7VKXA_P#1.O\ RMV]'VKXA_\
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M .B=?^5NWH^U?$/_ *)U_P"5NWKUVBCZAA_Y?Q?^8>TEW/(OM7Q#_P"B=?\
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MT=X/_P"@;KG_ 'XA_P#CM 'L%%>/_P##1W@__H&ZY_WXA_\ CM'_  T=X/\
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M;;-$^JZ3*3LYC\2S1#Y8T3HJXZH3[ @= *HV-E#J.J>'K.X1'BE612'4,/\
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MCIQA H(['=7H-5[*PL],LX[.PM(+2UCSLA@C$:+DDG"C@9))_&K%:'(%%%%
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M [J1R2>!CGZU@ZO_ ,@[Q'_U^WO_ *46=5?"7_(*E_Y%/_7G_D,?Z[[J]/\
M9_KF@#T'Q7XAU2P\-7=S:Z9>V4R;-MQ*8&5,NH.0'8\@XZ'K5#X;^(M5U_\
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MG;@0:K&TDD4[?.NX2,!E#D8X'( / P:J73P^(OB3HB7L&QC:/'<0K(04D0S
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M@9VEN]2ZUI,&NZ3/IMT\B0S;=S1$!AA@PQD$=1Z5R7_"IM!_Y^]2_P"_B?\
MQ% '2Q:A<PQ)%%X<U!(T4*JJ]L H'0#][5WPEXPL=7N;G28[6_AN[25DE$D&
MY Q9S@NA95^Z?O$9/3-<;_PJ;0?^?O4O^_B?_$5;^#]I'8:UXNLHBS1V]Q'$
MA<\D*TH&??BN',(1=!M]#2F_>/5J\U^-W_(F6?\ V$$_]%R5Z57FOQN_Y$RS
M_P"P@G_HN2O'PG\>/J;3^%G :!_R62;_ *_;O^4E>QUXHVGZLOQ(8Z7<P07M
MW<74MO(_(0!Y5;=E3S\C=CU'X=A_97Q(_P"A@TW_ +]C_P"-5],<IW=%<)_9
M7Q(_Z&#3?^_8_P#C5']E?$C_ *&#3?\ OV/_ (U0!W=%>:ZT?B!H6DSZE=:[
M9/##MW+%$I8Y8*,9C ZGUJ>QM?B)?Z?;7D6O6 CN(EE0/&N0& (S^ZZ\T >A
MT5P?]E?$C_H/Z;_W['_QJC^ROB1_T']-_P"_8_\ C5 '>5YA\8/^8-_VW_\
M:=:?]E?$C_H/Z;_W['_QJN5\8Z5XG>:QBUS4;2Z;RKB6'RA@*$0.^<(O) &.
MOX4 =3X"_P"1G\7_ /7Z/_0Y:[BYCDEM98X9#'*R$(X_A..#7#^ O^1G\7_]
M?H_]#EKO: .?&G:^C.HU)'C,VY2S?,$W' ^[UQ@?A6[$9#$AE55D*C>J-N /
M< X&1[X%/HH \<U__DLD/_7[:?RCKV.O'-?_ .2R0_\ 7[:?RCKV.@ HHHH
M*RY_^1JT_P#Z\KG_ -#@K4K+G_Y&K3_^O*Y_]#@H ROA;_R-7C?_ *_5_P#0
MYJ]/KS#X6_\ (U>-_P#K]7_T.:O3Z^<Q_P#O$OE^2.FG\*"BBBN0L**** "B
MBB@ KQ/QY_R.%Y_V_?\ INAKVRO$_'G_ ".%Y_V_?^FZ&O1RS^,_3]49U?A/
M2O"O^OU[_L(+_P"DT%=%7.^%?]?KW_807_TF@KHJYL7_ !Y>I4/A05QW@_\
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MM:ZQ':R75U+-<(8T61>!M)!.=[=U(Y[\]"*XOXL_\C5:_P#7DG_H;UZ:NO\
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M9#:N\UM'(S-D%B5!)( P/PJ*QU;4[S6]5T[RK,&Q,66W-\V]-U &_7!?$/\
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M'<.<I\A_#*FMJN9^'W_(CZ=_VU_]&-734GN$/A04444%!1110 4444 %%%%
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M &"I_P#TMT^@"SX0TV'1M .EV[2-!97MY;QM(06*I<RJ"< #.!Z"MVL[1O\
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MB@*J@< #M3J** /%]9N8%M?$4#3QB9KV\Q&7&XYGM2..O1&_[Y/H:ZWX3?\
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M3:22GS<!N,=ZY4_V0+1#NNFG#99/*"Y'IOWG_P! KWO_ (1K0?\ H":;_P"
MB?X4?\(UH/\ T!--_P# 1/\ "@#S?PEJW@FVL+D:G:01R-/F-+J W+!-BC[P
M3'W@QZ#K5KQ1KG@V;PQ?V^BBTCO9E15\FR:(L!(K$;MHX^7/7M7??\(UH/\
MT!--_P# 1/\ "N+TW2-,D^+&L63Z=:-:QV:LD!@4HIQ%R%Q@'D_F: .B\/\
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MQTXK9H XC41XET*ZTF2?Q)]LANM1AM9(OL,<>58G/(R>@Q^-1>//^1J\'?\
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M?^$ETR.]N);DX\J!)$1@S[]N\@@$D8^G-;7_  FG@3_H6?\ R0@_^*H [O\
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MFKCN85[<JL>V>$)8YFUN6)UDC>_5D=#D,#;08(/<5TM<3\,/^1=F_P!^W_\
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MF1&ACC,,01L_-N_>$^^54>V#ZTDZQVNHI>M+L655MW7:2&8M^[Y[<LP]]PH
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M:Z^6/VA+.*S^(=MY33MYVGK,WG3O+AC++D+O)VKQPJX4=@* .T\-?\BKH_\
MUY0_^@"M2N%TOQ/X4\.W&I6,=]!#;_:%: 0(TB%?)B&=R@@G<&SSG.<UI?\
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M "N$\?2"'6-%D>W6XC6WOC)"TAC#IY(W#< 2#C/_ -;K7=UP7Q#_ .0AI?\
MUY:C_P"D] &#X0LK?4/B/KD>HV=M-@3N8I%$J*WG+TW#GJ1G KT;_A&M!_Z
MFF_^ J?X5P7@G_DJ/B#Z7'_HY:]1H R_^$:T'_H":;_X"I_A1_PC6@_] 33?
M_ 5/\*YJT^)%O-XG?2;FSCM8$EDC:[EN@%&W=@D%0!G '7O72_\ "2Z#_P!!
MO3?_  *3_&@#SZWMH+/XW+!:P1P0IG;'$@51FVR< <=:]5KRJWN8+SXW+/:S
MQSPOG;)$X93BVP<$<=:]5H **** "LN?_D:M/_Z\KG_T."M2LN?_ )&K3_\
MKRN?_0X* .%\*7MQ%XZ\3V=M;Q2O-<22DR3% H25AV5LYW_I7=V^H"6?[-/$
M]O<XW"-^0X'4JPX8?J.X&:\]\(R1I\4]=5W56D:Y5 3@L?-!P/4X!/X&N^UI
M!_9<USD+):J;B-R<;64$]?0C(/L36<MSKHM\AH5P/BSP+J.MZS-?VUW;.LR*
M@2X+KY 4#[N,@YP3R/XCWYKJ%\2Z3*Y2WN'NF"AF^R0/.%!SC)C4@'@\'FG_
M -O6?_/'4?\ P6W'_P 125T:249*S/,_#D$^EZ=XDM_,MA/:WMFGF2L1$&6X
M(RQZ[<CGVKH;_P 2^*K)5$/]@ZA.6 ^SV'FRR@$$[BH.=O'7W%4[K2HX[3Q.
MYDF^RZA<6LADN8'M0FZX;<N77H 1EL'KTK.T_P /6D7B6+4KCQ'H$4,=R+D)
M;W(/(8-L .,#MU.*HP5UHOZU-^;7?&UG$LVH6.D64+2K%YLV]E7=G!8H[;5R
M ,GNP]\:<EMXPO8FMKMM!%K,-DIB\[=L/#8SQG&:OW.OZ1<>7902P:G)=,8O
ML]O-&Y(VLQW L!MPI_,5+H&GW&F6+6\TA,0D)@B+[S#'V3=@9QS].F3BI-DM
M;7-6O/9);;0=:O%GMFO&:[O;I/WGEA2L4%T 1@DG<BC.1T.0<XKT*O-?%/\
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M'QG;N4C/ZTBQ]O=VUVK-;7$4RJVUC&X8 ^AQWJ:N,\$^#[[PW=75Q>743F5
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MM_V]_P#M&O?Z\$_:6@FF3PX\44CI"ET\K*I(1=T"Y;T&YE&3W('>@#0^%?\
MR3;2?^VW_HYZ[&N2^&4$UK\/]-M[B*2&>)YTDCD4JR,)I 00>00>U=;7R^(_
MC3]7^9UQ^%!1116(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** ,;Q;_ ,B9KO\ V#[C_P!%M7FWA#_D
M5?"/_7[/_P"@7->D^+?^1,UW_L'W'_HMJ\V\(?\ (J^$?^OV?_T"YKVLK^"7
MJ85=SO*KWDX@@ \S9)*PBC.W=\[<#COCJ?8&K%44,5[J3,8V/V)MJ.3\I=EY
MP/4 XS_M,*]0R)[.UCLK.*VBR4C4*">I]2?<GDTMU;1WEK+;RYV2*5)4X(]Q
MZ$=14U% %>RNENH68!E>-VC=6QD,IQSCUX/T(JQ5&206>IQ+Y:+%>$AG Y,H
M48S]54C_ ("!WJ]0!XYJ_P#R#O$?_7[>_P#I19T>'?!EEJV@VU]-8:W+)+NR
M]M-;+&<,1P'8-V[]\T:O_P @[Q'_ -?M[_Z46==Y\._^1$TW_MK_ .C7H Y?
M_A7>G?\ 0*\2?^!%G_\ %4?\*[T[_H%>)/\ P(L__BJ]0HH X7X;:7#81:V\
M8G5A?M;;)F4E5CZ9V\;OG.<'''%7?&W_ !]>&O\ L+P?SJ7P7_S,/_8;N?\
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M."#^(IWAK_D5='_Z\H?_ $ 5@V'@S1]8M?[3U?2W^VWDCSNKSR!E5G)12 0
M0I4=.U3^"+Y(/AY8W=[<8CACDW22,3M578 ?0   >P% #]#_ .1[\6?]N?\
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MUSZ?YS2-I&FL%!T^U(3&T>2O&  .W8 #\!0 EIJ]C?3M!;S%IE#%D:-E8;2
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MC\!_XA[]^M>VT %%%% !67/_ ,C5I_\ UY7/_H<%:E9<_P#R-6G_ /7E<_\
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M4M-<TVYNMIV+J.GPF5)1_>>)<M&V,9 !&<X..*OZ#XET?Q)!-+I%ZERL+[9
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M549B0HR3@ ],T >):+ISW?Q -@C6T;&>=06M@\0P'/\ JR<8XX&>./2O1_\
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M;?RKG;3>BL4>&+ ]U):11F]5FD3!LI%CFZWQ^5F( ]\GIFM+^P;S_GMXR_\
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M2>YK#X4%<S\0?^1'U'_ME_Z,6NFKF?B#_P B/J/_ &R_]&+0MPG\+.9^$?\
MS&/^V/\ [4KTRO,_A'_S&/\ MC_[4KTRB6Y%'X$%%%%(U"BBB@ HHHH ****
M "BBB@ HHK'\2WLMIH[1VI O+MUM;;)QAWXS^ R?PH$W97/-O&NL"[>YFC?/
MVR3R(3QQ;Q'J/4/+D_\ ;.OI7X6>%CX2^'^GV,L1CO)Q]JNP00?-?!P03P54
M*O']W-?-WA/3)?%7Q%M4T_2I-4T_3C'(;598XRUM$RKD^80IR2"5[[FZ=1]B
M5JMC@F[NX4444R0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ KQ_X\_P#(#D_[!4__ *6Z?7L%>$?M)7UQ:0:##!)L
MCNXKJ&<;0=Z![>0#GI\R*>/3TS0!UFC?ZF__ .PKJ'_I7-6C7#>%/$<EK\+H
M_$6I)<7DA>XN;G[/$I=BUPY9@O  &2QZ  'TKK=*U#^U=-AO?L=W9^9G]Q=Q
M>7*N"1\RY.,XR/8BOF,1%^TE+I=G5%Z(N4445@4%%%% !1110 4444 %%8'B
MCQ9;>$[:*YO+#4+B!\[I;6$.L6"H&\D@+DL /7FM/2M0_M738;W['=V?F9_<
M7<7ERK@D?,N3C.,CV(JG"2CS6T"ZO8N4445(!1110 4444 %%%% !17.^(/%
MT7AVZCAET;6;M752)K.U$D89FVJA;</F)QQ_M#UK<M+C[7907/DRP^=&LGE3
M+M=,C.UAV(Z$>M4X224GLPN34445(!1110 4444 %%%% !17.Z_XNBT#4(+.
M31M9O6G7,;V5J)$+?,=F=P^;"$X].:Z*J<&DF^H7,;Q;_P B9KO_ &#[C_T6
MU>9^%I4A\(^$Y'9547LPRQP,E+@ ?G7IGBW_ )$S7?\ L'W'_HMJ\O\ "<,M
M_P"$M!CM(X)I;"=[IXYW**<M,J_,%;D$YQCM]*]C*_@EZF%7<[C3K5[2S592
M&G<F29EZ%V.3CV[#V JW67Y^O?\ 0-TW_P &#_\ QFCS]>_Z!NF_^#!__C->
MH9&I167Y^O?] W3?_!@__P 9H\_7O^@;IO\ X,'_ /C- &I56^M?M4*;7V2Q
M2++&^,X(_P 1D'V)JKY^O?\ 0-TW_P &#_\ QFCS]>_Z!NF_^#!__C- 'D^H
MWGVC3==>&"5X9KN[=9?E  :>U/()W=AV_B'OCT7X=_\ (B:;_P!M?_1KUS.K
MM9:=9ZM87_AJ6;4IDN;A;R&T66-=Y+9$A ;:@= 6QP<^U:_@.75E\%Z>+6RL
MI(1YFUY;QT8_O&SE1$P'/N: .WHK+\_7O^@;IO\ X,'_ /C-'GZ]_P! W3?_
M  8/_P#&: ,OP7_S,/\ V&[G_P!EJ+QM_P ?7AK_ +"\'\ZP= OM;GO-=TG3
M(K:*Y;4Y[BXG:9L1#<H*J?+(R<':Q'8Y4<51U/3]37X@Z+8!LS!8[D)-J$LR
M2&-G;)9DRI(4CA<#\30!ZS167Y^O?] W3?\ P8/_ /&://U[_H&Z;_X,'_\
MC- &I7(^%?\ DM^O?]@]?Y05M>?KW_0-TW_P8/\ _&:P/!K3M\9]<-U%'',=
M/&Y(I"ZC_48PQ52>/85S8O\ @2]"H?$CUBBN7'C:(^(&T<:!KQE281-,+,>4
MJERHD+;O]6=K$-CH#Z5U%?.2A*.YU)W"N.^%?_)-M)_[;?\ HYZ[&N.^%?\
MR3;2?^VW_HYZTC_!EZK\F+[1V->:_&[_ )$RS_[""?\ HN2O2JXWXB;3!X=#
MXVG6X!ST/R256$_CQ]13^%G(>(O%GA77]!N=,_MSR//V_O/LDK;=K!NF!Z>M
M9?\ PE'_ %4;_P HG_UJ]+^S0?\ /"/_ +X%'V:#_GA'_P!\"OICE/-/^$H_
MZJ-_Y1/_ *U9.M:GITVCZB3XE74[VX7Y5&GO 6)>#))^[@+ .,#O7L/V:#_G
MA'_WP*/LT'_/"/\ [X% &5X4N_$]MX4TR&V\3WEK ENHCA%I;D(O89:,D_B:
MT_A1XEU2\\&+%-J,LWV&<V<8:%$$4:(@1 5^\-N#N.#DD<XR9P !@# '05S_
M ,&O^16U+_L*2_\ H$=<6/E*-&\78TIJ\CT;4?%$^F0PR7%R^)KB*W0*%R7D
M<(.OUR?8&KG]K7W_ #\-^0KSS6XG\;7IL=,NO+M-,+3&\3.TW@4B)58==A.Y
ML9YVCUKH="UM-8MG62,V^H6Q$=Y:,?FAD_JIZJW0BO(E.JHI\SOUU>G8V25]
MCB=4\2^+=0^+FH6%AXB-@+"S(@<V<4NU)! SKAASE@IR<XQ@=:X#XCG5+KQA
M8+XCUW[;(UM&IO/L:Q^5%YC_ ,"?>Q\Q]3G%=E%_R7/Q!_UY)_Z#!73W>D:9
M?RB6]TZTN9 NT/- KD#TR1TY/YU[]!MTHM]D<TMV>=OXEM_MES<6_CR.V^TN
M))(XM%<KN"*F1NR>BCO1_P )1_U4;_RB?_6KO/\ A&M!_P"@)IO_ (")_A1_
MPC6@_P#0$TW_ ,!$_P *U$>?2:UI]Y=6,FI>._M<-I=1W2Q?V0T>60^JC/3(
M_&I?$?B+2M?\5>%/[,NO/\B]'F?NV7;N>/'W@/0UWG_"-:#_ - 33?\ P$3_
M  IT7A_1894EBT?3XY$8,CI;("I'0@XX- 'G%A86VIZOX;M+R(2P.260DC.+
M"V8=/<"CP3J%_'XM@B6VGM;*\:0O#G$"AH_,CV+@ ':HYY)!_/.T]HY=3M[2
M^EUNTGM(L@*\-K)&WDP)PS[>"%8<G)78>I:MI;+342%%U3Q&JP?ZE1K%GB/@
MK\O[SC@D<=CB@#<_X2B+PYX:\.)*D&VYL$.^:1U *I'Q\D;DD[O0=*DD\1+:
MI=:\T"A9--T^0QO(0$$DDHY8*3@;L\+SCI7+W&BZ#<PPQW5WKDL4"[8EEU2R
M98QQPH,G X'3T%#V&@20&!]2UQH2B1F-M7LBI13E5QYF, DX':@#JXM?3Q%H
M#7,:1JL6J6L(:)V96_?0MD;E4_Q8Y':GV7C2*\\3#11# )/M$T! F<NHCW_,
M08PN#LZ!S]X>]<C!8:!:P>1;ZEKD,)<2&./5[)5W@@AL"3&00.?84R/2_#L5
MZ;V._P!92Z+%C.NK6(?)SD[O,SDY.?K0!IZ!XHB\.>"=!25(-MRMR=\TCJ 5
MEZ?)&Y).[T'2G/>?VC\4/#%]Y?E_:=+$VS.=NY)3C/?K6.^C>&98(8)+S5WA
MASY4;:I8E4R<G:/,P,GKBJ<=U%I'C?2YM--Q?)!;E4CO=0@.!M==HD5BBJ <
M@'^HH ]IHKBE\;ZFS8.B6*CU.MP59@\4ZM<K.8=%LI&AB:4I%JBRNP'8*B$D
MGH* .LHKDM(\5:QJ\%U,OAW[-';?>^T3R N06#!0L)+$%2"!SGBI?^$FU'_H
M#_\ CEY_\BT 'Q$_Y$34O^V7_HU*U?#7_(JZ/_UY0_\ H KC?&>NWMYX3O;>
M;3?)C?R\R;;D8PZG^.!5[=V'X]*9I'C36K71;"WB\'7]Q'%;QHDR%\2 * &'
M[L\'KUH ])J"]M(;^QGLYP3#/&T;@=<$8X]ZXK_A/->_Z$?4OS?_ .-T?\)Y
MKW_0CZE^;_\ QN@#;MM;;2 EAX@<PR(0D=\P(AN!V8MT1\#E21STR#3_ (;W
M$%SK/B%X)HY4WCYHV##FXNB.GJ"#]"*P?^$\U[_H1]2_-_\ XW47PNU2VA\0
M>)[Z\T^ZCN9IEPD5E+.\.YY"R$HA*\A>#C.WVXY,='FH.W]:ETW[Q[-7FOQN
M_P"1,L_^P@G_ *+DKL?^$GL/^??5O_!1=?\ QNO,_BSXMT76O#T6FV%U(]Y!
M?*TL+V\D;( C@YWJ,')''6O'PE.?MHNS-IM<IG_\UV_S_P ^U>H5XWINNVNI
M_%F+5X8[@6\F<*8B\G$!7[J;B>1VSQ7J/]NV?_/'4?\ P77'_P 17T9S&G6#
M807^HPS7#:U>P_Z5<1K'%'!M54E=% W1D]%'4U:_M^S_ .>.I?\ @MN/_B*P
MM/\ $KZ?#-;MX?UZ7_2KB19([$[65Y7=2-Q!Z,.HH W]#FGFTTFXG:>1+BXB
M\QU4%@DSJ,[0!G"CH!3]6UK3]"M5NM2N/(A=Q&K;&;+$$XPH)Z UE:'J\4.F
MD7%GJ<$CW%Q+Y;Z?,2H>9V&=JD9PPZ$US?Q/U*"\\-6T<4=TK"\5LS6DL0^X
M_=U SSTH Z[P_P");/Q+<ZA'IRR216;1CS@I"R!UR." 000PP1V![\;$\B6O
ME_:'6+S9!%'YAV[W/11GJ3Z5T]KXIT]?'>K3FWU?8^F62 #1[LMD2W1.5\K(
M'S#!(P><9P<<YX_\3#Q!>:99>'[*_N[G1+V/5;F-M-NE97C&8H2OE94R!F()
MP %Z\T -((.",$5Y)KOBNR\47ML]I')']GMM04I*/F*FVR&..!R&& 3]W/>O
MI+3_ !_H6J64=Y9+JT\+YPT6CW;@$<$96,C(.0<'J*\&^(NLVTG@WX>HBWT;
M0:--"[-:/&&+6T2#:TBA77/4J3P<@\B@#/\ !/\ R5'Q!]+C_P!'+7I<]I;W
M+(T\*2%,[2PSC(P?TKQ'0!+=_$;Y8&FDDN)V\N\;R6)VN?G*J=K#V'4=J]-\
MW7](/F&VM);-F5/+DU!W,1) !WF+.WGG.?7@ T :G_".Z/Y\DQTVW+RH$<E.
M"!GMT[GGOWJ[;VEO:*R6T*1*S;BJ# S]*H^?KW_0-TW_ ,&#_P#QFCS]>_Z!
MNF_^#!__ (S0!PG_ #7;_/\ S[5Z?7DWF7__  N??]FMOMG_ #R^T-Y?_'O_
M ']F>G/W>O'O7HOGZ]_T#=-_\&#_ /QF@#4HK+\_7O\ H&Z;_P"#!_\ XS1Y
M^O?] W3?_!@__P 9H U*RY_^1JT__KRN?_0X*//U[_H&Z;_X,'_^,UB:SKEW
MH6IVFJ:MI;?94MYHB]A(9PI9XL;RRH%'RX')S0!E>#;JW@\6^+(Y9XHW>])1
M7< MB23.!WZC\Q7<7-M#>6SV]PF^)QAER1G\J\Q\%&._^(FMR2VS*LJ3OY,Z
M?,N9E.&'8C."*[V6$:,RW-M\ED6"SP9^5 3C>O\ =QW XQD]1SG+<[*3]PM6
MNEV=E)YEO#M?:5W%BQV\<9)Z# P.W08K#U/6#I?B>XCCB62::RA(WL5150SL
MS$@$\#L!DUU%>=>.-1FM/$GV>"RAN9)+..?=([*8Q$9V8J592#@GOVQSFDM2
MIOE6A-%XBM]9BO-3"&-8_P"SA*HR<%;IR<<#/'M5JP\3GQ!JFC-';(EN;R7:
MXD)8%8)/E8%1R0X/!([5PC>*KZSC58K/3HXY%@(2/+ >5(9%S\Y.26YSR1Z5
MK>$=1EOO$ND.VGVUO"T\XC>%I#\PB8LH#.0H^=3P!GCTJK&*G=I?UN>K3P17
M4#P3('C<893WJM:Z18V4_GV]N$EV"/=N)PO' R>!P#CUYZDU=J"]NA9V<DY4
MN5'RH.KL> H]R2!^-0=+MN2R21Q(7D=44=68X%>7^);VTFU>2YBNH7MW:_5)
M5D!5B;&%0 >A.[CZ\5Z#;:6F5N+\)<WAY+N,K'[(#]T?J>^:\V\&:GIEKX>>
M+4O#MWJ:B\)25+)9D0N(UVY8\,2!QWR*N!SUV[)'LGA=E6?7=S 9U%0,GJ?L
MT%='7D5LL&J>/]$^TVF89[V[=K>YC&1FPMCAE.>1Z>HKT":$^'G2YM7;^S"X
M6XMV8E80QP)$S]T GE>F,D8P<^#C*:]L]=7_ )V_0(/W3=KCO!__ "'M:_X%
M_P"EU]6G_P )9I[:Y8:7''<R-?-*L%PJ#RF,2Y?DG)QTR 1GO69X/_Y#VM?\
M"_\ 2Z^K%1<:<K^7YCOJ=C1116!04444 %%%<[K_ (NBT#4(+.31M9O6G7,;
MV5J)$+?,=F=P^;"$X].:J,')VB#=CC?A_P#\B/IW_;7_ -&-735S/P__ .1'
MT[_MK_Z,:NFKZ=[FD/A04444B@IKR)$A>1U11U9C@"HKRZ6RLY;EU+"-<A5Z
ML>P'N3Q^-5;?2U<K<ZB$N;L\Y892+V0'H!TSU/>@5S+^'W_(CZ=_VU_]&-73
M4V,!8U    & *=0PBK*P5S/Q!_Y$?4?^V7_HQ:Z:N(^(^KQPZ)<Z2;6[:2>)
M)5F6/,2@2KG+9X/3M_$OK36Y-1VBS*^$?_,8_P"V/_M2O3*\S^$?_,8_[8_^
MU*],HEN31^!!6-XJU";2O#ES>P.R/&T?S)MS@R*&QN!&<$\D&MFHKBV@NX&@
MN88YH6QNCD0,IP<C(/O2-'JM#@? ?B+7M8UF6/4KAY;4V[M'NA1075D!Y"C)
M ;I[UZ'5.TTG3;"4RV>GVEO(5VEX850D>F0.G JY39,$TK,****184444 %4
M=:N);30=1N8&V30VLDB-@'#!20<'WJ]39(XYHGBE17C=2K(PR&!Z@CN*!/8\
MS\)^*]=U?Q1;Q37,KZ<\CJRO%'Q^[=E!95'/RYXQG!J;QWJY%Q=,C$+:1_9(
M?>:5<R'KR%CX]C(*ZZ]M=%\/6,^K)IEE"]M&S*\<"(V<8 ! [YQ^->4WUK=Z
MQX@M-$BBN;FX0L]RMK"))7F;]Y.50$;F4#;C//EU:U9SS;C&S9[Y^S_X7.C^
M"I-9G3;<ZO)O7.01"F53(([DNV1U!6O6ZK:=!;VNEVEO9PF"UBA1(8BI!1 H
M"K@\C P.:LU9S!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5X!^TU_S*W_;W_P"T:]_KQ?\ :!L;>[TJ":>/
M?)::?<30'<1L<W5E&3QU^5V'/KZXH S/ VDQ:Y\'K+3)KBX@BN%E1WMW"OM\
M]R0"0>#C!XY!(KM=*T_^RM-ALOMEW>>7G]_=R^9*V23\S8&<9P/8"J7A>QM]
M,TB:PLX_+M;74+V&%-Q.U%NI0HR>3@ =:V:^8Q$G[24>EV=45HF%%%%8%!11
M10 4444 %%%% &!XH\*6WBRVBMKR_P!0MX$SNBM9@BRY*D;P00V"H(].:T]*
MT_\ LK38;+[9=WGEY_?W<OF2MDD_,V!G&<#V JY15.<G'EOH%E>X4445(!11
M10 4444 %%%% 'G/Q-T/7]1NM/GT6XU4QD&.6&UFPBR*=T+%=RX^?J^?E"@]
MN>^L('M=.M;>62222*%$9Y)/,9B  26P-Q]\#/H*L45I*JY04'T$E9W"BBBL
MQA1110 4444 %%%% '.Z_P"$8M?U""\DUG6;)H%Q&EE="- WS#?C:?FPY&?3
MBNBHHJG-M)/H%BAKEC+J?A_4K"%D66ZM984+DA0S(0,X[<UY;I7P]^(&B6AM
M=.UK2((2Q<KRV2>^3$3VKV&BMJ.*J44U#J3*"EN>6?\ "*_$_P#Z&+2?^^!_
M\9H_X17XG_\ 0Q:3_P!\#_XS7J=%;?VC7\A>RB>6?\(K\3_^ABTG_O@?_&:/
M^$5^)_\ T,6D_P#? _\ C->IT4?VC7\@]E$\L_X17XG_ /0Q:3_WP/\ XS1_
MPBOQ/_Z&+2?^^!_\9KU.BC^T:_D'LHGC%]\-/'VI3O-=>(+)V=#&P6YE5=A
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M1I-I\MU5L ,6 )88) !Y]#70_P!E?$/^_P"%_P [C_"NY2UMX[F2Y2WB6>4
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MN+'4WN+BWDFEGGN9=LCLZ(@VDHXP G<'_#M:*+L/9Q.9^Q>*/^?W_P FXO\
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MCY?,XW4]/\;:I826CSZ) '*MYD#S*ZE6# @XXY K%_X0WQS_ -#)_P"3T_\
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MX4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+O&G_/C_ .4F'_Y8T?\ "7>-/^?'_P I,/\ \L:/K%'^=?>@Y9=CTZBO,?\
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M: .L\+WUOJ>D37]G)YEK=:A>S0OM(W(UU*5.#R,@CK6S7'?"O_DFVD_]MO\
MT<]=C7R^(_C3]7^9UQ^%!1116(PHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M21@JHH&223P !WKXS\>^*;KX@^.IKV".1HW9;6P@V_-Y8)"# _B8DD]>6QT
MKV/]H'QN=.TF+PI8RE;F^42WC*<%(<\+T_B(YYZ*01AJX;X->%#<7DGB2[C/
ME0$Q6@(^\Y&&;\ <?4GNM95ZJI4W-CBKNQ'\*/!%Q)KLNKZM9RPII[[8HITV
MDS8SD@\_*"#]2".AKW"BBOG,17E6GS,ZHQY58****Q&%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S/P&_Y <?_ &"H
M/_2W4*]@KQ#X VFHI&;F35/,L6TJ/99_9U&S-W=!?GZG!24^_G8_@%>WU]<<
M84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9NOZW9^&]!O=8OVVV
MUI$9&P1ECT"C/<D@#W(K2KYM_:!\<#4=5B\*6$P:ULF\V\*'(>?'"=/X0>>>
MK8(RM 'FA;5/B'XZ>21@;[4[DNQR2L2]>,G.U%& ,]% KZ8TO3;;1]+MM.LX
MPEO;QA$&!DX[G'4D\D]R2:\]^#WA0Z9H[Z[=1E;J_7$(.05ASD'_ ($0#] O
MK7IM>!F&(]I/D6R_,Z*<;*X4445P&@4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!S/P&_Y <?_ &"H/_2W4*]@
MKQ#X _VQY9\[[#_9G]E1^7LW^=_Q]W6S.?E^]]HS[>7C^*O;Z^N.,**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** .-^(7CVR\'^%M1NX;BWFU.(K!#
M;;PS+,XRN\#D +E\'&0.O(KY;\&:!<^-?&"QW<DDT9<W-],[$LRYRV23DLQ.
M,]>2>QKH/C1KWA?7_%B3^'8$:90POKU&;;<.#M4 =, +G</O;_:O3?ASX5'A
M?PQ&L\>W4+O$UR2!E3_"G3^$=N>2WK7)C*_L:>F[V+A'F9UL<:11K'&BHB *
MJJ,  = !3J**^<.D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** .9^ W_(#C_[!4'_ *6ZA7L%>(? &[U%
MXS;2:7Y=BNE1[+S[0IWXN[HK\G49+RCV\G/\8KV^OKCC"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "O,?C9XZ_P"$5\)G3K*;;JNJ Q1[6PT47\<G3K_"
M.ARV1]TUZ/>7=OI]C<7MU*(K:WC:660]%11DG\ #7QAXN\0W_P 0_'4MZB.S
M74JV]E;D_<CSA$ZX!YR>V230W8!_@KP?J'B.Y^U06\CV=O-&DS)($<9/)0G
M)4<]>,CKT/TG:6XM+2*W$LTHC4*))GWNWN3W/O6;X7\/V_ACP]:Z7!AC&N99
M ,&20_>8_CT]  .U;%?.8O$NM/R6QU0CRH****Y"@HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YGX#?\
M@./_ +!4'_I;J%>P5XA\ =5\V,Z?]@OD\O2H_P#27AQ"VV[NFX;/.?.P/4QR
M?W>?;Z^N.,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK(\4>(;3PIX:OM;O>
M8K6/<$&<R.>%08!QEB!GMG)XH \?_:%\;K#9Q>#[*4&6?;/?E2#M0'*1GT)(
M#'H<!>H:N8^#'A3)D\37:=-T-F#^3OT_X".?[WM7!65OJGQ"\;DSRL]W?SF6
MXFP2(DZL<$\!1P!GL .U?3-C96^G6%O96L?EV\$:QQKG.% P/K7FYCB.2'LU
MN_R-:4;NY8HHHKPS<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!S/P&_P"0''_V"H/_ $MU"O8*\7^ E_9R:>+-+N!K
MI-*AW0B0%UQ>7I.5Z\"2,G_?7U%>T5]<<84444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2HSR!N;GU/%=Y_PA?CC_ * ?C+_PL[;_ .-5ZCR^=1\]TKF7M$M#TVBO*O\
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MS:54\F-,,'0 Y50>A->N5P5J,J,^21I&2DKH****R&%<1XB^T_\ "P-&V?\
M"3?9?+3S/[/S]EW^:-GF=L8W[^^W9CO7;T5=.?([@U<\<^.__, _[>/_ &E7
MKOP2_P"20Z%_V\?^CY*\B^.__, _[>/_ &E7KOP2_P"20Z%_V\?^CY*]_ ?[
MO'Y_FSFJ?$ST"BBBNP@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y'QA\
M.- \8HTUU ;74MA6/4+7Y)1D8PV/OC QAL\$@8S7B6H>&/''PMO[B]CG%QI#
MON^T00EK<?-C,L0YBX .5! ^Z"<\?3=%3*,9*TE= G8\1\-_$C2M;\J"\Q87
MD@RJR.#')_NOT_#L>.2#7:5E>+_@MH^LK-=Z"8])OWRS1*F;6=MI W1_P'DX
M9,%<DX)KR^'5_&7PTU'^S->M2]CT@$\F8Y0, ^3-C ]=K=!P1DC/E8C+?M4O
MN-HU>Y[+16)H7BO2_$ :.VE:*[CR);2==DL9'4%3Z>U;=>5*,H.TE9FR=PHH
MHJ0"BBB@ HHHH *:[I%&TDC!40%F9C@ #J33J\V^+'BI=,TV/18?,:6[&ZY\
MIL,L&<8SV+'C//?@YK2C2=6:@A2=E<R=,L9/BQ\2D216.CPCS)N/N6J-\J]?
ME>5AR, A<$$BOIA55$5$4*JC  & !7%?"_P:?!_A2-;N-1JU[B>^8 ?*V/EC
M&.,(.,#C.['!KMJ^HA!0BHQV1RMW=PHHHJA!7QEK-U#8?&G4+RY?9!!XBDEE
M?!.U5N"2<#D\#M7V;7B&N_L\?VWXAU/5O^$I\G[==RW/E?V?NV;W+;<^8,XS
MC.!2DKJP&IIGC?0];\W^R9+Z_P#)QYGV33;F79G.,[8SC.#U]#6A_;,?_0-U
MS_P27G_QJN+_ .&9?^IN_P#*;_\ ;:/^&9?^IN_\IO\ ]MKS_P"S*/=_A_D:
M^UD=I_;,?_0-US_P27G_ ,:H_MF/_H&ZY_X)+S_XU7%_\,R_]3=_Y3?_ +;1
M_P ,R_\ 4W?^4W_[;1_9E'N_P_R#VLC4_P"%J>"_^@S_ .2LW_Q%:&F>-]#U
MOS?[)DOK_P G'F?9--N9=F<XSMC.,X/7T-<W_P ,R_\ 4W?^4W_[;1_PS+_U
M-W_E-_\ MM']F4>[_#_(/:R.T_MF/_H&ZY_X)+S_ .-4?VS'_P! W7/_  27
MG_QJN+_X9E_ZF[_RF_\ VVC_ (9E_P"IN_\ *;_]MH_LRCW?X?Y![61VG]LQ
M_P#0-US_ ,$EY_\ &JY__A:G@O\ Z#/_ )*S?_$5E_\ #,O_ %-W_E-_^VT?
M\,R_]3=_Y3?_ +;1_9E'N_P_R#VLCI-,\;Z'K?F_V3)?7_DX\S[)IMS+LSG&
M=L9QG!Z^AK0_MF/_ *!NN?\ @DO/_C5<7_PS+_U-W_E-_P#MM'_#,O\ U-W_
M )3?_MM']F4>[_#_ "#VLCM/[9C_ .@;KG_@DO/_ (U1_;,?_0-US_P27G_Q
MJN+_ .&9?^IN_P#*;_\ ;:/^&9?^IN_\IO\ ]MH_LRCW?X?Y![61S?Q2\:^'
M_$?ABVL])U#[1.EXLK)Y,B84(X)RR@=2*]#_ &<?^2>:A_V%9/\ T5%6!_PS
M+_U-W_E-_P#MM>G_  X\"_\ "O\ P]<:3_:/V_SKMKGS?(\K&41=N-S?W,YS
MWKLHT8T8<D3.4G)W9V%%%%:B.?\ '?\ R3SQ-_V"KK_T4U?*_P +?$&F>'/$
M]S>:M<_9X'LVB5_+9\L70@84$] :^N-=TS^V_#VIZ3YWD_;K26V\W;NV;T*[
ML9&<9SC(KQ#_ (9E_P"IN_\ *;_]MJ*E-5(.#ZC3L[G4:;XOTG6;=KC2QJ5]
M K[&DM=+N95#8!P2L9&<$<>XJY_;,?\ T#=<_P#!)>?_ !JN+_X9E_ZF[_RF
M_P#VVC_AF7_J;O\ RF__ &VN'^S*/=_A_D:>UD=I_;,?_0-US_P27G_QJHY_
M$-K:V\MQ<6>LPP1(7DDDT:[544#)))CP !WKC_\ AF7_ *F[_P IO_VVC_AF
M7_J;O_*;_P#;:/[,H]W^'^0>UD:G_"U/!?\ T&?_ "5F_P#B*U--\7Z3K-NU
MQI8U*^@5]C26NEW,JAL X)6,C."./<5R_P#PS+_U-W_E-_\ MM'_  S+_P!3
M=_Y3?_MM']F4>[_#_(/:R.T_MF/_ *!NN?\ @DO/_C5']LQ_] W7/_!)>?\
MQJN+_P"&9?\ J;O_ "F__;:/^&9?^IN_\IO_ -MH_LRCW?X?Y![61UE]XHT_
M3+.2\OX-5M+6/&^:?2;J-%R0!EC'@9) _&L?_A:G@O\ Z#/_ )*S?_$5E_\
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M+_Z#/_DK-_\ $5H:9XWT/6_-_LF2^O\ R<>9]DTVYEV9SC.V,XS@]?0US?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ655C9R0.I^4'U%)M)78%VBLK_A(],_YZS?^ TG_ ,31_P )'IG_ #UF_P#
M:3_XFI]I#NAV9JT50M-9L+ZY^SP3,9MA?:T3IE00"?F [L/SJ_5)IJZ$%%%%
M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y+Q)_P C
M!:?]>LG_ *&M=;7(^*'2+7;-Y&5$-M(-S' SN7BN7&)NA)(N'Q(IT5!]LM?^
M?F'_ +[%'VRU_P"?F'_OL5\[[.?8Z;HOZ)_R-<'_ %XS_P#H<-;VJ:PVF3!3
M:-+'Y$D[.K@8" $C![\BN?\ #\B3>*8FB=75;*<,5.<9>''\C^5=A+;P3_ZZ
M&.3*LGSJ#\IZCGL>XKZ' IJA%/S_ #.:I\1A7/BN&QM(KB[L[B)9(Y9.5(VA
M-O7< 1N+!1QU(I5\7Z<\3RH':..\-J[*0=H"EO,Z_<PI.?8UJC2M.$#0"PM1
M"RLC1B%=I5L;@1C&#@9'? IZV-HA0K:P*8U5$(C VJ 0 /0 ,P _VCZUUD&?
MINNG4+:XN?L;QPQ1+(#O4EPR!P /7!'?K5:V\5I<WL=JMA<"0E!(H^]'N8@9
M7J,8R<@$#G!K:BL[6W@,$-M#'"5"&-(P%V@;0,#L  /H*2UL+.R!%I:00!@
M?*C"Y SCI]3^= &/!XLM;R2:*QA>XEB>0,HD11L3;EP2<8.X8SC/L 35[3M6
M_M"ZNHEMI(XX)&C\Q@<.58J<'&.H/0FII-(TV94673[1U151 T*D*JYV@<<
M;C@>Y]:DAL;2WGDGAM8(II"3)(D8#-DY.2.O- %BBBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *Y?Q3XAO\ 1KRVALUMBLL;,QFC9CD$#C##UKJ*X+Q[
M_P A2Q_ZXO\ ^A"D]BZ:3DDRO_PG&M_W-/\ ^_#_ /Q='_"<:W_<T_\ [\/_
M /%USM%9\S.OV4.QW/AGQ-J.K:NUI=I:B,6[2@Q1LIR&4=V/'S&NNKSKP/\
M\C*W_7G)_P"AQUO>(=#U;4K]I["[6%?LXC7=,R;6^?)P%)Y#+T8=.<XQ6D7H
M<M5)2LCIZ*Y-O#VKM;W"/>B0OY2QC[0RC$>]<G*GEEV,1C[V[G@&IM7T75KU
M+<VUS&DR6WE,QG=5#D$$@8+?CN'N&IF9TU%<W<:#J45M!%I^H[?*F-R?-+89
MP%"Q@#[L9^;/7DYP<U!)X?U22R2'?$)%E1I9!=OFXPK@L0R%5)+*< 'IC/"T
M =713(5*01HP 95 (!SV]<#^5/H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWS($9Y%-Q(B0%HB!+NSM9?4'!Y^G8C,=KXMT>\_U%PS?OTM^8V'SN2%'3V-
MC;HK(_X2;3 \*O))&)W586>-@) V<,#_ '?E//T/0@U;CU.UDMXYU=C&]O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image02.jpg
<TEXT>
begin 644 image02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $R FL# 2(  A$! Q$!_\0
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M_P#?I?\ XJ@#WZBO ?\ AJ7P9_SXZO\ ]^E_^*H_X:E\&?\ /CJ__?I?_BJ
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MZ7>_9]GF9\V'.WZ;\TZ;XRZ9#Y&_2KT>>X1,2PG)(R,_/Q2]C4_E8?VEA/\
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MH>LZ;KVGI?:+?6]]9OPLL#AUSZ<=#STJ_0 4444 %%%% &#XZ_Y%/4/]U?\
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M/LT'_/"+_O@4?9H/^>$7_? JG]KO?^?>Q_\  P__ !NC[7>_\^]C_P"!A_\
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M_P",O^PF/_12UUE !1110!S?@7_CQU3_ +"UY_Z-:NDKF_ O_'CJG_86O/\
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M?>&U@TG5[6>]-W;M&EK*DLN1(#E4!Y(JW_PC_BMHMZ^+Y=Q7<%:T4'/H>>*
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MA<Q3W4P@C,]VC D@G V]^#UXI=/U7Q;#+<S7GACS&D4;5ANHU&X9Y.?R_ 4
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M.G>I(OB%JTN?*\&ZH^.NUP<?I0!W/]EZ?_SX6?\ WX7_  H_LO3_ /GPL_\
MOPO^%<#>?$K4+*-Y+OPCJ,*1KN8NX&!Z]*3_ (6D-N?[-M>F<?VG%0!UNJ^$
M]&U%ED:T6VND_P!7<VA\F5/HRX_6L_[/XJT3_CTN(=?LQ_RRN2(;@#V<?*WX
M@5#X<^)/A[6F$+7(L;O.TPW) !/L_P!T_G79@Y&1R#0!SFF^,=,NKI;.]\[2
M]0/'V6^3RF)_V2?E;VP>:Z.JNI:=9:I:M;ZC:PW4#=4E0,/P]#[BN=_X1>^T
MGYO"VK2V\8_Y<KS,\'T4GYE_ T =;17(_P#"6SZ7\GBO2Y]/ X-Y #/;'W)'
M*_B*Z:QO;6_MUGL;B&X@;I)$X93^(H L4444 %>*_&.^N=<U_3O#6ECS)[B9
M8E4'[S%L#\-W&>VTU[22%!+$ #DD]JXG]G;PY!XQ^+NM>+_*9=,TJ0BT^8D/
M*V0#S[;F]BPH ^FO!/AZW\*>$M*T.S \FQMUBSC&YNK,?<L2?QK;HHH ****
M "BBB@ KDO!4/VG0-7@$CQ&6_NTWH<,N7(R#V-=;7,?#]2NEZAN!'_$QN3R,
M?\M#0!X5\4;/2-%\9>&8-<@NUO7")$]Q>3W222!SAHR[L5!;8<'&..N*WJYK
M]K>XCM/'W@*YG;;##()'.,X42J3Q5)OB9X45B&U/:1U!A<'^5 '945QG_"SO
M"7_05'_?IO\ "C_A9WA+_H*C_OTW^% '9T5Q]O\ $CPK<3QPPZF&DD8(H\IN
M23@=J[ \&@ HHHH YOQ%_P C5X3_ .OBX_\ 2=ZZ2N;\1?\ (U>$_P#KXN/_
M $G>NDH **** *EU80W5PDLQ<[5VE V%89SR._/X4D6GPQ70FC,BX+$1[OD!
M;J0.Q/Y5<HH YOQ=_P A+PQ_V$U_] >NDKD_'U[;:=)X>O+Z98;6'4E:21LX
M4;&YXIW_  L/PE_T';7_ +Y?_P")H QOBIH]M/;Z*^Z:-O[2B0!'P%WGYB!V
M)J_\4M+CG\/&X%Q=0M;A8E6&8H'5W0$-CKP*Q_&7BS0M:_L6UTK4X;JX&IP/
ML0-G /)Y%=/\2/\ D4KS_KI%_P"C%H X6YL+JWE\5Z?9_:Y(%O-BW4KF5T+)
M'N.2>6VC@D\#/KS0UUK=8K)]9CN5UN5K?;@GRIG$I!E8  9VG ..H[YYZZV\
M-IK7B3Q1,^JZQ9;-0\OR[*[,2-^Z0Y(QR>>OL*I:?\/=/N[O47N-4UJ1K2XV
M1E[H-PH##.5.>>: #P)KGAG2="M%NM0=;M6D=XWCD98Y&8[B,+C.._/?U-=,
MWCOPUM/_ !-!T_YX2_\ Q-8WPGLX[OP<CW,MU(ZW,T8/VF10%#\#"L /P%;/
MC"S@L?"FL74$UU#-%:2M&_VR7A]AVXRW7.,4 1_#."U_X1'3[N&&$2S"4F54
M 9QYKXR>OYUJ6VAPQJR7,KW,6^5TB< (GF,S'@=3\Q&?2HO \,$/A#1Q:!!&
MULDAVG(+L,OSZ[B?ITK<H \T^)>GO:S:#=-,;E(9GC1;F/>HRO"L1R<G@=^.
M];NG>%YK>8R36^B3!DV[#;$ '/7G/-5_BI=>3I^D1!-S'4([CE@H"Q'<1D]S
MVKKQ>6S8/VB$9_Z:"@#S[PW FJ^--5\N.33E@LX(I/L \I/,RS%3E?O ,!^%
M=A_82_\ 03U7_P "!_\ $US?@*^W^*O$T!A8?:9([Y'#!EV,H !([\5WE '$
M>.K:;1O#%W?6>J:KY\93:3."!E@#V]*KV>@^(;RVBN(]8N8TE4,J273!E!['
M]WUK2^*K;? NH_*S9V#Y1G'SBMW2-2M[G3;28RQQEXU.QI%RO'0T <+I5W<Q
MZO8V[ZI>3O-;WHN;>682*IC"["/E!YR:T/ VF37'@[2H;N.W&FB(3B/[QF.,
MKN'0 'G'J!6'IMM(OC"UNB%-O/!J C8-G.T+G^==1X05KKPOH=J9'CB&G)(P
M1BK2$\ 9'( QDX]1^(!SG@/^Q5\ 74^IZ?;2BWEN=Y-J)"RJ2>N/ZUEZ/X8D
MMM,MXKWPG,]PBL';[/"V3Y6T<[N?FY_6I]'\&7L?@S5EN#;0W"O<_NI+?>_?
M'[S?QGUP<5UEUXMOHI;N-](3=;EE?%R.H*@XX_VQ0!S?BV[\,W?@^WFT.TMH
M&FN8'0):>4P'F#/(7'ZUZJ.E>-Z]X'CT#P;8SSLAOH9[=9-A<C)<9QE\?^.U
M[(.E "UR/Q&DT>+1+N+5;E[>:[MI(HU3=F8J"0I ![X_/KS775S>L\^./#6?
M^>=U_P"BQ0!%X<T>"W\#BWD-Q,MS:;I1<2ER,Q@;03T [#M1X,L8KGP7X?,C
M2KLLD0A&V[E(&0>^.!TQ6YJ]W;6=A*UY<P6ZLC*IFD" G:>!D]:Y[P/K6E0^
M#=%CFU33XY$M4#(]RBE3CH03Q0!UB*J(J( JJ,  < 4ZLS^W]&_Z#&F_^!<?
M^-']OZ-_T&--_P# N/\ QH TQU%>5:;_ *[_ +FS_P!IR5Z&-?T;/_(8TW_P
M+C_QKS;3[F(+'.C"2&3Q<JHZ'<&W*Z@@]QDT >F:QJUCHUHMSJEPMO SB,.5
M+98YP, $]C6))\0?"L1 EUB)">FZ*09_\=IGCB[C74?#=FP;S9-3BE''& KC
M^M4/%6C:?K?Q%T>SU6V2XMO[-G?8Q(&X.N#QB@#0_P"%C>$?^@Y;_P#?N3_X
MFE3X@>%)LB/6(9,<D+%(<?\ CM<7%X#L#::Q>W#QVEM;S7,$4<$6_8K;1NR3
MGCT]ZW/AWX4BT3Q!J-]8S6YLIH$C$"'>8CG/WLD$_+R.V: -W_A._#7_ $%%
M_P"_$O\ \31_PG?AK_H*+_WXE_\ B:V-2U33M+5&U*[MK59#A#,X7=],U0_X
M2SPY_P!!K3?^_P"M %;_ (3OPU_T%%_[\2__ !-'_"=^&3UU1?\ OQ+_ /$U
MH6'B#1=0NEMK'4K*XG8$K'%(&8X&3P/:FW7B/0[2YDM[O5+&&>,X>.20*RGW
M!H RS\0_"2-L.M0*P.-IBD!'_CM8NI^.O"_VN?[/;7+3]?MD%L48MZAL9/XU
M3UKQG8:C>7ULLH2UC/EB6WD#>9@KDKR <[U&.2,&NJL_&5A>Z\;*! +91*)+
MJ5@BJ\;*I7!Z_>7\Z *]A\0O#DEC$]SJD<<P4"5?*D^5N^?EP*Z33]2M;_\
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M%?"7[.XM?B'IUY;:NFI^&+*=;A_-B*%V'(4?POR!DCC'%?55 !1110 4444
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MG;2-'/&E_$LOD"6/".S!,N2/NX!##/'3IS0! ;NWBF\NYC:S&?,:&505\J(
M(@SQSP<#/0UG^(M"TZ_M9)=9M86EA1F:49&V:0@Y)7Y@$ !//J:Z:UU+3=7C
M$)*.SKG[/.FUB/\ =/4?2N;\8:9$S6&BV$DT;:I.PDC#Y5(@,ROSR#M^4<X^
M8T 9WA2T\6V^AV]_INHI?6\VZ2*PU+.\19^3$HY!(P>>*[#X2:AJWB+Q1JM[
M)I.GE;6,6PTR[N LTW!#F/(*LH.>3QR>:A\4:M'HWA>>XM,!POD6J =7/RJ
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M-"CU6\U&RUBV,\F4>%)T*,#M.[DDYRN.O;IS0!5^-,%P(=(NX$B=(Y'1Q(V
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M\BR27&^(?-YG'EC8>@7GH3T%0P207*_9X)ED;'V-3(/FY^:9\]>@QSCE/>@
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MK7GVJ:=XQUN;3H]2M=&AMK>[CN6:"9RWRGH,BO03R30 4444 %%%% ')7O\
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M<87[1;_-Z_*_^?QKN]Q]3^= 'GW_  M71_\ H&ZY_P" @_\ BJ/^%JZ/_P!
MW7/_  $'_P 57H.X^I_.C<?4_G0!Y3?_ !$LY;XW5G_;]LWEB/9_9T;C@YZL
M<C)I5^*:-X<=7L-476FMV 9+3]VLVTX/7IG':O5=Q]3^= 8YZG\Z /%]"^(.
MGV_B+4[V:UU29+AP5*6V6&$"G(W<<BK5A\0-/@O!*^F:MMVVP^6UY_=HZMW]
M6&/QKIOAO:I%?^)9\[IO[1EC#!\X0L6VC#$#DY]?7%=QN/J?SH \I_X6-IGE
MSC^S-8S)#.@_T3N[EA_%Z'FI5^).EAR?[-UG_CZ2;_CT_A"*#_%UR*]1W'U/
MYT;CZG\Z /)S\1--^R01_P!F:ON2V\H_Z)QG<A_O=/E/Z59B^)>E+-"QTW6<
M)<2RG%IV;=C^+K\PKT_<?4_G1N/J?SH \QA\>6]_IOV+1](UMKV(([+%;[2J
M[N><DX//:K=Y+<>+-0T>Q_LK5+.SB;S+Z6[M_*615VL$!R>KJOX5<\6>(="T
M;7G6^AO8M4:W5ENH$W?)D@#[W0$'@BK-KX_T%[6)KB]=)BHWK]FEX/X+0!U%
MW.+:VFGDR5C4N>,]!FN.\,Z<OC'XB:=HK.)885^TW.TY!!YD;/<8)0$=WC/:
MKH\?>&\9&H'VS!*!^97 KT?]G?23)I-]XFN0IFU*4B,CL@/./7G S_L^U 'K
MZJ%4*H 4#  ' I:** "BBB@ HHHH **** "BBB@ IDTJ0PO+,ZI&BEF9C@*!
MU)-/KPO]IKQ?<QV%EX%T!_\ B<:\=D[*?]3;?Q9]-W/_  $-ZT >6ZZ!\:/'
MFI:[?23)X;L'%IIR+QYJJV6//9NI^H]*]&1%C1410J* JJ!@ #M5#P_I-OH6
MC6NFV8Q#;IM![L>['W)YK1H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** .2O?^2J:5_V"9__ $8M:7C4 ^%-3#=#%@\9[BL/QR-2
MTC5HO%%A!:W%O8V$D,T<TA0G<X.1@<]*O:Q)?ZEX2U2WF@@74-XM_+C<[#EU
MVMDCH0<_I0!:\%QQQ6-XL0(3[6W6/8?N)_#@8KGO!,5Q'>-:>4OEO(MYYNYN
M%!/&"N"?G'0UTWA.PN-/T^:.[C2-WG:0*F, %5'8 =C5#PSH^H6&JO->^28O
ML_E(4Z@[@>>YZ?\ UJ .IHHHH **** "BBD4[@."/8T +7D7CLZ@OQ<TE](A
M-Q=):;A"'"B103D$GM7<IXH>5I?L^A:O.D<C1>8B1[25.#C+U@0VFI:G\3K'
M6CI=W9V,%JT+&XV@ECGH 30!9GUSQN86$'A:V$G\):Z4C_T*N>O+/QE>:E)>
MS:"H>1<,BW@"@[-O'S^^:];HH \GT"T\7:/JL]\GAY97EA\G8UVI &X'@EB>
MWZUU6BS>(-0\0VUQK.C1V%O;PR*'6=7W,V., GTKKJ* ,CQ=;7%[X6U6ULHO
M-N9K=HXTR!N)XZFN1GUOQ<MO%I;>&(09[=H5;[2N<!,$_>QWKT6J=Q [ZE9S
M*JE(Q(&8]1D#&* /([/0O%MK:F!-$++Y:HI-V!MPRGL_^SCCU-;VC7?CG2[:
M"UC\.036Z;BS270+DDD]=W3I7I5% '!W>I^+[VUEMIO"\2)*AC+K<H2H(QD?
M-3-(LO$<5U#]N>_:R6.-3%&L08-L^;!W] V /4<UW]% 'F<L'C19P\(NWC,D
MF8W\H!4^;9@A\D_=S^-7M1M/$$\B26<>H1K$S.L4K1,7.,+\V_C&6/?M7?44
M 8UAIKK9:>K+]G_<J+J)6^\P4<<<9SG)'6N7M])U'3_$]_=IHS7%K(LD<1BF
MCC*9<,&7)XXKT&B@#G8=6UH0H)?#LYDVC<1=1<GO4G]KZO\ ]"Y<?^!45;U%
M '">![>[B\9>*;F\MQ;_ &V2-A&9 [(44'!QQTE4UW=86EY_X235_FR/-Y&>
MG[FW[9_SG\]V@ HHHH *!UHHH XSX;E#)XE\L$#^U90<^N3GN:[.N/\ AXX>
M;Q(5;<!J<@SMV_Y^M=A0 4444 %%%% '+ZO_ ,AV_P '&=.Z_P# Q70&"7<?
M]+FZ^W^%<_JW_(=OO^P=_P"U!74M]X_6@#"U5"MOI^AVA>2YU"86T2G)W9.3
MDCH"2 3VW9[5]&Z)IT.D:3::?;?ZJWC" D8+'NQ]R<D^YKR#X162ZYXRO]89
M2;72LV\)92 92""1GT5FY'7S,?PU[90 4444 %%%% !1110 4444 %%%% &;
MXEUNR\.:#?:QJLHBLK.(RR,?0= /<G  ]2*^6/ @O?$^NZIX\UU2+S4W*VD;
M<^3 . !^0'X>]='^T%XAD\;>-+'X>Z3*1I]HXNM7E0]QTC_#/3U(]*U+>&.W
M@C@@01Q1J$1%Z*H& * )**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@"CKEA;:II-U9WWF?994(D\LX;;[5F:7;PZA>R7:7%S
M<6RJL8:5@I9U;/*@ \<?>%6_%6IRZ-X=OM1@CCE>VC\S8Y(!_*JYEN8=3GN(
MTA>-?+@F(RN6+#&/4@,.OK0!O44=** "BBB@ HHHH *R-?E>U6"Z>YF@LHRP
MG,.W<,XVMR#D @C Y^;VK7JG>VCW%U:RHZ8@+-L=<@L< -]0-W_?5 &)\/I_
MM&CWC>:\J#4+A4=UPQ7=QD8'\JZ>N2\'WUE8V-]'>ZA917#7]Q(Z/.JE<OZ$
M^U;O]MZ3_P!!33__  )3_&@#0HK/_MO2?^@II_\ X$I_C1_;>D_]!33_ /P)
M3_&@"U]I@^TFW\Z/SP QCW#=@YP<?@?RH@N8+AG$$T<A0X;8P.WZUQ_AZYL[
MVSN;S6-:L)+F]"(0DB1>6L;/M &XG)W'GWK.\0>)8-"\41-9:A!)97\!:58
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M_NZZ&N8\&W45Y-J$]O,LT;I;D.ISG]U73T 8.EK_ ,5-J[#_ )ZX/M^YMO\
M"MZN2BUK3K'Q'K7VN[MXG27A6E52?W-OV^OOV/X7=!\0P7\NI++>63"VN?*0
MPMP5V*>23R<D\CB@#H**B@N(;@,8)4DVG#;&S@XS@U+0 4#K3)76*-Y)&"HH
M+%B<  5S?AWQ98WUA!+>ZAIZ2R*S?+*$ PY7&&.0< '\: *OP[#";Q)O" _V
MI+]Q=HQGZ#GWKL:\_P#AYJ.GVO\ PD+S7MM'%-JDS1N\J@.,]CGFMVT\2V]W
MXD@L+:[LY(98)'"H^YRRMCJ#C!&3CK0!T=%%% !14$EW;Q2>7)/$CY VLP!R
M>@J>@"GJX@_LZ=[H$QQH7.UMIX'8]O3\:]"^!>BFP\(C4IXV2XU(B0*ZX9(A
MD(N.W5F(]6->;7L#ZQKFD>'[=9"]],/,9!D1H,DEOP5C@]=A%?1MM!';6\4$
M"!(8D"(HZ*H& * )**** "BBB@ HHHH **** "BBB@ KS7Q5\%/!/B7Q#;ZS
M>:6(;M)/,F6W.Q+KVD4=?J,'WKTJB@#PWQ+\--<\.?Z1X,E&I:>&!?3[I\21
MIWV-_$<=.A]=U<]I^MVMU/\ 9IMUK? E6MI_D<$=0 >M?2=<MXR\":#XK EU
M2UV7L:%8[R$[)8P??H1[$$4 >-ZQ/-';>598-[-E(L_P\<L?H/UP*P[36;O3
MG$&HH\@4<EOOCWSW'^<FM7^P=;T2(:MYJ:WI=Q,;:RV?)=-&#PRH2=X8Y/!S
M@9''%5Y[FR\0&*S@*2J#YEPKKAXE!^Z5/().!CTS0!M6\J3P1S1$E)%#J2,'
M!&1Q4E)TZ4M !65;7VHZAK$EEI.C75S!%CS;X@B!"02!E06R<>G<'H14NMW%
MQ#9E+&%KB\E(2*%7VER2!@'L><#W->X>"- 3PYX?@L_E-PW[VX=1C=(>N/88
M"@=@H% 'C2V7B$WDD)TI B1HXF)EVL26!4?N^HV@G_>%'V+Q#]L\G^RDV>7O
M\[,NW.<;?]7G/>OH.B@#Y\>R\0K=Q0C2D9'1W,H,NU"I7"G]WU.XX_W33I+#
MQ L\2+ID;*X8LX,N$QZ_N^]?0-% 'S]+8>($>(+IL3AVVDJ9?D&"<G]WTXQ^
M(I9-/U]&C"Z;$^YMI*F;Y1@G)_=].,?C7T!10!\^W%AXAB1632XY2652%:7(
M!.">8^@I+RR\0P6YDCTI)V#*/+C,N3E@">8^P.3[ U]!T4 ?/MY8^((+:26/
M2TG=!D1QF7<WL,QUP/QVM]8MOA_(;O3U6W>XB#R(7_=\Y&=R <GCK7V!7C7[
M6W_)%M0_Z^K?_P!&"@#Y[^% \8'PDG]@-HPLO.?'VL.7W=^AQBNRV_$;^_X;
M_P"^9?\ &JGP(_Y$&/\ Z^)/YBO1* .&V_$;^_X;_P"^9?\ &DV_$;^_X;_[
MYE_QKNJ* .&V_$;^_P"&_P#OF7_&C;\1O[_AO_OF7_&NYHH \VETCQ])KT&K
MM)X?^U0V[6R@"3;M9@3D>N1ZU/J-AX_U*QFL[I_#X@F&U_+$BMC/8YX->A44
M < WA;4V VPV\3;AEA<%V"CLI*\?CGTXIS>%K]6.R"%T(YS<; /48"D'\<UW
MM% %/1K9[/2+*VEQYD,*1M@Y&0,=:N45X_XG^,L=EJ<EKHM@EU%"^UIY7(#X
MZ[0.WN?RH ]@HKE? /C.S\8:?++!&;>Z@($T#-NVYZ$'N#@_E754 >.?M(1L
M+'P[+GY6EN4Q]!$?ZUV_PZMM;7X8:3=6FF"X"6A:*)3(7F )P!A",GZUQO[2
M7_(%\-?]?%W_ .@P5].? #_DC7A/_KS'_H1H X&XTW78H9'2PBE9%)"+YV7(
M[#]WWIR:9KIC4M90JQ&2N9C@^G^KKWRB@#YWN-$US5=$D@N;%;4W=L4D3,I>
M+>N",B/&1GZ<5F^&O!^M:=X>N+1;4(;MI)6642 QEU QA8L < X%?35% 'SC
M\.?"FJZ=I^D>'KR*59,3(+B52$^4LPZC.".G?%5YM$\3WM_J$^ESZ?'"EQ-9
M9DLYI#F&62,D$<=0Q_*OHW4;&#4+?R;E6*[@RLK%61AT92.0?<5%HVF0:19&
MUM=Y1II9V+MN+/+(TCG/NSL: /G'3_#'C)&OA<36;M(!$':SF7*A<Y7 ]7/7
MN*S/"O@#Q3HFH7\L4EJ0S;%,MI-AP<.6! R<%BOS?W?3%?5]% 'R/>_#;Q-J
M/C*YU2X:&$;8"/)BF5)]H(P?E)R.*[G^S]?-X\9TZ,1A%<2YFVL26!7'EYR,
M _\  A[U[_10!\_MIVO?:EB_LZ(Q,A8RYEV@Y'RD>7G/.:Y?4?A_J$_B*UF7
M2[06S#?(!;R%5,9&%)\O(W;CT'8Y[5]444 ?,]YX+9KBV1_"NFSJY8&3R)"(
ML#.3F+OTXJ>Y\(W"M;!?#>G3#<(<B*0>4F"<\Q=,@# ]17TC10!\U2^#)+>.
M,6_AC3) 7"E4AD&T'JQS%T%>3?M!Z+)H\>C9TRULUD,GSP*R[B,<'<J_UK[N
MKY=_;@_X\?"W_72;^2T 'P\M+>V\&Z-);P112364#RLB@%SL')]3R:Z2L+P)
M_P B3H'_ %X0?^@"MV@#Q[QYX;FU;4IXWT35I56ZEG$]I#&1)O" <E@> GTY
M]JN>$/#^K0RK'96;:=##;^63JMF'WG(Z;7]J]5HH XS0;.]\/^)+A-1OK66W
MU*.6[*PP>4L;Q^4G&22<AAQGM[U>UG4-0N+/3[?39X]/U"ZNO)9I$$GE 1R/
MG:>N0@'X^U="\4;NKO&K.F=K$9(SUQ^0_*AHHVD61HU,B_=8CD=NOXF@#D)M
M"\6SPO#/XGM'AD4JZ_V<HW*>HR#4,7AGQ/'"D:^(M/VHH49TJ,\ 8]:[FB@#
M@8O!^NP"U^S:SIT36\9C##3@Q<$Y);+$9^@%2-X8\3-/#,WB*Q\R$EHRNFHN
MTD8SP>>*[G-+0!Q-WIGC&"UGF_X2FU/EQL^/[.7G SZUU"Z@@NHHFP4*_/*#
M\JOV4_7FKK ,I! ((P0>]-$48CV!%"?W<<4 <.WAK4M707DNIV_^D30W8)M_
MF39RJ@@XQTSQS6W,/$5HWFQR6>H1X^>)E\EOP;I^=;R*L:JB *H& HXP*P_&
M<]VNBO::8C/J%\PM8%49.7X)_ 9- ';? &#^W)-1\63021([-9VJR#D $;R/
M4?*H]B'QPU>S5C>#="@\,^%],T>U&([2!8R>I9L?,2>Y)R:V: "BBB@ HHHH
M **** "BBB@ HHHH **** "CKUHHH PKOP]:Q1++I%K:V][#(LL+%,+D#&TX
MZ J2O'3.<'%<;K7PLBU6WDU3[4;3Q5.3-/<Q$F*1^R$<?*HPH88.!D]2*]/H
MH ^:[W^V_"<2Q>-;9(\#F^@&86]\_P#ZC_LXYK1BGBE@\Z.1&BQG>#QBO?+V
MTM[ZUDMKV"*XMY!AXY5#*P]P:\H\8?"BYW)-X(O8K%I)D$\%UN>-8\_,4[Y
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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)** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image03.jpg
<TEXT>
begin 644 image03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $] E\# 2(  A$! Q$!_\0
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MLR/F9>P)8 GCL!TJ>:M;;7_@>O<CGQ'+\.O]>9>C\6:2[6JB6=3<2F!-UM(
ML@.-C';\K9[&KVCZQ9ZNLYLGD)@?RY$DB:-D;&>58 ]*PH?"$L=Y:W)U5Y'B
MGDNG5X%*/,_\>.Q X'7'UK4\,Z*^BVT\<MX;R2:4S/,\85V8]2Q'7^@%53=5
MOWUI_P -Y^I5.5=R2FM/Z\S9HHHK<Z0HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8EE,]OI-NRIE9CM)W8R##C.<?-U&*+CL>R45X;<^*?%L4.D31ZOJCQ:AYO\
MS!H0T&QRH\P;OEW=1]>:70_&&OZSJ%C9VVOZRDEZ-T+2:%;JNW/5CYGR]SCK
MB@3T/<:*X*72O&":M;6?_": B6"64M_9,7&QHQCKWW_I7*^(M<\6>'M0N(-1
M\07LL*R+'#)9Z/%*9"4+<@E0OW2.IH&DWL>ST5X/+XZUF%ITE\0:VLL#(DD8
MT"W9E+],XD/''7IZ$FK*>*/%%Q?/96FMZH;J-YD=)]&@C&8XFD^4[SNR0%&.
M/F!/49!'M]%> Q^._$8A+7.L:U$V/,"C0H23'N5,\L#G<Q^4#G'O7:^%T\4^
M(M+%_;^+;JVB9L*MSHT"L> <X#'CG]* /2:*X#1]+\8:AID%TWC0(9%R5&E1
M''/UKF?%.K>,=!UUM._X2&6>,6T=Q]J_LR)(@6EV;6/(&/O'J<=L F@#V6BO
M";7Q7XPGL;ZZ.K:@HM89)FC&DPER$E$93']_G<5[ CDYJ)?'/B%/)6ZUK68I
M60-*HT*!O*)( 4_.,GG]*+= />Z*\_T2P\6ZMI-K?Q^,)K=+B,2+'/H\ =0>
MF0&.#^-.DTOQ@NKP67_":#$D$DV[^RHN-K(,=?\ ;_2@#OJ*\B\8W_C#PW>V
M,'_"0W=ZMT=OFP:1"5C).!NYXS6%)X[UNWTLWMYK^L01B!ISG1+8C"OL(SYG
MKZX[=R 1:[!?H>]45XG9^*/$5_'?_9/$6IJ]K$\@-SHD$2.5<(1G<2.6!Y'3
M/<$57T+Q3XNU:ZLX6UVXM&N&52EQID*R)D)SM[CY^,'G&>G1V!Z;GNE%<'JN
MD^,+'2[R[7QH',$+RA3I,0SM4G'7VKF?%.L^)_#=Q(+WQ3<2P16T=PS0:1"T
MC;W*85,_, <9.>-R\'-(#V*BO!W\;>(86NUN=;UE3#,D:*FAV[F17C#JW^LX
MZGCVSV.)]6\4^*=-O"DNO7\D 2%RT>D0EU\Q2?F7.  1C.[&<\X&:+=1V9[C
M17@]YXU\0P33(FNZM(L1&X_V) ">3NP-W)P,@#D^F!FK=YXC\5Q>0]OXAN98
MIK5+I0^E0I(=R@[ N3EL,#C/(63^[R!;6Q[;17C/AS6?%NLZM#8_\)/Y)<'+
MC3X6QC=R!QE3MR#Z$$XSBMJXB\80:-J5^?%Q?[')(GEII47S!6QDG/ [D]AF
M@1Z917AK^+_$,3>7)K^K2.L?F2-!HEN\:C:"2&+C(YXXR1@XP03#'XZUE[5+
MD>(-;\ET+HXT&W(8 $\$28Z#]?8X />**\'N/&^NH_E0:_K$DS':H;0H$3.[
M;RV_ _R.M:=GKGBFY\3)HP\0Z@LDES+;I,=%B",(PI,F20-A^< YY*< YIV"
MQ[+17 WFE^,+>\L(!XT#"ZE:,G^RHOEPC-GK_LU<_P"$?\7_ /0[C_P4P_XT
M@.RHKR#Q-JGBKP]JGV6\\27LL'E++]HM]&A< ,X0#&1SDGCT7/H*S/\ A--7
MVP;O$^JAYG"*G]AVY89QC.).,\^^58'!!I70>1[E17FGA9?%7B+3GNX?%=W9
MA)6A,=UHT"OE>I^5R,<^M7]4TCQA9:9=W2^- Y@A>4*=)B&=JDXZ^U,$[ZG>
M45D^$9I[CPOI4]Y.]Q<2VT<DDKA068J"3A0!^E:U !1110 4444 8'C3_D$Q
M?]=T_K6GHW_('L?^N$?_ *"*S/&G_()B_P"NZ?UJII7BBSCTNS1K:_RL* XM
MF/\ "* .JK,\07EW8V4<UA:O=/Y\2R1HNYA&7 <@>H&35+_A*[+_ )]M0_\
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MXBM[31;6">TU!947##[,W')K1_X2NR_Y]M0_\!FH Z"BN?\ ^$KLO^?;4/\
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M/7FEM>Z\XGN3=))-;F0Q'R]FU0>BX/3T)'>N_7Q39*H'V?4.!C_CV:CJ'F=
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MZS6^HVD;!@KQW6PA4V2;F)4=0Q0CGH/K5?Q=I>C^)]<CU*ZFURV>*&.*/[-
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M)((AM*/*HRNW//DL?;<OK1U'<IWA\96UK=7%MXGCGGV!A;QVY!E86P0@%HP
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M\A_V: -;P60WA#12.0;*$C_O@5LUB^"5V>#]$4=K*$?^."MJ@ HHHH ****
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M*[F/4G!Y/O4G]D6O_3;_ +_-_C7*W.M>-D$S0Z!:,/++1J7^8-YI4*?FP?D
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MR 2Z2EY"G'&Y<*?8\8Q20Z5XKN=+MK>^U)+>Z%U)))/;G=^[:-BJ@$#.V1L
M>BCK0".UHKAT@\:DM");6*.,OME.':3)&W\OF_2HX;7QN'NAY]JJEI#&S$-R
M9 1@>@3(P>] '>45P]D_BF]LKT7T#QO#?;52-EB,\0!Y1N<+DJ<GDA3ZU'=0
M>.':-8I+4*DP(.X#<H)^]ZJ1M&.N<GI0"U.\HK.\/G43I-L-95!?A!YI0C:6
M[XQ6C0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSDM@@\ ;>.<=&XQ[U0T/1_%UH52\UBV:!;1HD4'S"LV3M8DH-PY4]L8QSUH
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M/OC-&^B#J=9H_CFZUHN-)TP7A0;F$%U;N5'OB;BM/^VO$/\ T+5U_P!_8/\
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M-^S^(4U[J'V&VTMWN_.DMQ%YT 8R1_?49EY(Z_3FMK^VO$/_ $+5U_W]@_\
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MAC0!TC4<YXG/^- '0^;'_?3\Z0/"&+!H]Q&"<C)K _X1G0/[B_\ ?\_XT?\
M",Z!_<7_ +_G_&@#?5H59F4QAF^\01DTOFQ_WT_.N?\ ^$9T#^XO_?\ /^-'
M_",Z!_<7_O\ G_&@"UJ\B?VOH?SK_P ?$G?_ *8R5K>;'_?3\ZYX^&- )!,:
MDCI^_/'ZTO\ PC.@?W%_[_G_ !H Q_& \8MXBCD\*W-FMBL$?F)=,-COYOS
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M .)J:V\'3VUQ9SQ7]OYMFNVW9[:1_+&"O :4C."1GK@GUK6^PZ[_ -!JV_\
M #_[.@##_P"$6O?^?31O_'O_ (FJNGZ%>7J3LMEHZ^5,\/.[G:<9^[73?8==
M_P"@U;?^ '_V=5[+1M9M%E6+6K<B25YCFQ[L<G^.@#+_ .$6O?\ GTT;_P >
M_P#B:P-8GLM'N9H-2_LB"6)X8V#128)E)"8.S!R0<XZ=Z[O[#KO_ $&K;_P
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MDXW9^X?]FNJ^PZ[_ -!JV_\  #_[.H;W2=:O+.XMI=:MPDT;1L18\@$8_O\
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M8 [BBL+0%UB*\OEUB<SQ!TCMV5%4.!$I9RH7*Y?=U8^G'?=H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K&N+6^;Q3:W,<Q2Q6%ED0R'#GM\O
M3@]\?CV.S7/7-G#+XVL[HZA)]HAMW M F5VGC<3VY]?2CJ'0Z&BBB@ HHHH
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M7_9MXZ0R3QR([M'%!(/-:)C(0#@ ,&;=U!&<]J&"&&R\'+'YCZDTZVBH<%\
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M4^Y\.:3<SB::RC:41"$."5(0$$ 8/'*CGKP* ..73O"-U=QF*^N$G$AC1=K
MF03GL5Y.\D8],'&.:AT?_A$[?41+#=WD;V,_V=!(X;&W?\HQEB,[SZ\<\8KN
M8O#^E17?VF.QB$VXN&YX8MO+8Z9W<YJ-_#.C/N+V$1+2&3))R&YY!SQ]YN!Z
MGUH#H<3'HW@D0*4O'EC(:($.0NUY.I. /O$X8]<'!.*1+#P7=O<S1ZO/*+AI
M9I%!9@^\K&1C;S@X&.OKQ7;+X7T52Q&G0_,06!R0V#D9&<$#L#P.U">&-&2$
M1K81A5& 03N'(/#9SU _*@#F'M/"IT=MNJ$P079W3;R2)EB$;9(&<;5Y(XZ\
MBJ<6B>$_(L8#?3.;PBV0[]@9H@V3\V#D;\<Y.,#D5VS^'-(>T:U:QB-NTC2F
M/G&YOO=^AR<CISTIUQX?TJX@$,UC$T0+,%Y RPP>GK@?D/2@#B+%_"VB75@T
M*7L$IDMXK>5D #F1953 /;!D&,=A@'BNJG\6V$+29AO&15\SS%BRK(&VE@<]
M.00?XL_+D@@6Y_#NESRO)-:AV=UD;+M@LJ[0<9QTX]QUH;PYI98-]F*E1&!M
ME=0/+^YP#_#VH UJ*1%"+M7./<YI: "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IOEI
MYGF;%\S&W=CG'IFG44 %%%% !1110 5'-!%.H$\4<@&<!U!ZC!Z^Q(_&I**
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F%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image04.jpg
<TEXT>
begin 644 image04.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $W EH# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZIHHHH **
M** "BBF1RQR[O*D1]IPVULX/I0 ^BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HID
MLT<.WS9$3<<+N8#)]*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %>
M1_M!?$S6?AS#H']@V-E>3:E-)$RW08X*A<8VL.I;O7KE>"?M5>%_$/B.TT"[
M\/:=]HCT9IKRXFDFCC1!A2/O,"3\AZ"@#D?^%[_%#^TFT_\ X1#2#>+%YQB"
MR$A,XS_K/6NKU+QMJ^C>"M(U3PSH:R>*I7_TZS>,K"1)O=R0&!)5L8).>3US
M7DGPSUS4-;\2WFNZZ;2&,VPM49'502#NQC.>AZUZ:-6TXXQ>V_.,?O!WZ4 9
M?_"Z/BS_ -"5I7_?,G_QRC_A='Q9_P"A*TK_ +YD_P#CE:O]J6 _Y?+?H3_K
M!VZ_E5J*1)HEDB=7C895E.010!Q]O^T'\2+B6SCA\*:.[W:NT "2_.$.&Q^\
M[$5H_P#"Z/BS_P!"5I7_ 'S)_P#'*K:/X,@TS4[*\&I7UP+-9%@AEV;$$A)8
M<*#U/K75T <[_P +H^+/_0E:5_WS)_\ '*/^%T?%G_H2M*_[YD_^.5T5% '+
MV?[2GBG3;FYM_$G@F&>9'1 +.9XMC-T5LA\D]NE:G_#2^J?]$WU'_P ##_\
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M/0]_K6G]FM_^>$/_ '[%4/"O_(O6.<_</48/WC6K0!%]F@S_ *B'_O@5%I@
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M<?S-="ME:;A_HMOU_P">2_X5@_#?_D1M'_ZX_P#LQH Z6JI'_$T0_P#3!O\
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M%%% !1110 4444 %8WC*'4;CPOJ46B3I;ZBT)$,KGY4/<G@]L]O\:V:AOO\
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MB6,$.?FQ@D$D<#D8Z] :H_#>ZA7P-HX>10P@R1Z<F@#K*K$#^T4.#GR6&?\
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M9/J:Q/$$0DL]5+;"?LR8+ ';RWJ: +7A[_D Z=_U[I_Z"*T:S_#_ /R M/\
M^N"?R%:% !1110 4444 <_8\>*-;PQ^[;_+Z?(>?\^E:V3ZFLFRQ_P )1K?]
M[;;Y_P"^#6K7)#9^K_-GG9ZE]<_[=I_^FXF?<.X\1:4H^Z4FSQ_LBMS<?4_G
M6'/O_P"$ATO;N\O9-NQT^Z,5MUK1^UZ_HCU(V^J8>W\K_P#3D]_ZVL#1)/A)
MV8*#N&'*\CD<BBHYA 57[3&LB;A@''WL\'GWK*\97<]AX5U6ZM)#%<10%HW
MR5/KS75+^&O5_H<%._UNI_AA^<S9HKFHM!U%XD8^*-7RR@GY8>X_W*?_ ,(_
MJ'_0TZO_ -\P_P#Q%9G8=%17">,+;5M"\.W6HVWB34Y98-I"2I%M.6 YP@/>
MNW@8M!$S<DH"?RH DHHHH YOQI_S ?\ L+VW_H5=)7-^-/\ F _]A>V_]"KI
M* "BBB@ HHHH **** "BBB@#DO$O@'1==DO+B2!8+ZY0J]PJACGUP>,].>M>
M>R>"O%W@B\DO_!VIW4:10[MUK(Q>5QU!C Z$?[PXZU[?10!Q?A#]I;7-%F2P
M\?:-]L5%5GNK0!)E4]"R?=/YK7J^N?'?PC%X!U'Q!H.HV]]=VZ*(["0F.5I&
M("@J><<Y)'8&N'UOP_I>MP2Q:C:))YJ['=?E<C.?O#FO$/B7\/[71;NT_LJ2
M>::_G2&*#RP%BSD<D>IQCIT;K0!]/?"OX_>'?'.H6NDSVUUI>N7'RI X\V.1
M@"3M<#T!^\!7LE>6_#7X*^&O!&IZ?K-E%,=8ALOL\K-)O1I& WR 'H3R..,$
MUZE0 4444 %07W_'C<?]<V_E4]07_P#QXW'_ %S;^5 'SGX5S_PCUCG.=ASG
MK]XUJUPVFM?3W.A65I<^3 MA+/( S*&;S-JD@8) YX)'7VJ2/1M0U34M11_$
MVL6RVLHB5+:14'*@\Y!]: -Z[\/V5WJDE],)?.EB6)PKE00IR.G.>:YJZ\%P
MRZ7=SP:GK$61*PACNF*$@MV//.*Q[W4-1T>WNX[G4[JZM;76H+9IY[@^:\1V
MEE*A<'()[BN\T6UL;G3(9X45XI"SHVXG<I8D'\J ,:UTC0K0Z<]OJ,BS6+R/
M'(S!B2^=V<C'\1K9^W6__09_\<3_ .)J]]@MO^>0_P"^C_C1]@MO^>0_[Z/^
M- %'[=;_ /09_P#'$_\ B:/MUO\ ]!G_ ,<3_P")J]]@MO\ GD/^^C_C1]@M
MO^>0_P"^C_C0!1^W6_\ T&?_ !Q/_B:/MUO_ -!G_P <3_XFKWV"V_YY#_OH
M_P"-'V"V_P">0_[Z/^- %!KZW*G_ (G';^XG_P 36;X+\/3:79Z?+<7C7&RV
M"J&0@C<J\$ECP-H '%:^K6<$6EWDD:;76%V5@QR"%.#UKG/!L#V5]:6_VF>=
M6@=V:5LEOEC(SCKC)YZT =O7)^/O$LV@)81VVF'4GNG93$JEBH SG;W_ #KK
M*Q]6U.YM]6T_3[1(@;H,6EDR0F!QA1C/YB@#E?#WC.\%BXE\+>('_>MM6"U#
M*B\';DMGKD_C6B?%":I<VNE7FAZ[IWVV0)'-=6R*FY?GQRQ_N^AKJ;.W%M$5
MWM([L7D=NK,>_P"@'T%87BLA=:\*EB !J#<DX_Y8O0!:T;P[;:5=&>"61F.X
MX94')&.H /;I57Q]_P @>S_["5I_Z.6NA\Z+_GK'_P!]"N<\>2(VD681T8_V
ME:<!@?\ ELM '3GJ:*4@Y/!I,'T- %+6#C3W)Z*\;'V =23^5-_MC3_^?R+\
MZOX(]:-Q]3^= '+:G:Z-J$[2RZ@JEG63 5#\PQCDJ3CY1Q6G9W^FVELL*7L;
M!23D\9)))X P.3VK65]P!5L@]"#F@/GHV><<&@#)N-0M+F:RCMYTD?[0IVKR
M<8:M:C)]310 JGYA]:XOP/;QCX?Z3(J?O-BG(8C_ ):?6NT7[P^M<AX'./AW
MI)QN_=KQ_P!M* .JN3-Y3?9]GF_P[\[?QQ7)R>)+Q)FA>6S61',; QOC=N(_
M+&.?K78'K7/77A:UN;AYGE<,Q<\11G&XDGJO/WCUH VK+[1]F7[:83/_ !&+
M.WVQGFIBH96RY3 W9 !/';FF.Z00,\C!(XURS,<  #DFJB:E87*%8[@2,R,R
M+&3N;&>F!GM6M'^(CBS+_=*GHQEW>QGR/W5P/WJGF!_?VI+K54A (CF !RY:
M%AA:SY7:0P[H=3VJX<\3$\9Z97KT]*9=Q+<631[;\RNP9O.M994X[8(&<5D=
MIHR7\4EQ921K<,A+$$0,=P*GIQ6=<3"?QWH^U9%Q9W(Q)&5SS'ZU';A+=[&%
MUU(*BD+Y4,J*#LP0JXX'YU7N;RUM_&NE2S2W,2"SN 6NPR]TZ;OZ4 :[^);&
M/S/,6Y0IC*M$03DXR!W&?Y51O-7M=0L]6^S;R/LHY9<#AF'K[^U6[ZQT_7Y)
MMMT'*J$D551B,9Q]X$CJ>E5[BRBTS2]8BCF=@8$=B55<<%1P,#HH_P#KT :W
MA_\ Y 6G_P#7!/Y"M"L_P_\ \@+3_P#K@G\A6A0 444E "T444 <]9$?\)1K
M8QSMMR3_ , -:U95F?\ BI];&.BVYS_P UJUR0V?J_S9Y^>_[Y_VY3_]-Q,Z
MX5CXBTMA]T)-GG_9%;E85P!_PDFDG(!"3\>ORBMVM*/VO7]$>HK_ %3#?X'_
M .G)@LAB8,J%R?EP 3U[\ US_P 0/^1)UK_KV/\ ,5O23&WC:4#(0%FXSA>Y
MZCM_DURGQ"U2Q3P+>R-<QB.]@V6[9XD)&X ?@#79+^''U?Z'G4O][J_X8?G,
MZFW_ ./>+_<7^525SD'C+PV((@=<L 0@!'FCTI__  F?AK_H.:?_ -_161VE
M3XI''@34\^B?^ABNFM?^/6''_/-?Y5Y]\2?$VAZCX*U.SL-6L[BZE15CBCD!
M9CN'05T&AV>IIINCR2H(GLK=4,#2 F8E0&R1D#';]<4 ;IO[,,RM>6RLK%64
MRJ"".H(S4HFB(!$L9!Z$,*XA-!L'TZ_6^\/PSZJ4EF=W6-G^<MM)8MST_2H/
M#7@#0;OPSITEW93K</ AD(N7!W8Y/#8H W/&;HQT$*ZD_P!KVW0Y_BKIJ\K\
M)>%=)B\9S?N[AC92S2V^Z9R%*3%5SD\X KU2@ HHHH **** "BBB@ HHHH *
M*** *]_=)96<UQ)RL:YQGJ>P_&N<^"NJ7?Q#\9:PZZ3I]QI5@%8I<SLHD)R%
M&=C9&5W#@8_X$:P/C=K_ /9OA_['$V)KCY?S_P !D^QV&O<_V:O!_P#PB7PO
ML//BV7^I?Z;<9'(W#Y ?HN/S- '=^%=$_L*QD@$K,))#((@[&. '^"/<20H_
M4Y/'2MJBB@ HHHH *AOO^/*X_P"N;?RJ:N3^(UY&WAG5[".&YN+DV4DQ6W;8
M8@ 2KEB0!R.F<G!X- 'SQ::9JCQZ-J.CO #%:R02))-MW R9!W;'!'7L.O6I
M+.U\96UU=2K#X?87+^8X,TW!  &/D]!2?#[0+NS\*646MSM+=\R*8IFP$8?*
M#TYQ70_V/:X _?X&/^6S=OQH XV?PMKUQ%+)?M;2//JL5_+;VDF$*J5ROSJ"
M3@=V S75Z;=7"6:J-+N0 SX :)0/G/;?5C^R;4_\]OXO^6K=^O>K=K EM;I#
M%NV)P-S$GKGJ: *WVRY_Z!EU_P!_(O\ XNC[9<_] RZ_[^1?_%U>K)EM=8:5
MS'JD"(6)53:9P.PSNYH L?;+G_H&77_?R+_XNC[9<_\ 0,NO^_D7_P 757['
MK7_06M__  "_^RH^QZU_T%K?_P  O_LJ +7VRY_Z!EU_W\B_^+H^V7/_ $#+
MK_OY%_\ %U5^QZU_T%K?_P  O_LJ/L>M?]!:W_\  +_[*@!VHS7=QI]U#'IE
MSODB9%S)%C)!']^L/PG'?27]M->V$UH8X'1E<' XC Y(&3\IZ9^M;7V/6O\
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MT3PQ<2M]^12H'K[?B2!^.>U '!Z1IC_$_P"..G:4<OIUO)Y]S@\"),%OS^5
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M5[2=5U;489G'B'3K5X93#)%=Z=Y4BL "<J9<]Q72+HT-E:W TP2Q2NA*A)"
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M,C\Z -KS/&?]NBQ^T6OV7<<WG]GG9M\L,#_K.I8E<>V>]:OV'Q/_ -!S3O\
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M886-G8!AT)'S$?1,#_@9H ^C_#^D6F@Z)9:5IT8BM+2)8HU QP!_7K6A110
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MHDDC\(:PR.H92&CY!Z=ZRK_6+W4_&/A%+S0[[3%2[F*O<%<.?*/ P:[K1?\
MD#V'_7O'_P"@BL#Q=_R-?@O_ *_9O_1)H L>-_\ 5:)_V%K?_P!FK+\)>'M'
MU"WU.XOM,L[B=M4NP9)(@S'$S8YK4\;_ .IT3_L+6_\ )J/ G_(.U'_L*7G_
M *.:@# _X1[1E\"ZU<+I=F+B-=1V2"(!EVR3!<'V  _"MKX:21CP%H8WID6R
MY&X<=:SY-3L(?"FKZ=?7)M99&OHV:2-MJ;Y9<,3CIA@:\[U:X&IVMG;OXL\/
M0+:H$C:""13CZX]J /2OBM*C>$I44J[+(DS*"#\B,&8_E766-Q'=6<,\(81R
M(&7<NTX(XXKQC1+775\&^($L[[1Y]-MTE#7$ENVZ8&(%MC<?3GO7KWA]U?0=
M.9&5E^SQC(.1]T4 :%<%XINS'\0-,:0L([&U,Z!$W%F=PA!]MN>G>N]K@?$=
MUY'CR6'R5D^TZ0Z;RV#'@L=PXY/'M0!OW'BBQ%O*;<SF;8?+S;OC=CCMZUD_
M"7S(O#$UD[AH[*[D@C.W#8.'.[WRY';I6G)X2TY[9EB^TK*R$*QN7X;'!ZUC
M_!Z9[KPQ<WCA5%S>R.%!R1A54Y/?[N?QH [JN&^)DDL-SX>DBQN6YD91MR2P
M3(_E7<UPWQ-ADN+CP]#$X0R7+H#D@@E,9R.E %_7/$%E=Z#J-O#]H:>:UEC1
M?(<99D( SCU-<;]G2V'B!(YTG'VO2!O08'RX7'4\X45U^O>&M/M=!U*>'[2L
MT-I+(C?:'X94)!Z^HKD6O/MO_"02&%(?]+TCY5;(.<,#T'/S4 =CXJT^+5-)
M\26,LRP7,T?R2.,D1A58;1D<9#=.^:I77AFSTVPL)]+N)H+VVQME5Q)GY#GY
M6!'Z5U&OZ3;:WIMS8WFX1S+L+I@.HSG@]NE<'?\ PNT2SL+FX%[K&8HV<;9\
MG@>@% #H1>>($M+35M7EEM93%-)&(H5#$2D8R$SCY16G>6EI:_$OPW]CAABW
M6EX6\L 9X7TKA_#/@?\ M[1;.\LX[>VVQ+%()9I&9Y ,L_3C.>G;%64T"#3/
M%.FV:-<65Y$)$FNK.Z8-(&0$8W#CK@CO0![+17,_\(I+_P!#+XA_\"Q_\35'
M5_"VH+;*UEXJU^(AQO=IO,PO<XP* -#P[_R-/BS_ *^;?_TG2LSQQJZ7%Q'I
M%G:7UW>VMS;7<RV\!<+&&SG(^E:W@W1ETJWO';59]5NKF4-/<S$9+*H4#VPN
M*S_$?A\/XBM+^TU'4K*XOI%MI_LLVP,BJ2.U %G_ (32T:YG@&F:R9H0K2I]
MB;*!LX)],X/Y5,/%"D9&C:Z0>A^PM6=X8M5TKQ1XGANKVXN5$5HQEO)-[D;9
M.,XZ5TLC;PYM&$;E!M<N OY<_P J ,S_ (2A?^@+KO\ X O7/^//$27G@[6;
M1-,U>.22#9NEM&55)(QN/8?6NSDW[I/-D$L)"[41PISW]/Y_A6+X\FMV\':V
ML;Q^8(1O P#]X8H S]'OTL?'.KV]P0JMI]FV<9.5##^IJ3P1J#:EXN\4SL%
M5X84V@C*H\Z@_4@5SVJ174_Q"U V5E->?Z%;*QCCB=4Z]2YXZ'I5GPS!K>A>
M)-<MK'3K;49&6"67_21 L>YI6 'R\_>/0#I0!4TVZTY_ OB6QNKZ&":2\N@%
M\T+)C>#Q]<4>)'\)V4=E;Q3VL<<T,[O+#/E]S",%>N/FP,Y[+Q572]$@U'P'
MK]])86HU475RH:1LA/G4D9 YQCCC\JFUCP1#96T-M8W6+JY6XN,FWR!D1<Y#
M#&W QG.2QXH ] \&)IL?ANRCT.7S+!5PAWEL'N,GWS65=>.88;V>W31=8E\N
M4Q"1(D"N0<9&6'!K4\%:7/HOAFQT^[9'EA3EDS\V3GN.#S7 7GB82^);ZVU6
M")WAU'[/%Y<IC)"E5# $-TP3@D#K0!V \73F[^S#PQKWG[/,V>7'G;G&?O\
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MW<5WE</\2H&N;KP]")"@EN9(SQTRF,^M #-8\817NC7]I'87 EN+:2%2TL.
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M=/K7=7:I]CF_TH_<_P"@DW]T_P"?>O&?#6E2Z3XA@@NS-)*UU:LP8"1\>:P
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M#Z&BLNRTO[->_:-R$GS-Q"D,^YLC)SVZ5J4 %%%% !@^E%9EWI?VB_\ M.Y
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MT_> .!@"NYQXT_Y[>'?^_<_^-9^O:3XLUK2+G3[N7P]Y4Z;2RQS;E]",GJ*
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MZI_XA_=-<A'X2U)UW3'P] V?N1:>[J/Q,@-+)X.O7C93<:(-P(R-+;(_\BT
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M$'/N/S- &%9^)M:2'$O@G486S]V&2,K_ $_E4K^*]61&9O"&L!5!).Z/@?\
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MH XK_A7MG_T&=>_\#3_A1_PKVS_Z#.O?^!I_PKM:* .*_P"%>V?_ $&=>_\
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M..GXYYS6C0!F:+I$.DBX\J:>5IV#,TI!Q@< 8 P*TZ** "BBB@ I#TXXI:*
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M]0!A8HQ6^WP;NS(C?\)== *""HM%P<XZ_-0WP;NS(C?\);= +G*_9%P<_P#
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M?^3$G_Q5 '5?VC8_\_MI_P!_E_QKDM#O;1?B)XE=KJW"-!;A6,JX/!Z'-/\
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M2*.8;F234@&P0>"-G':M8>$/#@Z:%IH^ENO^%)_PA_AL]=!TS_P&7_"@#/\
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MOF_5=<O/$7C?3]1U&V6VFDD@PB*0"N1@C/K0!^DT/^J3_=%.IL/^J3_=%.H
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M^UN8TA40VX01CR\8ZKGM7KU% "*-J@#L,4M%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
J**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image05.jpg
<TEXT>
begin 644 image05.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $[ F<# 2(  A$! Q$!_\0
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M** "BBB@ HHHH **** "BBB@ HHHH ***;YJ>9LWKO\ [N>: '4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M4U94=BJ.K,O4 Y(H =1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG# ;L9&>XXJU]J^/?_/AX6_[^?\ UZ]MM[>&V5A;PQQ!V+L(U"[F/4G'>I:
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M$:TS_GE/_P"!4O\ \56Q10!5T^PMM/A:.TC**S;FRQ8DXQDDDD\ ?E5JBB@
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MV0KG)X+D'V^5>.N*N"UN=N"H\TU)[(^AM-LXM/TZULK9$CAMXEB1$&%55
M'IQ15FBM3V@HHHH **** /%O#&FSQ_M6>,+YPH@?1( O/)W&$#CZQ-^E>TUY
MAH?_ "</XG_[ EI_Z&U>GT %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTZ;3+[QM%>Q2P7DDMK,\3A2%5O.*X96.>I]*Z3XI)=?\)O;-;&-E.GR*8I.
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MXJ^[Y?\ 95C]<[YOTKOZX#0PW_"[/%1W#9_95B-N.<[YN<T =_1110 4444
M%%%% !1110 4444 %%%% !2.RHC,Y"JHR23@ 4M>*_M*^+;VUTBR\%^&MTGB
M'Q$_V=4C/S)"3AC[;NF?3=0!S7A1?^%S?&RX\2SH9/"/AEO)T]6'RSS Y#_F
M-WT"5]'US'PU\(6G@;P9IVA66UOLZ9FE QYLIY=_Q/3V ':NGH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[B/48Q^)H T:*** "BBN1^*U_%I'@:_U:X>Z6+3C'=L+5]DC['!V@^AZ'VH
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M0#4_%UK)<[B2T-M&%QVZK3[_ ,._$Y[.5;'Q; ER1\C2VT>T'/?"^F:]6HH
M\@T?PW\68UE_M?QC92L2/+\BV08'.<Y7Z5?D\/\ Q',;;/%<8?!VDV\>,]OX
M:]0HH \:TCPU\7X[ACJOC+3I82ORB"V4,&S[ITZUK_\ "/\ Q%_Z&I/_  'B
M_P#B:].HH \7\._#[QRWQ.TOQ+XNU^PU&UTY)HH(XXMDBH_0'"@$]*]HHHH
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MX(O_ !]X,32-*NK>UN5NH[@23@[?ESZ?6N,C\)_&Z.-$3QOHX50% ^R#H/\
M@%>ZT4 >&?\ "+?&_P#Z'C1__ 0?_$54A^&'Q&U;QIX;UCQAXETO4(-(N1.J
M1P[&QWQA1GIWKWZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#G_ !AX.T/Q?9"WURQ28IS%.IV2PMZHXY!KQCQIH_C.PU;1? DU]?ZY
MX2UBX19;TP'[1!$IRT+R#"D$#J><#C' /T/10!%:6\-I:PVUM&L4$*".-%&
MJ@8 %2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7.^(M8UO3[M(])\-2ZK"R;FE
M2[CB"GTPW-=%5&_N+Z*4"TLUG3&2QDVX-'(ZGNQ=ON_4/K5/"_O:D.==K2?_
M *39F)'KOB%M1@@?PG.EL[8>X^W1$1C<1G;U/ !X]:TKN_U2.X9+?2#-&,XD
M\]5SS@?3UJ9;G43<(K6*"(GYG\WH,^E9E]K5W;WDL0DTM4$A1?,GPV>, CUZ
M_I1[.4/B=_N_0/KE+%:TZ?);RDK_ /@3?X%BXU+6([B58=$:6)3A6^T(N_KV
MS]/SI\>HZH742:.ZJ9-I83H<+G[V,U5&KW\=W!%.=,".2#BXPQ],#'/\7Y5%
M8ZSJ=RR*?[)SQO\ +N2V.YP,>F30!?N+[5TD<0Z2LB#;M;SU!.<9X]N?RI9[
M_55FD6'22ZJ2%<S* <'@]>]9K:[J$=NC2_V0K&+<3]JPN[(([=,<U>AN]9F1
MY([>Q>)H]T+I,2&.>,\=,8_.@":"^U-IE2?2BB$'+K,I /;^E1Q:AJ\C*#HY
MCSU+SK@?EG_)J(3^)1&,V>G%\C/[YNF.>WK5ZQDU-IV%[!;)%QAHY"2>#GC'
MKB@"W9232VD3W,/D3,N7CW!MI],BIJ** "BBB@ HHHH **** "BBB@ HHHH
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M"[< CCCM5>/4]/DN!!'=0-,> @8;ORJ[0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7->+?#+Z_-;R)=K;F)2
MI!BWYS^(KI:* . M/A]+!=P3-JB,(Y%<J+<C.#G&=]=O]BMO/\[R(_-Y^<+S
MSUYJQ10!2_LJPR3]C@R<Y^0<YX-*VEV##YK2$_\  !5RB@"JNG6:3+,MM")5
LZ.$&1^-6J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image06.jpg
<TEXT>
begin 644 image06.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $I F$# 2(  A$! Q$!_\0
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M;.VFN4@NGDX&!/M+GH 3CWK+;P%IT<UPQTB420QAI&&H#)7DXSLY[T >A?\
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MRF022N$4MOB.,GO@'CVH \V^$>@W>D:OHS7LUN8H;&YMHS#%,!,\DJR[OG0
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MRFL:MITD/B\1W]HQFL@D0693YC>4XPO/)R>U=7XB94T*^9V"JL+$DG  QUH
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M,V[#R9$"72R7$<16-Q,V'Q(6 (Q\O- 'NT>@6$5CI]G$LT=O80B" 13O&50
M*!N4@GA1U-5+[PAH]^R-=I>RLG0F_N.1Z'Y^1['BO.M)76K_ ,00VYO];2T<
M3?:(C?.)K(*#M+G&T[C@8'K[5Z3X%O)]0\$>'KV[<R7%SIUO-*YZLS1*2?S-
M &'#HUCI/Q&TW[!$\?G65R\FZ5WW-O0Y^8GGDUVY52<D _A7,:A_R4;1_P#K
MPN/_ $*.H=4TRQNX]4FNK.VFF^W0IODC#-C,7&3VY- '6@ = !]*"H/4 _45
MCZ196MCK.I)96T-NC1PDK$@4$_/Z51UVPL[V;6GN[6"=H[%=ADC#%>).F>E
M'3!0.@ ^@JMJBSMI]P+-E6YV'RV*;L-VX/6LK3M.LK'6[9K*TM[<O9-N,487
M=\R=<4FIV5K?>++%+VVAN$6QG8+*@8 ^9%SS0!+X2&JG2]^OA1>F1L*$52J
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M '[:M;5+O[+JEQBVN9]UH/\ 4INV_,W7FN?\":;8Q>%_"=U#96\=RT:DRK$
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M8[UXK?\ AHC1_#WPZC\,MA"I'N%%5OBK_P B1??[T?\ Z&*O?#__ )$G1/\
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MPS=I/A[X==SEGL(6)]25%5/BW$DW@/4(ID5XW,896&01O'6M#X>@+X'T,*,
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MSC<K#!'Y&L;P[X0TCP^]P]A;G?.Q9FE.XC)R<?4\D]2>M08\9^OAW\IJ0?\
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MX=\-Z9X?L/LFGP 1[MQ+@$]  /0    #  %;-<QCQGZ^'?RFHQXS]?#WY34
M;TE_:Q7T-E)<1+=S*SQPEL,ZCJ0.^,TCZA9I>Q6C7,(NI@S1Q;QN8+U('M7#
M7/ASQ3?^-=$UR^DT15TU9XPL+2Y(D4#.".2#VR/K5'QM\.]6U*Z%UX;U2#3K
M\P/%]M9Y1*C.V]V4*VT9..F/Q'% 'HD>J64FIR:<EPIO8UWO%@Y ]?UK+O\
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M1+/Q=/++'RYB\ILC!Z@#U(_*M35/$NBZ5J=IIVI:G:VU]=%5@@ED"M(6;:H
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MG]:]1D\*Z5*RM)%,Y3(7=.YVY ''/L/RH ]6_P"%V?#[./\ A(X,]<>5)_\
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M(."%)!_"@#BYOBKX/AOFLI]5,5VI4-$]O(K+G&,@KQG(_.M'_A//#W_/\?\
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MO!I^EW5VT<L@AC:0I$,NV!T ]:\%'Q0\0?;XP)P;9M4%FUL(,W0BP3O/\()
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MM96YL"T\LA&]]V<)&"< _+DDYZC [C@K4!;6%1R!&H!_"O3_ (T_\DG\5?\
M8/E_E7EUC_QXVW_7)/\ T$4 3T444 %%%% !5?4+I;*QGN6!81(6"CJQ[#\3
MQ5BLK4"+K4[:T_Y91?Z3/]!]P?GS_P !H \ZUJ_UN^\-:;H<UC]DU_5[WRA
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M <CKVK^*=1UCPWI%]I%G:R7=T+N"0S$KF!?-VMC/7&/_ -5>/_"O=_9]QYF
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MNC1OGDRP[AC\,5'J?BCP9=VAC74M)#JP==\0920>A&.0>A^M*O@",')>Q/\
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M'%$Z2;(_F9B^X9W\XVK^=4M8U*VBFNKB?Q)%<Q+82LT-H\2-*5P0@/S<G+
M?TH R90__"R? A?0ETK"W0# (?,_T;IE>F/0_AT->,_#AV73;H)G>\CHI';-
MS<<_A7K'AC5V\1:YX7UZ^2#3K:R\Y@+[58VF17B:/;Y01<$MM/)Z#WKQ3P#K
M%A96T\L][IJN)9HPD]['$R_OY6W8)Z$./R- 'IT:+'&J( %48&!BHKL%5690
M28CD@8&5[CG\_P !6'_PENF_\_\ H_\ X-(J/^$MTTC!OM&(_P"PI%0!DZ00
MWQ(E*D$&&[((Z']Y#71>,O\ D4]8_P"O23_T$UYYHVMV=I\1;F5M3LI83;S%
M=]W$L2;GB(59.YP.GL:Z;Q+XFT^[\/:E;I?:1NEMW0;=2C8Y([ =: -ZX_Y&
M^T_Z\I?_ $-*V%ZBN"F\03V_C"TEU9;&R@FTUIH!-="/AG'!9A@GCH*VAXNT
MW(_T_1__  :14 >J_L]?\B#/_P!A2]_]'-6CXNO+WPC<Z/+I4R-::IK$%I+:
MS)E8_-9B[(1R#QG'3))KA_@7XYT'3?#UCI%[?V\=YJ-_?S1?OD*!1*QY;/<=
M/6NF^*NJZ?>_\(?%9W]I<2?\)'9'9%,KG&6YP#0!)^T?_P D3\4_]<(__1J5
MY-X!MIK'P[%;W<9BG1CN0D$C//;CO7LGQXM5OOA3K=I(Q1+CR(F8=5#3Q@G]
M:\*N_"#7<WFW.OO))@*6-O&,@=.AH U+"\B3XZ^#(CORL<P)"DC+ XZ?0U]+
MZ??6FHV_VBPN8;F L5\R%PZY!P1D>E?*NG>"K.VU.WO+C43=>3N*H8U3DC&<
M@YXKT[X:W=S)\,8-(\-%AJ8O+K:X!\N!%NY#AGQ@94!0.N&SC H ]:U.5(K&
M?>V"8GP.I.%/0=3^%?,/PXN4N/#KN@=5:[N)%WC&5>5F4_B&%=1\9M2LM5\:
M>$HKMY+95L[WSK>X8PF-_P!T!GD ]\$$@\X)KS>'P?8PPQQ1^*XMD:A%S'$2
M%'0?>H S_C5#*\=Q.D;-"D%NKN",*3,<9YSS@]*3P?J-K:>'3<Q6L4^IV][Y
M(5G/^K\S=O(!P-OF-@D=<=ZO:GX2M)M'N[1_%<1@D D=!'$N]D^9<G=G&:X'
M2[NVDM[>X:_2*:,.@08Q@NS'OSUZ^PH ]\6RL(-2N;A4476/-D8L3@$;=V.@
MR%(R/0U:6XA::"(2+OF0R1CNRC&2/^^A^=>*?\)+<[E9M:W-GYR=OSKESM/S
M=/G/Y5'_ &]<&6*0:V5>+<L;#;\JG9E1\W3]V/S- '9V=WKOBA)+R"STU((;
MB6V4/<S(6V,1DA>*NV>G>);.<2P6^D[@" 'N[AA^1KCO /CVVTS2Y;2XBMV=
MKJ>4NUVL>=SD]"/ZUUC?$?2560LUOE&"D"\C.21GCU'O0!L:)JFJRZY<Z;K%
MO8QO';I<(]J[D$,S+@[O]VL_Q_:ZQJ.FW-A"NG)I]P8U$DHD:3<&#8VJ".2,
M5SD7CJ"3Q;<WEC9?:T:RCB(6Y4;2'8]<'UK3NO'!NH&AFT)RC8Z7B@@@Y!!V
M\$'!H ]3_9O@GAN/%AGL+:R5Y[<JMI$8X3B,@X# '/KQ7G?QJ_Y.6TC_ *XP
M_P#H$M=?\!O&,OF>(UN['4YT6:$(((//9<H<[W4 9_ 5YC\5_%5A?_'RTU0I
M<VEI:(D<OVM!$X*K(#\I.<9- 'J-)7!7_P 2_#,UI-$ET[,1@!E #>W6L^+X
MC:#;Z5JBV\_V>XD\Q[=(PI"'RP%]OO#/2@#TZO,/CM_R!K/Z3?\ H%=1X-U3
MS?"?EM;>)=4UGSHI-RV#.!$Z1R.3@8'WI OMMKBOV@+VPF\F72QK,<"IY!AO
M[8PJCL'+=>=_"\'MF@!WB;P7I;Z#91)JTMO<R>5)_I<V4VC&< +U]*T=0T>Q
MMM8\(WNFW,EQ$VH",LSA@?D;I@#N*W="U>Z&AZ5+J%O:+'<VZ-&[3A!G8#@Y
M'I_*LWQ?K,*WOAR21[&..+4E=F^V)M'R-U..![T =Y5#7_\ D#7?^Y_45E_\
M)=IO_/\ Z/\ ^#2*J>L>*M,DTNZ4W^E8*$G9J,;MQSPHZGVH U?"?_'MJ/\
MV$;G_P!&&MRN"\ Z[]MTO6]2CD3^SH]2F==Z[2(VPQ).>HW&MOQ!XJM=*A$D
M"+?C:7<0SJ-BAD7)/3&7'7' - '14E<IX7\:VFNAVDMVT] NY&N)D^?G!QBM
MF2_%R9ET^YMV$*;Y)%(DP>RX!X]: .B_9\_Y#WB3_<C_ /0Y*])^(7_($LO^
MPMIW_I9#7A_P)UJ:?QG+:Z1=*1>V[RSF:$$91LJ%P?N'<>:]0\8>)[>ZB@TR
MYB>UNH;W3[AC*0JL%O4#E><D+L+$]AS0!V/B!=4%KYNCRH)(P286C#&3V!)
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M*R?^$ATG_G]3_OEO\*1O$&DLK#[:@R,?=;_"@#/O]22UBU76Y"/+MT-M;Y.
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M^#_A=X.\':G_ &CX=T6.TOO*,/G>;([;3C/WF(&<#D"NTHHH **** "BBB@
MHHHH **** "BBB@#A/CCI%_KWPLU[3=(MGNKZXB58H4(!8[@>]</\$_B+J^I
MZK9^")?##VDFBVHBU"YDN0PAV#:!@ _,6&,9]3VJU^T!XRU:&\T7P/X)N7A\
M3ZS*K&:)L-;0@_>R.F<'_@*M[5U/P7^'H^'WAF:WNYTO-9O9VN+^\7/[UR3@
M GG 'KW)/>@#S;]H."ZG\?Z>-*DM5U!+.%D$MM+(P7_2\MN4A57 .<C.2.<
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MEX]YA,Z\''3K7EW[06E^/KG5K";P&<VTML8+M62(C/SJ""XR/EE?H?3TKE/
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MS*YSQC' ]:3=AI7.[_X3#13HAU076ZV#*A55+2!F;:H*#D$GI5?_ (3?3/\
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MP:[J2/:W#(&GO'""-1DDX&<UYQHO@W7;G4/",5SI$,L=D T@GM]GV51MX)P
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M%% !7D?[1_C.;PYX2BTG1[J6/Q#K3_9;..%59F!P&)R?E'S ;ASDBO7*\O\
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MARJ%9(HQ&F3@$[0K9^G%7]0O-2\7?#_4QX<D?2M9DC>WB>=MGDS XSE=W'N
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
0B@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image00007.jpg
<TEXT>
begin 644 image00007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !4 'X# 2(  A$! Q$!_\0
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M  TFE94B&HS(78X 9D4*/Q-+^T=975[\+;W[*LCQP3Q3W*QC+&%6^8CZ<'Z
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M=L]&TUIFM+4,L9F8,YRQ8Y( [D]JS_"VC72W<NM:X5?5;A<*@^[;I_<7^O\
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7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975867313456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 20, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Eterna Therapeutics Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000748592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-1103425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10355 Cambridge Street, Suite 18A,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">582-1199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.005 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ERNA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,127,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">248<span></span>
</td>
<td class="text">688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">GRANT THORNTON LLP<span></span>
</td>
<td class="text">Marcum LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, New York<span></span>
</td>
<td class="text">New York, NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864768912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 11,446<span></span>
</td>
<td class="nump">$ 16,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivable</a></td>
<td class="nump">951<span></span>
</td>
<td class="nump">684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,284<span></span>
</td>
<td class="nump">1,097<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">13,681<span></span>
</td>
<td class="nump">18,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">4,095<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets - operating leases</a></td>
<td class="nump">1,030<span></span>
</td>
<td class="nump">2,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,044<span></span>
</td>
<td class="nump">2,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment in non-controlling interest</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,134<span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">22,279<span></span>
</td>
<td class="nump">31,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,620<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">3,626<span></span>
</td>
<td class="nump">1,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party, current</a></td>
<td class="nump">1,750<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">363<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">7,654<span></span>
</td>
<td class="nump">3,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesNoncurrent', window );">Due to related party, non-current</a></td>
<td class="nump">1,206<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Warrant liabilities</a></td>
<td class="nump">331<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">887<span></span>
</td>
<td class="nump">2,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">10,172<span></span>
</td>
<td class="nump">6,022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.005 par value, 100,000 shares authorized at December 31, 2022 and 2021; 5,127 and 2,601 issued and outstanding at December 31, 2022 and 2021, respectively</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">177,377<span></span>
</td>
<td class="nump">166,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(165,297)<span></span>
</td>
<td class="num">(140,702)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">12,107<span></span>
</td>
<td class="nump">25,503<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">22,279<span></span>
</td>
<td class="nump">31,525<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.005 par value, 1,000 shares authorized, 156 designated and outstanding of Series A convertible preferred stock at December 31, 2022 and 2021, $156 liquidation preference</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975867211584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred stock, liquidation preference</a></td>
<td class="nump">$ 156<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">5,127<span></span>
</td>
<td class="nump">2,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">5,127<span></span>
</td>
<td class="nump">2,601<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975868646592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">$ 10,392<span></span>
</td>
<td class="nump">$ 12,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfOngoingProject', window );">Impairment of in-process research and development</a></td>
<td class="nump">5,990<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">80,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">16,835<span></span>
</td>
<td class="nump">14,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashMergerRelatedCosts', window );">Transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,765<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">33,217<span></span>
</td>
<td class="nump">113,732<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(33,217)<span></span>
</td>
<td class="num">(113,732)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>Other income (expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Loss on sale of NTN assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,648)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_WarrantLiabilitiesExpense', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">10,795<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LossOnNonControllingInvestment', window );">Loss on non-controlling investment</a></td>
<td class="num">(941)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income, net</a></td>
<td class="num">(1,171)<span></span>
</td>
<td class="nump">899<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expenses), net</a></td>
<td class="nump">8,683<span></span>
</td>
<td class="num">(8,749)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(24,534)<span></span>
</td>
<td class="num">(122,481)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(24,579)<span></span>
</td>
<td class="num">(122,545)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsAndOtherAdjustments', window );">Series A preferred stock dividend</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (24,595)<span></span>
</td>
<td class="num">$ (122,561)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (in dollars per share)</a></td>
<td class="num">$ (8.06)<span></span>
</td>
<td class="num">$ (56.61)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (in dollars per share)</a></td>
<td class="num">$ (8.06)<span></span>
</td>
<td class="num">$ (56.61)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding - basic (in shares)</a></td>
<td class="nump">3,051<span></span>
</td>
<td class="nump">2,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding - diluted (in shares)</a></td>
<td class="nump">3,051<span></span>
</td>
<td class="nump">2,165<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LossOnNonControllingInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss on non-controlling investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LossOnNonControllingInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_WarrantLiabilitiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_WarrantLiabilitiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfOngoingProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfOngoingProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashMergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashMergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864324656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF MEMBERS'/STOCKHOLDERS' EQUITY - USD ($)<br></strong></div></th>
<th class="th">
<div>Membership Equity [Member] </div>
<div>Class A [Member]</div>
</th>
<th class="th">
<div>Membership Equity [Member] </div>
<div>Class B [Member]</div>
</th>
<th class="th">
<div>Membership Equity [Member] </div>
<div>Class C [Member]</div>
</th>
<th class="th">
<div>Membership Equity [Member] </div>
<div>Common [Member]</div>
</th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th">
<div>Preferred Stock [Member] </div>
<div>Series A Preferred Stock [Member]</div>
</th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Series A Preferred Stock [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 23,202,000<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 198,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (18,141,000)<span></span>
</td>
<td class="nump">$ 7,659,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits', window );">Brooklyn rights offerings membership units</a></td>
<td class="nump">10,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity', window );">Elimination of Eterna LLC's historical members' equity</a></td>
<td class="num">(33,702,000)<span></span>
</td>
<td class="num">(1,400,000)<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="num">(198,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">36,300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValueAcquisitions1', window );">Common stock to be retained by NTN stockholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">8,178,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,178,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesAcquisitions1', window );">Common stock to be retained by NTN stockholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders', window );">Issuance of Series A preferred stock retained by NTN stockholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders', window );">Issuance of Series A preferred stock retained by NTN stockholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PartnersCapitalAccountAcquisitions', window );">Issuance of common stock to Eterna LLC members</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PartnersCapitalAccountUnitsAcquisitions', window );">Issuance of common stock to Eterna LLC members (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,946,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock to Financial Advisor upon consummation of merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">5,765,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,765,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock to Financial Advisor upon consummation of merger (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from the exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from the exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValueStockPurchaseAgreement', window );">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">52,024,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">52,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement', window );">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValueAcquisitions2', window );">Issuance of common stock in connection with the acquisition of Novellus, Inc.</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">58,682,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">58,684,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesAcquisitions2', window );">Issuance of common stock in connection with the acquisition of Novellus, Inc. (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">351,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Cash dividends to Series A preferred stockholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,000)<span></span>
</td>
<td class="num">(8,000)<span></span>
</td>
<td class="num">$ (8,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsShares', window );">Cash dividends to Series A preferred stockholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValueInLieuOfDividends', window );">Issuance of common stock in lieu of cash dividend to Series A convertible preferred stockholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="num">(8,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesInLieuOfDividends', window );">Issuance of common stock in lieu of cash dividend to Series A convertible preferred stockholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">5,235,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(122,545,000)<span></span>
</td>
<td class="num">(122,545,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">166,191,000<span></span>
</td>
<td class="num">(140,702,000)<span></span>
</td>
<td class="nump">25,503,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,601,000<span></span>
</td>
<td class="nump">156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts', window );">Issuance of common stock and pre-funded warrants in connection with March 2022 private offering, net.</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts', window );">Issuance of common stock and pre-funded warrants in connection with March 2022 private offering, net. (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts', window );">Issuance of common stock and warrants in connection with November 2022 private offering, net.</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">7,383,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,395,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts', window );">Issuance of common stock and warrants in connection with November 2022 private offering, net. (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,185,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants', window );">Issuance of common stock from exercise of pre-funded warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">874,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">874,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants', window );">Issuance of common stock from exercise of pre-funded warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of common stock from vested restricted stock units</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock from vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Cash dividends to Series A preferred stockholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(16,000)<span></span>
</td>
<td class="num">(16,000)<span></span>
</td>
<td class="num">$ (16,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsShares', window );">Cash dividends to Series A preferred stockholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,935,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,935,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(24,579,000)<span></span>
</td>
<td class="num">(24,579,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 26,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 177,377,000<span></span>
</td>
<td class="num">$ (165,297,000)<span></span>
</td>
<td class="nump">$ 12,107,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,127,000<span></span>
</td>
<td class="nump">156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease (increase) in additional paid in capital (APIC) for the increase in redemption of temporary equity as the result of a triggering event associated with the temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares Forfeiture of unvested restricted stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodSharesAcquisitions1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodSharesAcquisitions1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodSharesAcquisitions2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodSharesAcquisitions2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including exercise of pre-funded warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodSharesInLieuOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period in lieu of dividends to be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodSharesInLieuOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the shares of new stock issued of preferred stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares of stock issued common stock and prefunded warrants in connection with public offering during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares of stock issued common stock and warrants in connection with private offering during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been issued in a stock purchase agreement during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued common stock and warrants in connection with private offering during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValueAcquisitions1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValueAcquisitions1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValueAcquisitions2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValueAcquisitions2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of issuance of common stock from exercise of pre-funded warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Forfeiture of unvested restricted stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValueInLieuOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period in Lieu of Dividends to be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValueInLieuOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued of preferred stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued common stock and prefunded warrants in connection with private offering during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to rights offering membership units during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValueStockPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been issued in a stock purchase agreement during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValueStockPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalAccountAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in the different classes of partners' capital accounts during the year due to acquisitions. Partners include general, limited and preferred partners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 4.F)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalAccountAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalAccountUnitsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in the number of units for each class of partners' capital accounts during the year due to acquisitions. Partners include general, limited and preferred partners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=66023778&amp;loc=d3e9334-128500<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=66023778&amp;loc=d3e9337-128500<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=66023778&amp;loc=d3e9298-128500<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 05<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=66006417&amp;loc=d3e8580-128490<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalAccountUnitsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864178224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (24,579,000)<span></span>
</td>
<td class="num">$ (122,545,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">161,000<span></span>
</td>
<td class="nump">117,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">2,935,000<span></span>
</td>
<td class="nump">5,235,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use asset</a></td>
<td class="nump">336,000<span></span>
</td>
<td class="nump">342,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of right-of-use asset</a></td>
<td class="nump">772,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset', window );">Gain on remeasurement of operating lease liability and right-of-use-asset</a></td>
<td class="num">(642,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfOngoingProject', window );">Impairment of in-process research and development</a></td>
<td class="nump">5,990,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ResearchAndDevelopmentInProcessAssetAcquisition', window );">In-process research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">80,538,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_GainLossOnDisposalOfFixedAssets', window );">Loss on disposal of fixed assets</a></td>
<td class="nump">280,000<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_GainOnTerminationOfLease', window );">Gain on lease termination</a></td>
<td class="num">(85,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_WarrantLiabilitiesExpense', window );">Gain on warrant liabilities</a></td>
<td class="num">(10,795,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LossOnNonControllingInvestment', window );">Loss on non-controlling investment</a></td>
<td class="nump">941,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashMergerRelatedCosts', window );">Transaction costs - shares to Financial Advisor</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,765,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on sale of NTN assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,648,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan', window );">Gain on forgiveness of PPP loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(310,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="num">(262,000)<span></span>
</td>
<td class="num">(659,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(187,000)<span></span>
</td>
<td class="num">(850,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="num">(646,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">2,034,000<span></span>
</td>
<td class="num">(485,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedParties', window );">Due to related party</a></td>
<td class="nump">2,956,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liability</a></td>
<td class="num">(340,000)<span></span>
</td>
<td class="num">(322,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">155,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(20,976,000)<span></span>
</td>
<td class="num">(23,488,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(297,000)<span></span>
</td>
<td class="num">(154,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from the sale of fixed assets</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfAssetsInvestingActivities', window );">Purchase of NTN, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">147,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PaymentsToAcquireProductiveAssetsNet', window );">Purchase of Novellus, net of common stock issued and cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(22,854,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from the sale of NTN assets, net of cash disposed</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">119,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(47,000)<span></span>
</td>
<td class="num">(22,742,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock and warrants in connection with private offerings</a></td>
<td class="nump">19,706,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ExpensesPaidInConnectionWithPrivateOffering', window );">Expenses paid in connection with private offering</a></td>
<td class="num">(110,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants', window );">Issuance of common stock from exercise of pre-funded warrants</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payroll tax remitted on net share settlement of equity awards</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Principal payments on finance leases</a></td>
<td class="num">(2,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock', window );">Dividends paid to Series A preferred shareholders</a></td>
<td class="num">(16,000)<span></span>
</td>
<td class="num">(8,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit', window );">Cash paid for fractional shares in connection with reverse stock split</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ProceedsFromIssuanceOfCommonStockToLincolnPark', window );">Net proceeds of common stock issued to Lincoln Park</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">52,025,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from sale of members' equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PaymentsOfPaycheckProtectionProgramLoan', window );">Repayment of NTN's PPP loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(532,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payments on notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(410,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">19,579,000<span></span>
</td>
<td class="nump">61,585,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(1,444,000)<span></span>
</td>
<td class="nump">15,355,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">16,985,000<span></span>
</td>
<td class="nump">1,630,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">15,541,000<span></span>
</td>
<td class="nump">16,985,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CashPaidDuringThePeriodForAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ConversionOfWarrantLiabilityToEquity', window );">Conversion of Warrant Liability to Equity</a></td>
<td class="nump">867,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities', window );">Initial measurement of ROU assets and operating lease liabilities</a></td>
<td class="nump">1,706,000<span></span>
</td>
<td class="nump">866,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_UnpaidFeesIncurredInConnectionWithPrivateOffering', window );">Unpaid fees incurred in connection with private offering</a></td>
<td class="nump">208,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfFinanceLeaseLiabilities', window );">Initial measurement of finance lease liability</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend', window );">Issuance of common stock for Series A preferred stock dividend</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common stock for business combination</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,178,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IssuanceOfCommonStockForAssetAcquisition', window );">Issuance of common Stock for Novellus acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">58,684,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger', window );">Preferred shares issued in connection with reverse merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash at end of period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">11,446,000<span></span>
</td>
<td class="nump">16,985,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted Cash</a></td>
<td class="nump">4,095,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">$ 15,541,000<span></span>
</td>
<td class="nump">$ 16,985,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_CashPaidDuringThePeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_CashPaidDuringThePeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for fractional shares in connection with reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ConversionOfWarrantLiabilityToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The conversion of warrant liability to equity in non-cash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ConversionOfWarrantLiabilityToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ExpensesPaidInConnectionWithPrivateOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses paid in connection with private offering during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ExpensesPaidInConnectionWithPrivateOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_GainLossOnDisposalOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of fixed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_GainLossOnDisposalOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on forgiveness of PPP loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on remeasurement of right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_GainOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_GainOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialMeasurementOfFinanceLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of finance lease liabilities in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialMeasurementOfFinanceLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of Initial measurement of ROU assets and operating lease liabilities in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_IssuanceOfCommonStockForAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The issuance of common stock for asset acquisition in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_IssuanceOfCommonStockForAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of issuance of common stock for Series A preferred stock dividend in non-cash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash flows from issuance of common stock from exercise of pre-funded warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LossOnNonControllingInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss on non-controlling investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LossOnNonControllingInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of preferred stock issued in a reverse merger transaction in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PaymentsOfPaycheckProtectionProgramLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for payment of paycheck protection program loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PaymentsOfPaycheckProtectionProgramLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PaymentsToAcquireProductiveAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets excluding cash acquired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PaymentsToAcquireProductiveAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ProceedsFromIssuanceOfCommonStockToLincolnPark">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the proceeds from issuance of common stock to Lincoln Park to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ProceedsFromIssuanceOfCommonStockToLincolnPark</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ResearchAndDevelopmentInProcessAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ResearchAndDevelopmentInProcessAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_UnpaidFeesIncurredInConnectionWithPrivateOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of unpaid fees incurred in connection with private offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_UnpaidFeesIncurredInConnectionWithPrivateOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_WarrantLiabilitiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_WarrantLiabilitiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfOngoingProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfOngoingProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashMergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashMergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions that are classified as investing activities in which assets, which may include one or more investments, are sold to third-party buyers. This element can be used by entities to aggregate proceeds from all asset sales that are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975870151856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization and Description of Business Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Description of Business Operations</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">1)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Organization and Description of Business Operations</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);"> </span><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On October 11, 2022, Eterna Therapeutics Inc., a Delaware corporation, (&#8220;Eterna&#8221; or the &#8220;Company&#8221;), changed its name from
            Brooklyn ImmunoTherapeutics, Inc. to Eterna Therapeutics Inc. upon its filing with the Secretary of State of the State of Delaware a Certificate of Amendment to its Restated Certificate of Incorporation, as amended (the &#8220;Charter&#8221;).</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Eterna, together with its subsidiaries including Eterna Therapeutics LLC (formerly Brooklyn Immunotherapeutics LLC)
            (&#8220;Eterna LLC&#8221;), Novellus, Inc. (&#8220;Novellus&#8221;) and Novellus Therapeutics Limited (&#8220;Novellus Limited&#8221;), is a preclinical-stage biopharmaceutical company committed to realizing the potential of mRNA cell engineering to provide patients with
            transformational new medicines. Eterna has in -licensed a portfolio of over 100 patents covering key mRNA cell engineering
            technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice<sup style="line-height: 1; font-size: smaller; vertical-align: text-top;">TM</sup> and UltraSlice<sup style="line-height: 1; font-size: smaller; vertical-align: text-top;">TM</sup> gene-editing proteins, and the ToRNAdo<sup style="line-height: 1; font-size: smaller; vertical-align: text-top;">TM</sup> mRNA delivery system. Eterna plans to develop and advance a pipeline of therapeutic
            products both internally and through strategic partnerships, with the near-term focus on strategic partnerships. Eterna licenses its mRNA technology platform from Factor Bioscience Limited (&#8220;Factor Limited&#8221;) under an exclusive license
            agreement. As used herein, the &#8220;Company&#8221; refers collectively to Eterna and its subsidiaries.</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On August 12, 2020, Eterna (then known as &#8220;NTN Buzztime, Inc.&#8221;), Eterna LLC (then known as &#8220;Brooklyn Immunotherapeutics
            LLC&#8221;) and BIT Merger Sub, Inc., a wholly owned subsidiary of Eterna (the &#8220;Merger Sub&#8221;), entered into an agreement and plan of merger and reorganization (the &#8220;Merger Agreement&#8221;) pursuant to which, among other matters, Merger Sub merged with and
            into Eterna LLC, with Eterna LLC surviving the merger as a wholly owned subsidiary of Eterna (the &#8220;Merger&#8221;). The Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which Eterna LLC was deemed the
            acquiring company for accounting purposes.</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On March 26, 2021, Eterna sold its rights, title and interest in and to the assets relating to the pre-Merger business
            operated under the name &#8220;NTN Buzztime, Inc.&#8221; (the &#8220;Disposition&#8221;) to eGames.com Holdings LLC (&#8220;eGames.com&#8221;) in accordance with the terms of an asset purchase agreement dated September 18, 2020, as amended, between Eterna and eGames.com (the
            &#8220;Asset Purchase Agreement&#8221;).</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On July 16, 2021, Eterna and its newly formed, wholly owned subsidiary Brooklyn Acquisition Sub, Inc. entered into an
            agreement and plan of acquisition (the &#8220;Novellus Acquisition Agreement&#8221;) with Novellus LLC, Novellus (the sole equity holder of Novellus Limited and, prior to the closing under the Novellus Acquisition Agreement, a subsidiary of Novellus LLC),
            and (c) a seller representative, pursuant to which Eterna acquired Novellus and its subsidiary, Novellus Limited (the &#8220;Novellus Acquisition&#8221;). As part of the Novellus Acquisition, Eterna also acquired 25.0% of the total outstanding equity interests of NoveCite, Inc. (&#8220;NoveCite&#8221;), a corporation focused on developing an allogeneic mesenchymal stem cell product for patients
            with acute respiratory distress syndrome, including from COVID-19.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975870150016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidity and Capital Resources<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LIQUIDITYANDCAPITALRESOURCESAbstract', window );"><strong>LIQUIDITY AND CAPITAL RESOURCES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LiquidityAndCapitalResourcesTextBlock', window );">Liquidity and Capital Resources</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">2)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Liquidity and Capital Resources</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has incurred significant operating losses and has an accumulated deficit as a result of its efforts to develop
        product candidates, including conducting clinical trials and providing general and administrative support for operations. As of December 31, 2022, the Company had an unrestricted cash balance of approximately $11.4 million and an accumulated deficit of approximately $165.3
        million. For the year ended December 31, 2022, the Company incurred a net loss of $24.6 million, and the Company used cash in operating
        activities of $21.0 million.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On March 6, 2022, the Company entered into a securities purchase agreement (the &#8220;Q1-22 Purchase Agreement&#8221;) with an investor (the &#8220;Q1-22 PIPE Investor&#8221;), providing for the private placement (the
              &#8220;Q1-22 PIPE Transaction&#8221;) to the Q1-22 PIPE Investor of approximately 343,000 units, each unit consisting of (i) one share of our common stock, par value $0.005
              per share (or, in lieu thereof, one pre-funded warrant (each, a <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#8220;</span></span>Q1-22



















              Pre-Funded Warrant<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#8221;)</span></span> to purchase one share of common stock) and (ii) one
              warrant (each, a &#8220;Q1-22 Common Warrant&#8221;) to purchase one share of common stock, for an aggregate gross purchase price of approximately $12.0
              million. The Q1-22 PIPE Transaction closed on March 9, 2022.</span><br/>
          </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On October 18, 2022, the Company entered into a facility sublease agreement (the &#8220;Sublease&#8221;) for approximately 45,500 square feet of office and laboratory space in Somerville, Massachusetts.&#160; Pursuant to the Sublease, the Company delivered to the sublessor a security deposit in the
          form of a letter of credit in the amount of $4.1 million, which will be reduced on an incremental basis throughout the term of the
          lease.&#160; The letter of credit was issued by the Company&#8217;s commercial bank, which required that the Company cash collateralize the letter of credit by depositing $4.1 million in a restricted cash account with such bank.&#160; The amount of required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of
          credit over the term of the Sublease; and the amount of restricted cash reduces by an equal amount the Company&#8217;s available working capital.<br/>
        </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br/>
         </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On November 23, 2022, the Company entered into a securities purchase agreement (the &#8220;Q4-22 Purchase Agreement&#8221;) with certain investors (the &#8220;Q4-22 PIPE Investors&#8221;),
          providing for the private placement (the &#8220;Q4-22 PIPE Transaction&#8221;) to the Q4-22 PIPE Investors of approximately of 2,185,000 units,
          each unit consisting of (i) one share of common stock and (ii) two warrants, each exercisable to purchase one share of common stock at an exercise price of $3.28
          per share (the &#8220;Q4-22 Warrants&#8221;), at a purchase price of $3.53 per unit (inclusive of $0.125 per Q4-22 Warrant). <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company received aggregate gross proceeds of approximately $7.7
            million, </span>and the Q4-22 PIPE Transaction closed on December 2, 2022. Each Q4-22 Warrant becomes exercisable six months
          following the date of closing, expires <span style="-sec-ix-hidden:Fact_cd1a85f5a00d40e2a9ec630f5346c135">five-and-one-half</span> years following such date, and is subject to customary adjustments.</span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
       <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">In
















            connection with preparing the accompanying consolidated financial statements as of and for the year ended December 31, 2022, the Company&#8217;s management concluded that there is substantial doubt regarding the Company&#8217;s ability to continue as a
            going concern because it does not expect to have sufficient cash or working capital resources to fund operations for the twelve-month period subsequent to the issuance date of these financial statements. The Company will need to raise
            additional capital, which could be through public or private equity offerings, debt financings, strategic partnerships or other means. The Company currently has no arrangements for such capital, and no assurances can be given that it will be
            able to raise such capital when needed, on acceptable terms, or at all.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The
        accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The accompanying consolidated financial
        statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to the Company&#8217;s ability
        to continue as a going concern.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LIQUIDITYANDCAPITALRESOURCESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LIQUIDITYANDCAPITALRESOURCESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LiquidityAndCapitalResourcesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of liquidity and resource matters when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LiquidityAndCapitalResourcesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975871661888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Accounting Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">3)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Basis of Accounting Presentation and Summary of Significant Accounting Policies</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Basis of Accounting Presentation</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles
        (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;). All
        significant intercompany balances and transactions have been eliminated in consolidation.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">As described above, the Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which
          Eterna LLC was deemed the acquiring company for accounting purposes. Eterna LLC&#8217;s historical financial statements replaced Eterna&#8217;s historical financial statements with respect to periods prior to the completion of the Merger (when Eterna
          operated under the name &#8220;NTN Buzztime, Inc.&#8221;). The Company retrospectively adjusted the weighted average shares used in determining loss per common share to reflect the conversion of the outstanding Class A units, Class B units, Class C units,
          and common units of Eterna LLC that converted into shares of Eterna&#8217;s common stock upon consummation of&#160; the Merger and to reflect the effect of a <span style="-sec-ix-hidden:Fact_abe396817a904d8ea2336e844b48953a">2-to-1</span>
          reverse stock split of Eterna&#8217;s common stock that occurred immediately prior to the Merger.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Also as described above, the Novellus Acquisition closed on July 16, 2021. The Novellus Acquisition was accounted for as an
          asset acquisition, and substantially all of the value was attributed to in-process research and development (&#8220;IPR&amp;D&#8221;), with the exception of the cash paid for the investment in NoveCite, which has been accounted for as an investment in equity
          securities. The IPR&amp;D had no alternative future uses and no separate economic value from its originally intended purpose and was therefore expensed at the acquisition date.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none;">October 2022 Reverse Stock Split</div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As approved by the Company&#8217;s stockholders at the Company&#8217;s Annual Meeting of Stockholders held on September 21,
            2022, the Company effected a reverse stock split of its common stock at a ratio of <span style="-sec-ix-hidden:Fact_9ec8b708b2c6467a940f0725195187c5">1-for-20</span>, as determined by the Company&#8217;s Board of
            Directors within the parameters approved by the Company&#8217;s stockholders (the &#8220;October 2022 Reverse Stock Split&#8221;).&#160; The October 2022 Reverse Stock Split became effective under Delaware law at 11:59 p.m. Eastern time on October 16, 2022.</span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 27pt;"><br/>
        </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-variant: normal; text-transform: none;"> <span style="font-size: 10pt;"> </span> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"> Upon the effectiveness of the October
          2022 Reverse Stock Split, every twenty shares of the issued and outstanding common stock were automatically combined and reclassified into one issued and outstanding share of common stock. The October 2022 Reverse Stock Split did not affect any
          stockholder&#8217;s ownership percentage of the common stock, alter the par value of the common stock or modify any voting rights or other terms of the common stock. The number of authorized shares of common stock under the Charter remains unchanged.
          No fractional shares were issued in connection with the October Reverse Stock Split. In lieu of any fractional shares to which a stockholder would otherwise be entitled, the Company paid an amount of cash equal to the product of (i) the
          fractional share to which the holder would otherwise be entitled and (ii) the then fair value of a share as determined in good faith by the Board.&#160; The Company paid an aggregate of $719 for a total of 175 fractional shares.<br/>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">All share and per share data in this
          Annual Report on Form 10-K have been adjusted for all periods presented to reflect the October 2022 Reverse Stock Split.<br/>
        </div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Summary of Significant Accounting Policies</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Use of Estimates</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and
        assumptions that affect: (a) the reported amounts of assets and liabilities; (b) disclosure of contingent assets and liabilities at the date of the consolidated financial statements; (c) the reported amounts of expenses during the reporting period;
        and (d) the reported amount of the fair value of assets acquired in connection with business combinations. On an ongoing basis, the Company evaluates its estimates, including those related to the recoverability and useful lives of long-lived
        assets; stock-based compensation assumptions; valuation assumptions of warrants; contingencies; and the provision for income taxes, including the valuation allowance. The Company bases its estimates on a combination of historical experience and
        various other assumptions that it believes are reasonable under the circumstances. Actual results may differ materially from these estimates.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Cash, Cash Equivalents and Restricted Cash</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company classifies highly liquid investments with a remaining contractual maturity at date of purchase of three months or
        less as cash equivalents. The Company had no cash equivalents as of December 31, 2022 or 2021.</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> Restricted cash consists of a cash collateralization of $4.1 million for a security deposit in the form of a letter of credit issued by the Company&#8217;s commercial bank and delivered to the sublessor of the Sublease. The amount of
        required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of credit over the term of the Sublease.<br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Property and Equipment</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Property and equipment are recorded at cost and are depreciated over their estimated useful lives using the straight-line
        method. Laboratory and manufacturing equipment are depreciated over an estimated useful life of seven years. Leasehold improvements are
        depreciated over the shorter of their estimated useful life, or the lease term. Computer equipment are depreciated over an estimated useful life of three years. Upon retirement or other disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the resulting gain or losses are reflected in the results of
        operations. Expenditures for maintenance and repairs are charged to operations. Renewals and betterments are capitalized.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Goodwill</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in the acquisition
        of IRX Therapeutics, Inc. (&#8220;IRX&#8221;) in November 2018 (the &#8220;IRX Acquisition&#8221;), which was accounted for as a business combination. Goodwill is not amortized but is tested for impairment annually or if events occur or circumstances change that would
        reduce the fair value of a reporting unit below its carrying value. Because management evaluates the Company as a single reporting unit, goodwill is tested for impairment at the entity level by first performing a qualitative assessment to determine
        whether it is more likely than not that the fair value of the entity is less than its carrying value. Such qualitative factors include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and
        other relevant events.&#160; If the entity does not pass the qualitative assessment, then the entity&#8217;s carrying value is compared to its fair value. Goodwill is considered impaired if the carrying value of the entity exceeds its fair value.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">IPR&amp;D</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">IPR&amp;D assets represent the fair value assigned to technologies that were acquired in connection with the IRX Acquisition,
        which have not reached technological feasibility and have no alternative future use. IPR&amp;D assets are considered to be indefinite lived until the completion or abandonment of the associated research and development projects. During the period
        that the IPR&amp;D assets are considered indefinite-lived, they are tested for impairment on an annual basis or more frequently if the Company becomes aware of any events occurring or changes in circumstances that indicate that the fair value of
        the IPR&amp;D assets are less than their carrying amounts. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize products associated with the IPR&amp;D assets, these assets
        are then deemed definite-lived and are amortized based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a full or partial impairment charge related to the IPR&amp;D
        assets, calculated as the excess of carrying value of the IPR&amp;D assets over fair value.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Research and Development</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company expenses its research and development costs as incurred. Research and development expenses consist of costs
        incurred for company-sponsored research and development activities, as well as support for selected investigator-sponsored research. Upfront payments and milestone payments made for the licensing of technology are expensed as research and
        development in the period in which they are incurred if the technology is not expected to have any alternative future uses other than the specific research and development project for which it was intended. IPR&amp;D that is acquired through an
        asset acquisition (as opposed to a business combination) and has no alternative future uses and, therefore, no separate economic values, is expensed to research and development costs at the time the costs are incurred.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The major components of research and development costs include preclinical study costs, clinical manufacturing costs, clinical
        study and trial expenses, insurance coverage for clinical trials, expensed licensed technology, expensed IPR&amp;D, consulting, scientific advisors and other third-party costs, salaries and employee benefits, stock-based compensation expense,
        supplies and materials and allocations of various overhead costs related to our product development efforts.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has contracted with third parties to perform various clinical study and trial activities in the development and
        testing of potential products. The financial terms of these agreements vary from contract to contract and may result in uneven payment flows. The Company accrues for third party expenses based on estimates of the services received and efforts
        expended during the reporting period. If the actual timing of the performance of the services or the level of effort varies from the estimate, the accrual is adjusted accordingly. The expenses for some third-party services may be recognized on a
        straight-line basis if the expected costs are expected to be incurred ratably during the period. Payments under the contracts depend on factors such as the achievement of certain events or milestones, the successful enrollment of patients, the
        allocation of responsibilities among the parties to the agreement, and the completion of portions of the clinical study or trial or similar conditions. Preclinical and clinical study and trial associated activities such as production and testing of
        clinical material require significant up-front expenditures.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Income Taxes</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company records deferred tax liabilities and assets based on the differences between the consolidated financial statements
        carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and establishing a valuation allowance when it was more likely than not that some portion or all of
        the deferred tax assets would not be realized. Income tax expense consists of the tax payable for the period and the change during the period in deferred tax assets and liabilities.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Tax benefits from uncertain tax positions are recognized only if it is more likely than not that the tax position will be
        sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a
        greater than 50% likelihood of being realized upon ultimate resolution. The Company has no material uncertain tax positions for any of the reporting periods presented.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Loss Per Share</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Basic and diluted loss per common share have been computed by dividing the losses attributable to common stockholders by the
        weighted average number of common shares outstanding. The Company&#8217;s basic and fully diluted loss per share calculations are the same because the increased number of shares that would be included in the diluted calculation from assumed exercise of
        common stock equivalents would be anti-dilutive to the net loss in each of the years shown in the consolidated financial statements.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Segment Reporting</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company&#8217;s chief operating decision maker, who is the chief executive officer, reviews operating results on a consolidated
        basis to make decisions about allocating resources and assessing performance of the Company.&#160; As a result, in accordance with ASC No. 280, <span style="font-style: italic;">Segment Reporting,</span> the Company has determined that it operates as one operating segment.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Concentration of Credit Risk</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company maintains its cash balances in financial institutions located in the United States. Accounts at each institution
        are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $250,000. The Company&#8217;s cash balances are uninsured for deposit accounts that exceed the FDIC insurance limit.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In the Company&#8217;s business, vendor concentrations could be indicative of vulnerabilities in the Company&#8217;s supply chain, which
        could ultimately impact the Company&#8217;s ability to continue its research and development activities. For the years ended December 31, 2022 and 2021, there was no vendor concentration related to the Company&#8217;s research and development activities.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Fair Value of Financial Instruments</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly
        transaction between willing market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to
        unobservable inputs. The fair value hierarchy is as follows:</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 1 Inputs &#8211; Valued based on quoted prices in active markets
          for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 2 Inputs &#8211; Valued based on inputs other than quoted prices
          included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities
          in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or
          corroborated by market data by correlation or other means.</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 3 Inputs &#8211; Valued based on inputs for which there is
          little or no market value, which require the reporting entity to develop its own assumptions.</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The carrying amounts reported on the balance sheet for cash and cash equivalents, accounts receivable, prepaid assets and other
        current assets, accounts payable and accrued expenses, other current liabilities and other liabilities approximate fair value based due to their short maturities.</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Leases</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The Company accounts for its leases under
        ASC Topic 842, <span style="font-style: italic;">Leases.</span> Operating lease liabilities represent the present value of lease payments not yet paid. Right-of-use (&#8220;ROU&#8221;) assets represent the Company&#8217;s right to use an underlying asset and are
        based upon the operating lease liabilities adjusted for prepaid or accrued lease payments, initial direct costs, lease incentives and impairment of operating lease assets. If the interest rate implicit in the lease is not readily determinable, the
        Company uses the incremental borrowing rates for collateralized borrowings in an amount equal to the lease payments under similar terms.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The Company has elected the practical
        expedient to not separate non-lease components from the lease components to which they relate and instead account for each as a single lease component for all underlying asset classes. Some leasing arrangements require variable payments that are
        dependent on usage or may vary for other reasons, such as payments for insurance, tax payments and other miscellaneous costs. The variable portion of payments contemplated in the lease that do not depend on an index or rate are not included in the
        ROU assets or lease liabilities. Rather, variable payments that do not depend on an index or rate are expensed when the obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease
        contract are accounted for as lease expenses.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has also elected not to recognize ROU and lease liabilities for short-term leases that have a term of 12 months
          or less.</div>

<div><br/>
        </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Commitment and Contingencies</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company follows ASC No.450-20, <span style="font-style: italic;">Loss Contingencies,</span> to report accounting for
        contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be
        reasonably estimated.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Stock-Based Compensation</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company recognizes stock-based compensation expense for equity awards granted to employees, directors and certain
        consultants. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-lined basis.</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Warrants</span><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an
        assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480, <span style="font-style: italic;">Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging.</span> The assessment considers
        whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or meet all of the requirements for equity classification under ASC 815, including whether the warrants are
        indexed to the Company&#8217;s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification. This assessment, which
        requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.<span style="text-decoration: underline;"><br/>
        </span></div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Recent Accounting Standards</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="text-decoration: underline;"> </span><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;">Newly Adopted Accounting
        Standards:</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In July 2021, the FASB issued Accounting
        Standards Update (&#8220;ASU&#8221;) 2021-05, <span style="font-style: italic;">Leases (Topic 842) &#8211; Lessors - Certain Leases with Variable Lease Payments,</span> which amends the lessor classification guidance to introduce additional criteria when
        classifying leases with variable lease payments that do not depend on a reference index or a rate. The Company adopted this ASU effective January 1, 2022, which did not have a material impact on its financial statements.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In May 2021, the FASB issued ASU 2021-04<span style="font-style: italic;">, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40):
          Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options</span>. ASU 2021-04 addresses the accounting for certain modifications or exchanges of freestanding equity-classified written call
        options. The Company adopted this ASU effective January 1, 2022, which did not have a material impact on the Company&#8217;s financial statements.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In November 2021, the FASB issued ASU
        2021-10, <span style="font-style: italic;">Disclosures by Business Entities about Government Assistance, </span> which requires a business entity to disclose information about certain government assistance that it has received, including (i) the
        type of assistance, (ii) an entity&#8217;s accounting for the assistance and (iii) the effect of the assistance on the entities accounting statements.&#160; The Company adopted this standard effective January 1, 2022, which did not have a material impact on
        the Company&#8217;s financial statements. The Company has approximately $0.6 million in payroll tax refunds recorded in other receivable on
        the accompanying consolidated balance sheets as of December 31, 2022 and 2021 pursuant to the Employee Retention Credit program under the CARES Act.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;">Accounting Standards to
        be Adopted:</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">In June 2022, the FASB issued ASU No.
        2022-03, <span style="font-style: italic;">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions </span>(&#8220;ASU 2022-03&#8221;). The FASB issued ASU 2022-03 to (1) clarify the guidance in
        Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new
        disclosure requirements for equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is
        not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years
        with early adoption permitted. The Company is evaluating when to adopt the amendments in ASU 2022-02. The Company does not expect a material impact as a result of adopting this ASU.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975963273936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger, Disposition and Acquisition Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Merger, Disposition and Acquisition Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Merger, Disposition and Acquisition Transactions</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">4)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Merger, Disposition and Acquisition Transactions</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Merger</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">On
        August 12, 2020, Eterna, Eterna LLC and the Merger Sub entered into the Merger Agreement and consummated the Merger on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which Eterna LLC was deemed the acquiring company for
        accounting purposes. Eterna LLC, as the accounting acquirer, recorded the assets acquired and liabilities assumed of Eterna in the Merger at their fair values as of the acquisition date.</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
       <br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Eterna LLC was determined to be the accounting acquirer based upon the terms of the Merger and other factors including that (i) Eterna LLC members received common stock in the Merger that represented</span><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> 96.35% <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">of Eterna&#8217;s outstanding common stock on a fully diluted basis, (ii) all of the directors of Eterna immediately after the Merger were
              designated by Eterna LLC under the terms of the Merger Agreement and (iii) existing members of Eterna LLC&#8217;s management became the management of Eterna immediately after the Merger.</span></span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">At the closing of the Merger, all the outstanding membership interests of Eterna LLC converted into the right to receive an
        aggregate of approximately 1,999,000 shares of common stock, of which 53,000 shares were issued as compensation to Eterna LLC&#8217;s financial advisor for its services to Eterna LLC in connection with the Merger.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The purchase price of $8.2
        million, which represents the consideration transferred in the Merger to stockholders of Eterna immediately before the Merger, was calculated based on the closing price of $108 per share of common stock for approximately 76,000 shares
        that those stockholders owned on March 25, 2021 immediately prior to the Merger because that represented a more reliable measure of the fair value of consideration transferred in the Merger.<br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Under the acquisition method of accounting, the total purchase price has been allocated to the acquired tangible and intangible
        assets and assumed liabilities of Eterna based on their estimated fair values as of March 25, 2021, the Merger closing date. Because the consideration paid by Eterna LLC in the Merger is more than the estimated fair values of Eterna&#8217;s net assets
        deemed to be acquired, goodwill is equal to the difference of approximately $8.6 million, which has been calculated using the fair values
        of the net assets of Eterna as of March 25, 2021.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The allocation of the purchase price to
        the tangible and intangible assets acquired and liabilities deemed to be assumed from Eterna, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Historical Balance<br/>
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Sheet of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Eterna at</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 25, 2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair Value</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Adjustment to<br/>
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Eterna</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Pre-Merger</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Assets</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Purchase</div>
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Price</div>
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Allocation<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Cash and cash equivalents</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">148</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">148</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Accounts receivable</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">103</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">103</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Prepaid expense and other current assets</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">329</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">329</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Property and equipment, net</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,015</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,015</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Software development costs</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,296</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(368</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">928</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Customers</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">548</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">548</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Trade name</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">299</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">299</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Accounts payable, accrued liabilities and other current liabilities</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(3,781</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(3,781</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Net assets acquired, excluding goodwill</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(890</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">479</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(411</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total consideration</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">8,178</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Net assets acquired, excluding goodwill</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(411</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Goodwill</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">8,589</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Eterna LLC was obligated under the Merger Agreement to have $10.0 million in cash and cash equivalents on its balance sheet at the effective time of the Merger. To ensure Eterna LLC had the required funds, certain beneficial holders of Eterna LLC&#8217;s
        Class A membership interests entered into contractual commitments to invest $10.0 million into Eterna LLC immediately prior to the
        closing of the Merger. During March 2021, Eterna offered its Class A unit holders an additional 5% rights offering for an additional $0.5 million to be raised by a rights offering. Eterna received funds from the rights offering between February 17, 2021 and April 5, 2021.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Disposition</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On March 26, 2021, Eterna sold its rights, title and interest in and to the assets relating to the business it operated (under
        the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $2.0 million and assumption of
        specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of the Disposition are as follows <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">(in thousands)</span>:</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Proceeds from sale:</div>
            </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Cash</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">132</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Escrow</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">50</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Assume advance/loans</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,700</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Interest on advance/loans</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">68</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Carrying value of assets sold:</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Cash and cash equivalents</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(14</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Accounts receivable</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(75</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Prepaids and other current assets</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(124</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Property and equipment, net</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(1,014</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Software development costs</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(927</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Customers</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(548</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Trade name</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(299</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Goodwill</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(8,589</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Other assets</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(103</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Liabilities transferred upon sale:</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Accounts payable and accrued expenses</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">113</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Obligations under finance leases</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">17</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Lease liability</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">26</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Deferred revenue</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">55</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Other current liabilities</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">149</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Transaction costs</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(265</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Total loss on sale of assets</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">(9,648</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">)</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Acquisition</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On July 16, 2021, Eterna and Brooklyn Acquisition Sub, Inc. entered into the Novellus Acquisition Agreement. The Novellus
          Acquisition closed contemporaneously with the execution and delivery of the Novellus Acquisition Agreement. At the closing:</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -18pt; margin-left: 36pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; Eterna acquired all of the outstanding equity interests of Novellus as the
          result of the merger of Brooklyn Acquisition Sub, Inc. with and into Novellus, following which, Novellus, as the surviving corporation, became Eterna&#8217;s wholly owned subsidiary and Novellus Limited became Eterna&#8217;s indirectly owned subsidiary; and<span style="color: rgb(0, 0, 0);"><br/>
          </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Eterna acquired 25.0% of the total outstanding equity interests of NoveCite.</span></div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As consideration for the Novellus Acquisition, Eterna paid $22.9 million in cash and delivered approximately 351,000 shares of common stock, which under the terms of the Novellus Acquisition Agreement, were valued at a total of $102.0 million based on an agreed upon price of $290.51
          per share.&#160; At the date of issuance, the fair value of the shares was approximately $58.7 million.<br/>
        </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Novellus Acquisition Agreement contained customary representations, warranties and certain indemnification provisions. Approximately 37,000 of the shares issued as consideration were placed in escrow to secure indemnification obligations to Eterna under the Novellus Acquisition Agreement, and all such shares were released to the sellers in
          July 2022.&#160; The Novellus Acquisition Agreement also contains certain non-competition and non-solicitation provisions pursuant to which Novellus LLC agreed not to engage in certain competitive activities for a period of five years following the closing, including customary restrictions relating to employees. No employees of Novellus Limited or Novellus prior to the
          Novellus Acquisition continued their employment, or were otherwise engaged by Eterna, immediately following the Novellus Acquisition.<br/>
        </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> In connection with the Novellus Acquisition, the co-founders of Novellus entered into lock-up agreements with respect to approximately 169,000 of the shares of common stock received in the Novellus Acquisition, and Eterna&#8217;s Chairman of the Board and its former Chief Executive Officer and President entered into identical lock-up agreements with
          respect to their current holdings of Eterna stock. Each lock-up agreement extends for a period of three years, provided that up to 75% of the shares of common stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock
          on the Nasdaq exceeds specified thresholds. The lock-up agreements include customary exceptions for transfers during the applicable lock-up period.<br/>
        </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company executed the Novellus Acquisition to advance its evolution into a platform company with a pipeline of next generation mRNA cellular and gene editing programs.<br/>
        </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Although Eterna acquired all of the outstanding equity interests of Novellus, the Company accounted for the Novellus Acquisition as an asset acquisition (as the assets acquired did not constitute a business as defined in
          ASC Topic 805, <span style="font-style: italic;">Business Combinations</span>), and was measured by the amount of cash paid and by the fair value of the shares of common stock issued. As a result, substantially all of the value acquired was
          attributed to IPR&amp;D, with the exception of the cash paid for the investment in NoveCite, which is being accounted for as an investment in equity securities, as discussed further below.<br/>
        </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;<span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Eterna paid $22.9 million
            in cash, net of cash acquired, as part of the consideration for the Novellus Acquisition, of which $1.0 million was paid in cash for
            the investment in NoveCite. Eterna also issued approximately 351,000 shares of the Company&#8217;s common stock, of which approximately 182,000 shares are unrestricted and 169,000
            shares are subject to the three-year lockup. The unrestricted shares were valued at $201 per share, which was the closing price of Eterna&#8217;s common stock on July 16, 2021. The fair value of the restricted shares was discounted by approximately 35% to $130.60 per restricted share,
            which was derived from the average discount rate between the Black Scholes and Finnerty valuation models.</span></span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The resulting fair value of the asset acquired is as follows (in thousands):</span></span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair Value of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Consideration</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Cash paid</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">22,882</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Cash acquired</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(28</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 83.46%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Unrestricted shares</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">36,628</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 83.46%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Restricted shares</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">22,056</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 83.46%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total fair value of consideration paid</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">81,538</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 83.46%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Less amount of cash paid for NoveCite investment</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(1,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 83.46%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Fair value of IPR&amp;D acquired</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">80,538<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">IPR&amp;D that is acquired through an asset purchase that has no alternative future uses and no separate economic values from
          its original intended purpose is expensed in the period the cost is incurred. Accordingly, the Company expensed the fair value of the IPR&amp;D during the third quarter of 2021 in the amount of $80.5 million.<br/>
        </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Investment in NoveCite</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">As a result of the Novellus Acquisition, Eterna acquired and currently owns 25% of NoveCite, and Citius Pharmaceuticals, Inc. (&#8220;Citius&#8221;) owns the remaining 75%.
        A member of the Company&#8217;s management is entitled to hold one of three board seats on NoveCite&#8217;s board of directors. Citius&#8217; s officers
        and directors hold the other two board seats. The Company is accounting for its interest in NoveCite under ASC Topic 323, <span style="font-style: italic;">Investments &#8211; Equity Method and Joint Ventures.</span> The investment was recorded at cost,
        which was $1.0 million, and is adjusted for the Company&#8217;s share of NoveCite&#8217;s earnings or losses, which are reflected in the accompanying
        consolidated statements of operations. The investment may also reflect an equity loss in the event that circumstances indicate an other-than-temporary impairment.&#160; For the year ended December 31, 2022, the Company recorded approximately $0.9 million in losses from its investment in NoveCite, and, of the $0.9 million loss for year ended December 31, 2022, $0.5 million related to NoveCite&#8217;s year ended
        December 31, 2021.&#160; The Company does not guarantee obligations of NoveCite nor is it otherwise committed to provide&#160; financial support for NoveCite.&#160; Therefore, the Company will record losses only up to its investment carrying amount.<br/>
      </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975963273936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">5)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Fair Value of Financial Instruments</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">There were no liabilities measured
        at fair value as of December 31, 2021. The following tables summarize the liabilities that are measured at fair value as of December 31, 2022 (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31, 2022</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 1</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 2</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 3</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Liabilities:</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Q1-22 Common Warrants</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">331</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">331</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">On March 9, 2022, upon closing the Q1-22 PIPE Transaction, the Company issued to the Q1-22 PIPE Investor the Q1-22 Pre-Funded Warrants, exercisable
        for approximately 68,000 shares of common stock, and the Q1-22 Common Warrants, exercisable for approximately 343,000 shares of common stock.&#160; On July 12, 2022, the Q1-22 PIPE Investor exercised all of the Q1-22 Pre-Funded Warrants at an exercise price of $0.10 per share for an aggregate exercise price of approximately $7,000 in cash,&#160; and the Company issued 68,000 shares of common stock to the Q1-22 PIPE Investor upon
        receipt of the cash proceeds.&#160; Following the exercise, no Q1-22 Pre-Funded Warrants remained outstanding.&#160; See Note 15 for more
        information related to the Q1-22 PIPE Transaction.<br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Q1-22 Common Warrants and Q1-22 Pre-Funded Warrants were accounted for as liabilities under ASC 815-40,&#160;</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-style: italic;">Derivatives














          and Hedging, Contracts in Entity&#8217;s Own Equity</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">&#160;(&#8220;ASC 815-40&#8221;), as these warrants
          provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40.&#160; These warrant liabilities were measured at fair value at inception and are then subsequently measured on a recurring
          basis, with changes in fair value presented within the Company&#8217;s statements of operations.</span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
        </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> The Company uses a Black-Scholes option pricing model to estimate the fair value of the Q1-22 Common Warrants, which is considered a Level 3 fair value measurement.&#160; Certain inputs used in this Black-Scholes pricing model may
          fluctuate in future periods based upon factors that are outside of the Company&#8217;s control.&#160; A significant change in one or more of these inputs used in the calculation of the fair value may cause a significant change to the fair value of the
          Company&#8217;s warrant liabilities, which could also result in material non-cash gains or losses being reported in the Company&#8217;s consolidated statement of operations.<br/>
        </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
        </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> The estimated fair value of the Q1-22 Pre-Funded Warrants was deemed a Level 2 measurement as all significant inputs to the valuation model used to estimate the fair value of the Q1-22 Pre-Funded Warrants were directly observable
          from the Company&#8217;s publicly-traded common stock.&#160; Upon exercise of the Q1-22 Pre-Funded Warrants on July 12, 2022, the Company reclassified the approximately $0.9 million fair value of the Pre-Funded Warrants to equity.<br/>
        </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
        </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> The fair values of the Q1-22 Common Warrants and the Q1-22 Pre-Funded Warrants at the issuance date totaled $12.6
          million in the aggregate, which was $0.6 million more than the $12.0 million proceeds received in the Q1-22 PIPE Transaction.&#160; The excess $0.6
          million represents an inducement to the purchaser to enter into the Q1-22 PIPE Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of operations.<br/>
        </span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
        </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
      </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"> <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);">The Company remeasured the fair value of the Q1-22 Common Warrants as of
                December 31, 2022. The following table presents the changes in the warrant liabilities from the issuance date (in thousands):</span></span></span></div>

<div><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);"> <br/>
              </span></span></span></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Q1-22</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pre-Funded </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Warrants</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Level 2)</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Q1-22 </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Warrants</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Level 3)</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Warrant<br/>
                </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Liabilities</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at January 1, 2022</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at March 9, 2022 (issuance date)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,646</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9,943</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,589</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in fair value of warrant liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1,779</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(9,612</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,391</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Exercise of Q1-22 Pre-Funded Warrants</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(867</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(867</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at December 31, 2022</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">331</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">331</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> </span></div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975867058048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">6)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Property and Equipment</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Property and equipment consist of the following (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Laboratory and manufacturing equipment</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">28</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">258</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Leasehold improvements<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">464</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">Computer equipment and programs</div>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">240</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">155</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">268</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">877</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Less accumulated depreciation and amortization</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(32</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(207</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Property and equipment, net</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">236</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">670</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">During the year ended December 31, 2022, the Company consolidated its research and development activities in Cambridge,
        Massachusetts and entered into lease termination agreements for its Brooklyn, New York and San Diego, California facilities. (See Note 7 for more information on lease terminations.)&#160; As a result, the Company disposed of certain assets it would no
        longer use and recognized a loss on disposal of fixed assets of approximately $0.3 million, which was composed of $0.6 million in remaining net book value of such assets, offset by proceeds received from selling certain fixed assets for approximately $0.3 million. </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Depreciation expense totaled $161,000
        and $117,000 for the years ended December 31, 2022 and 2021, respectively. No depreciation expense is recorded on fixed assets in process
        until such time as the assets are completed and are placed into service.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975952819552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">7)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Leases</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he </span>Company has operating leases for office and
        laboratory space in the borough of Manhattan in New York, New York, in Cambridge, Massachusetts and in Somerville, Massachusetts, which expire in 2026, 2028, and 2032 respectively<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company also leased a facility in Brooklyn, New York (the &#8220;Brooklyn Lease&#8221;). On March 5, 2022, the Company entered into an
        agreement to assign the Brooklyn Lease to Regen Lab USA LLC (&#8220;Regen&#8221;).&#160; Regen agreed to purchase certain equipment from the Company for $50,000,
        which partially reimbursed the Company for certain existing unamortized leasehold improvements, and to reimburse the Company for the existing security deposit the Company had under the Brooklyn Lease of approximately $63,000.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On March 25, 2022, the Company entered into an Assignment and Assumption of Lease Agreement (the &#8220;Assignment Agreement&#8221;) with
        Regen. The effective date of the assignment was March 28, 2022.&#160; Under the Assignment Agreement, Regen assumed all of the obligations, liabilities, covenants and conditions of the Company as tenant under the Brooklyn Lease.&#160; As a result of the
        lease assignment, the Company wrote off the remaining ROU asset balance of approximately $1.4 million and the corresponding lease
        liability of approximately $1.5 million.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On March 31, 2022, the Company entered into a facility lease in San Diego, California (the &#8220;San Diego Lease&#8221;) with Torrey Pines
        Science Center Limited Partnership for approximately 5,200 square feet of laboratory and office space.&#160; The term of the San Diego Lease
        was 62 months and the lease commencement date was April 19, 2022. The Company recorded a $1.7 million ROU asset and $1.7 million lease liabilities for the
        San Diego Lease.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">During 2022, the Company decided to consolidate its research and
          development efforts in Cambridge, Massachusetts, and the Company determined to sublease the San Diego </span>laboratory<span style="font-size: 10pt; font-family: 'Times New Roman';"> and office space.&#160; As a result, the Company recognized an
          impairment charge of approximately $0.8 million on the San Diego Lease ROU asset during 2022, which is recorded in general and
          administrative expense on the consolidated statements of operations.</span></div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On November 30, 2022, the Company and the lessor of the San Diego Lease entered into a lease termination agreement, as amended
        on December 29, 2022 (the &#8220;Lease Termination Agreement&#8221;), pursuant to which the lessor agreed to terminate the San Diego lease effective January 31, 2023 provided that (i) the Company pay a $0.1 million lease termination fee and (ii) the lessor was able to enter into a new lease for the space with a new tenant by January 15, 2023.&#160; On January 9, 2023, the lessor
        provided notice to the Company that it had entered into a new lease with a new tenant, and the Company paid the $0.1 million termination
        fee.&#160; As a result, the San Diego Lease terminated on January 31, 2023.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Lease Termination Agreement was accounted for as a modification to the San Diego Lease rather than as a lease termination
        because the Company did not contemporaneously terminate the San Diego Lease upon the November 30, 2022 modification date and had a continued right-of-use of the facility through January 31, 2023.&#160; As a result, the Company remeasured the remaining
        lease payments, including the $0.1 million termination fee, and reduced the lease liability the Company had on its balance sheet at the
        time of the modification by approximately $1.4 million to the present value of the remeasured lease liability of approximately $0.2 million.&#160; For a lease modification that is not accounted for as a separate contract, a lessee recognizes the amount of the remeasured lease
        liability as an adjustment to the corresponding ROU asset without affecting profit or loss.&#160; However, because the ROU asset balance as of the modification date was only $0.8 million due to the impairment charge of $0.8 million the Company recognized during the second
        quarter of 2022 (as discussed above), the Company reduced the ROU asset to zero, and the remaining $0.6 million of the $1.4 million
        adjustment was recognized as a credit to general and administrative expense on the consolidated statement of operations for the year ended December 31, 2022.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On October 18, 2022, the Company entered into the Sublease with E.R. Squibb &amp; Sons, L.L.C., a Delaware limited liability
        company and subsidiary of Bristol-Myers Squibb Company (&#8220;Sublessor&#8221;), for office, laboratory and research and development space (the &#8220;Premises&#8221;). The Premises consist of approximately 45,500 square feet on the ninth floor of the building currently under construction located at 250 Water Street, Somerville, Massachusetts 02141.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Payments of the Sublease rent commence on the date that is the earlier of (i) the date that the Company commences business
        operations from the Premises and (ii) the one-year anniversary of the date that Sublessor obtained the primary landlord&#8217;s consent for the Sublease, which was November 29, 2022 (such applicable date, the &#8220;Rent Commencement Date&#8221;). The Sublease has a
        term of 10 years from the Rent Commencement Date (the &#8220;Term&#8221;), subject to a five-year extension in accordance with the terms of the Sublease.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the Sublease, the Company paid the Sublessor a security deposit in the form of a letter of credit in the amount of
        approximately $4.1 million. Provided there are no events of default by the Company under the Sublease, the letter of credit will be
        reduced on an incremental basis throughout the Term. Pursuant to the Sublease, the Company has agreed to pay base rent of approximately $0.5
        million per month during the first year of the Term, increasing on an incremental basis each subsequent year of the Term for a total of approximately $63.0
        million in base rental payments, as well as parking and traditional lease expenses, including certain taxes, operating expenses and utilities.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the Sublease, the Sublessor will provide the Company with a tenant improvement allowance of $190 per rentable square foot, or $8.6
        million.&#160; Tenant improvements to the Premises in excess of this amount, if any, will be at the Company&#8217;s own cost. As of December 31, 2022, the Premises had not been made available for the Company to begin the construction of the tenant
        improvements.&#160; It is expected that the Premises will be made available to begin the construction in March or April 2023, and it is anticipated that the construction will be complete and ready for operational use in November or December 2023.&#160; As a
        result, the commencement date of the Sublease did not occur as of December 31, 2022, and accordingly, the Company did not recognize
        a lease liability and corresponding ROU asset for the Sublease as of December 31, 2022.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of December 31, 2022, the Company had incurred approximately $0.6 million in costs in connection with the Sublease, which consisted of approximately $0.5 million for the architect to design the tenant improvements to the Premises and for a project manager to manage the construction of the tenant improvements as well as approximately $0.1 million in bank fees related to the issuance of the letter of credit discussed above.&#160; These costs are recorded in other assets in the accompanying
        consolidated balance sheet as of December 31, 2022.</div>

<div> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For the years ended December 31, 2022 and 2021, the net operating lease expenses were as follows (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Years ended December 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; font-weight: bold;">2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Operating lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">595</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">688</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Sublease income</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(84</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(84</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Variable lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">150</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">19</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Total lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">661</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">623</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2022 and
            the ending balances as of December 31, 2022, including the changes during the period (in thousands).</div>

<div><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operating </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Lease</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">ROU Assets</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">Operating lease ROU assets at January 1, 2022</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">2,567</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Initial measurement of ROU asset</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">1,706</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Amortization of operating lease ROU assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(336</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Impairment of ROU asset</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(772</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Remeasurment of ROU asset</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(813</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Reclassification from fixed assets to ROU assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">50</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Write off of ROU asset due to lease termination</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(1,372</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">Operating lease ROU assets at December 31, 2022</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">1,030</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operating</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Lease</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Liabilities</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Operating lease liabilities at January 1, 2022</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">2,723</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Initial measurement of operating lease liabilities</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">1,706</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Principal payments on operating lease liabilties</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(340</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Remeasurment of lease liability</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(1,454</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Write off of lease liability due to lease termination</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(1,453</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Operating lease liabilities at December 31, 2022</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">1,182</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Less non-current portion</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">887</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Current portion at December 31, 2022</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">295</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
        </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of December 31, 2022, the Company&#8217;s operating leases had a weighted-average remaining life of 4.5 years with a weighted-average discount rate of 9.98%.
          <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The maturities of the
          operating lease liabilities are as follows (in thousands):</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2023</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">403</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2024</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">272</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2025</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">274</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2026</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">267</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2027</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">163</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Thereafter</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">82</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total payments</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,461</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Less imputed interest</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(279</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total operating lease liabilities</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,182</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The maturities of the operating lease liabilities show in the table above does not include future payments due under the
            Sublease that the Company entered into in October 2022, as the commencement date of the Sublease had not begun as of December 31, 2022, and therefore, the Company did not record a corresponding lease liability and ROU asset.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
          </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Sublease Agreement</div>

<div><br/>
              </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">In April 2019, the Company entered into a sublease agreement with Nezu Asia Capital Management, LLC
              (the &#8220;Tenant&#8221;), whereby the Tenant agreed to sublease approximately 999 square feet of space currently rented by the Company in
              the borough of Manhattan in New York, New York commencing on May 15, 2019. The term of this sublease expires on October 31, 2026 with no option to extend the sublease term. Rent payments provided by the Tenant under the sublease agreement
              began on September 1, 2019. The sublease agreement stipulates an annual rent increase of 2.25%. The Tenant is also responsible for
              paying to the Company all tenant energy costs, annual operating costs, and annual tax costs attributable to the subleased space during the term of the sublease.</div>

<div><br/>
              </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company received sublease payments of approximately $0.1 million for each of the years ended December 31, 2022 and 2021, respectively. In accordance with ASC Topic 842, the Company treats the sublease as a separate
              lease, as the Company was not relieved of the primary obligation under the original lease. The Company continues to account for the Manhattan lease as a lessee and in the same manner as prior to the commencement date of the sublease. The
              Company accounts for the sublease as a lessor of the lease. The sublease is classified as an operating lease, as it does not meet the criteria of a sale-type or direct financing lease.</div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">The following tables shows the future payments the Company expects to receive from the Tenant over
              the remaining term of the sublease (in thousands):</div>

<div><br/>
              </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of</div>
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">$ <br/>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">84<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">86<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">88<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">75<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">333<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975870365696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>In-Process Research &amp; Development and Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>In-Process Research &amp; Development and Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">In-Process Research &amp; Development and Goodwill</a></td>
<td class="text">
<div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">8)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;">In-Process Research &amp; Development and Goodwill</div>
                </td>

  </tr>


</table>
        </div>

<div><br/>
        </div>

<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">In-Process Research
          &amp; Development</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          2018, the Company acquired IRX, which was accounted for as a business combination.&#160; The Company recorded IPR&amp;D in the amount of $6.0
          million, which represented the fair value assigned to technologies that were acquired in connection with the IRX acquisition and which have not reached technological feasibility and have no alternative future use.</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          June 2022, the Company received results from the INSPIRE phase 2 trial of IRX-2, a multi-cytokine biologic immunotherapy, in patients with newly diagnosed stage II, III or IVA squamous cell carcinoma of the oral cavity. The IRX-2 multi-cytokine
          biologic immunotherapy represents substantially all the fair value assigned to the technologies of IRX that the Company acquired. Despite outcomes that favored IRX-2 in certain predefined subgroups, the INSPIRE trial did not meet the primary
          endpoint of Event-Free Survival. Significant additional clinical development work would be required to advance IRX-2 in the form of additional Phase 2 and 3 studies to further evaluate the treatment effect of IRX-2 in patient subgroups and in
          combination with checkpoint inhibitor therapies.&#160; The INSPIRE trial was the only Company-sponsored study of IRX-2.&#160; Based on the totality of available information, the Company currently does not have plans to further develop the IRX-2 product
          candidate. As such, the Company determined that the carrying value of the IPR&amp;D asset was impaired and recognized a non-cash impairment charge of approximately $6.0 million on the consolidated statement of operations during 2022, which reduced the value of the asset to zero.</div>

<div><br/>
        </div>

<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Goodwill</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The
















          Company recorded goodwill in the amount of $2.0 million related to the IRX Acquisition. As of December 31, 2022, the Company performed
          a qualitative assessment to determine whether it was more likely than not that the fair value of the entity is less than its carrying value of goodwill. Such qualitative factors include macroeconomic conditions, industry and market
          considerations, cost factors, overall financial performance and other relevant events.&#160; Due to the decline in the Company&#8217;s stock price during 2022, the Company determined there were indications of impairment of the goodwill. Accordingly, the
          Company proceeded to a quantitative assessment of impairment and determined that the fair value of the reporting unit exceeded the carrying amount of goodwill, and therefore, the goodwill was not impaired as of December 31, 2022.
        </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975952925504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">
<div>
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="align: right; vertical-align: top; width: 9pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: -36pt; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-left: 36pt;"><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9)</span></div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">Related Party Transactions</span></span></div>
              </td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;">Agreements Related to Factor Bioscience and Dr. Matthew Angel</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          September 2022, the Company entered into a Master Services Agreement (the &#8220;MSA&#8221;) with Factor Bioscience Inc. (&#8220;Factor Bioscience&#8221;), pursuant to which Factor Bioscience has agreed to provide services to the Company as agreed between the Company
          and Factor Bioscience and as set forth in one or more work orders under the MSA, including the first work order included in the MSA (&#8220;WO1&#8221;). Under WO1, Factor Bioscience has agreed to provide the Company with mRNA cell engineering research
          support services, including access to certain facilities, equipment, materials and training, and the Company has agreed to pay Factor Bioscience an initial fee of $5.0 million, payable in twelve equal monthly installments of approximately $0.4 million. Of the $5.0 million, the
          Company allocated $3.5 million to the License Fee Obligation (as defined below). Following the initial 12-month period, the Company has
          agreed to pay Factor Bioscience a monthly fee of $0.4 million until such time as WO1 is terminated. The Company paid a deposit of $0.4 million, which will be applied to the last month of the first work order.</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company may terminate WO1 under the MSA on or after the second anniversary of the date of the MSA, subject to providing
          Factor Bioscience with 120 days&#8217; prior notice.&#160; Factor Bioscience may terminate such work order only on and after the fourth anniversary of the date of the MSA, subject to providing the Company with 120 days&#8217; prior notice.&#160; The MSA contains customary confidentiality provisions and representations and warranties of the parties, and the MSA may be terminated by ether party
          upon 30 days&#8217; prior notice, subject to any superseding termination provisions contained in a particular work order.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In connection with entering into the MSA, Factor Bioscience&#8217;s subsidiary, Factor Limited, entered into a waiver agreement
          (the &#8220;Waiver Agreement&#8221;) with Eterna LLC, pursuant to which Factor Limited agreed to waive payment of $3.5 million otherwise payable to
          it (the &#8220;License Fee Obligation&#8221;) in October 2022 by Eterna LLC under the Original Factor License Agreement, as defined in Note 13,&#160;<span style="font-style: italic;">License Agreements</span>.&#160; Under the terms of the Waiver Agreement, the License
          Fee Obligation is waived conditionally on the Company paying Factor Bioscience amounts due under the MSA.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As a result of entering into the Waiver Agreement and the MSA, the Company recognized $3.5 million in research and development expense, as the license does not have an alternative future use, and a corresponding liability for the License
          Fee Obligation.&#160; As of December 31, 2022, there was approximately $3.0 million of the License Fee Obligation remaining, which is
          recorded on the accompanying consolidated balance sheet in the &#8220;due to related party&#8221; line items.</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">In September 2022, Novellus and Eterna entered into a Second Amendment to the Limited
        Waiver and Assignment Agreement (the &#8220;Waiver and Assignment Agreement&#8221;) with Drs. Matthew Angel and Christopher Rohde (the &#8220;Founders&#8221;) whereby the Company has agreed to be responsible for all future, reasonable and substantiated legal fees, costs,
        settlements and judgments incurred by the Founders, the Company or Novellus for certain claims and actions and any pending or future litigation brought against the Founders, Novellus and/or the Company by or on behalf of the Westman and Sowyrda
        legal matters described in Note 12 (the &#8220;Covered Claims&#8221;).&#160; The Founders will continue to be solely responsible for any payments made to satisfy a judgement or settlement of any pending or future wage act claims.&#160; Under the Waiver and Assignment
        Agreement, the Founders agreed that they are not entitled to, and waived any right to, indemnification or advancement of past, present or future legal fees, costs, judgments, settlement or other liabilities they may have been entitled to receive
        from the Company or Novellus in respect of the Covered Claims. The Company and the Founders will share in any recoveries up to the point at which the parties have been fully compensated for legal fees, costs and expenses incurred, with the Company
        retaining any excess recoveries. The Company has the sole authority to direct and control the prosecution, defense and settlement of the Covered Claims.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">In September 2022, the Company entered into an assignment and assumption of contracts
        agreement (the &#8220;Assignment and Assumption Agreement&#8221;) with Factor Bioscience, pursuant to which the Company assumed certain contracts with third parties that Factor Bioscience had previously entered into in anticipation of entering into a sublease
        for premises in Somerville, Massachusetts.&#160; In October 2022, the Company entered into a sublease for the premises (see Note 7).&#160; Under the Assignment and Assumption Agreement, the Company agreed to reimburse Factor Bioscience for costs already
        incurred or paid by it under the assumed contracts in the amount of approximately $0.1 million, and the Company assumed the future
        obligations under these contracts, which relate to the design and build-out of the subleased space.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          November 2022, following the expiration of one of the delineated milestone deadlines for certain regulatory filings required under the Novellus-Factor License Agreement (as defined in Note 12), which permitted Factor Limited to terminate the
          license granted to Novellus Limited thereunder, the Company entered into the first amendment to the Original Factor License Agreement (the &#8220;Amended Factor License Agreement&#8221;), pursuant to which, among other things, Factor Limited granted to
          Eterna LLC an exclusive, sublicensable license under certain patents owned by Factor Limited (the &#8220;Factor Patents&#8221;) for the purpose of identifying and pursuing certain opportunities to grant to third parties sublicenses to the Factor Patents. The
          Amended Factor License Agreement also (i) terminated the Novellus-Factor License Agreement, (ii) confirmed Factor Limited&#8217;s grant to Eterna LLC of the rights and licenses Novellus Limited previously granted to Eterna LLC under the Novellus-Factor
          License Agreement on the same terms and conditions as granted by Novellus Limited to Eterna LLC under such agreement, (iii) confirmed that sublicense granted by Novellus Limited in accordance with the Novellus-Factor License Agreement to NoveCite
          (as discussed in Note 12), survived termination of the Novellus-Factor License Agreement; and (iv) removed Novellus Limited from the Amended Factor License Agreement and the NoveCite Agreement (as defined in Note 12) and replaced Novellus Limited
          with Factor Limited as the direct licensor to Eterna LLC and NoveCite under such agreements, respectively.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The















          agreements discussed above have been deemed related party transactions, as the Company&#8217;s Chief Executive Officer, Dr. Matthew Angel, is also the Chairman and Chief Executive Officer of Factor Bioscience and a Director of Factor Limited.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);"> <br/>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Exacis Option Agreement</span><br/>
          <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On October 8, 2022, the Company entered into an option agreement (the &#8220;Exacis Option Agreement&#8221;) with Exacis Biotherapeutics,
          Inc., a Delaware corporation (&#8220;Exacis&#8221;), pursuant to which Exacis granted the Company the option to negotiate and enter into an exclusive worldwide sublicense by December 31, 2022 to certain technology licensed by Exacis for the treatment of
          cancer in humans (the &#8220;Exacis Option&#8221;). Under the Exacis Option Agreement, the Company paid Exacis a fee of $0.3 million for the Exacis
          Option, which would be creditable against the fees or purchase price payable under any such license if entered into by the Company in accordance with the Exacis Option Agreement. The Exacis Option Agreement provided for certain payments upon the
          execution of a definitive license agreement, which would become payable only upon execution and in accordance with the terms of the applicable license agreement, if any.&#160; The Company decided not to exercise the Exacis Option, and the Exacis
          Option Agreement expired in accordance with its terms on December 31, 2022.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Exacis Option Agreement has been deemed a related party transaction, as one of the Company&#8217;s Board members, Dr. Gregory
          Fiore, is the Chief Executive Officer of Exacis.&#160; Additionally, the Company&#8217;s Chief Executive Office, Dr. Matthew Angel, is Chairman of Exacis&#8217; scientific advisory board. Dr. Angel is also the Chairman and Chief Executive Officer of Factor
          Bioscience LLC, which is the majority shareholder of Exacis.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;">Q4-22 PIPE Transaction </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On November 23, 2022, the Company entered into the Q4-22 Purchase Agreement with the Q4-22 PIPE Investors in respect of
              the Q4-22 PIPE Transaction, pursuant to which the Company issued and sold to the Q4-22 PIPE Investors approximately 2,185,000
              units, each unit consisting of (i) one share of common stock and (ii) two Q4-22 Warrants, at a purchase price of $3.53 per unit
              (inclusive of $0.125 per Q4-22 Warrant). The Company received aggregate gross proceeds of approximately $7.7 million, The Q4-22 PIPE Transaction closed on December 2, 2022.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Each Q4-22 Warrant becomes exercisable six months following the date of closing, expires <span style="-sec-ix-hidden:Fact_1f3e03cde5674ee69b274ec5dc980a3c">five-and-one-half</span> years following such date,
                and is subject to customary adjustments.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Mr. Charles Cherington, Chairman of the Company&#8217;s Board of Directors, and Mr. Nicholas Singer, a director of the
                Company, participated in the Q4-22 PIPE Transaction on the same terms and subject to the same conditions as all other Q4-22 PIPE Investors.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On the closing date of the Q4-22 PIPE Transaction, the Company and the Q4-22 PIPE Investors, including Messrs. Cherington
              and Singer, entered into a registration rights agreement, pursuant to which the Company has agreed to prepare and file a registration statement on Form S-3 with the Securities and Exchange Commission no later than 30 days following the date
              on which the Company becomes eligible to use Form S-3 to register the resale of the shares of common stock included in the units described above and the shares of common stock issuable upon exercise of the Q4-22 Warrants.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975952925504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">10)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Accrued Expenses</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Accrued expenses consisted of the following (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Accrued compensation</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,065</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">656</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Legal fees and related</span></div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,138</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">241</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Clinical</span></div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">570</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">200</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Q4-22 PIPE</span></td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">208</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">Other<br/>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">645</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">152</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total accrued expenses</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,626</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,249</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
              <div>&#160;</div>
            </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975870365696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">11)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Debt</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Loans Payable</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In connection with the IRX Acquisition in 2018, Eterna LLC assumed certain notes payable (the &#8220;IRX Notes&#8221;) in the amount of $0.4 million. On January 27, 2020, the IRX Notes were amended to extend the maturity date to the earlier of (i) a change of control, as defined in the
          IRX Notes, and (ii) December 31, 2021. On December 31, 2021, the Company paid the outstanding $0.4 million in principal plus accrued
          and unpaid interest of approximately $0.2 million under the IRX Notes, and the Company has no further obligations thereunder.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Payment Protection Program Loan</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On May 4, 2020, Eterna LLC issued a note in the principal amount of approximately $0.3 million to Silicon Valley Bank evidencing a loan (the &#8220;Eterna LLC PPP Loan&#8221;) that Eterna LLC received under the Paycheck Protection Program (the &#8220;PPP&#8221;) of the Coronavirus
          Aid, Relief, and Economic Security Act administered by the U.S. Small Business Administration (the &#8220;CARES Act&#8221;). Eterna LLC PPP Loan incurred interest at a rate of 1.0% per annum.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Under the terms of the CARES Act, certain amounts of the Eterna LLC PPP Loan could be forgiven if they were used for
          qualifying expenses, as described in the CARES Act. In September 2021, the lender informed Eterna LLC that the U.S Small Business Administration approved the forgiveness of 100% of the outstanding principal and interest of the Eterna LLC PPP
          Loan. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">As a result, the Company recognized a gain during 2021 of $0.3 million during recorded in other (expense) income, net, on the accompanying consolidated statements of operations. The Company has no further obligations under this loan</span>.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975872157136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">12)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Commitments and Contingencies</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Litigation Matters</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The









          Company is involved in litigation and arbitrations from time to time in the ordinary course of business. Legal fees and other costs associated with such actions are expensed as incurred. In addition, the Company assesses the need to record a
          liability for litigation and contingencies. The Company reserves for costs relating to these matters when a loss is probable, and the amount can be reasonably estimated.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;"> <span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </span></span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;">Dhesh Govender v. Eterna Therapeutics LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021)</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On









            or about February 5, 2021, Dhesh Govender, a former short-term consultant of Eterna LLC, filed a complaint against Eterna LLC and certain individuals that plaintiff alleged were directors of Eterna LLC. Plaintiff alleged that Eterna LLC and
            certain of its officers and directors (&#8220;defendants&#8221;) engaged in unlawful and discriminatory conduct based on race, national origin and hostile work environment. Plaintiff also asserted various breach of contract, fraud and quantum meruit claims
            based on an alleged oral agreement pursuant to which he alleged Eterna LLC agreed to hire him as an executive once the Merger was completed. On December 15, 2022, the parties executed a Confidential Settlement Agreement and Release of All
            Claims. On January 11, 2023, the parties filed a Stipulation to Discontinue in the Court action. Also on January 11, 2023, Govender voluntarily dismissed the arbitration.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">John Westman v.
              Novellus, Inc., Christopher Rohde, and Matthew Angel, Civil Action No. 2181CV01949 (Middlesex County (Massachusetts) Superior Court)</span></div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On or about September 7, 2021, John Westman, a former employee of Novellus, Inc.
          filed a Complaint in Middlesex County (Massachusetts) Superior Court against Novellus, Inc. and Novellus, Inc.&#8217;s founders and former executives, Dr. Christopher Rohde and Dr. Matthew Angel (collectively, &#8220;Defendants&#8221;).&#160; The case includes
          allegations that Novellus, Inc. violated the Massachusetts Wage Act (&#8220;Wage Act&#8221;).&#160; Eterna acquired Novellus, Inc. on July 16, 2021.&#160; Mr. Westman&#8217;s claims relate to alleged conduct that took place before Eterna acquired Novellus, Inc.&#160; Westman
          agreed to dismiss the lawsuit and proceed with his claims in arbitration.&#160; Following mediation, the parties settled this dispute in December 2022.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> The aggregate settlement amount payable by the Company for the two matters
          discussed above is approximately $0.5 million.<br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="text-decoration: underline;">Novellus, Inc. v. Sowyrda et al., C.A. No. 2184CV02436-BLS2</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On October 25, 2021 Novellus, Inc. filed a complaint in the Superior Court of Massachusetts, Suffolk County, against former
            Novellus, Inc. employees Paul Sowyrda and John Westman and certain other former investors in Novellus LLC (Novellus, Inc.&#8217;s former parent company prior to our acquisition of Novellus, Inc.), alleging breach of fiduciary duty, breach of contract
            and civil conspiracy. Eterna acquired Novellus, Inc. on July 16, 2021.&#160; On May 27, 2022 Novellus, Inc. amended the complaint to withdraw all claims against all defendants except Paul Sowyrda and John Westman.&#160; On July 1, 2022, Westman filed a
            motion to compel arbitration or in the alternative, to stay the litigation pending the disposition of certain litigation in the Court of Chancery for the State of Delaware filed by Mr. Sowyrda against Novellus LLC, Dr. Christopher Rohde, Dr.
            Matthew Angel, Leonard Mazur and Factor Bioscience, Inc. captioned&#160;<span style="font-style: italic;">Zelickson et al., v. Angel et al.,</span>&#160;C.A. 2021-1014-JRS and by Westman against Novellus LLC captioned&#160;<span style="font-style: italic;">Westman

























              v. Novellus LLC</span>, C.A. No. 2021-0882-NAC (the &#8220;Delaware Actions&#8221;).&#160; On July 1, 2022, Sowyrda answered the complaint and asserted counterclaims against Novellus, Inc, and third-party defendants Dr. Matthew Angel and Dr. Christopher Rohde
            alleging violations of the Massachusetts Wage Act, Massachusetts Minimum Fair Wage Law, the Fair Labor Standards Act, breach of contract, unjust enrichment and quantum meruit.&#160; Sowyrda also joined in Westman&#8217;s motion to stay the case pending
            the Delaware Actions.&#160; Novellus, Inc.&#8217;s claims and Mr. Sowyrda&#8217;s counterclaims relate to alleged conduct that took place before Eterna acquired Novellus, Inc.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On November 15, 2022, prior to a decision on Westman&#8217;s and Sowyrda&#8217;s motion to compel or stay, the Parties agreed to
            voluntarily dismiss and consolidate the Delaware Actions with this action.&#160; On December 15, 2022, Sowyrda filed an Amended Answer to the Amended Complaint, asserted affirmative defenses and filed Amended Counterclaims against Dr. Angel, Dr.
            Rohde, Novellus LLC, Novellus Inc., Factor Bioscience Inc., and Eterna Therapeutics Inc. (&#8220;Counterclaim Defendants&#8221;) alleging against various Counterclaim Defendants breach of contract, breaches of the implied duty of good faith and fair
            dealing, breaches of fiduciary duty, breaches of the operating agreement, aiding and abetting breaches of fiduciary duty, tortious interference with contract, equitable accounting, violations of the Massachusetts Wage Act, Massachusetts Minimum
            Fair Wage Law, the Fair Labor Standards Act, unjust enrichment, and quantum meruit.&#160; Also on December 15, 2022, Westman filed an answer to the Amended Complaint and asserted similar counterclaims against the same Counterclaim Defendants.&#160;
            Westman and Sowyrda each asserted claims for indemnification and/or advancement against Novellus, Inc.&#160; On January 11, 2023, Westman and Sowyrda served a joint motion to enforce their advancement and/or indemnification rights against Novellus
            Inc.&#160; Novellus Inc. vigorously opposes this motion and served its opposition on January 27, 2023.&#160; On February 8, 2023, Westman and Sowyrda served a reply in support of their motion to enforce indemnification/advancement rights, and submitted
            the motion to the Court.&#160; Novellus Inc. answered Westman and Sowyrda&#8217;s counterclaims on January 27, 2023, denying liability.&#160; The remaining Counterclaim Defendants served a motion to dismiss most of the remaining counterclaims on January 27,
            2023.&#160; Sowyrda&#8217;s and Westman&#8217;s oppositions to the motion to dismiss were served on March 3, 2023, and Counterclaim Defendants&#8217; reply is due March 24, 2023, at which point the motion to dismiss will be fully briefed.&#160; The Court announced that it
            would hold oral argument on April 5, 2023 on (a) the Counterclaim Defendants&#8217; motion to dismiss, and (b) Sowyrda&#8217;s and Westman&#8217;s motion to enforce.&#160;&#160; The parties attended an initial status and scheduling conference with the Court on February 7,
            2023.&#160; The Court deferred entering a case scheduling until after the April 5 hearing.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Under applicable Delaware law and Novellus Inc.&#8217;s organizational documents, the Company may be
            required to advance or reimburse certain legal expenses incurred by former officers and directors of Novellus, Inc. in connection with the foregoing Westman and Sowyrda matters. However, a future advance or reimbursement is not currently
            probable nor can it be reasonably estimated.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
          </div>

<div style="display:none;"><br/></div>
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"> <span style="text-decoration: underline;">Emerald Private Equity Fund, LLC Matter</span></div>

<div style="display:none;"><br/></div>
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"><span style="text-decoration: underline;"> <br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> By a letter dated July 7, 2021, Emerald Private Equity Fund, LLC (&#8220;Emerald&#8221;), a stockholder of Eterna, made a demand
            pursuant to 8 Del. C. 220 to inspect certain books and records of Eterna. The stated purpose of the demand was to investigate possible wrongdoing by persons responsible for the implementation of the Merger and the issuance of paper stock
            certificates, including investigating&#160; whether: (i) Eterna&#8217;s stock certificates were issued in accordance with the Merger Agreement; (ii) certain restrictions on the sale of Eterna common stock following the Merger were proper and applied
            without favor; (iii) anyone received priority in post-Merger issuances of Eterna&#8217;s stock certificates that allowed them to benefit from an increase in the trading price of Eterna&#8217;s common stock; and (iv) it should pursue remedial measures
            and/or report alleged misconduct to the SEC. Eterna responded to the demand letter and produced certain information to Emerald in connection with the demand, which is subject to the terms of a confidentiality agreement entered into among the
            parties, including certain additional stockholders who subsequently joined as parties to such agreement.&#160; Following discussions, with no admission of wrongdoing, the Company and the Emerald Plaintiffs entered into a confidential settlement
            agreement, pursuant to which the Company paid $1.2 million in 2022 in full settlement of all of the Emerald Plaintiffs&#8217; purported
            claims, including a release by the Emerald Plaintiffs in favor of the Company in respect of any and all such claims.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Licensing
              Agreements</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>

<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Exclusive Factor
              License Agreement.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In April 2021, Eterna LLC and the Licensors entered into an exclusive license agreement (the &#8220;Original Factor License
            Agreement&#8221;) pursuant to which Eterna LLC acquired an exclusive worldwide license to the Licensed Technology for use in the development of certain mRNA, gene-editing, and cellular therapies to be evaluated and developed for treating human
            diseases, including certain types of cancer, sickle cell disease, and beta thalassemia.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As a result of the Novellus Acquisition, the rights and obligations of Novellus Limited under the Novellus-Factor License
            Agreement pertaining to any and all licensed products from Factor Limited inured to Eterna. The Company&#8217;s agreement with Factor Limited under the Original Factor License Agreement remained unchanged after the completion of the Novellus
            Acquisition.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">In November 2022, the Company
                    entered into the first amendment to the Original Factor License Agreement (the &#8220;Amended Factor License Agreement&#8221;), pursuant to which, among other things, Factor Limited granted to Eterna LLC an exclusive, sublicensable license under
                    the Factor Patents for the purpose of identifying and pursuing certain opportunities to grant to third parties sublicenses to the Factor Patents. The term of the Amended Factor License Agreement is five years from the effective date of this amendment and is extendable for an additional <span style="-sec-ix-hidden:Fact_7c1d5587e87d44e08e7579d3d8b39dd7">two and a half years</span> if the Company receives at least $100
                    million from sublicenses granted by it with respect to the sublicensing opportunities contemplated by the&#160; Amended Factor License Agreement. Pursuant to the Amended Factor License Agreement, the Company will pay to Factor Limited 20% of any sublicense fees it receives under a sublicense during the first <span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">five years</span> and 30% of any sublicense fees it receives during the potential additional <span style="-sec-ix-hidden:Fact_5dfb948eb44f4984b296bd33047f7cfb">two and a half years</span></span><span style="font-family: 'Times New Roman';">.</span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"><span style="text-decoration: underline;">USF</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Eterna LLC has license
                        agreements with University of South Florida Research Association, Inc. (&#8220;USF&#8221;), granting Eterna LLC the right to sell, market, and distribute IRX-</span><span style="font-family: 'Times New Roman';">2,<span style="font-size: 10pt; color: rgb(0, 0, 0);"> subject to a 7% royalty payable to USF based on a</span> percentage<span style="font-size: 10pt; color: rgb(0, 0, 0);"> of gross product sales. Under the license agreement with USF, Eterna LLC is obligated to repay patent prosecution expenses incurred by USF. To date, Eterna LLC has not recorded any product sales, or
                          obligations related to USF patent prosecution expenses. The license agreement terminates upon the expiration of the IRX-</span>2<span style="font-size: 10pt; color: rgb(0, 0, 0);"> patents.</span></span></div>

<div><span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Royalty Agreements</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">While the agreements described below remain in force, the Company currently does not have plans to further
                      develop the IRX-2 product candidate<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.</span><br/>
                    </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Collaborator Royalty Agreement</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Pursuant to a royalty agreement the
            Company assumed when it acquired the assets of IRX in November 2018, the Company will pay a former collaborator a royalty equal to 6%
            of any sales of IRX-2, for the period of time beginning with the first sale of IRX-2 through the later of (i) the twelfth anniversary of the first sale of IRX-2 or (ii) the expiration of the last IRX patent, or other exclusivity of IRX-</span><span style="font-family: 'Times New Roman';">2.</span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"><span style="text-decoration: underline;">Royalty Agreement with certain former IRX Therapeutics Investors</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to a royalty agreement (the &#8220;IRX Investor Royalty Agreement&#8221;) with certain former IRX investors the Company assumed
          when it acquired the assets of IRX in November 2018, when Eterna LLC becomes obligated to pay royalties to USF under the agreement described above under &#8220;Licensing Agreements-USF,&#8221; it will pay an additional royalty of 1% of gross sales to an entity organized by such former investors.</div>

<div><br/></div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Investor Royalty Agreement</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On March 22, 2021, Eterna LLC restated its royalty agreement with certain beneficial holders of Brooklyn ImmunoTherapeutics
        Investors GP LLC and Brooklyn ImmunoTherapeutics Investors LP, whereby such beneficial holders will continue to receive, on an annual basis, royalties in an aggregate amount equal to 4% of the net revenues of IRX-2, a cytokine-based therapy that was previously being developed by Eterna LLC to treat patients with cancer.</div>

<div><br/>
      </div>

<div style="text-align: justify; margin-right: 0.3pt; margin-top: 0.1pt; margin-bottom: 0.1pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Retirement Savings Plan</div>

<div style="margin-top: 0.1pt; margin-bottom: 0.1pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company established a defined contribution plan, organized under Section 401(k) of the Internal Revenue Code, which allows
        employees to defer up to 90% of their pay on a pre-tax basis. As of December 31, 2022, the Company had not contributed a match to the
        employees&#8217; contribution. Beginning on January 1, 2023, the Company began matching employees&#8217; contributions at a rate of 100% of the
        first 3% of the employee&#8217;s contribution and 50% of the next 2% of the employee&#8217;s contribution, for a maximum Company match
        of 4%.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975870230432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Loss per Common Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Basic and Diluted Loss per Common Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Basic and Diluted Loss per Common Share</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">13)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">
                <div><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Basic and Diluted Loss per Common Share</span></div>
              </div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted
        net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding plus dilutive securities.&#160; Shares of common stock issuable upon exercise, conversion or vesting of stock options, RSUs, warrants and
        other convertible securities, including our outstanding Series A Convertible Preferred Stock, are considered potential common shares and are included in the calculation of diluted net loss per share using the treasury method when their effect is
        dilutive. Diluted net loss per share is the same as basic net loss per share for periods in which the effect of potentially dilutive shares of common stock is antidilutive. <span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;">The following table presents the amount of warrants,
        stock options, convertible preferred stock and RSUs that were excluded from the computation of diluted net loss per common share for the years ended December 31, 2022 and 2021, as their effect was anti-dilutive (in thousands):<br/>
      </span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;"> <span style="font-weight: bold;">Years ended December 31,<br/>
                  </span></div>
              </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
                </div>
              </td>

    <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">&#160;<span style="font-size: 10pt; font-weight: bold;">2021</span></div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: middle; text-indent: -9pt; margin-left: 9pt; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="margin-left: 9pt;"><span style="font-size: 10pt;">Warrants</span></div>
              </td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td rowspan="1" style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td rowspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right; font-size: 10pt; white-space: nowrap;" valign="bottom">4,713</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td rowspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"/>

    <td rowspan="1" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Stock options</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">359</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; white-space: nowrap;" valign="bottom">199</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Preferred stock converted into common stock</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">2</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: middle; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><span style="font-size: 10pt;">RSUs</span></td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom">4</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom">12</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Total potential common shares excluded from computation</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,083</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom">213</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

      </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975859453504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">14)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Stock-Based Compensation</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Equity Incentive Plans</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company&#8217;s stock-based compensation plans consist of the Restated 2020 Equity Incentive Plan (the &#8220;Restated 2020 Plan&#8221;) and
        the 2021 Inducement Equity Incentive Plan (the &#8220;2021 Inducement Plan&#8221;). The Company&#8217;s board of directors has designated its Compensation Committee as the administrator of the foregoing plans (the &#8220;Plan Administrator&#8221;). Among other things, the Plan
        Administrator selects persons to receive awards and determines the number of shares subject to each award and the terms, conditions, performance measures, if any, and other provisions of the award.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The
        Restated 2020 Plan provides for (a) approximately 424,000 shares of common stock that can be issued under the Restated 2020 Plan and (b)
        an annual increase in the number of shares reserved for issuance on January 1 of each year from 2022 through 2031 equal to the lesser of (i) 5%
        of the number of shares of common stock outstanding on the immediately preceding December 31 and (ii) such smaller number of shares of common stock as may be determine by the board of directors (the &#8220;Annual Evergreen Shares&#8221;). Based on the number
        of shares of common stock outstanding on December 31, 2022, the maximum increase to the number of Annual Evergreen Shares of common stock that can be issued under the Restated 2020 Plan in 2023 is approximately 256,000 shares. As of December 31, 2022, there have been no
        Annual Evergreen Shares added to the Restated 2020 Plan.<br/>
      </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Awards under the Restated 2020 Plan may be granted to officers, directors, employees and consultants of the Company.&#160; Stock
        options granted under the Restated 2020 Plan may either be incentive stock options or nonqualified stock options, may have a term of up to ten years,
        and are exercisable at a price per share not less than the fair market value on the date of grant.&#160; As of December 31, 2022, there was approximately 166,000
        shares of common stock remaining to be issued under the Restated 2020 Plan. As of December 31, 2021, there were approximately 258,000
        stock options outstanding under the Restated 2020 Plan. There were no RSUs outstanding under the Restated 2020 Plan as of December 31,
        2022.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The 2021 Inducement Plan provides for the grant of up to 75,000 share-based awards as material inducement awards to new employees in accordance with the employment inducement grant rules set forth in Section 711(a) of the NYSE American LLC Company
        Guide. The 2021 Inducement Plan expires in May 2031. As of December 31, 2022, there was approximately 57,000 shares of common stock
        remaining to be issued under the Restated 2020 Plan. As of December 31, 2021, there were approximately 12,000 stock options outstanding
        and approximately 4,000 RSUs outstanding under the Restated 2020 Plan.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Equity Awards</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Stock Options</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company records stock-based compensation in accordance with ASC Topic 718, Compensation &#8211; Stock Compensation.&#160; The Company
        estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-lined basis.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The risk-free rate is based on the observed interest rates appropriate for the expected life. The expected life (estimated
        period of time outstanding) of the stock options granted is estimated using the &#8220;<span style="font-style: normal;">simplified</span>&#8221; method as permitted by the SEC&#8217;s Staff Accounting Bulletin No. 110, <span style="font-style: italic;">Share-Based
          Payment</span>. Expected volatility is based on the volatility of the Company&#8217;s peer group over the expected life of the stock option granted, and the Company assumes no dividends. Forfeitures are recognized as incurred.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;">&#160;<span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following weighted-average assumptions were used for stock options granted during the years ended December 31, 2022 and 2021: </span></div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom"><span style="font-weight: bold;">Year ended</span> <span style="font-weight: bold;">December 31,</span></td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="text-align: center; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" valign="bottom">2021</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Weighted average risk-free rate</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2.52</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">1.09</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Weighted average volatility</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">90.49</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">134.64</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Dividend yield</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">0</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">0</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Expected term</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom">5.79 years </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom">6.10 years <br/>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following table summarizes stock option activity for the years ended December 31, 2022 and 2021 (in thousands except for
        per-share and remaining contractual life data):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-weight: bold;">Outstanding</span></div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Options</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">
                <div>Weighted </div>
                <div>Average </div>
                <div>Exercise</div>
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Price per</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Share</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Average</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Remaining </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Contractual </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Life (in</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">years)</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Aggregate</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Intrinsic</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Outstanding January 1, 2021</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">199</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">168.04</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Outstanding December 31, 2021</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">199</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">168.04</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">9.38</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">287</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">17.29</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled</div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">(127</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">140.56</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Outstanding December 31, 2022</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">359</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">57.18</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">7.57</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$ <br/>
            </td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Options vested and exercisable at December 31, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">146</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">109.60</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">4.79<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The per-share weighted average grant-date fair value of stock options granted during the year ended December 31, 2022 and 2021 was $12.91 and $151.40, respectively.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">Pursuant



















          to a separation agreement entered into in May 2022 with the Company&#8217;s former chief executive officer, Dr. Howard Federoff, the Company accelerated the vesting of approximately 40,000 stock options under certain time-based vesting stock option grants previously awarded to Dr. Federoff.&#160; The Company also waived a performance condition under a performance-based
          stock option grant and accelerated the vesting of approximately 21,000 stock options under such grant.&#160; Lastly, the Company extended
          the post-termination exercise period from 90 days to 36 months immediately following his separation date for any options that were vested, including the options that accelerating in vesting, as described above.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
          </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The above modifications to Dr. Federoff&#8217;s stock options grants resulted in modification accounting under ASC 718, <span style="font-style: italic;">Compensation



















              &#8211; Stock Compensation</span>. As a result, the Company immediately recognized approximately $0.1 million during 2022 for the
            incremental fair value of stock options that were vested prior to the modification by calculating the difference between the fair value of the modified award and the fair value of the original award immediately before it was modified.&#160; For
            stock options that were not vested prior to the modification but then vested as a result of the acceleration, the Company reversed any stock compensation expense previously recognized, remeasured the fair value of the modified award and
            immediately recognized approximately $0.1 million during 2022 of stock compensation expense in full since there was no future service
            period required to be provided.</span></div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">As of December 31, 2022, the unamortized stock-based compensation expense related to outstanding unvested options was
        approximately $3.2 million with a weighted average remaining requisite service period of 2.70 years. The Company expects to amortize this expense over the remaining requisite service period of these stock options.<br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Vesting of all stock options grants is subject to continuous service with the Company through such vesting dates.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
      </div>

<div><span style="text-decoration: underline;">Restricted Stock Units</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following table summarizes RSU activity for the years ended December 31, 2022 and 2021 (in thousands except for per-share data):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Outstanding</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Restricted</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Stock Units</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Average</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value per</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Share</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">January 1, 2021</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">12</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">276.00</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">December 31, 2021</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">12</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);"><br/>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">276.00</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
              <div style="margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">55</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">38.60</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="margin-left: 9pt;">Released<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(3</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">271.42</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">(60</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">61.03</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">December 31, 2022</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">4</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">236.36</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Balance expected to vest at December 31, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">4</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The














          Company recognizes the fair value of RSUs granted as expense on a straight-line basis over the requisite service period. For performance based RSUs, the Company begins recognizing the expense once the achievement of the related performance goal
          is determined to be probable.</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Outstanding



















          RSUs are settled in an equal number of shares of common stock on the vesting date of the award. An RSU award is settled only to the extent vested. Vesting generally requires the continued employment or service by the award recipient through the
          respective vesting date. Because RSUs are settled in an equal number of shares of common stock without any offsetting payment by the recipient, the measurement of cost is based on the quoted market price of the stock at the measurement date,
          which is the grant date.</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In lieu of paying cash to satisfy withholding taxes due upon the settlement of vested RSUs, at the Company&#8217;s discretion, an employee may elect to have shares of
            common stock withheld that would otherwise be issued at settlement, the value of which is equal to the amount of withholding taxes payable.&#160; There were no RSUs that vested during the year ended December 31, 2021.&#160; <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal;">The following table shows the number of RSUs that vested and were settled during the year ended December 31, 2022, as well as the number of shares of common
            stock withheld to cover the withholding taxes and the net shares issued upon settlement (in thousands):</span></span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 54pt; margin-right: 0.7pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 54pt; margin-right: 0.7pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: top; width: 86%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year ended</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px; width: 86%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022
                  </div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 86%; background-color: rgb(204, 238, 255);" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs vested</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; background-color: rgb(204, 238, 255);" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 86%; padding-bottom: 2px;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Common stock withheld to cover taxes</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 86%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Common stock issued</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
           </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Restricted Stock</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Pursuant to the Merger, Eterna LLC&#8217;s approximately 3,000 outstanding restricted common units were exchanged for approximately 32,000
        shares of Eterna&#8217;s restricted common stock. There were no changes to any conditions and requirements of the restricted common stock. The shares vested quarterly beginning on March 31, 2021 and were to continue through December 31, 2022, contingent
        on continued service. Due to the modification of the restricted common units, the fair value of the restricted common stock immediately after the Merger was compared to the fair value of the restricted common units immediately prior to the Merger,
        and the change in fair value of $0.3 million was recognized in the statement of operations during the year ended December 31, 2021. The
        Company recognizes the fair value of restricted common stock as an expense on a straight-line basis over the requisite service period. During the year ended December 31, 2022, approximately 4,000 shares of unvested restricted common stock were forfeited due to the holders of such shares no longer providing services to the Company. As of December 31, 2022 there
        were no shares of unvested restricted stock outstanding.<br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Stock-Based Compensation Expense</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">For the years ended December 31, 2022 and 2021, the Company recognized stock-based compensation expense as follows (in
        thousands): <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;">
        <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: top; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ended December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2022<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2021<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Research and development</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,249</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,597</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">General and administrative</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,686</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,638</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,935</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,235</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
         </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975870230432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Equity and Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity and Warrants</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">15)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Equity and Warrants</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-style: italic;">Private Placements of Equity</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;">Q4-22 PIPE Transaction<br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On November 23, 2022, the Company entered into the Q4-22 Purchase Agreement with
            the Q4-22 PIPE Investors for the Q4-22 PIPE Transaction, pursuant to which the Company issued to the Q4-22 PIPE Investors an aggregate of&#160; approximately 2,185,000 units, with each unit consisting of (i) one share of common
            stock and (ii) two Q4-22 Warrants, each exercisable to purchase one share of common stock at an exercise price of $3.28 per, at a purchase
            price of $3.53 per unit (inclusive of $0.125
            per Q4-22 Warrant). The Company received aggregate gross proceeds of approximately $7.7 million, and the Q4-22 PIPE Transaction
            closed on December 2, 2022. The Company incurred fees of approximately $0.3 million through December 31, 2022 related to the Q4-22
            PIPE Transaction.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each Q4-22 Warrant has an exercise
              price of $3.28 per share, becomes exercisable six months following the closing of the Q4-22 PIPE Transaction, expires <span style="-sec-ix-hidden:Fact_ead7f34b09d749a6b4ac3742e9967755">five-and-one-half</span>
              years from the date of issuance and is subject to customary adjustments. Certain of the Q4-22 Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 4.99% immediately after exercise thereof, subject to increase to 9.99% at the option of the holder.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 27pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;">The Q4-22 Warrants meet the criteria for equity
              classification.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;">Q1-22 Private Placement</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On March 6, 2022, the Company entered into the Q1-22 Purchase Agreement with the
            Q1-22 PIPE Investor for the Q1-22 PIPE Transaction, pursuant to which, the Company issued to the Q1-22 PIPE Investor approximately 343,000
            units, each unit consisting of (i) one share of the Company&#8217;s common stock (or, in lieu thereof, one Q1-22 Pre-Funded Warrant to
            purchase one share of common stock) and (ii) one warrant Q1-22&#160; Common Warrant to purchase one share of common stock, for an
            aggregate gross purchase price of approximately $12.0 million (the &#8220;Subscription Amount&#8221;). The Q1-22 PIPE Transaction closed on March
            9, 2022. Pursuant to the Q1-22 Purchase Agreement, the Company was prohibited from issuing equity in variable rate transactions for a period of one-year
            following consummation of the Q1-22 PIPE Transaction, including issuing equity under the Second Purchase Agreement, which is discussed below.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each Q1-22 Pre-Funded Warrant had an exercise price of $0.10 per share of common stock, was immediately exercisable, could be exercised at any time, had no expiration date and was subject to customary
              adjustments. The Q1-22 Pre-Funded Warrants could not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 9.99% immediately after exercise thereof.&#160; Upon the closing of the Q1-22 PIPE Transaction, the Company issued 275,000 shares of common stock, approximately 68,000 Q1-22 Pre-Funded
              Warrants and approximately 343,000 Q1-22 Common Warrants.</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
              </span> </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each Q1-22 Common Warrant has an exercise price of $38.20 per share, became exercisable six months
              following the closing of the Q1-22 PIPE Transaction, expires <span style="-sec-ix-hidden:Fact_d45bfc25257042c4abeb3af3c960c760">five-and-one-half</span> years from the date of issuance and is subject to
              customary adjustments. The Q1-22 Common Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 4.99% immediately after exercise thereof, subject to increase to 9.99%
              at the option of the holder.</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Q1-22 Common Warrants and Q1-22 Pre-Funded Warrants were accounted for as liabilities under ASC 815-40, as these warrants provide for a cashless settlement provision
            that does not meet the requirements of the indexation guidance under ASC 815-40.&#160; These warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of
            operations.&#160; (See Note 5 for more information related to changes in fair value.) Upon exercise of the Q1-22 Common Warrants and Q1-22 Pre-Funded Warrants, the fair value on the exercise date is reclassified from warrant liabilities to equity.</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The fair values of the Q1-22 Common Warrants and the
              Q1-22 Pre-Funded Warrants at the issuance date totaled $12.6 million in the aggregate, which was $0.6 million more than the Subscription Amount.&#160; The excess $0.6 million represents an inducement to the Q1-22 PIPE Investor to enter into the Q1-22 PIPE Transaction and was recorded in warrant liabilities expense in the accompanying
              consolidated statement of operations.<br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On July 12, 2022, the Q1-22 PIPE Investor exercised its 68,000 Q1-22 Pre-Funded Warrants at an exercise price of $0.10 per share
            for an aggregate exercise price of approximately $7,000, in cash. The Company issued 68,000 shares of common stock to the Q1-22 PIPE
            Investor on July 14, 2022 upon receipt of the cash proceeds and reclassified approximately $0.7 million of the fair value of the
            exercised warrants as of the exercise date from warrant liabilities to equity. Subsequent to the exercise, no Q1-22 Pre-Funded Warrants remained outstanding.</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Company incurred fees of approximately $1.0 million
            through December 31, 2022 related to the Q1-22 PIPE Transaction, which were allocated to the fair value of the Q1-22 Warrants and the Q1-22 Pre-Funded Warrants and recorded in other expense, net on the accompanying consolidated statement of
            operations.</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">In connection with the Q1-22 PIPE Transaction, the Company and the Q1-22 PIPE Investor also entered into a registration rights agreement, dated March
            6, 2022, pursuant to which the Company agreed to prepare and file a registration statement with the SEC no later than 15 days
            following the filing date of the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021 (the &#8220;2021 Annual Report&#8221;) to register the resale of the shares of common stock included in the Units and the shares of common stock
            issuable upon exercise of the Q1-22 Pre-Funded Warrants and the Q1-22 Common Warrants. The Company agreed to use its best efforts to have such registration statement declared effective as promptly as possible after the filing thereof, subject
            to certain specified penalties if timely effectiveness were not achieved.&#160; The Company filed the 2021 Annual Report on April 15, 2022 and the registration statement on April 29, 2022.&#160; The resale registration statement became effective on May
            11, 2022.</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">Pursuant to the registration rights agreement, the Company is obligated to pay the Q1-22 PIPE Investor liquidated damages equal to 2% of the Subscription Amount per month, with a maximum aggregate payment of 12% of the Subscription Amount, in the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered for resale thereunder
            for more than a specified period of time.</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">On May 24, 2022, the Company notified the Q1-22 PIPE Investor that it was not able to use the registration agreement because the Company had not
            timely filed its Quarterly Report on Form 10-Q (the &#8220;Q1 2022 10-Q&#8221;) with the SEC, and that the Q1-22 PIPE Investor could not use the registration statement to resell the securities registered thereunder until the Company filed the Q1 2022
            10-Q.&#160; Because of the Q1-22 PIPE&#160; Investor&#8217;s inability to use the registration statement, the Company accrued $0.2 million during
            2022 for the contingent loss the Company incurred as liquidated damages as a result of the late Q1 2022 10Q filing, which is recorded in other expense, net for the year ended December 31, 2022 in the accompanying consolidated statements of
            operations.&#160; The Company paid such $0.2 million liquidated damages payment in June 2022.</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">On June 30, 2022, the Company filed its Q1 2022 10-Q along
            with an amended Annual Report on Form 10-K/A for the year ended December 31, 2021, and on July 1, 2022, the Company provided its notice to the Q1-22 PIPE Investor that it could resume use of the resale registration statement.</div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">The following table shows the Company&#8217;s warrant
            activity for the year ended December 31, 2022 (in thousands except for per-share data):</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 2022</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Pre-Funded</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">November 2022</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Balance as of January 1, 2022</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Granted</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">343</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">68</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,370</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,781</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Exercised</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(68</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(68</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Balance as of December 31, 2022</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">343</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,370</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,713</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As of December 31, 2022, the weighted average remaining
              contractual life of the warrants outstanding was 5.37 years and the weighted average exercise price was $5.82.</div>

<div><br/>
            </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Equity Line Offerings</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">On April 26, 2021, the Company entered into a common stock purchase agreement (the &#8220;First Purchase
            Agreement&#8221;) an investment group (the &#8220;Investment Group&#8221;), which provided that the Company could offer to the Investment Group up to an aggregate o</span>f $20 million of common stock over a 36-month period commencing after May 10, 2021, the date that a registration statement covering the resale of shares of common stock issued under the First
          Purchase Agreement was declared effective by the SEC. As of December 31, 2022, the Company had issued and sold an aggregate of approximately 56,000
          shares of common stock to the Investment Group pursuant to the First Purchase Agreement, resulting in gross proceeds of $20 million.</span></div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">On May 26, 2021, the Company entered into a second common stock purchase agreement (the &#8220;Second
          Purchase Agreement&#8221;) with the Investment Group, which provides that the Company may offer to the Investment Group up to an aggregate of $40
          million of common stock over a 36-month period commencing after June 4, 2021, the date that a registration statement covering the resale of shares of common stock issued under the Second Purchase Agreement was declared effective by the SEC. As of
          December 31, 2022, the Company had issued and sold an aggregate of approximately 121,000 shares of common stock to the Investment
          Group pursuant to the Second Purchase Agreement, resulting in gross proceeds of approximately $34 million. As of December 31, 2022,
          there were approximately 22,000 shares remaining to be sold under the Second Purchase Agreement.</span> </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Under the Second Purchase Agreement, the Company may direct the Investment Group to purchase up to 3,000 shares of common stock on any business day (the &#8220;Regular Purchase&#8221;), which amount may be increased up to 6,000 shares based on the closing price of the common stock, provided that&#160; the Investment Group&#8217;s maximum commitment in any single Regular Purchase
          may not exceed $2.0 million. The purchase price per share for each such Regular Purchase is based off of the common stock&#8217;s market
          immediately preceding the time of sale.<br/>
        </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Second Purchase Agreement also prohibits the Company from directing the Investment Group to purchase any shares of common
          stock if those shares, when aggregated with all other shares of common stock then beneficially owned by the Investment Group and its affiliates, would result in the Investment Group and its affiliates having beneficial ownership, at any single
          point in time, of more than 4.99% of the then total outstanding shares of common stock. The Company has the right to terminate the
          Second Purchase Agreement at any time, at no cost or penalty.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Actual sales of shares of common stock to the Investment Group under the Second Purchase Agreement depend on a variety of
          factors to be determined by us from time to time, including, among others, market conditions, the trading price of the common stock and determinations by the Company as to the appropriate sources of funding for the Company and its operations.<br/>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Pursuant to the Q1-22 Purchase Agreement in respect of the Q1-22 PIPE Transaction, the Company was prohibited from issuing additional shares under the Second Purchase Agreement for a period of one-year
            immediately following the closing of the Q1-22 PIPE Transaction.</span> </div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
        </div>

<div style="font-style: italic;">Merger </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Under the terms of the Merger Agreement (see Notes 1 and 4), on March 25, 2021, the Company issued shares of common stock to
          the equity holders of Eterna LLC. The 87,000 Class A units of Eterna LLC were converted into approximately 1,114,000 shares of common stock; the 15,000,000
          Class B units were converted into approximately 126,000 shares of common stock; the 10,000,000 Class C units were converted into approximately 84,000
          shares of common stock; approximately 630,000 shares of common units were converted into approximately 31,000 shares of common stock, and 10,500,000
          rights options were converted into approximately 591,000 shares of common stock.&#160; The Company also issued approximately 53,000 shares of common stock to the Financial Advisor pursuant to the Merger Agreement.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Acquisition</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Under the terms of the Novellus Acquisition (see Notes 1 and 4), on July 16, 2021, the Company issued approximately 351,000 shares of common stock, of which approximately 182,000
          shares are unrestricted and approximately 169,000 shares are subject to a three-year lockup agreement, provided that up to 75% of the shares of common
          stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock on the principal market for the common stock exceeds specified thresholds.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> Cumulative Convertible Preferred Stock </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">As a result of the Merger, the Company has authorized 156,000 shares of preferred stock, all of which is designated as Series A Cumulative Convertible Preferred Stock (the &#8220;Series A Preferred Stock&#8221;), and all of which were issued and
        outstanding as of December 31, 2022.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Series A Preferred Stock provides for a cumulative annual dividend of $0.10 per share, payable in semi-annual installments in June and December. Dividends may be paid in cash or with shares of common stock.<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company paid approximately $16,000 in cash for payment of dividends during the year ended December 31, 2022</span>.</span> The Company paid approximately $8,000 in cash and issued approximately 10 shares of common stock for payment of dividends during the
        year ended December 31, 2021.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Series A Preferred Stock has no voting rights and has a $1.00 per share liquidation preference over common stock. The registered holder has the right at any time to convert shares of Series A Preferred Stock into that number of shares of common
        stock that equals the number of shares of Series A Preferred Stock that are surrendered for conversion divided by the conversion rate.&#160; At December 31, 2022, the conversion rate was 23.9988 and, based on that conversion rate, one share of Series A Convertible Preferred Stock would have converted into approximately 0.04 shares of common stock, and all the outstanding shares of the Series A Convertible Preferred Stock would have converted into approximately 6,000 shares of common stock in the aggregate. There were no
        conversions during the years ended December 31, 2022 and 2021. There is no mandatory conversion term, date or any redemption features associated with the Series A Preferred Stock. The conversion rate will adjust under the following circumstances:</div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">1.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">If the Company (a) pays a dividend or makes a distribution in shares of its common stock, (b) subdivides its outstanding shares of common stock into a greater number of shares, (c) combines its outstanding
                shares of common stock into a smaller number of shares, or (d) issues by reclassification of its shares of common stock any shares of its common stock (other than a change in par value, or from par value to no par value, or from no par
                value to par value), then the conversion rate in effect immediately prior to the applicable event will be adjusted so that the holders of the Series A Convertible Preferred Stock will be entitled to receive the number of shares of common
                stock which they would have owned or have been entitled to receive immediately following the happening of the event, had the Series A Convertible Preferred Stock been converted immediately prior to the record or effective date of the
                applicable event.</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">2.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">If the outstanding shares of the Company&#8217;s common stock are reclassified (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result of a
                subdivision, combination or stock dividend), or if the Company consolidates with or merge into another corporation and the Company is not the surviving entity, or if the Company sells all or substantially all of its property, assets,
                business and goodwill, then the holders of the Series A Convertible Preferred Stock will thereafter be entitled upon conversion to the kind and amount of shares of stock or other equity securities, or other property or assets which would
                have been receivable by such holders upon such reclassification, consolidation, merger or sale, if the Series A Convertible Preferred Stock had been converted immediately prior thereto.</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">3.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">If the Company issues common stock without consideration or for a consideration per share less than the then applicable Equivalent Preference Amount (as defined below), then the Equivalent Preference Amount
                will immediately be reduced to the amount determined by dividing (A) an amount equal to the sum of (1) the number of shares of common stock outstanding immediately prior to such issuance multiplied by the Equivalent Preference Amount in
                effect immediately prior to such issuance and (2) the consideration, if any, received by the Company upon such issuance, by (B) the total number of shares of common stock outstanding immediately after such issuance. The &#8220;Equivalent
                Preference Amount&#8221; is the value that results when the liquidation preference of one share of Series A Convertible Preferred Stock (which is $1.00)
                is multiplied by the conversion rate in effect at that time; thus the conversion rate applicable after the adjustment in the Equivalent Preference Amount as described herein will be the figure that results when the adjusted Equivalent
                Preference Amount is divided by the liquidation preference of one share of Series A Convertible Preferred Stock.</div>
            </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975859443232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 35.9pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">16)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Income Taxes</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Loss before income taxes consist of the following (in thousands):</div>

<div><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="7" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ended December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="3" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2022</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="3" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top;" valign="bottom"><span style="font-weight: bold;">&#160;<span style="font-style: italic;">(in thousands)</span></span><br/>
              </td>

    <td colspan="3" rowspan="1" style="vertical-align: bottom; text-align: center; text-indent: 9pt; font-weight: bold; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="1" rowspan="1" style="text-indent: 9pt; font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="3" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Domestic</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(24,513</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(122,476</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Foreign</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(21</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(5</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total loss before income taxes</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(24,534</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(122,481</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">For each of the years ended December 31, 2022 and 2021, current tax provisions and current deferred tax provisions were
        recorded as follows (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Years ended December 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Current Tax Provision</div>
            </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Federal<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">State<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">4</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">5</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="margin-left: 9pt;">Foreign <br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">4</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">5</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Deferred Tax Provision<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Federal<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(6,851</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(5,840</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">State<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(1,602</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(1,414</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="margin-left: 9pt;">Foreign <br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">(187</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(1</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(8,640</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(7,255</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Change in valuation allowance</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">8,681</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">7,314</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total tax provision for income taxes</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">45</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">64</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Deferred tax assets and liabilities
        consist of the effects of temporary differences as shown in the table below (in thousands). Deferred tax assets have been fully reserved by a valuation allowance since it is more likely than not that such tax benefits will not be realized.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred Tax Assets:</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Net operating losses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9,382</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,457</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Foreign net operating losses<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">782</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">595</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;&#160;&#160; Stock compensation</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2,173</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">1,312</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">&#160; &#160; In-process research and development</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">1,233</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;&#160;&#160; Capitalized rearch and development expenses</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">1,502</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">R&amp;D credit carryforwards</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">517</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">288</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Compensation accrual</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">81</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">30</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; text-indent: 9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" valign="bottom">ROU Liabilities<br/>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">334</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">706</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;&#160;&#160; Other<br/>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">549</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total gross deferred tax assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,553</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">8,388</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Valuation allowance</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(16,157</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(7,467</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">396</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">921</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred Tax Liabilities:</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Fixed assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(168</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="margin-left: 9pt;">ROU Assets<br/>
                </div>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(291</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(666</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Intangibles - goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(160</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(112</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total deferred tax liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(461</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(946</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred taxes</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(65</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(25</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>
         </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">The






          reconciliation of computed expected income taxes to effective income taxes by applying the federal statutory rate of 21% is as
          follows:</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 27pt;">&#160;<br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 18pt;">
          <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31,</div>
                </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> 2022</td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> 2021</td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tax at federal income tax rate</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br/>
                  </div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.00</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-indent: 9pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><br/>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">21.00</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State income tax, net of federal tax</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6.52</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">1.15</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;Foreign tax differential</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">(0.01</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%)</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">0.00</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">% <br/>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-deductible expenses/excludable items</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6.09</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(16.30</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in valuation allowance</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">(35.38</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">(5.97</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Credits</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0.98</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">0.23</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">Uncertain tax positions<br/>
                </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">(0.49</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">0.00</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1.11</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">(0.16</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">%)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Provision for income taxes</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(0.18</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%)</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">(0.05</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%)</td>

  </tr>


</table>
          </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 18pt;"> &#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The net increase in the total valuation allowance for the year ended December 31, 2022 was an increase of approximately $8.8
              million. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets
              is dependent upon the generation of future taxable income during periods in which those temporary difference become deductible. Management considered the scheduled reversal of deferred tax liabilities, projected future taxable income and
              planning strategies in making this assessment.&#160; Based on the level of historical operating results and projections for the taxable income for the future, management has determined that it is more likely than not that the deferred taxes assets
              will not be utilized. Accordingly, the Company has recorded a full valuation allowance. The net deferred tax liability represents an indefinite life intangible liability related to tax deductible goodwill, partially offset by an indefinite
              life deferred tax asset.</span> </div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">At December 31, 2022 and 2021, the Company has available net operating loss (&#8220;NOL&#8221;) carryforwards of approximately $35.6 million and $20.7 million for
          federal income tax purposes, respectively, of which approximately $35.6 million can be carried forward indefinitely. The Company has
          available $28.8 million and $20.7
          million state NOLs for the years ended December 31, 2022 and 2021, respectively, which begin to expire in 2041. The Company also has
          foreign NOL carryforwards of approximately $6.3 million and $4.8 million for the years ended December 31, 2022 and 2021, respectively, which carry forward indefinitely. Section 382 of the Internal Revenue Code (&#8220;IRC&#8221;) imposes limits on
          the ability to use NOL carryforwards that existed prior to a change in control to offset future taxable income. Such limitations would reduce, potentially significantly, the gross deferred tax assets disclosed in the table above related to the
          NOL carryforwards.&#160; The Company continues to disclose the NOL carryforwards at their original amount in the table above as no potential limitation has been quantified. The Company has also established a full valuation allowance for all deferred
          tax assets, including the NOL carryforwards, since the Company could not conclude that it was more likely than not able to generate future taxable income to realize these assets.&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">At December 31, 2022 and 2021 the Company has federal and state income tax credit carryforwards of approximately $0.5 million and $0.3 million,
          respectively. The credits begin to expire in 2041.</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">In accordance with authoritative guidance, the impact of an uncertain income tax position on the income tax return must be
          recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The following table summarizes amounts the
          Company recorded for uncertain tax positions as of December 31, 2022 and 2021 (in thousands):</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">
          <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; font-weight: bold;"> 2022<br/>
                  </div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; font-weight: bold;">2021<br/>
                  </div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Beginning balance of uncertain tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Additions based on current year&#8217;s tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">45</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Net changes based on prior year&#8217;s tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">76</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Ending balance of uncertain tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">121</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
           </div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">It
          is reasonably possible that unrecognized tax benefits may increase or decrease within the next twelve months due to tax examination changes, expiration of statute of limitations, or changes in tax law.&#160; The Company does not anticipate any
          significant changes to unrecognized tax benefits over the next 12 months. </div>

<div> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The Company recognizes interest and penalties related to unrecognized tax positions within the income tax expense line in the
          accompanying consolidated statements of operations. There were no accrued interest and penalties associated with uncertain tax
          positions as of December 31, 2022 or December 31, 2021.</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The Company is subject to U.S. federal, state, and foreign income tax. The Company&#8217;s income tax returns are subject to
          examination by the relevant taxing authorities. As of December 31, 2022, the <span style="-sec-ix-hidden:Fact_f5787a4f89d441eb816e0f3918c8cfa1">2019 &#8211; 2022</span> tax years remain subject to examination in
          the U.S. federal tax, various state, and foreign tax jurisdictions. The Company is not currently under examination by federal state, or foreign jurisdictions.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;) was enacted into law. Among other changes to the tax code, the IRA imposes a 1% excise tax on
            certain repurchases of corporate stock by certain publicly traded corporations. The 1% stock buyback tax applies to redemptions by domestic corporations occurring in taxable years beginning after December 31, 2022.&#160; A number of exceptions to
            the stock buyback tax are available including exceptions to certain reorganizations. However, while these exceptions may be helpful in limiting the application of the stock buyback tax in situations in which it was not intended to apply, more
            guidance will be necessary for taxpayers to analyze the potential application of these exceptions and whether they will be able to rely upon them.<br/>
          </span></div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975870132480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Event [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 35.9pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">17)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Subsequent Event</div>
            </td>

  </tr>


</table>

<div>&#160;
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Cell Customization and License Agreement</span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">O<span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">n February 21, 2023, the Company and Lineage Cell Therapeutics, Inc. (&#8220;Lineage&#8221;) entered into an exclusive option and license agreement (the &#8220;Lineage Agreement&#8221;), pursuant to which, Lineage
            may request prior to August 22, 2023 that the Company develops for, and delivers to, Lineage certain induced pluripotent stem cell lines, which Lineage would use to evaluate the possible development of cell transplant therapies for treatment of
            diseases of the central nervous system in humans, excluding ophthalmologic indications, (b) diseases and conditions of the peripheral nervous system, (c) psychiatric, respiratory, musculoskeletal, and hematological diseases, disorders, and
            conditions, and (d) cancer.&#160; The Lineage Agreement also provides Lineage with the option to obtain an exclusive sublicense to certain related technology for preclinical, clinical and commercial purposes, which would permit Lineage to sublicense
            such intellectual property, subject to payment of certain sublicense royalty fees.&#160; Lineage has six months from our delivery to Lineage of such induced pluripotent stem cell lines to exercise such option, and upon any such exercise, Lineage
            would agree to use its commercially reasonable efforts to exploit and make commercially available one or more licensed products derived from such induced pluripotent stem cell lines in accordance with the Lineage Agreement. Upon entry into the
            Lineage Agreement, Lineage paid the Company a $250,000 non-refundable up-front payment.&#160; We are also entitled to certain cell line
            customization fees with respect to cell lines that Lineage may request that we develop for Lineage, and royalty payments with respect to any such licensed products, certain sublicense fees and certain milestone payments under the Lineage
            Agreements</span>.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975866268880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting Presentation</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Basis of Accounting Presentation</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles
        (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;). All
        significant intercompany balances and transactions have been eliminated in consolidation.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">As described above, the Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which
          Eterna LLC was deemed the acquiring company for accounting purposes. Eterna LLC&#8217;s historical financial statements replaced Eterna&#8217;s historical financial statements with respect to periods prior to the completion of the Merger (when Eterna
          operated under the name &#8220;NTN Buzztime, Inc.&#8221;). The Company retrospectively adjusted the weighted average shares used in determining loss per common share to reflect the conversion of the outstanding Class A units, Class B units, Class C units,
          and common units of Eterna LLC that converted into shares of Eterna&#8217;s common stock upon consummation of&#160; the Merger and to reflect the effect of a <span style="-sec-ix-hidden:Fact_abe396817a904d8ea2336e844b48953a">2-to-1</span>
          reverse stock split of Eterna&#8217;s common stock that occurred immediately prior to the Merger.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Also as described above, the Novellus Acquisition closed on July 16, 2021. The Novellus Acquisition was accounted for as an
          asset acquisition, and substantially all of the value was attributed to in-process research and development (&#8220;IPR&amp;D&#8221;), with the exception of the cash paid for the investment in NoveCite, which has been accounted for as an investment in equity
          securities. The IPR&amp;D had no alternative future uses and no separate economic value from its originally intended purpose and was therefore expensed at the acquisition date.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ReverseStockSplitPolicyTextBlock', window );">October 2022 Reverse Stock Split</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none;">October 2022 Reverse Stock Split</div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As approved by the Company&#8217;s stockholders at the Company&#8217;s Annual Meeting of Stockholders held on September 21,
            2022, the Company effected a reverse stock split of its common stock at a ratio of <span style="-sec-ix-hidden:Fact_9ec8b708b2c6467a940f0725195187c5">1-for-20</span>, as determined by the Company&#8217;s Board of
            Directors within the parameters approved by the Company&#8217;s stockholders (the &#8220;October 2022 Reverse Stock Split&#8221;).&#160; The October 2022 Reverse Stock Split became effective under Delaware law at 11:59 p.m. Eastern time on October 16, 2022.</span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 27pt;"><br/>
        </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-variant: normal; text-transform: none;"> <span style="font-size: 10pt;"> </span> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"> Upon the effectiveness of the October
          2022 Reverse Stock Split, every twenty shares of the issued and outstanding common stock were automatically combined and reclassified into one issued and outstanding share of common stock. The October 2022 Reverse Stock Split did not affect any
          stockholder&#8217;s ownership percentage of the common stock, alter the par value of the common stock or modify any voting rights or other terms of the common stock. The number of authorized shares of common stock under the Charter remains unchanged.
          No fractional shares were issued in connection with the October Reverse Stock Split. In lieu of any fractional shares to which a stockholder would otherwise be entitled, the Company paid an amount of cash equal to the product of (i) the
          fractional share to which the holder would otherwise be entitled and (ii) the then fair value of a share as determined in good faith by the Board.&#160; The Company paid an aggregate of $719 for a total of 175 fractional shares.<br/>
        </div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Use of Estimates</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and
        assumptions that affect: (a) the reported amounts of assets and liabilities; (b) disclosure of contingent assets and liabilities at the date of the consolidated financial statements; (c) the reported amounts of expenses during the reporting period;
        and (d) the reported amount of the fair value of assets acquired in connection with business combinations. On an ongoing basis, the Company evaluates its estimates, including those related to the recoverability and useful lives of long-lived
        assets; stock-based compensation assumptions; valuation assumptions of warrants; contingencies; and the provision for income taxes, including the valuation allowance. The Company bases its estimates on a combination of historical experience and
        various other assumptions that it believes are reasonable under the circumstances. Actual results may differ materially from these estimates.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Cash, Cash Equivalents and Restricted Cash</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company classifies highly liquid investments with a remaining contractual maturity at date of purchase of three months or
        less as cash equivalents. The Company had no cash equivalents as of December 31, 2022 or 2021.</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> Restricted cash consists of a cash collateralization of $4.1 million for a security deposit in the form of a letter of credit issued by the Company&#8217;s commercial bank and delivered to the sublessor of the Sublease. The amount of
        required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of credit over the term of the Sublease.<br/>
      </div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Property and Equipment</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Property and equipment are recorded at cost and are depreciated over their estimated useful lives using the straight-line
        method. Laboratory and manufacturing equipment are depreciated over an estimated useful life of seven years. Leasehold improvements are
        depreciated over the shorter of their estimated useful life, or the lease term. Computer equipment are depreciated over an estimated useful life of three years. Upon retirement or other disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the resulting gain or losses are reflected in the results of
        operations. Expenditures for maintenance and repairs are charged to operations. Renewals and betterments are capitalized.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Goodwill</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in the acquisition
        of IRX Therapeutics, Inc. (&#8220;IRX&#8221;) in November 2018 (the &#8220;IRX Acquisition&#8221;), which was accounted for as a business combination. Goodwill is not amortized but is tested for impairment annually or if events occur or circumstances change that would
        reduce the fair value of a reporting unit below its carrying value. Because management evaluates the Company as a single reporting unit, goodwill is tested for impairment at the entity level by first performing a qualitative assessment to determine
        whether it is more likely than not that the fair value of the entity is less than its carrying value. Such qualitative factors include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and
        other relevant events.&#160; If the entity does not pass the qualitative assessment, then the entity&#8217;s carrying value is compared to its fair value. Goodwill is considered impaired if the carrying value of the entity exceeds its fair value.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InProcessResearchAndDevelopmentPolicy', window );">IPR&amp;D</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">IPR&amp;D</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">IPR&amp;D assets represent the fair value assigned to technologies that were acquired in connection with the IRX Acquisition,
        which have not reached technological feasibility and have no alternative future use. IPR&amp;D assets are considered to be indefinite lived until the completion or abandonment of the associated research and development projects. During the period
        that the IPR&amp;D assets are considered indefinite-lived, they are tested for impairment on an annual basis or more frequently if the Company becomes aware of any events occurring or changes in circumstances that indicate that the fair value of
        the IPR&amp;D assets are less than their carrying amounts. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize products associated with the IPR&amp;D assets, these assets
        are then deemed definite-lived and are amortized based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a full or partial impairment charge related to the IPR&amp;D
        assets, calculated as the excess of carrying value of the IPR&amp;D assets over fair value.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Research and Development</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company expenses its research and development costs as incurred. Research and development expenses consist of costs
        incurred for company-sponsored research and development activities, as well as support for selected investigator-sponsored research. Upfront payments and milestone payments made for the licensing of technology are expensed as research and
        development in the period in which they are incurred if the technology is not expected to have any alternative future uses other than the specific research and development project for which it was intended. IPR&amp;D that is acquired through an
        asset acquisition (as opposed to a business combination) and has no alternative future uses and, therefore, no separate economic values, is expensed to research and development costs at the time the costs are incurred.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The major components of research and development costs include preclinical study costs, clinical manufacturing costs, clinical
        study and trial expenses, insurance coverage for clinical trials, expensed licensed technology, expensed IPR&amp;D, consulting, scientific advisors and other third-party costs, salaries and employee benefits, stock-based compensation expense,
        supplies and materials and allocations of various overhead costs related to our product development efforts.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has contracted with third parties to perform various clinical study and trial activities in the development and
        testing of potential products. The financial terms of these agreements vary from contract to contract and may result in uneven payment flows. The Company accrues for third party expenses based on estimates of the services received and efforts
        expended during the reporting period. If the actual timing of the performance of the services or the level of effort varies from the estimate, the accrual is adjusted accordingly. The expenses for some third-party services may be recognized on a
        straight-line basis if the expected costs are expected to be incurred ratably during the period. Payments under the contracts depend on factors such as the achievement of certain events or milestones, the successful enrollment of patients, the
        allocation of responsibilities among the parties to the agreement, and the completion of portions of the clinical study or trial or similar conditions. Preclinical and clinical study and trial associated activities such as production and testing of
        clinical material require significant up-front expenditures.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Income Taxes</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company records deferred tax liabilities and assets based on the differences between the consolidated financial statements
        carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and establishing a valuation allowance when it was more likely than not that some portion or all of
        the deferred tax assets would not be realized. Income tax expense consists of the tax payable for the period and the change during the period in deferred tax assets and liabilities.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Tax benefits from uncertain tax positions are recognized only if it is more likely than not that the tax position will be
        sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a
        greater than 50% likelihood of being realized upon ultimate resolution. The Company has no material uncertain tax positions for any of the reporting periods presented.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Share</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Loss Per Share</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Basic and diluted loss per common share have been computed by dividing the losses attributable to common stockholders by the
        weighted average number of common shares outstanding. The Company&#8217;s basic and fully diluted loss per share calculations are the same because the increased number of shares that would be included in the diluted calculation from assumed exercise of
        common stock equivalents would be anti-dilutive to the net loss in each of the years shown in the consolidated financial statements.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Segment Reporting</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company&#8217;s chief operating decision maker, who is the chief executive officer, reviews operating results on a consolidated
        basis to make decisions about allocating resources and assessing performance of the Company.&#160; As a result, in accordance with ASC No. 280, <span style="font-style: italic;">Segment Reporting,</span> the Company has determined that it operates as one operating segment.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Concentration of Credit Risk</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company maintains its cash balances in financial institutions located in the United States. Accounts at each institution
        are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $250,000. The Company&#8217;s cash balances are uninsured for deposit accounts that exceed the FDIC insurance limit.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In the Company&#8217;s business, vendor concentrations could be indicative of vulnerabilities in the Company&#8217;s supply chain, which
        could ultimately impact the Company&#8217;s ability to continue its research and development activities. For the years ended December 31, 2022 and 2021, there was no vendor concentration related to the Company&#8217;s research and development activities.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Fair Value of Financial Instruments</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly
        transaction between willing market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to
        unobservable inputs. The fair value hierarchy is as follows:</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 1 Inputs &#8211; Valued based on quoted prices in active markets
          for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 2 Inputs &#8211; Valued based on inputs other than quoted prices
          included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities
          in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or
          corroborated by market data by correlation or other means.</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 3 Inputs &#8211; Valued based on inputs for which there is
          little or no market value, which require the reporting entity to develop its own assumptions.</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The carrying amounts reported on the balance sheet for cash and cash equivalents, accounts receivable, prepaid assets and other
        current assets, accounts payable and accrued expenses, other current liabilities and other liabilities approximate fair value based due to their short maturities.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Leases</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The Company accounts for its leases under
        ASC Topic 842, <span style="font-style: italic;">Leases.</span> Operating lease liabilities represent the present value of lease payments not yet paid. Right-of-use (&#8220;ROU&#8221;) assets represent the Company&#8217;s right to use an underlying asset and are
        based upon the operating lease liabilities adjusted for prepaid or accrued lease payments, initial direct costs, lease incentives and impairment of operating lease assets. If the interest rate implicit in the lease is not readily determinable, the
        Company uses the incremental borrowing rates for collateralized borrowings in an amount equal to the lease payments under similar terms.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The Company has elected the practical
        expedient to not separate non-lease components from the lease components to which they relate and instead account for each as a single lease component for all underlying asset classes. Some leasing arrangements require variable payments that are
        dependent on usage or may vary for other reasons, such as payments for insurance, tax payments and other miscellaneous costs. The variable portion of payments contemplated in the lease that do not depend on an index or rate are not included in the
        ROU assets or lease liabilities. Rather, variable payments that do not depend on an index or rate are expensed when the obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease
        contract are accounted for as lease expenses.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has also elected not to recognize ROU and lease liabilities for short-term leases that have a term of 12 months
          or less.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitment and Contingencies</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Commitment and Contingencies</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company follows ASC No.450-20, <span style="font-style: italic;">Loss Contingencies,</span> to report accounting for
        contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be
        reasonably estimated.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Stock-Based Compensation</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company recognizes stock-based compensation expense for equity awards granted to employees, directors and certain
        consultants. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-lined basis.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives', window );">Warrants</a></td>
<td class="text">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Warrants</span><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an
        assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480, <span style="font-style: italic;">Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging.</span> The assessment considers
        whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or meet all of the requirements for equity classification under ASC 815, including whether the warrants are
        indexed to the Company&#8217;s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification. This assessment, which
        requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.<span style="text-decoration: underline;"><br/>
        </span></div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Recent Accounting Standards</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="text-decoration: underline;"> </span><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;">Newly Adopted Accounting
        Standards:</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In July 2021, the FASB issued Accounting
        Standards Update (&#8220;ASU&#8221;) 2021-05, <span style="font-style: italic;">Leases (Topic 842) &#8211; Lessors - Certain Leases with Variable Lease Payments,</span> which amends the lessor classification guidance to introduce additional criteria when
        classifying leases with variable lease payments that do not depend on a reference index or a rate. The Company adopted this ASU effective January 1, 2022, which did not have a material impact on its financial statements.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In May 2021, the FASB issued ASU 2021-04<span style="font-style: italic;">, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40):
          Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options</span>. ASU 2021-04 addresses the accounting for certain modifications or exchanges of freestanding equity-classified written call
        options. The Company adopted this ASU effective January 1, 2022, which did not have a material impact on the Company&#8217;s financial statements.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In November 2021, the FASB issued ASU
        2021-10, <span style="font-style: italic;">Disclosures by Business Entities about Government Assistance, </span> which requires a business entity to disclose information about certain government assistance that it has received, including (i) the
        type of assistance, (ii) an entity&#8217;s accounting for the assistance and (iii) the effect of the assistance on the entities accounting statements.&#160; The Company adopted this standard effective January 1, 2022, which did not have a material impact on
        the Company&#8217;s financial statements. The Company has approximately $0.6 million in payroll tax refunds recorded in other receivable on
        the accompanying consolidated balance sheets as of December 31, 2022 and 2021 pursuant to the Employee Retention Credit program under the CARES Act.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;">Accounting Standards to
        be Adopted:</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">In June 2022, the FASB issued ASU No.
        2022-03, <span style="font-style: italic;">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions </span>(&#8220;ASU 2022-03&#8221;). The FASB issued ASU 2022-03 to (1) clarify the guidance in
        Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new
        disclosure requirements for equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is
        not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years
        with early adoption permitted. The Company is evaluating when to adopt the amendments in ASU 2022-02. The Company does not expect a material impact as a result of adopting this ASU.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ReverseStockSplitPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the reverse stock split during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ReverseStockSplitPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for derivatives that either were not designated as hedging instruments or do not qualify for hedge accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InProcessResearchAndDevelopmentPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InProcessResearchAndDevelopmentPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975867310544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger, Disposition and Acquisition Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Merger, Disposition and Acquisition Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Tangible and Intangible Assets Acquired And Liabilities Assumed, Based on Estimated Fair Values</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The allocation of the purchase price to
        the tangible and intangible assets acquired and liabilities deemed to be assumed from Eterna, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):</div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Historical Balance<br/>
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Sheet of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Eterna at</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 25, 2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair Value</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Adjustment to<br/>
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Eterna</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Pre-Merger</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Assets</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Purchase</div>
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Price</div>
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Allocation<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Cash and cash equivalents</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">148</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">148</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Accounts receivable</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">103</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">103</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Prepaid expense and other current assets</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">329</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">329</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Property and equipment, net</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,015</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,015</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Software development costs</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,296</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(368</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">928</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Customers</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">548</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">548</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Trade name</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">299</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">299</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Accounts payable, accrued liabilities and other current liabilities</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(3,781</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(3,781</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Net assets acquired, excluding goodwill</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(890</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">479</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(411</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total consideration</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">8,178</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Net assets acquired, excluding goodwill</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(411</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Goodwill</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">8,589</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposition Details</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On March 26, 2021, Eterna sold its rights, title and interest in and to the assets relating to the business it operated (under
        the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $2.0 million and assumption of
        specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of the Disposition are as follows <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">(in thousands)</span>:</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Proceeds from sale:</div>
            </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Cash</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">132</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Escrow</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">50</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Assume advance/loans</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,700</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Interest on advance/loans</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">68</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Carrying value of assets sold:</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Cash and cash equivalents</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(14</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Accounts receivable</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(75</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Prepaids and other current assets</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(124</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Property and equipment, net</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(1,014</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Software development costs</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(927</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Customers</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(548</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Trade name</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(299</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Goodwill</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(8,589</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Other assets</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(103</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Liabilities transferred upon sale:</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Accounts payable and accrued expenses</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">113</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Obligations under finance leases</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">17</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Lease liability</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">26</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Deferred revenue</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">55</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Other current liabilities</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">149</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Transaction costs</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(265</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Total loss on sale of assets</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">(9,648</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">)</div>
            </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionTableTextBlock', window );">Fair Value of Asset Acquired</a></td>
<td class="text"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The resulting fair value of the asset acquired is as follows (in thousands):</span></span>
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair Value of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Consideration</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Cash paid</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">22,882</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Cash acquired</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(28</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 83.46%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Unrestricted shares</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">36,628</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 83.46%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Restricted shares</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">22,056</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 83.46%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total fair value of consideration paid</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">81,538</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 83.46%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Less amount of cash paid for NoveCite investment</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(1,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 83.46%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Fair value of IPR&amp;D acquired</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">80,538<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6911878&amp;loc=d3e8732-128492<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975873047536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Liabilities Measured at Fair Value</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">There were no liabilities measured
        at fair value as of December 31, 2021. The following tables summarize the liabilities that are measured at fair value as of December 31, 2022 (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31, 2022</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 1</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 2</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 3</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Liabilities:</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Q1-22 Common Warrants</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">331</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">331</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Changes in Warrant Liabilities</a></td>
<td class="text">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
      </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"> <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);">The Company remeasured the fair value of the Q1-22 Common Warrants as of
                December 31, 2022. The following table presents the changes in the warrant liabilities from the issuance date (in thousands):</span></span></span></div>

<div><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);"> <br/>
              </span></span></span></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Q1-22</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pre-Funded </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Warrants</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Level 2)</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Q1-22 </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Warrants</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Level 3)</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Warrant<br/>
                </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Liabilities</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at January 1, 2022</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at March 9, 2022 (issuance date)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,646</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9,943</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,589</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in fair value of warrant liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1,779</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(9,612</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,391</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Exercise of Q1-22 Pre-Funded Warrants</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(867</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(867</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at December 31, 2022</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">331</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">331</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> </span></div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975868740224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Equipment</a></td>
<td class="text">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Property and equipment consist of the following (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Laboratory and manufacturing equipment</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">28</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">258</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Leasehold improvements<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">464</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">Computer equipment and programs</div>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">240</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">155</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">268</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">877</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Less accumulated depreciation and amortization</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(32</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(207</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Property and equipment, net</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">236</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">670</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975867195280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Net Operating Lease Expense</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For the years ended December 31, 2022 and 2021, the net operating lease expenses were as follows (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Years ended December 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; font-weight: bold;">2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Operating lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">595</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">688</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Sublease income</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(84</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(84</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Variable lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">150</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">19</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Total lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">661</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">623</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock', window );">Operating Lease Right-of-use Assets and Liabilities</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2022 and
            the ending balances as of December 31, 2022, including the changes during the period (in thousands).</div>

<div><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operating </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Lease</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">ROU Assets</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">Operating lease ROU assets at January 1, 2022</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">2,567</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Initial measurement of ROU asset</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">1,706</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Amortization of operating lease ROU assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(336</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Impairment of ROU asset</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(772</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Remeasurment of ROU asset</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(813</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Reclassification from fixed assets to ROU assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">50</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Write off of ROU asset due to lease termination</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(1,372</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">Operating lease ROU assets at December 31, 2022</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">1,030</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operating</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Lease</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Liabilities</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Operating lease liabilities at January 1, 2022</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">2,723</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Initial measurement of operating lease liabilities</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">1,706</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Principal payments on operating lease liabilties</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(340</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Remeasurment of lease liability</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(1,454</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Write off of lease liability due to lease termination</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(1,453</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Operating lease liabilities at December 31, 2022</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">1,182</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Less non-current portion</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">887</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Current portion at December 31, 2022</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">295</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
        </div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Operating Lease Liabilities</a></td>
<td class="text"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The maturities of the
          operating lease liabilities are as follows (in thousands):</span>
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2023</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">403</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2024</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">272</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2025</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">274</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2026</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">267</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2027</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">163</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Thereafter</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">82</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total payments</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,461</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Less imputed interest</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(279</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total operating lease liabilities</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,182</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock', window );">Future Lease Payments from Sublease Agreement</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">The following tables shows the future payments the Company expects to receive from the Tenant over
              the remaining term of the sublease (in thousands):</div>

<div><br/>
              </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of</div>
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">$ <br/>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">84<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">86<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">88<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">75<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">333<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future lease payments of sublease agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating lease right-of-use assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975870232864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Expenses</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Accrued expenses consisted of the following (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Accrued compensation</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,065</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">656</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Legal fees and related</span></div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,138</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">241</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Clinical</span></div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">570</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">200</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Q4-22 PIPE</span></td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">208</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">Other<br/>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">645</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">152</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total accrued expenses</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,626</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,249</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
              <div>&#160;</div>
            </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975870132480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Loss per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Basic and Diluted Loss per Common Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Computation of Diluted Net Loss per Common Share</a></td>
<td class="text"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;">The following table presents the amount of warrants,
        stock options, convertible preferred stock and RSUs that were excluded from the computation of diluted net loss per common share for the years ended December 31, 2022 and 2021, as their effect was anti-dilutive (in thousands):<br/>
      </span>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;"> <span style="font-weight: bold;">Years ended December 31,<br/>
                  </span></div>
              </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
                </div>
              </td>

    <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">&#160;<span style="font-size: 10pt; font-weight: bold;">2021</span></div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: middle; text-indent: -9pt; margin-left: 9pt; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="margin-left: 9pt;"><span style="font-size: 10pt;">Warrants</span></div>
              </td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td rowspan="1" style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td rowspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right; font-size: 10pt; white-space: nowrap;" valign="bottom">4,713</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td rowspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"/>

    <td rowspan="1" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Stock options</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">359</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; white-space: nowrap;" valign="bottom">199</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Preferred stock converted into common stock</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">2</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: middle; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><span style="font-size: 10pt;">RSUs</span></td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom">4</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom">12</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Total potential common shares excluded from computation</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,083</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom">213</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

      </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864700016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Weighted-Average Assumptions Used for Grants Issued</a></td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following weighted-average assumptions were used for stock options granted during the years ended December 31, 2022 and 2021: </span>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom"><span style="font-weight: bold;">Year ended</span> <span style="font-weight: bold;">December 31,</span></td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="text-align: center; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" valign="bottom">2021</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Weighted average risk-free rate</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2.52</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">1.09</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Weighted average volatility</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">90.49</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">134.64</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Dividend yield</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">0</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">0</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Expected term</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom">5.79 years </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom">6.10 years <br/>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summarizes of Stock Option Activity</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following table summarizes stock option activity for the years ended December 31, 2022 and 2021 (in thousands except for
        per-share and remaining contractual life data):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-weight: bold;">Outstanding</span></div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Options</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">
                <div>Weighted </div>
                <div>Average </div>
                <div>Exercise</div>
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Price per</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Share</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Average</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Remaining </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Contractual </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Life (in</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">years)</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Aggregate</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Intrinsic</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Outstanding January 1, 2021</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">199</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">168.04</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Outstanding December 31, 2021</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">199</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">168.04</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">9.38</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">287</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">17.29</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled</div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">(127</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">140.56</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Outstanding December 31, 2022</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">359</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">57.18</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">7.57</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$ <br/>
            </td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Options vested and exercisable at December 31, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">146</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">109.60</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">4.79<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summarizes of RSU Activity</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following table summarizes RSU activity for the years ended December 31, 2022 and 2021 (in thousands except for per-share data):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Outstanding</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Restricted</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Stock Units</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Average</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value per</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Share</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">January 1, 2021</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">12</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">276.00</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">December 31, 2021</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">12</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);"><br/>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">276.00</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
              <div style="margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">55</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">38.60</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="margin-left: 9pt;">Released<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(3</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">271.42</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">(60</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">61.03</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">December 31, 2022</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">4</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">236.36</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Balance expected to vest at December 31, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">4</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock', window );">RSUs Vested and Settled</a></td>
<td class="text"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal;">The following table shows the number of RSUs that vested and were settled during the year ended December 31, 2022, as well as the number of shares of common
            stock withheld to cover the withholding taxes and the net shares issued upon settlement (in thousands):</span>
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 54pt; margin-right: 0.7pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 54pt; margin-right: 0.7pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: top; width: 86%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year ended</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px; width: 86%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022
                  </div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 86%; background-color: rgb(204, 238, 255);" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs vested</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; background-color: rgb(204, 238, 255);" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 86%; padding-bottom: 2px;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Common stock withheld to cover taxes</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 86%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Common stock issued</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
           </div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock-Based Compensation Expense</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">For the years ended December 31, 2022 and 2021, the Company recognized stock-based compensation expense as follows (in
        thousands): <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;">
        <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: top; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ended December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2022<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2021<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Research and development</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,249</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,597</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">General and administrative</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,686</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,638</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,935</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,235</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
         </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number RSUs vested and settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975866419728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Equity and Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Warrant activity</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">The following table shows the Company&#8217;s warrant
            activity for the year ended December 31, 2022 (in thousands except for per-share data):</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 2022</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Pre-Funded</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">November 2022</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Balance as of January 1, 2022</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Granted</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">343</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">68</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,370</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,781</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Exercised</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(68</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(68</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Balance as of December 31, 2022</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">343</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,370</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,713</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975859472128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Loss before Income Taxes</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Loss before income taxes consist of the following (in thousands):</div>

<div><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="7" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ended December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="3" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2022</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="3" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top;" valign="bottom"><span style="font-weight: bold;">&#160;<span style="font-style: italic;">(in thousands)</span></span><br/>
              </td>

    <td colspan="3" rowspan="1" style="vertical-align: bottom; text-align: center; text-indent: 9pt; font-weight: bold; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="1" rowspan="1" style="text-indent: 9pt; font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="3" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Domestic</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(24,513</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(122,476</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Foreign</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(21</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(5</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total loss before income taxes</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(24,534</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(122,481</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Income Tax Provision</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">For each of the years ended December 31, 2022 and 2021, current tax provisions and current deferred tax provisions were
        recorded as follows (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Years ended December 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Current Tax Provision</div>
            </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Federal<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">State<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">4</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">5</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="margin-left: 9pt;">Foreign <br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">4</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">5</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Deferred Tax Provision<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Federal<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(6,851</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(5,840</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">State<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(1,602</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(1,414</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="margin-left: 9pt;">Foreign <br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">(187</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(1</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(8,640</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(7,255</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Change in valuation allowance</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">8,681</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">7,314</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total tax provision for income taxes</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">45</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">64</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Deferred Tax Assets and Liabilities</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Deferred tax assets and liabilities
        consist of the effects of temporary differences as shown in the table below (in thousands). Deferred tax assets have been fully reserved by a valuation allowance since it is more likely than not that such tax benefits will not be realized.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred Tax Assets:</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Net operating losses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9,382</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,457</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Foreign net operating losses<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">782</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">595</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;&#160;&#160; Stock compensation</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2,173</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">1,312</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">&#160; &#160; In-process research and development</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">1,233</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;&#160;&#160; Capitalized rearch and development expenses</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">1,502</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">R&amp;D credit carryforwards</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">517</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">288</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Compensation accrual</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">81</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">30</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; text-indent: 9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" valign="bottom">ROU Liabilities<br/>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">334</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">706</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;&#160;&#160; Other<br/>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">549</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total gross deferred tax assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,553</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">8,388</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Valuation allowance</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(16,157</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(7,467</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">396</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">921</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred Tax Liabilities:</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Fixed assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(168</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="margin-left: 9pt;">ROU Assets<br/>
                </div>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(291</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(666</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Intangibles - goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(160</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(112</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total deferred tax liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(461</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(946</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred taxes</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(65</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(25</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>
         </div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of Computed Expected Income Taxes to Effective Income Taxes</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">The






          reconciliation of computed expected income taxes to effective income taxes by applying the federal statutory rate of 21% is as
          follows:</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 27pt;">&#160;<br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 18pt;">
          <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31,</div>
                </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> 2022</td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> 2021</td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tax at federal income tax rate</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br/>
                  </div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.00</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-indent: 9pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><br/>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">21.00</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State income tax, net of federal tax</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6.52</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">1.15</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;Foreign tax differential</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">(0.01</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%)</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">0.00</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">% <br/>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-deductible expenses/excludable items</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6.09</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(16.30</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in valuation allowance</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">(35.38</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">(5.97</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Credits</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0.98</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">0.23</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">Uncertain tax positions<br/>
                </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">(0.49</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">0.00</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1.11</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">(0.16</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">%)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Provision for income taxes</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(0.18</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%)</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">(0.05</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">%)</td>

  </tr>


</table>
          </div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Uncertain Tax Positions</a></td>
<td class="text"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The following table summarizes amounts the
          Company recorded for uncertain tax positions as of December 31, 2022 and 2021 (in thousands):</span>
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">
          <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; font-weight: bold;"> 2022<br/>
                  </div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; font-weight: bold;">2021<br/>
                  </div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Beginning balance of uncertain tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Additions based on current year&#8217;s tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">45</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Net changes based on prior year&#8217;s tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">76</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Ending balance of uncertain tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">121</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
           </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975859481680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business Operations (Details) - Patents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jul. 16, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Description of Business [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfInLicensedPortfolioPatents', window );">Number of patents</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=erna_NoveCiteINCMember', window );">NoveCite, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Description of Business [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of total outstanding equity interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NumberOfInLicensedPortfolioPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of in-licensed portfolio patents covering key mRNA cell engineering technologies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NumberOfInLicensedPortfolioPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=erna_NoveCiteINCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=erna_NoveCiteINCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975859634464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidity and Capital Resources (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 02, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 23, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 12, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 06, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Oct. 18, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract', window );"><strong>Liquidity and Capital Resources [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,446,000<span></span>
</td>
<td class="nump">$ 16,985,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(165,297,000)<span></span>
</td>
<td class="num">(140,702,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,579,000)<span></span>
</td>
<td class="num">(122,545,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (20,976,000)<span></span>
</td>
<td class="num">$ (23,488,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Aggregate gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NewFacilityLeaseAbstract', window );"><strong>New Facility Lease [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office and laboratory space | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Letter of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember', window );">Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract', window );"><strong>Liquidity and Capital Resources [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract', window );"><strong>Liquidity and Capital Resources [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember', window );">PIPE Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract', window );"><strong>Liquidity and Capital Resources [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,185,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_UnitPriceOfWarrants', window );">Unit price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Aggregate gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants to purchase of common stock</a></td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember', window );">PIPE Investor [Member] | Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract', window );"><strong>Liquidity and Capital Resources [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Aggregate gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember', window );">PIPE Investor [Member] | Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract', window );"><strong>Liquidity and Capital Resources [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ClassOfWarrantOrRightsExercisableTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ClassOfWarrantOrRightsExercisableTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NewFacilityLeaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NewFacilityLeaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_UnitPriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price of prefunded and common warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_UnitPriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975867209424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Basis of Accounting Presentation (Details)<br></strong></div></th>
<th class="th"><div>Sep. 21, 2022</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock conversion ratio</a></td>
<td class="nump">0.05<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_BasisOfPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_BasisOfPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864113344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies, October 2022 Reverse Stock Split (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 21, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ReverseStockSplitAbstract', window );"><strong>Reverse Stock-Split [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock conversion ratio</a></td>
<td class="nump">0.05<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit', window );">Amount paid for fractional share in connection with reverse stock split | $</a></td>
<td class="nump">$ 719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfSharesConsideredAsFractionalInReverseStock', window );">Number of fractional shares considered in reverse stock split (in shares) | shares</a></td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for fractional shares in connection with reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NumberOfSharesConsideredAsFractionalInReverseStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares considered as fractional in reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NumberOfSharesConsideredAsFractionalInReverseStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ReverseStockSplitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ReverseStockSplitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864873328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 18, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">$ 4,100<span></span>
</td>
<td class="nump">$ 4,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975868803616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Property and Equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=erna_LaboratoryAndManufacturingEquipmentMember', window );">Laboratory and Manufacturing Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=erna_LaboratoryAndManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=erna_LaboratoryAndManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975870268688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Segment Reporting (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>Segments</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975870531360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Recent Accounting Standards (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=erna_CoronavirusAidReliefAndEconomicSecurityActMember', window );">CARES Act [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Recent Accounting Standards [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Payroll tax refunds included in other receivable</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=erna_CoronavirusAidReliefAndEconomicSecurityActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=erna_CoronavirusAidReliefAndEconomicSecurityActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975866278848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Merger, Disposition and Acquisition Transactions, Merger (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Merger Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Number of shares of common stock owned by stockholders immediately before the Merger (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,127,000<span></span>
</td>
<td class="nump">2,601,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Merger Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of outstanding common stock received by members and financial adviser</a></td>
<td class="nump">96.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number of common stock issued in exchange of membership interests (in shares)</a></td>
<td class="nump">1,999,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of common stock issued as compensation for services (in shares)</a></td>
<td class="nump">53,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Purchase price</a></td>
<td class="nump">$ 8,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Closing price of common stock (in dollars per share)</a></td>
<td class="nump">$ 108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Number of shares of common stock owned by stockholders immediately before the Merger (in shares)</a></td>
<td class="nump">76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 8,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864646016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger, Disposition and Acquisition Transactions, Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expense and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts', window );">Software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable, accrued liabilities and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired, excluding goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(890)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement', window );">Cash and cash equivalents obligated to have under merger agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_BeneficialHoldersContractualCommitmentsToInvest', window );">Beneficial holders contractual commitments to invest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfAdditionalRightsOffering', window );">Percentage of additional rights offering</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ProceedsFromSaleOfRights', window );">Proceeds from right offering</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Fair Value Adjustment to Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expense and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts', window );">Software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(368)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable, accrued liabilities and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired, excluding goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Fair Value Adjustment to Assets [Member] | Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Fair Value Adjustment to Assets [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Purchase Price Allocation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expense and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts', window );">Software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable, accrued liabilities and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired, excluding goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(411)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Purchase Price Allocation [Member] | Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Purchase Price Allocation [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_BeneficialHoldersContractualCommitmentsToInvest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual commitment made by beneficial holders to invest in the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_BeneficialHoldersContractualCommitmentsToInvest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of software development costs recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents obligated to maintain under merger agreement on balance sheet at the effective time of the merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfAdditionalRightsOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of additional right offering made by the entity for unit holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfAdditionalRightsOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ProceedsFromSaleOfRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of rights during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ProceedsFromSaleOfRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=erna_NTNBuzztimeIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=erna_ProFormaFairValueAdjustmentToAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=erna_ProFormaFairValueAdjustmentToAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=erna_PurchasePriceAllocationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=erna_PurchasePriceAllocationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975865485856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger, Disposition and Acquisition Transactions, Disposition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 26, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities transferred upon sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Total loss on sale of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (9,648)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=erna_NTNBusinessMember', window );">NTN Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DispositionAbstract', window );"><strong>Disposition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets', window );">Sale of rights, title and interest in and to the assets relating to the business</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ProceedsFromDispositionAbstract', window );"><strong>Proceeds from sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash', window );">Cash</a></td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow', window );">Escrow</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans', window );">Assume advance/loans</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans', window );">Interest on advance/loans</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Carrying value of assets sold [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable</a></td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets', window );">Prepaids and other current assets</a></td>
<td class="num">(124)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="num">(1,014)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts', window );">Software development costs</a></td>
<td class="num">(927)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="num">(8,589)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets</a></td>
<td class="num">(103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities transferred upon sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases', window );">Obligations under finance leases</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability', window );">Lease liability</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts', window );">Transaction costs</a></td>
<td class="num">(265)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Total loss on sale of assets</a></td>
<td class="num">(9,648)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=erna_NTNBusinessMember', window );">NTN Business [Member] | Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Carrying value of assets sold [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(548)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=erna_NTNBusinessMember', window );">NTN Business [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Carrying value of assets sold [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">$ (299)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as Lease liability attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as Obligations under finance leases attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate proceeds received from assume advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate proceeds received from escrow deposits in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate proceeds received from interest on advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as software development cost attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of the business disposal including legal, accounting, and other costs incurred to consummate the business disposition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DispositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DispositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ProceedsFromDispositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ProceedsFromDispositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred revenue attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=erna_NTNBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=erna_NTNBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975868689600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger, Disposition and Acquisition Transactions, Acquisition (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 16, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PaymentsToAcquireProductiveAssetsNet', window );">Cash paid, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">22,854<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ResearchAndDevelopmentInProcessAssetAcquisition', window );">In-process R&amp;D acquired in Novellus asset acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 80,538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=erna_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Acquisition of common stock (in shares)</a></td>
<td class="nump">351,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition agreement</a></td>
<td class="nump">$ 102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AssetAcquisitionSharePrice', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 290.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Fair value of shares issued</a></td>
<td class="nump">$ 58,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_EscrowShares', window );">Escrow shares (in shares)</a></td>
<td class="nump">37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AcquisitionAgreementNonCompetitivePeriod', window );">Non-compete period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_EachLockUpAgreementExtendsTerm', window );">Each lock-up agreement extend term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PaymentsToAcquireProductiveAssetsNet', window );">Cash paid, net</a></td>
<td class="nump">$ 22,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LockUpPeriodForRestrictedShares', window );">Lock-up period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions', window );">Unrestricted shares, issued (in shares)</a></td>
<td class="nump">182,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AssetAcquisitionUnrestrictedSharesSharePrice', window );">Unrestricted shares, fair value per share (in dollars per share)</a></td>
<td class="nump">$ 201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions', window );">Restricted shares, issued (in shares)</a></td>
<td class="nump">169,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AssetAcquisitionRestrictedSharesSharePrice', window );">Restricted shares, fair value per share (in dollars per share)</a></td>
<td class="nump">$ 130.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfDiscountOnFairValueOfRestrictedShares', window );">Percentage of discount on fair value restricted shares</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Cash paid</a></td>
<td class="nump">$ 22,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions', window );">Unrestricted shares, value</a></td>
<td class="nump">36,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions', window );">Restricted shares, value</a></td>
<td class="nump">22,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AssetAcquisitionFairValueOfConsiderationPaid', window );">Total fair value of consideration paid</a></td>
<td class="nump">81,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Less amount of cash paid for NoveCite investment</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ResearchAndDevelopmentInProcessAssetAcquisition', window );">In-process R&amp;D acquired in Novellus asset acquisition</a></td>
<td class="nump">$ 80,538<span></span>
</td>
<td class="nump">$ 80,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=erna_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member] | Chairman of the Board of Directors, Chief Executive Officer and President [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Lock-up agreements common shares received in acquisition (in shares)</a></td>
<td class="nump">169,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=erna_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfCommonStockSubjectToLockUpAgreement', window );">Percentage of common stock subject to the lock-up agreement</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=erna_NoveCiteINCMember', window );">NoveCite, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of total outstanding equity interests</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AcquisitionAgreementNonCompetitivePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Acquisition Agreement contains non-competition and non-solicitation provisions pursuant to which the Seller has agreed not to engage in certain competitive activities for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AcquisitionAgreementNonCompetitivePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AssetAcquisitionFairValueOfConsiderationPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fair value of consideration paid in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AssetAcquisitionFairValueOfConsiderationPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AssetAcquisitionRestrictedSharesSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered with restrictions to be paid in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AssetAcquisitionRestrictedSharesSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AssetAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AssetAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AssetAcquisitionUnrestrictedSharesSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered without any restrictions to be paid in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AssetAcquisitionUnrestrictedSharesSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_EachLockUpAgreementExtendsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of lock-up agreement extend term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_EachLockUpAgreementExtendsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_EscrowShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares have been placed in escrow shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_EscrowShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LockUpPeriodForRestrictedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period in which shares are locked-up, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LockUpPeriodForRestrictedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PaymentsToAcquireProductiveAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets excluding cash acquired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PaymentsToAcquireProductiveAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfCommonStockSubjectToLockUpAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of shares of common stock subject to the lock-up agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfCommonStockSubjectToLockUpAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfDiscountOnFairValueOfRestrictedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of discount on restricted shares, which was derived from the average discount rate between the Black Scholes and Finnerty valuation models.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfDiscountOnFairValueOfRestrictedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ResearchAndDevelopmentInProcessAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ResearchAndDevelopmentInProcessAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued with restrictions during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued with restrictions during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued without any restrictions during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued without any restrictions during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=erna_NovellusTherapeuticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=erna_NovellusTherapeuticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=erna_NoveCiteINCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=erna_NoveCiteINCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975868810832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger, Disposition and Acquisition Transactions, Investment in NoveCite (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 16, 2021 </div>
<div>USD ($) </div>
<div>BoardMember</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=erna_NoveCiteINCMember', window );">NoveCite, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfBoardSeats', window );">Number of board seats | BoardMember</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Losses on investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=erna_NoveCiteINCMember', window );">NoveCite, INC. [Member] | Citius Pharmaceuticals, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage by Citius</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NumberOfBoardSeats">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of members of the company's management holds board seats on board of directors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NumberOfBoardSeats</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=erna_NoveCiteINCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=erna_NoveCiteINCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=erna_CitiusPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=erna_CitiusPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975863892496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments, Liabilities Measured at Fair Value (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 02, 2022</div></th>
<th class="th"><div>Jul. 12, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 23, 2022</div></th>
<th class="th"><div>Mar. 09, 2022</div></th>
<th class="th"><div>Mar. 06, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember', window );">PIPE Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate exercise price</a></td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member] | PIPE Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember', window );">Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember', window );">Common Warrants [Member] | PIPE Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | Common Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Common Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Common Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 331,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864843216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments, Changes in Warrant Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Changes in Fair Value of Warrant Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OverSubscriptionAmountReceived', window );">Over-subscription amount received</a></td>
<td class="nump">$ 600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Gross proceeds received</a></td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Fair value at March 9, 2022 (issuance date)</a></td>
<td class="nump">12,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(11,391)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Exercise of Q1-22 pre-funded warrants (in shares)</a></td>
<td class="num">(867)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, end of period</a></td>
<td class="nump">331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Changes in Fair Value of Warrant Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Fair value at March 9, 2022 (issuance date)</a></td>
<td class="nump">2,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(1,779)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Exercise of Q1-22 pre-funded warrants (in shares)</a></td>
<td class="num">(867)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, end of period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Changes in Fair Value of Warrant Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Fair value at March 9, 2022 (issuance date)</a></td>
<td class="nump">9,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(9,612)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Exercise of Q1-22 pre-funded warrants (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, end of period</a></td>
<td class="nump">$ 331<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OverSubscriptionAmountReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OverSubscriptionAmountReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975867335040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Property, Plant and Equipment, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 268,000<span></span>
</td>
<td class="nump">$ 877,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(32,000)<span></span>
</td>
<td class="num">(207,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">236,000<span></span>
</td>
<td class="nump">670,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_GainLossOnDisposalOfFixedAssets', window );">Loss on disposal of fixed assets</a></td>
<td class="nump">280,000<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RemainingNetBookValueOfFixedAssets', window );">Net book value of fixed assets</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sales of fixed assets</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expenses</a></td>
<td class="nump">161,000<span></span>
</td>
<td class="nump">117,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory and Manufacturing Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Property, Plant and Equipment, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">28,000<span></span>
</td>
<td class="nump">258,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Property, Plant and Equipment, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">464,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment and Programs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Property, Plant and Equipment, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="nump">$ 155,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_GainLossOnDisposalOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of fixed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_GainLossOnDisposalOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RemainingNetBookValueOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after depreciation of long-lived, physical assets used to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RemainingNetBookValueOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975865287760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Operating Lease (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 09, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 18, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Mar. 25, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 05, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LesseeCommitmentToPurchaseProperty', window );">Commitment to purchase equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Security deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU asset balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,030,000<span></span>
</td>
<td class="nump">$ 2,567,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,182,000<span></span>
</td>
<td class="nump">2,723,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OperatingLeaseArea', window );">Operating lease area | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">62 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfOperatingLeaseROUAssets', window );">Initial measurement of operating lease ROU assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,706,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfOperatingLeaseLiabilities', window );">Initial measurement of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,706,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of ROU asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">772,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LeaseTerminationFeePayable', window );">Lease termination fee payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Decrease in lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense', window );">Lease liability adjustment recognized as general and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of premises | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of sublease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">62 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Letter of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LeaseTerminationFee', window );">Lease termination fee paid</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ERSquibbSonsLLCMember', window );">E.R. Squibb &amp; Sons, L.L.C. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU asset balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of premises | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of sublease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extension term of sublease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OperatingLeasesMonthlyBaseRent', window );">Monthly base rent payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OperatingLeasesIncrementalBaseRentalPayment', window );">Incremental base rental payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_TenantImprovementAllowancePerRentableSquareFoot', window );">Tenant improvement allowance per rentable square foot</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_TenantImprovementAllowance', window );">Tenant improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ERSquibbSonsLLCMember', window );">E.R. Squibb &amp; Sons, L.L.C. [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SubleaseCost', window );">Sublease cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SubleaseCostForTenantImprovements', window );">Sublease cost for tenant improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CostRelatedToIssuanceOfLetterOfCredit', window );">Cost Related to Issuance of Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ERSquibbSonsLLCMember', window );">E.R. Squibb &amp; Sons, L.L.C. [Member] | Letter of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Letter of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_CostRelatedToIssuanceOfLetterOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of bank fees related to issuance of letter of credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_CostRelatedToIssuanceOfLetterOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialMeasurementOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of operating lease liabilities in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialMeasurementOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialMeasurementOfOperatingLeaseROUAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of operating lease ROU assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialMeasurementOfOperatingLeaseROUAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of lease liability adjustment recognized as general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LeaseTerminationFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of lease termination fees paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LeaseTerminationFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LeaseTerminationFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of lease termination fees payable by the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LeaseTerminationFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LesseeCommitmentToPurchaseProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property for which lessee committed to purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LesseeCommitmentToPurchaseProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OperatingLeaseArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of leased property under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OperatingLeaseArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OperatingLeasesIncrementalBaseRentalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount for base rental payments, as well as parking and traditional lease expenses including, certain taxes, operating expenses and utilities can be incremented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OperatingLeasesIncrementalBaseRentalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OperatingLeasesMonthlyBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of rental expense payable per month for operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OperatingLeasesMonthlyBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SubleaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred in connection with sublease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SubleaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SubleaseCostForTenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sublease cost for the architect to design the tenant improvements to the premises and for a project manager to manage the construction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SubleaseCostForTenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_TenantImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tenant improvement allowance to improvements of the Premises.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_TenantImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_TenantImprovementAllowancePerRentableSquareFoot">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tenant improvement allowance per rentable square foot for the improvements of premises.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_TenantImprovementAllowancePerRentableSquareFoot</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ERSquibbSonsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ERSquibbSonsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PledgingPurposeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PledgingPurposeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975867403680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Net Operating Lease Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Net Operating Lease Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 595<span></span>
</td>
<td class="nump">$ 688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(84)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease expense</a></td>
<td class="nump">$ 661<span></span>
</td>
<td class="nump">$ 623<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975868701696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Operating Lease Right-of-use Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OperatingLeaseAssestAbstract', window );"><strong>Operating Lease, Asset [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease ROU assets, Beginning</a></td>
<td class="nump">$ 2,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfOperatingLeaseROUAssets', window );">Initial measurement of ROU asset</a></td>
<td class="nump">1,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease ROU assets</a></td>
<td class="num">(336)<span></span>
</td>
<td class="num">$ (342)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of ROU asset</a></td>
<td class="num">(772)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RemeasurementOfOperatingLeaseRightOfUseAsset', window );">Remeasurement of ROU asset</a></td>
<td class="num">(813)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ReclassificationFromFixedAssetsToRightOfUseAsset', window );">Reclassification from fixed assets to ROU assets</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_WriteOffOfOperatingLeaseRightOfUseAsset', window );">Write off of ROU asset due to lease termination</a></td>
<td class="num">(1,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease ROU assets, Ending</a></td>
<td class="nump">1,030<span></span>
</td>
<td class="nump">2,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Operating Lease, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, Beginning</a></td>
<td class="nump">2,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfOperatingLeaseLiabilities', window );">Initial measurement of operating lease liabilities</a></td>
<td class="nump">1,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrincipalPaymentsOnOperatingLeaseLiabilities', window );">Principal payments on operating lease liabilities</a></td>
<td class="num">(340)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RemeasurementOfOperatingLeaseLiability', window );">Remeasurement of lease liability</a></td>
<td class="num">(1,454)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_WriteOffOfOperatingLeaseLiability', window );">Write off of lease liability due to lease termination</a></td>
<td class="num">(1,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, Ending</a></td>
<td class="nump">1,182<span></span>
</td>
<td class="nump">2,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Less non-current portion</a></td>
<td class="nump">887<span></span>
</td>
<td class="nump">2,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion</a></td>
<td class="nump">$ 295<span></span>
</td>
<td class="nump">$ 426<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialMeasurementOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of operating lease liabilities in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialMeasurementOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialMeasurementOfOperatingLeaseROUAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of operating lease ROU assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialMeasurementOfOperatingLeaseROUAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OperatingLeaseAssestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OperatingLeaseAssestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PrincipalPaymentsOnOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal payments on operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PrincipalPaymentsOnOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ReclassificationFromFixedAssetsToRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reclassification from fixed assets to right-of-use (ROU) assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ReclassificationFromFixedAssetsToRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RemeasurementOfOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of remeasurement of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RemeasurementOfOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RemeasurementOfOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of remeasurement of operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RemeasurementOfOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_WriteOffOfOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Write-off of operating lease liability due to lease termination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_WriteOffOfOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_WriteOffOfOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Write-off of operating lease right-of-use asset due to lease termination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_WriteOffOfOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975859918432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases, Maturities of Operating Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 29, 2022</div></th>
<th class="th"><div>Mar. 25, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract', window );"><strong>Weighted Average Remaining Lease Term and Discount Rate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">9.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Maturities of Operating Lease Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total payments</a></td>
<td class="nump">1,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 1,182<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 2,723<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864841152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Sublease Agreement (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 18, 2019 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AreaOfSubleaseSpaceCurrentlyRented', window );">Currently rented area | ft&#178;</a></td>
<td class="nump">999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments', window );">Percentage of annual rent increase</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract', window );"><strong>Future Lease Payments, Sublease Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths', window );">2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears', window );">2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLeasePayments', window );">Sublease payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AreaOfSubleaseSpaceCurrentlyRented">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The subleases rentable area for properties currently rented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AreaOfSubleaseSpaceCurrentlyRented</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of increase in annual lease payment for subleases for each year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals to be received by the seller-lessee for sale-leaseback transactions accounted for using the deposit method or as a financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from lease payment, classified as operating activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919320-209978<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919327-209978<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975859483312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>In-Process Research &amp; Development and Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>In-Process Research &amp; Development and Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,990<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfOngoingProject', window );">Non-cash impairment charges</a></td>
<td class="nump">5,990<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfOngoingProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfOngoingProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975865073264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 02, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 23, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 08, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 12, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 06, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Installment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract', window );"><strong>Related Party Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,392,000<span></span>
</td>
<td class="nump">$ 12,705,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember', window );">Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_Q422PIPETransactionAbstract', window );"><strong>Q4-22 PIPE Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_Q422PIPETransactionAbstract', window );"><strong>Q4-22 PIPE Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember', window );">PIPE Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_Q422PIPETransactionAbstract', window );"><strong>Q4-22 PIPE Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,185,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_UnitPriceOfWarrants', window );">Unit price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants to purchase of common stock</a></td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember', window );">PIPE Investor [Member] | Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_Q422PIPETransactionAbstract', window );"><strong>Q4-22 PIPE Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember', window );">PIPE Investor [Member] | Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_Q422PIPETransactionAbstract', window );"><strong>Q4-22 PIPE Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_FactorBioscienceIncMember', window );">Factor Bioscience Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract', window );"><strong>Related Party Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_MasterServiceAgreementInitialFeesPayable', window );">Master services agreement, initial fees payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfMonthlyInstallmentsForFeesPayable', window );">Number of monthly installments for fees payable | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RelatedPartyTransactionPeriodicFeesPaymentAmount', window );">Monthly installment fees amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialLicenseFeeObligation', window );">Initial license fees obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_MonthlyMasterServicesAgreementFeesPayable', window );">Monthly master services agreement fees payable initial 12-month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder', window );">Deposit paid to be applied to last month of first work order</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoticePeriodForFirstTerminationOfContract', window );">Notice period for first termination of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">120 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoticePeriodForSupersedingTerminationProvisions', window );">Notice period for superseding termination provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AgreedWaivePayment', window );">Agreed waive payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RemainingLicenseFeeObligation', window );">Remaining license fee obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ReimburseCostsIncurredOrPaid', window );">Reimburse costs incurred or paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ExacisBiotherapeuticsIncMember', window );">Exacis Biotherapeutics, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ExacisOptionAgreementAbstract', window );"><strong>Exacis Option Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PaymentOfOptionFee', window );">Payment of option fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AgreedWaivePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount agreed to waive payment as per waiver agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AgreedWaivePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ClassOfWarrantOrRightsExercisableTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ClassOfWarrantOrRightsExercisableTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deposit paid which will be applied to the last month of the first work order.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ExacisOptionAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ExacisOptionAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialLicenseFeeObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of initial license fees required to pay including non-refundable fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialLicenseFeeObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_MasterServiceAgreementInitialFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount agreed to pay an initial fee under Master Services Agreement (or "MSA").</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_MasterServiceAgreementInitialFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_MonthlyMasterServicesAgreementFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The monthly master service agreement ("MSA") fees payable to related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_MonthlyMasterServicesAgreementFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NoticePeriodForFirstTerminationOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company may terminate the first work under the MSA on or after the second anniversary of the date of the MSA, subject to providing Factor with prior notice, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NoticePeriodForFirstTerminationOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NoticePeriodForSupersedingTerminationProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Master Services Agreement (or "MSA") contains customary confidentiality provisions and representations and warranties of the parties, and the Master Services Agreement (or "MSA") may be terminated by ether party prior notice, subject to any superseding termination provisions contained in a particular work order, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NoticePeriodForSupersedingTerminationProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NumberOfMonthlyInstallmentsForFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equal monthly installments for initial fees payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NumberOfMonthlyInstallmentsForFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PaymentOfOptionFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of option fee related to licensing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PaymentOfOptionFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_Q422PIPETransactionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_Q422PIPETransactionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ReimburseCostsIncurredOrPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount reimburse for costs already incurred or paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ReimburseCostsIncurredOrPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RelatedPartyTransactionPeriodicFeesPaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of required periodic fees payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RelatedPartyTransactionPeriodicFeesPaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RemainingLicenseFeeObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of remaining license fee obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RemainingLicenseFeeObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_UnitPriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price of prefunded and common warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_UnitPriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_FactorBioscienceIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_FactorBioscienceIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ExacisBiotherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ExacisBiotherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975867091920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 1,065<span></span>
</td>
<td class="nump">$ 656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal fees and related</a></td>
<td class="nump">1,138<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AccruedClinicalCurrent', window );">Clinical</a></td>
<td class="nump">570<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AccruedPrivatePlacementInPublicEquityCurrent', window );">Q4-22 PIPE</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">645<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 3,626<span></span>
</td>
<td class="nump">$ 1,249<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AccruedClinicalCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to clinical trail cost (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AccruedClinicalCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AccruedPrivatePlacementInPublicEquityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to private placement in public equity (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AccruedPrivatePlacementInPublicEquityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975871729744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>May 04, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DebtInstrumentAbstract', window );"><strong>Debt Instrument [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payment of outstanding notes payable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 410,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=erna_PaycheckProtectionProgramLoanMember', window );">IRX Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DebtInstrumentAbstract', window );"><strong>Debt Instrument [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loans payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payment of outstanding notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PaymentOfAccruedAndUnpaidInterest', window );">Payment of accrued and unpaid interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=erna_PaycheckProtectionProgramMember', window );">Eterna LLC Paycheck Protection Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DebtInstrumentAbstract', window );"><strong>Debt Instrument [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Term loan amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DebtInstrumentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DebtInstrumentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PaymentOfAccruedAndUnpaidInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for accrued and unpaid interest related to notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PaymentOfAccruedAndUnpaidInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=erna_PaycheckProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=erna_PaycheckProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=erna_PaycheckProtectionProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=erna_PaycheckProtectionProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975872303856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies, Legal Matters (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LegalMattersAbstract', window );"><strong>Legal Matters [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LitigationSettlementAmountPayable', window );">Aggregate settlement amount payable</a></td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement, amount</a></td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LegalMattersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LegalMattersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LitigationSettlementAmountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount payable to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LitigationSettlementAmountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975872149408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies, Licensing Agreements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_ExclusiveFactorLicenseAgreementMember', window );">Exclusive Factor License Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LicenseAgreementTerm', window );">License agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LicenseAgreementExtensionTerm', window );">License agreement extension term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod', window );">Threshold income for automatic extension of license period</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod', window );">Percentage of sublicense fee payable by company before expiration date</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfSublicenseFeePayableDuringRenewalTerm', window );">Percentage of sublicense fee payable by company during renewal term</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=erna_UniversityOfSouthFloridaMember', window );">University of South Florida [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LossContingencyPercentageOfRoyaltyPayable', window );">Percentage of royalty payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LicenseAgreementExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The term of license agreement to be extendable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LicenseAgreementExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LicenseAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License agreement term in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LicenseAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LicensingAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LicensingAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LossContingencyPercentageOfRoyaltyPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of royalty payable from one party to another in licensing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LossContingencyPercentageOfRoyaltyPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of sublicense fee payable by the company before expiration date as per "Exclusive Factor License Agreement".</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfSublicenseFeePayableDuringRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of sublicense fee payable by the company during renewal period as per "Exclusive Factor License Agreement".</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfSublicenseFeePayableDuringRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum threshold income from sublicenses to the factor patents for automatic extension of license period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=erna_ExclusiveFactorLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=erna_ExclusiveFactorLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=erna_UniversityOfSouthFloridaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=erna_UniversityOfSouthFloridaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864699856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies, Royalty Agreements (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 22, 2021</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_InvestorRoyaltyAgreementMember', window );">Investor Royalty Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RoyaltyAgreementsAbstract', window );"><strong>Royalty Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness', window );">Percentage of royalty receive equal to revenues from sale of business</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales', window );">Percentage of payment of additional royalty on gross sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_CollaboratorRoyaltyAgreementMember', window );">Collaborator Royalty Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RoyaltyAgreementsAbstract', window );"><strong>Royalty Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LossContingencyPercentageOfRoyaltyPayable', window );">Percentage of royalty payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LossContingencyPercentageOfRoyaltyPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of royalty payable from one party to another in licensing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LossContingencyPercentageOfRoyaltyPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of additional royalty payable on gross sales by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of royalty payable equal to revenues generated from disposition of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RoyaltyAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RoyaltyAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=erna_InvestorRoyaltyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=erna_InvestorRoyaltyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=erna_CollaboratorRoyaltyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=erna_CollaboratorRoyaltyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975859918656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies, Retirement Savings Plan (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis', window );">Employees contribution, deferral percentage of their pay on a pre-tax basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=erna_RetirementPlan401KMember', window );">401K [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne', window );">Employer matching contribution up to first 3%</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DefinedContributionPlanEmployeeContributionAtThresholdOne', window );">Employee contribution threshold for matching percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo', window );">Employer matching contribution in excess of first 2%</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo', window );">Deferred compensation matched by employer, next match</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=erna_RetirementPlan401KMember', window );">401K [Member] | Maximum [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Maximum employer matching contribution</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan, deferral percentage of employee on their pay on pre-tax basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DefinedContributionPlanEmployeeContributionAtThresholdOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employee contribution to the plan that is fully matched by the employer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DefinedContributionPlanEmployeeContributionAtThresholdOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employee contribution to the plan that is fully matched by the employer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution up to a certain percentage matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution in excess of certain percentage matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=erna_RetirementPlan401KMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=erna_RetirementPlan401KMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864144176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Loss per Common Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">5,083<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">4,713<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Preferred Stock Converted into Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864277056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Equity Incentive Plans (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option outstanding (in shares)</a></td>
<td class="nump">359,000<span></span>
</td>
<td class="nump">199,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=erna_EquityIncentivePlan2020Member', window );">2020 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock-based compensation shares authorized (in shares)</a></td>
<td class="nump">256,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfSharesOfCommonStockOutstanding', window );">Percentage of number of shares of common stock outstanding</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of common stock shares to be issued (in shares)</a></td>
<td class="nump">166,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted stock units outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=erna_EquityIncentivePlan2020Member', window );">2020 Equity Incentive Plan [Member] | Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock-based compensation shares authorized (in shares)</a></td>
<td class="nump">424,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=erna_EquityIncentivePlan2020Member', window );">2020 Equity Incentive Plan [Member] | Incentive Stock Options [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock based compensation stock option term period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=erna_EquityIncentivePlan2020Member', window );">2020 Equity Incentive Plan [Member] | Nonqualified Stock Options [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock based compensation stock option term period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=erna_InducementPlan2021Member', window );">2021 Inducement Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of common stock shares to be issued (in shares)</a></td>
<td class="nump">57,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted stock units outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=erna_InducementPlan2021Member', window );">2021 Inducement Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock-based compensation shares authorized (in shares)</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfSharesOfCommonStockOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of common stock shares outstanding considered for equity number of shares under equity incentive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfSharesOfCommonStockOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=erna_EquityIncentivePlan2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=erna_EquityIncentivePlan2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=erna_IncentiveStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=erna_IncentiveStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=erna_NonQualifiedStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=erna_NonQualifiedStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=erna_InducementPlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=erna_InducementPlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975867195536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Weighted-Average Assumptions Used for Grants Issued (Details) - Stock Options [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Weightage-Average Assumptions Used for Stock Options Granted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted average risk-free rate</a></td>
<td class="nump">2.52%<span></span>
</td>
<td class="nump">1.09%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Weighted average volatility</a></td>
<td class="nump">90.49%<span></span>
</td>
<td class="nump">134.64%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">5 years 9 months 14 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975859962880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Stock Option Activity (Details) - Stock Options [Member] - USD ($)<br> $ / shares in Units, shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Option Share [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">287<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(127)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 168.04<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">17.29<span></span>
</td>
<td class="nump">168.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">140.56<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance (in dollars per share)</a></td>
<td class="nump">$ 57.18<span></span>
</td>
<td class="nump">$ 168.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract', window );"><strong>Weighted Average Remaining Contractual Life [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual life, outstanding</a></td>
<td class="text">7 years 6 months 25 days<span></span>
</td>
<td class="text">9 years 4 months 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract', window );"><strong>Options Vested and Exercisable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options vested and exercisable, Outstanding (in shares)</a></td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Options vested and exercisable, Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 109.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options vested and exercisable, weighted average remaining contractual life</a></td>
<td class="text">4 years 9 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Options vested and exercisable, aggregate intrinsic value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864896528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Summary of Stock Options (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,935,000<span></span>
</td>
<td class="nump">$ 5,235,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.91<span></span>
</td>
<td class="nump">$ 151.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Incremental fair value of stock options recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unamortized stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average remaining requisite service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod', window );">Exercise period of extended post-termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod', window );">Exercise period of extended post-termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=erna_TimeBasedStockOptionMember', window );">Time Based Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Number of accelerated vesting stock option (in shares)</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=erna_PerformanceBasedStockOptionMember', window );">Performance Based Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Number of accelerated vesting stock option (in shares)</a></td>
<td class="nump">21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of extended post-termination exercise period under the share-based compensation arrangements, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=erna_TimeBasedStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=erna_TimeBasedStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=erna_PerformanceBasedStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=erna_PerformanceBasedStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864141424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, RSUs (Details) - RSU [Member] - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Outstanding Restricted Stock Units [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, Beginning balance (in shares)</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, Ending balance (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber', window );">Balance expected to vest (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Fair Value Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Fair Value Per Share, Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">38.6<span></span>
</td>
<td class="nump">276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in dollars per share)</a></td>
<td class="nump">271.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">61.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Fair Value Per Share, Ending balance (in dollars per share)</a></td>
<td class="nump">$ 236.36<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options expected to vest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975868613264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Number of RSUs Vested and Settled (Details) - RSUs [Member] - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfAwardsVestedAndSettledAbstract', window );"><strong>Number of RSUs Vested and Settled [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (in shares)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CommonStockWithheldToCoverTaxes', window );">Common stock withheld to cover taxes (in shares)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued (in shares)</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_CommonStockWithheldToCoverTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares of common stock withheld to cover the withholding taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_CommonStockWithheldToCoverTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NumberOfAwardsVestedAndSettledAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NumberOfAwardsVestedAndSettledAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864922944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Restricted Stock (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">$ 2,935<span></span>
</td>
<td class="nump">$ 5,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Common Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock replaced during the period (in shares)</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of RSUs cancelled (in shares)</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of stock units awards outstanding (in shares)</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Common Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock replaced during the period (in shares)</a></td>
<td class="nump">32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of RSUs cancelled (in shares)</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of stock units awards outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975867403840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract', window );"><strong>Stock-Based Compensation Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 2,935<span></span>
</td>
<td class="nump">$ 5,235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract', window );"><strong>Stock-Based Compensation Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">1,249<span></span>
</td>
<td class="nump">1,597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract', window );"><strong>Stock-Based Compensation Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,686<span></span>
</td>
<td class="nump">$ 3,638<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975863200208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Warrants, Private Placement of Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 02, 2022</div></th>
<th class="th"><div>Nov. 23, 2022</div></th>
<th class="th"><div>Jul. 14, 2022</div></th>
<th class="th"><div>Jul. 12, 2022</div></th>
<th class="th"><div>Mar. 06, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Aggregate gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Warrants fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,589,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OverSubscriptionAmountReceived', window );">Over-subscription amount received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants outstanding weighted average contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 4 months 13 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember', window );">Q1-22 Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights', window );">Percentage of warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorOneMember', window );">Q4-22 PIPE Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,185,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants to purchase of common stock</a></td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_UnitPriceOfWarrants', window );">Unit price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate exercise price</a></td>
<td class="nump">7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_TransactionFeesPayable', window );">Transaction fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorOneMember', window );">Q4-22 PIPE Investor [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights', window );">Percentage of warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorOneMember', window );">Q4-22 PIPE Investor [Member] | Q4-22 Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfWarrantsInEachUnit', window );">Number of warrants in each unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorOneMember', window );">Q4-22 PIPE Investor [Member] | Q1-22 Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights', window );">Percentage of warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember', window );">Q1-22 PIPE Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,185,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Aggregate gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants to purchase of common stock</a></td>
<td class="nump">7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_UnitPriceOfWarrants', window );">Unit price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights', window );">Percentage of warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate exercise price</a></td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Warrants fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OverSubscriptionAmountReceived', window );">Over-subscription amount received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth', window );">Obligation to pay liquidated damages per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_TransactionFeesPayable', window );">Transaction fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AggregateCalendarDays', window );">Aggregate calendar days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimated contingent loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Liquidated damages payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember', window );">Q1-22 PIPE Investor [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ObligationToPayLiquidatedDamagesPercentage', window );">Obligated to pay liquidated damages percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember', window );">Q1-22 PIPE Investor [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember', window );">Q1-22 PIPE Investor [Member] | Q1-22 Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Aggregate gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_VariableRateTransactionsPeriod', window );">Variable rate transaction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightExercised', window );">Warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember', window );">Q1-22 PIPE Investor [Member] | Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightExercised', window );">Warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AggregateCalendarDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified aggregate calendar days (which need not be consecutive calendar days) during any 12-month period for resale in in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AggregateCalendarDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights exercised during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of securities that would be issuable upon the exercise of warrants or rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ClassOfWarrantOrRightsExercisableTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ClassOfWarrantOrRightsExercisableTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NumberOfWarrantsInEachUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrant consist in each unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NumberOfWarrantsInEachUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ObligationToPayLiquidatedDamagesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages percentage of aggregate payment on Subscription Amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ObligationToPayLiquidatedDamagesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages equal to the Subscription Amount per month.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OverSubscriptionAmountReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OverSubscriptionAmountReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PrivatePlacementOfEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PrivatePlacementOfEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_TransactionFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fees incurred related to PIPE transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_TransactionFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_UnitPriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price of prefunded and common warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_UnitPriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_VariableRateTransactionsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pursuant to the Purchase Agreement, the Company is prohibited from issuing equity in variable rate transactions for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_VariableRateTransactionsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=erna_PIPEInvestorOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=erna_PIPEInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975859927696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Warrants,Warrants activity (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant Activity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">4,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightExercisedInPeriod', window );">Exercised (in shares)</a></td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">4,713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_March2022WarrantsMember', window );">March 2022 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant Activity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightExercisedInPeriod', window );">Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant Activity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightExercisedInPeriod', window );">Exercised (in shares)</a></td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_November2022WarrantsMember', window );">November 2022 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant Activity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">4,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightExercisedInPeriod', window );">Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">4,370<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ClassOfWarrantOrRightExercisedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share warrants exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ClassOfWarrantOrRightExercisedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ClassOfWarrantOrRightGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ClassOfWarrantOrRightGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_March2022WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_March2022WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_November2022WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_November2022WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975865245760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Warrants, Equity Line Offerings (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 26, 2021</div></th>
<th class="th"><div>Apr. 26, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfferingsAbstract', window );"><strong>Private Placement Offerings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,706<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Number of shares authorized to sale in regular purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfferingsAbstract', window );"><strong>Private Placement Offerings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CommitmentAmountToMeetAnySingleRegularPurchase', window );">Maximum commitment in any single regular purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_FirstPurchaseAgreementMember', window );">First Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfferingsAbstract', window );"><strong>Private Placement Offerings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_FirstPurchaseAgreementMember', window );">First Purchase Agreement [Member] | Lincoln Park [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfferingsAbstract', window );"><strong>Private Placement Offerings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1', window );">Common stock, shares issued in consideration for purchase commitment (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_FirstPurchaseAgreementMember', window );">First Purchase Agreement [Member] | Lincoln Park [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfferingsAbstract', window );"><strong>Private Placement Offerings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_SecondPurchaseAgreementMember', window );">Second Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfferingsAbstract', window );"><strong>Private Placement Offerings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock issued and sold during period (in shares)</a></td>
<td class="nump">121,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Gross proceeds</a></td>
<td class="nump">$ 34,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SaleOfStockNumberOfSharesToIssuedInTransaction', window );">Number of remaining shares to be sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_SecondPurchaseAgreementMember', window );">Second Purchase Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfferingsAbstract', window );"><strong>Private Placement Offerings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Number of shares authorized to sale in regular purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_BeneficialOwnershipPercentageOnTotalOutstandingShares', window );">Beneficial ownership percentage on total outstanding shares that prohibits company to direct share purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_SecondPurchaseAgreementMember', window );">Second Purchase Agreement [Member] | Lincoln Park [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfferingsAbstract', window );"><strong>Private Placement Offerings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_BeneficialOwnershipPercentageOnTotalOutstandingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_BeneficialOwnershipPercentageOnTotalOutstandingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_CommitmentAmountToMeetAnySingleRegularPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of purchase price or commitment amount to meet any single regular purchase in share purchase transaction on any business day.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_CommitmentAmountToMeetAnySingleRegularPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PrivatePlacementOfferingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PrivatePlacementOfferingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SaleOfStockNumberOfSharesToIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares to be issued by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SaleOfStockNumberOfSharesToIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=erna_FirstPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=erna_FirstPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=erna_LincolnParkCapitalFundLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=erna_LincolnParkCapitalFundLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=erna_SecondPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=erna_SecondPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975862329264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Warrants, Merger (Details) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesAcquisitions1', window );">Stock issued, shares, acquisition (in shares)</a></td>
<td class="nump">53,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued in merger agreement (in shares)</a></td>
<td class="nump">87,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted to common stock (in shares)</a></td>
<td class="nump">1,114,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued in merger agreement (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted to common stock (in shares)</a></td>
<td class="nump">126,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued in merger agreement (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted to common stock (in shares)</a></td>
<td class="nump">84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightIssued', window );">Number of rights options issued (in shares)</a></td>
<td class="nump">10,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of rights options converted (in shares)</a></td>
<td class="nump">591,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued in merger agreement (in shares)</a></td>
<td class="nump">630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted to common stock (in shares)</a></td>
<td class="nump">31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesAcquisitions1', window );">Stock issued, shares, acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ClassOfWarrantOrRightIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued into which the class of warrant or right may be converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ClassOfWarrantOrRightIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_MergerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_MergerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodSharesAcquisitions1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodSharesAcquisitions1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975859937664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity and Warrants, Acquisition (Details) - Novellus, Ltd. [Member]<br></strong></div></th>
<th class="th">
<div>Jul. 16, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Acquisition of common stock (in shares)</a></td>
<td class="nump">351,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions', window );">Unrestricted shares, issued (in shares)</a></td>
<td class="nump">182,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_EachLockUpAgreementExtendsTerm', window );">Each lock-up agreement extend term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=erna_NovellusTherapeuticsLimitedMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfCommonStockSubjectToLockUpAgreement', window );">Percentage of common stock subject to the lock-up agreement</a></td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=erna_NovellusTherapeuticsLimitedMember', window );">Chair of the Board of Directors, Chief Executive Officer and President [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Lock-up agreements shares received in acquisition (in shares)</a></td>
<td class="nump">169,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_EachLockUpAgreementExtendsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of lock-up agreement extend term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_EachLockUpAgreementExtendsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfCommonStockSubjectToLockUpAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of shares of common stock subject to the lock-up agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfCommonStockSubjectToLockUpAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued without any restrictions during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=erna_NovellusTherapeuticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=erna_NovellusTherapeuticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975865224096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Warrants, Cumulative Convertible Preferred Stock (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract', window );"><strong>Cumulative Convertible Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock Series A, shares authorized (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock series A, shares issued (in shares)</a></td>
<td class="nump">156,000<span></span>
</td>
<td class="nump">156,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock series A, shares outstanding (in shares)</a></td>
<td class="nump">156,000<span></span>
</td>
<td class="nump">156,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Dividend paid in cash | $</a></td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Number of shares converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Cumulative Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract', window );"><strong>Cumulative Convertible Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock Series A, shares authorized (in shares)</a></td>
<td class="nump">156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock series A, shares issued (in shares)</a></td>
<td class="nump">156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock series A, shares outstanding (in shares)</a></td>
<td class="nump">156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Cumulative annual dividend payable per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Dividend paid in cash | $</a></td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsShares', window );">Shares issued for payment of dividends (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred stock, liquidation preference per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionRatio', window );">Preferred stock, conversion rate</a></td>
<td class="nump">23.9988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract', window );"><strong>Cumulative Convertible Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Dividend paid in cash | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsShares', window );">Shares issued for payment of dividends (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Each preferred stock converted into common stock (in shares)</a></td>
<td class="nump">0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Aggregate preferred stock to be convert into common stock (in shares)</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Number of shares converted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FeaturesOfConvertiblePreferredStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion for each share of preferred stock to be converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864506544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes, Loss before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Loss before Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (24,513)<span></span>
</td>
<td class="num">$ (122,476)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (24,534)<span></span>
</td>
<td class="num">$ (122,481)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864265760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes, Components of Income Tax Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current Tax Provision [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax provision</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred Tax Provision [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(6,851)<span></span>
</td>
<td class="num">(5,840)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(1,602)<span></span>
</td>
<td class="num">(1,414)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(187)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income tax provision</a></td>
<td class="num">(8,640)<span></span>
</td>
<td class="num">(7,255)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount', window );">Change in valuation allowance</a></td>
<td class="nump">8,681<span></span>
</td>
<td class="nump">7,314<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total tax provision for income taxes</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to decrease in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975864862336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes, Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred Tax Assets: [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign', window );">Net operating losses</a></td>
<td class="nump">$ 9,382<span></span>
</td>
<td class="nump">$ 5,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Foreign net operating losses</a></td>
<td class="nump">782<span></span>
</td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">2,173<span></span>
</td>
<td class="nump">1,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">In-process research and development</a></td>
<td class="nump">1,233<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts', window );">Capitalized research and development expenses</a></td>
<td class="nump">1,502<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">R&amp;D credit carryforwards</a></td>
<td class="nump">517<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences', window );">Compensation accrual</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DeferredTaxAssetsRightOfUseLiabilities', window );">ROU Liabilities</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Other</a></td>
<td class="nump">549<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">16,553<span></span>
</td>
<td class="nump">8,388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(16,157)<span></span>
</td>
<td class="num">(7,467)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">396<span></span>
</td>
<td class="nump">921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred Tax Liabilities: [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DeferredTaxAssetsRightOfUseAssets', window );">ROU Assets</a></td>
<td class="num">(291)<span></span>
</td>
<td class="num">(666)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Intangibles - goodwill</a></td>
<td class="num">(160)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(461)<span></span>
</td>
<td class="num">(946)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred taxes</a></td>
<td class="num">$ (65)<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets attributable to taxable temporary differences from research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards excluding foreign purpose.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DeferredTaxAssetsRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DeferredTaxAssetsRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DeferredTaxAssetsRightOfUseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from right-of-use liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DeferredTaxAssetsRightOfUseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensated absences (includes, but not limited to, sick and personal days).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966508&amp;loc=d3e9972-128506<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126966508&amp;loc=d3e9979-128506<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975865229696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes, Reconciliation of Computed Expected Income Taxes to Effective Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Reconciliation of Computed Expected Income Taxes to Effective Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income tax, net of federal tax</a></td>
<td class="nump">6.52%<span></span>
</td>
<td class="nump">1.15%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax differential</a></td>
<td class="num">(0.01%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Non-deductible expenses/excludable items</a></td>
<td class="nump">6.09%<span></span>
</td>
<td class="num">(16.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(35.38%)<span></span>
</td>
<td class="num">(5.97%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Credits</a></td>
<td class="nump">0.98%<span></span>
</td>
<td class="nump">0.23%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent', window );">Uncertain tax positions</a></td>
<td class="num">(0.49%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="nump">1.11%<span></span>
</td>
<td class="num">(0.16%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total tax provision for income taxes</a></td>
<td class="num">(0.18%)<span></span>
</td>
<td class="num">(0.05%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IncomeTaxAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">$ 8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Federal and state income tax credit carryforwards</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OperatingLossCarryforwardsExpirationYear', window );">Net operating loss carryforwards begin to expire</a></td>
<td class="text">2041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_TaxCreditCarryforwardExpirationYear', window );">Tax credits begin to expire</a></td>
<td class="text">2041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties related to uncertain tax positions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open tax year</a></td>
<td class="text">2019 2020 2021 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IncomeTaxAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry forward</a></td>
<td class="nump">$ 35,600,000<span></span>
</td>
<td class="nump">20,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_TaxCutsAndJobsActOperatingLossCarryforwards', window );">Net operating loss carryforwards under Tax Cuts and Jobs Act</a></td>
<td class="nump">35,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IncomeTaxAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry forward</a></td>
<td class="nump">28,800,000<span></span>
</td>
<td class="nump">20,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IncomeTaxAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry forward</a></td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to uncertain tax positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_IncomeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_IncomeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OperatingLossCarryforwardsExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of each operating loss carryforward included in operating loss carryforward, in YYYY format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OperatingLossCarryforwardsExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_TaxCreditCarryforwardExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration beginning year of the tax credit carryforward, in YYYY format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_TaxCreditCarryforwardExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_TaxCutsAndJobsActOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws from effect of Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_TaxCutsAndJobsActOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in YYYY format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975872031776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes, Uncertain Tax Positions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance of uncertain tax positions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on current year's tax positions</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Net changes based on prior year's tax positions</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance of uncertain tax positions</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139975871397712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Event (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Feb. 21, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LicenseAgreementAbstract', window );"><strong>Cell Customization and License Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ProceedsFromOptionAndLicenseAgreement', window );">Proceeds from option and license agreement</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LicenseAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LicenseAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ProceedsFromOptionAndLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from exclusive option and license agreement as a non-refundable up-front payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ProceedsFromOptionAndLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>brhc10049677_10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:erna="http://eternatx.com/20221231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="erna-20221231.xsd" xlink:type="simple"/>
    <context id="c20220101to20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20230320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2023-03-20</instant>
        </period>
    </context>
    <context id="c20210101to20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">erna:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">erna:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">erna:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">erna:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">erna:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">erna:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20221231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20221231_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">erna:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-16</instant>
        </period>
    </context>
    <context id="c20221123_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="c20220306_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-23</startDate>
            <endDate>2022-11-23</endDate>
        </period>
    </context>
    <context id="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="c20221202to20221202_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-02</startDate>
            <endDate>2022-12-02</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20221018">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-10-18</instant>
        </period>
    </context>
    <context id="c20210325to20210325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20220921to20220921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2022-09-21</startDate>
            <endDate>2022-09-21</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_PropertyPlantAndEquipmentByTypeAxis_LaboratoryAndManufacturingEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">erna:LaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_UnusualOrInfrequentItemAxis_CoronavirusAidReliefAndEconomicSecurityActMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">erna:CoronavirusAidReliefAndEconomicSecurityActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20221231_UnusualOrInfrequentItemAxis_CoronavirusAidReliefAndEconomicSecurityActMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">erna:CoronavirusAidReliefAndEconomicSecurityActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">erna:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">erna:PurchasePriceAllocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">erna:PurchasePriceAllocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">erna:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">erna:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">erna:PurchasePriceAllocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NTNBuzztimeIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">erna:NTNBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-26</startDate>
            <endDate>2021-03-26</endDate>
        </period>
    </context>
    <context id="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">erna:NTNBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-26</instant>
        </period>
    </context>
    <context id="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">erna:NTNBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-26</instant>
        </period>
    </context>
    <context id="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">erna:NTNBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-26</instant>
        </period>
    </context>
    <context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-16</instant>
        </period>
    </context>
    <context id="c20220101to20221231_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20210701to20210930_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c20210716_OwnershipAxis_CitiusPharmaceuticalsIncMember_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">erna:CitiusPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">erna:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-16</instant>
        </period>
    </context>
    <context id="c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">erna:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">erna:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">erna:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20221231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-09</instant>
        </period>
    </context>
    <context id="c20220712_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-12</instant>
        </period>
    </context>
    <context id="c20220309_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-09</instant>
        </period>
    </context>
    <context id="c20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-12</instant>
        </period>
    </context>
    <context id="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-12</startDate>
            <endDate>2022-07-12</endDate>
        </period>
    </context>
    <context id="c20211231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20211231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-03-05</instant>
        </period>
    </context>
    <context id="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-12-29</instant>
        </period>
    </context>
    <context id="c20220325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-03-25</instant>
        </period>
    </context>
    <context id="c20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20230109to20230109_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-09</startDate>
            <endDate>2023-01-09</endDate>
        </period>
    </context>
    <context id="c20221229to20221229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2022-12-29</startDate>
            <endDate>2022-12-29</endDate>
        </period>
    </context>
    <context id="c20221018_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-18</instant>
        </period>
    </context>
    <context id="c20221018_PledgingPurposeAxis_LetterOfCreditMember_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PledgingPurposeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-18</instant>
        </period>
    </context>
    <context id="c20221018to20221018_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-18</startDate>
            <endDate>2022-10-18</endDate>
        </period>
    </context>
    <context id="c20221231_BalanceSheetLocationAxis_OtherNoncurrentAssetsMember_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="c20190418to20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2019-04-18</startDate>
            <endDate>2019-04-18</endDate>
        </period>
    </context>
    <context id="c20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20221001to20221031_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c20221008to20221008_RelatedPartyTransactionsByRelatedPartyAxis_ExacisBiotherapeuticsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ExacisBiotherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-08</startDate>
            <endDate>2022-10-08</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20181231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20221231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200504_DebtInstrumentAxis_PaycheckProtectionProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-04</instant>
        </period>
    </context>
    <context id="c20210101to20211231_DebtInstrumentAxis_PaycheckProtectionProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20221231_DebtInstrumentAxis_PaycheckProtectionProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:PaycheckProtectionProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20221231_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExclusiveFactorLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20221101to20221130_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExclusiveFactorLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="c20221130_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExclusiveFactorLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="c20220101to20221231_LegalEntityAxis_UniversityOfSouthFloridaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:UniversityOfSouthFloridaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20181101to20181130_TypeOfArrangementAxis_CollaboratorRoyaltyAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:CollaboratorRoyaltyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:InvestorRoyaltyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-22</startDate>
            <endDate>2021-03-22</endDate>
        </period>
    </context>
    <context id="c20181101to20181130_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:InvestorRoyaltyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">erna:RetirementPlan401KMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c20230101to20230101_RangeAxis_MaximumMember_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">erna:RetirementPlan401KMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20221231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_PlanNameAxis_EquityIncentivePlan2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_PlanNameAxis_InducementPlan2021Member_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:InducementPlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20221231_PlanNameAxis_EquityIncentivePlan2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AwardTypeAxis_IncentiveStockOptionsMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:IncentiveStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AwardTypeAxis_NonQualifiedStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:NonQualifiedStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20221231_PlanNameAxis_InducementPlan2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:InducementPlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20211231_PlanNameAxis_InducementPlan2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:InducementPlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_PlanNameAxis_EquityIncentivePlan2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20201231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20221231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20211231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220501to20220531_AwardTypeAxis_TimeBasedStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:TimeBasedStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="c20220501to20220531_AwardTypeAxis_PerformanceBasedStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:PerformanceBasedStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20221231_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20221231_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20221231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="c20220306_InvestmentTypeAxis_PIPEInvestorMember_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20221202to20221202_InvestmentTypeAxis_PIPEInvestorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-02</startDate>
            <endDate>2022-12-02</endDate>
        </period>
    </context>
    <context id="c20220306to20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-06</startDate>
            <endDate>2022-03-06</endDate>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember_InvestmentTypeAxis_PIPEInvestorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-23</startDate>
            <endDate>2022-11-23</endDate>
        </period>
    </context>
    <context id="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="c20220306to20220306_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-06</startDate>
            <endDate>2022-03-06</endDate>
        </period>
    </context>
    <context id="c20220714to20220714_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-14</startDate>
            <endDate>2022-07-14</endDate>
        </period>
    </context>
    <context id="c20221231_InvestmentTypeAxis_PIPEInvestorMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20220601to20220630_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20211231_ClassOfWarrantOrRightAxis_November2022WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:November2022WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_ClassOfWarrantOrRightAxis_March2022WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:March2022WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20221231_ClassOfWarrantOrRightAxis_November2022WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:November2022WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_ClassOfWarrantOrRightAxis_March2022WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:March2022WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_March2022WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:March2022WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_November2022WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:November2022WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20210426to20210426_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember_TypeOfArrangementAxis_FirstPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:FirstPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-26</startDate>
            <endDate>2021-04-26</endDate>
        </period>
    </context>
    <context id="c20210526to20210526_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:SecondPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-26</startDate>
            <endDate>2021-05-26</endDate>
        </period>
    </context>
    <context id="c20210426to20210426_LegalEntityAxis_LincolnParkCapitalFundLLCMember_TypeOfArrangementAxis_FirstPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:FirstPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-26</startDate>
            <endDate>2021-04-26</endDate>
        </period>
    </context>
    <context id="c20221231_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:SecondPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20210426_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:SecondPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-26</instant>
        </period>
    </context>
    <context id="c20210426_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-26</instant>
        </period>
    </context>
    <context id="c20210526to20210526_TypeOfArrangementAxis_SecondPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:SecondPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-26</startDate>
            <endDate>2021-05-26</endDate>
        </period>
    </context>
    <context id="c20210426to20210426_TypeOfArrangementAxis_FirstPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:FirstPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-26</startDate>
            <endDate>2021-04-26</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_TypeOfArrangementAxis_SecondPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:SecondPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20210325_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_StatementClassOfStockAxis_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_StatementClassOfStockAxis_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_StatementClassOfStockAxis_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325to20210325_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">erna:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_IncomeTaxAuthorityAxis_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20221231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20221231_IncomeTaxAuthorityAxis_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_IncomeTaxAuthorityAxis_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20230221to20230221_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-21</startDate>
            <endDate>2023-02-21</endDate>
        </period>
    </context>
    <unit id="U001">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U002">
        <measure>shares</measure>
    </unit>
    <unit id="U003">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U004">
        <measure>erna:Patents</measure>
    </unit>
    <unit id="U005">
        <measure>pure</measure>
    </unit>
    <unit id="U006">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U007">
        <measure>erna:Segments</measure>
    </unit>
    <unit id="U008">
        <measure>erna:BoardMember</measure>
    </unit>
    <unit id="U009">
        <measure>erna:Installment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="c20220101to20221231"
      id="Fact_e05c6b7ffe0743eb9882dd8f0e4569f5">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="c20220101to20221231"
      id="Fact_2412ca9c247947aa9179e55ffcb0d40b">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="c20220101to20221231"
      id="Fact_33138cc39c2d49a0abf5aafdaeda9a21">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="c20220101to20221231"
      id="Fact_ce9465e70644499caac3b66eeab6d267">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="c20220101to20221231"
      id="Fact_835746ea76014b48a6c77b86f596f30f">0000748592</dei:EntityCentralIndexKey>
    <dei:AuditorName
      contextRef="c20210101to20211231"
      id="Fact_c4417aff140a4c9c8ba87a360a3b0175">Marcum LLP</dei:AuditorName>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      id="Fact_cd1a85f5a00d40e2a9ec630f5346c135">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="c20210325to20210325"
      decimals="INF"
      id="Fact_abe396817a904d8ea2336e844b48953a"
      unitRef="U005">0.5</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="c20220921to20220921"
      decimals="2"
      id="Fact_9ec8b708b2c6467a940f0725195187c5"
      unitRef="U005">0.05</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_1f3e03cde5674ee69b274ec5dc980a3c">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <erna:LicenseAgreementExtensionTerm
      contextRef="c20220101to20221231_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember"
      id="Fact_5dfb948eb44f4984b296bd33047f7cfb">P2Y6M</erna:LicenseAgreementExtensionTerm>
    <erna:LicenseAgreementExtensionTerm
      contextRef="c20220101to20221231_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember"
      id="Fact_7c1d5587e87d44e08e7579d3d8b39dd7">P2Y6M</erna:LicenseAgreementExtensionTerm>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20220306to20220306_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_d45bfc25257042c4abeb3af3c960c760">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorOneMember"
      id="Fact_ead7f34b09d749a6b4ac3742e9967755">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:OpenTaxYear
      contextRef="c20220101to20221231"
      id="Fact_f5787a4f89d441eb816e0f3918c8cfa1">2019 2020 2021 2022</us-gaap:OpenTaxYear>
    <dei:AuditorFirmId
      contextRef="c20220101to20221231"
      id="Fact_171a355144ac40c4a867492ecadd0a91">248</dei:AuditorFirmId>
    <dei:AuditorFirmId
      contextRef="c20210101to20211231"
      id="Fact_d4a22f6ee0d543c686e66a7f41ccef3c">688</dei:AuditorFirmId>
    <dei:DocumentType
      contextRef="c20220101to20221231"
      id="Fact_8ff40d95797942bd9fa79b086471aafa">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="c20220101to20221231"
      id="Fact_2821c35e756943febc9f4ca49b163084">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="c20220101to20221231"
      id="Fact_e1123512dd274d8c8b57628d05dd1b78">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="c20220101to20221231"
      id="Fact_b8abc9c77cb44053b6d406784b0442c4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="c20220101to20221231"
      id="Fact_4acf8ec6436b44ed809edf62b3611022">1-11460</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="c20220101to20221231"
      id="Fact_11a87ffe74f54c1e90a2172bf6cdb093">Eterna Therapeutics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220101to20221231"
      id="Fact_a143b70c877e42c4a7e080b9f5357134">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220101to20221231"
      id="Fact_daad45e37b084094a01ee9ab3e2d151a">31-1103425</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220101to20221231"
      id="Fact_7d15c6b6e097435e889371b8ed2f8741">10355 Cambridge Street, Suite 18A,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20220101to20221231"
      id="Fact_cfd84825eabc4308b77b5b14a4a4aa3e">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20220101to20221231"
      id="Fact_ff873037c90b4160aeaccdcc2ade5358">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220101to20221231"
      id="Fact_41f389f4a17947eea2ec2f3e40d9f611">02141</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20220101to20221231"
      id="Fact_cda1b37005af46d49cf4355cca5b3ba0">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220101to20221231"
      id="Fact_50fe65c25d2640eabb4031a837059f74">582-1199</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="c20220101to20221231"
      id="Fact_62d2660290e647f2b9fec2ad13fa5469">Common Stock, $0.005 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220101to20221231"
      id="Fact_a926f36d377a46e49d5518cf21baca43">ERNA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20220101to20221231"
      id="Fact_c60506f182794472a675d0397563cebf">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="c20220101to20221231"
      id="Fact_c32a3335746448a18a869c4f75e56d16">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="c20220101to20221231"
      id="Fact_e60644f741794cabb684d6c583031e9c">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="c20220101to20221231"
      id="Fact_4b4ca7b09f754c8c9332ca186d838ffe">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="c20220101to20221231"
      id="Fact_855ad3b2f36b4b858d43c22c16cbb119">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="c20220101to20221231"
      id="Fact_d9a134672de9430abb440b0c53e3a2b7">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="c20220101to20221231"
      id="Fact_f856c3f91280438393cc5f4e476dcb10">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220101to20221231"
      id="Fact_9285f17a1cf54d2982dfb47d228734d9">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="c20220101to20221231"
      id="Fact_c4821b01d94347b38d990bee31b96bac">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="c20220101to20221231"
      id="Fact_4d173ca4ef9948cab95514005e26ce4e">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="c20220630"
      decimals="-5"
      id="Fact_efd98dd7c1d24cadbeac24ad37ced73d"
      unitRef="U001">23800000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c20230320"
      decimals="INF"
      id="Fact_d79b1192c5f84302896ab803ab3d5f26"
      unitRef="U002">5127070</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName
      contextRef="c20220101to20221231"
      id="Fact_547e3b0034ca4c45a6d713aa4233c65d">GRANT THORNTON LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="c20220101to20221231"
      id="Fact_175ad20a0be54254bcca05d0065905af">New York, New York</dei:AuditorLocation>
    <dei:AuditorLocation
      contextRef="c20210101to20211231"
      id="Fact_da25c66401d14d4f8d79bb2762041132">New York, NY</dei:AuditorLocation>
    <us-gaap:Cash
      contextRef="c20221231"
      decimals="-3"
      id="Fact_4d6c08d38c45460aab422d206980b6c5"
      unitRef="U001">11446000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="c20211231"
      decimals="-3"
      id="Fact_fa4216fe2b2545c18eefd83f63559cdf"
      unitRef="U001">16985000</us-gaap:Cash>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_a25c429eac74421cb7f11979dda690ff"
      unitRef="U001">951000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d129541be24b45569d87311250fca146"
      unitRef="U001">684000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_096caa837e3e47b9a586941facf1705a"
      unitRef="U001">1284000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e0518ad7e2d54eeb985bb5394968b0c7"
      unitRef="U001">1097000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_2a4e0cdd20ae47febb93a9d36cd2dddb"
      unitRef="U001">13681000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0199ec07a3364086886bbbb1afe041ff"
      unitRef="U001">18766000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_dca6b6e7e7064a239705de6adcf6a8dd"
      unitRef="U001">4095000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_bddc55d04fc442c1a5f7b4ea0399372b"
      unitRef="U001">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20221231"
      decimals="-3"
      id="Fact_559b8bffd03f4eb1a2b2b85006f96050"
      unitRef="U001">236000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3441247eb41549809a8dc9e1c5376d7c"
      unitRef="U001">670000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20221231"
      decimals="-3"
      id="Fact_4780d8a0e2ec4d32965bddd68e4e64ae"
      unitRef="U001">1030000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c92593d9d4fd45fcac546968ae47d2fc"
      unitRef="U001">2567000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="c20221231"
      decimals="-3"
      id="Fact_8c6a8be77f4a43ab95cc31b6b00b6f04"
      unitRef="U001">2044000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e12ac8776c5f44f38d3565680fd35230"
      unitRef="U001">2044000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c20221231"
      decimals="-3"
      id="Fact_c0ade8ad05c64952be84febaa6642e6f"
      unitRef="U001">0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_273f811095694e37942fbe3e349da56a"
      unitRef="U001">5990000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="c20221231"
      decimals="-3"
      id="Fact_b4df2b38209c469b8048584daf03b517"
      unitRef="U001">59000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4b806e181fe34a728a1fa10e374ff550"
      unitRef="U001">1000000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_56ea93ebfa0f404bbfdda81aab753ac8"
      unitRef="U001">1134000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_5deba22fb82547adbecd9cd94a3e9769"
      unitRef="U001">488000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="c20221231"
      decimals="-3"
      id="Fact_d55ddb17f75940899552f5dbcbe5ca6f"
      unitRef="U001">22279000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20211231"
      decimals="-3"
      id="Fact_cc07c99f4d094a4e99e49cc445468ac2"
      unitRef="U001">31525000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_6a87d02e2e2d404aa79d6d048e45787d"
      unitRef="U001">1620000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_9428a2a24e3b446fad63385cb95718f4"
      unitRef="U001">1755000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_72c80b0d4bb941f0b4836b6667b5ee24"
      unitRef="U001">3626000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e40d068275154c51a5e9d01fe8faa47e"
      unitRef="U001">1249000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_333b50c41dfc49faa328d65d9bbd0ccf"
      unitRef="U001">1750000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_59bca42bfb394f129d7d5879c6fd6fa0"
      unitRef="U001">0</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_abf8c00b38494e8582097cec9b98af12"
      unitRef="U001">295000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_b7f1a296f84447cdbe71a84254218c50"
      unitRef="U001">426000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_c56446bf1ace474295302e5f8a648d60"
      unitRef="U001">363000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d3968758f9ba457da226f88119bcb149"
      unitRef="U001">247000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_d0db517431d2467cb7580a76e24a20c3"
      unitRef="U001">7654000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_8d75bf20760843a187d08b822efe95e0"
      unitRef="U001">3677000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_7ccc6572e0914262aebcd847b9189014"
      unitRef="U001">1206000</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_875e13870db9403395e604552a8a52fd"
      unitRef="U001">0</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_f15c1d79cdb642f5bc96ea7740575be2"
      unitRef="U001">331000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_74f42e7b69664793ba9d6ff733e7d8c6"
      unitRef="U001">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_be38b114bd654c7ea4f5d4039d3e6c66"
      unitRef="U001">887000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d97446b97d524f5b9261d9c5c1a178d4"
      unitRef="U001">2297000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_337cf3c0c30d4e8b913900f2cb147051"
      unitRef="U001">94000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ab4d1647afa147459fae6e9c70bac40e"
      unitRef="U001">48000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="c20221231"
      decimals="-3"
      id="Fact_ef521011624d46799d0cf8b010d7197c"
      unitRef="U001">10172000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_8d467db2bc084f999dc7508255130ebd"
      unitRef="U001">6022000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c20221231"
      id="Fact_46594c8591b04d57badf7d01cd474de1"
      unitRef="U001"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c20211231"
      id="Fact_385d4939437a4df7b11000566800a0e6"
      unitRef="U001"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20221231"
      decimals="3"
      id="Fact_6017e08797084dbfb77816978f71608b"
      unitRef="U003">0.005</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="3"
      id="Fact_01b245be86134eddb7d3627cdf857083"
      unitRef="U003">0.005</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20221231"
      decimals="-3"
      id="Fact_b13bb3bbe0074a339df9a7874070a235"
      unitRef="U002">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20211231"
      decimals="-3"
      id="Fact_26ac4c14d9ee40a4baafd8848ce3d3af"
      unitRef="U002">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20211231"
      decimals="-3"
      id="Fact_9f8016c60a574428b4a2d6230f579b82"
      unitRef="U002">156000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20221231"
      decimals="-3"
      id="Fact_0a12f4ff50a547f98b1bf23e79ee5680"
      unitRef="U002">156000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20211231"
      decimals="-3"
      id="Fact_1aef977bd5eb4c0cbea66703048adbf2"
      unitRef="U002">156000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20221231"
      decimals="-3"
      id="Fact_95ae1f1607154928ba9eea571e7003c3"
      unitRef="U002">156000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3358e6fbe7f34ff093a12aa3764fa44b"
      unitRef="U001">156000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c20221231"
      decimals="-3"
      id="Fact_2a2feaef5eb24c0caa2217eca6afb3d8"
      unitRef="U001">156000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockValue
      contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="-3"
      id="Fact_f176c9300f714c2f943a1bb6848ef5b8"
      unitRef="U001">1000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="-3"
      id="Fact_dffbc502186f44c9b9deb741760727e7"
      unitRef="U001">1000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20221231"
      decimals="3"
      id="Fact_b7792e63291c4405998a0ea8bfc06a71"
      unitRef="U003">0.005</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="3"
      id="Fact_1c2ec87765df47cfa1d8ce04b5530d75"
      unitRef="U003">0.005</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20221231"
      decimals="-3"
      id="Fact_547e1fc06cd24abbb539c716a0b0fc06"
      unitRef="U002">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3478ab00207149648f759d42c5b616e5"
      unitRef="U002">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20221231"
      decimals="-3"
      id="Fact_4fba1a51450b4c8183fe0e0196c35f84"
      unitRef="U002">5127000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20221231"
      decimals="-3"
      id="Fact_0e42136741c54654b4eecfd28f57782b"
      unitRef="U002">5127000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7ed27b6fb585414a9210c78b3ef181e5"
      unitRef="U002">2601000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20211231"
      decimals="-3"
      id="Fact_196458a81c2b4582914a2cff08cac4bc"
      unitRef="U002">2601000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="c20221231"
      decimals="-3"
      id="Fact_c58b9481d58b468881661ee656eefb3f"
      unitRef="U001">26000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c332b82d7dae4a078de9fd062293dbe1"
      unitRef="U001">13000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20221231"
      decimals="-3"
      id="Fact_5090af07b5034b148d8ffa132e2a9ecc"
      unitRef="U001">177377000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20211231"
      decimals="-3"
      id="Fact_95681a219a9a47979c03c08b575d789c"
      unitRef="U001">166191000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20221231"
      decimals="-3"
      id="Fact_c28db29db75b40a880d6198d633d7fd0"
      unitRef="U001">-165297000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20211231"
      decimals="-3"
      id="Fact_52e29e084d914b47b6303c262fae77ae"
      unitRef="U001">-140702000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="c20221231"
      decimals="-3"
      id="Fact_c285b2393179401f96e4ce6c810451a2"
      unitRef="U001">12107000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_1a665a92419c435797a1de8c6d1b94df"
      unitRef="U001">25503000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20221231"
      decimals="-3"
      id="Fact_9df133542e254975a181acb894863bfe"
      unitRef="U001">22279000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_bc8d9fd8f24249baac8b53a73f617996"
      unitRef="U001">31525000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_e08c059fff1b43a49e57b359cc17b951"
      unitRef="U001">10392000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_aab2b0e229d743aba3cdcc2faf44c529"
      unitRef="U001">12705000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_d72e700eead646edb3ba84b062c81424"
      unitRef="U001">5990000</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_65aeb867b41e49168cf63a3fec09c789"
      unitRef="U001">0</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_ffda5340ad8f4f91a6207889a73c7b77"
      unitRef="U001">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_ebc71e3531124b96903f24f9470295c1"
      unitRef="U001">80538000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_2a45a6a9d773439e87e292dee93cbefd"
      unitRef="U001">16835000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_78610be6d0674883880ee22dff2bff21"
      unitRef="U001">14724000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_c6ffcb643d00414cb575c8e1bc28c9c2"
      unitRef="U001">0</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_5f5b891ed393461eb76f8a72bd7fac7b"
      unitRef="U001">5765000</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:OperatingExpenses
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_4cda2738666e4360959c8b057cff78e6"
      unitRef="U001">33217000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c15733253f69402ca202fe690eeee00d"
      unitRef="U001">113732000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_48275537a4a34b6db026e3e25b12b70b"
      unitRef="U001">-33217000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_b38d7d3e579d48169c4183f281689e51"
      unitRef="U001">-113732000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_3d47b701ef6f4560bbd606e7181a6e9e"
      unitRef="U001">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_21fc45f14bed4a5ca127fbefaacc2971"
      unitRef="U001">-9648000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <erna:WarrantLiabilitiesExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_fc6da15ada4348e8a309b3ad6a9c7275"
      unitRef="U001">-10795000</erna:WarrantLiabilitiesExpense>
    <erna:WarrantLiabilitiesExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_06229dfc8e8d486bb2137bd5f13e3727"
      unitRef="U001">0</erna:WarrantLiabilitiesExpense>
    <erna:LossOnNonControllingInvestment
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_97e7c5792e974d9c9225dbff32550d1e"
      unitRef="U001">941000</erna:LossOnNonControllingInvestment>
    <erna:LossOnNonControllingInvestment
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_dc4b07ac9918405ca4f440a30cb96348"
      unitRef="U001">0</erna:LossOnNonControllingInvestment>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_8c0ce0f37a73416cb33c96937b38d7de"
      unitRef="U001">-1171000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_29162345e1cd4b6a93506063bc7a1bd0"
      unitRef="U001">899000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_bf2a073d681a42abbb145f8abede3091"
      unitRef="U001">8683000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_073cba25519842ebb94d23d4746ba362"
      unitRef="U001">-8749000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_3aff42effc934babab2dbbc0f79e5c12"
      unitRef="U001">-24534000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_fd97bac0eeb645569a5a5cdfa2afcd65"
      unitRef="U001">-122481000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_576b5a3f691e45ed8072acdb21caff56"
      unitRef="U001">45000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_90ac2edb68364de58268c75cd6d613ad"
      unitRef="U001">64000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_30f4f222aef1474ba5f920642b307c8b"
      unitRef="U001">-24579000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_a947ba21d25742d696a8801454066227"
      unitRef="U001">-122545000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_e8a3181d92e542c1a94e2e32ab82284b"
      unitRef="U001">16000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_de336daaa0cf428b830dd8464c2fb306"
      unitRef="U001">16000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_9c8af24a963c43e38d9b1e1c77db81c2"
      unitRef="U001">-24595000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_bc8a68ba0f68485badd4349e983cddbd"
      unitRef="U001">-122561000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20220101to20221231"
      decimals="2"
      id="Fact_d0cb27a84d6849a38ec7b70a107483dc"
      unitRef="U003">-8.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20220101to20221231"
      decimals="2"
      id="Fact_cb074f5d46c240a6ae4f00ddbdfd2ffd"
      unitRef="U003">-8.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_4b52e655a03b4ddbbdb856ea1053491d"
      unitRef="U003">-56.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_cf4e3640668d451f94234ac5951e5d1d"
      unitRef="U003">-56.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_c24a68b1ab2c4f4ea6c344f353e0ae8a"
      unitRef="U002">3051000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_aa3530300c8046619c4360e8eb819a8d"
      unitRef="U002">3051000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_662dd55fb5df4136a1dbd807f4a5f671"
      unitRef="U002">2165000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_37a45672ef3f4b438e836d7a976bd2ec"
      unitRef="U002">2165000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_555636185c664423aaddea628da53a0f"
      unitRef="U001">23202000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_07f41317349c4f04b90041c8b6902f6c"
      unitRef="U001">1400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_072f22ca85b04b0ba9ae65cea79c5564"
      unitRef="U001">1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_eeb037057c204eccaa16e98cf6617ac7"
      unitRef="U001">198000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_5d6f1206d0ba47bbb1623d1f0238ca4d"
      unitRef="U002">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_6b4088828d9c47e1880e127e8c982112"
      unitRef="U001">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_0c87ebdbbb42469e95009a3058134795"
      unitRef="U002">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_e794ec30c0914ac38958fbc9384ffd4b"
      unitRef="U001">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_d399a794e05e44dc94cc376ee3485a7a"
      unitRef="U001">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_5a9d947d39f74aacb9e7c75fcf577e36"
      unitRef="U001">-18141000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231"
      decimals="-3"
      id="Fact_35dd798edfc94e9db92a4df13f56f78f"
      unitRef="U001">7659000</us-gaap:StockholdersEquity>
    <erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_c2bba67bd80b45cb8c4868dfa06520b8"
      unitRef="U001">10500000</erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_7ab57bcdf6e943468a9e6e2cf473a8ce"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_3b54a96857c942f69a8cf062bb40348b"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_7bc651fdf5f24d459a66995939470d04"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4ec45699aa664ab3a91c0ecb6bd8f92e"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_c021601bd583463a94af959e17914db0"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_dda33a8cb8df41e99d732b813e4a4796"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_886001ba0e9f4b47b2fa7038e028f329"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_35918b7b2a8242c68ada1a99e24b1e5f"
      unitRef="U001">10500000</erna:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_aa6c2a573dd242e7b67dff1cf07429d3"
      unitRef="U001">-33702000</erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_e068f4df28af47dda3fb9b2b31f23c75"
      unitRef="U001">-1400000</erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_42d6c1f1400047a39dcce7a2414faee0"
      unitRef="U001">-1000000</erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_ff4550453e0140b7b2ad2e8ca6cf5762"
      unitRef="U001">-198000</erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ad47be85e3c8479092fff17ac9b767bc"
      unitRef="U001">0</erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_5521887e98df4a27a1bfaffa237ea338"
      unitRef="U001">0</erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_788cc9df1e50477e92d474140a02b48b"
      unitRef="U001">36300000</erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_fd44a75e7aa149699eae03fa1f9ac984"
      unitRef="U001">0</erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_35bbe7a1280044b7950fd206b831b920"
      unitRef="U001">0</erna:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <erna:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_312c842d26fe40909874cdbdd08df6b0"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions1>
    <erna:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_7c772195964a47308b283975f3309bef"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions1>
    <erna:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_4fd080ef23a545c3ab4d0aaa6f6dc37c"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions1>
    <erna:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_cb0f48730bb945488f9ebb08345e0e34"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions1>
    <erna:StockIssuedDuringPeriodSharesAcquisitions1
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_dcf84115009b4bc18e8927a28d7f7850"
      unitRef="U002">76000</erna:StockIssuedDuringPeriodSharesAcquisitions1>
    <erna:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4a71c3276adb445f98deb78e3a0e6cbe"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions1>
    <erna:StockIssuedDuringPeriodSharesAcquisitions1
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_58ce76a0f5f44a27be26fc7942f5913f"
      unitRef="U002">0</erna:StockIssuedDuringPeriodSharesAcquisitions1>
    <erna:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_31affa14796a41b08149a31c0dd454f6"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions1>
    <erna:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_fb764e119bad405b9d6defa53a6286b4"
      unitRef="U001">8178000</erna:StockIssuedDuringPeriodValueAcquisitions1>
    <erna:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_d7176b06bede4f7ab31c9cb844cf3cb7"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions1>
    <erna:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_4d11cff5e91a4605b5682ca04727b436"
      unitRef="U001">8178000</erna:StockIssuedDuringPeriodValueAcquisitions1>
    <erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_59b61b68d9214aa182ff545537931eb8"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_f5dbca3a144a40d087adc7ad22f405fc"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_c4a3cb7cee5f438ea52bad37410c4b22"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_a9cb5a0e4031415cafff92c0512741ff"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <erna:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_84cecac2f2f64b1b9503e5b82b257e45"
      unitRef="U002">0</erna:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders>
    <erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4f121dc32684441fb6351f73e5487406"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <erna:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_a48eeffa419b4f2fb0066154e0217b0f"
      unitRef="U002">156000</erna:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders>
    <erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_0dcee2e5e8c84cd5addd06298bbcfa4f"
      unitRef="U001">1000</erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_11f1a61c699d4414a3d7cdd911ce4255"
      unitRef="U001">-1000</erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_7b6c250642694df3b98be93ed4d11c34"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_bf177afe56124c5e92bb3760965b2050"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_9281f7ae521641839c817943595e8bdb"
      unitRef="U001">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_c84b275096094ef798847b6bb174fc2e"
      unitRef="U001">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_af6aaeb54fc04cab9cdd887b4c4763a6"
      unitRef="U001">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_9febf576f0234b1a86c5bf05ef772ece"
      unitRef="U001">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountUnitsAcquisitions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b71eab6cc29440f08850a1c7586f9161"
      unitRef="U002">1946000</us-gaap:PartnersCapitalAccountUnitsAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_2c61c2bc82704d2d9cfcce7f7c8c0735"
      unitRef="U001">10000</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountUnitsAcquisitions
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_294098517b2a48abb299feedef50cacd"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountUnitsAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_f5beceb37cc94b28bdc5dc585e80029b"
      unitRef="U001">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_3978adbd8ddb48ab96d327ea6b8c785c"
      unitRef="U001">-10000</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_c206ba7da5774fdcb6b745a614df83d2"
      unitRef="U001">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_9c0579b3a5e14b00a92398b788f4d8a4"
      unitRef="U001">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_3cc55cabfdbc46a184ab149511eb13c4"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_ee7d728d851b45378940fd136d1b4d3f"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_041436f7063b4c5faaf7b4a7a6248438"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_38c181256cba4935a7e6b9ad31ddce81"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b57fcb34f05d4c3eba2c50b462a2cf7e"
      unitRef="U002">53000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_f47d0e898bd243d5b0167a5e51b97d04"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_2902e5dc08234ca0a9f7077476f65146"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_121c2840789d4608ae5a084927fe9d43"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_ac6640a591554a6da8a5252caf6323b0"
      unitRef="U001">5765000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_a35166d30aa14d98bfda531a4a099bd8"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_1bea15cff057454ba3d464d0c1118542"
      unitRef="U001">5765000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_fcbd0295354b42559d97039578666ac9"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_bb85ede553e944d9a94c64381057e0d6"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_c5f912e848fe4424a1bf64f8f50c6044"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_4398291f6fea4eae878d796205a37158"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_fa536e41762e4fe7a6f0f2464cde0b56"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_8441c540220448478fc7b29a8f7e62cd"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_3065bc41630346c1b5a51c430a9cfde3"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_225beb7dc9754eeabfb32fb4ac586952"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_020f16cba680491c83ef0c2c7c4c3f1a"
      unitRef="U001">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_b077e68e8c8b42fbb6d87d20d178a9af"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_ed915aad8fca495e98a06187ba32ad04"
      unitRef="U001">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_ca2291eaa74b43e6b6e5017d21679e85"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_fd2b37e72d574c0ba621a361fa08471a"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_5ffc769bf9684b13b83f81379c1edd71"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_a194580142404f7289d49a9865b34bff"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodSharesStockPurchaseAgreement
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_1ca7301293604e2d82e76f09021731b4"
      unitRef="U002">178000</erna:StockIssuedDuringPeriodSharesStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_d8e8d013d1da46c4914c3ce855d7fe33"
      unitRef="U001">1000</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodSharesStockPurchaseAgreement
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_788953baf1ec433f94a33e1ddea93e90"
      unitRef="U002">0</erna:StockIssuedDuringPeriodSharesStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_388cef2d731e4774b486ba5a857a4465"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_9a32ac16ae5e438198e769ae30562f01"
      unitRef="U001">52024000</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_a83548f92bac437b9a10b3afb7d925c9"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_aacd82877e214839bac2b83db6ba0a43"
      unitRef="U001">52025000</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_91710d2316624ed5a6764ca8d5204029"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_ee5143e8466c4f2ea5a1cc920ad18d80"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_81b4fd595db54694b80b3e36f14e576e"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_bfe34a4a54b6488aad0e288eb766f021"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <erna:StockIssuedDuringPeriodSharesAcquisitions2
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_6ea2f4525c2841fd8664a58b92a589e3"
      unitRef="U002">351000</erna:StockIssuedDuringPeriodSharesAcquisitions2>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_e310329bcb7641098ef268c4f7b9889f"
      unitRef="U001">2000</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <erna:StockIssuedDuringPeriodSharesAcquisitions2
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_766210d8003e465e81f42103333b3382"
      unitRef="U002">0</erna:StockIssuedDuringPeriodSharesAcquisitions2>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_968220067b0f4b19909242f34882e7e5"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_8aafd6a34c754969b01c7243d4970a0b"
      unitRef="U001">58682000</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_605db32e513c4a5f8f8bc1313b8be09e"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_faf0c535de6f41e58111dbfa99320789"
      unitRef="U001">58684000</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_8580f9b6a149478ba4d590f689e2c284"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_e19f7fdbcaf94fbcbebff50e0b3c8fa3"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_a73f6d0bd76f4802a567f82ac4b99a1f"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_6d93da918a85490fa3081641bc8899f4"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:PreferredStockDividendsShares
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_146100a72ccc44cca46edfd4d6ba5853"
      unitRef="U002">0</us-gaap:PreferredStockDividendsShares>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_864d0215573549ae88bc25e71d0a7982"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:PreferredStockDividendsShares
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_23dc6fd82f7b483999c79e189b1d0554"
      unitRef="U002">0</us-gaap:PreferredStockDividendsShares>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_4f2a11e4b1d84335b26c0c5fa77f9181"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_24edb106ddcf4ce6be68b769b5179862"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_ab0023acd1334ca09defc7b3fd7c72be"
      unitRef="U001">8000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_3b3052c634344ff7b9e430039e02cd8e"
      unitRef="U001">8000</us-gaap:DividendsPreferredStockCash>
    <erna:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_b4724dbc34134ef8822b6eb2489c3c93"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueInLieuOfDividends>
    <erna:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_28bf35715bf64e5c97ad9cb8a7171373"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueInLieuOfDividends>
    <erna:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_83937ac681ec4c8e9ed9eebb758961cd"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueInLieuOfDividends>
    <erna:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_50990322af8d4a2a91f465e0a7d2c1d4"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueInLieuOfDividends>
    <erna:StockIssuedDuringPeriodSharesInLieuOfDividends
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a8649309bec048c8b2617470a64f263d"
      unitRef="U002">0</erna:StockIssuedDuringPeriodSharesInLieuOfDividends>
    <erna:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_e8922ef9ccf345aab1930a755e3a52d9"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueInLieuOfDividends>
    <erna:StockIssuedDuringPeriodSharesInLieuOfDividends
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_642b4f4502e9472d82eadee808b27d11"
      unitRef="U002">0</erna:StockIssuedDuringPeriodSharesInLieuOfDividends>
    <erna:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_7bd0bc183856491392af734b66b22ff5"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueInLieuOfDividends>
    <erna:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_051f51c9d0d044f4967e84c4c0b70c4e"
      unitRef="U001">8000</erna:StockIssuedDuringPeriodValueInLieuOfDividends>
    <erna:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_20fd4b4753d4455094d94796d8a91ca9"
      unitRef="U001">-8000</erna:StockIssuedDuringPeriodValueInLieuOfDividends>
    <erna:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_3e7e3ae653634029a904d6d1766294e3"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueInLieuOfDividends>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_fa0b3297694648399272b23494f8343f"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_1ce24c5cb52743b3b8e2274ff8d39cfb"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_d1e41edb91584e4095ae24d015ccee5a"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_e667dd0d0eb6440c8158e1b8d52fe1e9"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_325998a1c6f946e19de7f41cf4164a3d"
      unitRef="U002">3000</erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a5ba23d55608406bb06238863eedea65"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_837cec91f07f4d90902c3bd270cc2aa3"
      unitRef="U002">0</erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_899cdcb719174d77b56723295157a92d"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_22c6c21ff39a4e60a6f9c823cd92c263"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_b1218af8029a44d383316302bc5cccc1"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_76b5343a70a54fa4afb103c264b9f524"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_7472d3fd9ae4470592cbf11b57440732"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_d49e19a01c3a4699a27458b61aa2a041"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_c96f310e9a9d4ffe9cf318ca8025ac8d"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_4cdb7d1b51774a039a1bffba31b0589a"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_714168b550c14852832a275d1f4448d5"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_18cbeb1d310449f98b96aacefbf44a72"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_74247fc49dfe4c9782211af3f8fb845d"
      unitRef="U001">5235000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_912ca88dc03f4ce8b0fc0787a85c86bd"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_ba92007b645e4238aa41365e83171c66"
      unitRef="U001">5235000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_9299476f1d1a4c699ce908751b22ee96"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_da368bb2cd0d4d2aaea198bf8ad00e9b"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_b6f2f1a571b04ddd80fcf0163c7a8f29"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_0fdb9f2030ef47bb858e05658cfae40e"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b8cd9fe596f947f78f515e96be217e6a"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_b3bd3e1316864a89a578c474bf0248d0"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_a2d17fac40854fb7bddf0b15f91232a6"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_1e87ee6967de4855aa76bdb50b76356e"
      unitRef="U001">-122545000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_5bfff9707c464aedb8e393bb7f618261"
      unitRef="U001">-122545000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_09bece4e9d74429494a350c1775d009e"
      unitRef="U001">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_c7935a544ad143bf924dea7ada142d74"
      unitRef="U001">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_619c64d8e2594e199bfe05fa4d77aaf7"
      unitRef="U001">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_be8594789cdf48c98000e5361f910b82"
      unitRef="U001">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4c42a71ab60e4e1b9274a42b2a16905f"
      unitRef="U002">2601000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_8d838f73a04943528bd4fa524976b47f"
      unitRef="U001">13000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_3faa44e25efc4145b66aa79a976c38a6"
      unitRef="U002">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_45cb4cd0dd4e4048b94770f7e021294f"
      unitRef="U001">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_e14ce654f9d64d9c8c96409814829b8f"
      unitRef="U001">166191000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_82451e4e77c245fb820e061f9ab8cd1b"
      unitRef="U001">-140702000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_900e7846a8a1479a8319a8f4be0d9cfe"
      unitRef="U001">25503000</us-gaap:StockholdersEquity>
    <erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_fbe125244c6c4e3eaab99f0dbe677225"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_75967a1b4b8f42de90fd3b964da802fc"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_7a457b0ffb694bde82da04750744e2a8"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_581ffac312c440babb9b8f77895668f2"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b0774ce2e948467f8055541e777621ba"
      unitRef="U002">275000</erna:StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c8b1c63fe00f4e049565961ff9306055"
      unitRef="U001">1000</erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_399bb7a1995f43ffa74f056b00959057"
      unitRef="U002">0</erna:StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_1e3a1c682e764078b6d6fa643f723d5d"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0a1f8786e7664eaeb26b4c7e4589b58f"
      unitRef="U001">-1000</erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_16f0cc9a9ee3421e88383c6e04111e7f"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_da3e9543dbc5453f963ae03f3c6cea25"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_10fc6411d30548a198bdd09bb57cbcfd"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants>
    <erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_dadec8b3cd4d47daa279d1aba7e2655c"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants>
    <erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_7b66ae6ff2b4443fb81bbf87887b5e17"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants>
    <erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_646a6cff615646e6a40147ae14ea3db2"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants>
    <erna:StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_1028bfcab3324e15ade459f1bc0e4c8c"
      unitRef="U002">68000</erna:StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants>
    <erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_139a5ae7db3e4e86ae5337d1f7dc2a1c"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants>
    <erna:StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_78d469f0823e4ed3ad3a41acfcaf809a"
      unitRef="U002">0</erna:StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants>
    <erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_3cea3034c445455aae8eaa788b09efa6"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants>
    <erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_46e29913af4b481baa56df60c7a7851c"
      unitRef="U001">874000</erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants>
    <erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_ce4683563bfb478097ba9f03e9b7f9d3"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants>
    <erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_5bb92111aafb4e7084a72ea3879f8091"
      unitRef="U001">874000</erna:StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_1de2fe3106c7454bb9e6ba256e6b1a45"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_a7fc816ce2dc4be69bbdc3574b68617b"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_2c76568cb05645caa0203943cf0c2e46"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_2e392d46021949de922e51a7b0d5b8eb"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4bda2ea9703b4cb3889deadcac9c21f9"
      unitRef="U002">2185000</erna:StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_26d0e01ba2f640e6b2590ea49149a435"
      unitRef="U001">12000</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_ca07be54407d4c5ba35cf88d6c2dc209"
      unitRef="U002">0</erna:StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_cc383c3f6fc046f29189304ef874d440"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_b0db921ac38b48458c2e0fc1549c5af0"
      unitRef="U001">7383000</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_2c197ea5af5e46a1b258aed059252d95"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_56393247732345858b5dbd11b4bca243"
      unitRef="U001">7395000</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_fb0026ced3f5413d942435f3bb6a9e2c"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_40adb9743846491ab951f2970ea91be1"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_07ead9eac73c44bab73a1b9abceb4663"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_93e7156d5a674a5a97c38a7454766d0e"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_e976f47ec8e34c67b211cc21ef36f689"
      unitRef="U002">4000</erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ffcb67af4a764e04b48d2c3217fa8a23"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_881f00e9f85346789f0db0ca88a8d38d"
      unitRef="U002">0</erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_7d7aee6300734049b01add308349cdbd"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_b0a19c42f19c47d98a49e49eba061241"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_c6d87be84c52454a90338ec2fe460dcd"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_8b960748c7834ebe8e602a37f1dfb290"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_6ca66e0558f4411c8fe19eba3829d566"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_5972c92e19ae4b17bb562210abbe624a"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_87c9ab5982b2445688d5baab4effc6fc"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_a07b806ea7a04b68b7ede830a53bce11"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_0b681a7132144348ae51adfa97ff5087"
      unitRef="U002">2000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_adeb02b0a6c14445adc3c4baf2354f76"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_ce7752c926434abeb4ba99a3e73f5dbd"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_6e572f5078c54ce7a0cf25128124384b"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_d307a195ce1e46a2bcc74d6be0137006"
      unitRef="U001">-5000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_45c7ad202e7e408b965537b082242d3d"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_0b7463cfa66d413a936e26679c59d2a2"
      unitRef="U001">-5000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_6177b58a61a04193be85320ba19cc0c0"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_45f175ab105b469fa99bfec9c05b3ecc"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_a34a9f52f1344ae1b5115a6c773ebe3a"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_cc81cc446b904200980685b838f6258f"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:PreferredStockDividendsShares
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_9cbb445688c74ad2b03b643b1899e81a"
      unitRef="U002">0</us-gaap:PreferredStockDividendsShares>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_d60e99ac1f3d4566be66d92703f6d62b"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:PreferredStockDividendsShares
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_bbd83b30a3464b97a169e90fef819be2"
      unitRef="U002">0</us-gaap:PreferredStockDividendsShares>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_cce100584776444e979c8a8828c0fb15"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_bbd746125ec6481a9dd2fd380a3a2955"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_fca65238688142e8a5bb735db404f594"
      unitRef="U001">16000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_89496344140d4745a11864e639115867"
      unitRef="U001">16000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_04cec13c687444c895d1857a9194cce3"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_9cbc275b621848d19c370eeccc3dea51"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_dd274007dd7a4888a61e21af8667119a"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_5593e5e99c494e629ec7a7f2b6fedbcb"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_8c792d43a451425ba8d4bcbe401957ef"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_87e39e1c24704f62b5f9c0ee33f15008"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_1c130d83f3ea4a49bb7518c28e8926b8"
      unitRef="U001">2935000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_1506472e817145259e5b0d19d927eb52"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_f2ec80647a95454da8080fcabf1dc232"
      unitRef="U001">2935000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_26c03f5e8fa744c2bccb91b5afdc6e81"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_f2d29b34f5544ab7a28b5e3a8f79c254"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_bbe73b3ea48d4e41b133f4af1e7bafd4"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_a8be1c2f408c4e29b90809184a58e31a"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_6f89e3daa9f24876be385be67483305d"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_a62c7f6425e7455b927766632b827430"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_b222b790a21d4827a96e2401f3f438f0"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_d0db408060b24a6c9f7c7fef632b7320"
      unitRef="U001">-24579000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_ba6ace3d0225423dae8483bf7ce8a6fe"
      unitRef="U001">-24579000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="c20221231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_8ae924c88c4b46789788111191b5bb97"
      unitRef="U001">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20221231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_0ad3e5931350424fbd2efb061d8e4b74"
      unitRef="U001">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20221231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_816a331da5b64626b466dc1fc6940e41"
      unitRef="U001">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20221231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_25bf3a7c7520427a8be32efbbcb70ed1"
      unitRef="U001">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_9b88f6198b6746efb962d7ba097cb30f"
      unitRef="U002">5127000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a20785824bec4807a69656df781b83b5"
      unitRef="U001">26000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_5da8c0714c2f41c7b22b11d96889c53f"
      unitRef="U002">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_6a02c87ca8524f5c95e0f47404ee9c5d"
      unitRef="U001">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_f9467d34ef854f35a02a57d193afeb03"
      unitRef="U001">177377000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_16e0ec89d21242328e70870e658c79a6"
      unitRef="U001">-165297000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20221231"
      decimals="-3"
      id="Fact_4b51b834c0c947dfa6a9d19cc21de665"
      unitRef="U001">12107000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_97ae97b0f746486ab74dd483d3309d3f"
      unitRef="U001">-24579000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_521cc7943d01464ca6e251e21eff2472"
      unitRef="U001">-122545000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_995212e6d7184a7cbbae0e9179dd308c"
      unitRef="U001">161000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_2c406f47175c4a5484cc73223f49329b"
      unitRef="U001">117000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_8f2be070befa432c884fbc3e24a49e0a"
      unitRef="U001">2935000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_6b2077a4216a428e82fd850c11a0e4a5"
      unitRef="U001">5235000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_229dec39c4e4464fad5ca19ecd0e4621"
      unitRef="U001">336000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_d4da1ffadf11438db601c99e73c91571"
      unitRef="U001">342000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_7f6bdbe4830f42d69639e2febca59529"
      unitRef="U001">772000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_6b180a0afa2e433a8674f35779cea118"
      unitRef="U001">0</us-gaap:OperatingLeaseImpairmentLoss>
    <erna:GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_2fe99dcba24c4aa5ab24f7ae577af80f"
      unitRef="U001">642000</erna:GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset>
    <erna:GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_f3f2e3219e8649bd9f2860f26f21cf41"
      unitRef="U001">0</erna:GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_d993c1127ba14c158d937fc6f1a48e3d"
      unitRef="U001">5990000</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_5f3bc78ff44d45fc9fb3dcf7afe18214"
      unitRef="U001">0</us-gaap:ImpairmentOfOngoingProject>
    <erna:ResearchAndDevelopmentInProcessAssetAcquisition
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_91ef35c17ddb48b091e146bfd99890da"
      unitRef="U001">0</erna:ResearchAndDevelopmentInProcessAssetAcquisition>
    <erna:ResearchAndDevelopmentInProcessAssetAcquisition
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_a2f986a242fc4b70a58d77c41a150375"
      unitRef="U001">80538000</erna:ResearchAndDevelopmentInProcessAssetAcquisition>
    <erna:GainLossOnDisposalOfFixedAssets
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_b0854ac69a594f3e86a8baf811ae16aa"
      unitRef="U001">280000</erna:GainLossOnDisposalOfFixedAssets>
    <erna:GainLossOnDisposalOfFixedAssets
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_8caa3400228d4360962cd19c51b3a98f"
      unitRef="U001">13000</erna:GainLossOnDisposalOfFixedAssets>
    <erna:GainOnTerminationOfLease
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_322e5d7f53e34b69b33f8d566347b33e"
      unitRef="U001">85000</erna:GainOnTerminationOfLease>
    <erna:GainOnTerminationOfLease
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_8c1b1221683f42d6a528b240ca8970f0"
      unitRef="U001">0</erna:GainOnTerminationOfLease>
    <erna:WarrantLiabilitiesExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_5f906708b2954ed2aafcd7f1dbffbbd7"
      unitRef="U001">-10795000</erna:WarrantLiabilitiesExpense>
    <erna:WarrantLiabilitiesExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_d900b71a9de74a88a48cbf187fa216e6"
      unitRef="U001">0</erna:WarrantLiabilitiesExpense>
    <erna:LossOnNonControllingInvestment
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_91b436d942aa41f39f7bc2971c76346d"
      unitRef="U001">941000</erna:LossOnNonControllingInvestment>
    <erna:LossOnNonControllingInvestment
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_593d0fba8f1649159ddae3202cfd14cb"
      unitRef="U001">0</erna:LossOnNonControllingInvestment>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_99e1dbbf019b4613a0ddf40ab6e566fd"
      unitRef="U001">0</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_4fa60cf56543488b9c2c97dc821abc46"
      unitRef="U001">5765000</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_fafdcf4d10144edd9d5530ca2fc1cfe1"
      unitRef="U001">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_07db12df9a254ec2885d1b8ec0b4c17e"
      unitRef="U001">-9648000</us-gaap:GainLossOnDispositionOfAssets1>
    <erna:GainLossOnForgivenessOfPaycheckProtectionProgramLoan
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_fabbc27badc84bea9fb890a07f29b575"
      unitRef="U001">0</erna:GainLossOnForgivenessOfPaycheckProtectionProgramLoan>
    <erna:GainLossOnForgivenessOfPaycheckProtectionProgramLoan
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c70e48c6225d40f5b3273431539b61f4"
      unitRef="U001">310000</erna:GainLossOnForgivenessOfPaycheckProtectionProgramLoan>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_76a60c2b18354f0cb755833b2c05e689"
      unitRef="U001">262000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_9cc65d45214d45218d8cdf13cdabaea9"
      unitRef="U001">659000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_a04557f2838f4eb7a8bfc2f2a0d84f04"
      unitRef="U001">187000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_6a2c7e939cba4cb281f91a8ff6e524b8"
      unitRef="U001">850000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_dcbcd166c4494d61b3e6a9e0b857c3f6"
      unitRef="U001">646000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_a1001d16b9194180b215a3d4496f0f5e"
      unitRef="U001">0</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_4926bf6ac3ce4d5fb8df01210c228472"
      unitRef="U001">2034000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_64b9a54055c149ed8bde7b198f49c0d7"
      unitRef="U001">-485000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_1859b01d9a744104a3d3073aa4d6cf94"
      unitRef="U001">2956000</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_15f95142188c4d879b83c9b00bc98dd0"
      unitRef="U001">0</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <erna:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_6bb2bd76db7245288e1f4d882e122027"
      unitRef="U001">-340000</erna:IncreaseDecreaseInOperatingLeaseLiabilities>
    <erna:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c076d51c96214f50a9ca001259b8f5a5"
      unitRef="U001">-322000</erna:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_a0e003339978464d98080c31e4ebd301"
      unitRef="U001">155000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_7580c48d09f5451bac3101db0d8e187d"
      unitRef="U001">25000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_9438c6d8a00446beb4803abe7545c1a0"
      unitRef="U001">-20976000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c218a9208bd54844b95c96b7b03c7b6c"
      unitRef="U001">-23488000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_90c2b0f080d442ddaa45704c187d7964"
      unitRef="U001">297000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_9967ecc016e945adb3b34ec01ac26e53"
      unitRef="U001">154000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_4ef1ec54c5004d99ae288f0465d1be67"
      unitRef="U001">250000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_1fdf53e94a394869bd943ac9046e6256"
      unitRef="U001">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSalesOfAssetsInvestingActivities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_a88d2b95513848ab936cb1df79885596"
      unitRef="U001">0</us-gaap:ProceedsFromSalesOfAssetsInvestingActivities>
    <us-gaap:ProceedsFromSalesOfAssetsInvestingActivities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_14d3972df77847f18a5b13eb9f100081"
      unitRef="U001">147000</us-gaap:ProceedsFromSalesOfAssetsInvestingActivities>
    <erna:PaymentsToAcquireProductiveAssetsNet
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_165896434f174639a135a1cb62f54f97"
      unitRef="U001">0</erna:PaymentsToAcquireProductiveAssetsNet>
    <erna:PaymentsToAcquireProductiveAssetsNet
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_7445bfdefe694523a4a01d6f510195fc"
      unitRef="U001">22854000</erna:PaymentsToAcquireProductiveAssetsNet>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_8b72cfdc061b447e97dd15aea0d84490"
      unitRef="U001">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_8ebc215bf857469d991990792449453c"
      unitRef="U001">119000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_91a9d98a2e8a4770a5e4b6bfc676b5eb"
      unitRef="U001">-47000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_2518c08135a642b3864b8d85c80c0620"
      unitRef="U001">-22742000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_8a33d494f58d43208c34c609ac7be65c"
      unitRef="U001">19706000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_0f6c1d2e96094d949ec039dd1d4b0d63"
      unitRef="U001">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <erna:ExpensesPaidInConnectionWithPrivateOffering
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_68c2ff06f92e4ca7a0ca676d92ce0f7f"
      unitRef="U001">110000</erna:ExpensesPaidInConnectionWithPrivateOffering>
    <erna:ExpensesPaidInConnectionWithPrivateOffering
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_fd8289819c8c4464947d59b8bb2fe795"
      unitRef="U001">0</erna:ExpensesPaidInConnectionWithPrivateOffering>
    <erna:IssuanceOfCommonStockFromExerciseOfPreFundedWarrants
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_2acea41995d247f384e727bea044204c"
      unitRef="U001">-7000</erna:IssuanceOfCommonStockFromExerciseOfPreFundedWarrants>
    <erna:IssuanceOfCommonStockFromExerciseOfPreFundedWarrants
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_eedd1a24d03d46e1a9cdc589b7de8408"
      unitRef="U001">0</erna:IssuanceOfCommonStockFromExerciseOfPreFundedWarrants>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_19dd11c31af54ac780a62a9e50798fe0"
      unitRef="U001">5000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_7bbeefe3a4b541db9419da5adb62c51f"
      unitRef="U001">0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_d2377164fbf247ecb75db0a3a8028bbd"
      unitRef="U001">2000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_223d9ac43f1e45758cec394ff882eadb"
      unitRef="U001">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_2cd5d320c4b3447bbdf10524202f3909"
      unitRef="U001">16000</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_3a8f9dd656d34990a21318d03cae1789"
      unitRef="U001">8000</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_d80f39083e844ef88135cba101b4e409"
      unitRef="U001">1000</erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit>
    <erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_5286e282163b489ea6b1eebec9060420"
      unitRef="U001">0</erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit>
    <erna:ProceedsFromIssuanceOfCommonStockToLincolnPark
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_8db377942e9d43b7b940480f97dc3162"
      unitRef="U001">0</erna:ProceedsFromIssuanceOfCommonStockToLincolnPark>
    <erna:ProceedsFromIssuanceOfCommonStockToLincolnPark
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_d3f0b20d70bb4ad3a1e0c5b317b935f4"
      unitRef="U001">52025000</erna:ProceedsFromIssuanceOfCommonStockToLincolnPark>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_81059b5d6e2d417e9e46de0382e36b29"
      unitRef="U001">0</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_ec3b02e7f9cc433bb379f31c02ce0777"
      unitRef="U001">10500000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_20bd34df1d674c18853e9cebd227974f"
      unitRef="U001">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_69fb32a37e784ed2b6013e68688c0989"
      unitRef="U001">10000</us-gaap:ProceedsFromStockOptionsExercised>
    <erna:PaymentsOfPaycheckProtectionProgramLoan
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_c82ddc23f84b4376883f54ff3d123a51"
      unitRef="U001">0</erna:PaymentsOfPaycheckProtectionProgramLoan>
    <erna:PaymentsOfPaycheckProtectionProgramLoan
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_bc50e7369ee04aa1932e95398276c8a3"
      unitRef="U001">532000</erna:PaymentsOfPaycheckProtectionProgramLoan>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_46256f2dbc4643e59164b07c033e807c"
      unitRef="U001">0</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_4523452ea396420fb4aa5df88ffc392d"
      unitRef="U001">410000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_7e0935250a9d425586ca9850bc3d79fe"
      unitRef="U001">19579000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_ebb648f21fe448009b43ff11e100ee12"
      unitRef="U001">61585000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_a392c83c1f964fe4a1ebef3bf636d557"
      unitRef="U001">-1444000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_e6da942c86bc4f1fa36e6c1e89b89acb"
      unitRef="U001">15355000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20211231"
      decimals="-3"
      id="Fact_cd16d33f438845489c4a507bbec427d4"
      unitRef="U001">16985000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20201231"
      decimals="-3"
      id="Fact_a3a7542fb7124aba941849042f4847da"
      unitRef="U001">1630000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20221231"
      decimals="-3"
      id="Fact_0e1a65aa80df482d84072238ea16f061"
      unitRef="U001">15541000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20211231"
      decimals="-3"
      id="Fact_55d5dbdf0bda431cb015e1b474c98ff6"
      unitRef="U001">16985000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_16158331690542da9563876126fe224c"
      unitRef="U001">30000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_6036a4ad6cb147e1bf0cb91113e13497"
      unitRef="U001">225000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_ce5e6271ff3b45c5956e0cd02e8fc7d1"
      unitRef="U001">15000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_107a4b9de5944a26a6c1dd7619ff65b2"
      unitRef="U001">1000</us-gaap:IncomeTaxesPaidNet>
    <erna:ConversionOfWarrantLiabilityToEquity
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_2473d24f0ff9488187b48c9daf800fc7"
      unitRef="U001">867000</erna:ConversionOfWarrantLiabilityToEquity>
    <erna:ConversionOfWarrantLiabilityToEquity
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_3cf67b71fe254724a391a95b712f368e"
      unitRef="U001">0</erna:ConversionOfWarrantLiabilityToEquity>
    <erna:InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_a71e3ce637f2400c8ef97f8c9f0c9727"
      unitRef="U001">1706000</erna:InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities>
    <erna:InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_65df2dff199b4f43a0bbe85799f6d40d"
      unitRef="U001">866000</erna:InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities>
    <erna:UnpaidFeesIncurredInConnectionWithPrivateOffering
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_b1be55513a314f7c8ed96e2dd373ad75"
      unitRef="U001">208000</erna:UnpaidFeesIncurredInConnectionWithPrivateOffering>
    <erna:UnpaidFeesIncurredInConnectionWithPrivateOffering
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_7162d1ed923a4894a103eed6053c9584"
      unitRef="U001">0</erna:UnpaidFeesIncurredInConnectionWithPrivateOffering>
    <erna:InitialMeasurementOfFinanceLeaseLiabilities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_7a310ed939304861aa170fcd5f120549"
      unitRef="U001">10000</erna:InitialMeasurementOfFinanceLeaseLiabilities>
    <erna:InitialMeasurementOfFinanceLeaseLiabilities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_e924fbeaf7e047b1bbbb85471febc32b"
      unitRef="U001">0</erna:InitialMeasurementOfFinanceLeaseLiabilities>
    <erna:IssuanceOfCommonStockForSeriesAPreferredStockDividend
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_43b002cf4d7c45e3b7d386fa64c6c5c3"
      unitRef="U001">0</erna:IssuanceOfCommonStockForSeriesAPreferredStockDividend>
    <erna:IssuanceOfCommonStockForSeriesAPreferredStockDividend
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_26fd7c695cc44e3ab319f0809a3d4009"
      unitRef="U001">8000</erna:IssuanceOfCommonStockForSeriesAPreferredStockDividend>
    <us-gaap:StockIssued1
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_07593f35c2314c66958dc6fdf7a4d1d2"
      unitRef="U001">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_6bcac8f62de14dd4993167f85eb9e18b"
      unitRef="U001">8178000</us-gaap:StockIssued1>
    <erna:IssuanceOfCommonStockForAssetAcquisition
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_625555836d4b4915be65656c95b8bc73"
      unitRef="U001">0</erna:IssuanceOfCommonStockForAssetAcquisition>
    <erna:IssuanceOfCommonStockForAssetAcquisition
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_63ae8daa21f9468bb05dd349831ec7ea"
      unitRef="U001">58684000</erna:IssuanceOfCommonStockForAssetAcquisition>
    <erna:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_8e28e357347e4428a5f12d3a748dd905"
      unitRef="U001">0</erna:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger>
    <erna:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_d83c72c9f91a4cf987e8fdb78fa65220"
      unitRef="U001">1000</erna:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20221231"
      decimals="-3"
      id="Fact_432e2e37f14842ea8e2140377e01f649"
      unitRef="U001">11446000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a43f6f5bbd084f9886b9485ec94b06a7"
      unitRef="U001">16985000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_616e4d25d2cd41eda1b0215c19a53d2b"
      unitRef="U001">4095000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_78d4ee5de04b465d9fb6b4a4c4ee93e0"
      unitRef="U001">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20221231"
      decimals="-3"
      id="Fact_cc2d14d3c67f4c95907aee6c0af64665"
      unitRef="U001">15541000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20211231"
      decimals="-3"
      id="Fact_fbbcf0ee649d46dfaa8409b08cf1c01d"
      unitRef="U001">16985000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="c20220101to20221231"
      id="Text_e8e4b46423fc459bb75555fc7279ec7b">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;1)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Organization and Description of Business Operations&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;On October 11, 2022, Eterna Therapeutics Inc., a Delaware corporation, (&#x201c;Eterna&#x201d; or the &#x201c;Company&#x201d;), changed its name from
            Brooklyn ImmunoTherapeutics, Inc. to Eterna Therapeutics Inc. upon its filing with the Secretary of State of the State of Delaware a Certificate of Amendment to its Restated Certificate of Incorporation, as amended (the &#x201c;Charter&#x201d;).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Eterna, together with its subsidiaries including Eterna Therapeutics LLC (formerly Brooklyn Immunotherapeutics LLC)
            (&#x201c;Eterna LLC&#x201d;), Novellus, Inc. (&#x201c;Novellus&#x201d;) and Novellus Therapeutics Limited (&#x201c;Novellus Limited&#x201d;), is a preclinical-stage biopharmaceutical company committed to realizing the potential of mRNA cell engineering to provide patients with
            transformational new medicines. Eterna has in -licensed a portfolio of over 100 patents covering key mRNA cell engineering
            technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice&lt;sup style="line-height: 1; font-size: smaller; vertical-align: text-top;"&gt;TM&lt;/sup&gt; and UltraSlice&lt;sup style="line-height: 1; font-size: smaller; vertical-align: text-top;"&gt;TM&lt;/sup&gt; gene-editing proteins, and the ToRNAdo&lt;sup style="line-height: 1; font-size: smaller; vertical-align: text-top;"&gt;TM&lt;/sup&gt; mRNA delivery system. Eterna plans to develop and advance a pipeline of therapeutic
            products both internally and through strategic partnerships, with the near-term focus on strategic partnerships. Eterna licenses its mRNA technology platform from Factor Bioscience Limited (&#x201c;Factor Limited&#x201d;) under an exclusive license
            agreement. As used herein, the &#x201c;Company&#x201d; refers collectively to Eterna and its subsidiaries.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;On August 12, 2020, Eterna (then known as &#x201c;NTN Buzztime, Inc.&#x201d;), Eterna LLC (then known as &#x201c;Brooklyn Immunotherapeutics
            LLC&#x201d;) and BIT Merger Sub, Inc., a wholly owned subsidiary of Eterna (the &#x201c;Merger Sub&#x201d;), entered into an agreement and plan of merger and reorganization (the &#x201c;Merger Agreement&#x201d;) pursuant to which, among other matters, Merger Sub merged with and
            into Eterna LLC, with Eterna LLC surviving the merger as a wholly owned subsidiary of Eterna (the &#x201c;Merger&#x201d;). The Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which Eterna LLC was deemed the
            acquiring company for accounting purposes.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;On March 26, 2021, Eterna sold its rights, title and interest in and to the assets relating to the pre-Merger business
            operated under the name &#x201c;NTN Buzztime, Inc.&#x201d; (the &#x201c;Disposition&#x201d;) to eGames.com Holdings LLC (&#x201c;eGames.com&#x201d;) in accordance with the terms of an asset purchase agreement dated September 18, 2020, as amended, between Eterna and eGames.com (the
            &#x201c;Asset Purchase Agreement&#x201d;).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;On July 16, 2021, Eterna and its newly formed, wholly owned subsidiary Brooklyn Acquisition Sub, Inc. entered into an
            agreement and plan of acquisition (the &#x201c;Novellus Acquisition Agreement&#x201d;) with Novellus LLC, Novellus (the sole equity holder of Novellus Limited and, prior to the closing under the Novellus Acquisition Agreement, a subsidiary of Novellus LLC),
            and (c) a seller representative, pursuant to which Eterna acquired Novellus and its subsidiary, Novellus Limited (the &#x201c;Novellus Acquisition&#x201d;). As part of the Novellus Acquisition, Eterna also acquired 25.0% of the total outstanding equity interests of NoveCite, Inc. (&#x201c;NoveCite&#x201d;), a corporation focused on developing an allogeneic mesenchymal stem cell product for patients
            with acute respiratory distress syndrome, including from COVID-19.&lt;/div&gt;
</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <erna:NumberOfInLicensedPortfolioPatents
      contextRef="c20220101to20221231_RangeAxis_MinimumMember"
      decimals="0"
      id="Fact_dcba2fae1a6f4654a860fbf3ef6845f2"
      unitRef="U004">100</erna:NumberOfInLicensedPortfolioPatents>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="3"
      id="Fact_da6389e1d75345679e8be3f09903ccf4"
      unitRef="U005">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <erna:LiquidityAndCapitalResourcesTextBlock
      contextRef="c20220101to20221231"
      id="Text_fc15066e43c442738a9103a62a510e6f">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;2)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Liquidity and Capital Resources&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company has incurred significant operating losses and has an accumulated deficit as a result of its efforts to develop
        product candidates, including conducting clinical trials and providing general and administrative support for operations. As of December 31, 2022, the Company had an unrestricted cash balance of approximately $11.4 million and an accumulated deficit of approximately $165.3
        million. For the year ended December 31, 2022, the Company incurred a net loss of $24.6 million, and the Company used cash in operating
        activities of $21.0 million.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On March 6, 2022, the Company entered into a securities purchase agreement (the &#x201c;Q1-22 Purchase Agreement&#x201d;) with an investor (the &#x201c;Q1-22 PIPE Investor&#x201d;), providing for the private placement (the
              &#x201c;Q1-22 PIPE Transaction&#x201d;) to the Q1-22 PIPE Investor of approximately 343,000 units, each unit consisting of (i) one share of our common stock, par value $0.005
              per share (or, in lieu thereof, one pre-funded warrant (each, a &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#x201c;&lt;/span&gt;&lt;/span&gt;Q1-22



















              Pre-Funded Warrant&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#x201d;)&lt;/span&gt;&lt;/span&gt; to purchase one share of common stock) and (ii) one
              warrant (each, a &#x201c;Q1-22 Common Warrant&#x201d;) to purchase one share of common stock, for an aggregate gross purchase price of approximately $12.0
              million. The Q1-22 PIPE Transaction closed on March 9, 2022.&lt;/span&gt;&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On October 18, 2022, the Company entered into a facility sublease agreement (the &#x201c;Sublease&#x201d;) for approximately 45,500 square feet of office and laboratory space in Somerville, Massachusetts.&#160; Pursuant to the Sublease, the Company delivered to the sublessor a security deposit in the
          form of a letter of credit in the amount of $4.1 million, which will be reduced on an incremental basis throughout the term of the
          lease.&#160; The letter of credit was issued by the Company&#x2019;s commercial bank, which required that the Company cash collateralize the letter of credit by depositing $4.1 million in a restricted cash account with such bank.&#160; The amount of required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of
          credit over the term of the Sublease; and the amount of restricted cash reduces by an equal amount the Company&#x2019;s available working capital.&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;br/&gt;
         &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On November 23, 2022, the Company entered into a securities purchase agreement (the &#x201c;Q4-22 Purchase Agreement&#x201d;) with certain investors (the &#x201c;Q4-22 PIPE Investors&#x201d;),
          providing for the private placement (the &#x201c;Q4-22 PIPE Transaction&#x201d;) to the Q4-22 PIPE Investors of approximately of 2,185,000 units,
          each unit consisting of (i) one share of common stock and (ii) two warrants, each exercisable to purchase one share of common stock at an exercise price of $3.28
          per share (the &#x201c;Q4-22 Warrants&#x201d;), at a purchase price of $3.53 per unit (inclusive of $0.125 per Q4-22 Warrant). &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company received aggregate gross proceeds of approximately $7.7
            million, &lt;/span&gt;and the Q4-22 PIPE Transaction closed on December 2, 2022. Each Q4-22 Warrant becomes exercisable six months
          following the date of closing, expires &lt;span style="-sec-ix-hidden:Fact_cd1a85f5a00d40e2a9ec630f5346c135"&gt;five-and-one-half&lt;/span&gt; years following such date, and is subject to customary adjustments.&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
       &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;In
















            connection with preparing the accompanying consolidated financial statements as of and for the year ended December 31, 2022, the Company&#x2019;s management concluded that there is substantial doubt regarding the Company&#x2019;s ability to continue as a
            going concern because it does not expect to have sufficient cash or working capital resources to fund operations for the twelve-month period subsequent to the issuance date of these financial statements. The Company will need to raise
            additional capital, which could be through public or private equity offerings, debt financings, strategic partnerships or other means. The Company currently has no arrangements for such capital, and no assurances can be given that it will be
            able to raise such capital when needed, on acceptable terms, or at all.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The
        accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The accompanying consolidated financial
        statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to the Company&#x2019;s ability
        to continue as a going concern.&lt;/div&gt;
</erna:LiquidityAndCapitalResourcesTextBlock>
    <us-gaap:Cash
      contextRef="c20221231"
      decimals="-5"
      id="Fact_3be2952f3e3f4dc987debb8d207e6a9d"
      unitRef="U001">11400000</us-gaap:Cash>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20221231"
      decimals="-5"
      id="Fact_be6cebbb4ed14fd6879b7baa56c04bb4"
      unitRef="U001">-165300000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_16e04402cae34c39bc6f799ff00ef9d5"
      unitRef="U001">-24600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_131616b6a92e4ae583d9e3de79acf38d"
      unitRef="U001">-21000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_b8422f73819d423d91e7a1dd5566123f"
      unitRef="U002">343000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_6754e9a435094e6dbb04304ef5e49411"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="3"
      id="Fact_3e0725435892487abaac5494c55c1a24"
      unitRef="U003">0.005</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_4efa0081f13d4034b4a661cce9aaadd3"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_75d8b3941e6148d783374f924cd5c2d0"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_f1ff74e1588f460588a69fa22bccdbb8"
      unitRef="U001">12000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="c20221018"
      decimals="0"
      id="Fact_2d71ecbb551e4afa96782aa967f8a059"
      unitRef="U006">45500</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LineOfCredit
      contextRef="c20221018"
      decimals="-5"
      id="Fact_6c281fa60236482684fca3ae5e8a2fb8"
      unitRef="U001">4100000</us-gaap:LineOfCredit>
    <us-gaap:RestrictedCash
      contextRef="c20221018"
      decimals="-5"
      id="Fact_6dd9591faa5e4a908c2621d58b3da3cb"
      unitRef="U001">4100000</us-gaap:RestrictedCash>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_90b68aac26574835b71aa5fe8982958b"
      unitRef="U002">2185000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_a76abbeb1b9a46978e8b16cf0c4a3b89"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_4d35e2b46c9047d28fcc45d5ef215940"
      unitRef="U002">2</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="2"
      id="Fact_dee178fabbac40489a340f667d4b8d94"
      unitRef="U003">3.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <erna:UnitPriceOfWarrants
      contextRef="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="2"
      id="Fact_7662d2e7c59c471fb0bff7e6193b196b"
      unitRef="U003">3.53</erna:UnitPriceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact_3e6104e3640446c1b2b94632f956b01f"
      unitRef="U003">0.125</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c20221202to20221202_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_266c5121a65c49f49dda367ee7c54a20"
      unitRef="U001">7700000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <erna:ClassOfWarrantOrRightsExercisableTerm
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      id="Fact_bb556dac4b224e6582b90dc09b796b05">P6M</erna:ClassOfWarrantOrRightsExercisableTerm>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="c20220101to20221231"
      id="Text_58dd98addd9c452ab1c0163aa9b955ed">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;3)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Basis of Accounting Presentation and Summary of Significant Accounting Policies&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Basis of Accounting Presentation&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles
        (&#x201c;GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Updates (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;). All
        significant intercompany balances and transactions have been eliminated in consolidation.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;As described above, the Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which
          Eterna LLC was deemed the acquiring company for accounting purposes. Eterna LLC&#x2019;s historical financial statements replaced Eterna&#x2019;s historical financial statements with respect to periods prior to the completion of the Merger (when Eterna
          operated under the name &#x201c;NTN Buzztime, Inc.&#x201d;). The Company retrospectively adjusted the weighted average shares used in determining loss per common share to reflect the conversion of the outstanding Class A units, Class B units, Class C units,
          and common units of Eterna LLC that converted into shares of Eterna&#x2019;s common stock upon consummation of&#160; the Merger and to reflect the effect of a &lt;span style="-sec-ix-hidden:Fact_abe396817a904d8ea2336e844b48953a"&gt;2-to-1&lt;/span&gt;
          reverse stock split of Eterna&#x2019;s common stock that occurred immediately prior to the Merger.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Also as described above, the Novellus Acquisition closed on July 16, 2021. The Novellus Acquisition was accounted for as an
          asset acquisition, and substantially all of the value was attributed to in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;), with the exception of the cash paid for the investment in NoveCite, which has been accounted for as an investment in equity
          securities. The IPR&amp;amp;D had no alternative future uses and no separate economic value from its originally intended purpose and was therefore expensed at the acquisition date.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none;"&gt;October 2022 Reverse Stock Split&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;As approved by the Company&#x2019;s stockholders at the Company&#x2019;s Annual Meeting of Stockholders held on September 21,
            2022, the Company effected a reverse stock split of its common stock at a ratio of &lt;span style="-sec-ix-hidden:Fact_9ec8b708b2c6467a940f0725195187c5"&gt;1-for-20&lt;/span&gt;, as determined by the Company&#x2019;s Board of
            Directors within the parameters approved by the Company&#x2019;s stockholders (the &#x201c;October 2022 Reverse Stock Split&#x201d;).&#160; The October 2022 Reverse Stock Split became effective under Delaware law at 11:59 p.m. Eastern time on October 16, 2022.&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 27pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-variant: normal; text-transform: none;"&gt; &lt;span style="font-size: 10pt;"&gt; &lt;/span&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt; Upon the effectiveness of the October
          2022 Reverse Stock Split, every twenty shares of the issued and outstanding common stock were automatically combined and reclassified into one issued and outstanding share of common stock. The October 2022 Reverse Stock Split did not affect any
          stockholder&#x2019;s ownership percentage of the common stock, alter the par value of the common stock or modify any voting rights or other terms of the common stock. The number of authorized shares of common stock under the Charter remains unchanged.
          No fractional shares were issued in connection with the October Reverse Stock Split. In lieu of any fractional shares to which a stockholder would otherwise be entitled, the Company paid an amount of cash equal to the product of (i) the
          fractional share to which the holder would otherwise be entitled and (ii) the then fair value of a share as determined in good faith by the Board.&#160; The Company paid an aggregate of $719 for a total of 175 fractional shares.&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;All share and per share data in this
          Annual Report on Form 10-K have been adjusted for all periods presented to reflect the October 2022 Reverse Stock Split.&lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Summary of Significant Accounting Policies&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and
        assumptions that affect: (a) the reported amounts of assets and liabilities; (b) disclosure of contingent assets and liabilities at the date of the consolidated financial statements; (c) the reported amounts of expenses during the reporting period;
        and (d) the reported amount of the fair value of assets acquired in connection with business combinations. On an ongoing basis, the Company evaluates its estimates, including those related to the recoverability and useful lives of long-lived
        assets; stock-based compensation assumptions; valuation assumptions of warrants; contingencies; and the provision for income taxes, including the valuation allowance. The Company bases its estimates on a combination of historical experience and
        various other assumptions that it believes are reasonable under the circumstances. Actual results may differ materially from these estimates.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company classifies highly liquid investments with a remaining contractual maturity at date of purchase of three months or
        less as cash equivalents. The Company had no cash equivalents as of December 31, 2022 or 2021.&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; Restricted cash consists of a cash collateralization of $4.1 million for a security deposit in the form of a letter of credit issued by the Company&#x2019;s commercial bank and delivered to the sublessor of the Sublease. The amount of
        required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of credit over the term of the Sublease.&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Property and equipment are recorded at cost and are depreciated over their estimated useful lives using the straight-line
        method. Laboratory and manufacturing equipment are depreciated over an estimated useful life of seven years. Leasehold improvements are
        depreciated over the shorter of their estimated useful life, or the lease term. Computer equipment are depreciated over an estimated useful life of three years. Upon retirement or other disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the resulting gain or losses are reflected in the results of
        operations. Expenditures for maintenance and repairs are charged to operations. Renewals and betterments are capitalized.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in the acquisition
        of IRX Therapeutics, Inc. (&#x201c;IRX&#x201d;) in November 2018 (the &#x201c;IRX Acquisition&#x201d;), which was accounted for as a business combination. Goodwill is not amortized but is tested for impairment annually or if events occur or circumstances change that would
        reduce the fair value of a reporting unit below its carrying value. Because management evaluates the Company as a single reporting unit, goodwill is tested for impairment at the entity level by first performing a qualitative assessment to determine
        whether it is more likely than not that the fair value of the entity is less than its carrying value. Such qualitative factors include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and
        other relevant events.&#160; If the entity does not pass the qualitative assessment, then the entity&#x2019;s carrying value is compared to its fair value. Goodwill is considered impaired if the carrying value of the entity exceeds its fair value.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;IPR&amp;amp;D assets represent the fair value assigned to technologies that were acquired in connection with the IRX Acquisition,
        which have not reached technological feasibility and have no alternative future use. IPR&amp;amp;D assets are considered to be indefinite lived until the completion or abandonment of the associated research and development projects. During the period
        that the IPR&amp;amp;D assets are considered indefinite-lived, they are tested for impairment on an annual basis or more frequently if the Company becomes aware of any events occurring or changes in circumstances that indicate that the fair value of
        the IPR&amp;amp;D assets are less than their carrying amounts. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize products associated with the IPR&amp;amp;D assets, these assets
        are then deemed definite-lived and are amortized based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a full or partial impairment charge related to the IPR&amp;amp;D
        assets, calculated as the excess of carrying value of the IPR&amp;amp;D assets over fair value.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company expenses its research and development costs as incurred. Research and development expenses consist of costs
        incurred for company-sponsored research and development activities, as well as support for selected investigator-sponsored research. Upfront payments and milestone payments made for the licensing of technology are expensed as research and
        development in the period in which they are incurred if the technology is not expected to have any alternative future uses other than the specific research and development project for which it was intended. IPR&amp;amp;D that is acquired through an
        asset acquisition (as opposed to a business combination) and has no alternative future uses and, therefore, no separate economic values, is expensed to research and development costs at the time the costs are incurred.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The major components of research and development costs include preclinical study costs, clinical manufacturing costs, clinical
        study and trial expenses, insurance coverage for clinical trials, expensed licensed technology, expensed IPR&amp;amp;D, consulting, scientific advisors and other third-party costs, salaries and employee benefits, stock-based compensation expense,
        supplies and materials and allocations of various overhead costs related to our product development efforts.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company has contracted with third parties to perform various clinical study and trial activities in the development and
        testing of potential products. The financial terms of these agreements vary from contract to contract and may result in uneven payment flows. The Company accrues for third party expenses based on estimates of the services received and efforts
        expended during the reporting period. If the actual timing of the performance of the services or the level of effort varies from the estimate, the accrual is adjusted accordingly. The expenses for some third-party services may be recognized on a
        straight-line basis if the expected costs are expected to be incurred ratably during the period. Payments under the contracts depend on factors such as the achievement of certain events or milestones, the successful enrollment of patients, the
        allocation of responsibilities among the parties to the agreement, and the completion of portions of the clinical study or trial or similar conditions. Preclinical and clinical study and trial associated activities such as production and testing of
        clinical material require significant up-front expenditures.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company records deferred tax liabilities and assets based on the differences between the consolidated financial statements
        carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and establishing a valuation allowance when it was more likely than not that some portion or all of
        the deferred tax assets would not be realized. Income tax expense consists of the tax payable for the period and the change during the period in deferred tax assets and liabilities.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Tax benefits from uncertain tax positions are recognized only if it is more likely than not that the tax position will be
        sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a
        greater than 50% likelihood of being realized upon ultimate resolution. The Company has no material uncertain tax positions for any of the reporting periods presented.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Loss Per Share&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Basic and diluted loss per common share have been computed by dividing the losses attributable to common stockholders by the
        weighted average number of common shares outstanding. The Company&#x2019;s basic and fully diluted loss per share calculations are the same because the increased number of shares that would be included in the diluted calculation from assumed exercise of
        common stock equivalents would be anti-dilutive to the net loss in each of the years shown in the consolidated financial statements.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company&#x2019;s chief operating decision maker, who is the chief executive officer, reviews operating results on a consolidated
        basis to make decisions about allocating resources and assessing performance of the Company.&#160; As a result, in accordance with ASC No. 280, &lt;span style="font-style: italic;"&gt;Segment Reporting,&lt;/span&gt; the Company has determined that it operates as one operating segment.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company maintains its cash balances in financial institutions located in the United States. Accounts at each institution
        are insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) up to $250,000. The Company&#x2019;s cash balances are uninsured for deposit accounts that exceed the FDIC insurance limit.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;In the Company&#x2019;s business, vendor concentrations could be indicative of vulnerabilities in the Company&#x2019;s supply chain, which
        could ultimately impact the Company&#x2019;s ability to continue its research and development activities. For the years ended December 31, 2022 and 2021, there was no vendor concentration related to the Company&#x2019;s research and development activities.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly
        transaction between willing market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to
        unobservable inputs. The fair value hierarchy is as follows:&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; &lt;span style="color: rgb(0, 0, 0);"&gt;Level 1 Inputs &#x2013; Valued based on quoted prices in active markets
          for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; &lt;span style="color: rgb(0, 0, 0);"&gt;Level 2 Inputs &#x2013; Valued based on inputs other than quoted prices
          included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities
          in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or
          corroborated by market data by correlation or other means.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; &lt;span style="color: rgb(0, 0, 0);"&gt;Level 3 Inputs &#x2013; Valued based on inputs for which there is
          little or no market value, which require the reporting entity to develop its own assumptions.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The carrying amounts reported on the balance sheet for cash and cash equivalents, accounts receivable, prepaid assets and other
        current assets, accounts payable and accrued expenses, other current liabilities and other liabilities approximate fair value based due to their short maturities.&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Leases&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The Company accounts for its leases under
        ASC Topic 842, &lt;span style="font-style: italic;"&gt;Leases.&lt;/span&gt; Operating lease liabilities represent the present value of lease payments not yet paid. Right-of-use (&#x201c;ROU&#x201d;) assets represent the Company&#x2019;s right to use an underlying asset and are
        based upon the operating lease liabilities adjusted for prepaid or accrued lease payments, initial direct costs, lease incentives and impairment of operating lease assets. If the interest rate implicit in the lease is not readily determinable, the
        Company uses the incremental borrowing rates for collateralized borrowings in an amount equal to the lease payments under similar terms.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The Company has elected the practical
        expedient to not separate non-lease components from the lease components to which they relate and instead account for each as a single lease component for all underlying asset classes. Some leasing arrangements require variable payments that are
        dependent on usage or may vary for other reasons, such as payments for insurance, tax payments and other miscellaneous costs. The variable portion of payments contemplated in the lease that do not depend on an index or rate are not included in the
        ROU assets or lease liabilities. Rather, variable payments that do not depend on an index or rate are expensed when the obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease
        contract are accounted for as lease expenses.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company has also elected not to recognize ROU and lease liabilities for short-term leases that have a term of 12 months
          or less.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Commitment and Contingencies&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company follows ASC No.450-20, &lt;span style="font-style: italic;"&gt;Loss Contingencies,&lt;/span&gt; to report accounting for
        contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be
        reasonably estimated.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company recognizes stock-based compensation expense for equity awards granted to employees, directors and certain
        consultants. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-lined basis.&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Warrants&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an
        assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480, &lt;span style="font-style: italic;"&gt;Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging.&lt;/span&gt; The assessment considers
        whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or meet all of the requirements for equity classification under ASC 815, including whether the warrants are
        indexed to the Company&#x2019;s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification. This assessment, which
        requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.&lt;span style="text-decoration: underline;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Recent Accounting Standards&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;/span&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;"&gt;Newly Adopted Accounting
        Standards:&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In July 2021, the FASB issued Accounting
        Standards Update (&#x201c;ASU&#x201d;) 2021-05, &lt;span style="font-style: italic;"&gt;Leases (Topic 842) &#x2013; Lessors - Certain Leases with Variable Lease Payments,&lt;/span&gt; which amends the lessor classification guidance to introduce additional criteria when
        classifying leases with variable lease payments that do not depend on a reference index or a rate. The Company adopted this ASU effective January 1, 2022, which did not have a material impact on its financial statements.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In May 2021, the FASB issued ASU 2021-04&lt;span style="font-style: italic;"&gt;, Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40):
          Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&lt;/span&gt;. ASU 2021-04 addresses the accounting for certain modifications or exchanges of freestanding equity-classified written call
        options. The Company adopted this ASU effective January 1, 2022, which did not have a material impact on the Company&#x2019;s financial statements.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In November 2021, the FASB issued ASU
        2021-10, &lt;span style="font-style: italic;"&gt;Disclosures by Business Entities about Government Assistance, &lt;/span&gt; which requires a business entity to disclose information about certain government assistance that it has received, including (i) the
        type of assistance, (ii) an entity&#x2019;s accounting for the assistance and (iii) the effect of the assistance on the entities accounting statements.&#160; The Company adopted this standard effective January 1, 2022, which did not have a material impact on
        the Company&#x2019;s financial statements. The Company has approximately $0.6 million in payroll tax refunds recorded in other receivable on
        the accompanying consolidated balance sheets as of December 31, 2022 and 2021 pursuant to the Employee Retention Credit program under the CARES Act.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;"&gt;Accounting Standards to
        be Adopted:&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;In June 2022, the FASB issued ASU No.
        2022-03, &lt;span style="font-style: italic;"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions &lt;/span&gt;(&#x201c;ASU 2022-03&#x201d;). The FASB issued ASU 2022-03 to (1) clarify the guidance in
        Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new
        disclosure requirements for equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is
        not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years
        with early adoption permitted. The Company is evaluating when to adopt the amendments in ASU 2022-02. The Company does not expect a material impact as a result of adopting this ASU.&lt;/div&gt;
</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="c20220101to20221231"
      id="Text_00959b52567a41a3b8e8cec794fec4cb">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Basis of Accounting Presentation&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles
        (&#x201c;GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Updates (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;). All
        significant intercompany balances and transactions have been eliminated in consolidation.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;As described above, the Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which
          Eterna LLC was deemed the acquiring company for accounting purposes. Eterna LLC&#x2019;s historical financial statements replaced Eterna&#x2019;s historical financial statements with respect to periods prior to the completion of the Merger (when Eterna
          operated under the name &#x201c;NTN Buzztime, Inc.&#x201d;). The Company retrospectively adjusted the weighted average shares used in determining loss per common share to reflect the conversion of the outstanding Class A units, Class B units, Class C units,
          and common units of Eterna LLC that converted into shares of Eterna&#x2019;s common stock upon consummation of&#160; the Merger and to reflect the effect of a &lt;span style="-sec-ix-hidden:Fact_abe396817a904d8ea2336e844b48953a"&gt;2-to-1&lt;/span&gt;
          reverse stock split of Eterna&#x2019;s common stock that occurred immediately prior to the Merger.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Also as described above, the Novellus Acquisition closed on July 16, 2021. The Novellus Acquisition was accounted for as an
          asset acquisition, and substantially all of the value was attributed to in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;), with the exception of the cash paid for the investment in NoveCite, which has been accounted for as an investment in equity
          securities. The IPR&amp;amp;D had no alternative future uses and no separate economic value from its originally intended purpose and was therefore expensed at the acquisition date.&lt;/div&gt;
</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <erna:ReverseStockSplitPolicyTextBlock
      contextRef="c20220101to20221231"
      id="Text_46d89bbe0daa4b598267f4b6e0b73746">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none;"&gt;October 2022 Reverse Stock Split&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;As approved by the Company&#x2019;s stockholders at the Company&#x2019;s Annual Meeting of Stockholders held on September 21,
            2022, the Company effected a reverse stock split of its common stock at a ratio of &lt;span style="-sec-ix-hidden:Fact_9ec8b708b2c6467a940f0725195187c5"&gt;1-for-20&lt;/span&gt;, as determined by the Company&#x2019;s Board of
            Directors within the parameters approved by the Company&#x2019;s stockholders (the &#x201c;October 2022 Reverse Stock Split&#x201d;).&#160; The October 2022 Reverse Stock Split became effective under Delaware law at 11:59 p.m. Eastern time on October 16, 2022.&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 27pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-variant: normal; text-transform: none;"&gt; &lt;span style="font-size: 10pt;"&gt; &lt;/span&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt; Upon the effectiveness of the October
          2022 Reverse Stock Split, every twenty shares of the issued and outstanding common stock were automatically combined and reclassified into one issued and outstanding share of common stock. The October 2022 Reverse Stock Split did not affect any
          stockholder&#x2019;s ownership percentage of the common stock, alter the par value of the common stock or modify any voting rights or other terms of the common stock. The number of authorized shares of common stock under the Charter remains unchanged.
          No fractional shares were issued in connection with the October Reverse Stock Split. In lieu of any fractional shares to which a stockholder would otherwise be entitled, the Company paid an amount of cash equal to the product of (i) the
          fractional share to which the holder would otherwise be entitled and (ii) the then fair value of a share as determined in good faith by the Board.&#160; The Company paid an aggregate of $719 for a total of 175 fractional shares.&lt;br/&gt;
        &lt;/div&gt;
</erna:ReverseStockSplitPolicyTextBlock>
    <erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit
      contextRef="c20220921to20220921"
      decimals="0"
      id="Fact_f94d1a856ada47b48a889b068aa5dbdc"
      unitRef="U001">719</erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit>
    <erna:NumberOfSharesConsideredAsFractionalInReverseStock
      contextRef="c20220921to20220921"
      decimals="0"
      id="Fact_6457ce84a743435894692b11115e4c88"
      unitRef="U002">175</erna:NumberOfSharesConsideredAsFractionalInReverseStock>
    <us-gaap:UseOfEstimates
      contextRef="c20220101to20221231"
      id="Text_c45d270b2b8544d091aa6a102988a144">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and
        assumptions that affect: (a) the reported amounts of assets and liabilities; (b) disclosure of contingent assets and liabilities at the date of the consolidated financial statements; (c) the reported amounts of expenses during the reporting period;
        and (d) the reported amount of the fair value of assets acquired in connection with business combinations. On an ongoing basis, the Company evaluates its estimates, including those related to the recoverability and useful lives of long-lived
        assets; stock-based compensation assumptions; valuation assumptions of warrants; contingencies; and the provision for income taxes, including the valuation allowance. The Company bases its estimates on a combination of historical experience and
        various other assumptions that it believes are reasonable under the circumstances. Actual results may differ materially from these estimates.&lt;/div&gt;
</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="c20220101to20221231"
      id="Text_48422aca8e0b4de1b6a610801a9b8cb8">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company classifies highly liquid investments with a remaining contractual maturity at date of purchase of three months or
        less as cash equivalents. The Company had no cash equivalents as of December 31, 2022 or 2021.&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; Restricted cash consists of a cash collateralization of $4.1 million for a security deposit in the form of a letter of credit issued by the Company&#x2019;s commercial bank and delivered to the sublessor of the Sublease. The amount of
        required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of credit over the term of the Sublease.&lt;br/&gt;
      &lt;/div&gt;
</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="c20221231"
      decimals="-3"
      id="Fact_5d422f5f847e455cbfa8e72cc4b038ec"
      unitRef="U001">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_5035f7e500784769a9fc45b1573b9651"
      unitRef="U001">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="c20221231"
      decimals="-5"
      id="Fact_4f8f0674f714422db851006fbdde984b"
      unitRef="U001">4100000</us-gaap:RestrictedCash>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="c20220101to20221231"
      id="Text_2da43536e14c489382ce5eef9701b4b4">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Property and equipment are recorded at cost and are depreciated over their estimated useful lives using the straight-line
        method. Laboratory and manufacturing equipment are depreciated over an estimated useful life of seven years. Leasehold improvements are
        depreciated over the shorter of their estimated useful life, or the lease term. Computer equipment are depreciated over an estimated useful life of three years. Upon retirement or other disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the resulting gain or losses are reflected in the results of
        operations. Expenditures for maintenance and repairs are charged to operations. Renewals and betterments are capitalized.&lt;/div&gt;
</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20220101to20221231_PropertyPlantAndEquipmentByTypeAxis_LaboratoryAndManufacturingEquipmentMember"
      id="Fact_b2fff27d8bff45d1b89e1cac87d2521e">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20220101to20221231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"
      id="Fact_18482e3cc28e4ec4813b6299346bf6cc">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="c20220101to20221231"
      id="Text_c6a6f33ca0aa4d9d911c3133c23c4c45">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in the acquisition
        of IRX Therapeutics, Inc. (&#x201c;IRX&#x201d;) in November 2018 (the &#x201c;IRX Acquisition&#x201d;), which was accounted for as a business combination. Goodwill is not amortized but is tested for impairment annually or if events occur or circumstances change that would
        reduce the fair value of a reporting unit below its carrying value. Because management evaluates the Company as a single reporting unit, goodwill is tested for impairment at the entity level by first performing a qualitative assessment to determine
        whether it is more likely than not that the fair value of the entity is less than its carrying value. Such qualitative factors include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and
        other relevant events.&#160; If the entity does not pass the qualitative assessment, then the entity&#x2019;s carrying value is compared to its fair value. Goodwill is considered impaired if the carrying value of the entity exceeds its fair value.&lt;/div&gt;
</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:InProcessResearchAndDevelopmentPolicy
      contextRef="c20220101to20221231"
      id="Text_c2367262f15e42dd88fba84a270f0b9e">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;IPR&amp;amp;D assets represent the fair value assigned to technologies that were acquired in connection with the IRX Acquisition,
        which have not reached technological feasibility and have no alternative future use. IPR&amp;amp;D assets are considered to be indefinite lived until the completion or abandonment of the associated research and development projects. During the period
        that the IPR&amp;amp;D assets are considered indefinite-lived, they are tested for impairment on an annual basis or more frequently if the Company becomes aware of any events occurring or changes in circumstances that indicate that the fair value of
        the IPR&amp;amp;D assets are less than their carrying amounts. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize products associated with the IPR&amp;amp;D assets, these assets
        are then deemed definite-lived and are amortized based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a full or partial impairment charge related to the IPR&amp;amp;D
        assets, calculated as the excess of carrying value of the IPR&amp;amp;D assets over fair value.&lt;/div&gt;
</us-gaap:InProcessResearchAndDevelopmentPolicy>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="c20220101to20221231"
      id="Text_3a7f085e167c4fe3adab4b68b5c77eb4">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company expenses its research and development costs as incurred. Research and development expenses consist of costs
        incurred for company-sponsored research and development activities, as well as support for selected investigator-sponsored research. Upfront payments and milestone payments made for the licensing of technology are expensed as research and
        development in the period in which they are incurred if the technology is not expected to have any alternative future uses other than the specific research and development project for which it was intended. IPR&amp;amp;D that is acquired through an
        asset acquisition (as opposed to a business combination) and has no alternative future uses and, therefore, no separate economic values, is expensed to research and development costs at the time the costs are incurred.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The major components of research and development costs include preclinical study costs, clinical manufacturing costs, clinical
        study and trial expenses, insurance coverage for clinical trials, expensed licensed technology, expensed IPR&amp;amp;D, consulting, scientific advisors and other third-party costs, salaries and employee benefits, stock-based compensation expense,
        supplies and materials and allocations of various overhead costs related to our product development efforts.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company has contracted with third parties to perform various clinical study and trial activities in the development and
        testing of potential products. The financial terms of these agreements vary from contract to contract and may result in uneven payment flows. The Company accrues for third party expenses based on estimates of the services received and efforts
        expended during the reporting period. If the actual timing of the performance of the services or the level of effort varies from the estimate, the accrual is adjusted accordingly. The expenses for some third-party services may be recognized on a
        straight-line basis if the expected costs are expected to be incurred ratably during the period. Payments under the contracts depend on factors such as the achievement of certain events or milestones, the successful enrollment of patients, the
        allocation of responsibilities among the parties to the agreement, and the completion of portions of the clinical study or trial or similar conditions. Preclinical and clinical study and trial associated activities such as production and testing of
        clinical material require significant up-front expenditures.&lt;/div&gt;
</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="c20220101to20221231"
      id="Text_498e5018dea24bdf8cc2b8a498488b16">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company records deferred tax liabilities and assets based on the differences between the consolidated financial statements
        carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and establishing a valuation allowance when it was more likely than not that some portion or all of
        the deferred tax assets would not be realized. Income tax expense consists of the tax payable for the period and the change during the period in deferred tax assets and liabilities.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Tax benefits from uncertain tax positions are recognized only if it is more likely than not that the tax position will be
        sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a
        greater than 50% likelihood of being realized upon ultimate resolution. The Company has no material uncertain tax positions for any of the reporting periods presented.&lt;/div&gt;
</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="c20220101to20221231"
      id="Text_7951f8cc83434eda9aa97204d7a1dd30">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Loss Per Share&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Basic and diluted loss per common share have been computed by dividing the losses attributable to common stockholders by the
        weighted average number of common shares outstanding. The Company&#x2019;s basic and fully diluted loss per share calculations are the same because the increased number of shares that would be included in the diluted calculation from assumed exercise of
        common stock equivalents would be anti-dilutive to the net loss in each of the years shown in the consolidated financial statements.&lt;/div&gt;
</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="c20220101to20221231"
      id="Text_eed8acfbc096446e81415cdb77dd5376">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company&#x2019;s chief operating decision maker, who is the chief executive officer, reviews operating results on a consolidated
        basis to make decisions about allocating resources and assessing performance of the Company.&#160; As a result, in accordance with ASC No. 280, &lt;span style="font-style: italic;"&gt;Segment Reporting,&lt;/span&gt; the Company has determined that it operates as one operating segment.&lt;/div&gt;
</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c20220101to20221231"
      decimals="INF"
      id="Fact_46d5a933f8b0422fa6833aa11c3ed48b"
      unitRef="U007">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="c20220101to20221231"
      id="Text_8b2098fc4dcc48598043cbdf4eb2f4e7">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company maintains its cash balances in financial institutions located in the United States. Accounts at each institution
        are insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) up to $250,000. The Company&#x2019;s cash balances are uninsured for deposit accounts that exceed the FDIC insurance limit.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;In the Company&#x2019;s business, vendor concentrations could be indicative of vulnerabilities in the Company&#x2019;s supply chain, which
        could ultimately impact the Company&#x2019;s ability to continue its research and development activities. For the years ended December 31, 2022 and 2021, there was no vendor concentration related to the Company&#x2019;s research and development activities.&lt;/div&gt;
</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="c20220101to20221231"
      id="Text_2791aa3d01e245a0bf8c2ac430d9635d">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly
        transaction between willing market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to
        unobservable inputs. The fair value hierarchy is as follows:&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; &lt;span style="color: rgb(0, 0, 0);"&gt;Level 1 Inputs &#x2013; Valued based on quoted prices in active markets
          for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; &lt;span style="color: rgb(0, 0, 0);"&gt;Level 2 Inputs &#x2013; Valued based on inputs other than quoted prices
          included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities
          in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or
          corroborated by market data by correlation or other means.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; &lt;span style="color: rgb(0, 0, 0);"&gt;Level 3 Inputs &#x2013; Valued based on inputs for which there is
          little or no market value, which require the reporting entity to develop its own assumptions.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The carrying amounts reported on the balance sheet for cash and cash equivalents, accounts receivable, prepaid assets and other
        current assets, accounts payable and accrued expenses, other current liabilities and other liabilities approximate fair value based due to their short maturities.&lt;/div&gt;
</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="c20220101to20221231"
      id="Text_50f18a33557b4d308295462934021741">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Leases&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The Company accounts for its leases under
        ASC Topic 842, &lt;span style="font-style: italic;"&gt;Leases.&lt;/span&gt; Operating lease liabilities represent the present value of lease payments not yet paid. Right-of-use (&#x201c;ROU&#x201d;) assets represent the Company&#x2019;s right to use an underlying asset and are
        based upon the operating lease liabilities adjusted for prepaid or accrued lease payments, initial direct costs, lease incentives and impairment of operating lease assets. If the interest rate implicit in the lease is not readily determinable, the
        Company uses the incremental borrowing rates for collateralized borrowings in an amount equal to the lease payments under similar terms.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The Company has elected the practical
        expedient to not separate non-lease components from the lease components to which they relate and instead account for each as a single lease component for all underlying asset classes. Some leasing arrangements require variable payments that are
        dependent on usage or may vary for other reasons, such as payments for insurance, tax payments and other miscellaneous costs. The variable portion of payments contemplated in the lease that do not depend on an index or rate are not included in the
        ROU assets or lease liabilities. Rather, variable payments that do not depend on an index or rate are expensed when the obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease
        contract are accounted for as lease expenses.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company has also elected not to recognize ROU and lease liabilities for short-term leases that have a term of 12 months
          or less.&lt;/div&gt;
</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="c20220101to20221231"
      id="Text_4f18285a39af4e629713ec9c7a2a2f1d">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Commitment and Contingencies&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company follows ASC No.450-20, &lt;span style="font-style: italic;"&gt;Loss Contingencies,&lt;/span&gt; to report accounting for
        contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be
        reasonably estimated.&lt;/div&gt;
</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="c20220101to20221231"
      id="Text_326ab3d8fd264d64a32f3ad506798d11">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company recognizes stock-based compensation expense for equity awards granted to employees, directors and certain
        consultants. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-lined basis.&lt;/div&gt;
</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:DerivativesMethodsOfAccountingNonhedgingDerivatives
      contextRef="c20220101to20221231"
      id="Text_80aad676cc3543da99880f689a019949">
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Warrants&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an
        assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480, &lt;span style="font-style: italic;"&gt;Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging.&lt;/span&gt; The assessment considers
        whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or meet all of the requirements for equity classification under ASC 815, including whether the warrants are
        indexed to the Company&#x2019;s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification. This assessment, which
        requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.&lt;span style="text-decoration: underline;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;
</us-gaap:DerivativesMethodsOfAccountingNonhedgingDerivatives>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="c20220101to20221231"
      id="Text_ebab9e05a0a34b64914cfb784e536bc2">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Recent Accounting Standards&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;/span&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 18pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;"&gt;Newly Adopted Accounting
        Standards:&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In July 2021, the FASB issued Accounting
        Standards Update (&#x201c;ASU&#x201d;) 2021-05, &lt;span style="font-style: italic;"&gt;Leases (Topic 842) &#x2013; Lessors - Certain Leases with Variable Lease Payments,&lt;/span&gt; which amends the lessor classification guidance to introduce additional criteria when
        classifying leases with variable lease payments that do not depend on a reference index or a rate. The Company adopted this ASU effective January 1, 2022, which did not have a material impact on its financial statements.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In May 2021, the FASB issued ASU 2021-04&lt;span style="font-style: italic;"&gt;, Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40):
          Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&lt;/span&gt;. ASU 2021-04 addresses the accounting for certain modifications or exchanges of freestanding equity-classified written call
        options. The Company adopted this ASU effective January 1, 2022, which did not have a material impact on the Company&#x2019;s financial statements.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In November 2021, the FASB issued ASU
        2021-10, &lt;span style="font-style: italic;"&gt;Disclosures by Business Entities about Government Assistance, &lt;/span&gt; which requires a business entity to disclose information about certain government assistance that it has received, including (i) the
        type of assistance, (ii) an entity&#x2019;s accounting for the assistance and (iii) the effect of the assistance on the entities accounting statements.&#160; The Company adopted this standard effective January 1, 2022, which did not have a material impact on
        the Company&#x2019;s financial statements. The Company has approximately $0.6 million in payroll tax refunds recorded in other receivable on
        the accompanying consolidated balance sheets as of December 31, 2022 and 2021 pursuant to the Employee Retention Credit program under the CARES Act.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;"&gt;Accounting Standards to
        be Adopted:&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;In June 2022, the FASB issued ASU No.
        2022-03, &lt;span style="font-style: italic;"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions &lt;/span&gt;(&#x201c;ASU 2022-03&#x201d;). The FASB issued ASU 2022-03 to (1) clarify the guidance in
        Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new
        disclosure requirements for equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is
        not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years
        with early adoption permitted. The Company is evaluating when to adopt the amendments in ASU 2022-02. The Company does not expect a material impact as a result of adopting this ASU.&lt;/div&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:IncomeTaxesReceivable
      contextRef="c20211231_UnusualOrInfrequentItemAxis_CoronavirusAidReliefAndEconomicSecurityActMember"
      decimals="-5"
      id="Fact_3fa8f00f7f9043b5bc48dfc77028817d"
      unitRef="U001">600000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="c20221231_UnusualOrInfrequentItemAxis_CoronavirusAidReliefAndEconomicSecurityActMember"
      decimals="-5"
      id="Fact_6cb1962e20f04d99822d67367c4d82a3"
      unitRef="U001">600000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="c20220101to20221231"
      id="Text_affbe44113d8430c92fe1e05d1450975">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;4)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Merger, Disposition and Acquisition Transactions&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Merger&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;On
        August 12, 2020, Eterna, Eterna LLC and the Merger Sub entered into the Merger Agreement and consummated the Merger on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which Eterna LLC was deemed the acquiring company for
        accounting purposes. Eterna LLC, as the accounting acquirer, recorded the assets acquired and liabilities assumed of Eterna in the Merger at their fair values as of the acquisition date.&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
       &lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Eterna LLC was determined to be the accounting acquirer based upon the terms of the Merger and other factors including that (i) Eterna LLC members received common stock in the Merger that represented&lt;/span&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; 96.35% &lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;of Eterna&#x2019;s outstanding common stock on a fully diluted basis, (ii) all of the directors of Eterna immediately after the Merger were
              designated by Eterna LLC under the terms of the Merger Agreement and (iii) existing members of Eterna LLC&#x2019;s management became the management of Eterna immediately after the Merger.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;At the closing of the Merger, all the outstanding membership interests of Eterna LLC converted into the right to receive an
        aggregate of approximately 1,999,000 shares of common stock, of which 53,000 shares were issued as compensation to Eterna LLC&#x2019;s financial advisor for its services to Eterna LLC in connection with the Merger.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The purchase price of $8.2
        million, which represents the consideration transferred in the Merger to stockholders of Eterna immediately before the Merger, was calculated based on the closing price of $108 per share of common stock for approximately 76,000 shares
        that those stockholders owned on March 25, 2021 immediately prior to the Merger because that represented a more reliable measure of the fair value of consideration transferred in the Merger.&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Under the acquisition method of accounting, the total purchase price has been allocated to the acquired tangible and intangible
        assets and assumed liabilities of Eterna based on their estimated fair values as of March 25, 2021, the Merger closing date. Because the consideration paid by Eterna LLC in the Merger is more than the estimated fair values of Eterna&#x2019;s net assets
        deemed to be acquired, goodwill is equal to the difference of approximately $8.6 million, which has been calculated using the fair values
        of the net assets of Eterna as of March 25, 2021.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;The allocation of the purchase price to
        the tangible and intangible assets acquired and liabilities deemed to be assumed from Eterna, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Historical Balance&lt;br/&gt;
              &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Sheet of&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Eterna at&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;March 25, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Fair Value&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Adjustment to&lt;br/&gt;
              &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Eterna&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Pre-Merger&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Purchase&lt;/div&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Price&lt;/div&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Cash and cash equivalents&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;148&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;148&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Accounts receivable&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;103&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;103&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Prepaid expense and other current assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;329&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;329&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Property and equipment, net&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,015&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,015&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Software development costs&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,296&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(368&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;928&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Customers&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;548&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;548&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Trade name&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;299&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;299&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Accounts payable, accrued liabilities and other current liabilities&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(3,781&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(3,781&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Net assets acquired, excluding goodwill&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(890&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;479&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(411&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total consideration&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;8,178&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Net assets acquired, excluding goodwill&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(411&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Goodwill&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;8,589&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Eterna LLC was obligated under the Merger Agreement to have $10.0 million in cash and cash equivalents on its balance sheet at the effective time of the Merger. To ensure Eterna LLC had the required funds, certain beneficial holders of Eterna LLC&#x2019;s
        Class A membership interests entered into contractual commitments to invest $10.0 million into Eterna LLC immediately prior to the
        closing of the Merger. During March 2021, Eterna offered its Class A unit holders an additional 5% rights offering for an additional $0.5 million to be raised by a rights offering. Eterna received funds from the rights offering between February 17, 2021 and April 5, 2021.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Disposition&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;On March 26, 2021, Eterna sold its rights, title and interest in and to the assets relating to the business it operated (under
        the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $2.0 million and assumption of
        specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of the Disposition are as follows &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;(in thousands)&lt;/span&gt;:&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Proceeds from sale:&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Cash&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;132&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Escrow&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;50&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Assume advance/loans&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,700&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Interest on advance/loans&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;68&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Carrying value of assets sold:&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Cash and cash equivalents&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(14&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Accounts receivable&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(75&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Prepaids and other current assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(124&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Property and equipment, net&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(1,014&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Software development costs&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(927&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Customers&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(548&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Trade name&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(299&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Goodwill&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(8,589&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Other assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(103&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Liabilities transferred upon sale:&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Accounts payable and accrued expenses&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;113&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Obligations under finance leases&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;17&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Lease liability&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;26&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Deferred revenue&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;55&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Other current liabilities&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;149&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Transaction costs&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(265&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Total loss on sale of assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;(9,648&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquisition&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;On July 16, 2021, Eterna and Brooklyn Acquisition Sub, Inc. entered into the Novellus Acquisition Agreement. The Novellus
          Acquisition closed contemporaneously with the execution and delivery of the Novellus Acquisition Agreement. At the closing:&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -18pt; margin-left: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; Eterna acquired all of the outstanding equity interests of Novellus as the
          result of the merger of Brooklyn Acquisition Sub, Inc. with and into Novellus, following which, Novellus, as the surviving corporation, became Eterna&#x2019;s wholly owned subsidiary and Novellus Limited became Eterna&#x2019;s indirectly owned subsidiary; and&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; &lt;span style="color: rgb(0, 0, 0);"&gt;Eterna acquired 25.0% of the total outstanding equity interests of NoveCite.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;As consideration for the Novellus Acquisition, Eterna paid $22.9 million in cash and delivered approximately 351,000 shares of common stock, which under the terms of the Novellus Acquisition Agreement, were valued at a total of $102.0 million based on an agreed upon price of $290.51
          per share.&#160; At the date of issuance, the fair value of the shares was approximately $58.7 million.&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Novellus Acquisition Agreement contained customary representations, warranties and certain indemnification provisions. Approximately 37,000 of the shares issued as consideration were placed in escrow to secure indemnification obligations to Eterna under the Novellus Acquisition Agreement, and all such shares were released to the sellers in
          July 2022.&#160; The Novellus Acquisition Agreement also contains certain non-competition and non-solicitation provisions pursuant to which Novellus LLC agreed not to engage in certain competitive activities for a period of five years following the closing, including customary restrictions relating to employees. No employees of Novellus Limited or Novellus prior to the
          Novellus Acquisition continued their employment, or were otherwise engaged by Eterna, immediately following the Novellus Acquisition.&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; In connection with the Novellus Acquisition, the co-founders of Novellus entered into lock-up agreements with respect to approximately 169,000 of the shares of common stock received in the Novellus Acquisition, and Eterna&#x2019;s Chairman of the Board and its former Chief Executive Officer and President entered into identical lock-up agreements with
          respect to their current holdings of Eterna stock. Each lock-up agreement extends for a period of three years, provided that up to 75% of the shares of common stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock
          on the Nasdaq exceeds specified thresholds. The lock-up agreements include customary exceptions for transfers during the applicable lock-up period.&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company executed the Novellus Acquisition to advance its evolution into a platform company with a pipeline of next generation mRNA cellular and gene editing programs.&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Although Eterna acquired all of the outstanding equity interests of Novellus, the Company accounted for the Novellus Acquisition as an asset acquisition (as the assets acquired did not constitute a business as defined in
          ASC Topic 805, &lt;span style="font-style: italic;"&gt;Business Combinations&lt;/span&gt;), and was measured by the amount of cash paid and by the fair value of the shares of common stock issued. As a result, substantially all of the value acquired was
          attributed to IPR&amp;amp;D, with the exception of the cash paid for the investment in NoveCite, which is being accounted for as an investment in equity securities, as discussed further below.&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Eterna paid $22.9 million
            in cash, net of cash acquired, as part of the consideration for the Novellus Acquisition, of which $1.0 million was paid in cash for
            the investment in NoveCite. Eterna also issued approximately 351,000 shares of the Company&#x2019;s common stock, of which approximately 182,000 shares are unrestricted and 169,000
            shares are subject to the three-year lockup. The unrestricted shares were valued at $201 per share, which was the closing price of Eterna&#x2019;s common stock on July 16, 2021. The fair value of the restricted shares was discounted by approximately 35% to $130.60 per restricted share,
            which was derived from the average discount rate between the Black Scholes and Finnerty valuation models.&lt;/span&gt;&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The resulting fair value of the asset acquired is as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Fair Value of&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Consideration&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Cash paid&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;22,882&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Cash acquired&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(28&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 83.46%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Unrestricted shares&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;36,628&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 83.46%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Restricted shares&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;22,056&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 83.46%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total fair value of consideration paid&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;81,538&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 83.46%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Less amount of cash paid for NoveCite investment&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(1,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 83.46%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Fair value of IPR&amp;amp;D acquired&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;80,538&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;IPR&amp;amp;D that is acquired through an asset purchase that has no alternative future uses and no separate economic values from
          its original intended purpose is expensed in the period the cost is incurred. Accordingly, the Company expensed the fair value of the IPR&amp;amp;D during the third quarter of 2021 in the amount of $80.5 million.&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Investment in NoveCite&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;As a result of the Novellus Acquisition, Eterna acquired and currently owns 25% of NoveCite, and Citius Pharmaceuticals, Inc. (&#x201c;Citius&#x201d;) owns the remaining 75%.
        A member of the Company&#x2019;s management is entitled to hold one of three board seats on NoveCite&#x2019;s board of directors. Citius&#x2019; s officers
        and directors hold the other two board seats. The Company is accounting for its interest in NoveCite under ASC Topic 323, &lt;span style="font-style: italic;"&gt;Investments &#x2013; Equity Method and Joint Ventures.&lt;/span&gt; The investment was recorded at cost,
        which was $1.0 million, and is adjusted for the Company&#x2019;s share of NoveCite&#x2019;s earnings or losses, which are reflected in the accompanying
        consolidated statements of operations. The investment may also reflect an equity loss in the event that circumstances indicate an other-than-temporary impairment.&#160; For the year ended December 31, 2022, the Company recorded approximately $0.9 million in losses from its investment in NoveCite, and, of the $0.9 million loss for year ended December 31, 2022, $0.5 million related to NoveCite&#x2019;s year ended
        December 31, 2021.&#160; The Company does not guarantee obligations of NoveCite nor is it otherwise committed to provide&#160; financial support for NoveCite.&#160; Therefore, the Company will record losses only up to its investment carrying amount.&lt;br/&gt;
      &lt;/div&gt;
</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="4"
      id="Fact_c17727cbd89d4811ba8b4da8476f81a8"
      unitRef="U005">0.9635</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="0"
      id="Fact_2417794a2d164f84956927b50843373e"
      unitRef="U002">1999000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="0"
      id="Fact_dd6c22be1ee74994a9cf7a33621a9d2e"
      unitRef="U002">53000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_1caa9d0fb50d43f4b629ff9a89132ac8"
      unitRef="U001">8200000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="0"
      id="Fact_b3729adea0274fe8b79aaa853e748b4b"
      unitRef="U003">108</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="0"
      id="Fact_1493f3af1f804d17bf2405ce6f59f4dd"
      unitRef="U002">76000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:Goodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_37a5ca9bbc6d47d1a714068309ddfefc"
      unitRef="U001">8600000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_9d066e9db16c44f0b50877d1ebe9e227">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;The allocation of the purchase price to
        the tangible and intangible assets acquired and liabilities deemed to be assumed from Eterna, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Historical Balance&lt;br/&gt;
              &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Sheet of&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Eterna at&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;March 25, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Fair Value&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Adjustment to&lt;br/&gt;
              &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Eterna&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Pre-Merger&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Purchase&lt;/div&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Price&lt;/div&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Cash and cash equivalents&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;148&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;148&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Accounts receivable&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;103&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;103&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Prepaid expense and other current assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;329&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;329&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Property and equipment, net&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,015&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,015&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Software development costs&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,296&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(368&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;928&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Customers&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;548&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;548&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Trade name&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;299&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;299&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Accounts payable, accrued liabilities and other current liabilities&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(3,781&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(3,781&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Net assets acquired, excluding goodwill&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(890&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;479&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(411&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total consideration&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;8,178&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Net assets acquired, excluding goodwill&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(411&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Goodwill&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;8,589&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_df2e60fee30343198174af8f409e2d64"
      unitRef="U001">148000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_0e906023d6fb4638a2ea287ecdd91f4b"
      unitRef="U001">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_1efc876cb8f34d74871dbb90e69d3898"
      unitRef="U001">148000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_c12b5bf0fbbd439fab40c1121d69de4e"
      unitRef="U001">103000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_0d092678f1884e32aee877fb383d650b"
      unitRef="U001">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_df9ba9c3170241e3ab7dea4a33f3622c"
      unitRef="U001">103000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_f4d13cb9513c4eabaec8766690a1d2f2"
      unitRef="U001">329000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_03ccdc2c418d435caf7756c45fa6fa85"
      unitRef="U001">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_0778e548ac3c40789fbe258d7e0d2115"
      unitRef="U001">329000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_de463661e840477c827d34e55642d50e"
      unitRef="U001">1015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_dc377a0421e84ddb90cafcf654fe8805"
      unitRef="U001">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_3fc7edf645f8430a952da38fe62c45e4"
      unitRef="U001">1015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <erna:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_85f4b80aeedb4fb09b472abb793b8fc6"
      unitRef="U001">1296000</erna:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts>
    <erna:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_677de49fc4274c72b3cdf5ba565cb1ca"
      unitRef="U001">-368000</erna:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts>
    <erna:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_76cbd7496da14499b53d781feea00b87"
      unitRef="U001">928000</erna:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_fa88143e1b3747a980ba655928dc27e3"
      unitRef="U001">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_926683e6b88141c69484f4782414aa30"
      unitRef="U001">548000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_53e30b8c84784e9a9cabb0bab0abec48"
      unitRef="U001">548000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember"
      decimals="-3"
      id="Fact_21d715b1ae004087ad46d5895c3336c6"
      unitRef="U001">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_07dbdf362c7149ed9999a01e441930d3"
      unitRef="U001">299000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_4837654c2adf447c85af7e05c6678e69"
      unitRef="U001">299000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_4903545390344c2bad13962d51621e9b"
      unitRef="U001">3781000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_e114a9dfb0ab4285abc622997dfe0fd9"
      unitRef="U001">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_80b6bc7edfb24216a560f163e650983c"
      unitRef="U001">3781000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_bfb20e48c2b44cccbb68d8738146f393"
      unitRef="U001">-890000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_91384ea001654080a66d0d607d57fdb4"
      unitRef="U001">479000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_895926fcba8a4f7287e4164d275f89f8"
      unitRef="U001">-411000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_fbbb508bae76493299366d5a0c1f2fe8"
      unitRef="U001">8178000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_423da4ea4af8481aa45acef8b3524fc1"
      unitRef="U001">-411000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_b1d54f4a88d9477f86c52e4a5e7bade9"
      unitRef="U001">8589000</us-gaap:Goodwill>
    <erna:ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_f6ab42e138d04f86b1a2c3d69be281ac"
      unitRef="U001">10000000</erna:ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement>
    <erna:BeneficialHoldersContractualCommitmentsToInvest
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_255a3dc219134854821170fb24411524"
      unitRef="U001">10000000</erna:BeneficialHoldersContractualCommitmentsToInvest>
    <erna:PercentageOfAdditionalRightsOffering
      contextRef="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="2"
      id="Fact_653a2d2e80d64dfcb909e1b7e52c746b"
      unitRef="U005">0.05</erna:PercentageOfAdditionalRightsOffering>
    <erna:ProceedsFromSaleOfRights
      contextRef="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_f5edfb243c4f4525aac7d8e90e37fcc2"
      unitRef="U001">500000</erna:ProceedsFromSaleOfRights>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="c20220101to20221231"
      id="Text_ce7246fb9a084f1d95d792a5effb4108">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;On March 26, 2021, Eterna sold its rights, title and interest in and to the assets relating to the business it operated (under
        the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $2.0 million and assumption of
        specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of the Disposition are as follows &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;(in thousands)&lt;/span&gt;:&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Proceeds from sale:&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Cash&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;132&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Escrow&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;50&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Assume advance/loans&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,700&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Interest on advance/loans&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;68&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Carrying value of assets sold:&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Cash and cash equivalents&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(14&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Accounts receivable&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(75&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Prepaids and other current assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(124&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Property and equipment, net&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(1,014&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Software development costs&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(927&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Customers&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(548&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Trade name&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(299&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Goodwill&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(8,589&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Other assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(103&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Liabilities transferred upon sale:&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Accounts payable and accrued expenses&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;113&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Obligations under finance leases&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;17&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Lease liability&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;26&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Deferred revenue&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;55&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Other current liabilities&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;149&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Transaction costs&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(265&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Total loss on sale of assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;(9,648&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-5"
      id="Fact_4855ec7934374c378a32371c297c63b0"
      unitRef="U001">2000000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <erna:DisposalGroupIncludingDiscontinuedOperationProceedsFromCash
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_5b92b13117ad4a5d9f610a3bd298c90e"
      unitRef="U001">132000</erna:DisposalGroupIncludingDiscontinuedOperationProceedsFromCash>
    <erna:DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_fda03b9ccbad45fe80859698eee269b8"
      unitRef="U001">50000</erna:DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow>
    <erna:DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_29008d3ee45841a6ab6d3bcb7d3f7436"
      unitRef="U001">1700000</erna:DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans>
    <erna:DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_0db56ecde4aa4dcfb926e61441785c11"
      unitRef="U001">68000</erna:DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_3931cf3f6f6141debb687f27230ce3f0"
      unitRef="U001">14000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_fb617004c8f14998a28b6ecfc1825b88"
      unitRef="U001">75000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_70eb23598ef142288d8500d6bab28e53"
      unitRef="U001">124000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_43121df3ce124d1eb38943648ee6958c"
      unitRef="U001">1014000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <erna:DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_6153aeb995564d30ba1addd551420008"
      unitRef="U001">927000</erna:DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_2c49bd829b874b68a56c0a4ed6dc0d93"
      unitRef="U001">548000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_89a05edbd7e94ace9c3d5c16c24c5904"
      unitRef="U001">299000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_0a597d115cbc4168b23da3dd09baf83d"
      unitRef="U001">8589000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_0e4a99ef1d874087b9f7645a55f2db3c"
      unitRef="U001">103000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_9a482438dafe485b8d26db27321d28be"
      unitRef="U001">113000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
    <erna:DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_6f8813d38d7442d9a00cfbad720cd39c"
      unitRef="U001">17000</erna:DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases>
    <erna:DisposalGroupIncludingDiscontinuedOperationLeaseLiability
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_108c81db092d4cfdb686ddb51ef3bf4f"
      unitRef="U001">26000</erna:DisposalGroupIncludingDiscontinuedOperationLeaseLiability>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_5256d84bbd5345df9ecd2986dc9dccf5"
      unitRef="U001">55000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_f3c8743c27ad4c5d9316ae303db340bc"
      unitRef="U001">149000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities>
    <erna:DisposalGroupIncludingDiscontinuedOperationTransactionCosts
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_d20260ff9f1548f8890926d741c7358c"
      unitRef="U001">265000</erna:DisposalGroupIncludingDiscontinuedOperationTransactionCosts>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_52b4f4c50be14347ac0b54fd1674ba73"
      unitRef="U001">-9648000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="3"
      id="Fact_37705f8d38ec4b3781f01cd45f57d85c"
      unitRef="U005">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_bbb22e72c4c449c99a775b218b4ddbef"
      unitRef="U001">22900000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_3b75d178a95d4a2b812cac67f19186f9"
      unitRef="U002">351000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_372d16e35426419e8ce7346dbbca4497"
      unitRef="U001">102000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <erna:AssetAcquisitionSharePrice
      contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="2"
      id="Fact_b35aab21b444471f99c354870a69a705"
      unitRef="U003">290.51</erna:AssetAcquisitionSharePrice>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_22bba9598d434dd6846aff37e48c7b52"
      unitRef="U001">58700000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <erna:EscrowShares
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_20451241abb94c7dbae83c481c76c7b6"
      unitRef="U002">37000</erna:EscrowShares>
    <erna:AcquisitionAgreementNonCompetitivePeriod
      contextRef="c20220101to20221231_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      id="Fact_98f3ef9a3eab4660acde4ea44ae12b76">P5Y</erna:AcquisitionAgreementNonCompetitivePeriod>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember"
      decimals="0"
      id="Fact_2e18011f02894dbbaeaee754b98458b7"
      unitRef="U002">169000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <erna:EachLockUpAgreementExtendsTerm
      contextRef="c20220101to20221231_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      id="Fact_e194377eb5a94fad88ad9e3c9bdb6836">P3Y</erna:EachLockUpAgreementExtendsTerm>
    <erna:PercentageOfCommonStockSubjectToLockUpAgreement
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_f4b1b6b1559443fc9bebcf2d6ece341a"
      unitRef="U005">0.75</erna:PercentageOfCommonStockSubjectToLockUpAgreement>
    <erna:PaymentsToAcquireProductiveAssetsNet
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_a233acbe5f514502bbd75f968e1d863a"
      unitRef="U001">22900000</erna:PaymentsToAcquireProductiveAssetsNet>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_f625cb69e1934bbc83902cfe0bb572d1"
      unitRef="U001">1000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_5672bfe38f6646e391a33cc2f1829a93"
      unitRef="U002">351000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <erna:StockIssuedDuringPeriodUnrestrictedSharesAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_a461f4ae97f14b159714641b5572ee7a"
      unitRef="U002">182000</erna:StockIssuedDuringPeriodUnrestrictedSharesAcquisitions>
    <erna:StockIssuedDuringPeriodRestrictedSharesAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_d29ee4d102994573b6e8b1df06e944bf"
      unitRef="U002">169000</erna:StockIssuedDuringPeriodRestrictedSharesAcquisitions>
    <erna:LockUpPeriodForRestrictedShares
      contextRef="c20220101to20221231_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      id="Fact_b99cc2ae9caa4d488170fbb685d9b5d1">P3Y</erna:LockUpPeriodForRestrictedShares>
    <erna:AssetAcquisitionUnrestrictedSharesSharePrice
      contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_73aab93f296c436f8da7969996603a74"
      unitRef="U003">201</erna:AssetAcquisitionUnrestrictedSharesSharePrice>
    <erna:PercentageOfDiscountOnFairValueOfRestrictedShares
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="2"
      id="Fact_2203b0ab918d4853b9795e7e3635d4f8"
      unitRef="U005">0.35</erna:PercentageOfDiscountOnFairValueOfRestrictedShares>
    <erna:AssetAcquisitionRestrictedSharesSharePrice
      contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="2"
      id="Fact_5143e0a71b0d4c6b9e6444bb934360b2"
      unitRef="U003">130.6</erna:AssetAcquisitionRestrictedSharesSharePrice>
    <us-gaap:AssetAcquisitionTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_82e0e11bff704f09a63602ac532be334">&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The resulting fair value of the asset acquired is as follows (in thousands):&lt;/span&gt;&lt;/span&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Fair Value of&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Consideration&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Cash paid&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;22,882&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Cash acquired&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(28&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 83.46%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Unrestricted shares&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;36,628&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 83.46%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Restricted shares&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;22,056&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 83.46%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total fair value of consideration paid&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;81,538&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 83.46%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Less amount of cash paid for NoveCite investment&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(1,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 83.46%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Fair value of IPR&amp;amp;D acquired&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.31%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.44%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 12.34%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;80,538&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.31%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:AssetAcquisitionTableTextBlock>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_53607202de0448379de6303fa5fea874"
      unitRef="U001">22882000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_fb99541e6bf247bc8022dc108661d68b"
      unitRef="U001">28000</us-gaap:CashAcquiredFromAcquisition>
    <erna:StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_3022c2720cde401d85966300a4d31358"
      unitRef="U001">36628000</erna:StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions>
    <erna:StockIssuedDuringPeriodRestrictedSharesValueAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_14aec4b4acc44b8cbd976a50df925a9e"
      unitRef="U001">22056000</erna:StockIssuedDuringPeriodRestrictedSharesValueAcquisitions>
    <erna:AssetAcquisitionFairValueOfConsiderationPaid
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_d6300fcb446e49bf86f39c9566397561"
      unitRef="U001">81538000</erna:AssetAcquisitionFairValueOfConsiderationPaid>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_c4a618efe3454b278535a354dde5c820"
      unitRef="U001">1000000</us-gaap:PaymentsToAcquireInvestments>
    <erna:ResearchAndDevelopmentInProcessAssetAcquisition
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_9bd0c11dc926402ba0c880cbb5a139f4"
      unitRef="U001">80538000</erna:ResearchAndDevelopmentInProcessAssetAcquisition>
    <erna:ResearchAndDevelopmentInProcessAssetAcquisition
      contextRef="c20210701to20210930_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_d384157929fd4d0abbdb022c36c5ffc9"
      unitRef="U001">80500000</erna:ResearchAndDevelopmentInProcessAssetAcquisition>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="2"
      id="Fact_f1f61ae62a124fa7955884c159edb799"
      unitRef="U005">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c20210716_OwnershipAxis_CitiusPharmaceuticalsIncMember_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="2"
      id="Fact_7a0cb0f857624ee7974e6ac454b7fd23"
      unitRef="U005">0.75</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <erna:NumberOfBoardSeats
      contextRef="c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="INF"
      id="Fact_c8ff41475563408db23121c8d65c3cb1"
      unitRef="U008">3</erna:NumberOfBoardSeats>
    <us-gaap:EquityMethodInvestments
      contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="-5"
      id="Fact_d26d29deec634db1bc2e74f749d21531"
      unitRef="U001">1000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="c20220101to20221231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="-5"
      id="Fact_0463e72fdae34eb393c12fb13ed77eb3"
      unitRef="U001">900000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="c20220101to20221231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="-5"
      id="Fact_1ca20dbf79d24889b910e2a89ca28756"
      unitRef="U001">900000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="-5"
      id="Fact_33f95b64bbf4415bbcc320dcb5360054"
      unitRef="U001">500000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="c20220101to20221231"
      id="Text_37da32b66e184899b6d646f65abc294e">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;5)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Fair Value of Financial Instruments&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;There were no liabilities measured
        at fair value as of December 31, 2021. The following tables summarize the liabilities that are measured at fair value as of December 31, 2022 (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of December 31, 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Description&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 1&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 2&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 3&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Liabilities:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Warrant liabilities - Q1-22 Common Warrants&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;331&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;331&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;On March 9, 2022, upon closing the Q1-22 PIPE Transaction, the Company issued to the Q1-22 PIPE Investor the Q1-22 Pre-Funded Warrants, exercisable
        for approximately 68,000 shares of common stock, and the Q1-22 Common Warrants, exercisable for approximately 343,000 shares of common stock.&#160; On July 12, 2022, the Q1-22 PIPE Investor exercised all of the Q1-22 Pre-Funded Warrants at an exercise price of $0.10 per share for an aggregate exercise price of approximately $7,000 in cash,&#160; and the Company issued 68,000 shares of common stock to the Q1-22 PIPE Investor upon
        receipt of the cash proceeds.&#160; Following the exercise, no Q1-22 Pre-Funded Warrants remained outstanding.&#160; See Note 15 for more
        information related to the Q1-22 PIPE Transaction.&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;The Q1-22 Common Warrants and Q1-22 Pre-Funded Warrants were accounted for as liabilities under ASC 815-40,&#160;&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-style: italic;"&gt;Derivatives














          and Hedging, Contracts in Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;&#160;(&#x201c;ASC 815-40&#x201d;), as these warrants
          provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40.&#160; These warrant liabilities were measured at fair value at inception and are then subsequently measured on a recurring
          basis, with changes in fair value presented within the Company&#x2019;s statements of operations.&lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; The Company uses a Black-Scholes option pricing model to estimate the fair value of the Q1-22 Common Warrants, which is considered a Level 3 fair value measurement.&#160; Certain inputs used in this Black-Scholes pricing model may
          fluctuate in future periods based upon factors that are outside of the Company&#x2019;s control.&#160; A significant change in one or more of these inputs used in the calculation of the fair value may cause a significant change to the fair value of the
          Company&#x2019;s warrant liabilities, which could also result in material non-cash gains or losses being reported in the Company&#x2019;s consolidated statement of operations.&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; The estimated fair value of the Q1-22 Pre-Funded Warrants was deemed a Level 2 measurement as all significant inputs to the valuation model used to estimate the fair value of the Q1-22 Pre-Funded Warrants were directly observable
          from the Company&#x2019;s publicly-traded common stock.&#160; Upon exercise of the Q1-22 Pre-Funded Warrants on July 12, 2022, the Company reclassified the approximately $0.9 million fair value of the Pre-Funded Warrants to equity.&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; The fair values of the Q1-22 Common Warrants and the Q1-22 Pre-Funded Warrants at the issuance date totaled $12.6
          million in the aggregate, which was $0.6 million more than the $12.0 million proceeds received in the Q1-22 PIPE Transaction.&#160; The excess $0.6
          million represents an inducement to the purchaser to enter into the Q1-22 PIPE Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of operations.&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt; &lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);"&gt;The Company remeasured the fair value of the Q1-22 Common Warrants as of
                December 31, 2022. The following table presents the changes in the warrant liabilities from the issuance date (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);"&gt; &lt;br/&gt;
              &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Q1-22&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Pre-Funded &lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(Level 2)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Q1-22 &lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Common &lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(Level 3)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Total Warrant&lt;br/&gt;
                &lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at January 1, 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at March 9, 2022 (issuance date)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,646&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,943&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,589&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Change in fair value of warrant liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,779&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(9,612&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,391&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Exercise of Q1-22 Pre-Funded Warrants&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(867&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(867&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at December 31, 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;331&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;331&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;/span&gt;&lt;/div&gt;
</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_d1d410b472cb473a8933d35f428a2c09">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;There were no liabilities measured
        at fair value as of December 31, 2021. The following tables summarize the liabilities that are measured at fair value as of December 31, 2022 (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of December 31, 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Description&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 1&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 2&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 3&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Liabilities:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Warrant liabilities - Q1-22 Common Warrants&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;331&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;331&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20211231"
      decimals="0"
      id="Fact_0ffc98c2fb154979b9b42e9f05221925"
      unitRef="U001">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_7307f2cc6d634f328406c54b63035838"
      unitRef="U001">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_72412634565f49129d611b5cd50e3787"
      unitRef="U001">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_06f75986463441ebb4289c3f880b04cb"
      unitRef="U001">331000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20221231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact_d1b1594efe634bb59bcb2faa55b2211d"
      unitRef="U001">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20221231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_c55ca66ed6f7418393665f0c749e44c4"
      unitRef="U001">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20221231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_ebdcb4007f294bcabd970a22f4c7c3ca"
      unitRef="U001">331000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="0"
      id="Fact_86049ca8ac1f4efeba715640a658fbba"
      unitRef="U002">68000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20220309_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="0"
      id="Fact_965bc6302ede4b27881a1305194443a1"
      unitRef="U002">343000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="2"
      id="Fact_862ce396c4634a17917ad07b1cbb2853"
      unitRef="U003">0.1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-3"
      id="Fact_851dcf45c1794682aad239d8c9499fe0"
      unitRef="U001">7000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20220712_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_58cf6f0a8ec743a8900d095fe1d9cdda"
      unitRef="U002">68000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_f4d8f741bf4749d98ccddacaa6938a4e"
      unitRef="U002">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-5"
      id="Fact_b5bbb12080d34b528988244fcc14509f"
      unitRef="U001">900000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_cb74c340f89c44b8a6be3c849980ddc8"
      unitRef="U001">12600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <erna:OverSubscriptionAmountReceived
      contextRef="c20221231"
      decimals="-5"
      id="Fact_b1ec0706ef4840a6a78b337e1f7ddc71"
      unitRef="U001">600000</erna:OverSubscriptionAmountReceived>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="c20221231"
      decimals="-5"
      id="Fact_f6e2188c8d1743df8ca53a6dfcb14f7b"
      unitRef="U001">12000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <erna:OverSubscriptionAmountReceived
      contextRef="c20221231"
      decimals="-5"
      id="Fact_f116a653bf274fef9da6e485468f05d8"
      unitRef="U001">600000</erna:OverSubscriptionAmountReceived>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_4cd9c85c76984f399a48923ac3aac313">
&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt; &lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);"&gt;The Company remeasured the fair value of the Q1-22 Common Warrants as of
                December 31, 2022. The following table presents the changes in the warrant liabilities from the issuance date (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);"&gt; &lt;br/&gt;
              &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Q1-22&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Pre-Funded &lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(Level 2)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Q1-22 &lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Common &lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(Level 3)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Total Warrant&lt;br/&gt;
                &lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at January 1, 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at March 9, 2022 (issuance date)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,646&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,943&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,589&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Change in fair value of warrant liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,779&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(9,612&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,391&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Exercise of Q1-22 Pre-Funded Warrants&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(867&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(867&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at December 31, 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;331&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;331&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;/span&gt;&lt;/div&gt;
</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_e5bdef7f05164665b8b73ba2f7c41a6b"
      unitRef="U001">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20211231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_46a9a7e1d3384fd6a13800de9750db17"
      unitRef="U001">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_49a6d84b66cf451888709573ed10a17e"
      unitRef="U001">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_a8766fcc6171451aaafa816f2edef0d1"
      unitRef="U001">2646000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_333bb6bcb0df4a48973af904fe87ed23"
      unitRef="U001">9943000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_d49ca972a9be45a096747c6d43b7845d"
      unitRef="U001">12589000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_713654cd4d014070976ab5817050ef97"
      unitRef="U001">-1779000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_0a698463008941b8bd3ec8815093ed68"
      unitRef="U001">-9612000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_5b1f03d928d14dce9e2bcf13e2e46838"
      unitRef="U001">-11391000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_892906dba43041ea966dd0f55c6dec35"
      unitRef="U001">867000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_fb35795132b74d11b1e2fdaee52c41cc"
      unitRef="U001">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_18cc741a58124f59b24dc4cc453dd355"
      unitRef="U001">867000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_07acac25f6364630adde4603d4e54a73"
      unitRef="U001">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_48de475c55ff4e79ba91846c090d22a1"
      unitRef="U001">331000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20221231"
      decimals="-3"
      id="Fact_5b115fab52934bc4817f181334f828ea"
      unitRef="U001">331000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="c20220101to20221231"
      id="Text_04f70f6d71f24cdaa97b8877306a3d65">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;6)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Property and Equipment&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Property and equipment consist of the following (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of December 31,&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Laboratory and manufacturing equipment&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;28&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;258&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Leasehold improvements&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;464&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;Computer equipment and programs&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;240&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;155&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;268&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;877&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Less accumulated depreciation and amortization&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(32&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(207&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Property and equipment, net&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;236&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;670&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the year ended December 31, 2022, the Company consolidated its research and development activities in Cambridge,
        Massachusetts and entered into lease termination agreements for its Brooklyn, New York and San Diego, California facilities. (See Note 7 for more information on lease terminations.)&#160; As a result, the Company disposed of certain assets it would no
        longer use and recognized a loss on disposal of fixed assets of approximately $0.3 million, which was composed of $0.6 million in remaining net book value of such assets, offset by proceeds received from selling certain fixed assets for approximately $0.3 million. &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Depreciation expense totaled $161,000
        and $117,000 for the years ended December 31, 2022 and 2021, respectively. No depreciation expense is recorded on fixed assets in process
        until such time as the assets are completed and are placed into service.&lt;/div&gt;
</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="c20220101to20221231"
      id="Text_d6baae7027f6405f93a110b8d03de481">
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Property and equipment consist of the following (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of December 31,&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Laboratory and manufacturing equipment&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;28&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;258&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Leasehold improvements&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;464&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;Computer equipment and programs&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;240&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;155&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;268&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;877&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Less accumulated depreciation and amortization&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(32&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(207&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Property and equipment, net&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;236&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;670&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember"
      decimals="-3"
      id="Fact_330a19d003e64ffeaf752973f08fbcf9"
      unitRef="U001">28000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20211231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember"
      decimals="-3"
      id="Fact_cc68246183c249a9ad1850f3f09b4d26"
      unitRef="U001">258000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact_717211d7e35d48f1969608c5f3616e2c"
      unitRef="U001">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact_f3240e5512f04c7aa379362617a312ea"
      unitRef="U001">464000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"
      decimals="-3"
      id="Fact_39eca011b32b47b2b309303c39d94e37"
      unitRef="U001">240000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"
      decimals="-3"
      id="Fact_e343c90c44524bc18626bbaf3f276e3e"
      unitRef="U001">155000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20221231"
      decimals="-3"
      id="Fact_7b3501df5c4f4290b55e92d82a7a0854"
      unitRef="U001">268000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20211231"
      decimals="-3"
      id="Fact_806a995bb99944aa9a036df1d2fc3b66"
      unitRef="U001">877000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="c20221231"
      decimals="-3"
      id="Fact_df75fb3bcd8d486b973092faedb0146c"
      unitRef="U001">32000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="c20211231"
      decimals="-3"
      id="Fact_40e86deab4b546d4a61f584e8ad41637"
      unitRef="U001">207000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20221231"
      decimals="-3"
      id="Fact_3070d91807b9488f8cbf301e34fcce3b"
      unitRef="U001">236000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20211231"
      decimals="-3"
      id="Fact_bdb214ad875341bd80f7a9ce9d22c262"
      unitRef="U001">670000</us-gaap:PropertyPlantAndEquipmentNet>
    <erna:GainLossOnDisposalOfFixedAssets
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_3c914b6914e04441a8cedb54750b4f57"
      unitRef="U001">300000</erna:GainLossOnDisposalOfFixedAssets>
    <erna:RemainingNetBookValueOfFixedAssets
      contextRef="c20221231"
      decimals="-5"
      id="Fact_b0761f1b1ba146edabb1d5f75206aba5"
      unitRef="U001">600000</erna:RemainingNetBookValueOfFixedAssets>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_5f0e3bf2b28345cbbd62f77517a259e8"
      unitRef="U001">300000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:Depreciation
      contextRef="c20220101to20221231"
      decimals="0"
      id="Fact_2344b4c1e61844e389a4b2660e041f09"
      unitRef="U001">161000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_6054f0f9dd204838971c4fbad1d27691"
      unitRef="U001">117000</us-gaap:Depreciation>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="c20220101to20221231"
      id="Text_78e995807758407d9d97f05dc600df1c">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;7)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Leases&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;T&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;he &lt;/span&gt;Company has operating leases for office and
        laboratory space in the borough of Manhattan in New York, New York, in Cambridge, Massachusetts and in Somerville, Massachusetts, which expire in 2026, 2028, and 2032 respectively&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company also leased a facility in Brooklyn, New York (the &#x201c;Brooklyn Lease&#x201d;). On March 5, 2022, the Company entered into an
        agreement to assign the Brooklyn Lease to Regen Lab USA LLC (&#x201c;Regen&#x201d;).&#160; Regen agreed to purchase certain equipment from the Company for $50,000,
        which partially reimbursed the Company for certain existing unamortized leasehold improvements, and to reimburse the Company for the existing security deposit the Company had under the Brooklyn Lease of approximately $63,000.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;On March 25, 2022, the Company entered into an Assignment and Assumption of Lease Agreement (the &#x201c;Assignment Agreement&#x201d;) with
        Regen. The effective date of the assignment was March 28, 2022.&#160; Under the Assignment Agreement, Regen assumed all of the obligations, liabilities, covenants and conditions of the Company as tenant under the Brooklyn Lease.&#160; As a result of the
        lease assignment, the Company wrote off the remaining ROU asset balance of approximately $1.4 million and the corresponding lease
        liability of approximately $1.5 million.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;On March 31, 2022, the Company entered into a facility lease in San Diego, California (the &#x201c;San Diego Lease&#x201d;) with Torrey Pines
        Science Center Limited Partnership for approximately 5,200 square feet of laboratory and office space.&#160; The term of the San Diego Lease
        was 62 months and the lease commencement date was April 19, 2022. The Company recorded a $1.7 million ROU asset and $1.7 million lease liabilities for the
        San Diego Lease.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;During 2022, the Company decided to consolidate its research and
          development efforts in Cambridge, Massachusetts, and the Company determined to sublease the San Diego &lt;/span&gt;laboratory&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; and office space.&#160; As a result, the Company recognized an
          impairment charge of approximately $0.8 million on the San Diego Lease ROU asset during 2022, which is recorded in general and
          administrative expense on the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;On November 30, 2022, the Company and the lessor of the San Diego Lease entered into a lease termination agreement, as amended
        on December 29, 2022 (the &#x201c;Lease Termination Agreement&#x201d;), pursuant to which the lessor agreed to terminate the San Diego lease effective January 31, 2023 provided that (i) the Company pay a $0.1 million lease termination fee and (ii) the lessor was able to enter into a new lease for the space with a new tenant by January 15, 2023.&#160; On January 9, 2023, the lessor
        provided notice to the Company that it had entered into a new lease with a new tenant, and the Company paid the $0.1 million termination
        fee.&#160; As a result, the San Diego Lease terminated on January 31, 2023.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Lease Termination Agreement was accounted for as a modification to the San Diego Lease rather than as a lease termination
        because the Company did not contemporaneously terminate the San Diego Lease upon the November 30, 2022 modification date and had a continued right-of-use of the facility through January 31, 2023.&#160; As a result, the Company remeasured the remaining
        lease payments, including the $0.1 million termination fee, and reduced the lease liability the Company had on its balance sheet at the
        time of the modification by approximately $1.4 million to the present value of the remeasured lease liability of approximately $0.2 million.&#160; For a lease modification that is not accounted for as a separate contract, a lessee recognizes the amount of the remeasured lease
        liability as an adjustment to the corresponding ROU asset without affecting profit or loss.&#160; However, because the ROU asset balance as of the modification date was only $0.8 million due to the impairment charge of $0.8 million the Company recognized during the second
        quarter of 2022 (as discussed above), the Company reduced the ROU asset to zero, and the remaining $0.6 million of the $1.4 million
        adjustment was recognized as a credit to general and administrative expense on the consolidated statement of operations for the year ended December 31, 2022.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;On October 18, 2022, the Company entered into the Sublease with E.R. Squibb &amp;amp; Sons, L.L.C., a Delaware limited liability
        company and subsidiary of Bristol-Myers Squibb Company (&#x201c;Sublessor&#x201d;), for office, laboratory and research and development space (the &#x201c;Premises&#x201d;). The Premises consist of approximately 45,500 square feet on the ninth floor of the building currently under construction located at 250 Water Street, Somerville, Massachusetts 02141.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Payments of the Sublease rent commence on the date that is the earlier of (i) the date that the Company commences business
        operations from the Premises and (ii) the one-year anniversary of the date that Sublessor obtained the primary landlord&#x2019;s consent for the Sublease, which was November 29, 2022 (such applicable date, the &#x201c;Rent Commencement Date&#x201d;). The Sublease has a
        term of 10 years from the Rent Commencement Date (the &#x201c;Term&#x201d;), subject to a five-year extension in accordance with the terms of the Sublease.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Pursuant to the Sublease, the Company paid the Sublessor a security deposit in the form of a letter of credit in the amount of
        approximately $4.1 million. Provided there are no events of default by the Company under the Sublease, the letter of credit will be
        reduced on an incremental basis throughout the Term. Pursuant to the Sublease, the Company has agreed to pay base rent of approximately $0.5
        million per month during the first year of the Term, increasing on an incremental basis each subsequent year of the Term for a total of approximately $63.0
        million in base rental payments, as well as parking and traditional lease expenses, including certain taxes, operating expenses and utilities.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Pursuant to the Sublease, the Sublessor will provide the Company with a tenant improvement allowance of $190 per rentable square foot, or $8.6
        million.&#160; Tenant improvements to the Premises in excess of this amount, if any, will be at the Company&#x2019;s own cost. As of December 31, 2022, the Premises had not been made available for the Company to begin the construction of the tenant
        improvements.&#160; It is expected that the Premises will be made available to begin the construction in March or April 2023, and it is anticipated that the construction will be complete and ready for operational use in November or December 2023.&#160; As a
        result, the commencement date of the Sublease did not occur as of December 31, 2022, and accordingly, the Company did not recognize
        a lease liability and corresponding ROU asset for the Sublease as of December 31, 2022.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of December 31, 2022, the Company had incurred approximately $0.6 million in costs in connection with the Sublease, which consisted of approximately $0.5 million for the architect to design the tenant improvements to the Premises and for a project manager to manage the construction of the tenant improvements as well as approximately $0.1 million in bank fees related to the issuance of the letter of credit discussed above.&#160; These costs are recorded in other assets in the accompanying
        consolidated balance sheet as of December 31, 2022.&lt;/div&gt;

&lt;div&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the years ended December 31, 2022 and 2021, the net operating lease expenses were as follows (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-weight: bold;"&gt;2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;595&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;688&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Sublease income&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(84&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(84&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Variable lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;150&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;19&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Total lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;661&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;623&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2022 and
            the ending balances as of December 31, 2022, including the changes during the period (in thousands).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Operating &lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Lease&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;ROU Assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease ROU assets at January 1, 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;2,567&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Initial measurement of ROU asset&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;1,706&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Amortization of operating lease ROU assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(336&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Impairment of ROU asset&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(772&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Remeasurment of ROU asset&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(813&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Reclassification from fixed assets to ROU assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;50&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Write off of ROU asset due to lease termination&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(1,372&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease ROU assets at December 31, 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;1,030&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Operating&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Lease&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease liabilities at January 1, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;2,723&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Initial measurement of operating lease liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;1,706&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Principal payments on operating lease liabilties&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(340&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Remeasurment of lease liability&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(1,454&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Write off of lease liability due to lease termination&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(1,453&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease liabilities at December 31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;1,182&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Less non-current portion&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;887&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Current portion at December 31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;295&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of December 31, 2022, the Company&#x2019;s operating leases had a weighted-average remaining life of 4.5 years with a weighted-average discount rate of 9.98%.
          &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The maturities of the
          operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2023&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;403&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2024&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;272&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2025&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;274&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2026&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;267&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2027&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;163&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Thereafter&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;82&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total payments&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,461&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Less imputed interest&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(279&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total operating lease liabilities&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,182&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The maturities of the operating lease liabilities show in the table above does not include future payments due under the
            Sublease that the Company entered into in October 2022, as the commencement date of the Sublease had not begun as of December 31, 2022, and therefore, the Company did not record a corresponding lease liability and ROU asset.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Sublease Agreement&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
              &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In April 2019, the Company entered into a sublease agreement with Nezu Asia Capital Management, LLC
              (the &#x201c;Tenant&#x201d;), whereby the Tenant agreed to sublease approximately 999 square feet of space currently rented by the Company in
              the borough of Manhattan in New York, New York commencing on May 15, 2019. The term of this sublease expires on October 31, 2026 with no option to extend the sublease term. Rent payments provided by the Tenant under the sublease agreement
              began on September 1, 2019. The sublease agreement stipulates an annual rent increase of 2.25%. The Tenant is also responsible for
              paying to the Company all tenant energy costs, annual operating costs, and annual tax costs attributable to the subleased space during the term of the sublease.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
              &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company received sublease payments of approximately $0.1 million for each of the years ended December 31, 2022 and 2021, respectively. In accordance with ASC Topic 842, the Company treats the sublease as a separate
              lease, as the Company was not relieved of the primary obligation under the original lease. The Company continues to account for the Manhattan lease as a lessee and in the same manner as prior to the commencement date of the sublease. The
              Company accounts for the sublease as a lessor of the lease. The sublease is classified as an operating lease, as it does not meet the criteria of a sale-type or direct financing lease.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following tables shows the future payments the Company expects to receive from the Tenant over
              the remaining term of the sublease (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
              &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                    &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of&lt;/div&gt;
                    &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;$ &lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;84&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;86&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;88&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;75&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;333&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeasesTextBlock>
    <erna:LesseeCommitmentToPurchaseProperty
      contextRef="c20220305"
      decimals="0"
      id="Fact_e91821115ce54409917749435483b760"
      unitRef="U001">50000</erna:LesseeCommitmentToPurchaseProperty>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="c20220305"
      decimals="0"
      id="Fact_28400bc1fbc049d584ee25ff6e98a031"
      unitRef="U001">63000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20220325"
      decimals="-5"
      id="Fact_c4706f1f967d48ad98495effec51b69d"
      unitRef="U001">1400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20220325"
      decimals="-5"
      id="Fact_cb6858fdd0984d1ba6d67317aad140fa"
      unitRef="U001">1500000</us-gaap:OperatingLeaseLiability>
    <erna:OperatingLeaseArea
      contextRef="c20220331"
      decimals="0"
      id="Fact_dde15d4673de4167b065962b46b2f092"
      unitRef="U006">5200</erna:OperatingLeaseArea>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="c20221231"
      id="Fact_ac0621d1740b4392a1db4e13f43d80d7">P62M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <erna:InitialMeasurementOfOperatingLeaseROUAssets
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_010f920ee1d54527addb15cb440ef04c"
      unitRef="U001">1700000</erna:InitialMeasurementOfOperatingLeaseROUAssets>
    <erna:InitialMeasurementOfOperatingLeaseLiabilities
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_719df252a6d542a0b889d33f877b893e"
      unitRef="U001">1700000</erna:InitialMeasurementOfOperatingLeaseLiabilities>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_4fd82ef30bda4679b6e92357dc875572"
      unitRef="U001">800000</us-gaap:OperatingLeaseImpairmentLoss>
    <erna:LeaseTerminationFeePayable
      contextRef="c20221229"
      decimals="-5"
      id="Fact_9ed37d47cbd840ec8b35989281332f81"
      unitRef="U001">100000</erna:LeaseTerminationFeePayable>
    <erna:LeaseTerminationFee
      contextRef="c20230109to20230109_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-5"
      id="Fact_8b0c61eba14b4af9895aa58902d7356b"
      unitRef="U001">100000</erna:LeaseTerminationFee>
    <erna:LeaseTerminationFeePayable
      contextRef="c20221229"
      decimals="-5"
      id="Fact_b64ccdb89b6f47078db9633266d5c2e5"
      unitRef="U001">100000</erna:LeaseTerminationFeePayable>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="c20221229to20221229"
      decimals="-5"
      id="Fact_1b889a0d3c3543bd93875e0cdfe1e2d8"
      unitRef="U001">-1400000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20221229"
      decimals="-5"
      id="Fact_24fb0e0a422a4d0b845f02261d076136"
      unitRef="U001">200000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20221229"
      decimals="-5"
      id="Fact_fe18cd9fd1324065bc6a93131593ace0"
      unitRef="U001">800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_c7eb8c79e244468e946c9803f81d88e0"
      unitRef="U001">800000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20220630"
      decimals="-6"
      id="Fact_b6a5d1818cee43d897455a2cc2ca9e8e"
      unitRef="U001">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <erna:LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_145b210d76f5436f80fe3485661f4ab9"
      unitRef="U001">600000</erna:LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20220325"
      decimals="-5"
      id="Fact_dae2e78d87cc4d9898b88b36c7bd7834"
      unitRef="U001">1400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="c20221018_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="0"
      id="Fact_24fa6449ff594f16ae10d25bae25605b"
      unitRef="U006">45500</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      id="Fact_21efca9824da4ee99a1b41123c3442ea">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      id="Fact_2f86dfa8e5a240da8609cc76cac63b32">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LineOfCredit
      contextRef="c20221018_PledgingPurposeAxis_LetterOfCreditMember_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_52b1b0deb7c14801a8f3b9a2abfc8d18"
      unitRef="U001">4100000</us-gaap:LineOfCredit>
    <erna:OperatingLeasesMonthlyBaseRent
      contextRef="c20221018to20221018_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_5a7e226cebdc4b8db69f7cc7592b78f0"
      unitRef="U001">500000</erna:OperatingLeasesMonthlyBaseRent>
    <erna:OperatingLeasesIncrementalBaseRentalPayment
      contextRef="c20221018_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_1108b0c293284e99ae653fb206695184"
      unitRef="U001">63000000</erna:OperatingLeasesIncrementalBaseRentalPayment>
    <erna:TenantImprovementAllowancePerRentableSquareFoot
      contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="0"
      id="Fact_e61a172178014745b159fe7721dd5013"
      unitRef="U001">190</erna:TenantImprovementAllowancePerRentableSquareFoot>
    <erna:TenantImprovementAllowance
      contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_2f15e8abb85547b3b77fe7c2cd0a7b2b"
      unitRef="U001">8600000</erna:TenantImprovementAllowance>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-6"
      id="Fact_6b7e59e88d16443ab0be4e1fede1a87d"
      unitRef="U001">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-6"
      id="Fact_0d2657ff7d8d45b694bb8b68569be611"
      unitRef="U001">0</us-gaap:OperatingLeaseLiability>
    <erna:SubleaseCost
      contextRef="c20221231_BalanceSheetLocationAxis_OtherNoncurrentAssetsMember_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_1e5c366fcc054918bc7511e0b3afefd9"
      unitRef="U001">600000</erna:SubleaseCost>
    <erna:SubleaseCostForTenantImprovements
      contextRef="c20221231_BalanceSheetLocationAxis_OtherNoncurrentAssetsMember_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_ed111a1202bf47eaae5381bda7017d61"
      unitRef="U001">500000</erna:SubleaseCostForTenantImprovements>
    <erna:CostRelatedToIssuanceOfLetterOfCredit
      contextRef="c20221231_BalanceSheetLocationAxis_OtherNoncurrentAssetsMember_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_44cab13e85644cc5a65525e0e8c00765"
      unitRef="U001">100000</erna:CostRelatedToIssuanceOfLetterOfCredit>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_48e17f2ddd0d43088c17bf4695ba7c4a">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the years ended December 31, 2022 and 2021, the net operating lease expenses were as follows (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-weight: bold;"&gt;2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;595&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;688&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Sublease income&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(84&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(84&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Variable lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;150&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;19&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Total lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;661&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;623&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_c9e363e463724369a3065ad9d1c471a4"
      unitRef="U001">595000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_5e20e410669444118170b1825b58e270"
      unitRef="U001">688000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_0f3798459d434cfda5b2fd8b5e77392d"
      unitRef="U001">84000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_99ad558b94a749138e02191b597e0a86"
      unitRef="U001">84000</us-gaap:SubleaseIncome>
    <us-gaap:VariableLeaseCost
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_f3c0e28d2a3048129cf42abe0b7e658d"
      unitRef="U001">150000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_010c36b639d240669a4a4ffb854a3b9d"
      unitRef="U001">19000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_4b053b65301140cb8d1640b9a358bee2"
      unitRef="U001">661000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_529c7b0f65fb47859e41815c64394055"
      unitRef="U001">623000</us-gaap:LeaseCost>
    <erna:OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_a21c6faafd8b41f3b40b59e2c3ab2115">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2022 and
            the ending balances as of December 31, 2022, including the changes during the period (in thousands).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Operating &lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Lease&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;ROU Assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease ROU assets at January 1, 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;2,567&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Initial measurement of ROU asset&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;1,706&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Amortization of operating lease ROU assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(336&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Impairment of ROU asset&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(772&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Remeasurment of ROU asset&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(813&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Reclassification from fixed assets to ROU assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;50&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Write off of ROU asset due to lease termination&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(1,372&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease ROU assets at December 31, 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;1,030&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Operating&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Lease&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease liabilities at January 1, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;2,723&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Initial measurement of operating lease liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;1,706&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Principal payments on operating lease liabilties&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(340&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Remeasurment of lease liability&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(1,454&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Write off of lease liability due to lease termination&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(1,453&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease liabilities at December 31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;1,182&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Less non-current portion&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;887&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Current portion at December 31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;295&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;
</erna:OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20211231"
      decimals="-3"
      id="Fact_6aab0bd0b5c541868dec52b8076c6050"
      unitRef="U001">2567000</us-gaap:OperatingLeaseRightOfUseAsset>
    <erna:InitialMeasurementOfOperatingLeaseROUAssets
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_074853c096274371b493c1b541571492"
      unitRef="U001">1706000</erna:InitialMeasurementOfOperatingLeaseROUAssets>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_02b73af7552c4cdd9a963ec91e256300"
      unitRef="U001">336000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_c217a6a2ddde44cda806b4898670a876"
      unitRef="U001">772000</us-gaap:OperatingLeaseImpairmentLoss>
    <erna:RemeasurementOfOperatingLeaseRightOfUseAsset
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_68919775903a4717b9350fcd0dc0a7f0"
      unitRef="U001">813000</erna:RemeasurementOfOperatingLeaseRightOfUseAsset>
    <erna:ReclassificationFromFixedAssetsToRightOfUseAsset
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_cce457ac6cd145349b4078ad017d23ba"
      unitRef="U001">50000</erna:ReclassificationFromFixedAssetsToRightOfUseAsset>
    <erna:WriteOffOfOperatingLeaseRightOfUseAsset
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_373f06d41e0c400f86a43e94a98c60ae"
      unitRef="U001">1372000</erna:WriteOffOfOperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20221231"
      decimals="-3"
      id="Fact_865ca52e61d34b54ad3fd4ce466e04b8"
      unitRef="U001">1030000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20211231"
      decimals="-3"
      id="Fact_058b3b868ff9402494d8d859d0395027"
      unitRef="U001">2723000</us-gaap:OperatingLeaseLiability>
    <erna:InitialMeasurementOfOperatingLeaseLiabilities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_d0620834aa5647c5bcddeb520a5ad540"
      unitRef="U001">1706000</erna:InitialMeasurementOfOperatingLeaseLiabilities>
    <erna:PrincipalPaymentsOnOperatingLeaseLiabilities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_69986d0e447e471399a3cc7f0f335955"
      unitRef="U001">340000</erna:PrincipalPaymentsOnOperatingLeaseLiabilities>
    <erna:RemeasurementOfOperatingLeaseLiability
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_711e28c2dcfd491c9a2ef1b1389d4249"
      unitRef="U001">1454000</erna:RemeasurementOfOperatingLeaseLiability>
    <erna:WriteOffOfOperatingLeaseLiability
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_af966742a2864121adf289d83aaf1e95"
      unitRef="U001">1453000</erna:WriteOffOfOperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20221231"
      decimals="-3"
      id="Fact_152a7aae43224e6689c342999fefd44b"
      unitRef="U001">1182000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_fa584694b50f423ba53bbfbc425108b9"
      unitRef="U001">887000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_29b0d2c384944bcebe2a222b337640ac"
      unitRef="U001">295000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="c20221231"
      id="Fact_ac644f82de1645088f405552b1fb92e7">P4Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="c20221231"
      decimals="4"
      id="Fact_ddac135ce567429a871f47e3f5a763a5"
      unitRef="U005">0.0998</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_e03d0948964e4f94bf38b0d419663594">&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The maturities of the
          operating lease liabilities are as follows (in thousands):&lt;/span&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2023&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;403&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2024&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;272&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2025&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;274&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2026&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;267&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2027&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;163&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Thereafter&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;82&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total payments&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,461&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Less imputed interest&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(279&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total operating lease liabilities&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,182&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="c20221231"
      decimals="-3"
      id="Fact_02a4a5a179144f25badc714cacdc40f7"
      unitRef="U001">403000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="c20221231"
      decimals="-3"
      id="Fact_1ce5e45016be430a91b10fde9c5e4ab4"
      unitRef="U001">272000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="c20221231"
      decimals="-3"
      id="Fact_60f32a333d89420090c160cd98130dd0"
      unitRef="U001">274000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="c20221231"
      decimals="-3"
      id="Fact_7e9e19f1f0dc4540ba9b7ecaedbde6b4"
      unitRef="U001">267000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="c20221231"
      decimals="-3"
      id="Fact_70cf059c96864313800356418acfb2c3"
      unitRef="U001">163000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="c20221231"
      decimals="-3"
      id="Fact_61ca46739f7f44608c5736e21f0378d3"
      unitRef="U001">82000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="c20221231"
      decimals="-3"
      id="Fact_599484458f3d4f89a2c1770dcbde39b8"
      unitRef="U001">1461000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="c20221231"
      decimals="-3"
      id="Fact_2f50445dadd0457ea5a2e137dc596ded"
      unitRef="U001">279000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20221231"
      decimals="-3"
      id="Fact_c6a71605e9f04b8c88a9df250a5131ab"
      unitRef="U001">1182000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-6"
      id="Fact_fc5926badd0e45409fc03e2e39bf593f"
      unitRef="U001">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-6"
      id="Fact_69fe541da62445a2a24c3b83f6178141"
      unitRef="U001">0</us-gaap:OperatingLeaseLiability>
    <erna:AreaOfSubleaseSpaceCurrentlyRented
      contextRef="c20190418"
      decimals="0"
      id="Fact_223b9f91406d4ea9b3c6d90f099ca8b9"
      unitRef="U006">999</erna:AreaOfSubleaseSpaceCurrentlyRented>
    <erna:PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments
      contextRef="c20190418to20190418"
      decimals="4"
      id="Fact_bdc0edf3750b40e19d20998981d97344"
      unitRef="U005">0.0225</erna:PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments>
    <us-gaap:ProceedsFromLeasePayments
      contextRef="c20210101to20211231"
      decimals="-5"
      id="Fact_665ddcf16c5f4c7f89549d9dfe276f23"
      unitRef="U001">100000</us-gaap:ProceedsFromLeasePayments>
    <us-gaap:ProceedsFromLeasePayments
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_fc9713abc05c48f180775fe9df2f0cbc"
      unitRef="U001">100000</us-gaap:ProceedsFromLeasePayments>
    <erna:FutureLeasePaymentsSubleaseAgreementTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_75b8b2d545f54483bf68ce80fe030d20">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following tables shows the future payments the Company expects to receive from the Tenant over
              the remaining term of the sublease (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
              &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                    &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of&lt;/div&gt;
                    &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;$ &lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;84&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;86&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;88&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;75&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;333&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</erna:FutureLeasePaymentsSubleaseAgreementTableTextBlock>
    <erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths
      contextRef="c20221231"
      decimals="-3"
      id="Fact_50541847215c480c995d4113e4a367d7"
      unitRef="U001">84000</erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths>
    <erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears
      contextRef="c20221231"
      decimals="-3"
      id="Fact_b7a42098612f43b58c981aa9124b83ed"
      unitRef="U001">86000</erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears>
    <erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears
      contextRef="c20221231"
      decimals="-3"
      id="Fact_4ac4ac5c5af243769bdedd479b7d7403"
      unitRef="U001">88000</erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears>
    <erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears
      contextRef="c20221231"
      decimals="-3"
      id="Fact_c5eee822abdb481ea4f26c18ba7d0477"
      unitRef="U001">75000</erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears>
    <erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentals
      contextRef="c20221231"
      decimals="-3"
      id="Fact_0473a9500d3f47f3ba0a844616916c3f"
      unitRef="U001">333000</erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentals>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="c20220101to20221231"
      id="Text_0606de2f709c4b09b62da3884ecc3a1f">
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;8)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;In-Process Research &amp;amp; Development and Goodwill&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt;In-Process Research
          &amp;amp; Development&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In
          2018, the Company acquired IRX, which was accounted for as a business combination.&#160; The Company recorded IPR&amp;amp;D in the amount of $6.0
          million, which represented the fair value assigned to technologies that were acquired in connection with the IRX acquisition and which have not reached technological feasibility and have no alternative future use.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In
          June 2022, the Company received results from the INSPIRE phase 2 trial of IRX-2, a multi-cytokine biologic immunotherapy, in patients with newly diagnosed stage II, III or IVA squamous cell carcinoma of the oral cavity. The IRX-2 multi-cytokine
          biologic immunotherapy represents substantially all the fair value assigned to the technologies of IRX that the Company acquired. Despite outcomes that favored IRX-2 in certain predefined subgroups, the INSPIRE trial did not meet the primary
          endpoint of Event-Free Survival. Significant additional clinical development work would be required to advance IRX-2 in the form of additional Phase 2 and 3 studies to further evaluate the treatment effect of IRX-2 in patient subgroups and in
          combination with checkpoint inhibitor therapies.&#160; The INSPIRE trial was the only Company-sponsored study of IRX-2.&#160; Based on the totality of available information, the Company currently does not have plans to further develop the IRX-2 product
          candidate. As such, the Company determined that the carrying value of the IPR&amp;amp;D asset was impaired and recognized a non-cash impairment charge of approximately $6.0 million on the consolidated statement of operations during 2022, which reduced the value of the asset to zero.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt;Goodwill&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;The
















          Company recorded goodwill in the amount of $2.0 million related to the IRX Acquisition. As of December 31, 2022, the Company performed
          a qualitative assessment to determine whether it was more likely than not that the fair value of the entity is less than its carrying value of goodwill. Such qualitative factors include macroeconomic conditions, industry and market
          considerations, cost factors, overall financial performance and other relevant events.&#160; Due to the decline in the Company&#x2019;s stock price during 2022, the Company determined there were indications of impairment of the goodwill. Accordingly, the
          Company proceeded to a quantitative assessment of impairment and determined that the fair value of the reporting unit exceeded the carrying amount of goodwill, and therefore, the goodwill was not impaired as of December 31, 2022.
        &lt;/div&gt;
</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c20181231"
      decimals="-5"
      id="Fact_f16e4560ecec4d37947eb95c8603a157"
      unitRef="U001">6000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_73fa8e6d8b5d497c987e74392bc18b9e"
      unitRef="U001">6000000</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c20221231"
      decimals="-6"
      id="Fact_46f669bd5c744128962bc862cc648659"
      unitRef="U001">0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="c20221231"
      decimals="-5"
      id="Fact_481790f766df45848bc4934fd7e709d8"
      unitRef="U001">2000000</us-gaap:Goodwill>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="c20220101to20221231"
      id="Text_348a8a747cad464eb8f0428093b9c2c0">
&lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="align: right; vertical-align: top; width: 9pt;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: -36pt; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-left: 36pt;"&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9)&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt;Related Party Transactions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;"&gt;Agreements Related to Factor Bioscience and Dr. Matthew Angel&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In
          September 2022, the Company entered into a Master Services Agreement (the &#x201c;MSA&#x201d;) with Factor Bioscience Inc. (&#x201c;Factor Bioscience&#x201d;), pursuant to which Factor Bioscience has agreed to provide services to the Company as agreed between the Company
          and Factor Bioscience and as set forth in one or more work orders under the MSA, including the first work order included in the MSA (&#x201c;WO1&#x201d;). Under WO1, Factor Bioscience has agreed to provide the Company with mRNA cell engineering research
          support services, including access to certain facilities, equipment, materials and training, and the Company has agreed to pay Factor Bioscience an initial fee of $5.0 million, payable in twelve equal monthly installments of approximately $0.4 million. Of the $5.0 million, the
          Company allocated $3.5 million to the License Fee Obligation (as defined below). Following the initial 12-month period, the Company has
          agreed to pay Factor Bioscience a monthly fee of $0.4 million until such time as WO1 is terminated. The Company paid a deposit of $0.4 million, which will be applied to the last month of the first work order.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company may terminate WO1 under the MSA on or after the second anniversary of the date of the MSA, subject to providing
          Factor Bioscience with 120 days&#x2019; prior notice.&#160; Factor Bioscience may terminate such work order only on and after the fourth anniversary of the date of the MSA, subject to providing the Company with 120 days&#x2019; prior notice.&#160; The MSA contains customary confidentiality provisions and representations and warranties of the parties, and the MSA may be terminated by ether party
          upon 30 days&#x2019; prior notice, subject to any superseding termination provisions contained in a particular work order.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In connection with entering into the MSA, Factor Bioscience&#x2019;s subsidiary, Factor Limited, entered into a waiver agreement
          (the &#x201c;Waiver Agreement&#x201d;) with Eterna LLC, pursuant to which Factor Limited agreed to waive payment of $3.5 million otherwise payable to
          it (the &#x201c;License Fee Obligation&#x201d;) in October 2022 by Eterna LLC under the Original Factor License Agreement, as defined in Note 13,&#160;&lt;span style="font-style: italic;"&gt;License Agreements&lt;/span&gt;.&#160; Under the terms of the Waiver Agreement, the License
          Fee Obligation is waived conditionally on the Company paying Factor Bioscience amounts due under the MSA.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;As a result of entering into the Waiver Agreement and the MSA, the Company recognized $3.5 million in research and development expense, as the license does not have an alternative future use, and a corresponding liability for the License
          Fee Obligation.&#160; As of December 31, 2022, there was approximately $3.0 million of the License Fee Obligation remaining, which is
          recorded on the accompanying consolidated balance sheet in the &#x201c;due to related party&#x201d; line items.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;In September 2022, Novellus and Eterna entered into a Second Amendment to the Limited
        Waiver and Assignment Agreement (the &#x201c;Waiver and Assignment Agreement&#x201d;) with Drs. Matthew Angel and Christopher Rohde (the &#x201c;Founders&#x201d;) whereby the Company has agreed to be responsible for all future, reasonable and substantiated legal fees, costs,
        settlements and judgments incurred by the Founders, the Company or Novellus for certain claims and actions and any pending or future litigation brought against the Founders, Novellus and/or the Company by or on behalf of the Westman and Sowyrda
        legal matters described in Note 12 (the &#x201c;Covered Claims&#x201d;).&#160; The Founders will continue to be solely responsible for any payments made to satisfy a judgement or settlement of any pending or future wage act claims.&#160; Under the Waiver and Assignment
        Agreement, the Founders agreed that they are not entitled to, and waived any right to, indemnification or advancement of past, present or future legal fees, costs, judgments, settlement or other liabilities they may have been entitled to receive
        from the Company or Novellus in respect of the Covered Claims. The Company and the Founders will share in any recoveries up to the point at which the parties have been fully compensated for legal fees, costs and expenses incurred, with the Company
        retaining any excess recoveries. The Company has the sole authority to direct and control the prosecution, defense and settlement of the Covered Claims.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;In September 2022, the Company entered into an assignment and assumption of contracts
        agreement (the &#x201c;Assignment and Assumption Agreement&#x201d;) with Factor Bioscience, pursuant to which the Company assumed certain contracts with third parties that Factor Bioscience had previously entered into in anticipation of entering into a sublease
        for premises in Somerville, Massachusetts.&#160; In October 2022, the Company entered into a sublease for the premises (see Note 7).&#160; Under the Assignment and Assumption Agreement, the Company agreed to reimburse Factor Bioscience for costs already
        incurred or paid by it under the assumed contracts in the amount of approximately $0.1 million, and the Company assumed the future
        obligations under these contracts, which relate to the design and build-out of the subleased space.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In
          November 2022, following the expiration of one of the delineated milestone deadlines for certain regulatory filings required under the Novellus-Factor License Agreement (as defined in Note 12), which permitted Factor Limited to terminate the
          license granted to Novellus Limited thereunder, the Company entered into the first amendment to the Original Factor License Agreement (the &#x201c;Amended Factor License Agreement&#x201d;), pursuant to which, among other things, Factor Limited granted to
          Eterna LLC an exclusive, sublicensable license under certain patents owned by Factor Limited (the &#x201c;Factor Patents&#x201d;) for the purpose of identifying and pursuing certain opportunities to grant to third parties sublicenses to the Factor Patents. The
          Amended Factor License Agreement also (i) terminated the Novellus-Factor License Agreement, (ii) confirmed Factor Limited&#x2019;s grant to Eterna LLC of the rights and licenses Novellus Limited previously granted to Eterna LLC under the Novellus-Factor
          License Agreement on the same terms and conditions as granted by Novellus Limited to Eterna LLC under such agreement, (iii) confirmed that sublicense granted by Novellus Limited in accordance with the Novellus-Factor License Agreement to NoveCite
          (as discussed in Note 12), survived termination of the Novellus-Factor License Agreement; and (iv) removed Novellus Limited from the Amended Factor License Agreement and the NoveCite Agreement (as defined in Note 12) and replaced Novellus Limited
          with Factor Limited as the direct licensor to Eterna LLC and NoveCite under such agreements, respectively.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The















          agreements discussed above have been deemed related party transactions, as the Company&#x2019;s Chief Executive Officer, Dr. Matthew Angel, is also the Chairman and Chief Executive Officer of Factor Bioscience and a Director of Factor Limited.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt;Exacis Option Agreement&lt;/span&gt;&lt;br/&gt;
          &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;On October 8, 2022, the Company entered into an option agreement (the &#x201c;Exacis Option Agreement&#x201d;) with Exacis Biotherapeutics,
          Inc., a Delaware corporation (&#x201c;Exacis&#x201d;), pursuant to which Exacis granted the Company the option to negotiate and enter into an exclusive worldwide sublicense by December 31, 2022 to certain technology licensed by Exacis for the treatment of
          cancer in humans (the &#x201c;Exacis Option&#x201d;). Under the Exacis Option Agreement, the Company paid Exacis a fee of $0.3 million for the Exacis
          Option, which would be creditable against the fees or purchase price payable under any such license if entered into by the Company in accordance with the Exacis Option Agreement. The Exacis Option Agreement provided for certain payments upon the
          execution of a definitive license agreement, which would become payable only upon execution and in accordance with the terms of the applicable license agreement, if any.&#160; The Company decided not to exercise the Exacis Option, and the Exacis
          Option Agreement expired in accordance with its terms on December 31, 2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Exacis Option Agreement has been deemed a related party transaction, as one of the Company&#x2019;s Board members, Dr. Gregory
          Fiore, is the Chief Executive Officer of Exacis.&#160; Additionally, the Company&#x2019;s Chief Executive Office, Dr. Matthew Angel, is Chairman of Exacis&#x2019; scientific advisory board. Dr. Angel is also the Chairman and Chief Executive Officer of Factor
          Bioscience LLC, which is the majority shareholder of Exacis.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;"&gt;Q4-22 PIPE Transaction &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;On November 23, 2022, the Company entered into the Q4-22 Purchase Agreement with the Q4-22 PIPE Investors in respect of
              the Q4-22 PIPE Transaction, pursuant to which the Company issued and sold to the Q4-22 PIPE Investors approximately 2,185,000
              units, each unit consisting of (i) one share of common stock and (ii) two Q4-22 Warrants, at a purchase price of $3.53 per unit
              (inclusive of $0.125 per Q4-22 Warrant). The Company received aggregate gross proceeds of approximately $7.7 million, The Q4-22 PIPE Transaction closed on December 2, 2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Each Q4-22 Warrant becomes exercisable six months following the date of closing, expires &lt;span style="-sec-ix-hidden:Fact_1f3e03cde5674ee69b274ec5dc980a3c"&gt;five-and-one-half&lt;/span&gt; years following such date,
                and is subject to customary adjustments.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Mr. Charles Cherington, Chairman of the Company&#x2019;s Board of Directors, and Mr. Nicholas Singer, a director of the
                Company, participated in the Q4-22 PIPE Transaction on the same terms and subject to the same conditions as all other Q4-22 PIPE Investors.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;On the closing date of the Q4-22 PIPE Transaction, the Company and the Q4-22 PIPE Investors, including Messrs. Cherington
              and Singer, entered into a registration rights agreement, pursuant to which the Company has agreed to prepare and file a registration statement on Form S-3 with the Securities and Exchange Commission no later than 30 days following the date
              on which the Company becomes eligible to use Form S-3 to register the resale of the shares of common stock included in the units described above and the shares of common stock issuable upon exercise of the Q4-22 Warrants.&lt;/div&gt;
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <erna:MasterServiceAgreementInitialFeesPayable
      contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_b08af770d44d403d81e96daa3f53d7d1"
      unitRef="U001">5000000</erna:MasterServiceAgreementInitialFeesPayable>
    <erna:NumberOfMonthlyInstallmentsForFeesPayable
      contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="INF"
      id="Fact_3c03a9e15bc04c109ac272963890310e"
      unitRef="U009">12</erna:NumberOfMonthlyInstallmentsForFeesPayable>
    <erna:RelatedPartyTransactionPeriodicFeesPaymentAmount
      contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_25c3e0c940cf41b195062ed8e32f0924"
      unitRef="U001">400000</erna:RelatedPartyTransactionPeriodicFeesPaymentAmount>
    <erna:MasterServiceAgreementInitialFeesPayable
      contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_3b2db18238e84ee598e8f9ad7cb1150c"
      unitRef="U001">5000000</erna:MasterServiceAgreementInitialFeesPayable>
    <erna:InitialLicenseFeeObligation
      contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_aac6735f460e4ffd90abd02aee3fd20a"
      unitRef="U001">3500000</erna:InitialLicenseFeeObligation>
    <erna:MonthlyMasterServicesAgreementFeesPayable
      contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_027a1923189e4f36bdab7c9a2aec4b73"
      unitRef="U001">400000</erna:MonthlyMasterServicesAgreementFeesPayable>
    <erna:DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder
      contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_e3d58ba262b04d7ba3303bb765bdfbd2"
      unitRef="U001">400000</erna:DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder>
    <erna:NoticePeriodForFirstTerminationOfContract
      contextRef="c20220101to20221231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      id="Fact_8a0e7fbb7ad64b37bdecf9aa7b98c0a9">P120D</erna:NoticePeriodForFirstTerminationOfContract>
    <erna:NoticePeriodForSupersedingTerminationProvisions
      contextRef="c20220101to20221231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      id="Fact_752ad4a10420487884b4fa91eaec6847">P30D</erna:NoticePeriodForSupersedingTerminationProvisions>
    <erna:AgreedWaivePayment
      contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_ac30bc56904b413187fa910b16552616"
      unitRef="U001">3500000</erna:AgreedWaivePayment>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_a6e05fb286fe47cdaf44b04f9b04aded"
      unitRef="U001">3500000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <erna:RemainingLicenseFeeObligation
      contextRef="c20220101to20221231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_456114ca93ff4e0ea3d2a5d45a6a189d"
      unitRef="U001">3000000</erna:RemainingLicenseFeeObligation>
    <erna:ReimburseCostsIncurredOrPaid
      contextRef="c20221001to20221031_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_234179d7b0da40f4948f42fca0e47f2a"
      unitRef="U001">100000</erna:ReimburseCostsIncurredOrPaid>
    <erna:PaymentOfOptionFee
      contextRef="c20221008to20221008_RelatedPartyTransactionsByRelatedPartyAxis_ExacisBiotherapeuticsIncMember"
      decimals="-5"
      id="Fact_b2246484b5dd47b7bcede4def8b91596"
      unitRef="U001">300000</erna:PaymentOfOptionFee>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_bb361b9d5211413aa1b3cf9b3759cc0e"
      unitRef="U002">2185000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_c52529b759cc4ab5929bc1fc8a42683e"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_84b98019e2ae4e508759d9af2f49c7b9"
      unitRef="U002">2</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <erna:UnitPriceOfWarrants
      contextRef="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="2"
      id="Fact_5c025c553d7747eda10f79154f50b5f5"
      unitRef="U003">3.53</erna:UnitPriceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact_a57bed73a5ae4abab71d433fffd49f12"
      unitRef="U003">0.125</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c20221202to20221202_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_bd4fc959d8714e7aa3d6a6e370e1f5cf"
      unitRef="U001">7700000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <erna:ClassOfWarrantOrRightsExercisableTerm
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_0b8a030d69864c969b7286bfb3a2389c">P6M</erna:ClassOfWarrantOrRightsExercisableTerm>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="c20220101to20221231"
      id="Text_09ff2d1d1d51425899784ee7a9d40e93">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;10)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Accrued Expenses&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Accrued expenses consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Accrued compensation&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,065&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;656&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Legal fees and related&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,138&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;241&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Clinical&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;570&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;200&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Q4-22 PIPE&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;208&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;Other&lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;645&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;152&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total accrued expenses&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,626&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,249&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_7d93a6d21dd346b99df188153b132581">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Accrued expenses consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Accrued compensation&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,065&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;656&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Legal fees and related&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,138&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;241&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Clinical&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;570&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;200&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Q4-22 PIPE&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;208&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;Other&lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;645&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;152&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total accrued expenses&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,626&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,249&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_20cf85cd84c04ee8a9a3cf9785d883b3"
      unitRef="U001">1065000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_165e1ff05dab47babc45843935676f5c"
      unitRef="U001">656000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_e8ea9961d6c34861bc3854cab7f9991f"
      unitRef="U001">1138000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_69247117975741e58bb1b14e66138270"
      unitRef="U001">241000</us-gaap:AccruedProfessionalFeesCurrent>
    <erna:AccruedClinicalCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_ac64df674a5947278f7ff70fd7927751"
      unitRef="U001">570000</erna:AccruedClinicalCurrent>
    <erna:AccruedClinicalCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_bbeb0f1c7d07424c9a163e4a37806c60"
      unitRef="U001">200000</erna:AccruedClinicalCurrent>
    <erna:AccruedPrivatePlacementInPublicEquityCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_a342194857a04af989389ec97bcf416a"
      unitRef="U001">208000</erna:AccruedPrivatePlacementInPublicEquityCurrent>
    <erna:AccruedPrivatePlacementInPublicEquityCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_529db28790604a149681e7fd9c45bd36"
      unitRef="U001">0</erna:AccruedPrivatePlacementInPublicEquityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_2ca7139fea334124beab324422acdb82"
      unitRef="U001">645000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_1663c775cade4651af51a39608c5f5bb"
      unitRef="U001">152000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_db3678ff7e6a4d6a902d4bbe229a7388"
      unitRef="U001">3626000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ebd989d8fe924530a9103a3135fbe950"
      unitRef="U001">1249000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="c20220101to20221231"
      id="Text_e0a9604a8f0746a2a82ba18894737c70">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;11)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Debt&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Loans Payable&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;In connection with the IRX Acquisition in 2018, Eterna LLC assumed certain notes payable (the &#x201c;IRX Notes&#x201d;) in the amount of $0.4 million. On January 27, 2020, the IRX Notes were amended to extend the maturity date to the earlier of (i) a change of control, as defined in the
          IRX Notes, and (ii) December 31, 2021. On December 31, 2021, the Company paid the outstanding $0.4 million in principal plus accrued
          and unpaid interest of approximately $0.2 million under the IRX Notes, and the Company has no further obligations thereunder.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Payment Protection Program Loan&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;On May 4, 2020, Eterna LLC issued a note in the principal amount of approximately $0.3 million to Silicon Valley Bank evidencing a loan (the &#x201c;Eterna LLC PPP Loan&#x201d;) that Eterna LLC received under the Paycheck Protection Program (the &#x201c;PPP&#x201d;) of the Coronavirus
          Aid, Relief, and Economic Security Act administered by the U.S. Small Business Administration (the &#x201c;CARES Act&#x201d;). Eterna LLC PPP Loan incurred interest at a rate of 1.0% per annum.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Under the terms of the CARES Act, certain amounts of the Eterna LLC PPP Loan could be forgiven if they were used for
          qualifying expenses, as described in the CARES Act. In September 2021, the lender informed Eterna LLC that the U.S Small Business Administration approved the forgiveness of 100% of the outstanding principal and interest of the Eterna LLC PPP
          Loan. &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;As a result, the Company recognized a gain during 2021 of $0.3 million during recorded in other (expense) income, net, on the accompanying consolidated statements of operations. The Company has no further obligations under this loan&lt;/span&gt;.&lt;/div&gt;
</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LoansPayableCurrent
      contextRef="c20181231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember"
      decimals="-5"
      id="Fact_77513174f9d04964b205cc8116bf42da"
      unitRef="U001">400000</us-gaap:LoansPayableCurrent>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c20210101to20211231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember"
      decimals="-5"
      id="Fact_b1ff87ceec1545ef9e5cc5467a29a723"
      unitRef="U001">400000</us-gaap:RepaymentsOfNotesPayable>
    <erna:PaymentOfAccruedAndUnpaidInterest
      contextRef="c20210101to20211231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember"
      decimals="-5"
      id="Fact_54e5a754b95240639d5e5d92699cf406"
      unitRef="U001">200000</erna:PaymentOfAccruedAndUnpaidInterest>
    <us-gaap:LoansPayableCurrent
      contextRef="c20221231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember"
      decimals="-6"
      id="Fact_5a80d82c953d49369838120671354897"
      unitRef="U001">0</us-gaap:LoansPayableCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c20200504_DebtInstrumentAxis_PaycheckProtectionProgramMember"
      decimals="-5"
      id="Fact_51ccc2dc8fc84af18e67f284a46bc535"
      unitRef="U001">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20200504_DebtInstrumentAxis_PaycheckProtectionProgramMember"
      decimals="3"
      id="Fact_0004ad9747784720a6510c15e1911bbb"
      unitRef="U005">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c20210101to20211231_DebtInstrumentAxis_PaycheckProtectionProgramMember"
      decimals="-5"
      id="Fact_88d0143092824fae82fa8f52d9976301"
      unitRef="U001">300000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:LongTermDebt
      contextRef="c20221231_DebtInstrumentAxis_PaycheckProtectionProgramMember"
      decimals="0"
      id="Fact_3739e72ec6154d90a54d23203addbabc"
      unitRef="U001">0</us-gaap:LongTermDebt>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="c20220101to20221231"
      id="Text_2fde8b23a8364cbd9fe75501088788fb">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;12)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Commitments and Contingencies&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Litigation Matters&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The









          Company is involved in litigation and arbitrations from time to time in the ordinary course of business. Legal fees and other costs associated with such actions are expensed as incurred. In addition, the Company assesses the need to record a
          liability for litigation and contingencies. The Company reserves for costs relating to these matters when a loss is probable, and the amount can be reasonably estimated.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
            &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;&lt;span style="text-decoration: underline;"&gt;Dhesh Govender v. Eterna Therapeutics LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021)&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On









            or about February 5, 2021, Dhesh Govender, a former short-term consultant of Eterna LLC, filed a complaint against Eterna LLC and certain individuals that plaintiff alleged were directors of Eterna LLC. Plaintiff alleged that Eterna LLC and
            certain of its officers and directors (&#x201c;defendants&#x201d;) engaged in unlawful and discriminatory conduct based on race, national origin and hostile work environment. Plaintiff also asserted various breach of contract, fraud and quantum meruit claims
            based on an alleged oral agreement pursuant to which he alleged Eterna LLC agreed to hire him as an executive once the Merger was completed. On December 15, 2022, the parties executed a Confidential Settlement Agreement and Release of All
            Claims. On January 11, 2023, the parties filed a Stipulation to Discontinue in the Court action. Also on January 11, 2023, Govender voluntarily dismissed the arbitration.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-decoration: underline;"&gt;John Westman v.
              Novellus, Inc., Christopher Rohde, and Matthew Angel, Civil Action No. 2181CV01949 (Middlesex County (Massachusetts) Superior Court)&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On or about September 7, 2021, John Westman, a former employee of Novellus, Inc.
          filed a Complaint in Middlesex County (Massachusetts) Superior Court against Novellus, Inc. and Novellus, Inc.&#x2019;s founders and former executives, Dr. Christopher Rohde and Dr. Matthew Angel (collectively, &#x201c;Defendants&#x201d;).&#160; The case includes
          allegations that Novellus, Inc. violated the Massachusetts Wage Act (&#x201c;Wage Act&#x201d;).&#160; Eterna acquired Novellus, Inc. on July 16, 2021.&#160; Mr. Westman&#x2019;s claims relate to alleged conduct that took place before Eterna acquired Novellus, Inc.&#160; Westman
          agreed to dismiss the lawsuit and proceed with his claims in arbitration.&#160; Following mediation, the parties settled this dispute in December 2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; The aggregate settlement amount payable by the Company for the two matters
          discussed above is approximately $0.5 million.&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="text-decoration: underline;"&gt;Novellus, Inc. v. Sowyrda et al., C.A. No. 2184CV02436-BLS2&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;On October 25, 2021 Novellus, Inc. filed a complaint in the Superior Court of Massachusetts, Suffolk County, against former
            Novellus, Inc. employees Paul Sowyrda and John Westman and certain other former investors in Novellus LLC (Novellus, Inc.&#x2019;s former parent company prior to our acquisition of Novellus, Inc.), alleging breach of fiduciary duty, breach of contract
            and civil conspiracy. Eterna acquired Novellus, Inc. on July 16, 2021.&#160; On May 27, 2022 Novellus, Inc. amended the complaint to withdraw all claims against all defendants except Paul Sowyrda and John Westman.&#160; On July 1, 2022, Westman filed a
            motion to compel arbitration or in the alternative, to stay the litigation pending the disposition of certain litigation in the Court of Chancery for the State of Delaware filed by Mr. Sowyrda against Novellus LLC, Dr. Christopher Rohde, Dr.
            Matthew Angel, Leonard Mazur and Factor Bioscience, Inc. captioned&#160;&lt;span style="font-style: italic;"&gt;Zelickson et al., v. Angel et al.,&lt;/span&gt;&#160;C.A. 2021-1014-JRS and by Westman against Novellus LLC captioned&#160;&lt;span style="font-style: italic;"&gt;Westman

























              v. Novellus LLC&lt;/span&gt;, C.A. No. 2021-0882-NAC (the &#x201c;Delaware Actions&#x201d;).&#160; On July 1, 2022, Sowyrda answered the complaint and asserted counterclaims against Novellus, Inc, and third-party defendants Dr. Matthew Angel and Dr. Christopher Rohde
            alleging violations of the Massachusetts Wage Act, Massachusetts Minimum Fair Wage Law, the Fair Labor Standards Act, breach of contract, unjust enrichment and quantum meruit.&#160; Sowyrda also joined in Westman&#x2019;s motion to stay the case pending
            the Delaware Actions.&#160; Novellus, Inc.&#x2019;s claims and Mr. Sowyrda&#x2019;s counterclaims relate to alleged conduct that took place before Eterna acquired Novellus, Inc.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;On November 15, 2022, prior to a decision on Westman&#x2019;s and Sowyrda&#x2019;s motion to compel or stay, the Parties agreed to
            voluntarily dismiss and consolidate the Delaware Actions with this action.&#160; On December 15, 2022, Sowyrda filed an Amended Answer to the Amended Complaint, asserted affirmative defenses and filed Amended Counterclaims against Dr. Angel, Dr.
            Rohde, Novellus LLC, Novellus Inc., Factor Bioscience Inc., and Eterna Therapeutics Inc. (&#x201c;Counterclaim Defendants&#x201d;) alleging against various Counterclaim Defendants breach of contract, breaches of the implied duty of good faith and fair
            dealing, breaches of fiduciary duty, breaches of the operating agreement, aiding and abetting breaches of fiduciary duty, tortious interference with contract, equitable accounting, violations of the Massachusetts Wage Act, Massachusetts Minimum
            Fair Wage Law, the Fair Labor Standards Act, unjust enrichment, and quantum meruit.&#160; Also on December 15, 2022, Westman filed an answer to the Amended Complaint and asserted similar counterclaims against the same Counterclaim Defendants.&#160;
            Westman and Sowyrda each asserted claims for indemnification and/or advancement against Novellus, Inc.&#160; On January 11, 2023, Westman and Sowyrda served a joint motion to enforce their advancement and/or indemnification rights against Novellus
            Inc.&#160; Novellus Inc. vigorously opposes this motion and served its opposition on January 27, 2023.&#160; On February 8, 2023, Westman and Sowyrda served a reply in support of their motion to enforce indemnification/advancement rights, and submitted
            the motion to the Court.&#160; Novellus Inc. answered Westman and Sowyrda&#x2019;s counterclaims on January 27, 2023, denying liability.&#160; The remaining Counterclaim Defendants served a motion to dismiss most of the remaining counterclaims on January 27,
            2023.&#160; Sowyrda&#x2019;s and Westman&#x2019;s oppositions to the motion to dismiss were served on March 3, 2023, and Counterclaim Defendants&#x2019; reply is due March 24, 2023, at which point the motion to dismiss will be fully briefed.&#160; The Court announced that it
            would hold oral argument on April 5, 2023 on (a) the Counterclaim Defendants&#x2019; motion to dismiss, and (b) Sowyrda&#x2019;s and Westman&#x2019;s motion to enforce.&#160;&#160; The parties attended an initial status and scheduling conference with the Court on February 7,
            2023.&#160; The Court deferred entering a case scheduling until after the April 5 hearing.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Under applicable Delaware law and Novellus Inc.&#x2019;s organizational documents, the Company may be
            required to advance or reimburse certain legal expenses incurred by former officers and directors of Novellus, Inc. in connection with the foregoing Westman and Sowyrda matters. However, a future advance or reimbursement is not currently
            probable nor can it be reasonably estimated.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"&gt; &lt;span style="text-decoration: underline;"&gt;Emerald Private Equity Fund, LLC Matter&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; By a letter dated July 7, 2021, Emerald Private Equity Fund, LLC (&#x201c;Emerald&#x201d;), a stockholder of Eterna, made a demand
            pursuant to 8 Del. C. 220 to inspect certain books and records of Eterna. The stated purpose of the demand was to investigate possible wrongdoing by persons responsible for the implementation of the Merger and the issuance of paper stock
            certificates, including investigating&#160; whether: (i) Eterna&#x2019;s stock certificates were issued in accordance with the Merger Agreement; (ii) certain restrictions on the sale of Eterna common stock following the Merger were proper and applied
            without favor; (iii) anyone received priority in post-Merger issuances of Eterna&#x2019;s stock certificates that allowed them to benefit from an increase in the trading price of Eterna&#x2019;s common stock; and (iv) it should pursue remedial measures
            and/or report alleged misconduct to the SEC. Eterna responded to the demand letter and produced certain information to Emerald in connection with the demand, which is subject to the terms of a confidentiality agreement entered into among the
            parties, including certain additional stockholders who subsequently joined as parties to such agreement.&#160; Following discussions, with no admission of wrongdoing, the Company and the Emerald Plaintiffs entered into a confidential settlement
            agreement, pursuant to which the Company paid $1.2 million in 2022 in full settlement of all of the Emerald Plaintiffs&#x2019; purported
            claims, including a release by the Emerald Plaintiffs in favor of the Company in respect of any and all such claims.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-decoration: underline;"&gt;Licensing
              Agreements&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-decoration: underline;"&gt;Exclusive Factor
              License Agreement.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In April 2021, Eterna LLC and the Licensors entered into an exclusive license agreement (the &#x201c;Original Factor License
            Agreement&#x201d;) pursuant to which Eterna LLC acquired an exclusive worldwide license to the Licensed Technology for use in the development of certain mRNA, gene-editing, and cellular therapies to be evaluated and developed for treating human
            diseases, including certain types of cancer, sickle cell disease, and beta thalassemia.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;As a result of the Novellus Acquisition, the rights and obligations of Novellus Limited under the Novellus-Factor License
            Agreement pertaining to any and all licensed products from Factor Limited inured to Eterna. The Company&#x2019;s agreement with Factor Limited under the Original Factor License Agreement remained unchanged after the completion of the Novellus
            Acquisition.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;In November 2022, the Company
                    entered into the first amendment to the Original Factor License Agreement (the &#x201c;Amended Factor License Agreement&#x201d;), pursuant to which, among other things, Factor Limited granted to Eterna LLC an exclusive, sublicensable license under
                    the Factor Patents for the purpose of identifying and pursuing certain opportunities to grant to third parties sublicenses to the Factor Patents. The term of the Amended Factor License Agreement is five years from the effective date of this amendment and is extendable for an additional &lt;span style="-sec-ix-hidden:Fact_7c1d5587e87d44e08e7579d3d8b39dd7"&gt;two and a half years&lt;/span&gt; if the Company receives at least $100
                    million from sublicenses granted by it with respect to the sublicensing opportunities contemplated by the&#160; Amended Factor License Agreement. Pursuant to the Amended Factor License Agreement, the Company will pay to Factor Limited 20% of any sublicense fees it receives under a sublicense during the first &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;five years&lt;/span&gt; and 30% of any sublicense fees it receives during the potential additional &lt;span style="-sec-ix-hidden:Fact_5dfb948eb44f4984b296bd33047f7cfb"&gt;two and a half years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"&gt;&lt;span style="text-decoration: underline;"&gt;USF&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;Eterna LLC has license
                        agreements with University of South Florida Research Association, Inc. (&#x201c;USF&#x201d;), granting Eterna LLC the right to sell, market, and distribute IRX-&lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;2,&lt;span style="font-size: 10pt; color: rgb(0, 0, 0);"&gt; subject to a 7% royalty payable to USF based on a&lt;/span&gt; percentage&lt;span style="font-size: 10pt; color: rgb(0, 0, 0);"&gt; of gross product sales. Under the license agreement with USF, Eterna LLC is obligated to repay patent prosecution expenses incurred by USF. To date, Eterna LLC has not recorded any product sales, or
                          obligations related to USF patent prosecution expenses. The license agreement terminates upon the expiration of the IRX-&lt;/span&gt;2&lt;span style="font-size: 10pt; color: rgb(0, 0, 0);"&gt; patents.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;Royalty Agreements&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;While the agreements described below remain in force, the Company currently does not have plans to further
                      develop the IRX-2 product candidate&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;.&lt;/span&gt;&lt;br/&gt;
                    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Collaborator Royalty Agreement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;Pursuant to a royalty agreement the
            Company assumed when it acquired the assets of IRX in November 2018, the Company will pay a former collaborator a royalty equal to 6%
            of any sales of IRX-2, for the period of time beginning with the first sale of IRX-2 through the later of (i) the twelfth anniversary of the first sale of IRX-2 or (ii) the expiration of the last IRX patent, or other exclusivity of IRX-&lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;2.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"&gt;&lt;span style="text-decoration: underline;"&gt;Royalty Agreement with certain former IRX Therapeutics Investors&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Pursuant to a royalty agreement (the &#x201c;IRX Investor Royalty Agreement&#x201d;) with certain former IRX investors the Company assumed
          when it acquired the assets of IRX in November 2018, when Eterna LLC becomes obligated to pay royalties to USF under the agreement described above under &#x201c;Licensing Agreements-USF,&#x201d; it will pay an additional royalty of 1% of gross sales to an entity organized by such former investors.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Investor Royalty Agreement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;On March 22, 2021, Eterna LLC restated its royalty agreement with certain beneficial holders of Brooklyn ImmunoTherapeutics
        Investors GP LLC and Brooklyn ImmunoTherapeutics Investors LP, whereby such beneficial holders will continue to receive, on an annual basis, royalties in an aggregate amount equal to 4% of the net revenues of IRX-2, a cytokine-based therapy that was previously being developed by Eterna LLC to treat patients with cancer.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; margin-right: 0.3pt; margin-top: 0.1pt; margin-bottom: 0.1pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Retirement Savings Plan&lt;/div&gt;

&lt;div style="margin-top: 0.1pt; margin-bottom: 0.1pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company established a defined contribution plan, organized under Section 401(k) of the Internal Revenue Code, which allows
        employees to defer up to 90% of their pay on a pre-tax basis. As of December 31, 2022, the Company had not contributed a match to the
        employees&#x2019; contribution. Beginning on January 1, 2023, the Company began matching employees&#x2019; contributions at a rate of 100% of the
        first 3% of the employee&#x2019;s contribution and 50% of the next 2% of the employee&#x2019;s contribution, for a maximum Company match
        of 4%.&lt;/div&gt;
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <erna:LitigationSettlementAmountPayable
      contextRef="c20221231"
      decimals="-5"
      id="Fact_eba85e270580486baafb07c9bf31501e"
      unitRef="U001">500000</erna:LitigationSettlementAmountPayable>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_aa9e7c0a7b3e48b8bab9dbd7cfa8664f"
      unitRef="U001">1200000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <erna:LicenseAgreementTerm
      contextRef="c20220101to20221231_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember"
      id="Fact_dec72587a832402b960a9d7660274160">P5Y</erna:LicenseAgreementTerm>
    <erna:ThresholdIncomeForAutomaticExtensionOfLicensePeriod
      contextRef="c20221101to20221130_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember"
      decimals="-6"
      id="Fact_8aea9ab6be8b420595cb95a2a7ea9719"
      unitRef="U001">100000000</erna:ThresholdIncomeForAutomaticExtensionOfLicensePeriod>
    <erna:PercentageOfSublicenseFeePayableBeforeExpirationPeriod
      contextRef="c20221130_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember"
      decimals="2"
      id="Fact_af73d6ccd51e456da8c61823cd35cfbe"
      unitRef="U005">0.20</erna:PercentageOfSublicenseFeePayableBeforeExpirationPeriod>
    <erna:LicenseAgreementTerm
      contextRef="c20220101to20221231_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember"
      id="Fact_c6177993d28348cfa61fe84e760c19f5">P5Y</erna:LicenseAgreementTerm>
    <erna:PercentageOfSublicenseFeePayableDuringRenewalTerm
      contextRef="c20221130_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember"
      decimals="2"
      id="Fact_3a4cda8733de41fa967b189533a79ede"
      unitRef="U005">0.30</erna:PercentageOfSublicenseFeePayableDuringRenewalTerm>
    <erna:LossContingencyPercentageOfRoyaltyPayable
      contextRef="c20220101to20221231_LegalEntityAxis_UniversityOfSouthFloridaMember"
      decimals="2"
      id="Fact_97e6a69e50e6441e820dce56fae2e2cb"
      unitRef="U005">0.07</erna:LossContingencyPercentageOfRoyaltyPayable>
    <erna:LossContingencyPercentageOfRoyaltyPayable
      contextRef="c20181101to20181130_TypeOfArrangementAxis_CollaboratorRoyaltyAgreementMember"
      decimals="2"
      id="Fact_2b101bc1b0354b159d2a768f65596459"
      unitRef="U005">0.06</erna:LossContingencyPercentageOfRoyaltyPayable>
    <erna:PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales
      contextRef="c20181101to20181130_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember"
      decimals="2"
      id="Fact_6d7a303a95f042cb93f627e2613834ef"
      unitRef="U005">0.01</erna:PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales>
    <erna:PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness
      contextRef="c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember"
      decimals="2"
      id="Fact_3d74852687b142e7bede2c6092596278"
      unitRef="U005">0.04</erna:PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness>
    <erna:DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis
      contextRef="c20220101to20221231_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_86717dc9793e49b78819866638dd0dfd"
      unitRef="U005">0.90</erna:DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis>
    <erna:DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne
      contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="2"
      id="Fact_0ceed1df412848ac98179ad034244419"
      unitRef="U005">1</erna:DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne>
    <erna:DefinedContributionPlanEmployeeContributionAtThresholdOne
      contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="2"
      id="Fact_557e180571754c61951c6c5be061195e"
      unitRef="U005">0.03</erna:DefinedContributionPlanEmployeeContributionAtThresholdOne>
    <erna:DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo
      contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="2"
      id="Fact_e91ddbd9886b4e6f9de040241d095ce0"
      unitRef="U005">0.50</erna:DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo>
    <erna:DefinedContributionPlanEmployeeContributionAtThresholdTwo
      contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="2"
      id="Fact_4d3f007617364965ba17cd0b8fbf40e0"
      unitRef="U005">0.02</erna:DefinedContributionPlanEmployeeContributionAtThresholdTwo>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="c20230101to20230101_RangeAxis_MaximumMember_RetirementPlanNameAxis_RetirementPlan401KMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="2"
      id="Fact_4c61b01d00c24d71b25f1e07524089b2"
      unitRef="U005">0.04</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="c20220101to20221231"
      id="Text_73a0f143ec0e4578abb3a368832ca6c7">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;13)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;
                &lt;div&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"&gt;Basic and Diluted Loss per Common Share&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted
        net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding plus dilutive securities.&#160; Shares of common stock issuable upon exercise, conversion or vesting of stock options, RSUs, warrants and
        other convertible securities, including our outstanding Series A Convertible Preferred Stock, are considered potential common shares and are included in the calculation of diluted net loss per share using the treasury method when their effect is
        dilutive. Diluted net loss per share is the same as basic net loss per share for periods in which the effect of potentially dilutive shares of common stock is antidilutive. &lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;"&gt;The following table presents the amount of warrants,
        stock options, convertible preferred stock and RSUs that were excluded from the computation of diluted net loss per common share for the years ended December 31, 2022 and 2021, as their effect was anti-dilutive (in thousands):&lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt; &lt;span style="font-weight: bold;"&gt;Years ended December 31,&lt;br/&gt;
                  &lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;&#160;&lt;span style="font-size: 10pt; font-weight: bold;"&gt;2021&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; text-indent: -9pt; margin-left: 9pt; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="margin-left: 9pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Warrants&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;4,713&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"/&gt;

    &lt;td rowspan="1" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Stock options&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;359&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;199&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Preferred stock converted into common stock&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;7&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;2&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-size: 10pt;"&gt;RSUs&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;4&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;12&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Total potential common shares excluded from computation&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,083&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;213&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

      &lt;/div&gt;
</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="c20220101to20221231"
      id="Text_a07923affcd647b7ba6eb50b89054ae0">&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;"&gt;The following table presents the amount of warrants,
        stock options, convertible preferred stock and RSUs that were excluded from the computation of diluted net loss per common share for the years ended December 31, 2022 and 2021, as their effect was anti-dilutive (in thousands):&lt;br/&gt;
      &lt;/span&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt; &lt;span style="font-weight: bold;"&gt;Years ended December 31,&lt;br/&gt;
                  &lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;&#160;&lt;span style="font-size: 10pt; font-weight: bold;"&gt;2021&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; text-indent: -9pt; margin-left: 9pt; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="margin-left: 9pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Warrants&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;4,713&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"/&gt;

    &lt;td rowspan="1" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Stock options&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;359&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;199&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Preferred stock converted into common stock&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;7&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;2&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-size: 10pt;"&gt;RSUs&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;4&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;12&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Total potential common shares excluded from computation&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,083&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;213&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

      &lt;/div&gt;
</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="-3"
      id="Fact_bbb735eb7b3d4a588bf542634d47a25c"
      unitRef="U002">4713000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="-3"
      id="Fact_3d679e7c701a4f4cbc3b1b8727f1b984"
      unitRef="U002">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_23c18ec29f334944b245522b9dfec95b"
      unitRef="U002">359000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_c8b879610e524a5386bdb43d569e3c86"
      unitRef="U002">199000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact_c3b61d901c354c51b382c62b2889f7d9"
      unitRef="U002">7000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact_61008ca317854be0b7c51853cd3cd7a8"
      unitRef="U002">2000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_695fb40fc164486ab7f69d50cae94c22"
      unitRef="U002">4000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_0b25872cd95d4ad08451bf57d0706f0c"
      unitRef="U002">12000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_2e718d7222e64dafa979243029b74bae"
      unitRef="U002">5083000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_41f64da39bde4a69b5a1afc073a41b33"
      unitRef="U002">213000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="c20220101to20221231"
      id="Text_cbefb7b6443c4b948ef2e409c69e0a9e">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;14)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Stock-Based Compensation&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Equity Incentive Plans&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company&#x2019;s stock-based compensation plans consist of the Restated 2020 Equity Incentive Plan (the &#x201c;Restated 2020 Plan&#x201d;) and
        the 2021 Inducement Equity Incentive Plan (the &#x201c;2021 Inducement Plan&#x201d;). The Company&#x2019;s board of directors has designated its Compensation Committee as the administrator of the foregoing plans (the &#x201c;Plan Administrator&#x201d;). Among other things, the Plan
        Administrator selects persons to receive awards and determines the number of shares subject to each award and the terms, conditions, performance measures, if any, and other provisions of the award.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The
        Restated 2020 Plan provides for (a) approximately 424,000 shares of common stock that can be issued under the Restated 2020 Plan and (b)
        an annual increase in the number of shares reserved for issuance on January 1 of each year from 2022 through 2031 equal to the lesser of (i) 5%
        of the number of shares of common stock outstanding on the immediately preceding December 31 and (ii) such smaller number of shares of common stock as may be determine by the board of directors (the &#x201c;Annual Evergreen Shares&#x201d;). Based on the number
        of shares of common stock outstanding on December 31, 2022, the maximum increase to the number of Annual Evergreen Shares of common stock that can be issued under the Restated 2020 Plan in 2023 is approximately 256,000 shares. As of December 31, 2022, there have been no
        Annual Evergreen Shares added to the Restated 2020 Plan.&lt;br/&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Awards under the Restated 2020 Plan may be granted to officers, directors, employees and consultants of the Company.&#160; Stock
        options granted under the Restated 2020 Plan may either be incentive stock options or nonqualified stock options, may have a term of up to ten years,
        and are exercisable at a price per share not less than the fair market value on the date of grant.&#160; As of December 31, 2022, there was approximately 166,000
        shares of common stock remaining to be issued under the Restated 2020 Plan. As of December 31, 2021, there were approximately 258,000
        stock options outstanding under the Restated 2020 Plan. There were no RSUs outstanding under the Restated 2020 Plan as of December 31,
        2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The 2021 Inducement Plan provides for the grant of up to 75,000 share-based awards as material inducement awards to new employees in accordance with the employment inducement grant rules set forth in Section 711(a) of the NYSE American LLC Company
        Guide. The 2021 Inducement Plan expires in May 2031. As of December 31, 2022, there was approximately 57,000 shares of common stock
        remaining to be issued under the Restated 2020 Plan. As of December 31, 2021, there were approximately 12,000 stock options outstanding
        and approximately 4,000 RSUs outstanding under the Restated 2020 Plan.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Equity Awards&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company records stock-based compensation in accordance with ASC Topic 718, Compensation &#x2013; Stock Compensation.&#160; The Company
        estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-lined basis.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The risk-free rate is based on the observed interest rates appropriate for the expected life. The expected life (estimated
        period of time outstanding) of the stock options granted is estimated using the &#x201c;&lt;span style="font-style: normal;"&gt;simplified&lt;/span&gt;&#x201d; method as permitted by the SEC&#x2019;s Staff Accounting Bulletin No. 110, &lt;span style="font-style: italic;"&gt;Share-Based
          Payment&lt;/span&gt;. Expected volatility is based on the volatility of the Company&#x2019;s peer group over the expected life of the stock option granted, and the Company assumes no dividends. Forfeitures are recognized as incurred.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt;&#160;&lt;span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following weighted-average assumptions were used for stock options granted during the years ended December 31, 2022 and 2021: &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;Year ended&lt;/span&gt; &lt;span style="font-weight: bold;"&gt;December 31,&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="text-align: center; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" valign="bottom"&gt;2021&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Weighted average risk-free rate&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2.52&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;1.09&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Weighted average volatility&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;90.49&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;134.64&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Dividend yield&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;0&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;0&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Expected term&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom"&gt;5.79 years &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom"&gt;6.10 years &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The following table summarizes stock option activity for the years ended December 31, 2022 and 2021 (in thousands except for
        per-share and remaining contractual life data):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="font-weight: bold;"&gt;Outstanding&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Options&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;
                &lt;div&gt;Weighted &lt;/div&gt;
                &lt;div&gt;Average &lt;/div&gt;
                &lt;div&gt;Exercise&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Price per&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Share&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Weighted&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Average&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Remaining &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Contractual &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Life (in&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;years)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Aggregate&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Intrinsic&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Value&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Outstanding January 1, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;199&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;168.04&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Outstanding December 31, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;199&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;168.04&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;9.38&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;287&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;17.29&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;(127&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;140.56&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;Outstanding December 31, 2022&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;359&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;57.18&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;7.57&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$ &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Options vested and exercisable at December 31, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;146&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;109.60&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;4.79&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The per-share weighted average grant-date fair value of stock options granted during the year ended December 31, 2022 and 2021 was $12.91 and $151.40, respectively.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;Pursuant



















          to a separation agreement entered into in May 2022 with the Company&#x2019;s former chief executive officer, Dr. Howard Federoff, the Company accelerated the vesting of approximately 40,000 stock options under certain time-based vesting stock option grants previously awarded to Dr. Federoff.&#160; The Company also waived a performance condition under a performance-based
          stock option grant and accelerated the vesting of approximately 21,000 stock options under such grant.&#160; Lastly, the Company extended
          the post-termination exercise period from 90 days to 36 months immediately following his separation date for any options that were vested, including the options that accelerating in vesting, as described above.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;The above modifications to Dr. Federoff&#x2019;s stock options grants resulted in modification accounting under ASC 718, &lt;span style="font-style: italic;"&gt;Compensation



















              &#x2013; Stock Compensation&lt;/span&gt;. As a result, the Company immediately recognized approximately $0.1 million during 2022 for the
            incremental fair value of stock options that were vested prior to the modification by calculating the difference between the fair value of the modified award and the fair value of the original award immediately before it was modified.&#160; For
            stock options that were not vested prior to the modification but then vested as a result of the acceleration, the Company reversed any stock compensation expense previously recognized, remeasured the fair value of the modified award and
            immediately recognized approximately $0.1 million during 2022 of stock compensation expense in full since there was no future service
            period required to be provided.&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;As of December 31, 2022, the unamortized stock-based compensation expense related to outstanding unvested options was
        approximately $3.2 million with a weighted average remaining requisite service period of 2.70 years. The Company expects to amortize this expense over the remaining requisite service period of these stock options.&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Vesting of all stock options grants is subject to continuous service with the Company through such vesting dates.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;span style="text-decoration: underline;"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The following table summarizes RSU activity for the years ended December 31, 2022 and 2021 (in thousands except for per-share data):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Outstanding&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Restricted&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Stock Units&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Weighted &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Average&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Fair&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Value per&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Share&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;January 1, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;12&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;276.00&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;12&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;276.00&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;55&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;38.60&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Released&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(3&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;271.42&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;(60&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;61.03&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;December 31, 2022&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;4&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;236.36&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Balance expected to vest at December 31, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;4&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The














          Company recognizes the fair value of RSUs granted as expense on a straight-line basis over the requisite service period. For performance based RSUs, the Company begins recognizing the expense once the achievement of the related performance goal
          is determined to be probable.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Outstanding



















          RSUs are settled in an equal number of shares of common stock on the vesting date of the award. An RSU award is settled only to the extent vested. Vesting generally requires the continued employment or service by the award recipient through the
          respective vesting date. Because RSUs are settled in an equal number of shares of common stock without any offsetting payment by the recipient, the measurement of cost is based on the quoted market price of the stock at the measurement date,
          which is the grant date.&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In lieu of paying cash to satisfy withholding taxes due upon the settlement of vested RSUs, at the Company&#x2019;s discretion, an employee may elect to have shares of
            common stock withheld that would otherwise be issued at settlement, the value of which is equal to the amount of withholding taxes payable.&#160; There were no RSUs that vested during the year ended December 31, 2021.&#160; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal;"&gt;The following table shows the number of RSUs that vested and were settled during the year ended December 31, 2022, as well as the number of shares of common
            stock withheld to cover the withholding taxes and the net shares issued upon settlement (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 54pt; margin-right: 0.7pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 54pt; margin-right: 0.7pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 86%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year ended&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px; width: 86%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2022
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 86%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;RSUs vested&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 86%; padding-bottom: 2px;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Common stock withheld to cover taxes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 86%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Common stock issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
           &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Pursuant to the Merger, Eterna LLC&#x2019;s approximately 3,000 outstanding restricted common units were exchanged for approximately 32,000
        shares of Eterna&#x2019;s restricted common stock. There were no changes to any conditions and requirements of the restricted common stock. The shares vested quarterly beginning on March 31, 2021 and were to continue through December 31, 2022, contingent
        on continued service. Due to the modification of the restricted common units, the fair value of the restricted common stock immediately after the Merger was compared to the fair value of the restricted common units immediately prior to the Merger,
        and the change in fair value of $0.3 million was recognized in the statement of operations during the year ended December 31, 2021. The
        Company recognizes the fair value of restricted common stock as an expense on a straight-line basis over the requisite service period. During the year ended December 31, 2022, approximately 4,000 shares of unvested restricted common stock were forfeited due to the holders of such shares no longer providing services to the Company. As of December 31, 2022 there
        were no shares of unvested restricted stock outstanding.&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Stock-Based Compensation Expense&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;For the years ended December 31, 2022 and 2021, the Company recognized stock-based compensation expense as follows (in
        thousands): &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;"&gt;2022&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;"&gt;2021&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Research and development&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,249&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,597&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;General and administrative&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,686&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,638&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,935&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,235&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
         &lt;/div&gt;
</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="0"
      id="Fact_8d78243d7381405b8e9ecc900d00f49f"
      unitRef="U002">424000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <erna:PercentageOfSharesOfCommonStockOutstanding
      contextRef="c20221231_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="2"
      id="Fact_414fa7367af041bfb6485ee8c4ecf446"
      unitRef="U005">0.05</erna:PercentageOfSharesOfCommonStockOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20221231_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="0"
      id="Fact_08c8882607e94cfb95c2394b012c5c61"
      unitRef="U002">256000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c20220101to20221231_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="INF"
      id="Fact_49952b977ebd4ea1bdd9587fb407c98c"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20220101to20221231_AwardTypeAxis_NonQualifiedStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember"
      id="Fact_bfaa85c5a56e4c23b8b5f82bb20fb30d">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20220101to20221231_AwardTypeAxis_IncentiveStockOptionsMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember"
      id="Fact_2607e669317543b7ac211ccc4132f82f">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20221231_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="0"
      id="Fact_9d022489615c44739fe764706813131d"
      unitRef="U002">166000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20211231_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="0"
      id="Fact_058c6ab36b624a84a6a6b577df6b5a10"
      unitRef="U002">258000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20221231_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="INF"
      id="Fact_24cc8a7b44b040aaa3632dd70c2c942b"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20221231_PlanNameAxis_InducementPlan2021Member_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_dccbc67254b44d87b97e204d1e0e128a"
      unitRef="U002">75000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20221231_PlanNameAxis_InducementPlan2021Member"
      decimals="0"
      id="Fact_27ecb145d740486e91ba3b8263d0f1c8"
      unitRef="U002">57000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20211231_PlanNameAxis_InducementPlan2021Member"
      decimals="0"
      id="Fact_38c8e58ca2314d81951fd67e0625f7c8"
      unitRef="U002">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20211231_PlanNameAxis_InducementPlan2021Member"
      decimals="0"
      id="Fact_c18ed5f7a8a54f3bb3d59ad10b11c463"
      unitRef="U002">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_79d90495a65a437688a20cd2e3b15161">&lt;span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following weighted-average assumptions were used for stock options granted during the years ended December 31, 2022 and 2021: &lt;/span&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;Year ended&lt;/span&gt; &lt;span style="font-weight: bold;"&gt;December 31,&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="text-align: center; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" valign="bottom"&gt;2021&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Weighted average risk-free rate&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2.52&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;1.09&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Weighted average volatility&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;90.49&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;134.64&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Dividend yield&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;0&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;0&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Expected term&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom"&gt;5.79 years &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom"&gt;6.10 years &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_71914c47188441b0b5dc7f6e122fe22d"
      unitRef="U005">0.0252</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_67a5656d736c4eea902bad0b44e67d10"
      unitRef="U005">0.0109</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_29f5aad58ddc49c3a950f67dc64918e3"
      unitRef="U005">0.9049</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_f6817ef8d4134a50ac7db6731c92484a"
      unitRef="U005">1.3464</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_5dbace4d26eb47829bd34457f3425399"
      unitRef="U005">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_217ec9717b6f47ffa1b1d94c8b633d14"
      unitRef="U005">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_fd4b4f94bde24a5681e5b4fcbed68721">P5Y9M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_9a91271dbe164871984aea52d5caa451">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_e14ca8bd850640aaa46f800cb8a5947e">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The following table summarizes stock option activity for the years ended December 31, 2022 and 2021 (in thousands except for
        per-share and remaining contractual life data):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="font-weight: bold;"&gt;Outstanding&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Options&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;
                &lt;div&gt;Weighted &lt;/div&gt;
                &lt;div&gt;Average &lt;/div&gt;
                &lt;div&gt;Exercise&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Price per&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Share&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Weighted&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Average&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Remaining &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Contractual &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Life (in&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;years)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Aggregate&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Intrinsic&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Value&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Outstanding January 1, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;199&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;168.04&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Outstanding December 31, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;199&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;168.04&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;9.38&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;287&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;17.29&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;(127&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;140.56&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;Outstanding December 31, 2022&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;359&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;57.18&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;7.57&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$ &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Options vested and exercisable at December 31, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;146&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;109.60&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;4.79&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20201231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_d50827d95e3a42b49f4443476435cb43"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c20201231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_494aa0e6f02f41b98abb57a155605f60"
      unitRef="U003">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c20201231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_9a9b935584844d06a32556aa84db92da"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_0f5b96da021d4eacb28c6db7ea27da1a"
      unitRef="U002">199000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_9debdf03284440f1b70d106445fa8506"
      unitRef="U003">168.04</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_2e3ea5427dd24ceba0dc3ed29c840499"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_1287189444a6429d935985e8c72c801d"
      unitRef="U003">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_150365a7cd9a4e0fbbfa75edd035384d"
      unitRef="U002">199000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_5a9716246add402ca32d40b91e355869"
      unitRef="U003">168.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_fdd187b26ef1469bb6854ce39be5b72d">P9Y4M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_f368ddaa6074420aa09d74102eeb5adf"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_b29bcde23b824f05a13e2566d6312b1b"
      unitRef="U002">287000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_fea40b62edb54d759bec3129f8856fce"
      unitRef="U003">17.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_2ecdbb09f4b0484a81b1264c00c0a64f"
      unitRef="U002">127000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_7993359c01d646eabd1ef2dabeed1b8e"
      unitRef="U003">140.56</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_cb25c2092f1944a4acbc3f003791ae27"
      unitRef="U002">359000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_8add438f47ef400490816fd9f56f9a90"
      unitRef="U003">57.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_9ffb5a82fc894077b94f2161cc79bb27">P7Y6M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_f91b2f3c0fdd466ebb4f1a6dd9c9f971"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_b3161b8ec1bf487c86609b40b374b771"
      unitRef="U002">146000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_a19fe94541004e479e0d765a10dc2158"
      unitRef="U003">109.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_af62c6f9589a43c3ae4ddb5c1caf991c">P4Y9M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_43921ff8e5c942649a6387f565a7e780"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_6b0917ed604e48c6949cdb7256c3b092"
      unitRef="U003">12.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_785cfed293cd4884b23b1657366bf147"
      unitRef="U003">151.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="c20220501to20220531_AwardTypeAxis_TimeBasedStockOptionMember"
      decimals="0"
      id="Fact_3e1733b2fab74df9804f8be46ef6e722"
      unitRef="U002">40000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="c20220501to20220531_AwardTypeAxis_PerformanceBasedStockOptionMember"
      decimals="0"
      id="Fact_4d93a705e8784865839776e18e4c2a56"
      unitRef="U002">21000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember"
      id="Fact_b2dffa83e0fb4be0a8b7f2d66943a333">P90D</erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod>
    <erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember"
      id="Fact_4721a98264f242c695e54b0de1b97600">P36M</erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-5"
      id="Fact_e5548919a34648229b576f049fe87c1d"
      unitRef="U001">100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-5"
      id="Fact_4bd019647f6a49aca3c2396efc3404a4"
      unitRef="U001">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="1"
      id="Fact_6e4414df41e14a4cbe4d56d6918586fa"
      unitRef="U001">3.2</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_0d0b926b28764d2fb85855edf08387af">P2Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_9cd4792e81544e4da3dcf0dcca53502c">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The following table summarizes RSU activity for the years ended December 31, 2022 and 2021 (in thousands except for per-share data):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Outstanding&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Restricted&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Stock Units&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Weighted &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Average&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Fair&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Value per&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Share&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;January 1, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;12&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;276.00&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;12&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;276.00&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;55&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;38.60&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Released&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(3&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;271.42&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;(60&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;61.03&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;December 31, 2022&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;4&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;236.36&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Balance expected to vest at December 31, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;4&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_c1bc34fc93664f769ce418a2c668ef63"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_bd6d53e8ea2643f8a8c57a3060fbd0f8"
      unitRef="U003">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_d7dcbf180368456ba595369aa40a992b"
      unitRef="U002">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fact_4614d86ce41e4622a886c337afc0c001"
      unitRef="U003">276</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_9024ecb003154440b6dd275a4814048b"
      unitRef="U002">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fact_0c806c041cf94892a7dc958d53c4522d"
      unitRef="U003">276</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_b28c134b355040d88d672c548ea3ede8"
      unitRef="U002">55000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fact_ecf08e94126b429292ad68485c2cd0ac"
      unitRef="U003">38.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_a4202984efb047b981f950a74e5b5185"
      unitRef="U002">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fact_06865a1436154d839acd96566c7421c3"
      unitRef="U003">271.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_7246f86e56b6406aa9a3d2a000332b3f"
      unitRef="U002">60000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fact_4c810561639b48ba80f12d4cb3ebe139"
      unitRef="U003">61.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_187f9dece5af41efbe8f2c6e22fac34b"
      unitRef="U002">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fact_cb6df8e7358b42008adc82c2abae9f2b"
      unitRef="U003">236.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber
      contextRef="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_75cfa96e358c4ec989b2af5f22894ade"
      unitRef="U002">4000</erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_03024b08767343ac98fa851d73c16a95"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <erna:ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_38d30aca54634f919f03733502d22337">&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal;"&gt;The following table shows the number of RSUs that vested and were settled during the year ended December 31, 2022, as well as the number of shares of common
            stock withheld to cover the withholding taxes and the net shares issued upon settlement (in thousands):&lt;/span&gt;
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 54pt; margin-right: 0.7pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 54pt; margin-right: 0.7pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 86%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year ended&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px; width: 86%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2022
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 86%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;RSUs vested&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 86%; padding-bottom: 2px;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Common stock withheld to cover taxes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 86%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Common stock issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
           &lt;/div&gt;
</erna:ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_bcfdc372e7584c55a9e5db28a800e1c7"
      unitRef="U002">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <erna:CommonStockWithheldToCoverTaxes
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_a497138f117246a79184d05cf4efc929"
      unitRef="U002">1000</erna:CommonStockWithheldToCoverTaxes>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_8ef95b9ef2f84af5841a8b85f69b94a2"
      unitRef="U002">2000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_17074b36654a4ba1b37a61acd0d14e5a"
      unitRef="U002">3000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_6352884327534da0b53b8391721b85d5"
      unitRef="U002">32000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockMember"
      decimals="-5"
      id="Fact_5d3f7cbba2cf4a50a3a77fbae9c2353f"
      unitRef="U001">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_c3e6ac4459e6465e8949bab0d20f9f7e"
      unitRef="U002">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20221231_AwardTypeAxis_RestrictedStockMember"
      decimals="INF"
      id="Fact_0ce797c9211a47ad9d99c9edf3fd0c0a"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="c20220101to20221231"
      id="Text_ba87933c6b6740c9be4aa9fc77f92191">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;For the years ended December 31, 2022 and 2021, the Company recognized stock-based compensation expense as follows (in
        thousands): &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;"&gt;2022&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;"&gt;2021&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Research and development&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,249&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,597&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;General and administrative&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,686&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,638&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,935&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,235&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
         &lt;/div&gt;
</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20221231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_e5f9146dbfbe43b69f1587607183e6af"
      unitRef="U001">1249000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20211231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_9f93b8d6b4bb49b2aafa662afa2d31af"
      unitRef="U001">1597000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20221231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_395fcc523da0406dbdc0cdaff54a1903"
      unitRef="U001">1686000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20211231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_7a0be236d91f4acb82f9de304ca47c95"
      unitRef="U001">3638000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_24b83cddeb2845e48045d6b2f34e788c"
      unitRef="U001">2935000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_fc22bac1df644747aa74d3f658ea7c92"
      unitRef="U001">5235000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="c20220101to20221231"
      id="Text_521b4bd2711b4967be514bf5dae19c4c">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;15)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Equity and Warrants&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-style: italic;"&gt;Private Placements of Equity&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;&lt;span style="text-decoration: underline;"&gt;Q4-22 PIPE Transaction&lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On November 23, 2022, the Company entered into the Q4-22 Purchase Agreement with
            the Q4-22 PIPE Investors for the Q4-22 PIPE Transaction, pursuant to which the Company issued to the Q4-22 PIPE Investors an aggregate of&#160; approximately 2,185,000 units, with each unit consisting of (i) one share of common
            stock and (ii) two Q4-22 Warrants, each exercisable to purchase one share of common stock at an exercise price of $3.28 per, at a purchase
            price of $3.53 per unit (inclusive of $0.125
            per Q4-22 Warrant). The Company received aggregate gross proceeds of approximately $7.7 million, and the Q4-22 PIPE Transaction
            closed on December 2, 2022. The Company incurred fees of approximately $0.3 million through December 31, 2022 related to the Q4-22
            PIPE Transaction.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Each Q4-22 Warrant has an exercise
              price of $3.28 per share, becomes exercisable six months following the closing of the Q4-22 PIPE Transaction, expires &lt;span style="-sec-ix-hidden:Fact_ead7f34b09d749a6b4ac3742e9967755"&gt;five-and-one-half&lt;/span&gt;
              years from the date of issuance and is subject to customary adjustments. Certain of the Q4-22 Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 4.99% immediately after exercise thereof, subject to increase to 9.99% at the option of the holder.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 27pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;"&gt;The Q4-22 Warrants meet the criteria for equity
              classification.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;&lt;span style="text-decoration: underline;"&gt;Q1-22 Private Placement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On March 6, 2022, the Company entered into the Q1-22 Purchase Agreement with the
            Q1-22 PIPE Investor for the Q1-22 PIPE Transaction, pursuant to which, the Company issued to the Q1-22 PIPE Investor approximately 343,000
            units, each unit consisting of (i) one share of the Company&#x2019;s common stock (or, in lieu thereof, one Q1-22 Pre-Funded Warrant to
            purchase one share of common stock) and (ii) one warrant Q1-22&#160; Common Warrant to purchase one share of common stock, for an
            aggregate gross purchase price of approximately $12.0 million (the &#x201c;Subscription Amount&#x201d;). The Q1-22 PIPE Transaction closed on March
            9, 2022. Pursuant to the Q1-22 Purchase Agreement, the Company was prohibited from issuing equity in variable rate transactions for a period of one-year
            following consummation of the Q1-22 PIPE Transaction, including issuing equity under the Second Purchase Agreement, which is discussed below.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Each Q1-22 Pre-Funded Warrant had an exercise price of $0.10 per share of common stock, was immediately exercisable, could be exercised at any time, had no expiration date and was subject to customary
              adjustments. The Q1-22 Pre-Funded Warrants could not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 9.99% immediately after exercise thereof.&#160; Upon the closing of the Q1-22 PIPE Transaction, the Company issued 275,000 shares of common stock, approximately 68,000 Q1-22 Pre-Funded
              Warrants and approximately 343,000 Q1-22 Common Warrants.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
              &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Each Q1-22 Common Warrant has an exercise price of $38.20 per share, became exercisable six months
              following the closing of the Q1-22 PIPE Transaction, expires &lt;span style="-sec-ix-hidden:Fact_d45bfc25257042c4abeb3af3c960c760"&gt;five-and-one-half&lt;/span&gt; years from the date of issuance and is subject to
              customary adjustments. The Q1-22 Common Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 4.99% immediately after exercise thereof, subject to increase to 9.99%
              at the option of the holder.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
            &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;The Q1-22 Common Warrants and Q1-22 Pre-Funded Warrants were accounted for as liabilities under ASC 815-40, as these warrants provide for a cashless settlement provision
            that does not meet the requirements of the indexation guidance under ASC 815-40.&#160; These warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of
            operations.&#160; (See Note 5 for more information related to changes in fair value.) Upon exercise of the Q1-22 Common Warrants and Q1-22 Pre-Funded Warrants, the fair value on the exercise date is reclassified from warrant liabilities to equity.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
            &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The fair values of the Q1-22 Common Warrants and the
              Q1-22 Pre-Funded Warrants at the issuance date totaled $12.6 million in the aggregate, which was $0.6 million more than the Subscription Amount.&#160; The excess $0.6 million represents an inducement to the Q1-22 PIPE Investor to enter into the Q1-22 PIPE Transaction and was recorded in warrant liabilities expense in the accompanying
              consolidated statement of operations.&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On July 12, 2022, the Q1-22 PIPE Investor exercised its 68,000 Q1-22 Pre-Funded Warrants at an exercise price of $0.10 per share
            for an aggregate exercise price of approximately $7,000, in cash. The Company issued 68,000 shares of common stock to the Q1-22 PIPE
            Investor on July 14, 2022 upon receipt of the cash proceeds and reclassified approximately $0.7 million of the fair value of the
            exercised warrants as of the exercise date from warrant liabilities to equity. Subsequent to the exercise, no Q1-22 Pre-Funded Warrants remained outstanding.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
            &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;The Company incurred fees of approximately $1.0 million
            through December 31, 2022 related to the Q1-22 PIPE Transaction, which were allocated to the fair value of the Q1-22 Warrants and the Q1-22 Pre-Funded Warrants and recorded in other expense, net on the accompanying consolidated statement of
            operations.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
            &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;In connection with the Q1-22 PIPE Transaction, the Company and the Q1-22 PIPE Investor also entered into a registration rights agreement, dated March
            6, 2022, pursuant to which the Company agreed to prepare and file a registration statement with the SEC no later than 15 days
            following the filing date of the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2021 (the &#x201c;2021 Annual Report&#x201d;) to register the resale of the shares of common stock included in the Units and the shares of common stock
            issuable upon exercise of the Q1-22 Pre-Funded Warrants and the Q1-22 Common Warrants. The Company agreed to use its best efforts to have such registration statement declared effective as promptly as possible after the filing thereof, subject
            to certain specified penalties if timely effectiveness were not achieved.&#160; The Company filed the 2021 Annual Report on April 15, 2022 and the registration statement on April 29, 2022.&#160; The resale registration statement became effective on May
            11, 2022.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
            &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;Pursuant to the registration rights agreement, the Company is obligated to pay the Q1-22 PIPE Investor liquidated damages equal to 2% of the Subscription Amount per month, with a maximum aggregate payment of 12% of the Subscription Amount, in the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered for resale thereunder
            for more than a specified period of time.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
            &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;On May 24, 2022, the Company notified the Q1-22 PIPE Investor that it was not able to use the registration agreement because the Company had not
            timely filed its Quarterly Report on Form 10-Q (the &#x201c;Q1 2022 10-Q&#x201d;) with the SEC, and that the Q1-22 PIPE Investor could not use the registration statement to resell the securities registered thereunder until the Company filed the Q1 2022
            10-Q.&#160; Because of the Q1-22 PIPE&#160; Investor&#x2019;s inability to use the registration statement, the Company accrued $0.2 million during
            2022 for the contingent loss the Company incurred as liquidated damages as a result of the late Q1 2022 10Q filing, which is recorded in other expense, net for the year ended December 31, 2022 in the accompanying consolidated statements of
            operations.&#160; The Company paid such $0.2 million liquidated damages payment in June 2022.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;On June 30, 2022, the Company filed its Q1 2022 10-Q along
            with an amended Annual Report on Form 10-K/A for the year ended December 31, 2021, and on July 1, 2022, the Company provided its notice to the Q1-22 PIPE Investor that it could resume use of the resale registration statement.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;The following table shows the Company&#x2019;s warrant
            activity for the year ended December 31, 2022 (in thousands except for per-share data):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;March 2022&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Pre-Funded&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;November 2022&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Total&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Balance as of January 1, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Granted&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;343&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;68&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,370&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,781&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Exercised&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(68&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(68&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Balance as of December 31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;343&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,370&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,713&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;As of December 31, 2022, the weighted average remaining
              contractual life of the warrants outstanding was 5.37 years and the weighted average exercise price was $5.82.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Equity Line Offerings&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;On April 26, 2021, the Company entered into a common stock purchase agreement (the &#x201c;First Purchase
            Agreement&#x201d;) an investment group (the &#x201c;Investment Group&#x201d;), which provided that the Company could offer to the Investment Group up to an aggregate o&lt;/span&gt;f $20 million of common stock over a 36-month period commencing after May 10, 2021, the date that a registration statement covering the resale of shares of common stock issued under the First
          Purchase Agreement was declared effective by the SEC. As of December 31, 2022, the Company had issued and sold an aggregate of approximately 56,000
          shares of common stock to the Investment Group pursuant to the First Purchase Agreement, resulting in gross proceeds of $20 million.&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;On May 26, 2021, the Company entered into a second common stock purchase agreement (the &#x201c;Second
          Purchase Agreement&#x201d;) with the Investment Group, which provides that the Company may offer to the Investment Group up to an aggregate of $40
          million of common stock over a 36-month period commencing after June 4, 2021, the date that a registration statement covering the resale of shares of common stock issued under the Second Purchase Agreement was declared effective by the SEC. As of
          December 31, 2022, the Company had issued and sold an aggregate of approximately 121,000 shares of common stock to the Investment
          Group pursuant to the Second Purchase Agreement, resulting in gross proceeds of approximately $34 million. As of December 31, 2022,
          there were approximately 22,000 shares remaining to be sold under the Second Purchase Agreement.&lt;/span&gt; &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Under the Second Purchase Agreement, the Company may direct the Investment Group to purchase up to 3,000 shares of common stock on any business day (the &#x201c;Regular Purchase&#x201d;), which amount may be increased up to 6,000 shares based on the closing price of the common stock, provided that&#160; the Investment Group&#x2019;s maximum commitment in any single Regular Purchase
          may not exceed $2.0 million. The purchase price per share for each such Regular Purchase is based off of the common stock&#x2019;s market
          immediately preceding the time of sale.&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Second Purchase Agreement also prohibits the Company from directing the Investment Group to purchase any shares of common
          stock if those shares, when aggregated with all other shares of common stock then beneficially owned by the Investment Group and its affiliates, would result in the Investment Group and its affiliates having beneficial ownership, at any single
          point in time, of more than 4.99% of the then total outstanding shares of common stock. The Company has the right to terminate the
          Second Purchase Agreement at any time, at no cost or penalty.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Actual sales of shares of common stock to the Investment Group under the Second Purchase Agreement depend on a variety of
          factors to be determined by us from time to time, including, among others, market conditions, the trading price of the common stock and determinations by the Company as to the appropriate sources of funding for the Company and its operations.&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Pursuant to the Q1-22 Purchase Agreement in respect of the Q1-22 PIPE Transaction, the Company was prohibited from issuing additional shares under the Second Purchase Agreement for a period of one-year
            immediately following the closing of the Q1-22 PIPE Transaction.&lt;/span&gt; &lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="font-style: italic;"&gt;Merger &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Under the terms of the Merger Agreement (see Notes 1 and 4), on March 25, 2021, the Company issued shares of common stock to
          the equity holders of Eterna LLC. The 87,000 Class A units of Eterna LLC were converted into approximately 1,114,000 shares of common stock; the 15,000,000
          Class B units were converted into approximately 126,000 shares of common stock; the 10,000,000 Class C units were converted into approximately 84,000
          shares of common stock; approximately 630,000 shares of common units were converted into approximately 31,000 shares of common stock, and 10,500,000
          rights options were converted into approximately 591,000 shares of common stock.&#160; The Company also issued approximately 53,000 shares of common stock to the Financial Advisor pursuant to the Merger Agreement.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquisition&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Under the terms of the Novellus Acquisition (see Notes 1 and 4), on July 16, 2021, the Company issued approximately 351,000 shares of common stock, of which approximately 182,000
          shares are unrestricted and approximately 169,000 shares are subject to a three-year lockup agreement, provided that up to 75% of the shares of common
          stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock on the principal market for the common stock exceeds specified thresholds.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt; Cumulative Convertible Preferred Stock &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;As a result of the Merger, the Company has authorized 156,000 shares of preferred stock, all of which is designated as Series A Cumulative Convertible Preferred Stock (the &#x201c;Series A Preferred Stock&#x201d;), and all of which were issued and
        outstanding as of December 31, 2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Series A Preferred Stock provides for a cumulative annual dividend of $0.10 per share, payable in semi-annual installments in June and December. Dividends may be paid in cash or with shares of common stock.&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company paid approximately $16,000 in cash for payment of dividends during the year ended December 31, 2022&lt;/span&gt;.&lt;/span&gt; The Company paid approximately $8,000 in cash and issued approximately 10 shares of common stock for payment of dividends during the
        year ended December 31, 2021.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Series A Preferred Stock has no voting rights and has a $1.00 per share liquidation preference over common stock. The registered holder has the right at any time to convert shares of Series A Preferred Stock into that number of shares of common
        stock that equals the number of shares of Series A Preferred Stock that are surrendered for conversion divided by the conversion rate.&#160; At December 31, 2022, the conversion rate was 23.9988 and, based on that conversion rate, one share of Series A Convertible Preferred Stock would have converted into approximately 0.04 shares of common stock, and all the outstanding shares of the Series A Convertible Preferred Stock would have converted into approximately 6,000 shares of common stock in the aggregate. There were no
        conversions during the years ended December 31, 2022 and 2021. There is no mandatory conversion term, date or any redemption features associated with the Series A Preferred Stock. The conversion rate will adjust under the following circumstances:&lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);"&gt;1.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;If the Company (a) pays a dividend or makes a distribution in shares of its common stock, (b) subdivides its outstanding shares of common stock into a greater number of shares, (c) combines its outstanding
                shares of common stock into a smaller number of shares, or (d) issues by reclassification of its shares of common stock any shares of its common stock (other than a change in par value, or from par value to no par value, or from no par
                value to par value), then the conversion rate in effect immediately prior to the applicable event will be adjusted so that the holders of the Series A Convertible Preferred Stock will be entitled to receive the number of shares of common
                stock which they would have owned or have been entitled to receive immediately following the happening of the event, had the Series A Convertible Preferred Stock been converted immediately prior to the record or effective date of the
                applicable event.&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);"&gt;2.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;If the outstanding shares of the Company&#x2019;s common stock are reclassified (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result of a
                subdivision, combination or stock dividend), or if the Company consolidates with or merge into another corporation and the Company is not the surviving entity, or if the Company sells all or substantially all of its property, assets,
                business and goodwill, then the holders of the Series A Convertible Preferred Stock will thereafter be entitled upon conversion to the kind and amount of shares of stock or other equity securities, or other property or assets which would
                have been receivable by such holders upon such reclassification, consolidation, merger or sale, if the Series A Convertible Preferred Stock had been converted immediately prior thereto.&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);"&gt;3.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;If the Company issues common stock without consideration or for a consideration per share less than the then applicable Equivalent Preference Amount (as defined below), then the Equivalent Preference Amount
                will immediately be reduced to the amount determined by dividing (A) an amount equal to the sum of (1) the number of shares of common stock outstanding immediately prior to such issuance multiplied by the Equivalent Preference Amount in
                effect immediately prior to such issuance and (2) the consideration, if any, received by the Company upon such issuance, by (B) the total number of shares of common stock outstanding immediately after such issuance. The &#x201c;Equivalent
                Preference Amount&#x201d; is the value that results when the liquidation preference of one share of Series A Convertible Preferred Stock (which is $1.00)
                is multiplied by the conversion rate in effect at that time; thus the conversion rate applicable after the adjustment in the Equivalent Preference Amount as described herein will be the figure that results when the adjusted Equivalent
                Preference Amount is divided by the liquidation preference of one share of Series A Convertible Preferred Stock.&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember"
      decimals="INF"
      id="Fact_4503b28eb31d4c468fec151cca0a1b19"
      unitRef="U002">2185000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember"
      decimals="INF"
      id="Fact_15cfe76ee51549368e760bd792b6991c"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <erna:NumberOfWarrantsInEachUnit
      contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember_InvestmentTypeAxis_PIPEInvestorOneMember"
      decimals="INF"
      id="Fact_e2d761f5244a4e7ea4a6a591b0e9ef12"
      unitRef="U002">2</erna:NumberOfWarrantsInEachUnit>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember"
      decimals="INF"
      id="Fact_f32124102f924926bd748ea6ba27f1af"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember"
      decimals="2"
      id="Fact_65838fb5dcab43ebad34e9b73a8712e3"
      unitRef="U003">3.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <erna:UnitPriceOfWarrants
      contextRef="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorOneMember"
      decimals="2"
      id="Fact_b46beca1dc6f4f7da591ad392e3c451e"
      unitRef="U003">3.53</erna:UnitPriceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember_InvestmentTypeAxis_PIPEInvestorOneMember"
      decimals="3"
      id="Fact_eda40665fbff463e946c033769e0fa7a"
      unitRef="U003">0.125</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c20221202to20221202_InvestmentTypeAxis_PIPEInvestorOneMember"
      decimals="-5"
      id="Fact_2e9a78fd8d514ecaa3acb9e92f119730"
      unitRef="U001">7700000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <erna:TransactionFeesPayable
      contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember"
      decimals="-5"
      id="Fact_3ea099b16c394ebbaa3baa4e60c8c1f8"
      unitRef="U001">300000</erna:TransactionFeesPayable>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember"
      decimals="2"
      id="Fact_8534663d54194e6e8359b75f4615b032"
      unitRef="U003">3.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <erna:ClassOfWarrantOrRightsExercisableTerm
      contextRef="c20221123to20221123_InvestmentTypeAxis_PIPEInvestorOneMember"
      id="Fact_6b7096bda34041278445eea3543cec94">P6M</erna:ClassOfWarrantOrRightsExercisableTerm>
    <erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights
      contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorOneMember"
      decimals="4"
      id="Fact_c7790281356645a9a5aed3692714cfde"
      unitRef="U005">0.0499</erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights>
    <erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights
      contextRef="c20221123_InvestmentTypeAxis_PIPEInvestorOneMember_RangeAxis_MaximumMember"
      decimals="4"
      id="Fact_515c3c3edefa44c09689009781e74556"
      unitRef="U005">0.0999</erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_d158361e17204c3180180942639ee0f2"
      unitRef="U002">343000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_f78eaedc67bf482ead23b0289517b2f6"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_59e75f9e094043a2bd1d45f5a8f6a220"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_598138eda4204a4eb62f3d66891f8732"
      unitRef="U001">12000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <erna:VariableRateTransactionsPeriod
      contextRef="c20220306to20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_251bf9075f2e40a09a8583849ae94f30">P1Y</erna:VariableRateTransactionsPeriod>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="2"
      id="Fact_1c12c15f3d1046e4a79336a1965c6498"
      unitRef="U003">0.1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="4"
      id="Fact_d6f0a0c6012e4715b38beb26d2b3ca8e"
      unitRef="U005">0.0999</erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember_StatementEquityComponentsAxis_CommonStockMember"
      decimals="0"
      id="Fact_34d307abf12442729c6e25fd606a6ccd"
      unitRef="U002">275000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_5c57130310e8458a86316ccfdf7a7d90"
      unitRef="U002">68000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_219bcd9069d7427ab63112b686cd5777"
      unitRef="U002">343000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="2"
      id="Fact_92dcae471db84d328e76a6397ab126b3"
      unitRef="U003">38.2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <erna:ClassOfWarrantOrRightsExercisableTerm
      contextRef="c20220306to20220306_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_5d5fd8762df04a158d3b01f692a3ef9a">P6M</erna:ClassOfWarrantOrRightsExercisableTerm>
    <erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="4"
      id="Fact_15cfa72df4a144d49aff57a025a06ee3"
      unitRef="U005">0.0499</erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights>
    <erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="4"
      id="Fact_36353374c5884c169d6a3d338ab86f0f"
      unitRef="U005">0.0999</erna:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220306to20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_601b09d8a7d5453f9be0ba42bdd1b22e"
      unitRef="U001">12600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <erna:OverSubscriptionAmountReceived
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_ee92837a41cb4f6c8f488fe6cc49cbbc"
      unitRef="U001">600000</erna:OverSubscriptionAmountReceived>
    <erna:OverSubscriptionAmountReceived
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_02789ab4296745c080b40a3dc2002efe"
      unitRef="U001">600000</erna:OverSubscriptionAmountReceived>
    <erna:ClassOfWarrantOrRightExercised
      contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_8645794c5537420b811119543502dded"
      unitRef="U002">68000</erna:ClassOfWarrantOrRightExercised>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="2"
      id="Fact_db5a3a599a0949a8a8d8a1e5b26bb808"
      unitRef="U003">0.1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_ff0bd6a23cd94a16a65a719a915a8e28"
      unitRef="U001">7000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <erna:ClassOfWarrantOrRightExercised
      contextRef="c20220714to20220714_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_2452b5f23c3242b9bc8357340ecf75f9"
      unitRef="U002">0.7</erna:ClassOfWarrantOrRightExercised>
    <erna:TransactionFeesPayable
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_39d4a67ab2f5453297d524ec2b0ff9f7"
      unitRef="U001">1000000</erna:TransactionFeesPayable>
    <erna:AggregateCalendarDays
      contextRef="c20220306to20220306_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_135822312151432c9c2df34b7f900ab1">P15D</erna:AggregateCalendarDays>
    <erna:ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="2"
      id="Fact_c54b0d19fcac4015a04007f5a15d3781"
      unitRef="U005">0.02</erna:ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth>
    <erna:ObligationToPayLiquidatedDamagesPercentage
      contextRef="c20221231_InvestmentTypeAxis_PIPEInvestorMember_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_2faba044191541c6bec3802995796360"
      unitRef="U005">0.12</erna:ObligationToPayLiquidatedDamagesPercentage>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="c20221231_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_a44f0350da44468cb9d3a1a1e9f8ba5e"
      unitRef="U001">200000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="c20220601to20220630_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_ffa50ea0e1ac4067ab795f0079db7a51"
      unitRef="U001">200000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="c20220101to20221231"
      id="Text_be9dff19f7964586a75f66027ef892fa">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;The following table shows the Company&#x2019;s warrant
            activity for the year ended December 31, 2022 (in thousands except for per-share data):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;March 2022&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Pre-Funded&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;November 2022&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Total&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Balance as of January 1, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Granted&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;343&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;68&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,370&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,781&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Exercised&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(68&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(68&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Balance as of December 31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;343&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,370&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,713&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20211231_ClassOfWarrantOrRightAxis_March2022WarrantsMember"
      decimals="0"
      id="Fact_ddee430b7c2c400da5811fd4d8aad0c4"
      unitRef="U002">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="0"
      id="Fact_9a6a30b1c3fb4632ac9f1cd891004967"
      unitRef="U002">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20211231_ClassOfWarrantOrRightAxis_November2022WarrantsMember"
      decimals="0"
      id="Fact_5c4083057cdb479fa6716d83bd32daee"
      unitRef="U002">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20211231"
      decimals="0"
      id="Fact_5a09a18f59ce420f840ac40329681565"
      unitRef="U002">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <erna:ClassOfWarrantOrRightGrantsInPeriod
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_March2022WarrantsMember"
      decimals="0"
      id="Fact_6790011230ad4af783043293a9fa717c"
      unitRef="U002">343</erna:ClassOfWarrantOrRightGrantsInPeriod>
    <erna:ClassOfWarrantOrRightGrantsInPeriod
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="0"
      id="Fact_af7cc0a77f7142649db73575e1c1c35e"
      unitRef="U002">68</erna:ClassOfWarrantOrRightGrantsInPeriod>
    <erna:ClassOfWarrantOrRightGrantsInPeriod
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_November2022WarrantsMember"
      decimals="0"
      id="Fact_8386e74f116e4135a056c7e60aad84e9"
      unitRef="U002">4370</erna:ClassOfWarrantOrRightGrantsInPeriod>
    <erna:ClassOfWarrantOrRightGrantsInPeriod
      contextRef="c20220101to20221231"
      decimals="0"
      id="Fact_6eb319846652495997d523f96ecb1327"
      unitRef="U002">4781</erna:ClassOfWarrantOrRightGrantsInPeriod>
    <erna:ClassOfWarrantOrRightExercisedInPeriod
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_March2022WarrantsMember"
      decimals="0"
      id="Fact_249c7af14dda4593a7c291ffa7fe5b6d"
      unitRef="U002">0</erna:ClassOfWarrantOrRightExercisedInPeriod>
    <erna:ClassOfWarrantOrRightExercisedInPeriod
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="0"
      id="Fact_68b49594ace047a6ac348c8c2fc36eec"
      unitRef="U002">68</erna:ClassOfWarrantOrRightExercisedInPeriod>
    <erna:ClassOfWarrantOrRightExercisedInPeriod
      contextRef="c20220101to20221231_ClassOfWarrantOrRightAxis_November2022WarrantsMember"
      decimals="0"
      id="Fact_2534898dc02441d399275063fd38c4b0"
      unitRef="U002">0</erna:ClassOfWarrantOrRightExercisedInPeriod>
    <erna:ClassOfWarrantOrRightExercisedInPeriod
      contextRef="c20220101to20221231"
      decimals="0"
      id="Fact_0c91df92f1c846c89cc474847f7c37ae"
      unitRef="U002">68</erna:ClassOfWarrantOrRightExercisedInPeriod>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20221231_ClassOfWarrantOrRightAxis_March2022WarrantsMember"
      decimals="0"
      id="Fact_7176e1eb04034b57ab4c6572786fd508"
      unitRef="U002">343</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20221231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="0"
      id="Fact_48dfdfc40bb947378439f3fff1635f84"
      unitRef="U002">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20221231_ClassOfWarrantOrRightAxis_November2022WarrantsMember"
      decimals="0"
      id="Fact_10782c3233174a73bd860f2d636b78e2"
      unitRef="U002">4370</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20221231"
      decimals="0"
      id="Fact_9c5e3ed8a9fd4a60b49c132e1c299417"
      unitRef="U002">4713</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="c20221231_ClassOfWarrantOrRightAxis_WarrantMember"
      id="Fact_361203a64dc943dba28bcaece5872d36">P5Y4M13D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20221231_ClassOfWarrantOrRightAxis_WarrantMember"
      decimals="2"
      id="Fact_aa77d2416d2143a28723480de3521909"
      unitRef="U003">5.82</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20210426to20210426_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember_TypeOfArrangementAxis_FirstPurchaseAgreementMember"
      decimals="-6"
      id="Fact_f7004cff091844f8b82413345b014776"
      unitRef="U001">20000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
      contextRef="c20210426to20210426_LegalEntityAxis_LincolnParkCapitalFundLLCMember_TypeOfArrangementAxis_FirstPurchaseAgreementMember"
      decimals="0"
      id="Fact_3776e05ae3fc446c92aeb0dd9a04f296"
      unitRef="U002">56000</us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="c20210426to20210426_TypeOfArrangementAxis_FirstPurchaseAgreementMember"
      decimals="-6"
      id="Fact_517ebba79d0447d187cdff1aade0d82f"
      unitRef="U001">20000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20210526to20210526_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember"
      decimals="-6"
      id="Fact_bfc43931724e4d94ab577972ca1f1ac6"
      unitRef="U001">40000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c20210526to20210526_TypeOfArrangementAxis_SecondPurchaseAgreementMember"
      decimals="0"
      id="Fact_a26cdd7ddc6e424086ea65845239e1fa"
      unitRef="U002">121000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="c20210526to20210526_TypeOfArrangementAxis_SecondPurchaseAgreementMember"
      decimals="-6"
      id="Fact_a2a217e506034194871d13c87ab1a4ae"
      unitRef="U001">34000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <erna:SaleOfStockNumberOfSharesToIssuedInTransaction
      contextRef="c20220101to20221231_TypeOfArrangementAxis_SecondPurchaseAgreementMember"
      decimals="0"
      id="Fact_d739276be7334d2495de107f20fd5a7e"
      unitRef="U002">22000</erna:SaleOfStockNumberOfSharesToIssuedInTransaction>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20210426_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember"
      decimals="0"
      id="Fact_4a99e8ef52a04538b88a5272c36fb1e6"
      unitRef="U002">3000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20221231_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember"
      decimals="0"
      id="Fact_1efb4b4a98fc4a5688a4ea26720c791b"
      unitRef="U002">6000</us-gaap:CommonStockSharesAuthorized>
    <erna:CommitmentAmountToMeetAnySingleRegularPurchase
      contextRef="c20210426_RangeAxis_MaximumMember"
      decimals="-5"
      id="Fact_e5b6deba9b634ead95e94c64b67dd776"
      unitRef="U001">2000000</erna:CommitmentAmountToMeetAnySingleRegularPurchase>
    <erna:BeneficialOwnershipPercentageOnTotalOutstandingShares
      contextRef="c20210426_RangeAxis_MaximumMember_TypeOfArrangementAxis_SecondPurchaseAgreementMember"
      decimals="4"
      id="Fact_6527dd1fe4984164851a4eb8ca97cbdb"
      unitRef="U005">0.0499</erna:BeneficialOwnershipPercentageOnTotalOutstandingShares>
    <us-gaap:SharesIssued
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassAMember"
      decimals="0"
      id="Fact_8a2d69153d344bae9b74af4ce407d378"
      unitRef="U002">87000</us-gaap:SharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassAMember"
      decimals="0"
      id="Fact_9e22995c1e034e2ab149958394f19a68"
      unitRef="U002">1114000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:SharesIssued
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassBMember"
      decimals="0"
      id="Fact_dba32cf8775b4da594abed3a630d8765"
      unitRef="U002">15000000</us-gaap:SharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassBMember"
      decimals="0"
      id="Fact_c8d2fec43e5344feb1db55e0861a5c82"
      unitRef="U002">126000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:SharesIssued
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember"
      decimals="0"
      id="Fact_801ddb34b7324c2f8460b08e49af829e"
      unitRef="U002">10000000</us-gaap:SharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassCMember"
      decimals="0"
      id="Fact_c1d1cfe24ff74ac89f36ce2c7eb689e2"
      unitRef="U002">84000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:SharesIssued
      contextRef="c20210325_StatementEquityComponentsAxis_CommonStockMember"
      decimals="0"
      id="Fact_aca1de23f8894135b560e06134189047"
      unitRef="U002">630000</us-gaap:SharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c20210325to20210325_StatementEquityComponentsAxis_CommonStockMember"
      decimals="0"
      id="Fact_4decfe9df21744e2a4216444858eb400"
      unitRef="U002">31000</us-gaap:ConversionOfStockSharesConverted1>
    <erna:ClassOfWarrantOrRightIssued
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember"
      decimals="0"
      id="Fact_d735ea58fe394955ae40c86f6122ec14"
      unitRef="U002">10500000</erna:ClassOfWarrantOrRightIssued>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember"
      decimals="0"
      id="Fact_fd8d98cb8d914fc4a114ea75d5cc3154"
      unitRef="U002">591000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <erna:StockIssuedDuringPeriodSharesAcquisitions1
      contextRef="c20210325to20210325"
      decimals="0"
      id="Fact_0bd53fadc0574da29ff7c3fa7668f007"
      unitRef="U002">53000</erna:StockIssuedDuringPeriodSharesAcquisitions1>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_79d775385251499fb1b6bf96087c102a"
      unitRef="U002">351000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <erna:StockIssuedDuringPeriodUnrestrictedSharesAcquisitions
      contextRef="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_4e4948aeac794667accdc05ac3a0499d"
      unitRef="U002">182000</erna:StockIssuedDuringPeriodUnrestrictedSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember"
      decimals="0"
      id="Fact_d1f23cbd1d7f4c128705220096defef4"
      unitRef="U002">169000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <erna:EachLockUpAgreementExtendsTerm
      contextRef="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      id="Fact_37278f3a5b2048a38a07bef19531f4ae">P3Y</erna:EachLockUpAgreementExtendsTerm>
    <erna:PercentageOfCommonStockSubjectToLockUpAgreement
      contextRef="c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_5583be9459624b84bb8e25f83054b918"
      unitRef="U005">0.75</erna:PercentageOfCommonStockSubjectToLockUpAgreement>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact_f7ca598309e14ab49087af7b892b3419"
      unitRef="U002">156000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact_919b660f978d472789f00d9e0bc03c7d"
      unitRef="U002">156000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact_5c5d8b77706a4209a10526552053a391"
      unitRef="U002">156000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="2"
      id="Fact_52def56ee6fc4583afe61d8d9a5163dc"
      unitRef="U003">0.1</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact_0bf1c3913a3f4bbc92f53ffe6e8fc449"
      unitRef="U001">16000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact_bbfaa7d1f02747478c7d87882a6afae0"
      unitRef="U001">8000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:PreferredStockDividendsShares
      contextRef="c20210101to20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact_a6adea1deec84bb290023605f054bf2f"
      unitRef="U002">10</us-gaap:PreferredStockDividendsShares>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="2"
      id="Fact_2cefb91d99ee4333ab661e744bb53b0c"
      unitRef="U003">1</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="4"
      id="Fact_fd9048399b8f4ce5a5d1d9879b8a5199"
      unitRef="U005">23.9988</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="c20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="2"
      id="Fact_9314ce700ef44f5c8a0ad29b1cb2e9b8"
      unitRef="U002">0.04</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="c20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="0"
      id="Fact_4ea41a52c4044d6d84215f43648af106"
      unitRef="U002">6000</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="INF"
      id="Fact_fb2359418eb742759e6bd571dfb38380"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c20210101to20211231"
      decimals="INF"
      id="Fact_279c5c69f312489782e1d65e514cb5a6"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="2"
      id="Fact_d01734687aa2453688344c89047a4672"
      unitRef="U003">1</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="c20220101to20221231"
      id="Text_5e8fbae6b1184b969719cbe3a9c28eb5">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 35.9pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;16)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Income Taxes&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Loss before income taxes consist of the following (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="7" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="3" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="3" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;span style="font-style: italic;"&gt;(in thousands)&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="3" rowspan="1" style="vertical-align: bottom; text-align: center; text-indent: 9pt; font-weight: bold; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-indent: 9pt; font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="3" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Domestic&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,513&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(122,476&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Foreign&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(5&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total loss before income taxes&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,534&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(122,481&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;For each of the years ended December 31, 2022 and 2021, current tax provisions and current deferred tax provisions were
        recorded as follows (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Current Tax Provision&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Federal&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;State&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;4&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;5&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Foreign &lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;4&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;5&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Deferred Tax Provision&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Federal&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(6,851&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(5,840&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;State&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(1,602&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(1,414&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Foreign &lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;(187&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(1&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(8,640&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(7,255&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Change in valuation allowance&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;8,681&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;7,314&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total tax provision for income taxes&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;45&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;64&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Deferred tax assets and liabilities
        consist of the effects of temporary differences as shown in the table below (in thousands). Deferred tax assets have been fully reserved by a valuation allowance since it is more likely than not that such tax benefits will not be realized.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2022&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred Tax Assets:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Net operating losses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,382&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,457&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Foreign net operating losses&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;782&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;595&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&#160;&#160; Stock compensation&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;2,173&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;1,312&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;&#160; &#160; In-process research and development&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;1,233&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&#160;&#160; Capitalized rearch and development expenses&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;1,502&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;R&amp;amp;D credit carryforwards&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;517&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;288&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Compensation accrual&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;81&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;30&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; text-indent: 9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" valign="bottom"&gt;ROU Liabilities&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;334&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;706&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&#160;&#160; Other&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;549&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total gross deferred tax assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,553&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,388&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Valuation allowance&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(16,157&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(7,467&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net deferred tax assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;396&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;921&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred Tax Liabilities:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Fixed assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(10&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(168&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="margin-left: 9pt;"&gt;ROU Assets&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(291&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(666&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Intangibles - goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(160&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(112&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total deferred tax liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(461&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(946&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net deferred taxes&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(65&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(25&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
         &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;The






          reconciliation of computed expected income taxes to effective income taxes by applying the federal statutory rate of 21% is as
          follows:&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 27pt;"&gt;&#160;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 18pt;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt; 2022&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt; 2021&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tax at federal income tax rate&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.00&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-indent: 9pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;21.00&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;State income tax, net of federal tax&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6.52&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;1.15&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;Foreign tax differential&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;(0.01&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;0.00&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;% &lt;br/&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-deductible expenses/excludable items&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6.09&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(16.30&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Change in valuation allowance&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;(35.38&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;(5.97&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credits&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;0.98&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;0.23&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;Uncertain tax positions&lt;br/&gt;
                &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;(0.49&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;0.00&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.11&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;(0.16&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Provision for income taxes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(0.18&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;(0.05&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 18pt;"&gt; &#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The net increase in the total valuation allowance for the year ended December 31, 2022 was an increase of approximately $8.8
              million. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets
              is dependent upon the generation of future taxable income during periods in which those temporary difference become deductible. Management considered the scheduled reversal of deferred tax liabilities, projected future taxable income and
              planning strategies in making this assessment.&#160; Based on the level of historical operating results and projections for the taxable income for the future, management has determined that it is more likely than not that the deferred taxes assets
              will not be utilized. Accordingly, the Company has recorded a full valuation allowance. The net deferred tax liability represents an indefinite life intangible liability related to tax deductible goodwill, partially offset by an indefinite
              life deferred tax asset.&lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;At December 31, 2022 and 2021, the Company has available net operating loss (&#x201c;NOL&#x201d;) carryforwards of approximately $35.6 million and $20.7 million for
          federal income tax purposes, respectively, of which approximately $35.6 million can be carried forward indefinitely. The Company has
          available $28.8 million and $20.7
          million state NOLs for the years ended December 31, 2022 and 2021, respectively, which begin to expire in 2041. The Company also has
          foreign NOL carryforwards of approximately $6.3 million and $4.8 million for the years ended December 31, 2022 and 2021, respectively, which carry forward indefinitely. Section 382 of the Internal Revenue Code (&#x201c;IRC&#x201d;) imposes limits on
          the ability to use NOL carryforwards that existed prior to a change in control to offset future taxable income. Such limitations would reduce, potentially significantly, the gross deferred tax assets disclosed in the table above related to the
          NOL carryforwards.&#160; The Company continues to disclose the NOL carryforwards at their original amount in the table above as no potential limitation has been quantified. The Company has also established a full valuation allowance for all deferred
          tax assets, including the NOL carryforwards, since the Company could not conclude that it was more likely than not able to generate future taxable income to realize these assets.&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;At December 31, 2022 and 2021 the Company has federal and state income tax credit carryforwards of approximately $0.5 million and $0.3 million,
          respectively. The credits begin to expire in 2041.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;In accordance with authoritative guidance, the impact of an uncertain income tax position on the income tax return must be
          recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table summarizes amounts the
          Company recorded for uncertain tax positions as of December 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; font-weight: bold;"&gt; 2022&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; font-weight: bold;"&gt;2021&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Beginning balance of uncertain tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Additions based on current year&#x2019;s tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;45&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Net changes based on prior year&#x2019;s tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;76&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Ending balance of uncertain tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;121&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
           &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;It
          is reasonably possible that unrecognized tax benefits may increase or decrease within the next twelve months due to tax examination changes, expiration of statute of limitations, or changes in tax law.&#160; The Company does not anticipate any
          significant changes to unrecognized tax benefits over the next 12 months. &lt;/div&gt;

&lt;div&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;The Company recognizes interest and penalties related to unrecognized tax positions within the income tax expense line in the
          accompanying consolidated statements of operations. There were no accrued interest and penalties associated with uncertain tax
          positions as of December 31, 2022 or December 31, 2021.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;The Company is subject to U.S. federal, state, and foreign income tax. The Company&#x2019;s income tax returns are subject to
          examination by the relevant taxing authorities. As of December 31, 2022, the &lt;span style="-sec-ix-hidden:Fact_f5787a4f89d441eb816e0f3918c8cfa1"&gt;2019 &#x2013; 2022&lt;/span&gt; tax years remain subject to examination in
          the U.S. federal tax, various state, and foreign tax jurisdictions. The Company is not currently under examination by federal state, or foreign jurisdictions.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On August 16, 2022, the Inflation Reduction Act of 2022 (the &#x201c;IRA&#x201d;) was enacted into law. Among other changes to the tax code, the IRA imposes a 1% excise tax on
            certain repurchases of corporate stock by certain publicly traded corporations. The 1% stock buyback tax applies to redemptions by domestic corporations occurring in taxable years beginning after December 31, 2022.&#160; A number of exceptions to
            the stock buyback tax are available including exceptions to certain reorganizations. However, while these exceptions may be helpful in limiting the application of the stock buyback tax in situations in which it was not intended to apply, more
            guidance will be necessary for taxpayers to analyze the potential application of these exceptions and whether they will be able to rely upon them.&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;
</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_a3f4ee5e0f204eb396b5a3cc7b336925">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Loss before income taxes consist of the following (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="7" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="3" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="3" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;span style="font-style: italic;"&gt;(in thousands)&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="3" rowspan="1" style="vertical-align: bottom; text-align: center; text-indent: 9pt; font-weight: bold; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-indent: 9pt; font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="3" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Domestic&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,513&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(122,476&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Foreign&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(5&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total loss before income taxes&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,534&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(122,481&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_59392ae40e7446ebab90a0daae31253b"
      unitRef="U001">-24513000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_396a2c22843d40ad8e8e20dce508f2c7"
      unitRef="U001">-122476000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_3d27e6dace4a400ab7c45d03c60b3203"
      unitRef="U001">-21000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_2e9ea2b84bf94df0a41ab3f6d853b8ab"
      unitRef="U001">-5000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_ebd3c525c17f489fbd38f474675d9213"
      unitRef="U001">-24534000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_8a2bdba9582d41439204b8990e398cb3"
      unitRef="U001">-122481000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_d7cc4244179e400cafb6c5f814b5ad21">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;For each of the years ended December 31, 2022 and 2021, current tax provisions and current deferred tax provisions were
        recorded as follows (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Current Tax Provision&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Federal&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;State&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;4&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;5&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Foreign &lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;4&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;5&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Deferred Tax Provision&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Federal&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(6,851&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(5,840&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;State&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(1,602&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(1,414&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Foreign &lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;(187&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(1&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(8,640&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(7,255&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Change in valuation allowance&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;8,681&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;7,314&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total tax provision for income taxes&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;45&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;64&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_ea98f0814498471786f6c7cca18f2987"
      unitRef="U001">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_8cc2f1c7ff814b179d1132bc45a8a1fc"
      unitRef="U001">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_8ad889ddc4e84ec084741eff76bcb1f0"
      unitRef="U001">4000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_7185b4de95a0480fbb43542b71423948"
      unitRef="U001">5000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_af462f0cbde54e4f9683fefd3052d695"
      unitRef="U001">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_4e4e429ce5a54d1ba482ad694b799743"
      unitRef="U001">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_7769f449ab1e4f6f950f197f008cacda"
      unitRef="U001">4000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_d18a46096b99468085bb3d8a73c0ee8f"
      unitRef="U001">5000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_85498d73c9384a16bb0ceb86ffb6e177"
      unitRef="U001">-6851000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_0c83d7b3936f45bbadc303b345231a22"
      unitRef="U001">-5840000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_f2bc8ee654f24691890fd41f606d5d48"
      unitRef="U001">-1602000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_6ee82fd7bf9d477a91340ac9629fa697"
      unitRef="U001">-1414000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_397c920bc99c48eebb4fd1798f6f7901"
      unitRef="U001">-187000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_04cd743a21034090bdb0115a03e99314"
      unitRef="U001">-1000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_6259991b364549dbaa2898ec9bc89106"
      unitRef="U001">-8640000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_d77e85e13aa14013a5d51dea43af84da"
      unitRef="U001">-7255000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <erna:EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_777799ccf5264d72912e47661d49c587"
      unitRef="U001">8681000</erna:EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount>
    <erna:EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_213d293f40294767b27402270c139ee0"
      unitRef="U001">7314000</erna:EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_7fb1a268c54f411ab9d6bdd64c286f36"
      unitRef="U001">45000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_eb4bdb8dedea4831a6921e14a7f5fd83"
      unitRef="U001">64000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_ef8831b411254551aae495607bc6a985">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Deferred tax assets and liabilities
        consist of the effects of temporary differences as shown in the table below (in thousands). Deferred tax assets have been fully reserved by a valuation allowance since it is more likely than not that such tax benefits will not be realized.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2022&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred Tax Assets:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Net operating losses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,382&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,457&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Foreign net operating losses&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;782&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;595&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&#160;&#160; Stock compensation&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;2,173&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;1,312&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;&#160; &#160; In-process research and development&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;1,233&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&#160;&#160; Capitalized rearch and development expenses&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;1,502&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;R&amp;amp;D credit carryforwards&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;517&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;288&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Compensation accrual&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;81&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;30&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; text-indent: 9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" valign="bottom"&gt;ROU Liabilities&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;334&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;706&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&#160;&#160; Other&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;549&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total gross deferred tax assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,553&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,388&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Valuation allowance&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(16,157&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(7,467&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net deferred tax assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;396&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;921&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred Tax Liabilities:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Fixed assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(10&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(168&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="margin-left: 9pt;"&gt;ROU Assets&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(291&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(666&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Intangibles - goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(160&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(112&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total deferred tax liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(461&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(946&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net deferred taxes&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(65&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(25&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
         &lt;/div&gt;
</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign
      contextRef="c20221231"
      decimals="-3"
      id="Fact_be572ce6cd4e452e9b27939a1a28ad03"
      unitRef="U001">9382000</erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign>
    <erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign
      contextRef="c20211231"
      decimals="-3"
      id="Fact_867a178c9eb24c978d35415c5fca0519"
      unitRef="U001">5457000</erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="c20221231"
      decimals="-3"
      id="Fact_017a0901081e47428288099a10e5f3d4"
      unitRef="U001">782000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="c20211231"
      decimals="-3"
      id="Fact_1420e7f8c51d4b53b2203b8ef9431318"
      unitRef="U001">595000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="c20221231"
      decimals="-3"
      id="Fact_d35d87cd3f7d42129ae20b431985bef3"
      unitRef="U001">2173000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4fb2815f45a14caca08c8d2eb0a87217"
      unitRef="U001">1312000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="c20221231"
      decimals="-3"
      id="Fact_a123899d570746c583c19bc00f2860d5"
      unitRef="U001">1233000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="c20211231"
      decimals="-3"
      id="Fact_eacd34ed666d4a9c9933a50c9febdc3c"
      unitRef="U001">0</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <erna:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
      contextRef="c20221231"
      decimals="-3"
      id="Fact_120e3d6359574b6da453c8798f23eaa9"
      unitRef="U001">1502000</erna:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
    <erna:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
      contextRef="c20211231"
      decimals="-3"
      id="Fact_2bee8d3fc84b4e2597c01026cfc2c9af"
      unitRef="U001">0</erna:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="c20221231"
      decimals="-3"
      id="Fact_e5c9b0d259844bfb8177087dbcef95b1"
      unitRef="U001">517000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3ccd32feda43419fb8a68a5e74ff0329"
      unitRef="U001">288000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
      contextRef="c20221231"
      decimals="-3"
      id="Fact_98d134a9251546e09a3b31a5baf271dd"
      unitRef="U001">81000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
      contextRef="c20211231"
      decimals="-3"
      id="Fact_bd6c7564f0114fde8b5de855a565c6fd"
      unitRef="U001">30000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences>
    <erna:DeferredTaxAssetsRightOfUseLiabilities
      contextRef="c20221231"
      decimals="-3"
      id="Fact_8ad19b786a4343b2880ed86813edba8c"
      unitRef="U001">334000</erna:DeferredTaxAssetsRightOfUseLiabilities>
    <erna:DeferredTaxAssetsRightOfUseLiabilities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_526aea83e4a741bdbfbf024e81ee2134"
      unitRef="U001">706000</erna:DeferredTaxAssetsRightOfUseLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="c20221231"
      decimals="-3"
      id="Fact_43df09c6621347ba878f7bc5b22e5436"
      unitRef="U001">549000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="c20211231"
      decimals="-3"
      id="Fact_35a88a8f99da443b97ca76002fdfb07a"
      unitRef="U001">0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="c20221231"
      decimals="-3"
      id="Fact_652142c9712743cebfbaf2aa53d9e1c2"
      unitRef="U001">16553000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ce13051d3d044cffad8fcaadde55f9d6"
      unitRef="U001">8388000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="c20221231"
      decimals="-3"
      id="Fact_06d79b3334ec43e881433ce41cca31a3"
      unitRef="U001">16157000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="c20211231"
      decimals="-3"
      id="Fact_dc82b7498a334730a2307a72c5bd4df3"
      unitRef="U001">7467000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="c20221231"
      decimals="-3"
      id="Fact_c74e222a23174a83a37ded988be7458b"
      unitRef="U001">396000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="c20211231"
      decimals="-3"
      id="Fact_074a9ce39fad4c0ca9a36fe76c246fc7"
      unitRef="U001">921000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="c20221231"
      decimals="-3"
      id="Fact_6bb84d197a034542a6123984e4857a4d"
      unitRef="U001">10000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0447864f8ea24f5fa8beea561b253713"
      unitRef="U001">168000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <erna:DeferredTaxAssetsRightOfUseAssets
      contextRef="c20221231"
      decimals="-3"
      id="Fact_5ff0170ad28a4a35b3c2b53b8c6bf821"
      unitRef="U001">291000</erna:DeferredTaxAssetsRightOfUseAssets>
    <erna:DeferredTaxAssetsRightOfUseAssets
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0372b20819af4b77ab6d45f0cf11200f"
      unitRef="U001">666000</erna:DeferredTaxAssetsRightOfUseAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="c20221231"
      decimals="-3"
      id="Fact_55a0765a9dcf4f8f8dbc7610ef149624"
      unitRef="U001">160000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d2e6e3c929db4465ae17a3a641f4ccae"
      unitRef="U001">112000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="c20221231"
      decimals="-3"
      id="Fact_3d82a1ed4df44072bf6a0742ab19eb83"
      unitRef="U001">461000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_276affcd755042d88425029933107bb2"
      unitRef="U001">946000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="c20221231"
      decimals="-3"
      id="Fact_e4f4d3c0fab54077a34a1e8fa26ede5f"
      unitRef="U001">65000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_6de707a0f8104979bdecef0698526bcb"
      unitRef="U001">25000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_b153d71df5ac49be98073b30e08b0673">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;The






          reconciliation of computed expected income taxes to effective income taxes by applying the federal statutory rate of 21% is as
          follows:&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 27pt;"&gt;&#160;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 18pt;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt; 2022&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt; 2021&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tax at federal income tax rate&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.00&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-indent: 9pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;21.00&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;State income tax, net of federal tax&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6.52&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;1.15&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;Foreign tax differential&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;(0.01&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;0.00&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;% &lt;br/&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-deductible expenses/excludable items&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6.09&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(16.30&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Change in valuation allowance&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;(35.38&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;(5.97&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credits&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;0.98&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;0.23&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;Uncertain tax positions&lt;br/&gt;
                &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;(0.49&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;0.00&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.11&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;(0.16&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Provision for income taxes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(0.18&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;(0.05&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
          &lt;/div&gt;
</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_ff19066ae3f542768d820b853a686e08"
      unitRef="U005">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20220101to20221231"
      decimals="2"
      id="Fact_a71f2e69a0cf4b9995fe8dd1da4aeed5"
      unitRef="U005">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_8fd107d9e8334fcda6c210a53219d591"
      unitRef="U005">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20210101to20211231"
      decimals="4"
      id="Fact_3b38cae563f4453396c965389a24b7fe"
      unitRef="U005">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_990bc5b6cfa34c72b32072843715afb7"
      unitRef="U005">0.0652</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="c20210101to20211231"
      decimals="4"
      id="Fact_06f27729275f473ba57605cdfecac5cc"
      unitRef="U005">0.0115</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_414cac87c99e4f5ea9b58979d989f3ae"
      unitRef="U005">-0.0001</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="c20210101to20211231"
      decimals="4"
      id="Fact_78c12c88124142baa08052b81ea54062"
      unitRef="U005">0</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_195f9793309149bc8582284b442cba91"
      unitRef="U005">0.0609</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c20210101to20211231"
      decimals="4"
      id="Fact_008990e5cdc6453589bd4ed68c351169"
      unitRef="U005">-0.163</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_ecd5e668620a4f7eb8e1ff3e0bdb4f90"
      unitRef="U005">-0.3538</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="c20210101to20211231"
      decimals="4"
      id="Fact_217ae9f421f94fbb9755c370186e152b"
      unitRef="U005">-0.0597</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_707366dab331461b9dfb132eb6a551fa"
      unitRef="U005">0.0098</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="c20210101to20211231"
      decimals="4"
      id="Fact_72f568cf07f74288aff44860996fa9fc"
      unitRef="U005">0.0023</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <erna:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_390ba8fe08554ea0a05f1782c3edfac5"
      unitRef="U005">0.0049</erna:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent>
    <erna:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent
      contextRef="c20210101to20211231"
      decimals="4"
      id="Fact_e29ade52f6314861b415c26b154d6f98"
      unitRef="U005">-0</erna:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_d3bf84ccb7ce4de4b952fd05163b1b7d"
      unitRef="U005">0.0111</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="c20210101to20211231"
      decimals="4"
      id="Fact_8d9b6c2a5b1b458bb952eb3222f653af"
      unitRef="U005">-0.0016</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_51c84c79cbec46d2bcd6bae8f3e923fe"
      unitRef="U005">-0.0018</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c20210101to20211231"
      decimals="4"
      id="Fact_494736ddd45445caaf826cfe81589a7d"
      unitRef="U005">-0.0005</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_abd38b3a9b504b4286753bca9b9235f6"
      unitRef="U001">8800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20221231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-5"
      id="Fact_1ccf37d2860740898966fa4bd6ab45b5"
      unitRef="U001">35600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-5"
      id="Fact_15e6ee6726ba4667ae031d1ca6c773f4"
      unitRef="U001">20700000</us-gaap:OperatingLossCarryforwards>
    <erna:TaxCutsAndJobsActOperatingLossCarryforwards
      contextRef="c20221231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-5"
      id="Fact_5bd816b074a84402868ae388ac3c175e"
      unitRef="U001">35600000</erna:TaxCutsAndJobsActOperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20221231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="Fact_54b7d8830fa747c49016c76cc984dae7"
      unitRef="U001">28800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="Fact_07c6b3fcc1d245be8f8f47a1961857d6"
      unitRef="U001">20700000</us-gaap:OperatingLossCarryforwards>
    <erna:OperatingLossCarryforwardsExpirationYear
      contextRef="c20220101to20221231"
      id="Fact_c5542fec165249b78aee6c6c3ec8e0b5">2041</erna:OperatingLossCarryforwardsExpirationYear>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20221231_IncomeTaxAuthorityAxis_ForeignCountryMember"
      decimals="-5"
      id="Fact_5f00c8d37242483e948863eac8d333f1"
      unitRef="U001">6300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20211231_IncomeTaxAuthorityAxis_ForeignCountryMember"
      decimals="-5"
      id="Fact_0ff588c692274c32b3ecc58f9e16fb34"
      unitRef="U001">4800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="c20221231"
      decimals="-5"
      id="Fact_6599c7249ade4da1a3ee17da5ea32138"
      unitRef="U001">500000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="c20211231"
      decimals="-5"
      id="Fact_2d72dd45f16a4b35a80d450b93079ab1"
      unitRef="U001">300000</us-gaap:TaxCreditCarryforwardAmount>
    <erna:TaxCreditCarryforwardExpirationYear
      contextRef="c20220101to20221231"
      id="Fact_feb28f42dd9943988b6465d9700bab04">2041</erna:TaxCreditCarryforwardExpirationYear>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="c20220101to20221231"
      id="Text_415d751357954ea8bbe74b54f23b1d54">&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table summarizes amounts the
          Company recorded for uncertain tax positions as of December 31, 2022 and 2021 (in thousands):&lt;/span&gt;
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; font-weight: bold;"&gt; 2022&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; font-weight: bold;"&gt;2021&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Beginning balance of uncertain tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Additions based on current year&#x2019;s tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;45&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Net changes based on prior year&#x2019;s tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;76&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Ending balance of uncertain tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;121&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
           &lt;/div&gt;
</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c20211231"
      decimals="-3"
      id="Fact_624a5ed1c17b4778afec7205c5cbe4c2"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c20201231"
      decimals="-3"
      id="Fact_2ed9e194e4ac48a5962fbef53a92bc2a"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_88dacb737b034656913c4a350a08aceb"
      unitRef="U001">45000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_40dace3b9f5841dc80957ec6c7d8292c"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_ecf7de88742049cc81433c34a4890085"
      unitRef="U001">76000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_92622bbeac924a0e9c9517fa661cedcf"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c20221231"
      decimals="-3"
      id="Fact_cf12dc1d118d49ddb44cef0cbb5b1ce0"
      unitRef="U001">121000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f694e8fd54144272a7da0585772b4f00"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20211231"
      decimals="0"
      id="Fact_e65c42ca21ce47dba118855aa3f003e7"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20221231"
      decimals="0"
      id="Fact_80412a4e63734e999792a1d23ffcd1be"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="c20220101to20221231"
      id="Text_70b25e83691d4a44b87beca2cb618a2c">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 35.9pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;17)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Subsequent Event&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&#160;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Cell Customization and License Agreement&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;O&lt;span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;n February 21, 2023, the Company and Lineage Cell Therapeutics, Inc. (&#x201c;Lineage&#x201d;) entered into an exclusive option and license agreement (the &#x201c;Lineage Agreement&#x201d;), pursuant to which, Lineage
            may request prior to August 22, 2023 that the Company develops for, and delivers to, Lineage certain induced pluripotent stem cell lines, which Lineage would use to evaluate the possible development of cell transplant therapies for treatment of
            diseases of the central nervous system in humans, excluding ophthalmologic indications, (b) diseases and conditions of the peripheral nervous system, (c) psychiatric, respiratory, musculoskeletal, and hematological diseases, disorders, and
            conditions, and (d) cancer.&#160; The Lineage Agreement also provides Lineage with the option to obtain an exclusive sublicense to certain related technology for preclinical, clinical and commercial purposes, which would permit Lineage to sublicense
            such intellectual property, subject to payment of certain sublicense royalty fees.&#160; Lineage has six months from our delivery to Lineage of such induced pluripotent stem cell lines to exercise such option, and upon any such exercise, Lineage
            would agree to use its commercially reasonable efforts to exploit and make commercially available one or more licensed products derived from such induced pluripotent stem cell lines in accordance with the Lineage Agreement. Upon entry into the
            Lineage Agreement, Lineage paid the Company a $250,000 non-refundable up-front payment.&#160; We are also entitled to certain cell line
            customization fees with respect to cell lines that Lineage may request that we develop for Lineage, and royalty payments with respect to any such licensed products, certain sublicense fees and certain milestone payments under the Lineage
            Agreements&lt;/span&gt;.&lt;/div&gt;
</us-gaap:SubsequentEventsTextBlock>
    <erna:ProceedsFromOptionAndLicenseAgreement
      contextRef="c20230221to20230221_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-3"
      id="Fact_b632e2ba91c244f1bc208bd8fd784dd4"
      unitRef="U001">250000000</erna:ProceedsFromOptionAndLicenseAgreement>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>109
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( .XS=%8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #N,W16E"'SC>T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>R$Z@!Y/ZLK+3!H,5-G8SMMJ:Q;&Q-9*^_1*O31G; ^QHZ?>G
M3Z#.1&E"PN<4(B9RF.\FWP]9FKAE)Z(H ;(YH=>YGA/#W#R$Y#7-SW2$J,V'
M/B(TG&_ (VFK2<,"K.)*9*JS1IJ$FD*ZX*U9\?$S]05F#6"/'@?*(&H!3"T3
MXWGJ.[@!%AAA\OF[@'8EENJ?V-(!=DE.V:VI<1SKL2VY>0<!;T^/+V7=R@V9
M]&!P_I6=I'/$+;M.?FWO=_L'IAK>M!5OJX;O!9>MD'SSOKC^\+L)^V#=P?UC
MXZN@ZN#77:@O4$L#!!0    ( .XS=%:97)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M$454SZ]6;R3?E0]HKKF4/"E?;AD-F2B^H#Y_XESNWQ0[.#Q%?/-_4$L#!!0
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MM8:4&H*"*I?(L=4_PMU-8]O$28_*R4[EQ#]\AD:G?'%:2KJ=8)V>C7*B6/$
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M9A3:A3: ^TO.U>%$/Z#:KYS\!U!+ P04    " #N,W169E[2[#<-   G@0
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M_+FQ@(VE^OK/'4Q):2XIC9'2>$/3S?X B3E4!UV/M&$^*2T@I854M&XR/7/
MS).3:7$P)6G/59Y.3\!L,=%A%)>XN(3A$MY(E(OOAU&HRI0 5"N[!% ^WJ@
MEX3Z3NH;!*U=8NK]DO." !T^B2[]-[%#27-):8R4QAM:9VR<.L",%! JX4O9
M,I^4%I#20BI:-W5:I\G46TVZU.%Q*M^*H\1XNWR(BRPWMAOY_B)+ZS4\3Y>$
MUB*_%SF82:AU,L,E+BYAN(0W$MTL%9=X0$7#\6@(C*MHBX)36:&^"_N&2.N\
MF-HKRW0A@@Z\I+8,*<TEI3%2&F]HG4"R@6%7E2GA36JED-("4EI(1>OF5&NG
MF'H_Y6A.W>79VBA7PA"_BWP1%[5B]U:VJ=()GL.B9L,,E[BXA.$2;N+V"B[Q
M@(K Z2ONLIQ&"O4=UC<@6I?%U-LL/Q 0Z+!*Y!$T<41)<TEIC)3&3=P,PB4>
M:9M\4EI 2@NI:-T,:LTH4^]&'<V@7.R6#,KIRNZ%S39?K*JU)-%]+L1:I*7Q
M&)<KXWV<+K(D-3Y'^;?]<D6^39<OJ]/'ET8J2C"_<!,+E[BXA.$2;JHVE7H-
M=0ZHE+!5ZQI: \L!AF#<SSH"@Z:Z?X:E9;:>EJDWM?Z2&$+':U(OC)3FDM(8
M*8V;JM,%N:9S0*=$/ZDE1DH+2&DA%:V;<*TM9I[NBW42+JY/(M-F[TZ=6M4D
M*%K\MHV+^.F\\F/V())D6[PT_'3Q"DPFW"3#)2XN8;B$FZH-IBY^F0,J)3S5
MNH:3T42%^7BK@B,P=:0/]7W9,U:LUC>S3O?-?CA6L$%8WY9S!V%2FDM*8Z0T
M;JD&F3T$IB" 3EGU3^JAD=("4EI(1>LF5NNA67H/;185*V,9/\1+D2Z+:HYS
MS);6+$:P<!L-E[BXA.$2;J'^V!R7>'A%/B"Y5&<<P6FR$&A35];MWV>[B?3V
MV-G]BPZ.I X9*<TEI3%2&K=0XVN.2SS2-OFDM("4%@)?AGDL&UK'R^KI>,F8
M3V*QK5]_GC&=A)$3C0>1E_'71)PS..)&&"YQ<0G#)=S"C3!<X@$5 4M= 14X
M/J*M#O6=VO<0V7I@5D\/C"AHT!&7U!HCI;FD-$9*XQ;J><UQB4?:)I^4%I#2
M0BI:-\U:6\S2VV(\R^]$7&[S.M&V,FN*ZJJ;K*K,XT7YE#1@AN 6&"YQ<0G#
M)=S"+3!<XN$5^;@DP"6AOE/Z=GIK?5EZZ^O$3D>'2%*;BY3FDM(8*8U;T+XL
MX(0=M[I(V^63T@)26DA%ZV9,:W59>JMK=\.)ZF9$RVHVLA%I42^U =,"=Z=P
MB8M+&"[A%K[-"I=X0$5#RP;68.$M"DYEA?H>Z=OCK3%EZ8VICZ(TDJR 3RY0
M/V.&2UQ<PG )QR5S7.+A$A^07)J6-734O@O.T(;Z?NC;SZT?8NG]D"-W?C'!
M?L>M#5SBXA*&2[@%[/"!#B(G;00"ZC-'(W,*[ 8"I-5686A7<0!HK>%PH#8S
MU'=2WYN_M$:'K3<Z3KC]"Q@0>NS9]W\A]2Q(:8R4QFW5B[!& \"T (3@[A_2
MYOFDM("4%E+1NIG2.A?V[I+X7W-7&)MH%TN3/Y0TEY3&2&F<E#8GI7FD-)^4
M%I#20BI:-Q5;D\GNN0<K2I?51<_+NVVZE.<K,OOR*"T+R+7_$.6+575XLV2)
M^"$JQ?Y&,_7**7"%AXTZ)C-<XN(2ADNX#=\\[_ P@M_Q#J@+V@R--RG ):&^
M9_M&SK.;W?4T9"@C![MZI&_CV6,_[<WS:.^>1WO[/-6ZL<;J>=4<T"DQ3WL;
M/=K[Z-'>2._/,+/LULRR>YI95<+ILJQ:0E5MH3U[B$8MEADN<7$)PR6\D72&
M:& 5'B!3XE6M;&Q/U--)'V]5 +*FP/4)?=?V#9W6H+%[[ENB"!UTC";R*9J(
MHZ2YI#1&2N.V:@%9Y@0:I%&OR"-MF4]*"TAI(16MFVFM*V;_R(:PYYO!@"D2
MF#VH@3/#)2XN8;B$-Q*=$8!+/*"BR1C8H8(W*#@1%>H[K6]0M,:/W7./TRE!
M@0ZO1!9'$TN4-)>4QDAIW%8]I!&P[020*0%-V2Z?E!:0TD(J6C>/6CO-[KG/
MJ\ZC8PL0CM[?UL8=.%SBXA*&2W@CT0ZMJ,0#*KH$'%:\/<%II%#?87T#HO7=
M[)[[D/" 0(=5(C.IB2-*FDM*8Z0T;@-V'3"JHMZD1]HLGY06D-)"*EKW#OVM
M;^GH?4N2?20.NC%HADM<7,)P"6\DNK$4EWAX13X@N3158S$X41<"K3K0=;NX
M-=P<XJU"V.BHK^_<T9&4YI+2&"F-.^CFI#DN\4C;Y)/2 E):2$7KYDWKCCEZ
M=^P'%C8[N+^%2UQ<PG )=_!?<\(E'EZ1CTL"7!+J.Z5OI[?&EJ,WMH@6-NMK
M.7N()+6F2&F,E,8=8/.1>DEG#LB4@"5UIDAI 2DMI*)U,^;9CSSIG:ES%C;K
M46>G!27-):4Q4AIW4&=KCDL\1S6LK"FT"!L0*B/YB:R0ZHOH1F=K?CEZ\TNW
M"%M?].QH)/6F2&F,E,8=U'*:XQ(/E_B Y-)RAF/UIQ^#TZ4AU9?1C<C6)'+T
M)M&1Y>(6&*&HH3+#)2XN8;B$ Q(+N%$T( .6BT.J\=@>CX'!2)7*\^*A-56U
M 82US(&J#/6=U#<(6E/(T9M")RP7AP."U.\AI;FD-$9*XPZP9\BTU+B8 T)P
MN3AI\WQ26D!*"ZEHNTRY>O;+Z9OH7GR(\OLX+8Q$W$G\X-58#L[U[Q4^/2FS
M3?UCZE^SLLS6]<.5B)8BKP3R_;LL*Y^>5+_/_ICEW^HZKO\ 4$L#!!0    (
M .XS=%87%A=D$@L  "LW   8    >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL
MK5O;<MLX$OT5EG9J9Z8JBDCP(BEKN\JQG1E7);8K<B;/- E9W)"$!H1\V:_?
M!D@15-" Y"F]V+HTH=, NL_I)GCRS/B/9D6I\%ZJLFY.1RLAUA\FDR9;T2IM
MWK,UK>&;)>-5*N M?YPT:T[37%U4E1/B^\FD2HMZ=':B/KOC9R=L(\JBIG?<
M:S95E?+7C[1DSZ>C8+3]X&OQN!+R@\G9R3I]I LJOJWO.+R;]*/D147KIF"U
MQ^GR='0>?+A(9O("9?%709^;P6M/NO+ V _YYCH_'?D2$2UI)N00*?Q[HA>T
M+.5(@./O;M!1_YORPN'K[>B?E//@S$/:T M6?B]RL3H=S49>3I?IIA1?V?.?
MM',HEN-EK&S47^^YL_5'7K9I!*NZBP%!5=3M__2EFXC!!4%BN8!T%Y"?+X@L
M%X3=!:%RM$6FW+I,17IVPMFSQZ4UC"9?J+E15X,W12V7<2$X?%O =>+LXO9F
M<?OY^O+\_NK26]S#OR]7-_<+[_:3=W&^^-/[]/GV^\(;>]\6E]YOO_Q^,A'P
MH_+22=;]P,?V!XCE!P+B?6&U6#7>59W3?'> ":#M(9,MY(_$.>(ES=Y[8?#.
M(SXA"*"+PR\/''#"?@9#-5YHF\&T67E+"(?&6W)6>1!A/!5%_=ANT4(4M/F
MS5L[;(0/*\/W0[-.,WHZ@OAL*'^BH[-__RM(_/]@/A]IL)T9B/H9B%RCG]U
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M4N-8S:F!%#,D]AJ(:"8E;B9M=^X>?4),(@QB1)P@=L2Q\IHNB9LN;P[I7*#
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MX6AY,IQ/7YX=LGP4^*QI[7O/@CU96/N%7RZ3D^&$ 5%&*K &B9\;.J<L8T6
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M;$?$]UZ/7P]ZOLMQ^@"A.T H#@II<B1K@+#;]L;&X$*'0K52%KB>0 FLO9T
M@S,\&6809C%T$6F%B!<$G$!S)MF [.1_=V#J*Z^4%K=3!B(4TO2YP8'( J@8
M;0%*;23MF:N745 \?-99_:28ETU?!!P@$A!#TZ:1>+!RK5\H*8LFD$HT+(S'
MD(IBM2X"%16B0R<+R0,LM4#-QA&KP,M'_$#$TX[R.$2]?F/2[<,2U\H@&27=
MW"CQVF7L%7A)/71)ZAL\V5+(6]*#?;M"OPT5YE^KFD;J)5 ]D!EH%#;@5&MI
MUVA ^B:C#MAV.,!W:71*OG7<0)0?J8!S1=! J64*46\-X1<\XZL5S@$^$3>
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M\9M70^'2MU4Z";:.WS,+&_!U% \+?(Z2XP6XGUL;NA-.L/W O?P74$L#!!0
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M$@W ^Y5&Y1A^T +I$]]7_P=02P,$%     @ [C-T5E)FX!.- @  D@4  !D
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M>APYO-$S>R3?YRMM%/X0/QYKMP>+'P>S(IGH-<MAYJ,*-*A[\+-7+Z(T?'N
M:CQ0C0^A/VL<AQ&B\,C[K^&= W:.7**LM$&7+(FI@922HSX;49'7C4"/[#03
MA3Z:>'-M8W FT*Y V;EX=B[V$0V5<ME:9&:5YKWTHN,P3?"=)JGW 2K&20E8
M%1%1R)QA70R)1F./QI%WCBTT.>-><A8B:NA]BD\H)<NKY26:8^_$^X@,%4GC
MA$0)]3Y+@X#LGY:PVN@XI:FK3N,WCPTCV--)"ZIRV\!^C$Z87C*#=U@X\UYG
M?\+[;77-5-4(33B4F!J>GB4^4?T&Z TCUTYU*VE0P^Y8X]($90/POI32[ Q;
M8%C#V6]02P,$%     @ [C-T5JW/Q>;.!   [@H  !D   !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&ULC59=;^LV#'WOKR!\MXL6")S$S>TMVB1 ^C'L#NT6
M-.O=@&$/BLTD0F7)E>2FV:\?*3NN@Z;97EKK@X>'AZ3"X=K8)[="]/":*^U&
MT<K[XJ+;=>D*<^%B4Z"FDX6QN?"TM,NN*RR*+!CEJIOT>F?=7$@=C8=A;VK'
M0U-Z)35.+;@RSX7=7*$RZU'4C[8;#W*Y\KS1'0\+L<09^L=B:FG5;5 RF:-V
MTFBPN!A%D_[%U8#OAPO?):Y=ZQLXDKDQ3[SXEHVB'A-"A:EG!$'_7O :E6(@
MHO%<8T:-2S9L?V_1?PJQ4RQSX?#:J#]DYE>CZ#R"#!>B5/[!K'_&.IXOC)<:
MY<)?6%=W^V<1I*7S)J^-B4$N=?5?O-8ZM S.>Q\8)+5!$GA7C@++&^'%>&C-
M&BS?)C3^"*$&:R(G-2=EYBV=2K+SXQN<^V'7$Q*ONVEM=559)1]8]1.X-]JO
M'-SJ#+-=@"Y1:'@D6QY7R4'$&TQC..UW(.DER0&\TR:NTX!W>B N^&LR=]Y2
MXO_>%V(%,-@/P,UPX0J1XBBB:G=H7S :?_[4/^M='J W:.@-#J%_*/MAJW[_
MY"@$=F>$=C 5&S%7"-\TI$;KNL[7TJ_ KVC[X4^8I,^E=#(<2$WB]L\[<.O1
M:@%W=]<@''4C9I"B]=3!H(U'!T4-?,PPGS^=)TGODM%^Y=.P[E^>,!Z?B]R4
MVH-9P ^]>$ UJA1YB^$W#;\(75*G0_(UY+77:7@%)%BC97OD&@)O %\]?8=+
MU&^EE7X#F?#(9[R)PBJ)EGT=RQ,0D*Z$7B*O20!OC>I01-R4)%Q6$SQJ_-$A
MH1]+,J5RPWQ.4'7)]0/?=[L5X6N3%T)O2!99D:/'S7G"DGJY$S1[+*S4J2R$
M@D*5CEZ=U):8';'G4@<$J4E_=$$R4136O$J*%M6&L9(&JR15[*Y@50!M2BL*
M5QM8E)9V29BYDDO!V79\S6( B;E22&4/4TLP59G0Y]**/)02QWXO-C#8IJE5
M(9(JA+04H32V.7\+\BW[[T(Y;4*A],VDDI0C^"Z4P@U<"?T$^"(S)!Q248!B
M'NV":W&83J>!9U-Z?B5\FZ2EQ-'CGK5$HY#I!RQ]VA=SVPUA-[ 4126N-5J\
M2%NZHXG,.O" 5':+2OU;BL+D,H49IE6%3E(/(J.W63I.; ;S38!YC&<QS'(*
M&*Y*1Q7I'$SJ>S8D:8?(]>3A=L9@6SHQ[)& ,D!N+;;*B*008+E-B'\_[OT(
M!6D@M"[S&!X;0>AV[IH0M\XZ3>M7F6QN[/.=FE)1> @T#"Q);V(3+F^J3BX=
MT:*CH^=2*+G8<&+QE<8'%TJ7&].E5LZ;UGRC$?,C-L/"5_WWUGL*0P!2\_Q!
MABU:H0AJH?]#YU";7!]\?4N>[[%B/5*L#KK=V*T:U[M-^UZ>(Y8GAHGC3*"C
MB6#WY:#Z-$LM_PF-M&2U,ZH=<L*!UD_G6[O49VQDLTHL$]K[N%:3W][4Y-@!
MC>3)U ]QFE;NV)BJU!DE^?7,@&(B8;'.+@UTE2PNAM__WUNR;2OI0I_N^P'L
MMF:0'.TR3%J.2T;[:AQI=IMA;E+-,&_7JTGP7E""R*O"!9GVXJ]?(K#5=%4M
MO"G"1#,WGN:C\+FB@10M7Z#SA:&6KQ?LH!EQQ_\"4$L#!!0    ( .XS=%:*
M6N)!71,  &PT   9    >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;)U;:W,;
M-[+]SE^!TFZVY"J:$BG9<>)'E2S;N]FR8Y6UV=Q[M_8#. .2B&<&## CBOOK
M[^EN #-\2,FF*A6+PT&CGZ<? %]MG/\:5L:TZKZNFO#Z9-6VZ^_/SD*Q,K4.
M$[<V#;Y9.%_K%A_]\BRLO=$E+ZJKL]GY^?.S6MOFY,TK?G;CW[QR75O9QMQX
M%;JZUG[[UE1N\_ID>I(>?+'+54L/SMZ\6NNEN37M3^L;CT]GF4II:],$ZQKE
MS>+UR=7T^[>7]#Z_\$]K-F'PMR))YLY]I0\_E*]/SHDA4YFB)0H:_]R9:U-5
M1 AL_!IIGN0M:>'P[T3] \L.6>8ZF&M7_6S+=O7ZY,6)*LU"=U7[Q6W^9J(\
MSXA>X:K _U<;>?<2.Q9=:%T=%^-S;1OY5]]'/0P6O#A_8,$L+I@QW[(1<_E.
MM_K-*^\VRM/;H$9_L*B\&LS9AHQRVWI\:[&N?7/MZMJVT'(;E&Y*=>V:UC9+
MTQ36A%=G+;:@%\^*2.ZMD)L]0&XZ4Y] 8174^Z8TY2Z!,_"6&9PE!M_.'J7X
MSA03=3$=J]GY;/8(O8LL\ 73N_@C JM_7<U#Z^$J_SXFNU"^/$Z9PN?[L-:%
M>7V"^ C&WYF3-W_YT_3Y^<M'^+[,?%\^1OV_-]3CY*:S)Z/'5?'1MG:I.70^
MZ;8U/JA_K PM6NMFJVQ0MKESU9TI\8>J^K>)E/9S"SW2YZ 6WM6J12BKULF_
M6-"NC'*^M V@0!6N\P&?%VK>!7 :PD1]-$M=J84QPIS# H\7 S$;@BNL;K'U
MQK8K($JQXOBFW;0WRMP#M *^UL1ET7EORHGZ ;R5I:77QKQ_D@7T#/W'#QN#
M=6#4FP+\*3VJK)Y;R+=5P,!]08NASB:DH4PU^D#@9<*X-Y6FUUD1*WR/4!;5
M;E8&!%7E0B#5KKV;ZWEEQKP)L:5KUS6M*G2CY@:$=' -WM@J$Z!2TL5$O0/)
ME?JKNS,(/J_N)NH]B#>:V/)Z;;K6%C#LQ^NQ MSK:C*&3DISKWYT$_7\V?F+
MRV^!YK.I.OUQ\K\3==NM)^JZG2C^=-UN)Q2$TR?J<S."2'H.D%<?S-QW9,-G
M'*((U%TN( $IH 8_8>5\^Q0<U:2V -S4D A&CUPR8PM;D=WP1KVND%3 YQ+_
MA';PEFC>^!9?P+ZEO;-EIRNRGVZ5++.+!22LS)*<Q, G2@N+M@ZZWMEQHFX.
MWF<RN]N-TG98;%NBL; %&8Y8Z4F?_N5/+V:S\Y?("Y >X@5^,'WY1)EFJ9<2
M+%U3Z<VBJ^+B4'@+:->@0*'0E%W1<JJ!UR/S 5'&JF&70T X;Y=6?&\%GX*V
M..^!_)WUKJ%HWA4I./9O3]%RI[UU75!S^ ]"!K*0_Q+>0?%>=R73_;4#XUVM
M8+/.PN5 K ZCS! \,"G*>7"DE]X8VE>M$<6TEMQ[L[+8@1PWOCO4)ZW@(%M!
M<_A?38$*NN;>%!VE:>Q3&/;[3\8OX3L;O, N8=C3/S<*B<'4<WPU%<^;24RO
MM6\)OH04NQ)P;6%+,&C!+<J,MA)VKS+C)/475 I:0.BJJD;7+#7O]'?=L(=/
M)0M=[&Z4'/:VM>NN$F2 9.]@5L:&+L/=-5"NC3@UP2:PC#M&O0]@5R'F83.$
M.=RDMB&8B 8]OD[4W]VJ43\#!VJH\&XR^A'KJZH+%-T%8OQZY2T*B34!Z!>W
M*B.J$*JO4#9= ;XJO(4HJM25%$L$"+/IB^GU/\^GWUU^ITX_V;*L %CW)$4#
M+#S]!*^"$W4!"@U/""P,G,N+E(01*F/$K5FW8JMO$T@,>1Y A(&%W=:P%7;%
M&"4]7V=@@%K_2[8RENS29G7L/J*PG7[[DL"[(UM(H"<NDYOBY7=^<JA@?IF^
MV=&Q.D6UQN4H=MJ.5<2*=P=8(7FD(&]$]JJZTH01AU%,J(Q/>R+<65=Q1N2@
M&2I!_0S<(<-F=$H/^OUB<.KBUPX1N:\,=M,.3CA]+O:#8! NFB^K2H!"DASG
M^A3Z"=.8[Q85.F$TXGMNH%#S6YO';48]:L188%&!I(%0BC2.K%F85!2L;.:(
M\'(8,!]@!K>A/%R;TNJ^($@Q'1@D2)<@@MW60!*BDC&'\$:LI)=@:TD"AQY9
M8K)>ZRTE<37?[I0;5 _0YW;C4OX?41;H.+P1,L _[*O7D.>><SM4_^?SR3,T
M %7%$NP;'\G:;;:^U#FQ7T^N)BF,+Q'&L\N+YT_??KR=461^1K9B,6+2WJ=W
MF(0CA.V%$Z)TQ]7&>&&Q<-77&([C'' 2.7O0E,,]J!NT45D&LN4.J WSO12"
M,1)1@N(5RKRVR4)PCCE],)YY(2Q-ABJB2=8L%%P+8HDC!JX3#W'HR5C<FKRG
M3Z/(+QTJ4L!XV9'8APEVQ#(PQE+QL[9XN/T#@?>9RO&MF@F2S@Z0K*;4(2C0
M6X_R,6*B]'I#W*>X2,:A1WW% G@K -B/FT02([.6LF\R5G2>4>U2+B1& '^#
M&*3<$%U*5ZP" L4QO1Q:+>$RJ+11S9=<-J\,AZ/KK9/<8O#V3KK%*]<KC6K"
M]X%WVU*\XIMW@*H--0S",^*4<"W+O)<LI$ ]"OC\>+2743\:5&R>$NU_R*N@
MP0^:RD3UUKJ ?J&APHZM5N@U<0X6_L]4MOB*VCX',F);LD=ZD/#P;K+K\9\E
M O9JHNS9&B8N+ ]37'. W<1=E#L_.S @")%U!"MO(E9F6!X=*5=2CQ1<94O.
M"EB9M7X56S;&:\;:5!P=K^^28:*'->HJ>OM5$U#CQZXJ/\V5PKBO@#7J=AKF
M4(W)+A]B?RDT^Z60Q/B]."'31]N2N:/E=]TC?Y+:Z\#B\3EM>:PY8W=(>7K(
MA3HL$WH@2@RF^OZ!A4?K?GEFN"TB[5DHS4(%!&3T;.D<M*/)1*PG;?VH-+K"
MOKN+CV-@3]@A=4CWFSL&Z,%R8//,8(X4TL/J<:)09LLB6A)P@<:.=,H.U(MD
M *8M9UY=%*0*YE4J)':XR-'Q,FF\]_R3;6S=U:,/D%Q>^J@W$@/\Z",RMB=,
M@9)]&81$U_S2P2"F\6B#HJ@'K57?!!QQ]CTXI23XJ).+#I.?!W24E::YPS%'
M)@(!J>(A1YF,AIDWEQ;D.WF'2'+!2%Z:NK'HB/-@Y(R*__*.@%<JHN.%]]'N
MZMC>/$JADN071[+VT&0:<""]HMW;4KC89\[3G#8<,#1B?G:B%QZS=![.!CQS
M:R0=GA#9#(S$7^2+1P+K/B_U8L5$?<&RYF')B]\EJS=K;(UT%CK0EF0F<A[*
MOR?FV5 3(K)X8.CFM47-68[("7HZ.6/N*T'<#OP<8;4O_7?<[(CX8Z!MLZ7H
MSN,TJ9^]H:,#^N(AT,KJZ)E-V:5V(2EE0.@Q9D9BBWW^2:;]E-C;,R0%'7+
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MZ?E9#+:]B;0#9ZIP^J^-X[M$^"SX\H;6;^#UC>'@NH%W,%P'E_\"4$L#!!0
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M!?!\J:&0\Q?(H/YZ\M5_ 5!+ P04    " #N,W16"I$>BE 4  #H10  &0
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MNP$Y7:!0/E<E/-6PKWKWX?=:5T]"%JGXERQ+653VS44%@/'QQ=H!><] %@-
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MF!5"^JW5@TK;5*(N,DL.Y8J*<@OA(P/%<P['\V^ X+!A\3)NM3D]&-CD<_K
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MXLQ'R$9>I%T@^$GSLG&G;=PHKH<VP26G[QD:#P+^,"_8EEO@.<-SQ73#@N2
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M%T#R&?C[;'MLEP2F@=M),DUIX87K62O;>T?V% \.BC^+ 8G'(K<@R256"=C
M#2#XKPQ/0V6\)FND8\&5_K[4/+YA\3P:2B@S9UC,35,[L?V3ID<Q'*HQ[^GU
M_Q"=!3AAWZ_-H1$ZZ!;-T7<I6\#17P I14W:I:H+JH]?WG=!I7/V/K(DIS8?
M@QG1MQD#6]5.C9B ,4'= Z<4H9$F%0W2.>FZ 6!M94U&CYM,&@5-B$^S!F\O
M/:#M3)T1)",[@5NEJ7S/ CL[^$-O@(M%U<+*R>885<$ER"5N]'K#E5R;.S6
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MM!<2E5?E98.,E*/^$\^ DS )824YP\<:%P;?F*\[,)8;!.VQ:V >4=3\"+I
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MV<)F9U KJ\G.\.]W)>/=3B89-+SR,_@,L_R%K+FTFS$/0JZ;SK\RNG"T3\Q
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M"^V0PKZYQJ.6#"_ _%)KUW980?=,OOD;4$L#!!0    ( .XS=%;_R,G-BP,
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MT<5X&%#3KIQ6<+IJQGRM'2Z-YEGBE@;C#?![H;7;"SY M_?3?U!+ P04
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M<P6*&2X6U-&E[U]PVVEHH]H)UDX5$YB:)=!78$I3L$)1##.4,U!-J"D3<]O
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M-!0[ZGBCEQ;[?;[21N&?\6-?N3TLW ^SW3+1#4MAYF([:%"/X"9O7@6Q_^Z
MU'"0&AZB_R=UG[Z7$6!;;"JQE;3!)9D34P+))<>>K$1!CBJ!*[+53&3Z>.+,
MM?7!XX=Z!<I>@6.OP'X"9PM.96W)S':7\]H)3OPXPC&.8N<C%(R3'# K$K%Y
M.<.\Z!*,Q@X- ^<"U58IXTYT[B/5=SZ'IY22Y?7R"LVQ<^I\0H6*Q&%$@H@Z
M]](@D/U3$F8;G<0T[K+3\.V^<_=V>J,&570O@#V,5IB^38;5X9&9][WUQ[U_
MH6Z8*BJA"8<<0_VS\\@EJN_ZWC"RZ3IM)0WV;3<M\:$$91UP/Y?2; V;8'AZ
MD]]02P,$%     @ [C-T5F*,-?D' P  U 8  !D   !X;"]W;W)K<VAE971S
M+W-H965T,S N>&ULI55-;]LP#+W[5Q >,'1 6L=.TJ\E 9IVPP:L0]"T*X9A
M!\6F8Z&RY$ERT_[[4;+CI46:RRZV*)&/[U$T/5XK_6 *1 M/I9!F$A;65N=1
M9-("2V:.5(623G*E2V;)U*O(5!I9YH-*$27]_G%4,B[#Z=COS?5TK&HKN,2Y
M!E.7)=//,Q1J/0GC<+-QPU>%=1O1=%RQ%2[0WE5S35;4H62\1&FXDJ QGX07
M\?ELZ/R]PP^.:[.U!J=DJ=2#,[YFD[#O"*' U#H$1J]'O$0A'!#1^--BAEU*
M%[B]WJ!_]MI)RY(9O%3BGF>VF(2G(628LUK8&[7^@JV>D<-+E3#^">O&=T09
MT]I85;;!9)=<-F_VU-9A*^"T_T9 T@8DGG>3R+.\8I9-QUJM03MO0G,++]5'
M$SDNW:4LK*933G%V.F.&I\!D!E=<U!8S^*:,@0HU7*JRI+HM"J81#F[94J#Y
M,(XL976Q4=IFF#49DC<RQ E<*VD+ Y]DAME+@(CH=IR3#>=9LA?Q"M,C&,0]
M2/I)L@=OT-5@X/$&_UF#7Q=+8S7UT>]=56AR#'?G<-_6N:E8BI.0/AZ#^A'#
MZ?MW\7'_XQX%PT[!<!_ZE&A6M66^SU7>R?A.'_5.*;OX[\VPF_]M@9 K01\V
MERNPKD/ GTIKP-(A*U4MK:.T9EHSVNX%U-+I ZC*D34]2)5\1&UY&YNCUL2\
M<7)7<K.X<UC,PAKI#O I%36U$>1:E3Y'^E)[UFJ7I%ULM*>-=N.OD2:9#WQ&
MI@V@:TJ@EL)R29Z;MO*Y:4$F\UJX!LQSFB4DQ="IY8<^%<T4.."27%1M*,A\
M. ]^OH$<.&3WB(/[MAXP[)W$ S@,%MME"0:C,XC/SH+YJXJTU2*;2ZLZ7>XL
M.($D\-4:0IP$M\HR 96R=!F<5MLE,*_*N%7"8-3KGPX@(4Z[^C+:FC0EZI6?
MIX8 Z)J;H=/M=B/[HIE4_]R;>7_-](I+ P)S"NT?G8Q"T,T,;0RK*C^WELK2
M%/3+@GX[J)T#G>>*Q+6&2]#]R*9_ 5!+ P04    " #N,W16\V?<4X\%   H
M#P  &0   'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6RM5]MNXS80?>=7#-QL
MD0"VK+OM-#&0R^YVBRXV2#:[*(H^T-+8%B*)+DG;2;^^0\I6E$01-D5?="&'
MAV<X9X;DR5;(.[5$U'!?Y*4Z[2VU7AT/ARI98L&5(U984L]<R()K^I6+H5I)
MY*D=5.1#WW7C8<&SLC<]L6U7<GHBUCK/2KR2H-9%P>7#.>9B>]KS>ON&ZVRQ
MU*9A.#U9\07>H+Y=74GZ&]8H:59@J3)1@L3Y:>_,.SX?&WMK\"W#K6I\@_%D
M)L2=^?F4GO9<0PAS3+1!X/3:X 7FN0$B&G_O,'OUE&9@\WN/_L'Z3K[,N,(+
MD7_/4KT\[8U[D.*<KW-]+;:_XLZ?R. E(E?V"=O*-O)[D*R5%L5N,#$HLK)Z
M\_O=.C0&C-U7!OB[ ;[E74UD65YRS:<G4FQ!&FM",Q_653N:R&6E"<J-EM2;
MT3@]O=$BN1N<DU\I7(B"8JVX7:[#KWR6HSHZ&6J:QA@/DQWD>07IOP+I^?!9
ME'JIX'V98OH48$C\:I+^GN2YWXEXB8D#@=<'W_7]#KR@=CJP>,%;G?[S;*:T
M)*7\U>9V!1JV@YKL.58KGN!IC])#H=Q@;_KS3U[L_M)!.:PIAUWHT^]67I@.
MSC8H*5O@3%$>K0QK!;?&$4I0^"AYJ15\HK[G"U^YT#E)NPM?ETC8.65O5BY@
MN^?!=SQX@\<6)<)Z3T:950:QZUL8:M23KJ7!T83Z@%PJ0",2H!!C,4-9AQEX
MF9H/[YC]078M9LR:&1.V7QW8LY*9NAO,)=(7U\A\)_+9._ <=P+O7EIO1$[Q
MSS/]P":N$TZ,:1 Z<4C&E]DF2VER>,@P3YE+?2XUO[]?45TA#(VR@,@937;N
MQ([G[CX[PA[588\ZPWYC:V7V#RH0<["ZA2]V1>',U#.BW!;F3M ?";,VR;^K
MU';V9C"K4DI3VS#_>"3A,"O)7*P5M9#Y?8(K;3#8"N5 +3FIQ]A*-+N)H9%0
M'3'IN.8YY-D<(:4:=W3,OJRUTF1J;*KE4(]1W6?(^WN42:80KF26(- <<&/F
M>&EY74]XT9CP=S.AH6R].V)GBX7$!<D)/I%11OM2 M]XOL8G='[CY9IV-ZB<
M]]B '; !V"?[6.4 \R83YL5CQPW9!2\3VI*(C#%J CU?1\\..]@/G#C!N D*
M_G@$WLCQ)PW,0\\?P1%XH>M$<2>Z#T$T@0.(1HXWAI$3C>B'".VR=X/*)@Q%
M!ZMEM0+A^B40\\+8T'0G3NRRD#+#KD!',L1U,L1O2(;KF]O.'.C$^D\Y8&;\
MOZ4/C])OT?8U+3N)URQ]E?NW9:9;I/Z!9[+28D/FK4I\U*#/_%'LN"YK$5K=
MMQ=7%$$P-O&\IO.4W3</ Q*6/_*<T&\*+G:I.:9"&[S ]2$D3?E![ 0Q.^>Y
M&40KL:^CPHJL75)AEWQ&M7Q&G?*A\"GX]BAD.G#JO'V;[ 1Z@W:68JNL2LJU
M=:B2K6DB-QLY93=.5?%YOD.^IJT^;;TT,,_-^^D<5D\V21)1%*)D5?7>9GJY
MI$W,K'4B2#IVF&T5>5K1OJ=QAI$%I#O!#BJS)PI8KZCZ5SSI8*Z?JOJHN5._
MC#ZSGE=.LX!=6&;P*C/#A!UZ[.BI946$^5V"&->"&'?7D]>.@69S+Q6V*:,3
ML5T9']Y4*?K6UM#AY0-MA8E8E%1]TLK_P<RR39ILL6)K9% )4)FXL.=Q:9O:
M'J&8S7DJ-624+"V1%#=T75O9&%,I[_OAQ+ZCR8A]Q)**3F[M>$I7DLP<F<W=
MB@SB<<R"?DQ;TU>AR>B ^?U)$-$[ZOOT;HO:L'%[*5 N[!U-D8_K4E<7F;JU
MO@:>5;>?1_/J#OF9RP5MS)#CG(:ZSH@.0K*ZEU4_6JSL76@F--VL[.>2KK(H
MC0'USX70^Q\S07TYGOX+4$L#!!0    ( .XS=%:^2XB5O0(  !<&   9
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MM2A*QM>'!\.@?W&IH&Y(.!L2Y"JMX1J9!#2%!BH3%G.47:G@*.-D)"I%5ZT
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MKO5M":3IH+\OA<!=Q01H[E_Q;U!+ P04    " #N,W16(),CU^4)    <0
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M'96_V;*=;G;9U[S)UWX@KP>J,\EE]B@'<U7SR>B/+J4B82X2QI PCH1Y2)@
MP30=.CL=.B;Z_-;/5UT*,Y;JJS DS$7"&!+&M[!I!2L';(]SRW*<R6@TNAH^
MMM73L>'D<C8^V%" JJ<I8[Q3QMBHC+=!L(DWD5_(13D2"X.PZ!**$=)7*$B8
MBX0Q)(QO89-6^[^V)F-Z.3V42M>FSF@ZHH=B 551$\MD)Y:)42P?U10G2O.N
MGO;&6+*O0I P%PEC2!B?'#8[=<;3RT.!=&QI43IV.LXFH!IJ IGN!#(]*9!
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M8S6MG4>9'-Y:ET.#>E":0-%TE;6>3F!,)_]L'LY,[RTUYZ Y]VX3XD(#LHZ
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M.G(^.BB!)5YG\IYMOT 93U_SQ2P3YA=M2UO/0?%:2):78.5!3JC]QT^E#GN
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M1H.IO8&Z:0S-!%7EB_%.H2WM?EC:7@K:&=C]7"D\3-P!77=._@)02P,$%
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M"XU'[^XIT:&W0H"J]?6\5VB[PP]K^QR!=@EVO50*3X';8'C@LK]02P,$%
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ME"GL?Z:O[R*>2]25"UNAU_K==E!Z>%UXZ/W(0RH&Q!M?$,_QW!;S=;>Y#\&
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M ?+[%:7BN*$J*%>(SO\'4$L#!!0    ( .XS=%8MY0RUT0<  &T[   9
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M,06< %,-Y/LMI>)84!VTURW+;U!+ P04    " #N,W16%*RB%4L(  #";@
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MRFRY>ONMVZPLL_GJPP<3STQ>_T#U_;LL*[]^4K^CU^9MZZ[^!U!+ P04
M" #N,W16KX2D!"($   ($0  &0   'AL+W=O<FMS:&5E=',O<VAE970T."YX
M;6R]6-%NVS84_15"*X8$2"*1=F0[LPTT2;,5:+ L69N'H@^T=&T1E4B/I.P,
MZ,>7E&1)@27"2(*^V*)$GGONU>4YIJ=;(;^K!$"CIRSE:N8E6J\O?%]%"614
MG8DU</-D*61&M1G*E:_6$FA<+,I2GP1!Z&>4<6\^+>[=R?E4Y#IE'.XD4GF6
M4?G_):1B._.PM[MQSU:)MC?\^71-5_  ^O/Z3IJ17Z/$+ .NF.!(PG+FO<<7
MEV1H%Q0SOC#8JM8ULJDLA/AN!Q_CF1=81I!"I"T$-5\;N((TM4B&QW\5J%?'
MM O;USOTFR)YD\R"*K@2Z2.+=3+SQAZ*84GS5-^+[5]0)71N\2*1JN(3;:NY
M@8>B7&F158L-@XSQ\IL^585H+2"D9P&I%I""=QFH8'E--9U/I=@B:6<;-'M1
MI%JL-N08MV_E04OSE)EU>GY#F41?:)H#$DMTPSCE$:,I^LB5EKDIOU8GZ"JA
M? 4*,8X>J924:_2)T05+F6;F]M$U:,I2=8S>V2G_)B)7E,=JZFO#T,;QHXK-
M9<F&]+#!!-T*KA.%/O 8XN< ODFMSH_L\KLD3L1KB,[0 )\@$A""/C]<HZ-W
MQP[<05VW08$[Z,%ME>1Y";L*]/5>I"DR7;2E,O[6598RV+ [F-V9%VI-(YAY
M9NLID!OPYK__AL/@#T<JPSJ5H0M]_O<&Y*G*%RJ2;%UNE4SD)@4)$9@M$W<1
M+B%'!:3=^9MY& 13?]/!X[SF<>[D\:<42J&U%!% K)S12Z"P%1T;&>J)'];Q
M0V?\XCUN['L\00M8,<X97]E7N@;)1">/<(]'#X=1S6%T( =$-;JE,DK0I&K>
M(Z94;K8GH)AJ..[B,^JHR_EXTLUI7',:.SF5K6X[?=FP,V795IV>-IW>Q6F\
MQ^D4X\$$=Y.:U*0F3E(?GD!&3!5$_L&GICQF9YPN<RL;.V9&F0QIE5"S9SK+
M-=FG-@Y'W<1PT"AJ<' ? 8_='51AM3D,!CVUP2U1QTX*GV #*2+HZRUD"Y#?
MT ]TUY3G<5>>W>-.8LX(+Y0D3)H,R*_4URK:&V?3F 5V"OA+I*5"/$!;<"/T
MV*WTKU27"KU-B83#L(=5(_O8K?NOU!>\;P:G>#3J$3W<N %VV\&;* S>=PB'
MQ#0N@0^UB4,D9M\5^CJIL03L]H128 9M@;D262;X@>+B1'_I=FR\ T]^J;@X
MK>J%V9#&;\CA?G.@N)!]U^EI"=)X#G%[SBO%I4)O4YI,AH,>5HV/$*>ROU9<
M*O1G^W<28M)#JS$$XC:$-Q$7<K!%D,8BR*$6<8"RD/U3P/Z/%[]U.,U KHHC
MN$*1/6*4Y]3Z;GW,?U\>;IOIY7\$IJE,>RN4PM(L#<Y&1OIE>>PN!UJLBZ/N
M0FAS<"XN$Z Q2#O!/%\*H7<#&Z#^\V/^$U!+ P04    " #N,W16*#:W1Q@$
M  !:$@  &0   'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6RU6-MNVS@0_15"
M6RQ:((U$V9;EK&T@L=O= DUA-.CN0[$/M#2RA8JB2E)VNE^_I*3H$ET2!\Z+
MK<O,X9G#(6?$^9'Q'V(/(-$]C6*Q,/92)E>F*;P]4"(N60*Q>A,P3HE4MWQG
MBH0#\3,G&IFV93DF)6%L+.?9LPU?SEDJHS"&#4<BI93P7S<0L>/"P,;#@Z_A
M;B_U W,Y3\@.[D!^2S9<W9DEBA]2B$7(8L0A6!C7^&J%9]HAL_@[A*.H72,=
MRI:Q'_KFD[\P+,T((O"DAB#J[P KB"*-I'C\+$"-<DSM6+]^0/^8!:^"V1(!
M*Q;]$_IROS!< _D0D#227]GQ+R@"FF@\CT4B^T7'W':LC+U42$8+9\6 AG'^
M3^X+(6H.V.EQL L'^['#N,=A5#B,LD!S9EE8:R+)<L[9$7%MK=#T1:9-YJVB
M"6,]C7>2J[>A\I/+#5<9P>4O1&(???B9AHF:(XG>KD&2,!+OT'OT[6Z-WKYY
M-S>E&D][F5Z!?9-CVSW8V$:W+)9[@3[$/OA- %,1+=G:#VQO[$'$-7B7:(0O
MD&W9=@>AU?/=\0"=42G>*,,;/2'>!=I$1*G6T/ "_<F9$.C[]59(KM+UWRX%
M\P'&W0/H-7PE$N+!PE"+5  _@+'\_3?L6']T17\FL(86XU*+\1!Z,Y&@$F&G
M1>B*/(>;9G!ZLSDL;<>U+&MN'NHQM<W<Z;1NUF [*=E.!ME^!C4SQ/-2FD9$
M@J]6OM+$"TF^MZ@0"&5<AO]E#[KHY_A.C=?[D=VFWV%F6_W\G9*_\R*U8Y!=
M9)T6"WODM,FVS1Q-M8?KM.0Z'=9:KP*EJA^*A D2(1:@(+Q7HA,A0'8FQ[1-
MV+7:A-MF>-3+URWYNH-\OZCBJ>L..I HA>>P==NZ61UL!X=]X?*<E4'-GDH8
M#\ 7*.",(C4+()X3V:P]#Y..R-IF/7. K:HN68.$U_4%"?>J;1'02;' :22!
M@]L<N^QP_TK$M0J*A_.;;!DGDO%\-=Z2. W4=I_R,-[52NKW6Z!;X)U58'B$
M4\O N=":>MB5'O9K5\5BA'/I<2:TIAY5DX 'Z^[IE;' :^U^CQ.ZPVSB]B=T
M5<GQ<"G_#*HOWK/(1Y]HPMD!-%\QG,"#B"=/V)G0FO%7O0&>O'H"#[8?)^MQ
M)K2F'E6O@5_6;/0G<+N1:"5OVV3LC/N3MVHV\'"WL6(T227PVLZK::L8=IS0
M)[)X$/KD63L36E.(JHO![JMG\9DZED*/U^A_<-4 X2<[H!.S>-;^0AEW-#\=
M=G@R::>R6?M*I\!WV>&%0!Y+8YE_ I=/RP.2Z^Q8X-'S&WUPDGW]5S#YJ<LM
MX;LP%BB"0$%:EU.U<?#\("._D2S)S@*V3$I&L\L]$!^X-E#O \;DPXT>H#Q.
M6OX/4$L#!!0    ( .XS=%:#H2P,3PH  '9[   9    >&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;*V=6V_;.!J&_PKA70QF@6YL23ZEDP1HHP-)M&C13&<N
M!GLAVTRB'1U<24[:Q?SXI0ZQ3(NA+<R;B\1VQ.>CY/>32+XB=?6<Y7\6CT*4
MY'L2I\7UZ+$LMV_'XV+]*)*PN,BV(I7_N<_R)"SEV_QA7&QS$6[J0DD\MB>3
M^3@)HW1T<U5_]CF_N<IV91REXG-.BEV2A/F/]R+.GJ]'UNCE@R_1PV-9?3"^
MN=J&#^).E%^WGW/Y;KRG;*)$I$64I207]]>C=]9;/JT+U%O\%HGGXN UJ79E
ME65_5F_8YGHTJ6HD8K$N*T0H_SR)6Q''%4G6XUL+'>UC5@4/7[_0_7KGY<ZL
MPD+<9O'OT:9\O!XM1V0C[L-=7'[)GJEH=VA6\=997-2_R7.S[6(^(NM=469)
M6UC6((G2YF_XO3T0!P5L^Y4"=EO /K> TQ9PC@N\5J5I6V!Z;H196V!V;H%Y
M6V!^;H%%6V!Q5,!:OE)@V198GAOALBUP>6X!:_+RS4UJ!35?>:T7-RS#FZL\
M>R9YM;WD52]JT=7EI4RBM,J/NS*7_XUDN?+F@Y#B*MZ03UN1AV64/I#Z$_*S
M*\HPBHM_78U+&:;:>+QND5Z#M%]!6C;YF*7E8T&\=",V*F LZ[>OI/U2R?>V
MD<C#](),+M\0>V([Y.N=2W[^IZYBMV:,*]87Q&XPM@'CFC&?UN4%L98JAMR7
M/_W#6BQ_T1VO,ZKE6">KY9^/L0R8X,2QWLEC[4Q.UH::,1_#_&"G# >'G<&Q
M9R>KP\_ 3(P819G./GV<FNL8TX?\\6Y5E+D\U_]'4[7W#6*J1U07P+?%-ER+
MZY&\PA4B?Q*C&WFXYA/=X;I%PEPDS$/"?"0L0,(H$L:0, Z"*8DPW2?"U$2_
MN<V2)"IEPZDD94:VNWS]6%U&Q+==M*T^U>6%D3@T+Y P%PGSD# ?"0N0,(J$
M,22,-[!%#:OZ"T\WLXG\N1H_:00_VPM^9A3\G5CO\JC\(1OCVZR(M (W$H8*
M' ESD3 /"?.1L  )HT@80\+XK"?PN?.JP.=[@<^- O_RZ2L)BT)VT5=A'*9K
MH5.X$3%4X?/>;BPG2J(VVD7&]/HQK8G3#^KWM[-G\T5ONZ"_W=$6%%E]IJG^
M5'/,."BH(J3%7D@+HY":#F4<A:LHEB=,G8R,@*$R:F#SPZ]*)R-D3&_1_QZL
MI=V7D:9N"]OIRPA9.8J$,<V>SG2* P55%+?<*VYI5%PWF!'7V@MS$9*_3+W0
M]T;@4 4B82X2YB%A/A(6(&%TV4NSF7VL4(:,R$$P1>Z7>[E?GG&"+46>Z)1M
M+#M4V4B8BX1YYD,TMTE2CTGJ=(RL1X"$422,(6$<!%/T;DVZ0>N)\>MD:51&
M84P2J?Q=+NIAA^R>9$?G_7T35O>UOS?'&)H94)H+I7DM3;EH+R;S?O,$&C:
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MLTS5X 2N'=3Y@C&YV>@$S2B._@)02P,$%     @ [C-T5B2R,^=G!    1,
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MI@+'*,,O":1"7[A[Q]/7#]PF8J,5H5&WR)1;'?&^*'3;R[8[X/P:?4VRC:I
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M,-[![6^TQH/A$W0/:/874$L#!!0    ( .XS=%89=Z29FP,  /$-   9
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M=B]ZJUIM>W':"T*<!A5PSC9-.^V/GPT4QX4ZL#YYTT+@^=K^8#_V%SS;4_;
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M4%"%FJRTL<)V8_7^UU#V GI3FS3=;0NT4[@@K%T0MG_'L4X>79>.H)8(5"V
M4C/Q:DN$ST\RGT ZF26H6@"E9FXZT;YH8/=%<&^?!LU/0I-1<SZQUZ?WCA-0
M*^,>[*E*";LO]J9QR27/1+F]JOZUWO]V6>SZ<O7MY>:YZY#=Q](V)F0C0[VS
MB9SX6+D?K3P1=%?LT%I1(6A:'&Y)N"9,W2"O;R@5+R>J@'I7X.(_4$L#!!0
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M;(;N22W.0"Q-BY(DYIM<V1)5K59=<&R*_\7Z!+NC;69_:&QK?:!BR; &I+!
M2J_=QT<A;+NR$\4+4_'G7&'_,,,5=G@0.@#W%YRKXT0?4/UGB'X#4$L#!!0
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MV5;&$85'CL0V20C_;P(QVX\L;!TV9M%J+?6&/1YNR KF()\VCURM[-Q*&"5
M1<0HXK <67?X=HI[6L%(_(Q@+PKO2%-9,/:B%]_#D>5H1!!#(+4)HAX[F$(<
M:TL*QY_,J)7[U(K%]X/U;X:\(K,@ J8L_A6%<CVR!A8*84FVL9RQ_3^0$3(
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MF!'5MH-V863M*NI,&JS/;EIB!P5E#?#_7$JS7M@#^IZ<_0902P,$%     @
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M 52+H!J':@*J2:BF4)H=QKV/7:)KA9?=A4ZCSD'<:H?W9E\=WIL=08?E4$U
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M#VTCD<N'1EX_8K;CP/<\;^AN]Q&M21R)&)2(@15QPM)4<4P2*@2Z0C^FD,Z
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M7!(<$*X;J/=SQN3V1@?(_Z Q_@]02P,$%     @ [S-T5AY, R^2 @  \ 8
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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M,<E.9-S\H?8BMU<V2F>\L(=ZVS%[+?C:[(0HLK3C75U%G8S+O/7A_;&MF>[
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ [C-T5IE<G",0!@  G"<  !,
M             ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" #N,W1678TDP1$(  !1/   &               @($,"   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ [C-T5N;?L!6L!@  7QT  !@
M             ("!4Q   'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4
M Q0    ( .XS=%9]-1II% ,   ,+   8              " @347  !X;"]W
M;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #N,W16.O$7!EP%  "[
M%   &               @(%_&@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL
M4$L! A0#%     @ [C-T5F9>TNPW#0  )X$  !@              ("!$2
M 'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( .XS=%87%A=D
M$@L  "LW   8              " @7XM  !X;"]W;W)K<VAE971S+W-H965T
M-BYX;6Q02P$"% ,4    " #N,W16*"ZN[:$&  #4$   &
M@('&.   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ [C-T
M5D@/D=0T"   A!0  !@              ("!G3\  'AL+W=O<FMS:&5E=',O
M<VAE970X+GAM;%!+ 0(4 Q0    ( .XS=%;+L@*"+AH  "=+   8
M      " @0=(  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .XS=%:X9($<4 8  .P.   9              "
M@2F.  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ [C-T
M5CN>PZ;1#@  [BL  !D              ("!L)0  'AL+W=O<FMS:&5E=',O
M<VAE970Q-2YX;6Q02P$"% ,4    " #N,W164F;@$XT"  "2!0  &0
M        @(&XHP  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0
M   ( .XS=%:MS\7FS@0  .X*   9              " @7RF  !X;"]W;W)K
M<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ [C-T5HI:XD%=$P  ;#0
M !D              ("!@:L  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q0
M2P$"% ,4    " #N,W16[SVE)/D#   :"@  &0              @($5OP
M>&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( .XS=%8Q[$SW
ME0T  $DI   9              " @47#  !X;"]W;W)K<VAE971S+W-H965T
M,C N>&UL4$L! A0#%     @ [C-T5@J1'HI0%   Z$4  !D
M ("!$=$  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #N
M,W16T1J86VT,  #9(   &0              @(&8Y0  >&PO=V]R:W-H965T
M<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( .XS=%8"?[54$@4  -@+   9
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M970R-RYX;6Q02P$"% ,4    " #N,W16&"'+1?8$  #(#0  &0
M    @($3( $ >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    (
M .XS=%94K //CP(  (8%   9              " @4 E 0!X;"]W;W)K<VAE
M971S+W-H965T,CDN>&UL4$L! A0#%     @ [C-T5F*,-?D' P  U 8  !D
M             ("!!B@! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"
M% ,4    " #N,W16\V?<4X\%   H#P  &0              @(%$*P$ >&PO
M=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( .XS=%:^2XB5O0(
M !<&   9              " @0HQ 0!X;"]W;W)K<VAE971S+W-H965T,S(N
M>&UL4$L! A0#%     @ [C-T5A"N,C^E!@  '!$  !D              ("!
M_C,! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #N,W16
M&]8#3]("  "+"0  &0              @(':.@$ >&PO=V]R:W-H965T<R]S
M:&5E=#,T+GAM;%!+ 0(4 Q0    ( .XS=%8@DR/7Y0D   !Q   9
M      " @>,] 0!X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%
M  @ [C-T5N+.*&<O @  204  !D              ("!_T<! 'AL+W=O<FMS
M:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " #N,W16'^BJ:DP#   %"P
M&0              @(%E2@$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+
M 0(4 Q0    ( .XS=%8;0<0L@@(  %8'   9              " @>A- 0!X
M;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ [C-T5BI13WV0
M @  J0<  !D              ("!H5 ! 'AL+W=O<FMS:&5E=',O<VAE970S
M.2YX;6Q02P$"% ,4    " #N,W16+_'%P#\"  #L!   &0
M@(%H4P$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( .XS
M=%9MMZ0]<0(  &@&   9              " @=Y5 0!X;"]W;W)K<VAE971S
M+W-H965T-#$N>&UL4$L! A0#%     @ [C-T5I!?=4HM!   M!(  !D
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M=#0V+GAM;%!+ 0(4 Q0    ( .XS=%84K*(52P@  ,)N   9
M  " @<9X 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @
M[C-T5J^$I 0B!   "!$  !D              ("!2($! 'AL+W=O<FMS:&5E
M=',O<VAE970T."YX;6Q02P$"% ,4    " #N,W16*#:W1Q@$  !:$@  &0
M            @(&AA0$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4
M Q0    ( .XS=%:#H2P,3PH  '9[   9              " @?") 0!X;"]W
M;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ [C-T5O4OJF>P @
ME@<  !D              ("!=I0! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX
M;6Q02P$"% ,4    " #N,W16)+(SYV<$   !$P  &0              @(%=
MEP$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( .XS=%;S
M'0@^"P0  )<6   9              " @?N; 0!X;"]W;W)K<VAE971S+W-H
M965T-3,N>&UL4$L! A0#%     @ [C-T5AOU"/Z' P  AP\  !D
M     ("!/: ! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .XS=%:#P2,,70(  $P%   9              "
M@;RZ 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ [C-T
M5AEWI)F; P  \0T  !D              ("!4+T! 'AL+W=O<FMS:&5E=',O
M<VAE970V,"YX;6Q02P$"% ,4    " #N,W16%.2/M/P"  "J"@  &0
M        @($BP0$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0
M   ( .XS=%:[=R5]M@,  )L/   9              " @57$ 0!X;"]W;W)K
M<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ [C-T5L^=AZ.7 P  &!$
M !D              ("!0L@! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q0
M2P$"% ,4    " #N,W16^AEX+5@%   A*   &0              @($0S $
M>&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( .XS=%;P%OF[
M\P(  #\(   9              " @9_1 0!X;"]W;W)K<VAE971S+W-H965T
M-C4N>&UL4$L! A0#%     @ [C-T5D[&;-K8!   F!4  !D
M ("!R=0! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4    " #N
M,W16B\P/<?<$  !/'P  &0              @('8V0$ >&PO=V]R:W-H965T
M<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( .XS=%9"/CM2U@,  *$.   9
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M970W,BYX;6Q02P$"% ,4    " #O,W169@!?6G(#   ]$   &0
M    @($S_ $ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    (
M .\S=%;/;I#8*08  *4O   9              " @=S_ 0!X;"]W;W)K<VAE
M971S+W-H965T-S0N>&UL4$L! A0#%     @ [S-T5@N]WJT+!   DA<  !D
M             ("!/ 8" 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q02P$"
M% ,4    " #O,W16#/I](1@#  "."0  &0              @(%^"@( >&PO
M=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( .\S=%;  ?X0OP0
M -P8   9              " @<T- @!X;"]W;W)K<VAE971S+W-H965T-S<N
M>&UL4$L! A0#%     @ [S-T5AY, R^2 @  \ 8  !D              ("!
MPQ(" 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4    " #O,W16
M<EI=,FD#   _#   &0              @(&,%0( >&PO=V]R:W-H965T<R]S
M:&5E=#<Y+GAM;%!+ 0(4 Q0    ( .\S=%9#5S#34 0  &X0   9
M      " @2P9 @!X;"]W;W)K<VAE971S+W-H965T.# N>&UL4$L! A0#%
M  @ [S-T5I/?&\""!0  #!L  !D              ("!LQT" 'AL+W=O<FMS
M:&5E=',O<VAE970X,2YX;6Q02P$"% ,4    " #O,W16_>J\5/\"   Z"
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M+G)E;'-02P$"% ,4    " #O,W16HZC;7TH&  #H-@  #P
M@ %O+0( >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ [S-T5C1..WUZ @
M #$  !H              ( !YC," 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ [S-T5B!P#MDD @  J2\  !,              ( !
MF#8" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %L 6P#T&   [3@"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>243</ContextCount>
  <ElementCount>527</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>74</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>010000 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>030000 - Statement - CONSOLIDATED STATEMENTS OF MEMBERS'/STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF MEMBERS'/STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>060100 - Disclosure - Organization and Description of Business Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations</Role>
      <ShortName>Organization and Description of Business Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>060200 - Disclosure - Liquidity and Capital Resources</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LiquidityAndCapitalResources</Role>
      <ShortName>Liquidity and Capital Resources</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>060300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>060400 - Disclosure - Merger, Disposition and Acquisition Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/MergerDispositionAndAcquisitionTransactions</Role>
      <ShortName>Merger, Disposition and Acquisition Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>060500 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/FairValueOfFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>060600 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>060700 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>060800 - Disclosure - In-Process Research &amp; Development and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwill</Role>
      <ShortName>In-Process Research &amp; Development and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>060900 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>061000 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>061100 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>061200 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>061300 - Disclosure - Basic and Diluted Loss per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasicAndDilutedLossPerCommonShare</Role>
      <ShortName>Basic and Diluted Loss per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>061400 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>061500 - Disclosure - Equity and Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrants</Role>
      <ShortName>Equity and Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>061600 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>061700 - Disclosure - Subsequent Event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/SubsequentEvent</Role>
      <ShortName>Subsequent Event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>070300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>080400 - Disclosure - Merger, Disposition and Acquisition Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsTables</Role>
      <ShortName>Merger, Disposition and Acquisition Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/MergerDispositionAndAcquisitionTransactions</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>080500 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/FairValueOfFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/FairValueOfFinancialInstruments</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>080600 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/PropertyAndEquipment</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>080700 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/Leases</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>081000 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/AccruedExpenses</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>081300 - Disclosure - Basic and Diluted Loss per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasicAndDilutedLossPerCommonShareTables</Role>
      <ShortName>Basic and Diluted Loss per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/BasicAndDilutedLossPerCommonShare</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>081400 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/StockbasedCompensation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>081500 - Disclosure - Equity and Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrantsTables</Role>
      <ShortName>Equity and Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/EquityAndWarrants</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>081600 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/IncomeTaxes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>090100 - Disclosure - Organization and Description of Business Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails</Role>
      <ShortName>Organization and Description of Business Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>090200 - Disclosure - Liquidity and Capital Resources (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LiquidityAndCapitalResourcesDetails</Role>
      <ShortName>Liquidity and Capital Resources (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/LiquidityAndCapitalResources</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>090300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Basis of Accounting Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesBasisOfAccountingPresentationDetails</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Basis of Accounting Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>090302 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, October 2022 Reverse Stock Split (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies, October 2022 Reverse Stock Split (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>090306 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>090308 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>090310 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>090312 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Recent Accounting Standards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Recent Accounting Standards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>090400 - Disclosure - Merger, Disposition and Acquisition Transactions, Merger (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails</Role>
      <ShortName>Merger, Disposition and Acquisition Transactions, Merger (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>090402 - Disclosure - Merger, Disposition and Acquisition Transactions, Fair Value of Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>Merger, Disposition and Acquisition Transactions, Fair Value of Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>090404 - Disclosure - Merger, Disposition and Acquisition Transactions, Disposition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails</Role>
      <ShortName>Merger, Disposition and Acquisition Transactions, Disposition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>090408 - Disclosure - Merger, Disposition and Acquisition Transactions, Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails</Role>
      <ShortName>Merger, Disposition and Acquisition Transactions, Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>090410 - Disclosure - Merger, Disposition and Acquisition Transactions, Investment in NoveCite (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails</Role>
      <ShortName>Merger, Disposition and Acquisition Transactions, Investment in NoveCite (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>090504 - Disclosure - Fair Value of Financial Instruments, Liabilities Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails</Role>
      <ShortName>Fair Value of Financial Instruments, Liabilities Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>090506 - Disclosure - Fair Value of Financial Instruments, Changes in Warrant Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails</Role>
      <ShortName>Fair Value of Financial Instruments, Changes in Warrant Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>090600 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/PropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>090700 - Disclosure - Leases, Operating Lease (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LeasesOperatingLeaseDetails</Role>
      <ShortName>Leases, Operating Lease (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>090702 - Disclosure - Leases, Net Operating Lease Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails</Role>
      <ShortName>Leases, Net Operating Lease Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>090704 - Disclosure - Leases, Operating Lease Right-of-use Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails</Role>
      <ShortName>Leases, Operating Lease Right-of-use Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>090706 - Disclosure - Leases, Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases, Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>090708 - Disclosure - Leases, Sublease Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LeasesSubleaseAgreementDetails</Role>
      <ShortName>Leases, Sublease Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>090800 - Disclosure - In-Process Research &amp; Development and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwillDetails</Role>
      <ShortName>In-Process Research &amp; Development and Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwill</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>090900 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/RelatedPartyTransactions</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>091000 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/AccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/AccruedExpensesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>091100 - Disclosure - Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/DebtDetails</Role>
      <ShortName>Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/Debt</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>091200 - Disclosure - Commitments and Contingencies, Legal Matters (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails</Role>
      <ShortName>Commitments and Contingencies, Legal Matters (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>091202 - Disclosure - Commitments and Contingencies, Licensing Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails</Role>
      <ShortName>Commitments and Contingencies, Licensing Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>091204 - Disclosure - Commitments and Contingencies, Royalty Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails</Role>
      <ShortName>Commitments and Contingencies, Royalty Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>091206 - Disclosure - Commitments and Contingencies, Retirement Savings Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails</Role>
      <ShortName>Commitments and Contingencies, Retirement Savings Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>091300 - Disclosure - Basic and Diluted Loss per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails</Role>
      <ShortName>Basic and Diluted Loss per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/BasicAndDilutedLossPerCommonShareTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>091400 - Disclosure - Stock-Based Compensation, Equity Incentive Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails</Role>
      <ShortName>Stock-Based Compensation, Equity Incentive Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>091402 - Disclosure - Stock-Based Compensation, Weighted-Average Assumptions Used for Grants Issued (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails</Role>
      <ShortName>Stock-Based Compensation, Weighted-Average Assumptions Used for Grants Issued (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>091404 - Disclosure - Stock-Based Compensation, Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation, Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>091406 - Disclosure - Stock-Based Compensation, Summary of Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails</Role>
      <ShortName>Stock-Based Compensation, Summary of Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>091408 - Disclosure - Stock-Based Compensation, RSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationRsusDetails</Role>
      <ShortName>Stock-Based Compensation, RSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/StockbasedCompensationTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>091410 - Disclosure - Stock-Based Compensation, Number of RSUs Vested and Settled (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails</Role>
      <ShortName>Stock-Based Compensation, Number of RSUs Vested and Settled (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>091412 - Disclosure - Stock-Based Compensation, Restricted Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails</Role>
      <ShortName>Stock-Based Compensation, Restricted Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>091414 - Disclosure - Stock-Based Compensation, Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation, Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>091500 - Disclosure - Equity and Warrants, Private Placement of Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails</Role>
      <ShortName>Equity and Warrants, Private Placement of Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>091502 - Disclosure - Equity and Warrants,Warrants activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails</Role>
      <ShortName>Equity and Warrants,Warrants activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>091504 - Disclosure - Equity and Warrants, Equity Line Offerings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails</Role>
      <ShortName>Equity and Warrants, Equity Line Offerings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>091508 - Disclosure - Equity and Warrants, Merger (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrantsMergerDetails</Role>
      <ShortName>Equity and Warrants, Merger (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>091510 - Disclosure - Equity and Warrants, Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails</Role>
      <ShortName>Equity and Warrants, Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>091512 - Disclosure - Equity and Warrants, Cumulative Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails</Role>
      <ShortName>Equity and Warrants, Cumulative Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>091600 - Disclosure - Income Taxes, Loss before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes, Loss before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>091602 - Disclosure - Income Taxes, Components of Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes, Components of Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>091604 - Disclosure - Income Taxes, Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes, Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>091606 - Disclosure - Income Taxes, Reconciliation of Computed Expected Income Taxes to Effective Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails</Role>
      <ShortName>Income Taxes, Reconciliation of Computed Expected Income Taxes to Effective Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>091608 - Disclosure - Income Taxes, Uncertain Tax Positions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails</Role>
      <ShortName>Income Taxes, Uncertain Tax Positions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="brhc10049677_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>091700 - Disclosure - Subsequent Event (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/SubsequentEventDetails</Role>
      <ShortName>Subsequent Event (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/SubsequentEvent</ParentRole>
      <Position>83</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. brhc10049677_10k.htm 22359, 22367</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesNoncurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. brhc10049677_10k.htm 22468, 22476</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept ResearchAndDevelopmentInProcess in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. brhc10049677_10k.htm 23057, 23067</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 9 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, erna:LicenseAgreementExtensionTerm, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod, us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 -  brhc10049677_10k.htm 11</Log>
    <Log type="Warning">[dqc-0033-Document-Period-End-Date-Context] The ending date of 2021-12-31 used for AuditorFirmId must be the same as the Document Period End Date, 2022-12-31. The properties of this AuditorFirmId fact are Context: c20210101to20211231, Unit: (none), Rule Element Id: 2. brhc10049677_10k.htm 11</Log>
    <Log type="Warning">[dqc-0033-Document-Period-End-Date-Context] The ending date of 2021-12-31 used for AuditorLocation must be the same as the Document Period End Date, 2022-12-31. The properties of this AuditorLocation fact are Context: c20210101to20211231, Unit: (none), Rule Element Id: 2. brhc10049677_10k.htm 21758</Log>
    <Log type="Warning">[dqc-0033-Document-Period-End-Date-Context] The ending date of 2021-12-31 used for AuditorName must be the same as the Document Period End Date, 2022-12-31. The properties of this AuditorName fact are Context: c20210101to20211231, Unit: (none), Rule Element Id: 2. brhc10049677_10k.htm 11</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="brhc10049677_10k.htm">brhc10049677_10k.htm</File>
    <File>brhc10049677_ex10-16.htm</File>
    <File>brhc10049677_ex10-21.htm</File>
    <File>brhc10049677_ex10-22.htm</File>
    <File>brhc10049677_ex21-1.htm</File>
    <File>brhc10049677_ex23-1.htm</File>
    <File>brhc10049677_ex23-2.htm</File>
    <File>brhc10049677_ex3-1.htm</File>
    <File>brhc10049677_ex31-1.htm</File>
    <File>brhc10049677_ex31-2.htm</File>
    <File>brhc10049677_ex32-1.htm</File>
    <File>brhc10049677_ex32-2.htm</File>
    <File>erna-20221231.xsd</File>
    <File>erna-20221231_cal.xml</File>
    <File>erna-20221231_def.xml</File>
    <File>erna-20221231_lab.xml</File>
    <File>erna-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image00007.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="838">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>115
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10049677_10k.htm": {
   "axisCustom": 0,
   "axisStandard": 29,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 838,
    "http://xbrl.sec.gov/dei/2022": 39
   },
   "contextCount": 243,
   "dts": {
    "calculationLink": {
     "local": [
      "erna-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "erna-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "brhc10049677_10k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "erna-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "erna-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "erna-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 798,
   "entityCount": 1,
   "hidden": {
    "http://eternatx.com/20221231": 2,
    "http://fasb.org/us-gaap/2022": 7,
    "http://xbrl.sec.gov/dei/2022": 8,
    "total": 17
   },
   "keyCustom": 164,
   "keyStandard": 363,
   "memberCustom": 38,
   "memberStandard": 32,
   "nsprefix": "erna",
   "nsuri": "http://eternatx.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://eternatx.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060400 - Disclosure - Merger, Disposition and Acquisition Transactions",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactions",
     "shortName": "Merger, Disposition and Acquisition Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060500 - Disclosure - Fair Value of Financial Instruments",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://eternatx.com/role/FairValueOfFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060600 - Disclosure - Property and Equipment",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://eternatx.com/role/PropertyAndEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060700 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://eternatx.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060800 - Disclosure - In-Process Research & Development and Goodwill",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwill",
     "shortName": "In-Process Research & Development and Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060900 - Disclosure - Related Party Transactions",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://eternatx.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061000 - Disclosure - Accrued Expenses",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://eternatx.com/role/AccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061100 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://eternatx.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061200 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://eternatx.com/role/CommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061300 - Disclosure - Basic and Diluted Loss per Common Share",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://eternatx.com/role/BasicAndDilutedLossPerCommonShare",
     "shortName": "Basic and Diluted Loss per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010000 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://eternatx.com/role/ConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061400 - Disclosure - Stock-Based Compensation",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://eternatx.com/role/StockbasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061500 - Disclosure - Equity and Warrants",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://eternatx.com/role/EquityAndWarrants",
     "shortName": "Equity and Warrants",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061600 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://eternatx.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061700 - Disclosure - Subsequent Event",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://eternatx.com/role/SubsequentEvent",
     "shortName": "Subsequent Event",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "070300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "24",
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080400 - Disclosure - Merger, Disposition and Acquisition Transactions (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsTables",
     "shortName": "Merger, Disposition and Acquisition Transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080500 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://eternatx.com/role/FairValueOfFinancialInstrumentsTables",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080600 - Disclosure - Property and Equipment (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://eternatx.com/role/PropertyAndEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080700 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://eternatx.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081000 - Disclosure - Accrued Expenses (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://eternatx.com/role/AccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U003",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U003",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081300 - Disclosure - Basic and Diluted Loss per Common Share (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://eternatx.com/role/BasicAndDilutedLossPerCommonShareTables",
     "shortName": "Basic and Diluted Loss per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081400 - Disclosure - Stock-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://eternatx.com/role/StockbasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081500 - Disclosure - Equity and Warrants (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://eternatx.com/role/EquityAndWarrantsTables",
     "shortName": "Equity and Warrants (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081600 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://eternatx.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_RangeAxis_MinimumMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "erna:NumberOfInLicensedPortfolioPatents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090100 - Disclosure - Organization and Description of Business Operations (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails",
     "shortName": "Organization and Description of Business Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_RangeAxis_MinimumMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "erna:NumberOfInLicensedPortfolioPatents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090200 - Disclosure - Liquidity and Capital Resources (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
     "shortName": "Liquidity and Capital Resources (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220306_InvestmentTypeAxis_PIPEInvestorMember",
      "decimals": "3",
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U003",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Basis of Accounting Presentation (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesBasisOfAccountingPresentationDetails",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies, Basis of Accounting Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220921to20220921",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090302 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, October 2022 Reverse Stock Split (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies, October 2022 Reverse Stock Split (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220921to20220921",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090306 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Cash, Cash Equivalents and Restricted Cash (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies, Cash, Cash Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_PropertyPlantAndEquipmentByTypeAxis_LaboratoryAndManufacturingEquipmentMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090308 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Property and Equipment (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies, Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_PropertyPlantAndEquipmentByTypeAxis_LaboratoryAndManufacturingEquipmentMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentInProcess",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U007",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090310 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Segment Reporting (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies, Segment Reporting (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U007",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxesReceivable",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231_UnusualOrInfrequentItemAxis_CoronavirusAidReliefAndEconomicSecurityActMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxesReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090312 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Recent Accounting Standards (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies, Recent Accounting Standards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxesReceivable",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231_UnusualOrInfrequentItemAxis_CoronavirusAidReliefAndEconomicSecurityActMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxesReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090400 - Disclosure - Merger, Disposition and Acquisition Transactions, Merger (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails",
     "shortName": "Merger, Disposition and Acquisition Transactions, Merger (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember",
      "decimals": "4",
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090402 - Disclosure - Merger, Disposition and Acquisition Transactions, Fair Value of Assets Acquired and Liabilities Assumed (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
     "shortName": "Merger, Disposition and Acquisition Transactions, Fair Value of Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090404 - Disclosure - Merger, Disposition and Acquisition Transactions, Disposition (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
     "shortName": "Merger, Disposition and Acquisition Transactions, Disposition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueAcquisitions",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090408 - Disclosure - Merger, Disposition and Acquisition Transactions, Acquisition (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
     "shortName": "Merger, Disposition and Acquisition Transactions, Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090410 - Disclosure - Merger, Disposition and Acquisition Transactions, Investment in NoveCite (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
     "shortName": "Merger, Disposition and Acquisition Transactions, Investment in NoveCite (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember",
      "decimals": "INF",
      "lang": null,
      "name": "erna:NumberOfBoardSeats",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U008",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090504 - Disclosure - Fair Value of Financial Instruments, Liabilities Measured at Fair Value (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
     "shortName": "Fair Value of Financial Instruments, Liabilities Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "erna:OverSubscriptionAmountReceived",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090506 - Disclosure - Fair Value of Financial Instruments, Changes in Warrant Liabilities (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
     "shortName": "Fair Value of Financial Instruments, Changes in Warrant Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090600 - Disclosure - Property and Equipment (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://eternatx.com/role/PropertyAndEquipmentDetails",
     "shortName": "Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "030000 - Statement - CONSOLIDATED STATEMENTS OF MEMBERS'/STOCKHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
     "shortName": "CONSOLIDATED STATEMENTS OF MEMBERS'/STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220305",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "erna:LesseeCommitmentToPurchaseProperty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090700 - Disclosure - Leases, Operating Lease (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://eternatx.com/role/LeasesOperatingLeaseDetails",
     "shortName": "Leases, Operating Lease (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220305",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "erna:LesseeCommitmentToPurchaseProperty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090702 - Disclosure - Leases, Net Operating Lease Expenses (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails",
     "shortName": "Leases, Net Operating Lease Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090704 - Disclosure - Leases, Operating Lease Right-of-use Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails",
     "shortName": "Leases, Operating Lease Right-of-use Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "lang": null,
      "name": "erna:RemeasurementOfOperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090706 - Disclosure - Leases, Maturities of Operating Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails",
     "shortName": "Leases, Maturities of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20190418",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "erna:AreaOfSubleaseSpaceCurrentlyRented",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U006",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090708 - Disclosure - Leases, Sublease Agreement (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://eternatx.com/role/LeasesSubleaseAgreementDetails",
     "shortName": "Leases, Sublease Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20190418",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "erna:AreaOfSubleaseSpaceCurrentlyRented",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U006",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090800 - Disclosure - In-Process Research & Development and Goodwill (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwillDetails",
     "shortName": "In-Process Research & Development and Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20181231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090900 - Disclosure - Related Party Transactions (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://eternatx.com/role/RelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember",
      "decimals": "-5",
      "lang": null,
      "name": "erna:MasterServiceAgreementInitialFeesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091000 - Disclosure - Accrued Expenses (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://eternatx.com/role/AccruedExpensesDetails",
     "shortName": "Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RepaymentsOfNotesPayable",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091100 - Disclosure - Debt (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://eternatx.com/role/DebtDetails",
     "shortName": "Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231_DebtInstrumentAxis_PaycheckProtectionProgramLoanMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:LoansPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "erna:LitigationSettlementAmountPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091200 - Disclosure - Commitments and Contingencies, Legal Matters (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
     "shortName": "Commitments and Contingencies, Legal Matters (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "erna:LitigationSettlementAmountPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "erna:LicenseAgreementTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091202 - Disclosure - Commitments and Contingencies, Licensing Agreements (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
     "shortName": "Commitments and Contingencies, Licensing Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_TypeOfArrangementAxis_ExclusiveFactorLicenseAgreementMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "erna:LicenseAgreementTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "erna:PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091204 - Disclosure - Commitments and Contingencies, Royalty Agreements (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails",
     "shortName": "Commitments and Contingencies, Royalty Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "erna:PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_RangeAxis_MaximumMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "erna:DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091206 - Disclosure - Commitments and Contingencies, Retirement Savings Plan (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails",
     "shortName": "Commitments and Contingencies, Retirement Savings Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_RangeAxis_MaximumMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "erna:DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091300 - Disclosure - Basic and Diluted Loss per Common Share (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails",
     "shortName": "Basic and Diluted Loss per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091400 - Disclosure - Stock-Based Compensation, Equity Incentive Plans (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
     "shortName": "Stock-Based Compensation, Equity Incentive Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231_PlanNameAxis_EquityIncentivePlan2020Member",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091402 - Disclosure - Stock-Based Compensation, Weighted-Average Assumptions Used for Grants Issued (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails",
     "shortName": "Stock-Based Compensation, Weighted-Average Assumptions Used for Grants Issued (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20211231_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091404 - Disclosure - Stock-Based Compensation, Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
     "shortName": "Stock-Based Compensation, Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091406 - Disclosure - Stock-Based Compensation, Summary of Stock Options (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
     "shortName": "Stock-Based Compensation, Summary of Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U003",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091408 - Disclosure - Stock-Based Compensation, RSUs (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://eternatx.com/role/StockbasedCompensationRsusDetails",
     "shortName": "Stock-Based Compensation, RSUs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091410 - Disclosure - Stock-Based Compensation, Number of RSUs Vested and Settled (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
     "shortName": "Stock-Based Compensation, Number of RSUs Vested and Settled (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "decimals": "-3",
      "lang": null,
      "name": "erna:CommonStockWithheldToCoverTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060100 - Disclosure - Organization and Description of Business Operations",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations",
     "shortName": "Organization and Description of Business Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091412 - Disclosure - Stock-Based Compensation, Restricted Stock (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails",
     "shortName": "Stock-Based Compensation, Restricted Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091414 - Disclosure - Stock-Based Compensation, Stock-Based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails",
     "shortName": "Stock-Based Compensation, Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091500 - Disclosure - Equity and Warrants, Private Placement of Equity (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
     "shortName": "Equity and Warrants, Private Placement of Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231_ClassOfWarrantOrRightAxis_WarrantMember",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U003",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091502 - Disclosure - Equity and Warrants,Warrants activity (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails",
     "shortName": "Equity and Warrants,Warrants activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "0",
      "lang": null,
      "name": "erna:ClassOfWarrantOrRightGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091504 - Disclosure - Equity and Warrants, Equity Line Offerings (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails",
     "shortName": "Equity and Warrants, Equity Line Offerings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210426_RangeAxis_MaximumMember",
      "decimals": "-5",
      "lang": null,
      "name": "erna:CommitmentAmountToMeetAnySingleRegularPurchase",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210325to20210325",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "erna:StockIssuedDuringPeriodSharesAcquisitions1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091508 - Disclosure - Equity and Warrants, Merger (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://eternatx.com/role/EquityAndWarrantsMergerDetails",
     "shortName": "Equity and Warrants, Merger (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210325to20210325",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "erna:StockIssuedDuringPeriodSharesAcquisitions1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091510 - Disclosure - Equity and Warrants, Acquisition (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
     "shortName": "Equity and Warrants, Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210716to20210716_BusinessAcquisitionAxis_NovellusTherapeuticsLimitedMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091512 - Disclosure - Equity and Warrants, Cumulative Convertible Preferred Stock (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails",
     "shortName": "Equity and Warrants, Cumulative Convertible Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091600 - Disclosure - Income Taxes, Loss before Income Taxes (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes, Loss before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091602 - Disclosure - Income Taxes, Components of Income Tax Provision (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails",
     "shortName": "Income Taxes, Components of Income Tax Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "erna:LiquidityAndCapitalResourcesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060200 - Disclosure - Liquidity and Capital Resources",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://eternatx.com/role/LiquidityAndCapitalResources",
     "shortName": "Liquidity and Capital Resources",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "erna:LiquidityAndCapitalResourcesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091604 - Disclosure - Income Taxes, Deferred Tax Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails",
     "shortName": "Income Taxes, Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091606 - Disclosure - Income Taxes, Reconciliation of Computed Expected Income Taxes to Effective Income Taxes (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails",
     "shortName": "Income Taxes, Reconciliation of Computed Expected Income Taxes to Effective Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091608 - Disclosure - Income Taxes, Uncertain Tax Positions (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails",
     "shortName": "Income Taxes, Uncertain Tax Positions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20230221to20230221_SubsequentEventTypeAxis_SubsequentEventMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "erna:ProceedsFromOptionAndLicenseAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091700 - Disclosure - Subsequent Event (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://eternatx.com/role/SubsequentEventDetails",
     "shortName": "Subsequent Event (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20230221to20230221_SubsequentEventTypeAxis_SubsequentEventMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "erna:ProceedsFromOptionAndLicenseAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049677_10k.htm",
      "contextRef": "c20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 74,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "erna_AccruedClinicalCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to clinical trail cost (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Clinical, Current",
        "terseLabel": "Clinical"
       }
      }
     },
     "localname": "AccruedClinicalCurrent",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_AccruedPrivatePlacementInPublicEquityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to private placement in public equity (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Private Placement in Public Equity, Current",
        "terseLabel": "Q4-22 PIPE"
       }
      }
     },
     "localname": "AccruedPrivatePlacementInPublicEquityCurrent",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_AcquisitionAgreementNonCompetitivePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Acquisition Agreement contains non-competition and non-solicitation provisions pursuant to which the Seller has agreed not to engage in certain competitive activities for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquisition Agreement, Non Competitive Period",
        "terseLabel": "Non-compete period"
       }
      }
     },
     "localname": "AcquisitionAgreementNonCompetitivePeriod",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "erna_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease (increase) in additional paid in capital (APIC) for the increase in redemption of temporary equity as the result of a triggering event associated with the temporary equity.",
        "label": "Adjustments to Additional Paid in Capital, Elimination Historical Member Equity",
        "terseLabel": "Elimination of Eterna LLC's historical members' equity"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_AggregateCalendarDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified aggregate calendar days (which need not be consecutive calendar days) during any 12-month period for resale in in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Aggregate Calendar Days",
        "terseLabel": "Aggregate calendar days"
       }
      }
     },
     "localname": "AggregateCalendarDays",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "erna_AggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Intrinsic Value [Abstract]"
       }
      }
     },
     "localname": "AggregateIntrinsicValueAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_AgreedWaivePayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount agreed to waive payment as per waiver agreement.",
        "label": "Agreed Waive Payment",
        "terseLabel": "Agreed waive payment"
       }
      }
     },
     "localname": "AgreedWaivePayment",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_AreaOfSubleaseSpaceCurrentlyRented": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The subleases rentable area for properties currently rented.",
        "label": "Area of Sublease, Space Currently Rented",
        "terseLabel": "Currently rented area"
       }
      }
     },
     "localname": "AreaOfSubleaseSpaceCurrentlyRented",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "erna_AssetAcquisitionFairValueOfConsiderationPaid": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fair value of consideration paid in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.",
        "label": "Asset Acquisition, Fair Value of Consideration Paid",
        "totalLabel": "Total fair value of consideration paid"
       }
      }
     },
     "localname": "AssetAcquisitionFairValueOfConsiderationPaid",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_AssetAcquisitionRestrictedSharesSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered with restrictions to be paid in asset acquisition.",
        "label": "Asset Acquisition, Restricted Shares, Share Price",
        "terseLabel": "Restricted shares, fair value per share (in dollars per share)"
       }
      }
     },
     "localname": "AssetAcquisitionRestrictedSharesSharePrice",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "erna_AssetAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in asset acquisition.",
        "label": "Asset Acquisition, Share Price",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "AssetAcquisitionSharePrice",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "erna_AssetAcquisitionUnrestrictedSharesSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered without any restrictions to be paid in asset acquisition.",
        "label": "Asset Acquisition, Unrestricted Shares, Share Price",
        "terseLabel": "Unrestricted shares, fair value per share (in dollars per share)"
       }
      }
     },
     "localname": "AssetAcquisitionUnrestrictedSharesSharePrice",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "erna_BasisOfPresentationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation [Abstract]",
        "terseLabel": "Basis of Presentation [Abstract]"
       }
      }
     },
     "localname": "BasisOfPresentationAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesBasisOfAccountingPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_BeneficialHoldersContractualCommitmentsToInvest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual commitment made by beneficial holders to invest in the entity.",
        "label": "Beneficial Holders Contractual Commitments To Invest",
        "terseLabel": "Beneficial holders contractual commitments to invest"
       }
      }
     },
     "localname": "BeneficialHoldersContractualCommitmentsToInvest",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_BeneficialOwnershipPercentageOnTotalOutstandingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of shareholders, partners or other equity holders in consolidated entity.",
        "label": "Beneficial Ownership Percentage on Total Outstanding Shares",
        "terseLabel": "Beneficial ownership percentage on total outstanding shares that prohibits company to direct share purchases"
       }
      }
     },
     "localname": "BeneficialOwnershipPercentageOnTotalOutstandingShares",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_BrooklynPaycheckProtectionProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the Paycheck Protection Program for Brooklyn.",
        "label": "Brooklyn Paycheck Protection Program [Member]",
        "terseLabel": "Eterna Paycheck Protection Program [Member]"
       }
      }
     },
     "localname": "BrooklynPaycheckProtectionProgramMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of software development costs recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Software Development Costs",
        "terseLabel": "Software development costs"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_CashPaidDuringThePeriodForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid During the Period for [Abstract]",
        "terseLabel": "Cash paid during the period for:"
       }
      }
     },
     "localname": "CashPaidDuringThePeriodForAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for fractional shares in connection with reverse stock split.",
        "label": "Cash Paid for Fractional Shares in Connection with Reverse Stock Split",
        "negatedLabel": "Cash paid for fractional shares in connection with reverse stock split",
        "terseLabel": "Amount paid for fractional share in connection with reverse stock split"
       }
      }
     },
     "localname": "CashPaidForFractionalSharesInConnectionWithReverseStockSplit",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails",
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of chairman of the board of directors, chief executive officer and president.",
        "label": "Chairman of the Board of Directors Chief Executive Officer and President [Member]",
        "terseLabel": "Chair of the Board of Directors, Chief Executive Officer and President [Member]",
        "verboseLabel": "Chairman of the Board of Directors, Chief Executive Officer and President [Member]"
       }
      }
     },
     "localname": "ChairmanOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_CitiusPharmaceuticalsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Citius Pharmaceuticals, Inc. Ownership interest.",
        "label": "Citius Pharmaceuticals, Inc. [Member]"
       }
      }
     },
     "localname": "CitiusPharmaceuticalsIncMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_ClassOfWarrantOrRightExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights exercised during the period.",
        "label": "Class of Warrant or Right Exercised",
        "verboseLabel": "Warrants exercised (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercised",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_ClassOfWarrantOrRightExercisedInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share warrants exercised during the current period.",
        "label": "Class of Warrant or Right Exercised in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisedInPeriod",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_ClassOfWarrantOrRightGrantsInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on warrants.",
        "label": "Class of Warrant or Right Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightGrantsInPeriod",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_ClassOfWarrantOrRightIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued into which the class of warrant or right may be converted.",
        "label": "Class of Warrant or Right, Issued",
        "terseLabel": "Number of rights options issued (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightIssued",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of securities that would be issuable upon the exercise of warrants or rights.",
        "label": "Class of Warrant or Right Percent of Securities that Would be Issuable Upon Exercise of Warrants or Rights",
        "terseLabel": "Percentage of warrants exercisable"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_ClassOfWarrantOrRightsExercisableTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Class of Warrant or Rights Exercisable Term",
        "terseLabel": "Warrant exercisable term"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightsExercisableTerm",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "erna_CollaboratorRoyaltyAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative royalty arrangement in licensing deal with the company.",
        "label": "Collaborator Royalty Agreement [Member]",
        "terseLabel": "Collaborator Royalty Agreement [Member]"
       }
      }
     },
     "localname": "CollaboratorRoyaltyAgreementMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_CommitmentAmountToMeetAnySingleRegularPurchase": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchase price or commitment amount to meet any single regular purchase in share purchase transaction on any business day.",
        "label": "Commitment Amount to Meet any Single Regular Purchase",
        "terseLabel": "Maximum commitment in any single regular purchase"
       }
      }
     },
     "localname": "CommitmentAmountToMeetAnySingleRegularPurchase",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_CommonStockWithheldToCoverTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares of common stock withheld to cover the withholding taxes.",
        "label": "Common Stock Withheld to Cover Taxes",
        "negatedLabel": "Common stock withheld to cover taxes (in shares)"
       }
      }
     },
     "localname": "CommonStockWithheldToCoverTaxes",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_CommonUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than provided to common units, representing ownership interest in a corporation.",
        "label": "Common Units [Member]",
        "verboseLabel": "Common [Member]"
       }
      }
     },
     "localname": "CommonUnitsMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_CommonWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A common warrant represents the right to purchase a company's stock at a specific price and at a specific date.",
        "label": "Common Warrants [Member]",
        "terseLabel": "Common Warrants [Member]",
        "verboseLabel": "Q1-22 Common Warrants [Member]"
       }
      }
     },
     "localname": "CommonWarrantsMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_CommonWarrantsOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A common warrant represents the right to purchase a company's stock at a specific price and at a specific date.",
        "label": "Common Warrants One [Member]",
        "terseLabel": "Q4-22 Common Warrants [Member]"
       }
      }
     },
     "localname": "CommonWarrantsOneMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_ConversionOfWarrantLiabilityToEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The conversion of warrant liability to equity in non-cash investing and financing activities.",
        "label": "Conversion of Warrant Liability to Equity"
       }
      }
     },
     "localname": "ConversionOfWarrantLiabilityToEquity",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_CoronavirusAidReliefAndEconomicSecurityActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coronavirus Aid, Relief, and Economic Security Act (CARES Act).",
        "label": "Coronavirus Aid Relief and Economic Security Act [Member]",
        "terseLabel": "CARES Act [Member]"
       }
      }
     },
     "localname": "CoronavirusAidReliefAndEconomicSecurityActMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_CostRelatedToIssuanceOfLetterOfCredit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of bank fees related to issuance of letter of credit.",
        "label": "Cost Related to Issuance of Letter of Credit"
       }
      }
     },
     "localname": "CostRelatedToIssuanceOfLetterOfCredit",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DebtInstrumentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Abstract]",
        "terseLabel": "Debt Instrument [Abstract]"
       }
      }
     },
     "localname": "DebtInstrumentAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets attributable to taxable temporary differences from research and development costs.",
        "label": "Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs",
        "terseLabel": "Capitalized research and development expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards excluding foreign purpose.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards Excluding Foreign",
        "terseLabel": "Net operating losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DeferredTaxAssetsRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from right-of-use assets.",
        "label": "Deferred Tax Assets Right of Use Assets",
        "negatedLabel": "ROU Assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsRightOfUseAssets",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DeferredTaxAssetsRightOfUseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from right-of-use liabilities.",
        "label": "Deferred Tax Assets Right Of Use Liabilities",
        "terseLabel": "ROU Liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsRightOfUseLiabilities",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined contribution plan, deferral percentage of employee on their pay on pre-tax basis.",
        "label": "Defined Contribution Plan, Deferral Percent of Their Pay on Pre-tax Basis",
        "terseLabel": "Employees contribution, deferral percentage of their pay on a pre-tax basis"
       }
      }
     },
     "localname": "DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_DefinedContributionPlanEmployeeContributionAtThresholdOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employee contribution to the plan that is fully matched by the employer.",
        "label": "Defined Contribution Plan Employee Contribution at Threshold One",
        "terseLabel": "Employee contribution threshold for matching percentage"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployeeContributionAtThresholdOne",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employee contribution to the plan that is fully matched by the employer.",
        "label": "Defined Contribution Plan Employee Contribution At Threshold Two",
        "terseLabel": "Deferred compensation matched by employer, next match"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployeeContributionAtThresholdTwo",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution up to a certain percentage matched.",
        "label": "Defined Contribution Plan Employer Matching Contribution Percent of Match One",
        "terseLabel": "Employer matching contribution up to first 3%"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution in excess of certain percentage matched.",
        "label": "Defined Contribution Plan Employer Matching Contribution Percent of Match Two",
        "terseLabel": "Employer matching contribution in excess of first 2%"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deposit paid which will be applied to the last month of the first work order.",
        "label": "Deposit Paid to be Applied to Last Month of First Work Order",
        "terseLabel": "Deposit paid to be applied to last month of first work order"
       }
      }
     },
     "localname": "DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Detailed information about Liquidity and Capital Resources [Abstract]",
        "verboseLabel": "Liquidity and Capital Resources [Abstract]"
       }
      }
     },
     "localname": "DetailedInformationAboutLiquidityAndCapitalResourcesAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_DisposalGroupIncludingDiscontinuedOperationLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as Lease liability attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Lease liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLeaseLiability",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as Obligations under finance leases attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Obligations under finance leases",
        "terseLabel": "Obligations under finance leases"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate proceeds received from assume advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Disposal Group, Including Discontinued Operation, Proceeds from Assume Advance/Loans",
        "terseLabel": "Assume advance/loans"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Disposal Group, Including Discontinued Operation, Proceeds from Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationProceedsFromCash",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate proceeds received from escrow deposits in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Disposal Group, Including Discontinued Operation, Proceeds from Escrow",
        "terseLabel": "Escrow"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate proceeds received from interest on advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Disposal Group, Including Discontinued Operation, Proceeds from Interest on Advance/Loans",
        "terseLabel": "Interest on advance/loans"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as software development cost attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Software development costs",
        "negatedLabel": "Software development costs"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DisposalGroupIncludingDiscontinuedOperationTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs of the business disposal including legal, accounting, and other costs incurred to consummate the business disposition.",
        "label": "Disposal Group, Including Discontinued Operation, Transaction Costs",
        "negatedLabel": "Transaction costs"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationTransactionCosts",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_DispositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposition [Abstract]"
       }
      }
     },
     "localname": "DispositionAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_ERSquibbSonsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A Delaware limited liability company (\"Sublessor\"), for office, laboratory and research and development space (the \"Premises\").",
        "label": "E.R. Squibb &amp; Sons, L.L.C. [Member]",
        "terseLabel": "E.R. Squibb &amp; Sons, L.L.C. [Member]"
       }
      }
     },
     "localname": "ERSquibbSonsLLCMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_EachLockUpAgreementExtendsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of lock-up agreement extend term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Each Lock-up Agreement Extends Term",
        "terseLabel": "Each lock-up agreement extend term"
       }
      }
     },
     "localname": "EachLockUpAgreementExtendsTerm",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to decrease in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Decrease in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to uncertain tax positions.",
        "label": "Effective Income Tax Rate Reconciliation Uncertain Tax Positions Percent",
        "negatedLabel": "Uncertain tax positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_EquityIncentivePlan2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation equity incentive plan 2020.",
        "label": "Equity Incentive Plan 2020 [Member]",
        "terseLabel": "2020 Equity Incentive Plan [Member]"
       }
      }
     },
     "localname": "EquityIncentivePlan2020Member",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_EscrowShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares have been placed in escrow shares.",
        "label": "Escrow Shares",
        "terseLabel": "Escrow shares (in shares)"
       }
      }
     },
     "localname": "EscrowShares",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_ExacisBiotherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A Delaware corporation the company entered into Option Agreement.",
        "label": "Exacis Biotherapeutics, Inc. [Member]",
        "terseLabel": "Exacis Biotherapeutics, Inc. [Member]"
       }
      }
     },
     "localname": "ExacisBiotherapeuticsIncMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_ExacisOptionAgreementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exacis Option Agreement [Abstract]"
       }
      }
     },
     "localname": "ExacisOptionAgreementAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_ExclusiveFactorLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of license agreement.",
        "label": "Exclusive Factor License Agreement [Member]"
       }
      }
     },
     "localname": "ExclusiveFactorLicenseAgreementMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_ExpensesPaidInConnectionWithPrivateOffering": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expenses paid in connection with private offering during the period.",
        "label": "Expenses Paid In Connection with Private Offering",
        "negatedLabel": "Expenses paid in connection with private offering"
       }
      }
     },
     "localname": "ExpensesPaidInConnectionWithPrivateOffering",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_FactorBioscienceIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A corporation the company entered into agreement to provide the Company with MRNA cell engineering research support services, including access to certain facilities, equipment, materials and training, and the Company.",
        "label": "Factor Bioscience Inc. [Member]",
        "terseLabel": "Factor Bioscience Inc. [Member]"
       }
      }
     },
     "localname": "FactorBioscienceIncMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_FirstPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about purchase agreement between the entities.",
        "label": "First Purchase Agreement [Member]"
       }
      }
     },
     "localname": "FirstPurchaseAgreementMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future lease payments of sublease agreements.",
        "label": "Future Lease Payments, Sublease Agreement [Table Text Block]",
        "terseLabel": "Future Lease Payments from Sublease Agreement"
       }
      }
     },
     "localname": "FutureLeasePaymentsSubleaseAgreementTableTextBlock",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "erna_GainLossOnDisposalOfFixedAssets": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of fixed assets.",
        "label": "Gain (Loss) on Disposal of Fixed Assets",
        "terseLabel": "Loss on disposal of fixed assets",
        "verboseLabel": "Loss on disposal of fixed assets"
       }
      }
     },
     "localname": "GainLossOnDisposalOfFixedAssets",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_GainLossOnForgivenessOfPaycheckProtectionProgramLoan": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on forgiveness of PPP loan.",
        "label": "Gain (Loss) on Forgiveness of Paycheck Protection Program Loan",
        "negatedLabel": "Gain on forgiveness of PPP loan"
       }
      }
     },
     "localname": "GainLossOnForgivenessOfPaycheckProtectionProgramLoan",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on remeasurement of right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Gain (Loss) on Remeasurement of Operating Lease Liability and Right-of-Use-Asset",
        "negatedLabel": "Gain on remeasurement of operating lease liability and right-of-use-asset"
       }
      }
     },
     "localname": "GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_GainOnTerminationOfLease": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain on termination of lease before expiration of lease term.",
        "label": "Gain on Termination of Lease",
        "negatedLabel": "Gain on lease termination"
       }
      }
     },
     "localname": "GainOnTerminationOfLease",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_IncentiveStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on incentive basis.",
        "label": "Incentive Stock Options [Member]",
        "terseLabel": "Incentive Stock Options [Member]"
       }
      }
     },
     "localname": "IncentiveStockOptionsMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_IncomeTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax [Abstract]",
        "terseLabel": "Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the operating lease liabilities.",
        "label": "Increase (Decrease) in Operating Lease Liabilities",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_InducementPlan2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement award inducement plan 2021.",
        "label": "Inducement Plan 2021 [Member]",
        "terseLabel": "2021 Inducement Plan [Member]"
       }
      }
     },
     "localname": "InducementPlan2021Member",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_InitialLicenseFeeObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of initial license fees required to pay including non-refundable fee.",
        "label": "Initial License Fee Obligation",
        "terseLabel": "Initial license fees obligation"
       }
      }
     },
     "localname": "InitialLicenseFeeObligation",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_InitialMeasurementOfFinanceLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of initial measurement of finance lease liabilities in noncash financing activities.",
        "label": "Initial Measurement of Finance Lease Liabilities",
        "terseLabel": "Initial measurement of finance lease liability"
       }
      }
     },
     "localname": "InitialMeasurementOfFinanceLeaseLiabilities",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_InitialMeasurementOfOperatingLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of initial measurement of operating lease liabilities in noncash financing activities.",
        "label": "Initial Measurement of Operating Lease Liabilities",
        "terseLabel": "Initial measurement of operating lease liabilities"
       }
      }
     },
     "localname": "InitialMeasurementOfOperatingLeaseLiabilities",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_InitialMeasurementOfOperatingLeaseROUAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of initial measurement of operating lease ROU assets.",
        "label": "Initial Measurement of Operating Lease ROU Assets",
        "terseLabel": "Initial measurement of ROU asset",
        "verboseLabel": "Initial measurement of operating lease ROU assets"
       }
      }
     },
     "localname": "InitialMeasurementOfOperatingLeaseROUAssets",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of Initial measurement of ROU assets and operating lease liabilities in noncash financing activities.",
        "label": "Initial Measurement of Right of Use Assets and Operating Lease Labilities",
        "terseLabel": "Initial measurement of ROU assets and operating lease liabilities"
       }
      }
     },
     "localname": "InitialMeasurementOfRightOfUseAssetsAndOperatingLeaseLabilities",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_InvestorRoyaltyAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement other than collaborative applicable to investor royalty.",
        "label": "Investor Royalty Agreement [Member]",
        "terseLabel": "Investor Royalty Agreement [Member]"
       }
      }
     },
     "localname": "InvestorRoyaltyAgreementMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_IssuanceOfCommonStockForAssetAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The issuance of common stock for asset acquisition in noncash financing activities.",
        "label": "Issuance of Common Stock for Asset Acquisition",
        "terseLabel": "Issuance of common Stock for Novellus acquisition"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForAssetAcquisition",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_IssuanceOfCommonStockForSeriesAPreferredStockDividend": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of issuance of common stock for Series A preferred stock dividend in non-cash investing and financing activities.",
        "label": "Issuance of Common Stock for Series A Preferred Stock Dividend",
        "verboseLabel": "Issuance of common stock for Series A preferred stock dividend"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForSeriesAPreferredStockDividend",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash flows from issuance of common stock from exercise of pre-funded warrants.",
        "label": "Issuance of Common Stock from Exercise of Pre-funded Warrants",
        "negatedLabel": "Issuance of common stock from exercise of pre-funded warrants"
       }
      }
     },
     "localname": "IssuanceOfCommonStockFromExerciseOfPreFundedWarrants",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_LIQUIDITYANDCAPITALRESOURCESAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIQUIDITY AND CAPITAL RESOURCES [Abstract]"
       }
      }
     },
     "localname": "LIQUIDITYANDCAPITALRESOURCESAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "xbrltype": "stringItemType"
    },
    "erna_LaboratoryAndManufacturingEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and service.",
        "label": "Laboratory and Manufacturing Equipment [Member]",
        "terseLabel": "Laboratory and Manufacturing Equipment [Member]"
       }
      }
     },
     "localname": "LaboratoryAndManufacturingEquipmentMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of lease liability adjustment recognized as general and administrative expense.",
        "label": "Lease Liability, Recognized as General and Administrative Expense",
        "terseLabel": "Lease liability adjustment recognized as general and administrative expense"
       }
      }
     },
     "localname": "LeaseLiabilityRecognizedAsGeneralAndAdministrativeExpense",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_LeaseTerminationFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of lease termination fees paid.",
        "label": "Lease Termination Fee",
        "terseLabel": "Lease termination fee paid"
       }
      }
     },
     "localname": "LeaseTerminationFee",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_LeaseTerminationFeePayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of lease termination fees payable by the company.",
        "label": "Lease Termination Fee Payable",
        "terseLabel": "Lease termination fee payable"
       }
      }
     },
     "localname": "LeaseTerminationFeePayable",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_LegalMattersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Matters [Abstract]",
        "terseLabel": "Legal Matters [Abstract]"
       }
      }
     },
     "localname": "LegalMattersAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_LesseeCommitmentToPurchaseProperty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property for which lessee committed to purchase.",
        "label": "Lessee, Commitment to Purchase Property",
        "terseLabel": "Commitment to purchase equipment"
       }
      }
     },
     "localname": "LesseeCommitmentToPurchaseProperty",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee Operating Lease Weighted Average Remaining Lease Term And Discount Rate Abstract [Abstract]",
        "terseLabel": "Weighted Average Remaining Lease Term and Discount Rate [Abstract]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_LicenseAgreementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "License Agreement [Abstract]",
        "terseLabel": "Cell Customization and License Agreement [Abstract]"
       }
      }
     },
     "localname": "LicenseAgreementAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_LicenseAgreementExtensionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The term of license agreement to be extendable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "License Agreement Extension Term",
        "terseLabel": "License agreement extension term"
       }
      }
     },
     "localname": "LicenseAgreementExtensionTerm",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "erna_LicenseAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement term in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "License Agreement Term",
        "terseLabel": "License agreement term"
       }
      }
     },
     "localname": "LicenseAgreementTerm",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "erna_LicensingAgreementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licensing Agreements [Abstract]",
        "terseLabel": "Licensing Agreements [Abstract]"
       }
      }
     },
     "localname": "LicensingAgreementsAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_LincolnParkCapitalFundLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity.",
        "label": "Lincoln Park Capital Fund, LLC [Member]",
        "terseLabel": "Lincoln Park [Member]"
       }
      }
     },
     "localname": "LincolnParkCapitalFundLLCMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_LiquidityAndCapitalResourcesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liquidity and Capital Resources [Line Items]"
       }
      }
     },
     "localname": "LiquidityAndCapitalResourcesLineItems",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_LiquidityAndCapitalResourcesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about liquidity and capital resources.",
        "label": "Liquidity and Capital Resources [Table]"
       }
      }
     },
     "localname": "LiquidityAndCapitalResourcesTable",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_LiquidityAndCapitalResourcesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of liquidity and resource matters when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). going concern.",
        "label": "Liquidity And Capital Resources [Text Block]",
        "terseLabel": "Liquidity and Capital Resources"
       }
      }
     },
     "localname": "LiquidityAndCapitalResourcesTextBlock",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResources"
     ],
     "xbrltype": "textBlockItemType"
    },
    "erna_LitigationSettlementAmountPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount payable to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Payable",
        "terseLabel": "Aggregate settlement amount payable"
       }
      }
     },
     "localname": "LitigationSettlementAmountPayable",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_LockUpPeriodForRestrictedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period in which shares are locked-up, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Lock-up Period for Restricted Shares",
        "terseLabel": "Lock-up period"
       }
      }
     },
     "localname": "LockUpPeriodForRestrictedShares",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "erna_LossContingencyPercentageOfRoyaltyPayable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of royalty payable from one party to another in licensing agreement.",
        "label": "Loss contingency, Percentage of Royalty Payable",
        "terseLabel": "Percentage of royalty payable"
       }
      }
     },
     "localname": "LossContingencyPercentageOfRoyaltyPayable",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_LossOnNonControllingInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss on non-controlling investment.",
        "label": "Loss on Non-controlling Investment",
        "negatedLabel": "Loss on non-controlling investment",
        "terseLabel": "Loss on non-controlling investment"
       }
      }
     },
     "localname": "LossOnNonControllingInvestment",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_March2022WarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "March 2022 Warrants [Member]"
       }
      }
     },
     "localname": "March2022WarrantsMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_MasterServiceAgreementInitialFeesPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount agreed to pay an initial fee under Master Services Agreement (or \"MSA\").",
        "label": "Master Service Agreement, Initial Fees Payable",
        "terseLabel": "Master services agreement, initial fees payable"
       }
      }
     },
     "localname": "MasterServiceAgreementInitialFeesPayable",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_MembershipEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity membership interest in entity.",
        "label": "Membership Equity [Member]",
        "terseLabel": "Membership Equity [Member]"
       }
      }
     },
     "localname": "MembershipEquityMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_MergerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merger [Abstract]"
       }
      }
     },
     "localname": "MergerAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_MonthlyMasterServicesAgreementFeesPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The monthly master service agreement (\"MSA\") fees payable to related party.",
        "label": "Monthly Master Services Agreement Fees Payable",
        "terseLabel": "Monthly master services agreement fees payable initial 12-month"
       }
      }
     },
     "localname": "MonthlyMasterServicesAgreementFeesPayable",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_NTNBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the disposal group.",
        "label": "NTN Business [Member]",
        "terseLabel": "NTN Business [Member]"
       }
      }
     },
     "localname": "NTNBusinessMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_NTNBuzztimeIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of acquiree entity.",
        "label": "NTN Buzztime, Inc [Member]",
        "terseLabel": "NTN Buzztime, Inc [Member]"
       }
      }
     },
     "localname": "NTNBuzztimeIncMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_NewFacilityLeaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Facility Lease [Abstract]"
       }
      }
     },
     "localname": "NewFacilityLeaseAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_NonQualifiedStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Non-qualified Stock Option [Member]",
        "terseLabel": "Nonqualified Stock Options [Member]"
       }
      }
     },
     "localname": "NonQualifiedStockOptionMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of further shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Further Shares Issued1",
        "terseLabel": "Number of shares remaining to be sold in purchase commitment (in shares)"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationFurtherSharesIssued1",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of preferred stock issued in a reverse merger transaction in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Preferred Shares Issued in Connection with Reverse Merger",
        "terseLabel": "Preferred shares issued in connection with reverse merger"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_NoticePeriodForFirstTerminationOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company may terminate the first work under the MSA on or after the second anniversary of the date of the MSA, subject to providing Factor with prior notice, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Notice Period for First Termination of Contract",
        "terseLabel": "Notice period for first termination of contract"
       }
      }
     },
     "localname": "NoticePeriodForFirstTerminationOfContract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "erna_NoticePeriodForSupersedingTerminationProvisions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Master Services Agreement (or \"MSA\") contains customary confidentiality provisions and representations and warranties of the parties, and the Master Services Agreement (or \"MSA\") may be terminated by ether party prior notice, subject to any superseding termination provisions contained in a particular work order, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Notice Period for Superseding Termination Provisions",
        "terseLabel": "Notice period for superseding termination provisions"
       }
      }
     },
     "localname": "NoticePeriodForSupersedingTerminationProvisions",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "erna_NoveCiteINCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of company involved in licensing agreement.",
        "label": "NoveCite, INC. [Member]",
        "terseLabel": "NoveCite, INC. [Member]"
       }
      }
     },
     "localname": "NoveCiteINCMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_NovellusTherapeuticsLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of company involved in licensing agreement.",
        "label": "Novellus Therapeutics Limited [Member]",
        "terseLabel": "Novellus, Ltd. [Member]"
       }
      }
     },
     "localname": "NovellusTherapeuticsLimitedMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_November2022WarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "November 2022 Warrants [Member]"
       }
      }
     },
     "localname": "November2022WarrantsMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_NumberOfAwardsVestedAndSettledAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Awards Vested and Settled [Abstract]",
        "terseLabel": "Number of RSUs Vested and Settled [Abstract]"
       }
      }
     },
     "localname": "NumberOfAwardsVestedAndSettledAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_NumberOfBoardSeats": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of members of the company's management holds board seats on board of directors.",
        "label": "Number of Board Seats",
        "terseLabel": "Number of board seats"
       }
      }
     },
     "localname": "NumberOfBoardSeats",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "erna_NumberOfInLicensedPortfolioPatents": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of in-licensed portfolio patents covering key mRNA cell engineering technologies.",
        "label": "Number of In-licensed Portfolio Patents",
        "terseLabel": "Number of patents"
       }
      }
     },
     "localname": "NumberOfInLicensedPortfolioPatents",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "erna_NumberOfMonthlyInstallmentsForFeesPayable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equal monthly installments for initial fees payable.",
        "label": "Number of Monthly Installments for Fees Payable",
        "terseLabel": "Number of monthly installments for fees payable"
       }
      }
     },
     "localname": "NumberOfMonthlyInstallmentsForFeesPayable",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "erna_NumberOfSharesConsideredAsFractionalInReverseStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares considered as fractional in reverse stock split.",
        "label": "Number of Shares Considered as Fractional in Reverse Stock",
        "terseLabel": "Number of fractional shares considered in reverse stock split (in shares)"
       }
      }
     },
     "localname": "NumberOfSharesConsideredAsFractionalInReverseStock",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_NumberOfWarrantsInEachUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrant consist in each unit.",
        "label": "Number of warrants in each unit"
       }
      }
     },
     "localname": "NumberOfWarrantsInEachUnit",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "erna_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents obligated to maintain under merger agreement on balance sheet at the effective time of the merger.",
        "label": "Obligated to Maintain Cash and Cash Equivalents Under Merger Agreement",
        "terseLabel": "Cash and cash equivalents obligated to have under merger agreement"
       }
      }
     },
     "localname": "ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_ObligationToPayLiquidatedDamagesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages percentage of aggregate payment on Subscription Amount.",
        "label": "Obligation to Pay Liquidated Damages Percentage",
        "terseLabel": "Obligated to pay liquidated damages percentage"
       }
      }
     },
     "localname": "ObligationToPayLiquidatedDamagesPercentage",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages equal to the Subscription Amount per month.",
        "label": "Obligation to Pay Liquidated Damages Percentage on Subscription Amount per Month",
        "terseLabel": "Obligation to pay liquidated damages per month"
       }
      }
     },
     "localname": "ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_OperatingLeaseArea": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of leased property under operating lease.",
        "label": "Operating Lease Area",
        "terseLabel": "Operating lease area"
       }
      }
     },
     "localname": "OperatingLeaseArea",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "erna_OperatingLeaseAssestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Asset [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseAssestAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for lessee's operating lease right-of-use assets and liabilities.",
        "label": "Operating Lease Right-of-use Assets and Liabilities [Table Text Block]",
        "terseLabel": "Operating Lease Right-of-use Assets and Liabilities"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "erna_OperatingLeasesIncrementalBaseRentalPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount for base rental payments, as well as parking and traditional lease expenses including, certain taxes, operating expenses and utilities can be incremented.",
        "label": "Operating Leases, Incremental Base Rental Payment",
        "terseLabel": "Incremental base rental payment"
       }
      }
     },
     "localname": "OperatingLeasesIncrementalBaseRentalPayment",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_OperatingLeasesMonthlyBaseRent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of rental expense payable per month for operating leases.",
        "label": "Operating Leases, Monthly Base Rent",
        "terseLabel": "Monthly base rent payable"
       }
      }
     },
     "localname": "OperatingLeasesMonthlyBaseRent",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_OperatingLossCarryforwardsExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of each operating loss carryforward included in operating loss carryforward, in YYYY format.",
        "label": "Operating Loss Carryforwards, Expiration Year",
        "terseLabel": "Net operating loss carryforwards begin to expire"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsExpirationYear",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "erna_OverSubscriptionAmountReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.",
        "label": "Over-Subscription Amount Received",
        "terseLabel": "Over-subscription amount received"
       }
      }
     },
     "localname": "OverSubscriptionAmountReceived",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_PIPEInvestorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private investment in public equity, often called a PIPE deal, involves the selling of publicly traded common shares or some form of preferred stock or convertible security to private investors. It is an allocation of shares in a public company not through a public offering in a stock exchange. PIPE deals are part of the primary market. In the U.S., a PIPE offering may be registered with the Securities and Exchange Commission on a registration statement or may be completed as an unregistered private placement.",
        "label": "PIPE Investor [Member]",
        "terseLabel": "PIPE Investor [Member]",
        "verboseLabel": "Q1-22 PIPE Investor [Member]"
       }
      }
     },
     "localname": "PIPEInvestorMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_PIPEInvestorOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private investment in public equity, often called a PIPE deal, involves the selling of publicly traded common shares or some form of preferred stock or convertible security to private investors. It is an allocation of shares in a public company not through a public offering in a stock exchange. PIPE deals are part of the primary market. In the U.S., a PIPE offering may be registered with the Securities and Exchange Commission on a registration statement or may be completed as an unregistered private placement.",
        "label": "PIPE Investor One [Member]",
        "terseLabel": "Q4-22 PIPE Investor [Member]"
       }
      }
     },
     "localname": "PIPEInvestorOneMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_PaycheckProtectionProgramLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the debt instrument.",
        "label": "Paycheck Protection Program Loan [Member]",
        "terseLabel": "IRX Notes [Member]"
       }
      }
     },
     "localname": "PaycheckProtectionProgramLoanMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_PaycheckProtectionProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paycheck Protection Program [Member]",
        "label": "Paycheck Protection Program [Member]",
        "terseLabel": "Eterna LLC Paycheck Protection Program [Member]"
       }
      }
     },
     "localname": "PaycheckProtectionProgramMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_PaymentOfAccruedAndUnpaidInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for accrued and unpaid interest related to notes payable.",
        "label": "Payment of Accrued and Unpaid Interest",
        "terseLabel": "Payment of accrued and unpaid interest"
       }
      }
     },
     "localname": "PaymentOfAccruedAndUnpaidInterest",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_PaymentOfOptionFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of option fee related to licensing agreement.",
        "label": "Payment of Option Fee",
        "terseLabel": "Payment of option fee"
       }
      }
     },
     "localname": "PaymentOfOptionFee",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_PaymentsOfPaycheckProtectionProgramLoan": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash outflow for payment of paycheck protection program loans.",
        "label": "Payments of Paycheck Protection Program Loan",
        "negatedLabel": "Repayment of NTN's PPP loan"
       }
      }
     },
     "localname": "PaymentsOfPaycheckProtectionProgramLoan",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_PaymentsToAcquireProductiveAssetsNet": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets excluding cash acquired.",
        "label": "Cash paid, net",
        "negatedLabel": "Purchase of Novellus, net of common stock issued and cash acquired",
        "verboseLabel": "Cash paid, net"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssetsNet",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_PercentageOfAdditionalRightsOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of additional right offering made by the entity for unit holders.",
        "label": "Percentage of Additional Rights Offering",
        "terseLabel": "Percentage of additional rights offering"
       }
      }
     },
     "localname": "PercentageOfAdditionalRightsOffering",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_PercentageOfCommonStockSubjectToLockUpAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of shares of common stock subject to the lock-up agreement",
        "label": "Percentage of Common Stock Subject to Lock-up Agreement",
        "terseLabel": "Percentage of common stock subject to the lock-up agreement"
       }
      }
     },
     "localname": "PercentageOfCommonStockSubjectToLockUpAgreement",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_PercentageOfDiscountOnFairValueOfRestrictedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of discount on restricted shares, which was derived from the average discount rate between the Black Scholes and Finnerty valuation models.",
        "label": "Percentage of Discount on Fair Value of Restricted Shares",
        "terseLabel": "Percentage of discount on fair value restricted shares"
       }
      }
     },
     "localname": "PercentageOfDiscountOnFairValueOfRestrictedShares",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of increase in annual lease payment for subleases for each year.",
        "label": "Percentage of Lessee Sublease, Increase In Annual Lease Rent Payments",
        "terseLabel": "Percentage of annual rent increase"
       }
      }
     },
     "localname": "PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of additional royalty payable on gross sales by the entity.",
        "label": "Percentage of Payment Of Additional Royalty On Gross Sales",
        "terseLabel": "Percentage of payment of additional royalty on gross sales"
       }
      }
     },
     "localname": "PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of royalty payable equal to revenues generated from disposition of business.",
        "label": "Percentage of Royalty Payable Equal to Revenues from Sale of Business",
        "terseLabel": "Percentage of royalty receive equal to revenues from sale of business"
       }
      }
     },
     "localname": "PercentageOfRoyaltyPayableEqualToRevenuesFromSaleOfBusiness",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_PercentageOfSharesOfCommonStockOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of common stock shares outstanding considered for equity number of shares under equity incentive plan.",
        "label": "Percentage of Shares of Common Stock Outstanding",
        "terseLabel": "Percentage of number of shares of common stock outstanding"
       }
      }
     },
     "localname": "PercentageOfSharesOfCommonStockOutstanding",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_PercentageOfSublicenseFeePayableBeforeExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of sublicense fee payable by the company before expiration date as per \"Exclusive Factor License Agreement\".",
        "label": "Percentage of Sublicense Fee Payable Before Expiration Period",
        "terseLabel": "Percentage of sublicense fee payable by company before expiration date"
       }
      }
     },
     "localname": "PercentageOfSublicenseFeePayableBeforeExpirationPeriod",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_PercentageOfSublicenseFeePayableDuringRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of sublicense fee payable by the company during renewal period as per \"Exclusive Factor License Agreement\".",
        "label": "Percentage of Sublicense Fee Payable During Renewal Term",
        "terseLabel": "Percentage of sublicense fee payable by company during renewal term"
       }
      }
     },
     "localname": "PercentageOfSublicenseFeePayableDuringRenewalTerm",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "erna_PerformanceBasedStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on performance basis.",
        "label": "Performance Based Stock Option [Member]"
       }
      }
     },
     "localname": "PerformanceBasedStockOptionMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_PreFundedWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A pre-funded warrant that allows the warrant holder to purchase a specified number of a company's securities at a nominal exercise price.",
        "label": "Pre-funded Warrants [Member]",
        "terseLabel": "Pre-funded Warrants [Member]"
       }
      }
     },
     "localname": "PreFundedWarrantsMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_PrincipalPaymentsOnOperatingLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal payments on operating lease liabilities.",
        "label": "Principal payments on operating lease liabilities",
        "negatedLabel": "Principal payments on operating lease liabilities"
       }
      }
     },
     "localname": "PrincipalPaymentsOnOperatingLeaseLiabilities",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_PrivatePlacementOfEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement of Equity [Abstract]",
        "terseLabel": "Private Placement of Equity [Abstract]"
       }
      }
     },
     "localname": "PrivatePlacementOfEquityAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_PrivatePlacementOfferingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Offerings [Abstract]"
       }
      }
     },
     "localname": "PrivatePlacementOfferingsAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_ProFormaFairValueAdjustmentToAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value adjustment to acquisition-date assets reported in proforma information.",
        "label": "Pro Forma Fair Value Adjustment to Assets [Member]",
        "terseLabel": "Fair Value Adjustment to Assets [Member]"
       }
      }
     },
     "localname": "ProFormaFairValueAdjustmentToAssetsMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_ProceedsFromDispositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Disposition [Abstract]",
        "terseLabel": "Proceeds from sale [Abstract]"
       }
      }
     },
     "localname": "ProceedsFromDispositionAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_ProceedsFromIssuanceOfCommonStockToLincolnPark": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the proceeds from issuance of common stock to Lincoln Park to the entity.",
        "label": "Proceeds From Issuance of Common Stock to Lincoln Park",
        "verboseLabel": "Net proceeds of common stock issued to Lincoln Park"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStockToLincolnPark",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_ProceedsFromOptionAndLicenseAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from exclusive option and license agreement as a non-refundable up-front payment.",
        "label": "Proceeds from Option and License Agreement",
        "terseLabel": "Proceeds from option and license agreement"
       }
      }
     },
     "localname": "ProceedsFromOptionAndLicenseAgreement",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_ProceedsFromSaleOfRights": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of rights during the period.",
        "label": "Proceeds From Sale Of Rights",
        "terseLabel": "Proceeds from right offering"
       }
      }
     },
     "localname": "ProceedsFromSaleOfRights",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_PurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about purchase agreement between the entities.",
        "label": "Purchase Agreement [Member]",
        "terseLabel": "Purchase Agreements [Member]"
       }
      }
     },
     "localname": "PurchaseAgreementMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_PurchasePriceAllocationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price allocation of acquisition-date assets and liability assumed.",
        "label": "Purchase Price Allocation [Member]",
        "terseLabel": "Purchase Price Allocation [Member]"
       }
      }
     },
     "localname": "PurchasePriceAllocationMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_Q422PIPETransactionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Q4-22 PIPE Transaction [Abstract]"
       }
      }
     },
     "localname": "Q422PIPETransactionAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_ReclassificationFromFixedAssetsToRightOfUseAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reclassification from fixed assets to right-of-use (ROU) assets.",
        "label": "Reclassification from Fixed Assets to Right-of-use Asset",
        "terseLabel": "Reclassification from fixed assets to ROU assets"
       }
      }
     },
     "localname": "ReclassificationFromFixedAssetsToRightOfUseAsset",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Cash Cash Equivalents and Restricted Cash in Condensed Consolidated Statements Of Cash Flows [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash at end of period:"
       }
      }
     },
     "localname": "ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_ReimburseCostsIncurredOrPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount reimburse for costs already incurred or paid.",
        "label": "Reimburse Costs Incurred or Paid",
        "terseLabel": "Reimburse costs incurred or paid"
       }
      }
     },
     "localname": "ReimburseCostsIncurredOrPaid",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_RelatedPartyTransactionPeriodicFeesPaymentAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of required periodic fees payment.",
        "label": "Related Party Transaction, Periodic Fees Payment, Amount",
        "terseLabel": "Monthly installment fees amount"
       }
      }
     },
     "localname": "RelatedPartyTransactionPeriodicFeesPaymentAmount",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_RemainingLicenseFeeObligation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of remaining license fee obligation.",
        "label": "Remaining License Fee Obligation",
        "terseLabel": "Remaining license fee obligation"
       }
      }
     },
     "localname": "RemainingLicenseFeeObligation",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_RemainingNetBookValueOfFixedAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after depreciation of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Remaining Net Book Value of Fixed Assets",
        "terseLabel": "Net book value of fixed assets"
       }
      }
     },
     "localname": "RemainingNetBookValueOfFixedAssets",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_RemeasurementOfOperatingLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of remeasurement of operating lease liability.",
        "label": "Remeasurment of lease liability",
        "negatedLabel": "Remeasurement of lease liability"
       }
      }
     },
     "localname": "RemeasurementOfOperatingLeaseLiability",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_RemeasurementOfOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of remeasurement of operating lease right-of-use asset.",
        "label": "Remeasurement of Operating Lease Right-of-use Asset",
        "negatedLabel": "Remeasurement of ROU asset"
       }
      }
     },
     "localname": "RemeasurementOfOperatingLeaseRightOfUseAsset",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_ResearchAndDevelopmentInProcessAssetAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process, Asset Acquisition",
        "terseLabel": "In-process R&amp;D acquired in Novellus asset acquisition",
        "verboseLabel": "In-process research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcessAssetAcquisition",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_RetirementPlan401KMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A defined-contribution retirement account which allows employees to save a portion of their salary in a tax-advantaged manner. The money earned in a 401(k) Plan is not taxed until after the employee retires, at which time their income will typically be lower than during their working years.",
        "label": "Retirement Plan, 401K [Member]",
        "terseLabel": "401K [Member]"
       }
      }
     },
     "localname": "RetirementPlan401KMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_ReverseStockSplitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Stock-Split [Abstract]"
       }
      }
     },
     "localname": "ReverseStockSplitAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_ReverseStockSplitPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the reverse stock split during the period.",
        "label": "Reverse Stock Split [Policy Text Block]",
        "verboseLabel": "October 2022 Reverse Stock Split"
       }
      }
     },
     "localname": "ReverseStockSplitPolicyTextBlock",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "erna_RoyaltyAgreementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Agreements [Abstract]",
        "terseLabel": "Royalty Agreements [Abstract]"
       }
      }
     },
     "localname": "RoyaltyAgreementsAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of minimum sublease rentals to be received by the seller-lessee for sale-leaseback transactions accounted for using the deposit method or as a financing.",
        "label": "Sale Leaseback Transactions, Future Minimum Sublease Rentals",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "SaleLeasebackTransactionsFutureMinimumSubleaseRentals",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale Leaseback Transactions, Future Minimum Sublease Rentals, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Future Lease Payments, Sublease Agreement [Abstract]"
       }
      }
     },
     "localname": "SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails": {
       "order": 2.0,
       "parentTag": "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Sale Leaseback Transactions, Future Minimum Sublease Rentals, Next Twelve Months",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails": {
       "order": 6.0,
       "parentTag": "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Sale Leaseback Transactions, Future Minimum Sublease Rentals, within Four Years",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinFourYears",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails": {
       "order": 5.0,
       "parentTag": "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Sale Leaseback Transactions, Future Minimum Sublease Rentals, within Three Years",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails": {
       "order": 3.0,
       "parentTag": "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Sale Leaseback Transactions, Future Minimum Sublease Rentals, within Two Years",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_SaleOfStockNumberOfSharesToIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares to be issued by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares to Issued in Transaction",
        "terseLabel": "Number of remaining shares to be sold (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesToIssuedInTransaction",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number RSUs vested and settled.",
        "label": "Schedule of Restricted Stock Units Vested and Settled [Table Text Block]",
        "terseLabel": "RSUs Vested and Settled"
       }
      }
     },
     "localname": "ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "erna_SecondPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about second purchase agreement between the entities.",
        "label": "Second Purchase Agreement [Member]"
       }
      }
     },
     "localname": "SecondPurchaseAgreementMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options expected to vest.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Number",
        "terseLabel": "Balance expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of extended post-termination exercise period under the share-based compensation arrangements, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Extended Post-Termination, Exercise Period",
        "terseLabel": "Exercise period of extended post-termination"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares Forfeiture of unvested restricted stock during the period.",
        "label": "Shares Issued, Shares, Forfeiture of unvested restricted stock",
        "negatedLabel": "Forfeiture of unvested restricted stock (in shares)"
       }
      }
     },
     "localname": "SharesIssuedSharesForfeitureOfUnvestedRestrictedStock",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_StockIssuedDuringPeriodRestrictedSharesAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued with restrictions during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Restricted Shares, Acquisitions",
        "terseLabel": "Restricted shares, issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodRestrictedSharesAcquisitions",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": 4.0,
       "parentTag": "erna_AssetAcquisitionFairValueOfConsiderationPaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued with restrictions during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Restricted Shares, Value, Acquisitions",
        "terseLabel": "Restricted shares, value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodRestrictedSharesValueAcquisitions",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_StockIssuedDuringPeriodSharesAcquisitions1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions1",
        "terseLabel": "Common stock to be retained by NTN stockholders (in shares)",
        "verboseLabel": "Stock issued, shares, acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions1",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_StockIssuedDuringPeriodSharesAcquisitions2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions2",
        "terseLabel": "Issuance of common stock in connection with the acquisition of Novellus, Inc. (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions2",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including exercise of pre-funded warrants.",
        "label": "Stock Issued During Period Shares Exercise of Pre-funded Warrants",
        "terseLabel": "Issuance of common stock from exercise of pre-funded warrants (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesExerciseOfPreFundedWarrants",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_StockIssuedDuringPeriodSharesInLieuOfDividends": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period in lieu of dividends to be paid.",
        "label": "Stock Issued During Period, Shares, in Lieu of Dividends",
        "terseLabel": "Issuance of common stock in lieu of cash dividend to Series A convertible preferred stockholders (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesInLieuOfDividends",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the shares of new stock issued of preferred stock during the period.",
        "label": "Stock Issued During Period, Shares, New Issues of Preferred Stock, Retained by Stockholders",
        "terseLabel": "Issuance of Series A preferred stock retained by NTN stockholders (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of stock issued common stock and prefunded warrants in connection with public offering during the period.",
        "label": "Stock Issued During Period Shares of Common Stock and Prefunded Warrants in Connection with Public Offering Net of Offering Costs",
        "terseLabel": "Issuance of common stock and pre-funded warrants in connection with March 2022 private offering, net. (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOfCommonStockAndPrefundedWarrantsInConnectionWithPublicOfferingNetOfOfferingCosts",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of stock issued common stock and warrants in connection with private offering during the period.",
        "label": "Stock Issued During Period Shares of Common Stock and Warrants in Connection with Private Offering Net of Offering Costs",
        "terseLabel": "Issuance of common stock and warrants in connection with November 2022 private offering, net. (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been issued in a stock purchase agreement during the period.",
        "label": "Stock Issued During Period, Shares, Stock Purchase Agreement",
        "terseLabel": "Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockPurchaseAgreement",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued without any restrictions during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Unrestricted Shares, Acquisitions",
        "terseLabel": "Unrestricted shares, issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodUnrestrictedSharesAcquisitions",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "erna_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "erna_AssetAcquisitionFairValueOfConsiderationPaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued without any restrictions during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Unrestricted Shares, Value, Acquisitions",
        "terseLabel": "Unrestricted shares, value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued common stock and warrants in connection with private offering during the period.",
        "label": "Stock Issued During Period Value 0f Common Stock and Warrants in Connection with Private Offering Net of Offering Costs",
        "terseLabel": "Issuance of common stock and warrants in connection with November 2022 private offering, net."
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_StockIssuedDuringPeriodValueAcquisitions1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions1",
        "terseLabel": "Common stock to be retained by NTN stockholders"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions1",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_StockIssuedDuringPeriodValueAcquisitions2": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions2",
        "terseLabel": "Issuance of common stock in connection with the acquisition of Novellus, Inc."
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions2",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of issuance of common stock from exercise of pre-funded warrants issued during the period.",
        "label": "Stock Issued During Period Value Exercise of Pre-funded Warrants",
        "terseLabel": "Issuance of common stock from exercise of pre-funded warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Forfeiture of unvested restricted stock during the period.",
        "label": "Stock Issued During Period, Value, Forfeiture of Unvested Restricted Stock",
        "terseLabel": "Forfeiture of unvested restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_StockIssuedDuringPeriodValueInLieuOfDividends": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued during the period in Lieu of Dividends to be paid.",
        "label": "Stock Issued During Period, Value, in Lieu of Dividends",
        "terseLabel": "Issuance of common stock in lieu of cash dividend to Series A convertible preferred stockholders"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueInLieuOfDividends",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued of preferred stock during the period.",
        "label": "Stock Issued During Period, Value, New Issues of Preferred Stock, Retained by Stockholders",
        "terseLabel": "Issuance of Series A preferred stock retained by NTN stockholders"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued common stock and prefunded warrants in connection with private offering during the period.",
        "label": "Stock Issued During Period Value of Common Stock and Prefunded Warrants in Connection with Private Offering Net of Offering Costs",
        "terseLabel": "Issuance of common stock and pre-funded warrants in connection with March 2022 private offering, net."
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOfCommonStockAndPrefundedWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to rights offering membership units during the period.",
        "label": "Stock Issued During Period, Value, Rights Offering Membership Units",
        "terseLabel": "Brooklyn rights offerings membership units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRightsOfferingMembershipUnits",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_StockIssuedDuringPeriodValueStockPurchaseAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been issued in a stock purchase agreement during the period.",
        "label": "Stock Issued During Period, Value, Stock Purchase Agreement",
        "terseLabel": "Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockPurchaseAgreement",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_SubleaseCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred in connection with sublease.",
        "label": "Sublease Cost",
        "terseLabel": "Sublease cost"
       }
      }
     },
     "localname": "SubleaseCost",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_SubleaseCostForTenantImprovements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sublease cost for the architect to design the tenant improvements to the premises and for a project manager to manage the construction.",
        "label": "Sublease Cost for Tenant Improvements",
        "terseLabel": "Sublease cost for tenant improvements"
       }
      }
     },
     "localname": "SubleaseCostForTenantImprovements",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_TaxCreditCarryforwardExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration beginning year of the tax credit carryforward, in YYYY format.",
        "label": "Tax Credit Carryforward Expiration Year",
        "terseLabel": "Tax credits begin to expire"
       }
      }
     },
     "localname": "TaxCreditCarryforwardExpirationYear",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "erna_TaxCutsAndJobsActOperatingLossCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws from effect of Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards under Tax Cuts and Jobs Act"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOperatingLossCarryforwards",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_TenantImprovementAllowance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tenant improvement allowance to improvements of the Premises.",
        "label": "Tenant Improvement Allowance",
        "terseLabel": "Tenant improvement allowance"
       }
      }
     },
     "localname": "TenantImprovementAllowance",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_TenantImprovementAllowancePerRentableSquareFoot": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tenant improvement allowance per rentable square foot for the improvements of premises.",
        "label": "Tenant Improvement Allowance, per Rentable Square Foot",
        "terseLabel": "Tenant improvement allowance per rentable square foot"
       }
      }
     },
     "localname": "TenantImprovementAllowancePerRentableSquareFoot",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_ThresholdIncomeForAutomaticExtensionOfLicensePeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum threshold income from sublicenses to the factor patents for automatic extension of license period.",
        "label": "Threshold Income for Automatic Extension of License Period",
        "terseLabel": "Threshold income for automatic extension of license period"
       }
      }
     },
     "localname": "ThresholdIncomeForAutomaticExtensionOfLicensePeriod",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_TimeBasedStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on time basis.",
        "label": "Time Based Stock Option [Member]"
       }
      }
     },
     "localname": "TimeBasedStockOptionMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_TransactionFeesPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fees incurred related to PIPE transaction.",
        "label": "Transaction Fees Payable",
        "terseLabel": "Transaction fees"
       }
      }
     },
     "localname": "TransactionFeesPayable",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_UnitPriceOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price of prefunded and common warrants.",
        "label": "Unit Price of Warrants",
        "verboseLabel": "Unit price (in dollars per share)"
       }
      }
     },
     "localname": "UnitPriceOfWarrants",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "erna_UniversityOfSouthFloridaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal entity involved in litigation.",
        "label": "University of South Florida [Member]",
        "terseLabel": "University of South Florida [Member]"
       }
      }
     },
     "localname": "UniversityOfSouthFloridaMember",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "erna_UnpaidFeesIncurredInConnectionWithPrivateOffering": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of unpaid fees incurred in connection with private offering.",
        "label": "Unpaid Fees Incurred in Connection with Private Offering",
        "terseLabel": "Unpaid fees incurred in connection with private offering"
       }
      }
     },
     "localname": "UnpaidFeesIncurredInConnectionWithPrivateOffering",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_VariableRateTransactionsPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuant to the Purchase Agreement, the Company is prohibited from issuing equity in variable rate transactions for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Variable Rate Transactions Period",
        "terseLabel": "Variable rate transaction period"
       }
      }
     },
     "localname": "VariableRateTransactionsPeriod",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "erna_WarrantLiabilitiesExpense": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to warrant liabilities.",
        "label": "Warrant Liabilities Expense",
        "negatedLabel": "Change in fair value of warrant liabilities",
        "terseLabel": "Gain on warrant liabilities"
       }
      }
     },
     "localname": "WarrantLiabilitiesExpense",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_WriteOffOfOperatingLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of operating lease liability due to lease termination.",
        "label": "Write- off of Operating Lease Liability",
        "negatedLabel": "Write off of lease liability due to lease termination"
       }
      }
     },
     "localname": "WriteOffOfOperatingLeaseLiability",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "erna_WriteOffOfOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of operating lease right-of-use asset due to lease termination.",
        "label": "Write-off of Operating Lease Right-of-use Asset",
        "negatedLabel": "Write off of ROU asset due to lease termination"
       }
      }
     },
     "localname": "WriteOffOfOperatingLeaseRightOfUseAsset",
     "nsuri": "http://eternatx.com/20221231",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r393",
      "r563",
      "r588",
      "r624",
      "r625",
      "r637",
      "r643",
      "r652",
      "r699",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails",
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r393",
      "r563",
      "r588",
      "r624",
      "r625",
      "r637",
      "r643",
      "r652",
      "r699",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r381",
      "r393",
      "r428",
      "r429",
      "r430",
      "r561",
      "r563",
      "r588",
      "r624",
      "r625",
      "r637",
      "r643",
      "r652",
      "r692",
      "r699",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails",
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails",
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r381",
      "r393",
      "r428",
      "r429",
      "r430",
      "r561",
      "r563",
      "r588",
      "r624",
      "r625",
      "r637",
      "r643",
      "r652",
      "r692",
      "r699",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails",
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails",
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Accounting Presentation and Summary of Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r28",
      "r650"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails",
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Legal fees and related"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r85",
      "r208"
     ],
     "calculation": {
      "http://eternatx.com/role/PropertyAndEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r23",
      "r650"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r437",
      "r438",
      "r439",
      "r682",
      "r683",
      "r684",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r123",
      "r124",
      "r400"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "Stock based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Stock based compensation expense",
        "terseLabel": "Stock-based compensation expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Total potential common shares excluded from computation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of a real estate property.",
        "label": "Area of premises",
        "terseLabel": "Area of office and laboratory space"
       }
      }
     },
     "localname": "AreaOfRealEstateProperty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails",
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionTableTextBlock": {
     "auth_ref": [
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of asset acquisition.",
        "label": "Fair Value of Asset Acquired"
       }
      }
     },
     "localname": "AssetAcquisitionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r175",
      "r189",
      "r211",
      "r233",
      "r280",
      "r289",
      "r291",
      "r297",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r483",
      "r485",
      "r504",
      "r650",
      "r697",
      "r698",
      "r813"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and Liabilities, Lessee [Abstract]"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r204",
      "r215",
      "r233",
      "r297",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r483",
      "r485",
      "r504",
      "r650",
      "r697",
      "r698",
      "r813"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying value of assets sold [Abstract]"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r403",
      "r404",
      "r405",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://eternatx.com/role/StockbasedCompensationRsusDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r155",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Accounting Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Accounting Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r479",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r138",
      "r139",
      "r479",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Purchase price",
        "terseLabel": "Total consideration"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Number of common stock issued in exchange of membership interests (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails",
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of outstanding common stock received by members and financial adviser"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Closing price of common stock (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merger Agreement [Abstract]",
        "terseLabel": "Description of Business [Abstract]",
        "verboseLabel": "Acquisitions [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails",
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Prepaid expense and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedLabel": "Accounts payable, accrued liabilities and other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r140",
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Net assets acquired, excluding goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r140",
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merger, Disposition and Acquisition Transactions [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r601",
      "r602",
      "r650",
      "r663"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "erna_AssetAcquisitionFairValueOfConsiderationPaid",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "negatedLabel": "Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r59",
      "r206",
      "r627"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, at Carrying Value [Abstract]",
        "terseLabel": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r60",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r54",
      "r59",
      "r65"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "verboseLabel": "Total Cash, cash equivalents and restricted cash at end of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r54",
      "r167"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r663"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r212",
      "r213",
      "r214",
      "r233",
      "r258",
      "r259",
      "r262",
      "r264",
      "r271",
      "r272",
      "r297",
      "r322",
      "r325",
      "r326",
      "r327",
      "r331",
      "r332",
      "r361",
      "r362",
      "r366",
      "r370",
      "r378",
      "r504",
      "r626",
      "r662",
      "r677",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails",
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails",
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r112",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Warrant exercise price (in dollars per share)",
        "terseLabel": "Warrant exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Number of common stock (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Number of rights options converted (in shares)",
        "verboseLabel": "Warrants exercisable (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Warrants outstanding (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r112",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r37",
      "r181",
      "r194"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and contingencies (Note 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r91",
      "r314",
      "r315",
      "r619",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r94",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Commitment and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common Class A [Member]",
        "verboseLabel": "Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Common Class B [Member]",
        "verboseLabel": "Class B [Member]"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation.",
        "label": "Common Class C [Member]",
        "terseLabel": "Common Class C [Member]",
        "verboseLabel": "Class C [Member]"
       }
      }
     },
     "localname": "CommonClassCMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r682",
      "r683",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails",
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized (in shares)",
        "terseLabel": "Number of shares authorized to sale in regular purchase (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r22",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding (in shares)",
        "terseLabel": "Number of shares of common stock owned by stockholders immediately before the Merger (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r22",
      "r650"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.005 par value, 100,000 shares authorized at December 31, 2022 and 2021; 5,127 and 2,601 issued and outstanding at December 31, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Components of Income Tax Provision [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment and Programs [Member]",
        "terseLabel": "Computer Equipment [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r186",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r62",
      "r63",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Number of shares converted to common stock (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r361",
      "r362",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Preferred Stock Converted into Common Stock [Member]"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r20",
      "r21",
      "r102",
      "r105",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Each preferred stock converted into common stock (in shares)"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r680",
      "r794",
      "r796"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r680",
      "r794"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r135",
      "r461",
      "r471",
      "r680"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Current income tax provision"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current Tax Provision [Abstract]"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r680",
      "r794",
      "r796"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customers [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r97",
      "r230",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r349",
      "r356",
      "r357",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r15",
      "r16",
      "r17",
      "r176",
      "r178",
      "r188",
      "r237",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r522",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r169",
      "r170",
      "r333",
      "r522",
      "r633",
      "r634"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r33",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "verboseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r34",
      "r237",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r522",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r34",
      "r102",
      "r106",
      "r107",
      "r108",
      "r168",
      "r169",
      "r170",
      "r185",
      "r237",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r358",
      "r522",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r680",
      "r795",
      "r796"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r135",
      "r680",
      "r795"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r57",
      "r135",
      "r462",
      "r470",
      "r471",
      "r680"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Deferred Income tax provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred Tax Provision [Abstract]"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r18",
      "r19",
      "r177",
      "r187",
      "r455"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r680",
      "r795",
      "r796"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r456"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r133",
      "r793"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r792"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred Tax Assets: [Abstract]"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r133",
      "r793"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Foreign net operating losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r131",
      "r133",
      "r793"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "R&amp;D credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences": {
     "auth_ref": [
      "r133",
      "r793"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensated absences (includes, but not limited to, sick and personal days).",
        "label": "Compensation accrual"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r133",
      "r793"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Stock compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "auth_ref": [
      "r133",
      "r793"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r457"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r127",
      "r792"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred taxes"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "auth_ref": [
      "r133",
      "r150",
      "r151",
      "r793"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill",
        "negatedLabel": "Intangibles - goodwill"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "terseLabel": "Deferred Tax Liabilities: [Abstract]"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r133",
      "r793"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Fixed assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan [Abstract]"
       }
      }
     },
     "localname": "DefinedContributionPlanAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Contribution Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedContributionPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Maximum employer matching contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanTable": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.",
        "label": "Defined Contribution Plan [Table]"
       }
      }
     },
     "localname": "DefinedContributionPlanTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.",
        "label": "Security deposit"
       }
      }
     },
     "localname": "DepositsAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r57",
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation expenses"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r57",
      "r278"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents derivative instrument obligations meeting the definition of a liability which are reported as of the balance sheet date. Derivative instrument obligations are generally measured at fair value, and adjustments to the carrying amount of hedged items reflect changes in their fair value (that is, losses) that are attributable to the risk being hedged and that arise while the hedge is in effect.",
        "label": "Warrant Liabilities [Member]"
       }
      }
     },
     "localname": "DerivativeFinancialInstrumentsLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r216"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Warrant liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for derivatives that either were not designated as hedging instruments or do not qualify for hedge accounting.",
        "label": "Warrants"
       }
      }
     },
     "localname": "DerivativesMethodsOfAccountingNonhedgingDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r402",
      "r433",
      "r434",
      "r436",
      "r441",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Compensation [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "negatedLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred revenue attributable to disposal group held for sale or disposed of.",
        "label": "Deferred revenue"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "negatedLabel": "Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "negatedLabel": "Intangible assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r82",
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Other current liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets",
        "negatedLabel": "Prepaids and other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "negatedLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r311",
      "r675",
      "r691"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Total loss on sale of assets",
        "verboseLabel": "Loss on sale of NTN assets"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Cumulative annual dividend payable per share (in dollars per share)"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DividendsPreferredStockCash": {
     "auth_ref": [
      "r110",
      "r184"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Preferred Stock, Cash",
        "negatedLabel": "Cash dividends to Series A preferred stockholders",
        "terseLabel": "Dividend paid in cash"
       }
      }
     },
     "localname": "DividendsPreferredStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r28",
      "r324",
      "r325",
      "r326",
      "r330",
      "r331",
      "r332",
      "r552",
      "r681"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to related party, current"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r35",
      "r324",
      "r325",
      "r326",
      "r330",
      "r331",
      "r332",
      "r552",
      "r681"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.",
        "label": "Due to related party, non-current"
       }
      }
     },
     "localname": "DueToRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and Diluted Loss per Common Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r223",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r255",
      "r258",
      "r262",
      "r263",
      "r264",
      "r268",
      "r497",
      "r498",
      "r583",
      "r586",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per common share - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r223",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r258",
      "r262",
      "r263",
      "r264",
      "r268",
      "r497",
      "r498",
      "r583",
      "r586",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Net loss per common share - diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Anti-dilutive Securities [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r69",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Basic and Diluted Loss per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedLossPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r446"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Total tax provision for income taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r235",
      "r446",
      "r473"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Federal statutory tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r790",
      "r797"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r790",
      "r797"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign tax differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r790",
      "r797"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Non-deductible expenses/excludable items"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r790",
      "r797"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "State income tax, net of federal tax"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "auth_ref": [
      "r790",
      "r797"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average remaining requisite service period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r789"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unamortized stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Stock Options [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails",
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory and Manufacturing Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r101",
      "r200",
      "r220",
      "r221",
      "r222",
      "r238",
      "r239",
      "r240",
      "r243",
      "r251",
      "r253",
      "r270",
      "r301",
      "r380",
      "r437",
      "r438",
      "r439",
      "r466",
      "r467",
      "r496",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r548",
      "r591",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails",
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Ownership percentage",
        "terseLabel": "Percentage of total outstanding equity interests"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r670",
      "r671",
      "r675"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Losses on investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r75",
      "r281",
      "r664"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investment",
        "verboseLabel": "Investment in non-controlling interest"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r500",
      "r501",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r163",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r347",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r501",
      "r558",
      "r559",
      "r560",
      "r633",
      "r634",
      "r638",
      "r639",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r162",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r347",
      "r382",
      "r387",
      "r501",
      "r558",
      "r638",
      "r639",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r347",
      "r382",
      "r387",
      "r501",
      "r559",
      "r633",
      "r634",
      "r638",
      "r639",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r347",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r501",
      "r560",
      "r633",
      "r634",
      "r638",
      "r639",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Changes in Fair Value of Warrant Liabilities [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r161"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair value at March 9, 2022 (issuance date)",
        "terseLabel": "Warrants fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r160"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value, end of period",
        "periodStartLabel": "Fair value, beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r347",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r558",
      "r559",
      "r560",
      "r633",
      "r634",
      "r638",
      "r639",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetAssetLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosure [Abstract]"
       }
      }
     },
     "localname": "FairValueNetAssetLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r165",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FeaturesOfConvertiblePreferredStockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Features of Convertible Preferred Stock [Abstract]",
        "terseLabel": "Cumulative Convertible Preferred Stock [Abstract]"
       }
      }
     },
     "localname": "FeaturesOfConvertiblePreferredStockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r529",
      "r535"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedLabel": "Principal payments on finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r310",
      "r565",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r77",
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r675"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "negatedLabel": "Loss on sale of NTN assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r57",
      "r95",
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Gain on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative [Member]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r209",
      "r304",
      "r582",
      "r631",
      "r650",
      "r689",
      "r690"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwillDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "In-Process Research &amp; Development and Goodwill [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "In-Process Research &amp; Development and Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r305",
      "r306",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ImpairmentOfOngoingProject": {
     "auth_ref": [
      "r57",
      "r81"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned.",
        "label": "Impairment of in-process research and development",
        "verboseLabel": "Non-cash impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfOngoingProject",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
      "http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentPolicy": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.",
        "label": "In Process Research and Development, Policy [Policy Text Block]",
        "terseLabel": "IPR&amp;D"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r234",
      "r472"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r40",
      "r173",
      "r182",
      "r197",
      "r280",
      "r288",
      "r290",
      "r292",
      "r584",
      "r630"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r234",
      "r472"
     ],
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Loss before Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r9",
      "r10",
      "r11",
      "r12",
      "r88",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r312",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r235",
      "r447",
      "r453",
      "r460",
      "r468",
      "r474",
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r236",
      "r252",
      "r253",
      "r279",
      "r445",
      "r469",
      "r475",
      "r587"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes",
        "totalLabel": "Total tax provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "terseLabel": "Reconciliation of Computed Expected Income Taxes to Effective Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r219",
      "r443",
      "r444",
      "r453",
      "r454",
      "r459",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r180",
      "r195",
      "r668"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "verboseLabel": "Payroll tax refunds included in other receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedParties": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.",
        "label": "Due to related party"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r674",
      "r809"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Decrease in lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r674"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/InprocessResearchDevelopmentAndGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r226",
      "r228",
      "r229"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r538",
      "r649"
     ],
     "calculation": {
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease expense"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Operating Lease Expense [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Net Operating Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Description [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Maturities of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r539"
     ],
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r539"
     ],
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r539"
     ],
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r539"
     ],
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r539"
     ],
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r539"
     ],
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r539"
     ],
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r539"
     ],
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Extension term of sublease"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term",
        "verboseLabel": "Term of sublease"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r30",
      "r233",
      "r297",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r484",
      "r485",
      "r486",
      "r504",
      "r629",
      "r697",
      "r813",
      "r814"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r27",
      "r179",
      "r192",
      "r650",
      "r679",
      "r688",
      "r806"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r32",
      "r205",
      "r233",
      "r297",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r484",
      "r485",
      "r486",
      "r504",
      "r650",
      "r697",
      "r813",
      "r814"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.",
        "label": "Change in fair value of warrant liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r157"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities, fair value disclosure"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities transferred upon sale [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r17",
      "r178",
      "r188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Letter of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation settlement, amount"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableCurrent": {
     "auth_ref": [
      "r31"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.",
        "label": "Loans Payable, Current",
        "terseLabel": "Loans payable"
       }
      }
     },
     "localname": "LoansPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r17",
      "r178",
      "r190",
      "r346",
      "r360",
      "r633",
      "r634"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Term loan amount"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r92",
      "r93",
      "r316",
      "r317",
      "r318",
      "r694",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r693",
      "r694",
      "r695"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Liquidated damages payment"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r317",
      "r318",
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Estimated contingent loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r13",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Merger, Disposition and Acquisition Transactions"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Ownership percentage by Citius"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r54",
      "r55",
      "r58"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net cash used in operating activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r41",
      "r58",
      "r183",
      "r196",
      "r203",
      "r217",
      "r218",
      "r222",
      "r233",
      "r242",
      "r246",
      "r247",
      "r248",
      "r249",
      "r252",
      "r253",
      "r260",
      "r280",
      "r288",
      "r290",
      "r292",
      "r297",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r498",
      "r504",
      "r630",
      "r697"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r246",
      "r247",
      "r248",
      "r249",
      "r255",
      "r256",
      "r261",
      "r264",
      "r280",
      "r288",
      "r290",
      "r292",
      "r630"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net loss attributable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "Recent Accounting Standards [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r67",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r248",
      "r254",
      "r268",
      "r294",
      "r295",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r437",
      "r438",
      "r439",
      "r464",
      "r465",
      "r466",
      "r467",
      "r480",
      "r481",
      "r482",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r520",
      "r521",
      "r523",
      "r524",
      "r525",
      "r526",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r566",
      "r567",
      "r568",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashMergerRelatedCosts": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger.",
        "label": "Noncash Merger Related Costs",
        "terseLabel": "Transaction costs - shares to Financial Advisor",
        "verboseLabel": "Transaction costs"
       }
      }
     },
     "localname": "NoncashMergerRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1": {
     "auth_ref": [
      "r62",
      "r63",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Common stock, shares issued in consideration for purchase commitment (in shares)"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expenses), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonrecurringAdjustmentAxis": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Axis]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonrecurringAdjustmentDomain": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Domain]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OpenTaxYear": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax year that remains open to examination under enacted tax laws, in YYYY format.",
        "label": "Open tax year"
       }
      }
     },
     "localname": "OpenTaxYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r280",
      "r288",
      "r290",
      "r292",
      "r630"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r532",
      "r649"
     ],
     "calculation": {
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r807"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Impairment of right-of-use asset",
        "negatedLabel": "Impairment of ROU asset",
        "terseLabel": "Impairment of ROU asset"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Operating Lease Liabilities [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r528"
     ],
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Total operating lease liabilities",
        "periodEndLabel": "Operating lease liabilities, Ending",
        "periodStartLabel": "Operating lease liabilities, Beginning",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r528"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "periodEndLabel": "Current portion",
        "terseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r528"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Less non-current portion",
        "terseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "periodEndLabel": "Operating lease ROU assets, Ending",
        "periodStartLabel": "Operating lease ROU assets, Beginning",
        "terseLabel": "Right-of-use assets - operating leases",
        "verboseLabel": "ROU asset balance"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r675"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "negatedLabel": "Amortization of operating lease ROU assets",
        "terseLabel": "Amortization of right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r537",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r536",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining lease term (years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating loss carry forward"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization and Description of Business Operations [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r14",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization and Description of Business Operations"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses [Abstract]",
        "terseLabel": "Other income (expenses):"
       }
      }
     },
     "localname": "OtherExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r31",
      "r650"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Assets [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other (expense) income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivable"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PartnersCapitalAccountAcquisitions": {
     "auth_ref": [
      "r109",
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in the different classes of partners' capital accounts during the year due to acquisitions. Partners include general, limited and preferred partners.",
        "label": "Partners' Capital Account, Acquisitions",
        "terseLabel": "Issuance of common stock to Eterna LLC members"
       }
      }
     },
     "localname": "PartnersCapitalAccountAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PartnersCapitalAccountUnitsAcquisitions": {
     "auth_ref": [
      "r110",
      "r146",
      "r147",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in the number of units for each class of partners' capital accounts during the year due to acquisitions. Partners include general, limited and preferred partners.",
        "label": "Partners' Capital Account, Units, Acquisitions",
        "terseLabel": "Issuance of common stock to Eterna LLC members (in shares)"
       }
      }
     },
     "localname": "PartnersCapitalAccountUnitsAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Expenses [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock",
        "negatedLabel": "Dividends paid to Series A preferred shareholders"
       }
      }
     },
     "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Payroll tax remitted on net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Less amount of cash paid for NoveCite investment"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r224",
      "r799",
      "r800",
      "r801"
     ],
     "calculation": {
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "erna_AssetAcquisitionFairValueOfConsiderationPaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Cash paid"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PledgingPurposeAxis": {
     "auth_ref": [
      "r562",
      "r648",
      "r651",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by pledging purpose of pledged asset owned.",
        "label": "Pledging Purpose [Axis]"
       }
      }
     },
     "localname": "PledgingPurposeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PledgingPurposeDomain": {
     "auth_ref": [
      "r562",
      "r648",
      "r651",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pledging purpose of pledged asset owned.",
        "label": "Pledging Purpose [Domain]"
       }
      }
     },
     "localname": "PledgingPurposeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockConvertibleConversionRatio": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares issuable upon conversion for each share of preferred stock to be converted.",
        "label": "Preferred stock, conversion rate"
       }
      }
     },
     "localname": "PreferredStockConvertibleConversionRatio",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_PreferredStockConvertibleSharesIssuable": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares issuable upon conversion of preferred stock.",
        "label": "Aggregate preferred stock to be convert into common stock (in shares)"
       }
      }
     },
     "localname": "PreferredStockConvertibleSharesIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockDividendsAndOtherAdjustments": {
     "auth_ref": [
      "r68",
      "r686"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.",
        "label": "Preferred Stock Dividends and Other Adjustments",
        "negatedLabel": "Series A preferred stock dividend"
       }
      }
     },
     "localname": "PreferredStockDividendsAndOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockDividendsShares": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.",
        "label": "Cash dividends to Series A preferred stockholders (in shares)",
        "terseLabel": "Shares issued for payment of dividends (in shares)"
       }
      }
     },
     "localname": "PreferredStockDividendsShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "auth_ref": [
      "r21",
      "r102",
      "r103",
      "r677",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.",
        "label": "Preferred stock, liquidation preference per share (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "auth_ref": [
      "r231",
      "r366"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
        "label": "Preferred stock, liquidation preference"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r21",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock Series A, shares authorized (in shares)",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r21",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock series A, shares issued (in shares)",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred stock series A, shares outstanding (in shares)",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r21",
      "r650"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.005 par value, 1,000 shares authorized, 156 designated and outstanding of Series A convertible preferred stock at December 31, 2022 and 2021, $156 liquidation preference"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r669"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from the sale of NTN assets, net of cash disposed"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from sale of common stock",
        "terseLabel": "Proceeds from issuance of common stock and warrants in connection with private offerings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from issuance of warrants to purchase of common stock",
        "terseLabel": "Aggregate exercise price",
        "verboseLabel": "Proceeds from issuance of warrants to purchase of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "verboseLabel": "Gross proceeds"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLeasePayments": {
     "auth_ref": [
      "r541",
      "r542"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from lease payment, classified as operating activity.",
        "label": "Proceeds from Lease Payment, Operating Activity",
        "terseLabel": "Sublease payments received"
       }
      }
     },
     "localname": "ProceedsFromLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesSubleaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the issuance of equity classified as other.",
        "label": "Proceeds from Other Equity",
        "terseLabel": "Proceeds from sale of members' equity"
       }
      }
     },
     "localname": "ProceedsFromOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from the sale of fixed assets",
        "terseLabel": "Proceeds from sales of fixed assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfAssetsInvestingActivities": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions that are classified as investing activities in which assets, which may include one or more investments, are sold to third-party buyers. This element can be used by entities to aggregate proceeds from all asset sales that are classified as investing activities.",
        "label": "Proceeds from Sales of Assets, Investing Activities",
        "verboseLabel": "Purchase of NTN, net of cash acquired"
       }
      }
     },
     "localname": "ProceedsFromSalesOfAssetsInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": {
     "auth_ref": [
      "r672"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Proceeds from Sales of Business, Affiliate and Productive Assets",
        "terseLabel": "Sale of rights, title and interest in and to the assets relating to the business"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r51",
      "r122"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from the exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r673"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "negatedLabel": "Exercise of Q1-22 pre-funded warrants (in shares)"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r90",
      "r621",
      "r622",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r84",
      "r207"
     ],
     "calculation": {
      "http://eternatx.com/role/PropertyAndEquipmentDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Gross [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r86",
      "r193",
      "r585",
      "r650"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://eternatx.com/role/PropertyAndEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net, by Type [Abstract]",
        "terseLabel": "Property and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetByTypeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r86",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule of Property, Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r388",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDueFromToRelatedPartyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r388",
      "r551",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r549",
      "r550",
      "r552",
      "r553",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Principal payments on notes payable",
        "terseLabel": "Principal payment of outstanding notes payable"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development",
        "verboseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "In-process research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r663",
      "r676",
      "r821",
      "r822"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r663",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r618",
      "r665",
      "r676"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Common Shares [Member]"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "RSU [Member]",
        "terseLabel": "Restricted Common Units [Member]",
        "verboseLabel": "RSUs [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails",
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://eternatx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r24",
      "r110",
      "r191",
      "r595",
      "r600",
      "r650"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r200",
      "r238",
      "r239",
      "r240",
      "r243",
      "r251",
      "r253",
      "r301",
      "r437",
      "r438",
      "r439",
      "r466",
      "r467",
      "r496",
      "r591",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r643",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r643",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Common stock issued and sold during period (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Computation of Diluted Net Loss per Common Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r138",
      "r139",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails",
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Income Tax Provision"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative liabilities at fair value.",
        "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]",
        "terseLabel": "Changes in Warrant Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r9",
      "r10",
      "r11",
      "r12",
      "r88",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposition Details"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Computed Expected Income Taxes to Effective Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Loss before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Tangible and Intangible Assets Acquired And Liabilities Assumed, Based on Estimated Fair Values"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r171",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r399",
      "r401",
      "r403",
      "r404",
      "r405",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://eternatx.com/role/StockbasedCompensationRsusDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r115",
      "r116",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Summarizes of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Weighted-Average Assumptions Used for Grants Issued"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Summarizes of RSU Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r98",
      "r99",
      "r100",
      "r102",
      "r103",
      "r104",
      "r106",
      "r107",
      "r108",
      "r110",
      "r212",
      "r213",
      "r214",
      "r271",
      "r361",
      "r362",
      "r364",
      "r366",
      "r370",
      "r376",
      "r378",
      "r637",
      "r662",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails",
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r112",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Warrant activity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r647",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Uncertain Tax Positions"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [
      "r666",
      "r667",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A preferred stock.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Cumulative Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]",
        "terseLabel": "Stock-based Compensation [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://eternatx.com/role/StockbasedCompensationRsusDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Cancelled (in shares)",
        "terseLabel": "Number of RSUs cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://eternatx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Cancelled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Restricted stock units outstanding (in shares)",
        "periodEndLabel": "Outstanding, Ending balance (in shares)",
        "periodStartLabel": "Outstanding, Beginning balance (in shares)",
        "terseLabel": "Number of stock units awards outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://eternatx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Outstanding Restricted Stock Units [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted Average Fair Value Per Share, Ending balance (in dollars per share)",
        "periodStartLabel": "Weighted Average Fair Value Per Share, Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Fair Value Per Share [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "RSUs vested (in shares)",
        "negatedLabel": "Released (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Released (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weightage-Average Assumptions Used for Stock Options Granted [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Weighted average volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Weighted average risk-free rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://eternatx.com/role/StockbasedCompensationRsusDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Stock-based compensation shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Number of common stock shares to be issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Outstanding, ending balance",
        "periodStartLabel": "Outstanding, beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r407",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Stock option outstanding (in shares)",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "periodStartLabel": "Outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Number of Option Share [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r407",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price per Share [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Vested and Exercisable [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Options vested and exercisable, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Options vested and exercisable, Outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Options vested and exercisable, Weighted average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "terseLabel": "Number of shares issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r403",
      "r404",
      "r405",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://eternatx.com/role/StockbasedCompensationRsusDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Cancelled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r406",
      "r425",
      "r426",
      "r427",
      "r428",
      "r431",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Abstract]",
        "terseLabel": "Stock-Based Compensation Expense [Abstract]"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.",
        "label": "Number of accelerated vesting stock option (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock based compensation stock option term period",
        "terseLabel": "Warrant expiration term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails",
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted-average remaining contractual life, outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Options vested and exercisable, weighted average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Incremental fair value of stock options recognized"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "terseLabel": "Number of shares issued in merger agreement (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r212",
      "r213",
      "r214",
      "r233",
      "r258",
      "r259",
      "r262",
      "r264",
      "r271",
      "r272",
      "r297",
      "r322",
      "r325",
      "r326",
      "r327",
      "r331",
      "r332",
      "r361",
      "r362",
      "r366",
      "r370",
      "r378",
      "r504",
      "r626",
      "r662",
      "r677",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails",
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r39",
      "r101",
      "r200",
      "r220",
      "r221",
      "r222",
      "r238",
      "r239",
      "r240",
      "r243",
      "r251",
      "r253",
      "r270",
      "r301",
      "r380",
      "r437",
      "r438",
      "r439",
      "r466",
      "r467",
      "r496",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r548",
      "r591",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails",
      "http://eternatx.com/role/EquityAndWarrantsMergerDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED BALANCE SHEETS [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF MEMBERS'/STOCKHOLDERS' EQUITY [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r238",
      "r239",
      "r240",
      "r270",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r62",
      "r63",
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Issuance of common stock for business combination"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r21",
      "r22",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Acquisition of common stock (in shares)",
        "verboseLabel": "Issuance of common stock to Financial Advisor upon consummation of merger (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r38",
      "r101",
      "r102",
      "r110",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Number of shares converted (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Number of common stock issued as compensation for services (in shares)",
        "terseLabel": "Lock-up agreements shares received in acquisition (in shares)",
        "verboseLabel": "Lock-up agreements common shares received in acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r101",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Restricted stock replaced during the period (in shares)",
        "terseLabel": "Issuance of common stock from vested restricted stock units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r21",
      "r22",
      "r101",
      "r110"
     ],
     "calculation": {
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "totalLabel": "Common stock issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r21",
      "r22",
      "r101",
      "r110",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Issuance of common stock from the exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r39",
      "r101",
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of common stock to Financial Advisor upon consummation of merger",
        "verboseLabel": "Acquisition agreement"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r21",
      "r22",
      "r101",
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Fair value of shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r21",
      "r22",
      "r101",
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Issuance of common stock from vested restricted stock units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r39",
      "r101",
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock from the exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Aggregate gross purchase price",
        "terseLabel": "Aggregate gross purchase price",
        "verboseLabel": "Gross proceeds received"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Private placement (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r22",
      "r25",
      "r26",
      "r74",
      "r650",
      "r679",
      "r688",
      "r806"
     ],
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedStatementsOfMembersStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and Warrants [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r113",
      "r232",
      "r362",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r375",
      "r377",
      "r380",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Equity and Warrants"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Stock conversion ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesBasisOfAccountingPresentationDetails",
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesOctober2022ReverseStockSplitDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r534",
      "r649"
     ],
     "calculation": {
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r519",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r519",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r519",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r519",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r555",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Federal and state income tax credit carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
      "http://eternatx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://eternatx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails",
      "http://eternatx.com/role/EquityAndWarrantsEquityLineOfferingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r442",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending balance of uncertain tax positions",
        "periodStartLabel": "Beginning balance of uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Accrued interest and penalties related to uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Additions based on current year's tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Net changes based on prior year's tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRecentAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r71",
      "r72",
      "r73",
      "r273",
      "r274",
      "r276",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r458"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r533",
      "r649"
     ],
     "calculation": {
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable lease expense"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrants [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedLossPerCommonShareDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Activity Abstract"
       }
      }
     },
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsWarrantsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants outstanding weighted average contractual life"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r257",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted average shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r255",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted average shares outstanding - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.F)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=66006417&loc=d3e8580-128490",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=66023778&loc=d3e9298-128500",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=66023778&loc=d3e9334-128500",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=66023778&loc=d3e9337-128500",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966508&loc=d3e9972-128506",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966508&loc=d3e9979-128506",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.23)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919320-209978",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919327-209978",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r653": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r654": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r655": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r656": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r657": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r658": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r659": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r661": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>116
<FILENAME>0001140361-23-012418-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-23-012418-xbrl.zip
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MQZ/V&0D\Q[L/7PG,BM:2PJUX43L"F?[2(.O;8 # MA#WFCCVA7=*)DY$W(.
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M4N9@X/MF39>W&/U^O:A8138..;)1?E1\8[KWV\[3?&6X6?F]WXC?NW2H6 6
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M%MWH5J)U3Z)5KQO=;8E6A..U2^U[Q[N_CH.)'TIC*P)[\FIX&E!;3KT"^&8
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M-8U%X+RFP= /QM@^X?5#=>EB#A"X&ZF1JB_.\<KKBRORC*GS?=TAXE(HKEO
MH#)[<U_<M_KV,*C(]'F=^73%D'RQ#+A=F4"+?4<5J [3AU3!];4RU(I*RVXA
M5P JMV]I+<YX"" Z4$Y80:_DA'7A6?X8;!P ,<XMTXD4%DE)8(WZ@ +T@;K^
M!!\Y>YI@[<9R@VW!LC) 7+:^@R/(O"FQ"/Z_4(\&Q(7MZ=MCQW, Y0D&WP\'
M U9:X<&;'14.[ \'7@,?J.3  ?( !/NREEE77NG!NT+7K&05N]//C+K9V)9^
MUM#;J[4R^R-!:YX<AV<W?0_^E-4?L(G7*U"Q7[3UV<(]4\M#Y#9O9[BC-^IZ
M>VM>#=V4<ETW*^K>EH@&OJNO5+TX]^ASU31@!2+NCTSA+;5#W&J'PA?E1%M0
M"%6.L"0107UT"]BV)HZ]">PI%8-'I6U5&"6<\=4+@O7@N5PBO ()M#/]<DEG
MW5=1_W !/NR\>N'N2@\ 9&0OJ,HTVZ+RIA+/TBY/Z:/;L*^WJ[*5'N8EUMI>
M&9->AP-4F7P'C DY&_!5&W5OV[SJ&$T!2/A5&?/E$ N[Q[9.W6BNB&WJH]M(
MNUC-BUQ)C_TBS&YKF;UJQG%H$-';R4&N=D.O8+,%]MI>_=!6>WOM(Y<X42[]
M![9"_.YA>$SGKVA'A+>#NBCSX?45H_^' ZPYRSD$2%T']#SV;&H?!J3F+.<U
M0"J?1%9QPX/,$UL=S!43/7  5[SW=0*XHMO78A]6!'@@D*I4GG+!R]";)@^C
ML%]_?*'WQ#UC$V'P^N)XEN]ZUR3X?DHF3D1<Q,PO7TX7^TC_0-?'U;"/VW'/
MLDK9,^=.$$;7,? A$M+^?4#9K7+#OW E O:+UK.YVW5W#EV;.A]S$!8K60+G
MG<E^$/S-NKE2U"GWZ'-/>;02O&_M'.]O*7S??B6(OWTDV0JM+=S#/1#;%C"_
MM3KFM[:(^<_C^!5GK_COMFRO ^:BNX_*;I]9EDTOK?#CD/ CQS]VB!\' ^M2
M;7A683X $BP5H912-ZQTO<-3O')1C8J.#S"R8>@-LW4HI^!+=C#=P.1GL[4M
MJ9H!E/ ULT4H0&*7/[T2*.77D(>0NI@# U'_D$#4/T@0G1X2B';@'-HIB(1F
M6='3CA1*%5Q+%$KUT2WH&D60K;2.PX9OQ6;?(F0K-?150+9C2#\._/KC4QPZ
M'@499 $S"YVD?B'FKKAN'-Z-:$ F-(X<*_SBC)V(VN4&\YP%*2DY"Y>U2X!W
MZL:J7AWUT9( _(\;ZL(T[&N8^/0N(%Y(+-8@_M-4O<.YPH@XV)+J:@C#??))
M8%\-/SL!M2(_"$]'#AV>/5$KQI*A5\.A8]&@[]G7 0T9!KQ-!%MY JO#09X5
MW@(T*KJ83Q>O(]2T=_S=9S[-7E L[U"?KT7=PK@T[ /-#6D0O(HB_RNH4PM6
M=8!^]6QMZ K6+V+W[J4.M%K]^XX\]>-HY <R2>[<#ZAS[YWZL1<%TW+#M7@)
M*5"+UK(SE^(.RC@4 H@A,R@X6-?<_7L<.*'M6.5O_;H,5DN6M2.P[: Y]ARP
M?8:+(6@C!T%8A8MY]915@:@,5+001)5TVC^ %K*Y2CJ5E?4UD+28AL]^_7$;
M#T+Z9XQQH >JE"/*72\WW.8L0@%<T6IVIM$WZKI9-U?2Z'./KJ?1QY[# ?M-
MUXT$-F-*PCB@)T[H-TVC\_';[6?YOKPE_\8!B@8S9P83*QF1@(;KCM9(1K.=
M!P"W^LQE/*8!B?Q@P]G/O(\7/U//'SM>T;"KKB,SQ(?L[)<LMSFS>?S,,\#5
MB];>O-8<4$S@Y[ICM6?&BJ/@8_CG,%IWI$[Q&F\YQ:R]R&[Q<,S)J]+JZB/V
MBD>\0-[INCC)Q2-^<)X^ HKX<6#1D/\YHL1FW 'PX.3?_^W?_TW3\-^?X$\M
MC*8N<+TAT&=]2,:.._VH_9\[8%2A=DD?M1M_3+S_\Z/&[H?.7_2C9NB3Z$<-
MJ;E.7)#_'S67#N&*Y;M^\%'[F\[^^?'H!+_!OR)^PA^C0'YQX <PJ8^:YWOT
M1XW_51_X4>2/X1N3)RWT7<?6!BZQOB?W(W_R46OF;XXH'OQF,WM*YS%D_\"K
M\,Q] $J*7<_?4A=AP<[2X$=M3()[QZOCFCYJ)([\Y%+ O\*N'6D?,ON97Z>R
MM44?$1,)[@?O])J&__\^N\=-W&-VX5$L;N"[MK@T'TY')]\N+^[./FNW=_V[
ML]N?!@',,YE49K[[G.3MV>FWFXN[B[-;K7_Y63O[_?37_N4O9]KIU=>O%[>W
M%U>76Y^KN>E<_T'"D>/=1[Y7TSX?GQYKIMYJ]HKFEVST\T@+Z#\#MEG S7PN
M2U@S^)[=%4%*CXX=C3YJ8VH[\3BYRL;($:48I3[V_ZK'(:VS_6<7)6E\U(#R
M!+%(8C21%L5'C-8/<T"T30K<_<9O'2N[FV(EV%YC[2?@[0 IIDDXEN81U%_Q
M(.MGWXK'0IT\8H+EG%C1']WAL*G;O5:GU^DUS8'=&Y).;Z!WV\V.0<B0'&E"
M3;NAP\((RM&)H==_8S(E_>Z)MIS-5*11#M(X^2F<$"^S_1G$.P)@?L!'MD]:
MRS[\[BL)OFM7'GTO9[ !,:J/1V3@4M@YUX7A+&#A/Q_I1^SO";'MY&^,J/Q\
M]/GV^OR+$T9W^-*1G*>$D:[_L)0F"]:L8J'Z6ZA?48*7#S2('##,);A!S<F]
MG@[Q4V0O>DWBE=F9F<)BGI51X@HXUEH,:BT$\("7$1<?6<;/^IX7$_>&3OP@
M4OB:V34-J]&BG5:[UVP,Z<#J#9L6:?8&1KNA=YO+^1K,%^80_7SDP(: V?]Q
MX/ON /1M/QKX3T<G__6W)[-MF#_F65^.6'([_2&RGP=$3LTE F+_\O);_XMV
M<W9]=7.G77^[N?W6O[S3[JXT4.GN0&_3C(9V=0-<[9W]7KLZU^Y^/=,4;2_1
M]/JG=WC;Z#6:*V\>(YH/43"'KO[]W^ FDN\.%-YG(_^.%/'GS@OV#*<"VH06
MC:AV[H2 B=H_*0FT,ZQRMES%N&9^GC/N_5%HDJ*7M668MFUVFG;7Z@Y:G;;9
MM?66;1N#3G<]FOQHP^@@9;UHA%.HVV1:G\(LZ]0[.OE,+>Y?:Q@U#5^?I=)B
M6;B:+G%UL^*#6B6Q=BZQUO93%*D:VQ!%+/&/)6_-B*-!EX $LCH=:]!LZJW&
MH&TW]7:GVQSHS:9I;4T<Z:441UN!T-U-__+V@@F4 Y USZ'#S67#<V&PE)WM
M<W)28D4)&6H\XJ - W^L_2'^ ?1-?I=I^AN)BOVH"'@FPPDQ:@7J 8@GX#4H
M:^<RR#,6:\)'^9,*8VP2:]BE5KO9: -GI'97[U%[V#8'C;9A .];Q?]0-XQF
M6U\FX;?H<RBRPU$^C.^U,+" 18_)/67!P>-_3>Z/-.("W[X/R&3D6&B(5RZ*
MS;QW"\86 YE&&^&3^:"XMCZ:OR!%\N^:&WO/EY#>#;T'M1"+W5["'87\#(-T
M.\,A[32'K:9ET)Y.3*-C#H9MRQ[HO<8*Y'<683!*4Y/3M0O/.IZAQY+:.^_.
MGF GV)9I_E +DJW22*B%$VIA.-_6'$]SHE"S1B2 ";VO/)IE9!?;U;@R-D'1
M[!77Z&+D7LV*X]O-?FXJF#*V7@H^ETQ">$;^6A"JS:U/56]39!.&7X%^G+$;
MQ&2:/9C+:L;AEKC 4GZ(J5$!F&@$M426!R4RUDY]6V6/Q&@V!AW=ZG8Z%,TT
MTJ%Z5Q_TAJU&JV,T-C';0OS:)/ ?<$[<5>&21X+Y#\7Z2V9_BJV2HETWYVTZ
M;B+B[,]'!EJ-1AMMQI6'+2$P[\C3A4B[LAA 9Y1,FQ"[V:*-SD#O-O5>D^@&
MI3TR:%#3-EK&*D&N!FJ9>J.)9WX7R;4\RUX(O;D69;F)ZQVC& W,K2NPMP)-
MS1U$$3K'HM[6YS/$RV81W!//^8O]_;XBFP1,%\<WQ[?'VMEXXOI3M,]V#)<,
M$6J7_O%JP"B@ OFKP*>R1<6J$M/[1M$EG+UOVP&>BN7_^>)XU%"X>@=XM]4>
MM*G>ZS0;+=KM]AH=8]"EMCGL=IK&2JD+C59+.R7C0>#8]U2[C0)*HYIV&SO
MX(QNOS:;V+#2E$_AYU5PYS]ZRH2MH=UM=LT6)0.KV="[@TYGT!H838+_1QIT
MA0DG4\W/J[;BQ!CKO@JN00%Q/$O5=8:P:0V]T;%Z^J )[(U08EFV99G$IJ#N
MK!"=.?G:?\5*#,\SW#^V7_N8U?F_SB2GBS:-8:/;&S:)T>DU.Y02DUKFL$$Q
M?6?8-E9!=]TTFD:EO[P3.XVZRG4 9.!,B*LE]18T7G AK%2)=,< '37$Q]))
M=+E]I?$FS25R% G]@)(<65LV,0:-CJZWR+#9MIL]:PC"K&59I#5H#(B^ EG#
M?_)$_7Z^.&#'?:Y'OC?KC&_I0]IN66;+-MM-'<34H*DW#-*%Z;5ZP\X*YNY)
MJVN"H=3KK>*-WQ.$4F?H?_VM:QJ='T/0LUPZP2W1/+8G-0VX@ANCRJ<AS+*X
M7_G\RN3S>RLA@N?B_2V(M\")''B0^[AI0&UM$@=AC,[NR-?@"6:Y&>:[P7L4
MCAA-[5O1Q^VZ5>>P[#=M?#4:<X1Z_A2,F1QTF3N+.=QBJ_AW='+G1"X+F)P1
M:Z2Q(B3S,BF>I449\S9&8(6Z,S]NH$XUYJEIY=WY@##!=#L=PY5WQ7IJ^??]
MU6'\I8@0,H0_>[)&6#=+ W[YCY$#5VX2IOH,>&S!HIJ[L=NQ#Q:8L4+"3 US
MP+B#HEFV35 IV[K9TVF[V1F:@]Z0HF?!: Q)J]GNK>+Z8(5 -5;$J*;]IWX,
M*C,@8Z ]$#>>C9YL;M6N3Q/;9#L[AY)@'YQ[J+&NGMD>-MIVH],AS39M]NQ6
MR^A:0], Y9(T5TH%N+F<]0"5'1"[)9>M)YM*(I,,*)?08;7UEMX>&EVSTVLV
M.R9I=UJVWNAU6NV&10?##2*6%+XD@Y5WH!%>DM F?W)"U/"$#HVT+U].YR6>
M;M6]M+/ P-9"_7D<<3P,BV!NSW%KLO @QEH3OO!L#+10;3#5K!$%2(SQK)3#
ME78EB<4)-:(]@A9=_^[YC[!&2D(P]&RX$<9HZ9)0L^G0\7B.RTT,6ET3.*M0
M_Q6K 2R!8^V?-.0DIOW7WWJ=9O/'97[G?\"G?\,OWXH/7[#OJBC;,$FCT6AU
MFNUFLTN,+NFV>U9SV&G15MLVVBLPGDL_CWWJ)-L+_4,[\SF5 /*>'\&5/V,'
M33VP\(:8K1FPY/2PV/1K8$"5IT^G!N"QV,T9X(N_EJ# __AN[$4D8!F@0:B>
M"&GK /-AIXD^;8L,!NUNTVY;K6Y#;QBT9U6@7P7TCR/*XO Y^+\SWFLCH&X$
MNJT1UTT@KZ+$@(H'8,P%6*#P@43U!<Q(.3,\A]GTF@V/@7&"[TP":E%FJABF
MQ@[JA-H[&!@$C!;&H#*'(Q^3Z62:=C0B47X1CR2<Q6#VLEC,>^!@GJV],_EB
M!R"FX/[@7[ 4\3Q.0 S!ZGFP[[/YD3#2>KIFDVEXG&#-*AA]&@<!#,6/>: R
M%9$H5A&[.0!T[@ST'G"QIM6U>HV&:0%K:]O=1G<X7"74]T^LZ;((L[,SOO2S
MI/EV\1[1 #!@[$01X QU 1,"WT/USIUJ%%2]J7:!"AN6Z'Z@VF<2$9[&GB.+
M= R54Z* 3+%>2$JP_6*7ISW<UN^T=[A=G1_-AGF<B%*'Y8Y.,'=TUS3")\Y?
M1WH)WZ^'W<KNX.8(9%>+!K1:Q&X,S"$F[0^ZK:[=;%BF:1EM:S PC%6LN0J[
M-\1NIL^Y) #^2RP+L#O \O(,SJC,>857T;=?+[P1@KD!/P4W!3Q,<=ORQZ#O
M3E$4P+# .]%A?J_=!_YC-))WCT$R4#9'ID2R8S<LL(JQ%5/_<=Y,V6WC1_G8
MT@=FYBDGD#R(4D \/&>N\DFIYAKFH&Y* :=*M>.RYA$KT\C&+_+G)#?VIB_P
MAV?\YMLY!S7C8E_AN.F,+3G/LF_I*UOVV:TM!M&78DPNYDNYP5<Z9KEHVG.3
M4S9U#_6WM(Y"A^7>8;7"2;3@%-9^[P=3-4^X1XQ&L]TQ;=IK-G2,?S?U@6ZU
M&K1!S$%G$^<)^R#;84M\$/THET7\>#5#IO2H=3N/5:^F?;#794,,-3^MVVI;
MC6'/,+MZL]%M]!J6U1HV:;/3MJV!L4*BQ.85/<I"#!K(L^690YLA0.&AQLP'
MS^:)U57 *E_^A;U[RE]5P-LSNZVAT2&&-6PU;;/7->WAH-FQ3;/;:33M%73*
MS4_(E^VH]Y[UT>$"?0\S8U;T/Z$=QJPOX&_HB ++) ZYK@BSIZR62,%9;5 W
M\5ON%#_^Z$2C=-]1&_5@[CXREP<G9(S3(Y[E$!<E,Y[AP;>PI+!- CO4\*"-
M8\_+<VB\(^\+];_#-39$=9?U+6KA11)<'<.>J' 3L(_Q1!-N)^PLGI"$+Q/>
MT#U)KR)A"+P<+\G=IL,A90:F)_(PX<T4SH['SI2ZC.0#W]5\X%D*J%/)$L,N
M!0E FWI3R5RY)<& P/CUJR>73A&NVCNCI7T[OL62C1VSC6DN[W$'TN6*G)B!
M"QQ,0:BA$XRYZ0WV^H3@0X"#S(-NLT63V'8B,2^!/0)Y9E.#UBDT [08IIXW
M^/"ZN3MSZ54%=;JSH>PJ$\HQ5-.3Y<3Q. %_3?C6AB[SML$ERP\"FAP$0C82
M!.AM\W'C'AP_#MVIW+>BKQ[/HSEMK?H\2]";6;6X/!_X$9]A.G&YS<I6,,@G
M'A:D <MG?B1 =7<:.AR#/12:@-)U;4"0-2$7HU[(B0/=/'"/N5F3SZN[FQ +
M3?*0?=[X+53]10%PU <$1C('SC=50:7BA?!$-?5C0_]<UPS CN/YHOK"&@9]
M1&4_Z*>4?>Z2>S5>TX29#G3#!AVYV1DTNG:OIP\H;1B#7GM 5G#:;RZI-T**
M=<WH#1PRX0@L:R$C,^9^<6*FV6K5-/D_^2"QB %OL]1(DN')1V;7'DC@$$_Y
M'A,[3" C>$0^Z-')5'M7$"+,^$Z SR0N1N'(F(D8+=/Z<0-GM<*F;70:%FG2
M8:_7[%IDT&NUC*:NMZC9MFAS!3_ZIKBVR/_8_O&@%#X,ZI/[>\!I1/HQC^BS
MK!H)8(OGWH0LY ^08FR,^12'* 3@M2)Y09*++D9:!L*FPWC+ OXW]D,EK(1\
MTXM :#"=D*(N"4#T/10?K##=GS$KR*"]^WOL4:VA\W)O[VOLA3CB')=U0*/
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M0!T*:WK=45O6P>W"XPGEH%H?G?">;LJEUZH.<3QKE=ZTZYV6E->D(N6&WI,
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M["D#8)UY'+$L?Y'MQ\/L/$)*O\]<3,&2NS$FT_RE1\=U9ZYE%H<@"!W0/TB
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M3J7"Y\UE7P8_A4!#ERCQF,5CJ!8/C\_3(!!^45= JVB2[+OSIBEK@HI[I^*
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M0^(H0"?B RR*R@OR\:V[]WT;GX5=&TP94#[YV 4(:WP[@/>8=ZX81\E"[\$
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MR?/[&)'$SD(PH8FH0BY/47('H?+(V,%VY-YS:?<M!PT;5="P"AJNG#@ UF?
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MA3OJ1J3E<T()G>R$^*'H93#@&8/L,+!$(GM5'&6'?4&E &09S^!E$H!.EJ(
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MT<;"J6\$ZI7!NPCSB['\O/^IKNO&1^D]^4JC$?9'1?%R+;5<5$+N> =RWA<
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M3?ON1*(MBDT?'(OR!3L>+!X_S6@!9T]Y:31ENDN&B)0]JVGWV-B(\G0B_FQ
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M^S, &PE_>_1=]#<]$?>M=^#-_.*=VGF0P_H3J9V3:M:X+.@=B@\C']KS.<(
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M&JOS'<UL%Q!J;>&(1PFN4)*MP L@!%Y\&_=&5PS$=C:6!-(>&"[ZG+L"D$"
M\="U\VV"L5M&W#@(GP<?VX]FBSH+KC)^ _ZV1U\/O8K:C2L7Z_67QP]R,3)\
M"6_FR^-XWD4@O'IY#)IO(29%5U]D3=ZRP0&>9XZ"]!ZGM'D&:3S\#6WB_7Y?
M-8MX^MBXIN%'TU87'4QQD155V_&[QU.NKC''L9JX:HY7#H1Z5S2.,F+58KP
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MYH+8@UN^A'-9T.M;R6(A'XD9 X'P"/AXXY?!*KI%1L*J?8^!2%#-*$%@Z3B
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M-@DE70A)")85#VH,]970P%D-?@J/[NV/%)ES&4(#].58&V6"-SJ8C! !14=
M[=VEVEVJC[Q4:]<0O 2]#:K0 GM)8\((/MVC; 68-F#_3%\/S%.T>&J*EOV
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M<F-;)D),\S(Y7T.X>:4P0>#_$</;>42>UD+ ]6,08HK5+5P?&V4P4C*R+N'
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M\WK6$US+51@2SHB,1$03>C&I8B_Q&,9H @H.V/HR/-DD%21P@!NU\N_JEL[
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M)(#4VR:LXDSTFX#]5 VP.N<0(;%!8'1V$+$SGD9(#!LY-\64=\5:W5VCH[M
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MIL.2]K+MW$H#L?BJL)A7O7,3'B.;P4UA/'(CM'A]_  VQDG.(PRFO!1QKT>
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M?)'VTE$"S+$:X4)&A,',6(?^0Z*BP*"(\;U+:O7$XPFN>]-R=+!^U.-W'N_
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M3DQ-J%JF1<QU4?@1-\7,R*'X?FEOV2E;M+$^3K?/=4NU;)W(86,B[]^P!3W
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M*EH8O8*W 3$Q$_D/9G0WJ 1]N5\6O*+^8]A=LJPF.09FZ(ARD$+/D)9QJ(+
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MJJ0:@AMD71FY$!SAUHZ(PS@RX#3.\V"7%;ZT$04;Q^4\$9PUB]NVI!QI:3F
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MKJ*Q8AK/]C)3_M\,#NHD)Q$IO09=O0KAPZ^+_;9@T(?Q+YYL['/(@"(>HXB
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M"$+'Y.3=N)PE/UZF'\TZV5GH13=#JB[3^:</NG9(#7O-O8_]Q6E>V%8"#,%
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MAGY]\O-9D4_BLN14U"3>0 WH3?9F5>?X^BMQSP*TF4%V%JS<O8SH!A.Y*?;
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M_6A\F90PVGJ>9W9G1R :]8QAY17._4-<7. Y1(D1F.&8D.M%2@CYMCW06\,
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MI$KX3208?HC0A1A\53*+TX5=@4E"<(/FR>=O3FD@_UE'1147L!6?8T+4@_'
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MGGD'\,?1P;FO9ON:*\YD3&TDL(?.U,SB^$WUSWDGI??)#,XC -N-1HEN7N,
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M3K'E[*$Y/2=TDF='U]^S[EMO9S!?#."7( DSM,'X'1]$!J1HFK)X'Q82H@(
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MLWPG2$MZGS(N4"*R\@EZ#_;*I<P3ZA"I@MBD<<VQRQ80>:-]9FG?_FO6$;%
MQC07SNBO5\]JNT,QV3V_\.8T@[/FI))*7HLEOWAJ4#^D9KA9/9*#39!GM!O,
MQV']N:('U2]11T":597-7$^KJ[2ZRD/H*K=HJK#XH/=( ^_-S"XDWX12%9Q&
M2+/2")X&$@]T[=?W:4;)HRJL"7:-Z4"B4F&=D6MECGJ$<E>/0)D1\[44.TS,
M.K0?5J8HRF_@$G/X1,L[*D^WO..)\XYSHRZPT9')(6CF:!F0%EH=JZ S%G4A
MK5]UL#7[_%J*;RF^I?CMH?CW3NS!\7DK@8\%]JXM.>O"=Q(NN H>DRZL9L!Q
MQ("2--2TCZ]RZMJDTQQLTMQO!H"G:]P#*A>!%7#Z=Z@->XF5+J8M,3HXU%LQ
M;]CI<JEV1=._>"^3:J%YRY5:KM1RI>WA2I>JM<<L2]$$;!B0\5!2YUC%3Q0?
MH ERRB]IF1!:(8J!C'&"TI_P%@X!PA)R4>+7 @"W_*#E!]7_M/Q@'78)I56[
M[G-?,0A?Q1%,&!\YADT458Y^O](H@I4<U7E[1K7!R>NJ,SSL99Z"4L]%E4_!
M4;[6"'PP_S+5C6B&SYTPJ"Z*2BKUY&]3)2EZH*_Z)@ T+WNIUJ0=_W-33X:F
M^(ZY8<P'T7TY)"-*4[RJ(=:S(.94:1RNXH?<E=RF[VMD;4YBF'7E(Q1H?G&_
MC-T" ?R/DT@VIU9UB:JME=)=[MYQP&G^^/2J358 UEKH\ZR!L@@'V5JJ1;"7
M3WYQ9CB/4-_*>!ZB:F.ORT3K)(JHJQ$:.P40:6 B(B9GY;:]P=1,\$QGG_=7
MV^IL:M?*S>H_(<3>V^9JS[S1]>$]-:@_?;/US:[IYCWGZM?4TOH!^E]\3 OO
MS*04WZ'_NVU%>:D[C[P#@18-6K*X'[(XWWJR<+J1&ASP& FP"CZ+\K R;N8S
M9Z, (:'K3\V[>\:$Y-[#<ZYQ[[8])Y])A?L"=%MJ.,;GL\LOWOOW[^\BMM#D
M3+/<]&Y2K9F>N]BZOXE#W<XCD%P*"_S9'EYLO9^G&5@.Z$SFX9SH>MHJ8;4*
MV;Q]?WEQ_N73Y97WO\4([O/B?R[.?__R_I\7WJ=W[]Z?7UQ>;:H=&^;2)F(D
M3<)RJ&^&?7[U'I^Y=I]$&24M:9_*@/Q_:1ZI*4J]".=2CH?*&>/K]DD!IMZB
M%\<B "_V%XZ<LF-S"]4>%/TGSK,B<YR%N2RP^J,8<D<OY6K1F>(\\^U6>L%R
M3(<EU?WQ'R7YX(IB,<[A&?W7BK[^VS.A@Z.]T_^>Y06L]9@-:B4(!+)'<W3J
MM:ZWXQHUDOD(2+D4O<\_3F?O^+#A.*,H#&, JKI+]SRWWOS\2^<X0N>@,8[P
M7 ]SM-?=7S.B+6#5-R/?V:#%O:=ZF*.C;6%QGY6X_#$OQW,KM1"-20>,HT3N
M:F.H6Q$F:EHA++G3?0E60SENG,6RC*ITOR)C=4!A8Z@"-(*)=Y8,9+Q6Q-U>
M''VL^[Z!KT^&42%W4:<B]\,$%,1;H<CA_C.%[V/=]R*>>QL$L!,*;+?[YE[0
MVM#<#G[8X*_"D^UW#L%:.3B&_SHZNHUX 8TE"3.XMU]A_7S)\,BMY?V:#K$=
M1/383W>3:KW,Z>Z-41\=MG?U;$^W6-%>%R.<T_A_._C_;0YT!6(L$][/99:E
M\7*SG)^> O%8]_U "O'1\3.%[V/=]WTKQ/\$'F?G=OF*_]TZ8/)8M-[SH<BP
MA/I\*#$/KF@UWV=\NJW2?(\[[5T]V]-M2O,54382IGG6FU1DC<56CT/O_3F3
M@S2;@BA+L_5&8[87D1[KOA]*[3UXIO!]K/N^;[7WN7AW_XCB.!(C[P_Y+5[2
ME_%<9>_3/MUVZ;CK9;^/_:Z>]NDVH^-N%\._S0D^1L$PC47N_;KG747)8,WL
M?'L1Z+'N^Z%R'%K=]G'M>]MT6_U7<]+[G1/'9^M;*MEMS37F,UU8YA0>;6Z'
ME>PS7VW/^SS<>[OG4]TT9:536?^\M),\PK99OXJD%-G4XWK_ VZ0E7-I?31R
M??6TC@7)G)GFB9S-T.<W?1!3-?CW<Q;A *&4JOU\[VVVQ^< V.SV41KCI'"!
MO_7>1&E.C;%5BX?JT;"76'V'<S;F>IWP9^1UHI8'9IO4*HCWNM_I=O< "&K>
MK=FA/;ZSU8MO(HARGX;K<"LBG!2/FZ0N$33DF9HQ8]V =\8SE*9J![2O/0<&
M3E\'>U":3$ZGNV)HV$'Q5S+(9 %7Z--$=*RRS/0M"G,)>%+>I_YNF25GU[$
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M^ADL@B^YDD$F"Y%-]YIP=(O1.)2(-A<%V*!-6(L(*,)T7!"BZ<?/TR0L@X+
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M'X U]Q5L?)#GP1#_YB=1, AO@!XKYR8RD)5[WIG)N;EA_ZAH<H[(OUG%D\D
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MAF4&V,=KC,<Q'!$1=2I%MN?!/G*[DXG, (-%')2Q4!L209!FH4@"": HAK,
M\+QW9U=OO+.K<^]+.HX"[Z0+M'J>CL8RR07NQ",)WGWM7='VW*]\3WX+Y+B
MS8G"$\G4DP"V$9X,CM-/L[Z,BA*@X$U$[H51CA#(0AGN8=L%3WBAS(,LH@/C
M+^B,>5Z.% C*G$\1P#O+0D,A3.-89.K4 .8@'21 1R&^T.M'"9PV$C% $_8Q
MDO0(WA#\O.GXXS(;I[G,?2^7TON8PMZ[P++HL+MO!.Z@>F2Z9GX2;C:E?YS#
M;M,X"@GL[\P6KO06$"F20D2)@R9G25+",Y>T.0\ @)TH@!?L_GUO?^_2(@^
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M" 7#*%$_PL#?4&+ L8>92F$&:@*'<A(Y9572)V-;6\VAC &0V72!-:QL!-%
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M&A/55]39]?'LX3$:<4VUD*;UN7NP&Z' D%:Q$CHC^:*6.R@]C_OE5?!$>\#
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MLV,4Z44].: B%U@8GUJX**5A Q=2"2^5=#/*LSXP_];KF!NOT&K%1WUD5TF
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MYUU[^T<%%T\$R-K>6$3G;[3=5.F@I]%JG'1.7LW>[I^"5X4N[?15$UXZ?W,
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MV7<@+8#'\*>V2Z>P_E,@ -[ WQW2K\@:(&!B*=4$48=S,,?X33BVN2@RG5D
M<V_$9.:L,SS&921@&64)KAGXR=S2SX.%0 +?'0DL2[!Y$'BFS5D":0SX)A?N
MK1-XZN1C"I#.;]2WO1EX*R%Z,H\1!B>P03/T8N2<N8#%YTV) +Z5,(#]B O%
MI1M2TL!5=V8H1W\B;^RW(A+P#>6' ^:!0V%/"*X;P H) &/A40BI6<"U+>R_
M_1W_,&DP%M+^[YD=@@25[A%^Y'CNXS&@9*+N,7X1@AUVS'F(^2,TJ.#KXR&%
M95,7(%FE]T C$*F,/YDYH2WB%E&D =YE>U; Y9\@1CA?P7L^)G]#-,T 91A
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M>&&GZL9^:T%D50/4.D.C&4 S@&: 6M!=:R*K7._8;H'!J(O>ZT!WK8E\I4I
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M/1^,<S+U@H#A_^.I/_PPV8E@3'T@\9O'P_#XN/N-!2&WO:?>$^I1 )R@(QH
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M?13A+0PC9-(\!?-LHH2R;(N?@HIO9U,G$MDQ10NE!.H]=_Z&Z8+@P8M!/<>
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MO4@?BP\Y8AP*]@0OFO1&#7%ZL:$DX)YEFA"YR.'U0>C^ISHQX#!1#M:6!WS
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M=%1R9>84&V8)= 2F-V4BYI7@;BKD#-CK3?(IJ8['%,S"!1"6):])SG[7@C>
MSG\<QZ PNDHFS&?1#-(=PV#":G.7M-/!8V4='BM[TW[+*W7F0V;9TBM;%LA$
M7::BEZP<;<L[,"&$V9D9OE4:O8D0NT">YT;!!AG,R5UMHE9Z33'R(^JR<B I
MH. %,U_NWDP6+_$-C:O%+?Z]R.NEUK*!V6+$B\\"T5$2HYDP]V 4Q4 BP=*0
MHHR?/3#I+$C$(/P&/#/9TH_[O%$X7T;WDPF+#$]J.W,.)0!3)BL@N(9/CZ<
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M 6TR,..$_[>5MNNO!7HD;P430?[Q[#.X A?WOUU<H#.>@NE'ZO!S'_=CQL(
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M0,6S&=@+08-<N>9<-_9$DKUH.:-[&U],>BX3W$QM%^^=$JWFR2BVK0+%MMJ
MV/77]2]&QO0;(W1FV2&_J@K^-O%B2>H^8XK05(S ' V0G>B"P=65O+Q43&FN
M$X8RPAU@A!OQ)W8\;7S-;S]Y0\''<N@3]1F,X$\]$>Q[6R:MR!#!;!C8EDU]
MO#;@#2X;!D.,UOMSL7;\7^WW;XMB]=&E80ZWKM555D" O_3B^&4CO1CBT@2\
MF8!,TB&:("=$PWB(IB%N_$6?=33GL^(?+I%7+N!S*H4N>@9E+NH;+ %B_.IB
MYQF&'3$?D];@B\ **NL;,TMZ-9)%BU:^"0 AWLR'%>3<UBCD-3(5UY>3$;5]
M!Q8)EI0Z#EAN@$%\%+Z> FE!]A53+[#Y!7*RP8C<^U*Q-P>G]#H(;"6[%\P<
M@2,[+'7[$ICRP4L>K0#!Z:50X0P["CR&]V!CH!)O9^=B3M9!3$4W->PA\LA<
MF(B#5^R9)IN&XEIL'.!/UX[#/WQ%SR: #I,6JZ#\(N[]J9U?/2G131"M.U(P
M#UF%DLN 7 ?Q6UV %:?4YS>5![,)_B <TU#E+M@]X$V\!]EV9XS?$T,>U9DU
MR5E +#LP9T$@M@_#&L2(XAI+)4@C-1Q 8\9%$24NJ";'"_CN_V!T&[V3TP9L
M#[%FOJ!4"M+_Q]ZW-K>5(UE^GXCY#USWQ'15!%6#1^)5W5L1*I=KVKMNVVN[
MIV,^322 1)E3$NDA*5>Y?_WB7E(R)5U)I/@"*=13%B42P,US,A,XR+QC[^^[
M[, &DV:8L:6-C-.S4?Z]UAQ'38?'7MNF?=R>\.8TIC'N_-+5#/J],0XFU#J?
M*>8%R*L81Q=^VD,_NKBV2G/>S^_D!V>-S>?)=ZS9#9=RN8!_O6HX??4^37_I
MUMF,Z9<F1)PM9A[,U9"S!\:SR:@7:1+& [^X],W,[^#>.&I\2[/*9Q<QOT->
M<8R-P<U>;I_^>6/&<S+KI?'HO)UIGG&V*YJ1;U[7BV;P32O[Z9?#P>2/.!G,
M2&SNIG:'R\D=3Z1YD'/G\2GS^6!N0-=]W)5=?.U-_EWO3?:V-WYKT&XGTN^-
MBVU<P^4T+V/?FV_7-:+K1NIQ,FN=VOCV-F[]KI?#V-;\>I]F&K<%;D^#\?F\
M.6NK@FO!UGSR7 YW"?/%.IJ?VP:LV>1FV= WUZC_V]XW\U"D%<U]#?2RVVL&
M,>]V%>>M7@<+8KSVL^?!Q-==UDN::4<]CFT8?#7*OWWW_KM>HM@XI1M\];6#
M5HY_)U<^'S]]RO-JMU[&%V?SIE9Y 2[.YO[Y=@>NYB>NNG#E 9T/)I/F&5V^
M93O1K6#J41E+0Z 7H7DB5R9PU_(U-!GS,[R:]6PJF8Y&D\57YP]M1C>_4<MV
M[?1S6--$#;.5;3\I/[>1;V@F_Q).1L-VI1MO-6X^^OHSFM'R;Q^I)?<[X\_&
M;-*86BJ["CJ;AW#Y(_VK]XB9OAM C<<-98SSK^51S>CURI(F+:,NVF'C7_O-
M%FF>6_ZL/$$:_I)AV[XXGV(3-<ZG. L7\YJV.=C,V8Y'9[U1!L;"#&8=V3)B
M6H^;W7;SF]<7X.H!]9L/O0F/^3KFSYTU/6X>1P/ YO.7_>R>SRO<S/<R$/QT
MD;/ 2;N6<]II?NHV\U!*LW1C2)/)7>RVRA*TYI>_;#*(WVX8PB4!#D?9>8>/
MEV,ITD\]^^'- JQ:MWR%@UFT/ J40Y[925&V_&9BK<,83'Z=W&G#ETO<A8 '
M[/M&CK. RYOC:> [\T#S"*6QA'9<W_7>-PN_\,-7<Z/?\^(,\UOU&]O 7B;Y
M:>-F!GE<]+DIOAQH'O9<AGEXWCB+&7,VH6:."N?O>><<9^YQMJQMG/3U\S_C
MV05.K]Z[*S&YO@)M6_%V&R(_^D'*=)_7-X]Z<-XF)^>8(RG_9<$WM_T4?Z,<
M..?_W_B\QJ2;='>>!>-B1ML]D;\WP?K9@#[/"?,K#>?E;1:LB2\7V-%_#7*^
MYN.'N77WO'&9H:F[W<[WK[/@=T>^[^K#9XN]&'E__7K0\MU5E-PF+]DZ,F &
MH_B5X.]T1G,7V.ZGG9]?# =MV\L&BS<BFVLOSZ*9&SAM/ZOYL4$>',W#"<R+
M^0W_=KZSU%+(S. GS6<L@JD=R7QR,SZYF<%=<Z+YW;\1WV98?1Z=?9X'!VVL
M-6CS^1S>G)UEM]?B/&=0_SUC_W[SJ4U^>D:_YV<3?_EJXY'RQV9FH'B5A(YG
M3BS3>.A\%L4;]:S0Q9\'OW\_' U?7[1;&+TAGN?/BS3XOK7JT;CID/FL/75I
MKWPH,"0]8Q("0@"%.AHN$4%(&;2*SUKWF(?[KCDZ#$VNRSCCTU'S%1>2/_OA
MW]^=OO[0^_"7-^]>?WCSNO?JU=L__]NU070<9Y;@"B\WR"<T_MSN2G0GV;-E
MRW3<N(HVUR]S.@\]^%>CT/+_PL/G1F$4#)DG!4*!#P&9BHQIY9C"M,3#;\;T
MGZ/QK_W>Y5>W'OX&#K]67XWN/G5W'T!O?@2W9K=M <=]D[A4:MPC\-B=B./N
M$@_WKM6J0H[VS8H4<]Q\4M>4&W>H/#JE3_L4==R%Y#OPW?6])44>__Q/"VYV
M%?+8L>9!/%[ \+!JH4.W,/]6A[S@SB=S^RUVXIL^S(*[1:E!_U)]WD9W'=J$
M4>J>PTX&W"%*F!]*-ZDIC7/0^>MP]-NPB1I^'(]&OYY]&?9>-D'SZ/9)]K?W
M360E9!6B:NA6C![.'%<41_3N4#!LRCQNSK_W"-4!OUMUL-YI;9<Y7#NPO5/3
MT.L2*S1@OZYIF.L79N]YAXAA]N+M=6J.Y.:_V'TPQ^^0._16UB1TR1#F'[TO
M,<+,%&ZORKV+L*@:Z-T^VK^Q^/,97CV"I59\UR?RI=),=P6EWYL#")PV9=S?
MXAA_R6SPL;4VSO_4FYWC/[_['/]JKG?GFCNBT%O'_]<H<T=:@/-1<[YRD4WH
M-@PZ#JNO'_]_Q$G[[Y4,8''+M1$#S,_/AD2QW1"?'=$W%80:S.2YI1SRMZ^<
M-XZA193/"[T J4E>\.8@Y#K:VE.="7W5"TR6/_[_XUT'_[=7X-:*?3W\_^-&
MCOT??N2[TP"4@HQ.U.>L9O&PY.V8/@]&%Y/,?"\S .Z\A%/2%/9..'/I3P;F
M@B'*RXWCQO4\;(^W"6 \>S(SY]=IPM>$E*W36\+ESK Y;I*9YH"R/?0Z?.?U
M5=+RYFY)2ZDS6E\9\\=-:6+^V$'6G<,J0!'SK-55/-NL"N;V]#ME,64H8<HU
MZ'(4,[<?:)>$YAA5,_<AN5-&L_"@#DDX\\<UYW]=0[.2;*9< )8CI^EX#*V^
MYNE(:FZOP,)6P]'*:C:,C<W<ZEM37U,NWHN2Z=PV^ [=SKZE.EN3Z73,?GG=
MSAH65A30YIJ?APJ[!@!N,"4.#"&X8#U:@U(SE)YQHV9ZB8OS^99^;P-'!MVM
M>,[./MU[^%_D$L_6YD@69;/91P/%JXVY]NAD]'6OY+?&Z?W2K!F-/U_N$.>$
M;'[H,C]HN118W2'3[F*9/_4^CG[+OG1\)3V?W1)N.*(CLZ09F=ZG[KH^LIG6
M*_/-6?;(TYY@7.;?'H\N?OEXMP*L4.-]A"PLHE!!:V \<HB0;#3.>V&T8,"Y
M%+=E8?Q*%L9OR<+^\V%!V#[7YS0'B6<]KB[O;M/OS4E4&WK--AC[O;LW;V>%
MN;-W>MD>=\T"P<8%MK_:O.G+8;N)_0%_ITE_#I#?/@["+"-O-BJ;]/3_7 SS
M)]WH5O5(4<U]6^!+=>4XVD)#G<:RI&9-/NG"0X_5J>U;H[8J FJOH4O]TQU]
M?I:H4[:7\5[KO#,7Y=VHNGU+FC=_O3?[@7+F\LW+9ELD.YCL2"97#NE3#JB:
M78BKW91;JK*RF@G-V2&D:?NKC^\N]+#3OZOPV2(3M B^IV#CY_83&N9MO-;5
M:%=I([1:<Y+[/CQ/\&9CE#T/1#PXD!M=C^8/9][YZ)Y1+1OO7>*N:V=I\?2U
MJ[+CX]ZUC<4VT^1DB0=\V\RK[3UIV^/':7NST&K%<KHKLO/J3[OK&9R^?[\0
M%VQKO2^M8)U6MFM ISO+6K4O]D9M;)M45E=^8RM?)I"OU7UWL]Q@?O[2G+\^
MI@74XSWDEDUH&Z#8'S3K&NX+9+/TR33MSSMVAYX_?_'BYY\WA46<?-RV1YW7
M?G]@NOPQL]VYK:PQULZSB7_9(?MU]BN=-T38V(3FQQL_CS&TF^^S\XV+R<DO
MB)^^;\QMX6 #H@[,1FD#*- ,T8,043#M+/,ZJ([[[NUQ1N]B.)A][V^,Y3]&
M"H-S/)O\[V<G,J]"GGK^S/S5[ S@?S\;_#[]?GAQ?A)'TY/YSS[[@?,^@+X\
M#+D<\.I=%HHQL,V#H2*W(K<;N0E!<)U(>*% !6Z)4K0R::F4"[&C4@7?(')U
MWUEU_,C==;"QD8CB32N&'%.@P>=FH[F<Z*(X(MK''N']3+(QNFBMX-V5$4Q>
MTW2>]BV02"-K .$(@X%,)\&;Q+DS+D;4CJ6N<C>;(Q&G>+D,4IZ#K^ I##R1
M"Z> >Q+@02GMHC4R.UG%4D .>JL>6%LX$O#LVL=V;MAO.\M_V]SN'C17!3[1
M\/(6]:P*>KBV&5>.L][,.NTSRWCP#&Q/LWEDCK'YZ3R"&>>&_&)FQZ?#V%+E
M:6N[MRF2.1T0K30D"8QWJ*QVP!.&Q U3N-WMA;XHF21+Q5=EB,H0NV,(8HI;
MC(9$5$#DG57>*^G :>M9,-O=QN@S9YXH0QS8UL:\8?6'T;2Y;%MHR%0<P97'
M41NCF;L(12 0"[$IXIM#CD3>.XDN2AVBB#'Z[88<LJ]MW=6HD#DHR##N' 5F
M4$H-S&IKM<]_<4S$<K"^Y:,$VS>ZX$/ W3O5\>BWE0QGT%::^;YWXA;N&GW=
M?-B1FF'NH)N;8>-!6WVEJ9NX \5FQW(=Q@GJ P,O]IAZ5?O<W*GI_?3VU?2:
MH]+7HV&XO64;4'M-A@S3@$(ZPU0DC3$DC39V]7;8'--!SC:ZSDRK^52\5KQV
MXM7'&)2*#%( $(&C2L8#(9/.22,Z@OG'1R9I\#O%DW_0>/3LAY/CA6GY>7_G
M/<+.,Y6F?.ST2WN6TI2!^32K4C2D:=T2>(KYS:5!O#W#X?1T&%]<VL1K6B05
MI9RW/J7(9 +*:8[PPEO%F$Y.,\6V&@0(>2RY3H7/TX2/!. "#'G@"IQE+@?.
MP1$/2AH=3=BN[,&P(X'/KOWPMA4.[QK#/!FEDXL)S3?F>R>7!=Z'O[2%@ZB@
MO?J#.J<\J%/('9PQOKDTJU>-5;6F]R;];4+M#N?B]09C6;3(2%" *(73*J<4
M45L"TH"T9?T!DP6S50$ J&BM:%U :W!".1E=A!1!I8!!@7;:-@=Y4:3M1A:B
MKW3!6H"GD_YWQ!;_/AK%IOE-.=%#<:13'K-LC#XNG_X"4]B@T7HR)@&"1.]4
M"))[[1GS.C'8;@K?9U"PKK \YUW!LE>P$!<8K#$ZJ 20I(U2::4M2_D+(3OV
MNS;J5H\'+,>6LK\<GK3M#"9MSR=J^X.W#0GH,YV-VJV?<CQNS0 .. -X.8R4
M!DT;I5>#SQ1?#J<X_&7@SV8IP.3%[TTGBYP@=+!78!C)8F0J:'!*>+*0R"-J
M#8+T1J\H/G0$6 AI%0"%BMN*V_MQ*XQ,EG/FE'9 TC@0R9,D"2ZBTAU7?S88
M=:B^<T]@Z^T@D_F7P\\T:W;:=#O*S^=DWCOKK#DF:!MJY=?+"3R*8ZGRJ&AC
M?/.B;7S^5YI^',6O=C)95 1!3,)+*Y@+H)VW#*RR$#$QZ17ON"^TP<Q?N7(Y
MI3S/7X%3$G @0T43MSQE%XQ&6.0).<N>&5)27:J7S5ZT8P7[XZ*=[E[J%<QJ
M")5VOZY>."Z+OLJX<+QPO[A31*PTH9/D$[($#+Q/,:+EB-XHB<%N603 9<'[
MGZ4BJG)"Y82M<D(DCT(D;X4"@]%3B"[_ RC)&>VV&@V!M4^4$?8=.\'C.E_<
M78F@] CIG@F71WEQ=-&T5%KQ(155!W:C$UOF-O?BY4:E8O3<)*,<,.N<4B*I
MZ(,G%7"S)R6WSWE%7YB"MT?V"HR*WXK?A_$; C/!N021Y3@$R#D"%P(TE=DM
MAJXFLYO#K^1])0JNZ+P^,(I7;]13VJ+'NJ-3VJ>WL-5BJ\76@_0'4M"N=GRO
M7I[^^/+5RP\O7[SOG;[^J??^PYOG__<O;U[]].+=^W_]@Q7<_*GWXO_][>6'
M_RPG02W.A,H#X)-:HFI%U8H*(.2M=WF;5RP]&Z ?G VF ]I.V\4:2Q4%PKJP
MU6*KQ9:^L.5'_QT>Y32$///II/<)O]0N7X\84.E[T9O;:)Y;RMN9H=RN_ZO1
MFL@$Y;\C,$ T+NK(P!(HDU_:LD!&BV.1!E9X57C=AI<#85&@ )(>0">,6DJK
M@G?*<)LZ+JMO5'EK5,''.D7[Z6TGA=ERQA?TM2E8.2[\*4:!98;7CR.DQJQ>
M?=UJN,U)1@3+/(O@?=./BWFP4GNMM?&*2&RW@(;,+K_@*I@%&']%:D7J9?4.
M8)%I*XSB"H+BJ,A%QA/9A BFHX3=1J,' 06+NHK: -AFVXZ-A!LW?_S!7_CI
M@GK346],9]CT\_B$X^F7_E7SK>[6'KW.YA[=W]U_"X&B^P24W0S@,17_LT%]
M&+V;F=/;;$V=A">E](H%X#$%<)GDI+!1J^B\CRR$[<I8FW2I:S?BB9A"1=&Q
MH$@Y'Q"$3UXZ2%RX:**RQ@6=HDZXT>N^A7?.>-)[#&^N%^!>/("^<N5UWZ%F
M,QO(9JZ7^;U,:K[<YB;TR0;&O+3@@*QJBGF80,%Y9S%SU78OJG3VX#JRA*:"
MM8RQ'@%8O4D<A=/) H )T9/A:$$H$-R&+=<-@:>P3[CKD*/SAN\&JX:$VUJW
M<B*,%29?W@6[A4OT!;+6(\?\&/)J[.S>7=.@-(#VF;H"@8'L]"43I))%#3;J
M[?;XDEJ6RUI[!4#%:<7I]8:\TFEKE$W.(R@348@<:5C.G0^>PW;K< @HN.''
M^@ XGJV,:R4WB@XO:DYTP#G1_4S%8E-?%"2/ K0)/K,60Z-)  H6Y%8C"M/7
MJN J8@58?85HA:B-1ODDF-',@D3>J)JMMT)0(J=HNUL5LJ]-P>%$49L5!4LE
MYJ%&M_2A+59^K_RARASJ 6W7 6UG$4(30M#*"&*.@] "R8=HP7C'K6-\NR),
MWA>L:W/UB5A#!=(1 <D:15Q:DT-T!TS*[.PU Z4$6E0B=5Q@JF*'RZ$5[<RW
MOJ7P=QR/\?IFPD%Y]ETG")LRTP+&O:,DYP&&H_'@,TX'GVDAL^GDN,15X-&X
M$+T&D90/3A,: TSEK(>V*YJ0DI='=0784 5M!>U]H#600)#QVFD-QDF/+NJ4
MC)1DH@WZ"04F16U [+I8P[TJS(5=A7(.,HK;"BUOOW/;6JQ.1O$DK><<?-0*
M@B&$I&+.>5R4I(/N8)0-A@'6%KS#6=Y)0\50F1B*SC3B(&>B$AD^W@G-HPLY
MOD9N;-QN00;1%^Y84+1K7[S'5FA%J@UJ[Z.RV*R@WD</9292FI!D8$&R"&2]
MX](QED2CNC),\:W&$:Y@+4.IF*JL4%EAZZR 'B+78#!AI@%0+B%I<L&P/$1@
MVRTV ;4KVG["J(UW13N(8.D@6BOE05YV'QK_XK]A_5[SS[<'0',KCGP]+=AB
MO9RD!&><:P$1M'$NLI"L9YQ%PYT)VQ55L#XWXG!HK'9!JU#='U1M ]#HA0_,
M0G(9JL$H9H527#+R&Y5MW(*J[F?D'S-2=QU5%)!AE'L$6\+)69DB\*>WL-5B
MJ\4>PR%Z^2K^YZ/S\\'TG)HV"3B,;3B1G2H-0Z/S^^;U:$H]+KX]*,5?T0JA
MLF5 ]X[NWOAUP9!.A_'YHADMQ+.@E8-@E>.>053&8TPF,AXB&(BT])[Z[Y/!
M]\/!67X&XPOJ$OG0^:?IEV<_W(Y>.^SXR=A$A=.1P4E:%<%)!](@9"1YSAEC
M2FO+&#):6CSWA.&T:S^_SWRPRG/W/^[#B,"/:,&KA5<+/X %W_5>Y H;U^^G
MH_#KQ]%9I/'DLFDV_<_%8/JEH :MQ6U$E+>-\Z26J%I1M:(":/9N]["RRO;M
MF!*-QQ3SSV1"[O?^Y?X4\NKG6_Y^B^,WX_?3YI[X?^#9!;VE\?N/.*;%)I>,
M&V+6.,,L1)^\,99K9VPR>2VM7VIS1BX>-GX]:V0/G#5N>"J,>P'*D]5< L7H
M391:F!"357EV':6H.A+C1TZ%?9=3\(YCTQO?:"JF-)9U0?W>*K-OISHYO9A^
M'(T'_Z"X>/.%2^_S/\28 932Q>306 /,,!12+?4 Q2-/BS<T!Z$Q0. 0'1$P
M!(^8HK5@ \DHL:.W2<>3>^P<>)^QKMXF-Q_=I!U_#Z\F\)A'^.9B.IGBL#G#
M7FR%F2SC.FB&R@ (ZP%%U$*RI(SSMN,2\P;GOZE),.0B04HJSP),<M9SGX0D
MDQ^JTG:YVK*[F\3+R>3BFA%RI.2,\5&1A\"")]3:,,G 8B;&TA["K?$[A<13
M)FW#%;AL1)@7/AL4)Y-I;<E*?(\&D>HJFK/R-_*'3[);;8M+-2=3HZ^6UANE
MWGL:#VARTX7V>J?-U%K/W(AU/EWWF3V<]GZB0.>>QCW)^[UFYNV[-X]P18_Z
M:I!SH(C-S\U>H&&@UB%=NT2@+.GDR229 <&<S-! E$9#0H .G[I! <_&9R-0
M),K8R+ 0#2X0L^$8"J@Q>1GM=I6#R]A5[^SK/.9/OYG(+LXO#VJ_J80MCS*U
M"X_0[EU'TDW0)&YT<)*Q'$9#$,DUA1>]USFFR4CR=X'FO]H(MSD!>GZ&D\F;
MU+[YZ>^#R7_-N._T^L?^M66U#4&M7-5? 4"IJ*ZH_J^8D@\JNVNK$T#3F"F2
M-Y"QSHPP9.YP[!75Q[2+OJK>JD/E-9-@9>.[VM1I%O3:8E[^/&M__&'=P&BX
M[#:)-\8)TE(X'@"8<LXB([0^!:;1+"?'V<J.SVKSX$%0L,9H%1.8D)!'&XB!
M5TJR:#HV/G:^W?/G?VN>Z_5=GTT]Z7NV4W+ZG3/!_#1#%(#>>R5=,%PC\ZSY
M]AXS\>4F(,%8]'D,.9<%I\$FHUP$$9377--RC_;1J2QCR^T(73[=6QM#3<;Y
MT'.^E9%>OEM.3&\GN ^]6[,"\S?XTZ9-[-9& R2/'!4'Q3P$RZU,Q(AQIX-4
MR2Y7GW='YG7'5A6!X%)GSQT4: 4>B$**PB9EC!7+;7H_=@:JST57I9-NZ[IM
M"\W.Q88?<?<J&8K">)V\L@HXH!.<!6.]I,0MWS(*US72;(V@+-KL)7S^(CL[
M0!%28C9@ -]QWW&#@Q=]S;H"KSL(9- ._M:&UYHLL@II]'MY#3]1:(KWG7TI
M9X>DN(2IO*QH8ZG/ J9NYCU!6>_ \IC_#]I:R[7F1%IIHN3E=GO/E]SKLKS=
MAXJ8,A CI?!61!.1 )FQD5R*3 OA9/1==QXV> 3 "^ZS6')FO_6:::<Q#IK'
M@6<Y)1S$[(][ 3\-IGA6CLNMVY<'O'WYU<#>9OMZ.7P^LZ[%O0'F&"9FO&(2
M/ <;;4K(I2"!CL*6ZX 8TY=/H1U416H98SUDI#JE+4?!'3H$XXP+3 9FO3(J
M&NN6RV ?C52M^]S5PX/E)K5NK=;-!!<A7)Q?S!JS14J#,"BH;GKM6[TULMID
MW^IO[B>M=S3%P9#B"QP/\].<+)C<3S.+6TR!A(U>N.B-\L#06A8U=S9J*:/)
MN="ZD<:D7<^3!XE,E5U9>DU"^.';"O(*\KV!7.6\P5%S=<!Q\&"\ECE*$5HD
M)&-P[<JH2X(<6-^P RI;MAV0%Q'+[*C=_>3.^XFEJSYK'>I#X]9=Y(.+]VU?
MM'9\/9127D@GN7' >'*:() .EC-0.4?<[J:-Z'-V: %4 7BJC% 986N,P%%K
MA4X =P&D,LX@CV2#CMP[B,O=F'OTB:SJ*U;P&5.M2O_5R%:J2M_*1HXGLCJ(
M^MB7[#*O-+WBX_WA7[:Q_!NES4=.;.G*V:?#>"]5NIBXE IRIJK &87<<@S>
M.K!:^M21HFY2O"+ZPKC#H<I:^;XB^V"0[8.-+D6;! AP'C%8KR0:F71.E-Q&
MVPC?[OW-^TITW0$X&F1W1#J77_WS/^47,#_\J]<68XV45_TDX?G@[,OWO3]^
M&)SGR.(U_=9[-SK'X1__U&M?GPS^D<? YWKE:Y'%Y1IVO??B6@3*3W?\I]X\
MGKO>I&'U07SX2#T,872>E_]+(\ =CJ9-3#3.WQ[V!OFS?AFWRIWQM+F,/OU(
M$VHLK,T+VF.W-!CB, S:[:GYC:_)=_?-9BLK%9I+9O_[V8_OWO[\%G^A'\>$
MOY[F_US94S@C'+=&\_&JX/1T]&G^&9??N32<^0=_-8(''L>SFP-X?=%(E-L1
M_'!-D[S"[-N+5)=Q^XQ^YJ__1@U=-=:<P7IV^4O-!UQ][]D//Y_ 7.E\<\7N
M6;.K]?J4OW/BFV^=8,I3_+Z'9[_AE\D-@OOSQ_'E;\P)<PY'UD"O8]%G+4;:
M5R^!RUB&[L?YE-J\Y>:D._*8^4O/LF$L-[V_$,;F@N%\M(L??F-*+5]C[^.X
M8<L_?#C]\=6+-S\_?_/ZPXO7']YW/<[YRC=:AD&X]0@SR!K6:.#3E+=M\''U
M7+"CL&S'=&Y:_+4_+_YI\>OVSVO@KG>;@F\N_GS<?UZD_\<3UZ55^^SZ'L-E
M2Z-U,^39,>AG/[SX\.+=Z]/>A[^\>'?Z]L7?/KQ\_K[W\O7SVX2X,;I?=]6R
M8;]_\^KE3Z<?7OS4>_\A_^^OC9WWWOS<RR!HXHXW;_-D/KS,/Y>-_W^=G)P.
MP\?1^.2DM=^O+Y8SI6]>#K.G&EU,<FH_Z??H]T"?IKU/-)Y=6^OA>::2Z>3;
MG7JI-G3(DS]K0IV076U[X[+Y\SQJ:?\\(]'VRZW!]AKQ7GFND*;M$)]UA#Z7
M7V]PNV>[Y^8;^_#%T'0+ WGD&??74>G[=\#6P-VS'_XS.^\>#6,.\A;O7*T=
M[:\<X6_V<>UB,[-:]T:L6ZQNW5V&W%X2W,X^[IYMN5K)1JV$'Z>5[(+Q.O/2
M[A$O5"1?PYRZ'NN=6T0/C6/+)MXUUA7&)#:U3@]LI.UHE>J3*_+)E<42W=OH
M;W(2ATV'H)S4?:+AA";K5^9_Z%QZ#R[Q88>W/ZO:Z\SK:N]?G+$9'= [FN3T
M,GQLY1>1/M/9Z%-S=K"-6&M[UPNWX!&W=AOLVEBW=/JZTRN(#T_H(='_S 1/
MA_&GKP;X8N987OP>SBZ:&/PT_,_%8$SQY?#M>!1H,GD^FBS>!B!F U,NI<0]
M2 1'RGBI7 C<>*>Z2LLQSOATM&'%*NM+MX7; 'NST,V@J4*_0G]KT$?TPC,2
MPD63H>]1AAB"2-@42E7"=6@QKJ"_R7O+HF\Z*S,>&?1W'>@\O'O1:7DOSS_A
M8-S84W/D.QB>?)H93U-NK,"09Q]9_WJ5<_:4_B]95.G.T=W/2%^MYDUZ,_QE
ME.DGD\Y_4U@DG&A$T]B""*,&3=%+CQ8\TR)8#J*K"N4V8@W5=ZZK5NB1&47%
MT['C22LD;[7QP D<US8D+5$F"LP%8[?DP&>=IO]!X]&S'TX.'$:'N?GPLG2G
M_&22D5U33!F)QE5"L=@])454$AA&FR YCEHP8ZU#(X/QIJ//PB9\^T-<=&0I
M1 5L!>RF $L^&$Y2R1P)@'?:,9E$1BX8)IP*7>5.MY']6]97TAX_=(O(_KLM
MZM]I2,TMB2:$P'@^& XFT^:8\C.5F-H7EWZ4EW*LR2%S>\@4<GK-&N;[B]?Z
M#()"C2X:(T$ZLH:$$Y'(R> IQ5T='NB^E87M();GXRN<2H>3L9HS3SHR;<!:
M:2TC$B*F)'S^=U<NF4/?"#@2..W:[VZOP-8/'\8XG,Q-+(PFS3VL?;KGC<QT
MKXG$QFO&[#?5V.YT'L%\KT?#@)./?Z7Q+S1^1VT]PN8,<C$-"3JEX#7(R!AP
M"$VMY&")^R!L<*&K3M9Q[QN4"JM*#)48=DD,JNFY[#A%Z21H3M[H9-$('TW"
M8+HZLF\C&%)]HPM++7:&KR)BIXT46I^5S1K=DE\7&$$=(!L>(N5MA=>N]/WS
MW&Z1SR!$%$9:K36!U,PI%ZQGRH24C*6N#J_;V"N1LB_X%DJ#[J;4<GEQ387K
M<<(U<&6D%$HF[8")@!F&B;1CE/]BK&-K<SM[,5SVC2Q,&'UXUSOOUV TM00$
M@WY/2)O_H]2WZY=_?S6:3'II/#J_C#I&PSU'&YN>=UEGP%USN4$K>2IS2KE>
M/*) /MSM]#H-^(&6$U?<^7(81N?4F/MBL&.%44H:!)3@=?1,:)(DE.?"&];5
MK?N1P<YRW29*C'JVBL?.1[I^WYE*0)6 #H* O+311$G*N B6:Q> 6YE$_M(Z
MZKK6]MCP;<EV-R7&<:4RT"XBPNZK_(\3T+R9?J1Q;]#:8>^;R[VE;S=VM[^>
M]^_MO/^(EJA:4;6BXE/QQ^@BVE0[QP<3G)6I??WA=0\G$]JW0.*@CCP/ZD!S
MT\>55U6V.VI+/G13ZZ?!Y-,HF]Z_YP%]>CV:YC\WH>5@>$'QS>76S[_C8-B8
MZ9OAY8\OQ*HR@LE),:>D$RC-O(^::3)-TPM-KJO;Q7%+( H 3D7Y4T/Y ^GF
M^C 7/ 50B8.G"*@"<F&2IX08@G!FYRFIZVLXIHL7JS_R<K+1=K4&PTC#G(V>
MN(66#E]5#!LH[G"/0N+Y1QS^0CF)[24<C)OQ7[3!U&\X'N-P>JWEV.[*C-9[
MZYLSKQ7SE]7NK=-XB-__?68K"^V ;FO<4] 1N<*((,&21<F<EQ@UNF"$4;L^
M&>"L;UR7P.O(3*.BZIA1Q713Q2F%#*@(5GLON#0^YFA#DLRPJI4@2MCZ6-G+
M+[=!O_%8X')#)3_-D\9NQJ.SLT8U.1A^ILFT+0U58@BPH=4J*T';YQ2V>7:X
MVASN2,Y:?IPE7*]'P^=?3?7EE:4N=A4U9((R3I S$%UP0JCH4Y)Y1"SR+>VS
MW,Z[@.^/*[?Q<+ZM$*\07WL.FT!X#."9P> <M\!40$@ +*<8P3N=TXVC#H-V
M:%B[/B=:5XPY.Z"_/)G_=GY4W^\-:<^%L@Y$[%0EY5]MZ2%94F-JF:I&U^5)
MMU,V&U@@EJ1!(X'KX*4,3KN<MK72I0U&(TMNA/2YZ0I,#D]GOH;RJ *] OW2
M8C:$<^&X%A(4\1#!:W12,<VT],$@]Y'MJLZ6<T<![I(CDHW(61Z^Q=JM-BPU
MFCFH\_%Z\7_K%_\?)$R?!#(CH[8<0:#WGH-*%CU%DLSMJB.)[6LK#X R"\!7
M98C*$!M+H):AB$P/P:-0BCL+@KQW$$4CHP/M4>J.HD';E=+8OH%#"*\V_S#+
MD=!LH/5)>^[E*3]JNHROIOA[%;P\[:/Y!_CJZ_6SG\>C\^<S36!&WI4H</)C
M:U&SG_O0V-.+WZ=CS,P[&.+XR\LIG4^:@DB+>]M3&M.U7DT24\I,EU)P$CSF
MOT7T/K!D'*G -U@F;3G&$]!7LJM&9)$&ML,3J@K+IP3+%)W)3I41>0U*:8<*
M58@)!:80=8>:;<O73(7H@]WC^?*ZN#S(?9R'(XNWX]'GP:2QTOSXRH\M-KXJ
M1Y:RE<*8.YS:4G2;:72>K/U(0TJ#1:I41GN%33DE3J H6F8$AN@%#SFV4;NJ
M?P9[U/IN%U8[#'(J/U1^V#0_.(9!4/3:2@V1E!7:!I.#*1TUE[BK@FMZCTG-
MKOEA%\'6)NMLO*9I[RQ']"5NO!27U967R:V],TS3SEH_DB5(0@BDQ,& 1Y6<
M8!J$E\P$N_-B8\W>B"EL._@P53,5:H5!#1T8CX)'H0R(J)U&:QD'!4QKL<E[
M1LOO=ZC.D/Y8L7:0&R3=$WY/X^8V\6GOTY@2C<<4\\!&X==>?G$0:1B/81/D
MN!*;(TMFUJ7)MY>&^[ZQVY_F9CLY'<96'G@:__MB=D?A6N--BY);'IT@!2+P
MS*DD2 KT5@@+&PQ7'FB:5Q9K%G5@74FEDLI!D4HD*75$1!82".NM9#%:T!!$
MRFE0Q^[J=LK55U*Y>Y+[#MU@Q5M3E]LM/9Q.QP-_,45_1KWI**_'^7E3;Z^Q
MSX^CLPR@PAKIW#W3 JDSCBZ:=5URS)U/ZE\VM?P;)=$-3&R5-/7T,P[.&A/]
M,'K>&NC[!?O\$2>#L+C;'"PF >BT#"!)VN@\)QZ,B=[R3;8=7'[/J+,,34'D
MN<Z#+"SLJ@11">)^@O"9(+3UR)*V8)7/!@02'#DK0XQ^@\=1*^QTZ<(O:&Z?
M(78=0ZTE!2J^%&DI)_#['_>.2I36!:\67BW\"!;\8'/Y3S2^RM\_XIAZ)WFM
M<NC3PV'LQ<'9Q90*.W>IL?HCE__ 8O47.![FYSYY2^/WC67^-#/&Q4U.%KPP
M:"'FF-RAM!2:POG(F0$K8U@Q:9>+,;E8",3GL3E[("1?;3HW$XS@\ZB3BJ"#
M (8:"1)C36J1HDBI(\'8ZF3L=ZQK[_9I9QN5XRK'[9CCP"M!6BEDTD-F Q^]
M59HRQRD)CJ^Z[[!GCDM 4C?:(!M!\>1 2,"@G.*DXLXGH_1WG3LH3YODB@AE
M-Z,H^GNK,Z;8PSP0_(5F(>ZD-[J83J8YP&V*&!]&O'L$DH!%-CT&3<#&YM-I
MNO<3[:5AG\[L^O7%N:?QFS1W'RWW3MY\-?)%"A;0[&-S]") IF/400(DJ20Q
M)(LKAIGBD<* 1TWOUKQN^A?$/ \F&0N6@=;<!9":D25ON4.[:@S]V,G)/E,'
MZ5<*8)G*DY4GM\Z3#Q*)UB)&I9)7,0&7&GG.PRTS"5 EO7)OKIVRY!).0!H$
MI8V@)!-XD):LU-&@,]I'01T;)UN9GNASW:5Q>)(\V1%V7W[US_^47V@.JJ]>
M6RP,V=ZH2W@^./OR?>^/'P;G.<!]3;_UWHW.<?C'^8V[R> ?>3R<M74CKY<8
MN%S>Q?=>&,3B1RVN8*"F_,6?>@NUQ;^V>%]]3!\^4@]#&)WG9?K2Q.7#T33_
M4K,CC</>('_6+V,\RX]C/&W:D$T_TH0:*VV5F=C$^&DPQ&$8Y!_*%C^E5A'Y
MW<W);7;I.A:O8S%[X0PG&1D_OGO[\]L,U!_'A+^>YO]<668X(QRWYO?QJ@7,
M=/1I_JF7W[DTP?E0EGY$SVX.8,84[0A^^'-CEX]8#]L,[-+X9TQ_Q^7.V2\U
M'W#UO6<__'R2@=]\] ]W/*&N-;M:KT_Y.R>^^=8)ICS%[WMX]AM^F=S( __\
M<7SY&W/?- <V:T#<L>@MO&>O7E( 8YD$/LZGU,I%;TZZ@PSF+SW+IK+<]/Y"
MF(=W-;_%#[\QI=;G8>_CN.'>/WPX_?'5BS<_/W_S^L.+UQ_>=SW.^<H/IMDH
MPJU'F('7JC@SI)J:. UFKIX+WK+VV_;]$ (6_[3X=?OG-9#8NTWF-Q=_/NYK
M=/9X,KNT:C\ZBX_AMQT3:L>@G_WPXL.+=Z]/>Q_^\N+=Z=L7?_OP\OG[WLO7
MSV^19">)[675LF&_?_/JY4^G'U[\U'O_(?_OKXV=]][\W/OKB[_^^.+=^W_]
M@Q7<_.G?WG]X\_S__N7-JY^^?J^7<=*$/"_^W]]>?OC/C(W_=7)R.@P?1^.3
MD]:\9R\\[ WW,_>?1^/&S?6^9)J:]&@8LX_[B0(UW-V3O-]KDM9VVZJ)RLH9
M]S<OAWG<HXM)'MKDV_O&M?'(9:9(#W361%LA1Q'M'G#SYWD8U_YYY@O:+[?&
M/M?\QY4##FG:#O%91Y!W^?7F=EDW)3Y;YNVWFWC>]5&PHYQ]OY*<_7^4/JYU
M[J"Y+HK<]S"7*J%R]_!7&&9^OKVKV]=7]\VZ*M%M8;G+L(EM8.^.M\Z97><3
MN^.S1%=4?R.R.\W>K=DKP;.KZ/T8@%HL(8KC(L2ZS@<B >VZO[H-%]/Y.5MV
M:S>.#_)'SJ]=7\M1;H1_76<"]Z4]7>39^VN;4TT^#C[U7OS/Q6#Z9?<[SCOO
M!W;03UYOZ,'/KGWUVGM?]9GO?R#+&<)#0]N0=52KV#T3//"98D.X?XN#>#(8
MUH=[C _W-(2+\XLSW)*0KS[@-1[P+H+YPVLDN<^H_H#]_*8(XWFS.=\[K62Q
M_X&4:!@_5L/8_T!*-(SGU3#V/Y"B#&.VGU#-8O\#*<HL>C,M;K6+_0^D*+LX
M/1]=#+?2H[V:Q0&;166+4@92E%E4MBAE($69Q7/\U&B[JUWL?R!%V47O)TJ#
M,*B$4<! BC*,#Z,CH(M=;,MW%YK8O'7LPR(?-K7]Z:[V.O.ZVG6UZVK7U:ZK
M75>[KG9)GUE7NZYV7>VZVG6UZVIO<N8[V4J8WP87G:7HFUT@P:#?$]+F_RAU
MUU[0O?L_=UVS' PC#?.W3MQ"+9EF+;_ON?92_8]XAL/0%-N9]OX/#B]P_*4W
M*R_ NZZ ]GK;V#Q:I^?#TNNWUVIO&QIVEPGLLWZRVO;<[B^"MMBS:79Y:Z'.
MF5)*2\VM"EH#"(D8(Z$6-J*2R-+M.F>LJ6[V7^\O"TBU0J\WJ?V0T]\'D_^:
M*7S:;Y_.KHU]_>'9Q^>?^#0:-H5TVE_X>K=L]O+LSYOIKBED/P^YK'II9:&S
MLDIEE8VS2E,&DDMN)+@ B8%WC $/UFO'1-(=U1-78)4?]\XJO ^,55*II%))
M9:>D(I(0 :WRF5&81X>D52 T+N0H!M8BE><%D JKI%))I9+*3DF%R#-IF#*9
M+X!"0.2:G U):VXPF,>2RM\R(TSVSRG.5D:IC++'81\>6]Q3%%Y%G;A@.N;@
M XSWGFLA(T\L#RH@=#3/N$$6G02PT%F["_M+EHY/@]\IGOR#QJ-G/YQ4T%?0
MUS!BAV&$]L"LM<)&%\ 0MY81%X9L<+;I![$59E@R*JC,4)FAE&$?'NKO"0=8
ML(9\S'$ "-".G&+,H63*<@G&J=5SAUF%V=.K^K(+T'^ *KI^I<81E2T*6.X:
M1ZRP'6$<4) L,,<!@[1.V>2#DQ92BN#+HI0:@%1*J912.*5$Z1PVM,(4 <3@
M( 1I-)$$J]!TM#-=)C7Y6DZ]J13Y<CB_8UM9HK)$,<O]Y%CBFW6$8.BB Y/9
M(AE #-Z1"4:ED)0Q)/7C:.(=37$PI'C9]GY%?KAJ5W__*8?M<^CJ)GP$E-'Y
MG)?K4E]II=+*OH,/J6(TSE),.>X@%[T3"#%QF91.QMXE+]W,Z:?I:^6.DQ8*
M$>JO+L%?4F\_'HU^/?LRG%GZI#=*.1-M_$?O_&LCBL9$ME(#:GDF+([CRMN[
MW2CGT'B(,\)Y.9E<4/SIHK&*M]DV1O$_\.R"WK7V\F9N+E^E%:T<8X&7@O >
MM6DZEGM0P=L 5MN8D&DEF+>W>>E&>^]#$<!SUE>ER<K*2Y0JC@\4QP:],C[$
MI,F!!&W1D281$AB)-M"&<+QSR7G!FR$5O16]&T*O] K0::M,S@Y$TBY#-C&=
M?3,P";;CM.-1Z-VYMKNBMZ+W^-&;_:Y6/,6DDH (RJ'6SBDG'1@66<=]C%71
MNQ<1=05O!6\!X#VIEE8M[1C<!%  E1T#9O< Z"4Z'A@%KWVTR8E54K2G*9*M
M6'PZ6*RL7RWM*%@_9/+6C/NHK 2=21\PY=R N'$<HF?K) =5TE@"9"J(CQ[$
M,:)LMM&]C0DX.1>-%-YR28!@7(<F:+70[4F)""LN*RXWA$MK=4:$1T8N@0?C
M14+#I"4F;)+"K8O+-55[%9 5D$\+D%(Y;GW&(5H!(FB+$3DZ1P(\)]4A<[L!
MR"KVV+N6;2EIWB;$;2_.!N>#(;9V.$J]%]/&#'NO7CW_US]8P<V?)KV/@\ET
M-&X&?*EWF[_4HY:NJ_RW/.GE84I[[[@QT!+C:?SOB\FT"1(F'T9WA.H+MOR7
M*Z.=\>0M+3"B#@*5D3%FDB3CM8DI\9"8 >&B/"3-W7(7$Z3LFV.M/MMI3O5B
M0F6F V0F8MHFB$E83&":78_DG1=>\B1D,!V%',I5$2YY9>IX*]A68BKND51B
M>B0Q@8@Z\,0S6!D8E"Z&0 8%<$A(M-8IRJX%DLL2T]%6P:W$5-PCJ<3T2&)*
M"91BH"2Q3$[MSE<49$-.\9(RNJ/>7;':SR5YZ5@KZ596*NZ1'!4K[5?1M/]'
M4A'PU!&PRRW6",:3522#!>.8$RFEIHZ]\T8;W]%WIVIM"S/@RA=/G2^JQZP(
M>-H(V*''5$IP:PVY1N*(PB#W"5-"(0VAE&L5 JDZY;(MOQ)-)9J=$8VQ-@07
M$R?%P&3"$3E6!PX,F?"KU3K8D9;ZMIQ!]^6Q;LY7%CF083]M%DD1 (TB@\C!
M:><(B<F$/+F<Y-M5:BX\8>7W_JVXDD8EC9V1AE3>9\;@PC(&X(U3+$7!M+>2
M>R<>5A%4_)>L7-^$)GVVL9M_)Z>;O>FHYZDWGKN"GO_2>_WA]>RU>9W?6G6U
M7I-9N"9S&C+E3%J:FO!%XN$B6!!1Z$3 ''/60(@^1F9CTNM= M]GE=6"J:V\
MH*6B]4#0:H(Q@COE='.[6S+KA97.J"0E<YX>OL16D JZHK6B];C1"BE[449)
M2%2@@D0/D2&B3CH&:58YZM^[-+BBM:+UN-$:/$M@LU/UWH$":Y,C[YF5H(B1
MK+52#\H2*U@/':RSMLYWH36&9('SIIVS!Q^X)>N$06&C2<:J5?+6Q\CHENS4
M?+O?D:X0+&-$12Q1X1"\/[I%PX,41F/T "HY&\D;2Q(9Z>!KT=A2++UB[Q"Q
M=[_[4S901AY+*D&CB?,D= JF:=&A')=K;01M4Q.WI-^LJ*VH/4C4/G#6TLA6
M>5.6$X'GU)*#0\D#BS$GG&F56IU5R%J,15;0'C5HDS<:B'/G,0)3WD4=*:&2
MJ(75?FTYUPY$H;;/36%7HRL@*R ?"<AHN-&>:4^1(!GTV8.ZX"U 2#)X4_65
M^[:N"L"C!B!$SD-*BAQ'T-DE*FU%0 8FYZ$@'PYCJU<[X$*ZM[[Y&"UC8W$X
M#-04UYUE+KW3WJ?+1&2N<5Q5W=@L82V)4IK2]NBDW_=1YFOZK7TEI^;7T^K+
MH.+'+^\7K'AQ0\]YS;VVT0D.B-R*S+"@E#1.<CK<;O<%AT#[-_S*,Y5G=LPS
M244?4"('0&"168,QY'^%2,!4VI0FK2I(2S+\RC.59W;,,P&PV8P)1"J!M(1*
M>(S2 &<!O-A ]<FJ?2W.\"O/5)[9,<^@"UXA(V"2 U<!4TI.!*:XR%R3-G C
MIJIV2[/[2C.59AXGIWH\SU@(%#"())(&S[U33)+R5GBA#,$J_4>VJ#>NM%%I
MHY1A'P5MK!F=0.*"QR"%M@ Y'/%:*IY,9@ZP!MC:W9F/7B.]?S.NK%%98]?!
M!H(E2@F!.P\YXO",:<T54&8%X]FAJ[MO=^Y0A5V+VC\.*NU4VMEQL,)B(!*D
MR(:<[42%,4:FA;/>A\Q%Q;+.HUMQ5\ZIG%,Y9Y%S[NM/MAW2X3QQU#QHYV+.
MD !E-"%&QWD@R',I0UZ_9 .RXR243DNI[<<JZ1QJH&.\#D(Q#4([B$GZ'.*0
MDQ1;9?-*E5Z>\ V"_=MRI8Y*'3NF#I^X,9A(:2X@*'+">VDT<UIYP98H.U-9
MH.2+$9NHT[QXMR'<J-G\8MK89N_5J^>]\YE8H)9I?DIWKBXF)[\@?OK^+8ZG
MP_STY]G(:0@90=/%"U<+G..$Y<D@*<$U<"M=L-PXD,HILCZNTI:F7@W8OQE6
MI!XM4H,%+XS*T0!S0,DX:R$G&]YS RF(54IB57']_LVP(O5HD8I)(Y)7&98,
M GH78K36> A@M,2U2O%4>7I%:GE+=*A(=8E\4D8G)B1XCE8'Y1-3V;T:06$#
M/K4*O"M0"UJBXH':XN4.M'K#";T.03@ EIBUBB$/1EF='->\#)GT[9.[OH/"
M)$@5A16%CW"7(F@>A ]6& 911!=2"&22"38P([=]3^'16IS">A97]%7T/=8'
M9M?'G%7<>(%@T7OA<A!+D9)B 4,L54=W^'>,*FHK:A_A,Y/R.9'TTH3@P OK
M8U#Y'ZO(9E2XM0Y8"A"^5L!6P!8 V#NTI8]"K'3&8O31QN@;%^MTE,(0:F^#
ML6J5*D;[5XT>7.A;HB"TXO8 '&UH.MJCB:B,@12#U]Z 0LTA)BOC*D6!GK#P
MLCK-"K[''*0$IHSS$A5Q\(RA$])9;ZQ-$"T^K'JN.%H8SE.MUGQ3T?CS8)A?
M&N!9[S1^'DQ&X]Y%9N3&E"87Y]D*&J/-OW9.XU]H7*LV;\QX]S_L@Y&#7[+E
MLK7N%_.,$)0*Z%/T 31R"^@Y.,4Y>2[#!GH"5^EE<89=>:3RR(9YA,A$(VRT
MBGM0TE@'+$4N=<Q_CNNU:ZS"T$(-N_)(Y9$-\P@##E(GP[3T$%1"3,8#&M0"
M+,A-=8FHLM62#+OR2.613><U-G#+A=+!(SBIT)#V#J/D,0:RJ\CTJJCV0.RZ
MTDBED4?0R.T^](MR7V52\!(24Q&")(\B*.9!B_Q%,JN(\W<I]U6RDD,EATH.
M:Y/#?3%& A,966=]%""C\HQK@XH4]RZ_LG:5G5K[N++"<2WWL;#"O2&#<$R0
MBH%9(2$@0Y<,,P:,3EIQ6.OF;55'EVW@E4\JGVPXRN""!V&!&>LB:&:1%#(+
M3IA$^3NR5#JIX4FEDP-;[J= )QBT!H;*<:4 =42+2B@1,&DII'^XOM].A.7W
M;V[TC5:5*BI55*K8+E5(Q;6.DB%RB,[Z%%%)CH#,.1]7.8M]PF+V_=MJI89*
M#9M.2CPA5R$EI@PH\"AS;@*1!<ZY5?#P/9<:"1R$,G\?FOLT'IWWIA^I1[_3
M. PF[4_,7AI]:@VQ1)5]<418'L7MG+S:U][,;.;%W)CBX@%.\)$)IV1FL*85
MBXO.,.F4L5IK#*Z*WP_**BMPGPIPO;>*(BDER4%.3=!!T" MS^$(L;BIXJ95
M;5Z!6\@2'0EP@TJ."[)@$P$(0.Z3AF2;PE&:P::NFU5Y=P5N(4MT), %Z:QP
M/.E$"(1DC8W&:<$42L/5!NYE5#UUQ6U!2U0^;F<BI =S7%12$W"C!4$B@SJQ
M)$!#B,2\6B54WJ* N>*PXO!0<;B4_[0 /"A@0N0HUX*Q*1@O'-ID2(N52J8^
M3:UPA6&%X0;<H61:^0!<2R9!!^X5*AY ,G0A12I635?]: 7PD0-X*3\JA/+D
M30S.*"!"G[P4R0,&9;53JQ18K&K88HRSXO>IX)<)EGAS*5];!HX'*RFQ((()
M$&3B> #RT\,K9UR!68'YX)$J,SD3M62#]9 ]JM?1FBA8Y,:BPU4*>#UAL6?%
M8L7B^EBDZ+A"C#8%!*?(662:6^-1"ESF8GEU=/L4399;SGA,9YFC8U/6>/:-
M3Q?C\!$GU,-?QM22=Y[(]&/OU6"81S[LO<7QK[UY#-7[.4^HWWOUZGF_-Z1I
MB2+,_8N_2]0,'Y-FG<9#?)A;W\[-^O32JA<E*"B$XX1HP(,D[34IQG.HP[5Q
M9%?I'UA%GX=BWY5.*IULATY2%%X:,B(J X%YU(*CU#PUE_3-2AL:58IZ*/9=
MZ:32R7;H1*44C'8^.6W!<^FM3)9+XP*G&,T&ZI96@6QQ]EWII-+)=N@$N0-E
M&0<!#)(130TAA\YJY27XM(&V#%6V6YIY5S:I;+(JFRR(I^ZC$Q[02,:%DYH!
MB6@%&9V8RV1A)/?;KGCZV&K(W-A*$I4D*DFL1Q++A1S1DHV,R\@C@@[@. 09
MR"H532*YBL)RBTKGVQQ1&:(R1&6(]1ABR3#"6.N4])@X!9 R.4 IB<=(Z"2Y
M56H05A'V@=EYI95**]L)/*2U@9*(.1,A,,WIKM4>%5IE$$"O=;!;I>%EFWEE
ME<HJVV$5UVCN M=(BIH*0\Z2T0Y),J5%8JL<R.RM7K+H,P&5,BIE5,K8!66@
ME0IL<B*/'J3Q#CGS$I,WT0FU4EG!)RREW[_)5H:H#+$EAL 0K;#&D.!@I<N3
M$-[*Z'/"PG")GBX;# QJ_>0CJY\\&#;6,Z29R;9R_J::,GZMY-W\RNO19SH[
MNYCT>R^'X;L2Q?S%461YY+=;6ENL!2\64R1N.(N9E;060%&A-AH"VJ@R;)FH
M990/RQ0K6H\:K42*@R0+6@=(@E A#\$)AI';:-<Z?*F"]8K6\I;HD-%JN8<4
ME5/1*] .O&5>DM2) RFC5^D_7_7@^S?%BM:C1JM/) $!%7@-UB)&1L):\D;K
ME %9Y=:'9(D5K(<.UMM]VA?1J@E% B54TU^9IVBUSM"UWHG\7[=2+<A=JIFE
M*DRK6#%8,?C89%1R)H7S(7M(X,Q92D+;G)<:[ZQU:U>=VI)86%0 EC&B(I:H
M< #>[P1S9)HQ%2UCDD KLCQ!_H;,?WDI;;$%50]?BUM16U'[V!,7;85@3!O/
M$GCN'',"1)(YYQ1DJ$I=#](B*VB/&K06,46-$H)1X+3SC <C0$9PAB'SAZ D
MM?W,/!6198RHB"4Z9$1JIJ*7@A27 5 EFZP/7#95=SPQM\KARA,6:E8 5@ ^
M$H )$PM*JD@Z 2=E.>?1)W1."F;LP\JA#;JUPBY('(K"<9UBQZL)'I_CY&,O
M_]8@_UR<-#6,9ZE*[[3WZ3+SF$D@/X[.(HTGM19Q>?K;8]*!7Y9Z_^G2)J\G
MP(V]+H;_RK+DO$8.#HSU"%$YEK1U))H#J*J2/$);KM11J6-]ZB#NDDG1!TP.
MD@^>?$J*$?,RV(1K-2VLDLU";;E21Z6.]:D#C4PZ,A]-SK L$ZBT259@ .\<
M\@T4 *WZT>)LN5)'I8[UJ4-')R,Z;M$JR)D*2F:Y!NZ#M<ZE#20L5<Q:FBE7
MYJC,<1]S7">,*QZ928P6"P6#YHRA$2$$@! 0-,44(385N:PJ1%I;J:!202G#
M/C@J6'+74T/,D%;*R!Q$(%GK@U!D>,SLX%:2%VY1X%N)H!)!*<,^.")8-B80
M,@:=HA7)^*;HC7/!..+6^4P&2JV53U2E<=E&73FD<LCZP00D@9P39,*P(*7R
M0@<65$)CDN-VK>NU5?9<MDE7!JD,LCZ#-/6I/&<ZQI @D/:DK6_Z+2J>LQ&]
M=CJR>0UV)85*"J4,NT!2^&8CAZ0^1_D20^120D#F(J5@O$S1!"-\23KP6]K5
M(^ULUOFPOZV*SLH;!?&&])(I$;0$"9":F@4$DC'IB(D0[<.\42E@.Q2P8PW\
MGJK\G@WHHOU^MLKN KZ/^<1+A?TC!?:]6C6XWOU9O/OS<O@JV^F;=$6IB_72
MP B(/DC@$BA9*X37Y 58%V1PFQ*V5DU\O:U7R!(=.F*%]4DJPY5/&D@%9S"Z
MX"T:;K@T58I^6.98$7OTB+7228-!VZ;9:K#D*#HB[XVR3O,0JP+\H,RQ(O;H
M$:N8<TP*@<E&0(&.IZ8R&T,31>"Q"J\/RAHK8 \=L#,ETWV(1:O!2>8\!08V
M6"\T-V 8:DA"RU5\[-.4.U< 5@"NX3').B$HN1"2!(7H>48C&J5(HA)Q[8Z;
M1Z\RKOBK^%O' 6H0'A(H)LB!$=$*PDAD67:%)O)BE7G5<U;D'C-R'_2<QD?F
M [?2JAS"<NERUFDD>*V]$"G52L(':945N$</7*9X4CRXR"*#['J=-F0A0&#>
ML !K:]9V4$VX,-U*!>33 >0=\J_UCD99BN#!*!D!E&(.8HZ%G8X6'0^X=A*Z
MIHITTB[ZR;%ALD2A:,7M 3E2288DDE92RZ9;.3H&44?>-,9QL$07N!J8+@SG
M*"L/_SP:)QI,+\:M#/-B^)DF4XJ]<?[?>!"FEZK(JDZOZO1M7G5[D.:^VNF;
M]+>YE;Z[,M+V-Z\57V=>"F>T ]W>QQ=&>"'!0;(2Y*9* U;Q94G&7KFE<LL.
MN(4'$A!4\$H8D%YZ2R)_E9*-TH6T2J^C*A,]%&.OW%*Y90?<$CD!I^@=5Q8(
MF%.8R28RKD(@4E@%K4=H[)5;*K?L@%M(:Q.;(Q7R&H %FSF&N+=1B42<5MG#
MK=+; ['U2BU/G5KN/0V::9]:<IE]O1JC2*&<L\B#3@XT<1?)). A_ZL!2Y$&
MWSH'DL?)$B6>%NT?DI5)#BI(0>51R*B49A:8]I[I/'*K)5$DU*MHMIZFVGG_
MIEN9HC+%UD(.*TV@X'AB.=*(CCDF@O11&!:"P/7:Q54Q=MF67HFE$LL.0A#K
M7(C!&^ZX@6B,5]H(*9SBRJ 3:Q45J++QLFV^4DREF!U0C!!!!\%3D@Z!-$.=
M7+!"ANA$$'KM%E*U5'-EC>-=[J?*&IX+;C'91L@+$*65DFO)A \JY+]6N8BZ
M[5+.E2XJ790R[*=*%T9[)4&B8:@@(6#RG,D<7H!W28F'2RU5Y!=]1:!SH!NX
M$=#:45ZL"<6F+/,G&DZP>7CUWM%3NG=T62W^-/[WQ63:Q R3#Z,[\HIV([<U
MF.<+]O*.<I QR4-Z3^//@T S(GM'8?3+L'V7EM,6":NIKB%3=$@ AJF<"_G$
MN5<&@!FY2@.;*MK?OQ%7G%><=^(\@B/ND/$@$;1S* PHZS5'%,A@K8(Z54!?
M<5[>$CU-G >GD^2,'+H(*9$+^8\VH&5"8;"U.O-A&7'%><5Y)\XA1&\B;_I,
M&D F'7*?DD?)/5/6;>#22A665Y@7M$0[A?E)M;1J:4_+H1@.7%NO% L<K!)6
MBIPCJL@3 -A81<"E8*2B=O^HK?ZA6MH3\P_<!D^>1\D9@$O.>J<Q3R;Y["#0
MK'504!6:)8"KPKW"?>%<4(!) 5Q,!,$9*S**,<EDD[>@UKYFNH-RP*HOI*I0
M+F-$12S1TX2RXR*@M3$PF2"0]2P%9JQ!JX+5?FTH/PT)8X5NA>[.H>O1"<:,
MUZ (A+2(P*569"4W/&B]'3GA47O272L&EQ- ?L)L1\-?3F;O\'U/?/K],6+#
MA4]@_5[SS[=SB#RH0'Q-T][9:#(YA-H5RZ]6^2KLG<_ED=+LT3C2>'&4O<GH
M;!!OV-H>%-R7M)P-^.4PC,[I5;;BQ?!'. =&)QXY0M#.!7+,&L6]$$3N80ZM
M"L<CL?Q*23M&<26I94DJHM36>Q$BBQ %(B%WUB>+D3%RM;YQ):E#GTPEJ4,G
M*:^32!R5X9Y!C-&R%!+C6@:#-HD-%#.MVM+#PW4EJ4I2!9$42]&[))ADE,!X
M;Y4EIK2R(2$!6Z6/917&'@NL*T=5CMH*1^U7"'8 QEJ15Y%74'3@;8@ND7)-
M]723C$V**W+:D^"&]"K79IZFROD 4%HIIU).=?85>15Y1X.\1SI[Z:,D+KFV
M&M Z5,8&,. 3$V CJY+URE7',9G*58?.52@B-PD#,*L@>>-C3,QSE5PF(H&K
MJ%1J=>(#0&REGTH_N^P]]Q#_<+*&2#MM(H%5"M%H'[UBWFBI]"K')MNX)#!I
M']+) SIE+D1?06%*Y:WBM],$#J+_7"6L2ECK$);R*25GF F0DSN*WI)TTGN3
M-+="/US0L'+/_KAGUY<P5K])D;+QG/Q&#6*:MSR+R]ZC^!'/<!AHTL-I[R<*
MK9OK29[7.MM=[\]^W/NWVQ]<JSP_P7MD[?[/QVQ:-)[,8J9%&8OSV7B 7#0
MPH$#E$UI'F-49,QUQ6/UKD)IQE;Q>#1X#,9)A0H (P?IDQ,0"0U&Y" R1M?"
M8Y7E5SP6LD2'@D?-7= 0+0GE@+AS/A%3"9OFD8C)K(7'JD"O>"QDB0X%CYYL
M!J*Q+L0$-CC+&",E-4^.,V^[RH-5L75AME;A>%!P;#NYO[F83J8X;/9OKE4'
M!X&&H]<LYY#<.V$ 07B!7+OL)A]$XV/$C4NV6[^U<R;ZFO&*LC)&5,02E82R
M^YR>C5;:9"0R<""5L#Y"0B7 &>W!; =FCRWBPV7%6!DC*F*)2L+8/9Y,)D2
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M8L^\ 81Y)*&0&!#G!2<VH$%7Y;XWOWNY[^5^<[G7P,;X(17$7Q-!J# H/,=
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M] ] SC45BD$%")18.T$Q CKFVAE@GM3%J@\2[1CK]@C2B2D<%X(0ZB&G2D-
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MTR>8%])AJY3TB C.M,.":L<X$1@#^N0&ND<5FGU@NVBO'O3(<V3JP6'Q:2^
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MS]9%_;::=M RG66.7WC??-=\G=X_ 6"R561=)GXU[E^;.1*;XT[-U3KL6)M
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MR< 5/V^+YH]3;W;+Z>OY>"^^[.[-O*?VLS9!Y:RU[L=?WKQY]^[]^\?(=OW
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MQ#2QR8#E 6%:Q9*L9,D9,A7C8;GEI3"4('"3P63HRHTPX4# P4'I9@P"%N5
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M\=SHR':&(YM.!?\S[2[]DV ^ZM /^=\BMUP&3GA?<D*% $=&L".;3KW#+S)
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MM.*T?Z*FT :O=_5]V4NJ_$8'(8BMT0BCG^]LE'IWO0O8$7@]@MEB4Z_5[\L
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MTD]"'>'JWVPVT9@T\+1,E#D-4#D3WX-^U/)LR-J0:0):+GE^+ O:%&'570#
M5W[\2+@H.Z8H\:TFEZ-TESJ^T6*K'B--2M;S=VHJR[BF3I>-TRJ=N*11KN#6
M7I9':^!]+%=0C%(#88XE;55R9+U<'[6@A1A I*Q5_O7,S=#BJ8XN%=U6ZE:*
MT9EKP;#I0YK,[A\:+7(6&N18/T!9RF2BF_% 2\W6,-6/N<64K>D:<U&U>[E8
MT4$&@AI9M58:C6@UUQO]7P-S%SD[66.)CEP]@SN%UO'*T/IZV=9!(.Z]6^61
MZ=PIM(Y7AM;7DZP#G7L)];KLX'DD_\R%OAI<#BRQ9@<684I(AU,JH_:H9-,9
M?S;?*_NK^+29HCKW;26)S,VF3VV< QG D07QSFR6ZDBEP7VX-Z*_?(&^7EU7
MR@]S(-0=/L^U;TL)>:%/0Y.+=V%E+#;)!,PB_&N<02Q6([WF0CI.^278I>4$
M,S(B:9QWQQ*/DU'R+ !Q;:S,;?W],IR)?"0U?Q4<EJ/B405X@OD+D"%,]V&]
M*B6,@R+$@R \7XV:69S,TA)7M*$"2$6T:3?LA1WV:Z<0)UY95;A^ZW78K_MH
M1W@FNGNGV)*WLJIP:^KV61I6]=596<Y=^>&4'##^*8,1G"=2E!MS3AA6\JS2
MDPLULZ%%UU52<+WFZNPD@0"ESMC(78.FKJ[*Y*@#,X,S\#X5>9KZ5X#>TWG(
MQ2R,PS'_W<B:YSS#& 8U&^MD^%S+MN0H>9HK.2>,I;,\T;@B1<UB*5V)-< :
MHRMG(OT:@R]7'1BB=$3F4JF:NWX2U%.LP#.Z*A)1\CK[:?Q8:/]&>R]36^;?
M7>;;0ZX0H"?IU^O%@UD5.=O%X"^*#.X47@.Z= &E">E<*0#YC)X-A4H*:(-'
M0_[4CHQR $!P:JI&[L?:^0H>]?HI6*O^R!WLN;%1FA:5LENW-FC-/%$J-J&C
MYSH-"\I]+$RH&JQ/SA&  @W$AR$5V4@9I"GE_E/"'@ @J(A8,)%.(8&]<.2G
ME:&69]*KF\'C"BYD,4Z3T:BX=:+$!]QTT82\KLZZ7 $!"S&NP+,>DV(RU?[3
M RMXOO*T-WM!:_;)3U#];7.3 E?H/0I+IWA)G>NUA"M%LYJ.HQLE+]WCE=>^
MMMT+&N8[6.,]P2WE+J\H4%.:C!)05,M:60T_<S:Y-&:RJ"7_G\@[[76*4'O[
MJ%KM<QZ^URE*[*TK<'VGT<2^D&\K&F%&H?!L%')!'$RY#!ES:$C4QS@,*=I+
M(TSJ"Q'@T'/M -O0H%CX.!(!<P+I2M0#[[6AD_4%4-=.X+'V.H5LO-5%JVN)
MWF&E]N"Q-JFAQU5AO4YA(F]UL>I:4G6@;W?W<^N6:56&]Z[WFI)6T :DT.K$
ME'QKHEB"76I"I/70<8[^)W3$GHKID\BS?MDZB,O: 3@7D2\/=!A#GF^P#)+S
M(J^B%6.CL,,MJ<&7'.<M9PK56Q<-+HQY7J4JFC1J134#E2K.'DQ&>0MTHTD:
MR!VRR]/&M6Z8*R16#L@^G[S0H'P^6=/H QZC]<>\(L]Z5^)+%BIH PBE()W2
MZ77&0>$SSUW<I;ID"@(6]$6@5]M@YBA_9*>"URD@Z*WN:[=V)W?8_OMPMIZ'
M4\'K%!#T5G?3VI:ZO74J@.S*_8+&R)R-"^M);\Z\'CDK$05*V] D4VU2BE)_
MD,'/H:+N8<S@=;EM_HT\%NBQ.?:/NEL+-M.\R4C3AFS7KE1CFBC)4 F7XI7&
M"I[69UJ;2+SA06"H8PRF:C9 E4=! &:YF:QDC2 I*)L6[S34 +]-S:16QB&9
M%G$VS_ZS(6'\ #V.U"2HT.VN<H%JDKC )PP6&-B@R6A6S:_N&AHGE96V;#UU
MK=?XN2#6O".CUH+C5.9;I[B5M] -YQR2B[Q.L2,O7&.3O24I9,5E'T6J^S@M
M-\T"91:"/1:ZV,6"DXB0*'!LS ."."_PGW8RS21GODTP9@'VU'/MR!74B2AU
M_,AF)C/\Q*;9^R3++$4K2Q/K%,99IY"$MS(DL9[L'=;J7(VS3O$%?V5\86M2
M]=7.>JU,&&9"JK$Z6"!8"?L!.CT5/1)UPZ>J>Q,ST"@:I4^-.R[1XPO4D.DT
MC>EL6D\H+EHM%KW5S2%?RX_7Q5W@I<SCJ57[QOHHLGJ;R\8!6%9PTG(^D+O[
MO#@K,YTB&;=4<K1[&-JQT[Q6&#Z(QPQPY]7MU7B*;HQEJ7+NZ(;@<ZE7%&^M
MO<9H$AKG7GTAOD&.==9,$V\TI:P#LY;O(8H7+_7#(;<E]S9#G;F>'EB51&DJ
M^>%N;,KL(7D:;ZSOG.C4]SLY;?T30 T>I4OV>5:3HM75I/MHD3U4D[Z(:E*_
M4S#"7Q>,^"SN08A]*HP:H_@N5W\%O(])RNS(Q]@7(<+(8YP& >>>&^PC,A%2
M2<.08<2QP $F(<%^1!F)9,2Y@\+3J[\YT:R2:B?0@/U.X0E_97AB/>4[+->9
M:L!^I_"$OS(\L36I^JH!MVF1D%@@"T@ZI=X"[+7NH 3-O%(HN$MT.9GV5,.E
M2I]C1BE+I(P97).*K[%XRFI/*:'S3,>D2A6K9*^)*!1=PXK70G6>TGS+? 3S
MK&26LEKP(\MR/\Y\LDD^N0(SY3K3T#DP%$AES#-'3,  ,HJN/]]8'Y(KRPD5
MZ=>=/BWRXR(7((V:NH=F2^^BQ9.AC=!5 ZM1T(O.U'<%-?/W9G5 =)][)')=
M&5(;VD<0/W1=0@#F37 <M@&BS\OS.C1Z4(=&?_?A=DD+ZH7F"XJ_%Z'1*R[(
MS,!/I6EW"E7X^^@Y=73_FM\I!N"O;225C$';-H?IISC[UXU&=(??7M7EHV-'
MH628,X9#+PIM[#+*)1;443^"??2)DH'P&1.V*T+, J2XW66A(T/%^=RFB[ZU
MNA ]59^H.O&TDFK@\(%ZI] \.KF;_=6=H=8N2X>U_'Y*^?Q.7G%_=1.IM=3M
ML"1G6<JGT7C5_[(<!"Y[4#K'R( :*&6@\@FI2Z;Q=&8\9%KMJ-Q;OT/U/K<^
M3W7SQ*)]MJZ"T@ZHVKU-% !=.5$U^+@57'?7>),W"'E7%E;<).DDEQ\E^N'M
MFW<W)?SA; ):TG\[GGVA#/-V7V!S=O!^=;SG(X! 6-&7I$1$UFJ)060SXU-O
MK%5[C.+'N-NYO<-NZ!0<\%=W05K+V!UVP_>36N!WBB<$J[L@;4O=OLJ:=^.Z
MWE^YY?.:S0OKJQAS7=M5TP.@K*'TI&M,%6-)65]GHW'16+=6J##_=%VN] Q)
M0_$X1T.I>]7AT44$'?(7U,ULVOJ@HH5O7I8 *[RZYKG*JKZR;O-4)N-W-T4#
MB\W4X G032VO1-7)6>.DE2SSX"+SH]UD5*>Q,H)._OS%/-U>R) ]DJ63WS-8
MY_>\)7&JNP_>R=OB_%9'J3(;'EM;V#I!A AQN8V$@SUB4QDRAS#LVCSR78_O
MP32)/)O9D5##)R%VL1?ZOAN&$0]]C)2 LT_O]P2B6?\HX'9*NEDUPIW 'FG/
MZEU[UTI/Z/JUZ+" WX\]TIYIN?:NE<[3]=3ML"1G8X_<5BAI<6;0P"I0+(.O
MW@ROEQ5Z4T!L #R/L4G\O3#@7+$Y(I66GD&W=U*F C\;#R?D-</.?ZYE-</%
MN:>Q2 V')$7PT.40UKJHB\6*_Z#(\;H.[O80*ZU$G;S&L:G3(LI\[-RXJ!*R
MX_%D5A@7]QJY#.8)+7PA4U#--TESG>/?LP2.>TV"S/AFM29D!F2R]PS$/#/%
M7<+4N<WGPIMLC*>YQU>3GXT3"A6 .E!HAI=7<;9-,=;N69E 7GGVTY$W7R=W
M9; RLWK]/NJP^;X?\Z>]G'WM72LSJ]=3M\.2[!GQ8C?1A\)-UUB[./R?\Y4V
M09O%G]8&3WJOJXJ14FFT -)V _K9*#VUO.4U4J>>++") "H3P*ODXASK_J&H
MVZVL+*(+<@OXG#RG6MLP$!B[:M/ #L_@G7S"P4J?\'I>[<#@.T-$+&DH=8H0
M==#)ZQNL]/JNIU\'HB]DFG^?4L59)U5RK:<&*=:0,W6I4L^>+&26EB(:G;?2
M5(I:,8,15A,[@*833TTS/:4K3O.N,^/B+ZW<0/\72/HJD8*:<D_6:NW;!=N"
M9+QH>40E'=<]KTF!4L<K)ZY[[>CW7:PCYI;4LGXH$   I@VZ7INRQ OK:P+)
MJD7UX@1:]1GHC6P"74HNBN;5:9S]"P".INSJ1T/J2L4US2%3K:^KX8U!@X9,
M7)W_FJ3U:2O+/$UTUTP3$\@5;R7Z"?P)7XL\>[9LEZC.B'%VHH.ADR\^6.F+
M7R]N.LBH\#S3E().CO5PI6-]/:DZT'>AX<WW>0:X&YX!%3JD<7G'#=FGI,T4
M\E534\"F)8 V00M<\P)QI%6GU"VSM.=;.^HAUUWGV$]T7.$T<B+LY/T.5S;)
M6,^27;RP]GD*BO;DS;5WK6QYL3VM^NI>^U+O.5; %IB-4Q6JYF%Q*WL0PN"W
MZFBY1A."7VKE)Q=5@-PXXD"]R+6#F-<K\/4)78N\ ?C3>%HBX)>/*8K_=>JB
M1O#B-7A%<\X7-\_[MLRWC4^AK<$W4Q];<V 9*<1G19U,G)HNV% D.TM/ 1,0
M=G+NAPM^W</Q$WB8FFQ\P&A8V,FQ'J[#UG\O%+L)W2D]6Y[[[]D2A<1U/2^@
MF+MVZ$0>]IW(Q;:#@B)':Z<8&'(IE9)*%(12S8310)T,C 0^(=)7LSI]#,P0
MZ01AKK"36S=<Z=9=3^X.:_3]A+G"3F[=<*5;=SUU.RQ)+\-<FQ;*F<\ WI&,
M:U?JD9GXE?H$/E=369O+5YZGVO$PA0ZOL)_-%J^.84CH_Y),E* ,L;-)2K\1
M"X7N;)4I]^;YC;.WV4ZK^+WL8F-N*%'RP:7QK"-K,30'T+B2B;R$<MLBR>_3
MW>]ECE]KRZZ%)!CMTU%'_$P#(^7RS>@^!DO>M!=JU%@4N!KPP&3%]$IX3:!P
MH?  A$:NM#3G!WZ:6&.C&L=3 <QLKHIU9H^._\&0ZCVLY,(@S-1+7-&&GP9N
M50L5E^!1^?.SHK<8CZ'P.:^V,,I:H]JZX!\-BE_6.<-0H(<6^&2>=(F)KLPP
MW1=&D(B4YI DY259'ETU2B;HC !^FM0&-6FB>Q8.,8T1>VSMJY-;/USIUE\O
MJSH(N#*4V%+[.2]B]BB]N@NJV@%VW!7M%#,(5\8,UB].AQ5=B$0>5H,_%ZZ9
M+T8N#IPC<U$GKVZXTJN[GB$Z<)$_R(6-UZ;#BD8K_<CK%Z?#BAXBEMA+3M@(
MVKYHRF0T20A]-?IQ@(.(QUH-3+2F4_;N4:^X-.I&K6-(B9V^\(VZO=9&R>18
M&Y5LK'0]P@N]6JL^NIX%\-LL**\=+3S.(*J-1HMZI\9^@+SPSX"'";?I[](4
MD"V-4E1XMC41P2%6JDM%)*W>%DKCT)N6I[,,0'( X9P\Y[#Z98 ,$&N2,?3[
M*&"^BX=J,Z&H9KDH8#BKOE9Y@"W.F%#ZWECH]@&@PIKDL&J4!5BHK.[7WA*E
ME];+A RI]%2X6;(*SYV,=:_7;S )O8A%R',.2J<B@+(,ZH'4>5U=V1,$QG^Q
MC)J;#:'LRJ+!4[5]0$?0($Q#^.B0:E+7:^.JW5G9R+0^!3/.PKEI:J5RG/X+
MS3<E3O]\AU5B[JT7,A2-$G0O8LVCN6E"LOD7=9*X1]-0.HOVJ%-H)5H96EDO
MI3N(]K ZK-<X5)>OQY'0ALX5;\A9BC>T1\2AOF(.[8@Z='K<H3;DH2YH1,<2
M6K41=9=>G>*6T<JXY<:"J$_NTDW403+*DE(GU,C"287@:[2!,6_QV>E$+@CT
M78*7J?")YD"\NJNW_ESQ*7*L1S6RAT8Z@M8MLHX'Z K>/!''=0HY1N[<Z;6X
M'3<GPN[V7-0I4!BM"Q0J9GN,IUJ-NQ[S&_V">S%F\:JX(98H=$*/N!&16/A.
M%"!7L(@%Q"&.1/NHG?,#*/MV$:6^AUT>1DZ D:L^<%Q7_8'Z">M1T%+OR@8Q
M3Q!?C#K%%Z/5@/QKEZ7#6GX_\<6H4WPQ6@W(ORUUS^'LRPNM"APN[-F7SD9(
M7!K(NK'S*BBN)$\ *NQ&<$7(>C(NJ]]W9;V?.U UOFSC&F6%QMJC81KZC4C\
MJ!MN Q!9'@V#^XWE? ' (GG@2QFH9)2WYRZ=#B686=YO(.6%"6Y:#4S2A!I
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M6'PCCQ/H;Z9]TNZ/S63:L7BJ]<\H7?I+\1.*5V35\BV9EA[WXMP@><70S0
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ML[DJC9U-;9YYWW-G!: U]W3=3=$>?%)'<S2UYF&N==7U/P\SUW&N3702O//
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M(3;6HRW1L4YAG.62_?35L,,A?=KBU1HWS!>M<G7:^K:4D40>#F481G;D^#S
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M^2GXWNOD$?<&C_@N-._D$??V7'OX'1QYUZ/I0S*[?]A'$:-Q'!8'*#%=>\
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MSMM["!,OY_F;$NBU6>+14F[1+XOOA?O\3BN$^^E]^V'[/L_7'"I+0%37)&V
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MK4M8,.Y],9EW 82GG16PARRQ./ &!IN'?4I8:SJW'K/%1 "Y-T"89--;@#8
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M31[&KA>%D8-#O9W$./:-.$ZT+\8UG.C=4[7:IPHFC4*0G],2%B6L47=7>1P
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MV@B+!B,!_OM!L]AGGB AX)J4&*V, NIYS.'<X2R2H3%4!7K@*N#Z2X"K(IP
MX$<P%H#[_O0;SO49)C[6?H(F/V>M@E!SV*_U*5P6?]7.7FS"U?'OOM?NW;8(
MHU[L$%L$?@(BS$]".Y$N#3W?)PEE\4[5=OLJX2T9SYZXBV#2D: GA0'G%!3\
M* 0I'KL^#V(1A*ZI ?)Q\I!::<<-ET?>VHZ1H)P!!46DBA!:3OU1GORN([]3
M^;>L\.^P;I1169[D.=(\S>TNUM[UDA(]K_@\PZ,GX=K$(&6R53%&Y0!]?_'U
MPKKY^R*-8^M?V?WL5^M&94A^NOAT\?8"-:-W<L(>,<ME4F;WU,I.0PF\%5(H
M%G&1BA3M,T#;-SG@>C8Y__PD\Z)Z4;6V*O=>+0D]O(W#OZFM.>NGU2QMSJ$=
MSNW8PC5PZ+2015-A@#9W]:FB-EC>4'E>TU01+(^KY*MDD_>*1 WY^J \,T"M
M*$F\B";$9Q*8M^/%P-0\W_:,7<!L$O[/5ZEZ-6("U=,W,+H+O8#BS5/[&STH
M\ZN&)I[7IT]O3?[?D<E.U#OSUF8[:7X%P@^0*)ED30 I7J03I>26R?  3ITO
MB]">YPL-T4G&%8\#3=WQ;.MO#'6.FWD.SSY;7MEDV0ZAY+"\;52^(WF.A$<R
M*N.1O)B4Q^O2&U.')BO.E2MUOLPKJU!1:)^4-OU400C+)ZG69*N 7G--M_V/
M?E(!N%M@@F,KP[$M=JL*GYI_= )D +QS)9'9= J2/2]*#MA];\WJK"S&0IA2
M;Y[E0'IP/5AQ F GD&&1X%?-HE1Y42GS*QBT6\74OK8FOJK[I<QF$[  T;V+
M"]!RH2YW@H>^;:?FO8-+NGRRAC=6/[*6,Z?,7]Q?>J)#9 +:?.A0P:B44<1(
M3+&' G<I-4XFU".S=F>7AOQ&/$10 >U!>J/NM%"C@1F$'?F#&VYD&DC&_P4C
M7Q6I;0\\>)U\9!-\9!MR2>B+A(423")J"Q;Z=L1YX'/&?3=V36DQAX-<;3<E
M0 "*& 8PA)6 OIOJCC_HG,F%<EPH961>)L<.*/ZP'']49I_S')E]SJC,/N?%
M9/9=M](\NMS.&)9OF"D;5OV51=>(IDK!LR:@06AQ4%IFY16UDZ]EV6WC2OT$
M7!RXFGIFNP&4$Y/8%C(..*%P."Q,W#AB#HL3'@IB]#JC"G@]D>(6B!Y@@0W
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M8D_!6C\.)':W!0,'A(O+8CN65))$"@D&4&#J'G!P&MTXVKMKQHPM'-\+DB3
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M\RX7%X)QXGI<>N@1CE@8D(0&TDT\%O@N,_F"AUS<:W-Q6C/Q<V<-%X\NHG#
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M@6-F)UD!E&]*0K1]VQ?220([XC2VH]AW!'/#D$K.749,Q+YM$J+C,S\)11S
M'RP]#@4+_$#Z010XPA7N( EQR^X$Z[(S.G2PW83*=S?7'SZEA<[A')^)U<ZS
M6I^6U1<8)K(VZZ$-9RM76KY8IV+VF=@\FVTQ8S#\9>VX]NY+V6*>+7FIZ8#-
M8G)==Q?C4C].SU4905%87V4!EA:_L_Z5W<.+W\D'.<EF*B\<<\DKLMEJ0OT2
M?MO^;>W<]U8JZ"K^.))-F',2U]/A".)=GK Y;O+PIC2V1+)ZGA*JE63M8,<4
M]8[)5IRD6SRM/WM@><JFK><I;)ZCGH6:#7ZN<J?W<23&6O)U-ZTL):_YZ4$
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MT?2T_UQ,9=FT<6YJ90%:PV*"M?-5.>W'+S?7'[^^MV9W6![K6'-XZP3I!92
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M;6[6-NN:1*@-L:$)#,/=9A/#JT9=9@_&7[$5'-)*"<.0BZ':!(J'N4O3ZFQ
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M>,-A+D9<U:3XWK76+$D-K4$F:7':4'0XR+FSCHN0N\SN[[-Q\?JDR@JJ%]&
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M"HP]2C@A9&]FZ*\?8>CVFI_3<7H_NU\1R?R2352NQR]>QKZG^&.^&,\$*1T
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MP8SW4L"L+WEB9O.=D9(O_#%?0IHF+O$O=Y/R.04\LH"O^0!5ZU@/AYNTOY9
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M?$OUDMHY^YZ#1@HN8P('K'ED.%4QE3%HI^MC%.O.>9/*$NWNPKO9X,,+/@'
M9YRH."RP9XHC=<\-C  2R:?PSS)T0?>OSMS:IB.N'5SVQ2PHJP.PE?2@T'S&
MP":-KFR>"7!H;_' YFZ6,T).FIS0*ED\9N<LQEOE*\<=YRL?3XQ_VF@A V&E
MCBG=#>1@DB^(<PMF32G/*SS=*-(]3UJ25@M!C<)Z=R23PN7%I4X>F9KYK L/
MDQ@.@]29#6NM0G>7-"-C!R[F!!25?AO!W:5IO[)09ZN[#0IK!T-'@^[-/M);
M6(2.J>YX8W GOCJ S-_NWYWE=X/Q5>#\'#/F7-_^.!T4O-L1^Y7;T'V:><_(
M:),=]&+VEG?52]Z;S"4=BL_FW<C//Z\E:Q<"N=YM$70AK9$UE#.*8LHB,#>-
M9$KP1$G=((:/K!Y%=99.9QS]&F]S7-UPOL+3?ZI8L,>'B0/&0N)[,_84$F#N
MT2GPWA?K>1>"R>X'H\)MM7"$&\BH./7B:.'#*(47YI, 9,G8C,1P\K!3=O4!
M7*Q5@FX2GJ;J8C])L"WXX,)/91AN;U%Y"(R35BF/R4K*8U\EQ6U13>*4D'R#
M_W6M]WX'AZPV0 Y>7Q:!"_R8R<.2^]4"9:=97OHXM"F(L>#LT[P02EY=<LOP
MY ;&RW#JJ/W*635 ]%YP '\O-#!W9-HG*N2%N3K)A-ZHI7N>7[W9XTA>R96*
M9XB\ H-W:,&C'+O(4]AQ 3$[+1B0TR87;BS%23HNTR'R%OK>04C<*OTT64D_
M/6%T^>@@:96MFO0R6_42S>U[-/?]4K#B_T/7&#?Q2E 5@?V.G3NM9%+EI6_>
MOPIJON]%)YP+>57Z/'!-SR]=O,J'Z'3!"!V3+WC[+CS;L3!1!?Q@);"-:U=U
MMYBB63=N;3H<IM\JHZ'RBFS<Q!Y.ZH-(O55N3;);;DW/5)WNO ))JTR;9"73
MIJ&"X]GO_V6RSX"#)[3XDU:QBJ3S6$6K0^P,"*VB%\D91B^<'I=7W*?$MCEW
M^SDW)O@S=78]\MH9?7[E]%/?]!"D0U/.31G_7ZL?+\4^ U/4'-VE0UB3O^'5
MQ!GWP=NW+PM;=$N.0"TAH#Y03V =<Q0132B5PG"94&&I,C1,-$D:.CVBD.#H
M;Q^KQ(NRY-A[\KT97WCV_=>W';K06=+L0_<O"F[]*Y; 4D2+8?VNY\HLO6F/
MO(J7_M8<?B@W6 #Q9?7$>NHQ-QAS'BED0D(-%A)1^,@(IQ9Q$:\#9!F;?Q20
MHBN$Z#X1HR+,T K/M!0$*\N $4BJA1O=(8TF(B:A9DGCK/;=@?*B2Z!$#B);
MLZL+M'M1HMTI$4TQC:U1E)@(2-8:B;2,(A.R&(E(L8;F:JT0K5.8XLT!L.[0
MC(5(:TFH3 BF"EM&XU"&S(#LL0SSQ@R9G4'RLDN0A&O1K,2MEX^!6T@C90VF
MUH(84(Q;$BN#56)DS'A3X[Y6N-4E(%DS!]M>"?'K?BEVS?@FE$#:8&(9XVX>
MK8SBT(0Q(A0Q#MK/5GPK<KR<4@"ZCVN>,@>5!UV706BR!M]6X'-ZQ*.P2FNX
MMA@EU(E/BE%,*641,Y*&#1-,UB+>"2%*]LI"O/*JX;Y#$U8E:4(B(R)F#>@6
M/(H$J&J*Q39&&!N%&AKO/AZ+BW:0I#YDXIR9A9/T8*QK N(L^\^H:3:8#  +
MQ7!H](N'Y2X\]<))S31G2L*_B+K\$]"6C$@B'2E%4-0?0$=\+SR\*5-&ZO$K
M'\*M4I)W3J]T3ROP\X^IR[TNIGJ4^3SSXKZ%UD:AU!&Q0JLP2D 1Q-RZ"1]6
M)'',;!BNXYAS2N\&9/ME2LUJXLKRQ.!6?QWD+C"WY(A;-@UWB-@=SSIOE8>1
M=)Z'\;@NBE:9&<E*9L:I6XS4R.<QH=<J(LQ6(L)GC4*L5<B6G4W(=HV7R[7<
M'@ZG>5!#Q;6>KO^<@JA C<5E>TB5F;*]JV"ICRSA&L!/6(0CYWFQ$LE86AZ'
M+%$HQ(W%+ FJ:B/@K[^]*/-@:R^8]1YW@ !YF8FQF4X&*G\[N'>AD2YUR6A/
M91*^*--P#Y37?XW@^9-LH&!#&T%,P8RF3!@!?('&<2*4<F)<*")" 'G#T.A^
M@1BQYN*(!EO1)7%.:W#QN-X9"A??OTZSCR;[.E +N58:64R4U$@GEBJ$61)&
M&(<AC[6QQC9JG1T!^6\?S-"ES[D6#0^UN%K^XJ'^2Z'*WHD!@!I,.WC<BU1D
M^IW]P^?YI5G^\FY@[*OOH&R[4KEWUL(>L]N1?@]['^B.2\%BOI%NW$GF4_D_
MOJ+ 5;<V]C#U]/%*J+NW<&Q_C6?ZVZOO$S/2^7+[4C<)R1(121P"01 FPD0:
MBWA$D%U3A]49(32T-G4AZ]R,GOT^N8-U^\#J2H_3(6S,I2+.RRX6V]=L2MKW
MT*EE#-8K8S\6L/V4+D&NWL4A8D0:3B,>8RH9E9(9'%E&PHA*CAI=XYVA]"X9
MXE%S!]2MZ81)M#Z9<'L6:PTKW0WN@*[K)U055F1F6-15%'E+M4LK_N0-9SCT
MX0 $^:!X_RPS:;GDH_P1[)@Q&#)E?E.58K1P<9'QGP<N?V!@!QY3X)4N!)4?
M.161M<HP8ITWN#MMC+QRWN^Y:S+OD+K25K+37M4+YLRNO:J#E]/[*4@/5S1=
M^OX&KI4E" -K,E=4[?E(<(*N**Q5Y@9;R=PX3),_3&G'B4?3:MC#$8'5*F&#
MM6^-TFCA' &"5:9J[IL)^,3]A<#^<JT^7#>K3=NB]<UPNN;O;AY]8A,E(@XB
MD!M$A:0<[!1A$\DXEJZV>UUEVWKG(NB2 U#=%Y?0H:*U_\X;2_HXXC*.0\L3
MIJG3H[@-0\U-*%5(5-)@1)S?QE=\]I&*-)-)DH2QH#CDPE?C1Q$.(R((1_W;
M-%K386S[%S7-9SQC\54 Q)7D5';KP/75R(&R?<D.D%FQI^!V5XFQV("FO'?I
MHGG-JK?@ZN_WD89Y&XZYR*\7?ZR9Z[N+7[<]YVV56\96<LO.24R=HCW[>39F
MQVL;LW?6DKV?S=@/:L/^V W8MS=.[]!L:)6&R=JG89Y84RNJ3YOY^[Q76)%B
MKN:B0XQ&KA0)UNU\3GJ'-F!_E)?F[\6#.^VBBOV]R;Q8K\MSK(V-8F-BJVC$
MB+ F1BY<+"(4$ZV.*,];3FL);U"#CVQ6L7X5C(LMNXJ!W-P/KDOH#48@"H=#
MM^;<_>9[<SE16HG$FV &M<IA,18#%[@/7$=75[WHJW'7Q**[K2OIV=B7IUI^
M$BR<VKEWKRP83&7O>>3=JX77G&LL$.]+P/Z%O >+%*CZH.];*J7BV$;$ M\P
MKK<);3+XEEI*=< \4%L?>[.+O:)QQWJ!?WBG)1"XGC$$/9VUY'-.Z<"X\=ZK
MVG0I26?U.Z<X#RFM$(E&-L0)A?\RL#U9PA@6L;#"-&:<5>>!'OD\V.;C\/6A
M^T==%Y<[@^)*-P  D#8N[=$HY\O''(Q,$H>1=>Y\V]R4N7/(M<Y)VSGG9P>D
MGBMW&[ ;'==6;)7DPU:2?,[)5FP/K%;)0*Q]FY8^*<K.D3E*@Z^I[\129ETZ
M5N$]G-O[5-8I\NW@[].!]M O?C C5=>/L3)6<J0Y-X:"1B9D'".34& 7$9%A
M#_5C=-/$4><=G8;S'9=N+;?EHJ7M:EN0HD>M[ZE<%&PM-0BIM?IPX;\RW;7&
MB=:>HL^']0';D?=<-/58F+.EJL\-7&[^#NI\L8:F.]>^L.BZZX/H\*U+%7*1
MR#0K%^W2NTO>.&N<4_L%=$U3Y9O>3M;UQ5VZH3YJ="=TK#D)YTGG']QA+:3S
M\I RPKEDKKXM$I$&!&4)? :KC1_3X[ZF7<W67I[DAG/&5M$2J/:JWC5.3)9!
MZ)*RRACTPNEN<J<6K8SNQ-<.LO[]&]:[QO\:IZ/Y2=6C P3!V21A:"RE-E),
MA$)C+I&2V,!);3VD@[/_]S&IPX:FMIMR_YW[V>%[<W>A29U['_^@UI+0_*"<
M0V A_TM0)"*L:$BICC6C&(&8)#%EPJ)P[=3>1REVV2N_NVS<->L@YKEXU6[X
M@$2O>@E,'<*S,H0Z?Y*81)PB9F1"<1)Q$TL=)4A;21AA#0;)6@/Q8#B_^?/U
M&DC[E". ]BSEZ$30P0E7D8JY)0A3QA.&#=)Q9"+@%S(2C1TB%XR.;G8[2K<'
MP.;B=\Z45TSA?)TM[!F%-QM*'!QXM0VT0- ^TNRASNE=ONY5T1S?.3]!HP!R
M-O>^DB:PIO!O!2"U4C68]\6;;- 2"_5E11X/@'$)[9356K>/>8<.-<C4]-ZQ
M-&7R7XZJP;=*2.<K">F/W7OCF##BK?+5>9&O/O%.8&6&P]('Z4G"?1Z[SB_5
MYR( \\?']Z_?@J+[J1 4+7.N%D-(]9,IQF8O!XMJ!%:/N+B_?YMD"U&8ZHK?
M)GHYDL0:L[V*LYGH?9X2>,8%[*-:]B0=-[LVG9FQQ]/%=)*N>7H3_JZ91+T1
M.]_8A627G\5SY_-P]N \;)(!\_EBBN]<OJ&<%O@XJDE35R^ZJ._\+)^[#,?B
M,7G1KVQK4\5J @V(8>$F@2Q;*O!8]=S=(5TZZ/)#5P<@;WY+?N^* )O> GO^
M63\OG&B^;UMF/,H/+)R$WWVYYS4O6&QCN@R<X.>B+:EOVRD"=>=R5!T\QR(+
MOHKAU/@5^'3/V5?.3@0YT'!)\>WJYF>WS>YY?E7VN&S@\?#Z8KC)4HOA09K5
MVM0-8?^.09BO?C2*DPO2E*+!I7FD\Y$]M4XENVNVY0.-&XXS= FGJ0.]<>&\
M=9;K:GIM>?;%$WVJ!]S[4%>;BSZO:59\D@9@TO3*]?VH[@ 69E3K2.4!<N4G
MN^R\6__>F@:_#NZ9"]KXY<['S^AR3,Q2=]'B/\L'-?- ;F1SGH'^ZP('K?YR
M@LI+AF.)K%;IOORLYEGS5LF]G%S$\AI\[5 LXWZ*Y?5^@E)@SQK%+TJ?S-0$
M%G"68\B;!O'B+Q&+:;6B@3$76H$3/5>E+"]E:E9NH-(]GOLG#A9U%*"A/!TZ
M7RR PQLT3D-QF;NE7!\5NP6>.2YCW=ZF6JQ)]",-?)W&-/LZ\+VXO01X:'IE
M[NBN2![,W/+=H4R*CN%E1J$3\:Z'*R %/ $ ;R;YU>K69Z,VW((^IZEV J\F
ME%O+3#\=J9B>5A>?TW$Z6C 8"X'R93 J*]J*"1X+\K0L%,G*WNEEW[%\9I1?
MS7^K=ER<N]MSE5KI1.WJ]N?2MI"PGJF!=N6G)%1[]VOVWRPK75>UL_<?[XMJ
M>W<H8+Q?5<>V$]B<I-XN@!U8)VG_Y6>KP@:^4MC0:_E)+Y)P#>9U* E)/R7A
M0C'YDKAS,@ DI6<.LPGA7EH5&8$+7]<B>HX/>Y$XZ_U?TYN="Q6$FK-RYA'.
MH$@(!#/9I:[;HJ6X ;.@;EAMNG.5)7KN76<\ON!/3U5AB7BSJWCI8AMS+R*=
MU/KY]KF?'5E<Y*-\U8WY]-XQ])_1\RW&4\7S:^I&HS'BN?*@G%(8W+LAB "P
M>>!O(] &#3;:)HMS\65.6OV,GU>FZ_Q$/=<'U+BJK#:]W&=]+E"JIUVY2WY^
M43RM&/C0&CB%T%UX?.%$+0L3YC!9W?X*D,IJ!:>?N*65*I:SJ N-*B\FG?@:
MT#4!:=LB\O?SK""CTRP ':*$T)@E0F :D9@Q0JGR?=& I5<=TWN?!?!\]>
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M'S&7:M=U]=7$Z4G"2:LU[LA]=K!=<,0Y1Y+$-**N@9C C#.CN%2,HS ^M1K
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M1'5L^4%=!%LFP1X_+>H'KX4\:)[:B5Q [R9W)NN?$7?:%D(=-EO?K]G.8QN
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MG0)R[>,>J7/0Y/!8X>,D/J EIHX+RX<RK#<T7X5[COCN]*%JBT"LM]OVL1B
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M8* ),\I=ZY-1U:FYCL"N@MHOPYG.KJ&M\U#YE_GN$/>^VRE04#J;<N&;!&1
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M^X+577ADRZ^RXI7^.Q^L.0U(FV*RBR&0W_Y5IOK!D\/=Y'X(?_P_4$L#!!0
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MP)YKO)YK46_459UE? MG\_)VU]U90L@HX=VN\N0X:$EUE4XFV;*AWUVO>"&
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MO?PE.1E\ZHNI2;C$74WY8)S0Q.#M^9"A24>GQ\/WIZ,WO_23X^&;X>EQLD-
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MZZ"8THR9D0.%12[HZEZ.A=FU,*LC\=5L>9)ELL:@I&2V%=QZ+*G/U^P?#XU
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M_\MWHPNFWX#GQ.]^&)SBP$UCT#5,!49]_'%HIC<XNE1/6 +C^#X,SB]_L49
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MU*0Y_%_+>-,2]8]R\KGN6]A^Q>,FU$3HGDDYE1^9UUQDMO(F1 *QQ0>4.D6
M@0@.BNAD>%*K92DH3%A?5Z*)N-*\"4_2I<\ILA.].8;.(I66-_ZLK-Y&SZ&<
MUI?(']I20(_9BHI3<1:+]%MD.%M@^)Y(+7NQ?0HW548G=<+[?5.4SQ8'Z>[C
MTX]FJ[O=1JPSCYPM"N!2(2"8]4,A]@&()&V7=$&UQ&T>K,\M=$M>E+MH!CK'
M_P:4UY5E0QI=<*?M(&/80P=J."="Q0..8_ N+7TQCCJJX'P$-#$V2^K5@;\P
M?"96!E>E73;E]SD:1,MW2U2:"8Y<U%&A Y9W,0;-)RQ_8T2/1U5@'UQQ$C$&
M]/&HDD^4_Z\5VI%OPZ 4W DYI:GT(J9L"\H*D6,W*H4Z_!KQY[JRM[!^<_%F
MAEGX';=HMPQ%^\+ 00@:(!IZ:#.1M1Q=..&!,K7\Q+!NF)HSZFI1QB$DT($2
MW*&8"DNN#O1BYXTU!*'9")[X^VIZQ3(U@0$$)X<>&>-YF$^Y/0)GP,.>YEPV
MBA+G_7R&B.X>.S4<J!VQ$)0$&B#LH,5(8\A*0K!'W>+WQ]3NL-$DIV6Q:V/3
M]08?8#Y%Q+KB03%DQ6J! <#&+^_1!ATJJP4AZ=]D8J]P_@ "378U@.26D65:
M4T#X+>\ 6!,]*"2RBN&.#-'&_;(HSY";64$W*@E<$A@^7U-N0V'M*91"2?DU
MM;IO/=- H I_9]>4M/XP8X.!L51";@=%R5%T1]6,L #AICO;:)@.U>:;G<:W
MTSS[9J=Y>%S+RZ^*:WF?UY-L/A>LN \V#>BW']ORUE8C.8%[ @_QF[):+;P0
M%R^,E"(V7P^3MV<_#\]/A\?):XJ[38[.3B\NSS_"%Q]/CX<<NSOBR-7SX\'I
MT9#C:#'&\V3PZ<+$EOZOC^>CB^,1!X7"\Y_>C8[>^7&I@W-XY>QH<#DT=P3T
MZ?:E!,.>OO4'VN?(7PI7I=#ARS,,+CT?7ER<_$)0\CCBX>GEA0DS?C^"O^&I
M#\/SB[/3P8D_-GQZ='$)+[B)0&L_C\X^7MB@W3ZAFW\:C'X>4E/XT)N/)R?#
MBTOHG%[^@*&LEY=,.*!$G^.),=87(UXIJ/D"8V$'ES HF,'/P]./PP1F=GH&
M;Y^?00/PH)L_# P>&6';.)&=B9H9#.%B>/[S"*@/](:7CS#\&9<%^GP_.#W%
MA?IX^>[L?/3_\HC>#RXN@&X?+X:7\#Z,S]Y3\,:;$9/E^.U[[ XG?3[D93XU
M,<.OS\\^OGUW223GG7#Q;L!;!H9U=/+Q D-]<:2O1Z<4\?SQPQD'1.-:C8!P
MO%J_;8_0!T$\>(U<R@\(\Z*))(Y1@6VR@P;MJZ)R*C^SOE=#3 467O-*@[:
MX#"ARYGO7V?-8'=VW9&&I TD'@R40W\*:QY26<*\%N0X#\G420C7DJKD"E33
M,/H61KR?+!D5PL2RW*)=$NN)92;."ZX?A-?Q9+(@_Z\?D21@8M^7;=4N:D'V
M"GJT:B";R)&F#7#%RYFN$!T0= !*<&*DSLQ5@4 AR8&7Q6S>Z612K>)H*SZT
MBD5?QPPK0YDV"EQ,727=A@#PYF7YV8# A!A7C0(QBZ.LM<TP\3*=O]Z<_JV*
M=.+]XRYX.N[I''3D&^AF"BOK:\[L6^QPB:JT8#Q?J0OZ]<"T'/H!1SI9S9#U
MYYR[AH,XI\(-??:=B!) 5DL)51(&H>R@$N%CQF[;H+_]9GC;6K5&Z;VLU:C)
M*)M@$^5ZS@2 T#4S;QB;YJ'[2*<):S.22T9:EK&W_;8U4N!0,+6!<QY=K- B
MF\'XNV\,9X*0M$\T-K.VAW72VB@0YIZ(A5N8\'D).U,+5INAU)*^G^N85CK3
MYK8@4X-Q9B#C]LI(V/0O/19S11D#L#^.1UVUNR#>D\A7&)D.$OP\S1?,F#Y1
MT4/_D+<2T9PT>3RZ( 'N@J2DT?L/)R,0BSX-SL\'IR!]DBS7$FDO/HXN!] D
MYDBYQH7-HI &XN(Q-//AX_F',Y1GO6PX^YQ+OP)ISZW@A\$OF!7V_[7WK<UM
M)-?9WU.5_S!196.P"M*2$B6M=KVN DEPA5@B99+R>M]4*C4 !N1X 0PR Y""
M?_W;Y]9]NJ<'%U)<:6,X*9LB@9F^][D\YWG()J3RM^.WG8N?V+PBRXR-RI/N
M!WB5^; UQ8RI=M*[BE6)<1F9L4)-N]^C86_&PM7LF<_#(.BJ,/M"&<I8>9P;
M36.F_K4'/8?O]<[::N31^3!M,^8^%:M!-Z$Y?E>5<<Q]AMHV^+/Y/(ZY:S+/
M)PT(6/;G'\V3CHRW 39N&ZO8SD]/R38_^8A&;AN&#3Y[>=4A&Q:Z?'1!M8;&
MI#86_T]@3]-OPO&Q_["3>/(1#5_X<VS<VL8MZN(<\BC!)WF9[<(@01CDY2X,
M\N5IHSHAG\QIYJ/G>LQ6C1)4J143QJ1BV<_G3BO&FAT,I@1#J8\T"0ZJR\:#
MNQ8]+P"#[(/4"@J#B9Y= \E>7LT6H'<#DSZX:2L8BYMPXW)H1 :A:FM\L([*
M-*:/8YM"ES(Z;9 1A4KK,@-P'W2,J'T<$V0]1[B6LB?1@G@>11#:F\!_9,?:
M#6D4E1CDDI$(>>02D?D\S$ ^@] 1#0$7^S4, (IE63%;O_M"!:G8'\6P6&+.
MFA(IR,4 !@I8Y<S-S2TT)DV.0'KA^.DO!1D,QN90,)E(Z6/\1TG1M,'G-?T0
M")3U3Q_57/GIH3OM&'!-60D#Y&VPJT((2L#[6L&K$-CN+M,@W&6>2S-0KU.I
M?'3AIWDF@N%4%"DX;/<T1Y*F!5GLRQGA04D2TWS4DLX"R!-+@-!6%LKB=HQM
M3>=8O(;7LEY<C(?Y1-."\=)/!0*489RI)_\ <HZX;;BFP&PF2!36!M=L$YT4
MM2D8CZ3*?'FXH)2B2,./9,"Q' AF@.%EMA?V)&UZ@QR.$())YU37A(<ANI9F
M?XWP%QASHOU%H2:F=Q<.(/5MPGJ0YK17^0KA+46BQ=)%LQDHGA?,WZJ:WKP"
MK(6([!'VU7 SR[D4>4YM]4+"&FMX,1H1CIS%=N2369I;MBNZB]SJ\GHO,D/3
MH!!'E0L7EA-E91.)M'4 Q%<TWC5B$[/2253(/=DL(R7YZP_,XV+GWS8>4+%8
MB7.HS@I0%?<1!E?DD@J%2&UH/&A<=8.Z[C4T <H-F^]B:&XJ03D%+DD9!B!*
M/AH7$\+EM."1F;.\3GW.84U[NJ3>&>;#:]WQ-;?L65KH[S'GJ;<94T%L LUL
M77&ZOVO:.1UX67/\4^Z8>.D3M?C5HW;N/[?IG.K6)2H0ICX%>'+N(IBZHS\'
M 9206A+B\P$V3>$WA> 8, )*SV@N#' BACA+69<YJHBH0K/-)0I,F*#;AGO@
M'GJ+O]4$_OFA9LXY%%':<?_6#?I%-J8QN,EG>C;/"DILK(BX2IB283=%J4Z9
MOF6TTTD8@L[ PM!DG(#T1$91,4-M@SQ,P\S<-(-\!OX.<F*CS0E/F)H;U7RX
MS6I/D(G ^[:4RL1BP,1/<:HE52EGI>;<$N187E$,$\O%S9F;Z=9CY+I*@6;5
MU6C;(HB.L,PY&"]2?K)]JWZ3P_/=-A1JX4WW-DLQ3/I]XL$ PHMOD,Y8 8M2
M53?\-6MJL, 7K#CCWE>X-LQLI;,;QNJ3PZF3"%RR2$29I;/"!\PXAI=20?6,
M6*W7)HRGY^#*HK<)0.$KH:+^6', #<2M44H)9BHAEP1O=YHJX&[3(]03U .T
MIT<8(A'"7/?%VA7,=[E++*ISV!SJ1)3/B0,5>X_X(6!&LN&!2H%T.I \#V/%
M86<.YGQH&.N]%H^GL\(/EE?21F,C+ :9OR,+!)>7I(W"RLKF"1&M#6=1V,-.
MH155+,)7C6G,2D.>,&;X!(T%W[\4Z9:A:J++W4E[&D'<PDN %2L$"'<.HTCZ
MA4I/Q"],496(CS4M8F_RQ:EBO""<,W%:!8AZY5B0JK!?409KC<NV'50-',4=
M5 \NU9_#9_UH@2?_)M_8X>": L"O=@'@!U^([Q\.. >0M'<)=AQV.H:*P!(?
MS'/+*=-VI3_F]T0H@^=_R1)+0,5/X8C4DO4#LCDEC@'14H&^8=D?JO8M2K"$
M15.E114</HFR"[+:L Y37= K]MK$S6\>6U2Y924G46:R:CY.<S#\+^=(@#XQ
MIUX;JDWF$,@PEQ(P;FHU=OJ L3$7Y92P[+.Y8T1OQ^M(TN$0KC>G0&C-T3X)
M+.*C.8[#'Q:/)#3T7._I@B3Y56'VH5-3'B%<*T@M U'Q<=!=6TW!TVVI8"TI
M$%:44V!?5,^(H .5X6I5-< U P0@.+<N+L@/4H"H4?HIF>*94H7WL>"HJAJV
M"?L:5,[)<&/)0EE,\P&5&(VSV0W^RZP#3ZN/)ZVMA;ZPER)K(_7QMO4\.'DE
MZ\A1P=57C^.@0'G+%\Q X0)1RN^!I_:7D9UA>@ #*'M ;BPKKJ,  ( <LEV:
MVF=R4T*I*OPX]V)%'_Q9'F;5H,S[L$3[!</IW9O<.$6DL?!]VT[-HWH09P\]
M,'L8,31+%)OMQ26 D:RFJ04AZ<4X+0420ZMM9HPK=C#5/_7G63C4W$-098E"
MO<P'=DWUG?P\M47I#]J7L;6>GA?15/2IR:-INW*EF.(TKM;[M@*.I*/ESHR%
M>S"9TNA6I=3U8@9]6TQS>R+J#_>7X:TPK3(:MRGO?/LF.+U2%'JE:PMJSQ9C
MLD4U$1-$B:L?B%;-'-Q4C %-(=,D*1?CC&AX%-&ETH+OY]=8GT.,H$29+0P\
M"*,KS49W>4('T2)U6CH+<V\91>LDV:+.B/X22,.&9A"&*1JAHHLNY^6C;IKS
M>\:6F;FS"HM[I$M>Z+Q>PN-B&6AN2%5LM.('<6LDYQ->&WAJ/>KX?-@&RU2/
M2Q3C'"Z)(.UN$9EXB#IU5;Z?A@OQ7N- 3QHU]M# +P;VFXI4/2XA*3&$*NM+
M\^$4+QS*JMQ06W _3$-")]_="U"+BNN%F9DDF&D34(T$$M0?[BX$2"*.I>GO
M,B#JPYWE +3@TWF07V&?DSTW-;^@K#X!%#01Y*.NC[\\&*9!6M\^T.T*CY$A
M2*LLG%I7C4]$9Q%5=,^>LA2TNB,D7>57S09LNG#"PAYCX#@&1:1ECMO"'&U%
M4^*8T>]N<F-K]U'GXF+KN<"3#*DW= BE1C$%)9P9)@V8S-/C&17P!P(XQ7SR
M"9 TMCTQ)U]I[O,!UPF"<H.F&:WQ&N\%C(T-T5TX=$/>D@A125NDF[6L%:@X
MM]TT6Z5Y6U5LH>D$*\%$S*=T0MK:5$YAX:;BAT5YIG$!5YFBF(YE%\$J<JHE
MBFH*&J;+EG41 6>--*.9,\B;)6#(&K-$>;=%/I3#:5@L^@0Q,'-$4S@L,B52
MP6-;H%?EE3E;/QO &R6?VL(M<4,R#L#H4Y1E/B1  )YC.1"_MM[\L5K,9/W?
M@HMJCCW9 [CTY\7LAV1L%N%3"5\<2# &(S;5!!!6I=D5\YL_?FN>]J>]9#0N
MJ)(CUJ#?X,UF:97IP*P+FR)1*J6U2A95Z[J80HD"Q"4UWZACZF!T 0\E6M[T
MJEU@+@C,O=X%YAY\S5P^Z,I70@4_VR#U?RY*$-S,T[&^>];*M/2N #^.:BRV
M"/2H>_5SMWN6-$FX6"0\RZE *:!?]4<0;_B6^=@O K4_.6_K>>;*REA%9>?#
MAW>]8\1X8W$EUF(F5Q>]SCOX\W]^O/A%ZA\[C.7&LD@27S$-1J&5[@459$HQ
M(Z#]>PC %CB\WV@1E$$]%/J<U%B:AET X+]WB2_XB"(N -^F#_S< 3&9LS,S
M&% R0)6E7AFK>9SN^T7W'<'#W_8^>&!R?ZC;2;2JX",)P9P?'W_\T#D[_B6$
M]]>+'4X_7F"'<*(O<0;;VTQ  -Z'>H/>>RAH8!T=-=HM&CKS"EN@>M*Y.K_X
M1?=??V,/1]&\XOW[SL4OP41ZLYP<F;%$*9VS\[.G'SJ_8 &KZ3P6#N#@_<(S
M)W^\Z/[E8^^".A6I%;B/[,RVF_WJGK"7$V9F!<H7G[,TS)!R7I3\&D^/PLNP
M6?GK;,BQ'^,1C#FX'DLN6K,/\KIXV4JLSPIJX&-\Z0LWSX\HF\9C^_%AOM.Z
MTU':26L$8+H0+$?+N[GV*Z]4RGH@WY@[DYBEC6O\&F306(Z9'#7$)@*@J"@+
M2KR%Z6!>!/#36OJVI_T&IYB8YN/*VIND18+-"2'$UHD <U:Q[E <WI?R&RU*
M1Y;2''9XU*7PUP<GN]!\/44[\XJ,O[CBCS(Y*PNQ);V$5,Q&L<;U0PM?BC(4
M_VEXOY,B%5FZ\+G\X43[U&X%,J6-:&5&?)N>*QOP2([-JVA]5.3-,[U76U1_
MF8(4\E\IY/M $0?1SKA(!A"GQO-(#@WS&5'KX5Z?2J% J$,4UT4"PBOS$E^M
MCPL9=/P<B@>NI\)B:,.TBKYRA A0LO:_S<;9+=*(CXL^@#WJ,X=/XFXR+1#@
MG;(A=9H@-I7=W)[DDP/\H@=2%).JZ165:02D%NE#HR@@PNGU+AS0&B&YWI<)
MA"/OHY/%-LUS@:K$(9RSQ!]I1:K%_K7QQ2%8I[]B/?P60XVR5-[8,(NV,WH
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M1\0L<WV.4U[:@GM21G"F)IB5F'%82+P6 KO&*7<91Y>[:.6W>[&J$AH9"$O
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M2!3[0H,SN%.*187,M/+T6&M\-25[YHW06O?F>4,_+PUT>E5T,MUKY9_VVI[
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MB9WBH XG9&+AS7P,AZELZKE- Q$NR,9R_91F!,*W!@2'KMLV74EYGX-8,IF
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MAQ7_GIJ#!P\*M%\071>)A@9U+>>C$1@B'7R#AA.MD*!W V.UZ-N0FQLNL#Z
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ME2K2:&O'2W6\0?;+Z9-6A,#5?M%K]X7WQ4 G0B>/'<H+TQI5P_48<=;:08;
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M"V)EP!7\6RB%.%038Q+-C\W+0U^^VU^@:%#01==F*DV"I P%NKGQ]2<.IKA
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M'":D4!<@C>7(N^RY(6C"+?@1J+G4_47CX==F 2QUS9![,4XD0<$;8A>KJ_Y
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M=<,G@9I10SUNUMA@QGC@L8%(ID($K'_W\.#\RNX[7:?'>I<=IWOIL$N@O_/
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M@'@CB.Z3<^5/0M*/3'K<HDXHO);9$Y,SXG"7%<*H*,?B48VIXX")<Y?>Z/P
MJ%T2F\YP@6MFL7&?R3QFATJ>]&>$NC;I,V_*F OVZW2:_R4/K7:S2[J-5K/=
M:)(&F*[9(;>MNU:O>4T>ZIU>N]GI?FP]Y D%B@Z=4LF GS''M#6ATG.95",^
M(>_6U=8M< %Q:R?4E/_Q!_PSSW&:V29PTZZ3WL=FI_[0_$^OU>B25KM1C'%C
M"3D1TIAP;2YZ#+)TTE3%5)=='94;A5XE,_1TG'5($X,GB!/_LD%:L7V(P=C^
M+>GB/CE]T7 [*I:6Q3#Q5B^:13?]34+'T)8W]B'O!D*.F71FY+,KIB[&#I0Y
M\=F9N:0U'ONN@#B2=,*@T%JFSA;?Q\/-&U$HM!!;E+M!T-NZZ-Y1:8T@!DV
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MNLH<MQ/*JE:!G:5QF)B@ @7JQ+W(E7-S&WOVNG0/]T0WD]]4 JNFQU$['>O
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MQ5\UK*YXU? ?L?:_^ .<F[R?M\4W>F[Z\N#NOM$S*LIB.]PZ/\ O2-4;P;?
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M3SN51[F1QOWB(ED*]6WY'U!+ P04    " #O,W16FE@ T=X"  #W!@  %P
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MN+BK0BGMF3QOMK?P>V6KK,/?W&C6?[O1GM(HI6X]_1-D0O&[^PE02P,$%
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M0GM(CW12#LV R$T Z/!4(E,9CR05G"?;S 9Z?-S.9D%4$4O#%QR%IW>;MX4
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MC?^!50)WF2WKWA<"<O"V6V!7B6*U%AZ.+].BV.RBDJ9,S!&']$9"@%,L[._
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MEV.S>1Y <?6YD.H ZDT$*+O_-MOQFT_]+=;DF&I$F(:\3=FKW^^V'HMUW,1
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MMD]7]E2G;O]BZVN/2K'?\C&=^[=]3+<RH[PZ.\:/$.U%\:7E_P%02P,$%
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M$71^V#>"&[:LKY=7)T?ZFTMS47U8^C]02P,$%     @ [S-T5GT940_/!
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M3\L$3H\K7TG3/6R1%O-<1O8/6P&.#MW0)P>MPZ#IDU;EI,CDS86@:_1)Z7J
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MABO>2OP)O/BUG0(^G# O" G,_<T8%RCXUW&"A^Q_0/8_G&W<BH\GG,X:-T!
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MHA+"P"DBVU8-*P;ST7Q\&'O%[@6E-[X7+C8:<.H)FC@8W7&**V[J5.J]$L)
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MOS+_/YT ^X&]H$ORU_\#4$L#!!0    ( .\S=%87LD673AH  %J  0 5
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MO)3(RZBM^[#WFC[GZ2:-\>S1(X99VNRXD VPP^\/990G$4I,IK1C2>:SW1[
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MFFD=+$Y,[6T[BW'203>W'#'_-"ELLRMIJ'V.-#;_1V];7.-S#X;=^52,\Z/
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M=C ;BA@U>$\&R>T)!O"28" S2IT P.1;PG#<$D#LB!O>];>["L7;J "K9P3
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M-WM9%!P49ED)QX12-DC[F^AOYHA0N)LFXM9926D"1%!8QHV8.43D6L#0;>"
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M7M*3ONL>NF$11S_+,IU;K&PK+)L)9DT]CVY"VSCXJ!LQ8;Z2Z=]>)-OY1KL
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M8./K:2X+ FGNTUWUXQU$D^B&M(YV+%9Y0I+^X$4\R.,4%#?@.<H^1R4NX_J
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M 234-%8%AI"[[TB >U"4*(W+5JPO6+GB_N$+(V!4@G8?-<JEG0$P5+15A86
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M^O)"@H::,60Z?,C,!S;KX<T9=NH)'I3':F,+<X\=J;H]SI^/T">*5A BUR-
M.QE\L\KPL#HM,T_<"72W@*%I#1T>_%X5G%P=F :H/4WR,;R]I*@F9J<-LLFW
M'UINAV_P*'75AHK;0/:DZ-!N^^DEWEIA#$PY8IGUW!P@I*2MQ15:S]C>=I:O
MHA3](\HJ\!E$)%4F 29YV.E+#I\*@%[)*'R=OU1E<0]BF,=IEK9)A/$$3S(4
MGD5%6MRDT1/^4K[7N0O'3J+3.EJS.*HC>.P>HVW5(.](HJZGZ&Z@,X;%]2M
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MP'7R=$$00FJL5BZJ"T']-MQL]>PXR'1:R%=$:,A#)J(1&S>.W3G<[6"^OW?
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M@OZ$5R]J9P(227KN\VD#^AF 1$UG&X^H#;C[7F?<PCR.BNT:W46H;/]8Q7C
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MII)Y/W\*UNFI2=<,&"K5Z_$.X"$$-O%FDB4B N;8F;OE&'7)$NALJ4AMU>%
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M:AK".D%<MA7\]4%-'L&M8"W(^*WS)M9D0Z"X[_;]*V/7K@I]1V]=33/>!(%
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M1*!2LL1%N1MG*0'D%D),@*$PSHS0! .'@/"NXI-0KL]C(L3C;#BTGAA@+NV
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MO]ED1$)RO:@;Z_IU",SZ?"$2TAX7;S X:)^EV GVN*HET:$4+0]F*85#.0[
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M>G%[3N]CZ(]+JW=8>B<;?J+JJ-(/)>0YIYB;13@UBITMPO%=.UJ$DWU/+ZF
MS07@2_)M\#7Y$IOX$.VNHV?>G4 @V3H$RV6GAD^9=7#H^[D,?0E^8/=YRR(@
MP)\T>BGU5\W'Z%!]3@],O2\5T8YJ^IZB!75_:M!+ VK+U'JT5-MWC3-[4Z\0
M3Y,@1J=:*S0QH05J(5?+O3: B29/K2',UV1IG,0%R49/>'N1% 02].* \F":
MWZ*_IQG;W_$AVF/^]C<S[3:RZVE/YZ"./ZN%KY%K!4NU+:Y*I3=,"[5JU8';
M"\0TJRUA5#>4?6&&,$NM]/V(\3J&!C% OPV!!85WSVU3>4<[Z6NJ@\%8TUT@
M&/J:*0@(W!H& *XU!?GIKM N_8,X!,H 33#.R[H9S/>A$2#7^;Z]\#S-</R0
MG*;'I,B>^5/;$I&:N5R1J13E&+6_?4;L1,H\D=JJ>A+*Y+6L[U+X;ST@!$>Z
MAWRA-4>0L#=RDC@PP<.R!<1M] 6MC\5CFM$]]Z\#'J(AD2$^/ V AC?(QW1"
M[>J^#-7+ 11APM7OH1*>2 >Y>0=35R"',IX #*SH<SI=E4<[-EO^X?8#BIB
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M0\!/T_WA2,HG%E V](_N#@I*L?/[>_* WK/;>Q+6RIY5.JB#U40@@L*;@0]
M1#1N>5",MK^9Q%JSYJ/S4EX0++C,11_)8 GUC2[0>I\>D]#>!G@9G-:K<X,B
MM==].2R+7$?Q]@,65C@C@6&ETA&P%9\:D^XJAZ$+4,CH*]7,#VFX..XM'NFX
MOZ^ .XTLEP,#2TX 8#_1C,SK]_YR<"8R?;1 Y.'+!8(JBFH@P7]4(Q$7QT_"
MMWT$,N/8UI6QA^[6JFZ$@UR")?$#!/I ;W4=/=/7%MF4&>FJ8[+-Z639[K@E
M@Y68#&**1YR1)[56,"3@=#&?!_P>$3*A%1>086C/%79<!,>Q!R/8#$-D^W2!
M3H]9YO]NJ\DX48=,3:#X#ISEE2C*UV4$8L/P.1*SQ8*!87=E(M\1B X\U1!?
MC1'U)0__DM]=P("!!I<$7*L.H6(_9@J<F.*D%SE#O@C*#H144=000_YB:8:C
M')_A\K\7R16MCNCI#V72*R^4'8=6':TVTL*TIK,)XL?-M@$-SPK"@2VMV".4
MT!M?RX<H8D^]$TX+).FD'ARQ$6)@0$ZXS_D0:C/\Z_BT!,XR.3 I]'TM_P,=
MA96@;770^JO!K#B%. 1M. FFG'%.'B[IOR_CZ"[>Q<7XXEE-/7&2$>G9)S'?
MD^7MFEI.-6DLL;6JQ2AY=^R/72T0'&D54)'35MV+2M[R32B8*_,;!G77FPU=
M]LNOHV<Z!T#W@F\VV9$4155K8ZPN%76,"$D-,V*=X1"W+L;WYLW0"P!@PZM:
M$AU*4?:J8E0*(UPN-@:7S+6@)PT2ND!010R(/7GX@+?(&RL<UK(Z37!#"7&E
MVU#END.5R@CJ6/G&%G!A/!]=@BF;SX[X-OV(=W0.XCK*0*E6HB/,K%P=ZR&#
MX\5MF2QVJ!<.1'96Y %%7%8^(FDQ"Z\NEN%!2F!%=ZGHRE&7LU/H+PPNLD%V
MNQ8&G![E*,AG1GL*;J:<.B[FFP\=.S68;1H:J69!VV7]X/*I$ 3J621!-X'F
MCSJZ@*FCD:=9<.=ZEI/C;CKD5'.;'[\&*.K-94["8C"E6#-3<QH=XB+:B=^[
MT514SV&.%-U-8@Y<S3"MH7!M.)?),[8Z?226<,ZV@]6"U:H9&Y[MVE' +\&1
M5X4BV/2FI'_!\YL#&\ )3J[G68'L,M\HW-I#L23_-)"NU$)Z46,V-,-3DW4X
MAY.J:!YM5Q8TINF5FO*Q"U_333')\^5FJ[*F=X,:4VBM&M_LPITO5"-&75VJ
MNA)49?*, ,I-L>]Y8>MZ,"3S:Q&QJN%1FZ0"G@-WB6F]H9-E4 >3H:XS?(CB
M[1F^QUF&M]5[BNMDRYH/W'ZH8T28MV!&K,<"B-M9YN8T&J(7)L"&5Y5DLX#,
MQF+E^SIA;VW4 J T9.C"014\(/;D<03>(F_<<)@R=9K@AA;B1%K3I7Z5G[*E
M3*YA;J:<GR7@'#L?38+)O#=%NOG'8[K;XBPOK]G[F.YV[]/L<Y1ME2D7I"W,
MM0IMZX%$ZL_MRC/$M5[@4%L4!8RNYA_JRT _46U4J0<W/P3#F318@#M?%22D
MAN31 = &/U%AB^_C)"[P9?R$MQ=)06 8TPTQ+%Z=?ZE.\?TU3;>?X]UN%!;,
MU)NXH*L^.3#H.72PZ&'4 'E\,#!) L2;0Y9N<)XC\IMA0LU'5CYL\1/>I8=]
M .\[&T(KM=/=PUB@9ZD?#$Q:X0'I%JMH,^>V8<XJYUKM#=-#K6)5)*/O&UU4
M*WL_'-,/]H75\KS@]U8AEW=0B\Z8XCYM,MG@Z63Z]NPYR$,\^W+^C356]8>^
MZ<+OFA3T>PZQWA/L0YECPWX_6XS"7-N:G;QL>[DZ-ZH-E]7*9_RO,JXRH45G
M8G]-#Q,,8E[?!"#":*B#$&^Q[(FT@U9QM\3+:53@AS2+_\5.]/L-[^]P-@IO
M4(4FXJD5)I-#Y<+NR!WH34X@D)%5*Y<'<RD&& "I:1<-B:32[7,+YLD_V[CW
M@HD$N&RR=-_6T*0[MH#OL>(J==B Z(- [IL2=ID0_ZI[G(:R8GS[OA^IB4["
MO:U"B1&B<XN[54<VW6!Z:!X&ZKY6/\8'L_].W&]<6'-_:!&N<_[..8$M'\B^
MQ&38B?NOVN>B$^1@PM6/H1*>"'VY>9LL 'F2$0)@8%5^Z)<+P.Y-33JASQ"Y
M7I<L$ _^>%,V1W[L(D"RQQB!I!6Z<&U;GTM1^U*S1:P=$%7DG3KBB?+7YY&$
MJS1FB,2V6^18FYT!^)D FR7%#958H%(FO ,9[6)*,%EC!U2>)G%XR: Y%^@Z
M>F8UU=D1_Q>.LO?QTQ#1INJ2@D:N[J#$D3ET7?0 ?.N604J3*P*"_QX"+PU@
MHRB4H%VI+IUDEE3%E+H5(3-]?4^JD8ETY]K0Y/S QDS$[WEU5,:9M<)&'!C;
M7=T^X@Q']/.7$1+XT#*("\*>-@L./7,F$8+3'E^8MUR &K; "> [16OGY2"J
MOFC>$7I>T/Z[P]5:)",'HD80M?*UTT1:!?O@R0NHG&\_IQ,*YXZV0=W,M&<L
MFXD_7U5SZ]I6T5Q;I#7SGUX&\X>(,2R9!]UH7C$30Z8%<].&4/C]$2?X<[2[
MQ=D>P&>.M(2_/6D'?.W8GZ6N'?O3)>70PNK\2X$3=CD]:=&>WA2<'^_8.='A
M49/7^0HJ"GI(3;V.HHIJ(Q_ND>:TFN3XF@@S6858B2(J^QHAIU';F6,NH'J-
M-NGJGMY4R]E_ %>01/6A@@.Z]5TX.)0$[%27>1PCJ]O@([L  PJFB7M)S;6^
MKHIN/$^SP$XKT!O5%'R?TV&WK)9 65WQ>A&G$=ZG0FX<Y-U@[L1E<<%W-QUN
M)Y(2HXY_M?SK1>/)?&@\":?D$"X.$2Y,65SMJ)LLKC+U.1=7B2%OBZNM;VN+
MJ[5).E'T[^%Q%@0;T\7505=.6%PEEHP75YM6A,ST#_A+<?L9[Y[P;R0\/0[W
M\$\UH\G\L9F9(L#0L8]((&B#C8C -4TCP]N7$1F$\#*($+*N-HL40XLF$8/?
MJI C!YL/)SZG[,#JZ9LL)97Z<RXF48_>EI,ZSJTM*#4V:3SX\\N(!V/LF"XJ
M#;MSPK(2-66\L-2V(SC._YYLXYQ='$4/^**GIZSW]%\ZO%?9@'!?;,,E_T5>
M'9Q..:4=QN% :I?-"OR"+O:'([W?*0[BY(-I0(,&"DB_:P0+D3EPP)"WQQ<#
MYMF8I6J!$_ #-V9U3:#2!BJ-?.TL,=F7Y90F7M?Y6#//<+[)X@-]??^67O'#
M3:%2R?%K9&-)>R\##6W;+WQE;H"O G&U^V\"+5!'"'UB8N&\"23L:_Z;0+).
M$;X(-%02O C$MQU<2?I;5!PS\E_61ITWF8$6(.6HR(++5,SW.=MP5.K>. E+
MK*ZJ9_38__1^F(?#N4-A"M2@J5;=]QIYEF\,G&5E;0DGQ5[&";XH\)X_J:V4
MEJ;:CK23=-O8=Y]RAZ[TTV[?@C3U4E'$9(/,OV,0*',PMZ<@>;A15.?B@8]0
M\G&GA8(C<S2U)'F7J^4@UW+\S+([6>Q7-[&*+%6'*@1S+(\N-A2)4M%QZN3(
M,:!*B$*?\P'3Z0R,Q*<E5,IF67J)XZL"K<;4B3W4!K0-FK=,8KC,:+BZ.-NB
MHG9R28MH9[R*,'9L8QVQVBA-6X8.U<?AT52*#H/UP^G+AB:KA;.^B.WEW6N;
MKUL;O6']=4!WXFO3IMCUEF5(FT[3O! .5 3/F[PQ>CZ9@P.+=D?Z?.-R3O%T
M5O2X[^'$6WWW6CA5F:CW4N //B3!0+2/=JX=KZ@6H5F$8GOH=5"_]"V#(-NM
M0'8,HM5MFH'@4HI'  ZY^+-4"G2L6<SU ZO@7JS??%H@^LE+Z3YA,E7UG^]T
MJ%A!DTH-@XKUE3"N72=ITF!%2ZPI2YF! !JR%J7\]058EZTI26QZHP&]H/!B
M?\C2)\P*5>Y5(0#)+AU$DC8HP;?M8)):Y4O)#XGVJA% 70GTJ90)H9Y4]/:0
M*^INX?"%KS3BC,RV6TC9K0CD?B;@:?E5 4I6;4Q&E,^*1'3S!O]A-^#:NV^C
M;\YZM:%SRP9'(;Q%/&[/#+$,N%&C+S<";!#W:!0D:U[=GV9X&Q>",D$LTL"5
M)S(9M&.C=J$KM"\'L$!M53YAYPJP9\'$:4G_I?#?>PCML70?X")K7F#>[JI[
M'\797Z/=$:^W?S^6]]D, 0\2KJ&O$)Y* JEYJW2 >)(20VU@=?I(M#&]P?Z>
MB* G*D,)\SG*LB@IT"Z8W8\P#*0F/34@DE2O1RF AU#(=1;GFUV:'[/1&C=(
M6$*NKK #<K7F[8\^(>YT&38PL.K(++HDVS9RX1&+T_\*8O%[24VL5D]%K*$'
MYU"S-RH%N9J&L^4 :%0,,3ET]HJ!)AJD6D2:KZ&JM&&B(:R6$BBFVQOR@MRX
M+J"$'LWI-Q@ZM[+AC)_U8 %F(&"\#=*'$S* \7G;OJM[TK!#FD>[7[/T>+A(
MJMO;:7/3I(B3(]Y6*S3BO>N6S(VY;&C.'LN-&N"(_U/: HP,YBYZ,8-\G.3W
M.".C='0\I DB!@/: V,+KOP8,QDRPNAC9%D0ER:TTG/$6B?;FR+=_(-.S)/!
MT?D_CW'QK(Y,(+5Q!%*HV8LT4D<N1XT0Q\#PH3:UNKQ8O[NXO+B].+]!ZP]G
MZ.;VZO3_^9]7EV?G'V_^@,[_U^\7M_\53'B 888?!L#]*:2[U(* U@"O,T+6
MQ>@3Y-067OLC4A0E6U0*A9C,G*)5/4AU E?_ U=N$S73C&9Z<<Y1^UM180ZG
MT+*W<77 R;PC_0>$F7S8M#2AHWG2T&'?+$EBUN1@(RE(D\'KA)IAQ-?%FO\(
M+P[FXKAMDR$NH[%>X!7$V&#PK8 R*$ *\&D[[+F*<)K!;!RW7E)GJD.0I#?]
M!Y;38Y9)-X(,!,9AIA&P!\S*I,N@TW<!1&I7J0I!F_*C($/1L.OX(.;\V$(H
M5[("1/<L.4&#BV@U,*\/A>&2</7HY<) '=+ . @FP*DG7P6"PH#G8H)U8-K1
M(@W?BQ[P^S.FI^,H^$MH^ ?.,DFZ0$4'Q402U[(?=B2XWI\ZXL/X4<. [J/)
MF&^-V47YR*X<UP/QSE;F#?O4-XHYW9&J?\8A4ENI/C:'VG[06,0/; GOAOSV
M._8&2WG,\_ISE&WQ]C:]*AYQ=AUEG$E- ]T&SUJZDP&OX<TN(_0=RRFC:V_5
MJJ"\T5F@*(2#U8T E%KHUR%%-<ST.:SMWPO)TRC)KZ-G^JJP8,@IEJ@)RY.8
M2LNQ3?OKV$(?4IX)M%;L 3V9BS[QS!Y)GZ7@'WG A+%P#^\B6VZ 8&_ *;9O
M@()E#8/J42B#SDEX$ T[C0#A:^"9)@_T@M@S?#<.<.-'363K/IJ,Y-:8@U@V
M,BZ'[T"\O(!]1_HLC/3/ZY-4_5L.$=I*]:$YU+;<M1:CT]BP3K^R>)0\O&&]
M2S]\6=TJC#RP?O46:_+\E.V#?,#)YODLVD</.*=G'K+-W*/P Y)N(I)">C*2
MI?:M#H! KN1H5UL@@YQ_'N,MO14.;4N!^O14WUR ]7MJU#E#PD@5^QP"^/#/
MJACGEZ*+)Y2"7"[U!:W2J&O:'8,X7N#D&2FOZ'/4$PCI7@EU'PMY(^H-&66Z
M.F*VC"T'013N)6A2(1%!+%U]QC7KE!C@"\_$BEQ"!'''F;PK93Q0W6S&E9?B
MW_=]9OWL=9X7\9ZD_JO[:_(@)DVC O("3*[#+\-$.G:+,;X7AR69U*%&82:Q
MLZJ?;=&F5BC(.#3WO5M#"Q3B&DW=9])*C:\NJ==D_GP0\C></> L7V]($9['
M=#J<[N8L7Q\K_]F^VYJ+3DB=9J3Z@4V-3.2PF5N;I)[4 AG+)QA>E;H+U)%F
MFZ([QM M?1,TVC!+?J/!1 "F-N'0CQ=F]KH!9$J+O$24.$GIK8@7U37I5Y\3
MTOS'^'"-"0N3@@Q7WSU?1YR5+ /-.G;H:$X-&'!?5J.$MEMI:-"TMFH$T*&1
M0'?/Z)1 \.B;_0:X22=WZ(#G<",]<NOZ]L'H#VF28;I?E]0P[>EAZR_QL%)7
M"U8_FDQP(CW%IFVR4>E%1CZ%\JK[''4.=OM$13P/9@%=G.IV1I])8ITN<526
MP^')6;J/X@3$E+ZHE"NUJ!.VE,;=\Z7G1Y\Q'74Q9TJA(%DSZ&XE;\;= F%.
MJ:7F3M>Z%_;@XC3*'Z^S]"G>XNV[Y]]SO+U(WL=)E&QH2\E XZE\W9"_)=W<
M0,TT P-3^:?MTOK.!.,F2 EK9G1%E=#]+OV<(\H<=%\KH*C1\+Q!?@+,4EL=
M/^"]MJU>-#!LB1?D6]NX8>[>/NR7Y5TY#/NU*AU;?4^U49S\@!H#J+40S"DE
M/@DAV(#B@Q&>-K,(&MM<O-0V%I8N)8KR-,E5=!,D.*ZLO_*J[=H@+HB,L7"P
MH>'@6$8 E#;W:+5Y,$C6R^"C9KNB8T$DY]@ D%OH>58$NTYO$K?VX+O\AE]1
MM\X/X+"RTD7RA'.3K"11E&<EKJ(;3G-<S965Q*X-:"TR-F9U7$N&SFH9?-2L
M5G0LB-0<&P!2"SW/BF#764GBUAY\U8.L1K$SR/IZT*R7HZS".:P<Q1GF&4\T
M&D\PSCB],E>.$KNV,Z,RR%&'#L=YLXA!,EL&(:.Y$AN3AF93(S-/$GJ:'+0[
M*6@^&?CUH'GRC)\YG,/*4YQDJK<P!C"@/;9RO3 F<3G7PIBZ"7:*5OG"&&_H
M%>;"& 1F1E6K\<*8Q)99$3O'PIC"K8<QFH6%,:55DS%;Z MCLQ!B\G#.'B/"
M2IN<>5*]M DPH+U0YCIM2ES.E3;53;"S B%/F[QUB##3)@1F1@L2QFE38LML
M?6*.M*EPZV'!S4+:5%I5I<W&P M*F[,08O)*G3U&^$N;%\DFW?/>Q.4^:Y-=
M]]ET-K?67,Q0CJPK:#B09P3S_Q8LOT-2P.\XPG<K-H#N4-]VSVJ%8$CU,3:O
MU;?+E]NYXN@%[-UQS)G<O2<6,^S8LE;/GI0]6WZ(OJ<?_X#619'%=\>B/CFA
M?-GJI?7\R=2>/PD@VZR?HGA'^^$V/4WW^S3I7BKT+LKCC2P?P;5Y&0NB;9,:
M:G]NLQ[8/YAA0(M-<$71@'D;IM6[[RT@&FK 2T14O3Z7,%EM2,AU:!OFQ[K-
MH9B);\M 7W*33:U*^Z=41EWM!6+Z7R/L(;6+<]Q[&W-]7F\V]%17,AHDP\2$
M_+EA)Y+3HQY.'PDL<7Z1=&7B9!,?=I*Y2VL6FVQIP>+DJ#*Y#0ZF.VVU21Z
M['A9?<3T6 '4"I+X$R7;*-N&- %D#[RI,_0,X]1DX_W89:FM83#.8FZWUIX9
MZ$9J "[1?C_0\V[9>4JE+;J9NB/96/M&23UXO01.AE=C7&5EX[EMYQU.:L66
MNJZ V'(7W]3>K1Z08:$AAA$-:']R* OA+%8[R(5%,#T @4.7VBPP:$';]Y*B
MU:7@S'%K]B9&K4MK)YA/;D$(T6O8&!<1K.]C1<STXU/7$$HS91B[#.6,=7N8
MMA#/N+"R$],N>0>[6VIG8+'M.MW%F^?R_T6'[9JJJR.70-U=H.(ZG'.&1M8
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M+$CG0=X@[%GVU(N33K[%BPNLHO4;FS9MA%![ZT(V6A%,L-19:K+FQR0LAK,
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MYNR^1\&Q+'^%8J2PHI\A^F$P[P9QNR:%_*##UR6Z<OTW)<86?&*4^^+/^-$
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MK0CH<^\_BXSNTVMO%!T?.#=G5(Q-/$9/0]-8U10CDU"KS< D$#:TKP#.H5L
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MG1DENB4D9/I8ML7GOJ4QO2>!,J&::U\'$#?+G#8+,Y0DR_ER*/<[11(P5S3
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M7_3/N:XX:NKGN%@F6;'-\3W^67XBJO_4&O@D?-(1C\OGQ1MP-$TTQHDUF[L
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MGC<)/B)4Q__Y?W\Y_OCY%Y3C#?F@1%3!EH]R5MB/N/YUM"RI2GI:Y!5'.9%
MKZI_SM+RB=AL1)4^Q804IV@5O<Z]L*2)P,P8)X-L.RE?:ZXZXOW"'"8.T=/C
M ' 2@5"B\6X>J@D1I3PP: D"#S!L.88<:@6 \8:>,@>$G=0(D[K. P.8(-P
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M/F7TV,(++DK,\A;K\ZOE3M'<!U#ML)@Y(V1PJ,A(SNXTD87Z:0T"Z'2IE5Y
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MV$'GY&U 1Q <.$('-#"H=\VNU]5R,8E"!G 3$]0OQ2-P@?98'OC@+U0A1+.
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M>5<TNU(/>$]/* !"US%"LH3N9!$2>W9#3. I*O#I8XXQC0T,0B6Y (V8223
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MKG0CP'?#&J,G0,,"39VKLJ:NUY5^HKV(5SC'J]-BU[;+M-N.@;':"Z@_K8T
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M5'F\E^.,W9JMK;O]9C L"*(G +%C>&VH#336MM -!>:3#IAU??2; ;,@7)\
MS* ;K3?1*[OM[WI-_K5\PLL_;_*LK/23?SWFT?-5%J4#JS#DJC^1-I>+K6HJ
M 8^KS/0*3=1$S"">&AW(VE2RZ+--+8S8:R.-_I.*0PF1-_>VKBF@,OO>[MNK
MIH#65HT43H1CF*C)4"$$@DFTU%!3D#;T:,> :@Y$60X>HH( R2-&'0,C TV@
M09&A7@BLGM##ZQV/^O7^ZR\DQK^Y8?[SX*$I"'<\0M-+F'.?L8+ .2;*5ENB
M]@6?%@4NBZ]XN$5IPC((<.0L$ 8GT^ MM-%0JK0TI0P6U(Q#F;JH'ALGHG1%
M**JJA_$S"6-><#V&L*!F@_/R]0AM$IH(0&GIY>(;9K>_-FQL[6G%"HP4OQVA
M(EN7/Z(<'S'ZK'S".9GLE.1-V&64$6LA85HFVQ6-W%G[HNI%YEZ$,L+IT/)U
M<<2W>AGWR.35JJ8P#-A824>;LTD<=X[9L=J>!XPW100$"CB@V$>EQDO@HZ/4
M&7@DY&GK,=.(A_C9)-D657W9T0V_53F[RC=WO.,!@U41$X&"U7'W5E<-Z)4;
M)DJ=P?KQ#7E)P4ZN%^"![NHVI:^OU]45/^SPR$66,XV=JSH&$#9EJS^+/IN+
M:>EJ 0_+#14++<Q(#@O/8U$%<QJJLV"Y=[E-S)(LV*BPCE/"2$-H>I#H)803
M)<;@RAPZOF^PNA):HS53.16J86)J4XT@>#[NE^.O+QZ[:\',>+KWY;T!K IB
M<*]@=8S%350!'J,U50L"6?X-$CO(-F%ZUP6_ =0*@G&OJ 5=HOQ:#9'7^4V4
ME_4?'7TWA!?G9$)5%VQATRU!V98O.'_$^<!0O,EORJG RW<Z8P_='/AB+)Y:
M*#ZB[T4ABPC[A_<VC:3^V@"[ :TYQ/_,)* RC]*B.E1>/6\BQ5_9!G9>-C_\
MUO5GOZ.Z^40T6N$UNQDT*KK2BB9;,&JN;V;7LD7K-7D9THIE]IC&_V1L;'&7
MJ.L<&D,/V[)B6&6D!92AV"8ERX"A:@D_CC<5V[*:=M;[F(2BDY^(_G;3>8>_
M(?9AV.WF3/@FR]F;DV]&F;H?8Z>T2DHVTSMS+01OKB:;PKH'A12@5>WJ+/AY
MB>"\)E#A'E]-F]9?TK(_M>\B-LR\0_-W1_81:J4WM8$N6R<Z3"AM*@-52MY-
MWP6B>VW[KF6)?+0)LFJ1K_9-ZP'HMLHN0*KK9+;&/4RP[<=+[\;M L&]-F[0
MR>9E2EH2)5]P5&QSECUQO;Z-'Y_(?[X5]0; :;JZ)N%D1 /0*T)(#;,.CX?K
M\S#2FF5[5VE.*TENRN$7^4':(UYX A#/F0#68HG3:N72GV^OOS73+99GTTA%
M"17;FW\%OF< !/@,'G6#Y2\WP;M5,8@&SFR70-L4, WQ:9%T4Z,VP"\# Z2"
MV(V"](KMG26VTA 3AZX"J9X3H)V)=D?",337O13W%D!NL<"TQJ>YG>S,S7J\
M>S<S$82"-3/0>/Q;2O.6+C"MQ+_<TKF!6=$#:_[Z\UKPN_@88W7@<;5M"X2.
MQ$[@[OKM;5I=HX%9\%M)T#EP.W,D; ^\# (+?>]@+*KU!Y:-F-P&8&)8:]6P
MZ"=Q:L6'*".Z[* ^[)H),X%>$'I.C'K'\-)*)V! ::T?%OLG+?:-/?Z;Q+X@
M'IP8^Z Q']%&EWB)MNOUH$SKZWUV_M>6_'=@028LS:VZ6BQ.%Z9I: "/WPR4
MBN\_TY51G4ELJ7GUJ5\9L!A+O7;YH<I/8272V.(EF0$&N)1I!*G,LLL'EYEI
M<.\N+=-6-06&@:ZA-=#FC%YZ?+ 'W6&M?O:M*_H#AJ+H)E@?6 2]K/T6%YA\
MO*?3=/49O^ D8T>9+^EQ^24N"L71&4ON^B,9<[O8H*$R\"'%3K_0/FW$#2KZ
M-*?>5S03D ECH\AJ)ZY97JQR&W/<'KNLDBG'9W&>HA=,1B<4)25M)3WNA=9;
M>@X>;0O,Q%,Q] 0\7F?D7S_RN"PQ=1SK?HXA.XG?2<F<UW?8XCQS!U_?H1@*
M:GV+50,F-C>8T<]2,:2A'=-B+AV+ZO!1D-><1Z$=_YD!Y()A<T*4.ZXW6&@T
M6FU0'8*VU ^)=K9!]6%3$0B'DC<';<&2PH30=CS4;Z$1L$:[I79(8'_L ?OV
M_XJ>-__/YUX(M#L,-XR$WAS<!44#)H0[:"D!>N-359/^%C]WMW$'>[;-_(RT
M<[#!.S I.('U!X80Z.(>W/6#3[' FB3T(D :.M<H/=*KQ7ZEERG]1@N,Y7B0
MY)%3]@_9^@.;/S$WDSV4$3N21CCQSV5UQ1T]FRO* 'F=>?8$B/W,"_KZ/LM=
M=NO&H)HYOZ'"3,[@VN+91(_K2_]^O6HL\W9HF:.LQG;!DX:^MXW=$JD?F-AW
M&Y0#*W C=)PHPC0"M-H;7),\&^/)[@;.T?@H'/.8%79'SP_1NQ6J@16X%<)N
MD4?%$[T5X3,[RG__A&_8TC,MQ_%0E/0R^N$&N39#LSVNP>"TL:B4#[BMJ*U+
MO*FH*:*JM<=NN/F\NY2I(F:1[O>&_K]FWE/4!T1FUV6#_40E\VXW45>/?_P!
MYE?I*W0$X4FGX./X9C *PO]SH- 3# 7@T -UY;>8?BHR<+#%@>LU;0+]?[IK
M_A(EM(8)'5 P41\O25!$G[&,K!6]&V=%_E%D2;RB\=)=2?Z753VIQ%PDV8]"
M,"!,K;;=.)]*K=L"\C2MA-P[G+;%DM7J*1NRZ*MCI0JI[V/_TU%936Q;I=7S
M*IVZTHNZBM%.,[JN)3+EP8S>DUMO-J=E#!?FIVE"9T5_TG?>%\<%&!M-W>P@
MO-<)SWO1W-BCJH(9'KBO?.>^V/.H1#AEV4959#=S5/<F7))P:_R 79+W^BH7
M+/D;]Q91]&JI*#@E=5.$G- GQ 6*)JF'(M=M=/1;)HI3YR3FG_NNTOSQ090U
M46%/=N9; Q3JX]T"(=*CW%+%$T+?7\D1A5(HT(M+B=1,@ZVU($L9>(*P0240
M8 Q[J/ AT>:YFH=",Q22Q54Z^-YZYK,P$^+8H-0&,(Z!0ZYE3G5\QM5_+U/^
MOA4OY#+F;$,N TXWD]56Y"'D,M4ML5DS4=5M,S43^G55L_W67>_/,:NB3?ZJ
M5_[K4RJ2:CNSAUGF>,O<@# T;6TA'=,V5#PAW*'"+&.E4$!G85:#\L\MR@F2
M13E, 01:DX%8&&AY1[%SH&6D#330,M8,A642:%T+7._L,=5DD!7&5-XA"QM3
M<2_#(1_S_"?.EW%!'MSD^&*;KO"J/A ]"JX<1$CO\5.)@+]/2JX1/NZR;X3A
M15,:,CL)\=7J%=LGI'8EN0V0/L6UX/I>F ]K)KNIGS%[*.:"3ODU5?IHT;FQ
M2BY-<7N53E/F,!>?%P?J:0<W%.F%@M0>SCOV<+.SAT;&&S8'HWL'/=N#E_L(
MU6I!L\==&@%N%_Q;"_7'B3=L%T8W&WJV"]#HDB:<7Z?W.'^.TWJ#ET6T XM2
MD76.6_+)7$^%\*1Z.1HI420]P"'D&QYCI.=W=Y3TYVJ"]E#5>L$_-W$^>$3I
M SB=* 5 9M!9X^,3/([>H0BQ2%_(@CO+)]-@A:GCW5&?^SZ4&,D!($5RWLT:
M*@!GTT2BP4^<R1190:9S.FSG4VJR \"+Y&26-5[ Q]GJ8-<%^3CQ"TXQ^6-]
M$[TNG_#RSYL\*ZNJI^1?CWGT?)5%PS)R+B)&Y1!,1,"<Z-37Z+'D@7$C- YM
M&LH4ES58[P2QF>G-#4H(5P COS7LQN<O[6 @.G"I+XUSQ-*T*7/8 71% 7/M
MX!8PKAIP,0!^+0'M1*!:!J)"WK ]*.L 3&@08&?]S=1Z.MUOW@APP^C$:(*A
MX TC7WGV?D+D3["_E^5W.(]Q<;J[J)3^_CE^B5<X76EM\&G*D.[P*67 +]$J
M5$ZTQZ?7"L,U6AVAO!1WX:IMEJ-*(CJE*[;_?WM?_-PVCJSYKZ"VZFXR5<[<
MQ?/>5;VZ*E4Y3K+/=TGLYS@[-S4_T2)D<8<B-"1EQ_O7'QH *9(B2(!HD+2E
M_6''D=#=$/EUXT,#:!07&HLO0Z7U9=7"=X-R=Y[7 EDF>=X>=3V)7J/.3.)=
M/I<$#<WC^U7GHF#5C?;W@LLO"R5'[196ZX+>_<++RJ"!7=2BQ$Z]P/>/SL5!
MDV'FJ/W#:GW0NW^@\E-13):&&:Q,MO;HCGV.DB6+DYL@_;/A;\.$U4.T%7:)
M"7:VT#GH(//:(#! F[Q>23)$V%<F-P2(6CY*6<]&,PY:I9. 4O@W2/,?/7UI
MU8$H9,[8J$<#.SUE&!AB?EQ7P"&,P^PB.@&GB(40 2FB)8P-L!\9NC5D<#1X
M.](_>X.HO&^8>428<Z;WE>;[N-Z,Y!#B:7CD&-<0NM$PCDKAO@6Q//MY'W!3
M:9!D@4AK9I_$K5-?HB3:[#;?=O=B:\ M$)4X^Q1ERR#^G0;IEX"W@F*C[>7=
M/&E7#QY=NTOH0.X,WMCIJ6/:J./%W@*TDE(MJ>H](U(S4:I)H9LHY;R!4$]
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M4X_@?>^<6;R? TK<*E%EP!TJ?8$)+9?0:6$0C&2F0'Q-X'MQ]H=<K]1N]E>
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M>-^:_UTT+ZM0W)?:B^(3 -](J"J*%\]B>^Y0 #)W5#2VRMLIVN]Z']*!D?T
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MSE,5#G]$P]BB&_B:-3=,X]^KA*)EM8V!4$3E%U]W<)_K]>KB*4C#[!\T@R*
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M1<PM.E$O7];HMWOUYZ_KU6LO4+9Z]:AC%-<>[;*;=9!N@B7=Y3#3RZZ29>N
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M3&QLQ\6=@8WEN=/,O-K[,OVL2]^O<?R7S[8N6BC'R?]LT/.B_&\.$ZN/&<?
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M>DI]&NUIK%[C2-%#UX$IJ6U/GS!"2J>)=KJ;*1$2[F5$]8KC(+Z]V!\0P4S
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M1X\%?3:Z4W"AOJYDR_XH6DQ\OU/O"V4V#[^1AM:([///W3I]805S%:/'S"#
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M4N_D[D2-[JJ<[L1@6VOM#3DXZ3V=5C^7<1DEZ?1"+9=P39]E<\*!X;5;1D!
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M[D_=<J7KF*CW"S <BF1FQP%:G/CL&XF=,-",J'8S.:*)CBT-<4$#ER,=Z3>
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MST- L;]<-J5P&#0!&0]RJ<81%"+D,[F%>WC:R\K&0@3O<\]H#C][C@6)/"I
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M Q)/$3 \GN$^ECJ2] )OB(!CGZF(IO.8LFG\APE$.$64<%A:SH3G0IG\AR$
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M*%=VAS$+0WUCH\*!XM=(1P?QFHT:H)]WU3AZP*H_M[ZGPGS\6D+%P.> Z@B
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M8D>!,TTM'<[831OBS%7(P6<K]3*G3Y&U_^@U>&^FF]N']3#CW$'\@O)GE(^
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MZU+L<<E"@B)06&VD\?EW0 HQNL6JJW;R[-C'<]9*7EZ;QUW[2>.DP/UQ(TO
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MC]^P)L9'I16AO2M]M(AFZ^<P0-[5;7G9X2%^29W39ZHTR^M@N"E_W"AFZ.B
M.&YJ#S2/"ES.*USE!D#N%]? <5/\J&',T-#A4-Q4KI] )A00)Z\FUKA?7 ?$
M=?'C!O%40P<$<5VYY22@?H%XL29;>$,D,WDHPGG$XV@Q+=+588 ]:H&S^X\'
M@[@FJC6!?,38=0)7DV B?A8Z#Q#Z-5NU3EFTNGR+">EB0_^E E<9#PAV^3R.
M"\A 7<V(:GX+-,*;CB.B-]!X7CD4[46'\\$FB_/5>-?,W\,W@^,:V:&:&FM+
M+D87T5Q=FN;%<X[J&RJGR*U!Y%;SJG>GI8=M%*,V C5]I\^U[=7=Y>@$%QB\
MKBXNX.'@4Y93&C8)8.CL5)IWU[.);8B>ZP=PZ#S?2WN>-_]=9%E%EIST'U2,
MSH",8&.!4W<3U(23AT"SIQD9 HUJ\NT:\D/4YF!_BN+?'_,H*XB41/#BJBJK
M''U)LF13;3H!FV=0BRNR&(U2Z@EHHWQYV2)FXMZ]D&";NV.U2D(JK/(T4:%'
MP19S 0S/H^ZA:;'<^/HY#3N-]FT"U1+KMZ1\2;+';Y@JR\I@8G,T&4ICCJ>!
M!%&UG\-HW.2CF.I;H6AD@>UA-.%I82#U>)Z&$DS=7@^F7J/UPUJ\&TXTQ,'R
M:)JP-!],/9:GL012ML]#J==F@\>9_!E)-H:.C;%R&AP\=?HY&DRB<CQ_FVQ>
M;XO,+6:]=F<3OO$)Q5V.8X16!<TA7JN$Y\V5T>VR]G'I/(0A5"JIGY7/Q^8,
MYGMRA/,HC?^TN]QMOT77V98JNBCN"4_2[R\7Z!6E>$M5O<A6OV*\^I:DJ<,#
MOZX)I#771.CL.2$VI$F?06\GIIBFS>-XH+7*M@!5+.O"TER3CEX3RUH2X+RB
M23,OW^*T6A%L=:*,M*-;?)?"5K6X,W.EAP-LK**AD5-J19/D5K7V<&_D[M\3
M(D8Q>\9$+#(%_ --QK2<L,.G@#! )$+%-L6<H!Y]G^8KRI^P4WQQ;"!GX(9L
ML^:Q11,;8V5E?MCEUSU*:=#C7927[_T]BL/5#:])G 4-E'R7B%E&[F(H/L0O
M:%6E:+GFM>_L??"%/A4_]OB8\.@\/GH\7*@,UL#%6S+>9*H7E$"'5="U1BXP
M35TBD'Q(P)"P([#GUKPB^L+Y68*+.$%93*.#OJ#-$QK?7972M:T5T#F;H@0J
MQG#)AA/3E">=?02\?(M6N'R+XJ0@32U?R-9^BZHRB0M>[\.(6T7)B#W%@9*,
M$##(&,YQ].Y(FT"3C0'FCJ]9<27-\P13YI93OASRY,1H[8 -)M71H8A..\;=
M(:L_R,P\U]DK*DJZ"7TDM3"6-7R"G7-J2N!>DG/2.<\X;]_@9LX(\ ),2=D%
M+ :S7]]=-C7BG-E^/D%WG,$@<&8*%+2- ;(-Q[><>7W0P6 ZQYK&F5;',Y4R
MPD5:[68H"-,//&-)[:6EF8E53Y"YM<[I<]#+]6]13H0NEWG]MBIC(I+2M?H5
MT'DC'G,;#: 4B6A_8WV.-QN<M;44S#E(1-(UEDGB;(!#M(Q!@@T'LH O':YL
M?K[MJ.]R=%51-Z^PTR54NV *#I7O70\33ZGWN2P#WT#+;3)6L6L G7:K$"'3
M#[S\@,Z2EE8A@NJ"3(_($?\FR=!UB39 G_^$7.SI[Y%[)/-%A6A$V",>>#J4
M#LM +,2ZD;"P-_5]B0IB4A]0_IK$^_0+[>/'5ZA.-<$X'5,MUDH++^:;<Q36
MIUA;,R#GJ; 1U"[!*_=M"79;T97!<EU?$4W?K[.BC-*TCL>\PCD?B,KE6GTK
ME L6BKJZL8-%A=I]N\K($?FN?K$OB=NVUQ&LK,QHNL7%4X*@>+ (-=24':"J
M-\*WNX*M@;\A1C\K$&GP\BE-GFNU3)S_4LJ=UU] &2S@X/+;P9:P/M\NRK66
M>K"(*':K",%B4+5<MQJ$EPL6<+JZL;0>A-=N<&UM%C!>H"TNDO(N2E:/^ PM
MMMLT0>3/&R)++=9R?97D1?D;SG]?TK:/0*E=ONT C?+!@M145W; JM$*9SFB
M>;L87)(1UJP<Z"*7-I<^=)9DM6Z6ZW,B!\.1H%RNV\7 RP4+3EW=6-K%P&LW
M2 =]"# ^5%M:#;W.TQ/@+L>O24%=G6)(0DNS@2DO?2SP5-33+""5MT'_U?IY
MH%HO25:_1<EK=PMWA$8^09>_E$$0+*:DTMJ!#:L:_0S-KN_W=?>+Z:.B^RO&
MEV];NO/:W61<Q']424ZO.MXUUY+/<3'UWQASVKER##@%"U][^K/EX#%H3SL@
M?G%P)9'KG>S>T97[>T"T.[ *:0.&(UP'M@ GK+%S=WMS^'*/DLU313A3R-.+
M#C3C]6J9TZW8!%!RTAV>1*0!PPFL 5MH$E78@2G46!IP+ '_N$#EO!W4);O*
M!<<#DDI=W(H0WA=;;NO.['Q_G(@&$.W@MAB7UF)X7K,XI;EL:%U7DW=F^01=
M4!Z#P!GB83K& +&&8!;RK</Q&/P"OPB@8CU4L*UN)B3<7<2H<X;3?__+Y\_T
M3DA/$HXU %"V^A)2.DD!4.+X]WNTK<BZG^;VRO%S'FVZF(2'%X*H8E&5+_0.
M!ZK]S7OB\9K'"J\N)8 9+V<##0(%;%=5PS$H:$"='M"LXB O,3*C4'<BH[C-
M 7<>I2E:G;U?1O'+D':$<VO\1/<UU/CYCG?;*E/"O(7*?8N\^IHEY5U.=LT[
ML<;G$@**5H=,"M^!)!=+"1I,=OIA2^ZS:S&Q?OF&<K+H0B-)VZ_%)XA]@_(0
MV30Y#]_A9T,UYK9+7J&SD"FK27NOBZ**,H&1@Q$STO>RB'W'GI*P2B"3<=:/
M>;*^*6..AZ(=$#1"BY[D0NP9KXS(?DW+^(X9'='-[=.T@G ?J:^W1$]T]W..
M-_0DK.U=(NYS[;LX>]^3=/'/WZ)\=?FV3?)H'R$]WBS;YMMMG.WQ]1W<<ZE0
M;4-MKQ%S!$9YZF.$>\S4/8Q"WI:OG89T]U?Q-NJ\*;)ZM>JO55UW"3@)++:3
M)Q66.6Y@G?1JM>3F.VQ2X44<YQ5:M?$J+G,)MY<%BD6VJAL5I;PTP@#*_=$<
MG]+%PNARLTWQ.T(M?'HO9K0/@8^/3*'TW;&IG-[9P(=T&U87>3B^!974!VER
MYD%ZZ]MA3/:D:U30.-SF1C8;5##B+O950NP[G)2$5<*2C+-'I[)M4\\)91)'
MJ1 6'*(A'"9$@<! +)Q.]T\X^G9_=P?3Y)68O+LTBMN\#7?54YK$EW]42?DN
M,10*1<=F U0T$/3H*$+/I(#J"==?O:2YKUMAI6L@&'&K;AFQ[TA3$E8)6S+.
MSN[HVEK\2($$56O \)D%.7+0Z+BH)^^1'G;C>X&>2H>[W;IZV0. 8J+=77(V
MD8N12-M"<_'D59U$EY'.04#1DV="X5X81O9</@%3%'?Y<H?MN(TVB)DL5T;&
ME*I/9C4J.WY!\>]D<U6BN+UA2H/N;G#$SCRO4&+O')*7<&;PI9V!=60>VGU>
M'6T\MYRW;XG>N(U6@XP:7,*&REPPF3,;KPE$SG*,?T_?,S6H*)9JU0@NY35T
M]&2'0PC,?P[/BC-=CS,Z R=?D5J[/,Y\5N$F<1:M&R?:D^9F9G";*B[@%XB&
M@MQP,BU+J)C+O1NCO,K<=%P#O?,W0WPB]HK;Z6:(+I2Z%&ALAX2 HI6'2>')
M(&3Y'^02"0U8S^G Y!3N ^'W:-N$,17+]2V9WSC9#F5DN]OO/#*/L0&4#0H0
M/CO?EIR[J[&M(VV1K;YFVRBA;U<C(BTCO@%&/[Z S*?W&!:JTD+Q >#K[*C.
M\@1_%<6(F2Q:1L:<-?MD'N,&*!L4+GQVX1ZS#67J<'\?E>BAK*/74!Y3W3R+
MO;20@DPDB0L&@RT%^?70)JY _V#._<VZ7\FVL[C!18&*97;Y5B;9<Y44+XUA
MIDH8 0],W^H;0.\QS%2EA:(+P#?<NR4WN,D\R4 /Z]-N(]7_Y#$F!#+ MTY]
M%H%?D) Y*:;.'\B5" Y7AA/(0M(E#_4H<:#Q?$$:7K2;R9T%6P&1!U:>X"!^
MHC_Y/00VQZGZ0KY;0-_G3.KG=&ED"<UE328BE,4)*F[0<Y1^B4HZ-!Q&80A:
M* W.T"K;>[]5H:P]5T1?[QRY1"3=9,HDL=C*I&SS63Z@DM2X?QZ'[34#TW?M
ME],[,S5"]6-U68=FA\6]7C+(N8;K>^4+5]\II1F;ZN#(^C(7&%J"LE*8,<L&
M"#FY#DSAQZPAW(6$WJ2!059YJ&JEFNH^8-9@<]3[L_JH,R?3M-Q=+L73(F2.
M18B%O3[-E-YK&"ND5$RTV_^SB4RE*E#\XS-^_6F%DD8@\L=>#O*/9LEU26HN
MWQDQI)RO_856_^O\S6UJ8\:'LCYU]TX'GZRF;'LE=H3P7JX?<%6^7*4X3U81
M,T@+1KQ/Y"8D=I?!EZ5EK"C=*'EOCV6;P$W(*G!7!V],82&$&2N5/8_Z[O"@
M;+BA5!)[B65&::0H)K?=@J+/)<A0JD?">[GNI:9A&'$A3:LU#HV3^U+[1M"9
M_Q9GT?Z7?IH+II75+-W=K5(M;3-5?9Q6!;%\5Z0*G+?/9^R6@$QAE<KL4M>#
MRC@;_[H=B/74,307BI4WR<]!E89KD,7F YL.N6$',"NK;_FI5A*NPN4S(,2B
M0^=!#B\7Z2'L;\AN.+'%<D+>QNQFC@ACQHZ?Y_Z64^[<>P)*VTW?VSM&KDX1
MR:"Q8Q)W(Q"@90P2;#0*^7P;/R.+GV^WV,:MO*2.+YI@!M#U3%H.!D:TH8%!
M)*H1*D:,?0LG?B1?BQ><KJZS&&_0%<X754EVI642[UJ^7+=",=.H&G#H=C,Z
M''P'F+E:E&"G59UOV87V@8K+]4.=I*9]D[ ]-SQ#:YPC25I?,R9=%+PF$]]1
M:44Y2L#4K=%9H+0F-B^JG.C@'F7H6Y0RYE;M\D!$,LJ'#D:92JSBD%&9LR1&
MO*7<8'?SWI?H'K]':?G.B6A1+<?<30G+^0XU716H+?W@E<P1,>W2YS'=D&.5
MW:_$^W'3#ZD5<@W]L$E^F@)UA8 /5@0,PTW5KA\: SG_-PV.X=1Q;'&YK=$[
MQ<6<XF).1ZVGHU;=9>]U]HH*0CPV)TPI8<2M4#+B$$]5E11@?)PJJ\TW;_@Y
M3@E0<!Y!\00OL#/X\@(AXDI9$<;8@M0XASO]=%A_.JP_Q&%]6*%KH1[63S8A
MG$6^E*[+EL2G.WGZYARZ\@ZRYN?C5J7GY?-F]<-OZ^4?590^XGOTBK(*U<_0
M/D3TT;*SJB"CLI@\^VO.B7&NH<S);S#:4Y("/(TJ]2TZH2_,/@77:I50141I
M*]\R^S4G@Y(*(\*I&@,&/*$,PD&EEDHTP0BM*_#$O+"C$>AJ0^5@1,#S="PR
MP['(A[HQ?#H6L7<L@LHDKT?H0_1*?BWNTB@['8WX>#1R@=9DV-=MRY.GJHY/
M(IW%?HM&3KK+:R@B=9-0N(,D;0A-\LXX+1$3[9()LXG\D(IY$UE&QI7,_@WE
M81W_\J=/_\5T2LO(F"WNDSE\KUNB:PR6;K0,Y3!NDCOS& :^+I*,R(DN@0]!
ML-E.-7DLCT$ ##=3E8"7(?BLV>KTS4%<Y&7/TI)_[:TL^<??[ZECFS55C'_O
M+-+^]X,VD6U%IU_ZS30XR-9JZ)?H+=E4[!>#F-_:QHZ^N3-&#'5B<=-'9F?/
M@ Z.4<%P#<QT,& 1^!A*V9G??J%P%0*VN!PKHFAD]UR"O"7[4#T5Z(^*"'SY
M2L]C254,BRNA:C7'I?)$,.;Z7$K'%\Y@A6Y;/*9=%]*PQ7)NY^7=@6&"#8<Q
MERT=PQQVX9I V7"=JI +>ZD:N]E#P#!<14+G$IA]5)M9N#PMQ\T[]77M77$3
ME[K8\R4H*/:#,0MZI!'NDW(@:K'L<P23\-1<XS)*VS.ZY?KQ!27Y7?2^S.YR
M]!B]G44%XY5J"[PDW0_DY9O)82=RMZ<ND&T:YGXWJMRWX!6..)>;;8K?4?XE
M*DE?9<^#[YV(]<=E!O39:[$4@UJ19<#8-E&>+8@KML&WJ!>Q5*C_^Z+<)7Y0
MA3> #PC30C[A QFN)LOH%5;L6^8.XX'X^ W;-LX]EK:,<\TR?$QK*>_PQKEN
M@V]Y0/0&K2J\ 7R,C/.1 !FNI@,9YSYD#Y\W9*X=;WL4L\BR*DK['PLR8#N-
MM&,7!G,=CF+ JW$,&/H&JK,U"-2:$'BN$PWW%K_S@.\)0FL4])&-X-]0G+O:
M'D@U?Z]*-?K+%M=*UXX15HB -(P4%M<49+PP=;K%1/J+)*U*TEQ<4%M*-8.S
MAQ?260X#A"^C/*OCE%%>-X7C )>1=1GMN61.3FGC%[2JZ"VH!8'=BFH_>44/
M**[RI"0 K//%DVZDMZ5(;VRKIKN7Z[$8K)C@>9AWY\*6F3O):&+6\K-W-@-&
M?,0!:NHRI<Q9DS^=Q VGAI(+U6487FTL\V]U!@1VT ;S6RO-Z)N[1!_03L!B
M>49)/"1<Z=P\XN9/**O*A-=N81Y*'/^^W%+AV0^ZR.BZ*8]/%P1"H'*JHT7
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M;XC#O8UMZ6TK&@79&N<R_J8#G,__-+)-.R64(<T71S]S<8ACN;N.0%1:U0=
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M(7D/79 $_!/SV7\ 4$L! A0#%     @ [S-T5AYJM))Z6 0 V(TM !0
M         ( !     &)R:&,Q,# T.38W-U\Q,&LN:'1M4$L! A0#%     @
M[S-T5MRY8$H5TP  ) D$ !@              ( !K%@$ &)R:&,Q,# T.38W
M-U]E>#$P+3$V+FAT;5!+ 0(4 Q0    ( .\S=%9["-KBT18  %.$   8
M          "  ?<K!0!B<FAC,3 P-#DV-S=?97@Q,"TR,2YH=&U02P$"% ,4
M    " #O,W16]2(!A2T-   .5@  &               @ '^0@4 8G)H8S$P
M,#0Y-C<W7V5X,3 M,C(N:'1M4$L! A0#%     @ [S-T5JO$+T^* P  -@L
M !<              ( !85 % &)R:&,Q,# T.38W-U]E>#(Q+3$N:'1M4$L!
M A0#%     @ [S-T5II8 -'> @  ]P8  !<              ( !(%0% &)R
M:&,Q,# T.38W-U]E>#(S+3$N:'1M4$L! A0#%     @ [S-T5GKG4"=I!
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M,2YH=&U02P$"% ,4    " #O,W16UAOQ6M4$  #-$   %P
M@ %[GP4 8G)H8S$P,#0Y-C<W7V5X,S(M,BYH=&U02P$"% ,4    " #O,W16
M[[Y#6+LB  "8G@$ $0              @ &%I 4 97)N82TR,#(R,3(S,2YX
M<V102P$"% ,4    " #O,W16%[)%ETX:  !:@ $ %0              @ %O
MQP4 97)N82TR,#(R,3(S,5]C86PN>&UL4$L! A0#%     @ [S-T5N,I7.8:
M;   -:T' !4              ( !\.$% &5R;F$M,C R,C$R,S%?9&5F+GAM
M;%!+ 0(4 Q0    ( .\S=%8ZJ'D/T48! &0O%  5              "  3U.
M!@!E<FYA+3(P,C(Q,C,Q7VQA8BYX;6Q02P$"% ,4    " #O,W16YJ]<HH>@
M  #XI0L %0              @ %!E0< 97)N82TR,#(R,3(S,5]P<F4N>&UL
M4$L! A0#%     @ [S-T5C/3G/QA"0  ' H   X              ( !^S4(
E &EM86=E,# P,#<N:G!G4$L%!@     2 !( P@0  (@_"     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
